Citrus Sinensis ID: 015594

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400----
Protein Sequence
MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP
Secondary Structure (PSIPRED)
cccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccEEEEEEEcccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccccccccccccccccccEEEEEEEcccccHHHHHHHcccccccHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccEEEEEEccccccccEEEEEEcccEEEEEEEEEcccccEEEEcccccccHHHHHHHcccccccccccccccccccccccccccHHHHcccHHcEEEEEEEEccccEEEEEEEEcccEEEEEEccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccccccccccccccccEEEEEEEccccccHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEEccccccccccccccccccHHHHHccccccHcHHHHHHEEHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccHcccccHHHHHHHHHHHHccccccccccccccccEEccccccc
Coil and Loop (DISEMBL)
mkeksetgggyvradqidLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHhhhlhgvqgghhphhqhlprpiytrsrsssttsasvrrqeweidpaklIIKGafargtfgtvhrgiydgQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHkldhpnvtkfigatmgtselniqtdnghigmpsNFCCVVVEychggalkSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGvarleasnphdmtgetgtlgymapevlngsaynrkcdvysfGICLWeiyccdmpypdlsfsEVTSAVVRqnlrpeiprccpsslaNVMKrcwdanpdkrpeMDEVVAMLEAIdtskgggmipvdqpqgcscfrkyrgp
Flexible Loop (DISEMBL)
mkeksetgggyvradqidlkslDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRpiytrsrsssttsasvrrqeweidpaklIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLarglsylqskkivhrdvktenmlldktrtvKIADfgvarleasnphdmtgeTGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLrpeiprccpsslanVMKRCWDANPDKRPEMDEVVAMLEAIDtskgggmipvdqpqgcscfrkyrgp
Low Complexity Region (SEG)
MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEhhhhlhgvqgghhphhqhlpRPIYtrsrsssttsasvrrQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP
Disordered region (IsUnstruct)
*********************************************************************************************WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA******TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA***********VAMLEAI**************************
Disordered Region (DISOPRED)
***************QIDL**************************************************************************WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSE*EIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS****MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA********************FRKYRG*
Disordered Region (DISEMBL)
**********YVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHH***************LPRPIY**************RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP
Disordered Region (DISPRO)
*****ETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSC*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	404	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.683	0.707	0.378	2e-54
Q55GU0	916	Probable serine/threonine	yes	no	0.680	0.300	0.320	9e-45
Q54XQ2	1125	RGS domain-containing ser	no	no	0.636	0.228	0.348	6e-42
Q05609	821	Serine/threonine-protein	no	no	0.628	0.309	0.368	5e-41
P18160	2410	Dual specificity protein	no	no	0.665	0.111	0.321	5e-41
Q54TM7	1288	Probable serine/threonine	no	no	0.638	0.200	0.342	9e-41
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.631	0.153	0.323	1e-40
Q95UN8	1161	Mitogen-activated protein	yes	no	0.648	0.225	0.330	5e-40
Q54RB7	527	Dual specificity protein	no	no	0.638	0.489	0.340	1e-39
Q54RZ7	1634	Probable serine/threonine	no	no	0.638	0.157	0.329	9e-39

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  213 bits (542), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 167/296 (56%), Gaps = 20/296 (6%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           R+EW  D ++L I   FA G    ++RGIY  + VAVK++     +H+ E   A L   F
Sbjct: 76  REEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIP--THKEETR-AKLEQQF 132

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             EVA+  +L HPN+ +FI A                  P  +C ++ EY   G L+ YL
Sbjct: 133 KSEVALLSRLFHPNIVQFIAACKK---------------PPVYC-IITEYMSQGNLRMYL 176

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            K     L+ + V++LALD++RG+ YL S+ ++HRD+K+ N+LL+    VK+ADFG + L
Sbjct: 177 NKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCL 236

Query: 271 EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 330
           E +   +  G  GT  +MAPE++    Y RK DVYSFGI LWE+    +P+  ++  +  
Sbjct: 237 E-TQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAA 295

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            AV  +N RP +P  C  +LA+++KRCW  NP KRP+   +VA+LE  D     G+
Sbjct: 296 FAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGL 351

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  181 bits (459), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 97/303 (32%), Positives = 163/303 (53%), Gaps = 28/303 (9%)

Query: 80  RSSSTTSASVRRQEW----EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE 135
            S S      ++Q++    EI  ++L I      GTFG V++G++ G  VA+K +   E+
Sbjct: 637 NSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED 696

Query: 136 SHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCC 195
            +    E       F +E+ +  +L HPN+   + A      L                C
Sbjct: 697 VNNQVLE------EFRKELTILSRLRHPNIVLLMAACTAPPNL----------------C 734

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
            + EY  GG+L   L  +++ K+  ++  +LA+ +A+G++YL    ++HRD+K+ N+LLD
Sbjct: 735 FITEYLPGGSLYDAL-HSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLD 793

Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           +   VKI DFG+++L+ S   +MT   G+  +M+PE+L G  Y  K DVY+FGI LWE+ 
Sbjct: 794 EHMNVKICDFGLSKLK-SKSTEMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELG 852

Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
             ++PY  L   ++  AV  ++LRP IP   P  L+++++ CW  +P KRP   E++ +L
Sbjct: 853 TGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLL 912

Query: 376 EAI 378
             I
Sbjct: 913 NEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54XQ2|RCKA_DICDI RGS domain-containing serine/threonine-protein kinase A OS=Dictyostelium discoideum GN=rckA PE=1 SV=1

 Score =  172 bits (435), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 99/284 (34%), Positives = 155/284 (54%), Gaps = 27/284 (9%)

Query: 95   EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
            EI  + + I    A G+ G V+ G Y G+DVA+K+L      H    E       F +EV
Sbjct: 836  EISYSDVSIHKWIASGSSGRVYNGQYKGKDVAIKVLGPEVCVHFDLNE-------FKREV 888

Query: 155  AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            A+     H N+ + +GA         Q D+ +  +         EYCH G+L SYL +++
Sbjct: 889  ALMSIFKHDNLARCLGAG--------QYDDKYFHL--------TEYCHNGSLFSYL-RDQ 931

Query: 215  RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
            R  ++F   +  AL +ARG+ YL S  I+HRD+K+ N+LL K   +KI DFG +R+  +N
Sbjct: 932  RNNISFGQRLHFALGIARGMRYLHSMSIIHRDLKSMNILLTKRLKIKIVDFGTSRV--AN 989

Query: 275  PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
             ++MT   GT  +MAPE+     Y  K DVYS+ I L+EI+     Y + +   + + V+
Sbjct: 990  KYNMTTHVGTQAWMAPEIFTSRTYTNKVDVYSYAIILFEIFTRKSAYDENANINIPNMVM 1049

Query: 335  RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +   RPE+P+   +S++N++K+CW   P  RP   ++VA LE+I
Sbjct: 1050 KGE-RPELPKDMQTSISNIIKKCWQQKPSNRPSFIKIVAYLESI 1092

Serine/threonine kinase involved in negative regulation of chemotaxis.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  169 bits (427), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 104/282 (36%), Positives = 153/282 (54%), Gaps = 28/282 (9%)

Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRA-AFTQEVAVWHK 159
           L IK     G+FGTVHR  + G DVAVK+L         E +  + R   F +EVA+  +
Sbjct: 551 LNIKEKIGAGSFGTVHRAEWHGSDVAVKIL--------MEQDFHAERVNEFLREVAIMKR 602

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKL 218
           L HPN+  F+GA      L+I                V EY   G+L   L K+  R +L
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSI----------------VTEYLSRGSLYRLLHKSGAREQL 646

Query: 219 AFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
             +  + +A D+A+G++YL ++   IVHRD+K+ N+L+DK  TVK+ DFG++RL+AS   
Sbjct: 647 DERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 706

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                 GT  +MAPEVL     N K DVYSFG+ LWE+     P+ +L+ ++V +AV  +
Sbjct: 707 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 766

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             R EIPR     +A +++ CW   P KRP    ++ +L  +
Sbjct: 767 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  169 bits (427), Expect = 5e-41,   Method: Composition-based stats.
 Identities = 98/305 (32%), Positives = 157/305 (51%), Gaps = 36/305 (11%)

Query: 91   RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
            R E+EID  +L       +G FG V RG +   DVA+K++      +R + +  S    F
Sbjct: 2105 RSEYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKII------YRDQFKTKSSLVMF 2158

Query: 151  TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
              EV +  KL HPNV +F+GA     E              +  C+V E+  GG+L+ +L
Sbjct: 2159 QNEVGILSKLRHPNVVQFLGACTAGGE--------------DHHCIVTEWMGGGSLRQFL 2204

Query: 211  IKN-RRRKLAFKVVIQLALDLARGLSYLQ--SKKIVHRDVKTENMLLD-----KTRTV-- 260
              +    +    + ++LALD+A+G++YL   +  I+HRD+ + N+LLD     K   V  
Sbjct: 2205 TDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSS 2264

Query: 261  ------KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
                  KI+DFG++RL+      MT   G + YMAPEV  G + + K DVYS+G+ L+E+
Sbjct: 2265 RQDIKCKISDFGLSRLKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFEL 2324

Query: 315  YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
               D P  D+   ++      ++ RP IP    S    ++ +CWD+NPD RP   +++  
Sbjct: 2325 LTSDEPQQDMKPMKMAHLAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVH 2384

Query: 375  LEAID 379
            L+ ++
Sbjct: 2385 LKEME 2389

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  168 bits (425), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 156/289 (53%), Gaps = 31/289 (10%)

Query: 93   EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
            EWE+  +++ I     RG +G V RG + G +VAVK+L      + +   I+ LR    +
Sbjct: 843  EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKML---FNDNVNLKLISDLR----K 895

Query: 153  EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
            EV +  KL HPN+  F+GA    S                  C+V EY   G+L + L+ 
Sbjct: 896  EVDLLCKLRHPNIVLFMGACTEPSS----------------PCIVTEYLSRGSLANILL- 938

Query: 213  NRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARL 270
            +   ++ + + +QL  D ARG++YL S+   I+HRD+KT+N+L+D +  VK+ADFG+A +
Sbjct: 939  DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATV 998

Query: 271  EASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 329
            ++   H       GT G++APEVL    Y  K DVYS+ I LWE+    +PY   +  +V
Sbjct: 999  KS---HTFAKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQV 1055

Query: 330  TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              ++ R    P +P  CP   A +M RCW+ +P  RP   E++ ++E +
Sbjct: 1056 VRSIDRGERLP-MPAWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGM 1103

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  167 bits (424), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 92/284 (32%), Positives = 155/284 (54%), Gaps = 29/284 (10%)

Query: 94   WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
            W I+  ++ +      G++G V+RG +   DVA+K      +    E  +  +R    +E
Sbjct: 1392 WVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKF---IKQKIDENHLLGIR----EE 1444

Query: 154  VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +A   KL HPN+   +GA++    +                C+V EY   G L+  + + 
Sbjct: 1445 IAFLKKLHHPNIITMVGASLKKPNI----------------CIVTEYMAKGNLRDAM-RT 1487

Query: 214  RRRKLAFKVVIQLALDLARGLSYLQS--KKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
               KL +   I++ +++A+G+SYL S    I+HRD+K  N+L+D+   VKIADFG AR++
Sbjct: 1488 CTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIK 1547

Query: 272  ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
              N   +    GT  + APE++    Y+ K DV+SFGI +WE+  C  P+   +F ++T 
Sbjct: 1548 EENA--IMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITM 1605

Query: 332  AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
             ++ +++RP+IP+ CP   A +M++CW A   KRP MD+V+ +L
Sbjct: 1606 DIL-EDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVL 1648

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1

 Score =  165 bits (418), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/303 (33%), Positives = 155/303 (51%), Gaps = 41/303 (13%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRS-EAEIASLRAAF 150
           Q  EI+  +L IK     G F  VHRG YDG++VA+K+      +H++ E ++  +R   
Sbjct: 133 QPHEIEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKI------AHQTGEDDMQRMRDNV 186

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            QE  ++  L H N+    G  + T                   C+V+EY  GG+L   L
Sbjct: 187 LQEAKLFWALKHENIAALRGVCLNTK-----------------LCLVMEYARGGSLNRIL 229

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSK---KIVHRDVKTENMLLDKT--------RT 259
                 K+   V++  A+ +ARG++YL ++    I+HRD+K+ N+L+ +         +T
Sbjct: 230 AG----KIPPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKT 285

Query: 260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM 319
           +KI DFG+AR E  N   M+   GT  +M PEV++ S Y++  DV+S+G+ LWE+   + 
Sbjct: 286 LKITDFGLAR-EMYNTQRMSA-AGTYAWMPPEVISVSTYSKFSDVWSYGVLLWELITGET 343

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID 379
           PY       V   V    L   IP+ CP +   +MK CW  +P KRP   E++  LE+I 
Sbjct: 344 PYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIA 403

Query: 380 TSK 382
            SK
Sbjct: 404 CSK 406

Activates the JUN N-terminal pathway during dorsal closure.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1

 Score =  164 bits (414), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 158/291 (54%), Gaps = 33/291 (11%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           EI   ++  +     G+FGTV++G    +DVAVK++         + +  +L   F +EV
Sbjct: 39  EISETEITTESILGDGSFGTVYKGRCRLKDVAVKVM-------LKQVDQKTL-TDFRKEV 90

Query: 155 AVWHKLDHPNVTKFIGATMGT-SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           A+  K+ HPN+  F+GA   T  +L I T+                    G L+S L+ +
Sbjct: 91  AIMSKIFHPNIVLFLGACTSTPGKLMICTE-----------------LMKGNLESLLL-D 132

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLE 271
              KL     +++A D A G+ +L S     +HRD+KT N+L+D   TVK+ DFG+++++
Sbjct: 133 PMVKLPLITRMRMAKDAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLSQIK 192

Query: 272 ASNPHDMTGETGTLG---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFS 327
               +   G+ G  G   +MAPEVL G  +N K DVYSFG+ LW+I+     +P+  +F 
Sbjct: 193 QRGENLKDGQDGAKGTPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFDNFF 252

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  +A+  + LRP IP  CP SL  ++++CWD NP+ RP  + +V+ LE I
Sbjct: 253 KFVAAICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEI 303

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54RZ7|Y1199_DICDI Probable serine/threonine-protein kinase DDB_G0282895 OS=Dictyostelium discoideum GN=DDB_G0282895 PE=3 SV=1

 Score =  161 bits (407), Expect = 9e-39,   Method: Composition-based stats.
 Identities = 93/282 (32%), Positives = 153/282 (54%), Gaps = 24/282 (8%)

Query: 95   EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
            +I+ ++L I      G    VH+GI+ G++VAVK+ + G  S R E         F +EV
Sbjct: 1371 QIEESELQILQFLGEGALAEVHKGIWKGKEVAVKIFNEGSFSFRLED--------FLKEV 1422

Query: 155  AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            A+   + HPN+ K  GA +                 S F  +V E  H G L   +  N+
Sbjct: 1423 AILGLISHPNLLKLKGACIAPRS-----------HKSTFM-IVTELMHKGTLLEVI--NK 1468

Query: 215  RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             + L+ + +I+ AL +A+GL+YL S   +HRD+K  N+L+DK    K+ DFG++R+   N
Sbjct: 1469 NKPLSLEDIIKYALSVAQGLAYLHSVDFIHRDIKAANILVDKNNNAKVGDFGLSRV-IDN 1527

Query: 275  PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAV 333
              +MT   GT  + +PE L G AY    DVYS+G+ L+E+   D P+ ++ S  E+  +V
Sbjct: 1528 NFNMTAVAGTPKWESPECLMGEAYTSASDVYSYGMMLFELATGDEPFLEIQSIVELARSV 1587

Query: 334  VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
              + L+P+I    P+ +++++K C   +P KRP M++++  L
Sbjct: 1588 CDKKLKPKISSSVPNFISSLIKDCLHNSPKKRPTMNQIIQKL 1629

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
449446652	385	PREDICTED: serine/threonine-protein kina	0.952	1.0	0.826	0.0
224141303	383	predicted protein [Populus trichocarpa]	0.940	0.992	0.820	0.0
449489453	395	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.950	0.972	0.826	0.0
255552602	446	protein kinase atmrk1, putative [Ricinus	0.943	0.854	0.825	0.0
224059956	382	predicted protein [Populus trichocarpa]	0.938	0.992	0.808	0.0
15232131	411	protein kinase domain-containing protein	0.985	0.968	0.788	0.0
116643284	422	flag-tagged protein kinase domain of put	0.985	0.943	0.788	0.0
297828594	411	predicted protein [Arabidopsis lyrata su	0.985	0.968	0.788	0.0
147768303	381	hypothetical protein VITISV_010542 [Viti	0.943	1.0	0.804	0.0
225457064	381	PREDICTED: serine/threonine-protein kina	0.943	1.0	0.804	0.0

>gi|449446652|ref|XP_004141085.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus]

 Score =  684 bits (1766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/404 (82%), Positives = 354/404 (87%), Gaps = 19/404 (4%)

Query: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGV 60
           MKEKSETGGGYVRADQIDLKSLDEQLQRHLS+AWTMEKNK R++      EE      G 
Sbjct: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSKAWTMEKNKRRED------EEGVGIGGGG 54

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
            GG         RP             ++ RQEWEIDP+KLIIK   ARGTFGTVHRG+Y
Sbjct: 55  GGGGGGGGVGGGRP-------------AITRQEWEIDPSKLIIKAVIARGTFGTVHRGVY 101

Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DGQDVAVKLLDWGEE HRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT+G+S+L+I
Sbjct: 102 DGQDVAVKLLDWGEEGHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATIGSSDLHI 161

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
           QT+NG IGMPSN CCVVVEYC GGALKSYLIKNRR+KLAFKVV+QLALDLARGLSYL S+
Sbjct: 162 QTENGQIGMPSNICCVVVEYCPGGALKSYLIKNRRKKLAFKVVVQLALDLARGLSYLHSQ 221

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           KIVHRDVKTENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNG+ YNR
Sbjct: 222 KIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 281

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
           KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA
Sbjct: 282 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 341

Query: 361 NPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           NPDKRPEMDEVV MLEAIDTSKGGGMIP+DQ QGC CFR+YRGP
Sbjct: 342 NPDKRPEMDEVVTMLEAIDTSKGGGMIPLDQSQGCFCFRRYRGP 385

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224141303|ref|XP_002324014.1| predicted protein [Populus trichocarpa] gi|222867016|gb|EEF04147.1| predicted protein [Populus trichocarpa]

 Score =  682 bits (1761), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/402 (82%), Positives = 353/402 (87%), Gaps = 22/402 (5%)

Query: 3   EKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQG 62
           +KSE+ GGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKN+K+              G QG
Sbjct: 4   QKSESDGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNKKD--------------GDQG 49

Query: 63  GHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG 122
                 +  PR       +++  S ++ RQEWEIDP+KLIIK   ARGTFGTVHRGIYDG
Sbjct: 50  --EGDIEETPR------LANNNNSTTIARQEWEIDPSKLIIKSVIARGTFGTVHRGIYDG 101

Query: 123 QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
           QDVAVKLLDWGEE HRS+AEIASLRAAFTQEV VWHKLDHPNVTKFIGAT+G+SELNIQT
Sbjct: 102 QDVAVKLLDWGEEGHRSDAEIASLRAAFTQEVVVWHKLDHPNVTKFIGATIGSSELNIQT 161

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
           +NGHIGMPSN CCVVVEYC GGALKSYLIKN RRKLAFKVVIQ+ALDLARGLSYL SKKI
Sbjct: 162 ENGHIGMPSNICCVVVEYCPGGALKSYLIKNWRRKLAFKVVIQMALDLARGLSYLHSKKI 221

Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKC 302
           VHRDVKTENMLLDKTRTVKIADFGVARLEASNP++MTGETGTLGYMAPEVLNG+ YNRKC
Sbjct: 222 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPNEMTGETGTLGYMAPEVLNGNPYNRKC 281

Query: 303 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 362
           DVYSF ICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS+L NVMKRCWDANP
Sbjct: 282 DVYSFSICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSALGNVMKRCWDANP 341

Query: 363 DKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           DKRPEM+EVV+MLEAIDTSKGGGMIP DQPQGC CFR+YRGP
Sbjct: 342 DKRPEMEEVVSMLEAIDTSKGGGMIPSDQPQGCLCFRRYRGP 383

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449489453|ref|XP_004158316.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Cucumis sativus]

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/403 (82%), Positives = 353/403 (87%), Gaps = 19/403 (4%)

Query: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGV 60
           MKEKSETGGGYVRADQIDLKSLDEQLQRHLS+AWTMEKNK R++      EE      G 
Sbjct: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSKAWTMEKNKRRED------EEGVGIGGGG 54

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
            GG         RP             ++ RQEWEIDP+KLIIK   ARGTFGTVHRG+Y
Sbjct: 55  GGGGGGGGVGGGRP-------------AITRQEWEIDPSKLIIKAVIARGTFGTVHRGVY 101

Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DGQDVAVKLLDWGEE HRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT+G+S+L+I
Sbjct: 102 DGQDVAVKLLDWGEEGHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATIGSSDLHI 161

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
           QT+NG IGMPSN CCVVVEYC GGALKSYLIKNRR+KLAFKVV+QLALDLARGLSYL S+
Sbjct: 162 QTENGQIGMPSNICCVVVEYCPGGALKSYLIKNRRKKLAFKVVVQLALDLARGLSYLHSQ 221

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           KIVHRDVKTENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNG+ YNR
Sbjct: 222 KIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 281

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
           KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA
Sbjct: 282 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 341

Query: 361 NPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRG 403
           NPDKRPEMDEVV MLEAIDTSKGGGMIP+DQ QGC CFR+YRG
Sbjct: 342 NPDKRPEMDEVVTMLEAIDTSKGGGMIPLDQSQGCXCFRRYRG 384

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255552602|ref|XP_002517344.1| protein kinase atmrk1, putative [Ricinus communis] gi|223543355|gb|EEF44886.1| protein kinase atmrk1, putative [Ricinus communis]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/400 (82%), Positives = 351/400 (87%), Gaps = 19/400 (4%)

Query: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGV 60
           MKEKSE+GGGYVRADQIDLK LDEQLQRHLSRAWTMEKNKN+K+  +             
Sbjct: 1   MKEKSESGGGYVRADQIDLKRLDEQLQRHLSRAWTMEKNKNKKDTGEEGEAATAAA---- 56

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
                       RP+          + ++ RQEWEIDP+KLIIKG  ARGTFGTVHRGIY
Sbjct: 57  ------AAAAAQRPL---------KNNTITRQEWEIDPSKLIIKGVIARGTFGTVHRGIY 101

Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DGQDVAVKLLDWGEE HRS+AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG+S+L+I
Sbjct: 102 DGQDVAVKLLDWGEEGHRSDAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGSSDLHI 161

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
           QT+NGHIGMPSN CCVVVEYC GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL S+
Sbjct: 162 QTENGHIGMPSNICCVVVEYCPGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLHSQ 221

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           KIVHRDVKTENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNG+ YNR
Sbjct: 222 KIVHRDVKTENMLLDKTRTVKIADFGVARMEASNPNDMTGETGTLGYMAPEVLNGNPYNR 281

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
           KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP+IPRCCPSSLANVMKRCWDA
Sbjct: 282 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPDIPRCCPSSLANVMKRCWDA 341

Query: 361 NPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRK 400
           NPDKRPEMDEVV+MLEAIDTSKGGGMIP DQPQGC CFR+
Sbjct: 342 NPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRR 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224059956|ref|XP_002300019.1| predicted protein [Populus trichocarpa] gi|222847277|gb|EEE84824.1| predicted protein [Populus trichocarpa]

 Score =  679 bits (1753), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/402 (80%), Positives = 350/402 (87%), Gaps = 23/402 (5%)

Query: 3   EKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQG 62
           +KSE+GGGYVRADQIDLKSLDEQLQRHLSRAWT+EKNK++ +              G QG
Sbjct: 4   QKSESGGGYVRADQIDLKSLDEQLQRHLSRAWTVEKNKSKND--------------GDQG 49

Query: 63  GHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG 122
                 Q L         + +  S ++   EWEIDP+KLIIK   ARGTFGTVHRGIYDG
Sbjct: 50  EGEGETQRL---------TQNNNSTTITSHEWEIDPSKLIIKSVIARGTFGTVHRGIYDG 100

Query: 123 QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
           QDVAVKLLDWGEE HRSEAE+ASLRAAFTQEVAVWHKLDHPNVTKFIGA +G+SELNIQT
Sbjct: 101 QDVAVKLLDWGEEGHRSEAEVASLRAAFTQEVAVWHKLDHPNVTKFIGAAIGSSELNIQT 160

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
           +NGHIGMPSN CCVVVEYC GGALKSYLIKNRRRKLAFKVV+QLALDLARGLSYL SKKI
Sbjct: 161 ENGHIGMPSNICCVVVEYCPGGALKSYLIKNRRRKLAFKVVVQLALDLARGLSYLHSKKI 220

Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKC 302
           VHRDVKTENMLLDKTRTVK+ADFGVAR+EASNP+DMTGETGTLGYMAPEVLNG+ YNRKC
Sbjct: 221 VHRDVKTENMLLDKTRTVKLADFGVARIEASNPNDMTGETGTLGYMAPEVLNGNPYNRKC 280

Query: 303 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 362
           DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLAN+MKRCWDANP
Sbjct: 281 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANIMKRCWDANP 340

Query: 363 DKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           D+RPEM+ VV MLEAIDTS GGGMIP+DQPQGC CFR+YRGP
Sbjct: 341 DRRPEMEVVVFMLEAIDTSMGGGMIPLDQPQGCLCFRRYRGP 382

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15232131|ref|NP_186798.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|6016708|gb|AAF01534.1|AC009325_4 putative protein kinase [Arabidopsis thaliana] gi|16323087|gb|AAL15278.1| AT3g01490/F4P13_4 [Arabidopsis thaliana] gi|22531108|gb|AAM97058.1| putative protein kinase [Arabidopsis thaliana] gi|23197996|gb|AAN15525.1| putative protein kinase [Arabidopsis thaliana] gi|110742522|dbj|BAE99178.1| protein kinase like protein [Arabidopsis thaliana] gi|332640153|gb|AEE73674.1| protein kinase domain-containing protein [Arabidopsis thaliana]

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/417 (78%), Positives = 359/417 (86%), Gaps = 19/417 (4%)

Query: 1   MKEKSETGGG--YVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLH 58
           MKEK+E+GGG  YVRADQIDLKSLDEQLQRHLS+AWTMEK K+  + EDN+    H+   
Sbjct: 1   MKEKAESGGGVGYVRADQIDLKSLDEQLQRHLSKAWTMEKRKSLSDGEDNVNNTRHNQ-- 58

Query: 59  GVQGGHHPHHQHL-PRPIYTRSRSSS----------TTSASVRRQEWEIDPAKLIIKGAF 107
                +  H Q +  RP+     S++          +T     R+EWEIDP+KLIIK   
Sbjct: 59  ----NNFGHRQLVFQRPLLGGGYSNNNNSSKNDIIRSTEVEKSRREWEIDPSKLIIKSVI 114

Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           ARGTFGTVHRGIYDGQDVAVKLLDWGEE HRS+AEIASLRAAFTQEVAVWHKLDHPNVTK
Sbjct: 115 ARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEIASLRAAFTQEVAVWHKLDHPNVTK 174

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
           FIGA MGTSE++IQT+NG +GMPSN CCVVVEYC GGALKS+LIK RRRKLAFKVVIQL+
Sbjct: 175 FIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPGGALKSFLIKTRRRKLAFKVVIQLS 234

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           LDLARGLSYL S+KIVHRDVKTENMLLDK+RT+KIADFGVARLEASNP+DMTGETGTLGY
Sbjct: 235 LDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARLEASNPNDMTGETGTLGY 294

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 347
           MAPEVLNGS YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP
Sbjct: 295 MAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 354

Query: 348 SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           SSLANVMKRCWDANP+KRPEM+EVVAMLEAIDTSKGGGMIP DQ QGC CFR++RGP
Sbjct: 355 SSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTSKGGGMIPPDQQQGCFCFRRHRGP 411

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116643284|gb|ABK06450.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct]

 Score =  671 bits (1731), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/417 (78%), Positives = 359/417 (86%), Gaps = 19/417 (4%)

Query: 1   MKEKSETGGG--YVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLH 58
           MKEK+E+GGG  YVRADQIDLKSLDEQLQRHLS+AWTMEK K+  + EDN+    H+   
Sbjct: 1   MKEKAESGGGVGYVRADQIDLKSLDEQLQRHLSKAWTMEKRKSLSDGEDNVNNTRHNQ-- 58

Query: 59  GVQGGHHPHHQHL-PRPIYTRSRSSS----------TTSASVRRQEWEIDPAKLIIKGAF 107
                +  H Q +  RP+     S++          +T     R+EWEIDP+KLIIK   
Sbjct: 59  ----NNFGHRQLVFQRPLLGGGYSNNNNSSKNDIIRSTEVEKSRREWEIDPSKLIIKSVI 114

Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           ARGTFGTVHRGIYDGQDVAVKLLDWGEE HRS+AEIASLRAAFTQEVAVWHKLDHPNVTK
Sbjct: 115 ARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEIASLRAAFTQEVAVWHKLDHPNVTK 174

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
           FIGA MGTSE++IQT+NG +GMPSN CCVVVEYC GGALKS+LIK RRRKLAFKVVIQL+
Sbjct: 175 FIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPGGALKSFLIKTRRRKLAFKVVIQLS 234

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           LDLARGLSYL S+KIVHRDVKTENMLLDK+RT+KIADFGVARLEASNP+DMTGETGTLGY
Sbjct: 235 LDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARLEASNPNDMTGETGTLGY 294

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 347
           MAPEVLNGS YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP
Sbjct: 295 MAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 354

Query: 348 SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           SSLANVMKRCWDANP+KRPEM+EVVAMLEAIDTSKGGGMIP DQ QGC CFR++RGP
Sbjct: 355 SSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTSKGGGMIPPDQQQGCFCFRRHRGP 411

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|297828594|ref|XP_002882179.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297328019|gb|EFH58438.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  671 bits (1731), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/417 (78%), Positives = 358/417 (85%), Gaps = 19/417 (4%)

Query: 1   MKEKSETGGG--YVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLH 58
           MKEKSE+GGG  YVRADQIDLKSLDEQLQRHLS+AWTMEK K+  + EDN+    H+   
Sbjct: 1   MKEKSESGGGVGYVRADQIDLKSLDEQLQRHLSKAWTMEKRKSLSDGEDNVNNTRHNQ-- 58

Query: 59  GVQGGHHPHHQHL-PRPIYTRSRSSS----------TTSASVRRQEWEIDPAKLIIKGAF 107
                +  H Q +  RP+     S++          +T     R+EWEIDP+KLIIK   
Sbjct: 59  ----NNFGHRQLVFQRPLLGGGYSNNNNNSKNDIIRSTEVGRSRREWEIDPSKLIIKSVI 114

Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           ARGTFGTVHRGIYDGQDVAVKLLDWGEE HRS+AEIASLRAAFTQEVAVWHKLDHPNVTK
Sbjct: 115 ARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEIASLRAAFTQEVAVWHKLDHPNVTK 174

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
           FIGA MGTSE++IQT+NG +GMPSN CCVVVEYC GGALKS+LIK RRRKLAFKVVIQL+
Sbjct: 175 FIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPGGALKSFLIKTRRRKLAFKVVIQLS 234

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           LDLARGLSYL S+KIVHRDVKTENMLLDK+RT+KIADFGVARLEASNP+DMTGETGTLGY
Sbjct: 235 LDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARLEASNPNDMTGETGTLGY 294

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 347
           MAPEVLNGS YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP
Sbjct: 295 MAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 354

Query: 348 SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           SSL NVMKRCWDANP+KRPEM+EVVAMLEAIDTSKGGGMIP DQ QGC CFR++RGP
Sbjct: 355 SSLVNVMKRCWDANPEKRPEMEEVVAMLEAIDTSKGGGMIPPDQQQGCFCFRRHRGP 411

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147768303|emb|CAN64754.1| hypothetical protein VITISV_010542 [Vitis vinifera]

 Score =  670 bits (1728), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/404 (80%), Positives = 353/404 (87%), Gaps = 23/404 (5%)

Query: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGV 60
           MKE S+   G+VRADQIDLKSLDEQL++HL+R WTM+KNK +++   + A          
Sbjct: 1   MKESSD---GFVRADQIDLKSLDEQLEKHLNRVWTMDKNKKKEDDSSSAAAAI------- 50

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
                        P    S ++STT+ +  RQ+WEIDP+KLIIK   ARGTFGTVHRG+Y
Sbjct: 51  -------------PTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVJARGTFGTVHRGVY 97

Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DGQDVAVKLLDWGEE HR+EAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG++ELNI
Sbjct: 98  DGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGSAELNI 157

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
           QT+NGHIGMPSN CCVVVEY  GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL S+
Sbjct: 158 QTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLHSQ 217

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           KIVHRDVKTENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNGS YNR
Sbjct: 218 KIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGSPYNR 277

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
           KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP+SLANVMKRCWDA
Sbjct: 278 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPNSLANVMKRCWDA 337

Query: 361 NPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           NPDKRPEMDEVVAM+EAIDTS+GGGM+PVDQPQGC CFRKYRGP
Sbjct: 338 NPDKRPEMDEVVAMIEAIDTSRGGGMLPVDQPQGCFCFRKYRGP 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225457064|ref|XP_002283021.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/404 (80%), Positives = 353/404 (87%), Gaps = 23/404 (5%)

Query: 1   MKEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGV 60
           MKE S+   G+VRADQIDLKSLDEQL++HL+R WTM+KNK +++   + A          
Sbjct: 1   MKESSD---GFVRADQIDLKSLDEQLEKHLNRVWTMDKNKKKEDDSSSAAAAI------- 50

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
                        P    S ++STT+ +  RQ+WEIDP+KLIIK   ARGTFGTVHRG+Y
Sbjct: 51  -------------PTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVIARGTFGTVHRGVY 97

Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DGQDVAVKLLDWGEE HR+EAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG++ELNI
Sbjct: 98  DGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGSAELNI 157

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
           QT+NGHIGMPSN CCVVVEY  GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL S+
Sbjct: 158 QTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLHSQ 217

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           KIVHRDVKTENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNGS YNR
Sbjct: 218 KIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGSPYNR 277

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
           KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP+SLANVMKRCWDA
Sbjct: 278 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPNSLANVMKRCWDA 337

Query: 361 NPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
           NPDKRPEMDEVVAM+EAIDTS+GGGM+PVDQPQGC CFRKYRGP
Sbjct: 338 NPDKRPEMDEVVAMIEAIDTSRGGGMLPVDQPQGCFCFRKYRGP 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	404
TAIR|locus:2084193	411	AT3G01490 [Arabidopsis thalian	0.774	0.761	0.900	6.6e-175
TAIR|locus:2170106	385	AT5G50000 [Arabidopsis thalian	0.938	0.984	0.764	5.9e-160
TAIR|locus:2094329	378	AT3G22750 [Arabidopsis thalian	0.767	0.820	0.712	1.7e-135
TAIR|locus:2130230	364	AT4G14780 [Arabidopsis thalian	0.774	0.859	0.699	3.3e-132
TAIR|locus:2077244	391	ATMRK1 [Arabidopsis thaliana (	0.774	0.800	0.707	2.2e-121
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.457	0.450	0.440	1.3e-59
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.457	0.449	0.430	6.9e-59
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.445	0.329	0.419	4.2e-51
TAIR|locus:2102802	475	AT3G46930 [Arabidopsis thalian	0.445	0.378	0.429	2.9e-50
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.445	0.315	0.381	1.7e-47

TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)]

 Score = 1524 (541.5 bits), Expect = 6.6e-175, Sum P(2) = 6.6e-175
 Identities = 282/313 (90%), Positives = 299/313 (95%)

Query:    92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
             +EWEIDP+KLIIK   ARGTFGTVHRGIYDGQDVAVKLLDWGEE HRS+AEIASLRAAFT
Sbjct:    99 REWEIDPSKLIIKSVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEIASLRAAFT 158

Query:   152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
             QEVAVWHKLDHPNVTKFIGA MGTSE++IQT+NG +GMPSN CCVVVEYC GGALKS+LI
Sbjct:   159 QEVAVWHKLDHPNVTKFIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPGGALKSFLI 218

Query:   212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
             K RRRKLAFKVVIQL+LDLARGLSYL S+KIVHRDVKTENMLLDK+RT+KIADFGVARLE
Sbjct:   219 KTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARLE 278

Query:   272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
             ASNP+DMTGETGTLGYMAPEVLNGS YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS
Sbjct:   279 ASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 338

Query:   332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQ 391
             AVVRQNLRPEIPRCCPSSLANVMKRCWDANP+KRPEM+EVVAMLEAIDTSKGGGMIP DQ
Sbjct:   339 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTSKGGGMIPPDQ 398

Query:   392 PQGCSCFRKYRGP 404
              QGC CFR++RGP
Sbjct:   399 QQGCFCFRRHRGP 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)]

 Score = 1558 (553.5 bits), Expect = 5.9e-160, P = 5.9e-160
 Identities = 302/395 (76%), Positives = 326/395 (82%)

Query:    10 GYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEXXXXXXXXXXXXXXXXX 69
             G+VRADQIDLKSLDEQL+RHLSRA T+EKNK +K+ ED  A                   
Sbjct:     7 GFVRADQIDLKSLDEQLERHLSRALTLEKNK-KKDEEDTTA-------------VAIGGS 52

Query:    70 XXXRPIYXXXXXXXXXXXXXXXQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKL 129
                 P+                 EWEIDP+KLIIK   ARGTFGTVHRGIYDGQDVAVKL
Sbjct:    53 ASSSPV--TLNGGGFVGKRKQRLEWEIDPSKLIIKTVLARGTFGTVHRGIYDGQDVAVKL 110

Query:   130 LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGM 189
             LDWGEE HRSEAEI SLRA F QEVAVWHKLDHPNVTKFIGATMG S L +QT++G + M
Sbjct:   111 LDWGEEGHRSEAEIVSLRADFAQEVAVWHKLDHPNVTKFIGATMGASGLQLQTESGPLAM 170

Query:   190 PSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
             P+N CCVVVEY  GGALKSYLIKNRRRKL FK+V+QLALDLARGLSYL S+KIVHRDVKT
Sbjct:   171 PNNICCVVVEYLPGGALKSYLIKNRRRKLTFKIVVQLALDLARGLSYLHSQKIVHRDVKT 230

Query:   250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
             ENMLLDKTRTVKIADFGVAR+EASNP+DMTGETGTLGYMAPEVLNG+ YNRKCDVYSFGI
Sbjct:   231 ENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 290

Query:   310 CLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
             CLWEIYCCDMPYPDL+FSEVTSAVVRQNLRP+IPRCCPS+LA VMKRCWDANPDKRPEMD
Sbjct:   291 CLWEIYCCDMPYPDLTFSEVTSAVVRQNLRPDIPRCCPSALAAVMKRCWDANPDKRPEMD 350

Query:   370 EVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRGP 404
             EVV MLE+IDT+KGGGMIP DQ QGC CFR+ RGP
Sbjct:   351 EVVPMLESIDTTKGGGMIPNDQQQGCLCFRRKRGP 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009506 "plasmodesma" evidence=IDA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)]

 Score = 1247 (444.0 bits), Expect = 1.7e-135, Sum P(2) = 1.7e-135
 Identities = 226/317 (71%), Positives = 271/317 (85%)

Query:    92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
             +EWEI+ AKL ++   ARG +G V++GIYDGQDVAVK+LDWGE+ + + AE ++LRA+F 
Sbjct:    65 EEWEIELAKLEMRNVIARGAYGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALRASFR 124

Query:   152 QEVAVWHKLDHPNVTKFIGATMGTSELNI----QTDNGHIGMPSNFCCVVVEYCHGGALK 207
             QEVAVWHKLDHPNVT+F+GA+MGT+ L I    +T+N    +P   CCVVVEY  GG LK
Sbjct:   125 QEVAVWHKLDHPNVTRFVGASMGTANLKIPSSAETENS---LPQRACCVVVEYIPGGTLK 181

Query:   208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
              YL +NRR+KLAFKVV+QLALDL+RGLSYL S++IVHRDVKTENMLLD  R +KIADFGV
Sbjct:   182 QYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIADFGV 241

Query:   268 ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
             AR+EA NP DMTGETGTLGYMAPEVL+G  YNR+CDVYSFGICLWEIYCCDMPYPDLSF+
Sbjct:   242 ARVEAQNPKDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFA 301

Query:   328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
             +V+SAVVRQNLRP+IPRCCP++LA +MKRCW+ANP+KRPEM+EVV++LEA+DT+KGGGMI
Sbjct:   302 DVSSAVVRQNLRPDIPRCCPTALATIMKRCWEANPEKRPEMEEVVSLLEAVDTTKGGGMI 361

Query:   388 PVDQPQGCSCFRKYRGP 404
             P DQ  GC CF   RGP
Sbjct:   362 PEDQRPGCFCFVSGRGP 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2130230 AT4G14780 [Arabidopsis thaliana (taxid:3702)]

 Score = 1206 (429.6 bits), Expect = 3.3e-132, Sum P(2) = 3.3e-132
 Identities = 219/313 (69%), Positives = 258/313 (82%)

Query:    92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
             +EWEID AKL      ARGT+GTV++GIYDGQDVAVK+LDW ++ + + A+ A+ RA F 
Sbjct:    52 EEWEIDLAKLETSNVIARGTYGTVYKGIYDGQDVAVKVLDWEDDGNETTAKTATNRALFR 111

Query:   152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
             QEV VWHKL+HPNVTKF+GA+MGT+ LNI++ +    +P   CCVVVEY  GG LK +LI
Sbjct:   112 QEVTVWHKLNHPNVTKFVGASMGTTNLNIRSADSKGSLPQQACCVVVEYLPGGTLKQHLI 171

Query:   212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
             +++ +KLAFK VI+LALDLARGLSYL S+KIVHRDVKTENMLLD  + +KIADFGVAR+E
Sbjct:   172 RHKSKKLAFKAVIKLALDLARGLSYLHSEKIVHRDVKTENMLLDAQKNLKIADFGVARVE 231

Query:   272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
             A NP DMTGETGTLGYMAPEV++G  YNR+CDVYSFGICLWEIYCCDMPYPDLSF +V+S
Sbjct:   232 ALNPKDMTGETGTLGYMAPEVIDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFVDVSS 291

Query:   332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQ 391
             AVV  NLRPEIPRCCP++LA +MK CWD NP KRPEM EVV MLE +DTSKGGGMIP DQ
Sbjct:   292 AVVLHNLRPEIPRCCPTALAGIMKTCWDGNPQKRPEMKEVVKMLEGVDTSKGGGMIPEDQ 351

Query:   392 PQGCSCFRKYRGP 404
              +GC CF   RGP
Sbjct:   352 SRGCFCFAPARGP 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)]

 Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
 Identities = 225/318 (70%), Positives = 257/318 (80%)

Query:    92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
             QEWEID +KL +K   A GT+GTV+RG+Y GQ+VAVK+LDWGE+ + + AE  +LRA+F 
Sbjct:    74 QEWEIDLSKLDMKHVLAHGTYGTVYRGVYAGQEVAVKVLDWGEDGYATPAETTALRASFE 133

Query:   152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQT--DNGHIGM---PSNFCCVVVEYCHGGAL 206
             QEVAVW KLDHPNVTKFIGA+MGTS+L I    D G  G    P+  CCVVVEY  GG L
Sbjct:   134 QEVAVWQKLDHPNVTKFIGASMGTSDLRIPPAGDTGGRGNGAHPARACCVVVEYVAGGTL 193

Query:   207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
             K +LIK  R KL  K VIQLALDLARGLSYL SK IVHRDVK+ENMLL   +T+KIADFG
Sbjct:   194 KKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFG 253

Query:   267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
             VAR+EA NP DMTGETGTLGYMAPEVL G  YNRKCDVYSFG+CLWEIYCCDMPY D SF
Sbjct:   254 VARVEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSF 313

Query:   327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
             +E++ AVV +NLRPEIP+CCP ++AN+MKRCWD NPD+RPEM+EVV +LEAIDTSKGGGM
Sbjct:   314 AEISHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKLLEAIDTSKGGGM 373

Query:   387 IPVDQPQGCSCFRKYRGP 404
             I  DQ QGC CF K RGP
Sbjct:   374 IAPDQFQGCLCFFKPRGP 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 462 (167.7 bits), Expect = 1.3e-59, Sum P(2) = 1.3e-59
 Identities = 82/186 (44%), Positives = 128/186 (68%)

Query:   195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             C+V EY  GG+++ +L + + R +  K+ ++ ALD+ARG++Y+  +  +HRD+K++N+L+
Sbjct:   205 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLLI 264

Query:   255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
                +++KIADFGVAR+E      MT ETGT  +MAPE++   AYN+K DVYSFGI LWE+
Sbjct:   265 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWEL 323

Query:   315 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
                 +P+ +++  +   AVV + +RP +P  C   L+++M RCWDANP+ RP   EVV +
Sbjct:   324 ITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVVKL 383

Query:   375 LEAIDT 380
             LEA +T
Sbjct:   384 LEAAET 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 447 (162.4 bits), Expect = 6.9e-59, Sum P(2) = 6.9e-59
 Identities = 80/186 (43%), Positives = 123/186 (66%)

Query:   195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             C+V EY  GG+++ +L K + R +  K+ +  ALD+ARG++Y+  +  +HRD+K++N+L+
Sbjct:   206 CIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLLI 265

Query:   255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
                R++KIADFGVAR+E      MT ETGT  +MAPE++    Y +K DVYSFGI LWE+
Sbjct:   266 SADRSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 324

Query:   315 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
                 +P+ +++  +   AVV + +RP +P  C   L  +M RCWDA+P+ RP   E+V +
Sbjct:   325 ITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIVNL 384

Query:   375 LEAIDT 380
             LEA +T
Sbjct:   385 LEAAET 390

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 403 (146.9 bits), Expect = 4.2e-51, Sum P(2) = 4.2e-51
 Identities = 78/186 (41%), Positives = 124/186 (66%)

Query:   195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
             C+V E+   G++  +L K   +K AFK+  ++++ALD+A+G+SYL    I+HRD+KT N+
Sbjct:   357 CIVTEFMARGSIYDFLHK---QKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANL 413

Query:   253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
             L+D+   VK+ADFGVAR++  +   MT ETGT  +MAPEV+    YN K DV+S+ I LW
Sbjct:   414 LMDEHGLVKVADFGVARVQIESGV-MTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLW 472

Query:   313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             E+   D+PY  L+  +    VV++ LRP+IP+     +  +++RCW  +P++RP  +E++
Sbjct:   473 ELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEII 532

Query:   373 AMLEAI 378
              ML+ I
Sbjct:   533 EMLQQI 538

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)]

 Score = 418 (152.2 bits), Expect = 2.9e-50, Sum P(2) = 2.9e-50
 Identities = 79/184 (42%), Positives = 123/184 (66%)

Query:   195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             C++ EY   G+L+SYL K  ++ L  + +I   LD+A+G+ Y+ S++IVH+D+K EN+L+
Sbjct:   235 CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLI 294

Query:   255 DKTRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
             D    +KIADFG+A  E     D+ G+  GT  +MAPEVL    + RKCDVYSFG+ LWE
Sbjct:   295 DNDFHLKIADFGIACEEEYC--DVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWE 352

Query:   314 IYCCDMPYPDLSFSE-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             +    +PY ++ F+E +  AV+ + +RP IP  CP+++  +++RCW +  DKRPE  ++V
Sbjct:   353 MVAGALPYEEMKFAEQIAYAVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIV 412

Query:   373 AMLE 376
              +LE
Sbjct:   413 KVLE 416

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009644 "response to high light intensity" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 374 (136.7 bits), Expect = 1.7e-47, Sum P(2) = 1.7e-47
 Identities = 71/186 (38%), Positives = 119/186 (63%)

Query:   195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
             C+V E+   G++  +L K+   K  FK+  ++++ALD+++G++YL    I+HRD+KT N+
Sbjct:   363 CIVTEFMTRGSIYDFLHKH---KGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANL 419

Query:   253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
             L+D+   VK+ADFGVAR++  +   MT ETGT  +MAPEV+    Y+ + DV+S+ I LW
Sbjct:   420 LMDEHEVVKVADFGVARVQTESGV-MTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLW 478

Query:   313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             E+   ++PY  L+  +    VV++ LRP+IP+     L  ++++CW  +P  RP   E++
Sbjct:   479 ELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEII 538

Query:   373 AMLEAI 378
              ML  +
Sbjct:   539 EMLNQL 544

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_XVII000074 hypothetical protein (383 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	404
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-76
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-76
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-75
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-74
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-64
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-52
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-51
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-47
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-46
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-45
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-44
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-44
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-42
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-42
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-41
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-41
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-41
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-41
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-40
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-40
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-39
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-39
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-39
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-39
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-38
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-37
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-37
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-37
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-36
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-36
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-36
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-35
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-35
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-35
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-34
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-34
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-34
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-34
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-34
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-34
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-33
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-33
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-33
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-33
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-32
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-32
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-31
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-31
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-31
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-31
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-31
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-30
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-30
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-30
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-30
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-30
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-30
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-29
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-29
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-29
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-29
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-28
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-28
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-28
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-28
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-28
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-28
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-27
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-27
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-27
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-27
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-26
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-26
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-25
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-25
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-25
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-25
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-25
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-24
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-24
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-24
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-23
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-22
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-22
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-22
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-22
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-22
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-22
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-22
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-21
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-21
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-21
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-21
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-20
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-20
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-20
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-18
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-18
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-18
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-16
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-15
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  237 bits (607), Expect = 2e-76
 Identities = 98/283 (34%), Positives = 136/283 (48%), Gaps = 40/283 (14%)

Query: 109 RGTFGTVHRGIYDG-----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
            G FG V++G   G      +VAVK L    E    E      R  F +E  V  KL HP
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEE-----RKDFLKEARVMKKLGHP 56

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------RR 216
           NV + +G           T+   +        +V+EY  GG L  YL K+R       + 
Sbjct: 57  NVVRLLGVC---------TEEEPL-------YLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100

Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
            L+ K ++  A+ +A+G+ YL SKK VHRD+   N L+ +   VKI+DFG++R    + +
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160

Query: 277 DMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 333
                 G L   +MAPE L    +  K DV+SFG+ LWEI+     PYP LS  EV    
Sbjct: 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY 219

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           +R+  R   P  CP  L  +M  CW  +P+ RP   E+V  LE
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  237 bits (606), Expect = 3e-76
 Identities = 92/276 (33%), Positives = 132/276 (47%), Gaps = 35/276 (12%)

Query: 109 RGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
            G FG V++G   G        VAVK L    E    E      R  F +E ++  KL H
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEE-----REEFLEEASIMKKLSH 60

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ + +G       L                 +V EY  GG L  +L +    KL  K 
Sbjct: 61  PNIVRLLGVCTQGEPL----------------YIVTEYMPGGDLLDFL-RKHGEKLTLKD 103

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           ++Q+AL +A+G+ YL+SK  VHRD+   N L+ +   VKI+DFG++R    + +      
Sbjct: 104 LLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163

Query: 283 GTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLR 339
           G L   +MAPE L    +  K DV+SFG+ LWEI+   + PYP +S  EV   ++    R
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LELLEDGYR 222

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
              P  CP  L  +M +CW  +P+ RP   E+V  L
Sbjct: 223 LPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  233 bits (598), Expect = 3e-75
 Identities = 92/275 (33%), Positives = 139/275 (50%), Gaps = 33/275 (12%)

Query: 109 RGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
            G FG V++G   G       +VAVK L       + +A        F +E  +  KLDH
Sbjct: 9   EGAFGEVYKGTLKGKGDGKEVEVAVKTL-------KEDAS-EQQIEEFLREARIMRKLDH 60

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ K +G       L                 +V+EY  GG L  YL KNR ++L+   
Sbjct: 61  PNIVKLLGVCTEEEPL----------------MIVMEYMPGGDLLDYLRKNRPKELSLSD 104

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGE 281
           ++  AL +ARG+ YL+SK  +HRD+   N L+ +   VKI+DFG++R    +  + + G 
Sbjct: 105 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRP 340
              + +MAPE L    +  K DV+SFG+ LWEI+   + PYP +S +EV    +++  R 
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL-EYLKKGYRL 223

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
             P  CP  L  +M +CW  +P+ RP   E+V +L
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  231 bits (591), Expect = 4e-74
 Identities = 93/275 (33%), Positives = 136/275 (49%), Gaps = 34/275 (12%)

Query: 109 RGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
            G FG V++G   G       +VAVK L       + +A        F +E  +  KLDH
Sbjct: 9   EGAFGEVYKGKLKGKGGKKKVEVAVKTL-------KEDAS-EQQIEEFLREARIMRKLDH 60

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PNV K +G       L                 +V+EY  GG L SYL +  R KL+   
Sbjct: 61  PNVVKLLGVCTEEEPL----------------YIVMEYMEGGDLLSYL-RKNRPKLSLSD 103

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGE 281
           ++  AL +ARG+ YL+SK  +HRD+   N L+ +   VKI+DFG++R    +  +   G 
Sbjct: 104 LLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRP 340
              + +MAPE L    +  K DV+SFG+ LWEI+   + PYP +S  EV    ++   R 
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-EYLKNGYRL 222

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
             P  CP  L ++M +CW  +P+ RP   E+V +L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  204 bits (522), Expect = 8e-64
 Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 31/270 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG V+       G+ VA+K++         + +I   R    +E+ +  KL HPN+ 
Sbjct: 9   EGSFGKVYLARDKKTGKLVAIKVIK--------KKKIKKDRERILREIKILKKLKHPNIV 60

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +               D   +        +V+EYC GG L   L K  R  L+       
Sbjct: 61  RLYDVF---------EDEDKL-------YLVMEYCEGGDLFDLLKKRGR--LSEDEARFY 102

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +   L YL SK IVHRD+K EN+LLD+   VK+ADFG+AR        +T   GT  
Sbjct: 103 LRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK-LTTFVGTPE 161

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC- 345
           YMAPEVL G  Y +  D++S G+ L+E+     P+P           + +   P  P   
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW 221

Query: 346 -CPSSLANVMKRCWDANPDKRPEMDEVVAM 374
                  +++++    +P+KR   +E +  
Sbjct: 222 DISPEAKDLIRKLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  190 bits (484), Expect = 1e-58
 Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 62/271 (22%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FGTV+       G+ VA+K++   + S   E           +E+ +  KL+HPN+ 
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE--------LLREIEILKKLNHPNIV 54

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K  G                +    N   +V+EYC GG+LK   +K    KL+   ++++
Sbjct: 55  KLYG----------------VFEDENHLYLVMEYCEGGSLKDL-LKENEGKLSEDEILRI 97

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVARLEASNPHDMTGETGTL 285
            L +  GL YL S  I+HRD+K EN+LLD     VK+ADFG+++L  S+   +    GT 
Sbjct: 98  LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157

Query: 286 GYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
            YMAPEVL G   Y+ K D++S G+ L+E+                              
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------ 187

Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
                L +++++    +P+KRP   E++  L
Sbjct: 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  185 bits (473), Expect = 2e-56
 Identities = 88/273 (32%), Positives = 140/273 (51%), Gaps = 35/273 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FGTV++  +   G+ VAVK+L   + S +S+ +  + R     E+ +  +L HPN+ 
Sbjct: 9   SGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARR-----EIRILRRLSHPNIV 61

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + I             D  H+        +V+EYC GG L  YL +     L+     ++
Sbjct: 62  RLID---------AFEDKDHL-------YLVMEYCEGGDLFDYLSRGGP--LSEDEAKKI 103

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           AL + RGL YL S  I+HRD+K EN+LLD+   VKIADFG+A+    +   +T   GT  
Sbjct: 104 ALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPW 163

Query: 287 YMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP-- 343
           YMAPEVL G   Y  K DV+S G+ L+E+     P+   +  +    ++R+ L P +   
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFD 222

Query: 344 ----RCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                       +++K+C + +P KRP  +E++
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  174 bits (444), Expect = 4e-52
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 29/275 (10%)

Query: 102 IIKGAF-ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
             +G    RG+FG+V+  +    G+ +AVK +   E S  SE E+ +L     +E+ +  
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALE----REIRILS 54

Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            L HPN+ ++ G     SE + +          N   + +EY  GG+L S L   +  KL
Sbjct: 55  SLQHPNIVRYYG-----SERDEEK---------NTLNIFLEYVSGGSLSSLL--KKFGKL 98

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
              V+ +    +  GL+YL S  IVHRD+K  N+L+D    VK+ADFG A+         
Sbjct: 99  PEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158

Query: 279 TGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVR 335
              +  GT  +MAPEV+ G  Y R  D++S G  + E+     P+ +L +       +  
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218

Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 370
               PEIP        + +++C   +P KRP  DE
Sbjct: 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  171 bits (436), Expect = 4e-51
 Identities = 95/288 (32%), Positives = 137/288 (47%), Gaps = 35/288 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W I+  +L +     +G FG V  G Y GQ VAVK L       + ++  A    AF  E
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL-------KDDSTAAQ---AFLAE 50

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V   L HPN+ + +G         +      + +       V EY   G+L  YL   
Sbjct: 51  ASVMTTLRHPNLVQLLG---------VVLQGNPLYI-------VTEYMAKGSLVDYLRSR 94

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  +     +  ALD+  G+ YL+ K  VHRD+   N+L+ +    K++DFG+A+ EAS
Sbjct: 95  GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EAS 153

Query: 274 NPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
              D    +G L   + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V 
Sbjct: 154 QGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             V +   R E P  CP  +  VMK CW+ +P KRP   ++   L  I
Sbjct: 210 PHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  161 bits (410), Expect = 2e-47
 Identities = 86/267 (32%), Positives = 136/267 (50%), Gaps = 30/267 (11%)

Query: 109 RGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           +G FG V++G+  G  +VAVK       + RS      L+  F QE  +  + DHPN+ K
Sbjct: 5   KGNFGDVYKGVLKGNTEVAVK-------TCRST-LPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            IG  +    + I                V+E   GG+L ++L K + R L  K ++Q++
Sbjct: 57  LIGVCVQKQPIYI----------------VMELVPGGSLLTFLRKKKNR-LTVKKLLQMS 99

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL-- 285
           LD A G+ YL+SK  +HRD+   N L+ +   +KI+DFG++R E    + ++     +  
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPR 344
            + APE LN   Y  + DV+S+GI LWE +   D PYP +S  + T   +    R   P+
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERIESGYRMPAPQ 218

Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEV 371
            CP  +  +M +CW  +P+ RP   E+
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  158 bits (401), Expect = 7e-46
 Identities = 87/276 (31%), Positives = 135/276 (48%), Gaps = 35/276 (12%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G + G+ DVA+K++    E   SE +       F +E 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDD-------FIEEA 50

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HPN+ +  G         + T    I        +V EY   G L +YL + R
Sbjct: 51  KVMMKLSHPNLVQLYG---------VCTKQRPI-------FIVTEYMANGCLLNYL-RER 93

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           + KL  + ++ +  D+   + YL+S   +HRD+   N L+ +   VK++DFG+AR    +
Sbjct: 94  KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153

Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            +  T   GT   + +  PEV + S ++ K DV+SFG+ +WE++    MPY   S SEV 
Sbjct: 154 QY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            + V    R   P+  P+ +  +M  CW   P+ RP
Sbjct: 212 ES-VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP 246

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  157 bits (399), Expect = 2e-45
 Identities = 91/306 (29%), Positives = 139/306 (45%), Gaps = 51/306 (16%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASL 146
           WE+   K+ +     +G+FG V+ G+  G         VA+K +        +E      
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--------NENASMRE 52

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIG-ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           R  F  E +V  + +  +V + +G  + G   L                 VV+E    G 
Sbjct: 53  RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL-----------------VVMELMAKGD 95

Query: 206 LKSYLIKNRRRKLAFKVV---------IQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++RR +               IQ+A ++A G++YL +KK VHRD+   N ++ +
Sbjct: 96  LKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Query: 257 TRTVKIADFGVARLEASNPHDMTGETGT----LGYMAPEVLNGSAYNRKCDVYSFGICLW 312
             TVKI DFG+ R       D   + G     + +MAPE L    +  K DV+SFG+ LW
Sbjct: 155 DLTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212

Query: 313 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           E+    + PY  LS  EV   V+      ++P  CP  L  +M+ CW  NP  RP   E+
Sbjct: 213 EMATLAEQPYQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Query: 372 VAMLEA 377
           V+ L+ 
Sbjct: 272 VSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  154 bits (392), Expect = 2e-44
 Identities = 79/278 (28%), Positives = 134/278 (48%), Gaps = 44/278 (15%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V+  R   DG+   +K +D    S+ SE E    R     EV +  KL+HPN+ 
Sbjct: 10  KGSFGKVYLVRRKSDGKLYVLKEIDL---SNMSEKE----REDALNEVKILKKLNHPNII 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF------ 220
           K+  +           + G +       C+V+EY  GG L S  IK ++++         
Sbjct: 63  KYYES---------FEEKGKL-------CIVMEYADGGDL-SQKIKKQKKEGKPFPEEQI 105

Query: 221 -KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDM 278
               +QL L     L YL S+KI+HRD+K +N+ L     VK+ DFG+++ L ++     
Sbjct: 106 LDWFVQLCL----ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-- 159

Query: 279 TGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
             +T  GT  Y++PE+     YN K D++S G  L+E+     P+   +  E+   +++ 
Sbjct: 160 -AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG 218

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
              P IP    S L N++      +P++RP + +++  
Sbjct: 219 QYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  154 bits (390), Expect = 3e-44
 Identities = 83/278 (29%), Positives = 131/278 (47%), Gaps = 37/278 (13%)

Query: 110 GTFGTVHRGIY---DGQ--DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G FG+V +G+Y    G+  +VAVK L         +  IA+ +  F +E +V  +LDHP 
Sbjct: 6   GNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLDHPC 57

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + + IG   G                     +V+E    G L  YL K R  ++    + 
Sbjct: 58  IVRLIGVCKGEP-----------------LMLVMELAPLGPLLKYLKKRR--EIPVSDLK 98

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG- 283
           +LA  +A G++YL+SK  VHRD+   N+LL      KI+DFG++R   +        T  
Sbjct: 99  ELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158

Query: 284 --TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRP 340
              L + APE +N   ++ K DV+S+G+ LWE +     PY ++  +EV  A++    R 
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERL 217

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             P  CP  + ++M  CW   P+ RP   E+ +     
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  149 bits (378), Expect = 1e-42
 Identities = 88/284 (30%), Positives = 142/284 (50%), Gaps = 33/284 (11%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  KL +      G FG V +G Y GQ VAVK +         + ++ +   AF +E
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI---------KCDVTA--QAFLEE 49

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            AV  KL H N+ + +G  +            H G+      +V+E    G L ++L   
Sbjct: 50  TAVMTKLHHKNLVRLLGVIL------------HNGL-----YIVMELMSKGNLVNFLRTR 92

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  ++   ++Q +LD+A G+ YL+SKK+VHRD+   N+L+ +    K++DFG+AR+   
Sbjct: 93  GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--- 149

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 332
               +      + + APE L    ++ K DV+S+G+ LWE++     PYP +S  EV   
Sbjct: 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            V +  R E P  CP+ +  +M  CW+  P KRP   ++   LE
Sbjct: 210 -VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (377), Expect = 2e-42
 Identities = 81/267 (30%), Positives = 130/267 (48%), Gaps = 42/267 (15%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G FG V++  +   G++VA+K++    ES   + +I         E+ +  K  HPN+ 
Sbjct: 10  KGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKII-------NEIQILKKCKHPNIV 60

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K+ G+ +   EL I                V+E+C GG+LK  L+K+  + L    +  +
Sbjct: 61  KYYGSYLKKDELWI----------------VMEFCSGGSLKD-LLKSTNQTLTESQIAYV 103

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTL 285
             +L +GL YL S  I+HRD+K  N+LL     VK+ DFG++ +L  +   +     GT 
Sbjct: 104 CKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTP 161

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA--VVRQNLRPEIP 343
            +MAPEV+NG  Y+ K D++S GI   E+     PY +L       A   +  N  P + 
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLR 218

Query: 344 RCCPS----SLANVMKRCWDANPDKRP 366
              P        + +K+C   NP+KRP
Sbjct: 219 --NPEKWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  148 bits (376), Expect = 9e-42
 Identities = 89/311 (28%), Positives = 139/311 (44%), Gaps = 50/311 (16%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           EWE+   +L +      G FG V +    G D       VAVK+L    +   +E +++ 
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSD 61

Query: 146 LRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           L      E+ +   +  H N+   +G           T  G +        VVVEY   G
Sbjct: 62  L----VSEMEMMKMIGKHKNIINLLGVC---------TQEGPL-------YVVVEYAAHG 101

Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ +L   R                 L  K ++  A  +ARG+ +L SKK +HRD+   
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY--MAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L    MAPE L    Y  + DV+SFG
Sbjct: 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 221

Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R E P+ C   L ++M+ CW   P +RP 
Sbjct: 222 VLLWEIFTLGGSPYPGIPVEELF-KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPT 280

Query: 368 MDEVVAMLEAI 378
             ++V  L+ +
Sbjct: 281 FKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  146 bits (371), Expect = 2e-41
 Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 34/276 (12%)

Query: 109 RGTFGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
            G+FG V RG +         VAVK L       +S+ +++ +   F +E A+ H LDH 
Sbjct: 5   DGSFGVVRRGEWSTSGGKVIPVAVKCL-------KSD-KLSDIMDDFLKEAAIMHSLDHE 56

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ +  G  +    +                 +V E    G+L   L K+         +
Sbjct: 57  NLIRLYGVVLTHPLM-----------------MVTELAPLGSLLDRLRKDALGHFLISTL 99

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGET 282
              A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  +  H +  E 
Sbjct: 100 CDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159

Query: 283 GTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLR 339
             +   + APE L    ++   DV+ FG+ LWE++   + P+  LS S++   + ++  R
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            E P  CP  + NVM +CW  NP  RP    +   L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  146 bits (370), Expect = 2e-41
 Identities = 90/290 (31%), Positives = 133/290 (45%), Gaps = 34/290 (11%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++     G FG V  G ++G   VAVK L  G  S            AF Q
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----------PEAFLQ 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  KL H  + +          + I                V EY   G+L  +L  
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEEPIYI----------------VTEYMSKGSLLDFLKS 94

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              +KL    ++ +A  +A G++YL+S+  +HRD+   N+L+ +    KIADFG+ARL  
Sbjct: 95  GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154

Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            + +  T   G    + + APE  N   +  K DV+SFGI L EI     +PYP ++  E
Sbjct: 155 DDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           V   V R   R   P  CP  L ++M +CWD +P++RP  + + + LE  
Sbjct: 213 VLEQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  145 bits (368), Expect = 5e-41
 Identities = 93/280 (33%), Positives = 136/280 (48%), Gaps = 35/280 (12%)

Query: 109 RGTFGTVHRGIY---DGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           +G FG V+ G     DGQ +  AVK L+   +    E         F +E  +     HP
Sbjct: 5   KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--------FLKEGIIMKDFSHP 56

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV   +G  + +            G P     VV+ Y   G L+++ I++       K +
Sbjct: 57  NVLSLLGICLPSE-----------GSP----LVVLPYMKHGDLRNF-IRSETHNPTVKDL 100

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPHDMT 279
           I   L +A+G+ YL SKK VHRD+   N +LD++ TVK+ADFG+AR     E  + H+ T
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
           G    + +MA E L    +  K DV+SFG+ LWE+      PYPD+   ++T  ++ Q  
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGR 219

Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           R   P  CP  L  VM  CW   P+ RP   E+V+ +E I
Sbjct: 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  145 bits (367), Expect = 9e-41
 Identities = 87/292 (29%), Positives = 143/292 (48%), Gaps = 34/292 (11%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRA 148
           +EI    + +      G FG V++G+Y   +     VAVK       + ++     S+R 
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-------TCKNCTS-PSVRE 52

Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
            F QE  +  + DHP++ K IG         + T+N     P     +V+E    G L+S
Sbjct: 53  KFLQEAYIMRQFDHPHIVKLIG---------VITEN-----PV---WIVMELAPLGELRS 95

Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           YL  N+   L    +I  +  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG++
Sbjct: 96  YLQVNKYS-LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154

Query: 269 R-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSF 326
           R LE  + +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +  
Sbjct: 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           ++V    +    R  +P  CP +L ++M +CW  +P KRP   E+ A L  I
Sbjct: 215 NDVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  144 bits (365), Expect = 1e-40
 Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 45/294 (15%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFT 151
           WE++   + +K     G +G V+ G++      VAVK L   E++   E         F 
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEE--------FL 50

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL 
Sbjct: 51  KEAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLR 94

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           +  R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL 
Sbjct: 95  ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL- 153

Query: 272 ASNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYP 322
                 MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP
Sbjct: 154 ------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207

Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            +  S+V   ++ +  R E P  CP  +  +M+ CW  NP  RP   E+    E
Sbjct: 208 GIDLSQVYE-LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  142 bits (360), Expect = 5e-40
 Identities = 86/274 (31%), Positives = 135/274 (49%), Gaps = 29/274 (10%)

Query: 107 FARGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             +G FG V +G + D   VAVK           E     L+  F  E  +  + DHPN+
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTC--------KEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K IG       + I                V+E   GG   S+L + ++ +L  K +++
Sbjct: 55  VKLIGVCTQRQPIYI----------------VMELVPGGDFLSFL-RKKKDELKTKQLVK 97

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG-ETGT 284
            ALD A G++YL+SK  +HRD+   N L+ +   +KI+DFG++R E    +  +G +   
Sbjct: 98  FALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIP 343
           + + APE LN   Y+ + DV+S+GI LWE +   + PYP ++  +    V +   R   P
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCP 216

Query: 344 RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
           + CP  +  VM+RCWD  P+ RP+  E+   L A
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  141 bits (356), Expect = 3e-39
 Identities = 90/301 (29%), Positives = 135/301 (44%), Gaps = 43/301 (14%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIASLR 147
           E+    + +  A   G FG V+ G+Y G+D       VAVK L    ES   + E     
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL---PESCSEQDE----- 53

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
           + F  E  +  K +H N+ + IG +       I                ++E   GG LK
Sbjct: 54  SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI----------------LLELMAGGDLK 97

Query: 208 SYLIKNRRR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT---RT 259
           S+L +NR R      L  K ++  A D+A+G  YL+    +HRD+   N LL      R 
Sbjct: 98  SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157

Query: 260 VKIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            KIADFG+AR +  ++ +   G     + +M PE      +  K DV+SFG+ LWEI+  
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217

Query: 318 D-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             MPYP  +  EV   V     R + P+ CP  +  +M  CW   P+ RP    ++  ++
Sbjct: 218 GYMPYPGRTNQEVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Query: 377 A 377
            
Sbjct: 277 Y 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  141 bits (357), Expect = 4e-39
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 52/296 (17%)

Query: 109 RGTFGTVHRGIYD------GQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLD 161
            G FG V    YD      G+ VAVK L+  GEE HRS+         F +E+ +   LD
Sbjct: 14  EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---------FEREIEILRTLD 64

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK 221
           H N+ K+ G        ++               +++EY   G+L+ YL ++R +    K
Sbjct: 65  HENIVKYKGVCEKPGGRSL--------------RLIMEYLPSGSLRDYLQRHRDQINL-K 109

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM--- 278
            ++  +  + +G+ YL S++ +HRD+   N+L++    VKI+DFG+A++      D    
Sbjct: 110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYV 168

Query: 279 --TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTSAVV 334
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 169 KEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227

Query: 335 RQNL------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            Q +            R   P  CP  + ++MK CW+A P  RP   +++ +++ +
Sbjct: 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  139 bits (352), Expect = 7e-39
 Identities = 88/274 (32%), Positives = 135/274 (49%), Gaps = 31/274 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V  G    D   VAVK       S R E     L+A F QE  +  +  HPN+ 
Sbjct: 5   RGNFGEVFSGRLRADNTPVAVK-------SCR-ETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG       + I                V+E   GG   ++L +    +L  K +IQ+
Sbjct: 57  RLIGVCTQKQPIYI----------------VMELVQGGDFLTFL-RTEGPRLKVKELIQM 99

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG--ETGT 284
             + A G+ YL+SK  +HRD+   N L+ +   +KI+DFG++R E    +  TG  +   
Sbjct: 100 VENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIP 343
           + + APE LN   Y+ + DV+SFGI LWE +    +PY +LS ++ T   + Q +R   P
Sbjct: 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLPCP 218

Query: 344 RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             CP ++  +M+RCW+ +P +RP    V   L++
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  139 bits (352), Expect = 8e-39
 Identities = 82/276 (29%), Positives = 134/276 (48%), Gaps = 35/276 (12%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           I P++L +      G FG V  G +  +  VA+K +    E   SE +       F +E 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEED-------FIEEA 50

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G     S +                C+V E+   G L  YL + +
Sbjct: 51  QVMMKLSHPKLVQLYGVCTERSPI----------------CLVFEFMEHGCLSDYL-RAQ 93

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R K + + ++ + LD+  G++YL+S  ++HRD+   N L+ + + VK++DFG+ R    +
Sbjct: 94  RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153

Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++     PY + S SEV 
Sbjct: 154 QY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              +    R   PR    S+  +M+ CW   P+ RP
Sbjct: 212 ET-INAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  138 bits (348), Expect = 3e-38
 Identities = 88/288 (30%), Positives = 139/288 (48%), Gaps = 35/288 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +      + + A+      AF  E
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQ------AFLAE 49

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 50  ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 94

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL++   VHRD+   N+L+ +    K++DFG+ + EAS
Sbjct: 95  GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 153

Query: 274 NPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
           +  D    TG L   + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V 
Sbjct: 154 STQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              V +  + + P  CP  + +VMK+CW  +   RP   ++   LE I
Sbjct: 210 PR-VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  136 bits (345), Expect = 1e-37
 Identities = 88/291 (30%), Positives = 128/291 (43%), Gaps = 48/291 (16%)

Query: 109 RGTFGTVHRG-----IYDG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
            G FG V+ G     +  G     VAVK L  G             +  F +E  +    
Sbjct: 5   SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--------TDQEKKEFLKEAHLMSNF 56

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK--- 217
           +HPN+ K +G  +      I                ++E   GG L SYL   R  +   
Sbjct: 57  NHPNIVKLLGVCLLNEPQYI----------------IMELMEGGDLLSYLRDARVERFGP 100

Query: 218 --LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFGVAR- 269
             L  K ++ + LD+A+G  YL+    +HRD+   N L+     D  R VKI DFG+AR 
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160

Query: 270 LEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 326
           +  S+ +   GE G L   +MAPE L    +  + DV+SFG+ +WEI      PYP L+ 
Sbjct: 161 IYKSDYYRKEGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            EV    V    R + P  CP  +  +M  CW  +P +RP  D +  +L+ 
Sbjct: 220 QEVL-QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 2e-37
 Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 28/260 (10%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V++G+    G  VA+K +         E  + S+     QE+ +   L HPN+ 
Sbjct: 10  RGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIM----QEIDLLKNLKHPNIV 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K+IG+        I+T        S+   +++EY   G+L+  +IK +       +V   
Sbjct: 63  KYIGS--------IET--------SDSLYIILEYAENGSLRQ-IIK-KFGPFPESLVAVY 104

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              + +GL+YL  + ++HRD+K  N+L  K   VK+ADFGVA        D     GT  
Sbjct: 105 VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           +MAPEV+  S  +   D++S G  + E+   + PY DL+       +V Q+  P +P   
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGI 223

Query: 347 PSSLANVMKRCWDANPDKRP 366
              L + + +C+  +P+ RP
Sbjct: 224 SPELKDFLMQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  136 bits (344), Expect = 2e-37
 Identities = 83/281 (29%), Positives = 127/281 (45%), Gaps = 30/281 (10%)

Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G FG+V  G     D     VAVK +     ++    E       F  E A     DHPN
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-------FLSEAACMKDFDHPN 62

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V K IG     S L          +P     V++ +   G L S+L+ +R   L  K+ +
Sbjct: 63  VMKLIGVCFEASSLQ--------KIPKPM--VILPFMKHGDLHSFLLYSRLGGLPEKLPL 112

Query: 225 Q----LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           Q      +D+A G+ YL ++  +HRD+   N +L +  TV +ADFG+++   S  +   G
Sbjct: 113 QTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172

Query: 281 ETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQN 337
               +   ++A E L    Y  K DV++FG+ +WEI      PYP +   E+    +R  
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-YLRHG 231

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            R + P  C   L ++M  CW A+P  RP   ++  +LE I
Sbjct: 232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  134 bits (339), Expect = 7e-37
 Identities = 88/288 (30%), Positives = 133/288 (46%), Gaps = 35/288 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WE+    L +      G FG V  G Y+G   VA+K L  G  S            AF  
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----------PEAFLA 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  +L HP + +       T E            P     ++ EY   G+L  +L  
Sbjct: 51  EANLMKQLQHPRLVRLYAVV--TQE------------P---IYIITEYMENGSLVDFLKT 93

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               KL    +I +A  +A G+++++ K  +HRD++  N+L+ +T   KIADFG+ARL  
Sbjct: 94  PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153

Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSE 328
            N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  E
Sbjct: 154 DN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           V   + R   R   P  CP  L  +M+ CW   P++RP  + + ++LE
Sbjct: 212 VIQNLER-GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  133 bits (337), Expect = 1e-36
 Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 35/286 (12%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIEEA 50

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL H  + +  G    T +  I               +V EY   G L +YL +  
Sbjct: 51  KVMMKLSHEKLVQLYGVC--TKQRPIY--------------IVTEYMSNGCLLNYL-REH 93

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
            ++     ++++  D+  G++YL+SK+ +HRD+   N L+D    VK++DFG++R    +
Sbjct: 94  GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153

Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            +  T   G+   + +  PEVL  S ++ K DV++FG+ +WE+Y    MPY   + SE  
Sbjct: 154 EY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             V  Q LR   P      +  +M  CW    ++RP   ++++ +E
Sbjct: 212 EKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  133 bits (337), Expect = 1e-36
 Identities = 86/288 (29%), Positives = 127/288 (44%), Gaps = 34/288 (11%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEID   + +      G FG V  G+++    VAVK L  G                F  
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----------PKDFLA 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  KL HP + +       T E  I               +V E    G+L  YL  
Sbjct: 51  EAQIMKKLRHPKLIQLYAVC--TLEEPIY--------------IVTELMKYGSLLEYLQG 94

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              R L    +I +A  +A G++YL+++  +HRD+   N+L+ +    K+ADFG+AR+  
Sbjct: 95  GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154

Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            +        G    + + APE    + ++ K DV+SFGI L EI     MPYP ++ +E
Sbjct: 155 ED--IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           V    V Q  R   P  CP  L ++M  CW  +PD RP  + +   LE
Sbjct: 213 VLQQ-VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  134 bits (338), Expect = 2e-36
 Identities = 89/295 (30%), Positives = 138/295 (46%), Gaps = 37/295 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASL 146
           WE     L        G FG V      G         VAVK+L     +H SE E    
Sbjct: 30  WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSERE---- 83

Query: 147 RAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
             A   E+ +   L +H N+   +GA          T  G I        V+ EYC  G 
Sbjct: 84  --ALMSELKIMSHLGNHENIVNLLGAC---------TIGGPI-------LVITEYCCYGD 125

Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF 265
           L ++L + R   L  + ++  +  +A+G+++L SK  +HRD+   N+LL   + VKI DF
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185

Query: 266 GVAR--LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PY 321
           G+AR  +  SN + + G     + +MAPE +    Y  + DV+S+GI LWEI+     PY
Sbjct: 186 GLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           P +        ++++  R   P   P+ + ++MK CWDA+P KRP   ++V ++ 
Sbjct: 245 PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 1e-35
 Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 47/273 (17%)

Query: 109 RGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V++ I     Q VA+K++D  E    +E EI  +     QE+    +   P +T
Sbjct: 11  KGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDI----QQEIQFLSQCRSPYIT 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K+ G+ +  S+L I                ++EYC GG+    L   +  KL    +  +
Sbjct: 63  KYYGSFLKGSKLWI----------------IMEYCGGGSCLDLL---KPGKLDETYIAFI 103

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             ++  GL YL  +  +HRD+K  N+LL +   VK+ADFGV+    S         GT  
Sbjct: 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           +MAPEV+  S Y+ K D++S GI   E+   + P  DL    V            IP+  
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---------LIPKNN 214

Query: 347 PSSLANVM---------KRCWDANPDKRPEMDE 370
           P SL               C + +P +RP   E
Sbjct: 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  131 bits (330), Expect = 2e-35
 Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 54/297 (18%)

Query: 109 RGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           +G FG+V    YD      G+ VAVK L      H  +         F +E+ +   L H
Sbjct: 14  KGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---------FEREIEILKSLQH 64

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
            N+ K+ G        N++              +V+EY   G+L+ YL K+R R L  + 
Sbjct: 65  DNIVKYKGVCYSAGRRNLR--------------LVMEYLPYGSLRDYLQKHRER-LDHRK 109

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT--- 279
           ++  A  + +G+ YL SK+ VHRD+ T N+L++    VKI DFG+ ++   +        
Sbjct: 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 280 -GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YC---------------CDMPY 321
            GE+    Y APE L  S ++   DV+SFG+ L+E+  Y                 D   
Sbjct: 170 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228

Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             + +  +   +++ N R   P  CP+ +  +MK CW+ +P +RP   E+   +EAI
Sbjct: 229 QMIVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  129 bits (325), Expect = 7e-35
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 32/271 (11%)

Query: 102 IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
            I     +G+FG V + +   D +  A+K +D  + + R        R     E  V  K
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE-------REEAIDEARVLAK 55

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           LD   + ++  + +   +LNI                V+EY   G L   L   R R L 
Sbjct: 56  LDSSYIIRYYESFLDKGKLNI----------------VMEYAENGDLHKLLKMQRGRPLP 99

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
              V +  + +  GL++L SKKI+HRD+K+ N+ LD    VKI D GVA+L + N +   
Sbjct: 100 EDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
              GT  Y++PE+     YN K DV++ G+ L+E  CC   +P  + ++   A++ + +R
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHPFDANNQG--ALILKIIR 215

Query: 340 ---PEIPRCCPSSLANVMKRCWDANPDKRPE 367
              P + +     LA ++ +C   +  +RP+
Sbjct: 216 GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  128 bits (323), Expect = 1e-34
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 30/286 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    + +      G FG V  G Y+    VAVK L  G  S +          AF +
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----------AFLE 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +   L H  + +          + I                + EY   G+L  +L  
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYI----------------ITEYMAKGSLLDFLKS 94

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K+    +I  +  +A G++Y++ K  +HRD++  N+L+ ++   KIADFG+AR+  
Sbjct: 95  DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154

Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            N +    G    + + APE +N  ++  K DV+SFGI L+EI     +PYP +S S+V 
Sbjct: 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           SA+ R    P     CP  L ++MK CW    ++RP  D + ++L+
Sbjct: 215 SALQRGYRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  128 bits (323), Expect = 1e-34
 Identities = 78/281 (27%), Positives = 144/281 (51%), Gaps = 32/281 (11%)

Query: 103 IKGAF-ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           IKGA    G+FG+V+ G+    G+ +AVK ++    S  S+    S+  A  +E+A+  +
Sbjct: 3   IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE 62

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+ +++G+++    LNI                 +EY  GG++ + L  N      
Sbjct: 63  LQHENIVQYLGSSLDADHLNI----------------FLEYVPGGSVAALL--NNYGAFE 104

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
             +V      + +GL+YL ++ I+HRD+K  N+L+D    +KI+DFG+++   +N     
Sbjct: 105 ETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164

Query: 280 GET------GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                    G++ +MAPEV+  ++Y RK D++S G  + E+     P+PD +      A+
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAI 221

Query: 334 VR--QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            +  +N  PEIP    S   + +++ ++ + +KRP   E++
Sbjct: 222 FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  128 bits (323), Expect = 2e-34
 Identities = 79/282 (28%), Positives = 136/282 (48%), Gaps = 30/282 (10%)

Query: 109 RGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           +G FG+V            Q VAVK+L       +++   +S    F +E A   + DHP
Sbjct: 9   KGEFGSVREAQLKSEDGSFQKVAVKML-------KADIFSSSDIEEFLREAACMKEFDHP 61

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK----LA 219
           NV K IG ++ +         G + +P     V++ +   G L ++L+ +R  +    L 
Sbjct: 62  NVIKLIGVSLRSRA------KGRLPIP----MVILPFMKHGDLHTFLLMSRIGEEPFTLP 111

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
            + +++  +D+A G+ YL SK  +HRD+   N +L++  TV +ADFG+++   S  +   
Sbjct: 112 LQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171

Query: 280 GETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 336
           G    L   ++A E L  + Y    DV++FG+ +WEI      PY  +  SE+ + +++ 
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           N R + P  C   +  +M +CW   P  RP    +   LE I
Sbjct: 232 N-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  128 bits (322), Expect = 3e-34
 Identities = 87/279 (31%), Positives = 130/279 (46%), Gaps = 43/279 (15%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G F + +  R +  G  +AVK + +   +   + E+     A  +E+ +  +L+HP++ +
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE---ALRKEIRLMARLNHPHIIR 67

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VVIQ 225
            +GAT   S  N+                 VE+  GG++   L K      AFK  V+I 
Sbjct: 68  MLGATCEDSHFNL----------------FVEWMAGGSVSHLLSKYG----AFKEAVIIN 107

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKT-RTVKIADFGVA-RLEASNPHDMTGE-- 281
               L RGLSYL   +I+HRDVK  N+L+D T + ++IADFG A RL A      TG   
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA----KGTGAGE 163

Query: 282 -----TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---EVTSAV 333
                 GT+ +MAPEVL G  Y R CDV+S G  + E+     P+     S    +   +
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                 P IP      L +V  RC +  P+ RP   E++
Sbjct: 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  127 bits (321), Expect = 4e-34
 Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 40/284 (14%)

Query: 109 RGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           RG FG V      G +       V VK L         +  + S    F +E+ ++ KL 
Sbjct: 15  RGEFGEVFLAKAKGIEEEGGETLVLVKAL-----QKTKDENLQS---EFRRELDMFRKLS 66

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK---- 217
           H NV + +G          +    H         +++EY   G LK +L   + +     
Sbjct: 67  HKNVVRLLGL--------CREAEPH--------YMILEYTDLGDLKQFLRATKSKDEKLK 110

Query: 218 ---LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEAS 273
              L+ K  + L   +A G+ +L + + VHRD+   N L+   R VK++   +++ +  S
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 332
             + +      L ++APE +    ++ K DV+SFG+ +WE++   ++P+  LS  EV + 
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           +    L   +P  CPS L  +M RCW  NP  RP   E+V+ L 
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  126 bits (319), Expect = 5e-34
 Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 31/283 (10%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           I+P++L        G FG VH G +  Q  VA+K ++ G  S             F +E 
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----------FIEEA 50

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G       L I                V E+   G L +YL + R
Sbjct: 51  KVMMKLSHPKLVQLYGVCTQQKPLYI----------------VTEFMENGCLLNYL-RQR 93

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           + KL+  +++ +  D+  G+ YL+    +HRD+   N L+  T  VK++DFG+ R    +
Sbjct: 94  QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153

Query: 275 PH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 332
            +   +G    + +  PEV N S Y+ K DV+SFG+ +WE++    MP+   S  EV   
Sbjct: 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           + R   R   P+    ++  VM  CW   P+ RP   E++  +
Sbjct: 214 ISRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  125 bits (315), Expect = 2e-33
 Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 29/280 (10%)

Query: 110 GTFGTVHRGIYDGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G FG+V  G  +  D    VAVK +     + RSE E       F  E     + DHPNV
Sbjct: 10  GEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEME------DFLSEAVCMKEFDHPNV 62

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFK 221
            + IG  + T E          G PS    V++ +   G L S+L+ +R     + L  +
Sbjct: 63  MRLIGVCLQTVESE--------GYPSP--VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
           ++++   D+A G+ YL SK  +HRD+   N +L++   V +ADFG+++   +  +   G 
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172

Query: 282 TGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNL 338
              +   ++A E L    Y  K DV+SFG+ +WEI      PYP +  SE+    +RQ  
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD-YLRQGN 231

Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           R + P  C   L ++M  CW  NP  RP  + +   LE  
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  126 bits (317), Expect = 3e-33
 Identities = 90/317 (28%), Positives = 147/317 (46%), Gaps = 60/317 (18%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    +L++      G FG V R    G D         VAVK+L    + + ++ ++
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML----KDNATDKDL 61

Query: 144 ASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
           A L      E+ +   +  H N+   +G         + T  G +        V+VEY  
Sbjct: 62  ADL----ISEMELMKLIGKHKNIINLLG---------VCTQEGPL-------YVIVEYAA 101

Query: 203 GGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK 248
            G L+ +L   R                +L+FK ++  A  +ARG+ YL+S++ +HRD+ 
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161

Query: 249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT------LGYMAPEVLNGSAYNRKC 302
             N+L+ +   +KIADFG+AR      HD+     T      + +MAPE L    Y  + 
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217

Query: 303 DVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           DV+SFGI +WEI+     PYP +   E+   ++R+  R + P  C   L  +M+ CW A 
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAV 276

Query: 362 PDKRPEMDEVVAMLEAI 378
           P +RP   ++V  L+ +
Sbjct: 277 PTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 3e-33
 Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 41/276 (14%)

Query: 109 RGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           +G FG V+   YD   G+++AVK + +  +S  ++ E+ +L      E+ +   L H  +
Sbjct: 12  QGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALE----CEIQLLKNLQHERI 66

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY------LIKNRRRKLA 219
            ++ G            D+  +        + +EY  GG++K        L +   RK  
Sbjct: 67  VQYYGC---------LRDDETL-------SIFMEYMPGGSVKDQLKAYGALTETVTRKYT 110

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEA--SNPH 276
            +++         G+ YL S  IVHRD+K  N+L D    VK+ DFG + RL+   S+  
Sbjct: 111 RQIL--------EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
            M   TGT  +M+PEV++G  Y RK DV+S G  + E+     P+ +         +  Q
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
              P++P        N ++R +  N  KRP  +E++
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  125 bits (315), Expect = 3e-33
 Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 55/312 (17%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHR----GIYDGQD---VAVKLLDWGEESHRSEAEIASLR 147
           E     +       +G FG V +    G+   +    VAVK+L       + EA  A ++
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-------KEEAS-ADMQ 52

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
           A F +E A+  + DHPN+ K +G                +G P    C++ EY   G L 
Sbjct: 53  ADFQREAALMAEFDHPNIVKLLGVCA-------------VGKP---MCLLFEYMAYGDLN 96

Query: 208 SYLIKN--------------------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV 247
            +L                           L+    + +A  +A G++YL  +K VHRD+
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVY 305
            T N L+ +   VKIADFG++R   S  +    E   +   +M PE +  + Y  + DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 306 SFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           ++G+ LWEI+   M PY  ++  EV   V   N+    P  CP  L N+M+ CW   P  
Sbjct: 217 AYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSD 275

Query: 365 RPEMDEVVAMLE 376
           RP    +  +L+
Sbjct: 276 RPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  124 bits (312), Expect = 6e-33
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 34/271 (12%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G++G+V++   + D Q  A+K +D G     S+ E    R     E+ +   ++HPN+ 
Sbjct: 10  KGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKE----REDAVNEIRILASVNHPNII 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVV 223
            +  A +                  N  C+V+EY   G L S  I  R   R+ +  + +
Sbjct: 63  SYKEAFL----------------DGNKLCIVMEYAPFGDL-SKAISKRKKKRKLIPEQEI 105

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT-GET 282
            ++ + L RGL  L  +KI+HRD+K+ N+LL     VKI D G++++   N   M   + 
Sbjct: 106 WRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI 162

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GT  YMAPEV  G  Y+ K D++S G  L+E+     P+   S  ++   V R    P I
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPI 221

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           P      L N ++      P  RP  D+++A
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  123 bits (312), Expect = 7e-33
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 34/290 (11%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           IDP+ + I+     G FG V RG          DVA+K L  G             R  F
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------DKQRLDF 52

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             E ++  + DHPN+ +  G    +  + I                + EY   G+L  +L
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMI----------------ITEYMENGSLDKFL 96

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR- 269
            +    K     ++ +   +A G+ YL     VHRD+   N+L++     K++DFG++R 
Sbjct: 97  -RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155

Query: 270 LEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 327
           LE S   +   G    + + APE +    +    DV+SFGI +WE+    + PY D+S  
Sbjct: 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
           +V  A V    R   P  CPS+L  +M  CW  + ++RP   ++V+ L+ 
Sbjct: 216 DVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  123 bits (310), Expect = 8e-33
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 35/270 (12%)

Query: 105 GAFARGTFGTVHRGIYD----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           G    G FGTV +G+Y      + VAVK+L       +++    +L+    +E  V  +L
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKIL-------KNDNNDPALKDELLREANVMQQL 53

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
           D+P + + IG     S +                 +V+E    G L  +L KN+   +  
Sbjct: 54  DNPYIVRMIGICEAESWM-----------------LVMELAELGPLNKFLQKNKH--VTE 94

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMT 279
           K + +L   ++ G+ YL+    VHRD+   N+LL      KI+DFG+++ L A   +   
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154

Query: 280 GETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 336
              G   + + APE +N   ++ K DV+SFG+ +WE +     PY  +  +EVT  ++  
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIES 213

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
             R E P+ CP  + ++MK CW    D+RP
Sbjct: 214 GERMECPQRCPPEMYDLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 69/273 (25%), Positives = 129/273 (47%), Gaps = 36/273 (13%)

Query: 110 GTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           G FGTV++G++  +G+     VA+K+L   EE+     +          E  V   +DHP
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANK------EILDEAYVMASVDHP 69

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           +V + +G  + +                    ++ +    G L  Y+ +N +  +  + +
Sbjct: 70  HVVRLLGICLSSQ-----------------VQLITQLMPLGCLLDYV-RNHKDNIGSQYL 111

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
           +   + +A+G+SYL+ K++VHRD+   N+L+   + VKI DFG+A+L   +  +   E G
Sbjct: 112 LNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171

Query: 284 T--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRP 340
              + +MA E +    Y  K DV+S+G+ +WE+      PY  +   E+   + +   R 
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERL 230

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
             P  C   +  V+ +CW  + + RP   E++ 
Sbjct: 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  122 bits (308), Expect = 3e-32
 Identities = 94/303 (31%), Positives = 138/303 (45%), Gaps = 47/303 (15%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRG----IYDGQ---DVAVKLLDWGEESHRSEAEIASL 146
           WE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E ASL
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESASL 50

Query: 147 RA--AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           R    F  E +V       +V + +G                 G P+    VV+E    G
Sbjct: 51  RERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAHG 94

Query: 205 ALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
            LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++  
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154

Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWEI
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Query: 315 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V 
Sbjct: 215 TSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Query: 374 MLE 376
           +L+
Sbjct: 274 LLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  122 bits (307), Expect = 4e-32
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 53/288 (18%)

Query: 110 GTFGTVHRG-------IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           G FG V++G             VA+K L       +  AE   ++  F QE  +   L H
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTL-------KENAEPK-VQQEFRQEAELMSDLQH 67

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------- 214
           PN+   +G                        C++ EY   G L  +L++N         
Sbjct: 68  PNIVCLLGVCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 215 ------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
                 +  L     + +A+ +A G+ YL S   VHRD+   N L+ +  TVKI+DFG++
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 269 RLEASNPHD----MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
           R   S   D     +     + +M PE +    +  + D++SFG+ LWEI+   + PY  
Sbjct: 172 RDIYS--ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229

Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            S  EV   +  + L P  P  CP+ +  +M  CW+  P +RP   ++
Sbjct: 230 FSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  120 bits (304), Expect = 9e-32
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 37/274 (13%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FGTV   R   DG+ +  K +D+G   + +E E    +     EV +  +L HPN+ 
Sbjct: 10  KGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKE----KQQLVSEVNILRELKHPNIV 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR---KLAFKVV 223
           ++         ++      +I M         EYC GG L   LI+  ++    +  + +
Sbjct: 63  RYYD-----RIIDRSNQTLYIVM---------EYCEGGDLAQ-LIQKCKKERKYIEEEFI 107

Query: 224 IQLALDLARGLSY-----LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
            ++   L   L            ++HRD+K  N+ LD    VK+ DFG+A++   +    
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM--PYPDLSFSEVTSAVVRQ 336
               GT  YM+PE LN  +Y+ K D++S G  ++E+  C +  P+   +  ++ S +   
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL--CALSPPFTARNQLQLASKIKEG 225

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 370
             R  IP    S L  V+K   + +PDKRP  +E
Sbjct: 226 KFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (304), Expect = 1e-31
 Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 36/270 (13%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           +G+ G V++  +   G+  A+K +   G+E  R +           +E+      + P V
Sbjct: 11  QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---------RELKTLRSCESPYV 61

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K  GA             G I        +V+EY  GG+L   L+K +  K+   V+  
Sbjct: 62  VKCYGAFY---------KEGEI-------SIVLEYMDGGSLAD-LLK-KVGKIPEPVLAY 103

Query: 226 LALDLARGLSYL-QSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETG 283
           +A  + +GL YL   + I+HRD+K  N+L++    VKIADFG+++ LE +     T   G
Sbjct: 104 IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-G 162

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSEVTSAVVRQNLRP 340
           T+ YM+PE + G +Y+   D++S G+ L E      P+      SF E+  A+       
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDE 370
                      + +  C   +P KRP   E
Sbjct: 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  120 bits (303), Expect = 1e-31
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 57/280 (20%)

Query: 103 IKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G++G+V++ I+   GQ VA+K++   E+      EI+ L+           + 
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK-----------QC 55

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA- 219
           D P + K+ G+    ++L I                V+EYC  G++ S ++K   + L  
Sbjct: 56  DSPYIVKYYGSYFKNTDLWI----------------VMEYCGAGSV-SDIMKITNKTLTE 98

Query: 220 --FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPH 276
                ++   L   +GL YL S K +HRD+K  N+LL++    K+ADFGV+ +L  +   
Sbjct: 99  EEIAAILYQTL---KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                 GT  +MAPEV+    YN K D++S GI   E+     PY D+            
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---- 210

Query: 337 NLRPEIPRCCPSSLAN----------VMKRCWDANPDKRP 366
                IP   P +L++           +K+C   +P++RP
Sbjct: 211 -----IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 46/288 (15%)

Query: 109 RGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP-NVTK 167
            G+FG V+    D + VA+K+L       +     +     F +E+ +   L+HP N+ K
Sbjct: 10  EGSFGEVYLA-RDRKLVALKVL------AKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR-KLAFKVVIQL 226
                                       +V+EY  GG+L+  L K  R+  L+    + +
Sbjct: 63  LYD----------------FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT-VKIADFGVARL------EASNPHDMT 279
              +   L YL SK I+HRD+K EN+LLD+    VK+ DFG+A+L       +S P   +
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 280 GETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLS----------- 325
              GT GYMAPEVL G      +   D++S GI L+E+     P+               
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226

Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
             E+ +  +   L P  P     + ++++K+    +P  R      ++
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  119 bits (301), Expect = 2e-31
 Identities = 69/275 (25%), Positives = 123/275 (44%), Gaps = 28/275 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WE    +  ++     G FG V  G++  +  VA+K+L   +   + +         F +
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD---------FQK 51

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV    +L H ++            + I                + E    G+L ++L  
Sbjct: 52  EVQALKRLRHKHLISLFAVCSVGEPVYI----------------ITELMEKGSLLAFLRS 95

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    +I +A  +A G++YL+ +  +HRD+   N+L+ +    K+ADFG+ARL  
Sbjct: 96  PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS 331
            + +  + +     + APE  +   ++ K DV+SFGI L+E++    +PYP ++  EV  
Sbjct: 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            +     R   P  CP  +  +M  CW A P+ RP
Sbjct: 216 QITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  119 bits (299), Expect = 3e-31
 Identities = 86/286 (30%), Positives = 130/286 (45%), Gaps = 31/286 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L +      G FG V  G ++G   VAVK L  G  S            +F +
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE----------SFLE 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 51  EAQIMKKLRHDKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKD 93

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              R L    ++ +A  +A G++Y++    +HRD+++ N+L+      KIADFG+ARL  
Sbjct: 94  GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153

Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP ++  EV 
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             V R   R   P+ CP SL  +M +CW  +P++RP  + + + LE
Sbjct: 214 EQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  119 bits (300), Expect = 4e-31
 Identities = 88/302 (29%), Positives = 141/302 (46%), Gaps = 45/302 (14%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASL 146
           WE+   K+ +     +G+FG V+ GI  G         VA+K ++        EA     
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--------EAASMRE 52

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F  E +V  + +  +V + +G                 G P+    V++E    G L
Sbjct: 53  RIEFLNEASVMKEFNCHHVVRLLGVVSQ-------------GQPT---LVIMELMTRGDL 96

Query: 207 KSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
           KSYL ++ R ++         + K +IQ+A ++A G++YL + K VHRD+   N ++ + 
Sbjct: 97  KSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155

Query: 258 RTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI 
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215

Query: 316 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
              + PY  +S  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++ 
Sbjct: 216 TLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274

Query: 375 LE 376
           ++
Sbjct: 275 IK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  120 bits (301), Expect = 5e-31
 Identities = 92/311 (29%), Positives = 143/311 (45%), Gaps = 50/311 (16%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML----KSDATEKDLS 68

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 69  DLISEMEMMKMIG---KHKNIINLLGAC---------TQDGPL-------YVIVEYASKG 109

Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+FK ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229

Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 230 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 288

Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 289 FKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  119 bits (299), Expect = 7e-31
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 57/309 (18%)

Query: 100 KLIIKGAFARGTFGTVHR-------GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
            L++      G FG V +       G      VAVK+L        S +E+  L + F  
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFN- 55

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
              +  +++HP+V K  GA      L                 ++VEY   G+L+S+L +
Sbjct: 56  ---LLKQVNHPHVIKLYGACSQDGPL----------------LLIVEYAKYGSLRSFLRE 96

Query: 213 NRR----------------------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
           +R+                      R L    +I  A  ++RG+ YL   K+VHRD+   
Sbjct: 97  SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156

Query: 251 NMLLDKTRTVKIADFGVAR--LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ + R +KI+DFG++R   E  +    +     + +MA E L    Y  + DV+SFG
Sbjct: 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216

Query: 309 ICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI      PYP ++   + + +++   R E P  C   + N+M  CW   PDKRP 
Sbjct: 217 VLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT 275

Query: 368 MDEVVAMLE 376
             ++   LE
Sbjct: 276 FADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (299), Expect = 9e-31
 Identities = 73/292 (25%), Positives = 133/292 (45%), Gaps = 59/292 (20%)

Query: 97  DPAKL------IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRA 148
           DP +L      I +GA      G V++      G++VA+K +   +++          + 
Sbjct: 16  DPRELYKNLEKIGEGAS-----GEVYKATDRATGKEVAIKKMRLRKQN----------KE 60

Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
               E+ +     HPN+  +  + +             + +       V+EY  GG+L  
Sbjct: 61  LIINEILIMKDCKHPNIVDYYDSYL---------VGDELWV-------VMEYMDGGSLTD 104

Query: 209 YLIKNRRR----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD 264
            + +N  R    ++A+     +  ++ +GL YL S+ ++HRD+K++N+LL K  +VK+AD
Sbjct: 105 IITQNFVRMNEPQIAY-----VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLAD 159

Query: 265 FG-VARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           FG  A+L  E S  + +    GT  +MAPEV+    Y  K D++S GI   E+   + PY
Sbjct: 160 FGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216

Query: 322 PDLSFSEVTS-AVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDE 370
             L    + +  ++     P +  P        + + +C   +P+KRP  +E
Sbjct: 217 --LREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  117 bits (294), Expect = 2e-30
 Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 31/286 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++     G FG V    Y+    VAVK +  G  S            AF  
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----------VEAFLA 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + K                  H  +      ++ E+   G+L  +L  
Sbjct: 51  EANVMKTLQHDKLVKL-----------------HAVVTKEPIYIITEFMAKGSLLDFLKS 93

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K     +I  +  +A G+++++ +  +HRD++  N+L+  +   KIADFG+AR+  
Sbjct: 94  DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153

Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
            N +    G    + + APE +N  ++  K DV+SFGI L EI     +PYP +S  EV 
Sbjct: 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            A+ R   R   P  CP  L N+M RCW   P++RP  + + ++L+
Sbjct: 214 RALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  117 bits (294), Expect = 2e-30
 Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 35/270 (12%)

Query: 110 GTFGTVHRGIYDGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G FG V +G+Y  +    DVA+K+L    E         S+R    +E  + H+LD+P +
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--------SVRDEMMREAEIMHQLDNPYI 57

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + IG     + +                 +V+E   GG L  +L   ++ ++    V++
Sbjct: 58  VRMIGVCEAEALM-----------------LVMEMASGGPLNKFLS-GKKDEITVSNVVE 99

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-- 283
           L   ++ G+ YL+ K  VHRD+   N+LL      KI+DFG+++   ++       +   
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159

Query: 284 -TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             L + APE +N   ++ + DV+S+GI +WE +     PY  +   EV S  + Q  R +
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLD 218

Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            P  CP  +  +MK CW    + RP   +V
Sbjct: 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  117 bits (295), Expect = 2e-30
 Identities = 80/268 (29%), Positives = 119/268 (44%), Gaps = 36/268 (13%)

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GTFG V+  +    G+ +AVK +   +   ++  EIA        E+ V   L HPN+ K
Sbjct: 11  GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD-------EMKVLELLKHPNLVK 63

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
           + G  +   ++ I                 +EYC GG L+  L     R L   V+    
Sbjct: 64  YYGVEVHREKVYI----------------FMEYCSGGTLEELL--EHGRILDEHVIRVYT 105

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN----PHDMTGETG 283
           L L  GL+YL S  IVHRD+K  N+ LD    +K+ DFG A    +N      ++    G
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 284 TLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
           T  YMAPEV+    G  + R  D++S G  + E+     P+ +L         V    +P
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225

Query: 341 EIPRCCPSSLA--NVMKRCWDANPDKRP 366
            IP     S    + + RC +++P KRP
Sbjct: 226 PIPDSLQLSPEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  117 bits (293), Expect = 2e-30
 Identities = 88/286 (30%), Positives = 130/286 (45%), Gaps = 31/286 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 51  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 93

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 94  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153

Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE
Sbjct: 214 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  116 bits (292), Expect = 3e-30
 Identities = 87/286 (30%), Positives = 129/286 (45%), Gaps = 31/286 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L +     +G FG V  G ++G   VA+K L  G               AF Q
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE----------AFLQ 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  KL H    K +      SE  I               +V E+   G+L  +L +
Sbjct: 51  EAQIMKKLRH---DKLVPLYAVVSEEPIY--------------IVTEFMGKGSLLDFLKE 93

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    +HRD++  N+L+      KIADFG+ARL  
Sbjct: 94  GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153

Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             V R   R   P+ CP SL  +MK CW  +PD+RP  + + + LE
Sbjct: 214 EQVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  117 bits (294), Expect = 5e-30
 Identities = 74/266 (27%), Positives = 120/266 (45%), Gaps = 43/266 (16%)

Query: 125 VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN 184
           VAVK+L      +         R  F +EV +  +L  PN+ + +G              
Sbjct: 49  VAVKVLRPDASDN--------AREDFLKEVKILSRLSDPNIARLLGVCTV---------- 90

Query: 185 GHIGMPSNFCCVVVEYCHGGALKSYL---------IKNRRRKLAFKVVIQLALDLARGLS 235
                     C+++EY   G L  +L         +    + L+F  ++ +A  +A G+ 
Sbjct: 91  ------DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144

Query: 236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVL 293
           YL+S   VHRD+ T N L+ K  T+KIADFG++R L +S+ + + G     + +MA E +
Sbjct: 145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204

Query: 294 NGSAYNRKCDVYSFGICLWEIY--CCDMPYPDLSFSEV---TSAVVRQNLRPEI---PRC 345
               +  K DV++FG+ LWEI   C + PY  L+  +V        R + R      P  
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPN 264

Query: 346 CPSSLANVMKRCWDANPDKRPEMDEV 371
           CP  +  +M  CW  + + RP   E+
Sbjct: 265 CPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  116 bits (291), Expect = 7e-30
 Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 39/293 (13%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           ID + + I+     G FG V RG           VA+K L  G    +        R  F
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--------RRDF 52

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             E ++  + DHPN+    G    +  + I T                E+   GAL S+L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT----------------EFMENGALDSFL 96

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            +N  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R 
Sbjct: 97  RQNDGQFTVIQLVGMLR-GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155

Query: 271 EASNPHDMTGETGTLG------YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
              +  D T  T +LG      + APE +    +    DV+S+GI +WE+    + PY D
Sbjct: 156 LEDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214

Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           +S  +V +A + Q+ R   P  CP++L  +M  CW  + + RP+  ++V+ L+
Sbjct: 215 MSNQDVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 7e-30
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 32/261 (12%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V   R    G+  A+K+L   +   R E E        T E  +  +++HP + 
Sbjct: 3   KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE-----HTLT-ERNILSRINHPFIV 56

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K   A         QT+            +V+EY  GG L S+L  ++  + + +     
Sbjct: 57  KLHYA--------FQTEE--------KLYLVLEYAPGGELFSHL--SKEGRFSEERARFY 98

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A ++   L YL S  I++RD+K EN+LLD    +K+ DFG+A+  +S         GT  
Sbjct: 99  AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR--PEIPR 344
           Y+APEVL G  Y +  D +S G+ L+E+     P+    ++E    +  + L+     P 
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPE 214

Query: 345 CCPSSLANVMKRCWDANPDKR 365
                  +++      +P KR
Sbjct: 215 FLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  115 bits (289), Expect = 9e-30
 Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 22/275 (8%)

Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           + I++    +G+FGTV+  + D + VA + L   +E    E        A  QE  +  K
Sbjct: 1   RYILQQRLGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSK 58

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--IKNRRRK 217
           LDHP + KF  +        ++ D           C++ EYC G  L   L  +K+  + 
Sbjct: 59  LDHPAIVKFHASF-------LERDA---------FCIITEYCEGRDLDCKLEELKHTGKT 102

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L+   V +  + L  G+ Y+  ++I+HRD+K +N+ L K   +KI DFGV+RL   +   
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDL 161

Query: 278 MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 337
            T  TGT  YM+PE L    Y+ K D++S G  L+E+ C    +   +F  V   +V + 
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EG 220

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             P +P      L ++M+   + +P  RP   E++
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  116 bits (292), Expect = 9e-30
 Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 50/313 (15%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE    KL +      G FG V      G D         VAVK+L    +   +E +++
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML----KDDATEKDLS 65

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 66  DLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 106

Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                ++ FK ++     +ARG+ YL S+K +HRD+   
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226

Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P  RP 
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPT 285

Query: 368 MDEVVAMLEAIDT 380
             ++V  L+ I T
Sbjct: 286 FKQLVEDLDRILT 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  115 bits (290), Expect = 1e-29
 Identities = 81/292 (27%), Positives = 137/292 (46%), Gaps = 46/292 (15%)

Query: 110 GTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           G FG V    YD      G+ VAVK L    +       IA L+    +E+ +   L H 
Sbjct: 15  GHFGKVELCRYDPEGDNTGEQVAVKSL----KPESGGNHIADLK----KEIEILRNLYHE 66

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K+ G         I T++G  G+      +++E+   G+LK YL +N+  K+  K  
Sbjct: 67  NIVKYKG---------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPRNKN-KINLKQQ 111

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
           ++ A+ + +G+ YL S++ VHRD+   N+L++    VKI DFG+ +   ++    T +  
Sbjct: 112 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171

Query: 282 -TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF---------SEVT 330
               + + APE L  S +    DV+SFG+ L+E+   CD     ++           ++T
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT 231

Query: 331 SA----VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                 V+ +  R   P  CP  +  +M++CW+  P KR     ++   EAI
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 70/276 (25%), Positives = 134/276 (48%), Gaps = 41/276 (14%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH---P 163
           RG +G V+RG +   G+ VA+K+++        + +++ ++    +EVA+  +L     P
Sbjct: 11  RGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQ----REVALLSQLRQSQPP 62

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+TK+ G+ +    L                 +++EY  GG++++ +   +   +A K +
Sbjct: 63  NITKYYGSYLKGPRL----------------WIIMEYAEGGSVRTLM---KAGPIAEKYI 103

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
             +  ++   L Y+    ++HRD+K  N+L+  T  VK+ DFGVA L   N    +   G
Sbjct: 104 SVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG 163

Query: 284 TLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           T  +MAPEV   G  Y+ K D++S GI ++E+   + PY D+        + +   +P  
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KP-- 219

Query: 343 PRCCPSSLANVMKR----CWDANPDKRPEMDEVVAM 374
           PR   +  + +++     C D  P +R   +E++  
Sbjct: 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  114 bits (288), Expect = 3e-29
 Identities = 75/229 (32%), Positives = 114/229 (49%), Gaps = 32/229 (13%)

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E+ +      P + K+ GA +  S  +I      I M         EYC GG+L S   
Sbjct: 48  RELEINKSCKSPYIVKYYGAFLDESSSSIG-----IAM---------EYCEGGSLDSIYK 93

Query: 212 KNRRR--KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           K ++R  ++  KV+ ++A  + +GLSYL S+KI+HRD+K  N+LL +   VK+ DFGV+ 
Sbjct: 94  KVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153

Query: 270 LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP-----DL 324
            E  N    T  TGT  YMAPE + G  Y+   DV+S G+ L E+     P+P      L
Sbjct: 154 -ELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211

Query: 325 SFSEVTSAVVRQNLRPEIPRCCPS-------SLANVMKRCWDANPDKRP 366
              E+ S +V     PE+    P           + +K+C + +P +RP
Sbjct: 212 GPIELLSYIVNMPN-PELKD-EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 4e-29
 Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 33/277 (11%)

Query: 104 KGAF-ARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           KG     G+FG+V+ G+   DG   AVK +   ++    +  +  L     QE+A+  KL
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKL 59

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +++G       L I                 +E   GG+L   L   ++     
Sbjct: 60  QHPNIVQYLGTEREEDNLYI----------------FLELVPGGSLAKLL---KKYGSFP 100

Query: 221 KVVIQL-ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASNPHD 277
           + VI+L    +  GL YL  +  VHRD+K  N+L+D    VK+ADFG+A+  +E S    
Sbjct: 101 EPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160

Query: 278 MTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                G+  +MAPEV+     Y    D++S G  + E+     P+  L        + R 
Sbjct: 161 F---KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
              P IP        + + +C   +P  RP   E++ 
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  114 bits (287), Expect = 7e-29
 Identities = 90/315 (28%), Positives = 144/315 (45%), Gaps = 52/315 (16%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE+   +L +      G FG V      G D         VAVK+L    +   ++ ++
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML----KDDATDKDL 61

Query: 144 ASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
           + L      E+ +   +  H N+   +GA          T +G +        V+VEY  
Sbjct: 62  SDL----VSEMEMMKMIGKHKNIINLLGAC---------TQDGPL-------YVLVEYAS 101

Query: 203 GGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK 248
            G L+ YL   R                +L FK ++  A  +ARG+ YL S+K +HRD+ 
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161

Query: 249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYS 306
             N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 307 FGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           FG+ LWEI+     PYP +   E+   ++++  R + P  C   L  +M+ CW A P +R
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQR 280

Query: 366 PEMDEVVAMLEAIDT 380
           P   ++V  L+ + T
Sbjct: 281 PTFKQLVEDLDRVLT 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 7e-29
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 37/212 (17%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            GT+G V++      G+ VA+K   LD  EE         +LR     E+++  +L HPN
Sbjct: 9   EGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALR-----EISLLKELKHPN 59

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + K          L++      + +       V EYC    LK YL   R   L+  ++ 
Sbjct: 60  IVKL---------LDVIHTERKLYL-------VFEYCDMD-LKKYL-DKRPGPLSPNLIK 101

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            +   L RGL+Y  S +I+HRD+K +N+L+++   +K+ADFG+AR         T E  T
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT 161

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           L Y APE+L G         YS  + +W + C
Sbjct: 162 LWYRAPEILLG------SKHYSTAVDIWSVGC 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score =  113 bits (285), Expect = 8e-29
 Identities = 59/265 (22%), Positives = 126/265 (47%), Gaps = 26/265 (9%)

Query: 115 VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG 174
           +++GI++ ++V ++      + H+   +I         E+    ++D  N+ K  G  + 
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDI------TENEIKNLRRIDSNNILKIYGFIID 89

Query: 175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGL 234
             +           +P     +++EYC  G L+  L K +   L+FK  + +A+D  +GL
Sbjct: 90  IVD----------DLPR--LSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGL 135

Query: 235 SYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL 293
             L       ++++ + + L+ +   +KI   G+ ++ +S P         + Y + ++L
Sbjct: 136 YNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK---NVNFMVYFSYKML 192

Query: 294 NG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLA 351
           N   S Y  K D+YS G+ LWEI+   +P+ +L+  E+   ++ +N   ++P  CP  + 
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252

Query: 352 NVMKRCWDANPDKRPEMDEVVAMLE 376
            +++ C   +  KRP + E++  L 
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  112 bits (282), Expect = 1e-28
 Identities = 76/283 (26%), Positives = 134/283 (47%), Gaps = 42/283 (14%)

Query: 102 IIKGAF-ARGTFGTVHRG--IYDGQDVAVKLLDWGE-ESHRSEAEIASLRAAFTQEVAVW 157
            +KG    +GT+G V+    +  G+ +AVK ++     + R ++    +  A   E+   
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 158 HKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK 217
             LDH N+ +++G       L+I                 +EY  GG++ S L    R  
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSI----------------FLEYVPGGSIGSCL----RTY 102

Query: 218 LAFK--VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA--- 272
             F+  +V      +  GL+YL SK I+HRD+K +N+L+D     KI+DFG+++      
Sbjct: 103 GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162

Query: 273 SNPHDMTGETGTLGYMAPEVLN--GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 330
            N  +M+ + G++ +MAPEV++     Y+ K D++S G  + E++    P+ D    E  
Sbjct: 163 DNDQNMSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---EAI 218

Query: 331 SAVVR---QNLRPEIPRCCPSSL----ANVMKRCWDANPDKRP 366
           +A+ +   +   P IP     +L     + +  C+  NPD RP
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  111 bits (280), Expect = 2e-28
 Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 28/268 (10%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG VH  R   D + V +K +   E+  + E      R A   E  V   L HPN+ 
Sbjct: 10  RGAFGIVHLCRRKADQKLVIIKQIPV-EQMTKDE------RLAAQNECQVLKLLSHPNII 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++    +    L I                V+EY  GG L  Y+ K     L    ++  
Sbjct: 63  EYYENFLEDKALMI----------------VMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV-KIADFGVARLEASNPHDMTGETGTL 285
            + +   L ++ +K I+HRD+KT+N+LLDK + V KI DFG++++ +S     T   GT 
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTP 165

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
            Y++PE+  G  YN+K D+++ G  L+E+      +   +   +   ++     P   R 
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225

Query: 346 CPSSLANVMKRCWDANPDKRPEMDEVVA 373
            P  L  ++    + +P KRP++ +++A
Sbjct: 226 SP-DLRQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  111 bits (280), Expect = 2e-28
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 30/271 (11%)

Query: 109 RGTFG--TVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G FG  T++R   D   V  K ++    S +        R     E+ +   L HPN+ 
Sbjct: 10  KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-------RRDALNEIVILSLLQHPNII 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVVI 224
            +    M  + L I+                +EY +GG L  Y    R++   F  ++V+
Sbjct: 63  AYYNHFMDDNTLLIE----------------MEYANGGTL--YDKIVRQKGQLFEEEMVL 104

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
                +   +SY+    I+HRD+KT N+ L K   +K+ DFG++++  S         GT
Sbjct: 105 WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGT 164

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
             YM+PE+  G  YN K D+++ G  L+E+      +   +   +   +V+ N  P +  
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV 224

Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
              S L +++      +P+KRP  DEV+   
Sbjct: 225 YS-SELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  111 bits (279), Expect = 3e-28
 Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 35/293 (11%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYD--GQD---VAVKLLDWGEESHRSEAEIASLRAA 149
           EI P+ +  +     G FG V RGI    G+    VA+K L  G    +        R  
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ--------RQD 52

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  +  H N+ +  G         I                + EY   GAL  Y
Sbjct: 53  FLSEASIMGQFSHHNIIRLEGVVTKFKPAMI----------------ITEYMENGALDKY 96

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L  +     ++++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 97  LRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155

Query: 270 LEASNPHDMTGETG---TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P      +G    + + APE +    +    DV+SFGI +WE+    + PY D+S
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215

Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             EV  A +    R   P  CPS++  +M +CW  +  +RP   ++V +L+ +
Sbjct: 216 NHEVMKA-INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  112 bits (280), Expect = 4e-28
 Identities = 88/288 (30%), Positives = 127/288 (44%), Gaps = 50/288 (17%)

Query: 110 GTFGTVHRGIY--DG--QDVAVKLLD--WGEESHRSEAEIASLRAAFTQEVAVWHKL-DH 162
           G FG V R +   DG   + A+K+L     E  HR           F  E+ V  KL  H
Sbjct: 13  GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD----------FAGELEVLCKLGHH 62

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------- 214
           PN+   +GA      L I                 +EY   G L  +L K+R        
Sbjct: 63  PNIINLLGACENRGYLYI----------------AIEYAPYGNLLDFLRKSRVLETDPAF 106

Query: 215 ------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
                    L  + ++Q A D+A G+ YL  K+ +HRD+   N+L+ +    KIADFG++
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166

Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 327
           R E        G    + +MA E LN S Y  K DV+SFG+ LWEI      PY  ++ +
Sbjct: 167 RGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           E+    + Q  R E PR C   +  +M++CW   P +RP   ++   L
Sbjct: 226 ELYEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 4e-28
 Identities = 83/308 (26%), Positives = 137/308 (44%), Gaps = 60/308 (19%)

Query: 100 KLIIKGAFARGTFGTVH----RGI----------YDGQD--VAVKLLDWGEESHRSEAEI 143
           +L +K     G FG VH     G+          +DGQ   VAVK+L       R++   
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-------RADVT- 57

Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
            + R  F +E+ +  +L +PN+ + +G  +    L                C++ EY   
Sbjct: 58  KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL----------------CMITEYMEN 101

Query: 204 GALKSYL----------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           G L  +L            N    ++   ++ +A+ +A G+ YL S   VHRD+ T N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161

Query: 254 LDKTRTVKIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +    T+KIADFG++R L + + + + G     + +MA E +    +    DV++FG+ L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 312 WEIY--CCDMPYPDLSFSEV---TSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPD 363
           WE++  C + PY  LS  +V   T    R   R         CPS +  +M RCW  +  
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281

Query: 364 KRPEMDEV 371
            RP  +++
Sbjct: 282 DRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  110 bits (278), Expect = 5e-28
 Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 47/299 (15%)

Query: 101 LIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V  G    +    D   VAVK L         E      R  F +E
Sbjct: 7   IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--------KETASNDARKDFERE 58

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--- 210
             +     H N+ KF G           T+     M       V EY   G L  +L   
Sbjct: 59  AELLTNFQHENIVKFYGVC---------TEGDPPIM-------VFEYMEHGDLNKFLRSH 102

Query: 211 ---------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK 261
                      +   +L    ++Q+A+ +A G+ YL S+  VHRD+ T N L+     VK
Sbjct: 103 GPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162

Query: 262 IADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-D 318
           I DFG++R   +  +   G    L   +M PE +    +  + DV+SFG+ LWEI+    
Sbjct: 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Query: 319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            P+  LS  EV    + Q    + PR CPS + ++M  CW  +P +R  + ++   L+ 
Sbjct: 223 QPWYGLSNEEV-IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  111 bits (278), Expect = 7e-28
 Identities = 87/313 (27%), Positives = 138/313 (44%), Gaps = 61/313 (19%)

Query: 100 KLIIKGAFARGTFGTVH----RGIYDGQD--------------VAVKLLDWGEESHRSEA 141
           +L  K     G FG VH     G+    D              VAVK+L       R +A
Sbjct: 6   RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-------REDA 58

Query: 142 EIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC 201
              + R  F +E+ +  +L  PN+ + +   + +  L                C++ EY 
Sbjct: 59  N-KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL----------------CMITEYM 101

Query: 202 HGGALKSYLIKNR---------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
             G L  +L ++             +++  +I +A  +A G+ YL S   VHRD+ T N 
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161

Query: 253 LLDKTRTVKIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGIC 310
           L+ K  T+KIADFG++R L + + + + G     + +M+ E +    +    DV++FG+ 
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221

Query: 311 LWEI--YCCDMPYPDLSFSEV---TSAVVR-QNLRPEIPR--CCPSSLANVMKRCWDANP 362
           LWEI   C + PY  LS  +V   T    R Q  +  +P+   CP SL  +M  CW  N 
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281

Query: 363 DKRPEMDEVVAML 375
            +RP   E+ A L
Sbjct: 282 KERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  109 bits (275), Expect = 1e-27
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 35/292 (11%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAF 150
           ID + + I+     G FG V  G           VA+K L  G    +        R  F
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ--------RRDF 52

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             E ++  + DHPN+    G    +  + I                V EY   G+L ++L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMI----------------VTEYMENGSLDAFL 96

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            K+  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R+
Sbjct: 97  RKHDGQFTVIQLVGMLR-GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155

Query: 271 EASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 326
              +P   +   G    + + APE +    +    DV+S+GI +WE+    + PY ++S 
Sbjct: 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +V  A + +  R   P  CP++L  +M  CW  + ++RP+ +++V++L+ +
Sbjct: 216 QDVIKA-IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score =  111 bits (280), Expect = 1e-27
 Identities = 55/157 (35%), Positives = 89/157 (56%), Gaps = 3/157 (1%)

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           ++  +  +A+G+S+L SK  +HRD+   N+LL   R  KI DFG+AR   ++ + +    
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 283 GTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLR 339
             L   +MAPE +    Y  + DV+S+GI LWEI+     PYP +        ++++  R
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              P C PS + ++MK CWDA+P KRP   ++V ++E
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  109 bits (273), Expect = 2e-27
 Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 31/279 (11%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP +L  K     +G+FG V++GI     + VA+K++D  E    +E EI  ++    QE
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQ----QE 52

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  + D P +T++ G+ +  ++L I                ++EY  GG+    L   
Sbjct: 53  ITVLSQCDSPYITRYYGSYLKGTKLWI----------------IMEYLGGGSALDLLKPG 96

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     +++   ++ +GL YL S++ +HRD+K  N+LL +   VK+ADFGVA     
Sbjct: 97  PLEETYIATILR---EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                    GT  +MAPEV+  SAY+ K D++S GI   E+   + P  DL    V   +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-FL 212

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           + +N  P +           ++ C + +P  RP   E++
Sbjct: 213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  108 bits (270), Expect = 4e-27
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 31/272 (11%)

Query: 106 AFARGTFGTV----HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
              +G++G V    HR   DG+   +K L+    S R        R A  QE  +  +L 
Sbjct: 7   VVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRE-------RKAAEQEAQLLSQLK 57

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK 221
           HPN+  +  +  G   L                 +V+ +C GG L   L + + + L   
Sbjct: 58  HPNIVAYRESWEGEDGL---------------LYIVMGFCEGGDLYHKLKEQKGKLLPEN 102

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
            V++  + +A  L YL  K I+HRD+KT+N+ L +T  +K+ D G+AR+   N  DM   
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAST 161

Query: 282 -TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GT  YM+PE+ +   YN K DV++ G C++E+      +     + +   ++   L P
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-P 220

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            +P+     L  ++       P+KRP +  ++
Sbjct: 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  108 bits (272), Expect = 4e-27
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 39/295 (13%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           I   ++ +      GTFG +  GI         ++V VK +    + H SE ++  L   
Sbjct: 3   ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLL--- 55

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
             QE  + + L H N+   +   +   E                  V+  Y + G LK +
Sbjct: 56  -LQESCLLYGLSHQNILPILHVCIEDGE---------------PPFVLYPYMNWGNLKLF 99

Query: 210 LIKNR------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           L + R       + L+ + ++ +A+ +A G+SYL  + ++H+D+   N ++D+   VKI 
Sbjct: 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159

Query: 264 DFGVAR-LEASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMP 320
           D  ++R L   + H +   E   + +MA E L    Y+   DV+SFG+ LWE+      P
Sbjct: 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Query: 321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           Y ++   E+  A ++   R   P  CP  L  VM  CW  +P++RP   ++V  L
Sbjct: 220 YVEIDPFEMA-AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 50/290 (17%)

Query: 108 ARGTFGTVHRGIY--DG--QDVAVKLLD--WGEESHRSEAEIASLRAAFTQEVAVWHKL- 160
             G FG V +     DG   D A+K +     ++ HR           F  E+ V  KL 
Sbjct: 4   GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----------FAGELEVLCKLG 53

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------ 214
            HPN+   +GA      L +                 +EY   G L  +L K+R      
Sbjct: 54  HHPNIINLLGACEHRGYLYL----------------AIEYAPHGNLLDFLRKSRVLETDP 97

Query: 215 --------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
                      L+ + ++  A D+ARG+ YL  K+ +HRD+   N+L+ +    KIADFG
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157

Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           ++R +        G    + +MA E LN S Y    DV+S+G+ LWEI      PY  ++
Sbjct: 158 LSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            +E+    + Q  R E P  C   + ++M++CW   P +RP   +++  L
Sbjct: 217 CAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  107 bits (268), Expect = 1e-26
 Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 30/277 (10%)

Query: 102 IIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
            I+    +G F  V++ I   DG+ VA+K +   E         A  R    +E+ +  +
Sbjct: 5   KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD------AKARQDCLKEIDLLKQ 58

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN---RRR 216
           LDHPNV K++ + +  +ELNI                V+E    G L S +IK+   ++R
Sbjct: 59  LDHPNVIKYLASFIENNELNI----------------VLELADAGDL-SRMIKHFKKQKR 101

Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
            +  + + +  + L   L ++ SK+I+HRD+K  N+ +  T  VK+ D G+ R  +S   
Sbjct: 102 LIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP-YPD-LSFSEVTSAVV 334
                 GT  YM+PE ++ + YN K D++S G  L+E+     P Y D ++   +   + 
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           + +  P         L +++ RC + +P+KRP++  V
Sbjct: 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  107 bits (267), Expect = 2e-26
 Identities = 82/279 (29%), Positives = 134/279 (48%), Gaps = 31/279 (11%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP +L  K     +G+FG V +GI +     VA+K++D  E    +E EI  ++    QE
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQ----QE 52

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  + D P VTK+ G+ +  ++L I                ++EY  GG+    L   
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKDTKLWI----------------IMEYLGGGSALDLLEPG 96

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA     
Sbjct: 97  PLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                    GT  +MAPEV+  SAY+ K D++S GI   E+   + P+ +L   +V   +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            + N  P +       L   ++ C +  P  RP   E++
Sbjct: 214 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-26
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 40/280 (14%)

Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I G    G FG V++  +    +  A K++    E    +         F  E+ +  + 
Sbjct: 9   IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---------FMVEIDILSEC 59

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKL 218
            HPN+     A    ++L I                ++E+C GGAL S +++  R   + 
Sbjct: 60  KHPNIVGLYEAYFYENKLWI----------------LIEFCDGGALDSIMLELERGLTEP 103

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             + V +  L+    L++L S K++HRD+K  N+LL     VK+ADFGV+    S     
Sbjct: 104 QIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160

Query: 279 TGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
               GT  +MAPEV+       + Y+ K D++S GI L E+   + P+ +L+   V   +
Sbjct: 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220

Query: 334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           ++    P +  P    SS  + +K C   +PD RP   E+
Sbjct: 221 LKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  106 bits (266), Expect = 3e-26
 Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 50/293 (17%)

Query: 110 GTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           G FG V    YD      G+ VAVK L                 + + +E+ +   L H 
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--------NTSGWKKEINILKTLYHE 66

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K+ G         +Q              +++EY   G+L+ YL K+   KL    +
Sbjct: 67  NIVKYKGCCSEQGGKGLQ--------------LIMEYVPLGSLRDYLPKH---KLNLAQL 109

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGET 282
           +  A  +  G++YL S+  +HRD+   N+LLD  R VKI DFG+A+ +   + +    E 
Sbjct: 110 LLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169

Query: 283 GT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPY--PDLSFSEVTS------ 331
           G   + + A E L  + ++   DV+SFG+ L+E+   CD     P   F E+        
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD-SKQSPPKKFEEMIGPKQGQM 228

Query: 332 AVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            VVR      + +R   P+ CP  +  +MK CW+     RP    ++ +L+ +
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  105 bits (262), Expect = 1e-25
 Identities = 71/274 (25%), Positives = 135/274 (49%), Gaps = 38/274 (13%)

Query: 110 GTFGTVHRGIY--DGQDV----AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           G FGTV++GI+  +G+ V    A+K+L+   E+   +A +      F  E  +   +DHP
Sbjct: 18  GAFGTVYKGIWVPEGETVKIPVAIKILN---ETTGPKANVE-----FMDEALIMASMDHP 69

Query: 164 NVTKFIGATMG-TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           ++ + +G  +  T +L  Q       MP      +++Y H            +  +  ++
Sbjct: 70  HLVRLLGVCLSPTIQLVTQL------MPHG---CLLDYVH----------EHKDNIGSQL 110

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           ++   + +A+G+ YL+ +++VHRD+   N+L+     VKI DFG+ARL   +  +   + 
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 283 GTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLR 339
           G +   +MA E ++   +  + DV+S+G+ +WE+      PY  +   E+   + +    
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           P+ P  C   +  VM +CW  + D RP+  E+ A
Sbjct: 231 PQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  104 bits (261), Expect = 1e-25
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 31/279 (11%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP +L  K     +G+FG V +GI +   Q VA+K++D  E    +E EI  ++    QE
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQ----QE 52

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  + D P VTK+ G+ +  ++L I                ++EY  GG+    L   
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWI----------------IMEYLGGGSALDLLRAG 96

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA     
Sbjct: 97  PFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                    GT  +MAPEV+  SAY+ K D++S GI   E+   + P  D+    V   +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            + N  P +           +  C + +P  RP   E++
Sbjct: 214 PKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  105 bits (263), Expect = 1e-25
 Identities = 72/273 (26%), Positives = 135/273 (49%), Gaps = 36/273 (13%)

Query: 110 GTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
           G FGTV++G++  +G+     VA+K L         EA           E  V   +D+P
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKEILDEAYVMASVDNP 69

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           +V + +G  + TS + + T      MP             G L  Y+ +++   +  + +
Sbjct: 70  HVCRLLGICL-TSTVQLITQL----MPF------------GCLLDYVREHKDN-IGSQYL 111

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
           +   + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  ++  +   E G
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 284 T--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRP 340
              + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           + P  C   +  +M +CW  + D RP+  E++ 
Sbjct: 232 Q-PPICTIDVYMIMVKCWMIDADSRPKFRELII 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  105 bits (263), Expect = 2e-25
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 3/156 (1%)

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           +I  +  +ARG+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  +    
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234

Query: 283 GTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLR 339
             L   +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E     +++  R
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
              P      + ++M  CW  NP+ RP   E+V +L
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 50/273 (18%)

Query: 110 GTFGTVH--RGIYDGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           GT+G V+  R I  G+ VA+K+  L+ G++          ++    QE+++  +  HPN+
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGDD-------FEIIQ----QEISMLKECRHPNI 62

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----RKLAFK 221
             + G+ +   +L I                V+EYC GG+L+      R      ++A+ 
Sbjct: 63  VAYFGSYLRRDKLWI----------------VMEYCGGGSLQDIYQVTRGPLSELQIAY- 105

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTG 280
            V +  L   +GL+YL     +HRD+K  N+LL +   VK+ADFGV A+L A+     + 
Sbjct: 106 -VCRETL---KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161

Query: 281 ETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 337
             GT  +MAPEV        Y+ KCD+++ GI   E+     P  DL        + + N
Sbjct: 162 -IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN 220

Query: 338 LRP----EIPRCCPSSLANVMKRCWDANPDKRP 366
             P    +  +  P    + +K+C   +P KRP
Sbjct: 221 FPPPKLKDKEKWSP-VFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 55/284 (19%)

Query: 109 RGTFGTV----HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            G  G V    HR    G+ +AVK +       R E   A ++    +E+ + HK + P 
Sbjct: 11  AGNSGVVSKVLHRP--TGKIMAVKTI-------RLEINEA-IQKQILRELDILHKCNSPY 60

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR-------K 217
           +  F GA     +++I                 +EY  GG+L   L + + R       K
Sbjct: 61  IVGFYGAFYNNGDISI----------------CMEYMDGGSLDKILKEVQGRIPERILGK 104

Query: 218 LAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
           +A  V+        +GL+YL  K KI+HRDVK  N+L++    +K+ DFGV+  +  N  
Sbjct: 105 IAVAVL--------KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSL 155

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP-----DLSFSEVTS 331
             T   GT  YMAPE + G+ Y+ K D++S G+ L E+     PYP          E+  
Sbjct: 156 AKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214

Query: 332 AVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
            +V +   P +P         + +  C   +P +RP   E++  
Sbjct: 215 YIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 28/209 (13%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +    ES     + A LR     E+ +  +L+HPN+ K
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTA-LR-----EIKLLKELNHPNIIK 62

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
                     L++    G + +       V E+      K  LIK+R+R L   ++    
Sbjct: 63  L---------LDVFRHKGDLYL-------VFEFMDTDLYK--LIKDRQRGLPESLIKSYL 104

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S  I+HRD+K EN+L++    +K+ADFG+AR   S     T    T  Y
Sbjct: 105 YQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWY 164

Query: 288 MAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
            APE+L G   Y+   D++S G    E+ 
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 42/277 (15%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G    V+  I   + + VA+K +D      + +  +  LR    +EV    + +HPNV 
Sbjct: 11  VGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELR----KEVQAMSQCNHPNVV 62

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF-KVVIQ 225
           K+  + +   EL                 +V+ Y  GG+L   ++K+   +    + +I 
Sbjct: 63  KYYTSFVVGDEL----------------WLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIA 105

Query: 226 LAL-DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-- 282
             L ++ +GL YL S   +HRD+K  N+LL +  +VKIADFGV+   A    D T +   
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDRTRKVRK 164

Query: 283 ---GTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
              GT  +MAPEV+     Y+ K D++SFGI   E+     PY      +V    + QN 
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL-QND 223

Query: 339 RPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDE 370
            P +           S   ++  C   +P KRP  +E
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 6e-25
 Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 65/294 (22%)

Query: 108 ARGTFGTVHRGIY--DGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             GT+G V++  +   GQ VA+K++D   +E    + E   LR             +HPN
Sbjct: 15  GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR----------KYSNHPN 64

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA----LKSYLIKNRRRK--- 217
           +  F GA                G       +V+E C GG+    +K    K +R K   
Sbjct: 65  IATFYGAF---------IKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEW 114

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPH 276
           +A+  +++  L   RGL+YL   K++HRD+K +N+LL K   VK+ DFGV+  L+++   
Sbjct: 115 IAY--ILRETL---RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 277 DMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
             T   GT  +MAPEV+       ++Y+ + DV+S GI   E+     P  D+       
Sbjct: 170 RNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM------- 221

Query: 332 AVVRQNLRP--EIPRCCPSSLA----------NVMKRCWDANPDKRPEMDEVVA 373
                 +R   +IPR  P +L           + +  C   N ++RP M+E++ 
Sbjct: 222 ----HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  102 bits (255), Expect = 7e-25
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 40/288 (13%)

Query: 99  AKLIIKGAFARGTFGTVHRGIY--DGQDVAVK------LLDWGEESHRSEAEIASLRAAF 150
           A   I+    RG F  V+R     DG  VA+K      L+D            A  RA  
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD------------AKARADC 49

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +E+ +  +L+HPNV K+  + +  +ELNI                V+E    G L   +
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNI----------------VLELADAGDLSRMI 93

Query: 211 --IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
              K ++R +  K V +  + L   L ++ S++++HRD+K  N+ +  T  VK+ D G+ 
Sbjct: 94  KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP-YPDLSFS 327
           R  +S         GT  YM+PE ++ + YN K D++S G  L+E+     P Y D    
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213

Query: 328 EVTSAVVRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEVVAM 374
                 + Q   P +P    S  L  ++  C + +P+KRP++  V  +
Sbjct: 214 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  102 bits (255), Expect = 9e-25
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 51/291 (17%)

Query: 112 FGTVHRG------IYDGQDVAVKLL-DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           FG +++G      +   Q VA+K L D        E         F QE ++  +L HPN
Sbjct: 18  FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---------FQQEASLMAELHHPN 68

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---------- 214
           +   +G    T E  +              C++ EY + G L  +LI             
Sbjct: 69  IVCLLGVV--TQEQPV--------------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 215 -----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
                +  L     + +A+ +A G+ YL S   VH+D+   N+L+ +   VKI+D G++R
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172

Query: 270 -LEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSF 326
            + +++ + +  ++   + +M PE +    ++   D++SFG+ LWEI+   + PY   S 
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            EV   V ++ L P     CP  + ++M  CW   P +RP   ++   L +
Sbjct: 233 QEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 55/231 (23%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGE------ESH-RSEAEIASLRAAFTQEVAVWHKL 160
           G+FG V   R    G+  A+K+L   +        H  +E  I  L++           +
Sbjct: 12  GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI--LQS-----------I 58

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----- 215
            HP +    G+           D+ ++ +       V+EY  GG L S+L K+ R     
Sbjct: 59  RHPFLVNLYGSFQ---------DDSNLYL-------VMEYVPGGELFSHLRKSGRFPEPV 102

Query: 216 -RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
            R  A +VV  LAL+      YL S  IV+RD+K EN+LLD    +KI DFG A+     
Sbjct: 103 ARFYAAQVV--LALE------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154

Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS 325
            + +    GT  Y+APE++    Y +  D ++ GI ++E+     P+ D +
Sbjct: 155 TYTL---CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  101 bits (254), Expect = 2e-24
 Identities = 85/320 (26%), Positives = 136/320 (42%), Gaps = 69/320 (21%)

Query: 101 LIIKGAFARGTFGTVHR-GIYDGQD-----------------VAVKLLDWGEESHRSEAE 142
           L+ K     G FG VH   + + QD                 VAVK+L       R +A 
Sbjct: 7   LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-------RPDAN 59

Query: 143 IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
             + R  F +EV +  +L  PN+ + +G  +    L                C++ EY  
Sbjct: 60  -KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL----------------CMITEYME 102

Query: 203 GGALKSYLIKNRRRK-----------------LAFKVVIQLALDLARGLSYLQSKKIVHR 245
            G L  +L  +                     +++  ++ +AL +A G+ YL S   VHR
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162

Query: 246 DVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCD 303
           D+ T N L+ +  T+KIADFG++R L A + + + G     + +MA E +    +    D
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222

Query: 304 VYSFGICLWEIY--CCDMPYPDLSFSEV---TSAVVRQNLRPEI---PRCCPSSLANVMK 355
           V++FG+ LWEI   C + PY +L+  +V        R   R      P  CP  L  +M 
Sbjct: 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELML 282

Query: 356 RCWDANPDKRPEMDEVVAML 375
           +CW  +  +RP   ++ A L
Sbjct: 283 QCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  100 bits (252), Expect = 2e-24
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 63/279 (22%)

Query: 108 ARGTFGTVHRGIYDGQDV--AVKLL------DWGEESH-RSEAEIASLRAAFTQEVAVWH 158
             G FG V       ++   A+K +      + G++ H  SE EI        +E     
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI-------LEEC---- 50

Query: 159 KLDHPNVTKFIGATMGTSELNIQT--DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR 216
             +HP + K             +T  D  +I M       ++EYC GG L + L   R R
Sbjct: 51  --NHPFIVKLY-----------RTFKDKKYIYM-------LMEYCLGGELWTIL---RDR 87

Query: 217 KLAFKVVIQLALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
            L            AR           YL ++ I++RD+K EN+LLD    VK+ DFG A
Sbjct: 88  GL-------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFA 140

Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY--PDLSF 326
           +   S     T   GT  Y+APE++    Y+   D +S GI L+E+     P+   D   
Sbjct: 141 KKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
            E+ + +++ N + E P     +  +++K+    NP++R
Sbjct: 200 MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score =  103 bits (258), Expect = 2e-24
 Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 3/162 (1%)

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASNP 275
           L++  ++  +  +A G+ +L SK  VHRD+   N+L+ + + VKI DFG+AR  +  SN 
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295

Query: 276 HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVV 334
                    L +MAPE +  + Y    DV+SFGI LWEI+     PYP+L  +E     +
Sbjct: 296 ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           ++  R   P      +  +M++CW+   + RP+  ++V ++ 
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  102 bits (256), Expect = 3e-24
 Identities = 86/326 (26%), Positives = 140/326 (42%), Gaps = 68/326 (20%)

Query: 71  LPRPIYTRSRSSSTTSASVRRQEWEIDP-AKLIIKGAFARGTFGTVHRGIY--DGQDVAV 127
           LP P  + S SSS++S++           ++L        G  GTV++ I+   G+  A+
Sbjct: 45  LPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYAL 104

Query: 128 KLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHI 187
           K++    E         ++R    +E+ +   ++HPNV K            +   NG I
Sbjct: 105 KVIYGNHED--------TVRRQICREIEILRDVNHPNVVKCHD---------MFDHNGEI 147

Query: 188 GMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR----GLSYLQSKKIV 243
                   V++E+  GG+L+   I + +          LA D+AR    G++YL  + IV
Sbjct: 148 Q-------VLLEFMDGGSLEGTHIADEQ---------FLA-DVARQILSGIAYLHRRHIV 190

Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV----LNGSAYN 299
           HRD+K  N+L++  + VKIADFGV+R+ A          GT+ YM+PE     LN  AY+
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 300 RKC-DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ------------NLRPEIPRCC 346
               D++S G+ + E Y    P+           V RQ            +  PE P   
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF----------GVGRQGDWASLMCAICMSQPPEAPATA 300

Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                + +  C    P KR    +++
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLL 326

Length = 353

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  100 bits (250), Expect = 1e-23
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 3/161 (1%)

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +I  +  +ARG+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230

Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVV 334
           +   +    L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +  +E     +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           +   R   P      +  +M  CW  +P +RP    +V +L
Sbjct: 291 KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)

Query: 110 GTFGTV--HRGIYDG--QDVAVKLL-DWG-EESHRSEAEIASLRAAFTQEVAVWHKL-DH 162
           G FG V   R   DG   D A+K + ++  ++ HR           F  E+ V  KL  H
Sbjct: 18  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----------FAGELEVLCKLGHH 67

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------- 214
           PN+   +GA              H G    +  + +EY   G L  +L K+R        
Sbjct: 68  PNIINLLGACE------------HRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111

Query: 215 ------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
                    L+ + ++  A D+ARG+ YL  K+ +HRD+   N+L+ +    KIADFG++
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 327
           R +        G    + +MA E LN S Y    DV+S+G+ LWEI      PY  ++ +
Sbjct: 172 RGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           E+    + Q  R E P  C   + ++M++CW   P +RP   +++  L
Sbjct: 231 ELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 8/172 (4%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQL-ALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           VV+   GG L+ +L +  +        ++    ++   L YL SK I+HRD+K +N+LLD
Sbjct: 78  VVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134

Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           +   V I DF +A     +    T  +GT GYMAPEVL    Y+   D +S G+  +E  
Sbjct: 135 EQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193

Query: 316 CCDMPYPDLSFSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKR 365
               PY   S   +   +  +        P    +   + + +  + +P KR
Sbjct: 194 RGKRPYRGHS-RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 50/302 (16%)

Query: 101 LIIKGAFARGTFGTVHRG-------IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V            D   VAVK L         +    + R  F +E
Sbjct: 7   IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---------KDPTLAARKDFQRE 57

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--- 210
             +   L H ++ KF G       L                 +V EY   G L  +L   
Sbjct: 58  AELLTNLQHEHIVKFYGVCGDGDPL----------------IMVFEYMKHGDLNKFLRAH 101

Query: 211 -----------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT 259
                       +  + +L    ++ +A  +A G+ YL S+  VHRD+ T N L+     
Sbjct: 102 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161

Query: 260 VKIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
           VKI DFG++R + +++ + + G T   + +M PE +    +  + DV+SFG+ LWEI+  
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221

Query: 318 -DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              P+  LS +EV   +  Q    E PR CP  + ++M  CW   P +R  + E+  +L 
Sbjct: 222 GKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280

Query: 377 AI 378
           A+
Sbjct: 281 AL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V++      G+ VA+K +    E+ +    I ++R     E+ +  KL HPN+ +
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIR-----EIKLLQKLRHPNIVR 62

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQL 226
                + TS+                  +V EY  H   L   L+ +   K     +   
Sbjct: 63  LKE--IVTSK------------GKGSIYMVFEYMDHD--LTG-LLDSPEVKFTESQIKCY 105

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGTL 285
              L  GL YL S  I+HRD+K  N+L++    +K+ADFG+AR     N  D T    TL
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL 165

Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWEIY 315
            Y  PE+L G+  Y  + D++S G  L E++
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELF 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 98.9 bits (246), Expect = 4e-23
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 3/164 (1%)

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           ++ L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 275 P-HDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTS 331
           P +   G+    L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E   
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
             +++  R   P      +   M  CW   P +RP   E+V  L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 63/282 (22%), Positives = 106/282 (37%), Gaps = 51/282 (18%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESH-RSEAEIASLRAAFTQEVAVWHKLD-HPN 164
            G+F TV         ++ A+K+LD   +     E ++  +      E  V  +L+ HP 
Sbjct: 11  EGSFSTVVLAKEKETNKEYAIKILD---KRQLIKEKKVKYV----KIEKEVLTRLNGHPG 63

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + K          L                  V+EY   G L  Y+   +   L  K   
Sbjct: 64  IIKLYYTFQDEENLYF----------------VLEYAPNGELLQYI--RKYGSLDEKCTR 105

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--------------- 269
             A ++   L YL SK I+HRD+K EN+LLDK   +KI DFG A+               
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165

Query: 270 -LEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
               S             GT  Y++PE+LN     +  D+++ G  ++++     P+   
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           +       ++   L    P   P    +++++    +P  R 
Sbjct: 226 NEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.6 bits (240), Expect = 7e-23
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 28/279 (10%)

Query: 99  AKLIIKGAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV 156
           A   I+    RG F  V+R   + D + VA+K      +    E   A  R    +E+ +
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALK------KVQIFEMMDAKARQDCVKEIDL 55

Query: 157 WHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--IKNR 214
             +L+HPNV K++ + +  +ELNI                V+E    G L   +   K +
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNI----------------VLELADAGDLSQMIKYFKKQ 99

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           +R +  + V +  + L   + ++ S++++HRD+K  N+ +  T  VK+ D G+ R  +S 
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAV 333
                   GT  YM+PE ++ + YN K D++S G  L+E+     P Y D          
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219

Query: 334 VRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEV 371
           + Q   P +P    S  L  ++  C   +PD+RP++  V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 34/192 (17%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
            +V+EY  GG L S L++N         V  L  D+AR         L YL S  I+HRD
Sbjct: 69  YLVMEYLPGGDLAS-LLEN---------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--------GTLGYMAPEVLNGSAY 298
           +K +N+L+D    +K+ DFG++++          +         GT  Y+APEV+ G  +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 299 NRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVM 354
           ++  D +S G  L+E      P+    P+  F  + +  +     PE       ++ +++
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE---WPEDVEVSDEAI-DLI 234

Query: 355 KRCWDANPDKRP 366
            +    +P+KR 
Sbjct: 235 SKLLVPDPEKRL 246

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 3/157 (1%)

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASNPHDMTG 280
           +++ +  +A+G+ +L SK  +HRDV   N+LL   R  KI DFG+AR  +  SN      
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLR 339
               + +MAPE +    Y  + DV+S+GI LWEI+     PYP +  +     +V++  +
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              P   P  + ++MK CW+  P +RP   ++  +++
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 77/287 (26%), Positives = 138/287 (48%), Gaps = 39/287 (13%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRA 148
           E +  K+ + G+   G FGTV++GI+  DG++    VA+K+L     S ++  EI     
Sbjct: 6   ETELKKVKVLGS---GAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEI----- 56

Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
               E  V   +  P V + +G  + TS + + T      MP             G L  
Sbjct: 57  --LDEAYVMAGVGSPYVCRLLGICL-TSTVQLVTQL----MPY------------GCLLD 97

Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           Y+ +N+ R +  + ++   + +A+G+SYL+  ++VHRD+   N+L+     VKI DFG+A
Sbjct: 98  YVRENKDR-IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Query: 269 RLEASNPHDMTGETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLS 325
           RL   +  +   + G   + +MA E +    +  + DV+S+G+ +WE+      PY  + 
Sbjct: 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216

Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             E+   + +    P+ P  C   +  +M +CW  + + RP   E+V
Sbjct: 217 AREIPDLLEKGERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 96.1 bits (239), Expect = 1e-22
 Identities = 80/273 (29%), Positives = 131/273 (47%), Gaps = 48/273 (17%)

Query: 109 RGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           +GT+G V    Y  +D      +A+K     E   R    +  L     +E+A+   L H
Sbjct: 18  KGTYGIV----YAARDLSTQVRIAIK-----EIPERDSRYVQPLH----EEIALHSYLKH 64

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK- 221
            N+ +++G+          ++NG          + +E   GG+L S L++++   L    
Sbjct: 65  RNIVQYLGSD---------SENGFFK-------IFMEQVPGGSL-SALLRSKWGPLKDNE 107

Query: 222 -VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVA-RLEASNPHDM 278
             +I     +  GL YL   +IVHRD+K +N+L++  +  VKI+DFG + RL   NP   
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167

Query: 279 TGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
           T  TGTL YMAPEV++     Y    D++S G  + E+     P+ +L   E  +A+ + 
Sbjct: 168 TF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL--GEPQAAMFKV 224

Query: 337 NL---RPEIPRCCPSSLANVMKRCWDANPDKRP 366
            +    PEIP    +   N + RC++ +PDKR 
Sbjct: 225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 80/300 (26%), Positives = 133/300 (44%), Gaps = 49/300 (16%)

Query: 101 LIIKGAFARGTFGTVH----RGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ES R +         F +E
Sbjct: 7   IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---------FQRE 57

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             +   L H ++ +F G         + T+   + M       V EY   G L  +L  +
Sbjct: 58  AELLTVLQHQHIVRFYG---------VCTEGRPLLM-------VFEYMRHGDLNRFLRSH 101

Query: 214 RRR-------------KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
                           +L    ++ +A  +A G+ YL S   VHRD+ T N L+ +   V
Sbjct: 102 GPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161

Query: 261 KIADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC- 317
           KI DFG++R + +++ + + G T   + +M PE +    +  + D++SFG+ LWEI+   
Sbjct: 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221

Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             P+  LS +E    +  Q    E PR CP  +  +M+ CW   P +R  + ++ + L+A
Sbjct: 222 KQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 3/178 (1%)

Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
             +K+ L  +    L    ++     +ARG+ +L SK  VHRD+   N+LL + + VKI 
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279

Query: 264 DFGVAR--LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMP 320
           DFG+AR  +  SN          + +MAPE +  + Y    DV+S+GI LWEI+     P
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Query: 321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           YP +         ++   R   P      + ++M +CW++ P+KRP    +  ++E++
Sbjct: 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 27/203 (13%)

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEA-EIASLRAAFTQEVAVWHKLDHPNVT 166
           GT+  V++      G+ VA+K +  GE     +     +LR     E+ +  +L HPN+ 
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-----EIKLLQELKHPNII 65

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             +      S +N+                V E+      K  +IK++   L    +   
Sbjct: 66  GLLDVFGHKSNINL----------------VFEFMETDLEK--VIKDKSIVLTPADIKSY 107

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            L   RGL YL S  I+HRD+K  N+L+     +K+ADFG+AR   S    MT +  T  
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW 167

Query: 287 YMAPEVLNGS-AYNRKCDVYSFG 308
           Y APE+L G+  Y    D++S G
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVG 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 43/291 (14%)

Query: 102 IIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           I  G F +   G  HRG+   + V VK L       R+ A     +  F QEV  + +L+
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKAR-VVVKEL-------RASATPDE-QLLFLQEVQPYRELN 53

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLA 219
           HPNV + +G  + +                    +V+E+C  G LK+YL  NR    ++A
Sbjct: 54  HPNVLQCLGQCIESIPY----------------LLVLEFCPLGDLKNYLRSNRGMVAQMA 97

Query: 220 FKVVIQ-LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
            K V+Q +A ++A GL +L     +H D+   N  L    +VKI D+G+A  +    + +
Sbjct: 98  QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157

Query: 279 TGETGT--LGYMAPEVLNGSAYN-------RKCDVYSFGICLWEIY-CCDMPYPDLSFSE 328
           T +     L ++APE++     +       +K +++S G+ +WE++   D PYPDLS  +
Sbjct: 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217

Query: 329 VTSAVVR-QNL---RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           V   VVR Q++   +P++          VM+ CW  +P+ RP  +EV  +L
Sbjct: 218 VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 6/172 (3%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++ ++ R           A ++  GL +L  + I++RD+K +N+LL
Sbjct: 72  FFVMEYVNGGDLMFHIQRSGRFDEP--RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           D    +KIADFG+ + E       T    GT  Y+APE+L+   Y    D ++ G+ L+E
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188

Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +     P+      E+  +++   +R   PR       +++K     NP+KR
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 70/203 (34%), Positives = 99/203 (48%), Gaps = 28/203 (13%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+R      G+ VA+K L    E  +    I SLR     E+ +  KL HPN+  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLR-----EINILLKLQHPNIVT 68

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQL 226
                +G S L+       I M       V+EY  H   LKS L++  ++      V  L
Sbjct: 69  VKEVVVG-SNLD------KIYM-------VMEYVEH--DLKS-LMETMKQPFLQSEVKCL 111

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            L L  G+++L    I+HRD+KT N+LL+    +KI DFG+AR   S     T    TL 
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW 171

Query: 287 YMAPEVLNGSA-YNRKCDVYSFG 308
           Y APE+L G+  Y+   D++S G
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 82/266 (30%), Positives = 121/266 (45%), Gaps = 40/266 (15%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAE-IASLRAAFTQEVAVWHKLDHPNV 165
           RG FG V    Y   G+  A+K L  G+   R E E +   +  F  E A  +   HP +
Sbjct: 9   RGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF--ETA--NSERHPFL 64

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-----RRRKLAF 220
                          QT++ H+       C V+EY  GG L  ++  +     R    A 
Sbjct: 65  VNLFAC--------FQTED-HV-------CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA 108

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
            VV+        GL YL   KIV+RD+K +N+LLD    VKIADFG+ + E     D T 
Sbjct: 109 CVVL--------GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTS 159

Query: 281 E-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
              GT  ++APEVL  ++Y R  D +  G+ ++E+   + P+P     EV  ++V  N  
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDE 217

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKR 365
              PR       ++M+R    NP++R
Sbjct: 218 VRYPRFLSREAISIMRRLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 33/274 (12%)

Query: 109 RGTFGTVHRGIYD-GQDVAVK--LLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           +G +GTV+ G+ + GQ +AVK   LD       +E E   L+    +EV +   L H N+
Sbjct: 10  KGAYGTVYCGLTNQGQLIAVKQVELDTSNVL-AAEKEYEKLQ----EEVDLLKSLKHVNI 64

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +++G  +  + ++I                 +E+  GG++ S L  NR   L   V  +
Sbjct: 65  VQYLGTCLDDNTISI----------------FMEFVPGGSISSIL--NRFGPLPEPVFCK 106

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR------LEASNPHDMT 279
               +  G++YL +  +VHRD+K  N++L     +K+ DFG AR      L  ++ + + 
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVVRQNL 338
              GT  +MAPEV+N S Y RK D++S G  ++E+     P   +   + +      + L
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL 226

Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P +P    ++  + +  C   +  +RP   +++
Sbjct: 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 93.5 bits (232), Expect = 8e-22
 Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 32/276 (11%)

Query: 102 IIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           IIK     G+FG ++  +   D +   +K +D   +    E E      A  +EV +  K
Sbjct: 4   IIK-KIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKE------ASKKEVILLAK 55

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           + HPN+  F  +      L I                V+EYC GG L   +  NR+R + 
Sbjct: 56  MKHPNIVTFFASFQENGRLFI----------------VMEYCDGGDLMKRI--NRQRGVL 97

Query: 220 FK--VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV-KIADFGVARLEASNPH 276
           F    ++   + ++ GL ++  +KI+HRD+K++N+ L K   V K+ DFG+AR    +  
Sbjct: 98  FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                 GT  Y++PE+     YN K D++S G  L+E+     P+   +  ++   + + 
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
              P  P      L +++ + +  +P  RP +  ++
Sbjct: 218 YFAPISPN-FSRDLRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 94.8 bits (235), Expect = 9e-22
 Identities = 73/262 (27%), Positives = 122/262 (46%), Gaps = 30/262 (11%)

Query: 107 FARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       + E  IA    A T  E  V     HP
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T          + + QT         +  C V+EY +GG L  +L  +R R  +    
Sbjct: 56  FLTSL--------KYSFQT--------KDRLCFVMEYVNGGELFFHL--SRERVFSEDRT 97

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S KIV+RD+K EN++LDK   +KI DFG+ +   ++   M    G
Sbjct: 98  RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +    ++   ++ ++++   P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FP 215

Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R   +   +++      +P+KR
Sbjct: 216 RTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 47/275 (17%)

Query: 110 GTFGTVHRGIY--DGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G  GTV++  +    + +AVK+  LD   E  +   +I S       E+ + +K D P +
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMS-------ELEILYKCDSPYI 61

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             F GA    + ++I T                E+  GG+L  Y      RK+   V+ +
Sbjct: 62  IGFYGAFFVENRISICT----------------EFMDGGSLDVY------RKIPEHVLGR 99

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +A+ + +GL+YL S KI+HRDVK  NML++    VK+ DFGV+  +  N    T   GT 
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKT-YVGTN 157

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
            YMAPE ++G  Y    DV+S GI   E+     PYP +      S +  Q L+  +   
Sbjct: 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI-QKNQGSLMPLQLLQCIVDED 216

Query: 346 CP--------SSLANVMKRCWDANPDKRPEMDEVV 372
            P            + + +C    P +RP  + ++
Sbjct: 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 40/280 (14%)

Query: 108 ARGTFGTVHRGI--YDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            +GT+G V + +   +G   AVK+LD   +     EAE   L+A            DHPN
Sbjct: 27  GKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS----------DHPN 76

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRR-RKLA 219
           V KF G        N            +   +V+E C+GG++    K +L +  R  +  
Sbjct: 77  VVKFYGMYYKKDVKN-----------GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
              ++  AL    GL +L   K +HRDVK  N+LL     VK+ DFGV+    S      
Sbjct: 126 IAYILHEAL---MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 280 GETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
              GT  +MAPEV+       S Y+ +CDV+S GI   E+   D P  DL        + 
Sbjct: 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242

Query: 335 RQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           R N  P +  P    +   + +++C   + +KRP + +++
Sbjct: 243 R-NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 35/218 (16%)

Query: 108 ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAE----IASLRAAFTQEVAVWHKLD 161
             G +GTV++   +  G+ VA+K +          +E    +++LR     E+A+  +L+
Sbjct: 8   GEGAYGTVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLR-----EIALLKQLE 56

Query: 162 ---HPNVTKFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK 217
              HPN+ + +    G      +TD    + +       V E+     L +YL K  +  
Sbjct: 57  SFEHPNIVRLLDVCHG-----PRTDRELKLTL-------VFEHVDQD-LATYLSKCPKPG 103

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +  L   L RG+ +L S +IVHRD+K +N+L+     VKIADFG+AR+  S    
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMA 162

Query: 278 MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           +T    TL Y APEVL  S+Y    D++S G    E++
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 48/224 (21%)

Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLL------DWGEESHRSEAEIASLRAAFTQEV 154
           I G    G  G V   +    G+ VA+K +            +++  EI +L+A      
Sbjct: 4   ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP--NQALREIKALQA------ 55

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVV-EYCHGGALKSYLIKN 213
                  HP V K +                    P     V+V EY     L S ++++
Sbjct: 56  -----CQHPYVVKLLDVF-----------------PHGSGFVLVMEYM-PSDL-SEVLRD 91

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
             R L    V      L +G++Y+ +  I+HRD+K  N+L+     +KIADFG+ARL + 
Sbjct: 92  EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151

Query: 274 N-PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
             P   + +  T  Y APE+L G+   RK   Y  G+ LW + C
Sbjct: 152 EEPRLYSHQVATRWYRAPELLYGA---RK---YDPGVDLWAVGC 189

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 28/272 (10%)

Query: 107 FARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
             +G FG V+   YD   G+++AVK + +  ES  +  E+ +L      E+ +   L H 
Sbjct: 10  LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALEC----EIQLLKNLLHE 64

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            + ++ G      E  +               + +E+  GG++K  L       L   V 
Sbjct: 65  RIVQYYGCLRDPMERTLS--------------IFMEHMPGGSIKDQL--KSYGALTENVT 108

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS---NPHDMTG 280
            +    +  G+SYL S  IVHRD+K  N+L D    VK+ DFG ++   +   +   M  
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
            TGT  +M+PEV++G  Y RK D++S G  + E+     P+ +         +  Q   P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            +P        + +KR +      RP  DE++
Sbjct: 229 VLPPHVSDHCRDFLKRIF-VEAKLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 17/222 (7%)

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E  +  K+ HPN+  F  +            +GH+        +V+EYC GG L   + 
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEA---------DGHL-------YIVMEYCDGGDLMQKIK 90

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
             R +      ++Q  + +  G+ ++  K+++HRD+K++N+ L +   VK+ DFG ARL 
Sbjct: 91  LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150

Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
            S         GT  Y+ PE+     YN K D++S G  L+E+     P+   S+  +  
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
            V + + +P +P      L +++K+ +  NP  RP    +++
Sbjct: 211 KVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 49/284 (17%)

Query: 112 FGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           FG V++G   G       Q VA+K L       + +AE   LR  F  E  +  +L HPN
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTL-------KDKAEGP-LREEFKHEAMMRSRLQHPN 69

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI------------- 211
           +   +G         + T    + M       +  YC    L  +L+             
Sbjct: 70  IVCLLG---------VVTKEQPLSM-------IFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 212 -KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR- 269
            K  +  L     + +   +A G+ +L S  +VH+D+ T N+L+     VKI+D G+ R 
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 270 LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 327
           + A++ + + G +   + +M+PE +    ++   D++S+G+ LWE++   + PY   S  
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +V   +  + + P  P  CP+ +  +M  CW+  P +RP   ++
Sbjct: 234 DVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 27/256 (10%)

Query: 107 FARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
             RG FG V+   YD   G+++AVK + +  +S  +  E+ +L      E+ +   L H 
Sbjct: 10  LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQLLKNLRHD 64

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            + ++ G      E  +               + VEY  GG++K  L       L   V 
Sbjct: 65  RIVQYYGCLRDPEEKKLS--------------IFVEYMPGGSIKDQL--KAYGALTENVT 108

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG--- 280
            +    + +G+SYL S  IVHRD+K  N+L D    VK+ DFG ++   +     TG   
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
            TGT  +M+PEV++G  Y RK DV+S    + E+     P+ +         +  Q  +P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228

Query: 341 EIPRCCPSSLANVMKR 356
            +P     +  + +K+
Sbjct: 229 MLPDGVSDACRDFLKQ 244

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 91.4 bits (227), Expect = 4e-21
 Identities = 57/223 (25%), Positives = 110/223 (49%), Gaps = 21/223 (9%)

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +EVAV   + HPN+ ++  +           +NG++        +V++YC GG L  Y  
Sbjct: 48  KEVAVLSNMKHPNIVQYQESF---------EENGNL-------YIVMDYCEGGDL--YKK 89

Query: 212 KNRRRKLAF--KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
            N +R + F    ++   + +   L ++  +KI+HRD+K++N+ L K  T+K+ DFG+AR
Sbjct: 90  INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149

Query: 270 LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 329
           +  S         GT  Y++PE+     YN K D+++ G  L+E+      +   +   +
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209

Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
              ++R +  P +       L N++ + +  NP  RP ++ ++
Sbjct: 210 VLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 73/262 (27%), Positives = 117/262 (44%), Gaps = 30/262 (11%)

Query: 107 FARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T          +   QT         +  C V+EY +GG L  +L  +R R    +  
Sbjct: 56  FLT--------ALKYAFQT--------HDRLCFVMEYANGGELFFHL--SRERVFTEERA 97

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 98  RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 215

Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 216 RTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 44/275 (16%)

Query: 110 GTFGTVHRGIY--DGQD----VAVKLL-DW-GEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           G FGTVH+GI+  +G      VA+K + D  G ++ +            T  +     LD
Sbjct: 18  GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ----------EITDHMLAMGSLD 67

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK 221
           H  + + +G   G S   +Q              +V +    G+L  + ++  R  L  +
Sbjct: 68  HAYIVRLLGICPGAS---LQ--------------LVTQLSPLGSLLDH-VRQHRDSLDPQ 109

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD---M 278
            ++   + +A+G+ YL+  ++VHR++   N+LL     V+IADFGVA L    P D    
Sbjct: 110 RLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYF 167

Query: 279 TGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 336
             E  T + +MA E +    Y  + DV+S+G+ +WE+      PY  +   EV   ++ +
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEK 226

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             R   P+ C   +  VM +CW  + + RP   E+
Sbjct: 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 71/208 (34%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+R      G+ VA+K +    E  R    I+SLR     E+ +   L HPN+ +
Sbjct: 18  GTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSLR-----EITLLLNLRHPNIVE 70

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
                +G    +I            F  +V+EYC    L S L+ N     +   V  L 
Sbjct: 71  LKEVVVGKHLDSI------------F--LVMEYCEQD-LAS-LLDNMPTPFSESQVKCLM 114

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           L L RGL YL    I+HRD+K  N+LL     +KIADFG+AR        MT +  TL Y
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174

Query: 288 MAPEVLNGS-AYNRKCDVYSFGICLWEI 314
            APE+L G   Y    D+++ G  L E+
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAEL 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 28/272 (10%)

Query: 107 FARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
             +G FG V+   YD   G+++A K + +  ES  +  E+++L      E+ +   L H 
Sbjct: 10  LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQHE 64

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            + ++ G     +E  +               + +EY  GG++K  L       L   V 
Sbjct: 65  RIVQYYGCLRDRAEKTLT--------------IFMEYMPGGSVKDQL--KAYGALTESVT 108

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEA--SNPHDMTG 280
            +    +  G+SYL S  IVHRD+K  N+L D    VK+ DFG + RL+    +   +  
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
            TGT  +M+PEV++G  Y RK DV+S G  + E+     P+ +         +  Q   P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           ++P    S  A     C       RP  +E++
Sbjct: 229 QLPSHI-SEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 69/220 (31%), Positives = 101/220 (45%), Gaps = 36/220 (16%)

Query: 109 RGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHPNV 165
           +GTFG V   R    G+  A+K+L       + E  IA    A T  E  V     HP +
Sbjct: 5   KGTFGKVILVREKATGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFK 221
           T          + + QT         +  C V+EY +GG L  +L + R     R   + 
Sbjct: 58  TAL--------KYSFQT--------HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 101

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
             I  AL       YL S  +V+RD+K EN++LDK   +KI DFG+ +   S+   M   
Sbjct: 102 AEIVSALG------YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 35/289 (12%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRG---IYDGQD--VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I+     G FG + RG   +   ++  VA+  L  G             R  
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRG 52

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E     + DH N+ +  G     + + I                V EY   GAL S+
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMI----------------VTEYMSNGALDSF 96

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L K+  + +A +++  L   LA G+ YL     VH+ +    +L++     KI+ F   +
Sbjct: 97  LRKHEGQLVAGQLMGMLP-GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155

Query: 270 LEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 326
            + S      M+G++  L + APE +    ++   DV+SFGI +WE+    + PY D+S 
Sbjct: 156 EDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            +V  AV     R   PR CP+ L  +M  CW     +RP   ++ ++L
Sbjct: 215 QDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 46/127 (36%), Positives = 68/127 (53%), Gaps = 8/127 (6%)

Query: 206 LKSYLIKNRRR-KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD 264
           L +YL K  R   +   ++I+  +    GL YL +++I+HRDVKTEN+ ++    V I D
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQI--LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGD 200

Query: 265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
            G A+     P  + G  GT+   APEVL    YN K D++S GI L+E+    + YP  
Sbjct: 201 LGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM----LAYPST 255

Query: 325 SFSEVTS 331
            F +  S
Sbjct: 256 IFEDPPS 262

Length = 357

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 16/179 (8%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++  + R   A       A ++  GL +L  K I++RD+K +N+LLDK
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFDEARARF--YAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGET------GTLGYMAPEVLNGSAYNRKCDVYSFGIC 310
              +KIADFG+ +        M GE       GT  Y+APE+L G  YN   D +SFG+ 
Sbjct: 132 DGHIKIADFGMCKEN------MNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185

Query: 311 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
           L+E+     P+      E+  +++  N RP  PR       + + + ++ +P KR  +D
Sbjct: 186 LYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVD 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)

Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
           +L HPN+ ++    +    L I                V++   G  L  +    + +K 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYI----------------VMDLIEGAPLGEHFNSLKEKKQ 108

Query: 219 AF------KVVIQLALDLARGLSYL-QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
            F       + +Q+ L     L YL + K+IVHRD+   N++L +   V I DFG+A+ +
Sbjct: 109 RFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164

Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
                 +T   GT+ Y  PE++    Y  K DV++FG  L+++     P+   +   + +
Sbjct: 165 QPESK-LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            +V     P         + +V+  C   + + RP++ +V AM+
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 48/292 (16%)

Query: 89  VRRQEWEIDPAKLI-IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIAS 145
           VRR   ++DP ++  I G    G FG V++      G   A K+++      +SE E+  
Sbjct: 4   VRR---DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELED 55

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
               +  E+ +    +HP + K +GA     +L I                ++E+C GGA
Sbjct: 56  ----YMVEIEILATCNHPYIVKLLGAFYWDGKLWI----------------MIEFCPGGA 95

Query: 206 LKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           + + +++  R   +   +V+ +  L+    L YL S KI+HRD+K  N+LL     +K+A
Sbjct: 96  VDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152

Query: 264 DFGVARLEASNPHDMTGETGTLGYMAPEV-----LNGSAYNRKCDVYSFGICLWEIYCCD 318
           DFGV+              GT  +MAPEV     +  + Y+ K D++S GI L E+   +
Sbjct: 153 DFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212

Query: 319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLA----NVMKRCWDANPDKRP 366
            P+ +L+   V   + +    P +    PS  +    + +K   D +P+ RP
Sbjct: 213 PPHHELNPMRVLLKIAKSE-PPTLS--QPSKWSMEFRDFLKTALDKHPETRP 261

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.4 bits (221), Expect = 4e-20
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 47/297 (15%)

Query: 101 LIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ++ R +         F +E
Sbjct: 7   IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD---------FHRE 57

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK- 212
             +   L H ++ KF G  +    L                 +V EY   G L  +L   
Sbjct: 58  AELLTNLQHEHIVKFYGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAH 101

Query: 213 ----------NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI 262
                     NR  +L    ++ +A  +A G+ YL S+  VHRD+ T N L+ +   VKI
Sbjct: 102 GPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161

Query: 263 ADFGVAR-LEASNPHDMTGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DM 319
            DFG++R + +++ + + G T   + +M PE +    +  + DV+S G+ LWEI+     
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
           P+  LS +EV   + +  +  + PR CP  + ++M  CW   P  R  + E+ ++L+
Sbjct: 222 PWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 40/274 (14%)

Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I G    G FG V++       V  A K++D      +SE E+      +  E+ +    
Sbjct: 9   IIGELGDGAFGKVYKAQNKETGVLAAAKVID-----TKSEEELED----YMVEIDILASC 59

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKL 218
           DHPN+ K + A    + L I                ++E+C GGA+ + +++  R   + 
Sbjct: 60  DHPNIVKLLDAFYYENNLWI----------------LIEFCAGGAVDAVMLELERPLTEP 103

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             +VV +  L+    L+YL   KI+HRD+K  N+L      +K+ADFGV+          
Sbjct: 104 QIRVVCKQTLE---ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Query: 279 TGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
               GT  +MAPEV+         Y+ K DV+S GI L E+   + P+ +L+   V   +
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220

Query: 334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKR 365
            +    P +  P    S   + +K+C + N D R
Sbjct: 221 AKSE-PPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 42/230 (18%)

Query: 102 IIKGAF-ARGTFGTVHRGI--YDGQDVA---VKLLDWGEESHRSEAEIASLRAAFT--QE 153
           I KGA    GT+G V +      G+ VA   VK+++   +  +    +      FT  +E
Sbjct: 11  IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + + +++ H N+       MG  ++ ++ D         F  +V++       K   + +
Sbjct: 71  LKIMNEIKHENI-------MGLVDVYVEGD---------FINLVMDIMASDLKK---VVD 111

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
           R+ +L    V  + L +  GL+ L     +HRD+   N+ ++     KIADFG+AR    
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171

Query: 274 NPH--------------DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFG 308
            P+              +MT +  TL Y APE+L G+  Y+   D++S G
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221

Length = 335

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 70/295 (23%)

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVT 166
           GTFG+V+       G+ VA+K +   ++   S  E  +LR     EV    KL +HPN+ 
Sbjct: 10  GTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLR-----EVKSLRKLNEHPNIV 61

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQ 225
           K         E+  + D  +          V EY  G   +  L+K+R+ +  +  V+  
Sbjct: 62  KLK-------EVFRENDELYF---------VFEYMEGNLYQ--LMKDRKGKPFSESVIRS 103

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGT 284
           +   + +GL+++      HRD+K EN+L+     VKIADFG+AR + +  P+  T    T
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVST 161

Query: 285 LGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY------------------CCDMPYPDLS 325
             Y APE+L  S  Y+   D+++ G  + E+Y                  C  +  P   
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221

Query: 326 -FSEVTSAVVRQNLRPEIPRCCPSSL-----------ANVMKRC--WDANPDKRP 366
            + E      +   R   P+  P+SL            +++K    WD  P KRP
Sbjct: 222 DWPEGYKLASKLGFR--FPQFAPTSLHQLIPNASPEAIDLIKDMLRWD--PKKRP 272

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 57/185 (30%), Positives = 94/185 (50%), Gaps = 26/185 (14%)

Query: 142 EI-ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
           EI  ++R    +E+ V H+ + P +  F GA     E++I              C+  E+
Sbjct: 37  EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI--------------CM--EH 80

Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRT 259
             GG+L   L K  R  +   ++ ++++ + RGL+YL+ K KI+HRDVK  N+L++    
Sbjct: 81  MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138

Query: 260 VKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
           +K+ DFGV+        D    +  GT  YM+PE L G+ Y  + D++S G+ L E+   
Sbjct: 139 IKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Query: 318 DMPYP 322
             P P
Sbjct: 195 RYPIP 199

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 80/262 (30%), Positives = 116/262 (44%), Gaps = 44/262 (16%)

Query: 108 ARGTFGTVHR--GIYDGQDVAVKLLD-WGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            +GT+G V++     DG   AVK+LD   +     EAE   L++            +HPN
Sbjct: 31  GKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL----------PNHPN 80

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA----LKSYLIKNRRRKLAF 220
           V KF G      +L      G + +       V+E C+GG+    +K  LI  +R   A 
Sbjct: 81  VVKFYGMFYKADKLV----GGQLWL-------VLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
              I     L  GL +L + +I+HRDVK  N+LL     VK+ DFGV+    S       
Sbjct: 130 ISYILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 281 ETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
             GT  +MAPEV+        +Y+ +CDV+S GI   E+   D P  D+   +       
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF---- 243

Query: 336 QNLRPEIPRCCPSSLANVMKRC 357
                +IPR  P +L +  K C
Sbjct: 244 -----KIPRNPPPTLLHPEKWC 260

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)

Query: 192 NFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           ++  +V+EY +GG   S LIK     L      Q   ++  G+  L  + I+HRD+K EN
Sbjct: 70  DYLYLVMEYLNGGDCAS-LIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127

Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +L+D+T  +K+ DFG++R    N        GT  Y+APE + G   ++  D +S G  +
Sbjct: 128 LLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILGVGDDKMSDWWSLGCVI 183

Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E      P+    PD  F  + S  +  N   E+   C     +++ R    +P KR
Sbjct: 184 FEFLFGYPPFHAETPDAVFDNILSRRI--NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 16/175 (9%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++    +  L        A ++  GL +L SK IV+RD+K +N+LLD 
Sbjct: 74  VMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGET------GTLGYMAPEVLNGSAYNRKCDVYSFGIC 310
              +KIADFG+ +       +M G+       GT  Y+APE+L G  YN   D +SFG+ 
Sbjct: 132 DGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVL 185

Query: 311 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           L+E+     P+      E+  ++   N  P  PR       +++ + +   P++R
Sbjct: 186 LYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 43/293 (14%)

Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I  G F +   G V+ G    Q V VK L       R  A +      F +E   +  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQ-VVVKEL-------RVSASVQEQMK-FLEEAQPYRS 51

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+ + +G     +                   +V+E+C  G LK YL   R+ +L 
Sbjct: 52  LQHSNLLQCLGQCTEVTPY----------------LLVMEFCPLGDLKGYLRSCRKAELM 95

Query: 220 ---FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
                 + ++A ++A GL +L     +H D+   N LL    TVKI D+G++  +    +
Sbjct: 96  TPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155

Query: 277 DMTGETG--TLGYMAPEVLNGSAYN-------RKCDVYSFGICLWEIY-CCDMPYPDLSF 326
            +T +     L ++APE+++    N       ++ +V+S G+ +WE++     PY  LS 
Sbjct: 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215

Query: 327 SEVTSAVVR-QNLRPEIPRC-CPSS--LANVMKRCWDANPDKRPEMDEVVAML 375
            +V +  VR Q L+   PR   P S     VM+ CW   P++RP  +EV  +L
Sbjct: 216 EQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 45/276 (16%)

Query: 110 GTFGTVH--RGIYDGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           GT+G V+  R +  G+  A+K+  L+ GE+            A   QE+ +     H N+
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDF-----------AVVQQEIIMMKDCKHSNI 68

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS-YLIKNRRRKLAFKVVI 224
             + G+ +   +L I                 +E+C GG+L+  Y +     +     V 
Sbjct: 69  VAYFGSYLRRDKLWIC----------------MEFCGGGSLQDIYHVTGPLSESQIAYVS 112

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   +GL YL SK  +HRD+K  N+LL     VK+ADFGV+    +         GT
Sbjct: 113 RETL---QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT 169

Query: 285 LGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 341
             +MAPEV        YN+ CD+++ GI   E+     P  DL        + + N +P 
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP- 228

Query: 342 IPRC-----CPSSLANVMKRCWDANPDKRPEMDEVV 372
            P+        +S  + +K     NP KRP  ++++
Sbjct: 229 -PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 78/276 (28%), Positives = 123/276 (44%), Gaps = 43/276 (15%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R ++ G+  AVK++         + E     +   QE+ +  +  H N+  
Sbjct: 20  GTYGDVYKARNLHTGELAAVKII---------KLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS-YLIKNRRRKLAFKVVIQL 226
           + G+ +   +L I                 +EYC GG+L+  Y +     +L    V + 
Sbjct: 71  YFGSYLSREKLWI----------------CMEYCGGGSLQDIYHVTGPLSELQIAYVCRE 114

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            L   +GL+YL SK  +HRD+K  N+LL     VK+ADFGVA    +         GT  
Sbjct: 115 TL---QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 287 YMAPEVL----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           +MAPEV     NG  YN+ CD+++ GI   E+     P  DL        + + N +P  
Sbjct: 172 WMAPEVAAVEKNG-GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP-- 228

Query: 343 PRC-----CPSSLANVMKRCWDANPDKRPEMDEVVA 373
           P+        S+  N +K     NP KRP  + ++ 
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEA-EIASLRAAFTQEVAVWHKLDHPNVT 166
           GTFG V   R     Q VA+K +    E    E   I +LR     E+ +   L H NV 
Sbjct: 23  GTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALR-----EIKILQLLKHENVV 74

Query: 167 KFI-----GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK 221
             I      AT            G   +   FC    E+   G     L+ N+  K    
Sbjct: 75  NLIEICRTKATPYNR------YKGSFYLVFEFC----EHDLAG-----LLSNKNVKFTLS 119

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL----EASNPHD 277
            + ++   L  GL Y+   KI+HRD+K  N+L+ K   +K+ADFG+AR     + S P+ 
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179

Query: 278 MTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
            T    TL Y  PE+L G   Y    D++  G  + E++
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 32/209 (15%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 11  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 64  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASPLSGIPLPLIKSYL 106

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 166

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
            APE+L G  Y      YS  + +W + C
Sbjct: 167 RAPEILLGCKY------YSTAVDIWSLGC 189

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 49/169 (28%), Positives = 93/169 (55%), Gaps = 4/169 (2%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+E+ +GG L  + I+++ R   ++     A ++  GL +L SK I++RD+K +N++LD+
Sbjct: 74  VMEFLNGGDLM-FHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
              +KIADFG+ +      +  +   GT  Y+APE+L G  Y    D +SFG+ L+E+  
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191

Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              P+      E+  + +R +  P  PR       +++++ ++ +P +R
Sbjct: 192 GQSPFHGDDEDELFES-IRVD-TPHYPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 35/212 (16%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLL---DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G +G V   R    G+ VA+K     +  E+  ++     +LR     EV V  +L H N
Sbjct: 12  GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT-----ALR-----EVKVLRQLRHEN 61

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +     A      L +                V EY     L+  L++     L    V 
Sbjct: 62  IVNLKEAFRRKGRLYL----------------VFEYVERTLLE--LLEASPGGLPPDAVR 103

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETG 283
                L + ++Y  S  I+HRD+K EN+L+ ++  +K+ DFG AR L A     +T    
Sbjct: 104 SYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163

Query: 284 TLGYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           T  Y APE+L G   Y +  DV++ G  + E+
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 13/178 (7%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY +GG L  ++   R+RKL  +     A ++   L++L  + I++RD+K +N+LLD
Sbjct: 73  LVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130

Query: 256 KTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
               +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+
Sbjct: 131 ADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189

Query: 315 YCCDMPY------PDLSFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKR 365
                P+      PD++  +    V+ +  +P  IPR      ++V+K   + +P +R
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.1 bits (203), Expect = 8e-18
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 59/281 (20%)

Query: 109 RGTFGTVHRGIY----------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
           +GTF  +++G+            GQ+V+V L   G +   S A        F +  ++  
Sbjct: 5   QGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------FFETASLMS 56

Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR-K 217
           +L H ++ K  G  +          + +I        +V EY   G L  +L + +    
Sbjct: 57  QLSHKHLVKLYGVCVR---------DENI--------MVEEYVKFGPLDVFLHREKNNVS 99

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-------TRTVKIADFGVAR- 269
           L +K  + +A  LA  L YL+ KK+VH +V  +N+L+ +          +K++D G+   
Sbjct: 100 LHWK--LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157

Query: 270 -LEASNPHDMTGETGTLGYMAPEVL-NGSAY-NRKCDVYSFGICLWEIYC-CDMPYPDLS 325
            L      +       + ++APE + NG A      D +SFG  L EI    + P   LS
Sbjct: 158 VLSREERVE------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211

Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            SE       Q+  P +P C    LAN++ +CW  +P KRP
Sbjct: 212 SSEKERFYQDQHRLP-MPDCAE--LANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 5/172 (2%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENML 253
           C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN++
Sbjct: 71  CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128

Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++E
Sbjct: 129 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 188

Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           + C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 189 MMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.5 bits (203), Expect = 1e-17
 Identities = 70/282 (24%), Positives = 127/282 (45%), Gaps = 36/282 (12%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP K   +     +G  GTV+    I  GQ+VA+K ++  ++  +              E
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE---------LIINE 66

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  +  +PN+  ++ + +   EL                 VV+EY  GG+L   + + 
Sbjct: 67  ILVMRENKNPNIVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTET 110

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     V +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG       
Sbjct: 111 CMDEGQIAAVCRECL---QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA- 332
                +   GT  +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALY 225

Query: 333 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           ++  N  PE+  P    +   + + RC + + D+R    E++
Sbjct: 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 62/250 (24%), Positives = 112/250 (44%), Gaps = 32/250 (12%)

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           S+R    +E+ + H+   P +  F GA +         +  +I       C+ +E+   G
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFL---------NENNI-------CMCMEFMDCG 88

Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L    I  +   +  +++ ++A+ +  GL+YL +  +I+HRD+K  N+L++    +K+ 
Sbjct: 89  SLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLC 146

Query: 264 DFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY-- 321
           DFGV+  E  N    T   GT  YM+PE + G  Y  K DV+S GI + E+     P+  
Sbjct: 147 DFGVSG-ELINSIADTF-VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Query: 322 -PDLSFSEVTSAVVRQNLR-------PEIPRCC-PSSLANVMKRCWDANPDKRPEMDEVV 372
                  +     +   L+       P +P    P  L + +  C   +P +RP   ++ 
Sbjct: 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264

Query: 373 AMLEAIDTSK 382
           AM   I   +
Sbjct: 265 AMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 39/264 (14%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G  GTV+  I    GQ+VA+K ++  ++  +              E+ V  +  HPN+ 
Sbjct: 29  QGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE---------LIINEILVMRENKHPNIV 79

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            ++ + +   EL                 VV+EY  GG+L   + +    +     V + 
Sbjct: 80  NYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 123

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            L   + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT  
Sbjct: 124 CL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEIPRC 345
           +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+   
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQN- 237

Query: 346 CPSSLANVMK----RCWDANPDKR 365
            P  L+ + +    RC + + +KR
Sbjct: 238 -PEKLSAIFRDFLNRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 36/286 (12%)

Query: 101 LIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV-AVW 157
           L   G   RG FGTV++ ++   G  +AVK +     S   E E   L      ++  V 
Sbjct: 6   LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLL----MDLDVVM 57

Query: 158 HKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK 217
              D P + KF GA     +  I  +   I +   F   V  Y     LKS + +    K
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMELMDISL-DKFYKYV--YEV---LKSVIPEEILGK 111

Query: 218 LAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNP 275
           +A   V        + L+YL+ + KI+HRDVK  N+LLD+   +K+ DFG++ +L  S  
Sbjct: 112 IAVATV--------KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163

Query: 276 HDMTGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTS 331
              T + G   YMAPE ++ S    Y+ + DV+S GI L+E+     PYP   S  +  +
Sbjct: 164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221

Query: 332 AVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
            VV+ +   L     R    S  N +  C   +  KRP+  E++  
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 13/178 (7%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LLD 
Sbjct: 74  VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 132 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 316 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+        PD +  +    V+ +  +  IPR      A+V+K   + +P +R
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 36/282 (12%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP K   +     +G  GTV     +  GQ+VA+K ++  ++  +              E
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE---------LIINE 66

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  +L +PN+  F+ + +   EL                 VV+EY  GG+L   + + 
Sbjct: 67  ILVMKELKNPNIVNFLDSFLVGDEL----------------FVVMEYLAGGSLTDVVTET 110

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     V +  L   + L +L + +++HRD+K++N+LL    +VK+ DFG       
Sbjct: 111 CMDEAQIAAVCRECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA- 332
                +   GT  +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALY 225

Query: 333 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           ++  N  PE+  P        + + RC + + +KR    E++
Sbjct: 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 32/209 (15%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R E E   + +   +E+++  +L+HPN+ +
Sbjct: 10  GTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +      ++L +                V E+     LK Y+  +    L   ++    
Sbjct: 63  LLDVVHSENKLYL----------------VFEFLDLD-LKKYMDSSPLTGLDPPLIKSYL 105

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +G++Y  S +++HRD+K +N+L+D+   +K+ADFG+AR         T E  TL Y
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWY 165

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
            APE+L GS        YS  + +W I C
Sbjct: 166 RAPEILLGSRQ------YSTPVDIWSIGC 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 108 ARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             G+ G V        G+ VAVK +D  ++  R              EV +     HPN+
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHPNI 78

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +   + +   EL                 VV+E+  GGAL   +   R  +     V  
Sbjct: 79  VEMYSSYLVGDEL----------------WVVMEFLEGGALTDIVTHTRMNEEQIATVCL 122

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG-VARLEASNPHDMTGETGT 284
             L   + LS+L ++ ++HRD+K++++LL     VK++DFG  A++    P   +   GT
Sbjct: 123 AVL---KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-LVGT 178

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             +MAPEV++   Y  + D++S GI + E+   + PY
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 41/272 (15%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+FG V+  R +   + VA+K + + G++S+    +I        +EV    +L HPN  
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------IKEVRFLQQLRHPNTI 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++ G  +                      +V+EYC G A  S +++  ++ L    +  +
Sbjct: 79  EYKGCYLREHT----------------AWLVMEYCLGSA--SDILEVHKKPLQEVEIAAI 120

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
                +GL+YL S + +HRD+K  N+LL +  TVK+ADFG A L   +P +     GT  
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL--VSPANSF--VGTPY 176

Query: 287 YMAPEV---LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNLRPE 341
           +MAPEV   ++   Y+ K DV+S GI   E+     P  +++     SA+  + QN  P 
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNDSPT 233

Query: 342 IPRCCPS-SLANVMKRCWDANPDKRPEMDEVV 372
           +     S    N +  C    P  RP  +E++
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 36/282 (12%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP K   +     +G  GTV+    +  GQ+VA++ ++  ++  +              E
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINE 67

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  +  +PN+  ++ + +   EL                 VV+EY  GG+L   + + 
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTET 111

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     V +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG       
Sbjct: 112 CMDEGQIAAVCRECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA- 332
                +   GT  +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALY 226

Query: 333 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           ++  N  PE+  P    +   + + RC D + +KR    E++
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPN 164
           G +GTV+  R  + G  VA+K       S R +     L  +  +EVA+  +L   DHPN
Sbjct: 11  GAYGTVYKARDPHSGHFVALK-------SVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + + +     TS  + +T             +V E+     L++YL K     L  + + 
Sbjct: 64  IVRLMDVC-ATSRTDRETK----------VTLVFEHVDQD-LRTYLDKVPPPGLPAETIK 111

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            L     RGL +L +  IVHRD+K EN+L+     VK+ADFG+AR+  S    +T    T
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVT 170

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           L Y APEVL  S Y    D++S G    E++
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 110 GTFGTVHRGI--YDGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           GT+ TV++G     G+ VA+K   LD  EE   S A          +E+++  +L H N+
Sbjct: 11  GTYATVYKGRNRTTGEIVALKEIHLD-AEEGTPSTA---------IREISLMKELKHENI 60

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL-IKNRRRKLAFKVVI 224
            +            I T+N  +        +V EY     LK Y+     R  L    V 
Sbjct: 61  VRLHDV--------IHTENKLM--------LVFEYMDKD-LKKYMDTHGVRGALDPNTVK 103

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
                L +G+++    +++HRD+K +N+L++K   +K+ADFG+AR      +  + E  T
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 285 LGYMAPEVLNGS-AYNRKCDVYSFGICLWEIY 315
           L Y AP+VL GS  Y+   D++S G  + E+ 
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 23/180 (12%)

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 45  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 88

Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L + +R  +  +++ ++++ + RGL+YL+ K +I+HRDVK  N+L++    +K+ 
Sbjct: 89  SLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC 146

Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +   G   T  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 1/148 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++     R L  + VI  +  +  G+ +L S  IV+RD+K EN+LL
Sbjct: 69  CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL 128

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D     +++D G+A +E  +   +T   GT GYMAPE+L    Y+   D ++ G  ++E+
Sbjct: 129 DDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187

Query: 315 YCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
                P+ D         + R+ L  E+
Sbjct: 188 VAGRTPFKDHKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 41/244 (16%)

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 45  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 88

Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K    ++  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 89  SLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 146

Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +   G   T  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203

Query: 323 -------DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
                  +L F         ++     PR     L++         PD RP M    A+ 
Sbjct: 204 PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY-------GPDSRPPM----AIF 252

Query: 376 EAID 379
           E +D
Sbjct: 253 ELLD 256

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 45/286 (15%)

Query: 110 GTFGTVHRG-IYDGQDVA---VKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G FG V    IY    VA   VK L     S             F Q+   +  L HPN+
Sbjct: 6   GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE--------FLQQGDPYRILQHPNI 57

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVV 223
            + +G  +               +P     +V EYC  G LKSYL +    RR     ++
Sbjct: 58  LQCLGQCVE-------------AIPY---LLVFEYCELGDLKSYLSQEQWHRRNSQLLLL 101

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET- 282
            ++A ++A G++++     +H D+   N  L    TVK+ D+G+        +  T +  
Sbjct: 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161

Query: 283 -GTLGYMAPEV-------LNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAV 333
              L ++APE+       L  +   +  +V++ G+ LWE++     PY  LS  EV + V
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221

Query: 334 VRQN----LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           ++       +P++          V++ CW  +P+KR   +EV  +L
Sbjct: 222 IKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 110 GTFGTVHRGI--YDGQDVAVKL--LDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           GT+GTV +       + VA+K   LD  +E   S A    LR     E+ +  +L H N+
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LR-----EICLLKELKHKNI 61

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +         +L +                V EYC    LK Y   +    +  ++V  
Sbjct: 62  VRLYDVLHSDKKLTL----------------VFEYCDQD-LKKYF-DSCNGDIDPEIVKS 103

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
               L +GL++  S  ++HRD+K +N+L++K   +K+ADFG+AR         + E  TL
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL 163

Query: 286 GYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
            Y  P+VL G+  Y+   D++S G    E+
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 68/238 (28%), Positives = 116/238 (48%), Gaps = 36/238 (15%)

Query: 97  DPAKLI-IKGAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DPA +  +      GT+G V++G  +  GQ  A+K++D  E+    E EI         E
Sbjct: 13  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEI-------KLE 62

Query: 154 VAVWHKLDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           + +  K  H  N+  + GA +  S        GH     +   +V+E+C  G++   +  
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSP------PGH----DDQLWLVMEFCGAGSVTDLVKN 112

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLE 271
            +   L    +  +  ++ RGL++L + K++HRD+K +N+LL +   VK+ DFGV A+L+
Sbjct: 113 TKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172

Query: 272 ASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIY-----CCDM 319
            +     T   GT  +MAPEV+       + Y+ + D++S GI   E+       CDM
Sbjct: 173 RTVGRRNTF-IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 225 QLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
           ++A+ + + L YL SK  ++HRDVK  N+L+++   VK+ DFG++     +    T + G
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG-YLVDSVAKTIDAG 165

Query: 284 TLGYMAPEVLNG----SAYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSAVVRQN 337
              YMAPE +N       Y+ K DV+S GI + E+     PY      F ++   V  + 
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EE 223

Query: 338 LRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVVAM 374
             P++P    S    + + +C   N  +RP   E++  
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 45/129 (34%), Positives = 68/129 (52%), Gaps = 1/129 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++             I  A  +  GL +L  ++IV+RD+K EN+LL
Sbjct: 69  CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL 128

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    V+I+D G+A +E      + G  GT GYMAPEVL G  Y+   D ++ G  L+E+
Sbjct: 129 DDHGNVRISDLGLA-VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187

Query: 315 YCCDMPYPD 323
                P+  
Sbjct: 188 IAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 45/244 (18%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV----AVWHKLDHP 163
           GTFG VH  R        A+K++        +  E+  L+    Q V     V  ++ HP
Sbjct: 12  GTFGRVHLVRDRISEHYYALKVM--------AIPEVIRLKQ--EQHVHNEKRVLKEVSHP 61

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            + +             + D   + M       ++EY  GG L SYL +N  R   F   
Sbjct: 62  FIIRLFWT---------EHDQRFLYM-------LMEYVPGGELFSYL-RNSGR---FSNS 101

Query: 224 IQL--ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
             L  A ++   L YL SK+IV+RD+K EN+LLDK   +K+ DFG A+       D T  
Sbjct: 102 TGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWT 157

Query: 282 -TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GT  Y+APEV+    +N+  D ++ GI ++E+     P+ D +   +   ++   L  
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-- 215

Query: 341 EIPR 344
           E PR
Sbjct: 216 EFPR 219

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 10/172 (5%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFK--VVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           V+EY +GG L  Y I+   +   FK    +  A ++A GL +L SK I++RD+K +N++L
Sbjct: 79  VMEYVNGGDLM-YHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           D    +KIADFG+ + E       T    GT  Y+APE++    Y +  D ++FG+ L+E
Sbjct: 135 DAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193

Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +     P+      E+  +++  N     P+       ++ K     +P KR
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 81/306 (26%), Positives = 135/306 (44%), Gaps = 42/306 (13%)

Query: 77  TRSRSSSTTSASVRRQEWEIDPAKLIIK-GAFARGTFGTVH--RGIYDGQDVAVKLLDW- 132
           + SR+ S     +    ++ DP KL         G+FG V+  R +   + VA+K + + 
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS 61

Query: 133 GEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSN 192
           G++S+    +I        +EV    ++ HPN  ++ G  +                  +
Sbjct: 62  GKQSNEKWQDI-------IKEVKFLQRIKHPNSIEYKGCYL----------------REH 98

Query: 193 FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
              +V+EYC G A  S L++  ++ L    +  +     +GL+YL S  ++HRD+K  N+
Sbjct: 99  TAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156

Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV---LNGSAYNRKCDVYSFGI 309
           LL +   VK+ADFG A + +          GT  +MAPEV   ++   Y+ K DV+S GI
Sbjct: 157 LLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Query: 310 CLWEIYCCDMPYPDLSFSEVTSAV--VRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRP 366
              E+       P L      SA+  + QN  P +     S    N +  C    P  RP
Sbjct: 213 TCIEL---AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRP 269

Query: 367 EMDEVV 372
             +E++
Sbjct: 270 TSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 80/283 (28%), Positives = 124/283 (43%), Gaps = 42/283 (14%)

Query: 97  DPAKLIIK-GAFARGTFGTVH--RGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQ 152
           DP KL         G+FG V+  R + + + VA+K + + G++S+    +I        +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------IK 64

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV    KL HPN  ++ G  +                  +   +V+EYC G A  S L++
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYL----------------REHTAWLVMEYCLGSA--SDLLE 106

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             ++ L    +  +     +GL+YL S  ++HRDVK  N+LL +   VK+ DFG A + A
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 273 SNPHDMTGETGTLGYMAPEV---LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 329
                     GT  +MAPEV   ++   Y+ K DV+S GI   E+       P L     
Sbjct: 167 P----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNA 219

Query: 330 TSAV--VRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMD 369
            SA+  + QN  P +     S    N +  C    P  RP  +
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 52/277 (18%)

Query: 109 RGTFGTVHRGIY-----DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           +GTF  + +GI       G+    +V +K+LD   +SHR+ +E      +F +  ++  +
Sbjct: 5   QGTFTKIFKGIRREVGDYGELHKTEVLLKVLD---KSHRNYSE------SFFEAASMMSQ 55

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H ++    G  +   E         I        +V EY   G+L +YL KN+   + 
Sbjct: 56  LSHKHLVLNYGVCVCGDE--------SI--------MVQEYVKFGSLDTYLKKNKN-LIN 98

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-----DKTRT---VKIADFGVARLE 271
               +++A  LA  L +L+ K + H +V  +N+LL      KT     +K++D G++   
Sbjct: 99  ISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--I 156

Query: 272 ASNPHDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
              P ++  E   + ++ PE + N    +   D +SFG  LWEI+   D P   LS  + 
Sbjct: 157 TVLPKEILLE--RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP---LSALDS 211

Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              +     R ++P    + LAN++ +C D  PD RP
Sbjct: 212 QKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRP 248

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 44/175 (25%)

Query: 197 VVEYCHGGALKSYLIKNR--RRKLA-FKVV-IQLALDLARGLSYLQSKKIVHRDVKTENM 252
           V+EY  GG L + LI+      + A F +  + LALD    L +      +HRD+K +N+
Sbjct: 79  VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF------IHRDIKPDNI 132

Query: 253 LLDKTRTVKIADFGVA------------RLEASNPHDMTGET-----------------G 283
           L+D    +K+ADFG+               ++ N                         G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
           T  Y+APEVL G+ Y  +CD +S G+ L+E     M Y    F   T       +
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYE-----MLYGFPPFYSDTLQETYNKI 242

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GTFG V++      G+ VA+K +    E  +    I +LR     E+ +  KL HPNV  
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALR-----EIKILKKLKHPNVVP 71

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            I       ++ ++  +       +   V     H     S L++N   KL    +    
Sbjct: 72  LI-------DMAVERPDKSKRKRGSVYMVTPYMDHD---LSGLLENPSVKLTESQIKCYM 121

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP-----------H 276
           L L  G++YL    I+HRD+K  N+L+D    +KIADFG+AR     P            
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 277 DMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
             T    T  Y  PE+L G   Y    D++  G    E++
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 15/151 (9%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL-DLARGLSYLQSKKIVHRDVKTENMLL 254
           +V+EY  GG L S L  NR      + + Q  L +L   +  +     VHRD+K EN+L+
Sbjct: 78  LVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 255 DKTRTVKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLN------GSAYNRKCDVYSF 307
           D+T  +K+ADFG  ARL A+   +     GT  Y+APEVL          Y  +CD +S 
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 308 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
           G+  +E+     P     F E TSA    N+
Sbjct: 196 GVIAYEMIYGRSP-----FHEGTSAKTYNNI 221

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 36/238 (15%)

Query: 97  DPAKLI-IKGAFARGTFGTVHRG--IYDGQDVAVKLLD-WGEESHRSEAEIASLRAAFTQ 152
           DPA +  +      GT+G V++G  +  GQ  A+K++D  G+E    + EI  L+     
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-- 60

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
                    H N+  + GA +  +           GM      +V+E+C  G++   +  
Sbjct: 61  --------HHRNIATYYGAFIKKNP---------PGMDDQLW-LVMEFCGAGSVTDLIKN 102

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLE 271
            +   L  + +  +  ++ RGLS+L   K++HRD+K +N+LL +   VK+ DFGV A+L+
Sbjct: 103 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162

Query: 272 ASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIY-----CCDM 319
            +     T   GT  +MAPEV+       + Y+ K D++S GI   E+       CDM
Sbjct: 163 RTVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 33/229 (14%)

Query: 115 VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG 174
           + R  + G+ VAVK++D  ++  R              EV +     H NV +   + + 
Sbjct: 39  IAREKHSGRQVAVKMMDLRKQQRRE---------LLFNEVVIMRDYQHQNVVEMYKSYLV 89

Query: 175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGL 234
             EL                 V++E+  GGAL   + + R  +     V +  L   + L
Sbjct: 90  GEEL----------------WVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL---QAL 130

Query: 235 SYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN 294
            YL S+ ++HRD+K++++LL     VK++DFG     + +        GT  +MAPEV++
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190

Query: 295 GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
            + Y  + D++S GI + E+   + PY    FS+     +++ LR   P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKR-LRDSPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 4/169 (2%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L   + +  R K    V    A ++A GL +L SK I++RD+K +N++LD 
Sbjct: 79  VMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136

Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
              +KIADFG+ +    +        GT  Y+APE++    Y +  D ++FG+ L+E+  
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              P+      E+  +++  N+    P+        + K     +P KR
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 234 LSYLQSKK-IVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPE 291
           L YL+ K  ++HRDVK  N+LLD +  VK+ DFG++ RL  S     T   G   YMAPE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184

Query: 292 VLN----GSAYNRKCDVYSFGICLWEIYCCDMPYP--DLSFSEVTSAVVRQNLRPEIPRC 345
            ++       Y+ + DV+S GI L E+     PY      F EV + ++++   P +P  
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEEP-PSLPPN 242

Query: 346 CPSS--LANVMKRCWDANPDKRPEMDE 370
              S    + +  C   +  KRP+  E
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRE 269

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V++G     GQ VA+K +       R E+E   + +   +E+++  +L HPN+  
Sbjct: 11  GTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK-LAFKVVIQL 226
                M  S L +                + E+     LK YL    + + +  ++V   
Sbjct: 64  LQDVLMQESRLYL----------------IFEFLSMD-LKKYLDSLPKGQYMDAELVKSY 106

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              + +G+ +  S++++HRD+K +N+L+D    +K+ADFG+AR         T E  TL 
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW 166

Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APEVL GS  Y+   D++S G    E+
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 38/279 (13%)

Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           ++ +     +G +G+V++ ++    V + +     +  R E + +        E+ + HK
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHRPTGVTMAM-----KEIRLELDESKFNQ-IIMELDILHK 55

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL-KSYLIKNRRRKL 218
              P +  F GA                   + + C+  EY   G+L K Y        +
Sbjct: 56  AVSPYIVDFYGAFFIEG--------------AVYMCM--EYMDAGSLDKLYAGGVATEGI 99

Query: 219 AFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPH 276
              V+ ++   + +GL +L+ +  I+HRDVK  N+L++    VK+ DFGV+  L AS   
Sbjct: 100 PEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159

Query: 277 DMTGETGTLGYMAPEVLNG------SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV- 329
                 G   YMAPE +          Y  + DV+S G+ + E+     PYP  +++ + 
Sbjct: 160 T---NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216

Query: 330 --TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              SA+V  +  P +P        + + +C +  P++RP
Sbjct: 217 AQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 39/120 (32%), Positives = 65/120 (54%), Gaps = 1/120 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++          +  +  A ++  GL  L  ++IV+RD+K EN+LL
Sbjct: 76  CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A +E      + G  GT+GYMAPEV+    Y    D +  G  ++E+
Sbjct: 136 DDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 15/180 (8%)

Query: 196 VVVEYCHGGALKSYLIKNRRR-KLAFK------VVIQLALDLARGLSYLQSKKIVHRDVK 248
           +V++Y + G L+   IK+R +    F+      + IQ+ L     + ++ SK ++HRD+K
Sbjct: 116 LVLDYANAGDLRQE-IKSRAKTNRTFREHEAGLLFIQVLL----AVHHVHSKHMIHRDIK 170

Query: 249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYS 306
           + N+LL     VK+ DFG +++ A+   D  G T  GT  Y+APE+     Y++K D++S
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230

Query: 307 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            G+ L+E+     P+   +  EV    +     P  P   P  +  ++     ++P +RP
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP-EMQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 27/207 (13%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVT 166
           GT+G V+  R    G+ VA+K         R E +   +     +E+++   L     + 
Sbjct: 12  GTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---RKLAFKVV 223
           + +         +++  NG   +      +V EY     LK ++  N R   R L  K +
Sbjct: 65  RLLDVE------HVEEKNGKPSL-----YLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTI 112

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV-KIADFGVARLEASNPHDMTGET 282
                 L +G+++     ++HRD+K +N+L+DK + + KIAD G+ R  +      T E 
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 283 GTLGYMAPEVLNGSA-YNRKCDVYSFG 308
            TL Y APEVL GS  Y+   D++S G
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVG 199

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 33/89 (37%), Positives = 52/89 (58%)

Query: 233 GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV 292
           GL +L  ++I++RD+K EN+LLD    V+I+D G+A           G  GT G+MAPE+
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168

Query: 293 LNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           L G  Y+   D ++ G+ L+E+     P+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 120 YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN 179
           + G+ VAVK +D  ++  R              EV +     H NV     + +   EL 
Sbjct: 45  HTGKQVAVKKMDLRKQQRRE---------LLFNEVVIMRDYHHENVVDMYNSYLVGDEL- 94

Query: 180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS 239
                           VV+E+  GGAL   +   R  +   + +  + L + R LSYL +
Sbjct: 95  ---------------WVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHN 136

Query: 240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN 299
           + ++HRD+K++++LL     +K++DFG     +          GT  +MAPEV++   Y 
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196

Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
            + D++S GI + E+   + PY    F+E     +R+ +R  +P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY----FNEPPLQAMRR-IRDNLP 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 14/143 (9%)

Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYM 288
           +LA  L +L S  I++RD+K EN+LLD+   +K+ DFG+++    +        GT+ YM
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165

Query: 289 APEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR------QNLRPEI 342
           APEV+N   + +  D +SFG+ ++E+    +P+      E  + +++      Q L PE 
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPE- 224

Query: 343 PRCCPSSLANVMKRCWDANPDKR 365
                S L  + KR    NP  R
Sbjct: 225 ---AQSLLRALFKR----NPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 49/242 (20%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTV----HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRA 148
            W++  +   +      G+FG V    H+G   G+  A+K L         + EI  ++ 
Sbjct: 14  SWKL--SDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCL--------KKREILKMKQ 61

Query: 149 A--FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
                QE ++  +L HP +   + +    + +                  ++E+  GG L
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF----------------LLEFVVGGEL 105

Query: 207 KSYLIK-----NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK 261
            ++L K     N   K     ++ LA +      YL SK I++RD+K EN+LLD    VK
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELV-LAFE------YLHSKDIIYRDLKPENLLLDNKGHVK 158

Query: 262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           + DFG A+        +    GT  Y+APEV+    + +  D ++ G+ L+E      P+
Sbjct: 159 VTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Query: 322 PD 323
            D
Sbjct: 216 FD 217

Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 27/230 (11%)

Query: 165 VTKFI------GATMGTSELNIQTDNGHIGMPSNF--------CCVVVEYCHGGALKSYL 210
           V KF+       A    SEL+      H G+  +F          +++EY  GG L   +
Sbjct: 97  VAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI 156

Query: 211 IKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
            +  +  L F+   V  L   +   L  + S+K++HRD+K+ N+ L  T  +K+ DFG +
Sbjct: 157 KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216

Query: 269 RLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +  + +       +  GT  Y+APE+     Y++K D++S G+ L+E+     P+   S 
Sbjct: 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD----ANPDKRPEMDEVV 372
            E+   V+     P      P  +++ MK   D     NP  RP   +++
Sbjct: 277 REIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 43/127 (33%), Positives = 69/127 (54%), Gaps = 1/127 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++          +  I  A +L  GL  LQ ++IV+RD+K EN+LL
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A ++      + G  GT+GYMAPEV+N   Y    D +  G  ++E+
Sbjct: 136 DDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194

Query: 315 YCCDMPY 321
                P+
Sbjct: 195 IQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 36/225 (16%)

Query: 97  DPAKLIIK-GAFARGTFGTVHRGI--YDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQ 152
           DP ++ +       G+FG V+     +  + VAVK + + G++++    +I        +
Sbjct: 18  DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-------IK 70

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV    +L HPN  ++ G  +                  +   +V+EYC G A  S L++
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYL----------------KEHTAWLVMEYCLGSA--SDLLE 112

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             ++ L    +  +     +GL+YL S  ++HRD+K  N+LL +   VK+ADFG     A
Sbjct: 113 VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG----SA 168

Query: 273 SNPHDMTGETGTLGYMAPEV---LNGSAYNRKCDVYSFGICLWEI 314
           S         GT  +MAPEV   ++   Y+ K DV+S GI   E+
Sbjct: 169 SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 38/228 (16%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEES--H--RSEAEIASLR 147
           WE+ P +         G +G V        G+ VA+K L    +S  H  R+  E+  L+
Sbjct: 11  WEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK 69

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCV-VVEYCHGGAL 206
                     H +DH NV   IG       L++ T    +    +F  V +V +  G  L
Sbjct: 70  ----------H-MDHENV---IGL------LDVFTPASSL---EDFQDVYLVTHLMGADL 106

Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
            + +   + +KL+   +  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG
Sbjct: 107 NNIV---KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163

Query: 267 VARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWE 313
           +AR       +MTG   T  Y APE+ LN   YN+  D++S G  + E
Sbjct: 164 LAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 37/256 (14%)

Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 45  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 92

Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +     V    L + + LS L ++ 
Sbjct: 93  -------------WVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQG 136

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 302 CDVYSFGICLWEIYCCDMPY---PDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY   P L        ++R NL P++        SL   + R
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252

Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 253 LLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 23/183 (12%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+E+  GG L  ++   R+RKL  +     + +++  L++L  + I++RD+K +N+LLD 
Sbjct: 74  VIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 316 CCDMPY-------------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 362
               P+              D  F  +    +R      IPR      ++V+K   + +P
Sbjct: 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPRSLSVKASSVLKGFLNKDP 244

Query: 363 DKR 365
            +R
Sbjct: 245 KER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 54/202 (26%)

Query: 200 YCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT 259
           Y +G      L ++R RK  F+++        RG+ +  S  I+HRD+K EN+L+ ++  
Sbjct: 93  YPNG------LDESRVRKYLFQIL--------RGIEFCHSHNIIHRDIKPENILVSQSGV 138

Query: 260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLW------ 312
           VK+ DFG AR  A+     T    T  Y APE+L G + Y R  D+++ G CL       
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG-CLVTEMLTG 197

Query: 313 ----------------------------EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
                                       EI+  +  +  +   EV      + L    P+
Sbjct: 198 EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI---EPLEKRFPK 254

Query: 345 CCPSSLANVMKRCWDANPDKRP 366
                L ++ K+C   +PD RP
Sbjct: 255 LSGLVL-DLAKQCLRIDPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 36/79 (45%), Positives = 48/79 (60%), Gaps = 2/79 (2%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAP 290
           RGL YL S  I+HRD+K  N+L++    +KI DFG+AR+E  +    MT E  T  Y AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 291 EVLNGSA-YNRKCDVYSFG 308
           E+L GS  Y    D++S G
Sbjct: 174 EILMGSRHYTSAVDIWSVG 192

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 49/174 (28%), Positives = 88/174 (50%), Gaps = 15/174 (8%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E+  GG   ++L +N+R      V    A  +     YLQS  IV+RD+K EN+LLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165

Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           K   +K+ DFG A++  +  + +    GT  Y+APE+L    + +  D ++ GI ++EI 
Sbjct: 166 KDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Query: 316 CCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+    P L + ++   ++        P+   ++  ++MK+    +  KR
Sbjct: 223 VGCPPFYANEPLLIYQKILEGIIY------FPKFLDNNCKHLMKKLLSHDLTKR 270

Length = 340

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V++Y +GG L  +L   R R          A ++A  + YL S  I++RD+K EN+LLD 
Sbjct: 74  VLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              V + DFG+ + E   P + T    GT  Y+APEVL    Y+R  D +  G  L+E+ 
Sbjct: 132 QGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
               P+     S++   ++ + L  ++P  
Sbjct: 191 YGLPPFYSRDVSQMYDNILHKPL--QLPGG 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 10/137 (7%)

Query: 193 FCCV--------VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH 244
           +CC         V+E+ +GG L  ++ K+RR   A       A ++   L +L  K I++
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--YAAEITSALMFLHDKGIIY 119

Query: 245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDV 304
           RD+K +N+LLD     K+ADFG+ +    N    +   GT  Y+APE+L    Y    D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 305 YSFGICLWEIYCCDMPY 321
           ++ G+ L+E+ C   P+
Sbjct: 180 WAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGY 287
           RGL Y+ S  ++HRD+K  N+LL+    +KI DFG+AR+     HD    +T    T  Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE-HDHTGFLTEYVATRWY 175

Query: 288 MAPEV-LNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+ LN   Y +  D++S G  L E+   
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 28/75 (37%), Positives = 43/75 (57%), Gaps = 3/75 (4%)

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
            +HRD+K EN L+D +  +K+ DFG+++   +  + + G      YMAPEVL G  Y+  
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSP---DYMAPEVLRGKGYDFT 178

Query: 302 CDVYSFGICLWEIYC 316
            D +S G  L+E  C
Sbjct: 179 VDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 46/174 (26%), Positives = 87/174 (50%), Gaps = 14/174 (8%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   +  K      +  A +++ GL +L  + I++RD+K +N++LD 
Sbjct: 79  VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136

Query: 257 TRTVKIADFGVARLEASNPHDMTGET-----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
              +KIADFG+ +      H + G T     GT  Y+APE++    Y +  D +++G+ L
Sbjct: 137 EGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191

Query: 312 WEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+      E+  +++  N+    P+       ++ K     +P KR
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 1/127 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++             +  A ++  GL  L  ++IV+RD+K EN+LL
Sbjct: 76  CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL 135

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A +       + G  GT+GYMAPEV+    Y    D ++ G  L+E+
Sbjct: 136 DDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194

Query: 315 YCCDMPY 321
                P+
Sbjct: 195 IAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 27/212 (12%)

Query: 105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
                GT+ TV +G     +  V L +   E H   A   ++R     EV++   L H N
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIR-----EVSLLKNLKHAN 64

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVV-EYCHGGALKSYLIKNRRRKLAFKVV 223
           +                    H  + +  C  +V EY     LK YL  N    ++   V
Sbjct: 65  IVTL-----------------HDIIHTERCLTLVFEYLDSD-LKQYL-DNCGNLMSMHNV 105

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                 L RGLSY   +KI+HRD+K +N+L+++   +K+ADFG+AR ++      + E  
Sbjct: 106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165

Query: 284 TLGYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           TL Y  P+VL GS  Y+   D++  G  L+E+
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 44/177 (24%), Positives = 92/177 (51%), Gaps = 11/177 (6%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           ++++Y +GG L ++L +      + +V + +A ++   L +L    I++RD+K EN+LLD
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQLGIIYRDIKLENILLD 139

Query: 256 KTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNG--SAYNRKCDVYSFGICLW 312
               V + DFG+++   +   +      GT+ YMAPEV+ G    +++  D +S G+  +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199

Query: 313 EIYCCDMPYP----DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+       S SE++  +++    P  P+   +   + +++  + +P KR
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTL 285
           L RGL Y+ S  ++HRD+K  N+L+++   ++I DFG+AR  +S+P +    MT    T 
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWE 313
            Y APE+L     Y    D++S G    E
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAE 204

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 14/167 (8%)

Query: 197 VVEYCHGGALKSYLIKNR-----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           V+++ +GG L  +L + R     R +         A ++A  L YL S  IV+RD+K EN
Sbjct: 74  VLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLHSINIVYRDLKPEN 126

Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +LLD    V + DFG+ +   +     T   GT  Y+APEV+    Y+   D +  G  L
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVL 186

Query: 312 WEIYCCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKR 356
           +E+     P+     +E+   ++ +   LRP       S L  ++++
Sbjct: 187 YEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 1/127 (0%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++          +  +  A ++  GL  L  +  V+RD+K EN+LL
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL 135

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A ++      + G  GT+GYMAPEVLN   Y    D +  G  ++E+
Sbjct: 136 DDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194

Query: 315 YCCDMPY 321
                P+
Sbjct: 195 IEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 40/225 (17%)

Query: 108 ARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            RG FG V   R     +  A+KLL   E   RS++      A F +E  +    + P V
Sbjct: 52  GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSPWV 105

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRRKLAFK 221
            +   A           D+ ++ M       V+EY  GG L     +Y +  +  K  + 
Sbjct: 106 VQLFCAFQ---------DDKYLYM-------VMEYMPGGDLVNLMSNYDVPEKWAKF-YT 148

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTG 280
             + LALD       + S  ++HRDVK +NMLLDK   +K+ADFG   +++ +       
Sbjct: 149 AEVVLALDA------IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 281 ETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
             GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 4/81 (4%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL---EASNPHDMTGETGTLGYM 288
           RGL YL S  ++HRD+K  N+L++    +KI DFG+AR    +      +T    T  Y 
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 289 APEV-LNGSAYNRKCDVYSFG 308
           APE+ L+ S Y +  D++S G
Sbjct: 174 APELLLSSSRYTKAIDIWSVG 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 39/174 (22%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL------EASNPHDMTGETG 283
           L + L Y+ S  ++HRD+K  N+LL+    VK+ADFG+AR          NP  +T    
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP-VLTDYVA 174

Query: 284 TLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCC--------------------DMPYP 322
           T  Y APE+L GS  Y +  D++S G  L E+                         P  
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 323 -DLS--FSEVTSAVV-------RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            D+    S   + ++       R+ L   +P+    +L +++K+    NP+KR 
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL-DLLKKLLVFNPNKRL 287

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 36/86 (41%), Positives = 48/86 (55%), Gaps = 1/86 (1%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMA 289
           L RGL Y+ S  ++HRD+K  N+LL+    +KI DFG+AR  +     MT    T  Y A
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176

Query: 290 PEV-LNGSAYNRKCDVYSFGICLWEI 314
           PE+ LN S Y    DV+S G    E+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 6/163 (3%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V++Y +GG L  +L   R R          A ++A  L YL S  I++RD+K EN+LLD 
Sbjct: 74  VLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              V + DFG+ + E       T    GT  Y+APEVL    Y+R  D +  G  L+E+ 
Sbjct: 132 QGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190

Query: 316 CCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKR 356
               P+     +E+   ++ +   L+P I       L  ++++
Sbjct: 191 YGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 40/198 (20%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
           C+V+EY  GG   + L+KN         +  L +D+AR         L YL +  IVHRD
Sbjct: 77  CMVMEYVEGGDCAT-LLKN---------IGALPVDMARMYFAETVLALEYLHNYGIVHRD 126

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASN------PHDMTGET---------GTLGYMAPE 291
           +K +N+L+     +K+ DFG++++   +         +  +T         GT  Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186

Query: 292 VLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCP 347
           V+    Y +  D ++ GI L+E     +P+    P+  F +V S  +     PE     P
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---EWPEGDEALP 243

Query: 348 SSLANVMKRCWDANPDKR 365
           +   +++ R    NP +R
Sbjct: 244 ADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 39/106 (36%), Positives = 53/106 (50%), Gaps = 3/106 (2%)

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           LIK R+R L  K V      L + L ++    I HRD+K EN+L+     +K+ADFG  R
Sbjct: 89  LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCR 147

Query: 270 LEASNPHDMTGETGTLGYMAPE-VLNGSAYNRKCDVYSFGICLWEI 314
              S P   T    T  Y APE +L    Y  K D+++ G   +EI
Sbjct: 148 GIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 16/181 (8%)

Query: 138 RSEAEIASLRAAFTQEVAVWHKLD---HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFC 194
           R +     +  +  +EVAV   L+   HPNV +        S  + +T            
Sbjct: 36  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT-VSRTDRETK----------L 84

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
            +V E+     L +YL K     +  + +  +   L RGL +L S ++VHRD+K +N+L+
Sbjct: 85  TLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 143

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             +  +K+ADFG+AR+  S    +T    TL Y APEVL  S+Y    D++S G    E+
Sbjct: 144 TSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Query: 315 Y 315
           +
Sbjct: 203 F 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 40/225 (17%)

Query: 108 ARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            RG FG V   R     +  A+KLL   E   RS++      A F +E  +    + P V
Sbjct: 52  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSPWV 105

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRRKLAFK 221
            +   A         Q D         +  +V+EY  GG L     +Y +  +  +  + 
Sbjct: 106 VQLFYA--------FQDDR--------YLYMVMEYMPGGDLVNLMSNYDVPEKWARF-YT 148

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTG 280
             + LALD       + S   +HRDVK +NMLLDK+  +K+ADFG   ++          
Sbjct: 149 AEVVLALD------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 281 ETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
             GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 6/163 (3%)

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V++Y +GG L  +L   R R          A ++A  L YL S  IV+RD+K EN+LLD 
Sbjct: 74  VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131

Query: 257 TRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              + + DFG+ + E    +  T    GT  Y+APEVL+   Y+R  D +  G  L+E+ 
Sbjct: 132 QGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Query: 316 CCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKR 356
               P+   + +E+   ++ +   L+P I       L  ++++
Sbjct: 191 YGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 233

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 33/84 (39%), Positives = 50/84 (59%), Gaps = 4/84 (4%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
           RGL Y+ S  +VHRD+K  N+L+++   +KI DFG+AR++      MTG   T  Y APE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYVSTRYYRAPE 175

Query: 292 V-LNGSAYNRKCDVYSFGICLWEI 314
           + L    Y+ + D++S G    E+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM 199

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 16/141 (11%)

Query: 196 VVVEYCHGGAL----KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           +V+EY  GG L     +Y I  +  +     V+ LALD    + +      +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV-LALDAIHSMGF------IHRDVKPDN 172

Query: 252 MLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSA----YNRKCDVYS 306
           MLLDK+  +K+ADFG   +++A+         GT  Y++PEVL        Y R+CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 307 FGICLWEIYCCDMPYPDLSFS 327
            G+ L+E+   D P+   S  
Sbjct: 233 VGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 34/79 (43%), Positives = 51/79 (64%), Gaps = 2/79 (2%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAP 290
           RG++Y  S +++HRD+K +N+L+D+ T  +K+ADFG+AR         T E  TL Y AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 291 EVLNGS-AYNRKCDVYSFG 308
           E+L GS  Y+   D++S G
Sbjct: 173 EILLGSRHYSTPVDIWSVG 191

Length = 294

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 196 VVVEYCHGGALKSYLIK----NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           +V+ + +GG L  +L +    +  R   +   +  AL+       L    +++RD+K EN
Sbjct: 70  LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALE------NLHKFNVIYRDLKPEN 123

Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +LLD    + + DFG+ +L   +        GT  Y+APE+L G  Y +  D ++ G+ L
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLL 183

Query: 312 WEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
           +E+     P+ D + +E+   ++++ LR
Sbjct: 184 YEMLTGLPPFYDENVNEMYRKILQEPLR 211

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 35/88 (39%), Positives = 52/88 (59%), Gaps = 1/88 (1%)

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L RGLSY+  + I+HRD+K +N+L+  T  +K+ADFG+AR ++   H  + E  TL Y
Sbjct: 110 FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWY 169

Query: 288 MAPEVLNGSAYNRKC-DVYSFGICLWEI 314
             P+VL GS     C D++  G    E+
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)

Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236

Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 33/210 (15%)

Query: 110 GTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFT--QEVAVWHKLDHPNV 165
           G++ TV++G     GQ VA+K +       R E E     A FT  +E ++   L H N+
Sbjct: 16  GSYATVYKGRSKLTGQLVALKEI-------RLEHEEG---APFTAIREASLLKDLKHANI 65

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                    T    I T             +V EY     LK Y+           V + 
Sbjct: 66  V--------TLHDIIHTKKT--------LTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLF 108

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   L RGL+Y   ++++HRD+K +N+L+ +   +K+ADFG+AR ++      + E  TL
Sbjct: 109 L-FQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWEI 314
            Y  P+VL GS  Y+   D++  G   +E+
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 44/124 (35%), Positives = 67/124 (54%), Gaps = 8/124 (6%)

Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           C V+ +Y     L +Y+  +R   L  +  I +   L   L+YL  + I+HRDVKTEN+ 
Sbjct: 162 CMVMPKYKCD--LFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217

Query: 254 LDKTRTVKIADFGVA-RLEAS--NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC 310
           LD+     + DFG A +L+A    P    G +GTL   +PE+L    Y  K D++S G+ 
Sbjct: 218 LDEPENAVLGDFGAACKLDAHPDTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLV 276

Query: 311 LWEI 314
           L+E+
Sbjct: 277 LFEM 280

Length = 392

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 31/230 (13%)

Query: 89  VRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRS-EAEIAS 145
           V +  WE+ P +         G +G+V   I    G+ VA+K L       R  ++EI +
Sbjct: 6   VNKTVWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL------SRPFQSEIFA 58

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            RA   +E+ +   + H NV   +         + +  + ++ MP               
Sbjct: 59  KRA--YRELTLLKHMQHENVIGLLDVFTSAVSGD-EFQDFYLVMPY-------------- 101

Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF 265
           +++ L K     L+   V  L   +  GL Y+ S  I+HRD+K  N+ +++   +KI DF
Sbjct: 102 MQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDF 161

Query: 266 GVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
           G+AR       +MTG   T  Y APEV LN   YN+  D++S G  + E+
Sbjct: 162 GLAR---HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)

Query: 110 GTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFT--QEVAVWHKLDHPNV 165
           G++ TV++GI   +GQ VA+K++     S ++E  +      FT  +E ++   L H N+
Sbjct: 16  GSYATVYKGISRINGQLVALKVI-----SMKTEEGVP-----FTAIREASLLKGLKHANI 65

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                         +  D  H      F   V EY H   L  Y+I++      + V + 
Sbjct: 66  V-------------LLHDIIHTKETLTF---VFEYMHTD-LAQYMIQHPGGLHPYNVRL- 107

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
               L RGL+Y+  + I+HRD+K +N+L+     +K+ADFG+AR ++      + E  TL
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL 167

Query: 286 GYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
            Y  P+VL G+  Y+   D++  G    E+ 
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 40/185 (21%)

Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVE---- 199
           A  R     E  +   ++HP++ +      GT   N             F C+++     
Sbjct: 124 AGQRGGTATEAHILRAINHPSIIQL----KGTFTYN------------KFTCLILPRYKT 167

Query: 200 --YCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
             YC+  A         +R +A   ++ +   + R + YL   +I+HRD+K EN+ ++  
Sbjct: 168 DLYCYLAA---------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP 218

Query: 258 RTVKIADFGVARLEASNPHDMT-----GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
             V + DFG     A  P D+      G  GT+   APE+L    Y    D++S GI L+
Sbjct: 219 GDVCLGDFGA----ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLF 274

Query: 313 EIYCC 317
           E+  C
Sbjct: 275 EMATC 279

Length = 391

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)

Query: 103 IKGAFARGTFGTVHRGI----YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
           I+G   RGT+G V++       DG++ A+K      +  + +    S  A   +E+A+  
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSAC--REIALLR 57

Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
           +L H NV   +   +  ++ ++               ++ +Y         +IK  R+  
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVY--------------LLFDYAEHDLW--QIIKFHRQAK 101

Query: 219 AFKV----VIQLALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARL 270
              +    V  L   +  G+ YL S  ++HRD+K  N+L+     +   VKI D G+ARL
Sbjct: 102 RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Query: 271 EASNPHDMTGETG---TLGYMAPEVLNGSA-YNRKCDVYSFG 308
             +    +        T+ Y APE+L G+  Y +  D+++ G
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 53/269 (19%)

Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
           +E   L+  F +E  +   L HP +       +    +    D  +  MP         Y
Sbjct: 40  SENPLLKKRFLREAKIAADLIHPGI-------VPVYSICSDGDPVYYTMP---------Y 83

Query: 201 CHGGALKSYLIKNRRRK------LAFKVVIQLALDL----ARGLSYLQSKKIVHRDVKTE 250
             G  LKS L+K+  +K      LA K  +   L +       + Y+ SK ++HRD+K +
Sbjct: 84  IEGYTLKS-LLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142

Query: 251 NMLLDKTRTVKIADFGVA---------------RLEASNPHDMT--GE-TGTLGYMAPEV 292
           N+LL     V I D+G A                        MT  G+  GT  YMAPE 
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202

Query: 293 LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP----RCCPS 348
           L G   +   D+Y+ G+ L+++     PY      ++     R  +   I     R  P 
Sbjct: 203 LLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---SYRDVILSPIEVAPYREIPP 259

Query: 349 SLANVMKRCWDANPDKR-PEMDEVVAMLE 376
            L+ +  +    +P +R   + E+   LE
Sbjct: 260 FLSQIAMKALAVDPAERYSSVQELKQDLE 288

Length = 932

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 31/84 (36%), Positives = 55/84 (65%), Gaps = 1/84 (1%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
           RGL+Y   +K++HRD+K +N+L+++   +K+ADFG+AR ++      + E  TL Y  P+
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174

Query: 292 VLNGSA-YNRKCDVYSFGICLWEI 314
           VL GS+ Y+ + D++  G   +E+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 39/122 (31%), Positives = 67/122 (54%), Gaps = 7/122 (5%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             +++  +GG L  +L  ++    +   +   A ++  GL ++ ++ +V+RD+K  N+LL
Sbjct: 73  SFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130

Query: 255 DKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLW 312
           D+   V+I+D G+A       PH      GT GYMAPEVL  G AY+   D +S G  L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187

Query: 313 EI 314
           ++
Sbjct: 188 KL 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 13/132 (9%)

Query: 195 CVVVEYCHGGALKSYLIKN---RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           C +++  +GG L  +L ++     +++ F      A ++  GL ++ ++ +V+RD+K  N
Sbjct: 73  CFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNRFVVYRDLKPAN 127

Query: 252 MLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGI 309
           +LLD+   V+I+D G+A       PH      GT GYMAPEVL  G+AY+   D +S G 
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184

Query: 310 CLWEIYCCDMPY 321
            L+++     P+
Sbjct: 185 MLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +MTG   T 
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATR 181

Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   YN+  D++S G  + E+
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 7/129 (5%)

Query: 196 VVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           +V +Y  GG L  +L K  R     A   + +L L     L +L    IV+RD+K EN+L
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL----ALEHLHKYDIVYRDLKPENIL 128

Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLW 312
           LD T  + + DFG+++   ++        GT  Y+APEV L+   Y +  D +S G+ ++
Sbjct: 129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVF 188

Query: 313 EIYCCDMPY 321
           E+ C   P+
Sbjct: 189 EMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 11/96 (11%)

Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 168

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG 308
                MT    T  Y APEV+ G  Y    D++S G
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 31/86 (36%), Positives = 55/86 (63%), Gaps = 1/86 (1%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMA 289
           L RGL+Y   +K++HRD+K +N+L+++   +K+ADFG+AR ++      + E  TL Y  
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172

Query: 290 PEVLNGSA-YNRKCDVYSFGICLWEI 314
           P++L GS  Y+ + D++  G   +E+
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 41/226 (18%)

Query: 109 RGTFG--TVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG   V +    GQ  A+K+L+  E   R+E       A F +E  V    D   +T
Sbjct: 11  RGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET------ACFREERDVLVNGDRRWIT 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR---KLA-FKV 222
               A         Q +N           +V++Y  GG L + L K   R    +A F +
Sbjct: 65  NLHYA--------FQDEN--------NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108

Query: 223 V-IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTG 280
             + LA+D    L Y      VHRD+K +N+LLDK   +++ADFG   RL A        
Sbjct: 109 AEMVLAIDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV 162

Query: 281 ETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPY 321
             GT  Y++PE+L         Y  +CD +S G+C++E+   + P+
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 30/117 (25%), Positives = 57/117 (48%), Gaps = 14/117 (11%)

Query: 210 LIKNRRR---KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT-VKIADF 265
           L+K   +       K++ QL       L+ L    I+H D+K EN+L D+ +  + + D+
Sbjct: 99  LLKKEGKLSEAEVKKIIRQLV----EALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154

Query: 266 GVARLE-ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           G+ ++    + +D     GTL Y +PE + G  Y+   D ++ G+  +E+     P+
Sbjct: 155 GLCKIIGTPSCYD-----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 44/177 (24%), Positives = 90/177 (50%), Gaps = 11/177 (6%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           ++++Y +GG L ++L + R R    +V I    ++   L +L    I++RD+K EN+LLD
Sbjct: 82  LILDYINGGELFTHLSQ-RERFKEQEVQIYSG-EIVLALEHLHKLGIIYRDIKLENILLD 139

Query: 256 KTRTVKIADFGVAR-LEASNPHDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLW 312
               V + DFG+++              GT+ YMAP+++ G    +++  D +S G+ ++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199

Query: 313 EIYCCDMPYP----DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+       S +E++  +++    P  P+   +   ++++R    +P KR
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   L RGL Y+ S  I+HRD+K  N+ +++   ++I DFG+AR       +MTG   T 
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATR 179

Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   YN+  D++S G  + E+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 29/233 (12%)

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCC------VVVEYCHGGA 205
           +E+ V  K+  P+      A   T+ +  Q  + HI +    C       +V E+   G 
Sbjct: 31  KEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90

Query: 206 LKSYLIKNRRRK---LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--- 259
           L  ++     RK   L      ++A  LA  LSYL+ K +VH +V T+N+LL +      
Sbjct: 91  LDLFM----HRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146

Query: 260 ----VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
               +K++D G+     S    +      + ++APE +  S   +   D +SFG  LWEI
Sbjct: 147 CGPFIKLSDPGIPITVLSRQECVE----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
            Y  ++P  D + +E              P C    LA++M  C + +P++RP
Sbjct: 203 CYNGEIPLKDKTLAE-KERFYEGQCMLVTPSC--KELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 68/269 (25%), Positives = 110/269 (40%), Gaps = 47/269 (17%)

Query: 122 GQDVAVKLL--DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN 179
           G +VA+KLL  D  EE H+        RA F +E A+  +L HPN+   +          
Sbjct: 3   GHEVAIKLLRTDAPEEEHQ--------RARFRRETALCARLYHPNIVALL---------- 44

Query: 180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS 239
              D+G    P      V EY  G  L+  L  +    L      +L L +   L+   +
Sbjct: 45  ---DSGE--APPGLLFAVFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHN 97

Query: 240 KKIVHRDVKTENMLL---DKTRTVKIADFGVARL----EASNPHDMTGETGTLG---YMA 289
           + IVHRD+K +N+++         K+ DFG+  L      ++   +T  T  LG   Y A
Sbjct: 98  QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCA 157

Query: 290 PEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 349
           PE L G       D+Y++G+   E   C      +      + ++ Q L P +    P  
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLE---CLTGQRVVQ-GASVAEILYQQLSP-VDVSLPPW 212

Query: 350 -----LANVMKRCWDANPDKRPEMDEVVA 373
                L  V+++  + +P +R      +A
Sbjct: 213 IAGHPLGQVLRKALNKDPRQRAASAPALA 241

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 55/289 (19%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G  G V   R    G+  A+K+LD  E   R++ +    R    QE+     LDHP   
Sbjct: 11  KGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVK----RVLTEQEIL--ATLDHP--- 61

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            F+  T+  S    QT+         + C+V++YC GG L   L +   + L+ +V    
Sbjct: 62  -FL-PTLYAS---FQTET--------YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY 108

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA-------------- 272
           A ++   L YL    IV+RD+K EN+LL ++  + ++DF +++                 
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168

Query: 273 --SNPHDMTGET-------------GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
             S+ + +  ET             GT  Y+APEV++G  +    D ++ GI L+E+   
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Query: 318 DMPYPDLSFSEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKR 365
             P+   +  E  S ++++ +  P  P    SS  +++++    +P KR
Sbjct: 229 TTPFKGSNRDETFSNILKKEVTFPGSPP-VSSSARDLIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 4/103 (3%)

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
           +  KL+   +  L   + +GL Y+ +  I+HRD+K  N+ +++   +KI DFG+AR   S
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170

Query: 274 NPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIY 315
              +MTG   T  Y APEV LN   Y +  D++S G  + E+ 
Sbjct: 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E         +E+ +  +L+H N+  
Sbjct: 18  GTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 168 FIG-ATMGTSELNIQTDNGHIGMPSNFCCVVVEYC-HG--GALKSYLIKNRRRKLAFKVV 223
                T     L+ + D G       F  +V EY  H   G L+S L+      +     
Sbjct: 71  LKEIVTDKQDALDFKKDKG------AFY-LVFEYMDHDLMGLLESGLVHFSEDHIK---- 119

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL-EASNPHDMTGET 282
                 L  GL+Y   K  +HRD+K  N+LL+    +K+ADFG+ARL  +      T + 
Sbjct: 120 -SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 283 GTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
            TL Y  PE+L G   Y    DV+S G  L E++
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.6 bits (154), Expect = 4e-11
 Identities = 44/135 (32%), Positives = 65/135 (48%), Gaps = 16/135 (11%)

Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 169

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

Query: 333 VVRQNLRPEIPRCCP 347
           V+ Q   P     CP
Sbjct: 230 VIEQLGTP-----CP 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 60/243 (24%), Positives = 108/243 (44%), Gaps = 22/243 (9%)

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF--CCVVVEYCHGGALKSY 209
           +E+ +  +LDH N+ K +   +G S  ++  D   +G  +      +V EY     L + 
Sbjct: 51  REIKIIRRLDHDNIVK-VYEVLGPSGSDLTED---VGSLTELNSVYIVQEYMETD-LANV 105

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV-KIADFGVA 268
           L +     L+ +        L RGL Y+ S  ++HRD+K  N+ ++    V KI DFG+A
Sbjct: 106 LEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162

Query: 269 RL---EASNPHDMTGETGTLGYMAPE-VLNGSAYNRKCDVYSFGICLWEIYCCDMPYP-- 322
           R+     S+   ++    T  Y +P  +L+ + Y +  D+++ G    E+      +   
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222

Query: 323 -DLSFSEV---TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVVAMLEA 377
            +L   ++   +  VVR+  R E+    PS + N          D  P ++ E +  LE 
Sbjct: 223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ 282

Query: 378 IDT 380
           I T
Sbjct: 283 ILT 285

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 6/174 (3%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           ++++Y  GG + ++L +  R   +   V   + ++   L +L    IV+RD+K EN+LLD
Sbjct: 82  LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139

Query: 256 KTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWE 313
               V + DFG+++   S   + T    GT+ YMAPE++ G   + +  D +S GI ++E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199

Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKR 365
           +     P+         S V R+ L+  P  P        +++ +    +P KR
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 23/166 (13%)

Query: 192 NFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIV 243
           N+  +V++Y  GG L + L K   R         L  D+AR         +  +     V
Sbjct: 74  NYLYLVMDYYVGGDLLTLLSKFEDR---------LPEDMARFYIAEMVLAIHSIHQLHYV 124

Query: 244 HRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNG-----SA 297
           HRD+K +N+LLD    +++ADFG   ++        +   GT  Y++PE+L         
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184

Query: 298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           Y  +CD +S G+C++E+   + P+   S  E    ++    R + P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 43/123 (34%), Positives = 63/123 (51%), Gaps = 7/123 (5%)

Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           C V+ +Y     L +YL   R R L    V  +A  L   + Y+  + I+HRD+KTEN+L
Sbjct: 236 CLVLPKY--RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292

Query: 254 LDKTRTVKIADFGVA---RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC 310
           ++    + + DFG A   R   S P    G  GT+   APEVL G  Y    D++S G+ 
Sbjct: 293 VNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351

Query: 311 LWE 313
           ++E
Sbjct: 352 IFE 354

Length = 461

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 8/128 (6%)

Query: 197 VVEYCHGGALKSYLIKNRR---RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           V+EY +GG L   + ++R+    +  F      A ++   L +L    +++RD+K +N+L
Sbjct: 74  VMEYVNGGDLMFQIQRSRKFDEPRSRF-----YAAEVTLALMFLHRHGVIYRDLKLDNIL 128

Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           LD     K+ADFG+ +    N    T   GT  Y+APE+L    Y    D ++ G+ ++E
Sbjct: 129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYE 188

Query: 314 IYCCDMPY 321
           +     P+
Sbjct: 189 MMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 65/249 (26%), Positives = 105/249 (42%), Gaps = 41/249 (16%)

Query: 108 ARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            RG FG V        D   A+K+L+  E   R+E       A F +E  V    D+  +
Sbjct: 10  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDVLVNGDNQWI 63

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR---KLA--F 220
           T        T     Q +N           +V++Y  GG L + L K   R    +A  +
Sbjct: 64  T--------TLHYAFQDENN--------LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMT 279
              + +A+D    L Y      VHRD+K +N+L+D    +++ADFG   +L        +
Sbjct: 108 LAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161

Query: 280 GETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
              GT  Y++PE+L         Y  +CD +S G+C++E+   + P+   S  E    ++
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Query: 335 RQNLRPEIP 343
               R + P
Sbjct: 222 NHKERFQFP 230

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 28/202 (13%)

Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G++G V   R    GQ VA+K      +   SE +    + A  +E+ +  +L HPN+  
Sbjct: 12  GSYGVVFKCRNRETGQIVAIK------KFVESEDDPVIKKIAL-REIRMLKQLKHPNLVN 64

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            I       +L++                V EYC    L    ++   R +   ++ ++ 
Sbjct: 65  LIEVFRRKRKLHL----------------VFEYCDHTVLNE--LEKNPRGVPEHLIKKII 106

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
               + +++      +HRDVK EN+L+ K   +K+ DFG AR+      D T    T  Y
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 288 MAPEVLNG-SAYNRKCDVYSFG 308
            APE+L G + Y    DV++ G
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 49/233 (21%), Positives = 84/233 (36%), Gaps = 44/233 (18%)

Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            F       + +       VAVK ++    S      +        QE+    +L HPN+
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLL-------QQEIITSRQLQHPNI 61

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             +         +     +  + + S          +G      L+K    +   ++ I 
Sbjct: 62  LPY---------VTSFIVDSELYVVSPLMA------YGSC--EDLLKTHFPEGLPELAIA 104

Query: 226 LAL-DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASN----PHDM 278
             L D+   L Y+ SK  +HR VK  ++LL     V ++    +   ++        HD 
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 279 T-GETGTLGYMAPEVL--NGSAYNRKCDVYSFGICLWEIYCCDM-----PYPD 323
                  L +++PEVL  N   YN K D+YS GI       C++     P+ D
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT-----ACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 30/84 (35%), Positives = 49/84 (58%), Gaps = 6/84 (7%)

Query: 234 LSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR---LEASNPHDMTGETGTLGYMAP 290
           L +L  + I++RD+K EN+LLD    VK+ DFG+ +    E +  H      GT+ YMAP
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF---CGTIEYMAP 169

Query: 291 EVLNGSAYNRKCDVYSFGICLWEI 314
           E+L  S + +  D +S G  ++++
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDM 193

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGY 287
            GL Y+ S  ++HRD+K  N+L++    +KI DFG+AR  + NP +    MT    T  Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 288 MAPEV-LNGSAYNRKCDVYSFGICLWEIY 315
            APE+ L+  +Y +  DV+S G  L E+ 
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGTLGYM 288
           L + + +     IVHRD+K EN+L+     +K+ DFG AR L   +  + T    T  Y 
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168

Query: 289 APEVLNGSAYNRKCDVYSFGICLWEI 314
           +PE+L G+ Y +  D++S G  L E+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 11/102 (10%)

Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VI + LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR   
Sbjct: 115 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           +N   MT    T  Y APEV+ G  Y    D++S G  + E+
Sbjct: 175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 175 TSELNIQTDNGHIGMPSNFCC------VVVEYCHGGALKSYLIKNRRR-KLAFKVVIQLA 227
           T+ L  Q  + H+      C       +V E+   G L   L K + R  +A+K+ +  A
Sbjct: 66  TASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV--A 123

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRT-------VKIADFGVARLEASNPHDMTG 280
             LA  LSYL+ K +VH +V  +N+LL +          +K++D GV+    S    +  
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182

Query: 281 ETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEI-YCCDMPYPDLSFSEVTSAVVRQNL 338
               + ++APE +  G++ +   D +SFG  L EI +  ++P  + + SE      +++ 
Sbjct: 183 ---RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR 239

Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
            PE P C    LA ++ +C    P +RP
Sbjct: 240 LPE-PSC--KELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 47/220 (21%), Positives = 81/220 (36%), Gaps = 60/220 (27%)

Query: 197 VVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           V++Y  GG + S LI+       LA   + +L       +  +     +HRD+K +N+L+
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC----AIESVHKMGFIHRDIKPDNILI 134

Query: 255 DKTRTVKIADFGV------------------ARLEASNPHDMTGE--------------- 281
           D+   +K+ DFG+                   R ++  P +   E               
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194

Query: 282 ----------TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
                      GT  Y+APEVL  + Y + CD +S G+ L+E+     P+   + +E   
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWD------ANPDKR 365
            V+       IP       A + +   D         + R
Sbjct: 255 KVINWETTLHIPSQ-----AKLSREASDLILRLCCGAEDR 289

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 49/191 (25%)

Query: 196 VVVEYCHGGALKSYLIKN---RRRKLAFKVV-IQLALDLARGLSYLQSKKIVHRDVKTEN 251
           +++E+  GG + + L+K       +  F +    LA+D    L +      +HRD+K +N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF------IHRDIKPDN 131

Query: 252 MLLDKTRTVKIADFGVA-------------RLEASNPHDMT---------GET------- 282
           +LLD    VK++DFG+               L  S P D T          ET       
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191

Query: 283 ------GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSA 332
                 GT  Y+APEV   + YN+ CD +S G+ ++E+     P+    P  ++ +V + 
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251

Query: 333 VVRQNLRPEIP 343
                  PE+P
Sbjct: 252 KETLIFPPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 18/114 (15%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYM 288
           L R L+Y+ SK I HRD+K +N+L+D  T T+K+ DFG A+       ++     ++ Y+
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------NLLAGQRSVSYI 231

Query: 289 ------APEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
                 APE++ G+  Y    D++S G  + E+    + YP  S       +VR
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI---LGYPIFSGQSSVDQLVR 282

Length = 440

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 49/191 (25%)

Query: 196 VVVEYCHGGALKSYLIKN---RRRKLAFKVV-IQLALDLARGLSYLQSKKIVHRDVKTEN 251
           +++E+  GG + + L+K          F +    LA+D    L +      +HRD+K +N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF------IHRDIKPDN 131

Query: 252 MLLDKTRTVKIADFGVA-------------RLEASNPHDMT---------GET------- 282
           +LLD    VK++DFG+               L  + P D +          ET       
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 283 ------GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSA 332
                 GT  Y+APEV   + YN+ CD +S G+ ++E+     P+    P  ++ +V + 
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251

Query: 333 VVRQNLRPEIP 343
                  PE+P
Sbjct: 252 KETLVFPPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 60/181 (33%)

Query: 191 SNFCCVVVEYCHGGALKSYLIKN-------RRRKLAFKVVIQLALDLARGLSYLQSKKIV 243
            N+  +++EY  GG + + L+K         R  +A  +   LA+D    L Y      +
Sbjct: 73  ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAIDSIHKLGY------I 123

Query: 244 HRDVKTENMLLDKTRTVKIADFGV-----------------------ARLEASNPHDMTG 280
           HRD+K +N+LLD    +K++DFG+                            S P     
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183

Query: 281 ET---------------GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI------YCCDM 319
           +                GT  Y+APEV   + YN++CD +S G+ ++E+      +C D 
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243

Query: 320 P 320
           P
Sbjct: 244 P 244

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 1/86 (1%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGTLGYM 288
           L   + Y+  KK++HRD+K EN+ L+    + + DFG A   E        G  GT+   
Sbjct: 276 LLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATN 335

Query: 289 APEVLNGSAYNRKCDVYSFGICLWEI 314
           +PE+L G  Y    D++S G+ L ++
Sbjct: 336 SPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 43/225 (19%)

Query: 108 ARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            RGT+G V++    DG+D         +E    + E   +  +  +E+A+  +L HPNV 
Sbjct: 10  GRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                 +  S+  +               ++ +Y        ++IK  R   A K  +QL
Sbjct: 62  ALQKVFLSHSDRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKKPMQL 105

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFGVARLEAS 273
              + +        G+ YL +  ++HRD+K  N+L+     ++ R VKIAD G ARL  S
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFARLFNS 164

Query: 274 --NP-HDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
              P  D+     T  Y APE+L G+  Y +  D+++ G    E+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR---LEASNPHDMTGETGTLG 286
           L R L Y+ +  + HRD+K +N+L +    +KI DFG+AR    +       T    T  
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           Y APE L GS +++    Y+  I +W I C
Sbjct: 172 YRAPE-LCGSFFSK----YTPAIDIWSIGC 196

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 9e-07
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 49/228 (21%)

Query: 108 ARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
            RGT+G V++       D +D A+K           + E   +  +  +E+A+  +L HP
Sbjct: 10  GRGTYGHVYKAKRKDGKDDRDYALK-----------QIEGTGISMSACREIALLRELKHP 58

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV       +  ++  +               ++ +Y        ++IK  R   A K  
Sbjct: 59  NVISLQKVFLSHADRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKKP 102

Query: 224 IQLALDLAR--------GLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFGVARL 270
           +QL   + +        G+ YL +  ++HRD+K  N+L+     ++ R VKIAD G ARL
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFARL 161

Query: 271 EAS--NP-HDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
             S   P  D+     T  Y APE+L G+  Y +  D+++ G    E+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 27/77 (35%), Positives = 45/77 (58%), Gaps = 6/77 (7%)

Query: 196 VVVEYCHGGALKSYL--IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           +V+EY  GG +KS L        ++A K + ++AL     L YL    I+HRD+K +NML
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL----ALDYLHRHGIIHRDLKPDNML 136

Query: 254 LDKTRTVKIADFGVARL 270
           +     +K+ DFG++++
Sbjct: 137 ISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 63/243 (25%)

Query: 197 VVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           V++Y  GG + S LI+       LA   + +L       +  +     +HRD+K +N+L+
Sbjct: 79  VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC----AVESVHKMGFIHRDIKPDNILI 134

Query: 255 DKTRTVKIADFGV---------ARLEASNPH------DMTGE------------------ 281
           D+   +K+ DFG+         ++   S  H      D + E                  
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLER 194

Query: 282 --------------TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
                          GT  Y+APEVL  + Y + CD +S G+ L+E+     P+   +  
Sbjct: 195 RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254

Query: 328 EVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDKR---PEMDEVVA--MLEAID 379
           E    V+       IP   +  P +   ++K C    P+ R      DE+ A    + ID
Sbjct: 255 ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAHPFFKTID 312

Query: 380 TSK 382
            S 
Sbjct: 313 FSS 315

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 63/180 (35%)

Query: 191 SNFCCVVVEYCHGGALKSYLIKNR-------RRKLAFKVVIQLALDLARGLSYLQSKKIV 243
           + +  +++E+  GG L + LIK         R  +A  V   LA++    L +      +
Sbjct: 73  AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV---LAIEAVHKLGF------I 123

Query: 244 HRDVKTENMLLDKTRTVKIADFGVA-------------RL----EASNPHD--------- 277
           HRD+K +N+L+D+   +K++DFG++             +L       N  D         
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183

Query: 278 --------------------MTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
                               M   T GT  Y+APE+     Y ++CD +S G  ++E   
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 56/217 (25%)

Query: 197 VVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           V++Y  GG + S LI+       LA   + +L L     +  +     +HRD+K +N+L+
Sbjct: 79  VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVHKMGFIHRDIKPDNILI 134

Query: 255 DKTRTVKIADFGVA------------------RLEASNPHD--------------MTGE- 281
           D    +K+ DFG+                   R ++  P D               T E 
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194

Query: 282 --------------TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
                          GT  Y+APEVL    Y + CD +S G+ L+E+     P+   + +
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT 254

Query: 328 EVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDAN 361
           E    V+       IP   +  P ++  + K C  A 
Sbjct: 255 ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 11/170 (6%)

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+++  GG L S++ K     +  + V + A ++   L  L  + IV RD+   N+LLD
Sbjct: 62  LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
               +++  F     E  +  D  GE     Y APEV   S     CD +S G  L+E+ 
Sbjct: 120 DRGHIQLTYFSRWS-EVEDSCD--GEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
                    +  E   + +  +    IP        +++++    NP +R
Sbjct: 177 T------GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 26/147 (17%)

Query: 186 HIGMPSNFCCVVVEYC---HGGALKSYLIKNRRRKLAF------KVVIQLALDLARGLSY 236
           H+G+P  + C   + C   +   L   L++N +           K++  +  D+   L Y
Sbjct: 82  HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEY 141

Query: 237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL------------EASNPHDMTGETGT 284
           +    I H D+K EN+++D      I D+G+A              E  + H      GT
Sbjct: 142 IHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH-----RGT 196

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICL 311
           L Y   +  NG+   R+ D+ S G C+
Sbjct: 197 LYYAGLDAHNGACVTRRGDLESLGYCM 223

Length = 294

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 13/104 (12%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE---------T 282
           RGL+YL     +HR++K  ++L+     V ++  G++ L +   +    +         T
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 283 GTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
             L +++PE+L      YN K D+YS GI   E+    +P+ D+
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 5/61 (8%)

Query: 210 LIKNRRRKLAFKVVIQLALD-LARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGV 267
           L K   R+     +IQ  +  +   L  L S  IVHRDVK +N++    + + KI D G 
Sbjct: 246 LPKGLERE---NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGA 302

Query: 268 A 268
           A
Sbjct: 303 A 303

Length = 566

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 36/161 (22%)

Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN---RRRKLAFKVVIQLALDLARGLSYL 237
           Q + GH+      C V+ +Y  G  L  +++K+     R LA     Q+       L Y 
Sbjct: 201 QNETGHM------CIVMPKY--GPCLLDWIMKHGPFSHRHLA-----QIIFQTGVALDYF 247

Query: 238 QSK-KIVHRDVKTENMLLDKTRT----------------VKIADFGVARLEASNPHDMTG 280
            ++  ++H D+K EN+L++ + T                V+I D G    E    H  T 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTA 304

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
              T  Y +PEV+ G  +    D++S G  ++E+Y   + Y
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 23/72 (31%), Positives = 35/72 (48%), Gaps = 7/72 (9%)

Query: 204 GALKSYLIKNRR-------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           G L+ +++  ++        K    V+  +   +  GL  L    IVHRD+K EN+L+  
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344

Query: 257 TRTVKIADFGVA 268
              VKI DFG A
Sbjct: 345 DGQVKIIDFGAA 356

Length = 507

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 64/264 (24%), Positives = 89/264 (33%), Gaps = 75/264 (28%)

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVV-EYCHGGALKSYLI 211
           E+A   KL HPN+ K IG                    S     ++ EY  G  L   L 
Sbjct: 733 EIADMGKLQHPNIVKLIGLCR-----------------SEKGAYLIHEYIEGKNLSEVLR 775

Query: 212 K---NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
                RRRK+A  +   L     R L    S  +V  ++  E +++D             
Sbjct: 776 NLSWERRRKIAIGIAKAL-----RFLHCRCSPAVVVGNLSPEKIIIDGK--------DEP 822

Query: 269 RLEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICL-------------- 311
            L  S P  +  +T       Y+APE         K D+Y FG+ L              
Sbjct: 823 HLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882

Query: 312 --------WEIYC---C--DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCW 358
                   W  YC   C  DM + D S     S  V QN   E+         N+   C 
Sbjct: 883 GVHGSIVEWARYCYSDCHLDM-WIDPSIRGDVS--VNQNEIVEV--------MNLALHCT 931

Query: 359 DANPDKRPEMDEVVAMLEAIDTSK 382
             +P  RP  ++V+  LE+   S 
Sbjct: 932 ATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 48/223 (21%), Positives = 96/223 (43%), Gaps = 53/223 (23%)

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  +L H N+ ++I   +  +   +               +++E+C  G L   + K
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLY--------------ILMEFCDAGDLSRNIQK 107

Query: 213 NRRR--KLAFKVVIQLALDLARGLSYLQS-------KKIVHRDVKTENML---------- 253
             +   K+    ++ +   L   L+Y  +       ++++HRD+K +N+           
Sbjct: 108 CYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167

Query: 254 -------LDKTRTVKIADFGVAR---LEASNPHDMTGETGTLGYMAPEVL--NGSAYNRK 301
                  L+     KI DFG+++   +E S  H      GT  Y +PE+L     +Y+ K
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSC---VGTPYYWSPELLLHETKSYDDK 223

Query: 302 CDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQNLRPEIP 343
            D+++ G  ++E+     P+    +FS++ S + R    P++P
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG---PDLP 263

Length = 1021

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	404
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK10345	210	hypothetical protein; Provisional	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
smart00090	237	RIO RIO-like kinase.	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
KOG3087	229	consensus Serine/threonine protein kinase [General	99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.43
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.23
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.98
PRK09902	216	hypothetical protein; Provisional	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.94
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.75
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.73
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.64
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.48
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.24
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.19
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.11
PLN02876	822	acyl-CoA dehydrogenase	98.07
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.04
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.81
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.71
PRK10593	297	hypothetical protein; Provisional	97.67
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.48
KOG2270	520	consensus Serine/threonine protein kinase involved	97.48
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.43
PRK05231	319	homoserine kinase; Provisional	97.32
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.25
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.11
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.89
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.65
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.63
PLN02756	418	S-methyl-5-thioribose kinase	96.62
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.57
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.53
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.52
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.42
PLN02236	344	choline kinase	96.28
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.07
PRK12396	409	5-methylribose kinase; Reviewed	95.85
PTZ00384	383	choline kinase; Provisional	95.73
PTZ00296	442	choline kinase; Provisional	95.04
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.78
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.55
PRK10271	188	thiK thiamine kinase; Provisional	93.73
KOG2269	531	consensus Serine/threonine protein kinase [Signal	93.69
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	93.65

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-57  Score=433.18  Aligned_cols=290  Identities=43%  Similarity=0.750  Sum_probs=259.0

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEECCce-EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .....|.++...+.+...||+|+||+||+|.+.|+. ||||++.....+...       +..|.+|+.+|.+++|||||+
T Consensus        31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-------~~~f~~E~~il~~l~HpNIV~  103 (362)
T KOG0192|consen   31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-------RKAFRREASLLSRLRHPNIVQ  103 (362)
T ss_pred             ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-------HHHHHHHHHHHHhCCCCCeee
Confidence            345678899999999999999999999999999998 999999765443221       677999999999999999999


Q ss_pred             EEEEEecCC-ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC-ceec
Q 015594          168 FIGATMGTS-ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHR  245 (404)
Q Consensus       168 ~~~~~~~~~-~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g-ivH~  245 (404)
                      |+|++.++. .+                +|||||+++|+|.+++.+.....++...++.|+.||++||.|||+++ ||||
T Consensus       104 f~G~~~~~~~~~----------------~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr  167 (362)
T KOG0192|consen  104 FYGACTSPPGSL----------------CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR  167 (362)
T ss_pred             EEEEEcCCCCce----------------EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec
Confidence            999998776 34                89999999999999997755678999999999999999999999999 9999


Q ss_pred             ccCCCCEEEcCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccC--CCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          246 DVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN--GSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       246 Dikp~Nili~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      ||||+||||+.++ ++||+|||+++........++...||+.|||||++.  ...|+.++||||||+++|||+||+.||.
T Consensus       168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~  247 (362)
T KOG0192|consen  168 DLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE  247 (362)
T ss_pred             ccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence            9999999999997 999999999987665445666688999999999999  6699999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC-CCCCCCCCCCccccccC
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG-GMIPVDQPQGCSCFRKY  401 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~-~~~p~~~~~~~~~~~~~  401 (404)
                      +.........+...+.++.+|..|++.+..||.+||..||..||++.+|+..|+.+.+.... +..+......|.++...
T Consensus       248 ~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (362)
T KOG0192|consen  248 DLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPEDSADSDSCDSPLEP  327 (362)
T ss_pred             CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcccccccccccccccc
Confidence            99998888999999999999999999999999999999999999999999999999997774 55555666666665543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-55  Score=399.14  Aligned_cols=251  Identities=29%  Similarity=0.504  Sum_probs=223.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ..+..++++..+.||+|..|+||+++|  +++.+|+|++....        ....++++.+|+.+++.++||+||++||+
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--------~~~~~~Qi~rEl~il~~~~spyIV~~yga  145 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--------DPALQKQILRELEILRSCQSPYIVGFYGA  145 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--------CHHHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence            345567888899999999999999998  68999999994321        14457788999999999999999999999


Q ss_pred             EecCCc-cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCC
Q 015594          172 TMGTSE-LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKT  249 (404)
Q Consensus       172 ~~~~~~-~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp  249 (404)
                      |..... +                +|+||||++|+|.+++...  +.+++..+..++.+|++||.|||. ++||||||||
T Consensus       146 F~~~~~~i----------------sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP  207 (364)
T KOG0581|consen  146 FYSNGEEI----------------SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKP  207 (364)
T ss_pred             EEeCCceE----------------EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCH
Confidence            998885 5                8999999999999999665  679999999999999999999995 8999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-----  324 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~-----  324 (404)
                      +||||+..|.|||||||++......  ...+++||..|||||.+.+..|+.++||||||++++|+++|++||...     
T Consensus       208 sNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~  285 (364)
T KOG0581|consen  208 SNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL  285 (364)
T ss_pred             HHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence            9999999999999999999875544  556789999999999999999999999999999999999999999874     


Q ss_pred             CHHHHHHHHHhccCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          325 SFSEVTSAVVRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..+++.+++.. .+|..|.. +++++++||..||++||.+||++.+|++
T Consensus       286 ~~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  286 DIFELLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CHHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            777888777764 45666775 9999999999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-53  Score=409.98  Aligned_cols=267  Identities=26%  Similarity=0.445  Sum_probs=238.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|...+.||+|+|+.||++++  +|+.||+|++.+....      ....+..+.+|+.+.++|+|||||+|+++|++.
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~------k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs   90 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK------KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS   90 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc------CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence            35799999999999999999987  7999999999754322      233467788999999999999999999999998


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |||+|+|+.++|..++.  +++++++.+++.+++||+.||.|||+++|+|||||..|+||+
T Consensus        91 ~nV----------------YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~  152 (592)
T KOG0575|consen   91 NNV----------------YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN  152 (592)
T ss_pred             Cce----------------EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec
Confidence            887                99999999999999886  458999999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+|||+|||+|.....+.....+.||||.|.|||++.....+..+||||+||+||.|++|++||+..+..+++..+..
T Consensus       153 ~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~  232 (592)
T KOG0575|consen  153 ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL  232 (592)
T ss_pred             CcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence            99999999999999888777777889999999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCCCCc
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGC  395 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~p~~~~~~~  395 (404)
                      ..+.  +|..++.++++||.++|+.||.+|||+++|+.-     ...-.|..|...+..|
T Consensus       233 ~~Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h-----~Ff~~g~~p~~lp~~~  285 (592)
T KOG0575|consen  233 NEYS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH-----PFFKSGFTPARLPSSC  285 (592)
T ss_pred             cCcc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC-----HhhhCCCcCCCCCccc
Confidence            8775  677999999999999999999999999999852     2223456666555544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-53  Score=403.89  Aligned_cols=266  Identities=34%  Similarity=0.635  Sum_probs=239.1

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEECCc-eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~-~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      .+..|+++++.+.+.+.||+|.||+||.|.+++. .||+|.++-+...          ...|.+|+.+|++|+|+|||++
T Consensus       197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----------~~~f~~Ea~iMk~L~H~~lV~l  266 (468)
T KOG0197|consen  197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----------PEAFLREAQIMKKLRHEKLVKL  266 (468)
T ss_pred             ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----------hhHHHHHHHHHHhCcccCeEEE
Confidence            3789999999999999999999999999999887 9999999754322          3558899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      +|++.....+                |||||||+.|+|.+||....+..+...+.+.++.||+.|++||+++++|||||.
T Consensus       267 ~gV~~~~~pi----------------yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA  330 (468)
T KOG0197|consen  267 YGVCTKQEPI----------------YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA  330 (468)
T ss_pred             EEEEecCCce----------------EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence            9999988766                899999999999999988667889999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCc-ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +.||||+++..+||+|||+|+...++... ..+..-+..|+|||.++...++.++|||||||+||||+| |+.||+.++.
T Consensus       331 ARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn  410 (468)
T KOG0197|consen  331 ARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN  410 (468)
T ss_pred             hhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence            99999999999999999999954443332 223334667999999999999999999999999999999 9999999999


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .++... +..+++...|..||+++.+||..||..+|++|||++.+...|+++.+..
T Consensus       411 ~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  411 EEVLEL-LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHHHHH-HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            998766 5567788889999999999999999999999999999999999998754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-53  Score=389.54  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=219.6

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..+.|.+.+.||+|+||.|-+|..  +|+.||||+++.......+.. ... ...+.+|+.+|++|+|||||+++++|..
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-IAK-TRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-ccc-hhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            457899999999999999999987  799999999987654443321 111 1235799999999999999999999998


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      +...                ||||||++||+|.+.+..+  +.+.+..-..+++||+.||.|||++||+||||||+|||+
T Consensus       248 ~ds~----------------YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl  309 (475)
T KOG0615|consen  248 PDSS----------------YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL  309 (475)
T ss_pred             CCce----------------EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence            8877                8999999999999999776  568888889999999999999999999999999999999


Q ss_pred             cCC---CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKT---RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      ..+   ..+||+|||+|+... ....+.+.||||.|.|||++.+..   +..++|+|||||+||-+++|.+||.+..-..
T Consensus       310 ~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  310 SNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             ccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            665   779999999998755 677888899999999999998765   4458899999999999999999998766555


Q ss_pred             -HHHHHHhccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 -VTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 -~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       ...++....+.  +..+..++++..+||..||..||++||+++|+++
T Consensus       389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             55666666554  3456778999999999999999999999999884

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-52  Score=380.85  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=220.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +.+++|.+.++||+|+||.||.++.  +++.||+|++++..-..+      ...+....|..||.+++||+||+++..|+
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~------~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK------KEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh------hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            4578999999999999999998875  899999999976543222      12344678999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +.+.+                |+|+||+.||.|..+|.+.  +.+++..+.-++.+|+.||.|||++|||||||||+|||
T Consensus        96 t~~kL----------------ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL  157 (357)
T KOG0598|consen   96 TEEKL----------------YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL  157 (357)
T ss_pred             cCCeE----------------EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence            99988                9999999999999999655  68999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ||.+|+++|+|||+++..........+.+||+.|||||++.+.+|+..+|+||||+++|||++|..||...+...+...+
T Consensus       158 Ld~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I  237 (357)
T KOG0598|consen  158 LDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI  237 (357)
T ss_pred             ecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence            99999999999999986666656666689999999999999999999999999999999999999999999999999888


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      .... .+..+..++.+.++++.++|+.||++|.
T Consensus       238 ~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  238 LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            8776 3455667899999999999999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-54  Score=377.12  Aligned_cols=259  Identities=27%  Similarity=0.477  Sum_probs=225.3

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE-Ee
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA-TM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~  173 (404)
                      ..++|++.++||+|+||+||++..  +|..||.|.+.++..+       +..++.+..|+.+|++|+|||||++++. |.
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-------~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~   89 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-------AKARQDCVKEISLLKQLNHPNIVQYYAHSFI   89 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-------HHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence            356899999999999999999876  8999999999866543       3346778899999999999999999984 33


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhh--CC--ceeccc
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQS--KK--IVHRDV  247 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~--~g--ivH~Di  247 (404)
                      +...               .++||||||++|+|.+++..  ..++.++++.+|.++.|+++||..+|+  ..  |+||||
T Consensus        90 ~~~e---------------vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDI  154 (375)
T KOG0591|consen   90 EDNE---------------VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDI  154 (375)
T ss_pred             ccch---------------hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccC
Confidence            3333               12799999999999998844  345679999999999999999999999  45  999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ||.||+|+.+|.|||+|||+++.+..........+|||.||+||.+.+.+|+.++||||+||++|||+.-..||.+.+..
T Consensus       155 KPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~  234 (375)
T KOG0591|consen  155 KPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL  234 (375)
T ss_pred             cchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH
Confidence            99999999999999999999998877777777889999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ++..++....+++-.....|.+++.||..|+..||+.||+...++..+..
T Consensus       235 ~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  235 SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            98888888776655447889999999999999999999986555554444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-50  Score=371.31  Aligned_cols=248  Identities=27%  Similarity=0.474  Sum_probs=215.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|++  ++..||||.+.....       ....++.+..|+.+|+.++|||||.+++++...
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            46799999999999999999998  689999999964322       234566688999999999999999999999887


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      +.+                |+|||||+||+|.+|+.+.  +.+++..+..++.||+.||++||+++||||||||+||||+
T Consensus        82 ~~i----------------~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs  143 (429)
T KOG0595|consen   82 DFI----------------YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLS  143 (429)
T ss_pred             CeE----------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEec
Confidence            765                9999999999999999664  5899999999999999999999999999999999999996


Q ss_pred             CC------CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          256 KT------RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       256 ~~------~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      ..      -.+||+|||+|+... +.....+.+|++-|||||++....|+-|+|+||+|+++|++++|..||...+..++
T Consensus       144 ~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  144 TTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             cCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            54      468999999999765 44455568999999999999999999999999999999999999999999999998


Q ss_pred             HHHHHhcc-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 015594          330 TSAVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV  371 (404)
Q Consensus       330 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l  371 (404)
                      ...+.... ..+.++..+++.+.+++...++.+|..|-+..+.
T Consensus       223 ~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  223 LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            87665543 4556677788888899999999999999665543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=352.08  Aligned_cols=240  Identities=28%  Similarity=0.426  Sum_probs=216.8

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|++.+.||.|+||.|.+++.  +|..+|+|++++.+.-      -....+-..+|..+|+.+.||+++++++.|.+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV------klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV------KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH------HHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            357899999999999999998886  7899999999754321      12223446799999999999999999999998


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+||||++||.|.+++.+.  +++++..++-++.||+.||+|||+.+|++||+||+||||
T Consensus       116 ~~~l----------------ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl  177 (355)
T KOG0616|consen  116 NSNL----------------YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL  177 (355)
T ss_pred             CCeE----------------EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee
Confidence            8887                9999999999999999765  689999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      |.+|.+||+|||+|......   ..+.||||.|+|||++..++|+.++|+|+|||++|||++|.+||.+.+...++.+++
T Consensus       178 D~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~  254 (355)
T KOG0616|consen  178 DQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL  254 (355)
T ss_pred             ccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH
Confidence            99999999999999865433   445889999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKR  365 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  365 (404)
                      ...+.  +|..+++++++||+++|+.|-.+|
T Consensus       255 ~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGKVK--FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence            88765  889999999999999999999999

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=375.30  Aligned_cols=269  Identities=24%  Similarity=0.371  Sum_probs=231.5

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      .-.+.+|.+++.||+|+|++|++|+.  +++.||||++++.-.-      -+...+-+..|-.+|.+| +||.|++++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii------ke~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII------KEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH------hhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            45578999999999999999999987  7899999999643211      111123466888999999 89999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      |+|...+                |+|+||+++|+|.++|.+.  +.|++..++.++.+|+.||+|||++|||||||||+|
T Consensus       143 FQD~~sL----------------YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN  204 (604)
T KOG0592|consen  143 FQDEESL----------------YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN  204 (604)
T ss_pred             eecccce----------------EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence            9999988                8999999999999999765  789999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCC-------------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPH-------------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  318 (404)
                      ||||+++++||+|||.|..+.....             ....++||..|.+||+|.....++.+|||+|||+||+|+.|.
T Consensus       205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~  284 (604)
T KOG0592|consen  205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ  284 (604)
T ss_pred             eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence            9999999999999999986443211             124578999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH-------HHHhHhhcCCCCCCC
Q 015594          319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM-------LEAIDTSKGGGMIPV  389 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~-------L~~~~~~~~~~~~p~  389 (404)
                      +||.+.+.-.+...++.-.+  .+|..+|+.+++||+++|..||.+|+|..+|.+.       .+++.++-+-.+.|+
T Consensus       285 PPFra~NeyliFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  285 PPFRAANEYLIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             CCCccccHHHHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence            99999998888888876544  5888999999999999999999999999998763       455666666555554

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-49  Score=363.07  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=225.4

Q ss_pred             ccccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           87 ASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      .......|.+....|.+..+||.|.-++||+|+.  .+..||||+++.....        .....+.+|+..++.++|||
T Consensus        14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--------~~ld~l~kE~~~msl~~HPN   85 (516)
T KOG0582|consen   14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--------NDLDALRKEVQTMSLIDHPN   85 (516)
T ss_pred             cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--------hhHHHHHHHHHHhhhcCCCC
Confidence            3445567888899999999999999999999987  7899999999754322        12456789999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |++++..|.....+                |+||.||.+|++.+++...-...+.+..+..|+++++.||.|||.+|.||
T Consensus        86 Iv~~~~sFvv~~~L----------------WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IH  149 (516)
T KOG0582|consen   86 IVTYHCSFVVDSEL----------------WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIH  149 (516)
T ss_pred             cceEEEEEEeccee----------------EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            99999999998888                89999999999999998877778999999999999999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCCcc----cCCCCCccccCccccC--CCCCCcchhhHHHHHHHHHHHhCC
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDM----TGETGTLGYMAPEVLN--GSAYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~  318 (404)
                      ||||+.||||+.+|.|||+|||++........+.    ...+||+.|||||++.  ..+|+.|+||||||++..||.+|.
T Consensus       150 RdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~  229 (516)
T KOG0582|consen  150 RDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH  229 (516)
T ss_pred             cccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC
Confidence            9999999999999999999999987655554433    4458999999999964  346999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCC--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          319 MPYPDLSFSEVTSAVVRQNLR--------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .||..+.+..++...+....+        .+..+..+..++.+|..||+.||++|||++++++
T Consensus       230 aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  230 APFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            999999988776554443322        1222446778999999999999999999999984

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=368.09  Aligned_cols=256  Identities=28%  Similarity=0.506  Sum_probs=215.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..++...+.||+|+||+||++.+  +|..+|||.+......    .     .+.+.+|+.+|++++|||||+++|.....
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~----~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~   86 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP----T-----SESLEREIRILSRLNHPNIVQYYGSSSSR   86 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch----h-----HHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence            45688889999999999999998  4799999998754111    0     45578999999999999999999964333


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...              .+++.|||+++|+|.+++.+..+ ++++..++.+++||+.||.|||++||+||||||+||||+
T Consensus        87 ~~~--------------~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~  151 (313)
T KOG0198|consen   87 END--------------EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD  151 (313)
T ss_pred             cCe--------------eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence            321              23899999999999999988755 899999999999999999999999999999999999999


Q ss_pred             C-CCcEEEeeccccccccC---CCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHH
Q 015594          256 K-TRTVKIADFGVARLEAS---NPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEV  329 (404)
Q Consensus       256 ~-~~~vkL~Dfg~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~  329 (404)
                      . ++.+||+|||++.....   .........||+.|||||++... ...+++|||||||++.||+||+.||.. ....+.
T Consensus       152 ~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~  231 (313)
T KOG0198|consen  152 PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA  231 (313)
T ss_pred             CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH
Confidence            9 79999999999975442   12223457799999999999953 344699999999999999999999998 455555


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ...+......|.+|..+|++.++||.+|+..||++|||++++++.--.
T Consensus       232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            555566666779999999999999999999999999999999975443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=375.08  Aligned_cols=260  Identities=26%  Similarity=0.527  Sum_probs=225.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~  172 (404)
                      ....+|.+.+.||+|+||.|++|.+  +|+.||||+++........    ......+.+|+.+++.++ ||||++++.++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~----~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS----QKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc----cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            3457899999999999999999987  7899999988654211111    122344568999999998 99999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .....+                |+||||+.||+|.+++.+  .+++.+..+..+++||+.|++|||++||+||||||+||
T Consensus        90 ~t~~~~----------------~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi  151 (370)
T KOG0583|consen   90 ATPTKI----------------YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI  151 (370)
T ss_pred             ecCCeE----------------EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence            888775                899999999999999976  47899999999999999999999999999999999999


Q ss_pred             EEcCC-CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          253 LLDKT-RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       253 li~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      |++.+ +++||+|||++.............+||+.|+|||++.+.. |+ .++||||+||+||.|++|.+||.+.+...+
T Consensus       152 lld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l  231 (370)
T KOG0583|consen  152 LLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL  231 (370)
T ss_pred             EecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH
Confidence            99999 9999999999986544556777899999999999999987 75 899999999999999999999999888888


Q ss_pred             HHHHHhccCCCCCCCCC-cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          330 TSAVVRQNLRPEIPRCC-PSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ...+....+  .+|..+ ++++++|+.+||..||.+|+++.+|+ .-.-+..
T Consensus       232 ~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  232 YRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             HHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            777665544  467777 99999999999999999999999999 5555554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-49  Score=376.11  Aligned_cols=248  Identities=26%  Similarity=0.450  Sum_probs=218.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...|.....||+|+.|.||.+..  +++.||||.+++.....         ++.+.+|+.+|+..+|+|||.|++.|...
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---------keLilnEi~Vm~~~~H~NiVnfl~Sylv~  342 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---------KELLLNEILVMRDLHHPNIVNFLDSYLVG  342 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---------hhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence            35677788999999999998876  78999999998766543         34478999999999999999999998877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      +.+                |+||||++||+|.+.+...   .+++.+++.|+++++.||+|||.+||+|||||.+|||++
T Consensus       343 deL----------------WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~  403 (550)
T KOG0578|consen  343 DEL----------------WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT  403 (550)
T ss_pred             cee----------------EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence            666                8999999999999998654   599999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+|.+||+|||++.............+|||.|||||++..+.|++++||||||++++||+-|++||-..++...+..+..
T Consensus       404 ~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~  483 (550)
T KOG0578|consen  404 MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  483 (550)
T ss_pred             cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence            99999999999998766666677778999999999999999999999999999999999999999987665554444433


Q ss_pred             c-cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 Q-NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ......+..+++.|++|+.+||+.|+++|+++.+||+
T Consensus       484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            3 3344567889999999999999999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-49  Score=377.47  Aligned_cols=267  Identities=33%  Similarity=0.655  Sum_probs=228.2

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ...+|+|..+.+.+...||+|.||+||||.|.| +||||+++.....       .+..+.|.+|+.++++-+|.||+-|.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt-------~~qlqaFKnEVa~lkkTRH~NIlLFM  454 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPT-------PEQLQAFKNEVAVLKKTRHENILLFM  454 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCC-------HHHHHHHHHHHHHHhhcchhhheeee
Confidence            347999999999999999999999999999987 5999999755433       22467799999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      |+++.+..                 .||.-||+|.+|+.+|.-. +.+|.....+.|++||+.|+.|||.++|||||||.
T Consensus       455 G~~~~p~~-----------------AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKS  516 (678)
T KOG0193|consen  455 GACMNPPL-----------------AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKS  516 (678)
T ss_pred             hhhcCCce-----------------eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccc
Confidence            99987764                 5899999999999999554 46799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccC--CCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          250 ENMLLDKTRTVKIADFGVARLEAS--NPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      .|||+.+++.|||+|||++.+...  .........|...|||||++.   ..+|++.+||||||+|+|||+||.+||...
T Consensus       517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence            999999999999999999975332  222233456788999999985   447999999999999999999999999966


Q ss_pred             CHHHHHHHHHhccCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          325 SFSEVTSAVVRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ....++..+-++.+.+.   +...|+.++++|+..||..++++||.+.+|+..|+.+.-+.
T Consensus       597 ~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  597 NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            66666555556655543   34678999999999999999999999999999888887754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3e-48  Score=367.74  Aligned_cols=257  Identities=22%  Similarity=0.381  Sum_probs=219.7

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+..++|.++++||+|+||.||+|+-  +|..+|+|++++++...+.+      ..-+..|-.+|...++|+||+++
T Consensus       134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q------v~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ------VEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh------HHHHHHHHHHhhhcCCCcEEEEE
Confidence            33456788999999999999999999874  89999999998765543322      23366889999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      .+|++.+.+                |+||||++||++..+|.+.  +.|++..++.++.+++.|++.||..|++||||||
T Consensus       208 YsFQD~~~L----------------YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKP  269 (550)
T KOG0605|consen  208 YSFQDKEYL----------------YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKP  269 (550)
T ss_pred             EEecCCCee----------------EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCCh
Confidence            999999888                9999999999999999665  7899999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccC--------------------CCCcc---------------------------cCCC
Q 015594          250 ENMLLDKTRTVKIADFGVARLEAS--------------------NPHDM---------------------------TGET  282 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~--------------------~~~~~---------------------------~~~~  282 (404)
                      +|+|||..|++||+|||++.-...                    .+...                           ...+
T Consensus       270 dNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StV  349 (550)
T KOG0605|consen  270 DNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTV  349 (550)
T ss_pred             hheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhccc
Confidence            999999999999999999853111                    00000                           1136


Q ss_pred             CCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhh
Q 015594          283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDA  360 (404)
Q Consensus       283 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~  360 (404)
                      |||.|||||++.+.+|+..||+||||||+|||+.|.+||...++.++..+++.......+|  ..+++++++||.+||. 
T Consensus       350 GTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-  428 (550)
T KOG0605|consen  350 GTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-  428 (550)
T ss_pred             CCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-
Confidence            9999999999999999999999999999999999999999999999999998776444444  4578999999999998 


Q ss_pred             CCCCCCC---HHHHHH
Q 015594          361 NPDKRPE---MDEVVA  373 (404)
Q Consensus       361 dP~~Rpt---~~~ll~  373 (404)
                      ||++|..   ++||.+
T Consensus       429 d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  429 DPENRLGSKGAEEIKK  444 (550)
T ss_pred             CHHHhcCcccHHHHhc
Confidence            9999964   666653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=374.56  Aligned_cols=276  Identities=36%  Similarity=0.640  Sum_probs=241.5

Q ss_pred             CccccccccccCCCCeEEeeeeeeecceEEEEEEE--C-C--ce-EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh
Q 015594           86 SASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--D-G--QD-VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK  159 (404)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~-g--~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  159 (404)
                      ..+..++.|++..++..+.++||+|+||.||+|..  . +  .. ||||..+....      .....+..|.+|++++++
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~------~~~~~~~e~m~EArvMr~  217 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE------LTKEQIKEFMKEARVMRQ  217 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc------ccHHHHHHHHHHHHHHHh
Confidence            34678899999999999999999999999999987  2 2  23 89999864221      223446778999999999


Q ss_pred             cCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       160 l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      ++|||||+|||++....++                +||||+|+||+|.++|.++. ..++..+...++.+.+.||+|||+
T Consensus       218 l~H~NVVr~yGVa~~~~Pl----------------~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~  280 (474)
T KOG0194|consen  218 LNHPNVVRFYGVAVLEEPL----------------MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHS  280 (474)
T ss_pred             CCCCCEEEEEEEEcCCCcc----------------EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHH
Confidence            9999999999999998888                89999999999999998764 369999999999999999999999


Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CC
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CD  318 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~  318 (404)
                      ++++||||..+|||++.++.+||+|||+++.............-...|+|||.+....|+.++|||||||++||+++ |.
T Consensus       281 k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~  360 (474)
T KOG0194|consen  281 KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA  360 (474)
T ss_pred             CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence            99999999999999999999999999999754311111111224678999999999999999999999999999998 88


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      .||++....++...+....++...+...|.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus       361 ~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  361 EPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            899999999999999899999999999999999999999999999999999999999999877653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-47  Score=368.94  Aligned_cols=266  Identities=31%  Similarity=0.587  Sum_probs=218.4

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCc
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPN  164 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  164 (404)
                      .|.+..++|.+.+.||+|+||.||+|.+       +++.||||++.....        ......+.+|+.++..+ +|||
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~n   72 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--------ASEHKALMSELKILIHIGNHLN   72 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--------hHHHHHHHHHHHHHHHhccCcc
Confidence            3778889999999999999999999974       246899999863211        11234578999999999 8999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc------------------------------
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------------------------------  214 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------  214 (404)
                      |+++++++......               +++||||+++|+|.+++....                              
T Consensus        73 iv~~~~~~~~~~~~---------------~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (338)
T cd05102          73 VVNLLGACTKPNGP---------------LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRI  137 (338)
T ss_pred             eeeEEeEecCCCCc---------------eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccc
Confidence            99999988654321               389999999999999986532                              


Q ss_pred             ------------------------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          215 ------------------------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       215 ------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                                    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~D  217 (338)
T cd05102         138 EAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD  217 (338)
T ss_pred             ccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEee
Confidence                                          13478889999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          265 FGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       265 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      ||+++.......  ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+.............
T Consensus       218 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~  297 (338)
T cd05102         218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR  297 (338)
T ss_pred             cccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC
Confidence            999975432221  1122345678999999999899999999999999999997 9999988665544444444444555


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+..+++++.+||.+||+.||.+|||+.+|++.|+++...
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            6778899999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=362.57  Aligned_cols=263  Identities=25%  Similarity=0.388  Sum_probs=218.8

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccH-----HHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSE-----AEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .....+|++.+.||+|.||.|-+|++  +++.||||++++.+......     .....-.+.+.+|+.+|++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34467899999999999999999997  78999999997653221110     000011356889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCC-CcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK-LAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++.+..+...-.+              |||+|||..|.+...   -...+ +++.+++.++++++.||+|||.+||+|||
T Consensus       173 LiEvLDDP~s~~~--------------YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD  235 (576)
T KOG0585|consen  173 LIEVLDDPESDKL--------------YLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD  235 (576)
T ss_pred             EEEeecCcccCce--------------EEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence            9999887766544              999999999887642   22344 99999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeecccccccc-----CCCCcccCCCCCccccCccccCCC----CCCcchhhHHHHHHHHHHHhC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEA-----SNPHDMTGETGTLGYMAPEVLNGS----AYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g  317 (404)
                      |||+|+||+++|+|||+|||++....     .........+|||.|||||...+.    ..+.+.||||+||+||.|+.|
T Consensus       236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG  315 (576)
T KOG0585|consen  236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG  315 (576)
T ss_pred             cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence            99999999999999999999997542     222233457899999999999773    246889999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       318 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..||.+....++..+++...+.......+.+++++||.+||.+||++|.++.+|...
T Consensus       316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            999999999999999998877655555678999999999999999999999998654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-48  Score=387.32  Aligned_cols=268  Identities=31%  Similarity=0.543  Sum_probs=234.6

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP  163 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  163 (404)
                      ..-.++.+.+..+.+.||+|+||.||+|...       ...||||.++...        ....++.|.+|+.++..++||
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--------~~~~~~dF~REaeLla~l~H~  549 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--------ENQARQDFRREAELLAELQHP  549 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--------cHHHHHHHHHHHHHHHhccCC
Confidence            3445678899999999999999999999863       3679999996322        233578899999999999999


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------cC----CCcHHHHHHHHHHHH
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------RR----KLAFKVVIQLALDLA  231 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~----~l~~~~~~~i~~qi~  231 (404)
                      |||+|+|++...+.+                |+|+|||..|+|.+||..+.        +.    +++..+.+.||.||+
T Consensus       550 nIVrLlGVC~~~~P~----------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIA  613 (774)
T KOG1026|consen  550 NIVRLLGVCREGDPL----------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIA  613 (774)
T ss_pred             CeEEEEEEEccCCee----------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHH
Confidence            999999999999888                99999999999999996642        22    388999999999999


Q ss_pred             HHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCC-CCccc-CCCCCccccCccccCCCCCCcchhhHHHHH
Q 015594          232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN-PHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGI  309 (404)
Q Consensus       232 ~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~-~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  309 (404)
                      .|+.||-++.+|||||.++|+||.++..|||+|||+++..-.. .+... ...-..+|||||.+..+.|+.++|||||||
T Consensus       614 aGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV  693 (774)
T KOG1026|consen  614 AGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV  693 (774)
T ss_pred             HHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence            9999999999999999999999999999999999999854332 22222 334578999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          310 CLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       310 il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      +|||+++ |..||.+.+..++..-+..+.+ .+.|..||.++++||..||+.+|.+||+++||-..|++......
T Consensus       694 vLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  694 VLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             hhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            9999998 9999999999999988877777 78899999999999999999999999999999999998776554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-48  Score=373.58  Aligned_cols=248  Identities=29%  Similarity=0.503  Sum_probs=224.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .-|.+++.||.|+.|.|-+|++  +|+.+|||++.+.....      ......+.+|+.+|+.+.||||+.+|++|++..
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s------~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS------SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccc------cccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            4577889999999999999998  89999999997653221      122355789999999999999999999999998


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ++                |+|+||++||.|++++.+.  +++++++++++++||+.|+.|+|..+|+|||+||+|+||+.
T Consensus        86 ~l----------------ylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~  147 (786)
T KOG0588|consen   86 HL----------------YLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV  147 (786)
T ss_pred             eE----------------EEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence            88                9999999999999999765  78999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+++||+|||+|.... ++....+.||+|.|.|||++.|.+| +.++||||.|||||.|++|.+||.+.+...++.++.+
T Consensus       148 ~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~  226 (786)
T KOG0588|consen  148 KNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR  226 (786)
T ss_pred             ccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence            9999999999997644 4556677899999999999999988 5899999999999999999999999999999888887


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.+  ++|..+++++++||.+||..||++|.|+++|++
T Consensus       227 G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  227 GVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             Ccc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            765  477999999999999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.8e-47  Score=354.17  Aligned_cols=261  Identities=22%  Similarity=0.419  Sum_probs=220.4

Q ss_pred             cCCCCeEEe--eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIK--GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~--~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ++..++...  ..||+|++|.||+|.++|+.||||.++.....      .....+.+.+|+.++++++||||+++++++.
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~   88 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNILKIYGFII   88 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccc------cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence            444455544  57899999999999999999999998643221      1223466889999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~Ni  252 (404)
                      +...            ....+++||||+++|+|.+++.+.  ..+++.....++.|++.||.|||+. +++||||||+||
T Consensus        89 ~~~~------------~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~ni  154 (283)
T PHA02988         89 DIVD------------DLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF  154 (283)
T ss_pred             eccc------------CCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhE
Confidence            6111            011238999999999999999654  5789999999999999999999984 999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      +++.++.+||+|||+++.....   .....++..|+|||.+.+  ..++.++|||||||++|||++|..||...+..+..
T Consensus       155 ll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~  231 (283)
T PHA02988        155 LVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY  231 (283)
T ss_pred             EECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999999999999754332   123567899999999976  67999999999999999999999999999888887


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ..+.....++..+..+++++.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            7777777777777789999999999999999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-49  Score=371.99  Aligned_cols=255  Identities=29%  Similarity=0.596  Sum_probs=228.4

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ....|+|..+.+.-++.||.|+.|.||+|+..++.||||.++                +.-..++.-|++|+||||+.|.
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~----------------elkETdIKHLRkLkH~NII~Fk  178 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR----------------ELKETDIKHLRKLKHPNIITFK  178 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh----------------hhhhhhHHHHHhccCcceeeEe
Confidence            345799998988889999999999999999999999999873                2223567889999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      |+|....-+                |||||||..|-|...|..  +++++-...+.|..+|+.|+.|||.+.|||||||.
T Consensus       179 GVCtqsPcy----------------CIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS  240 (904)
T KOG4721|consen  179 GVCTQSPCY----------------CIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS  240 (904)
T ss_pred             eeecCCcee----------------EEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC
Confidence            999766655                999999999999999955  46889999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      -||||..+..|||+|||.++..... ..+-.++||..|||||++.+.+.+.|+|||||||+||||+||..||.+.+...+
T Consensus       241 PNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI  319 (904)
T KOG4721|consen  241 PNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI  319 (904)
T ss_pred             CceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence            9999999999999999999865544 344458999999999999999999999999999999999999999999887777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ...+-...+...+|..||+.|.-||+.||+..|..||++.+|+..|+.+.
T Consensus       320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            66666677778899999999999999999999999999999999988653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-48  Score=343.57  Aligned_cols=250  Identities=24%  Similarity=0.417  Sum_probs=213.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|+...++|+|+||+||++++  +|+.||||.+.-++++       ....+...+|+.+|++|+|||+|.++.+|....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-------~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-------PVVKKIALREIRMLKQLKHENLVNLIEVFRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-------HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence            4688889999999999999987  7999999999654433       344566789999999999999999999998887


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                ++|+||| .-++.+-|.+.+ ..++.+.+..++.|++.|+.|+|+++++||||||+||||+.
T Consensus        75 kl----------------hLVFE~~-dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~  136 (396)
T KOG0593|consen   75 KL----------------HLVFEYC-DHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ  136 (396)
T ss_pred             ee----------------EEEeeec-chHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence            77                8999999 556666666654 57899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +|.+||||||+|+....+....+..+.|..|.|||.+.| ..|+..+|||++||++.||++|..-|++.+..+.+..+..
T Consensus       137 ~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k  216 (396)
T KOG0593|consen  137 NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK  216 (396)
T ss_pred             CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence            999999999999988878888888999999999999988 5799999999999999999999999999887776555432


Q ss_pred             c--c-----------------CCCCCC----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 Q--N-----------------LRPEIP----------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~--~-----------------~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .  .                 ++...+          ..++.-+.+|++.||+.||++|++-++++.
T Consensus       217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1  0                 010001          224566889999999999999999999883

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=367.23  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=221.2

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      ..+..++|.+.++||+|+||.|+++..  +++.+|||+++++.--.+.+.+      ....|.+|+... +||.++.++.
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve------~~~~EkrI~~la~~HPFL~~L~~  436 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVE------SLMCEKRIFELANRHPFLVNLFS  436 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHH------HHHHHHHHHHHhccCCeEeeccc
Confidence            456778999999999999999999987  6789999999987665555443      345677777766 5999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      .|+..+++                |+||||+.||++..+.   ..+.+++..+.-++..|+.||.|||++||||||||.+
T Consensus       437 ~fQT~~~l----------------~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd  497 (694)
T KOG0694|consen  437 CFQTKEHL----------------FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD  497 (694)
T ss_pred             ccccCCeE----------------EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence            99999988                9999999999954432   3468999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |||+|.+|.+||+|||+++..........+.+|||.|||||++.+..|+.++|+|||||+||||+.|..||++.+.+++.
T Consensus       498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F  577 (694)
T KOG0694|consen  498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF  577 (694)
T ss_pred             heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            99999999999999999987665666777899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      ..++....  ..|..++.+..+||+++|.+||++|..+
T Consensus       578 dsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            99987654  4788999999999999999999999755

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-48  Score=366.13  Aligned_cols=247  Identities=31%  Similarity=0.525  Sum_probs=222.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|+.  +.+.||+|.+++...   .+.+    ...+.+|+++++.++|||||.++++|+...
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr---~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR---NEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC---chHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence            4688889999999999999975  789999999976543   2333    344679999999999999999999999888


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ++                |+|.||+.| +|..+|...  ..++++.+..++.+++.||.|||+.+|+|||+||.|||++.
T Consensus        75 ~~----------------~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~  135 (808)
T KOG0597|consen   75 HL----------------WVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK  135 (808)
T ss_pred             eE----------------EEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC
Confidence            77                899999955 999999765  68999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      .+.+|++|||+|+....+....+...|||.|||||.+.+.+|+..+|+|||||++||+++|++||-..+..++...+...
T Consensus       136 ~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d  215 (808)
T KOG0597|consen  136 GGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD  215 (808)
T ss_pred             CCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC
Confidence            99999999999998888777778888999999999999999999999999999999999999999999988888888776


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...  .|...+..+.+|+..+|.+||..|.+..+++.
T Consensus       216 ~v~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 PVK--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCC--CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            544  44578999999999999999999999999873

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-47  Score=328.22  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=228.2

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+++.||+|-||.||.|+.  ++-.||+|++.+      ++........++.+|+.|-+.|+||||+++|++|.+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfK------sqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFK------SQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeH------HHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            347999999999999999999997  578899999963      344445567788999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+++||..+|+|...|...+..++++...+.++.|++.||.|+|.++|+||||||+|+|+
T Consensus        94 ~~ri----------------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl  157 (281)
T KOG0580|consen   94 SKRI----------------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL  157 (281)
T ss_pred             ccee----------------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc
Confidence            8887                999999999999999987777889999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      +..+.+||+|||.+....  .......+||..|.+||+..+..++..+|+|++|++.||++.|..||...+..+++..+.
T Consensus       158 g~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~  235 (281)
T KOG0580|consen  158 GSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR  235 (281)
T ss_pred             CCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence            999999999999996543  455567899999999999999999999999999999999999999999999888888887


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ...+  .+|..++.+++++|.+|+..+|.+|.+..+++..
T Consensus       236 k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  236 KVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             Hccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            6654  4678899999999999999999999999998763

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=386.10  Aligned_cols=264  Identities=36%  Similarity=0.645  Sum_probs=229.6

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE---CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY---DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~---~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .+......+...||+|.||.||.|.+   .|.    .||||.++....    +    .....|.+|..+|+.++|||||+
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~----~----~~~~~Fl~Ea~~m~~f~HpNiv~  759 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS----E----QEVSDFLKEALLMSKFDHPNIVS  759 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC----H----HHHHHHHHHHHHHhcCCCcceee
Confidence            35678899999999999999999987   333    488888864321    2    22466999999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHhhCCc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----RRKLAFKVVIQLALDLARGLSYLQSKKI  242 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~gi  242 (404)
                      ++|++.+....                +|++|||+||+|..||++.+     ...++....+.++.||+.|+.||+++++
T Consensus       760 liGv~l~~~~~----------------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~f  823 (1025)
T KOG1095|consen  760 LIGVCLDSGPP----------------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHF  823 (1025)
T ss_pred             EEEeecCCCCc----------------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCC
Confidence            99999986665                89999999999999997752     3568999999999999999999999999


Q ss_pred             eecccCCCCEEEcCCCcEEEeecccccccc-CCCCcccCC-CCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCC
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVARLEA-SNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDM  319 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~  319 (404)
                      |||||..+||||+....|||+|||+|+... ...+...+. .-...|||||.+....++.++|||||||++||+++ |..
T Consensus       824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~  903 (1025)
T KOG1095|consen  824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT  903 (1025)
T ss_pred             cCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC
Confidence            999999999999999999999999999433 233333333 23468999999999999999999999999999999 899


Q ss_pred             CCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       320 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||++.+..+++..++.+. +.+.|..||+.+++||..||+.+|++||++..|++.+..+....-
T Consensus       904 PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  904 PYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             CCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            999999999998888887 889999999999999999999999999999999999998876653

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-46  Score=342.48  Aligned_cols=259  Identities=24%  Similarity=0.347  Sum_probs=224.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEECC--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+..+.|++.+.||.|.-|+||++...+  ..+|+|++++....      ......+...|-.||..++||.++.+|
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~------~rkKl~Ra~tE~eIL~~lDHPFlPTLY  143 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA------SRKKLKRAQTEREILSLLDHPFLPTLY  143 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh------hhhHHHHHHHHHHHHHhcCCCccchhh
Confidence            4456778899999999999999999999854  89999999754322      123345667899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +.|+...-+                |+|||||+||+|..++.++..+.+++..++-++.+++.||+|||..|||+|||||
T Consensus       144 a~fet~~~~----------------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP  207 (459)
T KOG0610|consen  144 ASFETDKYS----------------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP  207 (459)
T ss_pred             heeecccee----------------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence            999877655                9999999999999999999999999999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCC---------------------------------C--------------------
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNP---------------------------------H--------------------  276 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~---------------------------------~--------------------  276 (404)
                      +||||.++|+|.|+||.++......+                                 .                    
T Consensus       208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep  287 (459)
T KOG0610|consen  208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP  287 (459)
T ss_pred             ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence            99999999999999999875321100                                 0                    


Q ss_pred             ---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHH
Q 015594          277 ---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANV  353 (404)
Q Consensus       277 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  353 (404)
                         ....++||-.|.|||++.|...+.++|+|+|||++|||+.|..||.+.+..+++.+++.+.+...-...++..+++|
T Consensus       288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDL  367 (459)
T KOG0610|consen  288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDL  367 (459)
T ss_pred             CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHH
Confidence               00123689999999999999999999999999999999999999999999999999998877765556788999999


Q ss_pred             HHHhhhhCCCCCCC----HHHHH
Q 015594          354 MKRCWDANPDKRPE----MDEVV  372 (404)
Q Consensus       354 i~~cl~~dP~~Rpt----~~~ll  372 (404)
                      |+++|.+||.+|..    +.||-
T Consensus       368 Ir~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  368 IRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHhccChhhhhccccchHHhh
Confidence            99999999999988    66664

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=355.86  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      -++|.+.+.||.|+||.||+|+.  +|..||||.++..-..   ..+..     -.+|+..|++|+ |||||++.+++.+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~-----nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECM-----NLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHH-----HHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            46899999999999999999986  7899999998754322   22222     248999999998 9999999999988


Q ss_pred             CC-ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          175 TS-ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       175 ~~-~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .. .+                |+||||| ..+|.+++... ++.+++..+..|+.||+.||+|+|.+|+.|||+||+|||
T Consensus        81 ~~~~L----------------~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL  142 (538)
T KOG0661|consen   81 NDRIL----------------YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL  142 (538)
T ss_pred             cCceE----------------eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence            87 44                8999999 88999988654 889999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |.....|||+|||+||... +....+..+.|..|.|||++.. ..|+.++|+|++|||++|+++-++-|++.+..+.+.+
T Consensus       143 i~~~~~iKiaDFGLARev~-SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K  221 (538)
T KOG0661|consen  143 ISGNDVIKIADFGLAREVR-SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK  221 (538)
T ss_pred             ecccceeEecccccccccc-cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH
Confidence            9988899999999998543 4456777889999999999854 4689999999999999999999999999887776666


Q ss_pred             HHhc-------------------cCC--CC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          333 VVRQ-------------------NLR--PE-------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       333 ~~~~-------------------~~~--~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +..-                   +++  ..       .-..+++++.++|.+|+++||.+|||+.++++.
T Consensus       222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            5421                   111  10       112378899999999999999999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=357.04  Aligned_cols=248  Identities=30%  Similarity=0.495  Sum_probs=216.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|.....||+|+||.||+|.+  +++.||+|+++.....        .....+.+|+.++.+++++||.++|+++....
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--------deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--------DEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcc--------hhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            4577779999999999999998  7899999999764322        22344678999999999999999999999888


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                +++||||.||++.+.|...  ..+.+..+..++++++.||.|||.++.+|||||+.|||+..
T Consensus        85 ~L----------------wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~  146 (467)
T KOG0201|consen   85 KL----------------WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE  146 (467)
T ss_pred             cH----------------HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEec
Confidence            87                7899999999999998443  45589999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +|.|||+|||++...........+++||+.|||||++.+..|+.++||||||++++||++|.+||.+..+..++. ++..
T Consensus       147 ~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-lIpk  225 (467)
T KOG0201|consen  147 SGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-LIPK  225 (467)
T ss_pred             cCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-eccC
Confidence            999999999999876665555678999999999999999899999999999999999999999999988744432 2344


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+|.....+++.|++||..||+.||+.||++.+|++
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            5556666789999999999999999999999998874

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.8e-46  Score=353.93  Aligned_cols=243  Identities=27%  Similarity=0.432  Sum_probs=208.0

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +.||+|+||.||++.+  +|+.||||+++....      ........+.+|+.++.+++||||+++++++.....+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~----   70 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL----   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE----
Confidence            4689999999999987  689999999963211      1122234567899999999999999999999877665    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEE
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI  262 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL  262 (404)
                                  |+||||+++++|.+++.+.  ..+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||
T Consensus        71 ------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl  136 (323)
T cd05571          71 ------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKI  136 (323)
T ss_pred             ------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEE
Confidence                        8999999999999988654  57899999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 015594          263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       263 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  342 (404)
                      +|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+....  ..+
T Consensus       137 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~  214 (323)
T cd05571         137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRF  214 (323)
T ss_pred             eeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCC
Confidence            999999754433344455679999999999999999999999999999999999999998887777666655443  356


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      +..+++++.++|.+||+.||++||     ++.+|++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            778899999999999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-45  Score=358.15  Aligned_cols=265  Identities=29%  Similarity=0.554  Sum_probs=220.5

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|.+..++|.+.+.||+|+||.||++++       ++..||||+++.....        .....+.+|+.+++.+ +|
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~~h  101 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------DEREALMSELKILSHLGQH  101 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------HHHHHHHHHHHHHHhhccC
Confidence            456788889999999999999999999875       2357999998643211        1235578999999999 89


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------------------
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------------  214 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------------  214 (404)
                      |||+++++++......                |+||||+++|+|.+++....                            
T Consensus       102 ~nIv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (374)
T cd05106         102 KNIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK  165 (374)
T ss_pred             CceeeEeeEecCCCCe----------------EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcc
Confidence            9999999999877655                89999999999999985431                            


Q ss_pred             ----------------------------------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          215 ----------------------------------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       215 ----------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                                                              ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~  245 (374)
T cd05106         166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL  245 (374)
T ss_pred             cccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE
Confidence                                                    1247888999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS  331 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~  331 (404)
                      +.++.+||+|||+++........  .....+++.|||||++.+..++.++||||||+++|+|++ |..||..........
T Consensus       246 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~  325 (374)
T cd05106         246 TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY  325 (374)
T ss_pred             eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH
Confidence            99999999999999754322211  112235678999999998889999999999999999997 999998876655555


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ...........+..+++++.++|.+||+.||.+||++.+|+++|+++.
T Consensus       326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         326 KMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            555555666667778999999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-45  Score=352.90  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=212.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|.+  +++.||||++....      .........+.+|+.++++++||||+++++++.+.
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE------ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            47899999999999999999998  68899999996321      11122345678999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus        91 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~  152 (329)
T PTZ00263         91 NRV----------------YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD  152 (329)
T ss_pred             CEE----------------EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC
Confidence            665                8999999999999998654  5789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       153 ~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  229 (329)
T PTZ00263        153 NKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA  229 (329)
T ss_pred             CCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999754322   2235789999999999999999999999999999999999999998887777666655


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      ..  ..++..++..+++||.+||+.||.+||+     +++|+.
T Consensus       230 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            43  4467778999999999999999999986     677773

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-45  Score=359.64  Aligned_cols=264  Identities=32%  Similarity=0.594  Sum_probs=219.8

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|.++.++|.+.+.||+|+||.||+|++       ++..||||+++.....        .....+.+|+.++..+ +|
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~Ei~il~~l~~H   98 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNH   98 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--------HHHHHHHHHHHHHHHhcCC
Confidence            346778888999999999999999999974       3568999998633211        1235678999999999 89


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------------------
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------------  214 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------------  214 (404)
                      |||+++++++.+....                ++||||+++|+|.+++....                            
T Consensus        99 pnIv~l~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (375)
T cd05104          99 INIVNLLGACTVGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC  162 (375)
T ss_pred             cceeeeeeeeccCCcc----------------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence            9999999999877765                89999999999999986432                            


Q ss_pred             ---------------------------------------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          215 ---------------------------------------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       215 ---------------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                                                                   ...+++..+..++.||+.||.|||+.||+||||||
T Consensus       163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  242 (375)
T cd05104         163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA  242 (375)
T ss_pred             hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence                                                         12478888999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +|||++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence            9999999999999999999754332211  112334678999999999999999999999999999998 8999988766


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ................+...+.++.+||.+||+.||++||++.+|++.|++.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             hHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            5555556666666666777899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=344.77  Aligned_cols=248  Identities=25%  Similarity=0.504  Sum_probs=219.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.|-++..  .|+.||||.+++..-  .++..    .-.+.+|+.||+.|+||||+.++.+|+..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--kdeqD----lvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--KDEQD----LVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--ccHHH----HHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            46789999999999999999986  799999999975432  22222    33467999999999999999999999988


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      +.+                .|||||..+|.|.+|+.+.  +.+++.+++.+++||++|+.|+|.++++|||||.+|||+|
T Consensus       126 dKI----------------vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD  187 (668)
T KOG0611|consen  126 DKI----------------VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD  187 (668)
T ss_pred             ceE----------------EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence            887                8999999999999999654  7899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++++||+|||++..+. .....+++||++-|.+||+++|.+| ++.+|-|||||+||.|+.|.+||.+.+...+..++.
T Consensus       188 ~N~NiKIADFGLSNly~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs  266 (668)
T KOG0611|consen  188 QNNNIKIADFGLSNLYA-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS  266 (668)
T ss_pred             CCCCeeeeccchhhhhc-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence            99999999999997543 4566778999999999999999998 689999999999999999999999999998888887


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ++.++..   .-|++..-||+.||..||++|.|+++|..
T Consensus       267 ~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  267 RGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             cccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            7766532   34567899999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-45  Score=346.68  Aligned_cols=247  Identities=27%  Similarity=0.368  Sum_probs=211.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +|+.||||++.....      ........+.+|+.++++++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            3688999999999999999997  589999999864211      11122455789999999999999999998887665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~  136 (291)
T cd05612          75 FL----------------YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK  136 (291)
T ss_pred             eE----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence            54                8999999999999998654  57899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||++......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus       137 ~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~  213 (291)
T cd05612         137 EGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG  213 (291)
T ss_pred             CCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            999999999999754322   23356899999999999999999999999999999999999999988877777666654


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVAM  374 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~  374 (404)
                      .  ..++..+++.+.+||.+||+.||.+||+     ++++++.
T Consensus       214 ~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            3  3466778999999999999999999995     8887753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.6e-45  Score=341.87  Aligned_cols=250  Identities=26%  Similarity=0.334  Sum_probs=206.7

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |.+.+.||+|+||.||++.+  +|+.||||++.....      ........+.+|+.++.+++|+||+++++++.+...+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence            67889999999999999986  689999999863321      1112234577899999999999999999998877655


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++||||+++|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++
T Consensus        76 ----------------~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~  139 (285)
T cd05631          76 ----------------CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG  139 (285)
T ss_pred             ----------------EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC
Confidence                            8999999999999888655455799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--Q  336 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~--~  336 (404)
                      .++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..  .
T Consensus       140 ~~kl~Dfg~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  218 (285)
T cd05631         140 HIRISDLGLAVQIPE-GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK  218 (285)
T ss_pred             CEEEeeCCCcEEcCC-CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh
Confidence            999999999975332 2233456789999999999999999999999999999999999999987654322222211  1


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      ......+..+++++.+||.+||+.||.+||+     ++++++
T Consensus       219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            2233456678999999999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-46  Score=352.28  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=211.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|+..+.||+|+||.||+|++  +|+.||+|.+.+..+...       ......+|+.||++|+||||+++.+...+.
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-------~~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-------FPITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-------chHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            46688889999999999999997  799999999987654322       223356899999999999999999998877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..-.              +|||+||| .-+|.-++ .+..-+|++.++..++.||+.||+|||++||+|||||.+|||||
T Consensus       189 ~~~s--------------iYlVFeYM-dhDL~GLl-~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid  252 (560)
T KOG0600|consen  189 LSGS--------------IYLVFEYM-DHDLSGLL-SSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID  252 (560)
T ss_pred             CCce--------------EEEEEecc-cchhhhhh-cCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc
Confidence            3222              39999999 66777766 34466899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++|.+||+|||+|+..... ...++..+-|+.|.|||.+.|. .|+.++|+||.||||.||+.|++.|++.+..+.+..+
T Consensus       253 n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI  332 (560)
T KOG0600|consen  253 NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI  332 (560)
T ss_pred             CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence            9999999999999965443 4458888999999999999876 5999999999999999999999999999887776665


Q ss_pred             Hhc------------cC------CCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQ------------NL------RPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~------------~~------~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...            .+      .+.         ....++...-+|+..||..||.+|.|+.+.+.
T Consensus       333 fklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  333 FKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            431            01      011         11345778899999999999999999998774

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-44  Score=336.33  Aligned_cols=257  Identities=27%  Similarity=0.507  Sum_probs=215.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ++..+|.+.+.||+|+||.||+|.+     .+..||+|.++....        ......+.+|+.++.+++||||+++++
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~   73 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRGFLAEALTLGQFDHSNIVRLEG   73 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            5677899999999999999999975     356899999864321        112355889999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++......                ++||||+++|+|.+++.+. ...+++..++.++.||+.||+|||++|++||||||+
T Consensus        74 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~  136 (266)
T cd05064          74 VITRGNTM----------------MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH  136 (266)
T ss_pred             EEecCCCc----------------EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHh
Confidence            98876655                8999999999999998654 357899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      ||+|+.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||...+..+
T Consensus       137 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~  216 (266)
T cd05064         137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD  216 (266)
T ss_pred             hEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            99999999999999998764322211 1112335678999999999999999999999999999775 999999988777


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ....+. .......+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus       217 ~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         217 VIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            666554 3344556788999999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.2e-45  Score=335.56  Aligned_cols=258  Identities=31%  Similarity=0.590  Sum_probs=219.7

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |.+..++|++.+.||+|+||.||+|.+ ++..||+|.+.....          ..+.+.+|+.++++++|+||+++++.+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----------SVQAFLEEANLMKTLQHDKLVRLYAVV   70 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            678899999999999999999999987 567899998753211          134578999999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+....                ++||||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||||+||
T Consensus        71 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni  134 (261)
T cd05072          71 TKEEPI----------------YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV  134 (261)
T ss_pred             cCCCCc----------------EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence            766554                8999999999999999776667789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05072         135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM  214 (261)
T ss_pred             EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence            999999999999999976433221 1222345678999999998889999999999999999998 99999988777666


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+.. .........++.++.+++.+||..+|++||++++++++|+++
T Consensus       215 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         215 SALQR-GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHc-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            55543 344445567899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-46  Score=354.32  Aligned_cols=254  Identities=26%  Similarity=0.471  Sum_probs=228.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|...+++|+|+||.+++.++  +++.|++|.+.......+       .+....+|+.+++++.|||||.+.+.|...
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-------~r~~A~~E~~lis~~~hP~iv~y~ds~~~~   75 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-------ERRSAIQEMDLLSKLLHPNIVEYKDSFEED   75 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-------hhHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence            36788999999999999997765  678999999976654432       234567999999999999999999999888


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      +.+               +||||+||+||+|.+.+.+.++..++++.+..|+.||+.|+.|||+++|+|||||+.|||++
T Consensus        76 ~~~---------------l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt  140 (426)
T KOG0589|consen   76 GQL---------------LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT  140 (426)
T ss_pred             Cce---------------EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence            773               38999999999999999888778999999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.|+|+|||+|+.............||+.||+||++.+.+|+.++|||||||++|||++-+.+|...+...+...+..
T Consensus       141 k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~  220 (426)
T KOG0589|consen  141 KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR  220 (426)
T ss_pred             ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence            99999999999999877666566678899999999999999999999999999999999999999999999888888777


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .. ....|...+.+++.+|..||..+|..||++.+|+..
T Consensus       221 ~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 GL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            66 456788899999999999999999999999999975

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-45  Score=348.49  Aligned_cols=240  Identities=21%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||+|+||.||++.+  +++.||+|+++....      ........+.+|+.++.+++||||+++++++.+....      
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------   68 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL------   68 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE------
Confidence            69999999999987  578999999863211      1122245577899999999999999999998876655      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        69 ----------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~D  136 (312)
T cd05585          69 ----------YLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCD  136 (312)
T ss_pred             ----------EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEE
Confidence                      8999999999999998654  5799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 015594          265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR  344 (404)
Q Consensus       265 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  344 (404)
                      ||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...++.
T Consensus       137 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~  214 (312)
T cd05585         137 FGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPD  214 (312)
T ss_pred             CcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCC
Confidence            999975443333444567999999999999999999999999999999999999999988877776665544  345677


Q ss_pred             CCcHHHHHHHHHhhhhCCCCCCC---HHHHH
Q 015594          345 CCPSSLANVMKRCWDANPDKRPE---MDEVV  372 (404)
Q Consensus       345 ~~~~~l~~li~~cl~~dP~~Rpt---~~~ll  372 (404)
                      .+++++.++|.+||+.||.+||+   +.+++
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            88999999999999999999985   55554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-45  Score=350.58  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=215.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC---CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      .+.+..++|.+.+.||+|+||.||+|.+.   +..||||++.....      ........+.+|+.++..++||||++++
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   97 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI------IKQKQVDHVFSERKILNYINHPFCVNLY   97 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence            34566789999999999999999999862   36899999853211      1122245578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+...+                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.||+||||||
T Consensus        98 ~~~~~~~~~----------------~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp  159 (340)
T PTZ00426         98 GSFKDESYL----------------YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKP  159 (340)
T ss_pred             EEEEeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCH
Confidence            999877655                8999999999999998654  5799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +|||++.++.+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus       160 ~NILl~~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~  236 (340)
T PTZ00426        160 ENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI  236 (340)
T ss_pred             HHEEECCCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999999975432   22346789999999999998899999999999999999999999998887776


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVAM  374 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~  374 (404)
                      ...+....  ..+|..+++.+.++|++||+.||++|+     +++++++.
T Consensus       237 ~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        237 YQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            66665543  345777899999999999999999995     88888753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-45  Score=348.92  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=211.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||+|.+  +++.||||+++...      .........+.+|+.++..++||||+++++++.+..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL------LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            3689999999999999999998  58999999996421      111223456789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus        75 ~~----------------~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~  136 (333)
T cd05600          75 YL----------------YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA  136 (333)
T ss_pred             EE----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence            55                8999999999999998554  57899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...
T Consensus       137 ~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  213 (333)
T cd05600         137 SGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW  213 (333)
T ss_pred             CCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence            99999999999975433   334567899999999999999999999999999999999999999988877766655543


Q ss_pred             cCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          337 NLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       337 ~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ......+      ..+++++.++|.+||..+|.+||++.+|++.
T Consensus       214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            2222122      2468999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-44  Score=334.48  Aligned_cols=258  Identities=30%  Similarity=0.603  Sum_probs=220.7

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      |++...+|.+.+.||+|+||.||+|.+  +++.||+|++.....          ....+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLGV   70 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----------HHHHHHHHHHHHHhCCCCChhheEEE
Confidence            678888999999999999999999987  578999999853211          12457789999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.....+                ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+|
T Consensus        71 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~n  134 (263)
T cd05052          71 CTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN  134 (263)
T ss_pred             EcCCCCc----------------EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence            8776655                899999999999999976655678999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcc-cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      |+++.++.+||+|||++.......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||+..+..+.
T Consensus       135 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~  214 (263)
T cd05052         135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV  214 (263)
T ss_pred             EEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999997543322111 12234668999999998899999999999999999998 9999998877666


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ...+ ........+..+|.++.++|.+||+.||++||++.++++.|+.+
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         215 YELL-EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHH-HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            5444 44556677888999999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-45  Score=347.85  Aligned_cols=243  Identities=28%  Similarity=0.450  Sum_probs=207.1

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +.||+|+||.||++.+  +|+.||+|++.....      ........+.+|+.+++.++||||+++++++.....+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~----   70 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL----   70 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE----
Confidence            4689999999999987  689999999963211      1112234567899999999999999999999877655    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEE
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI  262 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL  262 (404)
                                  |+||||+++|+|..++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        71 ------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL  136 (323)
T cd05595          71 ------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI  136 (323)
T ss_pred             ------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEe
Confidence                        8999999999999888554  57899999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 015594          263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       263 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  342 (404)
                      +|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....  .+
T Consensus       137 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~  214 (323)
T cd05595         137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RF  214 (323)
T ss_pred             cccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CC
Confidence            9999987543333344456799999999999999999999999999999999999999998887776666654433  46


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      +..+++++.++|.+||+.||.+||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            778899999999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-44  Score=353.69  Aligned_cols=264  Identities=30%  Similarity=0.569  Sum_probs=220.6

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CC
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HP  163 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp  163 (404)
                      ..|+++.++|++.+.||+|+||.||+|++.       +..||||+++....        ....+.+.+|+.++.+++ ||
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~~l~~l~~Hp  101 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--------SSEKQALMSELKIMTHLGPHL  101 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCCC
Confidence            468888999999999999999999999862       24699999864321        122456889999999996 99


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----------------------------
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----------------------------  214 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------------  214 (404)
                      ||+++++++.+....                |+|||||++|+|.+++.+..                             
T Consensus       102 nIv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (400)
T cd05105         102 NIVNLLGACTKSGPI----------------YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRS  165 (400)
T ss_pred             CeeeEEEEEccCCce----------------EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccc
Confidence            999999999876655                89999999999999986532                             


Q ss_pred             -----------------------------------------------------------------cCCCcHHHHHHHHHH
Q 015594          215 -----------------------------------------------------------------RRKLAFKVVIQLALD  229 (404)
Q Consensus       215 -----------------------------------------------------------------~~~l~~~~~~~i~~q  229 (404)
                                                                                       ...+++..+..++.|
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~q  245 (400)
T cd05105         166 YVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQ  245 (400)
T ss_pred             hhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHH
Confidence                                                                             124778889999999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      |+.||.|||+.||+|+||||+|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||
T Consensus       246 i~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl  325 (400)
T cd05105         246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY  325 (400)
T ss_pred             HHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999975433221  1223446788999999999889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          308 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       308 G~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      |+++|+|++ |..||.................+...+..++.++.++|.+||+.||++||++.+|.++|+.+.
T Consensus       326 Gvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            999999997 999998876555444455555566677788999999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-44  Score=340.77  Aligned_cols=257  Identities=29%  Similarity=0.534  Sum_probs=207.8

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE------------------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHH
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY------------------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW  157 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~------------------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  157 (404)
                      +...+|.+.+.||+|+||.||++.+                  ++..||||++.....        ...+..|.+|+.++
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l   73 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--------KNARNDFLKEVKIL   73 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--------HHHHHHHHHHHHHH
Confidence            3457899999999999999999975                  234699999864321        12345688999999


Q ss_pred             hhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----------------cCCCcH
Q 015594          158 HKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----------------RRKLAF  220 (404)
Q Consensus       158 ~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~l~~  220 (404)
                      .+++||||+++++++.+....                ++||||+++++|.+++....                 ...+++
T Consensus        74 ~~l~h~niv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (304)
T cd05096          74 SRLKDPNIIRLLGVCVDEDPL----------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISY  137 (304)
T ss_pred             hhcCCCCeeEEEEEEecCCce----------------EEEEecCCCCcHHHHHHhccccccccccccccccccccccccH
Confidence            999999999999999876655                89999999999999985432                 124678


Q ss_pred             HHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCC
Q 015594          221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAY  298 (404)
Q Consensus       221 ~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~  298 (404)
                      ..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+..+
T Consensus       138 ~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (304)
T cd05096         138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence            88999999999999999999999999999999999999999999999975432211  1122345788999999988889


Q ss_pred             CcchhhHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHh---c---cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          299 NRKCDVYSFGICLWEIYC--CDMPYPDLSFSEVTSAVVR---Q---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       299 ~~~~DvwslG~il~el~~--g~~Pf~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      +.++||||||+++|+|++  +..||...+..+.......   .   ......+..++..+.+||.+||+.||.+|||+.+
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            999999999999999986  5688888776665443322   1   1122345678999999999999999999999999


Q ss_pred             HHHHHH
Q 015594          371 VVAMLE  376 (404)
Q Consensus       371 ll~~L~  376 (404)
                      |.+.|+
T Consensus       298 i~~~l~  303 (304)
T cd05096         298 IHAFLT  303 (304)
T ss_pred             HHHHHh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-47  Score=326.79  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=216.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|.+.++||+|.|+.|+++.+  +|+.+|+|+++......+.       -+.+.+|+.+-+.|+|||||++.....+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~-------~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-------FQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc-------HHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            46788999999999999999987  7999999999766544432       24467999999999999999999876655


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .-.                |+|+|+++|++|..-+...  --+++..+-..++||+.+|.|+|.+||||||+||+|+++.
T Consensus        83 ~~~----------------ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA  144 (355)
T KOG0033|consen   83 SFH----------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA  144 (355)
T ss_pred             cee----------------EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence            444                8999999999996555332  4689999999999999999999999999999999999994


Q ss_pred             ---CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 ---KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                         ..--|||+|||+|.... ......+.+|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+...++..
T Consensus       145 SK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~  223 (355)
T KOG0033|consen  145 SKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ  223 (355)
T ss_pred             eccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence               33469999999997655 66667789999999999999999999999999999999999999999999999999999


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      +....+..  .....++++.++||++||..||.+|.|+.|.+
T Consensus       224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            88876543  34567899999999999999999999988765

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.7e-45  Score=348.18  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=207.2

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +.||+|+||.||++.+  +|+.||||++......      .......+.+|+.+++.++||||+++++++.....+    
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~----   70 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL----   70 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE----
Confidence            3689999999999987  6899999999642211      112235677899999999999999999999877665    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEE
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI  262 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL  262 (404)
                                  |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus        71 ------------~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL  136 (328)
T cd05593          71 ------------CFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKI  136 (328)
T ss_pred             ------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEE
Confidence                        8999999999999888554  57999999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 015594          263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       263 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  342 (404)
                      +|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  ...+
T Consensus       137 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~  214 (328)
T cd05593         137 TDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKF  214 (328)
T ss_pred             ecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccC
Confidence            99999875333333344567999999999999989999999999999999999999999888777666555433  2356


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVAM  374 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~  374 (404)
                      +..+++++.++|.+||+.||.+|+     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            778899999999999999999997     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-45  Score=335.65  Aligned_cols=249  Identities=35%  Similarity=0.681  Sum_probs=206.9

Q ss_pred             EEeeeeeeecceEEEEEEEC------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          102 IIKGAFARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.+.||.|.||.||+|.+.      +..|+||+++...    ..    .....+.+|+..+++++||||++++|++...
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~----~~----~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~   73 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS----SE----EEEEEFLNEIQILRKLRHPNIVKLYGFCIEN   73 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS----SH----HHHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc----cc----ccceeeeeccccccccccccccccccccccc
Confidence            56789999999999999986      6889999994321    11    1245678999999999999999999999865


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++|+||+++|+|.++|.......+++..+..|+.||+.||.|||+++++|+||+++||+++
T Consensus        74 ~~~----------------~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~  137 (259)
T PF07714_consen   74 EPL----------------FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD  137 (259)
T ss_dssp             SSE----------------EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred             ccc----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            554                8999999999999999776567899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      .++.+||+|||++.......  ...........|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....
T Consensus       138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~  217 (259)
T PF07714_consen  138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK  217 (259)
T ss_dssp             TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999997652221  12223446788999999988889999999999999999999 7899999988887777


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      + ....+...+..++..+.++|.+||+.||++||++.+|++.|
T Consensus       218 ~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  218 L-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             H-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            6 55556667888999999999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=346.21  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=224.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEe
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  173 (404)
                      ....|.+.+.||+|.||.||+++.  +|+.+|+|++++.......      ....+.+|+.+|+++. |||||.++++|+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~------~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE------DREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc------cHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            356899999999999999999987  6899999999765443211      3456789999999998 999999999999


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                ++|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.||+||||||+|+|
T Consensus       107 ~~~~~----------------~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L  167 (382)
T KOG0032|consen  107 DPDSV----------------YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL  167 (382)
T ss_pred             cCCeE----------------EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence            98876                8999999999999999766   3999999999999999999999999999999999999


Q ss_pred             EcC----CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          254 LDK----TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       254 i~~----~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +..    ++.+|++|||++..... .......+||+.|+|||++...+|+..+||||+|+++|.|++|..||.+.+....
T Consensus       168 ~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~  246 (382)
T KOG0032|consen  168 LASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI  246 (382)
T ss_pred             eccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence            943    35799999999987655 6677889999999999999999999999999999999999999999999998888


Q ss_pred             HHHHHhccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..++....+.  .+....++..+.++|++||..||.+|+|+.++++
T Consensus       247 ~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  247 FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            8888877663  3445677999999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.1e-45  Score=317.15  Aligned_cols=251  Identities=26%  Similarity=0.368  Sum_probs=214.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|...+.||+|+||+||+|++  +|+.||||.++.++....       ......+|+..|+.++|+||+.++++|...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-------i~~talREIK~Lqel~h~nIi~LiD~F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-------INRTALREIKLLQELKHPNIIELIDVFPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-------ccHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence            4688889999999999999998  799999999987744321       1234579999999999999999999998888


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                .+|+||+ ..+|...+. .+...++...+..++.++++||+|||++.|+||||||.|+||+.
T Consensus        75 ~l----------------~lVfEfm-~tdLe~vIk-d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~  136 (318)
T KOG0659|consen   75 NL----------------SLVFEFM-PTDLEVVIK-DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS  136 (318)
T ss_pred             ce----------------EEEEEec-cccHHHHhc-ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence            77                6899999 778988774 45678999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +|.+||+|||+|+.+.......+..+-|..|.|||.+.|. .|+..+|+||.||++.||+-+.+-|++.+.-+.+..+.+
T Consensus       137 ~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~  216 (318)
T KOG0659|consen  137 DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR  216 (318)
T ss_pred             CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence            9999999999999988877777777899999999999876 599999999999999999999988888877776665543


Q ss_pred             ccC---------------------CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNL---------------------RPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~---------------------~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .--                     -+.     ....+++++-+|+.+||..||.+|+++.+.++.
T Consensus       217 ~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  217 ALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            210                     011     113356788999999999999999999998864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=362.99  Aligned_cols=265  Identities=28%  Similarity=0.558  Sum_probs=234.7

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      -.-||+++.+.|.++||.|.||.|++|..     ....||||.++-+-.        +..+..|+.|+.||-+++||||+
T Consensus       622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--------ekqrrdFL~EAsIMGQFdHPNII  693 (996)
T KOG0196|consen  622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNII  693 (996)
T ss_pred             hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--------HHHHhhhhhhhhhcccCCCCcEE
Confidence            34589999999999999999999999987     236799999975432        34477899999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++.|+......+                .||.|||++|+|..||+++. +.++.-++..+++.|+.|+.||-+.++||||
T Consensus       694 rLEGVVTks~Pv----------------MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRD  756 (996)
T KOG0196|consen  694 RLEGVVTKSKPV----------------MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRD  756 (996)
T ss_pred             EEEEEEecCcee----------------EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhh
Confidence            999999888877                78999999999999997764 6699999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCcccCCC---CCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYP  322 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~  322 (404)
                      |...||||+.+...|++|||++++..+++.......   -..+|.|||.+.-..++.++||||+||+|||.++ |..||+
T Consensus       757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence            999999999999999999999997665553322222   2578999999999999999999999999999776 999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ++++.++++++ .+.++...|..||..|.+||..||++|-.+||.+.+|+..|+++...-
T Consensus       837 dmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  837 DMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             ccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            99999998875 456788889999999999999999999999999999999999987543

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-44  Score=334.54  Aligned_cols=259  Identities=27%  Similarity=0.547  Sum_probs=221.7

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |+....+|.+.+.||.|+||+||+|.+ .++.+|+|++.....         .....+.+|+.+++.++||||+++++++
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   71 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---------LKQQDFQKEVQALKRLRHKHLISLFAVC   71 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---------hhHHHHHHHHHHHhcCCCcchhheeeeE
Confidence            344456799999999999999999997 578999999864321         1134577899999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+....                ++||||+++++|.+++.+.....+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus        72 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni  135 (261)
T cd05148          72 SVGEPV----------------YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI  135 (261)
T ss_pred             ecCCCe----------------EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence            776655                8999999999999999776667799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS  331 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~  331 (404)
                      ++++++.+||+|||++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus       136 lv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~  215 (261)
T cd05148         136 LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD  215 (261)
T ss_pred             EEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999999765433333334456778999999998889999999999999999998 899999888777666


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .+. ...+...+..+++++.++|.+||+.||.+|||+.+|++.|+.+
T Consensus       216 ~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         216 QIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            655 4455667788999999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-44  Score=337.51  Aligned_cols=258  Identities=29%  Similarity=0.548  Sum_probs=216.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECC-------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      +...+|++.+.||+|+||.||+|...+       ..||+|.+.....        ......+.+|+.++.+++||||+++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~   73 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--------PKVQQEFRQEAELMSDLQHPNIVCL   73 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--------HHHHHHHHHHHHHHHhcCCcccceE
Confidence            345689999999999999999998632       5699998853221        2234568899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------CCCcHHHHHHHHHHHHHHH
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------RKLAFKVVIQLALDLARGL  234 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L  234 (404)
                      ++++.+....                |++|||+++++|.+++.....              ..+++..+..++.||+.||
T Consensus        74 ~~~~~~~~~~----------------~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al  137 (283)
T cd05048          74 LGVCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGM  137 (283)
T ss_pred             EEEEcCCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence            9998776655                899999999999999966421              4688899999999999999


Q ss_pred             HHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHH
Q 015594          235 SYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW  312 (404)
Q Consensus       235 ~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  312 (404)
                      .|||++|++|+||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|
T Consensus       138 ~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~  217 (283)
T cd05048         138 EYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW  217 (283)
T ss_pred             HHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence            99999999999999999999999999999999997533222  1223345688999999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          313 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       313 el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ||++ |..||.+.+..+....+.. ...+..+..+|+++.+|+.+||+.||.+||++.+|++.|+++
T Consensus       218 el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         218 EIFSYGLQPYYGFSNQEVIEMIRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            9998 9999998888776655543 444556788999999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-44  Score=343.29  Aligned_cols=246  Identities=28%  Similarity=0.458  Sum_probs=205.4

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHH---hhcCCCceeEEEEEEecC
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW---HKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~  175 (404)
                      |.+.+.||+|+||.||++.+  +|+.||||+++.....      .......+.+|+.++   +.++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            67889999999999999987  6899999999643211      111223455565554   567899999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|..++..   ..+++..+..++.||+.||.|||+.||+||||||+||+++
T Consensus        75 ~~~----------------~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~  135 (324)
T cd05589          75 DHV----------------CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD  135 (324)
T ss_pred             CEE----------------EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence            655                899999999999888743   4799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~  215 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN  215 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999987543333444456799999999999999999999999999999999999999998887777766655


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ..  ...+..+++++.++|.+||+.||.+||     ++.++++
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         216 DE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            43  346677899999999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-44  Score=328.94  Aligned_cols=258  Identities=32%  Similarity=0.571  Sum_probs=218.5

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |++..++|++.+.||+|+||.||+|.+ +++.||||.++.....          ...+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----------PKDFLAEAQIMKKLRHPKLIQLYAVC   70 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----------HHHHHHHHHHHHHCCCCCccceeEEE
Confidence            677888999999999999999999987 5678999998643211          23477899999999999999999988


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......                |+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        71 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  134 (261)
T cd05068          71 TLEEPI----------------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV  134 (261)
T ss_pred             ecCCCe----------------eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence            766554                8999999999999999765556789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCc-ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.++|+|||++......... ..+...+..|+|||.+.+..++.++||||||+++|+|++ |..||...+.....
T Consensus       135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  214 (261)
T cd05068         135 LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL  214 (261)
T ss_pred             EEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            9999999999999999765422111 122233467999999998889999999999999999999 99999988777666


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+. .......+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         215 QQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            5554 3344455677899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.7e-44  Score=329.34  Aligned_cols=257  Identities=32%  Similarity=0.605  Sum_probs=218.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |+|..++|.+.++||+|+||.||+|.. +++.||+|.+......          ...+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----------PEAFLAEANLMKQLQHPRLVRLYAVV   70 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----------HHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence            678889999999999999999999987 6789999998643221          23477899999999999999999886


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ... .                +++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        71 ~~~-~----------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni  133 (260)
T cd05067          71 TQE-P----------------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI  133 (260)
T ss_pred             ccC-C----------------cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence            432 2                28999999999999998776667899999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus       134 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  213 (260)
T cd05067         134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI  213 (260)
T ss_pred             EEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            99999999999999997544222 12223445778999999998889999999999999999999 99999988776665


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+ ........+..++.++.++|.+||..+|++||++++|++.|+.+
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         214 QNL-ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HHH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            544 34445566777899999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-44  Score=343.43  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=206.9

Q ss_pred             eeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||++..     .++.||||+++....     .........+.+|+.+++.++||||+++++++.....+ 
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~-   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-----VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL-   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-----HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE-
Confidence            5799999999999875     578999999964211     11112234567899999999999999999999876655 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     |+||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus        76 ---------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~  138 (323)
T cd05584          76 ---------------YLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH  138 (323)
T ss_pred             ---------------EEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC
Confidence                           8999999999999998654  56889999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 015594          260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR  339 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~  339 (404)
                      +||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|..||...+.......+....  
T Consensus       139 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--  216 (323)
T cd05584         139 VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--  216 (323)
T ss_pred             EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--
Confidence            999999998754333333445679999999999999889999999999999999999999999888777666665543  


Q ss_pred             CCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          340 PEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       340 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ..++..+++++.++|.+||+.||++||     +++++++
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            356778899999999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-44  Score=346.28  Aligned_cols=264  Identities=33%  Similarity=0.599  Sum_probs=217.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCce
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV  165 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  165 (404)
                      |.++.++|++.+.||+|+||.||+|..       +++.||+|+++....    .    .....+.+|+.++.++ +|+||
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~----~----~~~~~~~~E~~~~~~l~~h~ni   73 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT----A----SEYKALMTELKILIHIGHHLNV   73 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC----H----HHHHHHHHHHHHHHhhccCcch
Confidence            788889999999999999999999864       247899999853211    1    1124567899999999 89999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc------------------------------
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------------------------------  215 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------  215 (404)
                      +++++++.....               ..+++|||+++++|.+++.....                              
T Consensus        74 v~~~~~~~~~~~---------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (337)
T cd05054          74 VNLLGACTKPGG---------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSS  138 (337)
T ss_pred             hheeeeEecCCC---------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCc
Confidence            999998865432               23899999999999999854321                              


Q ss_pred             -----------------------------CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeecc
Q 015594          216 -----------------------------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG  266 (404)
Q Consensus       216 -----------------------------~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg  266 (404)
                                                   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG  218 (337)
T cd05054         139 SQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG  218 (337)
T ss_pred             cccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccc
Confidence                                         268899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 015594          267 VARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIP  343 (404)
Q Consensus       267 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  343 (404)
                      +++........  .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..............+
T Consensus       219 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  298 (337)
T cd05054         219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP  298 (337)
T ss_pred             cchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence            99764332211  122345678999999999999999999999999999998 999998765555544555555555667


Q ss_pred             CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          344 RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       344 ~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ..+++++.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus       299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.6e-44  Score=348.56  Aligned_cols=267  Identities=29%  Similarity=0.569  Sum_probs=224.0

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-  161 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-  161 (404)
                      ....|++..++|.+.+.||+|+||.||+|++.       ++.||||+++....        ......+.+|+.++.++. 
T Consensus        28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~E~~~l~~l~~   99 (401)
T cd05107          28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--------SSEKQALMSELKIMSHLGP   99 (401)
T ss_pred             CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--------hhHHHHHHHHHHHHHhcCC
Confidence            34468999999999999999999999999863       35899999964321        111345789999999997 


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------------------
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------------------  215 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------------  215 (404)
                      ||||+++++++.....+                ++||||+++|+|.+++.+...                          
T Consensus       100 H~niv~~~~~~~~~~~~----------------~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (401)
T cd05107         100 HLNIVNLLGACTKGGPI----------------YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ  163 (401)
T ss_pred             CCCeEEEEEEEccCCCc----------------EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence            99999999999877655                899999999999999965421                          


Q ss_pred             ----------------------------------------------------------------------CCCcHHHHHH
Q 015594          216 ----------------------------------------------------------------------RKLAFKVVIQ  225 (404)
Q Consensus       216 ----------------------------------------------------------------------~~l~~~~~~~  225 (404)
                                                                                            ..+++..++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  243 (401)
T cd05107         164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG  243 (401)
T ss_pred             cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence                                                                                  2367778899


Q ss_pred             HHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchh
Q 015594          226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCD  303 (404)
Q Consensus       226 i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  303 (404)
                      ++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++......  .......++..|+|||.+.+..++.++|
T Consensus       244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  323 (401)
T cd05107         244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD  323 (401)
T ss_pred             HHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence            99999999999999999999999999999999999999999997543221  1222345678999999999888999999


Q ss_pred             hHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          304 VYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       304 vwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |||||+++|||++ |..||......+..........++..+..++.++.+||.+||..+|.+||++.+|++.|+.+.+
T Consensus       324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~  401 (401)
T cd05107         324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT  401 (401)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence            9999999999998 8999988776666666666666667788889999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.9e-44  Score=347.26  Aligned_cols=250  Identities=26%  Similarity=0.442  Sum_probs=203.4

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .....+|.+.+.||+|+||.||++.+  +|+.||||++.....        ......+.+|+.+++.++|+||+++++++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  141 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--------DTVRRQICREIEILRDVNHPNVVKCHDMF  141 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--------HHHHHHHHHHHHHHHhCCCCCcceeeeEe
Confidence            34457788899999999999999987  589999999853321        12345678999999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .....+                |+||||+++++|.+.      ...++..+..++.||+.||.|||++||+||||||+||
T Consensus       142 ~~~~~~----------------~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  199 (353)
T PLN00034        142 DHNGEI----------------QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL  199 (353)
T ss_pred             ccCCeE----------------EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            776655                899999999998653      2456788889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ||+.++.+||+|||+++.............||..|+|||++..     ...+.++|||||||++|||++|..||......
T Consensus       200 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  279 (353)
T PLN00034        200 LINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG  279 (353)
T ss_pred             EEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Confidence            9999999999999999865443333445679999999999853     33457899999999999999999999743322


Q ss_pred             HHHHH--HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          328 EVTSA--VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       328 ~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +....  .......+..+..++.++.+||.+||+.||++||++.+|++.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        280 DWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22111  122233455667889999999999999999999999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.8e-44  Score=346.50  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=207.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||++.+  +++.||||++....      .........+.+|+.++.+++||||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD------MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4688999999999999999987  68999999996321      111223456788999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus        75 ~~----------------~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~  136 (363)
T cd05628          75 NL----------------YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS  136 (363)
T ss_pred             eE----------------EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence            65                8999999999999999654  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC-----------------------------------CcccCCCCCccccCccccCCCCCCcc
Q 015594          257 TRTVKIADFGVARLEASNP-----------------------------------HDMTGETGTLGYMAPEVLNGSAYNRK  301 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  301 (404)
                      ++.+||+|||+++......                                   ......+||+.|+|||++.+..++.+
T Consensus       137 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~  216 (363)
T cd05628         137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL  216 (363)
T ss_pred             CCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence            9999999999986432110                                   00123579999999999999999999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCC---CCCCHHHHHHH
Q 015594          302 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPD---KRPEMDEVVAM  374 (404)
Q Consensus       302 ~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~---~Rpt~~~ll~~  374 (404)
                      +|||||||++|||++|..||...+..+....+........+|.  .+++++.++|.+|+. +|.   .||++++|++.
T Consensus       217 ~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            9999999999999999999998888877777665433333333  468899999998664 444   46899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=349.77  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=212.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +|+.||||+++....      ........+.+|+.++..++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM------IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH------hhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            3689999999999999999998  589999999964221      11123456789999999999999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++++|.+++.+.  ..+++..+..++.||+.||.|||+.||+||||||+||||+.
T Consensus        75 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~  136 (350)
T cd05573          75 HL----------------YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA  136 (350)
T ss_pred             eE----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence            55                8999999999999999665  67999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC-----------------------------CcccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          257 TRTVKIADFGVARLEASNP-----------------------------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      ++.+||+|||++.......                             .......||+.|+|||++.+..++.++|||||
T Consensus       137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  216 (350)
T cd05573         137 DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL  216 (350)
T ss_pred             CCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence            9999999999997544332                             22334568999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHHH
Q 015594          308 GICLWEIYCCDMPYPDLSFSEVTSAVVR--QNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVAM  374 (404)
Q Consensus       308 G~il~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~~  374 (404)
                      ||++|+|++|..||...+..+....+..  ..........+++++.+||.+||. ||.+||+ ++++++.
T Consensus       217 G~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         217 GVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             chhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999999999999998887777666665  223322233469999999999997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.9e-44  Score=335.46  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=204.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||.|+||+||+|.+  +++.||+|+++......        ....+.+|+.++++++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--------cchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            46799999999999999999987  68999999986433211        123456899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        76 ~~~----------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~  137 (288)
T cd07871          76 RCL----------------TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN  137 (288)
T ss_pred             CeE----------------EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            544                89999995 5999988554 34689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||+++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  217 (288)
T cd07871         138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF  217 (288)
T ss_pred             CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999999765444444455678999999999865 568999999999999999999999998877665544433


Q ss_pred             hccC--------------------CC--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNL--------------------RP--------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~--------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                    .+        .....+++++.+||.+||+.||.+|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            2100                    00        011246788999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-43  Score=339.95  Aligned_cols=251  Identities=25%  Similarity=0.464  Sum_probs=207.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|++.+.||+|+||.||++.+  +|..||+|++.....        ......+.+|+.++++++||||+++++++.
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            4567899999999999999999998  588999999864211        223456889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~Ni  252 (404)
                      +...+                ++||||+++++|.+++...  ..+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus        74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni  135 (331)
T cd06649          74 SDGEI----------------SICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI  135 (331)
T ss_pred             ECCEE----------------EEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence            77655                8999999999999998654  4689999999999999999999986 699999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |++.++.+||+|||++......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       136 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~  213 (331)
T cd06649         136 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI  213 (331)
T ss_pred             EEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998754322  23345689999999999999999999999999999999999999976655443221


Q ss_pred             HHh---------------------------------------------ccCCCCC-CCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          333 VVR---------------------------------------------QNLRPEI-PRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       333 ~~~---------------------------------------------~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      +..                                             ....+.. ...+++++.+||.+||+.||++||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp  293 (331)
T cd06649         214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA  293 (331)
T ss_pred             hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC
Confidence            110                                             0111111 224688999999999999999999


Q ss_pred             CHHHHHHH
Q 015594          367 EMDEVVAM  374 (404)
Q Consensus       367 t~~~ll~~  374 (404)
                      |+++|++.
T Consensus       294 t~~ell~h  301 (331)
T cd06649         294 DLKMLMNH  301 (331)
T ss_pred             CHHHHhcC
Confidence            99999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=348.36  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=208.8

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +|+.||||++.....      ........+.+|+.++..++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            3689999999999999999987  689999999963211      11223455778999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus        75 ~~----------------~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~  136 (364)
T cd05599          75 YL----------------YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA  136 (364)
T ss_pred             eE----------------EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence            65                8999999999999998654  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC--------------------------------------cccCCCCCccccCccccCCCCC
Q 015594          257 TRTVKIADFGVARLEASNPH--------------------------------------DMTGETGTLGYMAPEVLNGSAY  298 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~  298 (404)
                      ++.+||+|||++........                                      .....+||+.|+|||++.+..+
T Consensus       137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  216 (364)
T cd05599         137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY  216 (364)
T ss_pred             CCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence            99999999999864321100                                      0112468999999999999999


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 015594          299 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKRPE---MDEVVA  373 (404)
Q Consensus       299 ~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt---~~~ll~  373 (404)
                      +.++|||||||++|+|++|..||...+..+....+........++.  .+++++.++|.+||. +|.+|++   +.++++
T Consensus       217 ~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999999999999999999998887777666654433333333  468999999999996 9999987   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-44  Score=348.01  Aligned_cols=256  Identities=26%  Similarity=0.346  Sum_probs=213.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .+.+..++|.+.+.||+|+||.||++.+  +++.||||+++....      ........+.+|+.+++.++||||+++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~h~~iv~~~~  110 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM------IKRSDSAFFWEERDIMAHANSEWIVQLHY  110 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            4456678999999999999999999987  688999999963211      11122345778999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||+++|+|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+
T Consensus       111 ~~~~~~~~----------------~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~  171 (370)
T cd05596         111 AFQDDKYL----------------YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD  171 (370)
T ss_pred             EEecCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            98877655                899999999999998854   36889999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGS----AYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |||++.++.+||+|||++........ ......||+.|+|||++.+.    .++.++|||||||++|||++|..||...+
T Consensus       172 NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             HEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            99999999999999999975433221 22346799999999998654    37899999999999999999999999988


Q ss_pred             HHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 015594          326 FSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDK--RPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~  373 (404)
                      .......+........++.  .++.++.++|.+||+.+|.+  |+++++|++
T Consensus       252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         252 LVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            8777777765443333443  57899999999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.4e-44  Score=332.61  Aligned_cols=259  Identities=31%  Similarity=0.548  Sum_probs=213.7

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      |++..++|++.+.||+|+||.||+|.+.       +..||||++.....        ......+.+|+.+++.++||||+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv   72 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFNCHHVV   72 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence            6777889999999999999999998763       35799998753211        11234578999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHh
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQ  238 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH  238 (404)
                      ++++++......                ++||||+++++|.+++.+..        ...+++..+..++.|++.||.|||
T Consensus        73 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  136 (277)
T cd05062          73 RLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN  136 (277)
T ss_pred             eEEEEEcCCCCe----------------EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            999998766554                89999999999999986532        124678889999999999999999


Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcc--cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM--TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      +.|++|+||||+||++++++.++|+|||+++.........  ....+++.|+|||.+.+..++.++||||||+++|||++
T Consensus       137 ~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  216 (277)
T cd05062         137 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT  216 (277)
T ss_pred             HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence            9999999999999999999999999999987443222111  12345778999999999889999999999999999999


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          317 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       317 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                       |..||...+..+....+.... ....+..+++.+.+++.+||+.||++||++.++++.|++
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         217 LAEQPYQGMSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             789998887776665544433 345667789999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-44  Score=345.04  Aligned_cols=243  Identities=27%  Similarity=0.436  Sum_probs=205.9

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +.||+|+||.||++.+  +|+.||+|+++....      ........+.+|+.++..++||||+++++++.....+    
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~----   70 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL----   70 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE----
Confidence            3689999999999987  789999999964211      1112234567899999999999999999999877665    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEEcCCCcEE
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili~~~~~vk  261 (404)
                                  |+||||+++|+|..++.+.  ..+++..+..++.||+.||.|||+ .||+||||||+||||+.++.+|
T Consensus        71 ------------~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~k  136 (325)
T cd05594          71 ------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK  136 (325)
T ss_pred             ------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEE
Confidence                        8999999999999988554  578999999999999999999997 7999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...  ...
T Consensus       137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~  214 (325)
T cd05594         137 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIR  214 (325)
T ss_pred             EecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCC
Confidence            999999875433333444567999999999999999999999999999999999999999888777666555443  334


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ++..+++++.++|.+||+.||++|+     ++.++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            6778899999999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-43  Score=326.89  Aligned_cols=255  Identities=31%  Similarity=0.610  Sum_probs=216.8

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      |.++..+|.+.+.||+|+||.||++...|..||+|.++...           ..+.+.+|+.++++++|+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIV   69 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----------hHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            56778899999999999999999999999999999985321           1345789999999999999999999765


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ....               .+++||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+
T Consensus        70 ~~~~---------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil  134 (256)
T cd05082          70 EEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL  134 (256)
T ss_pred             cCCC---------------ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEE
Confidence            4322               1389999999999999997665556899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++.+||+|||++.......   ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       135 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05082         135 VSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR  211 (256)
T ss_pred             EcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999987433221   22334678999999999889999999999999999997 9999998877666555


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +. ....+..+..+++.+.++|.+||+.+|++|||+.++++.|+.+
T Consensus       212 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         212 VE-KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             Hh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            43 3445566778899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.1e-44  Score=348.03  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=205.7

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|.+.+.||+|+||+||+|.+  +++.||||++.....      ........+.+|+.++++++||||+++++++.+...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            688999999999999999987  678999999963221      112234568899999999999999999999987766


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.||+||||||+||||+.+
T Consensus        76 ~----------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~  137 (381)
T cd05626          76 L----------------YFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD  137 (381)
T ss_pred             E----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence            5                8999999999999998654  568999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC-----------------------------------------------CcccCCCCCccccCc
Q 015594          258 RTVKIADFGVARLEASNP-----------------------------------------------HDMTGETGTLGYMAP  290 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aP  290 (404)
                      +.+||+|||++.......                                               ......+||+.|+||
T Consensus       138 ~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  217 (381)
T cd05626         138 GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP  217 (381)
T ss_pred             CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCH
Confidence            999999999975321000                                               001234699999999


Q ss_pred             cccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhh--hhCCCCCC
Q 015594          291 EVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCW--DANPDKRP  366 (404)
Q Consensus       291 E~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl--~~dP~~Rp  366 (404)
                      |++.+..++.++|||||||++|||++|..||...+..+....+........++  ..+++++.++|.+|+  ..+|..||
T Consensus       218 E~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             HHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999899999999999999999999999998887766655555433223333  357899999999854  55666699


Q ss_pred             CHHHHHHH
Q 015594          367 EMDEVVAM  374 (404)
Q Consensus       367 t~~~ll~~  374 (404)
                      ++++|+..
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-44  Score=340.24  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC-ceeEEEEEEecCC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP-NVTKFIGATMGTS  176 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~  176 (404)
                      +|.+.+.||+|+||.||+|.+  +++.||||++......      .......+..|..++..++|+ +|+++++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            478999999999999999987  5679999999643211      112234567899999999765 5888988887766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~  136 (324)
T cd05587          75 RL----------------YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA  136 (324)
T ss_pred             EE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence            55                8999999999999988654  56899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus       137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (324)
T cd05587         137 EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (324)
T ss_pred             CCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            99999999999875333333444567999999999999999999999999999999999999999988877777666543


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~  373 (404)
                        ...++..+++++.++|.+||..||.+|++.     .++++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              345677889999999999999999999976     55553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-45  Score=320.55  Aligned_cols=271  Identities=25%  Similarity=0.394  Sum_probs=233.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      ..+|.-.+.||+|..++|.++.+  +|+.+|+|+++........+. ...++..-.+|+.+|+++ .||+|+++.++++.
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            35677788999999999999887  789999999987766555554 667788889999999999 79999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      +.-+                ++|+|+|+.|.|.++|...  -.+|++..+.|++|++.|+.|||.++||||||||+|||+
T Consensus        95 ~sF~----------------FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl  156 (411)
T KOG0599|consen   95 DAFV----------------FLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL  156 (411)
T ss_pred             cchh----------------hhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence            7665                8999999999999999543  689999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN------GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +++-++||+|||+|+.. ..+......||||+|+|||.+.      ..+|+..+|+|++|+++|.|+.|+.||......-
T Consensus       157 ddn~~i~isDFGFa~~l-~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  157 DDNMNIKISDFGFACQL-EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             ccccceEEeccceeecc-CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            99999999999999864 3556677889999999999984      3468999999999999999999999999887777


Q ss_pred             HHHHHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHhhcCCCCCC
Q 015594          329 VTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAIDTSKGGGMIP  388 (404)
Q Consensus       329 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~~~~~~~~p  388 (404)
                      ++..+..+++..  +.+...+...++||++||+.||++|.|++|.++  .+..+.....-.|.|
T Consensus       236 MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  236 MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            777777776544  445678899999999999999999999999985  455555555556777

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-44  Score=341.76  Aligned_cols=238  Identities=25%  Similarity=0.384  Sum_probs=201.8

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||++.+  +++.||||++.....      ........+..|..++..+ +||||+++++++.+...+   
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~---   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL---   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE---
Confidence            3689999999999987  578999999863211      1112234566788888776 799999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~k  136 (320)
T cd05590          72 -------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK  136 (320)
T ss_pred             -------------EEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence                         8999999999999988654  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....  ..
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~  214 (320)
T cd05590         137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VV  214 (320)
T ss_pred             EeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CC
Confidence            9999998754333344455679999999999999999999999999999999999999999988877776665443  34


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      .+..+++++.++|.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            566789999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-43  Score=326.44  Aligned_cols=252  Identities=31%  Similarity=0.602  Sum_probs=211.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +++++|.+.+.||+|+||.||++.+ ++..+|+|.+......          ...+.+|+.++++++||||+++++++.+
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----------EEDFIEEAKVMMKLSHPKLVQLYGVCTQ   70 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----------HHHHHHHHHHHHHCCCCCceeEEEEEcc
Confidence            3567899999999999999999988 4568999987533211          2347789999999999999999999877


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                ++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus        71 ~~~~----------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i  133 (256)
T cd05114          71 QKPL----------------YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV  133 (256)
T ss_pred             CCCE----------------EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE
Confidence            6655                89999999999999886542 468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||.++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05114         134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM  213 (256)
T ss_pred             cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999999875432221 1123345678999999998889999999999999999999 8999998887776666


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      +... .+...+...+.++.+++.+||+.+|++||++.+|++.|
T Consensus       214 i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         214 ISRG-FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHCC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            5543 34445667789999999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.6e-43  Score=327.27  Aligned_cols=256  Identities=32%  Similarity=0.576  Sum_probs=216.8

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |++..++|++.+.||+|+||.||++.. ++..||+|.+......          ...+.+|+.++++++|+|++++++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~   70 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLEEAQIMKKLRHDKLVQLYAVV   70 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence            678889999999999999999999987 5678999998643321          23478999999999999999999887


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .. ...                |+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        71 ~~-~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni  133 (260)
T cd05070          71 SE-EPI----------------YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI  133 (260)
T ss_pred             CC-CCc----------------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence            43 222                8999999999999999765556789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      ++++++.++|+|||++........ ...+..++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus       134 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~  213 (260)
T cd05070         134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL  213 (260)
T ss_pred             EEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999999975433221 1122345678999999988889999999999999999999 89999988777766


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ..+.. ......+..++..+.+|+.+||..+|++|||+.++.++|+.
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         214 EQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            55443 44555677889999999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.9e-44  Score=339.44  Aligned_cols=242  Identities=27%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh-cCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK-LDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||+|.+  +++.||||+++.....      .......+..|..++.. .+||||+++++++.....+   
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~---   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL---   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence            3689999999999987  5788999999643211      11112334556666654 4899999999998876655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~k  136 (316)
T cd05592          72 -------------FFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK  136 (316)
T ss_pred             -------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEE
Confidence                         8999999999999988654  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..  ..+.
T Consensus       137 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~  214 (316)
T cd05592         137 IADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPH  214 (316)
T ss_pred             EccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC
Confidence            99999997544333344456799999999999999999999999999999999999999998887776665543  3455


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVV  372 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll  372 (404)
                      ++..++.++.++|.+||+.||.+||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            6778899999999999999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=345.62  Aligned_cols=266  Identities=29%  Similarity=0.589  Sum_probs=236.3

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      -..|+++..++...++||-|.||.||.|+|.  .-.||||.++-.          ..-...|+.|+++|+.++|||+|++
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----------tMeveEFLkEAAvMKeikHpNLVqL  328 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQL  328 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----------chhHHHHHHHHHHHHhhcCccHHHH
Confidence            3789999999999999999999999999994  567999998521          2224568999999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      +|+|.....+                |||.|||..|+|.+||.+..+..++.-.+++++.||..|++||..+++|||||.
T Consensus       329 LGVCT~EpPF----------------YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA  392 (1157)
T KOG4278|consen  329 LGVCTHEPPF----------------YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA  392 (1157)
T ss_pred             hhhhccCCCe----------------EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence            9999888777                899999999999999999888888988999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCc-ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      ..|+|+.++..||++|||+++....+.+. ..+-.-...|.|||.+.-..++.++|||+|||+|||+.| |--||++.+.
T Consensus       393 ARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl  472 (1157)
T KOG4278|consen  393 ARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  472 (1157)
T ss_pred             hhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence            99999999999999999999975543322 222334678999999999999999999999999999998 7789999998


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ..++ .++...++.+.|..||+.+++||+.||+++|.+||++.||-+.|+.+..+..
T Consensus       473 SqVY-~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  473 SQVY-GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHHH-HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            8875 4567788999999999999999999999999999999999999998876653

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-43  Score=325.22  Aligned_cols=255  Identities=35%  Similarity=0.668  Sum_probs=219.3

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      |.++..+|.+.+.||.|+||.||++...|+.||||.++....          ..+.+.+|+.+++.++|+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   70 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQAFLAEASVMTTLRHPNLVQLLGVVL   70 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----------HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence            456778899999999999999999999999999999863211          2456789999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                ++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus        71 ~~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil  134 (256)
T cd05039          71 QGNPL----------------YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL  134 (256)
T ss_pred             CCCCe----------------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE
Confidence            75544                89999999999999997665557999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++.++|+|||.++.....   ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       135 i~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         135 VSEDLVAKVSDFGLAKEASQG---QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             EeCCCCEEEcccccccccccc---cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999999754222   113345678999999988889999999999999999997 9999988877666544


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +. .......+..+++++.++|.+||..+|++||++.+|++.|+.+
T Consensus       212 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         212 VE-KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             Hh-cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            43 3445566778899999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-43  Score=331.13  Aligned_cols=258  Identities=33%  Similarity=0.573  Sum_probs=217.3

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      |++..++|.+.+.||+|+||.||++...       +..||+|.+.....        ......+.+|+.++..++||||+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~   72 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--------MRERIEFLNEASVMKEFNCHHVV   72 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--------HHHHHHHHHHHHHHHhCCCCcee
Confidence            6788899999999999999999998863       36799999853221        11234577899999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHh
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQ  238 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH  238 (404)
                      ++++++......                ++||||+++++|.+++....        ...+++..+..++.||+.||.|||
T Consensus        73 ~~~~~~~~~~~~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  136 (277)
T cd05032          73 RLLGVVSTGQPT----------------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA  136 (277)
T ss_pred             EEEEEEcCCCCc----------------EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            999998876555                89999999999999986532        234788899999999999999999


Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      +.|++|+||||+||+++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       137 ~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  216 (277)
T cd05032         137 AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT  216 (277)
T ss_pred             hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence            99999999999999999999999999999875433221  1223446788999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          317 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       317 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                       |..||...+..+....+. .......+..++.++.++|.+||+.+|++|||+.+|++.|+
T Consensus       217 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         217 LAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             999999888777766655 44455667788999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.1e-44  Score=341.15  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||.||+|.+  +++.||||+++....      ........+..|..++..+ +||||+++++++.....+   
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~---   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL---   71 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE---
Confidence            3689999999999987  578999999864211      1112234566788888866 899999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++++|..++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~k  136 (321)
T cd05591          72 -------------FFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK  136 (321)
T ss_pred             -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence                         8999999999999988654  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....  ..
T Consensus       137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~  214 (321)
T cd05591         137 LADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VL  214 (321)
T ss_pred             EeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CC
Confidence            9999999754434444455679999999999999999999999999999999999999999988887777766543  23


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRP-------EMDEVVAM  374 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rp-------t~~~ll~~  374 (404)
                      .+..++.++.++|.+||+.||++||       ++.++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            5667899999999999999999999       77777743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.8e-44  Score=339.45  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=205.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTS  176 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  176 (404)
                      +|.+.+.||+|+||.||++.+  +++.||||++......      .......+..|..++..+ +|++|+++++++.+..
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            478899999999999999987  5689999999643211      111233456677787777 6899999999988776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~  136 (323)
T cd05616          75 RL----------------YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS  136 (323)
T ss_pred             EE----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence            55                8999999999999988654  56899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus       137 ~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~  216 (323)
T cd05616         137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  216 (323)
T ss_pred             CCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            99999999999975433333444567899999999999999999999999999999999999999998887777766654


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      .  ..+|..++.++.+++.+||+.||++|++.
T Consensus       217 ~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            3  34667789999999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-43  Score=326.53  Aligned_cols=256  Identities=30%  Similarity=0.588  Sum_probs=216.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ++++|.+.+.||+|+||+||+|.+.     ...||||+++....        ......|.+|+.++++++||||+++++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------DKQRLDFLTEASIMGQFDHPNIIRLEGV   73 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--------hHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence            4678999999999999999999872     35799998864321        1224567889999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +......                ++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+|
T Consensus        74 ~~~~~~~----------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~n  136 (266)
T cd05033          74 VTKSRPV----------------MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN  136 (266)
T ss_pred             EecCCce----------------EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            8766655                89999999999999986643 478999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      |+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~  216 (266)
T cd05033         137 ILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD  216 (266)
T ss_pred             EEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence            99999999999999999865422221  122345678999999998889999999999999999998 999998888777


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ....+.. ......+..+++.+.+++.+||+.+|++||++.+|++.|+++
T Consensus       217 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         217 VIKAVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            6655543 344455678899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-45  Score=340.91  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=224.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .-|.+.+.||+|.|.+|-++++  +|..||||++++.+.+...       ...+.+|++.|+.++|||||++|.+.....
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-------t~hlfqEVRCMKLVQHpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-------TGHLFQEVRCMKLVQHPNIVRLYEVIDTQT   90 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-------hhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence            4588889999999999998886  9999999999887655332       344679999999999999999999887666


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc-
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~-  255 (404)
                      .+                |+|+|+-++|+|++|+.++. ..+.+..+.+++.||+.|+.|+|...+|||||||+||++. 
T Consensus        91 Kl----------------yLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE  153 (864)
T KOG4717|consen   91 KL----------------YLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE  153 (864)
T ss_pred             eE----------------EEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence            66                99999999999999998874 5799999999999999999999999999999999999885 


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .-|-|||+|||++..+ .+....+..||++.|-|||++.|..|+ +++||||||||||-|+||+.||+..+..+.+..++
T Consensus       154 KlGlVKLTDFGFSNkf-~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm  232 (864)
T KOG4717|consen  154 KLGLVKLTDFGFSNKF-QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM  232 (864)
T ss_pred             ecCceEeeeccccccC-CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence            5688999999999653 456677889999999999999999886 78999999999999999999999999999888888


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAID  379 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~  379 (404)
                      .-.+.  +|..++.+.++||..||..||.+|.+.++|..  +|+.++
T Consensus       233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            87765  78889999999999999999999999999974  344443

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-43  Score=335.19  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=200.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++.......        ....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--------TPFTAIREASLLKGLKHANIVLLHDIIHTK   75 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--------cchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence            36899999999999999999997  68999999986443211        112356899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        76 ~~~----------------~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~  137 (303)
T cd07869          76 ETL----------------TLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS  137 (303)
T ss_pred             CeE----------------EEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            655                8999999 67888888654 35689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAV  333 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-~~~~~~  333 (404)
                      .++.+||+|||++..............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... +....+
T Consensus       138 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  217 (303)
T cd07869         138 DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI  217 (303)
T ss_pred             CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence            99999999999997544444444556789999999998654 5889999999999999999999999875432 222222


Q ss_pred             Hhcc----------------CCCC-----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQN----------------LRPE-----IP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~----------------~~~~-----~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                +.+.     .+         ...++++.+||.+||+.||.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            1100                0000     00         123567899999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.1e-43  Score=325.93  Aligned_cols=258  Identities=33%  Similarity=0.558  Sum_probs=215.3

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |.+...+|.+.+.||+|+||+||+|.+ +...||||+++.....          ...+.+|+.++++++||||+++++.+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~   70 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQLYAVV   70 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            567788999999999999999999987 3457999998632211          23578899999999999999999876


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+. ..                ++||||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        71 ~~~-~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Ni  133 (262)
T cd05071          71 SEE-PI----------------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI  133 (262)
T ss_pred             CCC-Cc----------------EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccE
Confidence            432 22                8999999999999999765556789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcc-cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.++|+|||.++......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       134 ll~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~  213 (262)
T cd05071         134 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  213 (262)
T ss_pred             EEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence            99999999999999997543332211 23346778999999998889999999999999999999 88899888776665


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ..+.. ......+..++..+.+||.+||+.+|++||++.+++++|+.+.
T Consensus       214 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         214 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            55433 3333445678999999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=353.17  Aligned_cols=317  Identities=26%  Similarity=0.456  Sum_probs=252.8

Q ss_pred             CCCCCCCCceeeeccccccchHHHHHHHHhhhcchhhcccccccccchhhhccccCCCCCCCCCCCCCCCCCCcccCCCC
Q 015594            2 KEKSETGGGYVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRS   81 (404)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s   81 (404)
                      |+.|..+.||-|..|   +.|-+++.+-.+..|.++.-||.-..-.                  +++.....+.      
T Consensus        44 k~eDLl~IGMgRp~q---RRLrea~kkm~~~~k~kswvkKvf~ga~------------------p~h~~~t~~~------   96 (1039)
T KOG0199|consen   44 KDEDLLEIGMGRPQQ---RRLREAIKKMSREMKNKSWVKKVFIGAD------------------PSHPAQTNSV------   96 (1039)
T ss_pred             chhhhhhhccCcHHH---HHHHHHHHHhhhhccccchHHHHhccCC------------------ccccccccCC------
Confidence            567778888888888   7777777777666665554443332210                  0010000000      


Q ss_pred             CCCCCccccccccccCCCCeEEeeeeeeecceEEEEEEEC---C--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHH
Q 015594           82 SSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD---G--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV  156 (404)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~  156 (404)
                          .........-|..+++.+.++||+|.||+|++|.|+   |  -.||||++.-.....        ....|.+|+.+
T Consensus        97 ----~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~  164 (1039)
T KOG0199|consen   97 ----ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASH  164 (1039)
T ss_pred             ----CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHH
Confidence                011112233466678888999999999999999983   4  368999996544322        34679999999


Q ss_pred             HhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH
Q 015594          157 WHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       157 l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      |.+|+|||++++||+..+ ..+                .+|+|+++.|+|.+.|.+.....|....+..++.||+.|+.|
T Consensus       165 M~~L~H~hliRLyGvVl~-qp~----------------mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~Y  227 (1039)
T KOG0199|consen  165 MLKLQHPHLIRLYGVVLD-QPA----------------MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQY  227 (1039)
T ss_pred             HHhccCcceeEEeeeecc-chh----------------hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHH
Confidence            999999999999999987 333                589999999999999988677889999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCC-CCCccccCccccCCCCCCcchhhHHHHHHHHH
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE  313 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  313 (404)
                      |.++++|||||...|+|+.....|||+|||+.+.+..+...  +... .-...|+|||.++...++.++|||+|||+|||
T Consensus       228 LeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWE  307 (1039)
T KOG0199|consen  228 LESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWE  307 (1039)
T ss_pred             HhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHh
Confidence            99999999999999999998999999999999976654433  2222 23567999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          314 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       314 l~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      |++ |+.||.+.....++..+- .+-+...|+.|+.+++++|..||..+|++|||+..|.+.+
T Consensus       308 MFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  308 MFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             hhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            998 899999999999988776 6677788999999999999999999999999999997443

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-43  Score=327.05  Aligned_cols=259  Identities=25%  Similarity=0.450  Sum_probs=213.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||+|+.  +++.||||.+.......      ......+.+|+.+++.++||||+++++++.+..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD------AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC------HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            5799999999999999999987  78999999886432211      122456788999999999999999999988765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..                ++|+||+++++|.+++...  ....+++..+..++.||+.||.|||++|++|+||||+||++
T Consensus        76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~  139 (267)
T cd08228          76 EL----------------NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI  139 (267)
T ss_pred             eE----------------EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence            54                8999999999999988542  23458999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--~~~~~~~  332 (404)
                      +.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||....  .......
T Consensus       140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~  219 (267)
T cd08228         140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK  219 (267)
T ss_pred             cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH
Confidence            99999999999998765443333334568899999999998889999999999999999999999986543  2333333


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +.....++..+..++..+.++|.+||+.+|++||++.++++.|+.+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            33333334444567889999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-44  Score=346.98  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=206.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++..  +++.||||++....      .........+.+|+.++.+++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE------MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3688999999999999999987  78999999985321      111223456789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.||+||||||+||||+.
T Consensus        75 ~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~  136 (377)
T cd05629          75 YL----------------YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR  136 (377)
T ss_pred             ee----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence            65                9999999999999998654  57899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-----------------------------------------------cccCCCCCccccC
Q 015594          257 TRTVKIADFGVARLEASNPH-----------------------------------------------DMTGETGTLGYMA  289 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-----------------------------------------------~~~~~~gt~~y~a  289 (404)
                      ++.+||+|||+++.......                                               .....+||+.|+|
T Consensus       137 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  216 (377)
T cd05629         137 GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA  216 (377)
T ss_pred             CCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccC
Confidence            99999999999863211000                                               0012468999999


Q ss_pred             ccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCCCC--
Q 015594          290 PEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKR--  365 (404)
Q Consensus       290 PE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~R--  365 (404)
                      ||++.+..++.++|||||||++|||++|..||...+..+....+........++.  .++.++.++|.+||. +|.+|  
T Consensus       217 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         217 PEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             HHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            9999999999999999999999999999999988877776666654333333333  478999999999997 77765  


Q ss_pred             -CCHHHHHHH
Q 015594          366 -PEMDEVVAM  374 (404)
Q Consensus       366 -pt~~~ll~~  374 (404)
                       +++.+++..
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=331.64  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=208.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|++.+.||+|+||+||++.+  +++.||||++.....      ........+.+|+.+++.++||||+++++.+.....
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh------hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            478889999999999999987  689999999853221      112224556789999999999999999999877665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||+++|+|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++++
T Consensus        75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~  138 (285)
T cd05605          75 L----------------CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY  138 (285)
T ss_pred             E----------------EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence            5                899999999999998866545679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~--  335 (404)
                      +.++|+|||++..... ........|++.|+|||++.+..++.++||||||+++|+|++|..||...........+..  
T Consensus       139 ~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~  217 (285)
T cd05605         139 GHIRISDLGLAVEIPE-GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV  217 (285)
T ss_pred             CCEEEeeCCCceecCC-CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh
Confidence            9999999999975432 2223445789999999999988899999999999999999999999987665433322221  


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVAM  374 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~  374 (404)
                      .......+..+++.+.+||.+||+.||.+||     +++++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         218 KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1223345667899999999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-44  Score=348.39  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=206.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||++.+  +++.||||++....      .........+.+|+.++++++||||+++++.+.+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            4789999999999999999987  68999999985321      111223455779999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~  136 (376)
T cd05598          75 NL----------------YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR  136 (376)
T ss_pred             EE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence            65                8999999999999999654  56899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCC-------------------------------------------CCcccCCCCCccccCcccc
Q 015594          257 TRTVKIADFGVARLEASN-------------------------------------------PHDMTGETGTLGYMAPEVL  293 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~  293 (404)
                      ++.+||+|||++......                                           .......+||+.|||||++
T Consensus       137 ~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  216 (376)
T cd05598         137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL  216 (376)
T ss_pred             CCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH
Confidence            999999999997422100                                           0001234699999999999


Q ss_pred             CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCC---CH
Q 015594          294 NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRP---EM  368 (404)
Q Consensus       294 ~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rp---t~  368 (404)
                      .+..++.++|||||||++|+|++|..||...+..+....+........+  ...+++++.++|.+|+ .+|.+|+   ++
T Consensus       217 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         217 LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            9999999999999999999999999999988877665555433222222  3457899999999987 5999999   88


Q ss_pred             HHHHHH
Q 015594          369 DEVVAM  374 (404)
Q Consensus       369 ~~ll~~  374 (404)
                      .++++.
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5e-44  Score=335.39  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=201.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++++  +++.||||++......       ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-------EEVKETTLRELKMLRTLKQENIVELKEAFRRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence            3689999999999999999998  5789999999754321       112355678999999999999999999987766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||++++.+..+. .. ...+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus        74 ~~----------------~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~  135 (287)
T cd07848          74 KL----------------YLVFEYVEKNMLELLE-EM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH  135 (287)
T ss_pred             EE----------------EEEEecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence            55                8999999877665443 32 357999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+||+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||+..+..+....+..
T Consensus       136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~  215 (287)
T cd07848         136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK  215 (287)
T ss_pred             CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999997643322 223345689999999999998899999999999999999999999988765443322211


Q ss_pred             cc-------------------CC-C----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN-------------------LR-P----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~-------------------~~-~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                   .. +          .....+++++.+||.+||+.||++|||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         216 VLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00                   00 0          011236788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-43  Score=346.90  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=206.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|.+.+.||+|+||+||+|.+  +++.||||++....      .........+.+|+.++++++||||+++++++.+...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD------VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            588999999999999999987  67899999986321      1122334567899999999999999999999987766


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        76 ~----------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~  137 (382)
T cd05625          76 L----------------YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD  137 (382)
T ss_pred             E----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            5                8999999999999998654  568999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC-----------------------------------------------CcccCCCCCccccCc
Q 015594          258 RTVKIADFGVARLEASNP-----------------------------------------------HDMTGETGTLGYMAP  290 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aP  290 (404)
                      +.+||+|||++.......                                               ......+||+.|+||
T Consensus       138 g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  217 (382)
T cd05625         138 GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP  217 (382)
T ss_pred             CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCH
Confidence            999999999975321000                                               001224689999999


Q ss_pred             cccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC-
Q 015594          291 EVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPE-  367 (404)
Q Consensus       291 E~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt-  367 (404)
                      |++.+..++.++|||||||++|||++|..||...+..+....+.........|  ..+++++.++|.+|+ .+|.+|++ 
T Consensus       218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             HHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            99999999999999999999999999999999888776666655433333333  457899999999987 59999987 


Q ss_pred             --HHHHHH
Q 015594          368 --MDEVVA  373 (404)
Q Consensus       368 --~~~ll~  373 (404)
                        +++++.
T Consensus       297 ~~~~ei~~  304 (382)
T cd05625         297 NGADEIKA  304 (382)
T ss_pred             CCHHHHhc
Confidence              888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-44  Score=343.07  Aligned_cols=239  Identities=25%  Similarity=0.395  Sum_probs=203.5

Q ss_pred             eeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||++..     +|+.||||+++....       .......+.+|+.++++++||||+++++++.+...+ 
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-   73 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL-   73 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE-
Confidence            5799999999998864     578999999963211       111234567899999999999999999999877655 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.
T Consensus        74 ---------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  136 (318)
T cd05582          74 ---------------YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH  136 (318)
T ss_pred             ---------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc
Confidence                           8999999999999998553  57899999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 015594          260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR  339 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~  339 (404)
                      +||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+....  
T Consensus       137 ~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--  214 (318)
T cd05582         137 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--  214 (318)
T ss_pred             EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--
Confidence            999999999754443334445678999999999999889999999999999999999999999888777666655443  


Q ss_pred             CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       340 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      ..++..+++++.+||.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3467778999999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.1e-43  Score=332.04  Aligned_cols=263  Identities=30%  Similarity=0.582  Sum_probs=220.7

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCC
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHP  163 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  163 (404)
                      ..|.+..++|.+.+.||+|+||.||++..       .+..||||+++....        ......+.+|+.+++++ +||
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~   99 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--------SSEREALMSELKIMSHLGNHE   99 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--------hHHHHHHHHHHHHHHhccCCC
Confidence            35677788999999999999999999874       245799998864321        11245678999999999 799


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                      ||+++++.+......                |+||||+.+|+|.+++.......+++.++..++.||+.||.|||+++++
T Consensus       100 ~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv  163 (302)
T cd05055         100 NIVNLLGACTIGGPI----------------LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI  163 (302)
T ss_pred             CcceEEEEEecCCce----------------EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            999999998776655                8999999999999999765444589999999999999999999999999


Q ss_pred             ecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 015594          244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       244 H~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      |+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p  243 (302)
T cd05055         164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP  243 (302)
T ss_pred             hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999975433221  1122345788999999999889999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      |......+..............+...++++.+++.+||..+|++||++.+|++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         244 YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            9887766655555665555566667889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-43  Score=338.13  Aligned_cols=243  Identities=24%  Similarity=0.371  Sum_probs=204.9

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||++.+  +++.||||+++....      ........+.+|..++..+ +||||+++++++.+...+   
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~---   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL---   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence            3689999999999988  578999999964211      1112234567888888888 799999999998877655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++++|..++.+.  ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+|
T Consensus        72 -------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k  136 (318)
T cd05570          72 -------------FFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK  136 (318)
T ss_pred             -------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEE
Confidence                         8999999999999988654  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||+++............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....  ..
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~  214 (318)
T cd05570         137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VR  214 (318)
T ss_pred             ecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC
Confidence            9999998753333333444578999999999999999999999999999999999999999888777666555433  34


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVA  373 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~  373 (404)
                      ++..++.++.+||.+||+.||.+||++     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            667789999999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-43  Score=337.97  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||.||++.+  +|+.||||+++.....      .......+..|..++..+ +||||+++++++.+...+   
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~---   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL---   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE---
Confidence            4689999999999997  6889999999642110      111223456677777654 899999999999877655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+.+|+|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k  136 (316)
T cd05620          72 -------------FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK  136 (316)
T ss_pred             -------------EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence                         8999999999999988654  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...  .+.
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~  214 (316)
T cd05620         137 IADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPH  214 (316)
T ss_pred             eCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC
Confidence            999999874333333445567999999999999999999999999999999999999999988877666555433  345


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVV  372 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll  372 (404)
                      .+..++.+++++|.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            6677899999999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-43  Score=351.83  Aligned_cols=262  Identities=23%  Similarity=0.361  Sum_probs=216.4

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ....+|.+.+.||+|+||+||++.+  +|+.||||+++.....   .    .....+.+|+.++..++|+||++++..+.
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~----~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS---E----ADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC---H----HHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            4457999999999999999999987  7899999999754322   1    12345778999999999999999988775


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ......        ......+++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.||+||||||+|
T Consensus       102 ~~~~~~--------~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~N  173 (496)
T PTZ00283        102 KKDPRN--------PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN  173 (496)
T ss_pred             cccccC--------cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            443210        01112348999999999999998643  23578999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      |||+.++.+||+|||+++.....  ........||+.|+|||++.+..++.++||||||+++|||++|..||...+..+.
T Consensus       174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~  253 (496)
T PTZ00283        174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV  253 (496)
T ss_pred             EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99999999999999999754332  1223345799999999999999999999999999999999999999998887777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+..... ...+..+++++.++|.+||+.||.+||++.++++
T Consensus       254 ~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        254 MHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            666655443 3467788999999999999999999999999986

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.3e-43  Score=324.60  Aligned_cols=253  Identities=30%  Similarity=0.603  Sum_probs=211.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECC-ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +++.+|.+.+.||+|+||+||++.+.+ ..+|||.+......          ...+.+|+.++++++||||+++++++..
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMKLSHEKLVQLYGVCTK   70 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----------HHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            356789999999999999999998754 46999988532211          2347889999999999999999999876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||++
T Consensus        71 ~~~~----------------~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili  133 (256)
T cd05113          71 QRPI----------------YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV  133 (256)
T ss_pred             CCCc----------------EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE
Confidence            6554                89999999999999986543 378999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||.++....... ...+..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~  213 (256)
T cd05113         134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK  213 (256)
T ss_pred             cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence            9999999999999875433221 1223345678999999998889999999999999999998 9999988877666555


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      +.. ..+...+...++.+.+++.+||+.+|.+||++.+|++.|+
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 VSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            543 3444556677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-43  Score=324.18  Aligned_cols=258  Identities=34%  Similarity=0.600  Sum_probs=219.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |+++.++|.+.+.||+|+||+||++.+ +++.||||.+......          ...+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----------PEAFLQEAQIMKKLRHDKLVQLYAVC   70 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----------HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence            678889999999999999999999987 4578999998643221          23477899999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......                ++||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||
T Consensus        71 ~~~~~~----------------~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni  134 (261)
T cd05034          71 SEEEPI----------------YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI  134 (261)
T ss_pred             ecCCce----------------EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence            765554                8999999999999999776556799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +|+.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.....
T Consensus       135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  214 (261)
T cd05034         135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL  214 (261)
T ss_pred             EEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987543221 11122335678999999999889999999999999999998 99999888777666


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+.. .+....+..++.++.+++.+||+.+|++||+++++.+.|+.+
T Consensus       215 ~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         215 EQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             HHHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            55543 344455667799999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-43  Score=336.97  Aligned_cols=243  Identities=27%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh-cCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK-LDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||+|.+  +++.||||+++....      ........+..|..++.. ++||||+++++++.+...+   
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~---   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL---   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE---
Confidence            4689999999999997  578999999964211      011112345567777776 4999999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~k  136 (316)
T cd05619          72 -------------FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIK  136 (316)
T ss_pred             -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence                         8999999999999998653  5689999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  +.
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~  214 (316)
T cd05619         137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC  214 (316)
T ss_pred             EccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC
Confidence            9999998753333333445678999999999999999999999999999999999999999888777666554332  34


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVVA  373 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~  373 (404)
                      .+..++.++.++|.+||+.||++||++. +++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            5667899999999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.9e-43  Score=323.49  Aligned_cols=257  Identities=32%  Similarity=0.572  Sum_probs=214.9

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEEC-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |++..++|.+...||+|+||.||++.+. +..+|+|.+.....          ....+.+|+.++++++|||++++++++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVV   70 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            5677788999999999999999999874 45799998753321          124577899999999999999999887


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ... ..                ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        71 ~~~-~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni  133 (260)
T cd05069          71 SEE-PI----------------YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI  133 (260)
T ss_pred             cCC-Cc----------------EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence            432 22                8999999999999999765555689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..
T Consensus       134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  213 (260)
T cd05069         134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL  213 (260)
T ss_pred             EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999975433221 1122345678999999998889999999999999999999 89999988776665


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+. .......+...+..+.+++.+||..||.+||++++|++.|+++
T Consensus       214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         214 EQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             HHHH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            5543 3444556677899999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-43  Score=330.02  Aligned_cols=245  Identities=22%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||+|+||+||++.+  +|+.||||++.....      ........+..|+.+++.++||||+++.+++.....+      
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~------   68 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL------   68 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE------
Confidence            68999999999987  689999999863221      1112234567899999999999999999998776655      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEE
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI  262 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL  262 (404)
                                |+||||+++|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|
T Consensus        69 ----------~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l  138 (280)
T cd05608          69 ----------CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI  138 (280)
T ss_pred             ----------EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence                      8999999999999887542  2356899999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCC
Q 015594          263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRP  340 (404)
Q Consensus       263 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~--~~~  340 (404)
                      +|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+............  ...
T Consensus       139 ~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  218 (280)
T cd05608         139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV  218 (280)
T ss_pred             eeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC
Confidence            999999755443333445678999999999999999999999999999999999999997654322222222111  123


Q ss_pred             CCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          341 EIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       341 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ..+..++.++.+++.+||+.||++||     +++++++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            45567899999999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-43  Score=344.34  Aligned_cols=256  Identities=26%  Similarity=0.350  Sum_probs=212.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ..+..++|++.+.||+|+||.||++.+  +++.||+|++.....      ........+.+|+.+++.++||||++++++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM------IKRSDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            445668899999999999999999997  578999999863211      111223457789999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+...+                |+||||+++|+|.+++...   .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       112 ~~~~~~~----------------~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~N  172 (370)
T cd05621         112 FQDDKYL----------------YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN  172 (370)
T ss_pred             EEcCCEE----------------EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence            9877655                8999999999999988543   58999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      ||++.++.+||+|||++........ ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.
T Consensus       173 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~  252 (370)
T cd05621         173 MLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL  252 (370)
T ss_pred             EEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999975433222 233567999999999997643    78999999999999999999999998888


Q ss_pred             HHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 015594          327 SEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDK--RPEMDEVVAM  374 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~  374 (404)
                      ......+........++.  .++..+.++|.+||..++.+  |+++.++++.
T Consensus       253 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         253 VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            777777766544444443  56899999999999855543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.3e-43  Score=331.34  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGAT  172 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~  172 (404)
                      .+|.+.+.||+|+||+||+|.+   .++.||||+++........       ...+.+|+.+++.+   +||||+++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~hpniv~~~~~~   73 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDVC   73 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-------hHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence            3688999999999999999986   3688999998754322111       12244566666655   799999999988


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......           .....++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+||
T Consensus        74 ~~~~~~-----------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni  141 (290)
T cd07862          74 TVSRTD-----------RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI  141 (290)
T ss_pred             ecccCC-----------CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence            532210           112348999999 57999999776566799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |++.++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus       142 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  220 (290)
T cd07862         142 LVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  220 (290)
T ss_pred             EEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence            9999999999999999754332 233446689999999999988899999999999999999999999998877666555


Q ss_pred             HHhccCCC-------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRP-------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~-------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +......+                         .+...+++.+.++|.+||+.||++|||+.++++
T Consensus       221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            54321000                         011346788899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-43  Score=338.82  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=199.1

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||+|++  +|+.||||.+......       ......+.+|+.++++++||||+++++++.....
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence            588999999999999999987  6899999998632211       1112457799999999999999999998864432


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .           ....+|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        74 ~-----------~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~  139 (338)
T cd07859          74 R-----------EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD  139 (338)
T ss_pred             C-----------CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence            1           112348999999 67899988554  569999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC---CcccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      +.+||+|||+++......   .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||...+.......
T Consensus       140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~  219 (338)
T cd07859         140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL  219 (338)
T ss_pred             CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence            999999999997533221   12234578999999999876  5789999999999999999999999987654332211


Q ss_pred             HHh----------------------ccCCCC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVR----------------------QNLRPE-------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~----------------------~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..                      ......       ....+++++.++|.+||+.||++||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            110                      000000       11246788999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-43  Score=339.21  Aligned_cols=239  Identities=25%  Similarity=0.369  Sum_probs=199.8

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHH-HHHhhcCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV-AVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||++.+  +|+.||||++......      .......+..|. .+++.++||||+++++.+.+....   
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~---   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL------KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL---   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE---
Confidence            4689999999999998  6899999998642211      111122344444 456789999999999999877655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|..++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~k  136 (323)
T cd05575          72 -------------YFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVV  136 (323)
T ss_pred             -------------EEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence                         8999999999999988654  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~  214 (323)
T cd05575         137 LTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--R  214 (323)
T ss_pred             EeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--C
Confidence            99999987543333444456799999999999999999999999999999999999999999888777766665432  3


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      .+..+++++.++|.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            4556799999999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-43  Score=352.66  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=211.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--C-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--D-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..|.+.+.||+|+||.||++..  + ++.||+|.+....     .    .....+.+|+.++..++||||+++++++...
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~  137 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----E----RQAAYARSELHCLAACDHFGIVKHFDDFKSD  137 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----H----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence            4599999999999999999986  3 6788999764321     1    1234467899999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ..+                |+||||+++|+|.+++...  ...++++..+..++.||+.||.|||++||+||||||+|||
T Consensus       138 ~~~----------------~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl  201 (478)
T PTZ00267        138 DKL----------------LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF  201 (478)
T ss_pred             CEE----------------EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence            665                8999999999999988542  2456899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |+.++.+||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus       202 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~  281 (478)
T PTZ00267        202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ  281 (478)
T ss_pred             ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999975433221  2334569999999999999999999999999999999999999999888777776


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+...... ..+..+++++.+||.+||+.||++||++.+++.
T Consensus       282 ~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        282 QVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            66655443 456678999999999999999999999999864

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-43  Score=338.62  Aligned_cols=243  Identities=21%  Similarity=0.371  Sum_probs=199.5

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||.||++.+  +++.||||+++....      ........+.+|..++..+ +||||+++++++.+...+   
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~---   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL---   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE---
Confidence            3689999999999987  688999999964321      1122234577899999988 799999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k  136 (329)
T cd05588          72 -------------FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK  136 (329)
T ss_pred             -------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence                         8999999999999988554  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHH-HHHH
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--------FSE-VTSA  332 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--------~~~-~~~~  332 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||....        ..+ ....
T Consensus       137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05588         137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV  216 (329)
T ss_pred             ECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence            9999998743333333445679999999999999999999999999999999999999996322        111 2222


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE------MDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt------~~~ll~  373 (404)
                      +...  ...+|..++.++.++|.+||+.||.+|++      ++++++
T Consensus       217 ~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         217 ILEK--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            2222  33467788999999999999999999987      567653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-43  Score=324.19  Aligned_cols=250  Identities=25%  Similarity=0.446  Sum_probs=214.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|+||.||++.+  +++.||+|.++....        ....+.+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   72 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH   72 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence            478899999999999999987  689999999864321        1123456789999999999999999999987765


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus        73 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~  136 (255)
T cd08219          73 L----------------YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN  136 (255)
T ss_pred             E----------------EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence            5                899999999999999876656678999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||.+..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... 
T Consensus       137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-  215 (255)
T cd08219         137 GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-  215 (255)
T ss_pred             CcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-
Confidence            9999999999976544443344567899999999999988999999999999999999999999887776665554433 


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .....+..++..+.+||.+||+.||++||++.+|+..
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            3344667789999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=341.58  Aligned_cols=260  Identities=33%  Similarity=0.559  Sum_probs=205.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..++|.-...||+|+||.||+|.. +|+.||||.+.......         ...|.+|+.++.+++|||+|+++|+|.+.
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~  143 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---------EREFLNEVEILSRLRHPNLVKLLGYCLEG  143 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---------hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence            446777888999999999999998 45899999876433211         12389999999999999999999999988


Q ss_pred             Cc-cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC---ceecccCCCC
Q 015594          176 SE-LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK---IVHRDVKTEN  251 (404)
Q Consensus       176 ~~-~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---ivH~Dikp~N  251 (404)
                      .. .                ++|+||+++|+|.++|.......++|..+.+|+.++++||+|||...   |+||||||+|
T Consensus       144 ~~~~----------------~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  144 GEHR----------------LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             CceE----------------EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            74 5                79999999999999996543228999999999999999999999864   9999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCC-CCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----  325 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~-----  325 (404)
                      ||+|++.+.||+|||+|+............ .||.+|+|||.+..+..+.++||||||+++.||++|+.|.....     
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~  287 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL  287 (361)
T ss_pred             eeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence            999999999999999997544311111222 79999999999998889999999999999999999997776432     


Q ss_pred             -HHHHHHHHHhcc-----CCCCCC-CCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          326 -FSEVTSAVVRQN-----LRPEIP-RCCP-----SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       326 -~~~~~~~~~~~~-----~~~~~~-~~~~-----~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                       ..+.....+...     ..+.+. ...+     ..+..+..+|++.+|.+||+|.+++++|+.+...
T Consensus       288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence             222211222221     112222 2222     2356778899999999999999999999766544

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.2e-43  Score=331.45  Aligned_cols=266  Identities=33%  Similarity=0.582  Sum_probs=220.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      .|++..++|.+.+.||+|+||.||++.+.         ...+|+|+++...    ..    .....+.+|+.++..+ +|
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~----~~~~~~~~e~~~l~~l~~h   83 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TE----KDLSDLISEMEMMKMIGKH   83 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----Ch----HHHHHHHHHHHHHHHhcCC
Confidence            46777789999999999999999998752         2469999986321    11    1134577899999999 79


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------CCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------RKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~  228 (404)
                      |||+++++++......                |+||||+++++|.+++.....              ..+++..++.++.
T Consensus        84 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  147 (307)
T cd05098          84 KNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY  147 (307)
T ss_pred             CCEeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            9999999999776655                899999999999999966421              3588999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||+.|++|+||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||
T Consensus       148 qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws  227 (307)
T cd05098         148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS  227 (307)
T ss_pred             HHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence            9999999999999999999999999999999999999998754322111  11223457899999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          307 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       307 lG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||+++|+|++ |..||...+..+.... +........+..++.++.+||.+||..+|++||++.+|++.|+++....+
T Consensus       228 lG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         228 FGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHH-HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            9999999998 8899988776655544 34444556777889999999999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.9e-43  Score=326.71  Aligned_cols=257  Identities=26%  Similarity=0.511  Sum_probs=212.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ++.++|++.+.||+|+||+||+|.+      .++.||+|.+.....        ......+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~   73 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--------PQQWGEFQQEASLMAELHHPNIVCLL   73 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCCCCeeeEE
Confidence            4457899999999999999999974      457899999853211        11234578899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---------------cCCCcHHHHHHHHHHHHHHH
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---------------RRKLAFKVVIQLALDLARGL  234 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L  234 (404)
                      +++......                |+||||+++++|.+++....               ...+++..+..++.||+.||
T Consensus        74 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  137 (283)
T cd05090          74 GVVTQEQPV----------------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM  137 (283)
T ss_pred             EEEecCCce----------------EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence            998776655                89999999999999985432               23578899999999999999


Q ss_pred             HHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHH
Q 015594          235 SYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW  312 (404)
Q Consensus       235 ~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  312 (404)
                      .|||++|++|+||||+|||++.++.+||+|||+++......  .......++..|+|||.+.+..++.++||||||+++|
T Consensus       138 ~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~  217 (283)
T cd05090         138 EYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW  217 (283)
T ss_pred             HHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence            99999999999999999999999999999999997543221  1122344577899999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          313 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       313 el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ||++ |..||...+..+....+. .......+..+++.+.++|.+||+.||.+||++.+|++.|..
T Consensus       218 el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         218 EIFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            9998 999998877665544443 344445677889999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.7e-43  Score=333.69  Aligned_cols=260  Identities=24%  Similarity=0.548  Sum_probs=214.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|++.+.||+|+||.||+|.+  +++    .||||+++....        ......+.+|+.+++.++||||++++
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~   75 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL   75 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3457899999999999999999986  344    489999853211        12245578899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.... .                ++|+||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||
T Consensus        76 g~~~~~~-~----------------~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp  137 (316)
T cd05108          76 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA  137 (316)
T ss_pred             EEEcCCC-c----------------eeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence            9986532 2                6899999999999998664 34688999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +|||++.++.+||+|||+++........  ..+..++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus       138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~  217 (316)
T cd05108         138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  217 (316)
T ss_pred             hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999999999864433221  122334678999999999999999999999999999997 9999988876


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .+.. .+.........+..++.++.++|.+||+.+|.+||++.+++..|..+....
T Consensus       218 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         218 SEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHHH-HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            6654 444455555566778999999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.7e-43  Score=339.09  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      +|++.+.||+|+||+||++..     +++.||+|++.....     .........+.+|+.++..+ +||||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence            488999999999999999875     578999999863211     11122345577899999999 5999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ....+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        76 ~~~~~----------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil  137 (332)
T cd05614          76 TEAKL----------------HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL  137 (332)
T ss_pred             cCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence            76655                8999999999999998654  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCH----H
Q 015594          254 LDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSF----S  327 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~----~  327 (404)
                      |+.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.....    .
T Consensus       138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  217 (332)
T cd05614         138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS  217 (332)
T ss_pred             ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence            9999999999999997543322 223345799999999999875 478999999999999999999999964322    2


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .....+.  ...+.++..+++.+.++|.+||+.||++||     +++++++
T Consensus       218 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         218 EVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHHHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            2222222  234556778899999999999999999999     7777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-43  Score=322.30  Aligned_cols=254  Identities=27%  Similarity=0.450  Sum_probs=215.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +.|.+.+.||+|++|.||++..  +++.||+|.+.......    ........+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence            5688999999999999999986  68999999986543221    11222456789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                ++|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus        78 ~~----------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~  139 (263)
T cd06625          78 TL----------------SIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS  139 (263)
T ss_pred             eE----------------EEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence            54                8999999999999998654  56899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++|+|||++..........   ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+........
T Consensus       140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  219 (263)
T cd06625         140 AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI  219 (263)
T ss_pred             CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence            9999999999987543221111   2345788999999999999999999999999999999999999887766666666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ........++..++..+.++|.+||..+|.+|||+.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            66666667788899999999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.3e-43  Score=321.93  Aligned_cols=250  Identities=28%  Similarity=0.477  Sum_probs=214.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++..  +++.|++|.+......       ......+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK   73 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence            478889999999999999987  6899999998643322       1224567899999999999999999999887655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~  137 (256)
T cd08529          74 L----------------NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY  137 (256)
T ss_pred             E----------------EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence            4                899999999999999977656789999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... 
T Consensus       138 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  216 (256)
T cd08529         138 DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-  216 (256)
T ss_pred             CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence            9999999999876554443344456889999999999999999999999999999999999999888766555554433 


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.++..++.++.++|.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            344556678899999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.7e-43  Score=326.67  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=214.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++..  +++.||||.+.....      ........+.+|+.+++.++||||+++++.+....
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh------hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            5688899999999999999986  789999998854221      11223456889999999999999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..                +++|||+++++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus        76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili  139 (267)
T cd08229          76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI  139 (267)
T ss_pred             eE----------------EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            55                8999999999999988542  23568999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~--~~~~~~  332 (404)
                      +.++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ......
T Consensus       140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  219 (267)
T cd08229         140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK  219 (267)
T ss_pred             cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh
Confidence            999999999999987654443333456789999999999998899999999999999999999999975433  233333


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +......+..+..+++.+.++|.+||+.||++|||+.+|++.+.++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            33333333344568899999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-43  Score=322.70  Aligned_cols=251  Identities=32%  Similarity=0.624  Sum_probs=210.7

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +..+|++.+.||+|+||.||++.+ .+..+|+|++..+...          ...+.+|+.+++.++||||+++++++.+.
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ   71 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----------HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            456789999999999999999987 4568999998533211          23467899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus        72 ~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~  134 (256)
T cd05059          72 RPI----------------FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG  134 (256)
T ss_pred             Cce----------------EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC
Confidence            554                89999999999999986543 4789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCc-ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~  333 (404)
                      .++.+||+|||+++........ ..+..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus       135 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05059         135 EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV  214 (256)
T ss_pred             CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            9999999999999754322111 122234567999999998889999999999999999998 89999887776665544


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      . ...+...+..++.++.+|+.+||..+|++||++.++++.|
T Consensus       215 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 S-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             H-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            3 4455666778999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-43  Score=338.11  Aligned_cols=264  Identities=31%  Similarity=0.580  Sum_probs=215.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCce
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV  165 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  165 (404)
                      |++..++|++.+.||+|+||+||+|.+       +++.||||+++....        ......+.+|+.++.++ +||||
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ni   73 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHHLNV   73 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--------hHHHHHHHHHHHHHHhccCCccH
Confidence            788889999999999999999999974       468899999863321        11134577899999999 78999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------------------------------
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------------------------------  214 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------  214 (404)
                      +++++++......               .++||||+++|+|.+++....                               
T Consensus        74 v~~~~~~~~~~~~---------------~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (343)
T cd05103          74 VNLLGACTKPGGP---------------LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRL  138 (343)
T ss_pred             hhhcceeecCCCc---------------eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhc
Confidence            9999987654322               389999999999999986432                               


Q ss_pred             ----------------------------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          215 ----------------------------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       215 ----------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                                        ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~  218 (343)
T cd05103         139 DSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVV  218 (343)
T ss_pred             cccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcE
Confidence                                              1246788889999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015594          261 KIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      ||+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus       219 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  298 (343)
T cd05103         219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG  298 (343)
T ss_pred             EEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc
Confidence            9999999975432221  1112335678999999988889999999999999999997 999998765444444444455


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      .....+..+++++.++|.+||+.||++||++.+|++.|+.+..
T Consensus       299 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            5556677788999999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-43  Score=340.16  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=209.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||+||++.+  +|+.||||+++....      ........+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL------LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            3688999999999999999987  689999999964221      11223456789999999999999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus        75 ~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~  137 (330)
T cd05601          75 NL----------------YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR  137 (330)
T ss_pred             eE----------------EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence            55                8999999999999998654 357999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-cccCCCCCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLN------GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      ++.+||+|||++........ ......||+.|+|||++.      +..++.++|||||||++|+|++|..||...+....
T Consensus       138 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~  217 (330)
T cd05601         138 TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT  217 (330)
T ss_pred             CCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH
Confidence            99999999999975443322 223346899999999986      45678999999999999999999999998887776


Q ss_pred             HHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+........++  ..+++++.+||.+||. +|.+||++++++.
T Consensus       218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            66665543322333  3578999999999997 9999999999884

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-44  Score=323.14  Aligned_cols=254  Identities=28%  Similarity=0.373  Sum_probs=215.9

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..+.|+..+.|++|+||.||||++  +++.||+|.++...+..       ..--.-.+|+.+|.+++|||||.+-.+..+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-------GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-------GFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-------CCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            357899999999999999999998  78999999997654322       112234689999999999999999998876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..--.|              ||||||| .-+|..++..- ..+++..++.-++.|+++||+|||.+.|+||||||+|+|+
T Consensus       147 ~~~d~i--------------y~VMe~~-EhDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm  210 (419)
T KOG0663|consen  147 SNMDKI--------------YIVMEYV-EHDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL  210 (419)
T ss_pred             ccccee--------------eeeHHHH-HhhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence            654433              9999999 66888888554 4789999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +..|.+||+|||+|+....+...++..+-|+.|.|||.+.|. .|+.++|+||+|||+.||+++.+-|++.+..+....+
T Consensus       211 ~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I  290 (419)
T KOG0663|consen  211 SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI  290 (419)
T ss_pred             ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence            999999999999999988888889999999999999999876 5999999999999999999999999988877766665


Q ss_pred             Hhc-----------------------------cCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQ-----------------------------NLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~-----------------------------~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                             .++..++.. +++.-.+|+..+|..||.+|.|+++.++
T Consensus       291 f~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  291 FKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            431                             111122222 5688899999999999999999999874

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-43  Score=338.90  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=199.9

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHH-HHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE-VAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E-~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||++.+  +++.||+|++......      .......+..| ..+++.++||||+++++++.....+   
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~---   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL---   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE---
Confidence            3689999999999987  6788999999632110      01111223334 4457889999999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~k  136 (325)
T cd05602          72 -------------YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV  136 (325)
T ss_pred             -------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence                         8999999999999988654  5688999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....  ..
T Consensus       137 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~  214 (325)
T cd05602         137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQ  214 (325)
T ss_pred             EccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cC
Confidence            9999999754333334445679999999999999999999999999999999999999999888877776665543  23


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      .+..+++.+.++|.+||+.||.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            4567899999999999999999999876433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4e-43  Score=327.84  Aligned_cols=256  Identities=30%  Similarity=0.529  Sum_probs=213.7

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ...+|.+.+.||+|+||.||+|.+       +++.||||+++....        ......+.+|+.+++.++||||++++
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~   74 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------NDARKDFEREAELLTNFQHENIVKFY   74 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------HHHHHHHHHHHHHHHhcCCCCchhee
Confidence            356788999999999999999975       247899999863321        11245688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc------------cCCCcHHHHHHHHHHHHHHHHHH
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------------RRKLAFKVVIQLALDLARGLSYL  237 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~L  237 (404)
                      +++......                ++||||+++++|.+++....            ...+++..+..++.||+.||.||
T Consensus        75 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l  138 (280)
T cd05049          75 GVCTEGDPP----------------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL  138 (280)
T ss_pred             eEEecCCCe----------------EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999877554                89999999999999996542            24578899999999999999999


Q ss_pred             hhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          238 QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       238 H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      |++|++|+||||+||+++.++.++|+|||++........  ......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       139 H~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~  218 (280)
T cd05049         139 ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF  218 (280)
T ss_pred             hhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH
Confidence            999999999999999999999999999999874322211  122334578899999999999999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          316 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       316 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      + |..||...+..+....+.. ......+..++..+.++|.+||+.||++||++.++++.|++
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         219 TYGKQPWYGLSNEEVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             hcCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            8 9999988877776655553 33444567789999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.7e-43  Score=335.07  Aligned_cols=250  Identities=26%  Similarity=0.479  Sum_probs=204.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|++.+.||+|+||.||++.+  ++..+|+|++.....        ......+.+|+.++++++||||+++++++.
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   73 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFY   73 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence            4568899999999999999999998  578999999864321        122456789999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~Ni  252 (404)
                      +...+                |+||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+. +++|+||||+||
T Consensus        74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni  135 (333)
T cd06650          74 SDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI  135 (333)
T ss_pred             ECCEE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence            77655                8999999999999998654  4689999999999999999999975 799999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |++.++.+||+|||++......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||......+....
T Consensus       136 li~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  213 (333)
T cd06650         136 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM  213 (333)
T ss_pred             EEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence            9999999999999998754322  22345689999999999998899999999999999999999999976544332211


Q ss_pred             H-------------------------------------------HhccCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          333 V-------------------------------------------VRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       333 ~-------------------------------------------~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      +                                           ......+..+ ...+.++.+||.+||+.||++|||+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~  293 (333)
T cd06650         214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL  293 (333)
T ss_pred             hcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH
Confidence            1                                           0011111111 2357889999999999999999999


Q ss_pred             HHHHH
Q 015594          369 DEVVA  373 (404)
Q Consensus       369 ~~ll~  373 (404)
                      .+++.
T Consensus       294 ~ell~  298 (333)
T cd06650         294 KQLMV  298 (333)
T ss_pred             HHHhh
Confidence            99964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.4e-43  Score=328.29  Aligned_cols=261  Identities=32%  Similarity=0.536  Sum_probs=215.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      |++..++|.+.+.||+|+||.||+|...       +..||+|.++....        ......+.+|+.+++.++||||+
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~   72 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--------LRERIEFLNEASVMKGFTCHHVV   72 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence            7889999999999999999999998652       45899998753221        11123477899999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHh
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQ  238 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH  238 (404)
                      ++++++.+....                |+||||+++|+|.+++.+..        ...++...+..++.||+.||.|||
T Consensus        73 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  136 (288)
T cd05061          73 RLLGVVSKGQPT----------------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN  136 (288)
T ss_pred             eEEEEEcCCCCc----------------EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            999998766554                89999999999999996532        234567788999999999999999


Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcc--cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM--TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      ++||+||||||+||+++.++.++|+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|||++
T Consensus       137 ~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~  216 (288)
T cd05061         137 AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS  216 (288)
T ss_pred             hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999987543322211  12234678999999998889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          317 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       317 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                       |..||...+..+....+.... ....+..+++.+.+++.+||+.||++||++.++++.|++..
T Consensus       217 ~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         217 LAEQPYQGLSNEQVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence             789999888777666555443 33456678899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.5e-43  Score=328.04  Aligned_cols=264  Identities=32%  Similarity=0.577  Sum_probs=220.3

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCC
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHP  163 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  163 (404)
                      ..|++..++|.+.+.||+|+||.||++.+.       ...+|+|.+.....    .    .....+.+|+.++.++ +||
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~   76 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----E----KDLSDLVSEMEMMKMIGKHK   76 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC----H----HHHHHHHHHHHHHHhhcCCC
Confidence            357788899999999999999999999863       26799999864221    1    1124477899999999 899


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--------------ccCCCcHHHHHHHHHH
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--------------RRRKLAFKVVIQLALD  229 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~q  229 (404)
                      ||+++++++.....+                +++|||+++++|.+++...              ....+++..+..++.|
T Consensus        77 ~i~~~~~~~~~~~~~----------------~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  140 (293)
T cd05053          77 NIINLLGVCTQEGPL----------------YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ  140 (293)
T ss_pred             CeeeEEEEEcCCCCe----------------EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence            999999998776655                8999999999999998642              2357899999999999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      |+.||.|||+.||+|+||||+||+++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++|||||
T Consensus       141 i~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  220 (293)
T cd05053         141 VARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF  220 (293)
T ss_pred             HHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence            99999999999999999999999999999999999999975433211  1222335678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          308 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       308 G~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |+++|+|++ |..||......+....+. .......+..++.++.+|+.+||..||++|||+.++++.|+++.+
T Consensus       221 G~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         221 GVLLWEIFTLGGSPYPGIPVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             hhHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence            999999997 999999888776655543 444556677889999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-42  Score=325.99  Aligned_cols=261  Identities=29%  Similarity=0.516  Sum_probs=217.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      |...+|.+.+.||+|+||.||++..       ++..+|+|.+....         ......+.+|+.++++++||||+++
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~   72 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVKF   72 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---------HHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4457899999999999999999874       34568999885321         1224567899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----------cCCCcHHHHHHHHHHHHHHHHHH
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----------RRKLAFKVVIQLALDLARGLSYL  237 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~L  237 (404)
                      ++++......                ++||||+++++|.+++....           ...+++..+..++.||+.||+||
T Consensus        73 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l  136 (288)
T cd05093          73 YGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL  136 (288)
T ss_pred             EEEEecCCcc----------------EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            9998866555                89999999999999986532           23589999999999999999999


Q ss_pred             hhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          238 QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       238 H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      |++|++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus       137 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~  216 (288)
T cd05093         137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF  216 (288)
T ss_pred             HhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999999999999975432221  112233577899999999888999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          316 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       316 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      + |..||...+..+....+.... ....+..++.++.+|+.+||+.||.+|||+.++++.|+++....
T Consensus       217 t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         217 TYGKQPWYQLSNNEVIECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             hCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            8 999998888777666655443 33456678999999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.4e-43  Score=340.99  Aligned_cols=257  Identities=26%  Similarity=0.348  Sum_probs=211.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+...+|.+.+.||+|+||.||++.+  +++.||+|++....      .........+.+|+.+++.++||||+++++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQLFY  110 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4456678999999999999999999987  68899999986321      111222345778999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||+++|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+
T Consensus       111 ~~~~~~~~----------------~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~  171 (371)
T cd05622         111 AFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD  171 (371)
T ss_pred             EEEcCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            99876655                899999999999998854   35899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      ||||+.++.+||+|||++....... .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+
T Consensus       172 NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             HEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            9999999999999999997543322 2233567999999999987543    7899999999999999999999999888


Q ss_pred             HHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 015594          326 FSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDK--RPEMDEVVAM  374 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~  374 (404)
                      .......+........++  ..++..+.++|.+||..++.+  |+++++|++.
T Consensus       252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         252 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            877777776544333333  468999999999999844433  6789988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=343.26  Aligned_cols=262  Identities=30%  Similarity=0.595  Sum_probs=225.7

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC----C--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD----G--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ..+++..+.+.+.+.||.|.||.||.|+++    |  -.||||..+......        ..+.|.+|+.+|+.++||||
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--------~tekflqEa~iMrnfdHphI  453 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--------DTEKFLQEASIMRNFDHPHI  453 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--------hHHHHHHHHHHHHhCCCcch
Confidence            457788888999999999999999999983    2  358999987543321        25669999999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      |+++|++.+..                 .+||||+++-|.|..||..+ ...++......++.||..||.|||+..+|||
T Consensus       454 ikLIGv~~e~P-----------------~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHR  515 (974)
T KOG4257|consen  454 IKLIGVCVEQP-----------------MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHR  515 (974)
T ss_pred             hheeeeeeccc-----------------eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhh
Confidence            99999997543                 28999999999999999776 4678999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCCccc-CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      ||...|||+...-.|||+|||+++.......-.. ...-...|||||.++-..++.++|||.||||+||++. |.-||.+
T Consensus       516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg  595 (974)
T KOG4257|consen  516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG  595 (974)
T ss_pred             hhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence            9999999999999999999999997665543322 2233567999999999999999999999999999887 8999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ..+.++.-.+ ..+-+...|..||+.|+.||.+||+.+|.+||++.+|...|..+..
T Consensus       596 vkNsDVI~~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  596 VKNSDVIGHI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ccccceEEEe-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            8887765443 4455778899999999999999999999999999999999998876

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.3e-43  Score=333.87  Aligned_cols=243  Identities=23%  Similarity=0.352  Sum_probs=203.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTS  176 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  176 (404)
                      +|.+.+.||+|+||+||++.+  +|+.||||++.....      ........+..|..++..+. |++|+++++++.+..
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            467889999999999999987  688999999863211      11112345667888888885 577888988887766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~  136 (323)
T cd05615          75 RL----------------YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS  136 (323)
T ss_pred             EE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence            55                8999999999999988654  56999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus       137 ~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (323)
T cd05615         137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (323)
T ss_pred             CCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            99999999999875433333334456899999999999999999999999999999999999999988877777666654


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      .  ...+..++.++.+++.+||+.+|.+|++.
T Consensus       217 ~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 N--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            3  34667789999999999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-42  Score=328.90  Aligned_cols=266  Identities=32%  Similarity=0.576  Sum_probs=221.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE---------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY---------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      .|++...+|.+.+.||+|+||.||++.+         ++..||+|++.....        ......+.+|+.+++.+ +|
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h   80 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIGKH   80 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--------hHHHHHHHHHHHHHHhhccC
Confidence            4678889999999999999999999874         234799998853211        11235578999999999 89


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~  228 (404)
                      |||+++++++......                |+||||+++++|.+++....              ...+++..+..++.
T Consensus        81 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (304)
T cd05101          81 KNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY  144 (304)
T ss_pred             CCchheeEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence            9999999998776554                89999999999999996542              23578889999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||++|++|+||||+||+++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||
T Consensus       145 qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  224 (304)
T cd05101         145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  224 (304)
T ss_pred             HHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHH
Confidence            9999999999999999999999999999999999999999754332221  22234567899999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          307 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       307 lG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||+++|+|++ |..||...+..+....+ ....+...+..++.++.+||.+||..+|++||++.+|++.|+++.+...
T Consensus       225 lG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         225 FGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            9999999998 78999888877766554 3444555677889999999999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-43  Score=321.96  Aligned_cols=246  Identities=31%  Similarity=0.577  Sum_probs=206.3

Q ss_pred             eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          106 AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      .||+|+||.||+|.+    +++.+|||+++.....       ......+.+|+.+++.++||||+++++++.+. ..   
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~---   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-------PALKDELLREANVMQQLDNPYIVRMIGICEAE-SW---   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-Cc---
Confidence            589999999999975    5789999998643221       22356688999999999999999999987532 22   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   ++||||+++++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||.||+++.++.+|
T Consensus        71 -------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~k  135 (257)
T cd05116          71 -------------MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK  135 (257)
T ss_pred             -------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEE
Confidence                         7999999999999998653  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015594          262 IADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      |+|||++.........   .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ..
T Consensus       136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~  214 (257)
T cd05116         136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SG  214 (257)
T ss_pred             ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CC
Confidence            9999999754433221   122234678999999988889999999999999999998 999999887766655544 44


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+..+..+++++.++|.+||+.||++||++.+|...|+++
T Consensus       215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            45667788999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-42  Score=326.70  Aligned_cols=259  Identities=31%  Similarity=0.530  Sum_probs=216.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ...+|.+.+.||+|+||.||++.+       ++..+|+|.+....         ......+.+|+.++++++||||++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~   73 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---------LAARKDFQREAELLTNLQHEHIVKFY   73 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence            356789999999999999999974       34568999875221         12235578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHH
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLS  235 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~  235 (404)
                      +++.+....                ++||||+++++|.+++..+.              ...+++..++.++.||+.||.
T Consensus        74 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  137 (291)
T cd05094          74 GVCGDGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV  137 (291)
T ss_pred             EEEccCCce----------------EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            998776655                89999999999999996542              235899999999999999999


Q ss_pred             HHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHH
Q 015594          236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE  313 (404)
Q Consensus       236 ~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  313 (404)
                      |||++|++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+
T Consensus       138 ~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  217 (291)
T cd05094         138 YLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE  217 (291)
T ss_pred             HHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999999999999975433221  1233456788999999999989999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          314 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       314 l~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      |++ |..||...+..+....+. ....+..+..+|..+.+++.+||+.+|.+||++.+|++.|+++...
T Consensus       218 l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         218 IFTYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            998 999998888777665543 3444455677899999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.1e-42  Score=328.89  Aligned_cols=267  Identities=31%  Similarity=0.581  Sum_probs=220.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE---------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-C
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY---------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-D  161 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  161 (404)
                      ..|.+..++|.+.+.||+|+||.||++..         ....||+|++.....    .    .....+.+|+.+++++ +
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~----~----~~~~~~~~E~~~l~~l~~   76 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT----D----KDLADLISEMELMKLIGK   76 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC----h----HHHHHHHHHHHHHHhccC
Confidence            45778889999999999999999999875         245799999863221    1    1134577899999999 6


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHH
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLA  227 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~  227 (404)
                      ||||+++++++.+....                |+||||+++|+|.+++....              ...+++..+..++
T Consensus        77 h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (314)
T cd05099          77 HKNIINLLGVCTQEGPL----------------YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA  140 (314)
T ss_pred             CCCeeeEEEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence            99999999998766544                89999999999999996532              2458899999999


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhH
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVY  305 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  305 (404)
                      .||+.||.|||++|++|+||||+|||++.++.+||+|||+++........  .....++..|+|||.+.+..++.++|||
T Consensus       141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  220 (314)
T cd05099         141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW  220 (314)
T ss_pred             HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhh
Confidence            99999999999999999999999999999999999999999754322111  1112345679999999988899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          306 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       306 slG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |||+++|+|++ |..||...+..+....+.. ......+..++.++.+++.+||..+|++||++.++++.|+++.....
T Consensus       221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         221 SFGILMWEIFTLGGSPYPGIPVEELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            99999999999 8999998887766655443 34455677889999999999999999999999999999999986544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-42  Score=320.88  Aligned_cols=258  Identities=27%  Similarity=0.507  Sum_probs=214.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||+|.+  +|+.||+|.++......      ......+.+|+.++++++|+||+++++++....
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD------AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc------hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            5799999999999999999998  68999999986432211      122456789999999999999999999998765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..                ++||||+++++|.+++...  ....+++..+..++.+|+.||.|||+.|++|+||+|+||++
T Consensus        76 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~  139 (267)
T cd08224          76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI  139 (267)
T ss_pred             eE----------------EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence            54                8999999999999998653  23568999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--~~~~~~~  332 (404)
                      +.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||....  ..+....
T Consensus       140 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  219 (267)
T cd08224         140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK  219 (267)
T ss_pred             CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh
Confidence            99999999999998755443333344568899999999998889999999999999999999999996443  2333333


Q ss_pred             HHhccCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          333 VVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       333 ~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +.... .+..+. .++..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus       220 ~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         220 IEKCD-YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCC-CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            33322 333333 78889999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-43  Score=340.59  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++.+  +++.||||++....      .........+.+|+.++..++||||+++++.+.+..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD------MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3688999999999999999987  68999999996321      111223456778999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus        75 ~~----------------~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~  136 (360)
T cd05627          75 NL----------------YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA  136 (360)
T ss_pred             EE----------------EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence            65                8999999999999998654  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC-----------------------------------CcccCCCCCccccCccccCCCCCCcc
Q 015594          257 TRTVKIADFGVARLEASNP-----------------------------------HDMTGETGTLGYMAPEVLNGSAYNRK  301 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  301 (404)
                      ++.+||+|||++.......                                   ......+||+.|+|||++.+..++.+
T Consensus       137 ~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~  216 (360)
T cd05627         137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL  216 (360)
T ss_pred             CCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence            9999999999986432110                                   00123569999999999999999999


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 015594          302 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKRPE---MDEVVA  373 (404)
Q Consensus       302 ~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt---~~~ll~  373 (404)
                      +|||||||++|||++|..||...+..+....+........++.  .+++++.++|.+|+ .||.+|++   ++++++
T Consensus       217 ~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         217 CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             ceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9999999999999999999998888777766654333333333  36889999999987 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.1e-43  Score=326.28  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=196.4

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||+|+||.||++..  +|+.||+|.+......      .......+..|+.++++++||||+++++++.....+      
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~------   68 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK------KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------   68 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE------
Confidence            69999999999986  6899999998532211      111123355799999999999999999998876655      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+||||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|
T Consensus        69 ----------~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~D  138 (277)
T cd05607          69 ----------CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD  138 (277)
T ss_pred             ----------EEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEee
Confidence                      8999999999999988666556789999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCC
Q 015594          265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS----EVTSAVVRQNLRP  340 (404)
Q Consensus       265 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~  340 (404)
                      ||++..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||......    +.......... .
T Consensus       139 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~  216 (277)
T cd05607         139 LGLAVELKD-GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-K  216 (277)
T ss_pred             ceeeeecCC-CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-c
Confidence            999875432 22333456899999999999988999999999999999999999999765332    22222222111 1


Q ss_pred             CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       341 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....+++++.+||.+||+.||++||++.++++
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            122457899999999999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-43  Score=336.13  Aligned_cols=238  Identities=23%  Similarity=0.377  Sum_probs=195.2

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||.||++.+  +++.||+|+++.....      .......+.+|+.++.++ +||||+++++++.....+   
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~---   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL---   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE---
Confidence            4689999999999987  6789999999743211      112234567888888777 899999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|..++...  ..+++..+..++.||+.||.|||++||+||||||+||+|+.++.+|
T Consensus        72 -------------~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k  136 (329)
T cd05618          72 -------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK  136 (329)
T ss_pred             -------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence                         8999999999999888554  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHH-HHHH
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--------FSE-VTSA  332 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--------~~~-~~~~  332 (404)
                      |+|||+++.............||+.|+|||++.+..++.++||||||+++|+|++|..||....        ... ....
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05618         137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  216 (329)
T ss_pred             EeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH
Confidence            9999999753333333445678999999999999999999999999999999999999995321        111 2222


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      +..  ....+|..++..+.++|.+||+.||++||++
T Consensus       217 i~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         217 ILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             Hhc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            222  2345778889999999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-43  Score=337.17  Aligned_cols=240  Identities=25%  Similarity=0.360  Sum_probs=199.7

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHH-HHhhcCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA-VWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||+||++.+  +|+.||||++......      .......+..|.. +++.++||||+++++++.....+   
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~---   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL---   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE---
Confidence            4689999999999987  6899999998642111      1112233445554 56779999999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|..++.+.  ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus        72 -------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k  136 (325)
T cd05604          72 -------------YFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV  136 (325)
T ss_pred             -------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence                         8999999999999888553  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.....  .
T Consensus       137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~  214 (325)
T cd05604         137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--V  214 (325)
T ss_pred             EeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--c
Confidence            99999987533333344456799999999999999999999999999999999999999998887777766665432  3


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      .+...+..+.++|.+||+.+|.+||++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            44567899999999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-42  Score=319.73  Aligned_cols=257  Identities=31%  Similarity=0.580  Sum_probs=216.7

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      |++..++|.+.+.||+|+||.||++.+ .+..+|+|.+.....          ....+.+|+.++++++|+||+++++.+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----------SVEAFLAEANVMKTLQHDKLVKLHAVV   70 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----------HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            778889999999999999999999986 567799998753211          134578899999999999999999988


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .. ...                +++|||+++++|.+++.+.....+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus        71 ~~-~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni  133 (260)
T cd05073          71 TK-EPI----------------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI  133 (260)
T ss_pred             cC-CCe----------------EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence            65 222                8999999999999999776556789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      +++.++.+||+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.....
T Consensus       134 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~  213 (260)
T cd05073         134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI  213 (260)
T ss_pred             EEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999999975433221 1222345678999999998889999999999999999998 99999988776665


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+. .......+...+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus       214 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         214 RALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHHh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            5443 3444455677889999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.4e-43  Score=340.50  Aligned_cols=245  Identities=24%  Similarity=0.435  Sum_probs=196.6

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+...+|.+.+.||+|+||.||++.+  +++.||||...               +..+.+|+.++++++||||+++++++
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~~  152 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGTF  152 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEEE
Confidence            35567899999999999999999987  68999999752               22356899999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......                ++|+|++ +++|..++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       153 ~~~~~~----------------~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NI  213 (391)
T PHA03212        153 TYNKFT----------------CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENI  213 (391)
T ss_pred             EECCee----------------EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhE
Confidence            766554                8999999 67898888554  4689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccC-CCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------
Q 015594          253 LLDKTRTVKIADFGVARLEAS-NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS------  325 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~------  325 (404)
                      ||+.++.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....      
T Consensus       214 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  293 (391)
T PHA03212        214 FINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC  293 (391)
T ss_pred             EEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence            999999999999999964322 2223345679999999999999999999999999999999999998764321      


Q ss_pred             -HHHHHHHHHh--------------------------ccCC-C-CCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 015594          326 -FSEVTSAVVR--------------------------QNLR-P-EIP-----RCCPSSLANVMKRCWDANPDKRPEMDEV  371 (404)
Q Consensus       326 -~~~~~~~~~~--------------------------~~~~-~-~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~l  371 (404)
                       .......+..                          .... + ..+     ..++.++.+||.+||+.||.+|||++++
T Consensus       294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el  373 (391)
T PHA03212        294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL  373 (391)
T ss_pred             chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence             0111111100                          0000 0 000     1246789999999999999999999999


Q ss_pred             HH
Q 015594          372 VA  373 (404)
Q Consensus       372 l~  373 (404)
                      ++
T Consensus       374 L~  375 (391)
T PHA03212        374 LD  375 (391)
T ss_pred             hc
Confidence            84

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.4e-43  Score=334.66  Aligned_cols=239  Identities=24%  Similarity=0.358  Sum_probs=198.6

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHH-HHHhhcCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV-AVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      ++||+|+||.||++.+  +|+.||+|++.....      ........+.+|. .+++.++||||+++++++.+....   
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~---   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL---   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE---
Confidence            3689999999999997  688999999863211      1111223344554 467889999999999998877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++++|...+.+.  ..+++..+..++.||+.||.|||+.||+||||||+||+|+.++.+|
T Consensus        72 -------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k  136 (321)
T cd05603          72 -------------YFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV  136 (321)
T ss_pred             -------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence                         8999999999999888543  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...  ...
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~  214 (321)
T cd05603         137 LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQ  214 (321)
T ss_pred             EccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCC
Confidence            999999875333333344567899999999999999999999999999999999999999988877766665544  334


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      ++...+.++.++|.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            6667889999999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-42  Score=321.23  Aligned_cols=256  Identities=28%  Similarity=0.578  Sum_probs=213.5

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--C---CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--D---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~---g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +..+|++.+.||+|+||.||+|.+  +   +..+|+|.++....        ......+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIHLEGV   73 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            467899999999999999999986  2   23799998854221        1124567899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +......                |+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        74 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~n  136 (267)
T cd05066          74 VTKSKPV----------------MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN  136 (267)
T ss_pred             EecCCcc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhc
Confidence            8766544                8999999999999999654 3568999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      |+++.++.++|+|||++..........   ....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~  216 (267)
T cd05066         137 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ  216 (267)
T ss_pred             EEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence            999999999999999997544332211   12223568999999998889999999999999999886 99999988776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +....+.. ..+...+..+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus       217 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         217 DVIKAIEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            66555543 344555667899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.6e-43  Score=327.15  Aligned_cols=257  Identities=26%  Similarity=0.504  Sum_probs=214.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ++..+|.+.+.||.|+||.||+|.+.       ++.||||+++....        ......+.+|+.++..++||||+++
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~   73 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--------GPLREEFKHEAMMRSRLQHPNIVCL   73 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeE
Confidence            45567889999999999999999862       47899999863321        1234568899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--------------ccCCCcHHHHHHHHHHHHHHH
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--------------RRRKLAFKVVIQLALDLARGL  234 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L  234 (404)
                      ++++......                ++++||+.+++|.+++...              ....+++..+..++.|++.||
T Consensus        74 ~~~~~~~~~~----------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL  137 (283)
T cd05091          74 LGVVTKEQPL----------------SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM  137 (283)
T ss_pred             EEEEcCCCce----------------EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence            9999877665                8999999999999998532              123578889999999999999


Q ss_pred             HHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHH
Q 015594          235 SYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW  312 (404)
Q Consensus       235 ~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  312 (404)
                      .|||++||+||||||+||++++++.+||+|||+++......  .......+++.|+|||.+.+..++.++||||||+++|
T Consensus       138 ~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  217 (283)
T cd05091         138 EFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW  217 (283)
T ss_pred             HHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999999999999987543221  1122334578899999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          313 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       313 el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ||++ |..||.+.+..+....+.... ....+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       218 el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         218 EVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            9998 888998888777666655444 334567899999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-42  Score=320.16  Aligned_cols=252  Identities=35%  Similarity=0.670  Sum_probs=214.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      |-+...+|.+.+.||+|+||.||++..+++.||+|.++...           ....+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVIL   69 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence            34556789999999999999999999999999999985321           1245788999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ... .                ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus        70 ~~~-~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil  132 (254)
T cd05083          70 HNG-L----------------YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL  132 (254)
T ss_pred             CCC-c----------------EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence            432 2                79999999999999997665567899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++.+||+|||++......   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....
T Consensus       133 i~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         133 VSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             EcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            999999999999998753221   222344678999999998889999999999999999997 9999998887766554


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      +. .......+..++.++.+++.+||+.+|++||++.+|++.|++
T Consensus       210 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 VE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             Hh-CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            43 445555667789999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-42  Score=319.85  Aligned_cols=255  Identities=28%  Similarity=0.531  Sum_probs=213.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+...||.|+||.||+|.+  +++.||+|.+...................+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467788999999999999987  678999999876554433333344455778899999999999999999999887665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        81 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~  142 (267)
T cd06628          81 L----------------NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK  142 (267)
T ss_pred             c----------------EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC
Confidence            5                8999999999999999654  578999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCC------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPH------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +.++|+|||.++.......      ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus       143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  222 (267)
T cd06628         143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF  222 (267)
T ss_pred             CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence            9999999999875442211      1123457889999999998889999999999999999999999998876554443


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+.. ...+..+..++..+.++|.+||+.||.+||++.+|++
T Consensus       223 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            3332 4456677788999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.6e-43  Score=346.74  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ...+|.+.+.||+|+||+||+|.+  +++.||||++....             ....+|+.+++.++||||+++++++..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence            346799999999999999999987  68999999884321             113469999999999999999988754


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ....        ......++++||||++ ++|.+++..  .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus       131 ~~~~--------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NI  201 (440)
T PTZ00036        131 ECFK--------KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL  201 (440)
T ss_pred             cccc--------cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHE
Confidence            3211        0011224579999994 678777743  2346799999999999999999999999999999999999


Q ss_pred             EEcCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          253 LLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||+.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+..
T Consensus       202 Ll~~~~~~vkL~DFGla~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  280 (440)
T PTZ00036        202 LIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL  280 (440)
T ss_pred             EEcCCCCceeeeccccchhccC-CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            998654 799999999975432 2233446789999999998664 6899999999999999999999999887665544


Q ss_pred             HHHHhcc---------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH--HHHHHhHh
Q 015594          331 SAVVRQN---------------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV--AMLEAIDT  380 (404)
Q Consensus       331 ~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll--~~L~~~~~  380 (404)
                      ..+....                           +...+|...++++.+||.+||+.||.+|||+.+++  ..++.+..
T Consensus       281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            4433210                           01123445788999999999999999999999998  45555543

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-42  Score=319.13  Aligned_cols=246  Identities=34%  Similarity=0.615  Sum_probs=203.9

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +.||+|+||.||+|++  +++.||+|.+.....        ......+.+|+.++++++||||+++++++......    
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----   68 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI----   68 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe----
Confidence            3689999999999987  789999998752211        12235678999999999999999999998776554    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEE
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI  262 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL  262 (404)
                                  ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||
T Consensus        69 ------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl  135 (252)
T cd05084          69 ------------YIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI  135 (252)
T ss_pred             ------------EEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEE
Confidence                        8999999999999998543 346899999999999999999999999999999999999999999999


Q ss_pred             eeccccccccCCCCccc--CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 015594          263 ADFGVARLEASNPHDMT--GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLR  339 (404)
Q Consensus       263 ~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~  339 (404)
                      +|||++...........  ....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+. ....
T Consensus       136 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~  214 (252)
T cd05084         136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVR  214 (252)
T ss_pred             CccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCC
Confidence            99999874332211111  1123457999999998889999999999999999998 899998877665544443 3445


Q ss_pred             CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       340 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ...+..++..+.+|+.+||+.+|++||++.+|+++|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            5667788999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=321.09  Aligned_cols=261  Identities=24%  Similarity=0.329  Sum_probs=211.2

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ...|++ ...|...+.||+|+||.|+.+.+  +|+.||||.+..       ..+.....++..+|+.+|+.++|+||+.+
T Consensus        15 ~~~~~i-~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-------~F~~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen   15 GELFEI-PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-------PFENQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             eeEEec-cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-------hhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence            344555 46677789999999999999987  789999999841       22233446677899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++..+..-           ..+..|+|+|+| +-+|.+.+..+  +.++...+..++.||++||.|+|+.+|+|||+|
T Consensus        87 ~di~~p~~~~-----------~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK  152 (359)
T KOG0660|consen   87 LDIFRPPSRD-----------KFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK  152 (359)
T ss_pred             Eeeccccccc-----------ccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence            9998763221           234469999999 88899888544  459999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccC--CCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEAS--NPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |.|+|++.+..+||+|||+|+....  ....++..+.|..|.|||++. ...|+.+.||||.||++.||++|++-|++.+
T Consensus       153 PsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d  232 (359)
T KOG0660|consen  153 PSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD  232 (359)
T ss_pred             hhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence            9999999999999999999997543  355678889999999999874 5579999999999999999999999998765


Q ss_pred             HHHHHHHHHh------------------------ccCCCCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          326 FSEVTSAVVR------------------------QNLRPEI-----PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~------------------------~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.+..++.                        ....+..     -...++.+.+|+.+||..||.+|+|++|.++
T Consensus       233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            4433322211                        1111111     1467889999999999999999999999885

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.7e-42  Score=323.43  Aligned_cols=257  Identities=31%  Similarity=0.560  Sum_probs=213.0

Q ss_pred             CeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594          100 KLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      +|++.+.||+|+||.||+|...       ...+|+|.+.....    ..    ....+.+|+.+++.++||||+++++.+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS----SS----ELRDLLSEFNLLKQVNHPHVIKLYGAC   72 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC----HH----HHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            4778899999999999999863       25689998853221    11    135578999999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------------cCCCcHHHHHHHHHHH
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------RRKLAFKVVIQLALDL  230 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi  230 (404)
                      ......                ++|+||+.+++|.+++....                      ...+++..++.++.|+
T Consensus        73 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i  136 (290)
T cd05045          73 SQDGPL----------------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI  136 (290)
T ss_pred             ecCCCc----------------EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence            766554                89999999999999985421                      2357889999999999


Q ss_pred             HHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHH
Q 015594          231 ARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG  308 (404)
Q Consensus       231 ~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  308 (404)
                      +.||.|||+.|++||||||+||++++++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||
T Consensus       137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG  216 (290)
T cd05045         137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG  216 (290)
T ss_pred             HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence            9999999999999999999999999999999999999975432221  12223456789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          309 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       309 ~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +++|+|++ |..||......+.... .........+..++.++.++|.+||+.+|++||++.++++.|+++..+
T Consensus       217 ~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         217 VLLWEIVTLGGNPYPGIAPERLFNL-LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            99999998 9999988877666544 444455566788899999999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-42  Score=332.18  Aligned_cols=239  Identities=23%  Similarity=0.366  Sum_probs=196.7

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+||.||++.+  +++.||||+++...      .........+.+|+.++.++ +||||+++++++.+...+   
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~---   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL---   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE---
Confidence            3689999999999987  67899999996421      11122345577899999888 699999999999877665   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|..++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        72 -------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~k  136 (327)
T cd05617          72 -------------FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK  136 (327)
T ss_pred             -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEE
Confidence                         8999999999999888554  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHh
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL------SFSEVTSAVVR  335 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~------~~~~~~~~~~~  335 (404)
                      |+|||++.............+||+.|+|||++.+..++.++||||||+++|+|++|..||...      ...+.......
T Consensus       137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  216 (327)
T cd05617         137 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL  216 (327)
T ss_pred             EeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence            999999875333333444567999999999999999999999999999999999999999532      22222222222


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      . ....+|..++..+.++|.+||+.||.+|+++
T Consensus       217 ~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         217 E-KPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             h-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2 2334677889999999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=351.38  Aligned_cols=274  Identities=22%  Similarity=0.377  Sum_probs=222.4

Q ss_pred             ccccccccccCCCCeEEeeeeeeecceEEEEEEE-C-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CC
Q 015594           87 ASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-D-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HP  163 (404)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp  163 (404)
                      .....+..+|...++++.++|++|+|+.||++.. . |..||+|.+-..         .+.....+.+|+.+|++|. |+
T Consensus        25 ~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---------de~~L~~v~~EI~~MK~L~gh~   95 (738)
T KOG1989|consen   25 NYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---------DEEALNAVKREIDIMKLLSGHK   95 (738)
T ss_pred             cCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---------CHHHHHHHHHHHHHHHHhcCCC
Confidence            3445577788999999999999999999999998 3 489999987432         1233456789999999996 99


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--  241 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--  241 (404)
                      |||.+++.+......     ++    ..-.++|+||||.||.|.+++.+.....|++.++++|+.|+++|+.+||...  
T Consensus        96 nIV~yidss~~~~~~-----~~----~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pP  166 (738)
T KOG1989|consen   96 NIVSYIDSSAINRSS-----NN----GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPP  166 (738)
T ss_pred             ceeeEeccccccccC-----CC----ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCc
Confidence            999999953222111     00    0112489999999999999997766667999999999999999999999997  


Q ss_pred             ceecccCCCCEEEcCCCcEEEeeccccccccCCCCcc---------cCCCCCccccCcccc---CCCCCCcchhhHHHHH
Q 015594          242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM---------TGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI  309 (404)
Q Consensus       242 ivH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~  309 (404)
                      |||||||-+||||+.+|+.||||||.|.-........         .....|+.|.|||++   .+.+.+.|+|||+|||
T Consensus       167 iIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc  246 (738)
T KOG1989|consen  167 IIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC  246 (738)
T ss_pred             cchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence            9999999999999999999999999997433333111         112369999999997   5778999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          310 CLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       310 il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      +||-||....||+....    .+|+..++........++.|.+||+.||+.||.+||++-+++..+.++....
T Consensus       247 lLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  247 LLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             HHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            99999999999987643    3456666665555678899999999999999999999999999998876543

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-42  Score=325.66  Aligned_cols=261  Identities=32%  Similarity=0.553  Sum_probs=214.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCc--eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQ--DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      ++|.+.+.||+|+||.||+|..  ++.  .+|+|.++....        ......+.+|+.++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--------ENDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--------HHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            5789999999999999999987  333  478887752111        11234578899999999 7999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      +...+                |+|+||+++++|.+++....              ...+++..++.++.||+.||+|||+
T Consensus        74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~  137 (297)
T cd05089          74 NRGYL----------------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE  137 (297)
T ss_pred             cCCcc----------------eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            76554                89999999999999996532              1358899999999999999999999


Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CC
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CD  318 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~  318 (404)
                      +|++||||||+|||++.++.+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus       138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~  216 (297)
T cd05089         138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG  216 (297)
T ss_pred             CCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999999986322111 1111223567999999998889999999999999999997 99


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      .||...+..+....+. .......+..++.++.+||.+||+.+|.+||+++++++.|+.+.......
T Consensus       217 ~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         217 TPYCGMTCAELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             CCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            9999888777665544 34455667789999999999999999999999999999999998777543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-42  Score=318.65  Aligned_cols=246  Identities=30%  Similarity=0.594  Sum_probs=204.7

Q ss_pred             eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          106 AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      .||+|+||.||+|.+    ++..||||++.....        ......+.+|+.++++++||||+++++++... .    
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-~----   68 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-A----   68 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-C----
Confidence            389999999999976    345799999853311        12345688999999999999999999987532 2    


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                  .++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+|
T Consensus        69 ------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k  135 (257)
T cd05115          69 ------------LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK  135 (257)
T ss_pred             ------------eEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence                        28999999999999988543 45789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 015594          262 IADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      |+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ...
T Consensus       136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~  214 (257)
T cd05115         136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQG  214 (257)
T ss_pred             eccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCC
Confidence            9999999754332221   122234578999999998889999999999999999996 99999988877665444 444


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .+...+..+++++.++|.+||..+|++||++.+|++.|+.+
T Consensus       215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            55677788999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-42  Score=334.28  Aligned_cols=253  Identities=24%  Similarity=0.299  Sum_probs=200.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +|+.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            47899999999999999999987  6899999998643211       11234567899999999999999999998755


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ....          .....|+||||+ +++|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        93 ~~~~----------~~~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~  157 (359)
T cd07876          93 KSLE----------EFQDVYLVMELM-DANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  157 (359)
T ss_pred             CCcc----------ccceeEEEEeCC-CcCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            4321          112348999999 456766653    3588999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       158 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~  236 (359)
T cd07876         158 SDCTLKILDFGLARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE  236 (359)
T ss_pred             CCCCEEEecCCCcccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999975322 2233446789999999999999999999999999999999999999987654332222111


Q ss_pred             cc--------------------CC--------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN--------------------LR--------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~--------------------~~--------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                    ..                    .......++++++||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            00                    00                    0111234678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.4e-42  Score=316.03  Aligned_cols=251  Identities=26%  Similarity=0.497  Sum_probs=211.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|++.+.||.|++|.||++.+  +++.||+|.+......       ......+.+|+.++++++|+|++++++.+.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG   73 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence            488999999999999999987  6789999998643221       1123457789999999999999999987754332


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                                     .+|+||||+++++|.+++.......+++.+++.++.|++.||.+||+.|++|+||||+||+++.+
T Consensus        74 ---------------~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~  138 (257)
T cd08223          74 ---------------LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT  138 (257)
T ss_pred             ---------------EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence                           23899999999999999977656679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus       139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  218 (257)
T cd08223         139 NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK  218 (257)
T ss_pred             CcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999999765443333445568999999999999999999999999999999999999998877666555544433


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       .+..+...++++.++|.+||+.||++||++.++++
T Consensus       219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 -LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             34456778899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-42  Score=325.75  Aligned_cols=262  Identities=30%  Similarity=0.539  Sum_probs=212.8

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCce--EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~--vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      +..++|.+.+.||+|+||.||+|.+  ++..  +|+|.++...    .    ......+.+|+.++.++ +||||+++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~----~----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~   75 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----S----KDDHRDFAGELEVLCKLGHHPNIINLLG   75 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC----C----HHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            4457899999999999999999986  4544  5666654211    1    12235677899999999 8999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHH
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ++......                |+||||+++++|.+++.+..              ...+++..++.++.||+.||+|
T Consensus        76 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~  139 (303)
T cd05088          76 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  139 (303)
T ss_pred             EECCCCCc----------------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence            98776554                89999999999999996542              2357899999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      ||++|++||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       140 LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  218 (303)
T cd05088         140 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  218 (303)
T ss_pred             HHhCCccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence            999999999999999999999999999999986322111 1112234678999999988889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          317 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       317 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                       |..||...+..+....+ ........+..+++++.+||.+||+.+|++||++++++..|+.+...+-
T Consensus       219 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         219 LGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             cCCCCcccCChHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence             99999887776655443 3344555666788999999999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-42  Score=321.77  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=207.1

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|+..+.||.|+||+||++.+  +++.||+|++.....      ........+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI------KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh------hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence            367788999999999999987  689999999853221      111223456789999999999999999999877665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+||||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.+
T Consensus        75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~  138 (285)
T cd05632          75 L----------------CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY  138 (285)
T ss_pred             E----------------EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence            5                899999999999988866555579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ-  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~-  336 (404)
                      +.++|+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+... 
T Consensus       139 ~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~  217 (285)
T cd05632         139 GHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV  217 (285)
T ss_pred             CCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence            99999999998653322 2233457899999999999888999999999999999999999999877654433333221 


Q ss_pred             -cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHH
Q 015594          337 -NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVAM  374 (404)
Q Consensus       337 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~~  374 (404)
                       ......+..++.++.+|+.+||+.||++||+     +.+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         218 LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             1123455678899999999999999999999     6777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-42  Score=321.75  Aligned_cols=254  Identities=27%  Similarity=0.479  Sum_probs=203.8

Q ss_pred             eEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594          101 LIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      |.+.+.||+|+||+||++.+      +++.||+|+++....        ......+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--------QQNTSGWKKEINILKTLYHENIVKYKGCCSE   77 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            48889999999999988653      567899999864321        1124557889999999999999999998765


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....              .+++||||+++++|.+++...   .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus        78 ~~~~--------------~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili  140 (283)
T cd05080          78 QGGK--------------GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL  140 (283)
T ss_pred             CCCc--------------eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE
Confidence            4322              238999999999999998553   69999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--H-
Q 015594          255 DKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS--E-  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~--~-  328 (404)
                      +.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  + 
T Consensus       141 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~  220 (283)
T cd05080         141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM  220 (283)
T ss_pred             cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh
Confidence            99999999999999754332211   11223566799999998888999999999999999999999998643211  0 


Q ss_pred             -----------HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          329 -----------VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       329 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                                 ..............+..++.++.+++.+||+.+|++|||+++|++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                       011112222333456778999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-42  Score=320.95  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=208.8

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  175 (404)
                      +.|.+.+.||+|+||.||+|..  +++.||+|++......          ...+.+|+.+++++ +||||+++++++...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            5688889999999999999987  6789999998643211          23466889999998 799999999998754


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...          .....+|+||||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||+++
T Consensus        76 ~~~----------~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~  145 (272)
T cd06637          76 NPP----------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT  145 (272)
T ss_pred             CCC----------CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence            321          0122458999999999999999776556799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      .++.++|+|||++..............|++.|+|||++.     +..++.++||||||+++|+|++|..||.........
T Consensus       146 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~  225 (272)
T cd06637         146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  225 (272)
T ss_pred             CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            999999999999975443333344567899999999986     345888999999999999999999999877655544


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........+...+..++.++.+||.+||..+|.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            4444433334445568899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-42  Score=322.23  Aligned_cols=250  Identities=28%  Similarity=0.425  Sum_probs=204.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|..  +++.||+|++......         ....+.+|+.++++++||||+++++.+...
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---------DFSLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---------hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            46799999999999999999986  6889999998643211         123467899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++
T Consensus        79 ~~~----------------~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~  140 (267)
T cd06646          79 EKL----------------WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT  140 (267)
T ss_pred             CEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence            655                8999999999999988543  5789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||++..............++..|+|||.+.   ...++.++||||||+++|+|++|..||......+....
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~  220 (267)
T cd06646         141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence            999999999999975543333334456889999999984   34578899999999999999999999976654433222


Q ss_pred             HHhccCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          333 VVRQNLRPEI---PRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       333 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +....+.+..   ...++..+.++|.+||+.+|++||++++|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         221 MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            2222222221   23467899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.9e-42  Score=319.26  Aligned_cols=260  Identities=26%  Similarity=0.527  Sum_probs=213.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++    .||||++.....        ......+.+|+.++..++||||++++
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~   75 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--------PKANKEILDEAYVMAGVGSPYVCRLL   75 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--------HHHHHHHHHHHHHHHhcCCCCCceEE
Confidence            3457899999999999999999986  444    489999853221        11234577899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +.+.... .                ++++||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||
T Consensus        76 ~~~~~~~-~----------------~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp  137 (279)
T cd05109          76 GICLTST-V----------------QLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA  137 (279)
T ss_pred             EEEcCCC-c----------------EEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            9886432 2                6899999999999998654 35689999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +|||+++++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  217 (279)
T cd05109         138 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA  217 (279)
T ss_pred             ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999999999754332221  222345678999999998889999999999999999998 8999987776


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ..... ..........+..++.++.++|.+||+.||++||++.++++.|+.+....
T Consensus       218 ~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         218 REIPD-LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHH-HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            55544 34444455566778999999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.4e-42  Score=319.47  Aligned_cols=259  Identities=29%  Similarity=0.500  Sum_probs=208.2

Q ss_pred             EEeeeeeeecceEEEEEEEC--Cc--eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          102 IIKGAFARGTFGTVHRGIYD--GQ--DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~~--g~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .+.+.||+|+||.||+|.+.  +.  .||||.++.....       ......+.+|+.+++.++||||+++++.+.....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-------RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE   74 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence            46788999999999999873  32  6899988653211       1123567889999999999999999998754332


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN----RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ..          .....+++|||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        75 ~~----------~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil  144 (272)
T cd05075          75 SE----------GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCM  144 (272)
T ss_pred             cc----------CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheE
Confidence            10          112248999999999999988432    2345899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      ++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..
T Consensus       145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  224 (272)
T cd05075         145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY  224 (272)
T ss_pred             EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999999754332211  112245678999999999999999999999999999999 89999888776666


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+... .....+..++..+.++|.+||+.||++|||+.+|++.|+++
T Consensus       225 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         225 DYLRQG-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            555443 33445667899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.3e-42  Score=318.15  Aligned_cols=256  Identities=29%  Similarity=0.580  Sum_probs=212.6

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +..+|.+.+.||+|+||.||+|..  ++   ..||||+++...    .    ......|..|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~   73 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----T----EKQRRDFLSEASIMGQFDHPNIIHLEGV   73 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----C----HHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            456789999999999999999987  33   369999985321    1    1224568899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+....                ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus        74 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~n  136 (269)
T cd05065          74 VTKSRPV----------------MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN  136 (269)
T ss_pred             ECCCCce----------------EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChhe
Confidence            8766655                8999999999999998654 4578999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCc--ccCC---CCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHD--MTGE---TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~---~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      |+++.++.++|+|||++.........  ....   ..+..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus       137 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             EEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence            99999999999999998754332211  1111   12457999999998889999999999999999886 999999888


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+....+. .......+..++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus       217 ~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         217 NQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            776665553 3445555677899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.3e-42  Score=323.11  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|++.+.||+|+||.||++.+  +++.||||.+......      .......+.+|+.++++++|+||+++++.+.+...
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            367788999999999999987  6889999998643211      11123446789999999999999999999877665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||+++++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus        75 ~----------------~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~  138 (285)
T cd05630          75 L----------------CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH  138 (285)
T ss_pred             E----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence            5                899999999999998866555679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---EVTSAVV  334 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~---~~~~~~~  334 (404)
                      +.++|+|||++..... ........|+..|+|||++.+..++.++||||||+++|+|++|..||......   +......
T Consensus       139 ~~~~l~Dfg~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~  217 (285)
T cd05630         139 GHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV  217 (285)
T ss_pred             CCEEEeeccceeecCC-CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh
Confidence            9999999999865332 22233457899999999999999999999999999999999999999865322   1122211


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                       .......+..+++++.+||.+||+.||++|||     ++++++
T Consensus       218 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 -KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             12233456678899999999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=329.72  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=205.8

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +++.||||++....      .........+.+|+.++..++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE------MLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4789999999999999999987  68999999986321      111223455788999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~  137 (331)
T cd05597          75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK  137 (331)
T ss_pred             eE----------------EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence            65                8999999999999998653 457899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-cccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ++.+||+|||++........ ......||+.|+|||++.+     ..++.++|||||||++|+|++|..||...+..+..
T Consensus       138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~  217 (331)
T cd05597         138 NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  217 (331)
T ss_pred             CCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH
Confidence            99999999999865433222 2223468999999999863     45788999999999999999999999988877776


Q ss_pred             HHHHhccCCCCC---CCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 015594          331 SAVVRQNLRPEI---PRCCPSSLANVMKRCWDANPDK--RPEMDEVVAM  374 (404)
Q Consensus       331 ~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~  374 (404)
                      ..+........+   ...++++++++|.+||..++.+  |++++++++.
T Consensus       218 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         218 GKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            666543322222   2347899999999988654433  7889888865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.8e-42  Score=326.34  Aligned_cols=255  Identities=23%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||+|.+  +++.||||.++.......        ...+.+|+.++++++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--------chhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            46799999999999999999987  678999999875432211        22356899999999999999999998876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus        77 ~~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~  138 (309)
T cd07872          77 KSL----------------TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN  138 (309)
T ss_pred             CeE----------------EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            655                89999995 5888887554 34689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       139 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  218 (309)
T cd07872         139 ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF  218 (309)
T ss_pred             CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999999754444444445678999999999865 458999999999999999999999998877655544332


Q ss_pred             hcc---------------------CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 015594          335 RQN---------------------LRP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAI  378 (404)
Q Consensus       335 ~~~---------------------~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~  378 (404)
                      ...                     +..       .....++.++.++|.+||+.||.+|||+.++++  .++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            210                     000       011246789999999999999999999999987  44443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.5e-42  Score=319.10  Aligned_cols=262  Identities=27%  Similarity=0.478  Sum_probs=216.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEEC------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ++.++|.+.+.||+|+||.||+|.+.      +..||+|.+....    .    ......+.+|+.++++++||||++++
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~----~----~~~~~~~~~e~~~l~~l~h~ni~~~~   74 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----S----EIQVTLLLQESCLLYGLSHQNILPIL   74 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC----C----HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            56789999999999999999999873      5889999875221    1    11235577899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                      +++......               .++++||+++++|.+++.....      ..+++..++.++.||+.||.|||+.+++
T Consensus        75 ~~~~~~~~~---------------~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~  139 (280)
T cd05043          75 HVCIEDGEP---------------PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVI  139 (280)
T ss_pred             EEEecCCCC---------------CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            987654222               2799999999999999866432      4689999999999999999999999999


Q ss_pred             ecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 015594          244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       244 H~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      |+||||+||+++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|++++ |..|
T Consensus       140 H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         140 HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             ecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCC
Confidence            9999999999999999999999999754322211  122345778999999998889999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      |...+..+....+ ........+..+++++.++|.+||..+|++|||+.++++.|+.+.+.
T Consensus       220 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         220 YVEIDPFEMAAYL-KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            9888766655443 33445455667899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.9e-42  Score=318.84  Aligned_cols=259  Identities=27%  Similarity=0.496  Sum_probs=211.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+|++.+.||+|+||+||+|.+  +++    .|++|.+....    .    ......+..|+.++.+++||||+++++
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~~~~~~~~l~~l~h~~iv~~~~   76 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS----G----RQTFQEITDHMLAMGSLDHAYIVRLLG   76 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc----c----hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            346788999999999999999987  455    46777764211    1    112345678888999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+.. .                ++++||+++|+|.+++... ...+++..+..++.||+.||.|||++|++|+||||+
T Consensus        77 ~~~~~~-~----------------~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~  138 (279)
T cd05111          77 ICPGAS-L----------------QLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR  138 (279)
T ss_pred             EECCCc-c----------------EEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence            875322 2                6899999999999999654 357899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      ||+++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus       139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  218 (279)
T cd05111         139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH  218 (279)
T ss_pred             eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999975433221  2233456778999999998889999999999999999998 99999887765


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .... +.........+..++.++.+++.+||..||.+||++.++++.|..+....
T Consensus       219 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         219 EVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHH-HHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            5433 34444555566778899999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=320.78  Aligned_cols=245  Identities=28%  Similarity=0.445  Sum_probs=218.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +.-++|.+.++||+|+||.|.+++.  +++.||+|++++..--.+.+      .+--..|-++|+..+||.++.+...|+
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE------VAHTlTE~RVL~~~~HPFLt~LKYsFQ  238 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE------VAHTLTENRVLQNCRHPFLTSLKYSFQ  238 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH------hhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence            5567899999999999999998886  79999999997543322222      122457889999999999999998888


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ..+++                |+||||..||.|.-+|.+  .+.+++..++-+..+|+.||.|||+++||+||||.+|+|
T Consensus       239 t~drl----------------CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl  300 (516)
T KOG0690|consen  239 TQDRL----------------CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL  300 (516)
T ss_pred             cCceE----------------EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence            88877                999999999999988855  468999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +|.+|++||+|||+++...........+||||.|+|||++....|+.++|+|.+||++|||+||++||...+...+...+
T Consensus       301 LDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  301 LDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             eccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            99999999999999987777778888899999999999999999999999999999999999999999999888888777


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      +...++  +|+.++++.+.|+..+|.+||.+|.
T Consensus       381 l~ed~k--FPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMEDLK--FPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             Hhhhcc--CCccCCHHHHHHHHHHhhcChHhhc
Confidence            776554  8899999999999999999999994

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-42  Score=322.27  Aligned_cols=255  Identities=29%  Similarity=0.515  Sum_probs=211.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      +...+|.+.++||+|+||.||++..       ++..+|+|.+....         ......+.+|+.+++.++|+||+++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~   72 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTVLQHQHIVRF   72 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---------HHHHHHHHHHHHHHhcCCCCCCceE
Confidence            4456889999999999999999863       35689999875321         1223568899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-------------CCCcHHHHHHHHHHHHHHHH
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-------------RKLAFKVVIQLALDLARGLS  235 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~  235 (404)
                      ++++.+....                ++||||+++++|.+++.....             ..+++..+..++.||+.||.
T Consensus        73 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~  136 (280)
T cd05092          73 YGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV  136 (280)
T ss_pred             EEEEecCCce----------------EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHH
Confidence            9998876654                899999999999999865421             35889999999999999999


Q ss_pred             HHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHH
Q 015594          236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE  313 (404)
Q Consensus       236 ~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  313 (404)
                      |||+.|++|+||||+|||+++++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       137 ~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  216 (280)
T cd05092         137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE  216 (280)
T ss_pred             HHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence            99999999999999999999999999999999874332211  1122335688999999999989999999999999999


Q ss_pred             HHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          314 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       314 l~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |++ |..||......+....+... .....+..+++.+.+||.+||+.||.+||++.+|++.|+
T Consensus       217 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         217 IFTYGKQPWYQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCCCCCCccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            998 89999887776666555433 344566788999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-42  Score=329.05  Aligned_cols=267  Identities=32%  Similarity=0.570  Sum_probs=221.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-C
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-D  161 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  161 (404)
                      ..|++...+|.+.+.||+|+||.||++.+.         +..||+|+++....        ......+.+|+.+++++ +
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~~   76 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--------DKDLSDLVSEMEMMKMIGK   76 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--------HHHHHHHHHHHHHHHhhcC
Confidence            568888899999999999999999999752         23689998753211        11235678899999999 8


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHH
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLA  227 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~  227 (404)
                      ||||+++++++.....+                +++|||+++|+|.+++.+..              ...+++..+..++
T Consensus        77 h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (334)
T cd05100          77 HKNIINLLGACTQDGPL----------------YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA  140 (334)
T ss_pred             CCCeeeeeEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence            99999999998766554                89999999999999996532              2357889999999


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhH
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVY  305 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  305 (404)
                      .||+.||.|||++|++||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++|||
T Consensus       141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  220 (334)
T cd05100         141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW  220 (334)
T ss_pred             HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhH
Confidence            99999999999999999999999999999999999999999754332211  1223345679999999998899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          306 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       306 slG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |||+++|||++ |..||...+..+....+. .......+..++.++.++|.+||+.+|.+||++.+|++.|+++.+..+
T Consensus       221 slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         221 SFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            99999999998 889999888777665544 344556677889999999999999999999999999999999986554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.1e-42  Score=317.49  Aligned_cols=257  Identities=29%  Similarity=0.584  Sum_probs=213.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      |...+|...+.||+|+||.||+|..  ++   ..+|||.++....        ....+.+.+|+.++++++||||+++++
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~   73 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--------EKQRQDFLSEASIMGQFSHHNIIRLEG   73 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence            4567889999999999999999986  33   3799998854321        112456789999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+....                |+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+
T Consensus        74 ~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~  136 (268)
T cd05063          74 VVTKFKPA----------------MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR  136 (268)
T ss_pred             EEccCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchh
Confidence            99776655                8999999999999998654 357899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      ||+++.++.+||+|||++..........   .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus       137 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~  216 (268)
T cd05063         137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN  216 (268)
T ss_pred             hEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence            9999999999999999997543322111   11223457999999998889999999999999999997 9999988877


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .+....+.. ......+..+++++.+++.+||+.+|++||++.+|++.|+++
T Consensus       217 ~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         217 HEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            766655543 334445567899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-43  Score=319.79  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=214.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc-eeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN-VTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~  174 (404)
                      ...|...+.||+|+||+||+|+.  +|+.||+|.+....+..       ..-....+|+.+++.|+|+| |+.+++++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-------G~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-------GVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-------CCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            45677778899999999999987  79999999997664421       11233568999999999999 9999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ....          .....+++|+||+ .-+|..++.....  ..++...+..+++||+.||+|||++||+||||||+||
T Consensus        83 ~~~~----------~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNl  151 (323)
T KOG0594|consen   83 SNNH----------RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNL  151 (323)
T ss_pred             cccc----------cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceE
Confidence            7631          1122348999999 8899999977643  3678889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ||+.+|.+||+|||+|+....+....+..++|..|.|||++.|. .|+..+||||+||+++||+++..-|++.+..+...
T Consensus       152 Li~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  152 LISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             EECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            99999999999999999877777778889999999999999887 69999999999999999999999999998877766


Q ss_pred             HHHhcc----------------CCCCC-----C-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          332 AVVRQN----------------LRPEI-----P-------RCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       332 ~~~~~~----------------~~~~~-----~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .+...-                +...+     +       ...+++..+++.+||+.+|.+|.|++..+..
T Consensus       232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            665321                00011     1       1122478899999999999999999998875

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.9e-42  Score=314.89  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=215.1

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|+..+.||.|+||.||.+..  +++.+++|.+.......       .....+.+|+.++++++|+||+++++++.+...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-------KERRDALNEIVILSLLQHPNIIAYYNHFMDDNT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-------hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence            588999999999999887765  78999999986443221       123457799999999999999999999987665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                ++||||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        74 ~----------------~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~  137 (256)
T cd08221          74 L----------------LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA  137 (256)
T ss_pred             E----------------EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence            5                899999999999999976655678999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.+||+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+....
T Consensus       138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (256)
T cd08221         138 GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN  217 (256)
T ss_pred             CCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999999765444433445678999999999998889999999999999999999999998887777766666554


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +. ..+..++.++.++|.+||..+|++||++.++++.
T Consensus       218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            44 3456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.5e-42  Score=322.36  Aligned_cols=256  Identities=31%  Similarity=0.535  Sum_probs=209.5

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEEC------------------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHh
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYD------------------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH  158 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~------------------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  158 (404)
                      ...+|++.+.||+|+||.||++.+.                  +..||+|.+.....        ......+.+|+.++.
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~   74 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--------DNAREDFLKEVKILS   74 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--------HHHHHHHHHHHHHHH
Confidence            4568999999999999999998763                  24689999864321        123456889999999


Q ss_pred             hcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---------cCCCcHHHHHHHHHH
Q 015594          159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---------RRKLAFKVVIQLALD  229 (404)
Q Consensus       159 ~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~q  229 (404)
                      +++||||+++++++......                ++||||+++++|.+++.+..         ...+++..++.++.|
T Consensus        75 ~l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05051          75 RLSDPNIARLLGVCTVDPPL----------------CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ  138 (296)
T ss_pred             hcCCCCEeEEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHH
Confidence            99999999999998776554                89999999999999996643         126899999999999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      ++.||.|||+.|++|+||||+||+++.++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||
T Consensus       139 i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  218 (296)
T cd05051         139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF  218 (296)
T ss_pred             HHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence            99999999999999999999999999999999999999875332221  1122345778999999988889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCHHHHHHHHHhc------cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          308 GICLWEIYC--CDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       308 G~il~el~~--g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |+++|+|++  +..||...+..+........      ......+..+|.++.++|.+||+.||++|||+.+|++.|+
T Consensus       219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            999999998  67899877766665554332      1112334567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.6e-42  Score=328.43  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=206.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +++.||||++....      .........+.+|..++..++|+||+++++++.+..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE------MLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            4789999999999999999987  67899999985321      111222445778999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||++||+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~  137 (331)
T cd05624          75 YL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM  137 (331)
T ss_pred             EE----------------EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence            55                8999999999999999653 357899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-cccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ++.+||+|||++........ ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||...+..+..
T Consensus       138 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~  217 (331)
T cd05624         138 NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  217 (331)
T ss_pred             CCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH
Confidence            99999999999975433222 1223568999999999876     45789999999999999999999999988877777


Q ss_pred             HHHHhccCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 015594          331 SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVAM  374 (404)
Q Consensus       331 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~  374 (404)
                      ..+.....+..++   ..+++++.++|.+||..++.+  |++++++++.
T Consensus       218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            6666544333333   346899999999999866544  4678888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-42  Score=318.23  Aligned_cols=260  Identities=30%  Similarity=0.530  Sum_probs=211.8

Q ss_pred             eEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          101 LIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      |.+.+.||+|+||.||+|...     +..||||.++.....   ..    ....+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT---YS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC---HH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence            467889999999999999862     367999998643221   11    134578999999999999999999988765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ....          .....++|+||+++++|..++....    ...+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        74 ~~~~----------~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~N  143 (273)
T cd05035          74 SSLQ----------KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN  143 (273)
T ss_pred             Cccc----------cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhe
Confidence            4421          1123489999999999999885432    2468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcc--cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDM--TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      |++++++.+||+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+
T Consensus       144 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~  223 (273)
T cd05035         144 CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE  223 (273)
T ss_pred             EEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999997543322111  11234678999999998889999999999999999999 899999888777


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ....+... .....+..+++++.++|.+||+.||.+||++.+|++.|+++
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 IYDYLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            66555443 34556778899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.9e-42  Score=329.01  Aligned_cols=253  Identities=23%  Similarity=0.374  Sum_probs=207.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +++.||+|++...      ..........+.+|+.++..++|+||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW------EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH------HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            3689999999999999999987  5788999998531      1111222345778999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus        75 ~~----------------~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~  137 (332)
T cd05623          75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM  137 (332)
T ss_pred             EE----------------EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence            65                8999999999999999653 356899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-cccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ++.+||+|||++........ ......||+.|+|||++.     ...++.++|||||||++|||++|..||...+..+..
T Consensus       138 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~  217 (332)
T cd05623         138 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  217 (332)
T ss_pred             CCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999865433222 223357999999999986     345889999999999999999999999998888877


Q ss_pred             HHHHhccCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 015594          331 SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVAM  374 (404)
Q Consensus       331 ~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~~  374 (404)
                      ..+.....+..++   ..+++++.+||.+||..++.+  |++++++++.
T Consensus       218 ~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            7776554333333   457999999999999665444  6889998766

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-42  Score=320.68  Aligned_cols=257  Identities=30%  Similarity=0.538  Sum_probs=213.0

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ++..+|.+.+.||+|+||.||++.+       ++..||+|++.....        ......+.+|+.++.+++||||+++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~iv~~   73 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDHPNIVKL   73 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--------HHHHHHHHHHHHHHHhcCCCchheE
Confidence            4567899999999999999999986       357899999863221        1223557889999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------------cCCCcHHHHHHHHH
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------------RRKLAFKVVIQLAL  228 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~  228 (404)
                      ++++.+....                ++||||+++++|.+++....                    ...+++..++.++.
T Consensus        74 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  137 (288)
T cd05050          74 LGVCAVGKPM----------------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAK  137 (288)
T ss_pred             EEEEcCCCcc----------------EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHH
Confidence            9998876655                89999999999999996432                    13578889999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||++|++||||||+||+++.++.++|+|||++.......  ........+..|+|||.+.+..++.++||||
T Consensus       138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (288)
T cd05050         138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA  217 (288)
T ss_pred             HHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence            99999999999999999999999999999999999999987433221  1122233467799999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          307 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       307 lG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ||+++|+|++ |..||...+..+....+..... ...+..++.++.+||.+||+.+|++||++.+|++.|++
T Consensus       218 lG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         218 YGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            9999999997 8889988887777666554443 33456788999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.5e-42  Score=319.58  Aligned_cols=256  Identities=31%  Similarity=0.558  Sum_probs=209.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      +...+|.+.+.||+|+||.||+|.+.       +..||+|.+.....        ......+.+|+.+++.++|+||+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~   74 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--------EQDESDFLMEALIMSKFNHQNIVRL   74 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            34567999999999999999999873       46789998753211        1123457889999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-----CCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                      ++++.+....                ++||||+++++|.+++.....     ..+++..+..++.||+.||.|||+++++
T Consensus        75 ~~~~~~~~~~----------------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  138 (277)
T cd05036          75 IGVSFERLPR----------------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI  138 (277)
T ss_pred             EEEEccCCCc----------------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            9998776655                899999999999999866432     2589999999999999999999999999


Q ss_pred             ecccCCCCEEEcCCC---cEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-C
Q 015594          244 HRDVKTENMLLDKTR---TVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-C  317 (404)
Q Consensus       244 H~Dikp~Nili~~~~---~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g  317 (404)
                      |+||||+||+++.++   .+||+|||+++........  ......+..|+|||++.+..++.++|||||||++|+|++ |
T Consensus       139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g  218 (277)
T cd05036         139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG  218 (277)
T ss_pred             ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCC
Confidence            999999999997654   5999999999754222111  112233568999999998889999999999999999997 9


Q ss_pred             CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       318 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ..||...+..+....+. .......+..++..+.++|.+||+.+|++||++.+|++.|+
T Consensus       219 ~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         219 YMPYPGRTNQEVMEFVT-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            99999887776655443 34455667888999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-42  Score=314.96  Aligned_cols=247  Identities=38%  Similarity=0.685  Sum_probs=211.5

Q ss_pred             eeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||++...     +..||||++.......        ....+.+|+.+++.++|+||+++++++.....+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~-   71 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL-   71 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--------HHHHHHHHHHHHhhcCCCChheeeeeecCCCce-
Confidence            46899999999999884     7899999986432211        345678999999999999999999998875544 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                                     ++||||+++++|.+++....       ...+++..++.++.||+.||.|||++|++|+||+|+||
T Consensus        72 ---------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni  136 (262)
T cd00192          72 ---------------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC  136 (262)
T ss_pred             ---------------EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence                           89999999999999986542       36799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      +++.++.++|+|||.+.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus       137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  216 (262)
T cd00192         137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV  216 (262)
T ss_pred             EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999998654432  22344567889999999998889999999999999999999 6999999887777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ...+.. ......+..+++++.+++.+||+.+|++||++.++++.|+
T Consensus       217 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         217 LEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            666554 4455667788999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.5e-42  Score=319.98  Aligned_cols=254  Identities=27%  Similarity=0.348  Sum_probs=199.7

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEEec
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGATMG  174 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~  174 (404)
                      +|++.+.||+|+||+||+|.+  +|+.||+|.++........       ...+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-------PLSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-------chHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            488899999999999999987  6899999998754322111       11234566665554   79999999998865


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....           .....++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+||++
T Consensus        74 ~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili  141 (288)
T cd07863          74 SRTD-----------RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV  141 (288)
T ss_pred             ccCC-----------CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            3221           1223489999995 689998876555679999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      +.++.+||+|||+++.... ........+|..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus       142 ~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~  220 (288)
T cd07863         142 TSGGQVKLADFGLARIYSC-QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  220 (288)
T ss_pred             CCCCCEEECccCccccccC-cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence            9999999999999975432 222334568999999999998889999999999999999999999998776655544433


Q ss_pred             hcc------------------CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQN------------------LRP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~------------------~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                  +.+       .....++.++.++|.+||+.||++|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            210                  000       111346788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.9e-42  Score=332.01  Aligned_cols=254  Identities=22%  Similarity=0.294  Sum_probs=201.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  .++.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   88 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ   88 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-------hHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence            47899999999999999999986  6899999998643221       12234567899999999999999999998755


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ....          .....|+||||+ .++|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus        89 ~~~~----------~~~~~~lv~e~~-~~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~  153 (355)
T cd07874          89 KSLE----------EFQDVYLVMELM-DANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  153 (355)
T ss_pred             cccc----------ccceeEEEhhhh-cccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence            4321          122348999999 457777663    2588999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus       154 ~~~~~kl~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (355)
T cd07874         154 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  232 (355)
T ss_pred             CCCCEEEeeCcccccCCC-ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999975332 2233446789999999999999999999999999999999999999987765443332221


Q ss_pred             ccC----------------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNL----------------------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ...                                        ....+...+.++++||.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            100                                        001112245678999999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-42  Score=319.49  Aligned_cols=248  Identities=33%  Similarity=0.614  Sum_probs=203.4

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |++.+.||+|+||+||++.+  +++.||+|++......       ........+|+.++++++||||+++++++......
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-------EEEREENIREIKILRRLRHPNIVQILDVFQDDNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-------HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-------ccccchhhhhhhccccccccccccccccccccccc
Confidence            78899999999999999998  5678999999754321       11122334599999999999999999999886655


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++||||+.+++|.+++..  ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++
T Consensus        74 ----------------~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~  135 (260)
T PF00069_consen   74 ----------------YIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG  135 (260)
T ss_dssp             ----------------EEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS
T ss_pred             ----------------cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc
Confidence                            899999988899999973  36799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE---VTSAVV  334 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~---~~~~~~  334 (404)
                      .++|+|||.+..............++..|+|||++. +..++.++||||||+++|+|++|..||......+   ......
T Consensus       136 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~  215 (260)
T PF00069_consen  136 EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL  215 (260)
T ss_dssp             EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence            999999999975433444555677899999999998 8889999999999999999999999999873322   222222


Q ss_pred             hccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......  ......+..+.++|.+||+.||++||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211111  111223489999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-41  Score=314.84  Aligned_cols=253  Identities=25%  Similarity=0.448  Sum_probs=209.7

Q ss_pred             CeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      +|.+.+.||+|+||+||+|.. +|+.+|||.++......   .........+.+|+.++++++|+||+++++++.+....
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV---LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI   77 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch---hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence            467889999999999999987 78899999987543221   11122345688999999999999999999998776544


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++|+||+++++|.+++.+.  .++++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus        78 ----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~  139 (265)
T cd06631          78 ----------------SIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG  139 (265)
T ss_pred             ----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC
Confidence                            8999999999999999654  4689999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCC------CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          259 TVKIADFGVARLEASN------PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++|+|||++......      ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~  219 (265)
T cd06631         140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY  219 (265)
T ss_pred             eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence            9999999998753221      1112335688999999999998899999999999999999999999987665544333


Q ss_pred             HHhc-cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQ-NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +... ...+..+..++.++.++|++||+.+|.+||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3332 3445677788999999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=333.27  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=197.2

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEEecCCccccc
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~i~  181 (404)
                      ||+|+||+||++.+  +|+.||||++.....      ........+..|..++..+   +||||+++++++.....+   
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~---   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL---   71 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE---
Confidence            69999999999987  689999999863211      1111123344566666655   799999999999877765   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus        72 -------------~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~k  136 (330)
T cd05586          72 -------------YLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA  136 (330)
T ss_pred             -------------EEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence                         8999999999999988653  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP  340 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  340 (404)
                      |+|||++..............||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.......
T Consensus       137 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  216 (330)
T cd05586         137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF  216 (330)
T ss_pred             EecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999997544333344456799999999998754 48999999999999999999999999888777766665444332


Q ss_pred             CCCCCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 015594          341 EIPRCCPSSLANVMKRCWDANPDKRP----EMDEVVA  373 (404)
Q Consensus       341 ~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~~ll~  373 (404)
                       ....+++++.++|.+||+.||.+||    ++.++++
T Consensus       217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             1234789999999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=313.92  Aligned_cols=247  Identities=32%  Similarity=0.584  Sum_probs=205.6

Q ss_pred             eeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||+|.+.     +..||+|.+......        .....+.+|+.+++.++||||+++++++... .. 
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~-   70 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PL-   70 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-ce-
Confidence            46899999999999862     267999998643221        2345678899999999999999999987533 22 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||..|++|+||||+||+++.++.
T Consensus        71 ---------------~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~  133 (257)
T cd05060          71 ---------------MLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ  133 (257)
T ss_pred             ---------------EEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc
Confidence                           7999999999999999665  37899999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCCccc---CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015594          260 VKIADFGVARLEASNPHDMT---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +||+|||+++..........   ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+ .
T Consensus       134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~  212 (257)
T cd05060         134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-E  212 (257)
T ss_pred             EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-H
Confidence            99999999975443322221   1223568999999998899999999999999999998 99999888776655444 3


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      .......+..++..+.++|.+||..+|++||++.+|++.|+++.
T Consensus       213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            44455667788999999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-41  Score=314.43  Aligned_cols=259  Identities=32%  Similarity=0.591  Sum_probs=214.3

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ++...+|.+.+.||+|+||.||+|.+.     ...||||.......        ....+.+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~   73 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------PSVREKFLQEAYIMRQFDHPHIVKLI   73 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCchhcee
Confidence            456678999999999999999999863     24689998753321        12345678999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+.. .                |+||||+++++|.+++.+. ...+++..+..++.||+.||.|||+.|++|+||||
T Consensus        74 ~~~~~~~-~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p  135 (270)
T cd05056          74 GVITENP-V----------------WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAA  135 (270)
T ss_pred             EEEcCCC-c----------------EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCh
Confidence            9876432 2                7999999999999999654 34689999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      +||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       136 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~  215 (270)
T cd05056         136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN  215 (270)
T ss_pred             heEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            999999999999999999875433321 1122334568999999988889999999999999999986 99999888776


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      +....+. .......+..+|..+.++|.+||..+|++|||+.++++.|+++..
T Consensus       216 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         216 DVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            6554443 333445677889999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-41  Score=318.18  Aligned_cols=257  Identities=30%  Similarity=0.539  Sum_probs=204.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ..+|.+.+.||+|+||+||++.+      +++.||||.+....         ......+.+|+.++++++||||++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~   73 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---------AEHLRDFEREIEILKSLQHDNIVKYKGV   73 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            35788999999999999999874      47899999985322         1223557899999999999999999998


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +......              ..++|+||+++++|.+++.+. ...+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        74 ~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n  138 (284)
T cd05081          74 CYSAGRR--------------NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN  138 (284)
T ss_pred             EccCCCC--------------ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence            7543322              238999999999999998654 3468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      |+++.++.+||+|||++..........   ....++..|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus       139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~  218 (284)
T cd05081         139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF  218 (284)
T ss_pred             EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence            999999999999999998543322111   11223456999999998889999999999999999999877654322110


Q ss_pred             ---------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 ---------------VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                                     ..............+..++.++.+||.+||+.+|++|||+.+|++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         219 MRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                           01122333334455677899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.5e-42  Score=318.16  Aligned_cols=256  Identities=29%  Similarity=0.530  Sum_probs=214.3

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..++|.+...||+|+||.||+|..       ..+.||+|.+.....        ......+.+|+.++++++||||++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~   74 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--------ENLQSEFRRELDMFRKLSHKNVVRLL   74 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--------hHHHHHHHHHHHHHHhcCCcceeeeE
Confidence            457899999999999999999985       246799998853221        12345688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-------CCCcHHHHHHHHHHHHHHHHHHhhCCc
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-------RKLAFKVVIQLALDLARGLSYLQSKKI  242 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~gi  242 (404)
                      +++.+....                |+||||+++++|.+++.....       ..+++..+..++.||+.||.|||+.||
T Consensus        75 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i  138 (275)
T cd05046          75 GLCREAEPH----------------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF  138 (275)
T ss_pred             EEECCCCcc----------------eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCc
Confidence            988765544                899999999999999966542       268999999999999999999999999


Q ss_pred             eecccCCCCEEEcCCCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      +|+||||+||+++.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       139 ~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             ccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998643222 222333456788999999988889999999999999999998 8899


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |.....................+..++..+.++|.+||+.+|++||++.+++..|.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         219 FYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            98877777666665555555566778999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.4e-42  Score=319.47  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=208.3

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      ....|++.+.||.|+||.||+|.+  +++.||+|++....      .    ....+..|+.++.++ +||||+++++++.
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------D----EEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------H----HHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            346788899999999999999997  67899999985321      1    123467889999988 7999999999986


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....          .....+|++|||+.+|+|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+
T Consensus        84 ~~~~~----------~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil  153 (282)
T cd06636          84 KKSPP----------GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL  153 (282)
T ss_pred             ccccc----------CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            43211          12234599999999999999997766667899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      ++.++.++|+|||++..............|++.|+|||.+.     +..++.++||||||+++|+|++|..||.......
T Consensus       154 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         154 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             ECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            99999999999999875443333334466899999999985     3458889999999999999999999998776554


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+............++.++.+||.+||+.||.+||++.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            444333333333334568899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.3e-42  Score=353.42  Aligned_cols=263  Identities=23%  Similarity=0.312  Sum_probs=210.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||++.....      .......++.+|+.++.+++||||+++++++.+..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS------ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            5799999999999999999987  589999999864221      11234567889999999999999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---------cCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      ..                |+||||++|++|.+++....         ...++...+..++.||+.||.|||++||+||||
T Consensus        76 ~l----------------yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDL  139 (932)
T PRK13184         76 PV----------------YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDL  139 (932)
T ss_pred             EE----------------EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence            55                89999999999999985421         134566788999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCC------------------CcccCCCCCccccCccccCCCCCCcchhhHHHHH
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNP------------------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI  309 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  309 (404)
                      ||+||+++.++.++|+|||++.......                  .......||+.|||||.+.+..++.++|||||||
T Consensus       140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV  219 (932)
T PRK13184        140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV  219 (932)
T ss_pred             chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence            9999999999999999999997541110                  0111246899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHhHhhcC
Q 015594          310 CLWEIYCCDMPYPDLSFSEVTSAVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKR-PEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       310 il~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~R-pt~~~ll~~L~~~~~~~~  383 (404)
                      ++|||++|..||................ ........+|+.+.+++.+||+.||++| ++++++++.|+.+.....
T Consensus       220 ILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p  295 (932)
T PRK13184        220 ILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP  295 (932)
T ss_pred             HHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence            9999999999998755443322211110 0111124678999999999999999999 578889999998876544

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-41  Score=313.40  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=209.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +.+|.+.+.||+|+||.||++.+  +|+.||||.+..........    .....+.+|+.++++++||||+++++++.+.
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   76 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS----KEVNALECEIQLLKNLLHERIVQYYGCLRDP   76 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH----HHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence            35789999999999999999987  68999999986543222211    2235678899999999999999999988654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...              ..++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        77 ~~~--------------~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~  140 (265)
T cd06652          77 MER--------------TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD  140 (265)
T ss_pred             CCc--------------eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence            322              237999999999999998654  4688999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCC---CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASN---PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||++......   ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus       141 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  220 (265)
T cd06652         141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK  220 (265)
T ss_pred             CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence            9999999999998743321   1122334688999999999888899999999999999999999999987765555555


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......+..+...+..+.++|.+|| .+|.+||++++|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence            55444556667778889999999999 49999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.3e-42  Score=331.91  Aligned_cols=253  Identities=23%  Similarity=0.285  Sum_probs=202.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  .++.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-------chhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            47899999999999999999987  6889999998643211       11234567899999999999999999988654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...          .....+|+||||+ +++|.+++..    .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        96 ~~~----------~~~~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  160 (364)
T cd07875          96 KSL----------EEFQDVYIVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  160 (364)
T ss_pred             ccc----------cccCeEEEEEeCC-CCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence            432          1123358999999 5678777632    488999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus       161 ~~~~~kL~DfG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  239 (364)
T cd07875         161 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  239 (364)
T ss_pred             CCCcEEEEeCCCccccCC-CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999975432 2233456789999999999999999999999999999999999999988776555444432


Q ss_pred             ccCC--------------------C--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR--------------------P--------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~--------------------~--------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..-.                    +                    ......++++++||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1000                    0                    011123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-41  Score=320.30  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=207.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +++.||+|.+......         ....+.+|+.+++.++||||+++++.+...
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~   89 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG   89 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence            36899999999999999999986  6889999998653321         124477899999999999999999998876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++..   ..+++.++..++.|++.||.|||+.||+|+||||+||+++
T Consensus        90 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~  150 (296)
T cd06654          90 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (296)
T ss_pred             CEE----------------EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence            554                899999999999998854   3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||..............
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~  230 (296)
T cd06654         151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT  230 (296)
T ss_pred             CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc
Confidence            99999999999987544333333445789999999999988899999999999999999999999987765444333332


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ....+..++..+.++|.+||..+|++||++.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            221 12335567889999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.5e-42  Score=334.32  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=201.1

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||+||++.+  +|+.||||.+......       ......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-------LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-------hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            467889999999999999986  7899999998532111       1123457799999999999999999999876542


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .           ....+|+|+||+ +++|.+++..  ...+++..+..++.||+.||.|||+.|++||||||+|||++.+
T Consensus        74 ~-----------~~~~~~lv~e~~-~~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~  139 (372)
T cd07853          74 D-----------PFEEIYVVTELM-QSDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN  139 (372)
T ss_pred             c-----------ccceEEEEeecc-ccCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence            1           012348999999 5788887744  3579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCC-CCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          258 RTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +.+||+|||+++..... ........+++.|+|||.+.+. .++.++|||||||++|||++|..||...+..+....+..
T Consensus       140 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  219 (372)
T cd07853         140 CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD  219 (372)
T ss_pred             CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            99999999999754322 2233445689999999999875 479999999999999999999999987765544333221


Q ss_pred             -----------------------ccCCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 -----------------------QNLRP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 -----------------------~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                             ....+       ......++++.+||.+||+.||.+|||+.++++
T Consensus       220 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                                   01111       123446789999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-41  Score=313.72  Aligned_cols=247  Identities=32%  Similarity=0.591  Sum_probs=208.7

Q ss_pred             eeeeeecceEEEEEEEC---C--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIYD---G--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~---g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|++|.||++.+.   +  ..||||.+......        .....+.+|+.++++++||||+++++.+.+ ... 
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~-   70 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPL-   70 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeE-
Confidence            36899999999999862   2  36999998643221        345678899999999999999999999876 333 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus        71 ---------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~  135 (257)
T cd05040          71 ---------------MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK  135 (257)
T ss_pred             ---------------EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE
Confidence                           89999999999999997654357899999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015594          260 VKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +||+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus       136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999765432211   112346788999999998889999999999999999998 9999998888877766665


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      .......+..+|..+.+++.+||+.+|++||++.+|++.|.
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            55555566778999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-41  Score=311.36  Aligned_cols=251  Identities=31%  Similarity=0.631  Sum_probs=210.8

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ++.+|++.+.||+|+||.||++.+ ++..+|+|.+......          ...+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----------EEDFIEEAQVMMKLSHPKLVQLYGVCTER   71 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence            567899999999999999999987 4789999988643221          13477899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++... ...++++.++.++.|++.+|.|||+.|++|+||||+||+++
T Consensus        72 ~~~----------------~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~  134 (256)
T cd05112          72 SPI----------------CLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG  134 (256)
T ss_pred             Cce----------------EEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence            554                8999999999999988654 34689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~  333 (404)
                      .++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+
T Consensus       135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05112         135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI  214 (256)
T ss_pred             CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            999999999999875433211 1223345678999999998889999999999999999998 99999887766665554


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      . .......+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       215 ~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         215 N-AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             h-CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            3 3334455667899999999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.9e-41  Score=309.98  Aligned_cols=246  Identities=34%  Similarity=0.632  Sum_probs=205.2

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccC
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD  183 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~  183 (404)
                      ++||+|+||.||+|.. +++.||+|++.....        ......+.+|+.++++++||||+++++.+......     
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-----   67 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI-----   67 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc-----
Confidence            3689999999999986 678899999853321        12234578999999999999999999998776654     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEe
Q 015594          184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA  263 (404)
Q Consensus       184 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~  263 (404)
                                 ++||||+++++|.+++... ...+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+
T Consensus        68 -----------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~  135 (250)
T cd05085          68 -----------YIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKIS  135 (250)
T ss_pred             -----------EEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEEC
Confidence                       8999999999999988654 3468999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCccc-CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 015594          264 DFGVARLEASNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPE  341 (404)
Q Consensus       264 Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  341 (404)
                      |||++........... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+..
T Consensus       136 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~  214 (250)
T cd05085         136 DFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMS  214 (250)
T ss_pred             CCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence            9999874332221111 1234567999999998889999999999999999998 999999887766655443 444556


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      .+..++..+.+|+.+||+.+|++||++.++++.|.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            67778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.7e-42  Score=317.94  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=204.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +++.||+|+++.....         ....+.+|+.+++.++||||+++++.+...
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---------DFAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---------HHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            35788899999999999999987  6899999998643211         123467899999999999999999998776


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus        79 ~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~  140 (267)
T cd06645          79 DKL----------------WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT  140 (267)
T ss_pred             CEE----------------EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            655                8999999999999988554  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||++..............|+..|+|||.+.   ...++.++|||||||++|+|++|..||...........
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~  220 (267)
T cd06645         141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL  220 (267)
T ss_pred             CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence            999999999999875544433444567899999999974   45588999999999999999999999976654433333


Q ss_pred             HHhccCCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEI---PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......+..   ...++..+.++|.+||+.+|++||++++|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         221 MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             hhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            3333322221   1246789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=319.70  Aligned_cols=257  Identities=29%  Similarity=0.534  Sum_probs=206.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECC----------------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDG----------------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK  159 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g----------------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  159 (404)
                      +...+|++.+.||+|+||.||++.+.+                ..||||.+.....        ...+..|.+|+.++.+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~ei~~l~~   73 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--------KTARNDFLKEIKIMSR   73 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--------HHHHHHHHHHHHHHHh
Confidence            345689999999999999999987522                3589999853211        1224568899999999


Q ss_pred             cCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------cCCCcHHHHHHHHHH
Q 015594          160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------RRKLAFKVVIQLALD  229 (404)
Q Consensus       160 l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~q  229 (404)
                      ++||||+++++++......                ++||||+.+++|.+++....          ...+++..+..++.|
T Consensus        74 l~h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  137 (295)
T cd05097          74 LKNPNIIRLLGVCVSDDPL----------------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ  137 (295)
T ss_pred             CCCCCcCeEEEEEcCCCcc----------------EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence            9999999999999776655                89999999999999985431          124688899999999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC-c-ccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH-D-MTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      ++.||.|||+.|++|+||||+||+++.++.+||+|||++........ . .....++..|+|||.+.+..++.++|||||
T Consensus       138 i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  217 (295)
T cd05097         138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF  217 (295)
T ss_pred             HHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence            99999999999999999999999999999999999999975432211 1 122345678999999998889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          308 GICLWEIYC--CDMPYPDLSFSEVTSAVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       308 G~il~el~~--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |+++|+|++  +..||...+..+.......      .......+..+|+.+.+||.+||+.||++||++++|++.|+
T Consensus       218 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            999999988  6678887776655443321      11122345567899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-41  Score=313.79  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=209.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|...+.||+|+||.||++.+  +++.||+|++.........    ......+.+|+.+++.++||||+++++.+.+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET----SKEVSALECEIQLLKNLQHERIVQYYGCLRDRA   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh----HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence            4688899999999999999986  6899999998765432211    122355789999999999999999999886543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..              .+++++||+++++|.+++...  ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.
T Consensus        78 ~~--------------~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~  141 (266)
T cd06651          78 EK--------------TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS  141 (266)
T ss_pred             CC--------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence            22              238999999999999998654  46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC---CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++|+|||++.......   .......++..|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus       142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~  221 (266)
T cd06651         142 AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI  221 (266)
T ss_pred             CCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence            9999999999987433211   1122345788999999999988999999999999999999999999887666655555


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......+.++..+++.+++++ +||..+|++||++++|++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            555556677778889999999 677789999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=327.85  Aligned_cols=261  Identities=30%  Similarity=0.556  Sum_probs=221.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECC-ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      -++..+.+.++++||+|.||.|.++...| ..||||.++....        ...+..|.+|+.+|.+|+||||+.++|+|
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--------~~~r~~F~kEIkiLsqLkhPNIveLvGVC  604 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--------KNARNDFLKEIKILSRLKHPNIVELLGVC  604 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--------hhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence            36778899999999999999999999866 9999999964332        33478899999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ..++.+                |+|+||+++|+|.+|+.++.-..+..+...+|+.||+.|++||.+.++|||||.+.||
T Consensus       605 ~~DePi----------------cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc  668 (807)
T KOG1094|consen  605 VQDDPL----------------CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC  668 (807)
T ss_pred             ecCCch----------------HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence            998888                8999999999999999887444456667788999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCC-Cccc-CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNP-HDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY--CCDMPYPDLSFSE  328 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~-~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~--~g~~Pf~~~~~~~  328 (404)
                      |+++++++||+|||+++..-..+ .... ..+-...|||||.+..+.++.++|||+||+++||++  |...||...+.++
T Consensus       669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~  748 (807)
T KOG1094|consen  669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ  748 (807)
T ss_pred             eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence            99999999999999998543332 2222 234578999999998888999999999999999975  4678999988777


Q ss_pred             HHHHHHhc------cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 VTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ........      ..-+..|..||..+.++|.+||..+-.+||++++|...|+..
T Consensus       749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            66543321      112356788999999999999999999999999999988764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.4e-41  Score=317.97  Aligned_cols=248  Identities=25%  Similarity=0.439  Sum_probs=209.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|++.+.||.|+||.||++.+  +|+.||||.+......         ....+.+|+.+++.++||||+++++.+...
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---------KKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---------hHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            35799999999999999999986  7899999998643221         124467899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|+||+++++|..++..   ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus        89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~  149 (296)
T cd06655          89 DEL----------------FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG  149 (296)
T ss_pred             ceE----------------EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence            655                899999999999998854   3689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~  229 (296)
T cd06655         150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  229 (296)
T ss_pred             CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999987544333333445688999999999988899999999999999999999999988776554444433


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ....+..+++.+.++|.+||..||++||++.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            222 22345678899999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.2e-41  Score=311.87  Aligned_cols=250  Identities=25%  Similarity=0.475  Sum_probs=212.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||+|+||.||++..  +|+.||+|.+......       ......+.+|+.++++++||||+++++.+.+...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-------PKEREESRKEVAVLSNMKHPNIVQYQESFEENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence            588999999999999999887  6899999998643221       1123457899999999999999999999876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus        74 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~  137 (256)
T cd08218          74 L----------------YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD  137 (256)
T ss_pred             E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence            4                899999999999999876555578999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+....
T Consensus       138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (256)
T cd08218         138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS  217 (256)
T ss_pred             CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence            99999999999755443333334467889999999998889999999999999999999999998877776666655443


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       .+..+..++.++.++|.+||+.+|++||++.+|++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             34556778999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-41  Score=316.77  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=201.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||+|.+  +++.||||.+.......       .....+.+|+.++++++||||+++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-------GVPSTAIREISLLKELQHPNIVCLQDVLMQESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-------CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence            478899999999999999987  68999999986543221       112446789999999999999999999987665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .                |+||||++ ++|.+++.... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        74 ~----------------~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~  136 (285)
T cd07861          74 L----------------YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN  136 (285)
T ss_pred             E----------------EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence            5                89999995 78988886543 267899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.++|+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+.......
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~  216 (285)
T cd07861         137 KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR  216 (285)
T ss_pred             CCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            9999999999997554443334455678999999988654 478999999999999999999999986654332222111


Q ss_pred             cc---------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN---------------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~---------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                           ........+++++.++|.+||+.||++|||+.+|++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         217 ILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00                           000112347889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-41  Score=320.06  Aligned_cols=257  Identities=30%  Similarity=0.544  Sum_probs=206.5

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEEC------------------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHh
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYD------------------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH  158 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~------------------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  158 (404)
                      ...+|++.+.||+|+||.||++.+.                  +..||+|++.....        ......+.+|+.+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~E~~~l~   74 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--------KNARNDFLKEIKIMS   74 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHH
Confidence            4567999999999999999987532                  34689999853211        122456889999999


Q ss_pred             hcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc---------CCCcHHHHHHHHHH
Q 015594          159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---------RKLAFKVVIQLALD  229 (404)
Q Consensus       159 ~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~q  229 (404)
                      .++||||+++++++......                ++||||+++++|.+++.....         ..+++..+..++.|
T Consensus        75 ~l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          75 RLKDPNIIRLLAVCITSDPL----------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             hCCCCCcceEEEEEecCCcc----------------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence            99999999999998776655                899999999999999865421         24778899999999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC-cc-cCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH-DM-TGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      |+.||+|||+.|++|+||||+|||++.++.++|+|||++........ .. ....+++.|+|||...+..++.++|||||
T Consensus       139 i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl  218 (296)
T cd05095         139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF  218 (296)
T ss_pred             HHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence            99999999999999999999999999999999999999875332211 11 12234678999999888889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCHHHHHHHHHh------ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          308 GICLWEIYC--CDMPYPDLSFSEVTSAVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       308 G~il~el~~--g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      |+++|||++  |..||...+..+.......      .......+..+++.+.+||.+||+.||.+||++.+|++.|++
T Consensus       219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         219 GVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            999999998  7789987776555433221      111223456788999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=312.41  Aligned_cols=250  Identities=27%  Similarity=0.460  Sum_probs=209.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||.|+||.||++.+  +++.+|+|++......         ....+.+|+.++++++||||+++++++.+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   72 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECRHPNIVAYFGSYLRR   72 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------hHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence            46799999999999999999987  5789999999643211         245678999999999999999999998776


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        73 ~~~----------------~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~  135 (262)
T cd06613          73 DKL----------------WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT  135 (262)
T ss_pred             CEE----------------EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence            655                8999999999999988654 35799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||++..............++..|+|||.+.+.   .++.++||||||+++|+|++|..||...+.......
T Consensus       136 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~  215 (262)
T cd06613         136 EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL  215 (262)
T ss_pred             CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999997654433334456788899999999877   789999999999999999999999988776665544


Q ss_pred             HHhccCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....+.+.   .+...+.++.++|.+||..+|.+|||+.+|+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            444433221   23345788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-41  Score=316.67  Aligned_cols=248  Identities=28%  Similarity=0.451  Sum_probs=205.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|++.+.||+|+||.||++.+  ++..+|+|.+....     .    .....+.+|+.+++.++||||+++++.+.....
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   76 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----E----EELEDYMVEIDILASCDHPNIVKLLDAFYYENN   76 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----H----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence            367788999999999999998  57889999985332     1    123457789999999999999999999877654


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+++++|..++.+. ..++++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        77 ~----------------~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~  139 (282)
T cd06643          77 L----------------WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD  139 (282)
T ss_pred             E----------------EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC
Confidence            4                8999999999998887543 3579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      +.+||+|||++..............+++.|+|||++.     +..++.++|||||||++|+|++|..||...+..+....
T Consensus       140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  219 (282)
T cd06643         140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK  219 (282)
T ss_pred             CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence            9999999999875443333344456899999999983     44578899999999999999999999988776665555


Q ss_pred             HHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...... ....+..++.++.+||.+||+.||.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         220 IAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            443322 22345668899999999999999999999998874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2e-41  Score=318.74  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=207.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|++.+.||+|+||.||++.+  +++.||+|++....         ......+.+|+.+++.++||||+++++.+...
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---------EEELEDYMVEIEILATCNHPYIVKLLGAFYWD   81 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence            46799999999999999999987  57999999986321         12245577899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|..++.+. ...+++..+..++.|++.+|.|||+.|++|+||||+||+++
T Consensus        82 ~~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~  144 (292)
T cd06644          82 GKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT  144 (292)
T ss_pred             CeE----------------EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc
Confidence            554                8999999999998887543 35789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      .++.++|+|||++..............+++.|+|||.+.     ...++.++||||||+++|+|++|..||...+.....
T Consensus       145 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  224 (292)
T cd06644         145 LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  224 (292)
T ss_pred             CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence            999999999999875444333444566889999999984     345788999999999999999999999887765554


Q ss_pred             HHHHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........ ....+..++.++.++|.+||..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         225 LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            44433222 12335567889999999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-42  Score=315.32  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=206.1

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|.-.+++|+|+||+||+|..  +++.||||.+-....             --.+|+.+|+.++|||||+++.+|.....
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------------~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------------YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            477788999999999999987  678999998732211             12379999999999999999999875543


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      -           +.-+..+||||+ ..+|.+++...  .+..++.-.+.-+..||++||.|||+.||+||||||.|+|+|
T Consensus        92 ~-----------d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD  159 (364)
T KOG0658|consen   92 S-----------DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD  159 (364)
T ss_pred             C-----------chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc
Confidence            2           123447899999 88999988532  346788889999999999999999999999999999999998


Q ss_pred             CC-CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          256 KT-RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      .+ |.+||||||.|+........ .....|..|.|||.+.|. .|+.+.||||.||++.||+-|+.-|++.+..+.+..+
T Consensus       160 ~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI  238 (364)
T KOG0658|consen  160 PDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI  238 (364)
T ss_pred             CCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence            66 99999999999876554333 556779999999999776 5999999999999999999999999998776665554


Q ss_pred             Hhc--------------c--------CC-----CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHhh
Q 015594          334 VRQ--------------N--------LR-----PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAIDTS  381 (404)
Q Consensus       334 ~~~--------------~--------~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~~  381 (404)
                      ..-              +        +.     ..+....++++.+|+.++|+.+|.+|.++.+++.  .++.+...
T Consensus       239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            321              0        00     0134557899999999999999999999999883  45555443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4e-41  Score=316.44  Aligned_cols=245  Identities=25%  Similarity=0.382  Sum_probs=209.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++.+  +++.||+|++.....      ........+.+|+.++++++||||+++++.+.+..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            3689999999999999999987  679999999863211      11223456789999999999999999999987766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+|+.
T Consensus        75 ~~----------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~  136 (290)
T cd05580          75 NL----------------YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS  136 (290)
T ss_pred             eE----------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence            55                8999999999999998654  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||++......   .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus       137 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  213 (290)
T cd05580         137 DGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG  213 (290)
T ss_pred             CCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            999999999999754433   33456889999999998888999999999999999999999999887766555555432


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVV  372 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll  372 (404)
                        ...++..+++.+.++|.+||+.||.+|+     ++++++
T Consensus       214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence              3456777899999999999999999998     777776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=317.26  Aligned_cols=249  Identities=29%  Similarity=0.477  Sum_probs=209.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||.|+||.||++.+  ++..||+|+++...         ......+.+|+.++++++||||+++++.+....
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---------EEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---------HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            5688999999999999999987  58899999986432         112345788999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.
T Consensus        76 ~~----------------~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~  138 (280)
T cd06611          76 KL----------------WILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL  138 (280)
T ss_pred             eE----------------EEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence            55                8999999999999988653 357999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ++.++|+|||++..............+++.|+|||.+.     +.+++.++||||||+++|+|++|..||...+......
T Consensus       139 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~  218 (280)
T cd06611         139 DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL  218 (280)
T ss_pred             CCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH
Confidence            99999999999875444443444566899999999974     3457889999999999999999999998887666555


Q ss_pred             HHHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+..... ....+..++.++.++|.+||+.+|.+||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            5443322 12345678899999999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-41  Score=310.55  Aligned_cols=253  Identities=27%  Similarity=0.505  Sum_probs=212.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|+||.||++.+  +++.||+|++......       ......+.+|+.++++++||||+++++.+.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            478889999999999999987  6789999998654322       1123557789999999999999999998764432


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHh-----hCCceecccCCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQ-----SKKIVHRDVKTE  250 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-----~~givH~Dikp~  250 (404)
                      .              .+|++|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.+++|+||+|+
T Consensus        74 ~--------------~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~  139 (265)
T cd08217          74 Q--------------TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA  139 (265)
T ss_pred             C--------------EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence            2              238999999999999998653  2467899999999999999999999     889999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||+++.++.+||+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       140 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  219 (265)
T cd08217         140 NIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA  219 (265)
T ss_pred             HEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH
Confidence            99999999999999999986554443344567899999999999988999999999999999999999999988765554


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..+. ....+.++...+..+.+++.+||+.+|++||++.+|++.
T Consensus       220 ~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         220 SKIK-EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            4443 344456677889999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-41  Score=313.07  Aligned_cols=258  Identities=26%  Similarity=0.551  Sum_probs=214.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|.+.+.||+|+||+||+|.+  +|+    .||+|.+.....        ......+.+|+.++.+++||||++++
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~   75 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLL   75 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4457899999999999999999986  333    589998754321        22345678999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.. ...                ++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++|+||||
T Consensus        76 ~~~~~-~~~----------------~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p  137 (279)
T cd05057          76 GICLS-SQV----------------QLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA  137 (279)
T ss_pred             EEEec-Cce----------------EEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence            99875 222                8999999999999998654 34689999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcc--cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDM--TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +||+++.++.+||+|||+++.........  .+..++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus       138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  217 (279)
T cd05057         138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA  217 (279)
T ss_pred             ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence            99999999999999999997544322211  12224568999999988889999999999999999998 9999998887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      .+....+. .......+..++.++.+++.+||..+|.+||++.++++.|+.+..
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         218 VEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            77655544 344455667788999999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-41  Score=324.57  Aligned_cols=248  Identities=20%  Similarity=0.356  Sum_probs=196.4

Q ss_pred             Eeeeeeee--cceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          103 IKGAFARG--TFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       103 ~~~~lg~G--~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      +.++||+|  +||+||++..  +|+.||||.++.....       ......+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-------NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL   74 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence            45789999  6889999987  7899999998643221       12234567899999999999999999999877665


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      |+||||+++++|.+++..+....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        75 ----------------~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~  138 (327)
T cd08227          75 ----------------WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG  138 (327)
T ss_pred             ----------------EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC
Confidence                            8999999999999999765556799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCC-------cccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          259 TVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      .++++||+.+........       ......++..|+|||++.+  ..++.++|||||||++|+|++|..||...+....
T Consensus       139 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  218 (327)
T cd08227         139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  218 (327)
T ss_pred             cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence            999999986543221111       0112346778999999976  4589999999999999999999999987654443


Q ss_pred             HHHHHhccCC--------------------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCC
Q 015594          330 TSAVVRQNLR--------------------------------------------PEIPRCCPSSLANVMKRCWDANPDKR  365 (404)
Q Consensus       330 ~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~R  365 (404)
                      ..........                                            ......+++++.+||.+||+.||++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  298 (327)
T cd08227         219 LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDAR  298 (327)
T ss_pred             HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhc
Confidence            3222211100                                            01122356789999999999999999


Q ss_pred             CCHHHHHH
Q 015594          366 PEMDEVVA  373 (404)
Q Consensus       366 pt~~~ll~  373 (404)
                      ||+++|++
T Consensus       299 pt~~ell~  306 (327)
T cd08227         299 PSASTLLN  306 (327)
T ss_pred             CCHHHHhc
Confidence            99999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.3e-41  Score=318.67  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||.|+||.||++.+  +++.||+|.+........        ...+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--------hhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            46899999999999999999987  578999999865432211        22356899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||++ ++|.+++.+. ...+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus        77 ~~~----------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~  138 (301)
T cd07873          77 KSL----------------TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN  138 (301)
T ss_pred             CeE----------------EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence            654                89999995 6999988654 45689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.++|+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+.
T Consensus       139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~  218 (301)
T cd07873         139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF  218 (301)
T ss_pred             CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999997544433344455678999999998654 57889999999999999999999998877655443322


Q ss_pred             hccC-----------------C---C--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNL-----------------R---P--------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~-----------------~---~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                 .   +        .....+++.+.+||.+||+.||.+|||++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            2100                 0   0        011346889999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=320.56  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=211.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||+||++..  +++.||||.+.......      ......+.+|+.+++.++||||+++++.+.+..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch------HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            3688999999999999999987  57999999997543221      123456789999999999999999999987665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+.+++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+|+.
T Consensus        75 ~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~  138 (316)
T cd05574          75 YL----------------CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE  138 (316)
T ss_pred             EE----------------EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence            54                89999999999999987665678999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-----------------------------cccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-----------------------------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      ++.++|+|||++........                             ......|+..|+|||.+.+..++.++|||||
T Consensus       139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl  218 (316)
T cd05574         139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL  218 (316)
T ss_pred             CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence            99999999999864322110                             1112357889999999999989999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 015594          308 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE----MDEVVA  373 (404)
Q Consensus       308 G~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~~ll~  373 (404)
                      |+++|+|++|..||...+.......+.............++.+.++|.+||..||++||+    +++++.
T Consensus       219 G~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            999999999999998888776666655544433333347899999999999999999999    777766

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-41  Score=311.35  Aligned_cols=251  Identities=33%  Similarity=0.584  Sum_probs=202.3

Q ss_pred             eeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||+|.+     .+..||+|.+.....        ......+.+|+.+++.++||||+++++++...... 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-   71 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS-   71 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--------HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCC-
Confidence            3689999999999985     235799998742211        11234577899999999999999999977543322 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                    .++||||+.+++|.+++.+. ...+++..+..++.||+.||.|||+.+++|+||||+|||++.++.
T Consensus        72 --------------~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~  136 (262)
T cd05058          72 --------------PLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT  136 (262)
T ss_pred             --------------cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc
Confidence                          27999999999999998654 345678888999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCC----CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015594          260 VKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~  334 (404)
                      +||+|||+++......    .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.
T Consensus       137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~  216 (262)
T cd05058         137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL  216 (262)
T ss_pred             EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            9999999997433211    11223345778999999988889999999999999999999 567788777666555543


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      . ...+..+..+++.+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       217 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         217 Q-GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             c-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            3 33444566789999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-41  Score=350.73  Aligned_cols=263  Identities=19%  Similarity=0.329  Sum_probs=207.7

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ..+....+|.+.+.||+|+||+||++.+  +++.||+|++.......       .....|..|+.++.+|+|||||++++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-------~~~~~~~~EI~IL~~L~HPNIVrl~d   79 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-------REKSQLVIEVNVMRELKHKNIVRYID   79 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-------HHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence            4455668999999999999999999997  67899999987543221       12456788999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhC-------C
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSK-------K  241 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-------g  241 (404)
                      +|.+...-              .+||||||+++++|.++|...  ....+++..++.|+.||+.||.|||+.       +
T Consensus        80 ~f~de~~~--------------~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~  145 (1021)
T PTZ00266         80 RFLNKANQ--------------KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER  145 (1021)
T ss_pred             EEEecCCC--------------EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence            98654332              238999999999999998653  235799999999999999999999985       4


Q ss_pred             ceecccCCCCEEEcC-----------------CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC--CCCCcch
Q 015594          242 IVHRDVKTENMLLDK-----------------TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--SAYNRKC  302 (404)
Q Consensus       242 ivH~Dikp~Nili~~-----------------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  302 (404)
                      |+||||||+||||+.                 .+.+||+|||++...... .......||+.|+|||++.+  ..++.++
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KS  224 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKS  224 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchh
Confidence            999999999999954                 345899999999754322 22234578999999999854  4588999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH--HHHHHh
Q 015594          303 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV--AMLEAI  378 (404)
Q Consensus       303 DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll--~~L~~~  378 (404)
                      |||||||+||+|++|..||............+..... ......+.++.+||..||+.+|.+||++.+++  ..+..+
T Consensus       225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        225 DMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            9999999999999999999766544333333332211 12245689999999999999999999999998  445444

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.1e-41  Score=308.86  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=211.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|+..+.||+|+||.||+|..  +++.||+|.+.........    ......+.+|+.+++.++|+||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG----QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc----hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence            467778999999999999987  6899999998765432221    1224557899999999999999999999876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+++++|.+++.+.  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus        77 ~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~  138 (258)
T cd06632          77 L----------------YIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN  138 (258)
T ss_pred             E----------------EEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence            4                8999999999999998654  468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.+||+|||++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||...............
T Consensus       139 ~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  217 (258)
T cd06632         139 GVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS  217 (258)
T ss_pred             CCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc
Confidence            999999999987543322 234456889999999987776 899999999999999999999999877655555454443


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+.++..+++++.++|.+||+.+|.+||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            4455677788999999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.7e-41  Score=313.65  Aligned_cols=243  Identities=28%  Similarity=0.486  Sum_probs=198.7

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||+|+||.||++.+  +++.||+|++.....        ......+.+|+.++.+++||||+++++.+.....
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   73 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--------VELQKQIMSELEILYKCDSPYIIGFYGAFFVENR   73 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE
Confidence            578889999999999999987  789999999864321        1123457899999999999999999999987765


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+++++|..+      ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+
T Consensus        74 ~----------------~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~  131 (279)
T cd06619          74 I----------------SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR  131 (279)
T ss_pred             E----------------EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC
Confidence            5                899999999999654      257888999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-------EVT  330 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-------~~~  330 (404)
                      +.++|+|||++......  ......++..|+|||.+.+..++.++||||||+++|+|++|..||......       ...
T Consensus       132 ~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  209 (279)
T cd06619         132 GQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL  209 (279)
T ss_pred             CCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH
Confidence            99999999999754322  234467899999999999989999999999999999999999999653221       111


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..+.............++++.++|.+||+.+|++||+++++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            12121111112234467899999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=314.76  Aligned_cols=247  Identities=29%  Similarity=0.483  Sum_probs=209.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||.|+||.||++.+  +++.||+|++.....        ......+.+|+.+++.++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence            3678889999999999999987  689999999864321        111244678999999999999999999988765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+|+||+++++|.+++...   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus        73 ~~----------------~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~  133 (274)
T cd06609          73 KL----------------WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE  133 (274)
T ss_pred             eE----------------EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence            54                8999999999999998543   7899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.++|+|||+++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+. .
T Consensus       134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~  212 (274)
T cd06609         134 EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-K  212 (274)
T ss_pred             CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-h
Confidence            999999999999865544344455678899999999999889999999999999999999999998776555443333 3


Q ss_pred             cCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+..+.. ++.++.+++.+||..+|++||+++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            334444444 8899999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.1e-41  Score=310.78  Aligned_cols=247  Identities=28%  Similarity=0.466  Sum_probs=194.8

Q ss_pred             eeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          105 GAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      +.||+|+||.||+|..    ++..+|+|.++.....        .....+.+|+.++++++||||+++++++.+....  
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--   70 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY--   70 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc--
Confidence            3689999999999975    2357999987533211        1123578899999999999999999998766554  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                                    ++||||+++|+|.+++....   ....++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        71 --------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~  136 (269)
T cd05087          71 --------------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD  136 (269)
T ss_pred             --------------EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC
Confidence                          89999999999999996532   2345677888999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCC--cccCCCCCccccCccccCCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          258 RTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGS-------AYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      +.+||+|||++........  ......++..|+|||++.+.       .++.++||||||+++|||++ |..||......
T Consensus       137 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  216 (269)
T cd05087         137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE  216 (269)
T ss_pred             CcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence            9999999999974332221  12234577889999998643       35789999999999999996 99999887766


Q ss_pred             HHHHHHHhcc-C---CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          328 EVTSAVVRQN-L---RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       328 ~~~~~~~~~~-~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      +......... .   .+.....+++.+.++|.+|| .+|++|||+++|+..|+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         217 QVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            6544433221 1   12233456889999999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=312.53  Aligned_cols=249  Identities=32%  Similarity=0.562  Sum_probs=202.9

Q ss_pred             eeeeeecceEEEEEEE--CCc--eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQ--DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  179 (404)
                      +.||+|+||.||+|..  ++.  .+|+|.++....        ......+.+|+.++.++ +||||+++++++...... 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-   71 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL-   71 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--------HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc-
Confidence            3689999999999987  343  468888752111        11234577899999999 899999999998776554 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                                     |+||||+++++|.+++....              ...+++..+..++.|++.||+|||+.|++|+
T Consensus        72 ---------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~  136 (270)
T cd05047          72 ---------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR  136 (270)
T ss_pred             ---------------eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence                           89999999999999986532              1357899999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      ||||+||+++.++.+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus       137 dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         137 DLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             ccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            999999999999999999999985322111 1111233567999999988889999999999999999997 99999888


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +..+....+. .......+..++.++.+++.+||..||.+||++.+++..|+.+.
T Consensus       216 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         216 TCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            7766655543 33455566778899999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-41  Score=314.90  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=204.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ..|++.+.||+|+||.||++.+      ++..||+|.++....        ......+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEIEILRNLYHENIVKYKGIC   75 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--------HHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            4578889999999999999874      478899999853221        11234578999999999999999999988


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+....              ..++||||+++++|.+++.+. ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus        76 ~~~~~~--------------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Ni  140 (284)
T cd05079          76 TEDGGN--------------GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV  140 (284)
T ss_pred             ecCCCC--------------ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheE
Confidence            765322              238999999999999998654 34689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS----  325 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~----  325 (404)
                      +++.++.++|+|||+++........   .....++..|+|||.+.+..++.++||||||+++|+|+++..|+....    
T Consensus       141 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~  220 (284)
T cd05079         141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL  220 (284)
T ss_pred             EEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh
Confidence            9999999999999999754432221   123446778999999988889999999999999999999776542210    


Q ss_pred             ----------HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          326 ----------FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       326 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                                .................+..++..+.+||.+||+.||++||++.++++.|+.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         221 KMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             hhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                      00111122223334445667899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-41  Score=318.18  Aligned_cols=247  Identities=25%  Similarity=0.432  Sum_probs=206.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||++..  +++.||+|.+......         ....+.+|+.+++.++||||+++++.+....
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            6899999999999999999986  6899999998653321         1234678999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++.+   ..+++..+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus        90 ~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~  150 (297)
T cd06656          90 EL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM  150 (297)
T ss_pred             EE----------------EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence            55                899999999999998854   36899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+...........
T Consensus       151 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~  230 (297)
T cd06656         151 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN  230 (297)
T ss_pred             CCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC
Confidence            99999999999875443333334456889999999999988999999999999999999999999766543332222221


Q ss_pred             c-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 N-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . .....+..++..+.++|.+||..+|++||++.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1 122345667889999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-40  Score=315.51  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=211.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++.+  +++.||||.+....      .........+.+|+.+++.++||||+++++.+.....
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   75 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN------LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH   75 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence            688999999999999999987  57899999986432      1122334567899999999999999999999887665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+||||++|++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        76 ~----------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~  137 (305)
T cd05609          76 L----------------CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM  137 (305)
T ss_pred             E----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC
Confidence            5                8999999999999998654  468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC---------------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          258 RTVKIADFGVARLEASNP---------------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      +.++|+|||+++......               .......++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus       138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999986321110               01112357889999999988889999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhccCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          323 DLSFSEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +.+..+........... +.....++.++.+||.+||+.||++||+..++.++|+.-
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         218 GDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             CCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            88877776666554432 223346789999999999999999999977777777663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.9e-41  Score=310.39  Aligned_cols=247  Identities=31%  Similarity=0.544  Sum_probs=195.4

Q ss_pred             eeeeeecceEEEEEEE-C---CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          105 GAFARGTFGTVHRGIY-D---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~---g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      +.||+|+||.||+|.. +   ...+|+|.+.....        ......+.+|+.+++.++||||+++++.+......  
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~--   70 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--------PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY--   70 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--------hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce--
Confidence            3689999999999975 2   35688887643211        11234578899999999999999999998766554  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                                    |+||||+++|+|.+++.....   ...++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        71 --------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~  136 (269)
T cd05042          71 --------------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD  136 (269)
T ss_pred             --------------EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC
Confidence                          899999999999999966532   335678889999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCC--cccCCCCCccccCccccC-------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          258 RTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLN-------GSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      +.+||+|||++........  ......++..|+|||++.       ...++.++||||||+++|||++ |..||......
T Consensus       137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (269)
T cd05042         137 LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE  216 (269)
T ss_pred             CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence            9999999999864322211  122344577899999874       3357889999999999999999 78999888776


Q ss_pred             HHHHHHHhccC----CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          328 EVTSAVVRQNL----RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       328 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      +..........    .+..+..++..+.+++..|| .||++||++++|+++|.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         217 QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            66555444322    22344567899999999999 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-41  Score=326.39  Aligned_cols=257  Identities=25%  Similarity=0.364  Sum_probs=203.1

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..|++ +++|.+.+.||+|+||+||++.+  +++.||||++.....       .......+.+|+.++++++||||++++
T Consensus         9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07878           9 TVWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-------SLIHARRTYRELRLLKHMKHENVIGLL   80 (343)
T ss_pred             HHhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-------hhHHHHHHHHHHHHHHhcCCCchhhhh
Confidence            34555 47899999999999999999986  678999999853211       112234567899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++......          ......|+++|++ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||||
T Consensus        81 ~~~~~~~~~----------~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp  146 (343)
T cd07878          81 DVFTPATSI----------ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKP  146 (343)
T ss_pred             hhhcccccc----------cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence            987644321          1123348999998 8999887742   4699999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +||+++.++.+||+|||+++....   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+
T Consensus       147 ~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  223 (343)
T cd07878         147 SNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID  223 (343)
T ss_pred             hhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            999999999999999999975432   3345678999999999876 568999999999999999999999998766544


Q ss_pred             HHHHHHhccC---------------------CCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNL---------------------RPE--------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~---------------------~~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+.....                     .+.        .....++.+.+||.+||..||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3333221100                     000        11235677899999999999999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=333.74  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=193.5

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC------CCcee
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD------HPNVT  166 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv  166 (404)
                      ++...+|.+.+.||+|+||+||+|.+  +++.||||+++....          ....+..|+.+++.+.      |++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~i~  194 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----------YTRDAKIEIQFMEKVRQADPADRFPLM  194 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----------hHHHHHHHHHHHHHHhhcCcccCccee
Confidence            34457899999999999999999987  678999999853211          1122344555655554      55688


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceec
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHR  245 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~  245 (404)
                      ++++++.....               .+|+|||++ +++|.+++.+.  ..+++..+..++.||+.||.|||+ .||+||
T Consensus       195 ~i~~~~~~~~~---------------~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHr  256 (467)
T PTZ00284        195 KIQRYFQNETG---------------HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHT  256 (467)
T ss_pred             eeEEEEEcCCc---------------eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence            99888865432               238999999 88999988654  579999999999999999999998 599999


Q ss_pred             ccCCCCEEEcCCC----------------cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHH
Q 015594          246 DVKTENMLLDKTR----------------TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI  309 (404)
Q Consensus       246 Dikp~Nili~~~~----------------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  309 (404)
                      ||||+|||++.++                .+||+|||.+...   .......+||+.|+|||++.+..|+.++|||||||
T Consensus       257 DlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv  333 (467)
T PTZ00284        257 DLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE---RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC  333 (467)
T ss_pred             CCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC---ccccccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence            9999999997665                4999999988532   22334567899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------------CCCCC---------------CCCCcHH
Q 015594          310 CLWEIYCCDMPYPDLSFSEVTSAVVRQN-------------------------LRPEI---------------PRCCPSS  349 (404)
Q Consensus       310 il~el~~g~~Pf~~~~~~~~~~~~~~~~-------------------------~~~~~---------------~~~~~~~  349 (404)
                      ++|||++|+.||...+..+....+....                         +.+..               ....++.
T Consensus       334 il~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (467)
T PTZ00284        334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL  413 (467)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence            9999999999998776554433221110                         00000               0011356


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHH--HHHH
Q 015594          350 LANVMKRCWDANPDKRPEMDEVVA--MLEA  377 (404)
Q Consensus       350 l~~li~~cl~~dP~~Rpt~~~ll~--~L~~  377 (404)
                      +.+||.+||..||.+|||++|+++  .|..
T Consensus       414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             HHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            789999999999999999999997  4544

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=331.31  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=209.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|.-.+.||+|+||.||-+++  +.+.||||.+.++...      ..+..+.+.+|+..|++++|||+|.+.|+|.....
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ------s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccc------cHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            366678899999999998887  7899999999865432      23446778999999999999999999999877665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      -                |+||||| -|+-.|++.-+ .+++-+..+..|+.+.+.||+|||+.+.||||||..|||+++.
T Consensus       101 a----------------WLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~  162 (948)
T KOG0577|consen  101 A----------------WLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP  162 (948)
T ss_pred             H----------------HHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC
Confidence            4                8999999 77877877544 5689999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      |.|||+|||.|.+..    ....++|||.|||||++.   .+.|+-++|||||||+..||.--++|+..++....+..+.
T Consensus       163 g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA  238 (948)
T KOG0577|consen  163 GLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  238 (948)
T ss_pred             CeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH
Confidence            999999999997533    234588999999999984   4569999999999999999999999999988776666655


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+--....+++.+++|+..||++-|.+|||.++++.
T Consensus       239 QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  239 QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            444333345678999999999999999999999998874

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7e-41  Score=316.85  Aligned_cols=258  Identities=26%  Similarity=0.580  Sum_probs=210.7

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+|+..+.||+|+||.||++.+  +|.    .||+|.+.....        ......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~niv~~~~   76 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--------PKANVEFMDEALIMASMDHPHLVRLLG   76 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            456788899999999999999986  454    478888753221        112235788999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      .+.... .                ++++||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+
T Consensus        77 ~~~~~~-~----------------~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~  138 (303)
T cd05110          77 VCLSPT-I----------------QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR  138 (303)
T ss_pred             EEcCCC-c----------------eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence            886432 2                6899999999999998654 346899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      ||+++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus       139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~  218 (303)
T cd05110         139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR  218 (303)
T ss_pred             eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999975433222  2223445778999999999899999999999999999997 89999887655


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +... +.........+..++.++.+++.+||..+|++||++.+|++.|+++...
T Consensus       219 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         219 EIPD-LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HHHH-HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            5443 3444444555667889999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-40  Score=306.27  Aligned_cols=249  Identities=27%  Similarity=0.474  Sum_probs=209.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||+|+||.||++..  +++.+|||.+.......       .....+.+|+.++++++||||+++++.+.....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-------DERLAAQNECQVLKLLSHPNIIEYYENFLEDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-------HHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence            588999999999999999886  68899999987543211       123567899999999999999999998876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+++++|.+++.......+++..+..++.+++.+|.|||++|++|+||+|+||+++.+
T Consensus        74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~  137 (256)
T cd08220          74 L----------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH  137 (256)
T ss_pred             E----------------EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence            4                899999999999999977655678999999999999999999999999999999999999755


Q ss_pred             -CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 -RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 -~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                       +.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus       138 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  216 (256)
T cd08220         138 KMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG  216 (256)
T ss_pred             CCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence             468999999997544322 223356789999999999888999999999999999999999999887766655554443


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ...++..++.++.+++.+||+.+|++|||+.+++.
T Consensus       217 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 T-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            3 33456678999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-41  Score=315.30  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=198.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++.+  +|+.||+|.++......       .....+.+|+.++++++||||+++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLYDVLHSDKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-------cCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence            478889999999999999998  68999999997543221       112346689999999999999999999877665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                ++|+||++ ++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus        74 ~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~  135 (284)
T cd07839          74 L----------------TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN  135 (284)
T ss_pred             e----------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence            4                89999995 6888887553 3579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVTSAVVR  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf-~~~~~~~~~~~~~~  335 (404)
                      +.+||+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|..|| ...+..+....+..
T Consensus       136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  215 (284)
T cd07839         136 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  215 (284)
T ss_pred             CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH
Confidence            999999999997554443444456678999999998764 4789999999999999999998885 44443333222211


Q ss_pred             cc------------------CC---------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN------------------LR---------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~------------------~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                  ..         ......+++++.++|.+||+.||.+|||+++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00                  00         0112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-42  Score=330.71  Aligned_cols=249  Identities=29%  Similarity=0.517  Sum_probs=221.6

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ....|.+.+.||+|.|+.|.++++  ++..||||++++....       ...++.+.+|+.+|..|+|||||+++.+...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t  126 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-------PSKRQKLGREVDIMKSLNHPNIVKLFSVIET  126 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-------hHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence            346799999999999999999997  8999999999765432       2223448899999999999999999999887


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+||||+.+|.+++++.++  ....+..+..++.|+++|++|||+++|||||||++|+||
T Consensus       127 ~~~l----------------ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL  188 (596)
T KOG0586|consen  127 EATL----------------YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL  188 (596)
T ss_pred             ccee----------------EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc
Confidence            7776                9999999999999999877  456679999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.+-++||+|||++..+. ........+|++.|.|||++.+..| ++.+|+||+|+++|.|++|.+||.+.+..+....+
T Consensus       189 ~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv  267 (596)
T KOG0586|consen  189 DENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV  267 (596)
T ss_pred             ccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh
Confidence            999999999999998655 5556677999999999999999876 68999999999999999999999999988888888


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..+++  +|..++.+..++|+++|-.+|.+|+++++|++
T Consensus       268 l~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  268 LRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            887776  55666778999999999999999999999985

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.5e-41  Score=307.41  Aligned_cols=248  Identities=26%  Similarity=0.475  Sum_probs=207.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||.|+||.||++..  +++.||+|.+...       ..    ...+.+|+.++++++||||+++++.+.+.
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------ED----LQEIIKEISILKQCDSPYIVKYYGSYFKN   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            36789999999999999999997  4789999998521       11    45688999999999999999999998876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+++||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        71 ~~~----------------~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~  133 (256)
T cd06612          71 TDL----------------WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN  133 (256)
T ss_pred             CcE----------------EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence            554                8999999999999998543 46789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~  213 (256)
T cd06612         134 EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN  213 (256)
T ss_pred             CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc
Confidence            99999999999997654433233345578899999999999999999999999999999999999987765544333222


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ....+..++.++.++|.+||+.||++||++.+|+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111 11234457789999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=306.92  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=212.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +.+|.+.+.||+|+||.||++.+  +++.||+|.+.........    ......+.+|+.++++++||||+++++.+.+.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   76 (264)
T cd06653           1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET----SKEVNALECEIQLLKNLRHDRIVQYYGCLRDP   76 (264)
T ss_pred             CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh----hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence            35799999999999999999986  6899999998654322111    22345688999999999999999999988654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..-              .+++|+||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus        77 ~~~--------------~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~  140 (264)
T cd06653          77 EEK--------------KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD  140 (264)
T ss_pred             CCC--------------EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence            322              237999999999999998654  4688999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCC---CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASN---PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||+++.....   ........++..|+|||.+.+..++.++||||||+++|+|++|..||..........+
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  220 (264)
T cd06653         141 SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK  220 (264)
T ss_pred             CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH
Confidence            9999999999999754321   1122335688999999999988899999999999999999999999988776666666


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......+.+|..+++.+.++|.+||+ +|..||++.+++.
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            666666677888899999999999998 5799999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.3e-41  Score=312.92  Aligned_cols=248  Identities=30%  Similarity=0.475  Sum_probs=209.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|+..+.||.|+||.||+|.+  ++..||||+++....        ......+.+|+.++++++||||+++++++.+..
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3577788999999999999987  578999999864321        112356789999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++..   .++++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus        76 ~~----------------~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~  136 (277)
T cd06640          76 KL----------------WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE  136 (277)
T ss_pred             EE----------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence            55                899999999999998853   46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ ..
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~  215 (277)
T cd06640         137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PK  215 (277)
T ss_pred             CCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hc
Confidence            99999999999975544333333456788999999999888999999999999999999999999887765544332 33


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ...+..+..++..+.++|.+||+.+|++||++.+++..
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            34555666788999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-40  Score=316.06  Aligned_cols=248  Identities=27%  Similarity=0.504  Sum_probs=202.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++.+  ++..+|+|.+.....        ......+.+|+.++++++||||+++++++.+..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--------PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            3688999999999999999987  678899999853211        123456788999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEEc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLLD  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili~  255 (404)
                      .+                |+||||+++++|.+++.+.  ..+++..+..++.||+.||.|||+ .+++|+||||+|||++
T Consensus        73 ~~----------------~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~  134 (308)
T cd06615          73 EI----------------SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN  134 (308)
T ss_pred             EE----------------EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence            65                8999999999999999654  578999999999999999999997 5999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++......  ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+..........
T Consensus       135 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~  212 (308)
T cd06615         135 SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR  212 (308)
T ss_pred             cCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC
Confidence            9999999999998643222  22345689999999999888899999999999999999999999975543332211110


Q ss_pred             -----------------------------------ccCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 -----------------------------------QNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 -----------------------------------~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                                                         ....+..+ ..++.++++||.+||..+|++||++.+|+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                               00111111 2367889999999999999999999998865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=335.41  Aligned_cols=249  Identities=27%  Similarity=0.464  Sum_probs=214.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +-|.|+..||.|+||.||++..  ++-..|-|++....     +.    ....|.-|+.||..++||+||+++++|.-..
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-----eE----ELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-----EE----ELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-----hh----HHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            3456678999999999999987  45667888885322     22    2456789999999999999999999998777


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                +|+.|||.||....++..- +..+++.++..+++|++.||.|||+++|+|||||..|||++-
T Consensus       103 kL----------------wiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl  165 (1187)
T KOG0579|consen  103 KL----------------WILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL  165 (1187)
T ss_pred             ce----------------EEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe
Confidence            76                8999999999998888654 568999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +|.|+|+|||++............+.|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++..++.
T Consensus       166 dGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll  245 (1187)
T KOG0579|consen  166 DGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL  245 (1187)
T ss_pred             cCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence            99999999999976555556667789999999999874     4579999999999999999999999999999888877


Q ss_pred             HHHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+..... ..-.|..++..+.+|+.+||..||..||++.+|++
T Consensus       246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            7655432 23457788999999999999999999999999874

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-40  Score=311.30  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=202.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||.||++.+  +|+.||+|++.......       ...+.+.+|+.++++++||||+++++++....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-------VIKKIALREIRMLKQLKHPNLVNLIEVFRRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-------cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence            4688999999999999999987  58999999986432211       11344678999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+++++|..++..  ...+++..+..++.||+.||.|||+.|++|+||||+||+++.
T Consensus        74 ~~----------------~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~  135 (286)
T cd07847          74 KL----------------HLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK  135 (286)
T ss_pred             EE----------------EEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence            55                899999988888776543  346899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus       136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  215 (286)
T cd07847         136 QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK  215 (286)
T ss_pred             CCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999999865444333344567889999999876 4578999999999999999999999987765544333221


Q ss_pred             cc-------------------C-CCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN-------------------L-RPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~-------------------~-~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                   . .+.         .....+..+.+||.+||+.+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00                   0 000         01245788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-42  Score=332.11  Aligned_cols=255  Identities=25%  Similarity=0.473  Sum_probs=210.8

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      .++..+||+|+|-+||+|.+  +|-.||--.++..+.     .......++|..|+.+|+.|+||||++|+..|.+....
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-----~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-----TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHh-----hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            34557899999999999998  566676544433222     22234468899999999999999999999999988875


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC--CceecccCCCCEEEcC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--KIVHRDVKTENMLLDK  256 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--givH~Dikp~Nili~~  256 (404)
                      .|              .+|.|++..|+|..|+.+.  +.+..+.+..|++||+.||.|||++  -|+|||||-+||||++
T Consensus       117 ~i--------------n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG  180 (632)
T KOG0584|consen  117 TI--------------NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG  180 (632)
T ss_pred             ee--------------eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC
Confidence            44              6899999999999999877  5788999999999999999999998  5999999999999965


Q ss_pred             -CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q 015594          257 -TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVV  334 (404)
Q Consensus       257 -~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~~~~~~  334 (404)
                       .|.|||+|+|+|+.....  ......|||.|||||++.. .|+..+||||||+|++||+|+.+||.. .+..++++++.
T Consensus       181 ~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYEE-~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~  257 (632)
T KOG0584|consen  181 NLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYEE-NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT  257 (632)
T ss_pred             CcCceeecchhHHHHhhcc--ccceeccCccccChHHHhh-hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence             589999999999865433  2333689999999999994 599999999999999999999999976 46677777777


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .+..+..+.+--.+++++||.+||.. ..+||++.|||.  ..+.+..
T Consensus       258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d  302 (632)
T KOG0584|consen  258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED  302 (632)
T ss_pred             cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence            66655556666689999999999998 999999999875  3444443

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=305.84  Aligned_cols=246  Identities=33%  Similarity=0.650  Sum_probs=205.0

Q ss_pred             eeeeeecceEEEEEEEC-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccC
Q 015594          105 GAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD  183 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~  183 (404)
                      ++||+|+||.||++.+. ++.||+|++......        .....+.+|+.++++++||||+++++++.+....     
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-----   67 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI-----   67 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe-----
Confidence            36899999999999874 899999988643221        2345688999999999999999999998777655     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEe
Q 015594          184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA  263 (404)
Q Consensus       184 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~  263 (404)
                                 ++||||+++++|.+++... ...+++..+..++.+++.+|.|||+++++|+||+|+||+++.++.++|+
T Consensus        68 -----------~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~  135 (251)
T cd05041          68 -----------YIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKIS  135 (251)
T ss_pred             -----------EEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEe
Confidence                       8999999999999998654 3468899999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCcc--cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 015594          264 DFGVARLEASNPHDM--TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRP  340 (404)
Q Consensus       264 Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~  340 (404)
                      |||++..........  .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+ ......
T Consensus       136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~  214 (251)
T cd05041         136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRM  214 (251)
T ss_pred             eccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCC
Confidence            999997543211111  11223567999999998889999999999999999999 88999888766554443 333445


Q ss_pred             CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       341 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ..+..++.++.+||.+||..+|.+||++.+|++.|+
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            566788999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=296.09  Aligned_cols=253  Identities=24%  Similarity=0.437  Sum_probs=208.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFI  169 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~  169 (404)
                      .+..+..++.+...||.|+-|+|+++++  +|...|||.+.....        .+..++++..+.++.+.+ .|+||+.+
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--------kee~kRILmDldvv~~s~dcpyIV~c~  157 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--------KEENKRILMDLDVVLKSHDCPYIVQCF  157 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--------HHHHHHHHHhhhHHhhccCCCeeeeee
Confidence            3345566777888999999999999988  579999999965432        122355667777777774 99999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVK  248 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dik  248 (404)
                      |+|..+..+                +|.||.| ...+..++.+. .+++++..+-.+...++.||.||..+ ||+|||+|
T Consensus       158 GyFi~n~dV----------------~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvK  219 (391)
T KOG0983|consen  158 GYFITNTDV----------------FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK  219 (391)
T ss_pred             eEEeeCchH----------------HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccC
Confidence            999998887                6788998 66777777554 46799999999999999999999865 89999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCC-
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDL-  324 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~-  324 (404)
                      |+|||+|..|++||||||.+.... +....+...|.+.|||||.+.   ...|+.++||||||++++||.||..||.+. 
T Consensus       220 PSNILlDe~GniKlCDFGIsGrlv-dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~  298 (391)
T KOG0983|consen  220 PSNILLDERGNIKLCDFGISGRLV-DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK  298 (391)
T ss_pred             ccceEEccCCCEEeecccccceee-cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence            999999999999999999997544 344556678999999999995   346999999999999999999999999873 


Q ss_pred             CHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          325 SFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+++..+++ ..++..+  ..+++++.+|+..||++|+.+||.+.+|++
T Consensus       299 tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  299 TDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            45666666666 3344443  347999999999999999999999998874

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-40  Score=312.04  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=205.5

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      +....++|.+.+.||+|+||.||++.+  +++.+|+|+++....          ....+.+|+.+++.+ +||||+++++
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------IDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----------hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            334567899999999999999999987  678999998753211          123466899999999 7999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++......           .....++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+++|||||
T Consensus        83 ~~~~~~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk  151 (286)
T cd06638          83 MYYKKDVK-----------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVK  151 (286)
T ss_pred             eeeecccC-----------CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence            87533211           122348999999999999987532  34568999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      |+||+++.++.++|+|||++..............|++.|+|||.+..     ..++.++||||||+++|+|++|..||..
T Consensus       152 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         152 GNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             HHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            99999999999999999999765433333344568999999999853     4478999999999999999999999987


Q ss_pred             CCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          324 LSFSEVTSAVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       324 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .............. .....+..++..+.+||.+||+.||++||++.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         232 LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            76544333322211 1112345568899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-40  Score=306.68  Aligned_cols=250  Identities=36%  Similarity=0.688  Sum_probs=209.2

Q ss_pred             eEEeeeeeeecceEEEEEEECC------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594          101 LIIKGAFARGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +++.+.||.|+||.||++.+..      ..||+|++......        .....+.+|+.++..++|+||+++++.+.+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--------QQIEEFLREARIMRKLDHPNIVKLLGVCTE   72 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--------HHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            3567899999999999999843      88999998543221        134567899999999999999999999887


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                +++|||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||++
T Consensus        73 ~~~~----------------~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~  136 (258)
T smart00219       73 EEPL----------------MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV  136 (258)
T ss_pred             CCee----------------EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence            6544                899999999999999866543339999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCccc-CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.++|+|||++........... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus       137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~  216 (258)
T smart00219      137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY  216 (258)
T ss_pred             ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999975443321111 2336789999999988889999999999999999998 8899988777776665


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      +... .....+..++.++.+++.+||..||++|||+.++++.|
T Consensus       217 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 LKKG-YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HhcC-CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            5443 34456667899999999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-40  Score=308.19  Aligned_cols=256  Identities=26%  Similarity=0.473  Sum_probs=206.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCc-ccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESH-RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +|.+.+.||.|+||.||+|..  +|+.||||.++...... ..........+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            578889999999999999986  68999999886432111 111222334567889999999999999999999987765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+++++|.+++.+.  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        82 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~  143 (272)
T cd06629          82 YL----------------SIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA  143 (272)
T ss_pred             ce----------------EEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC
Confidence            55                8999999999999998654  57899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++|+|||++.......  .......++..|+|||.+....  ++.++|+||||+++|+|++|..||......+....
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  223 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK  223 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence            9999999999997533211  1123345789999999987654  78999999999999999999999976665544433


Q ss_pred             HHhccCCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEI----PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +........+    ...++.++.++|.+||..+|++||++++|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            3333333322    2356899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=316.51  Aligned_cols=245  Identities=27%  Similarity=0.474  Sum_probs=211.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      -|.+..+||+|+||.||++.+  +|+.+|||.+....           -.+.+.+|+.++++++.|+||++||.+.....
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence            477889999999999999987  79999999985422           13456789999999999999999999988887


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                +||||||..|++.+++.. +++++++.++..+++.-+.||+|||...-+|||||..|||++.+
T Consensus       103 L----------------WIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~  165 (502)
T KOG0574|consen  103 L----------------WIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD  165 (502)
T ss_pred             e----------------EeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc
Confidence            7                899999999999998854 57899999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      |..||+|||+|....+.........|||.|||||++..-.|+.++||||||++..||..|++||.+..+..... .+..+
T Consensus       166 G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-MIPT~  244 (502)
T KOG0574|consen  166 GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-MIPTK  244 (502)
T ss_pred             chhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-eccCC
Confidence            99999999999876665555666789999999999999999999999999999999999999999876543211 11222


Q ss_pred             CCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .++  ..|..+++++.++|++||-.+|++|-|+.+|++
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            222  335678999999999999999999999988764

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=309.93  Aligned_cols=256  Identities=28%  Similarity=0.444  Sum_probs=207.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      .++|.+.+.||+|+||.||+|.+  +++.+|+|++.....          ....+.+|+.+++++ +|+||+++++.+..
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   74 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFIK   74 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence            47899999999999999999998  578999999864321          124578999999999 79999999999976


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ....          .....+|+||||+++++|.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        75 ~~~~----------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni  144 (275)
T cd06608          75 KNPP----------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI  144 (275)
T ss_pred             cCCC----------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence            5531          11233489999999999999986543  46799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      +++.++.++|+|||++..............++..|+|||.+..     ..++.++||||||+++|+|++|..||......
T Consensus       145 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  224 (275)
T cd06608         145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM  224 (275)
T ss_pred             EEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence            9999999999999998754443333445668999999998754     34678999999999999999999999876655


Q ss_pred             HHHHHHHhccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....+....... ..+..++.++.+||.+||..||++|||+.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         225 RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            5444443332211 122346789999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-41  Score=315.70  Aligned_cols=247  Identities=29%  Similarity=0.479  Sum_probs=207.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +.|...+.||+|+||.||+|.+  +++.||+|+++....        ......+.+|+.++++++||||+++++.+.+..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--------hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            3466778899999999999987  678999999864321        122456789999999999999999999987665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++..   ..+++..+..++.||+.||.|||++|++|+||+|+||+++.
T Consensus        76 ~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~  136 (277)
T cd06642          76 KL----------------WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE  136 (277)
T ss_pred             ce----------------EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence            54                899999999999998843   46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||........... ...
T Consensus       137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~  215 (277)
T cd06642         137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPK  215 (277)
T ss_pred             CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhc
Confidence            9999999999997544333333345678999999999998899999999999999999999999987665544333 233


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+..+..++.++.++|.+||+.+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            3344556678899999999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.9e-40  Score=306.79  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=203.0

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      +++...+.....||+|+||.||+|.+  ++..||+|.+.....         .....+.+|+.++++++|+||+++++++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   74 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHRNIVQYLGSD   74 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHHhcCCCCeeeeeeee
Confidence            34445555667899999999999986  578899998853321         1234578999999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCC--cHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL--AFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ......                ++|+||+++++|.+++.... ..+  ++..+..++.||+.||.|||++||+|+||||+
T Consensus        75 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~  137 (268)
T cd06624          75 SENGFF----------------KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD  137 (268)
T ss_pred             ccCCEE----------------EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence            776554                89999999999999986532 344  78889999999999999999999999999999


Q ss_pred             CEEEcC-CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          251 NMLLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       251 Nili~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ||+++. ++.++|+|||++..............+++.|+|||.+.+..  ++.++||||||+++|+|++|..||......
T Consensus       138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~  217 (268)
T cd06624         138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP  217 (268)
T ss_pred             HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999976 67899999999875443333333456899999999986643  789999999999999999999999765432


Q ss_pred             H-HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 E-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ...........+.++..+++++.+++.+||+.+|.+|||+.+|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         218 QAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            2 122222223345667788999999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.9e-41  Score=310.89  Aligned_cols=248  Identities=32%  Similarity=0.585  Sum_probs=202.9

Q ss_pred             eeeeeecceEEEEEEEC--------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594          105 GAFARGTFGTVHRGIYD--------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +.||+|+||.||+|.+.        ++.+|||.+.....        ......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE   72 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC
Confidence            36899999999999863        26799998753211        112345788999999999999999999987665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ..                ++||||+++++|.+++.+..     ...+++..+..++.||+.||.|||+.+++|+||||+|
T Consensus        73 ~~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n  136 (269)
T cd05044          73 PQ----------------YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN  136 (269)
T ss_pred             Ce----------------EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence            54                89999999999999996532     2347889999999999999999999999999999999


Q ss_pred             EEEcCCC-----cEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          252 MLLDKTR-----TVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       252 ili~~~~-----~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      |+++.++     .++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~  216 (269)
T cd05044         137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA  216 (269)
T ss_pred             EEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence            9998877     899999999874332211  1112345688999999998889999999999999999998 9999988


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      .+..+....+. .......+..+|..+.++|.+||..+|.+||++.+|++.|++
T Consensus       217 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         217 LNNQEVLQHVT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCHHHHHHHHh-cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            77666554433 334455667789999999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=311.30  Aligned_cols=258  Identities=28%  Similarity=0.573  Sum_probs=209.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEEC------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ...|.+.+.||+|+||.||++.++      ++.||||++......        .....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~~   74 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKGV   74 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEee
Confidence            356788899999999999999863      679999998643221        234568899999999999999999998


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +......              ..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+|
T Consensus        75 ~~~~~~~--------------~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  139 (284)
T cd05038          75 CEKPGGR--------------SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN  139 (284)
T ss_pred             eecCCCC--------------ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence            8664322              2389999999999999996643 369999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-  327 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-  327 (404)
                      |+++.++.++|+|||.+..........   ....++..|+|||.+.+..++.++||||||+++|+|++|..|+...... 
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~  219 (284)
T cd05038         140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF  219 (284)
T ss_pred             EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh
Confidence            999999999999999998654222111   1233456799999998888999999999999999999999988653221 


Q ss_pred             -------------HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          328 -------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       328 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                                   ...............+..++.++.+|+.+||+.+|++||++.+|+++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         220 LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                         112223334444455677889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-40  Score=308.46  Aligned_cols=260  Identities=22%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             CeEEeeeeeeecceEEEEEEEC---CceEEEEEeecCCCCccc-HHHHHHHHHHHHHHHHHHhh-cCCCceeEEEEEEec
Q 015594          100 KLIIKGAFARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRS-EAEIASLRAAFTQEVAVWHK-LDHPNVTKFIGATMG  174 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~---g~~vAvK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  174 (404)
                      .|.+.+.||+|+||.||++.+.   ++.+|||.+......... ..........+.+|+.++.+ ++||||+++++.+.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            3678889999999999999973   588999998654322111 01112233456788888875 799999999999887


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCC
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTEN  251 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~N  251 (404)
                      ....                ++||||+++++|.+++...  ....+++..++.++.|++.||.|||+ .|++|+||+|+|
T Consensus        81 ~~~~----------------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n  144 (269)
T cd08528          81 NDRL----------------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN  144 (269)
T ss_pred             CCeE----------------EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence            6655                8999999999999988442  34578999999999999999999996 789999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus       145 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~  223 (269)
T cd08528         145 IMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT  223 (269)
T ss_pred             EEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence            999999999999999997544332 3445678999999999998889999999999999999999999998777666665


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      .+......+.....+++++.++|.+||+.||++||++.++.++|.
T Consensus       224 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            655555444444467899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.3e-40  Score=305.20  Aligned_cols=249  Identities=31%  Similarity=0.536  Sum_probs=205.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++..  +++.||+|+++.....       ......+.+|+.+++.++|+||+++++.+.+...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence            578899999999999999986  6899999999755332       2234668899999999999999999998876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        74 ~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~  135 (264)
T cd06626          74 V----------------YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN  135 (264)
T ss_pred             E----------------EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence            5                8999999999999998653  458899999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCccc----CCCCCccccCccccCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDMT----GETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      +.+||+|||++...........    ...++..|+|||.+.+..   ++.++||||||+++|+|++|..||.........
T Consensus       136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~  215 (264)
T cd06626         136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI  215 (264)
T ss_pred             CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH
Confidence            9999999999976543332221    356788999999998776   889999999999999999999999766433222


Q ss_pred             HHHHhccCCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .........+.++..  ++..+.++|.+||+.+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         216 MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            222233334444444  4899999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-40  Score=307.80  Aligned_cols=239  Identities=25%  Similarity=0.415  Sum_probs=190.8

Q ss_pred             eeeeeecceEEEEEEEC--------------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594          105 GAFARGTFGTVHRGIYD--------------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~--------------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      +.||+|+||.||+|+..              ...||+|+++...         ......+.+|+.+++.++||||+++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~~~~~~l~~l~hp~iv~~~~   71 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---------RDISLAFFETASMMRQVSHKHIVLLYG   71 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---------hhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            36899999999999852              2358888875321         223456788999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+....                ++||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        72 ~~~~~~~~----------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  134 (262)
T cd05077          72 VCVRDVEN----------------IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK  134 (262)
T ss_pred             EEecCCCC----------------EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence            98876655                8999999999998887543 356899999999999999999999999999999999


Q ss_pred             CEEEcCCCc-------EEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHH-hCCCCC
Q 015594          251 NMLLDKTRT-------VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIY-CCDMPY  321 (404)
Q Consensus       251 Nili~~~~~-------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-~g~~Pf  321 (404)
                      ||||+.++.       ++++|||++.....    .....++..|+|||.+. +..++.++||||||+++|+|+ .|..||
T Consensus       135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (262)
T cd05077         135 NILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL  210 (262)
T ss_pred             cEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999976654       89999999864322    22345788999999886 566899999999999999997 588898


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ......+... ......  ......++++.+||.+||+.||.+||++.+|++.|+
T Consensus       211 ~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         211 KDKTLAEKER-FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             CCcchhHHHH-HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            8766544322 222222  122334678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=330.09  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=193.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...|.+.+.||+|+||.||++.+  .++.||||....               ..+.+|+.++++++|||||++++++...
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            34799999999999999999998  578899996421               2246899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|||++ .++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus       233 ~~~----------------~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~  294 (461)
T PHA03211        233 GLT----------------CLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN  294 (461)
T ss_pred             CEE----------------EEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence            554                8999999 67999888653 34799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------
Q 015594          256 KTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--------  325 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--------  325 (404)
                      .++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..|+....        
T Consensus       295 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~  374 (461)
T PHA03211        295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY  374 (461)
T ss_pred             CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCc
Confidence            999999999999975433221  1234569999999999999999999999999999999999876543211        


Q ss_pred             HHHHHHHHHhccC-------------------------CCCCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          326 FSEVTSAVVRQNL-------------------------RPEIP-------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~~~~-------------------------~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+...+.....                         .+...       ...+.++.+||.+||+.||.+|||+.||++
T Consensus       375 ~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        375 DAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            1122221111110                         00000       124568899999999999999999999986


Q ss_pred             H
Q 015594          374 M  374 (404)
Q Consensus       374 ~  374 (404)
                      .
T Consensus       455 h  455 (461)
T PHA03211        455 L  455 (461)
T ss_pred             C
Confidence            3

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-40  Score=308.99  Aligned_cols=247  Identities=30%  Similarity=0.484  Sum_probs=208.5

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      -|.+.+.||.|+||.||+|.+  +++.||||++.....        ......+.+|+.++.+++||||+++++++.+...
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   76 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   76 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence            467788999999999999986  678999999853321        1223567899999999999999999999987665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+||||+++++|.+++..   ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.+
T Consensus        77 ~----------------~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~  137 (277)
T cd06641          77 L----------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH  137 (277)
T ss_pred             E----------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC
Confidence            5                899999999999998853   468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ ...
T Consensus       138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~  216 (277)
T cd06641         138 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKN  216 (277)
T ss_pred             CCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcC
Confidence            9999999999875443332333456788999999998888999999999999999999999999877655544443 333


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..+..+..++.++.++|.+||+.+|.+||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            4455666788999999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.8e-41  Score=326.63  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-C-----CceeEEEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-H-----PNVTKFIG  170 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~  170 (404)
                      .+|.+.++||+|+||.|.+|.+  +++.||||+++...          ....+-..|+.+|..|+ |     -|+|++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            3778899999999999999998  68999999996322          22334567999999996 3     38999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      +|+-..++                |||+|++ .-+|.+++..++...++...++.++.||+.||..||..||||+||||+
T Consensus       256 ~F~fr~Hl----------------ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE  318 (586)
T KOG0667|consen  256 YFYFRNHL----------------CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPE  318 (586)
T ss_pred             ccccccce----------------eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence            99988887                9999999 899999999999999999999999999999999999999999999999


Q ss_pred             CEEEcCC--CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          251 NMLLDKT--RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       251 Nili~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      ||||...  ..|||+|||.|+.......   ...-+..|.|||++.|.+|+.+.|+||||||++||++|.+-|++.+..+
T Consensus       319 NILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  319 NILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             heeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            9999533  4799999999986543322   5677899999999999999999999999999999999988898887766


Q ss_pred             HHHHHHhc----------------------c----------------------------CCCCCC-----------CCCc
Q 015594          329 VTSAVVRQ----------------------N----------------------------LRPEIP-----------RCCP  347 (404)
Q Consensus       329 ~~~~~~~~----------------------~----------------------------~~~~~~-----------~~~~  347 (404)
                      .+..+..-                      .                            .....|           ..-.
T Consensus       396 Ql~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~  475 (586)
T KOG0667|consen  396 QLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADD  475 (586)
T ss_pred             HHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccH
Confidence            55443310                      0                            000011           1123


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          348 SSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       348 ~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.++|++||..||.+|+|..+.++
T Consensus       476 ~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  476 KLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHHHHHHHHhccCchhcCCHHHHhc
Confidence            45799999999999999999998875

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-40  Score=306.14  Aligned_cols=242  Identities=24%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             eeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||.|+||.||++++.  ++.||+|++......      .......+.+|+.+++.++||||+++++.+.+....      
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------   68 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI------   68 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc------
Confidence            689999999999985  899999999643211      122345688999999999999999999998877655      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+|+||+++++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus        69 ----------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~d  136 (262)
T cd05572          69 ----------YMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVD  136 (262)
T ss_pred             ----------EEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEee
Confidence                      8999999999999999654  4689999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCCC
Q 015594          265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       265 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~  342 (404)
                      ||++....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....  ..+....+.........
T Consensus       137 f~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  215 (262)
T cd05572         137 FGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF  215 (262)
T ss_pred             CCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC
Confidence            99997544332 2233467899999999988889999999999999999999999998776  55566666654556667


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      +..+++++.++|.+||+.+|++||+     ++++++
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            7777999999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.9e-41  Score=312.44  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||.|+||.||+|.+  +|+.||||.+.......       .....+.+|+.++++++||||+++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-------GVPSTAIREISLLKELNHPNIVKLLDVIHTENK   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-------ccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence            478899999999999999987  68999999986433221       123457789999999999999999999876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+ .++|.+++.......+++..+..++.||+.||+|||+.|++|+||+|+||+++.+
T Consensus        74 ~----------------~~v~e~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~  136 (284)
T cd07860          74 L----------------YLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE  136 (284)
T ss_pred             E----------------EEEeecc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence            4                8999999 5789998876666789999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.+||+|||++..............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+...
T Consensus       137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  216 (284)
T cd07860         137 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT  216 (284)
T ss_pred             CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999875444333344456788999999887654 688999999999999999999999876654433332211


Q ss_pred             cCCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .-.+                           .....++++++++|.+||+.||.+|||+++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000                           112346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-40  Score=315.56  Aligned_cols=244  Identities=24%  Similarity=0.350  Sum_probs=185.8

Q ss_pred             eeeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          104 KGAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      ..+||+|+||+||+|.+    +++.||+|.+.....           ...+.+|+.++++++||||+++++++...... 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-   73 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHADR-   73 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc-
Confidence            35799999999999985    457899999853221           12356899999999999999999998654332 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                                   .+|+||||+ +++|.+++....       ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus        74 -------------~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Ni  139 (317)
T cd07868          74 -------------KVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI  139 (317)
T ss_pred             -------------EEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence                         238999999 678888875321       23589999999999999999999999999999999999


Q ss_pred             EE----cCCCcEEEeeccccccccCCC---CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          253 LL----DKTRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       253 li----~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      |+    +.++.+||+|||+++......   .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         140 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             EEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99    456789999999997644322   223346789999999998764 5899999999999999999999999643


Q ss_pred             CHH---------HHHHHHHhc-----------------------cCCC-------------CCCCCCcHHHHHHHHHhhh
Q 015594          325 SFS---------EVTSAVVRQ-----------------------NLRP-------------EIPRCCPSSLANVMKRCWD  359 (404)
Q Consensus       325 ~~~---------~~~~~~~~~-----------------------~~~~-------------~~~~~~~~~l~~li~~cl~  359 (404)
                      ...         +....+...                       .+..             ......+.++.+||.+||+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  299 (317)
T cd07868         220 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT  299 (317)
T ss_pred             cccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhc
Confidence            210         111111000                       0000             0011234678899999999


Q ss_pred             hCCCCCCCHHHHHH
Q 015594          360 ANPDKRPEMDEVVA  373 (404)
Q Consensus       360 ~dP~~Rpt~~~ll~  373 (404)
                      .||.+|||++++++
T Consensus       300 ~dP~~R~t~~e~l~  313 (317)
T cd07868         300 MDPIKRITSEQAMQ  313 (317)
T ss_pred             cCcccCCCHHHHhc
Confidence            99999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.6e-40  Score=308.62  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=205.5

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      ..++|.+.+.||+|+||.||++..  +++.+|+|++.....          ....+.+|+.+++++ +|||++++++++.
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----------HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            357899999999999999999987  688999999853211          123466889999998 8999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ..+..           .....|+||||+++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus        90 ~~~~~-----------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n  158 (291)
T cd06639          90 KADKL-----------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN  158 (291)
T ss_pred             ecccc-----------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence            54322           122348999999999999988542  34578999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-----AYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      |+++.++.+||+|||++..............++..|+|||.+...     .++.++||||||+++|+|++|..||.....
T Consensus       159 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            999999999999999987544333333445688999999998643     368899999999999999999999988765


Q ss_pred             HHHHHHHHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          327 SEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       327 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......+..... ....+...+..+.++|.+||+.+|++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         239 VKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            544443332211 11224456788999999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-40  Score=322.24  Aligned_cols=246  Identities=25%  Similarity=0.399  Sum_probs=197.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +...+|.+.+.||+|+||.||++..    .++.||||.+...              ..+.+|+.++++++||||++++++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------~~~~~E~~il~~l~h~~iv~~~~~  154 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------KTPGREIDILKTISHRAIINLIHA  154 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------ccHHHHHHHHHhcCCCCccceeee
Confidence            3456799999999999999999875    3578999987532              123579999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.....+                |+|||++ +++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       155 ~~~~~~~----------------~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~N  215 (392)
T PHA03207        155 YRWKSTV----------------CMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN  215 (392)
T ss_pred             EeeCCEE----------------EEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence            8766655                8999999 6789888843  3679999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--
Q 015594          252 MLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS--  327 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~--  327 (404)
                      |||+.++.++|+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|..||.+....  
T Consensus       216 ill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  295 (392)
T PHA03207        216 IFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS  295 (392)
T ss_pred             EEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence            999999999999999997543322  1223467999999999999999999999999999999999999999754321  


Q ss_pred             -HHHHHHHh-------------------------ccCCCC--CC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          328 -EVTSAVVR-------------------------QNLRPE--IP-----RCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       328 -~~~~~~~~-------------------------~~~~~~--~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                       ..+..+..                         ...++.  .+     ...+.++.++|.+||..||++||++.+++..
T Consensus       296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             11111110                         000110  11     2346788999999999999999999999864

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-40  Score=307.26  Aligned_cols=253  Identities=31%  Similarity=0.534  Sum_probs=207.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|+..+.||+|+||.||++..  +++.||+|++.......   .........+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc---hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence            467788999999999999986  78999999987543221   1223345678899999999999999999999987766


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++|+||+++++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus        78 ~----------------~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~  139 (268)
T cd06630          78 F----------------NLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST  139 (268)
T ss_pred             E----------------EEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence            5                8999999999999998654  578999999999999999999999999999999999999877


Q ss_pred             C-cEEEeeccccccccCCCCc----ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---
Q 015594          258 R-TVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV---  329 (404)
Q Consensus       258 ~-~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~---  329 (404)
                      + .++|+|||.+.........    .....++..|+|||.+.+..++.++||||||+++|+|++|..||........   
T Consensus       140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  219 (268)
T cd06630         140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL  219 (268)
T ss_pred             CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH
Confidence            5 5999999998754432111    1234578899999999988899999999999999999999999975543322   


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..........+..+..+++++.+++.+||..+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            22223334456677788999999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.9e-40  Score=304.52  Aligned_cols=246  Identities=26%  Similarity=0.511  Sum_probs=194.2

Q ss_pred             eeeeecceEEEEEEE-CC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          106 AFARGTFGTVHRGIY-DG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~-~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      .||+|+||.||++.. ++   ..+++|.+.....        ......+.+|+.+++.++||||+++++.+.+....   
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~---   70 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY---   70 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------hHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc---
Confidence            589999999999875 33   3456666543211        11245688999999999999999999998876554   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                   |+||||+++|+|.+++.+..  ...++...+..++.||+.||.|||+.+++|+||||+|||++.++.
T Consensus        71 -------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~  137 (268)
T cd05086          71 -------------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT  137 (268)
T ss_pred             -------------EEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc
Confidence                         89999999999999996542  235677788899999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCC--CcccCCCCCccccCccccCC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          260 VKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNG-------SAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      ++|+|||++.......  .......++..|+|||++..       ..++.++||||||+++|||++ +..||...+..+.
T Consensus       138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~  217 (268)
T cd05086         138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV  217 (268)
T ss_pred             EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999986322211  12234567889999999853       245789999999999999997 5779988777666


Q ss_pred             HHHHHhcc----CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          330 TSAVVRQN----LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       330 ~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ...+....    ..+.++...++.+.+++.+|| .+|++||++++|++.|.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         218 LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            65554432    234445567889999999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-40  Score=308.22  Aligned_cols=237  Identities=26%  Similarity=0.402  Sum_probs=189.9

Q ss_pred             eeeeecceEEEEEEEC--------------------------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh
Q 015594          106 AFARGTFGTVHRGIYD--------------------------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK  159 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~~--------------------------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  159 (404)
                      .||+|+||.||+|...                          ...||+|+++..         .......+.+|+.+++.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~   72 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ   72 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence            5899999999998741                          135888887421         12234567889999999


Q ss_pred             cCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       160 l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      ++||||+++++++.+....                ++||||+++|+|..++.+. ...+++..+..++.||+.||.|||+
T Consensus        73 l~h~niv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~  135 (274)
T cd05076          73 VSHIHLAFVHGVCVRGSEN----------------IMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED  135 (274)
T ss_pred             CCCCCeeeEEEEEEeCCce----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc
Confidence            9999999999999876655                8999999999999888553 4578999999999999999999999


Q ss_pred             CCceecccCCCCEEEcCCC-------cEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHH
Q 015594          240 KKIVHRDVKTENMLLDKTR-------TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICL  311 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~-------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il  311 (404)
                      +||+||||||+|||++..+       .+||+|||++......    ....++..|+|||.+.+ ..++.++||||||+++
T Consensus       136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l  211 (274)
T cd05076         136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL  211 (274)
T ss_pred             CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence            9999999999999997543       4899999988643221    22356788999998865 5689999999999999


Q ss_pred             HHHH-hCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          312 WEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       312 ~el~-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      |||+ +|..||...+..+.... ....  ...+...++.+.++|.+||+.+|++||++.+|++.|
T Consensus       212 ~el~~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         212 LEICFDGEVPLKERTPSEKERF-YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHhCCCCCccccChHHHHHH-HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            9985 68999988766554332 2221  223344567899999999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-40  Score=311.50  Aligned_cols=251  Identities=26%  Similarity=0.505  Sum_probs=205.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|++.+.||+|+||+||++.+  +|+.||+|++.....        ......+.+|+.+++.++||||+++++.+.
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--------SSVRKQILRELQIMHECRSPYIVSFYGAFL   73 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--------chHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence            3456788999999999999999987  589999999864321        123456789999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Ni  252 (404)
                      ....+                ++||||+++++|.+++.+.  ..+++..+..++.+++.||.|||+ .+++|+||+|+||
T Consensus        74 ~~~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ni  135 (284)
T cd06620          74 NENNI----------------CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI  135 (284)
T ss_pred             cCCEE----------------EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHE
Confidence            77655                8999999999999988553  568999999999999999999997 6999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-----  327 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-----  327 (404)
                      +++.++.++|+|||++......  ......|+..|+|||++.+..++.++|||||||++|+|++|..||......     
T Consensus       136 l~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~  213 (284)
T cd06620         136 LVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD  213 (284)
T ss_pred             EECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence            9999999999999998643221  112356899999999998888999999999999999999999999865432     


Q ss_pred             ------HHHHHHHhccCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          328 ------EVTSAVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       328 ------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                            +....+.... .+.++. .++.++.+||.+||+.||++||++.++++..
T Consensus       214 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         214 DPMGILDLLQQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhhHHHHHHHHHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                  2222222222 222222 3788999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=296.83  Aligned_cols=269  Identities=20%  Similarity=0.324  Sum_probs=213.2

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      +....|+..+|++.+.||+|+|+-||++..  +++.||+|.+.....         +......+|+...++++||||+++
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---------~~~e~~~rEid~~rkf~s~~vl~l   83 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---------EDIEEALREIDNHRKFNSPNVLRL   83 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------HHHHHHHHHHHHHHhhCCcchHHH
Confidence            556678899999999999999999998875  889999999865431         113446799999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCC--cee
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKK--IVH  244 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH  244 (404)
                      +++......-           .....|++++|...|+|.+.+...  .+..+++.++++|+.+|++||.+||+..  ++|
T Consensus        84 ~dh~l~~~~D-----------~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH  152 (302)
T KOG2345|consen   84 VDHQLREEKD-----------GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH  152 (302)
T ss_pred             HHHHHHhhcc-----------CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence            8775433220           122349999999999999999654  3457999999999999999999999998  999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCC---C------CcccCCCCCccccCccccCCC---CCCcchhhHHHHHHHH
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASN---P------HDMTGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLW  312 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~---~------~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~  312 (404)
                      |||||.|||+.+.+..+|.|||.++.....   .      ++......|..|.|||.++-+   ..+.++|||||||++|
T Consensus       153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY  232 (302)
T KOG2345|consen  153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY  232 (302)
T ss_pred             cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence            999999999999999999999998742211   1      122345689999999998644   5789999999999999


Q ss_pred             HHHhCCCCCCCCCH--HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          313 EIYCCDMPYPDLSF--SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       313 el~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +|+.|.-||...-.  ..+..++....+........|+.+.++|+.||+.||.+||++.+|+..++++.
T Consensus       233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            99999999963211  11112233333332333348999999999999999999999999999998875

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.1e-40  Score=305.69  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=207.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||.|+||+||++..  ++..+|+|++.......        ....+.+|+.+++.++|+||+++++.+....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence            3688999999999999999986  67899999986432211        2355789999999999999999999987766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..                ++|+|++++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        73 ~~----------------~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~  136 (267)
T cd06610          73 EL----------------WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG  136 (267)
T ss_pred             EE----------------EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence            55                899999999999999966433 5789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCc----ccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      +++.++|+|||++.........    .....++..|+|||.+... .++.++|+||||+++|+|++|..||...+.....
T Consensus       137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~  216 (267)
T cd06610         137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL  216 (267)
T ss_pred             CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence            9999999999998754443222    1334588999999998776 7899999999999999999999999887765555


Q ss_pred             HHHHhccCCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPEIP-----RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........ +..+     ..+++.+.+++.+||+.||++||++.+|+.
T Consensus       217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         217 MLTLQNDP-PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHhcCCC-CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            44443321 1111     356889999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-40  Score=304.71  Aligned_cols=250  Identities=24%  Similarity=0.463  Sum_probs=209.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++..  +|..||+|.+.......       .....+.+|+.+++.++|+||+++++.+.....
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-------KEKEASKKEVILLAKMKHPNIVTFFASFQENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-------hhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence            478899999999999999987  67899999986432211       113456789999999999999999998876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++|+||+++++|.+++.+.....+++..+..++.||+.||.|||+.+++|+||+|+||+++++
T Consensus        74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~  137 (257)
T cd08225          74 L----------------FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN  137 (257)
T ss_pred             E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence            4                899999999999999977655578999999999999999999999999999999999999887


Q ss_pred             C-cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 R-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      + .++|+|||.+..............|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+........
T Consensus       138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  217 (257)
T cd08225         138 GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG  217 (257)
T ss_pred             CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence            5 469999999976544333333346889999999998888999999999999999999999999887766665554433


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ....+..++.++.++|.+||..+|++||++.+|++
T Consensus       218 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 Y-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             c-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            3 33455677899999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=350.69  Aligned_cols=281  Identities=23%  Similarity=0.343  Sum_probs=233.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+..++|.+.++||+|+||.|..+++  +++.||+|++.+.+...+.      -...|..|-.+|---+.+-||.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~------~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA------ETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch------hHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            3445678999999999999999998887  7899999999653322211      2456888999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      +|++...+                |+||||++||+|..++.+.  .++++..++.++..|+.||..||+.|+|||||||+
T Consensus       143 AFQD~~~L----------------YlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPD  204 (1317)
T KOG0612|consen  143 AFQDERYL----------------YLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPD  204 (1317)
T ss_pred             HhcCccce----------------EEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcc
Confidence            99988877                9999999999999999766  38999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeecccccccc-CCCCcccCCCCCccccCccccC----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEA-SNPHDMTGETGTLGYMAPEVLN----G-SAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      |||||..|+|||+|||.+-... +........+|||.|.+||++.    + +.|++.||+||+||++|||++|..||...
T Consensus       205 NvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  205 NVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             eeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            9999999999999999886544 3344556678999999999984    3 46999999999999999999999999999


Q ss_pred             CHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHHH--H-----HHhHhhcCCCCCCCCCC
Q 015594          325 SFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPE---MDEVVAM--L-----EAIDTSKGGGMIPVDQP  392 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt---~~~ll~~--L-----~~~~~~~~~~~~p~~~~  392 (404)
                      +..+++..+++-.-...+|  ..+|.++++||.+.+ -+|+.|..   ++++...  +     +.|..+. ...+|.-.+
T Consensus       285 slveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~-pP~vPevss  362 (1317)
T KOG0612|consen  285 SLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESV-PPVVPEVSS  362 (1317)
T ss_pred             HHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcC-CCCCCcCCC
Confidence            9999999998875555666  568999999999988 57888887   8887642  1     3333332 356666555


Q ss_pred             CCccccc
Q 015594          393 QGCSCFR  399 (404)
Q Consensus       393 ~~~~~~~  399 (404)
                      ...-|++
T Consensus       363 d~DTsnF  369 (1317)
T KOG0612|consen  363 DDDTSNF  369 (1317)
T ss_pred             CCccccc
Confidence            5555544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-41  Score=323.02  Aligned_cols=242  Identities=25%  Similarity=0.407  Sum_probs=191.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|.+  +++.||+|+....               ....|+.++++++||||+++++++...
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------------~~~~E~~~l~~l~h~~iv~~~~~~~~~  129 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------------TTLIEAMLLQNVNHPSVIRMKDTLVSG  129 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence            45799999999999999999998  5678999985321               124689999999999999999998876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|||++ .++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       130 ~~~----------------~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~  191 (357)
T PHA03209        130 AIT----------------CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN  191 (357)
T ss_pred             Cee----------------EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence            554                8999999 67898888653 45799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHH--H----
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY-PDLSFS--E----  328 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf-~~~~~~--~----  328 (404)
                      .++.+||+|||+++.... .....+..||+.|+|||++.+..++.++|||||||++|||+++..|+ ......  .    
T Consensus       192 ~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~  270 (357)
T PHA03209        192 DVDQVCIGDLGAAQFPVV-APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS  270 (357)
T ss_pred             CCCCEEEecCcccccccc-CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHH
Confidence            999999999999974322 22334567899999999999999999999999999999999865443 322110  0    


Q ss_pred             ---HHHHHHh-ccC-CCCC------------------------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 ---VTSAVVR-QNL-RPEI------------------------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ---~~~~~~~-~~~-~~~~------------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                         ....+.. ... ...+                              ...++.++.+||.+||+.||.+|||+.++++
T Consensus       271 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        271 CHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence               0011110 000 0000                              1235667888999999999999999999885

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-41  Score=308.49  Aligned_cols=239  Identities=26%  Similarity=0.447  Sum_probs=192.5

Q ss_pred             eeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          105 GAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +.||+|+||.||+|...         ...||+|.+...         .......+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~   71 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG   71 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence            36899999999999762         234888887421         122345678899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus        72 ~~~----------------~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~  134 (258)
T cd05078          72 DES----------------IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI  134 (258)
T ss_pred             CCc----------------EEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence            655                8999999999999998654 34689999999999999999999999999999999999997


Q ss_pred             CCCc--------EEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhC-CCCCCCCC
Q 015594          256 KTRT--------VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCC-DMPYPDLS  325 (404)
Q Consensus       256 ~~~~--------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g-~~Pf~~~~  325 (404)
                      .++.        ++++|||++.....    .....++..|+|||.+.+. .++.++||||||+++|+|++| ..||...+
T Consensus       135 ~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~  210 (258)
T cd05078         135 REEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD  210 (258)
T ss_pred             cccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence            7664        69999998864322    1224578899999999864 579999999999999999998 56776655


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ....... ...  ...++...+.++.+||.+||+.||++|||+++|++.|+
T Consensus       211 ~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         211 SQKKLQF-YED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHH-HHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            5443322 222  33456667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.6e-40  Score=308.93  Aligned_cols=267  Identities=17%  Similarity=0.248  Sum_probs=196.9

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHH--HHHHHHHHHHHHHhhcCCCceeE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIA--SLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ++...+|.+.+.||+|+||+||+|.+.     +..+|+|+..........+....  ........+...+..++|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            355678999999999999999999873     45778887654433221111110  01122334455667789999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      ++++........            .+.++++|++ ..++.+.+...  ...++..+..++.|++.||.|||+.+|+||||
T Consensus        88 ~~~~~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDi  152 (294)
T PHA02882         88 YYGCGSFKRCRM------------YYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDI  152 (294)
T ss_pred             EEEeeeEecCCc------------eEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            998765443221            1237888988 56777766443  34678889999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||+|||++.++.++|+|||+|+.......       ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       153 Kp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P  232 (294)
T PHA02882        153 KPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP  232 (294)
T ss_pred             CHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999975432211       11234689999999999999999999999999999999999999


Q ss_pred             CCCCCH-HHHHHHHH----hccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          321 YPDLSF-SEVTSAVV----RQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       321 f~~~~~-~~~~~~~~----~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |...+. ........    ..-... .....+++.+.+++..||+.+|++||++.+|++.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        233 WKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             CCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            987732 22211111    111111 123456899999999999999999999999998863

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.5e-40  Score=306.08  Aligned_cols=260  Identities=29%  Similarity=0.538  Sum_probs=207.5

Q ss_pred             eEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          101 LIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      |.+.+.||+|+||.||+|.+     +++.||||++......       ......+.+|+.++++++||||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            56778999999999999985     3688999998643221       11234577899999999999999999988654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ....          .....++++||+.+|+|.+++....    ...++...+..++.||+.||.|||++||+|+||||+|
T Consensus        74 ~~~~----------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~n  143 (273)
T cd05074          74 RAKG----------RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN  143 (273)
T ss_pred             CCCC----------cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhh
Confidence            3210          0012378999999999998875432    2357889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      |+++.++.+||+|||+++.......  ......+++.|++||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       144 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~  223 (273)
T cd05074         144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE  223 (273)
T ss_pred             EEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence            9999999999999999975432221  1122345678999999998889999999999999999999 899998887766


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ....+.... ....+..+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus       224 ~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 IYNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            655544332 3344556789999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.7e-40  Score=311.42  Aligned_cols=254  Identities=28%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||.||+|.+  +|+.||+|+++.......       ....+.+|+.++++++|+||+++++++.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-------IPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            457899999999999999999997  689999999875432211       11234579999999999999999999875


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...-              .+++||||+ .++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||++
T Consensus        78 ~~~~--------------~~~lv~e~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~  141 (309)
T cd07845          78 KHLD--------------SIFLVMEYC-EQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL  141 (309)
T ss_pred             CCCC--------------eEEEEEecC-CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            4321              238999999 46898888654 3579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+
T Consensus       142 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~  221 (309)
T cd07845         142 TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI  221 (309)
T ss_pred             CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999865544344444556888999999865 45899999999999999999999999988777665554


Q ss_pred             HhccCC-----------------CCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLR-----------------PEI-----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~-----------------~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......                 ...           ....++++.++|.+||+.||++|||+++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            431100                 000           0124788999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1e-39  Score=301.75  Aligned_cols=248  Identities=28%  Similarity=0.507  Sum_probs=210.5

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|++|.||++.+  +++.||||++......        .....+.+|+.++.+++||||+++++++.....
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE   73 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence            688899999999999999987  5899999998654321        234568899999999999999999999877655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili~~  256 (404)
                      .                ++|+||+++++|.+++...  ..+++..++.++.||+.||.|||+ .|++|+||+|+||+++.
T Consensus        74 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~  135 (264)
T cd06623          74 I----------------SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS  135 (264)
T ss_pred             E----------------EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC
Confidence            4                8999999999999999654  679999999999999999999999 99999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~---~~~~~~~~~  333 (404)
                      ++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...   ...+....+
T Consensus       136 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~  215 (264)
T cd06623         136 KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI  215 (264)
T ss_pred             CCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH
Confidence            99999999999976544433333456789999999999999999999999999999999999999877   344444444


Q ss_pred             HhccCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          334 VRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       334 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .. ...+..+.. ++..+.++|.+||..+|++||++.++++.
T Consensus       216 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         216 CD-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             hc-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            43 333444555 88999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-40  Score=309.55  Aligned_cols=249  Identities=23%  Similarity=0.465  Sum_probs=203.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||.||++.+  +|+.||+|.+.....        ......+.+|+.++++++||||+++++++....
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   72 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--------ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG   72 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence            3688899999999999999998  589999998853211        112355789999999999999999999887665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili  254 (404)
                      ..                |+||||+++++|..++.... ...+++..+..++.||+.||.|||+ .|++|+||||+||++
T Consensus        73 ~~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~  136 (286)
T cd06622          73 AV----------------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV  136 (286)
T ss_pred             eE----------------EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence            54                89999999999998885431 2378999999999999999999996 599999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +.++.++|+|||++......  ......+++.|+|||.+.+..      ++.++||||||+++|+|++|..||.......
T Consensus       137 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  214 (286)
T cd06622         137 NGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN  214 (286)
T ss_pred             CCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence            99999999999998754322  223345788999999986543      5889999999999999999999997665444


Q ss_pred             HHHHHH--hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+.  .....+..+..+++++.+||.+||+.+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            333221  223344566678999999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.9e-40  Score=306.90  Aligned_cols=244  Identities=27%  Similarity=0.394  Sum_probs=199.2

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||+|+||+||++.+  +|+.||+|++.....      ........+..|+.++++++||||+++++++......      
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------   68 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL------KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL------   68 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh------hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE------
Confidence            68999999999986  689999999864321      1122244567899999999999999999998776655      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+||||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        69 ----------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~d  138 (277)
T cd05577          69 ----------CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD  138 (277)
T ss_pred             ----------EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcc
Confidence                      8999999999999999776555799999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCC
Q 015594          265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--NLRPEI  342 (404)
Q Consensus       265 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~  342 (404)
                      ||++..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........+...  ......
T Consensus       139 fg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  217 (277)
T cd05577         139 LGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY  217 (277)
T ss_pred             Ccchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC
Confidence            999875432 22333456788999999998888999999999999999999999999765432111122111  223345


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      +..+++.+.++|.+||+.||.+||     ++.+++.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            667899999999999999999999     7777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-40  Score=306.88  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|+||.||++.+  +++.||+|++......      .......+.+|+.++++++||||+++++.+.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc------chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            488999999999999999987  5899999999643211      11234568899999999999999999988876665


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+.+++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++++
T Consensus        75 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~  136 (258)
T cd05578          75 M----------------YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ  136 (258)
T ss_pred             E----------------EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence            5                8999999999999998654  579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSAVVR  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~--~~~~~~~~~  335 (404)
                      +.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.  .+.......
T Consensus       137 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  215 (258)
T cd05578         137 GHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE  215 (258)
T ss_pred             CCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc
Confidence            999999999997544322 33446688999999999988899999999999999999999999987764  222222222


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM--DEVV  372 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~--~~ll  372 (404)
                      . .....+..++.++.++|.+||+.||.+||++  .+++
T Consensus       216 ~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         216 T-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             c-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1 4456677889999999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=306.96  Aligned_cols=246  Identities=28%  Similarity=0.500  Sum_probs=202.7

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---CCceeEEEEEEec
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPNVTKFIGATMG  174 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~  174 (404)
                      .|.+.+.||+|+||.||+|.+  +++.||||.++.....        .....+.+|+.++++++   |||++++++++.+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--------DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--------hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence            467788999999999999997  6899999998643221        11234678899999986   9999999999876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                |+||||+++++|.+++..   ..+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus        74 ~~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i  134 (277)
T cd06917          74 GPRL----------------WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV  134 (277)
T ss_pred             CCEE----------------EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence            6554                899999999999998844   378999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.++.++|+|||++..............|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~  214 (277)
T cd06917         135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI  214 (277)
T ss_pred             cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence            99999999999999765554444445678999999998865 45789999999999999999999999877654433222


Q ss_pred             HhccCCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ..+..+. ..+.++.++|.+||+.||++||++.+++.
T Consensus       215 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 PKS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            222 2223333 37889999999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.3e-40  Score=300.44  Aligned_cols=250  Identities=28%  Similarity=0.521  Sum_probs=214.0

Q ss_pred             CeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|+||.||++.+.  ++.||+|++......       ......+.+|+.+++.++|||++++++.+.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-------EKEREDALNEVKILKKLNHPNIIKYYESFEEKGK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence            4788899999999999999984  899999999654322       1224557789999999999999999999877654


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .                ++|+||+++++|.+++....  ...+++..+..++.+++.||.|||+.|++|+||+|+||+++
T Consensus        74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~  137 (258)
T cd08215          74 L----------------CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT  137 (258)
T ss_pred             E----------------EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc
Confidence            4                89999999999999986643  46799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.......
T Consensus       138 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  217 (258)
T cd08215         138 SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK  217 (258)
T ss_pred             CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence            99999999999997654443233345688999999999988899999999999999999999999988877666665554


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .. ....+..++..+.++|.+||..+|++||++.++++
T Consensus       218 ~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            43 44566788999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-40  Score=312.34  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|.....||+|+||.||++.+  +++.||||+++.....         ....+.+|+.+++.++||||+++++.+.....
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   92 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE   92 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---------hHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence            344456799999999999987  6899999998643221         13446789999999999999999999877655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+++++|.+++..   ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus        93 ~----------------~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~  153 (297)
T cd06659          93 L----------------WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD  153 (297)
T ss_pred             E----------------EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC
Confidence            5                899999999999987743   468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+....
T Consensus       154 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  233 (297)
T cd06659         154 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP  233 (297)
T ss_pred             CcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence            99999999998754443333445678999999999998889999999999999999999999998776655544433221


Q ss_pred             C-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          338 L-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       338 ~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      . ....+..++..+.++|.+||+.+|++||++++|++.
T Consensus       234 ~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1 112334578899999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-40  Score=313.57  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +.|.....||+|+||.||++.+  ++..||||.++...         ......+.+|+.+++.++||||+++++.+....
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   92 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD   92 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence            3444457799999999999987  68899999985321         122455789999999999999999999887665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++..   ..+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus        93 ~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~  153 (292)
T cd06658          93 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS  153 (292)
T ss_pred             eE----------------EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence            54                899999999999998743   46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|||++|..||...+.......+.. 
T Consensus       154 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-  232 (292)
T cd06658         154 DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-  232 (292)
T ss_pred             CCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence            9999999999987544333333445689999999999988899999999999999999999999988776555444332 


Q ss_pred             cCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          337 NLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       337 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .....  .....+..+.++|.+||..||.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            22222  223568899999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-39  Score=308.76  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...|.+.+.||+|+||+||++..  +|+.||+|++.......      ......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            35688889999999999999987  68999999986443211      12235578999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|+||+ .|+|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus        88 ~~~----------------~lv~e~~-~g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~  149 (307)
T cd06607          88 HTA----------------WLVMEYC-LGSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT  149 (307)
T ss_pred             CeE----------------EEEHHhh-CCCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC
Confidence            655                8999999 47887777543 35799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||++......    ....++..|+|||++.   ...++.++||||||+++|+|++|..||...+.......
T Consensus       150 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~  225 (307)
T cd06607         150 EPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (307)
T ss_pred             CCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH
Confidence            9999999999998653322    2356788999999874   45688999999999999999999999988776655444


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +.........+..++..+.++|.+||+.+|++||++.+|+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            433332222344578899999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-40  Score=303.67  Aligned_cols=237  Identities=27%  Similarity=0.465  Sum_probs=190.9

Q ss_pred             eeeeeecceEEEEEEECCc------------eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594          105 GAFARGTFGTVHRGIYDGQ------------DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~------------~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      +.||+|+||.||+|.+...            .+++|++.....         . ...+.+|+.++++++||||+++++++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------~-~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---------D-SLAFFETASLMSQLSHKHLVKLYGVC   70 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---------h-HHHHHHHHHHHHcCCCcchhheeeEE
Confidence            3689999999999998432            477887642211         0 35678999999999999999999988


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .. ...                ++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus        71 ~~-~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni  132 (259)
T cd05037          71 VR-DEN----------------IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI  132 (259)
T ss_pred             ec-CCc----------------EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence            76 333                89999999999999986653 3789999999999999999999999999999999999


Q ss_pred             EEcCCC-------cEEEeeccccccccCCCCcccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHh-CCCCCC
Q 015594          253 LLDKTR-------TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYC-CDMPYP  322 (404)
Q Consensus       253 li~~~~-------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~-g~~Pf~  322 (404)
                      +++.++       .+||+|||++.....    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.
T Consensus       133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~  208 (259)
T cd05037         133 LVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS  208 (259)
T ss_pred             EEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence            998887       799999999975432    2234567889999999877  78999999999999999999 588887


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ..+..+........   ...+......+.++|.+||..+|++||++.+|++.|+
T Consensus       209 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         209 TLSSSEKERFYQDQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCchhHHHHHhcC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            77644433332221   1122223378999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.2e-40  Score=306.84  Aligned_cols=245  Identities=25%  Similarity=0.423  Sum_probs=204.2

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|...+.||+|++|.||++..  +++.+|+|.++....         .....+.+|+.+++.++||||+++++++.....
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            344557999999999999986  678999998853221         123447789999999999999999999876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+|+||+++++|.+++..   .++++..+..++.||+.||.|||++|++||||+|+||+++.+
T Consensus        91 ~----------------~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~  151 (285)
T cd06648          91 L----------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD  151 (285)
T ss_pred             E----------------EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence            4                899999999999998855   468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||.+..............|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... 
T Consensus       152 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-  230 (285)
T cd06648         152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-  230 (285)
T ss_pred             CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-
Confidence            9999999998875443333333456899999999999888999999999999999999999999877766655554433 


Q ss_pred             CCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+..  +..++..+.++|.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            22222  3347889999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-40  Score=310.11  Aligned_cols=252  Identities=28%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||.|+||.||+|.+  +++.+|+|.++.....       ......+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-------EGFPITSLREINILLKLQHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence            5788999999999999999998  5889999999754322       112234668999999999999999999987662


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .              ...|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.
T Consensus        78 ~--------------~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~  141 (293)
T cd07843          78 L--------------DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN  141 (293)
T ss_pred             C--------------CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence            1              12399999995 69999886543 46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+..
T Consensus       142 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~  221 (293)
T cd07843         142 RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK  221 (293)
T ss_pred             CCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999999998655443444556678999999998764 468999999999999999999999987765554433321


Q ss_pred             c-----------------------------cCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 Q-----------------------------NLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~-----------------------------~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                             .+...++.. +++.+.++|.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            1                             011122222 5888999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=331.45  Aligned_cols=242  Identities=28%  Similarity=0.471  Sum_probs=203.5

Q ss_pred             eeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccC
Q 015594          106 AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD  183 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~  183 (404)
                      +||+|+||+||-|++  +...+|||-+....         ....+-+..|+.+.++|+|.|||+++|.+..+..+     
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~-----  647 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF-----  647 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE-----
Confidence            699999999999987  56678999885322         11234578999999999999999999997666544     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCC--cHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc-CCCcE
Q 015594          184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL--AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-KTRTV  260 (404)
Q Consensus       184 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~-~~~~v  260 (404)
                                 -|.||-++||+|.++|... =+++  .+..+..+.+||+.||.|||.+.|||||||-+||||+ -.|.+
T Consensus       648 -----------kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvl  715 (1226)
T KOG4279|consen  648 -----------KIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVL  715 (1226)
T ss_pred             -----------EEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceE
Confidence                       6899999999999998553 2455  7888899999999999999999999999999999995 46899


Q ss_pred             EEeeccccccccCCCCcccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc
Q 015594          261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSF-SEVTSAVVRQN  337 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~~-~~~~~~~~~~~  337 (404)
                      ||+|||.++....-.....++.||+.|||||++..+  +|+.++|||||||++.||.||++||-.+.. ...+.++-.-.
T Consensus       716 KISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK  795 (1226)
T KOG4279|consen  716 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK  795 (1226)
T ss_pred             EecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee
Confidence            999999998766555555568899999999999765  489999999999999999999999976643 33333444445


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..|++|..++.+.+++|.+|+..+|.+||++.+++.
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            678899999999999999999999999999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-40  Score=306.14  Aligned_cols=246  Identities=28%  Similarity=0.538  Sum_probs=203.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||.|+||.||++.+  +++.||+|.+.....        ......+.+|+.++++++||||+++++.+.....
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--------EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD   73 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--------hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence            577888999999999999998  489999999864321        1234567899999999999999999999876654


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili~~  256 (404)
                      .                ++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.
T Consensus        74 ~----------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~  136 (265)
T cd06605          74 I----------------SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS  136 (265)
T ss_pred             E----------------EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC
Confidence            4                89999999999999986543 678999999999999999999999 99999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~-----~~~~~~  331 (404)
                      ++.++|+|||.+.........  ...++..|+|||.+.+..++.++||||||+++|+|++|..||....     ..+...
T Consensus       137 ~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  214 (265)
T cd06605         137 RGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ  214 (265)
T ss_pred             CCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence            999999999998754322111  1668899999999999999999999999999999999999997652     222322


Q ss_pred             HHHhccCCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .... ...+..+.. +++++.++|.+||..||++|||+.+++.
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         215 YIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHhc-CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            3222 223334443 8899999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=313.88  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=213.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEE--ECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +.+....|..-++||+|+||.||-+.  .+|+.||+|.+++.-      .....-....++|-.+|.+++.+.||.+-.+
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR------iKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR------IKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH------HHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            34566788899999999999999665  589999999986432      2222223446789999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      |+..+.+                |+||..|+||+|.-+|.+.....++++.++-++.+|+.||++||+.+||+||+||+|
T Consensus       254 feTkd~L----------------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN  317 (591)
T KOG0986|consen  254 FETKDAL----------------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN  317 (591)
T ss_pred             ecCCCce----------------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence            9988888                999999999999998888777789999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ||+|+.|+|.|+|+|+|..+ ......++.+||.+|||||++.+..|+.+.|+|||||+||||+.|..||..........
T Consensus       318 ILLDd~GhvRISDLGLAvei-~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e  396 (591)
T KOG0986|consen  318 ILLDDHGHVRISDLGLAVEI-PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE  396 (591)
T ss_pred             eeeccCCCeEeeccceEEec-CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence            99999999999999999753 45566677799999999999999999999999999999999999999997654333222


Q ss_pred             HHHhcc--CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          332 AVVRQN--LRPEIPRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       332 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      .+.+..  -..+.+..+++++++|.+.+|+.||.+|....
T Consensus       397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            222222  23356788899999999999999999997543

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.3e-40  Score=306.27  Aligned_cols=248  Identities=25%  Similarity=0.467  Sum_probs=196.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHH-HhhcCCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV-WHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~  175 (404)
                      ++|.+.+.||+|+||.||++.+  +|+.||||.++.....   ..     ...+..|+.+ ++.++||||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~   72 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-----QKRLLMDLDISMRSVDCPYTVTFYGALFRE   72 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence            3688999999999999999997  6899999998654221   11     1223445554 6677999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCCE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENM  252 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~Ni  252 (404)
                      ...                |+||||+ .++|.+++...  ....+++..++.++.||+.||.|||++ +++||||||+||
T Consensus        73 ~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ni  135 (283)
T cd06617          73 GDV----------------WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV  135 (283)
T ss_pred             CcE----------------EEEhhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence            655                8999999 57888887543  235789999999999999999999997 999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG----SAYNRKCDVYSFGICLWEIYCCDMPYPDLS-FS  327 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~Pf~~~~-~~  327 (404)
                      +++.++.+||+|||++...... ...+...++..|+|||.+.+    ..++.++|+||||+++|+|++|..||.... ..
T Consensus       136 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  214 (283)
T cd06617         136 LINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF  214 (283)
T ss_pred             EECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH
Confidence            9999999999999999754322 22233568899999999865    457889999999999999999999997542 22


Q ss_pred             HHHHHHHhccCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVTSAVVRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +........ ..+..+ ..+|.++.++|.+||..+|++||++.+|++
T Consensus       215 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         215 QQLKQVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            333333332 233333 457899999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=303.85  Aligned_cols=270  Identities=28%  Similarity=0.472  Sum_probs=231.6

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH  162 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  162 (404)
                      ++++..+...++++...+.+|+||.||+|++       +.+.|-||.++-    +.++    .....+..|...+..+.|
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~----iQv~~~L~es~lly~~sH  346 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQ----IQVNLLLQESMLLYGASH  346 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccH----HHHHHHHHHHHHHhcCcC
Confidence            4456677788899999999999999999976       235677777642    1222    224568899999999999


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc------cCCCcHHHHHHHHHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------RRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ||+....+++.+....               .++++.++.-|+|+.||...+      .+.++..++..++.|++.|++|
T Consensus       347 ~nll~V~~V~ie~~~~---------------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~h  411 (563)
T KOG1024|consen  347 PNLLSVLGVSIEDYAT---------------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEH  411 (563)
T ss_pred             CCccceeEEEeeccCc---------------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHH
Confidence            9999999998765443               378999999999999997332      3567788899999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccC--CCCCccccCccccCCCCCCcchhhHHHHHHHHHH
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG--ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI  314 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  314 (404)
                      ||++|+||.||...|++|++..+|||+|=.+++.....+..+-+  ...+..||+||.+....|+..+||||||+++|||
T Consensus       412 lh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWEL  491 (563)
T KOG1024|consen  412 LHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWEL  491 (563)
T ss_pred             HHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHH
Confidence            99999999999999999999999999999999977766665544  4567889999999999999999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          315 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       315 ~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      +| |+.||.+.++.++... +..+++...|.+||++|..+|..||...|++||++++++..|.++.++.+
T Consensus       492 mtlg~~PyaeIDPfEm~~y-lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  492 MTLGKLPYAEIDPFEMEHY-LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             HhcCCCCccccCHHHHHHH-HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence            98 8999999999998654 56677888999999999999999999999999999999999999998876

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=305.33  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=197.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||++..  +++.||||.+........        ...+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--------PFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--------chhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            36899999999999999999987  689999999865332111        12356899999999999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+. ++|.+++.+.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus        76 ~~~----------------~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~  137 (291)
T cd07844          76 KTL----------------TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS  137 (291)
T ss_pred             CeE----------------EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc
Confidence            555                89999996 59999886553 4789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAV  333 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~-~~~~~~~~  333 (404)
                      .++.+||+|||+++.............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+....+
T Consensus       138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~  217 (291)
T cd07844         138 ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI  217 (291)
T ss_pred             CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence            9999999999998754333333344557889999999875 458899999999999999999999997654 22222111


Q ss_pred             Hhcc---------------------CCC-------CCCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQN---------------------LRP-------EIPRCCP--SSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~---------------------~~~-------~~~~~~~--~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                     ...       .....++  .++.++|.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            1100                     000       0001233  78899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.7e-40  Score=309.68  Aligned_cols=250  Identities=25%  Similarity=0.376  Sum_probs=201.8

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++.+  +++.||+|++.......       .....+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence            3688999999999999999998  57999999986433211       12345778999999999999999999987665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+|+||+++++|..+...  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        74 ~~----------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~  135 (286)
T cd07846          74 RL----------------YLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ  135 (286)
T ss_pred             eE----------------EEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence            55                899999998888876643  245899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.++|+|||++..............++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+..
T Consensus       136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  215 (286)
T cd07846         136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK  215 (286)
T ss_pred             CCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence            9999999999997654444444556788999999998753 478899999999999999999999976654433222221


Q ss_pred             c--------------------cCCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 Q--------------------NLRP---------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~--------------------~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                    ...+         .....++..+.+||.+||+.+|++||++.+|++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0                    0000         012356888999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-39  Score=307.16  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|++|+||+|.+  +|+.||||.+......       ......+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-------ccchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence            5799999999999999999987  6889999998543221       112345678999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+ +++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+||+++.
T Consensus        75 ~~----------------~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~  137 (294)
T PLN00009         75 RL----------------YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR  137 (294)
T ss_pred             eE----------------EEEEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC
Confidence            55                8999999 568888886654455788999999999999999999999999999999999985


Q ss_pred             -CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          257 -TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       257 -~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                       ++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~  217 (294)
T PLN00009        138 RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF  217 (294)
T ss_pred             CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             567999999999754443333445567899999998866 457899999999999999999999998776555444332


Q ss_pred             hccC-----------------------CC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNL-----------------------RP----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~-----------------------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...-                       ..    ......++++.++|.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        218 RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2100                       00    012346788999999999999999999999985

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-39  Score=305.25  Aligned_cols=249  Identities=26%  Similarity=0.469  Sum_probs=209.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...|.....||+|+||.||++.+  +++.||+|+++....          ....+.+|+.+++.++|+||+++++.+...
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            35688889999999999999998  489999999964322          234577899999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        88 ~~~----------------~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~  150 (286)
T cd06614          88 DEL----------------WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS  150 (286)
T ss_pred             CEE----------------EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence            555                89999999999999996653 4799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus       151 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~  230 (286)
T cd06614         151 KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT  230 (286)
T ss_pred             CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999986544333333445578899999999988899999999999999999999999988776655544444


Q ss_pred             ccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..... ..+..++..+.++|.+||+.+|.+||++.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            33322 223347899999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.5e-40  Score=308.35  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||+|.+  +|+.||||.+.......    ........+..|+.++++++|+||+++++++.+...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE----AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc----ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence            478889999999999999987  57899999997543221    011223456789999999999999999999887554


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.+
T Consensus        77 ~----------------~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~  138 (298)
T cd07841          77 I----------------NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD  138 (298)
T ss_pred             E----------------EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence            4                8999999 999999986542 379999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+...
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~  218 (298)
T cd07841         139 GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA  218 (298)
T ss_pred             CCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence            99999999999865544334444567889999999854 45789999999999999999998888776654444333221


Q ss_pred             cCC---------------------C-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLR---------------------P-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~---------------------~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                     .     ......+..+.++|.+||+.+|++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000                     0     011335788999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=296.66  Aligned_cols=248  Identities=29%  Similarity=0.517  Sum_probs=211.2

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|++|.||++..  +++.||+|.+......       ......+.+|+.++++++|||++++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence            478899999999999999987  6789999999654321       1234568899999999999999999999876554


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        74 ~----------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~  135 (254)
T cd06627          74 L----------------YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD  135 (254)
T ss_pred             E----------------EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence            4                8999999999999998654  579999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+......... ..
T Consensus       136 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~  214 (254)
T cd06627         136 GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QD  214 (254)
T ss_pred             CCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cc
Confidence            99999999999865544443445678999999999988889999999999999999999999998776554444433 23


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.++..+++.+.++|.+||..+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            345567778999999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-39  Score=305.64  Aligned_cols=249  Identities=26%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||+|.+  +|+.||||++.......       .....+.+|+.++++++||||+++++++.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-------GIPNQALREIKALQACQHPYVVKLLDVFPHGSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-------hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            588999999999999999987  68999999987543221       123457899999999999999999999877554


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++|+||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+
T Consensus        74 ~----------------~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~  135 (286)
T cd07832          74 F----------------VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD  135 (286)
T ss_pred             e----------------EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence            4                8999999 999999986543 679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC-CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          258 RTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      +.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+..
T Consensus       136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~  215 (286)
T cd07832         136 GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR  215 (286)
T ss_pred             CcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence            999999999997544332 123345689999999998654 468999999999999999999888877665444433322


Q ss_pred             ccCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..-.+                            ......+.++.++|.+||+.+|.+||++++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11000                            011345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-40  Score=306.74  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=201.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|++.+.||+|+||.||+|.+  +++.||||+++.....       ......+.+|+.++++++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-------EDVKKTALREVKVLRQLRHENIVNLKEAFRRKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-------ccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence            3689999999999999999987  5789999998643221       223456789999999999999999999998765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||++++.+..++.+  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        74 ~~----------------~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~  135 (288)
T cd07833          74 RL----------------YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE  135 (288)
T ss_pred             EE----------------EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence            54                899999977666554432  356899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      ++.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+.
T Consensus       136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  215 (288)
T cd07833         136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ  215 (288)
T ss_pred             CCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999875444332 33446678999999999888 78999999999999999999999998765544332221


Q ss_pred             hc--c--------------CC--------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQ--N--------------LR--------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~--~--------------~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..  .              ..              ...+..++.++.+||++||..+|++||+++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         216 KCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            10  0              00              0123345889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=299.84  Aligned_cols=248  Identities=22%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             CCeEEe-eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh-cCCCceeEEEEEEec
Q 015594           99 AKLIIK-GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK-LDHPNVTKFIGATMG  174 (404)
Q Consensus        99 ~~~~~~-~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  174 (404)
                      ++|.+. ++||-|-.|.|..+.+  +|+.+|+|++.-              .....+|+.+.-. -.|||||.++++|..
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------------s~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------------SPKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            566665 5799999999998887  789999999841              1234578887444 479999999999875


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      .-.-            ...+.+|||+|+||.|++.+.......++++++..|++||..|+.|||+.+|.||||||+|+|.
T Consensus       127 s~~~------------rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLy  194 (400)
T KOG0604|consen  127 SYQG------------RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLY  194 (400)
T ss_pred             hccC------------ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheee
Confidence            4322            3345789999999999999988888889999999999999999999999999999999999999


Q ss_pred             cC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----
Q 015594          255 DK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS----  327 (404)
Q Consensus       255 ~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~----  327 (404)
                      ..   +-.+||+|||+|+.. .......+.+-||.|.|||++....|+.++|+||+||++|-|+||.+||......    
T Consensus       195 t~t~~na~lKLtDfGFAK~t-~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp  273 (400)
T KOG0604|consen  195 TTTSPNAPLKLTDFGFAKET-QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP  273 (400)
T ss_pred             ecCCCCcceEeccccccccc-CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence            54   456999999999753 3356667788999999999999999999999999999999999999999654322    


Q ss_pred             HHHHHHHhccC--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+-..+....+  +.+-+.++|++.+++|+.+|..+|.+|.|++++++
T Consensus       274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            22233333333  23334678999999999999999999999999875

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6e-40  Score=309.04  Aligned_cols=249  Identities=25%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++..  +++.||+|.+.....         .....+.+|+.+++.++||||+++++.+...
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   88 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKHPNIVNYLDSYLVG   88 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---------hHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence            36889999999999999999986  678999999853221         1134578899999999999999999998776


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+|+||+++++|.+++.+   ..+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus        89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~  149 (293)
T cd06647          89 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  149 (293)
T ss_pred             CcE----------------EEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence            554                899999999999999854   3588999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|++++|..||...+.......+..
T Consensus       150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~  229 (293)
T cd06647         150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT  229 (293)
T ss_pred             CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc
Confidence            99999999999987544443333445688999999999888899999999999999999999999987655433222221


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ... ....+..++..+.++|.+||+.+|++||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111 112334567889999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-39  Score=297.05  Aligned_cols=251  Identities=31%  Similarity=0.520  Sum_probs=210.5

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|++|.||+|.+  +++.|++|++......       ......+.+|+.++++++||||+++++.+.+...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEEK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence            477889999999999999998  4899999998754332       2234567899999999999999999999876621


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                                    ..+++|+||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus        74 --------------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~  137 (260)
T cd06606          74 --------------NTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD  137 (260)
T ss_pred             --------------CeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence                          1238999999999999998665  389999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVV  334 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~-~~~~~~~~~  334 (404)
                      +.++|+|||.+........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.
T Consensus       138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  217 (260)
T cd06606         138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG  217 (260)
T ss_pred             CCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc
Confidence            9999999999976554432  1344668899999999998889999999999999999999999998776 222223333


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....+.++..++..+.++|.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            334455677788999999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.8e-40  Score=307.69  Aligned_cols=256  Identities=22%  Similarity=0.300  Sum_probs=200.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  175 (404)
                      ++|.+.+.||+|+||.||+|.+  +|+.||||+++......       .....+.+|+.+++.+. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   73 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-------GIPPTALREISLLQMLSESIYIVRLLDVEHVE   73 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-------CCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence            3688999999999999999987  68999999986432211       12244678999999994 69999999988765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ...           +...+|+||||++ ++|.+++....   ...+++..++.++.||+.||.|||++|++||||+|+||
T Consensus        74 ~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ni  141 (295)
T cd07837          74 EKN-----------GKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL  141 (295)
T ss_pred             CCC-----------CCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence            541           1122489999996 58988886542   24689999999999999999999999999999999999


Q ss_pred             EEcC-CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          253 LLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      +++. ++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus       142 l~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~  221 (295)
T cd07837         142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL  221 (295)
T ss_pred             EEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            9998 889999999999754443333344567889999998865 45789999999999999999999999877655443


Q ss_pred             HHHHhccC----------------------CC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNL----------------------RP----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~----------------------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.....                      .+    .....+++++.++|.+||..||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            33222100                      00    011347888999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-39  Score=307.29  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|...+.||+|+||.||++.+  ++..||+|++.......      ......+.+|+.++++++|||++++++++.+..
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc------hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            4578889999999999999987  68899999987543221      122345788999999999999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+. |+|.+++... ..++++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus        99 ~~----------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~  160 (317)
T cd06635          99 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE  160 (317)
T ss_pred             eE----------------EEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence            54                89999995 6888877543 456899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++|+|||++.....    .....+++.|+|||.+.   +..++.++||||||+++|+|++|..||...........+
T Consensus       161 ~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  236 (317)
T cd06635         161 PGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  236 (317)
T ss_pred             CCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            99999999999864322    22356788999999973   456889999999999999999999999887766666666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ............+++.+.+||.+||+.+|.+||++.+|++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            6555555555678899999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-39  Score=302.09  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=201.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|...+.||.|++|.||++.+  +++.||+|.+......        .....+.+|+.++++++||||+++++++.+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   72 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--------DLQKQILRELEINKSCKSPYIVKYYGAFLDES   72 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence            3688899999999999999998  6799999998643211        22455789999999999999999999886543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      .-              .+|+||||+++++|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||++
T Consensus        73 ~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~  138 (287)
T cd06621          73 SS--------------SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL  138 (287)
T ss_pred             CC--------------eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            22              238999999999999887542  34568999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-----CHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-----SFSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~-----~~~~~  329 (404)
                      +.++.++|+|||++.......  .....++..|+|||.+.+..++.++||||||+++|+|++|..||...     ...+.
T Consensus       139 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (287)
T cd06621         139 TRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL  216 (287)
T ss_pred             ecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence            999999999999986433221  12345788999999999888999999999999999999999999765     22333


Q ss_pred             HHHHHhccCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+... ..+..+      ...++++.++|.+||..+|++|||+.+|++
T Consensus       217 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         217 LSYIVNM-PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHHhcC-CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            3332221 111111      235678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=304.28  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |++.+.||.|++|.||+|.+  +|+.||||++.......       .....+.+|+.+++.++|||++++++++.+....
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-------GVPSTAIREISLLKELNHPNIVRLLDVVHSENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-------cchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence            56778999999999999987  68999999987543221       1123467899999999999999999998766544


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++
T Consensus        74 ----------------~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~  136 (283)
T cd07835          74 ----------------YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG  136 (283)
T ss_pred             ----------------EEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence                            8999999 57999998766545799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      .++|+|||++..............++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+....
T Consensus       137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (283)
T cd07835         137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL  216 (283)
T ss_pred             cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999997544333333445678899999988664 57899999999999999999999998776544333322210


Q ss_pred             C---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 L---------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                           .......++.++.++|.+||+.+|.+||+++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0                           00112456788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.4e-40  Score=311.51  Aligned_cols=243  Identities=23%  Similarity=0.343  Sum_probs=184.2

Q ss_pred             eeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          105 GAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ..||+|+||+||+|..    ++..||+|.+.....           ...+.+|+.++++++||||+++++++......  
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--   73 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHSDR--   73 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--
Confidence            5799999999999986    347899998853221           12356899999999999999999998654332  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc-------ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                                  .+++||||+ +++|.+++...       ....+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus        74 ------------~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil  140 (317)
T cd07867          74 ------------KVWLLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANIL  140 (317)
T ss_pred             ------------eEEEEEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEE
Confidence                        238999999 56888877432       1235889999999999999999999999999999999999


Q ss_pred             E----cCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          254 L----DKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       254 i----~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      +    +.++.+||+|||+++.......   ......+|+.|+|||++.+. .++.++||||||+++|||++|..||....
T Consensus       141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         141 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             EccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            9    5667899999999975443221   23345689999999998764 58999999999999999999999996432


Q ss_pred             HHH---------HHHHHHh-----------------------ccC-------------CCCCCCCCcHHHHHHHHHhhhh
Q 015594          326 FSE---------VTSAVVR-----------------------QNL-------------RPEIPRCCPSSLANVMKRCWDA  360 (404)
Q Consensus       326 ~~~---------~~~~~~~-----------------------~~~-------------~~~~~~~~~~~l~~li~~cl~~  360 (404)
                      ...         ....+..                       ...             ........+..+.+||.+||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~  300 (317)
T cd07867         221 EDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM  300 (317)
T ss_pred             ccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhcc
Confidence            110         0000000                       000             0001112356788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015594          361 NPDKRPEMDEVVA  373 (404)
Q Consensus       361 dP~~Rpt~~~ll~  373 (404)
                      ||.+|||+.++++
T Consensus       301 dP~~R~t~~e~l~  313 (317)
T cd07867         301 DPTKRITSEQALQ  313 (317)
T ss_pred             CcccccCHHHHhc
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-39  Score=302.54  Aligned_cols=249  Identities=26%  Similarity=0.418  Sum_probs=195.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||+|..  +|+.||||++.......        ....+.+|+.+++.++|+||+++++++.+..
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   76 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--------VPFTAIREASLLKGLKHANIVLLHDIIHTKE   76 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--------CcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence            5799999999999999999986  68999999986543211        1223568999999999999999999987665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+|+||+ +++|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.
T Consensus        77 ~~----------------~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~  138 (291)
T cd07870          77 TL----------------TFVFEYM-HTDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY  138 (291)
T ss_pred             eE----------------EEEEecc-cCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence            44                8999999 57888877544 346788889999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVV  334 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-~~~~~~~  334 (404)
                      ++.++|+|||+++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.. +......
T Consensus       139 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~  218 (291)
T cd07870         139 LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW  218 (291)
T ss_pred             CCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH
Confidence            9999999999997544333334445678999999998764 5788999999999999999999999765432 1111111


Q ss_pred             h----------------ccCCCC-----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 R----------------QNLRPE-----IP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~----------------~~~~~~-----~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                ......     .+         ...+.++.+++.+||+.||.+|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         219 TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0                000000     00         112568899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-40  Score=329.55  Aligned_cols=259  Identities=19%  Similarity=0.286  Sum_probs=189.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCc--------ccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESH--------RSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~--------~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ..+|.+.+.||+|+||+||++..   .+..+++|.+.......        ............+.+|+.++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            47899999999999999999875   23333333221110000        00011122345678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                      ++++++......                |+|+|++ +++|.+++....   ........+..++.||+.||.|||++||+
T Consensus       227 ~l~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi  289 (501)
T PHA03210        227 KIEEILRSEANT----------------YMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI  289 (501)
T ss_pred             cEeEEEEECCee----------------EEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            999999877665                8999999 678888775432   12344667889999999999999999999


Q ss_pred             ecccCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCC-CC
Q 015594          244 HRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PY  321 (404)
Q Consensus       244 H~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~-Pf  321 (404)
                      ||||||+||||+.++.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|.. ||
T Consensus       290 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999999999999997654332 22334679999999999999999999999999999999999875 44


Q ss_pred             CCCC--HHHHHHHHHhc------cCC---------------CCC---------CCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          322 PDLS--FSEVTSAVVRQ------NLR---------------PEI---------PRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       322 ~~~~--~~~~~~~~~~~------~~~---------------~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      ....  .......+...      .+.               ...         ...++.++.++|.+||+.||.+|||+.
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            3322  11111111110      000               000         113466788899999999999999999


Q ss_pred             HHHH
Q 015594          370 EVVA  373 (404)
Q Consensus       370 ~ll~  373 (404)
                      |++.
T Consensus       450 elL~  453 (501)
T PHA03210        450 ELLA  453 (501)
T ss_pred             HHhh
Confidence            9985

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-39  Score=314.54  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +|+.||||++......       ......+.+|+.++++++||||+++++++...
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-------VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-------hhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            47899999999999999999987  7899999998532211       11224466899999999999999999998755


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...          ......|+||||+ .++|.+.+..    .+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus        88 ~~~----------~~~~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~  152 (353)
T cd07850          88 KSL----------EEFQDVYLVMELM-DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  152 (353)
T ss_pred             CCc----------cccCcEEEEEecc-CCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence            432          1122348999999 5688887743    289999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus       153 ~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  231 (353)
T cd07850         153 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE  231 (353)
T ss_pred             CCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            9999999999999754332 223345678999999999999999999999999999999999999987664443332221


Q ss_pred             ccCC--------------------C---------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR--------------------P---------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~--------------------~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..-.                    +                     ..+...++.+.++|.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000                    0                     001234667899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=299.55  Aligned_cols=244  Identities=24%  Similarity=0.371  Sum_probs=197.1

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHH-HhhcCCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV-WHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||.|+||.||+|.+  +|+.||||++......     .... ...+..|..+ ....+||||+++++++......   
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~---   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL---   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHH-HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE---
Confidence            5689999999999987  6889999998643211     1111 1223344443 4455899999999999876655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+|+||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++
T Consensus        73 -------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~  137 (260)
T cd05611          73 -------------YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK  137 (260)
T ss_pred             -------------EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence                         8999999999999998654  5789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--C
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL--R  339 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~--~  339 (404)
                      |+|||++.....    .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.....  .
T Consensus       138 l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  213 (260)
T cd05611         138 LTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP  213 (260)
T ss_pred             Eeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC
Confidence            999999875332    2334678899999999888899999999999999999999999988877766655544332  2


Q ss_pred             CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       340 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ......+++.+.++|.+||+.+|++||++..+.+.|.
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            3344568999999999999999999997765555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-40  Score=313.00  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  168 (404)
                      .....|....|++.+.||.|+.+.||++.. +.+.||+|.+.....+       ......|.+|+..|.+| .|.+||.+
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-------~qtl~gy~nEI~lL~KLkg~~~IIqL  425 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-------NQTLDGYRNEIALLNKLKGHDKIIQL  425 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-------HHHHHHHHHHHHHHHHhcCCceEEEE
Confidence            345567778899999999999999999987 5577888877543322       33457789999999999 59999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      |++-..++.+                ||||||= .-+|..+|.+.......+ .+..+..||+.++.++|.+||||.|||
T Consensus       426 ~DYEv~d~~l----------------YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLK  487 (677)
T KOG0596|consen  426 YDYEVTDGYL----------------YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLK  487 (677)
T ss_pred             eeeeccCceE----------------EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhceeecCCC
Confidence            9998776555                9999997 789999997654433333 788899999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCC-----------CCcchhhHHHHHHHHHHH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSA-----------YNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~  315 (404)
                      |.|+|+-. |.+||+|||.|........  ....++||+.||+||.+....           .++++||||||||||+|+
T Consensus       488 PANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv  566 (677)
T KOG0596|consen  488 PANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV  566 (677)
T ss_pred             cccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence            99999975 6899999999986554432  234578999999999985332           568999999999999999


Q ss_pred             hCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcH-HHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          316 CCDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       316 ~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .|+.||.... .-..+.++...+...++|..-+. ++.++|+.||++||.+||+..+||+
T Consensus       567 YgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  567 YGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            9999998764 33334444444333344444333 3999999999999999999999985

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-39  Score=297.84  Aligned_cols=248  Identities=30%  Similarity=0.524  Sum_probs=209.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||+|+||.||++.+  +++.+|+|.+......       ......+.+|+.++++++|+||+++++.+.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-------QKEREDAVNEIRILASVNHPNIISYKEAFLDGNK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence            478899999999999999986  6789999998643321       1123456789999999999999999988876644


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .                |+|+||+++++|.+++.+.  ....+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus        74 ~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~  137 (256)
T cd08530          74 L----------------CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV  137 (256)
T ss_pred             E----------------EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe
Confidence            4                8999999999999998552  235689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..
T Consensus       138 ~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  215 (256)
T cd08530         138 ANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR  215 (256)
T ss_pred             cCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            9999999999999765433  23345688999999999999899999999999999999999999998887666555443


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ..+..+..++.++.++|.+||+.+|++||++.++++
T Consensus       216 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 G-KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             C-CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            3 334555678999999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-39  Score=300.93  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||.|+||.||++.+  +|+.||+|++.....      ........+.+|+.++++++||||+++++.+......      
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------   68 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------   68 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE------
Confidence            58899999999998  489999999864321      1123356678999999999999999999888765554      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+|+||+++++|.+++.+.  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus        69 ----------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~d  136 (265)
T cd05579          69 ----------YLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTD  136 (265)
T ss_pred             ----------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEe
Confidence                      8999999999999998654  3789999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCC--------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          265 FGVARLEASNPH--------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       265 fg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ||++........        ......++..|+|||...+..++.++||||||+++|+|++|..||......+....+...
T Consensus       137 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~  216 (265)
T cd05579         137 FGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG  216 (265)
T ss_pred             cccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            999875433321        223345788999999998888999999999999999999999999888877766665554


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ..........+..+.++|.+||+.+|.+|||+..+.+.|+
T Consensus       217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            3332222224899999999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=333.42  Aligned_cols=263  Identities=35%  Similarity=0.633  Sum_probs=225.8

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      .|+++.+++.+.+.||.|.||.|++|...         ...||||.++.....        ...+.+..|+.+|+.+ +|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------~~~~~~~~El~~m~~~g~H  361 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------SEKKDLMSELNVLKELGKH  361 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------HHHHHHHHHHHHHHHhcCC
Confidence            79999999999999999999999998742         357999998643221        2356688999999999 59


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc------------c--CCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------------R--RKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~  228 (404)
                      |||+.++|++.....+                ++|+||+..|+|.+++..++            .  ..++....+.++.
T Consensus       362 ~niv~llG~~t~~~~~----------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~  425 (609)
T KOG0200|consen  362 PNIVNLLGACTQDGPL----------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAY  425 (609)
T ss_pred             cchhhheeeeccCCce----------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHH
Confidence            9999999999886555                89999999999999997764            0  2389999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCC--CccccCccccCCCCCCcchhhH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETG--TLGYMAPEVLNGSAYNRKCDVY  305 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dvw  305 (404)
                      ||+.|++||++.++|||||...||||..+..+||+|||+|+...... .......+  ...|||||.+....|+.++|||
T Consensus       426 QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVW  505 (609)
T KOG0200|consen  426 QIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVW  505 (609)
T ss_pred             HHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhh
Confidence            99999999999999999999999999999999999999998543332 22233333  3459999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          306 SFGICLWEIYC-CDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       306 slG~il~el~~-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ||||+||||++ |..||++.. ..++ ...+..+.+.+.|..|++++++||+.||+.+|++||++.++.+.|+....
T Consensus       506 SfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  506 SFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            99999999999 899999977 5555 45788889999999999999999999999999999999999999999543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-39  Score=302.36  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=190.9

Q ss_pred             eeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHH---HHhhcCCCceeEEEEEEecCCcccc
Q 015594          106 AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA---VWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      .||+|+||.||++..  +++.||||++..........      ...+.+|..   ++...+||||+.+++++......  
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~--   72 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG------ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL--   72 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE--
Confidence            479999999999987  68999999986443221111      112233433   33445899999999998876655  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                    ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus        73 --------------~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~  136 (279)
T cd05633          73 --------------CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV  136 (279)
T ss_pred             --------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCE
Confidence                          8999999999999988654  569999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC
Q 015594          261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-SAVVRQNL  338 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~-~~~~~~~~  338 (404)
                      +|+|||++......  ......|++.|+|||.+. +..++.++||||||+++|+|++|..||......... ........
T Consensus       137 ~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  214 (279)
T cd05633         137 RISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV  214 (279)
T ss_pred             EEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC
Confidence            99999998643322  223356899999999986 456899999999999999999999999754322211 11122233


Q ss_pred             CCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          339 RPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       339 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ....+..+++++.++|.+||..||.+||     ++.++++
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            4556778899999999999999999999     5888877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-39  Score=305.52  Aligned_cols=251  Identities=27%  Similarity=0.473  Sum_probs=197.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      .++|...+.||+|+||.||++.+  +++.||||.+......        .....+.+|+.++.++. ||||+++++++..
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~   74 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR   74 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence            34677788999999999999987  6799999998643221        22456788999999996 9999999999876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHH---HhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCC
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL---IKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTE  250 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~  250 (404)
                      ....                +++|||+ +++|.++.   .......+++..+..++.|++.||+|||+. +++||||||+
T Consensus        75 ~~~~----------------~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~  137 (288)
T cd06616          75 EGDC----------------WICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPS  137 (288)
T ss_pred             CCcE----------------EEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHH
Confidence            6544                8999999 55665543   223346799999999999999999999975 9999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCH-
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLSF-  326 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~Pf~~~~~-  326 (404)
                      ||+++.++.++|+|||++...... .......++..|+|||++.+.   .++.++||||||+++|+|++|..||..... 
T Consensus       138 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  216 (288)
T cd06616         138 NILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV  216 (288)
T ss_pred             HEEEccCCcEEEeecchhHHhccC-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence            999999999999999999754322 222334688999999999776   689999999999999999999999976542 


Q ss_pred             HHHHHHHHhcc---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          327 SEVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       327 ~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .+.........   +....+..++.++.+||.+||+.+|++|||+++|+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12222222111   1112233578999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.6e-39  Score=292.69  Aligned_cols=246  Identities=30%  Similarity=0.561  Sum_probs=206.2

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|++|.||++.+  +++.+++|++.....         .....+.+|+.+++.++||||+++++.+.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            477889999999999999998  488999999864322         224567899999999999999999999877655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++++||+++++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus        72 ~----------------~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~  134 (253)
T cd05122          72 L----------------WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD  134 (253)
T ss_pred             E----------------EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence            4                89999999999999986542 578999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... .
T Consensus       135 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~  212 (253)
T cd05122         135 GEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-N  212 (253)
T ss_pred             CeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-c
Confidence            9999999999975443322 3445688999999999988899999999999999999999999988765554444333 2


Q ss_pred             CCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+..+..  ++..+.++|.+||+.||++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22223322  3889999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-39  Score=312.42  Aligned_cols=276  Identities=24%  Similarity=0.309  Sum_probs=213.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||+||++.+  +++.||||.+.......       .....+.+|+.+++.++||||+++++++....
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-------IDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-------chhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            5799999999999999999987  68999999986432111       11234568999999999999999999876543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..           .....|+|+||+ +++|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.
T Consensus        78 ~~-----------~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~  143 (337)
T cd07858          78 RE-----------AFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA  143 (337)
T ss_pred             cc-----------ccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence            21           112348999999 57898888543  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+||+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus       144 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  223 (337)
T cd07858         144 NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE  223 (337)
T ss_pred             CCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            999999999999765443333445568899999998864 4689999999999999999999999977654332221111


Q ss_pred             c-----------------------c-C--C---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhHhhcCC
Q 015594          336 Q-----------------------N-L--R---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM--LEAIDTSKGG  384 (404)
Q Consensus       336 ~-----------------------~-~--~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~~~~~~  384 (404)
                      .                       . .  .   ......+++++.++|.+||+.+|++|||++++++.  |+.+..... 
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~-  302 (337)
T cd07858         224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD-  302 (337)
T ss_pred             HhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc-
Confidence            0                       0 0  0   01124578899999999999999999999999976  776654443 


Q ss_pred             CCCCCCCCCCcccc
Q 015594          385 GMIPVDQPQGCSCF  398 (404)
Q Consensus       385 ~~~p~~~~~~~~~~  398 (404)
                        .|..+.+.-+||
T Consensus       303 --~~~~~~~~~~~~  314 (337)
T cd07858         303 --EPVCQTPFSFDF  314 (337)
T ss_pred             --CccCCCccchhh
Confidence              444555556665

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-39  Score=300.56  Aligned_cols=249  Identities=25%  Similarity=0.413  Sum_probs=201.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|++.+.||.|++|.||+|++  +|+.||||+++......        ....+.+|+.++++++||||+++++.+.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--------TPSTAIREISLMKELKHENIVRLHDVIHTENK   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence            478899999999999999998  68999999987543211        12345679999999999999999999987765


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .                ++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||+|+||++++
T Consensus        73 ~----------------~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~  135 (284)
T cd07836          73 L----------------MLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK  135 (284)
T ss_pred             E----------------EEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC
Confidence            5                89999996 58888885542 346899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.++|+|||++..............++..|++||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus       136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~  215 (284)
T cd07836         136 RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR  215 (284)
T ss_pred             CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9999999999997544433333445678999999988654 578999999999999999999999987766554443322


Q ss_pred             cc----------------CCCC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN----------------LRPE-----------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~----------------~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                +...           +...+++.+.++|.+||+.||.+||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11                0001           11245788999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=348.92  Aligned_cols=249  Identities=29%  Similarity=0.473  Sum_probs=211.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      ++.-...||.|.||.||-|.+  +|...|||-+.......       .....+.+|..++..++|||+|+++|+-...+.
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~-------k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH-------KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc-------ccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            344567899999999999986  79999999887654332       223446789999999999999999999888887


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                +|.||||++|+|.+.+..  ++..++.....+..|++.|+.|||+.|||||||||.||+++.+
T Consensus      1309 v----------------~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1309 V----------------YIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred             H----------------HHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence            7                779999999999998843  3567888888999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcc----cCCCCCccccCccccCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDM----TGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |.+|++|||.|.....+..++    ....||+.|||||++.+.   +-..++|||||||++.||+||+.||..++..=..
T Consensus      1371 g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI 1450 (1509)
T KOG4645|consen 1371 GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI 1450 (1509)
T ss_pred             CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH
Confidence            999999999998665554333    345799999999999654   4678999999999999999999999887655444


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      -..+..+-.|.+|..++++-++||..||+.||..|+++.+|++
T Consensus      1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            4445667788899999999999999999999999999887764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-39  Score=301.63  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=208.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  175 (404)
                      ++|.+.+.||+|+||.||++..  +|+.||+|++......      .......+.+|+.++++++ ||||+++++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            3689999999999999999987  6899999998643211      1112355778999999998 99999999988766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        75 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~  136 (280)
T cd05581          75 ENL----------------YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD  136 (280)
T ss_pred             ceE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence            554                8999999999999999664  4799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC--------------------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPH--------------------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      .++.++|+|||++........                    ......++..|+|||.+.+..++.++||||||+++|+++
T Consensus       137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~  216 (280)
T cd05581         137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML  216 (280)
T ss_pred             CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence            999999999999875443221                    112245788999999998888999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 015594          316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM----DEVVA  373 (404)
Q Consensus       316 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~~ll~  373 (404)
                      +|..||...+.......+..  ....++..+++.+.++|.+||+.+|.+||++    +++++
T Consensus       217 ~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         217 TGKPPFRGSNEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hCCCCCCCccHHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            99999988776555444442  3335667789999999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=309.00  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=201.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||+|.+  +|+.||||+++....        ......+.+|+.++++++||||+++++++....
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--------QTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--------chhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            6799999999999999999987  689999999853211        112345678999999999999999998876543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..           .....|+|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+||+++.
T Consensus        77 ~~-----------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~  141 (336)
T cd07849          77 FE-----------SFNDVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT  141 (336)
T ss_pred             cc-----------ccceEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence            21           112348999999 5688887733   47999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC---cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++.+||+|||++........   ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......
T Consensus       142 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~  221 (336)
T cd07849         142 NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL  221 (336)
T ss_pred             CCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999975432211   1233568899999998654 5689999999999999999999999987654333222


Q ss_pred             HHhcc------------------------CCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHhHh
Q 015594          333 VVRQN------------------------LRPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM--LEAIDT  380 (404)
Q Consensus       333 ~~~~~------------------------~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~~~~  380 (404)
                      +....                        ....     .....++++.++|.+||+.+|++|||+.++++.  |+.+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            21100                        0000     012357789999999999999999999999986  665543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-38  Score=301.13  Aligned_cols=245  Identities=26%  Similarity=0.415  Sum_probs=202.2

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |...+.||+|+||+||+|++  +|+.||+|++.......      ......+.+|+.+++.++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT------NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc------hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            56667899999999999987  68999999987543221      11234577899999999999999999999876655


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      |+||||+ .++|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++
T Consensus        97 ----------------~lv~e~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~  158 (313)
T cd06633          97 ----------------WLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG  158 (313)
T ss_pred             ----------------EEEEecC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC
Confidence                            8999999 56888877543 35789999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+||+|||++....    ......|+..|+|||.+.   +..++.++||||||+++|+|++|..||...+..........
T Consensus       159 ~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~  234 (313)
T cd06633         159 QVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  234 (313)
T ss_pred             CEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            99999999986322    223456889999999984   45688999999999999999999999988776555555544


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..........++..+.+||.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            44433444567888999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-39  Score=308.19  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             eeeeee--cceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          105 GAFARG--TFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       105 ~~lg~G--~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ..||+|  +||+||++.+  +|+.||||++......   .    ...+.+.+|+.+++.++||||++++++|......  
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~--   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---E----EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL--   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---H----HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce--
Confidence            346666  9999999987  7899999998654321   1    1235678899999999999999999999876655  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                    |+|+||+.+++|.+++.+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++.+
T Consensus        75 --------------~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~  140 (328)
T cd08226          75 --------------WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV  140 (328)
T ss_pred             --------------EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcE
Confidence                          899999999999999877655679999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCCCcc-------cCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          261 KIADFGVARLEASNPHDM-------TGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +++||+.+..........       ....++..|+|||++.+.  .++.++||||||+++|+|++|..||..........
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~  220 (328)
T cd08226         141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL  220 (328)
T ss_pred             EEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence            999998654322211110       112346679999999764  47899999999999999999999998776544432


Q ss_pred             HHHhcc---------------------------------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          332 AVVRQN---------------------------------------------LRPEIPRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       332 ~~~~~~---------------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      ......                                             .....+..+++.+.+||++||+.||++||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp  300 (328)
T cd08226         221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP  300 (328)
T ss_pred             HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence            222110                                             01111234577899999999999999999


Q ss_pred             CHHHHHH--HHHHhH
Q 015594          367 EMDEVVA--MLEAID  379 (404)
Q Consensus       367 t~~~ll~--~L~~~~  379 (404)
                      |++++++  .+..+.
T Consensus       301 ta~e~l~~~~~~~~~  315 (328)
T cd08226         301 SASSLLSHAFFKQVK  315 (328)
T ss_pred             CHHHHhhCHHHHHHH
Confidence            9999973  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.3e-39  Score=301.96  Aligned_cols=242  Identities=26%  Similarity=0.401  Sum_probs=201.4

Q ss_pred             EeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          103 IKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ....||+|+||.||++..  +|+.||||.+....         ......+.+|+.+++.++|+||+++++.+......  
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--   92 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL--   92 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE--
Confidence            346789999999999987  68999999875322         11245578999999999999999999999876655  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                    ++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus        93 --------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~  155 (292)
T cd06657          93 --------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV  155 (292)
T ss_pred             --------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence                          899999999999997743   368999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 015594          261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP  340 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  340 (404)
                      +|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+. .....
T Consensus       156 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~  234 (292)
T cd06657         156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPP  234 (292)
T ss_pred             EEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCc
Confidence            99999998754433333344568899999999988889999999999999999999999998776555443332 22222


Q ss_pred             C--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          341 E--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       341 ~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .  ....++..+.++|.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            2  23457889999999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9e-39  Score=301.32  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=203.4

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCcee
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVT  166 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  166 (404)
                      ....|.+..++|.+.+.||+|+||.||++.+.  ++.||||.++.....        .....+..|+.++.++ +||||+
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~~i~   77 (296)
T cd06618           6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--------EENKRILMDLDVVLKSHDCPYIV   77 (296)
T ss_pred             cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--------HHHHHHHHHHHHHHhccCCCchH
Confidence            34566778899999999999999999999984  899999998643211        1123455677666666 599999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceec
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHR  245 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~  245 (404)
                      ++++++.+....                |+||||+ +++|.+++... ...+++..+..++.||+.||.|||+ .||+|+
T Consensus        78 ~~~~~~~~~~~~----------------~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~  139 (296)
T cd06618          78 KCYGYFITDSDV----------------FICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHR  139 (296)
T ss_pred             hhheeeecCCeE----------------EEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence            999998876655                8999999 66888776553 3579999999999999999999997 599999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      ||+|+||+++.++.+||+|||++..... ........++..|+|||.+.+..    ++.++||||||+++|+|++|..||
T Consensus       140 dl~p~nill~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  218 (296)
T cd06618         140 DVKPSNILLDASGNVKLCDFGISGRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY  218 (296)
T ss_pred             CCcHHHEEEcCCCCEEECccccchhccC-CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999875432 22233446788999999987654    788999999999999999999999


Q ss_pred             CCCCH-HHHHHHHHhccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          322 PDLSF-SEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       322 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..... .+....+....... .....++.++.+||.+||..||.+||++++++..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            76432 23333333332211 1223478999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=305.14  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=194.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +|.+.+.||+|+||.||+|..    +++.||||++.......      ......+.+|+.++.+++||||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY------TGISQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc------cCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            478899999999999999997    57899999997543111      11224457899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ...              ..|+||||++ ++|.+++....   ...+++..++.++.||+.||.|||+.+|+||||||+||
T Consensus        75 ~~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Ni  139 (316)
T cd07842          75 ADK--------------SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI  139 (316)
T ss_pred             CCc--------------eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence            221              2389999994 57877774432   23689999999999999999999999999999999999


Q ss_pred             EEcC----CCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          253 LLDK----TRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       253 li~~----~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      +++.    ++.+||+|||++........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...
T Consensus       140 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             EEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            9998    99999999999975433322   22344678899999988664 5889999999999999999999999755


Q ss_pred             CHHH---------HHHHHHh------------------------ccCCCCCC-----------CCCcHHHHHHHHHhhhh
Q 015594          325 SFSE---------VTSAVVR------------------------QNLRPEIP-----------RCCPSSLANVMKRCWDA  360 (404)
Q Consensus       325 ~~~~---------~~~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~cl~~  360 (404)
                      ....         ....++.                        .......+           ...+.++.++|.+||+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  299 (316)
T cd07842         220 EAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY  299 (316)
T ss_pred             cccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcC
Confidence            4321         0000000                        00011111           14567899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 015594          361 NPDKRPEMDEVVA  373 (404)
Q Consensus       361 dP~~Rpt~~~ll~  373 (404)
                      ||++|||+.+++.
T Consensus       300 ~P~~Rps~~eil~  312 (316)
T cd07842         300 DPTKRITAEEALE  312 (316)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-38  Score=296.87  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=191.8

Q ss_pred             eeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccC
Q 015594          106 AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD  183 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~  183 (404)
                      .||+|+||.||++.+  +++.||+|++.......... +  .........+..++..+||||+++++++.+....     
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-----   72 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-E--TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL-----   72 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh-H--HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE-----
Confidence            479999999999886  67899999987543221111 1  1111111233445556899999999999877665     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEe
Q 015594          184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA  263 (404)
Q Consensus       184 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~  263 (404)
                                 |+||||+.|++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+
T Consensus        73 -----------~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~  139 (278)
T cd05606          73 -----------SFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS  139 (278)
T ss_pred             -----------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEc
Confidence                       8999999999999988543  579999999999999999999999999999999999999999999999


Q ss_pred             eccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccCCCC
Q 015594          264 DFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-SAVVRQNLRPE  341 (404)
Q Consensus       264 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~~  341 (404)
                      |||++......  ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||......... ...........
T Consensus       140 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  217 (278)
T cd05606         140 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE  217 (278)
T ss_pred             cCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC
Confidence            99998744322  22345789999999999754 6899999999999999999999999876322111 11112223455


Q ss_pred             CCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          342 IPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       342 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .+..++.++.+++.+||..+|.+||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            6677899999999999999999999     9999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.4e-39  Score=296.29  Aligned_cols=252  Identities=29%  Similarity=0.520  Sum_probs=204.2

Q ss_pred             CeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||+|+||.||++.+.  +..+++|+++..........+    ...+..|+.++++++||||+++++.+.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE----TVQANQEAQLLSKLDHPAIVKFHASFLERDA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcch----HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence            5888999999999999999873  456777776532221111111    2235578999999999999999998876655


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .                ++|+||+++++|.+++..  .....+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus        77 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~  140 (260)
T cd08222          77 F----------------CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK  140 (260)
T ss_pred             e----------------EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee
Confidence            4                899999999999998854  2345799999999999999999999999999999999999997


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      . +.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..........
T Consensus       141 ~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~  219 (260)
T cd08222         141 N-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE  219 (260)
T ss_pred             c-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence            5 569999999997654443334445688999999999888899999999999999999999999987766555444433


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       ...+..+..++.++.++|.+||..+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             3444566788999999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-38  Score=296.75  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=193.6

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSE  177 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  177 (404)
                      |.+.+.||+|+||.||++..  +++.||+|.++......   .     .....+|+.++.++. ||||+++++++.+...
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   72 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---E-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKT   72 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---h-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence            56788999999999999987  68999999986432211   1     112347888888885 9999999999876621


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      -              ..++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++. 
T Consensus        73 ~--------------~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-  135 (282)
T cd07831          73 G--------------RLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-  135 (282)
T ss_pred             C--------------cEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence            1              2289999995 6888887553 357899999999999999999999999999999999999999 


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.+||+|||++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+...
T Consensus       136 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~  214 (282)
T cd07831         136 DILKLADFGSCRGIYSK-PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV  214 (282)
T ss_pred             CCeEEEecccccccccC-CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence            99999999999754322 22334567899999997644 45789999999999999999999999887655543332210


Q ss_pred             c----------------CCCCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 N----------------LRPEI-----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~----------------~~~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                ....+           ...++.++.+||.+||+.+|++||++++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0                00001           1246789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-38  Score=299.25  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      +|.+.+.||+|+||.||++..     +++.||||+++....     .........+.+|+.++.++ +||||+++++.+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence            478889999999999999874     467899999863211     11122345678999999999 6999999999887


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                |+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        76 ~~~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil  137 (288)
T cd05583          76 TDTKL----------------HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL  137 (288)
T ss_pred             cCCEE----------------EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            66554                8999999999999998653  56899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCc-ccCCCCCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCC----H
Q 015594          254 LDKTRTVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLS----F  326 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~Pf~~~~----~  326 (404)
                      ++.++.++|+|||+++........ .....++..|+|||.+.+..  .+.++||||||+++|+|++|..||....    .
T Consensus       138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~  217 (288)
T cd05583         138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ  217 (288)
T ss_pred             ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence            999999999999998754333221 22345889999999987764  7889999999999999999999996432    2


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .+....+..  ..+..+..++..+.++|.+||+.||++|||+.++.+.|+..
T Consensus       218 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         218 SEISRRILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHHHHHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            222222222  23455677889999999999999999999998888777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-38  Score=300.82  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=200.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +.++|.+.+.||+|+||.||++..  +++.||||.+.......       .....+.+|+.++++++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-------GFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-------CchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            356899999999999999999987  68999999986433211       112335679999999999999999998876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....        ........++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus        83 ~~~~--------~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~  152 (310)
T cd07865          83 KATP--------YNRYKGSFYLVFEFC-EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI  152 (310)
T ss_pred             cccc--------ccCCCceEEEEEcCC-CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            5432        122334569999999 56888877543 3478999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCC----cccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +.++.+||+|||++........    ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+....
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~  232 (310)
T cd07865         153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ  232 (310)
T ss_pred             CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999975433221    22344578899999988664 478899999999999999999999987665433


Q ss_pred             HHHHHh--ccCCCC---------------C-------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVR--QNLRPE---------------I-------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~--~~~~~~---------------~-------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+..  ....+.               .             +...++.+.+||.+||..||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            222111  000000               0             1123567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=300.78  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=214.7

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      .+...+|.+..+||+|+||.|.++...  .+.||||++++..--+....+.      -..|-++|... +-|.++.+..+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvec------tm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVEC------TMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccc------eehhhhheecCCCCchHHHHHHH
Confidence            456678999999999999999999874  4789999998764333333222      23455566555 57789999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      |+..+.+                |+||||+.||+|--.+.+-  +++-+..++-++.+|+-||-+||++||++||||.+|
T Consensus       419 FQTmDRL----------------yFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDN  480 (683)
T KOG0696|consen  419 FQTMDRL----------------YFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDN  480 (683)
T ss_pred             hhhhhhe----------------eeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccc
Confidence            9888887                8999999999998888654  678899999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ||++.+|.+||+|||++...........+.+|||.|+|||++.-.+|+.++|+||+||+||||+.|+.||.+.+..++..
T Consensus       481 vmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~  560 (683)
T KOG0696|consen  481 VMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ  560 (683)
T ss_pred             eEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999999999876666777778999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      ++...+.  ..|+.+|.+..++....|...|.+|.
T Consensus       561 aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 AIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence            9988765  47889999999999999999999994

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-38  Score=299.79  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=204.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ...++|++.+.||.|+||.||+|.+  +|+.||||+++.......       ....+.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-------~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-------FPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-------chHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            3457899999999999999999998  689999999975432211       1234568999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +.....      .+..+...+|+|+||++ ++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+
T Consensus        77 ~~~~~~------~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nil  148 (302)
T cd07864          77 DKQDAL------DFKKDKGAFYLVFEYMD-HDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL  148 (302)
T ss_pred             Ccchhh------hccccCCcEEEEEcccC-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            655210      11122335699999995 4787777543 357899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +++++.+||+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+...
T Consensus       149 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~  228 (302)
T cd07864         149 LNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE  228 (302)
T ss_pred             ECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999997544332 222334567889999988654 57899999999999999999999998766554443


Q ss_pred             HHHhccCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+......+                            .....+|..+.++|.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            332211000                            012246889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-38  Score=300.00  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|...+.||+|+||.||+|++  +++.||||.+.......      ......+.+|+.+++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC------hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            4477778999999999999987  67899999986432211      112345778999999999999999999988765


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus        89 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~  150 (308)
T cd06634          89 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE  150 (308)
T ss_pred             ee----------------EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC
Confidence            44                89999995 6888877543 356899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++|+|||++.....    .....+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+..+....+
T Consensus       151 ~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  226 (308)
T cd06634         151 PGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (308)
T ss_pred             CCcEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH
Confidence            99999999999875432    22346788999999974   345788999999999999999999999887665555555


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ............++..+.+||.+||+.+|++||++.+++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            44444333455688999999999999999999999998865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-39  Score=332.57  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=195.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|+....||+|+||.||++++  +|+.||||.+....        .......+.+|+.++.+|+|||||+++.+|.+..
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            4567778999999999999987  89999999997543        1233455789999999999999999998865322


Q ss_pred             ccccccC----C------------C--------------------------CCC--------------------------
Q 015594          177 ELNIQTD----N------------G--------------------------HIG--------------------------  188 (404)
Q Consensus       177 ~~~i~~~----~------------~--------------------------~~~--------------------------  188 (404)
                      .......    .            +                          ..+                          
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence            1100000    0            0                          000                          


Q ss_pred             ---------------------------CCC--------CceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHH
Q 015594          189 ---------------------------MPS--------NFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARG  233 (404)
Q Consensus       189 ---------------------------~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~  233 (404)
                                                 ..+        .++||-||||+..+|.+++.++.... ....+++++++|+.|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence                                       011        57799999998888888886653221 367789999999999


Q ss_pred             HHHHhhCCceecccCCCCEEEcCCCcEEEeecccccccc------------------CCCCcccCCCCCccccCccccCC
Q 015594          234 LSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA------------------SNPHDMTGETGTLGYMAPEVLNG  295 (404)
Q Consensus       234 L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~  295 (404)
                      |.|+|++|||||||||.||+++.++.|||+|||+|....                  .+..+.++.+||.-|+|||++.+
T Consensus       710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            999999999999999999999999999999999997511                  11235577889999999999976


Q ss_pred             CC---CCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          296 SA---YNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVVRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       296 ~~---~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      ..   |+.|+|+|||||+++||+   +||.- +.....+..+....++.+   ....+ +.-+.+|+.|++.||.+|||+
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCH
Confidence            65   999999999999999998   45642 233333333332222222   11222 334789999999999999999


Q ss_pred             HHHHH
Q 015594          369 DEVVA  373 (404)
Q Consensus       369 ~~ll~  373 (404)
                      .+|+.
T Consensus       866 ~eLL~  870 (1351)
T KOG1035|consen  866 TELLN  870 (1351)
T ss_pred             HHHhh
Confidence            99984

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.8e-39  Score=304.13  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=195.2

Q ss_pred             EEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          102 IIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      .+.+.+|.|+++.|+++..+++.||||++.......       .....+.+|+.+++.++||||+++++++.+....   
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~---   74 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL---   74 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE---
Confidence            344555666777777777789999999997542211       1235588999999999999999999998876655   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   +++|||+++++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+|
T Consensus        75 -------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~k  141 (314)
T cd08216          75 -------------YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV  141 (314)
T ss_pred             -------------EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceE
Confidence                         8999999999999999776556789999999999999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCC-------cccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          262 IADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |+|||.+........       ......++..|+|||++.+.  .++.++||||||+++|+|++|..||...........
T Consensus       142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~  221 (314)
T cd08216         142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (314)
T ss_pred             EecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999998864332211       11234567889999998763  588999999999999999999999987654443322


Q ss_pred             HHhccCC--------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLR--------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~--------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......                                ......++.++.+||.+||+.||++|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            2211100                                0011223567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=299.68  Aligned_cols=256  Identities=34%  Similarity=0.592  Sum_probs=209.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc--CCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL--DHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~  175 (404)
                      ..++.+.+.||+|.||.||+|.|.|+.||||++.-.++            ..+.+|.++++..  +|+||+.|+++=...
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------------~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------------RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccch------------hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            36788999999999999999999999999999964332            3466777777765  999999999886544


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC--------Cceeccc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--------KIVHRDV  247 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------givH~Di  247 (404)
                      ...            ..-+++|.+|.+.|+|.|||.+   ..++....++++..++.||++||..        .|.||||
T Consensus       278 ~gs------------~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl  342 (513)
T KOG2052|consen  278 NGS------------WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL  342 (513)
T ss_pred             CCc------------eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence            332            2345999999999999999965   4899999999999999999999975        4999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCC----CCcccCCCCCccccCccccCCCC------CCcchhhHHHHHHHHHHHhC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASN----PHDMTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g  317 (404)
                      |..||||..++...|+|+|+|-.....    +......+||.+|||||++...-      .-..+||||||+++||++.-
T Consensus       343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999643322    12234578999999999997542      12468999999999999752


Q ss_pred             ----------CCCCCC-----CCHHHHHHHHHhccCCCCCCCCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          318 ----------DMPYPD-----LSFSEVTSAVVRQNLRPEIPRCCP-----SSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       318 ----------~~Pf~~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                                .+||.+     .+.+++..-+..+.++|.+|....     ..+..||+.||..||.-|.|+-.|-+.|.+
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence                      578854     466677666777888988886653     346788999999999999999999999998


Q ss_pred             hHh
Q 015594          378 IDT  380 (404)
Q Consensus       378 ~~~  380 (404)
                      +..
T Consensus       503 l~~  505 (513)
T KOG2052|consen  503 LSN  505 (513)
T ss_pred             Hhc
Confidence            874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=310.15  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=211.7

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      ++||.|.||+||-|++  +|+.||||++++-.-..+.+       .++.+|++||+.++||.||.+...|+..+.+    
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-------sqlR~EVaILq~l~HPGiV~le~M~ET~erv----  638 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-------SQLRNEVAILQNLHHPGIVNLECMFETPERV----  638 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchH-------HHHHHHHHHHHhcCCCCeeEEEEeecCCceE----
Confidence            6899999999998887  79999999998654433222       4467999999999999999999999988887    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc---CCCc
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRT  259 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~---~~~~  259 (404)
                                  ++|||-+ .|+..+++.....+.++++....++.||+.||.|||.++|+|+||||+|||+.   .-.+
T Consensus       639 ------------FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQ  705 (888)
T KOG4236|consen  639 ------------FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQ  705 (888)
T ss_pred             ------------EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCc
Confidence                        8999999 67777777677778999999999999999999999999999999999999994   3457


Q ss_pred             EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c
Q 015594          260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--N  337 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~--~  337 (404)
                      +||+|||+|++.... ......+|||.|+|||++..+.|+++-|+||.||++|.-++|..||....  ++..++...  -
T Consensus       706 vKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFM  782 (888)
T KOG4236|consen  706 VKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFM  782 (888)
T ss_pred             eeeccccceeecchh-hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccc
Confidence            999999999976543 44456789999999999999999999999999999999999999996542  333333332  3


Q ss_pred             CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH-----------HHHHHhHhhcCCC
Q 015594          338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV-----------AMLEAIDTSKGGG  385 (404)
Q Consensus       338 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll-----------~~L~~~~~~~~~~  385 (404)
                      +++..+..++.+..+||..+|+..-.+|.+.+.-+           .-|..+....|..
T Consensus       783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeR  841 (888)
T KOG4236|consen  783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGER  841 (888)
T ss_pred             cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcc
Confidence            45566788999999999999999999999987654           3456666666643

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-38  Score=305.11  Aligned_cols=277  Identities=25%  Similarity=0.313  Sum_probs=209.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      ..+|.+.+.||+|+||.||+|.+  +|+.+|||.+......       ......+.+|+.+++++ +||||+++++++..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-------chhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            36788999999999999999987  6889999988532111       11123466899999999 99999999998865


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....              ..|+||||+. ++|.+++...   .+++..+..++.||+.||.|||+.||+|+||||+||++
T Consensus        79 ~~~~--------------~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill  140 (337)
T cd07852          79 ENDK--------------DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL  140 (337)
T ss_pred             CCCc--------------eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            4322              2389999995 6998887543   78899999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCC-----cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPH-----DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +.++.+||+|||++........     ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+
T Consensus       141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~  220 (337)
T cd07852         141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN  220 (337)
T ss_pred             cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            9999999999999975443221     2233568899999998754 457899999999999999999999998765444


Q ss_pred             HHHHHHhcc----------------------CC-------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHH
Q 015594          329 VTSAVVRQN----------------------LR-------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM--LEA  377 (404)
Q Consensus       329 ~~~~~~~~~----------------------~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--L~~  377 (404)
                      ....+....                      ..       ......++.++.++|.+||+.||++|||+.++++.  ++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence            322221110                      00       01123368899999999999999999999999974  555


Q ss_pred             hHhhcCCCCCCCCCCCCccccccCC
Q 015594          378 IDTSKGGGMIPVDQPQGCSCFRKYR  402 (404)
Q Consensus       378 ~~~~~~~~~~p~~~~~~~~~~~~~~  402 (404)
                      +.+.   ...|....+.-.+|.+++
T Consensus       301 ~~~~---~~~~~~~~~~~~~~~~~~  322 (337)
T cd07852         301 FHNP---SDEPVLPYPITIPLDDNV  322 (337)
T ss_pred             hccC---CCCCCCCCCccCCccccc
Confidence            5332   233333344444555554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=303.82  Aligned_cols=256  Identities=22%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CCeE-EeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccH-----HHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           99 AKLI-IKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSE-----AEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        99 ~~~~-~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .+|. +.+.||.|+||+||++.+  +++.||||++..........     .........+.+|+.++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 557799999999999986  68999999986543221100     000001224678999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++......                |+||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+
T Consensus        88 ~~~~~~~~----------------~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~  148 (335)
T PTZ00024         88 VYVEGDFI----------------NLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPA  148 (335)
T ss_pred             EEecCCcE----------------EEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH
Confidence            98766544                89999995 7999988543  56899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccC--------------CCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEAS--------------NPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~  315 (404)
                      ||+++.++.++|+|||++.....              .........+++.|+|||.+.+. .++.++||||||+++|+|+
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999975441              11222334568889999998764 4689999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCC-------------------C-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          316 CCDMPYPDLSFSEVTSAVVRQNLR-------------------P-------EIPRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       316 ~g~~Pf~~~~~~~~~~~~~~~~~~-------------------~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      +|..||...+..+....+....-.                   .       .....++.++.++|.+||+.+|++||+++
T Consensus       229 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  308 (335)
T PTZ00024        229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK  308 (335)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence            999999887765554433221000                   0       01134578899999999999999999999


Q ss_pred             HHHH
Q 015594          370 EVVA  373 (404)
Q Consensus       370 ~ll~  373 (404)
                      +++.
T Consensus       309 ~~l~  312 (335)
T PTZ00024        309 EALK  312 (335)
T ss_pred             HHhc
Confidence            9985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=300.94  Aligned_cols=260  Identities=31%  Similarity=0.518  Sum_probs=214.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc--CCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL--DHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~  175 (404)
                      ...+.+.++||+|.||.||+|.++++.||||++..            ...+.|.+|-+|++..  .|+||++|+++-...
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCH------------HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            45677888999999999999999999999999962            2256677887777655  899999999987655


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC---------Cceecc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK---------KIVHRD  246 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------givH~D  246 (404)
                      ...            ..-+++|+||.+.|+|.+||..+   .++|....+++..|++||+|||+.         .|+|||
T Consensus       277 t~~------------~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD  341 (534)
T KOG3653|consen  277 TAD------------RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD  341 (534)
T ss_pred             Ccc------------ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence            422            11238999999999999999765   899999999999999999999975         499999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccC--CCCcccCCCCCccccCccccCCCC------CCcchhhHHHHHHHHHHHhC-
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEAS--NPHDMTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYCC-  317 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g-  317 (404)
                      ||..||||.++++..|+|||+|..+..  ...+..+++||.+|||||++.|.-      .-.+.||||+|.+||||++- 
T Consensus       342 lkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  342 LKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             ccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            999999999999999999999975443  233445689999999999997752      12468999999999999873 


Q ss_pred             -----------CCCCC-----CCCHHHHHHHHHhccCCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          318 -----------DMPYP-----DLSFSEVTSAVVRQNLRPEIPRCC-----PSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       318 -----------~~Pf~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                                 ++||+     ..+..++...+++.+.+|.++..+     ..-+.+.+..||+.||+.|.|+.=+.+.+.
T Consensus       422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             ccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence                       24453     346677878888888898887543     456899999999999999999999888888


Q ss_pred             HhHhhcCC
Q 015594          377 AIDTSKGG  384 (404)
Q Consensus       377 ~~~~~~~~  384 (404)
                      ++......
T Consensus       502 ~l~~~~~~  509 (534)
T KOG3653|consen  502 ELMMLWED  509 (534)
T ss_pred             HHhccCCc
Confidence            88776643

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.6e-39  Score=306.41  Aligned_cols=253  Identities=22%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++..  +|+.||+|++.......       .....+.+|+.++++++||||+++++++....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-------TLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-------cchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            6899999999999999999986  68999999986432211       12345678999999999999999998776433


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..            ...+|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.
T Consensus        78 ~~------------~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~  142 (334)
T cd07855          78 AD------------FKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE  142 (334)
T ss_pred             CC------------CceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence            11            23348999999 57898888543  56999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCC----cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ++.+||+|||++........    ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+......
T Consensus       143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~  222 (334)
T cd07855         143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK  222 (334)
T ss_pred             CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence            99999999999975433221    1234568899999999865 458999999999999999999999998766443322


Q ss_pred             HHHhc----------------------cCC--CC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQ----------------------NLR--PE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~----------------------~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+...                      ...  ..     .....++++.++|.+||+.+|++||++.+++.
T Consensus       223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            21110                      000  11     11346889999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.2e-38  Score=296.51  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=199.2

Q ss_pred             CeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      .|++.+.||.|+||.||++..     +|+.||+|++.....     .........+.+|+.++.++ +|+||+++++.+.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-----hhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence            478889999999999999875     678999999863211     11122345577899999999 6999999999887


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                |+|+||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++||||+|+|||
T Consensus        76 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil  137 (290)
T cd05613          76 TDTKL----------------HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL  137 (290)
T ss_pred             cCCeE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence            66544                8999999999999998654  56899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC----H
Q 015594          254 LDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLS----F  326 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~----~  326 (404)
                      ++.++.+||+|||++....... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....    .
T Consensus       138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~  217 (290)
T cd05613         138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ  217 (290)
T ss_pred             ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence            9999999999999997543322 122235688999999998753  46889999999999999999999996432    2


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .+....+..  ..+..+..+++.+.+++.+||+.||++||     ++++++.
T Consensus       218 ~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         218 AEISRRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHHHhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            222222222  23345677899999999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=297.20  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=202.1

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |.+.+.||+|++|.||++..  +|+.+|+|.++......       .....+.+|+.++++++|+||+++++++.+....
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence            45678899999999999987  68999999986433221       2235577899999999999999999988766544


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++|+||++ ++|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++
T Consensus        74 ----------------~~v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~  135 (283)
T cd05118          74 ----------------YLVFEFMD-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG  135 (283)
T ss_pred             ----------------EEEEeccC-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC
Confidence                            89999995 5888888653 35799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      .++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~  215 (283)
T cd05118         136 VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL  215 (283)
T ss_pred             cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99999999997655443334445678899999998776 78999999999999999999999998877655444332211


Q ss_pred             CC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LR----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                            ......++.++.++|.+||+.||.+||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00                            0112346789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=295.06  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEEecC
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGATMGT  175 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~  175 (404)
                      |.+.+.||+|+||.||++.+  +++.||||.+.......       .....+.+|+.+++++   +||||+++++++.+.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   73 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-------GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP   73 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-------hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence            57789999999999999998  48999999996543211       1123345677666655   699999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...           .....+++|||+. ++|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+||+++
T Consensus        74 ~~~-----------~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~  141 (287)
T cd07838          74 RTD-----------RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT  141 (287)
T ss_pred             cCC-----------CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence            541           1112389999995 6899988765545799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.++|+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       142 ~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07838         142 SDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD  220 (287)
T ss_pred             cCCCEEEeccCcceeccCC-cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence            9999999999998754322 222334578899999999998899999999999999999999999988876665554443


Q ss_pred             ccCC------------------CC-------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR------------------PE-------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~------------------~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                  ..       .....++.+.++|.+||+.||.+||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            2110                  00       01124577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=289.54  Aligned_cols=238  Identities=27%  Similarity=0.390  Sum_probs=201.7

Q ss_pred             eeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||.|+||.||++.+  +++.||+|++.......      ......+..|+.++++++||||+++++.+.+....      
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------   68 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL------   68 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee------
Confidence            68999999999987  48999999986432211      12244578899999999999999999888766555      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                |+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus        69 ----------~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d  136 (250)
T cd05123          69 ----------YLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTD  136 (250)
T ss_pred             ----------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEee
Confidence                      8999999999999999654  4689999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 015594          265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR  344 (404)
Q Consensus       265 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  344 (404)
                      ||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..  ....++.
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  214 (250)
T cd05123         137 FGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPE  214 (250)
T ss_pred             cCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCC
Confidence            99997654433334456688999999999988899999999999999999999999987776555555544  3445777


Q ss_pred             CCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          345 CCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       345 ~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      .++..+.++|.+||..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            78999999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-38  Score=292.45  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=189.9

Q ss_pred             CCeEEeeee--eeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           99 AKLIIKGAF--ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        99 ~~~~~~~~l--g~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      .+|.+.+.+  |+|+||.||++..  +++.+|+|++......   .           .|+.+...+ +||||+++++.+.
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~-----------~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A-----------IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h-----------hhHHHHHHhhcCCCEEEEEEEEe
Confidence            345555555  9999999999986  6889999998632211   0           122222222 7999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+
T Consensus        80 ~~~~~----------------~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil  141 (267)
T PHA03390         80 TLKGH----------------VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL  141 (267)
T ss_pred             cCCee----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            77655                8999999999999998654  38999999999999999999999999999999999999


Q ss_pred             EcCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          254 LDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++ .++|+|||++......    ....++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  217 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE  217 (267)
T ss_pred             EeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence            99888 9999999998754322    234678999999999998899999999999999999999999986543332111


Q ss_pred             HHh--ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 015594          333 VVR--QNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVA  373 (404)
Q Consensus       333 ~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~  373 (404)
                      ...  .......+..+++.+.++|.+||+.+|.+||+ ++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111  12223445578999999999999999999995 688874

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=304.41  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=208.5

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|.+.+.||.|+||.||++.+  +++.||||.+......       ....+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-------LIDAKRILREIKLLRHLRHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-------chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence            588999999999999999997  5799999998643211       1223557889999999999999999998876642


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .           ....+|+||||+. ++|.+++.+.  ..+++..+..++.||+.||.|||+.||+|+||||+||+++.+
T Consensus        74 ~-----------~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~  139 (330)
T cd07834          74 E-----------DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN  139 (330)
T ss_pred             c-----------cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence            1           1123489999995 6898888543  489999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCC---CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.++|+|||++.......   .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+
T Consensus       140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i  219 (330)
T cd07834         140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI  219 (330)
T ss_pred             CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            999999999998644432   223445678999999999888 7899999999999999999999999887765554443


Q ss_pred             HhccCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHh
Q 015594          334 VRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAIDT  380 (404)
Q Consensus       334 ~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~  380 (404)
                      ....-.+                             .....++.++.++|.+||+.+|.+||++++++.  .|+.+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            3311000                             012336788999999999999999999999997  3665544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=300.19  Aligned_cols=263  Identities=22%  Similarity=0.345  Sum_probs=207.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      |.+ .++|.+.+.||+|+||.||++..  +|+.||||++.....       .......+.+|+.+++.++||||++++++
T Consensus        11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (343)
T cd07880          11 WEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMKHENVIGLLDV   82 (343)
T ss_pred             hcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCccceeee
Confidence            444 57899999999999999999987  689999999853211       12224457799999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.......          .....++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus        83 ~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~N  148 (343)
T cd07880          83 FTPDLSLD----------RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN  148 (343)
T ss_pred             ecCCcccc----------ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            87654331          112348999999 8899888743   468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |+++.++.++|+|||++.....   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.....
T Consensus       149 ill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  225 (343)
T cd07880         149 LAVNEDCELKILDFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL  225 (343)
T ss_pred             EEEcCCCCEEEeeccccccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999975332   2234567899999999876 45889999999999999999999999876654433


Q ss_pred             HHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH--HHHHHhH
Q 015594          331 SAVVRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV--AMLEAID  379 (404)
Q Consensus       331 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll--~~L~~~~  379 (404)
                      ..+......                             ......+++.+.++|.+||+.||.+|||+.+++  ..++.+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            332211100                             011245678899999999999999999999999  5566554


Q ss_pred             hh
Q 015594          380 TS  381 (404)
Q Consensus       380 ~~  381 (404)
                      ..
T Consensus       306 ~~  307 (343)
T cd07880         306 DP  307 (343)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=317.00  Aligned_cols=256  Identities=28%  Similarity=0.533  Sum_probs=219.6

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CC----ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DG----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      .....++||+|+||+||+|.+  .|    -+||||++....        .......+..|+.+|.+++|||+++++|+++
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--------~~~~s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--------SPKASIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--------CchhhHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            445668999999999999998  33    579999985321        1222455789999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ... +                -||++|++.|+|.+|+..+ +.++.-+..+.|+.||++||.|||.+++|||||.+.|||
T Consensus       769 ~s~-~----------------qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL  830 (1177)
T KOG1025|consen  769 LST-L----------------QLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL  830 (1177)
T ss_pred             cch-H----------------HHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee
Confidence            776 3                4799999999999999775 568999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCC--CCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT  330 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~  330 (404)
                      |..-..|||+|||+++.............  -.+.|||-|.+....|+.++|||||||++||++| |..||.+.+..++.
T Consensus       831 VksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~  910 (1177)
T KOG1025|consen  831 VKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP  910 (1177)
T ss_pred             ecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh
Confidence            99999999999999997766655544333  3567999999999999999999999999999998 99999999988875


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .. +....+...|..|+-+++.+|.+||..|+..||+++++...+.++...-
T Consensus       911 dl-le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  911 DL-LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HH-HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            44 5555568889999999999999999999999999999999988775433

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=299.18  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +|+.||||+++.....       ......+.+|+.++++++||||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            47899999999999999999986  6899999998643211       11234467899999999999999999988654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ....          ..+..|++++++ +++|.+++..   ..+++..+..++.||+.||.|||+.||+|+||||+||+++
T Consensus        89 ~~~~----------~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~  154 (345)
T cd07877          89 RSLE----------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN  154 (345)
T ss_pred             cccc----------ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc
Confidence            3221          112347888887 8899887743   3689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++.....   ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.
T Consensus       155 ~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (345)
T cd07877         155 EDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  231 (345)
T ss_pred             CCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999875322   2334567899999999866 468899999999999999999999998766544333322


Q ss_pred             hccC------------------------CC-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          335 RQNL------------------------RP-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       335 ~~~~------------------------~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ....                        .+     ......++++.++|.+||+.||.+||++.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            1100                        00     0112357889999999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-37  Score=295.03  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=199.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||.|+||.||++.+  +++.||||++.........       ...+.+|+.+++.++||||+++++.+.+.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-------PITALREIKILKKLKHPNVVPLIDMAVER   79 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-------chhHHHHHHHHHhcCCCCccchhhheecc
Confidence            47899999999999999999997  6889999998654322111       12356899999999999999999887654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ....        ......+++|+||+ .++|...+... ...+++..+..++.||+.||.|||++|++|+||||+||+++
T Consensus        80 ~~~~--------~~~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~  149 (311)
T cd07866          80 PDKS--------KRKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID  149 (311)
T ss_pred             cccc--------cccCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            4321        12233558999999 55777776443 45799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC-----------cccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          256 KTRTVKIADFGVARLEASNPH-----------DMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      .++.++|+|||+++.......           ..+...+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+
T Consensus       150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            999999999999975433221           11223568889999988654 588999999999999999999999987


Q ss_pred             CCHHHHHHHHHhccCC---------------------CCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          324 LSFSEVTSAVVRQNLR---------------------PEI-------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~---------------------~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+.......+......                     ...       ....++.+.++|.+||+.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            7665544333221000                     000       0234467899999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=291.96  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=198.5

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |.+.+.||.|+||.||+|..  +|+.+|+|.+......       ......+.+|+.+++.++|||++++++++.+..  
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK-------EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccc-------ccchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence            56789999999999999987  5799999999754311       112345678999999999999999999987662  


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                  ...+++|+||++ ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+||++++++
T Consensus        72 ------------~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~  137 (287)
T cd07840          72 ------------KGSIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG  137 (287)
T ss_pred             ------------CCcEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC
Confidence                        112389999995 5898887543 25799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCC-CcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          259 TVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      .++|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+...
T Consensus       138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~  217 (287)
T cd07840         138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL  217 (287)
T ss_pred             CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            99999999997544332 12344567889999998765 45789999999999999999999999877655544433321


Q ss_pred             cCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                             ..+...++.++.++|.+||+.+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000                             0011224788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-38  Score=301.06  Aligned_cols=264  Identities=22%  Similarity=0.364  Sum_probs=205.1

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ....|++. .+|.+.+.||+|+||.||+|++  +|+.||||++......       ......+.+|+.+++.++||||++
T Consensus         7 ~~~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~   78 (342)
T cd07879           7 NKTVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-------EIFAKRAYRELTLLKHMQHENVIG   78 (342)
T ss_pred             hhhhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-------ccchhHHHHHHHHHHhcCCCCccc
Confidence            34456663 6899999999999999999986  6899999998643211       112344678999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.......          .....|+|+||+ ..+|..++    ...+++..+..++.|++.||.|||+.|++||||
T Consensus        79 ~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl  143 (342)
T cd07879          79 LLDVFTSAVSGD----------EFQDFYLVMPYM-QTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDL  143 (342)
T ss_pred             hhheecccccCC----------CCceEEEEeccc-ccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence            999986553321          122348999999 45777654    246899999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      ||+||+++.++.+||+|||+++....   ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus       144 kp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~  220 (342)
T cd07879         144 KPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY  220 (342)
T ss_pred             CHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999875322   2334567889999999876 4689999999999999999999999987765


Q ss_pred             HHHHHHHHhccC---------------------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HH
Q 015594          327 SEVTSAVVRQNL---------------------RPEI--------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA--ML  375 (404)
Q Consensus       327 ~~~~~~~~~~~~---------------------~~~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L  375 (404)
                      ......+....-                     .+..        ...++.++.++|.+||+.||.+||++.+++.  .+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f  300 (342)
T cd07879         221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF  300 (342)
T ss_pred             HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence            444433322100                     0000        1245778999999999999999999999994  46


Q ss_pred             HHhH
Q 015594          376 EAID  379 (404)
Q Consensus       376 ~~~~  379 (404)
                      +.+.
T Consensus       301 ~~~~  304 (342)
T cd07879         301 DSFR  304 (342)
T ss_pred             hhcc
Confidence            6654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-37  Score=298.69  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             CeEEeeeeeeecceEEEEEEEC----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594          100 KLIIKGAFARGTFGTVHRGIYD----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      +|.+.+.||+|+||.||++.+.    +..||||.+......       ....+.+.+|+.+++++ +||||+++++.+..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-------KILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-------chhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            4788999999999999999973    679999998532111       11234567899999999 59999999987543


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...            .....|+++||+ +++|.+++..  ...+++..++.++.||+.||.|||+.|++||||||+||++
T Consensus        74 ~~~------------~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili  138 (332)
T cd07857          74 FPG------------NFNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV  138 (332)
T ss_pred             ccc------------cCCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence            211            112348899999 5799998854  3579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCC----cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +.++.+||+|||++........    ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+....
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~  218 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ  218 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence            9999999999999975432211    2233568999999998765 4689999999999999999999999987654433


Q ss_pred             HHHHHhcc------------------------C--CC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQN------------------------L--RP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~------------------------~--~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+....                        .  ..   .....++..+.+++.+||+.||.+|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            32221100                        0  00   112335788999999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-38  Score=292.54  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=196.4

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSE  177 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  177 (404)
                      |.+.+.||+|+||+||+|..  +++.||||.+......        .......+|+..+.+++ ||||+++++++.+...
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   72 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--------WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE   72 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence            56788999999999999998  5789999988532211        01122457899999999 9999999999877554


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+
T Consensus        73 ~----------------~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~  135 (283)
T cd07830          73 L----------------YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP  135 (283)
T ss_pred             E----------------EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence            4                8999999 8899998876544578999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.++|+|||++..... ........++..|+|||++. +..++.++|+||||+++|+|++|..||+..+..+........
T Consensus       136 ~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~  214 (283)
T cd07830         136 EVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV  214 (283)
T ss_pred             CCEEEeecccceeccC-CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh
Confidence            9999999999975432 22234456788999999874 445789999999999999999999999877654443322210


Q ss_pred             -----------------cCCC-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 -----------------NLRP-----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 -----------------~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                       ....           ......+.++.++|.+||+.+|++||++++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                             0000           001122678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-37  Score=298.74  Aligned_cols=261  Identities=20%  Similarity=0.265  Sum_probs=199.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||.|+||.||+|..  +|+.||+|.+.....         .....+.+|+.++++++||||+++++++...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---------QSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---------chHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            36899999999999999999987  688999999865432         1134467899999999999999999887654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .....  ...........+|+||||+. ++|.+++..   ..+++..+..++.||+.||.|||+.|++||||||+||+++
T Consensus        75 ~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~  148 (342)
T cd07854          75 GSDLT--EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN  148 (342)
T ss_pred             ccccc--cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence            42211  00011223345699999995 689888743   4689999999999999999999999999999999999997


Q ss_pred             -CCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 -KTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 -~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                       .++.++|+|||++........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+..
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             456789999999975432111   1122457889999998754 56889999999999999999999999876654443


Q ss_pred             HHHHhcc-----------------------CCC-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQN-----------------------LRP-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~-----------------------~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......                       ...     .....++.++.++|.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            3332210                       000     012346788999999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.8e-37  Score=296.87  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||.|+||.||++..  +++.||||.+......       ......+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-------PVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-------cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            46799999999999999999986  6899999988543211       11234567899999999999999999988653


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..               .+|+|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus        82 ~~---------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~  142 (328)
T cd07856          82 LE---------------DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN  142 (328)
T ss_pred             CC---------------cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC
Confidence            32               238999999 7789888743   4688889999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.++|+|||.+....   .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.
T Consensus       143 ~~~~~~l~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~  219 (328)
T cd07856         143 ENCDLKICDFGLARIQD---PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT  219 (328)
T ss_pred             CCCCEEeCccccccccC---CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999987432   22234567889999998765 568999999999999999999999998765433221111


Q ss_pred             hc----------------------cC--CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          335 RQ----------------------NL--RPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       335 ~~----------------------~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..                      .+  ...     ....+++++.++|.+||+.+|++||++++++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10                      00  000     113467899999999999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-38  Score=302.28  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..|++ .++|.+...||+|+||.||+|.+  +++.||||++......       ......+.+|+.++++++||||++++
T Consensus         9 ~~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07851           9 TVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-------AIHAKRTYRELRLLKHMDHENVIGLL   80 (343)
T ss_pred             ceecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-------hhHHHHHHHHHHHHHhccCCCHHHHH
Confidence            34455 46899999999999999999998  5789999998542111       11234467899999999999999998


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++......          .....+|+|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.||+|+||+|
T Consensus        81 ~~~~~~~~~----------~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp  146 (343)
T cd07851          81 DVFTPASSL----------EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP  146 (343)
T ss_pred             HHhhccccc----------cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            877654431          1122348999999 7899998854   4699999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+
T Consensus       147 ~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~  223 (343)
T cd07851         147 SNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID  223 (343)
T ss_pred             HHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            9999999999999999999754322   344567889999999865 367899999999999999999999998776655


Q ss_pred             HHHHHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+....-.+                             .....++.++.++|.+||+.+|++|||+.+|+.
T Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         224 QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            444332211000                             011245889999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=308.00  Aligned_cols=238  Identities=24%  Similarity=0.374  Sum_probs=199.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      .+.|.+...+|.|+|++|-++.+  +++..+||++......             ..+|+.++... +||||+++.+++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------------~~~e~~~~~~~~~h~niv~~~~v~~~  387 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------------NQDEIPISLLVRDHPNIVKSHDVYED  387 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc-------------cccccchhhhhcCCCcceeecceecC
Confidence            56788888899999999999987  7899999999755221             12455444444 89999999999998


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..+.                |+|||.+.|+.|.+-+...   +.....+..|+.+|+.|+.|||++|+||||+||+|||+
T Consensus       388 ~~~~----------------~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~  448 (612)
T KOG0603|consen  388 GKEI----------------YLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL  448 (612)
T ss_pred             Ccee----------------eeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence            8877                8999999999988877554   23337888999999999999999999999999999999


Q ss_pred             -cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 -DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 -~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                       ++.++++|+|||.++.....   +.+.+-|..|.|||++...+|+.+|||||||++||+|++|..||.......   .+
T Consensus       449 ~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei  522 (612)
T KOG0603|consen  449 DGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EI  522 (612)
T ss_pred             cCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HH
Confidence             68999999999999864433   445667899999999999999999999999999999999999998776552   22


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...-..+.+..++|+.+++||.+||+.||.+||++.++..
T Consensus       523 ~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  523 HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            3333345556889999999999999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=290.17  Aligned_cols=248  Identities=28%  Similarity=0.429  Sum_probs=200.7

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |++.+.||+|.||.||+|+.  +++.||+|++......       ......+.+|+.++++++|+||+++++++.+....
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLKELKHPNIVKLLDVIHTERKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-------ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence            56678899999999999998  5899999999754311       11123456899999999999999999998776544


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++|+||++ ++|.+++.+.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++
T Consensus        74 ----------------~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~  135 (282)
T cd07829          74 ----------------YLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG  135 (282)
T ss_pred             ----------------EEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC
Confidence                            89999995 69999986542 4799999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      .++|+|||++..............++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+....
T Consensus       136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  215 (282)
T cd07829         136 VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL  215 (282)
T ss_pred             CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHh
Confidence            99999999997655444444555678889999998766 78999999999999999999999998776554433332110


Q ss_pred             --------------------CCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 --------------------LRP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 --------------------~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                          +..       ......+..+.++|.+||+.||++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                                000       011224778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=286.62  Aligned_cols=242  Identities=23%  Similarity=0.393  Sum_probs=197.7

Q ss_pred             eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      +.||+|+|+.|--++.  +|..||||++++...         ..+.++.+|+.++.++ .|+||+.++++|+++...   
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---------HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F---  151 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---------HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF---  151 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE---
Confidence            4689999999987765  899999999975422         2367789999999999 699999999999999887   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC---C
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT---R  258 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~---~  258 (404)
                                   |+|||-|.||.|...+.+.  ..+++.++.++..+|+.||.+||.+||.|||+||+|||....   .
T Consensus       152 -------------YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs  216 (463)
T KOG0607|consen  152 -------------YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS  216 (463)
T ss_pred             -------------EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC
Confidence                         9999999999999999665  689999999999999999999999999999999999999543   4


Q ss_pred             cEEEeeccccccccCC-------CCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          259 TVKIADFGVARLEASN-------PHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      -|||+||.+..-...+       .....+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||.+.-.
T Consensus       217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            5899999987532211       12334567889999999873     23589999999999999999999999975421


Q ss_pred             ---------------HHHHHHHHhccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          327 ---------------SEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       327 ---------------~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                     ..+...+..+.+.  ..-+..++++..++|+.+|..|+..|.++.+++.
T Consensus       297 ~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  297 ADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                           1223333333332  2233567999999999999999999999988886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.3e-37  Score=319.87  Aligned_cols=148  Identities=24%  Similarity=0.399  Sum_probs=129.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +++.||||++......      .......+.+|+.++..++||||+++++++...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   76 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI------NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA   76 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc------CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence            46899999999999999999998  4899999999643221      122345678899999999999999999988766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        77 ~~~----------------~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~  138 (669)
T cd05610          77 NNV----------------YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS  138 (669)
T ss_pred             CEE----------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence            655                8999999999999998654  4689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccc
Q 015594          256 KTRTVKIADFGVAR  269 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~  269 (404)
                      .++.+||+|||+++
T Consensus       139 ~~g~vkL~DFGls~  152 (669)
T cd05610         139 NEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCEEEEeCCCCc
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=308.60  Aligned_cols=255  Identities=26%  Similarity=0.432  Sum_probs=215.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      .+.++|..+||.|.+|.||+++.  +++.+|||+++...+..          .....|..+++.+ +|||++.++|+|.-
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----------eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----------EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----------HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            35688999999999999998775  89999999997665432          1134577787777 79999999999975


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...-           ...-+|+|||||.||+..+++....+..+.|..+..|++.++.||.+||...++|||||-.|||+
T Consensus        88 ~~~~-----------~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL  156 (953)
T KOG0587|consen   88 KDPG-----------NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL  156 (953)
T ss_pred             ecCC-----------CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE
Confidence            5441           23445999999999999999988888899999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-----AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +.++.|||+|||++...........+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+-++.+...
T Consensus       157 T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra  236 (953)
T KOG0587|consen  157 TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA  236 (953)
T ss_pred             eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence            999999999999998777766667778899999999999544     488899999999999999999999999987665


Q ss_pred             HHHHHhccCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..+.+...+ ...|..++.++.++|..||..|-++||++.++++
T Consensus       237 LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            5443332211 1336678899999999999999999999988874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=304.15  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=220.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEECCce--EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~--vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ....+..+++.....||-|+||.|=++...++.  +|+|++++..--...+      ..-+..|-.+|..++.|.||++|
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ------qeHv~sEr~Im~~~~s~fIvrLY  486 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ------QEHVFSERNIMMECRSDFIVRLY  486 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH------HHHHHhHHHHHHhcCchHHHHHH
Confidence            334566778888899999999999988876655  8999987543222111      23356899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      ..|.+...+                |++||-|-||.|...|.+  ++.+.+..+.-++.-++.|++|||++|||+|||||
T Consensus       487 rTfrd~kyv----------------YmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP  548 (732)
T KOG0614|consen  487 RTFRDSKYV----------------YMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP  548 (732)
T ss_pred             HHhccchhh----------------hhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence            999887766                899999999999999955  47899999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +|++++.+|-+||.|||+|+...... ...+++|||.|.|||++.++..+.++|+||||+++|||++|.+||.+.++..+
T Consensus       549 ENllLd~~Gy~KLVDFGFAKki~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt  627 (732)
T KOG0614|consen  549 ENLLLDNRGYLKLVDFGFAKKIGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT  627 (732)
T ss_pred             hheeeccCCceEEeehhhHHHhccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence            99999999999999999998766544 44558999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE  367 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  367 (404)
                      +..++..--...+|+.++....++|+++...+|.+|..
T Consensus       628 Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  628 YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            99999888778899999999999999999999999976

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=283.66  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHh-hcCCCcee
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH-KLDHPNVT  166 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv  166 (404)
                      ....|++..++++-...||.|+||+|++..+  .|+..|||.+.....        +...+++..|..+.. .-+.||||
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--------~keq~rll~e~d~~mks~~cp~IV  126 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--------EKEQKRLLMEHDTVMKSSNCPNIV  126 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--------hHHHHHHHHHHHHHHhhcCCcHHH
Confidence            3456777888888889999999999999887  799999999964432        222455677776644 44899999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHH---HhcccCCCcHHHHHHHHHHHHHHHHHHhhC-Cc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL---IKNRRRKLAFKVVIQLALDLARGLSYLQSK-KI  242 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-gi  242 (404)
                      +|+|+.....                .|||.||+| .-+|..+.   ..-....+++..+..|+.-.+.||.||... .|
T Consensus       127 kfyGa~F~EG----------------dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lki  189 (361)
T KOG1006|consen  127 KFYGALFSEG----------------DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKI  189 (361)
T ss_pred             HHhhhhhcCC----------------ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhh
Confidence            9999875544                459999999 66765543   222346799999999999999999999855 89


Q ss_pred             eecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC--CCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN--GSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      +||||||+|||++..|.|||||||.+.... +....+...|...|||||.+.  +..|+.++||||||++|||+.||..|
T Consensus       190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv-~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP  268 (361)
T KOG1006|consen  190 IHRDVKPSNILLDRHGDVKLCDFGICGQLV-DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP  268 (361)
T ss_pred             hhccCChhheEEecCCCEeeecccchHhHH-HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence            999999999999999999999999997543 334456678999999999995  34699999999999999999999999


Q ss_pred             CCCCCH-HHHHHHHHhccCCC-CCC---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          321 YPDLSF-SEVTSAVVRQNLRP-EIP---RCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       321 f~~~~~-~~~~~~~~~~~~~~-~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      |..++. .+....++....+. ..+   ...+..+..+|..||.+|-.+||.+.+|.+.
T Consensus       269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            988754 33334444433221 122   3368899999999999999999999998753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=307.94  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=202.1

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      +...+.||+|+||.||+|++  +|+.||||.+....        ....+++..+|+.+|++|+|||||+++++-.+... 
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~-   85 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL-   85 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--------ccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc-
Confidence            44457899999999999997  79999999986432        12235667899999999999999999987544331 


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE--c
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL--D  255 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili--~  255 (404)
                               +.......+|||||.||+|...|.+- +...+++.+++.++.++..||.|||.+||+||||||.||++  .
T Consensus        86 ---------~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~G  156 (732)
T KOG4250|consen   86 ---------GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIG  156 (732)
T ss_pred             ---------CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Confidence                     22334458999999999999999542 23579999999999999999999999999999999999999  2


Q ss_pred             CCC--cEEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HH
Q 015594          256 KTR--TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF----SE  328 (404)
Q Consensus       256 ~~~--~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~----~~  328 (404)
                      .+|  ..||+|||.|+.... ...++..+||+.|.+||++. ...|+..+|.|||||++|+.+||..||.....    .+
T Consensus       157 edgq~IyKLtDfG~Arel~d-~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~  235 (732)
T KOG4250|consen  157 EDGQSIYKLTDFGAARELDD-NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE  235 (732)
T ss_pred             CCCceEEeeecccccccCCC-CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch
Confidence            333  469999999986554 44788899999999999998 48899999999999999999999999954322    22


Q ss_pred             HHHHHHhcc-------------------CCCCCCCCCcHH----HHHHHHHhhhhCCCCCC--CHHHHHHHHHHhHhh
Q 015594          329 VTSAVVRQN-------------------LRPEIPRCCPSS----LANVMKRCWDANPDKRP--EMDEVVAMLEAIDTS  381 (404)
Q Consensus       329 ~~~~~~~~~-------------------~~~~~~~~~~~~----l~~li~~cl~~dP~~Rp--t~~~ll~~L~~~~~~  381 (404)
                      +...+...+                   ...++|..+++.    +-..+..+|..+|.+|.  ...+....+..|...
T Consensus       236 ~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  236 IMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            333322211                   011223344443    44567788899999998  777777777776643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-36  Score=278.15  Aligned_cols=218  Identities=22%  Similarity=0.253  Sum_probs=179.1

Q ss_pred             ecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCC
Q 015594          110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHI  187 (404)
Q Consensus       110 G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~  187 (404)
                      |.||.||++.+  +++.||+|.+.....              +.+|...+....||||+++++.+.+....         
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~---------   60 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------------YSRERLTIIPHCVPNMVCLHKYIVSEDSV---------   60 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------------hhhHHHHHHhcCCCceeehhhheecCCeE---------
Confidence            89999999987  789999999864321              22344445556799999999998876655         


Q ss_pred             CCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccc
Q 015594          188 GMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV  267 (404)
Q Consensus       188 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~  267 (404)
                             |+||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.
T Consensus        61 -------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~  131 (237)
T cd05576          61 -------FLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR  131 (237)
T ss_pred             -------EEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccc
Confidence                   8999999999999998654  4689999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCc
Q 015594          268 ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP  347 (404)
Q Consensus       268 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (404)
                      +.....   ...+..++..|+|||.+.+..++.++||||+|+++|+|++|..|+......      ........++..++
T Consensus       132 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~  202 (237)
T cd05576         132 WSEVED---SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVS  202 (237)
T ss_pred             hhcccc---ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCC
Confidence            764332   223455678899999999888999999999999999999999887543211      11122234567788


Q ss_pred             HHHHHHHHHhhhhCCCCCCCH
Q 015594          348 SSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       348 ~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      +.++++|.+||+.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            999999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=255.35  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=207.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|...++||+|+||+||++++  +++.||+|.+...+.+..-       .....+|+.+++.++|.|||+++++...+..
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-------pssalreicllkelkhknivrl~dvlhsdkk   75 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-------PSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-------cHHHHHHHHHHHHhhhcceeehhhhhccCce
Confidence            456678899999999999986  6789999999877654332       2335799999999999999999999877777


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                -+|+||| .-.|..|... .++.+..+.+..++.|+++||.++|++++.|||+||.|+||+.+
T Consensus        76 l----------------tlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n  137 (292)
T KOG0662|consen   76 L----------------TLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN  137 (292)
T ss_pred             e----------------EEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence            6                6899999 7788888744 45789999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~  335 (404)
                      |.+||+|||+++.+..+..-....+-|+.|.+|.++.|.. |+.+.|+||.||++.|+.. |.+-|++.+..+....+..
T Consensus       138 gelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~  217 (292)
T KOG0662|consen  138 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_pred             CcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence            9999999999998777766677788899999999998764 8999999999999999987 6777898888877776654


Q ss_pred             ccCC------C------------CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR------P------------EIP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~------~------------~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .--.      +            ..|         ..++..-+++++++|.-+|..|.++++.++
T Consensus       218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2111      0            011         112334589999999999999999998764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=276.63  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=208.8

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKF  168 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  168 (404)
                      ..|.+...+|.+..+||+|+|..|.++.+  +.+.||+|++++.-...      .+-..-+..|-.+..+. +||.+|-+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd------dedidwvqtek~vfe~asn~pflvgl  316 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNNPFLVGL  316 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC------cccchhHHhhHHHHHhccCCCeEEeh
Confidence            46778889999999999999999998887  67899999997542111      01122234566665555 89999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ..+|+..+.+                ++|.||++||+|-=.+.+.  ++++++.++.+..+|+.||.|||++||++||||
T Consensus       317 hscfqtesrl----------------ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlk  378 (593)
T KOG0695|consen  317 HSCFQTESRL----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLK  378 (593)
T ss_pred             hhhhcccceE----------------EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc
Confidence            9999988888                8999999999997766544  689999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC------
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP------  322 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~------  322 (404)
                      .+|+||+..|.+||+|+|+++....+.....+++|||.|.|||++.|..|+.++|+|+||++++||+.|+.||.      
T Consensus       379 ldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n  458 (593)
T KOG0695|consen  379 LDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN  458 (593)
T ss_pred             ccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence            99999999999999999999876667777778999999999999999999999999999999999999999995      


Q ss_pred             -CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 015594          323 -DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE  367 (404)
Q Consensus       323 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  367 (404)
                       +.+-++.+.+++... ...+|+.++-....+++.-|.+||.+|..
T Consensus       459 ~d~ntedylfqvilek-qiriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  459 PDMNTEDYLFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cccchhHHHHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence             233333333333222 23478888889999999999999999953

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=280.09  Aligned_cols=251  Identities=24%  Similarity=0.416  Sum_probs=201.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC--C----c
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH--P----N  164 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----n  164 (404)
                      ..++...+|.+.+.+|+|+||.|..+.+  ++..||||+++          .+...+....-|+.++.++.+  |    -
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----------~V~kYreAa~iEi~vLqki~~~DP~g~~r  152 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----------NVDKYREAALIEIEVLQKINESDPNGKFR  152 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHH----------HHHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence            3455578999999999999999999987  56899999983          456667778889999999932  2    3


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      +|.+.++|.-..++                |||+|.+ |-++.++|..+...+++...++.++.|++.++.+||+.+++|
T Consensus       153 cv~m~~wFdyrghi----------------Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~H  215 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHI----------------CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTH  215 (415)
T ss_pred             EEeeehhhhccCce----------------EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceee
Confidence            67777777666555                9999999 889999998888889999999999999999999999999999


Q ss_pred             cccCCCCEEEc--------------------CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhh
Q 015594          245 RDVKTENMLLD--------------------KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDV  304 (404)
Q Consensus       245 ~Dikp~Nili~--------------------~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  304 (404)
                      .||||+|||+.                    ....|+|+|||.|+...   ......+.|..|.|||++.+.+++..|||
T Consensus       216 TDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDv  292 (415)
T KOG0671|consen  216 TDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDV  292 (415)
T ss_pred             cCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCc
Confidence            99999999983                    13358999999997533   22355678999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccC----------------CCCCC-------------CC-------
Q 015594          305 YSFGICLWEIYCCDMPYPDLSFSE---VTSAVVRQNL----------------RPEIP-------------RC-------  345 (404)
Q Consensus       305 wslG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~----------------~~~~~-------------~~-------  345 (404)
                      ||+||||+|+++|..-|+..+..+   ++..++....                +..-+             .+       
T Consensus       293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~  372 (415)
T KOG0671|consen  293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM  372 (415)
T ss_pred             eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence            999999999999999998776555   2222221000                00000             00       


Q ss_pred             -----CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          346 -----CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       346 -----~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                           .-.+|.+||++||..||.+|+|+.|++.
T Consensus       373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             ccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence                 0135889999999999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.4e-36  Score=325.24  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=190.4

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .+...++||+|+||.||+|.+  ++..||||.++.....             ...|+.++++++|||||++++++.+...
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------------PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------------cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            345567899999999999986  6899999988532211             1245788999999999999999987765


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh---hCCceecccCCCCEEE
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ---SKKIVHRDVKTENMLL  254 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~givH~Dikp~Nili  254 (404)
                      .                |+||||+++|+|.+++.     .+++..+..++.||+.||+|||   +.+|+||||||+||++
T Consensus       758 ~----------------~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~  816 (968)
T PLN00113        758 A----------------YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII  816 (968)
T ss_pred             C----------------EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence            5                89999999999999983     3889999999999999999999   6699999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~-----~~~~  329 (404)
                      +.++..++. ||.......    .....+|+.|||||++.+..++.++|||||||++|||++|+.||....     ..+.
T Consensus       817 ~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  891 (968)
T PLN00113        817 DGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW  891 (968)
T ss_pred             CCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence            998887775 665543211    122367899999999999999999999999999999999999985321     1111


Q ss_pred             HHHHH-----hccCCCCC------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          330 TSAVV-----RQNLRPEI------PRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       330 ~~~~~-----~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      .....     .....+..      +.....++.+++.+||+.||++||++.++++.|+++..+...
T Consensus       892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence            11000     00011111      111233577899999999999999999999999998765543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-36  Score=291.18  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=204.4

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEE--ECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      +.+.-..+.+-|..++.||-|+||.|.++.  ++...||+|.+.+.+.-      ......-+..|-.||..-+.+-||+
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl------~rnQvaHVKAERDILAEADn~WVVr  693 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL------MRNQVAHVKAERDILAEADNEWVVR  693 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH------hhhhhhhhhhhhhhHhhcCCcceEE
Confidence            334445778889999999999999999876  47889999998643322      1222334567889999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +|..|++.+.+                |+||||++||++-.+|.+.  +-|.+..++.++.++.+|+++.|..|+|||||
T Consensus       694 LyySFQDkdnL----------------YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDi  755 (1034)
T KOG0608|consen  694 LYYSFQDKDNL----------------YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDI  755 (1034)
T ss_pred             EEEEeccCCce----------------EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceeccc
Confidence            99999999888                8999999999999999775  68999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeecccccccc---------CCCCcc---------------------------------cCCCCCc
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEA---------SNPHDM---------------------------------TGETGTL  285 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~---------~~~~~~---------------------------------~~~~gt~  285 (404)
                      ||+|||||.+|.+||+|||++.-+.         ......                                 ...+||+
T Consensus       756 KPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~  835 (1034)
T KOG0608|consen  756 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTP  835 (1034)
T ss_pred             CccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCC
Confidence            9999999999999999999985211         000000                                 0126999


Q ss_pred             cccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCC
Q 015594          286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPD  363 (404)
Q Consensus       286 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~  363 (404)
                      .|+|||++....|+..||+||.|||||||+.|+.||-+.+..+....++.-.-...++  ..++.+..++|.++. .+++
T Consensus       836 nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad  914 (1034)
T KOG0608|consen  836 NYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSAD  914 (1034)
T ss_pred             cccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChh
Confidence            9999999999999999999999999999999999999888777665554433333333  567889999988755 4566


Q ss_pred             CCC
Q 015594          364 KRP  366 (404)
Q Consensus       364 ~Rp  366 (404)
                      +|.
T Consensus       915 ~RL  917 (1034)
T KOG0608|consen  915 SRL  917 (1034)
T ss_pred             hhh
Confidence            774

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.7e-37  Score=272.94  Aligned_cols=254  Identities=22%  Similarity=0.367  Sum_probs=192.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE----C--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY----D--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~----~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ...|++.+.||+|+||.||+|..    +  .+.+|||.++-.++..       .......+|+.+++.++||||+.+..+
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-------GiS~SAcREiaL~REl~h~nvi~Lv~V   95 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-------GISMSACREIALLRELKHPNVISLVKV   95 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-------CcCHHHHHHHHHHHHhcCCcchhHHHH
Confidence            45799999999999999999964    2  2479999987543321       122335689999999999999999988


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      |...+.               .+++++||. .-+|..++.-++   .+.++...+..|+.||+.|+.|||++-|+|||||
T Consensus        96 fl~~d~---------------~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK  159 (438)
T KOG0666|consen   96 FLSHDK---------------KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK  159 (438)
T ss_pred             HhccCc---------------eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence            876321               138999999 567888775442   3578899999999999999999999999999999


Q ss_pred             CCCEEEcCC----CcEEEeeccccccccCCCCcc---cCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCC
Q 015594          249 TENMLLDKT----RTVKIADFGVARLEASNPHDM---TGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       249 p~Nili~~~----~~vkL~Dfg~a~~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      |.||||..+    |.|||+|||+++.+..+-...   ...+-|..|.|||.+.|. -|+++.|||+.||++.||++..+-
T Consensus       160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence            999999877    899999999999876654333   345678999999999876 599999999999999999998766


Q ss_pred             CCCCCH---------HHHHHHHHh-----------------------ccCCCC------------CCCCCcHHHHHHHHH
Q 015594          321 YPDLSF---------SEVTSAVVR-----------------------QNLRPE------------IPRCCPSSLANVMKR  356 (404)
Q Consensus       321 f~~~~~---------~~~~~~~~~-----------------------~~~~~~------------~~~~~~~~l~~li~~  356 (404)
                      |.+...         .+.+..+..                       ..++..            ....-++...+|+.+
T Consensus       240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k  319 (438)
T KOG0666|consen  240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK  319 (438)
T ss_pred             ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence            643210         000011100                       000000            011124457899999


Q ss_pred             hhhhCCCCCCCHHHHHHH
Q 015594          357 CWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       357 cl~~dP~~Rpt~~~ll~~  374 (404)
                      ||+.||.+|.|+++.++-
T Consensus       320 lL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  320 LLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HhccCchhhccHHHHhcc
Confidence            999999999999988753

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.1e-35  Score=264.45  Aligned_cols=235  Identities=32%  Similarity=0.524  Sum_probs=193.8

Q ss_pred             cceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCC
Q 015594          111 TFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIG  188 (404)
Q Consensus       111 ~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~  188 (404)
                      +||.||++.+  +|+.+|+|++........        ...+.+|+..+++++|+||+++++.+......          
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~----------   62 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--------RERILREISILKKLKHPNIVRLYDVFEDEDKL----------   62 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEE----------
Confidence            5899999998  469999999865432210        45678999999999999999999988766544          


Q ss_pred             CCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeecccc
Q 015594          189 MPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA  268 (404)
Q Consensus       189 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a  268 (404)
                            ++++||+.+++|.+++....  .++...++.++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+
T Consensus        63 ------~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~  134 (244)
T smart00220       63 ------YLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLA  134 (244)
T ss_pred             ------EEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccce
Confidence                  89999999889999986542  3899999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCC--
Q 015594          269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVVRQNLRPEIPRC--  345 (404)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~--  345 (404)
                      ....... ......++..|++||.+.+..++.++||||||+++|+|++|..||.. ......... ............  
T Consensus       135 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  212 (244)
T smart00220      135 RQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK-IGKPKPPFPPPEWK  212 (244)
T ss_pred             eeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HhccCCCCcccccc
Confidence            7644332 34456688999999999988899999999999999999999999987 444333333 332222222222  


Q ss_pred             CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          346 CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       346 ~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ++.++.+++.+||..+|++||++.++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            8899999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-37  Score=267.75  Aligned_cols=263  Identities=23%  Similarity=0.350  Sum_probs=202.4

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ++..+.+.|....+||+|+||.||+|+.  +|+.||+|++-...       +....-....+|+.+|..|+|+|++.++.
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-------eKeGfpitalreikiL~~lkHenv~nliE   83 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-------EKEGFPITALREIKILQLLKHENVVNLIE   83 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-------cccCCcHHHHHHHHHHHHhcchhHHHHHH
Confidence            4455678888889999999999998875  68889998763321       11222233568999999999999999988


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      .+........        ......|+|+++| .-+|.-+|. ++..+++...+..++.++..||.|+|+..|+|||+||.
T Consensus        84 ic~tk~Tp~~--------r~r~t~ylVf~~c-ehDLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaa  153 (376)
T KOG0669|consen   84 ICRTKATPTN--------RDRATFYLVFDFC-EHDLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAA  153 (376)
T ss_pred             HHhhccCCcc--------cccceeeeeHHHh-hhhHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHh
Confidence            8764443321        1223459999999 567887773 34567999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCC----CCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASN----PHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |+||+.+|.+||+|||+++.+...    ....+..+-|+.|.+||.+.|. .|+++.|||..||++.||+++.+-+.+.+
T Consensus       154 NvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  154 NVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             hEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            999999999999999999864433    2335566779999999998775 59999999999999999999998888777


Q ss_pred             HHHHHHHHH--hccCCCCCC-------------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          326 FSEVTSAVV--RQNLRPEIP-------------------------------RCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       326 ~~~~~~~~~--~~~~~~~~~-------------------------------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      ....+..+-  .+...++.+                               -.-+++..+||.++|..||.+|+++++++
T Consensus       234 eqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al  313 (376)
T KOG0669|consen  234 EQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL  313 (376)
T ss_pred             HHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence            655444331  111111111                               11135678999999999999999988776

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=248.82  Aligned_cols=221  Identities=26%  Similarity=0.433  Sum_probs=180.1

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEE--ECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCcee
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVT  166 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  166 (404)
                      ....+++..+.+.....||+|+||.|-+.+  .+|...|+|.+.-.-.        ....++..+|+.+..+. .+|.+|
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--------~q~q~r~L~dldi~~r~~~CPf~V  108 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--------SQEQKRLLMDLDIIMRTVDCPFTV  108 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--------hHHHHHHHHhhhhhccCCCCCeEE
Confidence            334477888888888999999999886554  5899999999864332        12245567888876555 899999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhhC-Cce
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQSK-KIV  243 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giv  243 (404)
                      .|+|+..+...+                +|.||.| .-+|..+..+  ..+..+++..+-+|+..++.||.|||++ .++
T Consensus       109 ~FyGa~~regdv----------------wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vI  171 (282)
T KOG0984|consen  109 HFYGALFREGDV----------------WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVI  171 (282)
T ss_pred             EeehhhhccccE----------------EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhh
Confidence            999998888777                7899999 6777766533  2467899999999999999999999987 899


Q ss_pred             ecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC----CCCCcchhhHHHHHHHHHHHhCCC
Q 015594          244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG----SAYNRKCDVYSFGICLWEIYCCDM  319 (404)
Q Consensus       244 H~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~  319 (404)
                      |||+||.||||+.+|+||+||||.+....+ ....+-..|...|||||.++.    ..|+.++||||||++++||.+++.
T Consensus       172 HRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~  250 (282)
T KOG0984|consen  172 HRDVKPSNILINYDGQVKICDFGISGYLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF  250 (282)
T ss_pred             hccCCcceEEEccCCcEEEcccccceeehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence            999999999999999999999999976443 333344678899999999853    369999999999999999999999


Q ss_pred             CCCCC-CHHHHHHHHHhc
Q 015594          320 PYPDL-SFSEVTSAVVRQ  336 (404)
Q Consensus       320 Pf~~~-~~~~~~~~~~~~  336 (404)
                      ||+.. ++.+.+++++..
T Consensus       251 PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  251 PYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cccccCCHHHHHHHHhcC
Confidence            99864 667777776654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-36  Score=276.35  Aligned_cols=257  Identities=21%  Similarity=0.418  Sum_probs=202.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+|+.||++.+  ..+.||||+-...+...  +...+...+-..+|..|.+.|+||.||++|++|.-+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr--dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR--DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh--hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            36788889999999999999986  67899999986655432  223344455567999999999999999999998644


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC--CceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--KIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--givH~Dikp~Nil  253 (404)
                      .+.               .|-|+|||+|.+|.=||..+  +-+++++++.|+.||+.||.||...  .|+|-||||.|||
T Consensus       540 tds---------------FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL  602 (775)
T KOG1151|consen  540 TDS---------------FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL  602 (775)
T ss_pred             ccc---------------ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence            433               28999999999999888766  5799999999999999999999977  5999999999999


Q ss_pred             E---cCCCcEEEeeccccccccCCCCcc-------cCCCCCccccCccccCCC----CCCcchhhHHHHHHHHHHHhCCC
Q 015594          254 L---DKTRTVKIADFGVARLEASNPHDM-------TGETGTLGYMAPEVLNGS----AYNRKCDVYSFGICLWEIYCCDM  319 (404)
Q Consensus       254 i---~~~~~vkL~Dfg~a~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~  319 (404)
                      +   +.-|.+||+|||++.+........       ....||..|++||.+.-+    ..+.++||||.||++|..+.|+-
T Consensus       603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK  682 (775)
T KOG1151|consen  603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK  682 (775)
T ss_pred             EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence            9   345889999999998766544331       234699999999987433    36889999999999999999999


Q ss_pred             CCCCCCH-HHHHHH--HHh-ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          320 PYPDLSF-SEVTSA--VVR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       320 Pf~~~~~-~~~~~~--~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ||..... .+++..  ++. ..........++++..+||++||+..-++|.+..+|..
T Consensus       683 PFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  683 PFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             CCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            9976532 222221  111 11222233567899999999999999999998888763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=289.74  Aligned_cols=240  Identities=27%  Similarity=0.444  Sum_probs=188.2

Q ss_pred             EEeeeeeeecceE-EEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccc
Q 015594          102 IIKGAFARGTFGT-VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       102 ~~~~~lg~G~~g~-V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  179 (404)
                      .-.+++|.|+-|+ ||+|.+.|+.||||.+-            .+.-....+|+..|+.. .|||||++++.-.+...+ 
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll------------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~-  578 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLL------------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL-  578 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCCceehHHHHh------------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE-
Confidence            3446789999885 68999999999999872            22334567999999999 599999999987666655 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC-
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-  256 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~-  256 (404)
                                     ||.+|.| ..+|.+++...  .......-..+.+..|++.||++||+.+||||||||.||||+. 
T Consensus       579 ---------------YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~  642 (903)
T KOG1027|consen  579 ---------------YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVP  642 (903)
T ss_pred             ---------------EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEcc
Confidence                           9999999 88999999663  1111111345788999999999999999999999999999954 


Q ss_pred             ----CCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHH
Q 015594          257 ----TRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE  328 (404)
Q Consensus       257 ----~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~Pf~~~~~~~  328 (404)
                          ..+++|+|||+++.......   ...+..||.+|+|||++....-+.++|||||||++|..++| ..||.+.-..+
T Consensus       643 ~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~  722 (903)
T KOG1027|consen  643 SADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ  722 (903)
T ss_pred             CCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence                35789999999986555433   24456799999999999999888999999999999998885 89998765443


Q ss_pred             HHHHHHhccCCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          329 VTSAVVRQNLRPE-IPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       329 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                        ..++..+.... ....-..+..+||.+|+..+|..||++.+|+
T Consensus       723 --~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  723 --ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             --hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence              23444443321 1111112889999999999999999999997

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-33  Score=285.40  Aligned_cols=257  Identities=17%  Similarity=0.172  Sum_probs=168.8

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--C----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--D----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .....++|.+.+.||+|+||.||+|++  +    +..||||.+....     ..+.      +..|  .++...+.++..
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~------~~~e--~l~~~~~~~~~~  193 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEI------WMNE--RVRRACPNSCAD  193 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHH------HHHH--HHHhhchhhHHH
Confidence            344668999999999999999999997  4    6899999875221     1110      0111  112222333333


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc------------------CCCcHHHHHHHHHH
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------------------RKLAFKVVIQLALD  229 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~------------------~~l~~~~~~~i~~q  229 (404)
                      ++..+.....          .......++|+||+.+++|.+++.....                  .......+..++.|
T Consensus       194 ~~~~~~~~~~----------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~q  263 (566)
T PLN03225        194 FVYGFLEPVS----------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQ  263 (566)
T ss_pred             HHHhhhcccc----------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHH
Confidence            3222211110          1122334899999999999998854321                  11123456789999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEEcC-CCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCC-----------
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGS-----------  296 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili~~-~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----------  296 (404)
                      |+.||.|||++||+||||||+|||++. ++.+||+|||+|+..... ........+|+.|||||.+...           
T Consensus       264 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~  343 (566)
T PLN03225        264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV  343 (566)
T ss_pred             HHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccc
Confidence            999999999999999999999999985 579999999999754322 2223446789999999976432           


Q ss_pred             -----------CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------cCCCC------CCCCC
Q 015594          297 -----------AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ-------------NLRPE------IPRCC  346 (404)
Q Consensus       297 -----------~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~-------------~~~~~------~~~~~  346 (404)
                                 .++.++|||||||++|||+++..|+.... ......+...             ...+.      .....
T Consensus       344 ~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  422 (566)
T PLN03225        344 ATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLD  422 (566)
T ss_pred             cccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcccc
Confidence                       23456799999999999999776654321 1111111110             00000      01112


Q ss_pred             cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          347 PSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       347 ~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +....+||.+||+.||.+|||+.++++.
T Consensus       423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        423 GGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             chHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            3345689999999999999999999873

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=261.59  Aligned_cols=278  Identities=24%  Similarity=0.340  Sum_probs=208.7

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      ++-.+.||.|+||+||..++  +|+.||+|.+..       -...-...+++.+|+.+|...+|.|++..++..+....-
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcch-------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            33447899999999999987  799999998741       122223357788999999999999999998877655433


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                      .++           .+|+|.|+| ..+|..++.  ..+.++...+.-++.||++||.|||+.+|.||||||.|+|++.+.
T Consensus       128 fFq-----------EiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC  193 (449)
T KOG0664|consen  128 FFQ-----------ELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC  193 (449)
T ss_pred             HHH-----------HHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc
Confidence            221           237889999 778888773  347899999999999999999999999999999999999999999


Q ss_pred             cEEEeecccccccc-CCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Q 015594          259 TVKIADFGVARLEA-SNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV--  334 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~--  334 (404)
                      .+||+|||+++... +....++..+-|..|.|||++.|. .|+.++||||.||++.||+-.+.-|...++.+.+.-+.  
T Consensus       194 vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdL  273 (449)
T KOG0664|consen  194 ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDL  273 (449)
T ss_pred             eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHH
Confidence            99999999999644 345667778889999999999886 58999999999999999998887887665544333221  


Q ss_pred             ---------------------hccCC-CCCC--------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          335 ---------------------RQNLR-PEIP--------RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       335 ---------------------~~~~~-~~~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                                           +...+ +.++        ..-.-+...++.++|..||++|.+..+.+..+.     .+.
T Consensus       274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~-----~~e  348 (449)
T KOG0664|consen  274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY-----LEE  348 (449)
T ss_pred             hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc-----ccc
Confidence                                 11111 1111        112235677888999999999998877665432     233


Q ss_pred             CCCCCCCCCCccccccCCCC
Q 015594          385 GMIPVDQPQGCSCFRKYRGP  404 (404)
Q Consensus       385 ~~~p~~~~~~~~~~~~~~~~  404 (404)
                      |..-...---|.||...+||
T Consensus       349 ~R~r~~sCmC~~~~tt~~~~  368 (449)
T KOG0664|consen  349 GRLRFHSCMCSCCYTKPNMP  368 (449)
T ss_pred             cceeeeeeeEeeeccCCCcc
Confidence            33334444445677777764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-33  Score=276.39  Aligned_cols=269  Identities=17%  Similarity=0.234  Sum_probs=185.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE------------------CCceEEEEEeecCCCCcccHHH-----HHHHHHHHHH
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY------------------DGQDVAVKLLDWGEESHRSEAE-----IASLRAAFTQ  152 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~------------------~g~~vAvK~~~~~~~~~~~~~~-----~~~~~~~~~~  152 (404)
                      ...++|.+.++||+|+||+||+|..                  .++.||||.+............     ..........
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            4578999999999999999999863                  3467999998643221100000     0011223445


Q ss_pred             HHHHHhhcCCCce-----eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------------
Q 015594          153 EVAVWHKLDHPNV-----TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------------  214 (404)
Q Consensus       153 E~~~l~~l~hpni-----v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------  214 (404)
                      |+.++.+++|.++     ++++++|.....-      |  .......++|+||+++++|.+++....             
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~------g--~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~  293 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTAD------G--AFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMA  293 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhccccccc------c--cccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhc
Confidence            7777888876654     6677776532110      0  011233489999999999999885421             


Q ss_pred             ---------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccC--CCC
Q 015594          215 ---------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG--ETG  283 (404)
Q Consensus       215 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~--~~g  283 (404)
                               ...+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++....... ....  ..+
T Consensus       294 g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~  372 (507)
T PLN03224        294 GKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGML  372 (507)
T ss_pred             CCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCC
Confidence                     1234567788999999999999999999999999999999999999999999996433221 1122  234


Q ss_pred             CccccCccccCCCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCCHHHHHH---------
Q 015594          284 TLGYMAPEVLNGSA--------------------Y--NRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTS---------  331 (404)
Q Consensus       284 t~~y~aPE~~~~~~--------------------~--~~~~DvwslG~il~el~~g~~-Pf~~~~~~~~~~---------  331 (404)
                      |+.|+|||.+....                    |  ..+.||||+||++|+|+++.. ||..........         
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~  452 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR  452 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence            78999999985432                    1  134799999999999999876 775432221111         


Q ss_pred             --HHHhccCCCCCCCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHH
Q 015594          332 --AVVRQNLRPEIPRCCPSSLANVMKRCWDANP---DKRPEMDEVVA  373 (404)
Q Consensus       332 --~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~~ll~  373 (404)
                        ......+.......+++..++|+.+||..+|   .+|+|++++++
T Consensus       453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence              1111222223345578999999999999766   68999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=261.65  Aligned_cols=134  Identities=23%  Similarity=0.370  Sum_probs=115.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-----C---CceeE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-----H---PNVTK  167 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~  167 (404)
                      ..+|.+.++||.|.|++||++.+  ..+.||+|+.+-          .+...+....|+.+|++++     |   ..||+
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            38999999999999999999998  578999999852          1234556778999999982     3   36999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-Cceecc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRD  246 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~D  246 (404)
                      |++.|.-.            ++.+.++|||+|++ |.+|..+|....-+.++...+.+|++||+.||.|||++ ||+|.|
T Consensus       147 LlD~Fkhs------------GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTD  213 (590)
T KOG1290|consen  147 LLDHFKHS------------GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTD  213 (590)
T ss_pred             eeccceec------------CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccC
Confidence            99988633            44567779999999 99999999988888999999999999999999999976 999999


Q ss_pred             cCCCCEEE
Q 015594          247 VKTENMLL  254 (404)
Q Consensus       247 ikp~Nili  254 (404)
                      |||+|||+
T Consensus       214 lKPENvLl  221 (590)
T KOG1290|consen  214 LKPENVLL  221 (590)
T ss_pred             CCcceeee
Confidence            99999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=283.30  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=213.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+...+|.|+||.||++++  +++..|||+++....+.         .....+|+-+++.++|||||.++|.+...
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---------~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---------FSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---------ccccccceeeeecCCCcChHHHHhhhhhh
Confidence            57899999999999999999987  78999999998754332         23356899999999999999999999888


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                ++.||||.||+|.+..  +-..++++.++..++++.+.||+|||+.|=+|||||-.||+++
T Consensus        85 dkl----------------wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt  146 (829)
T KOG0576|consen   85 DKL----------------WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT  146 (829)
T ss_pred             cCc----------------EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence            888                8999999999999976  3357899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      +.|.|||+|||.+......-.....+.||+.|||||+.   ....|+..||||++|++..|+--.+.|..+......+.-
T Consensus       147 d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L  226 (829)
T KOG0576|consen  147 DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL  226 (829)
T ss_pred             ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH
Confidence            99999999999998666555666778899999999986   455699999999999999999999999887776666555


Q ss_pred             HHhccCCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          333 VVRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       333 ~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      .....+.+.   -+...++.+.+|++.+|..+|.+||+++.++
T Consensus       227 mTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  227 MTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             hhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            555555442   2355789999999999999999999998765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.6e-33  Score=238.36  Aligned_cols=245  Identities=19%  Similarity=0.331  Sum_probs=195.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEe
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  173 (404)
                      ..++|++.+.+|+|.|+.||.|..  +++.++||+++.            -..+.+.+|+.+|..|. ||||++++++..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------------VkkkKIkREikIL~nL~gg~NIi~L~DiV~  103 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------------VKKKKIKREIKILQNLRGGPNIIKLLDIVK  103 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------------HHHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence            468899999999999999999985  789999999962            22455789999999996 999999999988


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ++..-.              ..+|+||+++.+...+.     ..++...++.++.+++.||.|+|+.||.|||+||.|++
T Consensus       104 Dp~Skt--------------paLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm  164 (338)
T KOG0668|consen  104 DPESKT--------------PSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM  164 (338)
T ss_pred             CccccC--------------chhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence            776532              26899999888877654     46889999999999999999999999999999999999


Q ss_pred             EcCC-CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHH
Q 015594          254 LDKT-RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVT  330 (404)
Q Consensus       254 i~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~~  330 (404)
                      ||.. ..++|+|+|+|.. -.+.......+.+..|-.||.+..- .|+.+-|+|||||++..|+..+.||.. .+..+.+
T Consensus       165 Idh~~rkLrlIDWGLAEF-YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL  243 (338)
T KOG0668|consen  165 IDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL  243 (338)
T ss_pred             echhhceeeeeecchHhh-cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence            9754 6799999999975 3445555666778889999998654 489999999999999999999999853 2222211


Q ss_pred             HHH------------H---------------hccC--------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAV------------V---------------RQNL--------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~------------~---------------~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      -.+            +               ....        ..+...-.++++.+|+.++|..|-++|+|+.|.+.
T Consensus       244 VkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  244 VKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            111            0               0000        01111224689999999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.7e-31  Score=236.60  Aligned_cols=210  Identities=38%  Similarity=0.690  Sum_probs=181.6

Q ss_pred             eeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ||.|.+|.||++...  ++.++||++.......        ....+.+|+.+++.+.|++|+++++++......      
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------   66 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL------   66 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE------
Confidence            689999999999985  8999999996443211        345688999999999999999999998776444      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC-CCcEEEe
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIA  263 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~-~~~vkL~  263 (404)
                                ++++||+.+++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+
T Consensus        67 ----------~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~  135 (215)
T cd00180          67 ----------YLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA  135 (215)
T ss_pred             ----------EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEe
Confidence                      89999998899999986532 46899999999999999999999999999999999999998 8999999


Q ss_pred             eccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 015594          264 DFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       264 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  342 (404)
                      |||.+..............+...|++||.+... .++.+.|+|+||+++++|                            
T Consensus       136 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------  187 (215)
T cd00180         136 DFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------  187 (215)
T ss_pred             cCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------
Confidence            999997654433234445678899999999887 789999999999999998                            


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                           ..+.+++.+|++.+|++||++.++++.
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                 578999999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=249.33  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=200.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +.+|.-...+|.|.- .|.-+.+  .++.||+|.+...-.       ...-.++..+|..++..+.|+||++++.+|...
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-------n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-------NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-------cCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            567888889999987 6666655  689999998754311       122245567999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+...          +..|+|||+| ..+|...+.    -.++-+.+..++.|++.|+.|||+.||+||||||+||++.
T Consensus        88 ~~l~~~----------~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~  152 (369)
T KOG0665|consen   88 KTLEEF----------QEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN  152 (369)
T ss_pred             ccHHHH----------HhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence            665432          2348999999 889988875    3577888999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||.|||+|+..... -.++..+.|..|.|||++.+..|...+||||+||++.||++|..-|++.+.-+.+.++..
T Consensus       153 ~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  153 SDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE  231 (369)
T ss_pred             chhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence            9999999999999864433 467788899999999999999999999999999999999999988876654443333221


Q ss_pred             c---------------------------------cC-----CC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 Q---------------------------------NL-----RP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~---------------------------------~~-----~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .                                 .+     +.  +.+..-...+++++.+||-.||++|.++++++.
T Consensus       232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            1                                 00     00  011122356899999999999999999999885

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-33  Score=265.56  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC------CCcee
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD------HPNVT  166 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv  166 (404)
                      ++.-.+|.+....|+|-||+|.+|.+  .|+.||||++...+          ...+.=++|+.+|.+|+      --+++
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----------~M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----------VMHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----------HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            44557888889999999999999998  57899999996332          22344568999999994      34788


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      +++..|....++                |||+|-+ ..+|.+.|.+.. .-.|....+..++.|++.||..|-..||+|.
T Consensus       498 rl~r~F~hknHL----------------ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHa  560 (752)
T KOG0670|consen  498 RLFRHFKHKNHL----------------CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHA  560 (752)
T ss_pred             HHHHHhhhccee----------------EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeec
Confidence            888887766666                9999999 899999997753 3468889999999999999999999999999


Q ss_pred             ccCCCCEEEcCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          246 DVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       246 Dikp~Nili~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      ||||+|||+++.. .+||||||.|....  ....+...-+..|.|||++.|.+|+...|+||.||+||||+||+.-|++.
T Consensus       561 DIKPDNiLVNE~k~iLKLCDfGSA~~~~--eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  561 DIKPDNILVNESKNILKLCDFGSASFAS--ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             ccCccceEeccCcceeeeccCccccccc--cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence            9999999998764 57999999996433  33455556677899999999999999999999999999999999999998


Q ss_pred             CHHHHHHHHHhc-----------------cCCC-----------------------CCC-CC----------Cc------
Q 015594          325 SFSEVTSAVVRQ-----------------NLRP-----------------------EIP-RC----------CP------  347 (404)
Q Consensus       325 ~~~~~~~~~~~~-----------------~~~~-----------------------~~~-~~----------~~------  347 (404)
                      +...++...+.-                 .+..                       ..| ..          +|      
T Consensus       639 TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~  718 (752)
T KOG0670|consen  639 TNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKI  718 (752)
T ss_pred             CcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHH
Confidence            877766543321                 0000                       000 00          11      


Q ss_pred             -HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          348 -SSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       348 -~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       ..|++|+.+||..||++|.|..+.|.
T Consensus       719 ~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  719 VQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHHHHhccChhhcCCHHHHhc
Confidence             35889999999999999999988764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=8.4e-30  Score=229.25  Aligned_cols=212  Identities=35%  Similarity=0.535  Sum_probs=174.2

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |.+.+.||.|++|.||++..  +++.+|+|.+......        .....+.+|+..+++++|+|++++++.+......
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   72 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL   72 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence            45778999999999999998  3699999998644322        2346688999999999999999999988766544


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                      ++++||+++++|.+++..... .+++..+..++.+++.+|.+||+.+++|+||+|.||+++.++
T Consensus        73 ----------------~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~  135 (225)
T smart00221       73 ----------------YLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG  135 (225)
T ss_pred             ----------------EEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence                            899999999999999865422 288999999999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccCCC-CcccCCCCCccccCcccc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 015594          259 TVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVVR  335 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~Pf~~-~~~~~~~~~~~~  335 (404)
                      .++|+|||.+....... .......++..|++||.+ ....++.++|||+||+++++|++|+.||.. ............
T Consensus       136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            99999999998654432 123345678889999998 666788899999999999999999999977 444434444443


Q ss_pred             cc
Q 015594          336 QN  337 (404)
Q Consensus       336 ~~  337 (404)
                      ..
T Consensus       216 ~~  217 (225)
T smart00221      216 FG  217 (225)
T ss_pred             cC
Confidence            33

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=258.05  Aligned_cols=204  Identities=24%  Similarity=0.373  Sum_probs=168.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---CCceeEEEEEEe
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPNVTKFIGATM  173 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~  173 (404)
                      ++|...+.+|.|+||.|++|++  +...|+||.+.+..--......... .-.+.-|+.||..|+   |+||++++++|+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk-LGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK-LGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc-cCccchhHHHHHHhhhcCccchhhhhheee
Confidence            5688999999999999999998  4578999988543111100000000 122456999999997   999999999999


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEecc-CCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      +.+.+                ||+||-- +|-+|++++...  ..+++..+..|++|++.|+++||+.||||||||-+|+
T Consensus       640 ddd~y----------------yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenv  701 (772)
T KOG1152|consen  640 DDDYY----------------YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENV  701 (772)
T ss_pred             cCCee----------------EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccE
Confidence            88876                8899865 566899999654  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      .++.+|-+||+|||.|.....  .....++||..|.|||++.|.+| +..-|||+||++||.++....||..
T Consensus       702 ivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  702 IVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999999999976443  34566889999999999999987 6789999999999999999888853

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-28  Score=219.64  Aligned_cols=259  Identities=17%  Similarity=0.304  Sum_probs=207.2

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  172 (404)
                      +..-.|.++++||.|+||+++.|++  ++++||||.-....+           ..++..|...++.| ..++|...+.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----------APQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----------APQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCC-----------cchHHHHHHHHHHHcCCCCCCceeeec
Confidence            4456899999999999999999986  899999998754332           23456788888877 567887776443


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ...                -+-.+|+|++ |-+|.|++ ..+++.++.+.++.+|.||+.-++|+|++.+|+|||||+|+
T Consensus        94 qeG----------------~~NiLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNF  155 (449)
T KOG1165|consen   94 QEG----------------KYNILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNF  155 (449)
T ss_pred             ccc----------------chhhhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccce
Confidence            322                2237999999 99999976 55678999999999999999999999999999999999999


Q ss_pred             EEcCC-----CcEEEeeccccccccCCC-------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          253 LLDKT-----RTVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       253 li~~~-----~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||...     ..|.|+|||+|+...++.       .......||..||+-....|...+++.|+-|||-++..++-|.+|
T Consensus       156 LIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP  235 (449)
T KOG1165|consen  156 LIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP  235 (449)
T ss_pred             eecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence            99543     358999999998644432       123446799999999999999999999999999999999999999


Q ss_pred             CCCCCHH---HHHHHHHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          321 YPDLSFS---EVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       321 f~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |.+....   +.+.++-.....-   .....+|.++..-|...-..+..+-|+++-+..++..+....|
T Consensus       236 WQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  236 WQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             cccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            9987443   3333332222111   2235678999999998889999999999999999999998876

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=231.77  Aligned_cols=262  Identities=23%  Similarity=0.338  Sum_probs=204.9

Q ss_pred             CeEEeeeeeeecceEEEEEEECC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC----CceeEEEEEE
Q 015594          100 KLIIKGAFARGTFGTVHRGIYDG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH----PNVTKFIGAT  172 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~  172 (404)
                      +|.+.+.||+|+||.||.+....   ..+|+|+.........         ..+..|..++..+..    +++..+++..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---------SVLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---------ccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            89999999999999999999743   4799998865432211         134567777777752    5778887766


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ..               ...+.||||+.+ |.+|.++......+.++...+..++.|++.+|.+||+.|++||||||.|+
T Consensus        90 ~~---------------~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~  153 (322)
T KOG1164|consen   90 RS---------------TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENF  153 (322)
T ss_pred             cC---------------CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHe
Confidence            31               122348999999 99999988666668999999999999999999999999999999999999


Q ss_pred             EEcCC-----CcEEEeeccccc--cccCCCC-------c-ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 015594          253 LLDKT-----RTVKIADFGVAR--LEASNPH-------D-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       253 li~~~-----~~vkL~Dfg~a~--~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      ++...     ..++|.|||+++  .......       . .....||..|+++..+.+...+++.|+||+++++.+++.|
T Consensus       154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g  233 (322)
T KOG1164|consen  154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG  233 (322)
T ss_pred             eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence            99654     469999999998  3222111       1 2345699999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhc---cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          318 DMPYPDLSFSEVTSAVVRQ---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       318 ~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                      .+||...........+...   ..........+..+..++..+-..+...+|.+..+...|+......+..+
T Consensus       234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~  305 (322)
T KOG1164|consen  234 SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKE  305 (322)
T ss_pred             CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCC
Confidence            9999876643332222221   11111345567889999999989999999999999999999988875443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=7.7e-29  Score=215.42  Aligned_cols=164  Identities=24%  Similarity=0.349  Sum_probs=131.1

Q ss_pred             CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCC
Q 015594          204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG  283 (404)
Q Consensus       204 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~g  283 (404)
                      |+|.+++... +..+++..++.++.||+.||.|||+.+      ||+|||++.++.+|+  ||++......     ...|
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g   66 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV   66 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence            7899998653 457999999999999999999999999      999999999999999  9998754332     2368


Q ss_pred             CccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC-----CCCCCCcH--HHHHHHH
Q 015594          284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRP-----EIPRCCPS--SLANVMK  355 (404)
Q Consensus       284 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~--~l~~li~  355 (404)
                      |+.|||||++.+..++.++|||||||++|||++|..||...... .....+.......     ..+...+.  ++.++|.
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            99999999999999999999999999999999999999765432 2223322221111     11122333  6999999


Q ss_pred             HhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          356 RCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       356 ~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +||+.+|.+||++.++++.+..+...
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHHHHH
Confidence            99999999999999999998877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=224.06  Aligned_cols=243  Identities=20%  Similarity=0.301  Sum_probs=181.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  175 (404)
                      +.|.+.+.||+|.||.+.++.+  +++.+++|.+....          ...+.|.+|...--.| .|.||+.-|++....
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----------hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            6789999999999999999998  56889999986322          1245688887664445 688998777654333


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE-
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-  254 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili-  254 (404)
                      ..               ++++++||++-|+|.+-+..   ..+.+.....++.|+++||.|+|++++||||||.+|||| 
T Consensus        94 ~d---------------~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif  155 (378)
T KOG1345|consen   94 SD---------------AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF  155 (378)
T ss_pred             Cc---------------eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence            33               33789999999999987643   468888999999999999999999999999999999999 


Q ss_pred             -cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 -DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-----AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 -~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                       .+.-+|||||||+.+......   ....-+..|.+||.....     ..++.+|||.||+++|..++|++||+.....+
T Consensus       156 ~~df~rvKlcDFG~t~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d  232 (378)
T KOG1345|consen  156 DADFYRVKLCDFGLTRKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD  232 (378)
T ss_pred             cCCccEEEeeecccccccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence             234589999999997433221   112236679999987433     25789999999999999999999998543322


Q ss_pred             HH---HHHHhccCCCCCC---CCCcHHHHHHHHHhhhhCCCCC---CCHHHHH
Q 015594          329 VT---SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDKR---PEMDEVV  372 (404)
Q Consensus       329 ~~---~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~R---pt~~~ll  372 (404)
                      ..   .....++..+..|   +-+++.+..+.++-|..+|++|   .++....
T Consensus       233 ~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  233 KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11   1112233333334   4467888899999999999999   4444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.2e-29  Score=267.25  Aligned_cols=200  Identities=22%  Similarity=0.267  Sum_probs=142.1

Q ss_pred             cCC-CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh
Q 015594          160 LDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ  238 (404)
Q Consensus       160 l~h-pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH  238 (404)
                      +.| +||+.++++|.....-         .......++++||+ +++|.++|... ...+++..++.++.||+.||.|||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLD---------GLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhHHHHHHHhhcccCCcccc---------ccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH
Confidence            355 5788888876322210         00112236788988 78999999543 456999999999999999999999


Q ss_pred             hCCceecccCCCCEEEcCC-------------------CcEEEeeccccccccCCC----------------CcccCCCC
Q 015594          239 SKKIVHRDVKTENMLLDKT-------------------RTVKIADFGVARLEASNP----------------HDMTGETG  283 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~-------------------~~vkL~Dfg~a~~~~~~~----------------~~~~~~~g  283 (404)
                      ++||+||||||+||||+..                   +.+||+|||+++......                .......|
T Consensus        98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181         98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence            9999999999999999654                   445666666664321100                00112357


Q ss_pred             CccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCC
Q 015594          284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPD  363 (404)
Q Consensus       284 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  363 (404)
                      |+.|||||++.+..|+.++|||||||+||||++|..|+....  .....+....+.+.... ..+...+++.+||+.+|.
T Consensus       178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~  254 (793)
T PLN00181        178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPS  254 (793)
T ss_pred             CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChh
Confidence            889999999999999999999999999999999888875322  12222222222222212 235567899999999999


Q ss_pred             CCCCHHHHHH
Q 015594          364 KRPEMDEVVA  373 (404)
Q Consensus       364 ~Rpt~~~ll~  373 (404)
                      +||++.+|++
T Consensus       255 ~Rps~~eil~  264 (793)
T PLN00181        255 CRPSMSELLQ  264 (793)
T ss_pred             hCcChHHHhh
Confidence            9999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=215.40  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=215.4

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      .|+...+.+..+|.....|..|+|++.|.++++|++...+...       .....|..|.-.|+-+.||||+.++|++..
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~-------risrdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA-------RISRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch-------hhcchhhhhCcceeeecCCchhhhhhhccC
Confidence            4666777788899999999999999999999999997554332       234568889999999999999999999988


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~Ni  252 (404)
                      +.++                .++..||+-|+|+..|.....-..+..++.+++.+|++|++|||+..  |.---|....+
T Consensus       259 ppnl----------------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hv  322 (448)
T KOG0195|consen  259 PPNL----------------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHV  322 (448)
T ss_pred             CCCc----------------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceE
Confidence            8776                78999999999999997765566778899999999999999999874  33445788899


Q ss_pred             EEcCCCcEEEe--eccccccccCCCCcccCCCCCccccCccccCCCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          253 LLDKTRTVKIA--DFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN---RKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       253 li~~~~~vkL~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      +||++.+.+|.  |--++.       ...+..-.|.||+||.+..++-+   +++|+|||++++|||.|...||.+.++.
T Consensus       323 midedltarismad~kfsf-------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm  395 (448)
T KOG0195|consen  323 MIDEDLTARISMADTKFSF-------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM  395 (448)
T ss_pred             Eecchhhhheecccceeee-------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence            99998877664  322221       12233447899999999877643   6899999999999999999999999999


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +.--++...+++..+|...+..+..||.-|+..||.+||.++.|+-.|++..
T Consensus       396 ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  396 ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            9888888999999999999999999999999999999999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.4e-28  Score=228.09  Aligned_cols=244  Identities=22%  Similarity=0.388  Sum_probs=187.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      ...|...++||.|+|++||++++     ..+.||+|.+.....           -.++.+|+.+|..+ .+.||+++.++
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----------p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----------PSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----------chHHHHHHHHHHHhccchhhhcchhh
Confidence            35688899999999999999875     457899999864432           23467899999999 69999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +...+..                ++||||++..+..+++.     .++...+..+++.++.||.++|.+|||||||||.|
T Consensus       104 ~rnnd~v----------------~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN  162 (418)
T KOG1167|consen  104 FRNNDQV----------------AIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN  162 (418)
T ss_pred             hccCCee----------------EEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence            9888877                89999999999999873     47789999999999999999999999999999999


Q ss_pred             EEEc-CCCcEEEeecccccc-ccCC------C-------C------------------------------cccCCCCCcc
Q 015594          252 MLLD-KTRTVKIADFGVARL-EASN------P-------H------------------------------DMTGETGTLG  286 (404)
Q Consensus       252 ili~-~~~~vkL~Dfg~a~~-~~~~------~-------~------------------------------~~~~~~gt~~  286 (404)
                      +|.+ ..+.-.|+|||+|.. ....      .       .                              ......||++
T Consensus       163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G  242 (418)
T KOG1167|consen  163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG  242 (418)
T ss_pred             cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence            9996 456788999999961 0000      0       0                              0011259999


Q ss_pred             ccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HH---------HHH-HHHhcc-------------
Q 015594          287 YMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSF-----SE---------VTS-AVVRQN-------------  337 (404)
Q Consensus       287 y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf~~~~~-----~~---------~~~-~~~~~~-------------  337 (404)
                      |.|||++...+ .+.++||||.|+++..++++.+||.....     .+         +.+ +...+.             
T Consensus       243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~  322 (418)
T KOG1167|consen  243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP  322 (418)
T ss_pred             CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence            99999997654 68899999999999999999999852210     00         000 000000             


Q ss_pred             ---------------------CCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 ---------------------LRPEI-PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ---------------------~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                           ..... ....+..+.+++.+||..||.+|.|+++.|+
T Consensus       323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                                 00011 1223457899999999999999999999884

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-27  Score=202.33  Aligned_cols=259  Identities=19%  Similarity=0.322  Sum_probs=201.8

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC-CceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~  171 (404)
                      .+...+|.+.+.||.|+||.+|.|.+  +|..||||+-......           ..+.-|..+++.|++ ..|..+..+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----------pqL~yEskvY~iL~~g~GiP~i~~y   79 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----------PQLLYESKVYRILQGGVGIPHIRHY   79 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----------cchhHHHHHHHHhccCCCCchhhhh
Confidence            45678999999999999999999987  8999999997543221           235678888888864 344444433


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ..+                ..+-.+|||++ |-+|.+++.- ..+.++.+.++-++-|++.-++|+|.++++||||||+|
T Consensus        80 ~~e----------------~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdN  141 (341)
T KOG1163|consen   80 GTE----------------KDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDN  141 (341)
T ss_pred             ccc----------------cccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccc
Confidence            332                22337999999 9999997744 45689999999999999999999999999999999999


Q ss_pred             EEEc---CCCcEEEeeccccccccCCC-------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          252 MLLD---KTRTVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       252 ili~---~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      +|..   ....+.|+|||+|+...+..       .......||..|.+-..+.+...+++.|+-|+|++|..+.-|.+||
T Consensus       142 FLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW  221 (341)
T KOG1163|consen  142 FLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW  221 (341)
T ss_pred             eeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence            9984   33469999999997543321       2234567999999999999998999999999999999999999999


Q ss_pred             CCCCHHHHH---HHHHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          322 PDLSFSEVT---SAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       322 ~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ++.......   ..+......-   ......|.++.-.+..|-..--++-|++.-|.+++..+.-..
T Consensus       222 Qglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  222 QGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             cccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            987654432   2232222221   234667899999999999999999999999888887765544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.3e-24  Score=203.32  Aligned_cols=251  Identities=29%  Similarity=0.438  Sum_probs=199.7

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC-ceeEEEEEEecCCccc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP-NVTKFIGATMGTSELN  179 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~  179 (404)
                      |.+...||.|+||.||++.+. ..+|+|.+........      .....+.+|+.++..+.|+ +|+++.+.+...... 
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~-   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL-   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE-
Confidence            678889999999999999888 8899999865433221      2456688999999999988 799999999555443 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                     +++++++.++++.+++..... ..++...+..++.|++.++.|+|+.|++|||+||+||+++..+
T Consensus        74 ---------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~  138 (384)
T COG0515          74 ---------------YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG  138 (384)
T ss_pred             ---------------EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence                           899999999999976644321 2789999999999999999999999999999999999999988


Q ss_pred             -cEEEeeccccccccCCCC------cccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--
Q 015594          259 -TVKIADFGVARLEASNPH------DMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLSF--  326 (404)
Q Consensus       259 -~vkL~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~~--  326 (404)
                       .++++|||.+........      ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||.....  
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~  218 (384)
T COG0515         139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS  218 (384)
T ss_pred             CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Confidence             799999999975443332      3456789999999999988   5789999999999999999999999877663  


Q ss_pred             --HHHHHHHHhccCC---CCCCCCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          327 --SEVTSAVVRQNLR---PEIPRCC----PSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       327 --~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                        ......+......   .......    ...+.+++.+|+..+|..|.+..+....
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              3333333333322   1122221    2578999999999999999988877664

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.3e-25  Score=211.55  Aligned_cols=169  Identities=20%  Similarity=0.190  Sum_probs=126.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ....+|.+.+.||+|+||+||+|.+   +++.||||++.........    ...+..|.+|+.+|.+++|+|+++.+..+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~----~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK----PLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc----HHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            3457899999999999999999987   5778899987422110001    12345688999999999999998533221


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc-CCCC
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV-KTEN  251 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di-kp~N  251 (404)
                         ...                |+||||++|++|.. +  .   ...   ...++.+++.+|.|||++||+|||| ||+|
T Consensus        91 ---~~~----------------~LVmE~~~G~~L~~-~--~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N  142 (365)
T PRK09188         91 ---GKD----------------GLVRGWTEGVPLHL-A--R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN  142 (365)
T ss_pred             ---CCc----------------EEEEEccCCCCHHH-h--C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence               112                89999999999963 2  1   111   1467889999999999999999999 9999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCC--------cccCCCCCccccCccccCCC
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPH--------DMTGETGTLGYMAPEVLNGS  296 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~  296 (404)
                      ||++.++.+||+|||+|+.......        +.++..+++.|+|||.+.-.
T Consensus       143 ILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        143 WLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999999999999986543321        11344578889999998543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.6e-26  Score=231.77  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=186.8

Q ss_pred             EEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          102 IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      ....++|.|++|.|+....  ....++.|...........+   ......+..|+.+-..+.|||++..+..+++.... 
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~---~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESE---RKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccH---HHHhhhhhhheeecccccCCchhhhHHHHhhcccc-
Confidence            3556889999997776654  34444444432110011111   12223377899999999999998776665544443 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     +-+||||++ +|..++...  ..++...+..++.|++.||.|+|..||.|||+|++|+++...|.
T Consensus       397 ---------------~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~  458 (601)
T KOG0590|consen  397 ---------------LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI  458 (601)
T ss_pred             ---------------hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc
Confidence                           334999988 999988553  47889999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCC----CcccCCCCCccccCccccCCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH
Q 015594          260 VKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGSAYNR-KCDVYSFGICLWEIYCCDMPYPDLSFSEVTS-AV  333 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~Pf~~~~~~~~~~-~~  333 (404)
                      +||+|||.+.++....    ....+.+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||......+... ..
T Consensus       459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~  538 (601)
T KOG0590|consen  459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN  538 (601)
T ss_pred             eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh
Confidence            9999999997654332    3456788999999999999999875 6899999999999999999997654443321 11


Q ss_pred             HhccCC------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLR------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......      ..+...+|...+.+|.+||+.||.+|.|+++|++
T Consensus       539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            110000      0123446788899999999999999999999985

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=2.2e-24  Score=197.63  Aligned_cols=251  Identities=19%  Similarity=0.260  Sum_probs=151.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC----------Ccee
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH----------PNVT  166 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv  166 (404)
                      ..+.....||.|+++.||.+++  +|+.+|||++........  ..    .+.+.+|.-....+.+          -.++
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~--~~----~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l   85 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA--NE----YEQLKEEQLAITLFPGVKNPKEAYRHLRFL   85 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT--TH----HHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch--HH----HHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence            3567788999999999999999  679999999977663222  22    2333444433333221          1222


Q ss_pred             EEEEEEe-cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh---ccc--CCCcHHHHHHHHHHHHHHHHHHhhC
Q 015594          167 KFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK---NRR--RKLAFKVVIQLALDLARGLSYLQSK  240 (404)
Q Consensus       167 ~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~qi~~~L~~LH~~  240 (404)
                      ..++... ......+....+.....-.+.+++|+-+ .++|.+++..   ...  ..+.......+..|+++.+++||+.
T Consensus        86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~  164 (288)
T PF14531_consen   86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY  164 (288)
T ss_dssp             --SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence            2222222 1111111111100000000236788877 7888887632   111  2244445566779999999999999


Q ss_pred             CceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC--------CCCCcchhhHHHHHHHH
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--------SAYNRKCDVYSFGICLW  312 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~  312 (404)
                      |+||+||+|+|++++.+|.++|+||+........   ......+..|.+||....        -.++.+.|.|+||+++|
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            9999999999999999999999999887643321   111334578999997733        24788999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 015594          313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR  365 (404)
Q Consensus       313 el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  365 (404)
                      .|.|+..||...........    .+  ......|+.++.||..+|+.||.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~----~f--~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW----DF--SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG----GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc----cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999999986643322111    11  1223678999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.9e-25  Score=212.16  Aligned_cols=226  Identities=24%  Similarity=0.364  Sum_probs=187.8

Q ss_pred             eeeeecceEEEEEE-----ECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCccc
Q 015594          106 AFARGTFGTVHRGI-----YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELN  179 (404)
Q Consensus       106 ~lg~G~~g~V~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  179 (404)
                      ++|+|+||.|+++.     +.|..+|+|++++.....+...       ....|..++..++ ||.+|++..+|+....+ 
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-------~t~~er~il~~~~~~~f~v~lhyafqt~~kl-   72 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-------HTKQERIILAFVHNTPFLVKLHYAFQTDGKL-   72 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-------ccccHHHHHhhccCCCceeeeeeeeccccch-
Confidence            46899999999543     3678899999876544433221       2345677777786 99999999999988887 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                     ++++++..||.|...+.+  ...+.+.....+...++.+++++|..|++|||+|++||+++.+|.
T Consensus        73 ---------------~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh  135 (612)
T KOG0603|consen   73 ---------------YLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH  135 (612)
T ss_pred             ---------------hHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc
Confidence                           789999999999887744  357888888899999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 015594          260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR  339 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~  339 (404)
                      +++.|||+++.......    .+||..|||||+++  +...++|.||||+++++|++|..||..    ++...+...  .
T Consensus       136 i~~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~  203 (612)
T KOG0603|consen  136 IKLTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--E  203 (612)
T ss_pred             cccCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--c
Confidence            99999999985443322    28999999999999  578899999999999999999999987    555555543  3


Q ss_pred             CCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          340 PEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       340 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      ..+|..++..+++++..++..+|.+|...
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            45788889999999999999999999654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.6e-24  Score=187.94  Aligned_cols=189  Identities=11%  Similarity=0.078  Sum_probs=136.2

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +-..+|.+.++||.|+||.||+...++..+|||++...........+.......+.+|+..+.++.||+|..+..++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            44688999999999999999997778889999999643322111111011123368999999999999999998887654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..-.+        .-.+..++||||++|.+|.++.      .+++    ....+++.+|..||+.|++|||++|.||+++
T Consensus       108 ~~~~~--------~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~  169 (232)
T PRK10359        108 ERKTL--------RYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS  169 (232)
T ss_pred             ccccc--------cccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence            32110        0112338999999999998863      2333    2456999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      .+| ++|+|||.+........ .           ........|+.++|+|+||+++.-+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a-~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKA-K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhh-H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            888 99999998864321110 0           01333445778999999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.4e-23  Score=184.23  Aligned_cols=146  Identities=16%  Similarity=0.185  Sum_probs=108.5

Q ss_pred             eeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHH-----------------HHHHHHHHHHHHHHHhhcCCCce
Q 015594          104 KGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAE-----------------IASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~-----------------~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ...||+|+||.||+|.+ +|+.||||+++.+.........                 .........+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999997 7999999999765322111100                 00112334569999999987765


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH-hhCCcee
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL-QSKKIVH  244 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~givH  244 (404)
                      .........  .                .++||||++|+++...+.+  ...++...+..++.|++.+|.+| |+.||+|
T Consensus        82 ~~p~~~~~~--~----------------~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH  141 (190)
T cd05147          82 PCPEPILLK--S----------------HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVH  141 (190)
T ss_pred             CCCcEEEec--C----------------CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            332222111  1                1799999988777655433  25789999999999999999999 7999999


Q ss_pred             cccCCCCEEEcCCCcEEEeecccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      |||||+|||++ ++.++|+|||+|..
T Consensus       142 rDlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147         142 ADLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             CCCCHHHEEEE-CCcEEEEEcccccc
Confidence            99999999998 47899999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-24  Score=218.27  Aligned_cols=246  Identities=20%  Similarity=0.242  Sum_probs=176.8

Q ss_pred             CeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      ++...+.||.+.|=.|.+|+++...|+||++-+......-    ....++ ..|+. ...+++||+++|.-+-.....  
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL----~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t~kA--   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL----RPFKQR-LEEIK-FALMKAPNCLPFQKVLVTDKA--   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc----hHHHHH-HHHHH-HHhhcCCcccchHHHHHhhHH--
Confidence            6888899999999999999997777999999765433211    112222 23444 566799999999765332222  


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                    .|+|-+|. ..+|.|.+..  +.-+..-+...|+.||+.||..+|..||+|||||.+||||+....
T Consensus        96 --------------AylvRqyv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW  158 (1431)
T KOG1240|consen   96 --------------AYLVRQYV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW  158 (1431)
T ss_pred             --------------HHHHHHHH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech
Confidence                          26788888 7889998844  345677788899999999999999999999999999999999999


Q ss_pred             EEEeecccccc--cc-CCCCcccCCCC----CccccCccccCCC----------C-CCcchhhHHHHHHHHHHHh-CCCC
Q 015594          260 VKIADFGVARL--EA-SNPHDMTGETG----TLGYMAPEVLNGS----------A-YNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       260 vkL~Dfg~a~~--~~-~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      +.|+||...+.  .. +++.+.+-+..    -..|.|||.+...          + .+++.||||+||+++||++ |.+|
T Consensus       159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl  238 (1431)
T KOG1240|consen  159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL  238 (1431)
T ss_pred             hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence            99999987642  11 23333333333    3469999998542          2 5789999999999999988 6777


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          321 YPDLSFSEVTSAVVRQN-LRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      |.-.   .+. ++...+ ..++  ....-+..++++|..|++.||.+|.++++.++.
T Consensus       239 F~LS---QL~-aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  239 FTLS---QLL-AYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccHH---HHH-hHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            7421   111 111110 0000  001113478999999999999999999999876

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.3e-22  Score=177.05  Aligned_cols=147  Identities=18%  Similarity=0.149  Sum_probs=111.6

Q ss_pred             eeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHH-----------------HHHHHHHHHHHHHHHhhcCCCce
Q 015594          104 KGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAE-----------------IASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~-----------------~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      .+.||+|+||.||+|.+ +|+.||||+++.+........+                 .......+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999997 6999999999876332111110                 01112345689999999999987


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCcee
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVH  244 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH  244 (404)
                      .....+....                  .|+||||++|+++......  ...++...+..++.|++.+|.+||+ .||+|
T Consensus        82 ~~p~~~~~~~------------------~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givH  141 (190)
T cd05145          82 PVPEPILLKK------------------NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVH  141 (190)
T ss_pred             CCceEEEecC------------------CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            5443332211                  1799999988765443222  2467888999999999999999999 99999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLE  271 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~  271 (404)
                      |||||+||+++ ++.++|+|||++...
T Consensus       142 rDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         142 GDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             CCCChhhEEEE-CCCEEEEEcccceec
Confidence            99999999999 789999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.2e-22  Score=208.50  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=184.8

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---CCc
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPN  164 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpn  164 (404)
                      -...+.++...+|.|.+.||+|+||.||+|.. +|+.||+|+-+......            |.=-..++.+|+   -+.
T Consensus       688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------------fYI~~q~~~RLk~~~~~~  755 (974)
T KOG1166|consen  688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------------FYICLQVMERLKPQMLPS  755 (974)
T ss_pred             CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------------eeehHHHHHhhchhhhcc
Confidence            34567788889999999999999999999987 79999999976443221            111123344444   122


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |..+..+..-                .+.+++|+||.+-|+|.+++.  ..+.+++..+..++.||+..++.||..+|||
T Consensus       756 ~~~~~~a~~~----------------~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIH  817 (974)
T KOG1166|consen  756 IMHISSAHVF----------------QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIH  817 (974)
T ss_pred             hHHHHHHHcc----------------CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceec
Confidence            2223222221                122379999999999999995  4578999999999999999999999999999


Q ss_pred             cccCCCCEEEc-------CCCcEEEeecccccc--ccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          245 RDVKTENMLLD-------KTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       245 ~Dikp~Nili~-------~~~~vkL~Dfg~a~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      +||||+|+||.       +...++|+|||.+..  ...+...+.+.++|-.+-.+|+..|.+|++.+|.|.|+.+++.|+
T Consensus       818 gDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL  897 (974)
T KOG1166|consen  818 GDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML  897 (974)
T ss_pred             ccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence            99999999993       234599999999863  223445677888999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccC---CCCCCCCCcHHH-HHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          316 CCDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPSSL-ANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       316 ~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l-~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .|++--           ...+..   ...+++..-.++ ..|+..+|..|-..=|...+|...|+.+...
T Consensus       898 FG~y~q-----------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  898 FGKYME-----------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             HHHHHH-----------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            986321           111111   111333333343 5677888884444448888888888877654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.3e-22  Score=183.55  Aligned_cols=214  Identities=19%  Similarity=0.302  Sum_probs=160.9

Q ss_pred             CCCceeEEEEEEecCCccc------cccC-----CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHH
Q 015594          161 DHPNVTKFIGATMGTSELN------IQTD-----NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD  229 (404)
Q Consensus       161 ~hpniv~~~~~~~~~~~~~------i~~~-----~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~q  229 (404)
                      +|||||++.++|.+.....      ++..     +.........+|+||.-+ .-+|..++..+   ..+....+-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            6999999999998765431      1000     112223456779999988 78999999654   6788888899999


Q ss_pred             HHHHHHHHhhCCceecccCCCCEEE--cCC--CcEEEeeccccccccC------CCCcccCCCCCccccCccccCCCCC-
Q 015594          230 LARGLSYLQSKKIVHRDVKTENMLL--DKT--RTVKIADFGVARLEAS------NPHDMTGETGTLGYMAPEVLNGSAY-  298 (404)
Q Consensus       230 i~~~L~~LH~~givH~Dikp~Nili--~~~--~~vkL~Dfg~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~-  298 (404)
                      +++|+.|||.+||.|||+|.+||||  +++  ..+.|+|||.+--...      ........-|...-||||+....+- 
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999999999999999999  333  4689999998742111      1122233457888999999876531 


Q ss_pred             -----CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          299 -----NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       299 -----~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                           -.++|.|+.|.+.||++....||.......+......+...+..|..||+.+++++..+|+.||.+|++..=...
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence                 258999999999999999999997744333333334445567788999999999999999999999998776666


Q ss_pred             HHHHh
Q 015594          374 MLEAI  378 (404)
Q Consensus       374 ~L~~~  378 (404)
                      .|+-.
T Consensus       510 vl~Ls  514 (598)
T KOG4158|consen  510 VLNLS  514 (598)
T ss_pred             HHHHH
Confidence            65543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.3e-21  Score=169.20  Aligned_cols=187  Identities=13%  Similarity=0.053  Sum_probs=138.7

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCccccc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~i~  181 (404)
                      ....|++|+||+||.+...+..++.+.++......     -......+.+|+.+|++|+ |++|++++++    ...   
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~-----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~---   73 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL-----RGVAWWLARREALALRQLDGLPRTPRLLHW----DGR---   73 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhh-----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE---
Confidence            44688999999999888888999987775322210     0111335789999999995 5788888875    112   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc-CCCCEEEcCCCcE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV-KTENMLLDKTRTV  260 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di-kp~Nili~~~~~v  260 (404)
                                   |++|||+.|.+|.+.+..        . ...++.|++.+|.++|++||+|||| ||+|||++.++.+
T Consensus        74 -------------~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i  131 (218)
T PRK12274         74 -------------HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSP  131 (218)
T ss_pred             -------------EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCE
Confidence                         799999999998754311        1 1357789999999999999999999 7999999999999


Q ss_pred             EEeeccccccccCCCCc----c---------cCCCCCccccCccccCCC-CCC-cchhhHHHHHHHHHHHhCCCCCCC
Q 015594          261 KIADFGVARLEASNPHD----M---------TGETGTLGYMAPEVLNGS-AYN-RKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~----~---------~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      +|+|||++.........    .         .-...++.|++|+...-. ..+ ...++++.|.-+|.++|+..+...
T Consensus       132 ~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        132 AVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             EEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            99999999754433211    0         001257888888865433 233 678999999999999999887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=5.1e-20  Score=164.83  Aligned_cols=142  Identities=22%  Similarity=0.298  Sum_probs=113.4

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      +.||+|++|.||+|.+.|..|+||+....... ..+.........+.+|+.++..+.|++|.....++.+....      
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~------   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYR-HPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF------   74 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCc-ChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC------
Confidence            57899999999999999999999986532211 11122223345678999999999999887666665544433      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                ++||||++|++|.+++...     .. ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|
T Consensus        75 ----------~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liD  137 (211)
T PRK14879         75 ----------IIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLID  137 (211)
T ss_pred             ----------EEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEE
Confidence                      8999999999999988543     12 7889999999999999999999999999999999 78899999


Q ss_pred             cccccc
Q 015594          265 FGVARL  270 (404)
Q Consensus       265 fg~a~~  270 (404)
                      ||.+..
T Consensus       138 f~~a~~  143 (211)
T PRK14879        138 FGLAEF  143 (211)
T ss_pred             CCcccC
Confidence            999863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=1.3e-21  Score=199.45  Aligned_cols=205  Identities=25%  Similarity=0.380  Sum_probs=154.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|..++.|..|+||.||..++  +.+.+|+|+-+.        .-             |     -+||..+-+    .
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq--------~l-------------i-----lRnilt~a~----n  131 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ--------NL-------------I-----LRNILTFAG----N  131 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc--------ch-------------h-----hhccccccC----C
Confidence            46788889999999999999987  478999965320        00             0     112333321    1


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .                  ++|      |+-...+..  -++++..        ++.+++|||+.||+|||+||+|.+|.
T Consensus       132 p------------------fvv------gDc~tllk~--~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT  177 (1205)
T KOG0606|consen  132 P------------------FVV------GDCATLLKN--IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT  177 (1205)
T ss_pred             c------------------cee------chhhhhccc--CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee
Confidence            1                  233      222233321  1344433        37899999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCc---------------ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          256 KTRTVKIADFGVARLEASNPHD---------------MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      .-|.+|++|||++....-....               ....+||+.|.|||++....|+..+|+|++|+++||++.|+.|
T Consensus       178 ~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvp  257 (1205)
T KOG0606|consen  178 SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP  257 (1205)
T ss_pred             ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeee
Confidence            9999999999998742211100               1234799999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcc-CCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 015594          321 YPDLSFSEVTSAVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRP  366 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rp  366 (404)
                      |.+.+.++++..++... ..++-...++++++++|.++|+.+|..|.
T Consensus       258 ffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  258 FFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            99999999988877654 34455667889999999999999999994

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=6.4e-21  Score=185.54  Aligned_cols=209  Identities=33%  Similarity=0.599  Sum_probs=166.4

Q ss_pred             HhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH
Q 015594          157 WHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       157 l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      |+.+.|.|+.+|+|++.+....                ++|.+||..|+|.+.+.. ....+++.-...+.++|+.||.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~----------------~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~y   63 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEM----------------IVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAY   63 (484)
T ss_pred             CcccchhhhhhheeeEecCCce----------------EEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHH
Confidence            3567999999999999988655                899999999999999966 35678888999999999999999


Q ss_pred             HhhCCc-eecccCCCCEEEcCCCcEEEeeccccccccC--CCCcccCCCCCccccCccccCCCC-------CCcchhhHH
Q 015594          237 LQSKKI-VHRDVKTENMLLDKTRTVKIADFGVARLEAS--NPHDMTGETGTLGYMAPEVLNGSA-------YNRKCDVYS  306 (404)
Q Consensus       237 LH~~gi-vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dvws  306 (404)
                      ||...| .|+.+++.|++++....+||+|||+......  .........-..-|.|||.+.+..       .+.+.||||
T Consensus        64 lh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs  143 (484)
T KOG1023|consen   64 LHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS  143 (484)
T ss_pred             HhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence            998865 9999999999999999999999999875432  111111122345699999997742       466799999


Q ss_pred             HHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcc---CCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          307 FGICLWEIYCCDMPYPDL----SFSEVTSAVVRQN---LRPEIPR--CCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       307 lG~il~el~~g~~Pf~~~----~~~~~~~~~~~~~---~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      ||++++|+++-..||...    +..+....+....   ++|.+..  .+++++..++..||..+|.+||+++.+-..++.
T Consensus       144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             HHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            999999999999999753    2234444444412   3444331  456689999999999999999999999999999


Q ss_pred             hHhhc
Q 015594          378 IDTSK  382 (404)
Q Consensus       378 ~~~~~  382 (404)
                      +....
T Consensus       224 ~~~~~  228 (484)
T KOG1023|consen  224 INKGG  228 (484)
T ss_pred             hcccc
Confidence            88755

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.9e-20  Score=163.50  Aligned_cols=139  Identities=14%  Similarity=0.211  Sum_probs=103.7

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-----CCCceeEEEEEEecCCc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-----DHPNVTKFIGATMGTSE  177 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~  177 (404)
                      -...||+|+||.||....++.. +||++......         ....+.+|+.+++.+     +||||++++|+++++..
T Consensus         6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CcceecCCCceEEEECCCCcCe-EEEEEeccccc---------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            3468999999999973334444 69988643221         124578999999999     67999999999987642


Q ss_pred             cccccCCCCCCCCCCceEEEEec--cCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHH-HHHhhCCceecccCCCCEEE
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEY--CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGL-SYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~givH~Dikp~Nili  254 (404)
                      ..            ..+.+|+||  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+++|+||||||+|||+
T Consensus        76 ~g------------~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl  138 (210)
T PRK10345         76 TG------------YVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILC  138 (210)
T ss_pred             Ce------------EEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence            10            012478999  5579999999542   46655  35678888787 99999999999999999999


Q ss_pred             cC----CCcEEEeecccc
Q 015594          255 DK----TRTVKIADFGVA  268 (404)
Q Consensus       255 ~~----~~~vkL~Dfg~a  268 (404)
                      +.    .+.++|+||+-+
T Consensus       139 ~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        139 QRISESEVIPVVCDNIGE  156 (210)
T ss_pred             eccCCCCCcEEEEECCCC
Confidence            63    347999995444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.9e-19  Score=159.65  Aligned_cols=138  Identities=20%  Similarity=0.270  Sum_probs=106.4

Q ss_pred             eeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCC
Q 015594          106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNG  185 (404)
Q Consensus       106 ~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~  185 (404)
                      .||+|+||.||++.++|..|++|+....... ..+.+......++.+|+.++..+.|+++.....++......       
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~-------   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYR-HPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK-------   72 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCc-CchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC-------
Confidence            4799999999999999999999996533211 11122222345678999999999888654443333333332       


Q ss_pred             CCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeec
Q 015594          186 HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF  265 (404)
Q Consensus       186 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Df  265 (404)
                               ++||||++|++|.+++....   .      .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++||
T Consensus        73 ---------~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDf  133 (199)
T TIGR03724        73 ---------TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDF  133 (199)
T ss_pred             ---------EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEEC
Confidence                     79999999999999874421   1      7889999999999999999999999999999 789999999


Q ss_pred             ccccc
Q 015594          266 GVARL  270 (404)
Q Consensus       266 g~a~~  270 (404)
                      |++..
T Consensus       134 g~a~~  138 (199)
T TIGR03724       134 GLGKY  138 (199)
T ss_pred             CCCcC
Confidence            99864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.4e-19  Score=164.37  Aligned_cols=148  Identities=21%  Similarity=0.241  Sum_probs=112.0

Q ss_pred             CeEEeeeeeeecceEEEEEE-E--CCceEEEEEeecCCCCcccH---------------HHHHHHHHHHHHHHHHHhhcC
Q 015594          100 KLIIKGAFARGTFGTVHRGI-Y--DGQDVAVKLLDWGEESHRSE---------------AEIASLRAAFTQEVAVWHKLD  161 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~-~--~g~~vAvK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~  161 (404)
                      -|.+.+.||+|+||.||+|. +  +|+.||||+++.........               .........+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 3  78999999997653211110               011123345678999999997


Q ss_pred             CCc--eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          162 HPN--VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       162 hpn--iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      +.+  +.++++.   . ..                ++||||++|++|..+....  ..+....+..++.||+.+|.+||.
T Consensus       109 ~~~i~~p~~~~~---~-~~----------------~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~  166 (237)
T smart00090      109 EAGVPVPKPIAW---R-RN----------------VLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK  166 (237)
T ss_pred             hcCCCCCeeeEe---c-Cc----------------eEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh
Confidence            533  3344432   1 11                7999999888887654222  356666788999999999999999


Q ss_pred             CC-ceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 KK-IVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 ~g-ivH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .| ++|+||||+||+++ ++.++|+|||.+..
T Consensus       167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             cCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            99 99999999999999 78999999999874

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.2e-20  Score=178.80  Aligned_cols=171  Identities=22%  Similarity=0.504  Sum_probs=133.9

Q ss_pred             CCceEEEEeccCCCCHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          191 SNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       191 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      ..++||.|++|.-.+|.++|... .....+......++.|++.|+.|   +|.+|+|+||.||++..+..+||.|||+..
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence            44569999999999999999643 34567788899999999999999   999999999999999999999999999987


Q ss_pred             cccCCC------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 015594          270 LEASNP------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEI  342 (404)
Q Consensus       270 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~  342 (404)
                      ......      ...+...||..||+||.+.+..|+.++||||||++|+|++. -..++....   ....+.+..+++.+
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPEF  481 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChHH
Confidence            544332      35567889999999999999999999999999999999987 444332211   11222223333333


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                      ....| .-+.|+..++.+.|.+||++
T Consensus       482 ~~d~p-~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  482 LQDYP-EEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             hhcCc-HHHHHHHHhcCCCcccCchH
Confidence            33333 34789999999999999943

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=1.1e-18  Score=177.29  Aligned_cols=142  Identities=20%  Similarity=0.255  Sum_probs=112.3

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      |...+.||+|+||+||++.+.+..+++|+....... ...........++.+|+.++..++|++++....++.+....  
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~--  411 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYR-HPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK--  411 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEeccccc-chhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC--
Confidence            345789999999999999998877777764322111 11112222345688999999999999998877666554433  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                    ++||||++|++|.+++.          ....++.+++.+|.+||+.|++||||||+|||+ .++.+
T Consensus       412 --------------~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        412 --------------TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             --------------EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcE
Confidence                          79999999999999874          346789999999999999999999999999999 57789


Q ss_pred             EEeecccccc
Q 015594          261 KIADFGVARL  270 (404)
Q Consensus       261 kL~Dfg~a~~  270 (404)
                      +|+|||+++.
T Consensus       467 ~liDFGla~~  476 (535)
T PRK09605        467 YLIDFGLGKY  476 (535)
T ss_pred             EEEeCccccc
Confidence            9999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.2e-18  Score=154.54  Aligned_cols=142  Identities=23%  Similarity=0.227  Sum_probs=107.7

Q ss_pred             eEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHH-------------HHHHHHHHHHHHHHHHhhcCCCc--
Q 015594          101 LIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEA-------------EIASLRAAFTQEVAVWHKLDHPN--  164 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hpn--  164 (404)
                      |.+.+.||+|+||.||++.. +|+.||||++..+........             ........+..|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            66778999999999999987 799999999875432111110             11122334678999999998874  


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      +...++.    ..                .++||||++|++|..+..        ......++.+++.++.++|+.||+|
T Consensus        97 v~~~~~~----~~----------------~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H  148 (198)
T cd05144          97 VPKPIDW----NR----------------HAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIH  148 (198)
T ss_pred             CCceeec----CC----------------ceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCc
Confidence            3444321    11                179999999999876532        0345678899999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeecccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +||||.||+|+.++.++|+|||.+..
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCcccc
Confidence            99999999999999999999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=5.6e-17  Score=147.55  Aligned_cols=147  Identities=16%  Similarity=0.137  Sum_probs=107.3

Q ss_pred             eeee-eecceEEEEEEECCceEEEEEeecCCCCcccHH----HHHHHHHHHHHHHHHHhhcCCCce--eEEEEEEecCCc
Q 015594          105 GAFA-RGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEA----EIASLRAAFTQEVAVWHKLDHPNV--TKFIGATMGTSE  177 (404)
Q Consensus       105 ~~lg-~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~~~  177 (404)
                      ..|| .|+.|+||+....+..++||.+..+..-.+...    .......++.+|+.++.+|.|++|  ++.+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            3566 788889998888899999998864321100000    001234567899999999998875  677766443322


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCC-CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHG-GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..            ...++|||+++| .+|.+++..   ..++...    +.+|+.+|.+||+.||+|+||||.|||++.
T Consensus       117 ~~------------~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~  177 (239)
T PRK01723        117 LF------------YRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDP  177 (239)
T ss_pred             cc------------eeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcC
Confidence            21            112599999987 689888743   3455543    568899999999999999999999999998


Q ss_pred             CCcEEEeecccccc
Q 015594          257 TRTVKIADFGVARL  270 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~  270 (404)
                      ++.++|+|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            88999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=7.3e-17  Score=141.52  Aligned_cols=143  Identities=24%  Similarity=0.241  Sum_probs=96.8

Q ss_pred             eeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHH---------------HHHHHHHHHHHHHHhhcCCCc--e
Q 015594          104 KGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEI---------------ASLRAAFTQEVAVWHKLDHPN--V  165 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~hpn--i  165 (404)
                      .+.||+|+||+||++.+ +|+.||||++.............               .........|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988 49999999987543221111100               000111235566666664432  3


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCcee
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVH  244 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH  244 (404)
                      .+.++..                    ..++||||++++++........  ... ..+..++.+++.++.++|. .||+|
T Consensus        82 ~~~~~~~--------------------~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~~~~ivH  138 (187)
T cd05119          82 PKPIDLN--------------------RHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYREAGLVH  138 (187)
T ss_pred             CceEecC--------------------CCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence            4443321                    1279999998854432111110  011 5678899999999999999 99999


Q ss_pred             cccCCCCEEEcCCCcEEEeecccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +||||+||+++ ++.++|+|||.+..
T Consensus       139 ~Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119         139 GDLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCCChhhEEEE-CCcEEEEECccccc
Confidence            99999999999 88999999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.3e-18  Score=176.82  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=188.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      ..|.+.+.||+|+|+.|-....   ....+|+|.+......   .    ........|..+-..+. |+|++.+++....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~---~----~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~   92 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS---E----DSSEHIDTETDIQKKLSKHSNTVHMIEPSSS   92 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc---c----chhhhcCccccccccccccccccccCCccCC
Confidence            4566667799999999987665   3345666665433211   1    11122335666666676 9999999998877


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh-hCCceecccCCCCEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ-SKKIVHRDVKTENML  253 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~givH~Dikp~Nil  253 (404)
                      ....                +++++|..|+++.+.+........+...+..++.|+..++.|+| ..++.|+||||+|.+
T Consensus        93 ~~~~----------------~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~  156 (601)
T KOG0590|consen   93 PRSY----------------LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL  156 (601)
T ss_pred             Cccc----------------ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence            7665                88999999999998773222225667778899999999999999 999999999999999


Q ss_pred             EcCCC-cEEEeeccccccccC-C--CCcccCCCC-CccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          254 LDKTR-TVKIADFGVARLEAS-N--PHDMTGETG-TLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       254 i~~~~-~vkL~Dfg~a~~~~~-~--~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ++..+ .++++|||+|..... .  .......+| ++.|+|||...+. ...+..|+||.|+++..+++|..||......
T Consensus       157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~  236 (601)
T KOG0590|consen  157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK  236 (601)
T ss_pred             hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence            99999 999999999986554 2  223344678 9999999999985 4578999999999999999999999766544


Q ss_pred             HHH-HHHHhc--cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVT-SAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~-~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ......  ..........+....+++.+++..+|..|.+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            322 111111  1123445667888999999999999999999888653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=5.3e-16  Score=130.26  Aligned_cols=132  Identities=21%  Similarity=0.203  Sum_probs=107.8

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC--CceeEEEEEEecCCcccc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH--PNVTKFIGATMGTSELNI  180 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~i  180 (404)
                      +.+.||.|.++.||++...+..++||.......           ...+.+|+.++..+.|  .++.++++++......  
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~--   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESDGWS--   68 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc--
Confidence            346789999999999999889999999853321           2457789999999976  4888888776654332  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC---CceecccCCCCEEEcCC
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK---KIVHRDVKTENMLLDKT  257 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---givH~Dikp~Nili~~~  257 (404)
                                    +++|||++++.+..+         +......++.+++.+|.+||..   +++|+|++|.||+++..
T Consensus        69 --------------~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~  125 (155)
T cd05120          69 --------------YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG  125 (155)
T ss_pred             --------------EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence                          899999988877653         4456677889999999999985   79999999999999998


Q ss_pred             CcEEEeecccccc
Q 015594          258 RTVKIADFGVARL  270 (404)
Q Consensus       258 ~~vkL~Dfg~a~~  270 (404)
                      +.++++|||.++.
T Consensus       126 ~~~~l~Df~~~~~  138 (155)
T cd05120         126 KILGIIDWEYAGY  138 (155)
T ss_pred             cEEEEEecccccC
Confidence            9999999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=2.5e-13  Score=134.16  Aligned_cols=145  Identities=25%  Similarity=0.315  Sum_probs=96.2

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHH--------------------------HHHHHH------HHH
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAE--------------------------IASLRA------AFT  151 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~--------------------------~~~~~~------~~~  151 (404)
                      +.||.|++|.||+|+. +|+.||||+...+.... ...+                          ..+...      .|.
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~-i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKT-IAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHH-HHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999997 79999999986542111 0000                          011111      255


Q ss_pred             HHHHHHhhcC-----CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHH
Q 015594          152 QEVAVWHKLD-----HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL  226 (404)
Q Consensus       152 ~E~~~l~~l~-----hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i  226 (404)
                      +|+..+.++.     +++| .+-.++.+-.               ...++||||++|++|.++..... ....   ...+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~---------------~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~i  261 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRT---------------SERVLTMEWIDGIPLSDIAALDE-AGLD---RKAL  261 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhc---------------CCceEEEEeECCcccccHHHHHh-cCCC---HHHH
Confidence            5666666552     3333 2222221111               11279999999999988764321 1222   2345


Q ss_pred             HHHHHH-HHHHHhhCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          227 ALDLAR-GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       227 ~~qi~~-~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +..++. .+..+|..|++|+|++|.||+++.++.++|+|||++..
T Consensus       262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~  306 (437)
T TIGR01982       262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR  306 (437)
T ss_pred             HHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence            556655 47889999999999999999999999999999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.5e-15  Score=148.34  Aligned_cols=249  Identities=24%  Similarity=0.236  Sum_probs=184.2

Q ss_pred             CCCeEEeeeeee--ecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           98 PAKLIIKGAFAR--GTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        98 ~~~~~~~~~lg~--G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      ...+.+.+.+|.  |.+|.||.+..    ++..+|+|.-+..-....       ...+-.+|+...+.+ .|+|.++.+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-------~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-------DSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-------ccccccchhhcccccCccccccccCc
Confidence            345567778999  99999996654    678899998432211100       011224666666777 4999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHH----HHHHHhhCCceecc
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR----GLSYLQSKKIVHRD  246 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~givH~D  246 (404)
                      ++++.+.+                |+-+|+| +.+|.++.... ..-++...++..+.+...    ||.++|+.+++|-|
T Consensus       186 ~~e~~~~l----------------fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~  247 (524)
T KOG0601|consen  186 AWEGSGIL----------------FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDD  247 (524)
T ss_pred             ccccCCcc----------------eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccc
Confidence            99988887                7888999 78888887443 345888899999999999    99999999999999


Q ss_pred             cCCCCEEEcCC-CcEEEeeccccccccCCCCccc-----CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          247 VKTENMLLDKT-RTVKIADFGVARLEASNPHDMT-----GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       247 ikp~Nili~~~-~~vkL~Dfg~a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      +||.||+...+ ...+++|||+...+....-...     ...|...|++||..++. ++...|+|+||.++.+..++..+
T Consensus       248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhccc
Confidence            99999999888 8899999999986554432222     22578899999999988 89999999999999998887544


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....-.. ....+-...+..++....+.+++..+..|++.+|..|++...++.
T Consensus       327 ~~~g~~~-~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  327 PSVGKNS-SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccCCCCC-CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            3222100 111112222344555566788888999999999999998666543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=4.3e-14  Score=141.29  Aligned_cols=159  Identities=16%  Similarity=0.177  Sum_probs=98.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-C-CceEEEEEeecCCCCc-------------------------ccHHHHHHHHHHHH
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-D-GQDVAVKLLDWGEESH-------------------------RSEAEIASLRAAFT  151 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-~-g~~vAvK~~~~~~~~~-------------------------~~~~~~~~~~~~~~  151 (404)
                      ..|.. +.||.|++|.||+|+. + |+.||||++..+....                         ....-..+....+.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            44555 7899999999999997 4 8999999997542110                         00111123334444


Q ss_pred             HHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc----CCCcHHHHHHHH
Q 015594          152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----RKLAFKVVIQLA  227 (404)
Q Consensus       152 ~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----~~l~~~~~~~i~  227 (404)
                      +|+...+..  .|+.++...|.+...+.++.-...+   .+.-++||||++|+.+.++-.-...    ..+....+..++
T Consensus       199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHH--HHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence            454444444  3444444444433333322211111   1123799999999999875311111    134444445555


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCC----cEEEeecccccc
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTR----TVKIADFGVARL  270 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~----~vkL~Dfg~a~~  270 (404)
                      .|++       ..|++|+|+||.||+++.++    +++++|||++..
T Consensus       274 ~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        274 TQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             HHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            5544       58999999999999999887    999999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.51  E-value=4.1e-13  Score=112.95  Aligned_cols=151  Identities=19%  Similarity=0.260  Sum_probs=115.3

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccccc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~  182 (404)
                      ....|-+|+-+.|+++.+.|+.+.||.- +.+.......+..-.+.+..+|+..+.++.--.|.-..=+|.+...-    
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~----   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG----   85 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----
Confidence            4567889999999999999999988863 34444444555566688889999999999644443332233333332    


Q ss_pred             CCCCCCCCCCceEEEEeccCC-CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC---
Q 015594          183 DNGHIGMPSNFCCVVVEYCHG-GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR---  258 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~---  258 (404)
                                  +|+|||++| .++.+++...............++.+|-..+.-||..+|+|+||.++||++..++   
T Consensus        86 ------------~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~  153 (229)
T KOG3087|consen   86 ------------QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI  153 (229)
T ss_pred             ------------eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence                        789999966 4889999877666666666689999999999999999999999999999995544   


Q ss_pred             cEEEeecccccc
Q 015594          259 TVKIADFGVARL  270 (404)
Q Consensus       259 ~vkL~Dfg~a~~  270 (404)
                      .+.|+|||++..
T Consensus       154 ~~~lIdfgls~~  165 (229)
T KOG3087|consen  154 TPILIDFGLSSV  165 (229)
T ss_pred             ceEEEeecchhc
Confidence            358999999964

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.49  E-value=7.6e-13  Score=115.57  Aligned_cols=144  Identities=14%  Similarity=0.155  Sum_probs=100.1

Q ss_pred             eeeeeeecceEEEEEEEC--------CceEEEEEeecCCCCcccHH-----------------HHHHHHHHHHHHHHHHh
Q 015594          104 KGAFARGTFGTVHRGIYD--------GQDVAVKLLDWGEESHRSEA-----------------EIASLRAAFTQEVAVWH  158 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~--------g~~vAvK~~~~~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~  158 (404)
                      ...||.|--+.||.|...        +..+|||+.+.+-...+...                 ..........+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357899999999999753        37999999865422111111                 11122233448999999


Q ss_pred             hcCC--CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH
Q 015594          159 KLDH--PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       159 ~l~h--pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ++..  -++.+.+++.   .+                 ++||||+.+..+.....+.  ..++...+..+..+++.+|..
T Consensus        82 rl~~~Gv~vP~pi~~~---~~-----------------~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~  139 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---KH-----------------VLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQ  139 (197)
T ss_pred             HHHHcCCCCCeEEEec---CC-----------------EEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHH
Confidence            9943  4555666541   11                 7999999654442221121  245566677888999999999


Q ss_pred             H-hhCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          237 L-QSKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       237 L-H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      | |..||||+||++.||++.+ +.++|+|||.+..
T Consensus       140 l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         140 LYKECNLVHADLSEYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             HHHhCCeecCCCCHHHEEEEC-CcEEEEECCCcee
Confidence            9 8999999999999999974 6799999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=5.6e-14  Score=127.49  Aligned_cols=202  Identities=20%  Similarity=0.337  Sum_probs=140.5

Q ss_pred             HHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHH
Q 015594          155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLAR  232 (404)
Q Consensus       155 ~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~  232 (404)
                      .-+-++.|-|||++..+|.+...-.           .....++.||++.|+|.++|.+.+  ...+......+|+-||+.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e-----------~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIls  187 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEE-----------KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILS  187 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhccccccc-----------ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            3445567999999999987665421           122367899999999999997643  356778888999999999


Q ss_pred             HHHHHhhC--CceecccCCCCEEEcCCCcEEEeecccccc--ccC--CCCcccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          233 GLSYLQSK--KIVHRDVKTENMLLDKTRTVKIADFGVARL--EAS--NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       233 ~L~~LH~~--givH~Dikp~Nili~~~~~vkL~Dfg~a~~--~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||.|||+.  -|+|+++.-+.|++..+|-+|+.--.-...  ...  .........+-++|.|||.=.....+-.+|||+
T Consensus       188 al~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~  267 (458)
T KOG1266|consen  188 ALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK  267 (458)
T ss_pred             hhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence            99999988  599999999999999999887753111100  000  000111234678899999877666788999999


Q ss_pred             HHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          307 FGICLWEIYCCDMP-YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       307 lG~il~el~~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      ||.+..+|..+..- -...+..+....+....+..+     ...-++++.+|++..|..||+|.+++
T Consensus       268 fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  268 FGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             hhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhh
Confidence            99999999887542 222222222222111111111     12236789999999999999999876

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=1.2e-12  Score=110.76  Aligned_cols=139  Identities=22%  Similarity=0.257  Sum_probs=104.2

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCC
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      ..+++|+-+.||.+.+-|..+++|. ...+.-...+......+.+-.+|+.++.++.--.|...+=++.++...      
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~------   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG------   74 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC------
Confidence            3578999999999988777766665 334444344445455567778999999999654443333333344433      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEee
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD  264 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~D  264 (404)
                                .|+|||++|-.|.+++...         ...++..+-.-+.-||..||+|+||.++||++.+.+ +.++|
T Consensus        75 ----------~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~ID  134 (204)
T COG3642          75 ----------LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFID  134 (204)
T ss_pred             ----------EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEE
Confidence                      6899999998999888554         145677888888999999999999999999998765 99999


Q ss_pred             cccccc
Q 015594          265 FGVARL  270 (404)
Q Consensus       265 fg~a~~  270 (404)
                      ||++..
T Consensus       135 fGLg~~  140 (204)
T COG3642         135 FGLGEF  140 (204)
T ss_pred             CCcccc
Confidence            999974

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3.3e-13  Score=116.16  Aligned_cols=126  Identities=17%  Similarity=0.153  Sum_probs=93.0

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee-EEEEEEecCCccccccC
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT-KFIGATMGTSELNIQTD  183 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~i~~~  183 (404)
                      +.|+.|.++.||++...++.|++|+.......          ...+.+|+.+++.+.+.+++ +++....  ...     
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~-----   66 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----------LINRENEAENSKLAAEAGIGPKLYYFDP--ETG-----   66 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCccc----------ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCC-----
Confidence            56788999999999999999999997533210          12245788888888655543 4444322  111     


Q ss_pred             CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCc-----eecccCCCCEEEcCCC
Q 015594          184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI-----VHRDVKTENMLLDKTR  258 (404)
Q Consensus       184 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi-----vH~Dikp~Nili~~~~  258 (404)
                                 ++||||++|.++...       ..   ....++.+++.+|..||+.++     +|+|++|.||+++ ++
T Consensus        67 -----------~lv~e~i~G~~l~~~-------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~  124 (170)
T cd05151          67 -----------VLITEFIEGSELLTE-------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG  124 (170)
T ss_pred             -----------eEEEEecCCCccccc-------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC
Confidence                       689999999887643       01   112456789999999999985     9999999999999 56


Q ss_pred             cEEEeeccccc
Q 015594          259 TVKIADFGVAR  269 (404)
Q Consensus       259 ~vkL~Dfg~a~  269 (404)
                      .++|+|||.+.
T Consensus       125 ~~~liDf~~a~  135 (170)
T cd05151         125 RLWLIDWEYAG  135 (170)
T ss_pred             eEEEEeccccc
Confidence            89999999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.46  E-value=4.3e-14  Score=145.16  Aligned_cols=252  Identities=20%  Similarity=0.288  Sum_probs=186.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +....+.+.+.+.+.+|.++.++.+.-  .|...++|+......-...      ..+....+-.++-..++|-++.+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~------~~~s~r~~s~~~i~p~~P~v~~~~~s  872 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN------DYESIRSKSNILITPRSPAVVRSFPS  872 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc------cccccCCccCccccCCCCceecccCC
Confidence            456677888889999999999997664  4555566655322111100      01112233333333456777766555


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.-...+                ++|++|+.+++|...|...  ...+...++.....+..+++|||+..+.|+|++|.|
T Consensus       873 ~~~rsP~----------------~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~  934 (1205)
T KOG0606|consen  873 FPCRSPL----------------PLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDS  934 (1205)
T ss_pred             CCCCCCc----------------chhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccc
Confidence            4444444                8999999999999988544  456777778888899999999999999999999999


Q ss_pred             EEEcCCCcEEEeecccccccc-CCC------------------------------CcccCCCCCccccCccccCCCCCCc
Q 015594          252 MLLDKTRTVKIADFGVARLEA-SNP------------------------------HDMTGETGTLGYMAPEVLNGSAYNR  300 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~-~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~  300 (404)
                      .++..++..+++|||...... .++                              .......+|+.|.+||.+.+.....
T Consensus       935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen  935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred             hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence            999999999999998433111 000                              0011235899999999999999999


Q ss_pred             chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       301 ~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      .+|+|++|++++|.++|..||...........+..... .+..+...+.+..+++.+.+..+|.+|..+.
T Consensus      1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999999999999999999999998888776665543 3345667789999999999999999997665

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=6.1e-12  Score=124.52  Aligned_cols=163  Identities=19%  Similarity=0.276  Sum_probs=121.7

Q ss_pred             CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEec
Q 015594          121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY  200 (404)
Q Consensus       121 ~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~  200 (404)
                      ++.+|.|...++...      +   ......+-+.-|+.++||||++++..+.....+                |||.|-
T Consensus        36 ~~~~vsVF~~~~~~~------~---~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~----------------ylvTEr   90 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG------E---VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTL----------------YLVTER   90 (690)
T ss_pred             cCCceEEEEEeCCCc------h---hhHHHHHHHHHhhhccCchhhhhhhhhcccCce----------------EEEeec
Confidence            788999999876543      1   112234567788999999999999998887766                899999


Q ss_pred             cCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh-hCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCccc
Q 015594          201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ-SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT  279 (404)
Q Consensus       201 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~  279 (404)
                      +  ..|..++.+     ++...+..-+.||+.||.+|| ..+++|++|....|+|+..|..||++|.++...........
T Consensus        91 V--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~  163 (690)
T KOG1243|consen   91 V--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK  163 (690)
T ss_pred             c--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc
Confidence            8  456666633     446778888999999999997 66899999999999999999999999998864222221111


Q ss_pred             CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 015594          280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       280 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      ...---.|..|+.+....  -..|.|.||+++++++.|
T Consensus       164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            112223456666554332  457999999999999998

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.30  E-value=1.8e-10  Score=110.93  Aligned_cols=215  Identities=18%  Similarity=0.221  Sum_probs=152.9

Q ss_pred             eEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCC
Q 015594          113 GTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMP  190 (404)
Q Consensus       113 g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~  190 (404)
                      .+.|++..  +|..|++|.+....... . ..       ...-+..|+++.|+|||+|..+|....-            .
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~-nk-------~t~lve~wkkl~h~NvV~frevf~t~tF------------~  348 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQS-T-NK-------DTSLVEAWKKLCHTNVVPFREVFLTYTF------------G  348 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccC-c-cc-------chHHHHHHHHhccCceeehhhhhhhhcc------------C
Confidence            56788876  89999999984322111 1 00       1245788999999999999999873221            2


Q ss_pred             CCceEEEEeccCC-CCHHHHHHhcc-------------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          191 SNFCCVVVEYCHG-GALKSYLIKNR-------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       191 ~~~~~lv~E~~~~-g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ...+++|++|.++ ++|.++...+.             +.+.++..+|.++.|++.||.++|+.|+..+-|.|.+|++++
T Consensus       349 D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G  428 (655)
T KOG3741|consen  349 DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG  428 (655)
T ss_pred             cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC
Confidence            2334899999975 57877664432             245778999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P-f~~~~~~~~~~~~~~  335 (404)
                      +-+++|...|...+...++.              |-+.   -..+-|.=.||.+++.|.||..- +..........    
T Consensus       429 ~~RIriS~C~i~Dvl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~----  487 (655)
T KOG3741|consen  429 KMRIRISGCGIMDVLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL----  487 (655)
T ss_pred             cceEEEecccceeeecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHH----
Confidence            98999999988876544430              1111   23467899999999999999543 11111111100    


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                          ..+....+.+++++|..+...++++ -++.+++.+
T Consensus       488 ----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  488 ----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                1133456788999999999999887 577777654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=4e-12  Score=124.51  Aligned_cols=250  Identities=21%  Similarity=0.197  Sum_probs=173.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      ..+|..+..||.|.|+.|+....   ++..|++|-+..+-.....  ++.     -..|+.+...+ -|.+++.+...|.
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~--di~-----sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS--DIF-----SLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh--hhc-----chhhhhHhhHhhcccccCCCCCCcc
Confidence            45677888999999999997654   5678999877544322211  111     12455555555 4788888777776


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                |+-.|||+++++...+.-  ...+.+...+.+..|++.++.++|+..++|+|++|+||+
T Consensus       337 ~~r~~----------------~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~  398 (524)
T KOG0601|consen  337 QLRQG----------------YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL  398 (524)
T ss_pred             ccccc----------------cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence            66665                577799999987765522  246778889999999999999999999999999999999


Q ss_pred             EcCC-CcEEEeeccccccccCCCCcccCCCCCcccc--CccccCCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCHHHH
Q 015594          254 LDKT-RTVKIADFGVARLEASNPHDMTGETGTLGYM--APEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEV  329 (404)
Q Consensus       254 i~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~el~~g~~-Pf~~~~~~~~  329 (404)
                      +..+ +..++.|||........   .......-.++  ++.......+..+.|++|||..+.+.+++.. ++....    
T Consensus       399 i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----  471 (524)
T KOG0601|consen  399 ISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----  471 (524)
T ss_pred             eccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----
Confidence            9775 78899999988632211   11122233344  5556666778899999999999999888753 332221    


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                       ...+..+..+..+ +....+..+.+.+...++..||.+.++.....-..+.
T Consensus       472 -~~~i~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  472 -SLTIRSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             -ceeeecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence             1112222222222 3337788888999999999999998887766655443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.23  E-value=1.4e-10  Score=101.04  Aligned_cols=132  Identities=27%  Similarity=0.298  Sum_probs=84.3

Q ss_pred             EEEEEEE-CCceEEEEEeecCCCCcc-----------------cHHHHHHHHHHHHHHHHHHhhcCCC--ceeEEEEEEe
Q 015594          114 TVHRGIY-DGQDVAVKLLDWGEESHR-----------------SEAEIASLRAAFTQEVAVWHKLDHP--NVTKFIGATM  173 (404)
Q Consensus       114 ~V~~~~~-~g~~vAvK~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~  173 (404)
                      .||.|.. +|..+|||+...+....+                 ........+....+|...|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3898887 789999999865421111                 1122333456678999999999765  456666442 


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccC--CCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH-HhhCCceecccCCC
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCH--GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY-LQSKKIVHRDVKTE  250 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~givH~Dikp~  250 (404)
                        .+                 +|||||++  |..+..+. ..   .++......++.+++..+.. +|..||+|+|+.+.
T Consensus        80 --~~-----------------~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~  136 (188)
T PF01163_consen   80 --RN-----------------VIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEY  136 (188)
T ss_dssp             --TT-----------------EEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STT
T ss_pred             --CC-----------------EEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChh
Confidence              11                 69999997  55555433 22   22244556777888885555 58999999999999


Q ss_pred             CEEEcCCCcEEEeecccccc
Q 015594          251 NMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ||+++++ .+.|+|||.+..
T Consensus       137 NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  137 NILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             SEEEETT-CEEE--GTTEEE
T ss_pred             hEEeecc-eEEEEecCccee
Confidence            9999887 899999999864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.19  E-value=4.3e-10  Score=103.63  Aligned_cols=144  Identities=15%  Similarity=0.063  Sum_probs=97.2

Q ss_pred             cceEEEEEEECCceEEEEEeecCCCCcccHHHHHHH------HHHHHHHHHHHhhcCCCce--eEEEEEEecCCcccccc
Q 015594          111 TFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASL------RAAFTQEVAVWHKLDHPNV--TKFIGATMGTSELNIQT  182 (404)
Q Consensus       111 ~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpni--v~~~~~~~~~~~~~i~~  182 (404)
                      ....|++....|+.|.||........    .-...+      ...+.+|...+.+|..-+|  ...+++.......    
T Consensus        34 ~~rrvvr~~~~g~~~~vKr~~~~~~~----~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~----  105 (268)
T PRK15123         34 EGRRTLRFELAGKSYFLKWHRGTGWG----EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP----  105 (268)
T ss_pred             CCceEEEEEECCEEEEEEEecCCcHH----HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC----
Confidence            33446677889999999976321110    000000      1136688888887743333  3334443321111    


Q ss_pred             CCCCCCCCCCceEEEEeccCCC-CHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC-----
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGG-ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-----  256 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~-----  256 (404)
                             .....++|+|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.     
T Consensus       106 -------~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 -------ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             -------ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCC
Confidence                   011238999999775 7999885433345667778899999999999999999999999999999974     


Q ss_pred             --CCcEEEeeccccc
Q 015594          257 --TRTVKIADFGVAR  269 (404)
Q Consensus       257 --~~~vkL~Dfg~a~  269 (404)
                        +..+.|+||+.+.
T Consensus       179 ~~~~~~~LIDl~r~~  193 (268)
T PRK15123        179 EEDLKLSVIDLHRAQ  193 (268)
T ss_pred             CCCceEEEEECCccc
Confidence              4689999999885

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=1.9e-09  Score=101.58  Aligned_cols=189  Identities=17%  Similarity=0.313  Sum_probs=139.2

Q ss_pred             eEEEEeccCCCC-HHHHHH----hcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeecccc
Q 015594          194 CCVVVEYCHGGA-LKSYLI----KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA  268 (404)
Q Consensus       194 ~~lv~E~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a  268 (404)
                      ..++|..+.|.. +..++.    +..-....|..++++++.|+.+...||..|.+-+|+.++|+|+++++.|.|.|-...
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            467888887654 222221    112245678999999999999999999999999999999999999999999986554


Q ss_pred             ccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCC-------HHH--HHHH-
Q 015594          269 RLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS-------FSE--VTSA-  332 (404)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g-~~Pf~~~~-------~~~--~~~~-  332 (404)
                      .+ ..+.......+|...|.+||..+     +-.-+...|.|.||+++++++.| ..||.+..       ..+  +... 
T Consensus       165 qi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            33 34566677788999999999876     33456789999999999999886 89997542       111  1100 


Q ss_pred             -----HHhccCCC---CCC-CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHhHhhcC
Q 015594          333 -----VVRQNLRP---EIP-RCCPSSLANVMKRCWDA--NPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       333 -----~~~~~~~~---~~~-~~~~~~l~~li~~cl~~--dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                           -....+.+   .+| ..+++++..+..+|+..  ++.-|||++..+..|..+.++.-
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence                 00111111   112 34689999999999964  35689999999999999888764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=4.2e-10  Score=101.03  Aligned_cols=142  Identities=23%  Similarity=0.224  Sum_probs=100.5

Q ss_pred             eeeeeecceEEEEEEECC-ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC--ceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIYDG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP--NVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~i~  181 (404)
                      +.|+.|.++.||++...+ +.+++|+.......        .....+.+|+.++..+.+.  ++.+++.+......    
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~----   71 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV----   71 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc----
Confidence            567899999999998754 89999997543221        0123467888999988653  45666665443220    


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh----------------------
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS----------------------  239 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------  239 (404)
                               .+..++||||++|.++.+.+..   ..++......++.+++.+|.+||+                      
T Consensus        72 ---------~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  139 (223)
T cd05154          72 ---------LGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV  139 (223)
T ss_pred             ---------cCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence                     1123799999999888764421   246666667777777777777773                      


Q ss_pred             ----------------------------------CCceecccCCCCEEEcC--CCcEEEeecccccc
Q 015594          240 ----------------------------------KKIVHRDVKTENMLLDK--TRTVKIADFGVARL  270 (404)
Q Consensus       240 ----------------------------------~givH~Dikp~Nili~~--~~~vkL~Dfg~a~~  270 (404)
                                                        ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                              24699999999999988  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=9.1e-10  Score=98.81  Aligned_cols=142  Identities=25%  Similarity=0.245  Sum_probs=104.7

Q ss_pred             eEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccH-------------HHHHHHHHHHHHHHHHHhhcCCC--c
Q 015594          101 LIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSE-------------AEIASLRAAFTQEVAVWHKLDHP--N  164 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp--n  164 (404)
                      ..++..||-|--|.||.|.. .|..+|||.-..+-.+.+..             ......+....+|..+|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34668899999999999998 69999999876553222211             12233356678999999999654  5


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |.+.+++                    +..++||||++|-.|...       ++..+..-.++..|+.-+.-+-..|+||
T Consensus       173 VP~P~~~--------------------nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVH  225 (304)
T COG0478         173 VPKPIAW--------------------NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVH  225 (304)
T ss_pred             CCCcccc--------------------ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence            5555543                    233799999988777543       1234445566667777777777999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      +|+++-||+++++|.++++||-.+.
T Consensus       226 GDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         226 GDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCchheEEEecCCCEEEEeCcccc
Confidence            9999999999999999999997775

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=2.5e-10  Score=113.61  Aligned_cols=145  Identities=21%  Similarity=0.313  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHhhC-CceecccCCCCEEEcCCCcEEEeeccccccccCCCC-cc---c-----CCCCCccccCccccCCCC
Q 015594          228 LDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH-DM---T-----GETGTLGYMAPEVLNGSA  297 (404)
Q Consensus       228 ~qi~~~L~~LH~~-givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~---~-----~~~gt~~y~aPE~~~~~~  297 (404)
                      .+++.||.|+|+. ++||++|.|++|.++..+..||+.|+.+.....+.. .+   +     -......|.|||.+.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            3455899999965 999999999999999999999999998753222111 01   0     012456799999999988


Q ss_pred             CCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          298 YNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       298 ~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      .+.++|+||||+++|.++. |+.-+...............  --.......+|+++++=|.+++..++..||++..+.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            9999999999999999995 44444443332222221111  112234577899999999999999999999766654

>PRK09902 hypothetical protein; Provisional

Probab=98.95  E-value=1.5e-08  Score=88.89  Aligned_cols=147  Identities=17%  Similarity=0.123  Sum_probs=104.6

Q ss_pred             eeecceEEEEEEECCceEEEEEeec-CCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCCccccccCC
Q 015594          108 ARGTFGTVHRGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       108 g~G~~g~V~~~~~~g~~vAvK~~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~i~~~~  184 (404)
                      |+|+-+-|++..+.|+.+-+|.-.. -....+    .+.-+..|.+|...+.+|..-+  +.+.+.+-........    
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r----~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~----   98 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR----YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW----   98 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCccccccc----CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce----
Confidence            6789999999888888888887631 000000    0112567899999999984322  4444422222222211    


Q ss_pred             CCCCCCCCceEEEEeccCC-CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc--EE
Q 015594          185 GHIGMPSNFCCVVVEYCHG-GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VK  261 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~--vk  261 (404)
                              ..+||+|-++| -+|.+++.+..-.+.+......++.+++..|.-||+.|+.|+|+.+.||+++.++.  |+
T Consensus        99 --------rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         99 --------RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             --------EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEE
Confidence                    22789997743 57888886654456788888899999999999999999999999999999986667  99


Q ss_pred             Eeecccccc
Q 015594          262 IADFGVARL  270 (404)
Q Consensus       262 L~Dfg~a~~  270 (404)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987763

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=1.1e-08  Score=91.15  Aligned_cols=109  Identities=18%  Similarity=0.189  Sum_probs=81.3

Q ss_pred             HHHHHHHHHHhhcCCCc--eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCC-CHHHHHHhcccCCCcHHHHH
Q 015594          148 AAFTQEVAVWHKLDHPN--VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG-ALKSYLIKNRRRKLAFKVVI  224 (404)
Q Consensus       148 ~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~  224 (404)
                      .+..+|...+..|..-.  +.+.+++........            ...++|+|++++. +|.+++....  ..+.....
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~------------~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~  121 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG------------YRSYLITEALPGAQDLRDLLQQWE--QLDPSQRR  121 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc------------eeEEEEEEeCCCcccHHHHHHhhc--ccchhhHH
Confidence            44667777777774322  344445444322211            2238999999874 7999886532  26677788


Q ss_pred             HHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC---cEEEeecccccc
Q 015594          225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR---TVKIADFGVARL  270 (404)
Q Consensus       225 ~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~---~vkL~Dfg~a~~  270 (404)
                      .++.+++..+.-||..||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999999999999999998877   899999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.80  E-value=8.3e-07  Score=88.76  Aligned_cols=147  Identities=20%  Similarity=0.251  Sum_probs=91.6

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCc-------------------------ccHHHHHHHHH------HHHH
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESH-------------------------RSEAEIASLRA------AFTQ  152 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~-------------------------~~~~~~~~~~~------~~~~  152 (404)
                      ..|+.++-|.||+|+. +|+.||||+...+-...                         .......+..+      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5788999999999998 59999999986542111                         11111122222      2445


Q ss_pred             HHHHHhhc-----CCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHH
Q 015594          153 EVAVWHKL-----DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA  227 (404)
Q Consensus       153 E~~~l~~l-----~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~  227 (404)
                      |+..+.++     +.++|.-..=++.-...-                .++|||++|-.+.++..... ..++.+.+....
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~----------------VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~  273 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRR----------------VLTMEWIDGIKISDIAALKS-AGIDRKELAELL  273 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCc----------------EEEEEeeCCEecccHHHHHh-cCCCHHHHHHHH
Confidence            56555555     244432111111111111                69999999988888753222 345544333322


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++  -+..+=..|++|.|.+|-||+++.+|++.+.|||+...
T Consensus       274 ~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         274 VRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             HHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceec
Confidence            222  13344458999999999999999999999999999874

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.75  E-value=8.7e-08  Score=85.36  Aligned_cols=142  Identities=20%  Similarity=0.175  Sum_probs=94.1

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHH---------------HHHHHHHHHHHHHHhhcC--CCcee
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEI---------------ASLRAAFTQEVAVWHKLD--HPNVT  166 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~--hpniv  166 (404)
                      ..|..|--+.||+|.. ++..+|||++...-...+.....               .....-..+|+..|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            4677888889999886 68999999996432221111000               011122446777777773  34455


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCH-HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCcee
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL-KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVH  244 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH  244 (404)
                      +.+++...                    .+||||+....+ .-.|   ..-.+....+..+..+++..+.-|-. .|+||
T Consensus       134 ~Pi~~~~n--------------------VLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVH  190 (268)
T COG1718         134 EPIAFRNN--------------------VLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVH  190 (268)
T ss_pred             CceeecCC--------------------eEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence            55544321                    699999943311 1111   11233344677888899999988876 89999


Q ss_pred             cccCCCCEEEcCCCcEEEeecccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +||+.-|||+. ++.+.|+|||.|..
T Consensus       191 gDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         191 GDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             ccchhhheEEE-CCeEEEEECccccc
Confidence            99999999999 77899999999864

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.73  E-value=3.1e-07  Score=81.03  Aligned_cols=150  Identities=17%  Similarity=0.152  Sum_probs=93.4

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHH--HHHHHHHHHHHhhc---CCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASL--RAAFTQEVAVWHKL---DHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~--~~~~~~E~~~l~~l---~hpniv~~~~  170 (404)
                      +...+|.+.+++-.....-|.+-..+|+.+.+|......  .+.+......  -....+++....++   .--....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            344677888888877788888888899999999874321  1111111111  00122333333333   2233333333


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      +..-...-           -....++||||++|..|.++.      .+++    .++..|..++.-||..|++|+|..|.
T Consensus       106 ~~ekk~~~-----------~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpg  164 (229)
T PF06176_consen  106 AAEKKIFR-----------YTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPG  164 (229)
T ss_pred             eeeeeecc-----------ceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcC
Confidence            33222111           011226899999999987753      1232    24456778899999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccc
Q 015594          251 NMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~  269 (404)
                      |+++++++ ++++||+..+
T Consensus       165 NFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  165 NFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             cEEEECCc-EEEEECcccc
Confidence            99998665 9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.64  E-value=2.4e-07  Score=78.19  Aligned_cols=131  Identities=24%  Similarity=0.265  Sum_probs=94.5

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ....+.|++|++|.||++.+.|..+|+|+-....           -+..+..|+.++..+.-.++.+=+-.+ +..    
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds-----------~r~~l~kEakiLeil~g~~~~p~vy~y-g~~----   87 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS-----------PRRNLEKEAKILEILAGEGVTPEVYFY-GED----   87 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecCCc-----------chhhHHHHHHHHHHhhhcCCCceEEEe-chh----
Confidence            3455789999999999999999999999864221           256688999999999877765433222 111    


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC-CCCEEEcCCCc
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK-TENMLLDKTRT  259 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik-p~Nili~~~~~  259 (404)
                                    ++.|||+.|-.|.+.-..     .+-    +-...++..-.-|-..||-|+.|. |...+|.+++.
T Consensus        88 --------------~i~me~i~G~~L~~~~~~-----~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~  144 (201)
T COG2112          88 --------------FIRMEYIDGRPLGKLEIG-----GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD  144 (201)
T ss_pred             --------------hhhhhhhcCcchhhhhhc-----ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCc
Confidence                          567999988888875421     112    223455566666778899999997 66666666668


Q ss_pred             EEEeecccccc
Q 015594          260 VKIADFGVARL  270 (404)
Q Consensus       260 vkL~Dfg~a~~  270 (404)
                      +.|+||..|+.
T Consensus       145 ~~iIDFd~At~  155 (201)
T COG2112         145 VYIIDFDSATF  155 (201)
T ss_pred             EEEEEccchhh
Confidence            99999999974

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.48  E-value=6.6e-06  Score=71.83  Aligned_cols=150  Identities=23%  Similarity=0.285  Sum_probs=100.3

Q ss_pred             CCeEEeeeeeeecc-eEEEEEEECCceEEEEEeec---CCCCcc---------cHHHHHHHHHHHHHHHHHHhhcC---C
Q 015594           99 AKLIIKGAFARGTF-GTVHRGIYDGQDVAVKLLDW---GEESHR---------SEAEIASLRAAFTQEVAVWHKLD---H  162 (404)
Q Consensus        99 ~~~~~~~~lg~G~~-g~V~~~~~~g~~vAvK~~~~---~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~---h  162 (404)
                      .+++..+.||.|.- |.||++..+|+.||+|++..   ......         +.........-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78999999999999 99999999999999999332   111100         01111133456888888887774   5


Q ss_pred             Cce--eEEEEEEecCCccccccC--CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh
Q 015594          163 PNV--TKFIGATMGTSELNIQTD--NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ  238 (404)
Q Consensus       163 pni--v~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH  238 (404)
                      .++  |+.+|+..-...-.+...  .+..........||-||++...           .++.+.    +.+|.+-|..+|
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHH
Confidence            555  999999854421111100  1222233444578999886544           223333    456777888999


Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeecccc
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVA  268 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a  268 (404)
                      ..||+-+|+++.|..   +  =+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999986   2  368999865

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2.8e-06  Score=76.67  Aligned_cols=135  Identities=13%  Similarity=0.142  Sum_probs=76.5

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCCcccccc
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSELNIQT  182 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~i~~  182 (404)
                      ..||.|..+.||+.  .|..+++|+.....    .       .....+|.++++.+..-.  +.+.+++..+....    
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~-------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~----   69 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----D-------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRL----   69 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC----C-------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCee----
Confidence            46799999999984  35678889875321    1       122467888887775332  34455554443333    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCC-HHHH--------------HHh----ccc---CCCcHHHH-HHHHH----------H
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGA-LKSY--------------LIK----NRR---RKLAFKVV-IQLAL----------D  229 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~-L~~~--------------l~~----~~~---~~l~~~~~-~~i~~----------q  229 (404)
                                  .+|||+++|.+ +...              +.+    -..   ...+.... ..+..          .
T Consensus        70 ------------glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~  137 (226)
T TIGR02172        70 ------------GLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD  137 (226)
T ss_pred             ------------eeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence                        68999998863 2111              111    000   01111110 00100          0


Q ss_pred             HHH-HHHHHh----hCCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          230 LAR-GLSYLQ----SKKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       230 i~~-~L~~LH----~~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      +.. ...+|.    ...++|+|+.|.||++++++ +.|+||+.+.
T Consensus       138 ~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       138 YKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             HHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            111 112222    12478999999999999888 9999999886

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=6.9e-06  Score=74.01  Aligned_cols=143  Identities=20%  Similarity=0.209  Sum_probs=81.1

Q ss_pred             eeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC--ceeEEEEEEecCCccccc
Q 015594          104 KGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP--NVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~i~  181 (404)
                      .+.|+.|..+.||+...++..+++|+...       .    .....+.+|..+++.+...  -+.+++.........   
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~-------~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~---   67 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRP-------P----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN---   67 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESS-------H----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET---
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCC-------C----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc---
Confidence            35789999999999998778999999742       1    1234456788888887433  345666543332222   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHH----------------HHHhcc-----cCCCcHHH---------HHHH-----
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKS----------------YLIKNR-----RRKLAFKV---------VIQL-----  226 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~----------------~l~~~~-----~~~l~~~~---------~~~i-----  226 (404)
                                ...+++|++++|..+..                .+..-.     ...+....         ....     
T Consensus        68 ----------~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (239)
T PF01636_consen   68 ----------GFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLR  137 (239)
T ss_dssp             ----------SEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ----------ccceEEEEEeccccccccccccccccccccchhhhhhccccccccccccccccccccccccccccccccc
Confidence                      11489999998887777                111100     00011000         0000     


Q ss_pred             -------HHHHHH-HHHHHh-------hCCceecccCCCCEEEc-CCCcEEEeecccccc
Q 015594          227 -------ALDLAR-GLSYLQ-------SKKIVHRDVKTENMLLD-KTRTVKIADFGVARL  270 (404)
Q Consensus       227 -------~~qi~~-~L~~LH-------~~givH~Dikp~Nili~-~~~~vkL~Dfg~a~~  270 (404)
                             ...+.. .+..++       ...++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  138 ASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             chhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                   111222 233333       24699999999999999 667778999998863

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.39  E-value=7.4e-06  Score=71.57  Aligned_cols=99  Identities=22%  Similarity=0.253  Sum_probs=79.0

Q ss_pred             HHHHHHHhhcCC-CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHH---HHhcccCCCcHHHHHHH
Q 015594          151 TQEVAVWHKLDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY---LIKNRRRKLAFKVVIQL  226 (404)
Q Consensus       151 ~~E~~~l~~l~h-pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~~l~~~~~~~i  226 (404)
                      .+|.-+++.+.+ +++.+++|+|-.                    ++|.||...+++...   +..  -...+|..+..|
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~--------------------~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~i   64 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR--------------------FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKI   64 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC--------------------EEEEEeecCcccccccccccc--ccccCHHHHHHH
Confidence            368888888866 699999999821                    579999977765421   101  124689999999


Q ss_pred             HHHHHHHHHHHhh---CCceecccCCCCEEEcCCCcEEEeeccccccc
Q 015594          227 ALDLARGLSYLQS---KKIVHRDVKTENMLLDKTRTVKIADFGVARLE  271 (404)
Q Consensus       227 ~~qi~~~L~~LH~---~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~  271 (404)
                      +.+++..+.+|+.   ..+.-.|++++|+.|++++++|++|...+...
T Consensus        65 A~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   65 ALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            9999999999987   35788999999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=6.9e-06  Score=82.03  Aligned_cols=146  Identities=19%  Similarity=0.263  Sum_probs=88.6

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHH-----------------------HHHHH------HHHHHH
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEI-----------------------ASLRA------AFTQEV  154 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~-----------------------~~~~~------~~~~E~  154 (404)
                      +.||.-+.|.||+|+. +|+.||||+.+.+-...-. ...                       .+...      .|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~-~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIM-LDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHH-HHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            5789999999999997 7899999998654322100 000                       11111      244455


Q ss_pred             HHHhhc----CCCc------eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHH
Q 015594          155 AVWHKL----DHPN------VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI  224 (404)
Q Consensus       155 ~~l~~l----~hpn------iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~  224 (404)
                      +...+.    .|-+      |.+++-.+...                  -.++||||+|..+.+.-. .....++-..+.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~------------------RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~  306 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTK------------------RVLTMEYVDGIKINDLDA-IDKRGISPHDIL  306 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcc------------------eEEEEEecCCccCCCHHH-HHHcCCCHHHHH
Confidence            444443    2333      33333222111                  169999999988766431 122345555443


Q ss_pred             HHHHHHHHHHHHHhhCCceecccCCCCEEEc----CCCcEEEeecccccccc
Q 015594          225 QLALDLARGLSYLQSKKIVHRDVKTENMLLD----KTRTVKIADFGVARLEA  272 (404)
Q Consensus       225 ~i~~qi~~~L~~LH~~givH~Dikp~Nili~----~~~~vkL~Dfg~a~~~~  272 (404)
                      .-+.+..  +.-+=..|++|+|-+|-||++.    .++.+.+.|||+.....
T Consensus       307 ~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  307 NKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            3333322  2233456899999999999997    46789999999987543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.19  E-value=1e-05  Score=85.62  Aligned_cols=201  Identities=19%  Similarity=0.235  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHH
Q 015594          148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA  227 (404)
Q Consensus       148 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~  227 (404)
                      .....|...+.++.|+|++.++.+........+.            ..+..|++...++...+..-  ...+...++.+.
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~------------~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~  292 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIV------------LDVLQEICSKVELRSLLQSV--GSIPLETLRILH  292 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHH------------HHHHHhhcCccchHHHHhhc--cccCHHHHHHHH
Confidence            3345677888888999999998887655433211            14566889888998887543  578889999999


Q ss_pred             HHHHHHHHHHhhCCceecccCCC---CEEEcCCCcEEEe--eccccccccCCCCcccCCCCCccccCccccCCCCCCcc-
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTE---NMLLDKTRTVKIA--DFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK-  301 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~---Nili~~~~~vkL~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-  301 (404)
                      .++..||.|+|+..+.|.-+...   +...+..+.+.++  ||+.+........ ......+..+.++|......+..+ 
T Consensus       293 ~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r  371 (1351)
T KOG1035|consen  293 QKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSR  371 (1351)
T ss_pred             HHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhh
Confidence            99999999999997666666555   4444566677777  8888865443322 233445677888888877765544 


Q ss_pred             -hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          302 -CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       302 -~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                       .|+|++|..+..+..|..+-...   .....+        .+..+...+.+...+|+..++++|+++.+++..
T Consensus       372 ~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  372 LTDLWCLGLLLLQLSQGEDISEKS---AVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhHHHHHHHHHhhhhhcCcccccc---cchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence             79999999999998875432111   000111        122222367889999999999999999998864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2.3e-05  Score=71.60  Aligned_cols=135  Identities=14%  Similarity=0.087  Sum_probs=78.3

Q ss_pred             eeeecc-eEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCccccccCC
Q 015594          107 FARGTF-GTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQTDN  184 (404)
Q Consensus       107 lg~G~~-g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~i~~~~  184 (404)
                      |..|.+ +.||+....+..+.||+.....            ...+.+|+.+++.+. +--+.+++++.......      
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~------   67 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRA------   67 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCcc------
Confidence            444555 7899987777788899875321            112456777777773 33355666665443222      


Q ss_pred             CCCCCCCCceEEEEeccCCCCHHHHH----------------Hhccc-----CCCcHH--HHHHHHH-------------
Q 015594          185 GHIGMPSNFCCVVVEYCHGGALKSYL----------------IKNRR-----RKLAFK--VVIQLAL-------------  228 (404)
Q Consensus       185 ~~~~~~~~~~~lv~E~~~~g~L~~~l----------------~~~~~-----~~l~~~--~~~~i~~-------------  228 (404)
                                ++|||+++|.+|....                .+-..     .++...  .......             
T Consensus        68 ----------~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  137 (244)
T cd05150          68 ----------WLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDF  137 (244)
T ss_pred             ----------EEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhC
Confidence                      7899999887776431                00000     011100  0000000             


Q ss_pred             -------HHHHHHHHH-------hhCCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          229 -------DLARGLSYL-------QSKKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       229 -------qi~~~L~~L-------H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                             .+...+..|       ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       138 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         138 DDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                   011112222       12358999999999999998778899999885

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.11  E-value=4.8e-07  Score=89.82  Aligned_cols=183  Identities=19%  Similarity=0.187  Sum_probs=127.4

Q ss_pred             EEeeeeeeecceEEEEEEECC-ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc-eeEEEEEEecCCccc
Q 015594          102 IIKGAFARGTFGTVHRGIYDG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN-VTKFIGATMGTSELN  179 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~~g-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~  179 (404)
                      ...+-+++|+++.+++.+.+. +....+.+...              ....-++.+|.+++||| .+..++-+..+..  
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~--  308 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY--  308 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc--------------hhhHHHHHHHHHccCCCCcccccccCCcccc--
Confidence            344567889999999887642 33335555311              11234678899999999 5555554443333  


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCC-CHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGG-ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR  258 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~  258 (404)
                                    .+++++++.++ +..... .-..-.+...+...+.+.-+++|++||+.-=+|+|    ||+..+ +
T Consensus       309 --------------~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~  368 (829)
T KOG0576|consen  309 --------------LWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E  368 (829)
T ss_pred             --------------cchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c
Confidence                          37899999877 221111 00112344445667778888999999998778888    777765 5


Q ss_pred             cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          259 TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       259 ~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      ..+..||+......... ......+|+.++|||+.....+....|+|++|.-..++.-|..|-
T Consensus       369 ~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  369 EVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            78999999987544332 344567899999999999999999999999999877777776654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.07  E-value=6.5e-05  Score=80.68  Aligned_cols=81  Identities=17%  Similarity=0.167  Sum_probs=53.6

Q ss_pred             eeeeeeecceEEEEEEECC----ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCce--eEEEEEEecCC
Q 015594          104 KGAFARGTFGTVHRGIYDG----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNV--TKFIGATMGTS  176 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~~  176 (404)
                      ...++.|.++.+|+....+    ..+++|+........        ....+.+|+.+++.+. |.+|  .+++.++.+..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~  114 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS  114 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence            4667889999999877643    467888764332110        1234678999999995 6665  77777765543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGA  205 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~  205 (404)
                      .+             +..|+||||++|..
T Consensus       115 v~-------------G~~flVME~v~G~~  130 (822)
T PLN02876        115 VI-------------GTAFYIMEYLEGRI  130 (822)
T ss_pred             cC-------------CCceEEEEecCCcc
Confidence            21             12389999998764

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.04  E-value=1e-06  Score=94.91  Aligned_cols=211  Identities=12%  Similarity=-0.001  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHH
Q 015594          146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVV  223 (404)
Q Consensus       146 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~  223 (404)
                      +++....|...++...|+++.....-.......              ..+.+++|+.+|.+.+.+.+..  ...+....+
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~--------------ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v 1337 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSEST--------------EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPV 1337 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCCh--------------HHHHHHHHHHHhHHHHHHHhccccCCcchhchH
Confidence            344556677777778899887665444333322              2278999999999999997642  233444444


Q ss_pred             HHHHHHHHHHHHHHhhC-----CceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC
Q 015594          224 IQLALDLARGLSYLQSK-----KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY  298 (404)
Q Consensus       224 ~~i~~qi~~~L~~LH~~-----givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  298 (404)
                      .....+.+....-+|+.     -.+|+++|+.|.+|..+-++|+.++|+.++............+++.|++|++.+.-.+
T Consensus      1338 ~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~ 1417 (2724)
T KOG1826|consen 1338 HLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF 1417 (2724)
T ss_pred             HHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh
Confidence            44444447777777765     2799999999999999999999999999855544444555678899999999999989


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 015594          299 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV  371 (404)
Q Consensus       299 ~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l  371 (404)
                      +.++|+|..|+.+|+..-|..+|-....... ..+++..-...++.-.|.+.-.+...+|-..-..||.-..+
T Consensus      1418 t~rsdilr~s~~ly~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1418 TKRSDILRRSLSLYLRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred             hhHHHHHHHHHHHHHHhcccHHHHHHHHHHH-cCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence            9999999999999999888777633221111 11222222234444445555555555555555667664443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.81  E-value=1.6e-05  Score=73.54  Aligned_cols=141  Identities=23%  Similarity=0.225  Sum_probs=99.3

Q ss_pred             eEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHH-------------HHHHHHHHHHHHHHHhhcCC-Cc-
Q 015594          101 LIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAE-------------IASLRAAFTQEVAVWHKLDH-PN-  164 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~h-pn-  164 (404)
                      +.+++.||-|--+.||.+.+ .|++.++|+-..+-.+.+.-..             ..-.+-...+|++.|+.|.- -. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45678899999999999888 5999999987654332222111             12224456789999888843 22 


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |.+.+++                    +..|+|||++.|-.|...-.        ...+..+...+..-+--|..+|+||
T Consensus       174 VPkpiD~--------------------~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv~la~~GlIH  225 (465)
T KOG2268|consen  174 VPKPIDH--------------------NRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIVRLANHGLIH  225 (465)
T ss_pred             CCCcccc--------------------cceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHHHHHHcCcee
Confidence            2333322                    22389999998888876421        1123345666777778889999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccc
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      +|..-=||+|.+++.++++||-...
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999997654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.76  E-value=0.00022  Score=64.82  Aligned_cols=30  Identities=27%  Similarity=0.467  Sum_probs=25.7

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +++|+|+.+.||++++++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            589999999999998766557999998853

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.00019  Score=66.06  Aligned_cols=134  Identities=17%  Similarity=0.135  Sum_probs=75.3

Q ss_pred             eeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce-eEEEEEEecCCccccccCCC
Q 015594          107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV-TKFIGATMGTSELNIQTDNG  185 (404)
Q Consensus       107 lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~i~~~~~  185 (404)
                      +..|-.+.+|+...+++.+++|+........         .....+|..+++.+....+ .++++...  .         
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~---------~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~---------   63 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL---------GVDRQREYQILQALSALGLAPKPILVNE--H---------   63 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccc---------cCcHHHHHHHHHHHHhcCCCCceEEEeC--C---------
Confidence            4457788999888888889999864321110         0113467777777753322 23333221  1         


Q ss_pred             CCCCCCCceEEEEeccCCCCHHH--------------HHHhcc-----cCCCcHH-HHHHHHHH---------HHHHHHH
Q 015594          186 HIGMPSNFCCVVVEYCHGGALKS--------------YLIKNR-----RRKLAFK-VVIQLALD---------LARGLSY  236 (404)
Q Consensus       186 ~~~~~~~~~~lv~E~~~~g~L~~--------------~l~~~~-----~~~l~~~-~~~~i~~q---------i~~~L~~  236 (404)
                               ++|+||++|..+..              .+.+-.     ..+++.. .+..+..+         +...+..
T Consensus        64 ---------~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  134 (256)
T TIGR02721        64 ---------WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQ  134 (256)
T ss_pred             ---------EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHH
Confidence                     58999998866532              111111     1112211 11121111         1112222


Q ss_pred             Hhh--------CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          237 LQS--------KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       237 LH~--------~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +-.        ..++|+|+.|.||++++++ +.|+||..+..
T Consensus       135 ~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       135 FRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             HHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            221        2589999999999999877 78999998863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.71  E-value=0.00076  Score=59.33  Aligned_cols=137  Identities=19%  Similarity=0.242  Sum_probs=88.1

Q ss_pred             eeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHH-------HHHHHHHHHHHHHHHHhhcC------CCceeEEEE
Q 015594          104 KGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEA-------EIASLRAAFTQEVAVWHKLD------HPNVTKFIG  170 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~------hpniv~~~~  170 (404)
                      ...||+|+.-.||..-. .....||+............       .-........+|+.-+..+.      +..|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            35789999999996433 34577888865440000000       00001233455665555554      888999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCC------CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG------GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      ..+.+..+                .+|+|.+.+      -||.+++..   ..++. .+.   ..+-.-..||-+.+|+.
T Consensus        85 ~veT~~G~----------------Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~---~~L~~f~~~l~~~~Iv~  141 (199)
T PF10707_consen   85 FVETNLGL----------------GLVVELIRDADGNISPTLEDYLKE---GGLTE-ELR---QALDEFKRYLLDHHIVI  141 (199)
T ss_pred             EEecCCce----------------EEEEEEEECCCCCcCccHHHHHHc---CCccH-HHH---HHHHHHHHHHHHcCCee
Confidence            99887776                678887643      358888843   34555 333   33444567888999999


Q ss_pred             cccCCCCEEEcC--CC--cEEEee
Q 015594          245 RDVKTENMLLDK--TR--TVKIAD  264 (404)
Q Consensus       245 ~Dikp~Nili~~--~~--~vkL~D  264 (404)
                      +|++|.||++..  ++  .+.|+|
T Consensus       142 ~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  142 RDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cCCCcccEEEEecCCCceEEEEEe
Confidence            999999999942  22  577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.00084  Score=63.23  Aligned_cols=82  Identities=9%  Similarity=-0.024  Sum_probs=53.8

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC---CceeEEEEEEecCCc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH---PNVTKFIGATMGTSE  177 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~  177 (404)
                      ..-.+.||.|..+.||+....+..+.+|+.+....           ...+..|...++.|.-   -.+.++++++.....
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            33456789999999999876555677787532100           1346788888888742   356777776654321


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCH
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGAL  206 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L  206 (404)
                      .             +..++|||+++|+++
T Consensus        85 ~-------------g~~~LVmE~i~G~~~  100 (297)
T PRK10593         85 P-------------GPDVLLLERLRGVSV  100 (297)
T ss_pred             C-------------CCeEEEEeccCCEec
Confidence            1             123899999988765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.64  E-value=0.00078  Score=61.00  Aligned_cols=30  Identities=23%  Similarity=0.459  Sum_probs=26.8

Q ss_pred             CceecccCCCCEEEcC-CCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDK-TRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~-~~~vkL~Dfg~a~~  270 (404)
                      +++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            6999999999999997 57899999998863

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.48  E-value=0.0018  Score=61.27  Aligned_cols=149  Identities=18%  Similarity=0.231  Sum_probs=81.3

Q ss_pred             CeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~  177 (404)
                      .......++.|....||+...++..+++|+.....    ..       .....|+.++..|....  +.+++....+.  
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~--   89 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KA-------EELPFFLALTTHLAARGLPVPKPVKSRDGR--   89 (307)
T ss_pred             CceeccccCCccccceEEEEeCCCcEEEEEecCCC----CH-------HHHHHHHHHHHHHHHCCCCCCccccCCCCC--
Confidence            34456677888888999887666678889864311    11       11234556666663222  34444321111  


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHH-----------HHHHhcc--cCCC-----------cHHHHH---------
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALK-----------SYLIKNR--RRKL-----------AFKVVI---------  224 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~-----------~~l~~~~--~~~l-----------~~~~~~---------  224 (404)
                       .       +....+..++|+||++|..+.           ..+.+-.  ...+           .+....         
T Consensus        90 -~-------~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (307)
T TIGR00938        90 -Q-------LSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ  161 (307)
T ss_pred             -e-------ehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence             0       111123458999999885431           1111100  0000           000000         


Q ss_pred             ---HHHHHHHHHHHHHhh-------CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          225 ---QLALDLARGLSYLQS-------KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       225 ---~i~~qi~~~L~~LH~-------~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                         .....+...++++..       .+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               011123344555532       589999999999999988767899999885

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.48  E-value=9.6e-05  Score=69.64  Aligned_cols=145  Identities=17%  Similarity=0.220  Sum_probs=92.7

Q ss_pred             EeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHH-----------------HHHHHHHHHHHHHHHHhhcCCCc
Q 015594          103 IKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEA-----------------EIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      +...|..|--+.||.++. +|..+|||+++-+....+...                 .-...+.-..+|++.|.+|+.-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345677788888999886 789999999864322111100                 00111223457888888885433


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCH-HHHHHhcccCCCcHHHHHHHHHHHHHHHHHH-hhCCc
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL-KSYLIKNRRRKLAFKVVIQLALDLARGLSYL-QSKKI  242 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~gi  242 (404)
                      |.-.       .++.+           ....|||+++....- .-.|   +...++...+..+-.+++.-+.-| +..++
T Consensus       228 IP~P-------ePIlL-----------k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~L  286 (520)
T KOG2270|consen  228 IPCP-------EPILL-----------KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRL  286 (520)
T ss_pred             CCCC-------Cceee-----------ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhce
Confidence            2211       00000           001699999942221 1111   234677778888888888888888 56699


Q ss_pred             eecccCCCCEEEcCCCcEEEeeccccc
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      ||.||.--|+|+.+ |.|+|+|-+.+.
T Consensus       287 VHADLSEfN~Lyhd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  287 VHADLSEFNLLYHD-GKLYIIDVSQSV  312 (520)
T ss_pred             eccchhhhhheEEC-CEEEEEEccccc
Confidence            99999999999975 679999988774

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.48  E-value=0.00028  Score=69.21  Aligned_cols=152  Identities=22%  Similarity=0.275  Sum_probs=93.5

Q ss_pred             HHHHHHHhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHH
Q 015594          151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDL  230 (404)
Q Consensus       151 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi  230 (404)
                      .-...+++.+.|+|...++.+.......               ..+|+|++ +.+|.+++....   +-....       
T Consensus        30 lgr~~~lktl~~~~l~~yl~~~r~~~~r---------------~IVV~e~~-~~Sled~~~~~~---l~~~s~-------   83 (725)
T KOG1093|consen   30 LGRFQYLKSLQHDNLCQYLDFSRGKHER---------------VIVVMEHY-TMSLEDILKTGN---LKDESL-------   83 (725)
T ss_pred             hhhhHHHHhhcCccceeeEeeecCccce---------------EEEEehhh-ccchHHHHHhcc---cchhhh-------
Confidence            3456778889999999999887655443               26899999 999999986542   211111       


Q ss_pred             HHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHH
Q 015594          231 ARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC  310 (404)
Q Consensus       231 ~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  310 (404)
                         +    .+|+.|-            +.++++| -++.    ..              |     .+..+++||||+|.+
T Consensus        84 ---~----~~~~~~~------------~~~~~td-~~~t----~~--------------~-----~~~~pKsdVwsl~~i  120 (725)
T KOG1093|consen   84 ---L----AHGVLHL------------NIIYITD-HFLT----KY--------------P-----SPIGPKSDVWSLGFI  120 (725)
T ss_pred             ---c----cccccee------------hhhhccc-cccc----cC--------------C-----CCCCcchhhhhHHHH
Confidence               1    2233332            1233444 1111    00              0     012249999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCCC----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 015594          311 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRP----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV  371 (404)
Q Consensus       311 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l  371 (404)
                      +.+++-|..-+......+....+..-...+          .+...++..+..+..+|+...|..||...++
T Consensus       121 ~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  121 ILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            999999877666655555444433222111          1223456777888899999999888865443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.43  E-value=0.001  Score=62.51  Aligned_cols=144  Identities=19%  Similarity=0.166  Sum_probs=80.8

Q ss_pred             eeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCCccccc
Q 015594          104 KGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSELNIQ  181 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~i~  181 (404)
                      .+.|..|....+|+...++..+++|+....     .       ......|+.++..+.+.+  +.+++....  ... + 
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~-------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~--g~~-~-   82 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S-------AEELPFFLALLDHLAERGLPVPRPIADRD--GEY-L-   82 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC-----C-------hHhccHHHHHHHHHHHCCCCCCccccCCC--CcE-e-
Confidence            456777888899988777778999987521     1       122445667666664322  444443211  110 0 


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHH-----------HHHhc----cc--C------CCcHHHH----------HHHHH
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKS-----------YLIKN----RR--R------KLAFKVV----------IQLAL  228 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~-----------~l~~~----~~--~------~l~~~~~----------~~i~~  228 (404)
                            ....+..++|++|++|..+..           .+.+-    ..  .      ...+...          .....
T Consensus        83 ------~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  156 (296)
T cd05153          83 ------SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRA  156 (296)
T ss_pred             ------eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHH
Confidence                  011233489999998866421           11110    00  0      0011000          00111


Q ss_pred             HHHHHHHHHhh-------CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          229 DLARGLSYLQS-------KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       229 qi~~~L~~LH~-------~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .+..++.++..       .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         157 LLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            12334444443       479999999999999988777899999885

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.32  E-value=0.0021  Score=61.19  Aligned_cols=30  Identities=27%  Similarity=0.461  Sum_probs=26.3

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .+++|+|+.|.||+++++...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            389999999999999876656899999886

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.25  E-value=0.0026  Score=59.98  Aligned_cols=29  Identities=28%  Similarity=0.470  Sum_probs=26.5

Q ss_pred             CceecccCCCCEEEcCC----CcEEEeeccccc
Q 015594          241 KIVHRDVKTENMLLDKT----RTVKIADFGVAR  269 (404)
Q Consensus       241 givH~Dikp~Nili~~~----~~vkL~Dfg~a~  269 (404)
                      +++|+|+.+.||+++++    +.++|+||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            68999999999999874    889999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.11  E-value=0.016  Score=56.64  Aligned_cols=29  Identities=21%  Similarity=0.373  Sum_probs=25.3

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      ..++|||+.+.||++..+ .++|+||.++.
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            369999999999999776 58999998775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.89  E-value=0.01  Score=55.30  Aligned_cols=30  Identities=23%  Similarity=0.496  Sum_probs=25.5

Q ss_pred             CceecccCCCCEEEcCCCc-EEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRT-VKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~-vkL~Dfg~a~~  270 (404)
                      .++|+|++|.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 46999999864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.77  E-value=0.015  Score=55.00  Aligned_cols=29  Identities=28%  Similarity=0.482  Sum_probs=25.8

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999987 678999999775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.65  E-value=0.013  Score=55.34  Aligned_cols=30  Identities=30%  Similarity=0.572  Sum_probs=27.4

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+++.||+|++.+-+=|.||+++.+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            489999999999999888899999999974

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.63  E-value=0.013  Score=56.18  Aligned_cols=30  Identities=17%  Similarity=0.363  Sum_probs=25.3

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ..++|||+.+.||++++++ ++++|+..+..
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            3689999999999998765 77999987753

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.62  E-value=0.031  Score=54.57  Aligned_cols=87  Identities=9%  Similarity=-0.037  Sum_probs=50.0

Q ss_pred             eeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---CCceeEEEEEEecCCcccc
Q 015594          104 KGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~i  180 (404)
                      .+.||.|....||+....++.++||.-..........-...  ..+-..|...|+.+.   ...+.+++.+..+..    
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~--~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~----  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMT--KERAYFEATALREHGRLCPDHVPEVYHFDRTMA----  110 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCC--ccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC----
Confidence            46789999999999888777899998652211000000000  111223455555442   346777877765332    


Q ss_pred             ccCCCCCCCCCCceEEEEeccCC--CCHHHHH
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHG--GALKSYL  210 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~--g~L~~~l  210 (404)
                                    +++|||+++  ..+.+.+
T Consensus       111 --------------vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        111 --------------LIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             --------------EEEEeecCCcceehhhhh
Confidence                          689999976  2444433

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.57  E-value=0.0087  Score=56.76  Aligned_cols=71  Identities=20%  Similarity=0.315  Sum_probs=57.7

Q ss_pred             ceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCCEEEcCCCcEEEeeccccccc
Q 015594          193 FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLE  271 (404)
Q Consensus       193 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~Nili~~~~~vkL~Dfg~a~~~  271 (404)
                      +.|++|++- |++|...      ..-.++++..++++.+..+.-+..+ .+-|||+.-.||||+ .|+|.|+||-+++..
T Consensus       300 y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         300 YLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             EEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            457888886 6666432      2345788899999999888888765 799999999999999 899999999999853

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.53  E-value=0.018  Score=54.47  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=27.8

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +++|+|+.+.|+|+++++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999998999999998863

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.52  E-value=0.031  Score=52.26  Aligned_cols=76  Identities=20%  Similarity=0.165  Sum_probs=44.1

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEEecCCc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGATMGTSE  177 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~  177 (404)
                      .+-...|+-|....+|+...+++.+.||+-....            ...|..|+.-|+.|   .--.+.+.+++......
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~------------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~   86 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG------------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD   86 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG------------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhh------------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence            4455678889999999988889999999976211            12356677777776   34456677776654433


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGG  204 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g  204 (404)
                      -                |+||||++.+
T Consensus        87 ~----------------fLlle~l~~~   97 (288)
T PF03881_consen   87 A----------------FLLLEFLEMG   97 (288)
T ss_dssp             C----------------EEEEE-----
T ss_pred             c----------------eEEEEeecCC
Confidence            3                7999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.42  E-value=0.042  Score=52.61  Aligned_cols=29  Identities=21%  Similarity=0.441  Sum_probs=25.7

Q ss_pred             ceecccCCCCEEEcC-CCcEEEeecccccc
Q 015594          242 IVHRDVKTENMLLDK-TRTVKIADFGVARL  270 (404)
Q Consensus       242 ivH~Dikp~Nili~~-~~~vkL~Dfg~a~~  270 (404)
                      ++|+|+.+.|||+++ ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999974 57899999999863

>PLN02236 choline kinase

Probab=96.28  E-value=0.062  Score=51.72  Aligned_cols=30  Identities=30%  Similarity=0.596  Sum_probs=26.4

Q ss_pred             CceecccCCCCEEEcC-CCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDK-TRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~-~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+++.||++++ ++.+.|+||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999976 47899999998863

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.07  E-value=0.046  Score=48.76  Aligned_cols=76  Identities=21%  Similarity=0.202  Sum_probs=51.6

Q ss_pred             eeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEEecCCcccc
Q 015594          104 KGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~i  180 (404)
                      .+.+.-|..-..|+..+...++-||+-.            ......|..|+.-|+.|   +.-+|.+.+.+-.+....  
T Consensus        21 r~~v~gG~inea~~v~dg~~~~FvK~n~------------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s--   86 (286)
T COG3001          21 REEVSGGDINEAWRLRDGTDPFFVKCNQ------------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHS--   86 (286)
T ss_pred             ccccCCccccceeEeecCCcceEEEecc------------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCee--
Confidence            3445557777778887888899999853            12245577777666666   345566777665554444  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHH
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALK  207 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~  207 (404)
                                    |+||||++-+.+.
T Consensus        87 --------------ylVle~L~~~~~d   99 (286)
T COG3001          87 --------------YLVLEYLPTGPLD   99 (286)
T ss_pred             --------------EEEEeeccCCCCC
Confidence                          9999999886654

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.85  E-value=0.041  Score=53.48  Aligned_cols=29  Identities=21%  Similarity=0.384  Sum_probs=25.3

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|||+.|.|||++++ .+|++|..++..
T Consensus       228 aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        228 ALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             hhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            59999999999999986 489999888853

>PTZ00384 choline kinase; Provisional

Probab=95.73  E-value=0.17  Score=49.44  Aligned_cols=29  Identities=24%  Similarity=0.236  Sum_probs=24.8

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      ..++|.|+-+.||+.+++ .++++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence            468999999999998654 59999998885

>PTZ00296 choline kinase; Provisional

Probab=95.04  E-value=0.34  Score=48.21  Aligned_cols=28  Identities=18%  Similarity=0.425  Sum_probs=24.4

Q ss_pred             CceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .++|.|+-+.|||.++++ ++|+||..|.
T Consensus       285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNKC-LRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCCC-EEEEeecccc
Confidence            589999999999887554 9999998885

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.78  E-value=0.22  Score=46.62  Aligned_cols=29  Identities=34%  Similarity=0.524  Sum_probs=24.6

Q ss_pred             ceecccCCCCEEEcCC--C---cEEEeecccccc
Q 015594          242 IVHRDVKTENMLLDKT--R---TVKIADFGVARL  270 (404)
Q Consensus       242 ivH~Dikp~Nili~~~--~---~vkL~Dfg~a~~  270 (404)
                      ++|||+++.|||+..+  |   .++++||-+++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999544  3   689999988863

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.55  E-value=0.073  Score=49.29  Aligned_cols=47  Identities=23%  Similarity=0.304  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHHHHHhhC--CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          224 IQLALDLARGLSYLQSK--KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       224 ~~i~~qi~~~L~~LH~~--givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ...+..+-.++.-++..  -++|+|+.|+|+++++.+.++|+||..|..
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            33455555566666554  599999999999999989999999998864

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.73  E-value=0.052  Score=47.12  Aligned_cols=29  Identities=21%  Similarity=0.335  Sum_probs=25.8

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      -.+|+|+.|.||++++++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            369999999999998877 99999999863

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=93.69  E-value=0.064  Score=50.27  Aligned_cols=93  Identities=17%  Similarity=0.175  Sum_probs=65.9

Q ss_pred             HHHHHHHhhc-----CCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHH
Q 015594          151 TQEVAVWHKL-----DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ  225 (404)
Q Consensus       151 ~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~  225 (404)
                      .+|...|.++     ..|-+|.+...                       .+||.|+...-+..-  +-+.-.++......
T Consensus       333 EkEmhNL~RMq~~GlpcP~vV~lkkh-----------------------vLVMsFiGd~~~aAP--kLK~v~l~d~E~~~  387 (531)
T KOG2269|consen  333 EKEMHNLSRMQKHGLPCPQVVKLKKH-----------------------VLVMSFIGDQGLAAP--KLKNVELTDDERRN  387 (531)
T ss_pred             HHHHHHHHHHHhcCCCCCceeeeecc-----------------------eEEEEeecCCCCCCc--cccccccChHHHHH
Confidence            3455555555     46777777543                       589999833222211  11234588888888


Q ss_pred             HHHHHHHHHHHH-hhCCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          226 LALDLARGLSYL-QSKKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       226 i~~qi~~~L~~L-H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .-.|+..++.-| |..-+||-|+.--|+|+..+ .+.++|-..+.
T Consensus       388 aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv  431 (531)
T KOG2269|consen  388 AYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSV  431 (531)
T ss_pred             HHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhcc
Confidence            888888888877 67789999999999999876 89999976663

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=93.65  E-value=0.25  Score=45.18  Aligned_cols=74  Identities=20%  Similarity=0.178  Sum_probs=50.1

Q ss_pred             eeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHH---HHHhhcCCCceeEEEEEEecCCcccc
Q 015594          105 GAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV---AVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ..+..|..+.|+.++. +|.++++|+.......              ..|.   ..|+..+-...|+++++-.+..    
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~--------------~~E~~g~~~L~~w~G~GaVrll~~d~~~~----   69 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA--------------EHEARGEAALRWWNGRGAVRLLAADPERG----   69 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccc--------------hhhhhHHhHhheeCCCCceeeeccccccc----
Confidence            4566799999999975 8999999997532211              1222   4577777788899998753332    


Q ss_pred             ccCCCCCCCCCCceEEEEeccCC-CCHHHHH
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHG-GALKSYL  210 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l  210 (404)
                                    .|++|.+.+ .+|.+..
T Consensus        70 --------------AlLLErl~~g~~L~~~~   86 (253)
T PF04655_consen   70 --------------ALLLERLDPGRSLASLP   86 (253)
T ss_pred             --------------hhhhhhccCCCchhhcc
Confidence                          578898844 4665543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	404
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-42
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-42
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-35
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-35
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-35
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-33
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-33
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-33
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-33
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-33
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-33
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-33
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-33
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-33
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-33
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-33
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-33
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-33
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-33
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-33
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-32
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-32
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-32
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-32
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-32
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-32
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-32
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-32
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-32
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-32
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-32
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-32
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-32
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-32
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-32
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-32
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-32
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-32
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-32
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-32
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-32
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-32
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-32
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-32
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-32
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-32
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-32
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-32
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-32
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-32
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-32
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-32
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-32
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-32
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-32
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-32
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-32
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-32
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-32
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-32
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-32
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-32
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-32
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-32
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-32
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-32
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-32
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-32
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-32
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-32
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-32
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-31
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-31
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-31
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-31
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-31
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-31
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-31
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-31
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-31
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-31
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-31
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-30
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-30
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-30
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-30
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-30
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-30
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-29
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-29
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-29
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-29
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-29
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-29
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-29
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-29
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-29
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-29
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-29
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-29
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-29
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-29
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-29
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-29
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-29
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-29
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-29
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-29
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-28
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-28
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-28
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-28
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-28
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-28
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-28
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-28
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-28
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-28
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-28
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-28
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-28
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-28
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-28
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-28
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-28
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-28
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-28
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-28
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-28
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-28
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-28
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-28
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-27
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-27
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-27
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-27
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-27
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-27
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-27
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-27
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-27
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-27
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-27
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-27
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-27
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-27
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-27
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-27
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-27
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-27
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-27
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-27
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-27
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-27
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-27
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-27
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-27
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-27
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-27
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-27
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-27
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-27
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-27
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-27
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-27
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-27
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-27
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-27
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-27
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-27
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-27
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-27
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-27
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-27
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-27
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-27
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-27
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-27
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-27
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-27
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-27
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-27
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-27
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-27
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-27
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-27
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-27
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-27
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-27
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-27
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-27
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-27
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-27
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-26
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-26
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-26
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-26
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-26
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-26
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-25
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-25
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-25
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-25
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-25
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-25
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-25
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-25
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-25
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-25
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-25
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-25
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-25
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-25
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-25
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-25
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-25
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-25
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-25
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-25
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-25
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-25
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-25
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-25
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-25
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-25
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-25
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-25
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-25
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-24
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-24
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-24
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-24
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-24
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-24
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-24
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-24
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-24
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-24
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-24
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-24
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-24
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-24
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-24
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-24
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-24
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-24
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-24
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-24
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-24
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-24
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-24
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-24
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-24
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-24
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-24
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-24
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-24
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-24
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-24
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-24
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-24
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-24
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-24
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-24
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-24
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-24
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-24
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-24
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-24
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-24
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-24
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-24
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-24
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-24
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-24
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-24
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-23
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-23
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-23
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-23
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-23
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-23
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-23
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-23
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-23
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-23
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-23
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-23
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-23
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-23
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-23
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-23
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-23
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-23
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-23
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-23
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-23
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-23
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-23
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-23
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-23
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-23
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-23
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-23
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-22
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-22
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-22
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-22
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-22
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-22
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-22
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-22
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-22
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-22
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-22
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-22
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-22
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-22
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-22
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-22
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-22
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-22
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-22
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-22
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-22
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-22
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-22
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-22
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-22
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-22
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-22
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-22
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-22
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-22
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-22
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-22
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-22
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-22
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-22
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-22
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-22
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-22
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-22
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-22
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-22
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-22
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-22
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-21
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-21
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-21
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-20
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-20
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-20
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-20
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-20
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-19
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-19
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-19
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-19
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-19
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-18
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-18
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-18
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-18
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-18
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-18
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-18
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-18
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-18
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-16
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-16
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		7e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		8e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-08

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/285 (36%), Positives = 155/285 (54%), Gaps = 28/285 (9%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRA-AFTQEVAVWHK 159
           L IK     G+FGTVHR  + G DVAVK+L         E +  + R   F +EVA+  +
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKIL--------MEQDFHAERVNEFLREVAIMKR 90
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKL 218
           L HPN+  F+GA               +  P N   +V EY   G+L   L K+  R +L
Sbjct: 91  LRHPNIVLFMGA---------------VTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQL 134
Query: 219 AFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
             +  + +A D+A+G++YL ++   IVHRD+K+ N+L+DK  TVK+ DFG++RL+AS   
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL 194
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                 GT  +MAPEVL     N K DVYSFG+ LWE+     P+ +L+ ++V +AV  +
Sbjct: 195 XSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             R EIPR     +A +++ CW   P KRP    ++ +L  +  S
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 104/285 (36%), Positives = 155/285 (54%), Gaps = 28/285 (9%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRA-AFTQEVAVWHK 159
           L IK     G+FGTVHR  + G DVAVK+L         E +  + R   F +EVA+  +
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKIL--------MEQDFHAERVNEFLREVAIMKR 90
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKL 218
           L HPN+  F+GA               +  P N   +V EY   G+L   L K+  R +L
Sbjct: 91  LRHPNIVLFMGA---------------VTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQL 134
Query: 219 AFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
             +  + +A D+A+G++YL ++   IVHR++K+ N+L+DK  TVK+ DFG++RL+AS   
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
                 GT  +MAPEVL     N K DVYSFG+ LWE+     P+ +L+ ++V +AV  +
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             R EIPR     +A +++ CW   P KRP    ++ +L  +  S
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 149/295 (50%), Gaps = 35/295 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 57
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 58  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 99
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K   K +I +A   ARG+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 100 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKS 159
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 160 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 219
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            ++   V R +L P++ +    CP  +  +M  C     D+RP    ++A +E +
Sbjct: 220 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 148/295 (50%), Gaps = 35/295 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 69
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQ-----------------LAIVTQWCEGSSLYHHL-H 111
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K   K +I +A   ARG+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A  ++
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            ++   V R +L P++ +    CP  +  +M  C     D+RP    ++A +E +
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 148/295 (50%), Gaps = 35/295 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 69
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 111
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K   K +I +A   ARG+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A  ++
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            ++   V R +L P++ +    CP  +  +M  C     D+RP    ++A +E +
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 148/305 (48%), Gaps = 42/305 (13%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           ID  ++ ++    RG FG V +  +  +DVA+K ++       SE+E    R AF  E+ 
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESE----RKAFIVELR 54
Query: 156 VWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR 215
              +++HPN+ K  GA +                  N  C+V+EY  GG+L  Y + +  
Sbjct: 55  QLSRVNHPNIVKLYGACL------------------NPVCLVMEYAEGGSL--YNVLHGA 94
Query: 216 RKLAFKVV---IQLALDLARGLSYL---QSKKIVHRDVKTENMLLDKTRTV-KIADFGVA 268
             L +      +   L  ++G++YL   Q K ++HRD+K  N+LL    TV KI DFG A
Sbjct: 95  EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
                    MT   G+  +MAPEV  GS Y+ KCDV+S+GI LWE+     P+ ++    
Sbjct: 155 ---CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 211
Query: 329 V-TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
                 V    RP + +  P  + ++M RCW  +P +RP M+E+V ++  +     G   
Sbjct: 212 FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 271
Query: 388 PVDQP 392
           P+  P
Sbjct: 272 PLQYP 276

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 148/305 (48%), Gaps = 42/305 (13%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           ID  ++ ++    RG FG V +  +  +DVA+K ++       SE+E    R AF  E+ 
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE-------SESE----RKAFIVELR 53
Query: 156 VWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR 215
              +++HPN+ K  GA +                  N  C+V+EY  GG+L  Y + +  
Sbjct: 54  QLSRVNHPNIVKLYGACL------------------NPVCLVMEYAEGGSL--YNVLHGA 93
Query: 216 RKLAFKVV---IQLALDLARGLSYL---QSKKIVHRDVKTENMLLDKTRTV-KIADFGVA 268
             L +      +   L  ++G++YL   Q K ++HRD+K  N+LL    TV KI DFG A
Sbjct: 94  EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
                    MT   G+  +MAPEV  GS Y+ KCDV+S+GI LWE+     P+ ++    
Sbjct: 154 ---CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
Query: 329 V-TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
                 V    RP + +  P  + ++M RCW  +P +RP M+E+V ++  +     G   
Sbjct: 211 FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
Query: 388 PVDQP 392
           P+  P
Sbjct: 271 PLQYP 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTAPQ-----------------LAIVTQWCEGSSLYHHL-H 95
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 96  IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 141/295 (47%), Gaps = 37/295 (12%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           EID A+L ++     G FG V+R  + G +VAVK        H  + +I+       QE 
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVK-----AARHDPDEDISQTIENVRQEA 57
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            ++  L HPN+    G  +    L                C+V+E+  GG L   L    
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNL----------------CLVMEFARGGPLNRVL---S 98
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIV---HRDVKTENMLLDK--------TRTVKIA 263
            +++   +++  A+ +ARG++YL  + IV   HRD+K+ N+L+ +         + +KI 
Sbjct: 99  GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 264 DFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           DFG+AR E      M+   G   +MAPEV+  S +++  DV+S+G+ LWE+   ++P+  
Sbjct: 159 DFGLAR-EWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +    V   V    L   IP  CP   A +M+ CW+ +P  RP    ++  L  I
Sbjct: 217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 81
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 123
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 124 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 183
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 184 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 101 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 160
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 161 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 29  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 80
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 122
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 123 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 182
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 183 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 243 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 300

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 55
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 56  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 97
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 98  IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 157
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 158 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 218 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 59  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 101 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 160
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 161 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 221 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 150/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 95
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++
Sbjct: 96  IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 149/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 22  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 73
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 115
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A  ++
Sbjct: 116 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS 175
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 176 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 236 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 293

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 149/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 81
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 123
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A  ++
Sbjct: 124 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS 183
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 184 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 149/298 (50%), Gaps = 35/298 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L+         A       AF  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN-------VTAPTPQQLQAFKN 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTKPQ-----------------LAIVTQWCEGSSLYHHL-H 95
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A  ++
Sbjct: 96  IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS 155
Query: 273 --SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SF 326
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY ++ + 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 327 SEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            ++   V R  L P++ +    CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 139/291 (47%), Gaps = 35/291 (12%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G +  +D VA+K +  G  S             F +E 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 53
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G  +  + +                C+V E+   G L  YL + +
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYL-RTQ 96
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R    +
Sbjct: 97  RGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 156
Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S SEV 
Sbjct: 157 QY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              +    R   PR   + +  +M  CW   P+ RP    ++  L AI  S
Sbjct: 215 ED-ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 142/294 (48%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSV 434
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 477
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+  T  VK+ DFG
Sbjct: 478 RSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFG 536
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 597 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 146/295 (49%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  +++E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IIIEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 20  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 76
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 77  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 112
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 113 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 171
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 172 KVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 232 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 288
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 289 RISAIFSTFIG 299

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 146/295 (49%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  +++E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IIIEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 140/291 (48%), Gaps = 31/291 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           +W ++   L++     RG FG V  G    D   VAVK       S R E     L+A F
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK-------SCR-ETLPPDLKAKF 159
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            QE  +  +  HPN+ + IG       + I                V+E   GG   ++L
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYI----------------VMELVQGGDFLTFL 203
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            +    +L  K ++Q+  D A G+ YL+SK  +HRD+   N L+ +   +KI+DFG++R 
Sbjct: 204 -RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 271 EASNPHDMTG--ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 327
           EA   +  +G      + + APE LN   Y+ + DV+SFGI LWE +     PYP+LS +
Sbjct: 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-N 321
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           + T   V +  R   P  CP ++  +M++CW   P +RP    +   L++I
Sbjct: 322 QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 140/294 (47%), Gaps = 35/294 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFT 151
           +W IDP++L        G FG VH G +  +D VA+K +  G  S             F 
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FI 51
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E  V  KL HP + +  G  +  + +                C+V E+   G L  YL 
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQAPI----------------CLVTEFMEHGCLSDYL- 94
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           + +R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R  
Sbjct: 95  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             + +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S S
Sbjct: 155 LDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV    +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 213 EVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 142/294 (48%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSV 54
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 97
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+  T  VK+ DFG
Sbjct: 98  RSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFG 156
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V    +    R  +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 217 KNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 140/294 (47%), Gaps = 35/294 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFT 151
           +W IDP++L        G FG VH G +  +D VA+K +  G  S             F 
Sbjct: 4   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FI 53
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E  V  KL HP + +  G  +  + +                C+V E+   G L  YL 
Sbjct: 54  EEAEVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYL- 96
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           + +R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R  
Sbjct: 97  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             + +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S S
Sbjct: 157 LDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV    +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 215 EVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                ++E+   G L  YL +
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------IIEFMTYGNLLDYLRE 103
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 104 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 161
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 162 -----MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 217 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 39  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 95
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 96  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 131
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 132 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 190
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 251 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 307
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 308 RISAIFSTFIG 318

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 21  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 77
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 78  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 113
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 114 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 172
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 233 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 289
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 290 RISAIFSTFIG 300

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 19  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 75
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 76  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 111
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 112 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 170
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 171 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 231 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 287
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 288 RISAIFSTFIG 298

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 13  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 69
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 70  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 105
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 106 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 164
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 165 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 225 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 281
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 282 RISAIFSTFIG 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 18  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 74
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 75  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 110
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 111 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 169
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 170 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 230 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 287 RISAIFSTFIG 297

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 21  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 77
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 78  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 113
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 114 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 172
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 233 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 289
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 290 RISAIFSTFIG 300

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 20  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 76
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 77  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 112
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 113 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 171
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 172 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 232 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 288
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 289 RISAIFSTFIG 299

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 40  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 96
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 97  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 132
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 133 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 191
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 192 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 252 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 308
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 309 RISAIFSTFIG 319

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 16  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 72
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 73  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 108
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ YL SKK VHRD+   N +LD+  TV
Sbjct: 109 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 167
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 228 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 284
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 285 RISAIFSTFIG 295

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 63
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 107
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 108 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 165
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 166 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 221 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 145/295 (49%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G FG V+ G++    + V +    E++   E         F +
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 56
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL +
Sbjct: 57  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLRE 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 101 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 158
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 159 -----MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 214 IDPSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 145/295 (49%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSV 434
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 477
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 478 RSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 597 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 6   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSV 57
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 58  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 100
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 101 RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 159
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 160 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 219
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 220 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 63
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                ++E+   G L  YL +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------IIEFMTYGNLLDYLRE 107
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 165
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 166 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 221 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 5   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSV 56
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 57  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 99
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 100 RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 158
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 159 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 218
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 219 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 142/295 (48%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 56
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                ++E+   G L  YL +
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------IIEFMTYGNLLDYLRE 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 101 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 158
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 159 -----MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 214 IDPSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 8   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSV 59
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 60  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 102
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 103 RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 222 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 139/291 (47%), Gaps = 31/291 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           +W ++   L++     RG FG V  G    D   VAVK       S R E     L+A F
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK-------SCR-ETLPPDLKAKF 159
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            QE  +  +  HPN+ + IG       + I                V+E   GG   ++L
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYI----------------VMELVQGGDFLTFL 203
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            +    +L  K ++Q+  D A G+ YL+SK  +HRD+   N L+ +   +KI+DFG++R 
Sbjct: 204 -RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 271 EASNPHDMTG--ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 327
           EA      +G      + + APE LN   Y+ + DV+SFGI LWE +     PYP+LS +
Sbjct: 263 EADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-N 321
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           + T   V +  R   P  CP ++  +M++CW   P +RP    +   L++I
Sbjct: 322 QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 31  RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSV 82
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 83  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 125
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 126 RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 184
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 185 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 244
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 245 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 19  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 75
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 76  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 111
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 112 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 170
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 171 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 231 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 287
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 288 RISAIFSTFIG 298

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 80  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 136
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 137 ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 172
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 173 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 292 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 348
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 349 RISAIFSTFIG 359

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSV 54
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 97
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 98  RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V    +    R  +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 217 KNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 34/293 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLR 147
           ++EI   ++ +      G FG VH+GIY   +     VA+K                S+R
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSVR 52
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
             F QE     + DHP++ K IG                  +  N   +++E C  G L+
Sbjct: 53  EKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGELR 95
Query: 208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG+
Sbjct: 96  SFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154
Query: 268 AR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLS 325
           +R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  + 
Sbjct: 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 215 NNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 22  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 78
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 79  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 114
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 115 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 173
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 174 KVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 234 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 290
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 291 RISAIFSTFIG 301

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSV 54
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 97
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 98  RSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V    +    R  +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 217 KNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 101/309 (32%), Positives = 146/309 (47%), Gaps = 45/309 (14%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 22  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 78
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 79  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 114
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 115 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 173
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 174 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233
Query: 317 CDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
               PYPD++  ++T  ++ Q  R   P  CP  L  VM +CW    + RP   E+V+ +
Sbjct: 234 RGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 292
Query: 376 EAIDTSKGG 384
            AI ++  G
Sbjct: 293 SAIFSTFIG 301

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 26  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 82
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 83  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 118
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 119 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 177
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 178 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 238 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 294
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 295 RISAIFSTFIG 305

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 101/309 (32%), Positives = 146/309 (47%), Gaps = 45/309 (14%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 21  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 77
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 78  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 113
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 114 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 172
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 317 CDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
               PYPD++  ++T  ++ Q  R   P  CP  L  VM +CW    + RP   E+V+ +
Sbjct: 233 RGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 291
Query: 376 EAIDTSKGG 384
            AI ++  G
Sbjct: 292 SAIFSTFIG 300

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 63
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 107
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 165
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 166 -----MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 221 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 102/311 (32%), Positives = 149/311 (47%), Gaps = 49/311 (15%)
Query: 92  QEWEIDPAKLII--KGAFARGTFGTVHRGIY---DGQDV--AVKLL----DWGEESHRSE 140
           Q   I P+ LI+       RG FG V+ G     DG+ +  AVK L    D GE S    
Sbjct: 21  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--- 77
Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                    F  E  +     HPNV   +G  + +            G P     VV+ Y
Sbjct: 78  ---------FLTEGIIMKDFSHPNVLSLLGICLRSE-----------GSP----LVVLPY 113
Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TV
Sbjct: 114 MKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 172
Query: 261 KIADFGVAR----LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           K+ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+  
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232
Query: 317 CDM-PYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               PYPD++  ++T  ++  R+ L+PE    CP  L  VM +CW    + RP   E+V+
Sbjct: 233 RGAPPYPDVNTFDITVYLLQGRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVS 289
Query: 374 MLEAIDTSKGG 384
            + AI ++  G
Sbjct: 290 RISAIFSTFIG 300

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 144/295 (48%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 71
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL +
Sbjct: 72  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLRE 115
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 116 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 173
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 174 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 228
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 229 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 63
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 107
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 165
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 166 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 221 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 103
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 104 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 161
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 162 -----MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 216
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 217 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 106
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 107 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 164
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 165 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 220 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 60
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 104
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 105 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 162
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 163 -----MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 218 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 144/295 (48%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 60
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL +
Sbjct: 61  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLRE 104
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 105 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 162
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 163 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 218 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 60
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 104
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 105 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 162
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 163 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 217
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 218 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 63
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 107
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 108 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 165
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 166 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 221 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 58
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 103 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 160
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 161 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 216 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 265
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 309
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HR++   N L+ +   VK+ADFG++RL  
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-- 367
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 368 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 423 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 140/294 (47%), Gaps = 34/294 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           +++EI   ++ +      G FG VH+GIY   +     VA+K                S+
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSV 54
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F QE     + DHP++ K IG                  +  N   +++E C  G L
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGEL 97
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG
Sbjct: 98  RSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 267 VAR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDL 324
           ++R +E S     +     + +MAPE +N   +    DV+ FG+C+WEI    + P+  +
Sbjct: 157 LSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216
Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             ++V   +      P +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 217 KNNDVIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 145/295 (49%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 56
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G    T E            P  +  ++ E+   G L  YL +
Sbjct: 57  EAAVMKEIKHPNLVQLLGVC--TRE------------PPFY--IITEFMTYGNLLDYLRE 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 101 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-- 158
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 159 -----MTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 214 IDPSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G +  +D VA+K +  G  S             F +E 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 53
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G  +  + +                C+V E+   G L  YL + +
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYL-RTQ 96
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R    +
Sbjct: 97  RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 156
Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S SEV 
Sbjct: 157 QY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 215 ED-ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G +  +D VA+K +  G  S             F +E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 51
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G  +  + +                C+V E+   G L  YL + +
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYL-RTQ 94
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R    +
Sbjct: 95  RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S SEV 
Sbjct: 155 QY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 213 ED-ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G +  +D VA+K +  G  S             F +E 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----------FIEEA 73
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G  +  + +                C+V E+   G L  YL + +
Sbjct: 74  EVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYL-RTQ 116
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R    +
Sbjct: 117 RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 176
Query: 275 PHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +  T  TGT   + + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S SEV 
Sbjct: 177 QY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 234
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 235 ED-ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 140/295 (47%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 304
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                + E+   G L  YL +
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLRE 348
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R+++   V++ +A  ++  + YL+ K  +HR++   N L+ +   VK+ADFG++RL  
Sbjct: 349 CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-- 406
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 407 -----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 461
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 462 IDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 155/297 (52%), Gaps = 35/297 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           WEI+ +++++      G+FGTV++G + G DVAVK+L   + +            AF  E
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ-------FQAFRNE 82
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           VAV  K  H N+  F+G                  M  +   +V ++C G +L  +L   
Sbjct: 83  VAVLRKTRHVNILLFMGY-----------------MTKDNLAIVTQWCEGSSLYKHLHVQ 125
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA- 272
             +   F++ I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +++ 
Sbjct: 126 ETKFQMFQL-IDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184
Query: 273 -SNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFS 327
            S    +   TG++ +MAPEV+   + + ++ + DVYS+GI L+E+   ++PY  + +  
Sbjct: 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244
Query: 328 EVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           ++   V R    P++ +    CP ++  ++  C     ++RP   ++++ +E +  S
Sbjct: 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 141/288 (48%), Gaps = 31/288 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +       +++A       AF  E
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-------KNDATAQ----AFLAE 55
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 56  ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 100
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ + EAS
Sbjct: 101 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 159
Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 332
           +  D TG+   + + APE L  +A++ K DV+SFGI LWEIY    +PYP +   +V   
Sbjct: 160 STQD-TGKL-PVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 217
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
            V +  + + P  CP ++  VMK CW  +   RP   ++   LE I T
Sbjct: 218 -VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 264

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 37/284 (13%)
Query: 108 ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G FG VH+G  + D   VA+K L  G+     E E+      F +EV +   L+HPN+
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K  G       +                  V+E+   G L   L+ ++   + + V ++
Sbjct: 86  VKLYGLMHNPPRM------------------VMEFVPCGDLYHRLL-DKAHPIKWSVKLR 126
Query: 226 LALDLARGLSYLQSKK--IVHRDVKTENMLL---DKTRTV--KIADFGVARLEASNPHDM 278
           L LD+A G+ Y+Q++   IVHRD+++ N+ L   D+   V  K+ADFG+++    + H +
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSV 183
Query: 279 TGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV--TSAVV 334
           +G  G   +MAPE +     +Y  K D YSF + L+ I   + P+ + S+ ++   + + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + LRP IP  CP  L NV++ CW  +P KRP    +V  L  +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 37/284 (13%)
Query: 108 ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G FG VH+G  + D   VA+K L  G+     E E+      F +EV +   L+HPN+
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K  G       +                  V+E+   G L   L+ ++   + + V ++
Sbjct: 86  VKLYGLMHNPPRM------------------VMEFVPCGDLYHRLL-DKAHPIKWSVKLR 126
Query: 226 LALDLARGLSYLQSKK--IVHRDVKTENMLL---DKTRTV--KIADFGVARLEASNPHDM 278
           L LD+A G+ Y+Q++   IVHRD+++ N+ L   D+   V  K+ADFG ++    + H +
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSV 183
Query: 279 TGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV--TSAVV 334
           +G  G   +MAPE +     +Y  K D YSF + L+ I   + P+ + S+ ++   + + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + LRP IP  CP  L NV++ CW  +P KRP    +V  L  +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 137/295 (46%), Gaps = 41/295 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WE++   + +K     G +G V+ G++    + V +    E++   E         F +
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--------FLK 77
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E AV  ++ HPN+ + +G         I                V EY   G L  YL +
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYI----------------VTEYMPYGNLLDYLRE 121
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R ++   V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL  
Sbjct: 122 CNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRL-- 179
Query: 273 SNPHDMTGETGT--------LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
                MTG+T T        + + APE L  + ++ K DV++FG+ LWEI    M PYP 
Sbjct: 180 -----MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 234
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  S+V   ++ +  R E P  CP  +  +M+ CW  +P  RP   E     E +
Sbjct: 235 IDLSQVYD-LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 138/290 (47%), Gaps = 35/290 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +       +++A       AF  E
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-------KNDATAQ----AFLAE 64
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 65  ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 109
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ + EAS
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 168
Query: 274 NPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
           +  D    TG L   + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V 
Sbjct: 169 STQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
              V +  + + P  CP ++  VMK CW  +   RP   ++   LE I T
Sbjct: 225 PR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 35/290 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +       +++A       AF  E
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-------KNDATAQ----AFLAE 236
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 237 ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 281
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ + EAS
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 340
Query: 274 NPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
           +  D    TG L   + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V 
Sbjct: 341 STQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
              V +  + + P  CP ++ +VMK CW  +   RP   ++   LE I T
Sbjct: 397 PR-VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 140/284 (49%), Gaps = 37/284 (13%)
Query: 108 ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G FG VH+G  + D   VA+K L  G+     E E+      F +EV +   L+HPN+
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K  G       +                  V+E+   G L   L+ ++   + + V ++
Sbjct: 86  VKLYGLMHNPPRM------------------VMEFVPCGDLYHRLL-DKAHPIKWSVKLR 126
Query: 226 LALDLARGLSYLQSKK--IVHRDVKTENMLL---DKTRTV--KIADFGVARLEASNPHDM 278
           L LD+A G+ Y+Q++   IVHRD+++ N+ L   D+   V  K+ADF +++    + H +
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSV 183
Query: 279 TGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV--TSAVV 334
           +G  G   +MAPE +     +Y  K D YSF + L+ I   + P+ + S+ ++   + + 
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + LRP IP  CP  L NV++ CW  +P KRP    +V  L  +
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 139/288 (48%), Gaps = 31/288 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +       +++A       AF  E
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-------KNDATAQ----AFLAE 49
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 50  ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 94
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ + EAS
Sbjct: 95  GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 153
Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 332
           +  D TG+   + + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V   
Sbjct: 154 STQD-TGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 211
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
            V +  + + P  CP ++  VMK CW  +   RP   ++   LE I T
Sbjct: 212 -VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 258

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 132/299 (44%), Gaps = 31/299 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 17  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 66
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 109
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 110 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 169
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 170 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 229
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIP 388
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   P
Sbjct: 230 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 97/309 (31%), Positives = 142/309 (45%), Gaps = 49/309 (15%)
Query: 98  PAKLIIKGAFARGTFG----TVHRGIYDGQDVAVK-LLDWGEESHRSEAEIASLRAAFTQ 152
           P+ LI      +G FG      HR    G+ + +K L+ + EE+ R+          F +
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRET--GEVMVMKELIRFDEETQRT----------FLK 56
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V   L+HPNV KFIG       LN                 + EY  GG L+  +IK
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNF----------------ITEYIKGGTLRG-IIK 99
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL-- 270
           +   +  +   +  A D+A G++YL S  I+HRD+ + N L+ + + V +ADFG+ARL  
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159
Query: 271 -EASNPHDMTG-----------ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD 318
            E + P  +               G   +MAPE++NG +Y+ K DV+SFGI L EI    
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
Query: 319 MPYPD-LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
              PD L  +      VR  L    P  CP S   +  RC D +P+KRP   ++   LE 
Sbjct: 220 NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
Query: 378 IDTSKGGGM 386
           +     G +
Sbjct: 280 LRMHLAGHL 288

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 35/301 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 65
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 108
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 109 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 168
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 169 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 226
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   
Sbjct: 227 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQFQ 285
Query: 388 P 388
           P
Sbjct: 286 P 286

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 35/301 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 62
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 105
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 106 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 165
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 166 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 223
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   
Sbjct: 224 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 282
Query: 388 P 388
           P
Sbjct: 283 P 283

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 35/301 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 15  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 64
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 107
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 108 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 167
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 168 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 225
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   
Sbjct: 226 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 284
Query: 388 P 388
           P
Sbjct: 285 P 285

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 139/295 (47%), Gaps = 32/295 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 96
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 97  EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 156
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            + +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 157 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 215
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAIDTSKGG 384
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D +  G
Sbjct: 216 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYG 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 139/287 (48%), Gaps = 31/287 (10%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           E+   ++ +      G FG V  G + GQ DVAVK++   +E   SE E       F QE
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDE-------FFQE 53
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
                KL HP + KF G    + E  I               +V EY   G L +YL ++
Sbjct: 54  AQTMMKLSHPKLVKFYGVC--SKEYPIY--------------IVTEYISNGCLLNYL-RS 96
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
             + L    ++++  D+  G+++L+S + +HRD+   N L+D+   VK++DFG+ R    
Sbjct: 97  HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
Query: 274 NPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTS 331
           + +    G    + + APEV +   Y+ K DV++FGI +WE++    MPY   + SEV  
Sbjct: 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216
Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             V Q  R   P     ++  +M  CW   P+KRP   ++++ +E +
Sbjct: 217 K-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 35/301 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 56
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 99
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 160 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMI 387
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   
Sbjct: 218 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276
Query: 388 P 388
           P
Sbjct: 277 P 277

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 103 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 162
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            + +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 163 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 221
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 222 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++     G FG V    Y+    VAVK +  G  S            AF  
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----------AFLA 232
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + K                  H  +      ++ E+   G+L  +L  
Sbjct: 233 EANVMKTLQHDKLVKL-----------------HAVVTKEPIYIITEFMAKGSLLDFLKS 275
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K     +I  +  +A G+++++ +  +HRD++  N+L+  +   KIADFG+AR+  
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
            N +    G    + + APE +N  ++  K DV+SFGI L EI     +PYP +S  EV 
Sbjct: 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            A+ R    P  P  CP  L N+M RCW   P++RP  + + ++L+   T+
Sbjct: 396 RALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 52
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 95
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 96  EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 155
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            + +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 156 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 214
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 215 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 96
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 97  EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 156
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            + +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 157 DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 215
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 216 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 32/290 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 68
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 111
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            + +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 230
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++     G FG V    Y+    VAVK +  G  S            AF  
Sbjct: 177 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----------AFLA 226
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + K                  H  +      ++ E+   G+L  +L  
Sbjct: 227 EANVMKTLQHDKLVKL-----------------HAVVTKEPIYIITEFMAKGSLLDFLKS 269
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K     +I  +  +A G+++++ +  +HRD++  N+L+  +   KIADFG+AR+ A
Sbjct: 270 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGA 329
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTS 331
             P         + + APE +N  ++  K DV+SFGI L EI     +PYP +S  EV  
Sbjct: 330 KFP---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 380
Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           A+ R    P  P  CP  L N+M RCW   P++RP  + + ++L+   T+
Sbjct: 381 ALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 429

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 13  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 62
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 105
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 106 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 165
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 166 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 225
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 226 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----------AFL 51
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 52  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 94
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 95  TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 154
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 155 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 214
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 215 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 12  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 61
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 104
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 105 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 164
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 165 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 224
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 225 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 275

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 32/290 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEIDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIE 68
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + +  G       + I                + EY   G L +YL +
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-R 111
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R   
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171
Query: 273 SNPHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            +    + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T
Sbjct: 172 DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T 230
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
           +  + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++     G FG V    Y+    VAVK +  G  S            AF  
Sbjct: 10  WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE----------AFLA 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V   L H  + K                  H  +      ++ E+   G+L  +L  
Sbjct: 60  EANVMKTLQHDKLVKL-----------------HAVVTKEPIYIITEFMAKGSLLDFLKS 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K     +I  +  +A G+++++ +  +HRD++  N+L+  +   KIADFG+AR+  
Sbjct: 103 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 162
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 330
            N +    G    + + APE +N  ++  K DV+SFGI L EI     +PYP +S  EV 
Sbjct: 163 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 222
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            A+ R    P  P  CP  L N+M RCW   P++RP  + + ++L+
Sbjct: 223 RALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 56
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 99
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 220 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 135/289 (46%), Gaps = 35/289 (12%)
Query: 106 AFARGTFGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
              +G FG V+ G Y  Q       A+K L    E  + EA        F +E  +   L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA--------FLREGLLMRGL 79
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
           +HPNV   IG  +    L       H+ +P          CHG  L+   I++ +R    
Sbjct: 80  NHPNVLALIGIMLPPEGLP------HVLLPY--------MCHGDLLQ--FIRSPQRNPTV 123
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPH 276
           K +I   L +ARG+ YL  +K VHRD+   N +LD++ TVK+ADFG+AR     E  +  
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVR 335
                   + + A E L    +  K DV+SFG+ LWE+      PY  +   ++T  + +
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
               P+ P  CP SL  VM++CW+A+P  RP    +V  +E I ++  G
Sbjct: 244 GRRLPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 57
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 100
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 101 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 160
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 161 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 218
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 219 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----------AFL 58
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 101
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 102 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 161
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 162 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 219
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 220 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----------DAFL 56
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 99
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL 
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 272 ASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 327
             N  + T   G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 160 EDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 218 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 31/292 (10%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           EWE+    L +      G FG V  G Y+G   VAVK L  G  S            AF 
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----------AFL 52
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E  +  +L H  + +                            ++ EY   G+L  +L 
Sbjct: 53  AEANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLK 95
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                KL    ++ +A  +A G+++++ +  +HR+++  N+L+  T + KIADFG+ARL 
Sbjct: 96  TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLI 155
Query: 272 ASNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 329
             N +    G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV
Sbjct: 156 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 215
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
              + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 216 IQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 266

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 139/304 (45%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 60
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 104
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++ 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 164
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R          G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP+ RP   E+V
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 373 AMLE 376
            +L+
Sbjct: 284 NLLK 287

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 139/304 (45%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 60
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 104
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++ 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 164
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 165 HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 373 AMLE 376
            +L+
Sbjct: 284 NLLK 287

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 138/304 (45%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 57
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 58  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 101
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++ 
Sbjct: 102 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 161
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R          G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 162 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 221
Query: 314 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V
Sbjct: 222 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 373 AMLE 376
            +L+
Sbjct: 281 NLLK 284

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 139/304 (45%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 60
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 104
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++ 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 164
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 165 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 373 AMLE 376
            +L+
Sbjct: 284 NLLK 287

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 60
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 61  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 104
Query: 206 LKSYLIKNRRRKLA---------FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R  +A            +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 105 LKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 163
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 164 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 224 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 138/304 (45%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 60
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 104
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++ 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 164
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R          G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 165 HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 373 AMLE 376
            +L+
Sbjct: 284 NLLK 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 55
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 56  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 99
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 100 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 158
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R          G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 159 DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 219 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 57
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 101
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 102 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 160
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 161 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 221 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 70
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 114
Query: 206 LKSYLIKNRRRKLA---------FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R  +A            +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 115 LKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 64
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 108
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 109 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 167
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R          G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 168 DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 228 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 63
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 107
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 108 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 166
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 167 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 227 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 64
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 108
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 109 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 167
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 168 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 228 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 61
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 105
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 106 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 164
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 165 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 225 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 92
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 93  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 136
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 137 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 195
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 196 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 256 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 314

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 63
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 107
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 108 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 166
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 167 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 227 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 139/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 70
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 114
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N ++ +
Sbjct: 115 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 140/304 (46%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 60
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 104
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHR++   N ++ 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVA 164
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 165 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 224
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP+ RP   E+V
Sbjct: 225 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 373 AMLE 376
            +L+
Sbjct: 284 NLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 140/304 (46%), Gaps = 47/304 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E AS
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESAS 61
Query: 146 LR--AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           LR    F  E +V       +V + +G                 G P+    VV+E    
Sbjct: 62  LRERIEFLNEASVMKGFTCHHVVRLLGVVSK-------------GQPT---LVVMELMAH 105
Query: 204 GALKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           G LKSYL   R        R     + +IQ+A ++A G++YL +KK VHR++   N ++ 
Sbjct: 106 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVA 165
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWE 313
              TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWE
Sbjct: 166 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 225
Query: 314 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I    + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP+ RP   E+V
Sbjct: 226 ITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIV 284
Query: 373 AMLE 376
            +L+
Sbjct: 285 NLLK 288

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V+EY   G+L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVIEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V      G         VAVK+L     +H +E    
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 92
Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA               IG P+    V+ EYC  
Sbjct: 93  --REALMSELKVLSYLGNHMNIVNLLGACT-------------IGGPT---LVITEYCCY 134
Query: 204 GALKSYLIKNRRRKLAFKV----------------VIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R   +  K                 ++  +  +A+G+++L SK  +HRD+
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 194
Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 314
Query: 365 RPEMDEVVAMLE 376
           RP   ++V ++E
Sbjct: 315 RPTFKQIVQLIE 326

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K ++        EA    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 57
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                 G P+    V++E    G 
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVV-------------SQGQPT---LVIMELMTRGD 101
Query: 206 LKSYLIKNRRRKL---------AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           LKSYL ++ R ++         +   +IQ+A ++A G++YL + K VHRD+   N  + +
Sbjct: 102 LKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAE 160
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI
Sbjct: 161 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220
Query: 315 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               + PY  LS  +V   V+   L  + P  CP  L  +M+ CW  NP  RP   E+++
Sbjct: 221 ATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V      G         VAVK+L     +H +E    
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 92
Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA               IG P+    V+ EYC  
Sbjct: 93  --REALMSELKVLSYLGNHMNIVNLLGACT-------------IGGPT---LVITEYCCY 134
Query: 204 GALKSYLIKNRRRKLAFKV----------------VIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R   +  K                 ++  +  +A+G+++L SK  +HRD+
Sbjct: 135 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 194
Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 314
Query: 365 RPEMDEVVAMLE 376
           RP   ++V ++E
Sbjct: 315 RPTFKQIVQLIE 326

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V      G         VAVK+L     +H +E    
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 69
Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA               IG P+    V+ EYC  
Sbjct: 70  --REALMSELKVLSYLGNHMNIVNLLGACT-------------IGGPT---LVITEYCCY 111
Query: 204 GALKSYLIKNRRRKLAFKV----------------VIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R   +  K                 ++  +  +A+G+++L SK  +HRD+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171
Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 365 RPEMDEVVAMLE 376
           RP   ++V ++E
Sbjct: 292 RPTFKQIVQLIE 303

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 135/294 (45%), Gaps = 30/294 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    + +      G FG V  G Y+    VAVK L  G  S +          AF +
Sbjct: 8   WEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----------AFLE 57
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +   L H  + +          + I                + EY   G+L  +L  
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYI----------------ITEYMAKGSLLDFLKS 101
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K+    +I  +  +A G++Y++ K  +HRD++  N+L+ ++   KIADFG+AR+  
Sbjct: 102 DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 161
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            N +    G    + + APE +N   +  K DV+SFGI L+EI     +PYP  + ++V 
Sbjct: 162 DNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
           +A+ +    P +   CP  L ++MK CW    ++RP  D + ++L+   T+  G
Sbjct: 222 TALSQGYRMPRVEN-CPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEG 274

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V      G         VAVK+L     +H +E    
Sbjct: 32  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 85
Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA               IG P+    V+ EYC  
Sbjct: 86  --REALMSELKVLSYLGNHMNIVNLLGACT-------------IGGPT---LVITEYCCY 127
Query: 204 GALKSYLIKNRRRKLAFKV----------------VIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R   +  K                 ++  +  +A+G+++L SK  +HRD+
Sbjct: 128 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 187
Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 248 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 307
Query: 365 RPEMDEVVAMLE 376
           RP   ++V ++E
Sbjct: 308 RPTFKQIVQLIE 319

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 128/305 (41%), Gaps = 44/305 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A  + 
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEG-------ATHSE 75
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            RA  ++   + H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 120
Query: 206 LKSYLIKNRRRKLAFKV------------VIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           L +YL   R   + +K             +I  +  +A+G+ +L S+K +HRD+   N+L
Sbjct: 121 LSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNIL 180
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           L +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+ L
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 312 WEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 370
           WEI+     PYP +   E     +++  R   P      +   M  CW   P +RP   E
Sbjct: 241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 371 VVAML 375
           +V  L
Sbjct: 301 LVEHL 305

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V      G         VAVK+L     +H +E    
Sbjct: 34  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 87
Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA               IG P+    V+ EYC  
Sbjct: 88  --REALMSELKVLSYLGNHMNIVNLLGACT-------------IGGPT---LVITEYCCY 129
Query: 204 GALKSYLIKNRRRKLAFKV----------------VIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R   +  K                 ++  +  +A+G+++L SK  +HRD+
Sbjct: 130 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 189
Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 250 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 309
Query: 365 RPEMDEVVAMLE 376
           RP   ++V ++E
Sbjct: 310 RPTFKQIVQLIE 321

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 128/303 (42%), Gaps = 42/303 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 81  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 118
Query: 206 LKSYLIKNRRRKLAFK----------VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           L +YL   R   + +K           +I  +  +A+G+ +L S+K +HRD+   N+LL 
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS 178
Query: 256 KTRTVKIADFGVARLEASNP-HDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           +   VKI DFG+AR    +P +   G+    L +MAPE +    Y  + DV+SFG+ LWE
Sbjct: 179 EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 238
Query: 314 IYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I+     PYP +   E     +++  R   P      +   M  CW   P +RP   E+V
Sbjct: 239 IFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 373 AML 375
             L
Sbjct: 299 EHL 301

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 135/293 (46%), Gaps = 35/293 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V+EY   G+L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVIEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            N  + T   G    + + APE      +  K DV+SFGI L E+     +PYP +   E
Sbjct: 166 DN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 223
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           V   V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 224 VLDQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 72  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 109
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 169
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 170 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 229
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 230 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 290 SELVEHL 296

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 31/298 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WE+    L +      G  G V  G Y+G   VAVK L  G  S            AF  
Sbjct: 8   WEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD----------AFLA 57
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  +L H  + +                            ++ EY   G+L  +L  
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-----------------IYIITEYMENGSLVDFLKT 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL-E 271
               KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+ARL E
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            +      G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  EV 
Sbjct: 161 DAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIP 388
             + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+  G   P
Sbjct: 221 QNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 81  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 118
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 299 SELVEHL 305

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 4   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 54  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 96
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 97  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 156
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 157 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 216
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 217 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 266

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 51
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 52  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 94
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 95  EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 154
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 155 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 214
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 215 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 264

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVCEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 311
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 312 EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 354
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 475 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP  L        G FG V  G + GQ DVA+K++   +E   SE E       F +E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIEEA 50
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V   L H  + +  G       + I                + EY   G L +YL +  
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYL-REM 93
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
           R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R    +
Sbjct: 94  RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
Query: 275 PHDMT-GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 332
            +  + G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE T+ 
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAE 212
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-MLEAID 379
            + Q LR   P      +  +M  CW    D+RP    +++ +L+ +D
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 81  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 118
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 299 SELVEHL 305

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V+EY   G L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVMEYMSKGCLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 228
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 229 EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 271
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 392 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 228
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 229 EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 271
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 392 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGCLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 6   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 55
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 56  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 98
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 99  ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 158
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 159 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 218
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 219 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 268

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 117
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 118 LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 155
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 275
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 335
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 336 SELVEHL 342

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  K+ H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 63  EAQVMKKIRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 10  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY + G+L  +L  
Sbjct: 60  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMNKGSLLDFLKG 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ ++  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 103 ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 162
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 163 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 222
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 223 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 67
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 68  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 108
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 109 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 168
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 229 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 287
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 288 FKQLVEDLDRI 298

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 81  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 118
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 299 SELVEHL 305

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 13  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 62
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 63  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 105
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD+   N+L+ +    K+ADFG+ARL  
Sbjct: 106 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIE 165
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 166 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 225
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 226 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 39/296 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           EID + + I+     G FG V RG           VA+K L  G    +        R  
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--------RRE 63
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + +HPN+ +  G    +             MP     ++ E+   GAL S+
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNS-------------MP---VMILTEFMENGALDSF 107
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L  N  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 108 LRLNDGQFTVIQLVGMLR-GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSR 166
Query: 270 LEASNPHDMTGETGTLG------YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
               N  D T ET +LG      + APE +    +    D +S+GI +WE+    + PY 
Sbjct: 167 FLEENSSDPT-ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 225
Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           D+S  +V +A + Q+ R   P  CP+SL  +M  CW  + + RP   +VV+ L+ +
Sbjct: 226 DMSNQDVINA-IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 142/316 (44%), Gaps = 54/316 (17%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT----LGYMAPEVLNGSAYNRKCDVY 305
            N+L+ +   +KIADFG+AR    N  D   +T      + +MAPE L    Y  + DV+
Sbjct: 186 RNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           SFG+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 302
Query: 365 RPEMDEVVAMLEAIDT 380
           RP   ++V  L+ I T
Sbjct: 303 RPTFKQLVEDLDRILT 318

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 140/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 78
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 79  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 119
Query: 205 ALKSYLIKNRRRKLAF--------------KVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R   L F              K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 120 NLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 251 NMLLDKTRTVKIADFGVAR--LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR           T     + +MAPE L    Y  + DV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 298
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 299 FKQLVEDLDRI 309

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 78
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 79  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 119
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 120 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 298
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 299 FKQLVEDLDRI 309

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 180 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----------AFLQ 229
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 230 EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMSKGSLLDFLKG 272
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ RL  
Sbjct: 273 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIE 332
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 333 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 392
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW  +P++RP  + + A LE   TS
Sbjct: 393 DQVER-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 442

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 142/316 (44%), Gaps = 54/316 (17%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT----LGYMAPEVLNGSAYNRKCDVY 305
            N+L+ +   +KIADFG+AR    N  D   +T      + +MAPE L    Y  + DV+
Sbjct: 186 RNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 243
Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           SFG+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +
Sbjct: 244 SFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 302
Query: 365 RPEMDEVVAMLEAIDT 380
           RP   ++V  L+ I T
Sbjct: 303 RPTFKQLVEDLDRILT 318

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 70
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 71  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 111
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 112 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 171
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 232 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 290
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 291 FKQLVEDLDRI 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 78
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 79  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 119
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 298
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 299 FKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 63
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 64  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 104
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 105 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 283
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 284 FKQLVEDLDRI 294

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 78
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 79  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 119
Query: 205 ALKSYL--------------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL                N   +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 298
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 299 FKQLVEDLDRI 309

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 133/293 (45%), Gaps = 35/293 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 3   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 52
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 53  EAQVMKKLRHEKLVQLYAVV---SEEPIX--------------IVTEYMSKGSLLDFLKG 95
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 96  ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 155
Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            N  + T   G    + + APE      +  K DV+SFGI L E+     +PYP +   E
Sbjct: 156 DN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 213
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           V   V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 214 VLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 128/306 (41%), Gaps = 45/306 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A  + 
Sbjct: 22  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSE 74
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            RA  ++   + H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 75  HRALMSELKILIHIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 119
Query: 206 LKSYLIKNRRRKLAFKV-------------VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           L +YL   R   + +K              +I  +  +A+G+ +L S+K +HRD+   N+
Sbjct: 120 LSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGIC 310
           LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+ 
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 311 LWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
           LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP   
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 370 EVVAML 375
           E+V  L
Sbjct: 300 ELVEHL 305

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 126/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+ E+C  G 
Sbjct: 72  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVITEFCKFGN 109
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 169
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 170 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 229
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 230 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 290 SELVEHL 296

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 64  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 119
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 120 DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 160
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 339
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 340 FKQLVEDLDRI 350

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 30/294 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    + +      G FG V  G Y+    VAVK L  G  S +          AF +
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----------AFLE 56
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +   L H  + +          + I                + E+   G+L  +L  
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYI----------------ITEFMAKGSLLDFLKS 100
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +   K+    +I  +  +A G++Y++ K  +HRD++  N+L+ ++   KIADFG+AR+  
Sbjct: 101 DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 160
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 330
            N +    G    + + APE +N   +  K +V+SFGI L+EI     +PYP  + ++V 
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVM 220
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
           SA+ +    P +   CP  L ++MK CW    ++RP  D + ++L+   T+  G
Sbjct: 221 SALSQGYRMPRMEN-CPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEG 273

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 50/311 (16%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
           WE+   +L++      G FG V      G D         VAVK+L    +S  +E +++
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDLS 71
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L +       +     H N+   +GA          T +G +        V+VEY   G
Sbjct: 72  DLISEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASKG 112
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L+ YL   R                +L+ K ++  A  +ARG+ YL SKK +HRD+   
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 172
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+L+ +   +KIADFG+AR      +      G L   +MAPE L    Y  + DV+SFG
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232
Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP 
Sbjct: 233 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 291
Query: 368 MDEVVAMLEAI 378
             ++V  L+ I
Sbjct: 292 FKQLVEDLDRI 302

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEEDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIITLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIIHLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 228
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY   G+L  +L  
Sbjct: 229 EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVGEYMSKGSLLDFLKG 271
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 273 SNPHDM-TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 330
            N +    G    + + APE      +  K DV+SFGI L E+     +PYP +   EV 
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391
Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 392 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L ++    +G FG V  G ++G   VA+K L  G  S            AF Q
Sbjct: 10  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------AFLQ 59
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  V  KL H  + +        SE  I               +V EY + G+L  +L  
Sbjct: 60  EAQVMKKLRHEKLVQLYAVV---SEEPIY--------------IVTEYMNKGSLLDFLKG 102
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              + L    ++ ++  +A G++Y++    VHRD++  N+L+ +    K+ADFG+ARL  
Sbjct: 103 ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 162
Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            N  + T   G    + + APE      +  K DV+SFGI L E+     +PYP +   E
Sbjct: 163 DN--EWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 220
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           V   V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 221 VLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 21  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 76
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 77  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 117
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 118 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 177
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 178 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 237
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 238 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 296
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 297 TFKQLVEDLDRILT 310

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 16  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 71
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 72  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 112
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 113 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTA 172
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 173 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 232
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 233 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 291
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 292 TFKQLVEDLDRILT 305

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 126/303 (41%), Gaps = 42/303 (13%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 81  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 118
Query: 206 LKSYLIKNRRRKLAFK----------VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           L +YL   R   + +K           +I  +  +A+G+ +L S+K +HRD+   N+LL 
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS 178
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+ LWE
Sbjct: 179 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 238
Query: 314 IYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           I+     PYP +   E     +++  R   P      +   M  CW   P +RP   E+V
Sbjct: 239 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 298
Query: 373 AML 375
             L
Sbjct: 299 EHL 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+ E+C  G 
Sbjct: 72  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVITEFCKFGN 109
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 169
Query: 252 MLLDKTRTVKIADFGVARLEASNP-HDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P +   G+    L +MAPE +    Y  + DV+SFG+
Sbjct: 170 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 229
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 230 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 290 SELVEHL 296

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 18  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 73
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 74  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 114
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 115 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 174
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 175 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 234
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 235 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 293
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 294 TFKQLVEDLDRILT 307

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 133/293 (45%), Gaps = 35/293 (11%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           WEI    L +      G FG V  G ++G   VA+K L  G  S  S          F +
Sbjct: 4   WEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES----------FLE 53
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E  +  KL H  + +        SE  I               +V EY + G+L  +L  
Sbjct: 54  EAQIMKKLKHDKLVQLYAVV---SEEPI--------------YIVTEYMNKGSLLDFLKD 96
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
              R L    ++ +A  +A G++Y++    +HRD+++ N+L+      KIADFG+ARL  
Sbjct: 97  GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIE 156
Query: 273 SNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 328
            N  + T   G    + + APE      +  K DV+SFGI L E+     +PYP ++  E
Sbjct: 157 DN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 214
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           V   V R   R   P+ CP SL  +M  CW  +P++RP  + + + LE   T+
Sbjct: 215 VLEQVER-GYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTA 266

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 126/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A ++ 
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L+          H   H NV   +GA                  P     V+ E+C  G 
Sbjct: 72  LKILI-------HIGHHLNVVNLLGACTK---------------PGGPLMVITEFCKFGN 109
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +KV              +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 169
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 170 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 229
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 230 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 290 SELVEHL 296

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   ++IADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 130
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+VEY   
Sbjct: 131 SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVEYASK 171
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 292 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 350
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 351 TFKQLVEDLDRILT 364

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 46/307 (14%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L  G       A  + 
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSE 75
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            RA  ++   + H   H NV   +GA                  P     V+VE+C  G 
Sbjct: 76  HRALMSELKILIHIGHHLNVVNLLGACTK---------------PGGPLMVIVEFCKFGN 120
Query: 206 LKSYLIKNRRRKLAFKV--------------VIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R   + +K               +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 180
Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P  +        L +MAPE +    Y  + DV+SFG+
Sbjct: 181 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 240
Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 241 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 300
Query: 369 DEVVAML 375
            E+V  L
Sbjct: 301 SELVEHL 307

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 140/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+V Y   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVAYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 137/302 (45%), Gaps = 47/302 (15%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIASLR 147
           E+   K+ +     +G+FG V+ G    I  G+    VAVK ++          E ASLR
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN----------ESASLR 61
Query: 148 --AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
               F  E +V       +V + +G                 G P+    VV+E    G 
Sbjct: 62  ERIEFLNEASVMKGFTCHHVVRLLGVV-------------SKGQPT---LVVMELMAHGD 105
Query: 206 LKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
           LKSYL   R        R     + +IQ+A ++A G++YL +KK VHRD+   N ++   
Sbjct: 106 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 165
Query: 258 RTVKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            TVKI DFG+ R      +   G  G L   +MAPE L    +    D++SFG+ LWEI 
Sbjct: 166 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 225
Query: 316 -CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
              + PY  LS  +V   V+      + P  CP  + ++M+ CW  NP  RP   E+V +
Sbjct: 226 SLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 284
Query: 375 LE 376
           L+
Sbjct: 285 LK 286

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           EID + + I+     G FG V RG           VA+K L  G    +        R  
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--------RRE 61
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + +HPN+ +  G    +             MP     ++ E+   GAL S+
Sbjct: 62  FLSEASIMGQFEHPNIIRLEGVVTNS-------------MP---VMILTEFMENGALDSF 105
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L  N  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 106 LRLNDGQFTVIQLVGMLR-GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSR 164
Query: 270 LEASNPHDMTGETGTLG------YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
               N  D T  T +LG      + APE +    +    D +S+GI +WE+    + PY 
Sbjct: 165 FLEENSSDPT-YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 223
Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           D+S  +V +A + Q+ R   P  CP+SL  +M  CW  + + RP   +VV+ L+ +
Sbjct: 224 DMSNQDVINA-IEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 140/314 (44%), Gaps = 50/314 (15%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L    +   +E ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL 84
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           + L +       +     H N+   +GA          T +G +        V+V Y   
Sbjct: 85  SDLVSEMEMMKMIGK---HKNIINLLGAC---------TQDGPL-------YVIVGYASK 125
Query: 204 GALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+  
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSF 307
            N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+SF
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 308 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           G+ +WEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +RP
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 367 EMDEVVAMLEAIDT 380
              ++V  L+ I T
Sbjct: 305 TFKQLVEDLDRILT 318

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 110 GTFGTVHRGIYDGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G FG+V +G+Y  +    DVA+K+L  G E   +E           +E  + H+LD+P +
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE--------MMREAQIMHQLDNPYI 72
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + IG     + +                 +V+E   GG L  +L+  +R ++    V +
Sbjct: 73  VRLIGVCQAEALM-----------------LVMEMAGGGPLHKFLV-GKREEIPVSNVAE 114
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-- 283
           L   ++ G+ YL+ K  VHRD+   N+LL      KI+DFG+++   ++    T  +   
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 284 -TLGYMAPEVLNGSAYNRKCDVYSFGICLWE-IYCCDMPYPDLSFSEVTSAVVRQNLRPE 341
             L + APE +N   ++ + DV+S+G+ +WE +     PY  +   EV  A + Q  R E
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRME 233
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            P  CP  L  +M  CW    + RP+   V   + A
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 110 GTFGTVHRGIYDGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           G FG+V +G+Y  +    DVA+K+L  G E   +E           +E  + H+LD+P +
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE--------MMREAQIMHQLDNPYI 398
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + IG     + +                 +V+E   GG L  +L+  +R ++    V +
Sbjct: 399 VRLIGVCQAEALM-----------------LVMEMAGGGPLHKFLV-GKREEIPVSNVAE 440
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-- 283
           L   ++ G+ YL+ K  VHR++   N+LL      KI+DFG+++   ++    T  +   
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 284 -TLGYMAPEVLNGSAYNRKCDVYSFGICLWE-IYCCDMPYPDLSFSEVTSAVVRQNLRPE 341
             L + APE +N   ++ + DV+S+G+ +WE +     PY  +   EV  A + Q  R E
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRME 559
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            P  CP  L  +M  CW    + RP+   V   + A
Sbjct: 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E +  + E+      F  E 
Sbjct: 49  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVYSEQDELD-----FLMEA 99
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 100 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 143
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 264 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 31/295 (10%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAF 150
           ID   LI+      G FG+V  G    +D     VAVK +     S R   E       F
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-------F 83
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             E A      HPNV + +G  +   E++ Q      G+P     V++ +   G L +YL
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCI---EMSSQ------GIPKPM--VILPFMKYGDLHTYL 132
Query: 211 IKNRR----RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           + +R     + +  + +++  +D+A G+ YL ++  +HRD+   N +L    TV +ADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 267 VARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPD 323
           +++   S  +   G    +   ++A E L    Y  K DV++FG+ +WEI    M PYP 
Sbjct: 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +   E+   ++  + R + P  C   L  +M  CW  +P  RP    +   LE +
Sbjct: 253 VQNHEMYDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           +++      G FG V+ G+Y        +VAVK       + + +  + + +  F  E  
Sbjct: 26  VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-------TCKKDCTLDN-KEKFMSEAV 77
Query: 156 VWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR 215
           +   LDHP++ K IG         I+ +   I         ++E    G L  YL +N+ 
Sbjct: 78  IMKNLDHPHIVKLIGI--------IEEEPTWI---------IMELYPYGELGHYLERNKN 120
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASN 274
             L    ++  +L + + ++YL+S   VHRD+   N+L+     VK+ DFG++R +E  +
Sbjct: 121 -SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 179
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAV 333
            +  +     + +M+PE +N   +    DV+ F +C+WEI      P+  L   +V   +
Sbjct: 180 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 239
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + +  P+ P  CP  L  +M RCWD +P  RP   E+V  L  +
Sbjct: 240 EKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           +++      G FG V+ G+Y        +VAVK       + + +  + + +  F  E  
Sbjct: 14  VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-------TCKKDCTLDN-KEKFMSEAV 65
Query: 156 VWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR 215
           +   LDHP++ K IG         I+ +   I         ++E    G L  YL +N+ 
Sbjct: 66  IMKNLDHPHIVKLIGI--------IEEEPTWI---------IMELYPYGELGHYLERNKN 108
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASN 274
             L    ++  +L + + ++YL+S   VHRD+   N+L+     VK+ DFG++R +E  +
Sbjct: 109 -SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAV 333
            +  +     + +M+PE +N   +    DV+ F +C+WEI      P+  L   +V   +
Sbjct: 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + +  P+ P  CP  L  +M RCWD +P  RP   E+V  L  +
Sbjct: 228 EKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 49  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 99
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  KL+H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 100 LIISKLNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 143
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 264 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 35  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 85
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  KL+H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 86  LIISKLNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 129
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 250 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 107 FARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
             +G FG+V       +D     VAVK+L       +++   +S    F +E A   + D
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKML-------KADIIASSDIEEFLREAACMKEFD 83
Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK---- 217
           HP+V K +G ++ +         G + +P     V++ +   G L ++L+ +R  +    
Sbjct: 84  HPHVAKLVGVSLRSRA------KGRLPIP----MVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +++  +D+A G+ YL S+  +HRD+   N +L +  TV +ADFG++R   S  + 
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 278 MTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 334
             G    L   ++A E L  + Y    DV++FG+ +WEI      PY  +  +E+ + ++
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-------EMDEVVAMLEAIDTSK 382
             N R + P  C   + ++M +CW A+P +RP       E++ ++  L  + TS+
Sbjct: 254 GGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           +++      G FG V+ G+Y        +VAVK       + + +  + + +  F  E  
Sbjct: 10  VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK-------TCKKDCTLDN-KEKFMSEAV 61
Query: 156 VWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR 215
           +   LDHP++ K IG         I+ +   I         ++E    G L  YL +N+ 
Sbjct: 62  IMKNLDHPHIVKLIGI--------IEEEPTWI---------IMELYPYGELGHYLERNKN 104
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASN 274
             L    ++  +L + + ++YL+S   VHRD+   N+L+     VK+ DFG++R +E  +
Sbjct: 105 -SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 163
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAV 333
            +  +     + +M+PE +N   +    DV+ F +C+WEI      P+  L   +V   +
Sbjct: 164 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 223
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            + +  P+ P  CP  L  +M RCWD +P  RP   E+V  L  +
Sbjct: 224 EKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 51/307 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 72
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 73  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 119 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 178 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 236
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 237 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 296
Query: 382 KGGGMIP 388
              G++P
Sbjct: 297 M-AGLVP 302

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 71
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 117
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 118 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 177 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 235
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 236 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295
Query: 382 KGG 384
             G
Sbjct: 296 MAG 298

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 75
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 76  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 121
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 122 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 180
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 181 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 239
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 240 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 299
Query: 382 KGG 384
             G
Sbjct: 300 MAG 302

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 74
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 75  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 121 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 179
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 180 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 238
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 239 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 298
Query: 382 KGG 384
             G
Sbjct: 299 MAG 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 73
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 74  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 119
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 120 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 179 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 237
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 238 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 297
Query: 382 KGG 384
             G
Sbjct: 298 MAG 300

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 86
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 133 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 192 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 250
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 251 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 310
Query: 382 KGG 384
             G
Sbjct: 311 MAG 313

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 174 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
Query: 382 KGG 384
             G
Sbjct: 293 MAG 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 174 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
Query: 382 KGG 384
             G
Sbjct: 293 MAG 295

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           AR+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 174 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
Query: 382 KGG 384
             G
Sbjct: 293 MAG 295

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 66
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 67  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 112
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 113 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 172 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 230
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I   
Sbjct: 231 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 290
Query: 382 KGG 384
             G
Sbjct: 291 MAG 293

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 41/303 (13%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA          T  G +        V+ EYC  G
Sbjct: 99  ELKI-------MSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 205 ALKSYLIKNRR--------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
            L ++L +           R L  + ++  +  +A+G+++L SK  +HRDV   N+LL  
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 195
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
               KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI LWEI
Sbjct: 196 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255
Query: 315 YCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           +   + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP   ++ +
Sbjct: 256 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 315
Query: 374 MLE 376
            L+
Sbjct: 316 FLQ 318

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 99
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 145
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 146 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 204
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 205 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I   
Sbjct: 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
Query: 382 KGG 384
             G
Sbjct: 324 MAG 326

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 41/303 (13%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA          T  G +        V+ EYC  G
Sbjct: 91  ELKI-------MSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 127
Query: 205 ALKSYLIKNRR--------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
            L ++L +           R L  + ++  +  +A+G+++L SK  +HRDV   N+LL  
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 187
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
               KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI LWEI
Sbjct: 188 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247
Query: 315 YCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           +   + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP   ++ +
Sbjct: 248 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 307
Query: 374 MLE 376
            L+
Sbjct: 308 FLQ 310

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 61  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELD-----FLMEA 111
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 112 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 155
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 156 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 215
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 216 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 275
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 276 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 40/296 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLRA 148
           EI P+ +  +     G FG V++G+           VA+K L  G    +        R 
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--------RV 91
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
            F  E  +  +  H N+ +  G       + I                + EY   GAL  
Sbjct: 92  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI----------------ITEYMENGALDK 135
Query: 209 YLIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           +L   R +   F V+  + +   +A G+ YL +   VHRD+   N+L++     K++DFG
Sbjct: 136 FL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 267 VARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
           ++R+   +P   +  +G    + + APE ++   +    DV+SFGI +WE+    + PY 
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252
Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +LS  EV  A +    R   P  CPS++  +M +CW     +RP+  ++V++L+ +
Sbjct: 253 ELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 34  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 84
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 85  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 128
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 249 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 35  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 85
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 86  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 129
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 190 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 250 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 51  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 101
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 102 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 145
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 146 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 206 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 265
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 266 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 41  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 91
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 92  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 135
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 136 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 195
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 196 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 255
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 256 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 34  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 84
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 85  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILMELMAGGDLKSFLRETR 128
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 249 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 49  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 99
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 100 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILMELMAGGDLKSFLRETR 143
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 263
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 264 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 136/300 (45%), Gaps = 47/300 (15%)
Query: 95  EIDPAKLIIKGAFARGTFGTV---------HRGIYDGQDVAVKLLDWGEESHRSEAEIAS 145
           EID + + I+     G FG V          R I+    VA+K L  G    +       
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF----VAIKTLKSGYTEKQ------- 77
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E ++  + DHPNV    G    ++ +                 ++ E+   G+
Sbjct: 78  -RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----------------MIITEFMENGS 120
Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF 265
           L S+L +N  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DF
Sbjct: 121 LDSFLRQNDGQFTVIQLVGMLR-GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 179
Query: 266 GVARLEASNPHDMTGETGTLG------YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-D 318
           G++R    +  D T  T  LG      + APE +    +    DV+S+GI +WE+    +
Sbjct: 180 GLSRFLEDDTSDPT-YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            PY D++  +V +A + Q+ R   P  CPS+L  +M  CW  + + RP+  ++V  L+ +
Sbjct: 239 RPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 52  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 102
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 103 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 146
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 147 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 266
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 267 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 75  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELD-----FLMEA 125
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 126 LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 169
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 290 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYD--GQ---DVAVKLLDWGEESHRSEAEIASLRAA 149
           EI+ + + I+     G FG V  G     G+    VA+K L  G    +        R  
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ--------RRD 69
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+    G    +  + I                V EY   G+L ++
Sbjct: 70  FLGEASIMGQFDHPNIIHLEGVVTKSKPVMI----------------VTEYMENGSLDTF 113
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L KN  +    ++V  L   ++ G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 114 LKKNDGQFTVIQLVGMLR-GISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSR 172
Query: 270 LEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P   +   G    + + APE +    +    DV+S+GI +WE+    + PY +++
Sbjct: 173 VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMT 232
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V  A V +  R   P  CP++L  +M  CW    + RP+ DE+V ML+ +
Sbjct: 233 NQDVIKA-VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 90
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 91  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 134
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 135 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 191
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 192 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 252 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 310

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 26  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 76
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 77  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 120
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 121 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +AR      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 181 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 240
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 241 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 86
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 133 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 192 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 250
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I
Sbjct: 251 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 63
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 107
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 108 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 164
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 225 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 283

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 67
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 68  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 113
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 114 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 173 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 231
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I
Sbjct: 232 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 80
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 81  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 124
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 125 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 181
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 182 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 242 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 300

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 136/293 (46%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIY--DGQ---DVAVKLLDWGEESHRSEAEIASLRAA 149
           EI+ +++ I+     G  G V  G     GQ    VA+K L  G    +        R  
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ--------RRD 96
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G              G + M      +V EY   G+L ++
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVT----------RGRLAM------IVTEYMENGSLDTF 140
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L +    +     ++ +   +  G+ YL     VHRD+   N+L+D     K++DFG++R
Sbjct: 141 L-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 270 LEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P   +  TG    + + APE +    ++   DV+SFG+ +WE+    + PY +++
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V S+ V +  R   P  CP +L  +M  CW  +  +RP   ++V++L+A+
Sbjct: 260 NRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 71
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++E+   G+L+ YL K++ R    
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLK--------------LIMEFLPYGSLREYLQKHKERIDHI 117
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 118 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 177 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 235
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 236 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295
Query: 382 KGG 384
             G
Sbjct: 296 MAG 298

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 134/300 (44%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V EY   G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEYMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
            R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 138/318 (43%), Gaps = 57/318 (17%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTV-------HRGIYDGQDVAVKLLDWGEESHRSEAEIAS 145
           +WE     L++      G FG V        +G      VAVK+L    + + S +E+  
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRD 72
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L + F     V  +++HP+V K  GA      L                 ++VEY   G+
Sbjct: 73  LLSEFN----VLKQVNHPHVIKLYGACSQDGPL----------------LLIVEYAKYGS 112
Query: 206 LKSYLIKNRR----------------------RKLAFKVVIQLALDLARGLSYLQSKKIV 243
           L+ +L ++R+                      R L    +I  A  +++G+ YL   K+V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172
Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRK 301
           HRD+   N+L+ + R +KI+DFG++R        +    G +   +MA E L    Y  +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 302 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+SFG+ LWEI      PYP +   E    +++   R E P  C   +  +M +CW  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQ 291
Query: 361 NPDKRPEMDEVVAMLEAI 378
            PDKRP   ++   LE +
Sbjct: 292 EPDKRPVFADISKDLEKM 309

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 132/309 (42%), Gaps = 47/309 (15%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA          T  G +        V+ EYC  G
Sbjct: 99  ELKI-------MSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L ++L + R                +L+ + ++  +  +A+G+++L SK  +HRDV   
Sbjct: 136 DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 195
Query: 251 NMLLDKTRTVKIADFGVAR--LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG 308
           N+LL      KI DFG+AR  +  SN          + +MAPE +    Y  + DV+S+G
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 255
Query: 309 ICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           I LWEI+   + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP 
Sbjct: 256 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 315
Query: 368 MDEVVAMLE 376
             ++ + L+
Sbjct: 316 FQQICSFLQ 324

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 136/293 (46%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRG---IYDGQDVAV--KLLDWGEESHRSEAEIASLRAA 149
           E+D + + I+     G FG V  G   +   +DVAV  K L  G    +        R  
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ--------RRD 90
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPNV    G                 G P     +V+E+   GAL ++
Sbjct: 91  FLCEASIMGQFDHPNVVHLEGVVTR-------------GKP---VMIVIEFMENGALDAF 134
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L K+  +    ++V  L   +A G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 135 LRKHDGQFTVIQLVGMLR-GIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSR 193
Query: 270 LEASNPHDMTGETG---TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P  +   TG    + + APE +    +    DV+S+GI +WE+    + PY D+S
Sbjct: 194 VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 253
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V  A + +  R   P  CP+ L  +M  CW     +RP+ +++V +L+ +
Sbjct: 254 NQDVIKA-IEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 45/307 (14%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA          T  G +        V+ EYC  G
Sbjct: 99  ELKI-------MSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 205 ALKSYLIKNRR------------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
            L ++L +  R              L+ + ++  +  +A+G+++L SK  +HRDV   N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGIC 310
           LL      KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI 
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 311 LWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
           LWEI+   + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP   
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315
Query: 370 EVVAMLE 376
           ++ + L+
Sbjct: 316 QICSFLQ 322

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 135/293 (46%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIY--DGQ---DVAVKLLDWGEESHRSEAEIASLRAA 149
           EI+ +++ I+     G  G V  G     GQ    VA+K L  G    +        R  
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ--------RRD 96
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G              G + M      +V EY   G+L ++
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVT----------RGRLAM------IVTEYMENGSLDTF 140
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L +    +     ++ +   +  G+ YL     VHRD+   N+L+D     K++DFG++R
Sbjct: 141 L-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 270 LEASNPHDMTGETG---TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P      TG    + + APE +    ++   DV+SFG+ +WE+    + PY +++
Sbjct: 200 VLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V S+ V +  R   P  CP +L  +M  CW  +  +RP   ++V++L+A+
Sbjct: 260 NRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 138/318 (43%), Gaps = 57/318 (17%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTV-------HRGIYDGQDVAVKLLDWGEESHRSEAEIAS 145
           +WE     L++      G FG V        +G      VAVK+L    + + S +E+  
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRD 72
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L + F     V  +++HP+V K  GA      L                 ++VEY   G+
Sbjct: 73  LLSEFN----VLKQVNHPHVIKLYGACSQDGPL----------------LLIVEYAKYGS 112
Query: 206 LKSYLIKNRR----------------------RKLAFKVVIQLALDLARGLSYLQSKKIV 243
           L+ +L ++R+                      R L    +I  A  +++G+ YL   K+V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172
Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRK 301
           HRD+   N+L+ + R +KI+DFG++R        +    G +   +MA E L    Y  +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 302 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+SFG+ LWEI      PYP +   E    +++   R E P  C   +  +M +CW  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQ 291
Query: 361 NPDKRPEMDEVVAMLEAI 378
            PDKRP   ++   LE +
Sbjct: 292 EPDKRPVFADISKDLEKM 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           +I+G    G FG V+ G   G         VAVK L    E    + E+      F  E 
Sbjct: 35  LIRG-LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD-----FLMEA 85
Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            +  K +H N+ + IG ++ +             +P     +++E   GG LKS+L + R
Sbjct: 86  LIISKFNHQNIVRCIGVSLQS-------------LPR---FILLELMAGGDLKSFLRETR 129
Query: 215 RR-----KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFG 266
            R      LA   ++ +A D+A G  YL+    +HRD+   N LL      R  KI DFG
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 189
Query: 267 VARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD 323
           +A+      +   G    L   +M PE      +  K D +SFG+ LWEI+    MPYP 
Sbjct: 190 MAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 249
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 250 KSNQEVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 69
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL K++ R    
Sbjct: 70  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQKHKERIDHI 115
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH---- 276
           K+ +Q    + +G+ YL +K+ +HR++ T N+L++    VKI DFG+ ++   +      
Sbjct: 116 KL-LQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 175 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 233
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 234 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 293
Query: 382 KGG 384
             G
Sbjct: 294 MAG 296

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAVK++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVKIID------KTQLNSSSLQKLF-REVRIMKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 226 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 134/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAVK++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVKIID------KTQLNSSSLQKLF-REVRIMKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G   Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 226 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 76  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 235
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRP 259

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 130/300 (43%), Gaps = 22/300 (7%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA      + + T+    G   NF     E   G 
Sbjct: 84  ELKI-------MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 205 ALK-----SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT 259
           +L        L K   R L  + ++  +  +A+G+++L SK  +HRDV   N+LL     
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 196
Query: 260 VKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI LWEI+  
Sbjct: 197 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 256
Query: 318 DM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP   ++ + L+
Sbjct: 257 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAVK++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVKIID------KTQLNSSSLQKLF-REVRIMKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 226 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAVK++D      +++   +SL+  F +EV +   
Sbjct: 13  KTIGKGNFAKVKLA---RHILTGKEVAVKIID------KTQLNSSSLQKLF-REVRIMKV 62
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 63  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGWMKEK 106
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 107 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 158
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 159 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 218
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 219 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 255

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 45/307 (14%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-------DVAVKLLDWGEESHRSEAEIA 144
           ++WE     L        G FG V      G         VAVK+L     +   EA ++
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            L+        + H   H N+   +GA          T  G +        V+ EYC  G
Sbjct: 99  ELKI-------MSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 205 ALKSYLIKNRR---RKLAFKV---------VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
            L ++L +  R      AF +         ++  +  +A+G+++L SK  +HRDV   N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGIC 310
           LL      KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI 
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 311 LWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
           LWEI+   + PYP +  +     +V+   +   P   P ++ ++M+ CW   P  RP   
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315
Query: 370 EVVAMLE 376
           ++ + L+
Sbjct: 316 QICSFLQ 322

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 50/283 (17%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VA+K++D      +++    SL+  F +EV +   
Sbjct: 18  KTIGKGNFAKVKLA---RHILTGREVAIKIID------KTQLNPTSLQKLF-REVRIMKI 67
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +++EY  GG +  YL+     K +
Sbjct: 68  LNHPNIVKLFEV--------IETEKT--------LYLIMEYASGGEVFDYLVAHGRMKEK 111
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K+IVHRD+K EN+LLD    +KIADFG      SN
Sbjct: 112 EARSKFRQIVS-------AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-----SN 159
Query: 275 PHDMTGETGTL----GYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEV 329
              + G+  T      Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+
Sbjct: 160 EFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 219
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
              V+R   R  IP    +   N++KR    NP KR  +++++
Sbjct: 220 RERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 260

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 25  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 82  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 122
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 241
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRP 265

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 33  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 90  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 130
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--- 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 249
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 250 PAGCPREMYDLMNLCWTYDVENRP 273

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 378 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 435 RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 475
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--- 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 594
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 595 PAGCPREMYDLMNLCWTYDVENRP 618

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 13  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 70  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 110
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 229
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 230 PAGCPREMYDLMNLCWTYDVENRP 253

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 76  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 235
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 236 PAGCPREMYDLMNLCWTYDVENRP 259

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 377 LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 434 RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 474
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--- 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 593
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 594 PAGCPREMYDLMNLCWTYDVENRP 617

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 92  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 132
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--- 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 251
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRP 275

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 92  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 132
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--- 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 251
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 252 PAGCPREMYDLMNLCWTYDVENRP 275

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FGTV +G Y    +   +     +  ++EA   +L+     E  V  +LD+P + 
Sbjct: 15  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + IG     S +                 +V+E    G L  YL +NR  K   K +I+L
Sbjct: 72  RMIGICEAESWM-----------------LVMEMAELGPLNKYLQQNRHVK--DKNIIEL 112
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
              ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T    
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R   
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 231
Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
           P  CP  + ++M  CW  + + RP
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRP 255

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 140/318 (44%), Gaps = 57/318 (17%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTV-------HRGIYDGQDVAVKLLDWGEESHRSEAEIAS 145
           +WE     L++      G FG V        +G      VAVK+L    + + S +E+  
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRD 72
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
           L + F     V  +++HP+V K  GA          + +G +        ++VEY   G+
Sbjct: 73  LLSEFN----VLKQVNHPHVIKLYGAC---------SQDGPL-------LLIVEYAKYGS 112
Query: 206 LKSYLIKNRR----------------------RKLAFKVVIQLALDLARGLSYLQSKKIV 243
           L+ +L ++R+                      R L    +I  A  +++G+ YL    +V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLV 172
Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRK 301
           HRD+   N+L+ + R +KI+DFG++R        +    G +   +MA E L    Y  +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 302 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+SFG+ LWEI      PYP +   E    +++   R E P  C   +  +M +CW  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQ 291
Query: 361 NPDKRPEMDEVVAMLEAI 378
            PDKRP   ++   LE +
Sbjct: 292 EPDKRPVFADISKDLEKM 309

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           EID + + I+     G FG V  G           VA+K L  G    +        R  
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--------RRD 61
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+    G       + I                + EY   G+L ++
Sbjct: 62  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMI----------------ITEYMENGSLDAF 105
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L KN  R    ++V  L   +  G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 106 LRKNDGRFTVIQLVGMLR-GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSR 164
Query: 270 LEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P   +   G    + + APE +    +    DV+S+GI +WE+    + PY D+S
Sbjct: 165 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 224
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V  A + +  R   P  CP +L  +M  CW      RP+  ++V ML+ +
Sbjct: 225 NQDVIKA-IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAV+++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVRIID------KTQLNSSSLQKLF-REVRIMKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 226 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 50/303 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
             +G FG+V    YD      G+ VAVK L    E H  +         F +E+ +   L
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSL 71
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G        N++              +++EY   G+L+ YL  +  R    
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLK--------------LIMEYLPYGSLRDYLQAHAERIDHI 117
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K+ +Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      
Sbjct: 118 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 280 ---GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTS--- 331
              GE+    Y APE L  S ++   DV+SFG+ L+E+  Y      P   F  +     
Sbjct: 177 KEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 235
Query: 332 ----------AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                      +++ N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I  +
Sbjct: 236 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 295
Query: 382 KGG 384
             G
Sbjct: 296 MAG 298

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           EID + + I+     G FG V  G           VA+K L  G    +        R  
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--------RRD 76
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+    G       + I                + EY   G+L ++
Sbjct: 77  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMI----------------ITEYMENGSLDAF 120
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L KN  R    ++V  L   +  G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 121 LRKNDGRFTVIQLVGMLR-GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 270 LEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P   +   G    + + APE +    +    DV+S+GI +WE+    + PY D+S
Sbjct: 180 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V  A + +  R   P  CP +L  +M  CW      RP+  ++V ML+ +
Sbjct: 240 NQDVIKA-IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAV+++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVRIID------KTQLNSSSLQKLF-REVRIMKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 113
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 226 LRGKYR--IPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VA+K++D      +++    SL+  F +EV +   
Sbjct: 21  KTIGKGNFAKVKLA---RHILTGREVAIKIID------KTQLNPTSLQKLF-REVRIMKI 70
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +++EY  GG +  YL+     K +
Sbjct: 71  LNHPNIVKLFEV--------IETEKT--------LYLIMEYASGGEVFDYLVAHGRMKEK 114
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K+IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 115 EARSKFRQIVS-------AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN-EFTV 166
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
              +    G   Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++KR    NP KR  +++++
Sbjct: 227 LRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           EID + + I+     G FG V  G           VA+K L  G    +        R  
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--------RRD 55
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+    G       + I                + EY   G+L ++
Sbjct: 56  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMI----------------ITEYMENGSLDAF 99
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L KN  R    ++V  L   +  G+ YL     VHRD+   N+L++     K++DFG++R
Sbjct: 100 LRKNDGRFTVIQLVGMLR-GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSR 158
Query: 270 LEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLS 325
           +   +P   +   G    + + APE +    +    DV+S+GI +WE+    + PY D+S
Sbjct: 159 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 218
Query: 326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +V  A + +  R   P  CP +L  +M  CW      RP+  ++V ML+ +
Sbjct: 219 NQDVIKA-IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 135/300 (45%), Gaps = 47/300 (15%)
Query: 95  EIDPAKLIIKGAFARGTFGTV---------HRGIYDGQDVAVKLLDWGEESHRSEAEIAS 145
           EID + + I+     G FG V          R I+    VA+K L  G    +       
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF----VAIKTLKSGYTEKQ------- 51
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E ++  + DHPNV    G    ++ +                 ++ E+   G+
Sbjct: 52  -RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----------------MIITEFMENGS 94
Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF 265
           L S+L +N  +    ++V  L   +A G+ YL     VHR +   N+L++     K++DF
Sbjct: 95  LDSFLRQNDGQFTVIQLVGMLR-GIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDF 153
Query: 266 GVARLEASNPHDMTGETGTLG------YMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-D 318
           G++R    +  D T  T  LG      + APE +    +    DV+S+GI +WE+    +
Sbjct: 154 GLSRFLEDDTSDPT-YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 212
Query: 319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            PY D++  +V +A + Q+ R   P  CPS+L  +M  CW  + + RP+  ++V  L+ +
Sbjct: 213 RPYWDMTNQDVINA-IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 82
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +  G  + T  + +                V E    G+L   L K++   L    + 
Sbjct: 83  LIRLYGVVL-TPPMKM----------------VTELAPLGSLLDRLRKHQGHFL-LGTLS 124
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE-- 281
           + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E  
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR 184
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRP 340
                + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  R 
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 341 EIPRCCPSSLANVMKRCWDANPDKRP 366
             P  CP  + NVM +CW   P+ RP
Sbjct: 245 PRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 63
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V E    G+L S+
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEXMENGSLDSF 107
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 108 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 164
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 225 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 283

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 132/278 (47%), Gaps = 42/278 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R I  G++VAVK++D      +++   +SL+  F +EV +   
Sbjct: 20  KTIGKGNFAKVKLA---RHILTGKEVAVKIID------KTQLNSSSLQKLF-REVRIXKV 69
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK-- 217
           L+HPN+ K            I+T+            +V EY  GG +  YL+ + R K  
Sbjct: 70  LNHPNIVKLFEV--------IETEKT--------LYLVXEYASGGEVFDYLVAHGRXKEK 113
Query: 218 ---LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
                F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 114 EARAKFRQIVS-------AVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSN-EFTF 165
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G   Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 166 GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +R   R  IP    +   N++K+    NP KR  ++++
Sbjct: 226 LRGKYR--IPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V E    G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEXMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 39/300 (13%)
Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAA 149
           E+D   + I      G FG V  G           VA+K L  G    +        R  
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--------RRD 92
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E ++  + DHPN+ +  G    +  + I                V E    G+L S+
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI----------------VTEXMENGSLDSF 136
Query: 210 LIKNRRRKLAFKVV--IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           L   R+    F V+  + +   +A G+ YL     VHRD+   N+L++     K++DFG+
Sbjct: 137 L---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPD 323
           +R+   +P   +   G    + + +PE +    +    DV+S+GI LWE+    + PY +
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           +S  +V  A V +  R   P  CP++L  +M  CW  + + RP+ +++V++L+ +  + G
Sbjct: 254 MSNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 72
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV-- 222
           + +  G  + T  + + T+   +G                   S L + R+ +  F +  
Sbjct: 73  LIRLYGVVL-TPPMKMVTELAPLG-------------------SLLDRLRKHQGHFLLGT 112
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE 281
           + + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 172
Query: 282 --TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
                  + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
           R   P  CP  + NVM +CW   P+ RP
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 101/325 (31%), Positives = 148/325 (45%), Gaps = 65/325 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 5   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 53
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 54  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 98
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 99  VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158
Query: 270 LEASNPHDMT--GETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 362 PDKRPEMDEVVAMLEAIDTSKGGGM 386
              R     +   L  +   +G  M
Sbjct: 279 GAARLTALRIKKTLSQLSQQEGIKM 303

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 82
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV-- 222
           + +  G  + T  + + T+   +G                   S L + R+ +  F +  
Sbjct: 83  LIRLYGVVL-TPPMKMVTELAPLG-------------------SLLDRLRKHQGHFLLGT 122
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE 281
           + + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 282 --TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
                  + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
           R   P  CP  + NVM +CW   P+ RP
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 135/278 (48%), Gaps = 38/278 (13%)
Query: 106 AFARGTFGTVHRGIY--DGQDV----AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
               G FGTV++GI+  +G+ V    A+K+L+   E+   +A +      F  E  +   
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN---ETTGPKANVE-----FMDEALIMAS 96
Query: 160 LDHPNVTKFIGATMG-TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
           +DHP++ + +G  +  T +L  Q       MP      ++EY H            +  +
Sbjct: 97  MDHPHLVRLLGVCLSPTIQLVTQL------MPHG---CLLEYVH----------EHKDNI 137
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             ++++   + +A+G+ YL+ +++VHRD+   N+L+     VKI DFG+ARL   +  + 
Sbjct: 138 GSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 197
Query: 279 TGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 335
             + G +   +MA E ++   +  + DV+S+G+ +WE+      PY  +   E+   + +
Sbjct: 198 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 257
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               P+ P  C   +  VM +CW  + D RP+  E+ A
Sbjct: 258 GERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAA 294

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 135/278 (48%), Gaps = 38/278 (13%)
Query: 106 AFARGTFGTVHRGIY--DGQDV----AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
               G FGTV++GI+  +G+ V    A+K+L+   E+   +A +      F  E  +   
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN---ETTGPKANVE-----FMDEALIMAS 73
Query: 160 LDHPNVTKFIGATMG-TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
           +DHP++ + +G  +  T +L  Q       MP      ++EY H            +  +
Sbjct: 74  MDHPHLVRLLGVCLSPTIQLVTQL------MPHG---CLLEYVH----------EHKDNI 114
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             ++++   + +A+G+ YL+ +++VHRD+   N+L+     VKI DFG+ARL   +  + 
Sbjct: 115 GSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 174
Query: 279 TGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 335
             + G +   +MA E ++   +  + DV+S+G+ +WE+      PY  +   E+   + +
Sbjct: 175 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 234
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               P+ P  C   +  VM +CW  + D RP+  E+ A
Sbjct: 235 GERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAA 271

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 76
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +  G  + T  + +                V E    G+L   L K++   L    + 
Sbjct: 77  LIRLYGVVL-TPPMKM----------------VTELAPLGSLLDRLRKHQGHFL-LGTLS 118
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE-- 281
           + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E  
Sbjct: 119 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRP 340
                + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  R 
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238
Query: 341 EIPRCCPSSLANVMKRCWDANPDKRP 366
             P  CP  + NVM +CW   P+ RP
Sbjct: 239 PRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 101/325 (31%), Positives = 148/325 (45%), Gaps = 65/325 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 8   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 56
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 57  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 101
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 102 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 161
Query: 270 LEASNPHDMT--GETGTLGYMAPEVLNGSAYN------RKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 162 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 221
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 222 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 281
Query: 362 PDKRPEMDEVVAMLEAIDTSKGGGM 386
              R     +   L  +   +G  M
Sbjct: 282 GAARLTALRIKKTLSQLSQQEGIKM 306

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 100/322 (31%), Positives = 147/322 (45%), Gaps = 65/322 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 6   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 54
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 55  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 99
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 100 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 159
Query: 270 LEASNPHDM--TGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 160 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 219
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 220 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 279
Query: 362 PDKRPEMDEVVAMLEAIDTSKG 383
              R     +   L  +   +G
Sbjct: 280 GAARLTALRIKKTLSQLSQQEG 301

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 3/156 (1%)
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGE 281
           +I  +  +ARG+ +L S+K +HRD+   N+LL +   VKI DFG+AR    NP +   G+
Sbjct: 201 LISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 282 TGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLR 339
           T   L +MAPE +    Y+ K DV+S+G+ LWEI+     PYP +   E   + +R+ +R
Sbjct: 261 TRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMR 320
Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
              P      +  +M  CW  +P +RP   E+V  L
Sbjct: 321 MRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 72
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV-- 222
           + +  G  + T  + + T+   +G                   S L + R+ +  F +  
Sbjct: 73  LIRLYGVVL-TPPMKMVTELAPLG-------------------SLLDRLRKHQGHFLLGT 112
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE 281
           + + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 282 --TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
                  + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
           R   P  CP  + NVM +CW   P+ RP
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 23  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 76
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV-- 222
           + +  G  + T  + + T+   +G                   S L + R+ +  F +  
Sbjct: 77  LIRLYGVVL-TPPMKMVTELAPLG-------------------SLLDRLRKHQGHFLLGT 116
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE 281
           + + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 282 --TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
                  + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 236
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
           R   P  CP  + NVM +CW   P+ RP
Sbjct: 237 RLPRPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 110 GTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           G+FG V RG +D        VAVK L   +    S+ E       F +EV   H LDH N
Sbjct: 19  GSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMD---DFIREVNAMHSLDHRN 72
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV-- 222
           + +  G  + T  + + T+   +G                   S L + R+ +  F +  
Sbjct: 73  LIRLYGVVL-TPPMKMVTELAPLG-------------------SLLDRLRKHQGHFLLGT 112
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGE 281
           + + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R L  ++ H +  E
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 282 --TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 338
                  + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRP 366
           R   P  CP  + NVM +CW   P+ RP
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 101/325 (31%), Positives = 148/325 (45%), Gaps = 65/325 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 11  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 59
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 60  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 104
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 105 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 164
Query: 270 LEASNPHDMT--GETGTLGYMAPEVLNGSAYN------RKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 165 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 224
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 225 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 284
Query: 362 PDKRPEMDEVVAMLEAIDTSKGGGM 386
              R     +   L  +   +G  M
Sbjct: 285 GAARLTALRIKKTLSQLSQQEGIKM 309

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 101/325 (31%), Positives = 148/325 (45%), Gaps = 65/325 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 44  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 92
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 93  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 137
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 270 LEASNPHDMT--GETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 362 PDKRPEMDEVVAMLEAIDTSKGGGM 386
              R     +   L  +   +G  M
Sbjct: 318 GAARLTALRIKKTLSQLSQQEGIKM 342

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 100/322 (31%), Positives = 147/322 (45%), Gaps = 65/322 (20%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           ++++ +  +G FG V RG + G++VAVK+    EE S   EAEI        Q V     
Sbjct: 31  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI-------YQTVM---- 79
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI A           DN   G  +    +V +Y   G+L  YL    R  + 
Sbjct: 80  LRHENILGFIAA-----------DNKDNGTWTQLW-LVSDYHEHGSLFDYL---NRYTVT 124
Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--R 269
            + +I+LAL  A GL++L  +         I HRD+K++N+L+ K  T  IAD G+A   
Sbjct: 125 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 184
Query: 270 LEASNPHDMT--GETGTLGYMAPEVLNGSAYN------RKCDVYSFGICLWEIY--CC-- 317
             A++  D+      GT  YMAPEVL+ S         ++ D+Y+ G+  WEI   C   
Sbjct: 185 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 244
Query: 318 ------DMPYPDL-----SFSEVTSAVVRQNLRPEIP---RCCPS--SLANVMKRCWDAN 361
                  +PY DL     S  E+   V  Q LRP IP   + C +   +A +M+ CW AN
Sbjct: 245 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 304
Query: 362 PDKRPEMDEVVAMLEAIDTSKG 383
              R     +   L  +   +G
Sbjct: 305 GAARLTALRIKKTLSQLSQQEG 326

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 80  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 121
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M++CW  + D RP+  E++
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 82
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 83  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 124
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 243
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M++CW  + D RP+  E++
Sbjct: 244 PPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 89
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 90  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 131
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 132 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 250
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M++CW  + D RP+  E++
Sbjct: 251 PPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 31/284 (10%)
Query: 92  QEWEIDPAKLIIK-GAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRA 148
           Q  + DP +L  K     +G+FG V +GI +     VA+K++D          E      
Sbjct: 14  QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--------EEAEDEIE 65
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              QE+ V  + D P VTK+ G+ +  ++L                 +++EY  GG+   
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKL----------------WIIMEYLGGGSALD 109
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
            L      +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA
Sbjct: 110 LLEPGPLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
                         GT  +MAPEV+  SAY+ K D++S GI   E+   + P+ +L   +
Sbjct: 167 GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           V   + + N  P +       L   ++ C +  P  RP   E++
Sbjct: 227 VLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
              G FG V    YD      G+ VAVK L    +       IA L+    +E+ +   L
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL----KPESGGNHIADLK----KEIEILRNL 80
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G         I T++G  G+      +++E+   G+LK YL KN+  K+  
Sbjct: 81  YHENIVKYKG---------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPKNKN-KINL 125
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K  ++ A+ + +G+ YL S++ VHRD+   N+L++    VKI DFG+ +   ++    T 
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 280 --GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSE------- 328
                  + + APE L  S +    DV+SFG+ L E+  YC     P   F +       
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
Query: 329 ---VTSAV--VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              VT  V  +++  R   P  CP  +  +M++CW+  P  R     ++   EA+
Sbjct: 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 132/284 (46%), Gaps = 31/284 (10%)
Query: 92  QEWEIDPAKLIIK-GAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRA 148
           Q   +DP +L  K     +G+FG V++GI  +  + VA+K++D          E      
Sbjct: 11  QHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDL--------EEAEDEIE 62
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              QE+ V  + D P +T++ G+ + +++L                 +++EY  GG+   
Sbjct: 63  DIQQEITVLSQCDSPYITRYFGSYLKSTKL----------------WIIMEYLGGGSALD 106
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
            L      +     +++   ++ +GL YL S++ +HRD+K  N+LL +   VK+ADFGVA
Sbjct: 107 LLKPGPLEETYIATILR---EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 163
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
                         GT  +MAPEV+  SAY+ K D++S GI   E+   + P  DL    
Sbjct: 164 GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 223
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           V   ++ +N  P +           ++ C + +P  RP   E++
Sbjct: 224 VL-FLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
              G FG V    YD      G+ VAVK L    +       IA L+    +E+ +   L
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL----KPESGGNHIADLK----KEIEILRNL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ K+ G         I T++G  G+      +++E+   G+LK YL KN+  K+  
Sbjct: 69  YHENIVKYKG---------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPKNKN-KINL 113
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT- 279
           K  ++ A+ + +G+ YL S++ VHRD+   N+L++    VKI DFG+ +   ++    T 
Sbjct: 114 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 280 --GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSE------- 328
                  + + APE L  S +    DV+SFG+ L E+  YC     P   F +       
Sbjct: 174 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 233
Query: 329 ---VTSAV--VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              VT  V  +++  R   P  CP  +  +M++CW+  P  R     ++   EA+
Sbjct: 234 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 96  IDPAKLIIK-GAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +DP +L  K     +G+FG V +GI +     VA+K++D          E         Q
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--------EEAEDEIEDIQQ 54
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E+ V  + D P VTK+ G+ +  ++L                 +++EY  GG+    L  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKL----------------WIIMEYLGGGSALDLLEP 98
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA    
Sbjct: 99  GPLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 155
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                     GT  +MAPEV+  SAY+ K D++S GI   E+   + P+ +L   +V   
Sbjct: 156 DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 215
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           + + N  P +       L   ++ C +  P  RP   E++
Sbjct: 216 IPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 96  IDPAKLIIK-GAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +DP +L  K     +G+FG V +GI +     VA+K++D          E         Q
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--------EEAEDEIEDIQQ 54
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E+ V  + D P VTK+ G+ +  ++L                 +++EY  GG+    L  
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKL----------------WIIMEYLGGGSALDLLEP 98
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA    
Sbjct: 99  GPLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 155
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                     GT  +MAPEV+  SAY+ K D++S GI   E+   + P+ +L   +V   
Sbjct: 156 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 215
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           + + N  P +       L   ++ C +  P  RP   E++
Sbjct: 216 IPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 135/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             + G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 86
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 87  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 127
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 128 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 248 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 31/280 (11%)
Query: 96  IDPAKLIIK-GAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +DP +L  K     +G+FG V +GI +     VA+K++D          E         Q
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL--------EEAEDEIEDIQQ 74
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E+ V  + D P VTK+ G+ +  ++L                 +++EY  GG+    L  
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKL----------------WIIMEYLGGGSALDLLEP 118
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
               +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA    
Sbjct: 119 GPLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 175
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                     GT  +MAPEV+  SAY+ K D++S GI   E+   + P+ +L   +V   
Sbjct: 176 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 235
Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           + + N  P +       L   ++ C +  P  RP   E++
Sbjct: 236 IPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 274

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 82
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 83  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 124
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 243
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 81
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 82  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G 
Sbjct: 123 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M++CW  + D RP+  E++
Sbjct: 243 -PPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             + G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 86
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 87  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 128
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 247
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 83
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 84  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 124
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 125 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 244
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 245 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             + G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 80  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 121
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 81
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 82  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 123 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 243 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 82
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 83  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 124
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 125 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 243
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 82
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 83  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 123
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 124 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 244 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 86
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 87  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 128
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 247
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 81
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 82  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 123
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 242
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 85
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 86  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 127
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 128 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 246
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 247 PPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 81
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 82  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 123
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G  
Sbjct: 124 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 242
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M++CW  + D RP+  E++
Sbjct: 243 PPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 80
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 81  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 121
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 122 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 241
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 242 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 80  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 120
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G 
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 241 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 141/309 (45%), Gaps = 54/309 (17%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           I+  + I +GAF R  F     G+   +    VAVK+L         E   A ++A F +
Sbjct: 49  IEYVRDIGEGAFGR-VFQARAPGLLPYEPFTMVAVKML--------KEEASADMQADFQR 99
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL-- 210
           E A+  + D+PN+ K +G                +G P    C++ EY   G L  +L  
Sbjct: 100 EAALMAEFDNPNIVKLLGVCA-------------VGKPM---CLLFEYMAYGDLNEFLRS 143
Query: 211 -------------IKNRRR-------KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
                        +  R R        L+    + +A  +A G++YL  +K VHRD+ T 
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 251 NMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFG 308
           N L+ +   VKIADFG++R + +++ +   G     + +M PE +  + Y  + DV+++G
Sbjct: 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263
Query: 309 ICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+   + PY  ++  EV   V   N+    P  CP  L N+M+ CW   P  RP 
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 368 MDEVVAMLE 376
              +  +L+
Sbjct: 323 FCSIHRILQ 331

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 80  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 121
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 130/270 (48%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 80
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + ++                   ++++    G L  Y ++  +  +  + ++ 
Sbjct: 81  CRLLGICLTST-----------------VQLIMQLMPFGXLLDY-VREHKDNIGSQYLLN 122
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 123 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 241
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 104
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 105 CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 146
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 147 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 265
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 73
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 74  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 115
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 234
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 131/270 (48%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP             G L  Y ++  +  +  + ++ 
Sbjct: 80  CRLLGICL-TSTVQLITQL----MPF------------GXLLDY-VREHKDNIGSQYLLN 121
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 34/242 (14%)
Query: 150 FTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           F  E+ V  KL  HPN+   +GA              H G    +  + +EY   G L  
Sbjct: 62  FAGELEVLCKLGHHPNIINLLGAC------------EHRG----YLYLAIEYAPHGNLLD 105
Query: 209 YLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           +L K+R                 L+ + ++  A D+ARG+ YL  K+ +HRD+   N+L+
Sbjct: 106 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 165
Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
            +    KIADFG++R +        G    + +MA E LN S Y    DV+S+G+ LWEI
Sbjct: 166 GENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224
Query: 315 YCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                 PY  ++ +E+    + Q  R E P  C   + ++M++CW   P +RP   +++ 
Sbjct: 225 VSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 283
Query: 374 ML 375
            L
Sbjct: 284 SL 285

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 34/242 (14%)
Query: 150 FTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           F  E+ V  KL  HPN+   +GA              H G    +  + +EY   G L  
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGAC------------EHRG----YLYLAIEYAPHGNLLD 115
Query: 209 YLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           +L K+R                 L+ + ++  A D+ARG+ YL  K+ +HRD+   N+L+
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
            +    KIADFG++R +        G    + +MA E LN S Y    DV+S+G+ LWEI
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
Query: 315 YCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                 PY  ++ +E+    + Q  R E P  C   + ++M++CW   P +RP   +++ 
Sbjct: 235 VSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 374 ML 375
            L
Sbjct: 294 SL 295

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 135/316 (42%), Gaps = 58/316 (18%)
Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE     L        G FG V      G         VAVK+L   E++  SE     
Sbjct: 39  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSE----- 91
Query: 146 LRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            R A   E+ +  +L  H N+   +GA          T +G I +       + EYC  G
Sbjct: 92  -REALMSELKMMTQLGSHENIVNLLGAC---------TLSGPIYL-------IFEYCCYG 134
Query: 205 ALKSYLIKNRRRK----------------------LAFKVVIQLALDLARGLSYLQSKKI 242
            L +YL +++R K                      L F+ ++  A  +A+G+ +L+ K  
Sbjct: 135 DLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193
Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNR 300
           VHRD+   N+L+   + VKI DFG+AR   S+ + +      L   +MAPE L    Y  
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 301 KCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD 359
           K DV+S+GI LWEI+   + PYP +        +++   + + P      +  +M+ CW 
Sbjct: 254 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 313
Query: 360 ANPDKRPEMDEVVAML 375
            +  KRP    + + L
Sbjct: 314 FDSRKRPSFPNLTSFL 329

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 50/302 (16%)
Query: 101 LIIKGAFARGTFGTVHRG-------IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V            D   VAVK L         +  +A+ R  F +E
Sbjct: 17  IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAA-RKDFQRE 67
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--- 210
             +   L H ++ KF G       L                 +V EY   G L  +L   
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPL----------------IMVFEYMKHGDLNKFLRAH 111
Query: 211 -----------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT 259
                       +  + +L    ++ +A  +A G+ YL S+  VHRD+ T N L+     
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 171
Query: 260 VKIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
           VKI DFG++R + +++ + + G T   + +M PE +    +  + DV+SFG+ LWEI+  
Sbjct: 172 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 318 -DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              P+  LS +EV   +  Q    E PR CP  + +VM  CW   P +R  + E+  +L 
Sbjct: 232 GKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 377 AI 378
           A+
Sbjct: 291 AL 292

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 76
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 77  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 118
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G  
Sbjct: 119 WCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 237
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 238 PPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 49/290 (16%)
Query: 112 FGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           FG V++G   G       Q VA+K L       + +AE   LR  F  E  +  +L HPN
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTL-------KDKAE-GPLREEFRHEAMLRARLQHPN 90
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI------------K 212
           V   +G       L++                +  YC  G L  +L+             
Sbjct: 91  VVCLLGVVTKDQPLSM----------------IFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 213 NRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR- 269
           +R  K A +    + L   +A G+ YL S  +VH+D+ T N+L+     VKI+D G+ R 
Sbjct: 135 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 270 LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 327
           + A++ + + G +   + +MAPE +    ++   D++S+G+ LWE++   + PY   S  
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
           +V   +  + + P  P  CP+ +  +M  CW+  P +RP   ++ + L A
Sbjct: 255 DVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 49/290 (16%)
Query: 112 FGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
           FG V++G   G       Q VA+K L       + +AE   LR  F  E  +  +L HPN
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTL-------KDKAE-GPLREEFRHEAMLRARLQHPN 73
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI------------K 212
           V   +G       L++                +  YC  G L  +L+             
Sbjct: 74  VVCLLGVVTKDQPLSM----------------IFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 213 NRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR- 269
           +R  K A +    + L   +A G+ YL S  +VH+D+ T N+L+     VKI+D G+ R 
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 270 LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 327
           + A++ + + G +   + +MAPE +    ++   D++S+G+ LWE++   + PY   S  
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
           +V   +  + + P  P  CP+ +  +M  CW+  P +RP   ++ + L A
Sbjct: 238 DVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHK 159
             +G FG+V    YD      G  VAVK L   G +  R           F +E+ +   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD----------FQREIQILKA 68
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L    + K+ G + G    +++              +V+EY   G L+ +L ++R R  A
Sbjct: 69  LHSDFIVKYRGVSYGPGRQSLR--------------LVMEYLPSGCLRDFLQRHRARLDA 114
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDM 278
            ++++  +  + +G+ YL S++ VHRD+   N+L++    VKIADFG+A+ L     + +
Sbjct: 115 SRLLL-YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 173
Query: 279 TGETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEV----- 329
             E G   + + APE L+ + ++R+ DV+SFG+ L+E+  YC     P   F  +     
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 233
Query: 330 -TSAVVRQNL------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
              A+ R         R   P  CP+ +  +MK CW  +P  RP    +   L+ + +  
Sbjct: 234 DVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 293
Query: 383 GG 384
            G
Sbjct: 294 RG 295

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 31/289 (10%)
Query: 97  DPAKLIIK-GAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           DP +L  K     +G+FG V +GI +   Q VA+K++D  E     E           QE
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI--------QQE 71
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           + V  + D   VTK+ G+ +  S+L                 +++EY  GG+    L   
Sbjct: 72  ITVLSQCDSSYVTKYYGSYLKGSKL----------------WIIMEYLGGGSALDLLRAG 115
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
              +     +++   ++ +GL YL S+K +HRD+K  N+LL +   VK+ADFGVA     
Sbjct: 116 PFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 172
Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                    GT  +MAPEV+  SAY+ K D++S GI   E+   + P  D+    V   +
Sbjct: 173 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 232
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
            + N  P +      S    +  C + +P  RP   E++     +  SK
Sbjct: 233 PKNN-PPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSK 280

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 133/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 81
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 82  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G 
Sbjct: 123 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 243 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHK 159
             +G FG+V    YD      G  VAVK L   G +  R           F +E+ +   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD----------FQREIQILKA 67
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L    + K+ G + G    +++              +V+EY   G L+ +L ++R R  A
Sbjct: 68  LHSDFIVKYRGVSYGPGRQSLR--------------LVMEYLPSGCLRDFLQRHRARLDA 113
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDM 278
            ++++  +  + +G+ YL S++ VHRD+   N+L++    VKIADFG+A+ L     + +
Sbjct: 114 SRLLL-YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 172
Query: 279 TGETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEV----- 329
             E G   + + APE L+ + ++R+ DV+SFG+ L+E+  YC     P   F  +     
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSER 232
Query: 330 -TSAVVRQNL------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
              A+ R         R   P  CP+ +  +MK CW  +P  RP    +   L+ + +  
Sbjct: 233 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 292
Query: 383 GG 384
            G
Sbjct: 293 RG 294

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 134/272 (49%), Gaps = 28/272 (10%)
Query: 106 AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G FGTV++G++  +G+ V + +          EA           E  V   +D+P
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPV----AIMELREATSPKANKEILDEAYVMASVDNP 111
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           +V + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + +
Sbjct: 112 HVCRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYL 153
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
           +   + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L  +   +   E G
Sbjct: 154 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 284 T--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRP 340
              + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 273
Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           + P  C   +  +M +CW  + D RP+  E++
Sbjct: 274 Q-PPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHK 159
             +G FG+V    YD      G  VAVK L   G +  R           F +E+ +   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD----------FQREIQILKA 80
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L    + K+ G + G    +++              +V+EY   G L+ +L ++R R  A
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLR--------------LVMEYLPSGCLRDFLQRHRARLDA 126
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDM 278
            ++++  +  + +G+ YL S++ VHRD+   N+L++    VKIADFG+A+ L     + +
Sbjct: 127 SRLLL-YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 279 TGETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEV----- 329
             E G   + + APE L+ + ++R+ DV+SFG+ L+E+  YC     P   F  +     
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 330 -TSAVVRQNL------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
              A+ R         R   P  CP+ +  +MK CW  +P  RP    +   L+ + +  
Sbjct: 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 383 GG 384
            G
Sbjct: 306 RG 307

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 86
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 87  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 128
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G  
Sbjct: 129 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 247
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 133/270 (49%), Gaps = 24/270 (8%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 79
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            + +G  + TS + + T      MP  F C++ +Y          ++  +  +  + ++ 
Sbjct: 80  CRLLGICL-TSTVQLITQL----MP--FGCLL-DY----------VREHKDNIGSQYLLN 121
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT- 284
             + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G  
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+ 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ- 240
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P  C   +  +M +CW  + D RP+  E++
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 133/271 (49%), Gaps = 26/271 (9%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
               G FGTV++G++  +   VK+    +E    EA           E  V   +D+P+V
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHV 83
Query: 166 TKFIGATM-GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
            + +G  +  T +L +Q       MP  F C++ +Y          ++  +  +  + ++
Sbjct: 84  CRLLGICLTSTVQLIMQL------MP--FGCLL-DY----------VREHKDNIGSQYLL 124
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG A+L  +   +   E G 
Sbjct: 125 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 285 --LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 341
             + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE++S + +    P+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 244
Query: 342 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P  C   +  +M +CW  + D RP+  E++
Sbjct: 245 -PPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
              G FG V    YD      G+ VAVK L         E     LR+ + +E+ +   L
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQREIEILRTL 67
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H ++ K+ G      E ++Q              +V+EY   G+L+ YL    R  +  
Sbjct: 68  YHEHIVKYKGCCEDQGEKSVQ--------------LVMEYVPLGSLRDYL---PRHCVGL 110
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMT 279
             ++  A  +  G++YL ++  +HR +   N+LLD  R VKI DFG+A+ +   + +   
Sbjct: 111 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 170
Query: 280 GETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVT----- 330
            E G   + + APE L    +    DV+SFG+ L+E+  YC     P   F+E+      
Sbjct: 171 REDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQG 230
Query: 331 -------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
                  + ++ +  R   P  CP  + ++MK CW+     RP    +V +L+ 
Sbjct: 231 QMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 284

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 99  AKLIIKGAFARGTFGTVHRG--IYDGQDVAVK---LLDWGEESHRSEAEIASLRAAFTQE 153
           A   I+    RG F  V+R   + DG  VA+K   + D  +         A  RA   +E
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD---------AKARADCIKE 82
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL--I 211
           + +  +L+HPNV K+  + +  +ELNI                V+E    G L   +   
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNI----------------VLELADAGDLSRMIKHF 126
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           K ++R +  + V +  + L   L ++ S++++HRD+K  N+ +  T  VK+ D G+ R  
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186
Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY--PDLSFSEV 329
           +S         GT  YM+PE ++ + YN K D++S G  L+E+     P+    ++   +
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
              + + +  P         L  ++  C + +P+KRP++  V
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
              G FG V    YD      G+ VAVK L         E     LR+ + +E+ +   L
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KEGCGPQLRSGWQREIEILRTL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H ++ K+ G      E ++Q              +V+EY   G+L+ YL    R  +  
Sbjct: 69  YHEHIVKYKGCCEDQGEKSVQ--------------LVMEYVPLGSLRDYL---PRHCVGL 111
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMT 279
             ++  A  +  G++YL ++  +HR +   N+LLD  R VKI DFG+A+ +   + +   
Sbjct: 112 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 171
Query: 280 GETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVT----- 330
            E G   + + APE L    +    DV+SFG+ L+E+  YC     P   F+E+      
Sbjct: 172 REDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQG 231
Query: 331 -------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
                  + ++ +  R   P  CP  + ++MK CW+     RP    +V +L+ 
Sbjct: 232 QMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 285

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 134/297 (45%), Gaps = 51/297 (17%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHK 159
             +G FG+V    YD      G  VAVK L   G +  R           F +E+ +   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD----------FQREIQILKA 64
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L    + K+ G + G     ++              +V+EY   G L+ +L ++R R  A
Sbjct: 65  LHSDFIVKYRGVSYGPGRPELR--------------LVMEYLPSGCLRDFLQRHRARLDA 110
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
            ++++  +  + +G+ YL S++ VHRD+   N+L++    VKIADFG+A+L   +     
Sbjct: 111 SRLLL-YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV 169
Query: 280 ----GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEV---- 329
               G++    Y APE L+ + ++R+ DV+SFG+ L+E+  YC     P   F  +    
Sbjct: 170 VREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 228
Query: 330 --TSAVVRQNL------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
               A+ R         R   P  CP+ +  +MK CW  +P  RP    +   L+ +
Sbjct: 229 RDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 52/297 (17%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLL--DWGEESHRSEAEIASLRAAFTQEVAVWH 158
              G FG V    YD      G+ VAVK L  D G +           R+ + QE+ +  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH----------RSGWKQEIDILR 71
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            L H ++ K+ G      E ++Q              +V+EY   G+L+ YL    R  +
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQ--------------LVMEYVPLGSLRDYL---PRHSI 114
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHD 277
               ++  A  +  G++YL S+  +HR++   N+LLD  R VKI DFG+A+ +   + + 
Sbjct: 115 GLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVT--- 330
              E G   + + APE L    +    DV+SFG+ L+E+  +C     P   F E+    
Sbjct: 175 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 234
Query: 331 ---------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                    + ++ +  R   P  CP  + ++MK CW+     RP  + ++ +L+ +
Sbjct: 235 QGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 34/242 (14%)
Query: 150 FTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           F  E+ V  KL  HPN+   +GA              H G    +  + +EY   G L  
Sbjct: 69  FAGELEVLCKLGHHPNIINLLGAC------------EHRG----YLYLAIEYAPHGNLLD 112
Query: 209 YLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           +L K+R                 L+ + ++  A D+ARG+ YL  K+ +HR++   N+L+
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILV 172
Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
            +    KIADFG++R +        G    + +MA E LN S Y    DV+S+G+ LWEI
Sbjct: 173 GENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231
Query: 315 YCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                 PY  ++ +E+    + Q  R E P  C   + ++M++CW   P +RP   +++ 
Sbjct: 232 VSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 290
Query: 374 ML 375
            L
Sbjct: 291 SL 292

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 136/291 (46%), Gaps = 40/291 (13%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           +LI  G F +  F   HR   DG+   ++ + +  E  ++E E+ +L            K
Sbjct: 18  ELIGSGGFGQ-VFKAKHR--IDGKTYVIRRVKYNNE--KAEREVKAL-----------AK 61
Query: 160 LDHPNVTKFIGATMG------TSELNIQT-----DNGHIGMPSNFCCVVV--EYCHGGAL 206
           LDH N+  + G   G      TS+ ++++     +N      S   C+ +  E+C  G L
Sbjct: 62  LDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           + ++ K R  KL   + ++L   + +G+ Y+ SKK++HRD+K  N+ L  T+ VKI DFG
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE-IYCCDMPYPDLS 325
           +      N    T   GTL YM+PE ++   Y ++ D+Y+ G+ L E ++ CD  +    
Sbjct: 182 LV-TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 240
Query: 326 -FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            F+++   +        I          ++++     P+ RP   E++  L
Sbjct: 241 FFTDLRDGI--------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 141/310 (45%), Gaps = 46/310 (14%)
Query: 106 AFARGTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
               G FGTVH+G++  +G+     V +K+++  ++S R   +      A T  +     
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQ------AVTDHMLAIGS 89
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           LDH ++ + +G   G+S                   +V +Y   G+L  + ++  R  L 
Sbjct: 90  LDHAHIVRLLGLCPGSS-----------------LQLVTQYLPLGSLLDH-VRQHRGALG 131
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDM 278
            ++++   + +A+G+ YL+   +VHR++   N+LL     V++ADFGVA  L   +   +
Sbjct: 132 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 279 TGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 336
             E  T + +MA E ++   Y  + DV+S+G+ +WE+      PY  L  +EV   ++ +
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LLEK 250
Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE----------AIDTSKGGGM 386
             R   P+ C   +  VM +CW  + + RP   E+                I    G G+
Sbjct: 251 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGI 310
Query: 387 IPVDQPQGCS 396
            P  +P G +
Sbjct: 311 APGPEPHGLT 320

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 141/310 (45%), Gaps = 46/310 (14%)
Query: 106 AFARGTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
               G FGTVH+G++  +G+     V +K+++  ++S R   +      A T  +     
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQ------AVTDHMLAIGS 71
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           LDH ++ + +G   G+S                   +V +Y   G+L  + ++  R  L 
Sbjct: 72  LDHAHIVRLLGLCPGSS-----------------LQLVTQYLPLGSLLDH-VRQHRGALG 113
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDM 278
            ++++   + +A+G+ YL+   +VHR++   N+LL     V++ADFGVA  L   +   +
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 279 TGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 336
             E  T + +MA E ++   Y  + DV+S+G+ +WE+      PY  L  +EV   ++ +
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LLEK 232
Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE----------AIDTSKGGGM 386
             R   P+ C   +  VM +CW  + + RP   E+                I    G G+
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGI 292
Query: 387 IPVDQPQGCS 396
            P  +P G +
Sbjct: 293 APGPEPHGLT 302

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 56/305 (18%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLL--DWGEESHRSEAEIASLRAAFTQEVAVWH 158
              G FG V    YD      G+ VAVK L  D G +           R+ + QE+ +  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH----------RSGWKQEIDILR 88
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            L H ++ K+ G        ++Q              +V+EY   G+L+ YL    R  +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQ--------------LVMEYVPLGSLRDYL---PRHSI 131
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
               ++  A  +  G++YL ++  +HRD+   N+LLD  R VKI DFG+A+      H+ 
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEX 190
Query: 279 T-----GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVT- 330
                 G++    Y APE L    +    DV+SFG+ L+E+  +C     P   F E+  
Sbjct: 191 YRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 331 -----------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID 379
                      + ++ +  R   P  CP+ + ++MK CW+     RP  + ++ +L+ + 
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
Query: 380 TSKGG 384
               G
Sbjct: 310 EKYQG 314

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 146/305 (47%), Gaps = 48/305 (15%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           QEW+I   +L I     +G FG V+ G + G +VA++L+D        E +      AF 
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLID-------IERDNEDQLKAFK 77
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +EV  + +  H NV  F+GA M    L                 ++   C G  L S ++
Sbjct: 78  REVMAYRQTRHENVVLFMGACMSPPHL----------------AIITSLCKGRTLYS-VV 120
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV---- 267
           ++ +  L      Q+A ++ +G+ YL +K I+H+D+K++N+  D  + V I DFG+    
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVV-ITDFGLFSIS 179
Query: 268 ARLEASNPHD-MTGETGTLGYMAPEVLNGSA---------YNRKCDVYSFGICLWEIYCC 317
             L+A    D +  + G L ++APE++   +         +++  DV++ G   +E++  
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 318 DMPYPDLSFSEVTSAVVRQ---NLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVA 373
           + P+     ++   A++ Q    ++P + +      +++++  CW    ++RP   +++ 
Sbjct: 240 EWPFK----TQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 374 MLEAI 378
           MLE +
Sbjct: 296 MLEKL 300

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 52/297 (17%)
Query: 107 FARGTFGTVHRGIYD------GQDVAVKLL--DWGEESHRSEAEIASLRAAFTQEVAVWH 158
              G FG V    YD      G+ VAVK L  D G +           R+ + QE+ +  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH----------RSGWKQEIDILR 71
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            L H ++ K+ G      E ++Q              +V+EY   G+L+ YL    R  +
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQ--------------LVMEYVPLGSLRDYL---PRHSI 114
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHD 277
               ++  A  +  G++YL ++  +HR++   N+LLD  R VKI DFG+A+ +   + + 
Sbjct: 115 GLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVT--- 330
              E G   + + APE L    +    DV+SFG+ L+E+  +C     P   F E+    
Sbjct: 175 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 234
Query: 331 ---------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                    + ++ +  R   P  CP  + ++MK CW+     RP  + ++ +L+ +
Sbjct: 235 QGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DG+ +  K LD+G     +EAE    +     EV +  +L HPN+ ++    +  +   +
Sbjct: 30  DGKILVWKELDYGS---MTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQ 238
                          +V+EYC GG L S + K    R+ L  + V+++   L   L    
Sbjct: 83  Y--------------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 239 SKK-----IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL 293
            +      ++HRD+K  N+ LD  + VK+ DFG+AR+   +        GT  YM+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 294 NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEIPRCCPSSLAN 352
           N  +YN K D++S G  L+E+ C  MP P  +FS+   A  +R+     IP      L  
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL-CALMP-PFTAFSQKELAGKIREGKFRRIPYRYSDELNE 246
Query: 353 VMKRCWDANPDKRPEMDEVV 372
           ++ R  +     RP ++E++
Sbjct: 247 IITRMLNLKDYHRPSVEEIL 266

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 29/278 (10%)
Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           LI  G F +  F   HR   DG+   +K + +  E  ++E E+ +L            KL
Sbjct: 18  LIGSGGFGQ-VFKAKHR--IDGKTYVIKRVKYNNE--KAEREVKAL-----------AKL 61
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVV-VEYCHGGALKSYLIKNRRRKLA 219
           DH N+  + G   G  + + +T + +       C  + +E+C  G L+ ++ K R  KL 
Sbjct: 62  DHVNIVHYNGCWDGF-DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
             + ++L   + +G+ Y+ SKK+++RD+K  N+ L  T+ VKI DFG+      N     
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRX 179
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE-IYCCDMPYPDLS-FSEVTSAVVRQN 337
              GTL YM+PE ++   Y ++ D+Y+ G+ L E ++ CD  +     F+++   +    
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI---- 235
Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
               I          ++++     P+ RP   E++  L
Sbjct: 236 ----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 49/301 (16%)
Query: 101 LIIKGAFARGTFGTVH----RGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ES R +         F +E
Sbjct: 43  IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---------FQRE 93
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             +   L H ++ +F G       L                 +V EY   G L  +L  +
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSH 137
Query: 214 -------------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
                            L    ++ +A  +A G+ YL     VHRD+ T N L+ +   V
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197
Query: 261 KIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC- 317
           KI DFG++R + +++ + + G T   + +M PE +    +  + DV+SFG+ LWEI+   
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             P+  LS +E    +  Q    E PR CP  +  +M+ CW   P +R  + +V A L+A
Sbjct: 258 KQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316
Query: 378 I 378
           +
Sbjct: 317 L 317

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DG+ +  K LD+G     +EAE    +     EV +  +L HPN+ ++    +  +   +
Sbjct: 30  DGKILVWKELDYGS---MTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQ 238
                          +V+EYC GG L S + K    R+ L  + V+++   L   L    
Sbjct: 83  Y--------------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 239 SKK-----IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL 293
            +      ++HRD+K  N+ LD  + VK+ DFG+AR+   +        GT  YM+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 294 NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEIPRCCPSSLAN 352
           N  +YN K D++S G  L+E+ C  MP P  +FS+   A  +R+     IP      L  
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL-CALMP-PFTAFSQKELAGKIREGKFRRIPYRYSDELNE 246
Query: 353 VMKRCWDANPDKRPEMDEVV 372
           ++ R  +     RP ++E++
Sbjct: 247 IITRMLNLKDYHRPSVEEIL 266

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 49/301 (16%)
Query: 101 LIIKGAFARGTFGTVH----RGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ES R +         F +E
Sbjct: 20  IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---------FQRE 70
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             +   L H ++ +F G       L                 +V EY   G L  +L  +
Sbjct: 71  AELLTMLQHQHIVRFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSH 114
Query: 214 -------------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
                            L    ++ +A  +A G+ YL     VHRD+ T N L+ +   V
Sbjct: 115 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 174
Query: 261 KIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC- 317
           KI DFG++R + +++ + + G T   + +M PE +    +  + DV+SFG+ LWEI+   
Sbjct: 175 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 234
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             P+  LS +E    +  Q    E PR CP  +  +M+ CW   P +R  + +V A L+A
Sbjct: 235 KQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 293
Query: 378 I 378
           +
Sbjct: 294 L 294

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 33/261 (12%)
Query: 121 DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI 180
           DG+ +  K LD+G     +EAE    +     EV +  +L HPN+ ++    +  +   +
Sbjct: 30  DGKILVWKELDYGS---MTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQ 238
                          +V+EYC GG L S + K    R+ L  + V+++   L   L    
Sbjct: 83  Y--------------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 239 SKK-----IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-TGTLGYMAPEV 292
            +      ++HRD+K  N+ LD  + VK+ DFG+AR+  ++  D   E  GT  YM+PE 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDEDFAKEFVGTPYYMSPEQ 187
Query: 293 LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEIPRCCPSSLA 351
           +N  +YN K D++S G  L+E+ C  MP P  +FS+   A  +R+     IP      L 
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYEL-CALMP-PFTAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 352 NVMKRCWDANPDKRPEMDEVV 372
            ++ R  +     RP ++E++
Sbjct: 246 EIITRMLNLKDYHRPSVEEIL 266

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 49/301 (16%)
Query: 101 LIIKGAFARGTFGTVH----RGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ES R +         F +E
Sbjct: 14  IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---------FQRE 64
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             +   L H ++ +F G       L                 +V EY   G L  +L  +
Sbjct: 65  AELLTMLQHQHIVRFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSH 108
Query: 214 -------------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
                            L    ++ +A  +A G+ YL     VHRD+ T N L+ +   V
Sbjct: 109 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 168
Query: 261 KIADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC- 317
           KI DFG++R + +++ + + G T   + +M PE +    +  + DV+SFG+ LWEI+   
Sbjct: 169 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 228
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             P+  LS +E    +  Q    E PR CP  +  +M+ CW   P +R  + +V A L+A
Sbjct: 229 KQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 287
Query: 378 I 378
           +
Sbjct: 288 L 288

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 124/274 (45%), Gaps = 37/274 (13%)
Query: 113 GTVHRGIYDGQDVAVKLL---DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G + +G + G D+ VK+L   DW     R           F +E        HPNV   +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRD----------FNEECPRLRIFSHPNVLPVL 73
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
           GA                  P+    ++  +   G+L + L +     +     ++ ALD
Sbjct: 74  GACQSP--------------PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 230 LARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           +ARG+++L + +  I    + + ++++D+  T +I+   V +    +P    G      +
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV-KFSFQSP----GRMYAPAW 174
Query: 288 MAPEVLNGSAYN---RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
           +APE L     +   R  D++SF + LWE+   ++P+ DLS  E+   V  + LRP IP 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                ++ +MK C + +P KRP+ D +V +LE +
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 36/281 (12%)
Query: 101 LIIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
            I K     G FG VH       G +  +K ++      RS+  +  + A    E+ V  
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIEA----EIEVLK 75
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI--KNRRR 216
            LDHPN+ K         E+     N +I         V+E C GG L   ++  + R +
Sbjct: 76  SLDHPNIIKIF-------EVFEDYHNMYI---------VMETCEGGELLERIVSAQARGK 119
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT---RTVKIADFGVARLEAS 273
            L+   V +L   +   L+Y  S+ +VH+D+K EN+L   T     +KI DFG+A L  S
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
           + H  T   GT  YMAPEV        KCD++S G+ ++ +    +P+   S  EV    
Sbjct: 180 DEHS-TNAAGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA 237
Query: 334 VRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             +  N   E     P ++ +++K+    +P++RP   +V+
Sbjct: 238 TYKEPNYAVECRPLTPQAV-DLLKQMLTKDPERRPSAAQVL 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 44/273 (16%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
              +GT+G V+ G      V + + +  E   R             +E+A+   L H N+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-------YSQPLHEEIALHKHLKHKNI 81
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL------IKNRRRKLA 219
            +++G+          ++NG       F  + +E   GG+L + L      +K+  + + 
Sbjct: 82  VQYLGSF---------SENG-------FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVA-RLEASNPHD 277
           F         +  GL YL   +IVHRD+K +N+L++  +  +KI+DFG + RL   NP  
Sbjct: 126 F-----YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 278 MTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
            T  TGTL YMAPE+++     Y +  D++S G  + E+     P+ +L   E  +A+ +
Sbjct: 181 ETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFK 237
Query: 336 QNL---RPEIPRCCPSSLANVMKRCWDANPDKR 365
             +    PEIP    +     + +C++ +PDKR
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 44/273 (16%)
Query: 106 AFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
              +GT+G V+ G      V + + +  E   R    +        +E+A+   L H N+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-------EEIALHKHLKHKNI 67
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL------IKNRRRKLA 219
            +++G+          ++NG       F  + +E   GG+L + L      +K+  + + 
Sbjct: 68  VQYLGSF---------SENG-------FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 111
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVA-RLEASNPHD 277
           F         +  GL YL   +IVHRD+K +N+L++  +  +KI+DFG + RL   NP  
Sbjct: 112 F-----YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 166
Query: 278 MTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
            T  TGTL YMAPE+++     Y +  D++S G  + E+     P+ +L   E  +A+ +
Sbjct: 167 ETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFK 223
Query: 336 QNL---RPEIPRCCPSSLANVMKRCWDANPDKR 365
             +    PEIP    +     + +C++ +PDKR
Sbjct: 224 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 256

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 3/161 (1%)
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVV 334
           +        L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E     +
Sbjct: 248 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 307
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           ++  R   P      +   M  CW   P +RP   E+V  L
Sbjct: 308 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 3/161 (1%)
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVV 334
           +        L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E     +
Sbjct: 255 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 314
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           ++  R   P      +   M  CW   P +RP   E+V  L
Sbjct: 315 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 3/161 (1%)
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVV 334
           +        L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E     +
Sbjct: 257 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 316
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           ++  R   P      +   M  CW   P +RP   E+V  L
Sbjct: 317 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 3/161 (1%)
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 278 MTGETG--TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVV 334
           +        L +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E     +
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
           ++  R   P      +   M  CW   P +RP   E+V  L
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 42/279 (15%)
Query: 100 KLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           K I KG FA+       R +  G++VAVK++D      +++    SL+  F +EV +   
Sbjct: 21  KTIGKGNFAKVKLA---RHVLTGREVAVKIID------KTQLNPTSLQKLF-REVRIMKI 70
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-----KNR 214
           L+HPN+ K            I+T+            +V+EY  GG +  YL+     K +
Sbjct: 71  LNHPNIVKLFEV--------IETEKT--------LYLVMEYASGGEVFDYLVAHGRMKEK 114
Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
             +  F+ ++         + Y   K IVHRD+K EN+LLD    +KIADFG +  E + 
Sbjct: 115 EARAKFRQIVS-------AVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSN-EFTV 166
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            + +    G+  Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V
Sbjct: 167 GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +R   R  IP    +   N++K+    NP KR  +++++
Sbjct: 227 LRGKYR--IPFYMSTDCENLLKKLLVLNPIKRGSLEQIM 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A      L                C V+EY +GG L  +L  +R R    +  
Sbjct: 71  FLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEERA 112
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 113 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 230
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 231 RTLSPEAKSLLAGLLKKDPKQR 252

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A      L                C V+EY +GG L  +L  +R R    +  
Sbjct: 66  FLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEERA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 225
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A      L                C V+EY +GG L  +L  +R R    +  
Sbjct: 66  FLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEERA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 225
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A      L                C V+EY +GG L  +L  +R R    +  
Sbjct: 66  FLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEERA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 225
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A         QT +          C V+EY +GG L  +L  +R R    +  
Sbjct: 69  FLTALKYA--------FQTHDR--------LCFVMEYANGGELFFHL--SRERVFTEERA 110
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 111 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 170
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 228
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 229 RTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A         QT +          C V+EY +GG L  +L  +R R    +  
Sbjct: 66  FLTALKYA--------FQTHDR--------LCFVMEYANGGELFFHL--SRERVFTEERA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 225
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT-QEVAVWHKLDHP 163
             +GTFG V   R    G+  A+K+L       R E  IA    A T  E  V     HP
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
            +T    A         QT +          C V+EY +GG L  +L  +R R    +  
Sbjct: 66  FLTALKYA--------FQTHDR--------LCFVMEYANGGELFFHL--SRERVFTEERA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    G
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ + +R   P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FP 225
Query: 344 RCCPSSLANVMKRCWDANPDKR 365
           R       +++      +P +R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 119/232 (51%), Gaps = 25/232 (10%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 49  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 92
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 93  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 150
Query: 264 DFGVARLEASNPHDMTGE-TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+        +M  E  GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 151 DFGVS---GQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRP 207
Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVVA 373
            ++  E+   +V +   P++P    S    + + +C   NP +R ++ +++ 
Sbjct: 208 PMAIFELLDYIVNEP-PPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 107 FARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
              G++G+V++ I+   GQ VA+K           +  + S      +E+++  + D P+
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIK-----------QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V K+ G+    ++L                 +V+EYC  G++ S +I+ R + L    + 
Sbjct: 86  VVKYYGSYFKNTDL----------------WIVMEYCGAGSV-SDIIRLRNKTLTEDEIA 128
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            +     +GL YL   + +HRD+K  N+LL+     K+ADFGVA              GT
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGT 188
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI-- 342
             +MAPEV+    YN   D++S GI   E+     PY D+        ++  N  P    
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTNPPPTFRK 247
Query: 343 PRCCPSSLANVMKRCWDANPDKR 365
           P     +  + +K+C   +P++R
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQR 270

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 103 IKGAFARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +     +G+F  V+R   I+ G +VA+K++D      +     A +      EV +  +L
Sbjct: 15  VGNLLGKGSFAGVYRAESIHTGLEVAIKMID------KKAMYKAGMVQRVQNEVKIHCQL 68
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++ +           N   D       SN+  +V+E CH G +  YL KNR +  + 
Sbjct: 69  KHPSILELY---------NYFED-------SNYVYLVLEMCHNGEMNRYL-KNRVKPFSE 111
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
                    +  G+ YL S  I+HRD+   N+LL +   +KIADFG+A  +   PH+   
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHY 170
Query: 281 ET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
              GT  Y++PE+   SA+  + DV+S G   + +     P+   +     + VV  +  
Sbjct: 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY- 229
Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            E+P        +++ +    NP  R  +  V+
Sbjct: 230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 17  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 73  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+  D     GTL 
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL--CGTLD 172
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 230
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 102 IIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           I+      GTFG V  G ++  G  VAVK+L+   +  RS   +  +R    +E+     
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIR----REIQNLKL 72
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
             HP++ K                   I  PS+   +V+EY  GG L  Y+ KN R  L 
Sbjct: 73  FRHPHIIKLYQV---------------ISTPSDIF-MVMEYVSGGELFDYICKNGR--LD 114
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
            K   +L   +  G+ Y     +VHRD+K EN+LLD     KIADFG++ +  S+   + 
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLR 173
Query: 280 GETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAVV 334
              G+  Y APEV++G  Y   + D++S G+ L+ + C  +P+ D      F ++   + 
Sbjct: 174 XSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233
Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                   P+    S+ +++K     +P KR  + ++
Sbjct: 234 YT------PQYLNPSVISLLKHMLQVDPMKRATIKDI 264

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FG V++G  +   VAVK L     +   +     L+  F QE+ V  K  H N+ 
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKL-----AAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + +G +    +L               C V V   +G  L      +    L++ +  ++
Sbjct: 94  ELLGFSSDGDDL---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--TGT 284
           A   A G+++L     +HRD+K+ N+LLD+  T KI+DFG+AR        +      GT
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGT 198
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             YMAPE L G     K D+YSFG+ L EI
Sbjct: 199 TAYMAPEALRGE-ITPKSDIYSFGVVLLEI 227

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              G FG V++G  +   VAVK L     +   +     L+  F QE+ V  K  H N+ 
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKL-----AAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + +G +    +L               C V V   +G  L      +    L++ +  ++
Sbjct: 94  ELLGFSSDGDDL---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--TGT 284
           A   A G+++L     +HRD+K+ N+LLD+  T KI+DFG+AR        +      GT
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGT 198
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             YMAPE L G     K D+YSFG+ L EI
Sbjct: 199 TAYMAPEALRGE-ITPKSDIYSFGVVLLEI 227

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 113 GTVHRGIYDGQDVAVKLL---DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G + +G + G D+ VK+L   DW     R           F +E        HPNV   +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRD----------FNEECPRLRIFSHPNVLPVL 73
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
           GA                  P+    ++  +   G+L + L +     +     ++ ALD
Sbjct: 74  GACQSP--------------PAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 230 LARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
            ARG ++L + +  I    + + ++ +D+  T +I+   V +    +P    G      +
Sbjct: 120 XARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADV-KFSFQSP----GRXYAPAW 174
Query: 288 MAPEVLNGSAYN---RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
           +APE L     +   R  D +SF + LWE+   ++P+ DLS  E+   V  + LRP IP 
Sbjct: 175 VAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPP 234
Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
                ++ + K C + +P KRP+ D +V +LE
Sbjct: 235 GISPHVSKLXKICXNEDPAKRPKFDXIVPILE 266

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 45/293 (15%)
Query: 104 KGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           K     G FG V++G+  DG  VA+K         R   E +     F  E+       H
Sbjct: 44  KFLIGHGVFGKVYKGVLRDGAKVALK---------RRTPESSQGIEEFETEIETLSFCRH 94
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAF 220
           P++   IG     +E+                 ++ +Y   G LK +L  +      +++
Sbjct: 95  PHLVSLIGFCDERNEM----------------ILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASNPHDM 278
           +  +++ +  ARGL YL ++ I+HRDVK+ N+LLD+    KI DFG+++   E    H  
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX 198
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC------DMPYPDLSFSE---- 328
               GTLGY+ PE         K DVYSFG+ L+E+ C        +P   ++ +E    
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 329 -----VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
                    +V  NL  +I         +   +C   + + RP M +V+  LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 45/293 (15%)
Query: 104 KGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           K     G FG V++G+  DG  VA+K         R   E +     F  E+       H
Sbjct: 44  KFLIGHGVFGKVYKGVLRDGAKVALK---------RRTPESSQGIEEFETEIETLSFCRH 94
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAF 220
           P++   IG     +E+                 ++ +Y   G LK +L  +      +++
Sbjct: 95  PHLVSLIGFCDERNEM----------------ILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR--LEASNPHDM 278
           +  +++ +  ARGL YL ++ I+HRDVK+ N+LLD+    KI DFG+++   E    H  
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX 198
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC------DMPYPDLSFSE---- 328
               GTLGY+ PE         K DVYSFG+ L+E+ C        +P   ++ +E    
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 329 -----VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
                    +V  NL  +I         +   +C   + + RP M +V+  LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G FG V++G  +   VAVK L     +   +     L+  F QE+ V  K  H N+ + +
Sbjct: 36  GGFGVVYKGYVNNTTVAVKKL-----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
           G +    +L               C V V   +G  L      +    L++ +  ++A  
Sbjct: 91  GFSSDGDDL---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG 135
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--TGTLGY 287
            A G+++L     +HRD+K+ N+LLD+  T KI+DFG+AR        +      GT  Y
Sbjct: 136 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAY 195
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEI 314
           MAPE L G     K D+YSFG+ L EI
Sbjct: 196 MAPEALRGEI-TPKSDIYSFGVVLLEI 221

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     +G FG V+  R       +A+K+L       +++ E A +     +EV +   L
Sbjct: 38  IGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHL 91
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +  G     + + +                ++EY   G +  Y    +  K   
Sbjct: 92  RHPNILRLYGYFHDATRVYL----------------ILEYAPLGTV--YRELQKLSKFDE 133
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +       +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+  D   
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL- 192
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R     
Sbjct: 193 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-- 249
Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             P        +++ R    NP +RP + EV+
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 17  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 73  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T  +GTL 
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS--RRTTLSGTLD 172
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 230
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     +G FG V+  R       +A+K+L       +++ E A +     +EV +   L
Sbjct: 38  IGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHL 91
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +  G     + + +                ++EY   G +  Y    +  K   
Sbjct: 92  RHPNILRLYGYFHDATRVYL----------------ILEYAPLGTV--YRELQKLSKFDE 133
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +       +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T 
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTT 191
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R     
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-- 249
Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             P        +++ R    NP +RP + EV+
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 47/299 (15%)
Query: 101 LIIKGAFARGTFGTVHRG----IYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           +++K     G FG V       +   QD   VAVK L    ++ R +         F +E
Sbjct: 15  IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD---------FHRE 65
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK- 212
             +   L H ++ KF G  +    L                 +V EY   G L  +L   
Sbjct: 66  AELLTNLQHEHIVKFYGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAH 109
Query: 213 ----------NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI 262
                     N   +L    ++ +A  +A G+ YL S+  VHRD+ T N L+ +   VKI
Sbjct: 110 GPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169
Query: 263 ADFGVAR-LEASNPHDMTGETGT-LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DM 319
            DFG++R + +++ + + G T   + +M PE +    +  + DV+S G+ LWEI+     
Sbjct: 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           P+  LS +EV   + +  +  + PR CP  +  +M  CW   P  R  +  +  +L+ +
Sbjct: 230 PWYQLSNNEVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 21  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 77  RLYGYFHDATRVYL----------------ILEYAPRGEVYKEL--QKLSKFDEQRTATY 118
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 176
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 234
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G FG V+  R       +A+K+L       +++ E A +     +EV +   L HPN
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +  G     + + +                ++EY   G +   L   +  K   +   
Sbjct: 87  ILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTA 128
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
               +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GT
Sbjct: 129 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGT 186
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 344
           L Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P 
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPD 244
Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVV 372
                  +++ R    NP +RP + EV+
Sbjct: 245 FVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 15  IGRPLGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L   +  K   + 
Sbjct: 71  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQR 112
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+  D     
Sbjct: 113 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C 170
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TF 228
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    NP +RP + EV+
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 21  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 77  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 176
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 234
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 21  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 77  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 176
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE + G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 234
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 235 TEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 20  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 76  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 117
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 175
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 233
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 234 TEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 12  IGRPLGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L   +  K   + 
Sbjct: 68  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQR 109
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   
Sbjct: 110 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLC 167
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TF 225
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    NP +RP + EV+
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 19  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 75  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 174
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 232
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 106 AFARGTFGTVHRGIY--DGQDV----AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
               G FGTV++GI+  DG++V    A+K+L     S ++  EI         E  V   
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEI-------LDEAYVMAG 75
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           +  P V++ +G  + ++                   +V +    G L  ++ +NR R L 
Sbjct: 76  VGSPYVSRLLGICLTST-----------------VQLVTQLMPYGCLLDHVRENRGR-LG 117
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
            + ++   + +A+G+SYL+  ++VHRD+   N+L+     VKI DFG+ARL   +  +  
Sbjct: 118 SQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 280 GETGT--LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 336
            + G   + +MA E +    +  + DV+S+G+ +WE+      PY  +   E+   + + 
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 237
Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
              P+ P  C   +  +M +CW  + + RP   E+V+
Sbjct: 238 ERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 12  IGRPLGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L   +  K   + 
Sbjct: 68  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQR 109
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   
Sbjct: 110 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLC 167
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TF 225
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    NP +RP + EV+
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 21  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 77  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLD 176
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 234
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 19  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 75  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 174
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 232
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 40/274 (14%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I G    G FG V++       V  A K++D      +SE E+      +  E+ +    
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELED----YMVEIDILASC 91
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKL 218
           DHPN+ K + A    + L                 +++E+C GGA+ + +++  R   + 
Sbjct: 92  DHPNIVKLLDAFYYENNL----------------WILIEFCAGGAVDAVMLELERPLTES 135
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             +VV +  LD    L+YL   KI+HRD+K  N+L      +K+ADFGV+          
Sbjct: 136 QIQVVCKQTLD---ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192
Query: 279 TGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
               GT  +MAPEV+         Y+ K DV+S GI L E+   + P+ +L+   V   +
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252
Query: 334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKR 365
            +    P +  P    S+  + +K+C + N D R
Sbjct: 253 AKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 17  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 73  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLD 172
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 230
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 12  IGRPLGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L   +  K   + 
Sbjct: 68  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQR 109
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   
Sbjct: 110 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTELC 167
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TF 225
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    NP +RP + EV+
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 11  IGRPLGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L   +  K   + 
Sbjct: 67  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQR 108
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   
Sbjct: 109 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLC 166
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TF 224
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    NP +RP + EV+
Sbjct: 225 PDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 125/267 (46%), Gaps = 30/267 (11%)
Query: 110 GTFG--TVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+FG   + +   DG+   +K ++    S +   E         +EVAV   + HPN+ +
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-------RREVAVLANMKHPNIVQ 87
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VVIQ 225
           +  +           +NG +        +V++YC GG L   +  N ++ + F+   ++ 
Sbjct: 88  YRESF---------EENGSL-------YIVMDYCEGGDLFKRI--NAQKGVLFQEDQILD 129
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
             + +   L ++  +KI+HRD+K++N+ L K  TV++ DFG+AR+  S         GT 
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
            Y++PE+     YN K D+++ G  L+E+      +   S   +   ++  +  P +   
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLH 248
Query: 346 CPSSLANVMKRCWDANPDKRPEMDEVV 372
               L +++ + +  NP  RP ++ ++
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 16  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 72  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTXLCGTLD 171
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 229
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 136/313 (43%), Gaps = 69/313 (22%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNV 165
            +G +G V RG + G++VAVK+      S R E        ++ +E  +++   L H N+
Sbjct: 17  GKGRYGEVWRGSWQGENVAVKIF-----SSRDEK-------SWFRETELYNTVMLRHENI 64
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             FI + M +   + Q              ++  Y   G+L  YL   +   L     ++
Sbjct: 65  LGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTLDTVSCLR 109
Query: 226 LALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           + L +A GL++L  +         I HRD+K++N+L+ K     IAD G+A + + + + 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 278 M----TGETGTLGYMAPEVLNGS-------AYNRKCDVYSFGICLWEIY----------- 315
           +        GT  YMAPEVL+ +       +Y R  D+++FG+ LWE+            
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVED 228
Query: 316 ----CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS-----SLANVMKRCWDANPDKRP 366
                 D+   D SF ++   V     RP IP    S     SLA +MK CW  NP  R 
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 367 EMDEVVAMLEAID 379
               +   L  ID
Sbjct: 289 TALRIKKTLTKID 301

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 136/313 (43%), Gaps = 69/313 (22%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNV 165
            +G +G V RG + G++VAVK+      S R E        ++ +E  +++   L H N+
Sbjct: 17  GKGRYGEVWRGSWQGENVAVKIF-----SSRDEK-------SWFRETELYNTVMLRHENI 64
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             FI + M +   + Q              ++  Y   G+L  YL   +   L     ++
Sbjct: 65  LGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTLDTVSCLR 109
Query: 226 LALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           + L +A GL++L  +         I HRD+K++N+L+ K     IAD G+A + + + + 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 278 M----TGETGTLGYMAPEVLNGS-------AYNRKCDVYSFGICLWEIY----------- 315
           +        GT  YMAPEVL+ +       +Y R  D+++FG+ LWE+            
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVED 228
Query: 316 ----CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS-----SLANVMKRCWDANPDKRP 366
                 D+   D SF ++   V     RP IP    S     SLA +MK CW  NP  R 
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 367 EMDEVVAMLEAID 379
               +   L  ID
Sbjct: 289 TALRIKKTLTKID 301

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 16  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 72  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLD 171
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 229
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 21  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 77  RLYGYFHDATRVYL----------------ILEYAPRGEVYKEL--QKLSKFDEQRTATY 118
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL--XGTLD 176
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 234
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 235 TEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 40/274 (14%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I G    G FG V++       V  A K++D      +SE E+      +  E+ +    
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELED----YMVEIDILASC 91
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKL 218
           DHPN+ K + A    + L                 +++E+C GGA+ + +++  R   + 
Sbjct: 92  DHPNIVKLLDAFYYENNL----------------WILIEFCAGGAVDAVMLELERPLTES 135
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             +VV +  LD    L+YL   KI+HRD+K  N+L      +K+ADFGV+          
Sbjct: 136 QIQVVCKQTLD---ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 279 TGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
               GT  +MAPEV+         Y+ K DV+S GI L E+   + P+ +L+   V   +
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252
Query: 334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKR 365
            +    P +  P    S+  + +K+C + N D R
Sbjct: 253 AKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G+FG V    +   GQ VA+K+++      +     + ++    +E++    L
Sbjct: 18  IVKTLGEGSFGKVKLAYHTTTGQKVALKIIN------KKVLAKSDMQGRIEREISYLRLL 71
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++ K         E+                 +V+EY  G  L  Y+++  R K++ 
Sbjct: 72  RHPHIIKLYDVIKSKDEI----------------IMVIEYA-GNELFDYIVQ--RDKMSE 112
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +   +    +   + Y    KIVHRD+K EN+LLD+   VKIADFG++ +  ++ + +  
Sbjct: 113 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKT 171
Query: 281 ETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLS----FSEVTSAVVR 335
             G+  Y APEV++G  Y   + DV+S G+ L+ + C  +P+ D S    F  +++ V  
Sbjct: 172 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY- 230
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                 +P+      A ++KR    NP  R  + E++
Sbjct: 231 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G+FG V    +   GQ VA+K+++      +     + ++    +E++    L
Sbjct: 8   IVKTLGEGSFGKVKLAYHTTTGQKVALKIIN------KKVLAKSDMQGRIEREISYLRLL 61
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++ K         E+                 +V+EY  G  L  Y+++  R K++ 
Sbjct: 62  RHPHIIKLYDVIKSKDEI----------------IMVIEYA-GNELFDYIVQ--RDKMSE 102
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +   +    +   + Y    KIVHRD+K EN+LLD+   VKIADFG++ +  ++ + +  
Sbjct: 103 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKT 161
Query: 281 ETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLS----FSEVTSAVVR 335
             G+  Y APEV++G  Y   + DV+S G+ L+ + C  +P+ D S    F  +++ V  
Sbjct: 162 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY- 220
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                 +P+      A ++KR    NP  R  + E++
Sbjct: 221 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G+FG V    +   GQ VA+K+++      +     + ++    +E++    L
Sbjct: 17  IVKTLGEGSFGKVKLAYHTTTGQKVALKIIN------KKVLAKSDMQGRIEREISYLRLL 70
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++ K         E+                 +V+EY  G  L  Y+++  R K++ 
Sbjct: 71  RHPHIIKLYDVIKSKDEI----------------IMVIEYA-GNELFDYIVQ--RDKMSE 111
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +   +    +   + Y    KIVHRD+K EN+LLD+   VKIADFG++ +  ++ + +  
Sbjct: 112 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKT 170
Query: 281 ETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLS----FSEVTSAVVR 335
             G+  Y APEV++G  Y   + DV+S G+ L+ + C  +P+ D S    F  +++ V  
Sbjct: 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY- 229
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                 +P+      A ++KR    NP  R  + E++
Sbjct: 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G+FG V    +   GQ VA+K+++      +     + ++    +E++    L
Sbjct: 12  IVKTLGEGSFGKVKLAYHTTTGQKVALKIIN------KKVLAKSDMQGRIEREISYLRLL 65
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++ K         E+                 +V+EY  G  L  Y+++  R K++ 
Sbjct: 66  RHPHIIKLYDVIKSKDEI----------------IMVIEYA-GNELFDYIVQ--RDKMSE 106
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +   +    +   + Y    KIVHRD+K EN+LLD+   VKIADFG++ +  ++ + +  
Sbjct: 107 QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKT 165
Query: 281 ETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLS----FSEVTSAVVR 335
             G+  Y APEV++G  Y   + DV+S G+ L+ + C  +P+ D S    F  +++ V  
Sbjct: 166 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY- 224
Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                 +P+      A ++KR    NP  R  + E++
Sbjct: 225 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 136/313 (43%), Gaps = 69/313 (22%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNV 165
            +G +G V RG + G++VAVK+      S R E        ++ +E  +++   L H N+
Sbjct: 46  GKGRYGEVWRGSWQGENVAVKIF-----SSRDEK-------SWFRETELYNTVMLRHENI 93
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             FI + M +   + Q              ++  Y   G+L  YL   +   L     ++
Sbjct: 94  LGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTLDTVSCLR 138
Query: 226 LALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           + L +A GL++L  +         I HRD+K++N+L+ K     IAD G+A + + + + 
Sbjct: 139 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 198
Query: 278 M----TGETGTLGYMAPEVLNGS-------AYNRKCDVYSFGICLWEIY----------- 315
           +        GT  YMAPEVL+ +       +Y R  D+++FG+ LWE+            
Sbjct: 199 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVED 257
Query: 316 ----CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS-----SLANVMKRCWDANPDKRP 366
                 D+   D SF ++   V     RP IP    S     SLA +MK CW  NP  R 
Sbjct: 258 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 317
Query: 367 EMDEVVAMLEAID 379
               +   L  ID
Sbjct: 318 TALRIKKTLTKID 330

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 123/274 (44%), Gaps = 40/274 (14%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I G    G FG V++       V  A K++D      +SE E+      +  E+ +    
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELED----YMVEIDILASC 91
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKL 218
           DHPN+ K + A    + L                 +++E+C GGA+ + +++  R   + 
Sbjct: 92  DHPNIVKLLDAFYYENNL----------------WILIEFCAGGAVDAVMLELERPLTES 135
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             +VV +  LD    L+YL   KI+HRD+K  N+L      +K+ADFGV+          
Sbjct: 136 QIQVVCKQTLD---ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 279 TGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
               GT  +MAPEV+         Y+ K DV+S GI L E+   + P+ +L+   V   +
Sbjct: 193 DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252
Query: 334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKR 365
            +    P +  P    S+  + +K+C + N D R
Sbjct: 253 AKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDAR 285

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 13  LGKGKFGNV----YLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 68
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 69  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 110
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 111 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLD 168
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 226
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 227 TEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 127/298 (42%), Gaps = 66/298 (22%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGE-ESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           ARG FG V +       VAVK+    + +S +SE EI S              + H N+ 
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPG-----------MKHENLL 72
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +FI A    S L ++              ++  +   G+L  YL  N    + +  +  +
Sbjct: 73  QFIAAEKRGSNLEVE------------LWLITAFHDKGSLTDYLKGN---IITWNELCHV 117
Query: 227 ALDLARGLSYLQSK-----------KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASN 274
           A  ++RGLSYL               I HRD K++N+LL    T  +ADFG+A R E   
Sbjct: 118 AETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK 177
Query: 275 -PHDMTGETGTLGYMAPEVLNGSA-YNR----KCDVYSFGICLWEIY----CCDMPYPDL 324
            P D  G+ GT  YMAPEVL G+  + R    + D+Y+ G+ LWE+       D P  + 
Sbjct: 178 PPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEY 237
Query: 325 ------------SFSEVTSAVVRQNLRPEI-----PRCCPSSLANVMKRCWDANPDKR 365
                       S  E+   VV + +RP I          + L   ++ CWD + + R
Sbjct: 238 MLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 104 KGAFARGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           K    RG FG V++G + DG  VAVK L   +E      E+      F  EV +     H
Sbjct: 43  KNILGRGGFGKVYKGRLADGTLVAVKRL---KEERXQGGELQ-----FQTEVEMISMAVH 94
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK--LAF 220
            N+ +  G  M  +E                  +V  Y   G++ S L +    +  L +
Sbjct: 95  RNLLRLRGFCMTPTE----------------RLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 221 KVVIQLALDLARGLSYLQSK---KIVHRDVKTENMLLDKTRTVKIADFGVARL-EASNPH 276
               ++AL  ARGL+YL      KI+HRDVK  N+LLD+     + DFG+A+L +  + H
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 198
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY--------------- 321
                 GT+G++APE L+    + K DV+ +G+ L E+      +               
Sbjct: 199 VXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 258
Query: 322 --PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
               L   +   A+V  +L+          L  V   C  ++P +RP+M EVV MLE 
Sbjct: 259 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 19  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 75  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLD 174
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 232
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 16  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 72  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLD 171
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 229
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 19  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 75  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL--CGTLD 174
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 232
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 18  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 74  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 115
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL--CGTLD 173
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 231
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 232 TEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 16  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 72  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL--CGTLD 171
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 229
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 18  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 74  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 115
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIA+FG +    S+    T   GTL 
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLD 173
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 231
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 232 TEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 16  LGKGKFGNV----YLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G    ++ + +                ++EY   G +   L   +  K   +     
Sbjct: 72  RLYGYFHDSTRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SKK++HRD+K EN+LL     +KIADFG +    S+        GTL 
Sbjct: 114 ITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRAALCGTLD 171
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ +    + R       P   
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF--TFPDFV 229
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 19  LGKGKFGNV----YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L   +  K   +     
Sbjct: 75  RLYGYFHDATRVYL----------------ILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIA+FG +    S+    T   GTL 
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLD 174
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFV 232
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    NP +RP + EV+
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 69/300 (23%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPN 164
             +G +G V  G + G+ VAVK+    EE            A++ +E  ++    + H N
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEE------------ASWFRETEIYQTVLMRHEN 92
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  FI A +  +    Q              ++ +Y   G+L  YL   +   L  K ++
Sbjct: 93  ILGFIAADIKGTGSWTQ------------LYLITDYHENGSLYDYL---KSTTLDAKSML 137
Query: 225 QLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVA--RLEASN 274
           +LA     GL +L ++         I HRD+K++N+L+ K  T  IAD G+A   +  +N
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 275 PHDMTGET--GTLGYMAPEVLNGSAYNRK-------CDVYSFGICLWEIY--CCD----- 318
             D+   T  GT  YM PEVL+ S  NR         D+YSFG+ LWE+   C       
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 319 ---MPYPDL-----SFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKR 365
              +PY DL     S+ ++   V  + LRP  P       C   +  +M  CW  NP  R
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 35/268 (13%)
Query: 106 AFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
              +G+FG V   +    GQ+ AVK++   +   +++ E      +  +EV +  +LDHP
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE------SLLREVQLLKQLDHP 110
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K               D G       +  +V E   GG L   +I   R++ +    
Sbjct: 111 NIMKL---------YEFFEDKG-------YFYLVGEVYTGGELFDEIIS--RKRFSEVDA 152
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVA-RLEASNPHDMT 279
            ++   +  G++Y+   KIVHRD+K EN+LL+   K   ++I DFG++   EAS    M 
Sbjct: 153 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 210
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +    
Sbjct: 211 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 269
Query: 340 PEIP--RCCPSSLANVMKRCWDANPDKR 365
            E+P  +    S  +++++     P  R
Sbjct: 270 FELPQWKKVSESAKDLIRKMLTYVPSMR 297

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 35/268 (13%)
Query: 106 AFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
              +G+FG V   +    GQ+ AVK++   +   +++ E      +  +EV +  +LDHP
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE------SLLREVQLLKQLDHP 109
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K               D G       +  +V E   GG L   +I   R++ +    
Sbjct: 110 NIMKL---------YEFFEDKG-------YFYLVGEVYTGGELFDEIIS--RKRFSEVDA 151
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVA-RLEASNPHDMT 279
            ++   +  G++Y+   KIVHRD+K EN+LL+   K   ++I DFG++   EAS    M 
Sbjct: 152 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 209
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +    
Sbjct: 210 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 268
Query: 340 PEIP--RCCPSSLANVMKRCWDANPDKR 365
            E+P  +    S  +++++     P  R
Sbjct: 269 FELPQWKKVSESAKDLIRKMLTYVPSMR 296

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 4/170 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
            V+EY +GG L  ++    +  L+       A ++  GL +L SK IV+RD+K +N+LLD
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           K   +KIADFG+ +             GT  Y+APE+L G  YN   D +SFG+ L+E+ 
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+      E+  ++   N  P  PR       +++ + +   P+KR
Sbjct: 213 IGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 260

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 4/170 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
            V+EY +GG L  ++    +  L+       A ++  GL +L SK IV+RD+K +N+LLD
Sbjct: 96  FVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHSKGIVYRDLKLDNILLD 153
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           K   +KIADFG+ +             GT  Y+APE+L G  YN   D +SFG+ L+E+ 
Sbjct: 154 KDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 213
Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+      E+  ++   N  P  PR       +++ + +   P+KR
Sbjct: 214 IGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 261

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 35/268 (13%)
Query: 106 AFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
              +G+FG V   +    GQ+ AVK++   +   +++ E      +  +EV +  +LDHP
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE------SLLREVQLLKQLDHP 86
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K               D G+         +V E   GG L   +I   R++ +    
Sbjct: 87  NIMKL---------YEFFEDKGYF-------YLVGEVYTGGELFDEIIS--RKRFSEVDA 128
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVA-RLEASNPHDMT 279
            ++   +  G++Y+   KIVHRD+K EN+LL+   K   ++I DFG++   EAS    M 
Sbjct: 129 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 186
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +    
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 340 PEIP--RCCPSSLANVMKRCWDANPDKR 365
            E+P  +    S  +++++     P  R
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMR 273

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 132/284 (46%), Gaps = 41/284 (14%)
Query: 95  EIDPAKLI-IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           ++DP ++  I G    G FG V++      G   A K+++      +SE E+      + 
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELED----YI 64
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E+ +    DHP + K +GA     +L                 +++E+C GGA+ + ++
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKL----------------WIMIEFCPGGAVDAIML 108
Query: 212 KNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           +  R   +   +VV +  L+    L++L SK+I+HRD+K  N+L+     +++ADFGV+ 
Sbjct: 109 ELDRGLTEPQIQVVCRQMLE---ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165
Query: 270 LEASNPHDMTGETGTLGYMAPEV-----LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
                        GT  +MAPEV     +  + Y+ K D++S GI L E+   + P+ +L
Sbjct: 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
Query: 325 SFSEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRP 366
           +   V   + + +  P +  P        + +K   D NP+ RP
Sbjct: 226 NPMRVLLKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRP 268

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G FG V++G  +   VAVK L     +   +     L+  F QE+ V  K  H N+ + +
Sbjct: 33  GGFGVVYKGYVNNTTVAVKKL-----AAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
           G +    +L               C V V   +G  L      +    L++    ++A  
Sbjct: 88  GFSSDGDDL---------------CLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQG 132
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--TGTLGY 287
            A G+++L     +HRD+K+ N+LLD+  T KI+DFG+AR        +      GT  Y
Sbjct: 133 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAY 192
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEI 314
            APE L G     K D+YSFG+ L EI
Sbjct: 193 XAPEALRGEI-TPKSDIYSFGVVLLEI 218

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 35/268 (13%)
Query: 106 AFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
              +G+FG V   +    GQ+ AVK++   +   +++ E      +  +EV +  +LDHP
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE------SLLREVQLLKQLDHP 92
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K               D G+         +V E   GG L   +I   R++ +    
Sbjct: 93  NIMKL---------YEFFEDKGYF-------YLVGEVYTGGELFDEIIS--RKRFSEVDA 134
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVA-RLEASNPHDMT 279
            ++   +  G++Y+   KIVHRD+K EN+LL+   K   ++I DFG++   EAS    M 
Sbjct: 135 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 192
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +    
Sbjct: 193 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 251
Query: 340 PEIP--RCCPSSLANVMKRCWDANPDKR 365
            E+P  +    S  +++++     P  R
Sbjct: 252 FELPQWKKVSESAKDLIRKMLTYVPSMR 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 95  EIDPAKLI-IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           ++DP ++  I G    G FG V++      G   A K+++      +SE E+      + 
Sbjct: 6   DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELED----YI 56
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E+ +    DHP + K +GA     +L                 +++E+C GGA+ + ++
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKL----------------WIMIEFCPGGAVDAIML 100
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           +   R L    +  +   +   L++L SK+I+HRD+K  N+L+     +++ADFGV+   
Sbjct: 101 E-LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 159
Query: 272 ASNPHDMTGETGTLGYMAPEV-----LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
                      GT  +MAPEV     +  + Y+ K D++S GI L E+   + P+ +L+ 
Sbjct: 160 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219
Query: 327 SEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRP 366
             V   + + +  P +  P        + +K   D NP+ RP
Sbjct: 220 MRVLLKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRP 260

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 33/251 (13%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ-EVAVWHKLDHPNVT 166
           G+FG VH  R  ++G+  A+K+L       + E  +   +   T  E  +   + HP + 
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G      ++                 ++++Y  GG L S L K++R      V    
Sbjct: 70  RMWGTFQDAQQI----------------FMIMDYIEGGELFSLLRKSQR--FPNPVAKFY 111
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A ++   L YL SK I++RD+K EN+LLDK   +KI DFG A+      + +    GT  
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL---CGTPD 168
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APEV++   YN+  D +SFGI ++E+     P+ D +  +    ++   LR   P   
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFF 226
Query: 347 PSSLANVMKRC 357
              + +++ R 
Sbjct: 227 NEDVKDLLSRL 237

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 31/265 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVT 166
           G    VH  R + D +DVAVK+L       R++ A   S    F +E      L+HP + 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSN-FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                           D G    P+     +V+EY  G  L+   I +    +  K  I+
Sbjct: 76  AVY-------------DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIE 120
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +  D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T     +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 286 G---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           G   Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPS 240
Query: 343 PR--CCPSSLANVMKRCWDANPDKR 365
            R     + L  V+ +    NP+ R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 5/173 (2%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENM 252
            C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN+
Sbjct: 226 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 283
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           +LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++
Sbjct: 284 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 343
Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+ C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 344 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 5/173 (2%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENM 252
            C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN+
Sbjct: 223 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           +LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340
Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+ C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 341 EMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 104 KGAFARGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           K    RG FG V++G + DG  VAVK L   +E      E+      F  EV +     H
Sbjct: 35  KNILGRGGFGKVYKGRLADGXLVAVKRL---KEERTQGGELQ-----FQTEVEMISMAVH 86
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK--LAF 220
            N+ +  G  M  +E                  +V  Y   G++ S L +    +  L +
Sbjct: 87  RNLLRLRGFCMTPTE----------------RLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 221 KVVIQLALDLARGLSYLQSK---KIVHRDVKTENMLLDKTRTVKIADFGVARL-EASNPH 276
               ++AL  ARGL+YL      KI+HRDVK  N+LLD+     + DFG+A+L +  + H
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 190
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY--------------- 321
                 G +G++APE L+    + K DV+ +G+ L E+      +               
Sbjct: 191 VXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 322 --PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
               L   +   A+V  +L+          L  V   C  ++P +RP+M EVV MLE 
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 31/265 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVT 166
           G    VH  R + D +DVAVK+L       R++ A   S    F +E      L+HP + 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSN-FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                           D G    P+     +V+EY  G  L+   I +    +  K  I+
Sbjct: 76  AVY-------------DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIE 120
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +  D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T     +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 286 G---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           G   Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240
Query: 343 PR--CCPSSLANVMKRCWDANPDKR 365
            R     + L  V+ +    NP+ R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 102 IIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           ++      GTFG V  G +   G  VAVK+L+      R +     +     +E+     
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKL 67
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKL 218
             HP++ K                   I  P++F  +V+EY  GG L  Y+ K+ R  ++
Sbjct: 68  FRHPHIIKLYQV---------------ISTPTDFF-MVMEYVSGGELFDYICKHGRVEEM 111
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             + + Q  L     + Y     +VHRD+K EN+LLD     KIADFG++ +  S+   +
Sbjct: 112 EARRLFQQILS---AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFL 167
Query: 279 TGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
               G+  Y APEV++G  Y   + D++S G+ L+ + C  +P+ D      F ++   V
Sbjct: 168 RDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                   IP     S+A ++      +P KR  + ++
Sbjct: 228 FY------IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 5/172 (2%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENML 253
           C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN++
Sbjct: 86  CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 143
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++E
Sbjct: 144 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 203
Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           + C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 204 MMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 40/278 (14%)
Query: 102 IIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           ++      GTFG V  G +   G  VAVK+L+      R +     +     +E+     
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKL 67
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKL 218
             HP++ K                   I  P++F  +V+EY  GG L  Y+ K+ R  ++
Sbjct: 68  FRHPHIIKLYQV---------------ISTPTDFF-MVMEYVSGGELFDYICKHGRVEEM 111
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             + + Q  L     + Y     +VHRD+K EN+LLD     KIADFG++ +  S+   +
Sbjct: 112 EARRLFQQILS---AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFL 167
Query: 279 TGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
               G+  Y APEV++G  Y   + D++S G+ L+ + C  +P+ D      F ++   V
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                   IP     S+A ++      +P KR  + ++
Sbjct: 228 FY------IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 10/176 (5%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  G  L  Y+       L+    I     +  G+ +    +IVHRD+K +N+L+D
Sbjct: 88  LVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             +T+KI DFG+A+  +      T    GT+ Y +PE   G A +   D+YS GI L+E+
Sbjct: 146 SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205
Query: 315 YCCDMPYP-----DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              + P+       ++   +  +V   N+  ++ +  P SL+NV+ R  + +   R
Sbjct: 206 LVGEPPFNGETAVSIAIKHIQDSV--PNVTTDVRKDIPQSLSNVILRATEKDKANR 259

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 5/172 (2%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENML 253
           C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN++
Sbjct: 85  CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 142
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++E
Sbjct: 143 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 202
Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           + C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 203 MMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 5/172 (2%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENML 253
           C V+EY +GG L  +L  +R R  +         ++   L YL S+K +V+RD+K EN++
Sbjct: 84  CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 141
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           LDK   +KI DFG+ +    +   M    GT  Y+APEVL  + Y R  D +  G+ ++E
Sbjct: 142 LDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 201
Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           + C  +P+ +    ++   ++ + +R   PR       +++      +P +R
Sbjct: 202 MMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 65/297 (21%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGE-ESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           ARG FG V +     + VAVK+    + +S ++E E+ SL             + H N+ 
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPG-----------MKHENIL 81
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +FIGA    + +++               ++  +   G+L  +L  N    +++  +  +
Sbjct: 82  QFIGAEKRGTSVDVD------------LWLITAFHEKGSLSDFLKAN---VVSWNELCHI 126
Query: 227 ALDLARGLSYLQSK----------KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEAS-N 274
           A  +ARGL+YL              I HRD+K++N+LL    T  IADFG+A + EA  +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 275 PHDMTGETGTLGYMAPEVLNGSA-YNR----KCDVYSFGICLWEI----YCCDMPYPDL- 324
             D  G+ GT  YMAPEVL G+  + R    + D+Y+ G+ LWE+       D P  +  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 325 -----------SFSEVTSAVVRQNLRPEI-----PRCCPSSLANVMKRCWDANPDKR 365
                      S  ++   VV +  RP +          + L   ++ CWD + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 31/265 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVT 166
           G    VH  R + D +DVAVK+L       R++ A   S    F +E      L+HP + 
Sbjct: 23  GGMSEVHLARDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSN-FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                           D G    P+     +V+EY  G  L+   I +    +  K  I+
Sbjct: 76  AVY-------------DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIE 120
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +  D  + L++     I+HRDVK  N+L+  T  VK+ DFG+AR  A + + +      +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 286 G---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           G   Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240
Query: 343 PR--CCPSSLANVMKRCWDANPDKR 365
            R     + L  V+ +    NP+ R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/321 (26%), Positives = 137/321 (42%), Gaps = 78/321 (24%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
           +D   L +     RG +G V++G  D + VAVK+  +              R  F  E  
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKN 57
Query: 156 VWHK--LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           ++    ++H N+ +FI   +G   +   T +G +        +V+EY   G+L  YL  +
Sbjct: 58  IYRVPLMEHDNIARFI---VGDERV---TADGRMEY-----LLVMEYYPNGSLXKYLSLH 106
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSK---------KIVHRDVKTENMLLDKTRTVKIAD 264
               ++     +LA  + RGL+YL ++          I HRD+ + N+L+    T  I+D
Sbjct: 107 TSDWVS---SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 265 FGVA------RLEASNPHD--MTGETGTLGYMAPEVLNGSAYNR-------KCDVYSFGI 309
           FG++      RL      D     E GT+ YMAPEVL G+   R       + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 310 CLWEIY--CCDMPYPDLS-----------------FSEVTSAVVRQNLRPEIPRC----- 345
             WEI+  C D+ +P  S                 F ++   V R+  RP+ P       
Sbjct: 224 IYWEIFMRCTDL-FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 346 -CPSSLANVMKRCWDANPDKR 365
               SL   ++ CWD + + R
Sbjct: 283 LAVRSLKETIEDCWDQDAEAR 303

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 135/315 (42%), Gaps = 74/315 (23%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +KGA  +G++G V   I +      A+K+++  +    +  ++  ++     EV +  KL
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT----EVRLMKKL 85
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL---------- 210
            HPN+ +            +  D  +I       C+V+E CHGG L   L          
Sbjct: 86  HHPNIARL---------YEVYEDEQYI-------CLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 211 ------------------------IKNRRRKLAF----KVVIQLALDLARGLSYLQSKKI 242
                                   I   R  L F    K++  +   +   L YL ++ I
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189
Query: 243 VHRDVKTENMLL--DKTRTVKIADFGVA----RLEASNPHDMTGETGTLGYMAPEVLNGS 296
            HRD+K EN L   +K+  +K+ DFG++    +L     + MT + GT  ++APEVLN +
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 297 --AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS----- 349
             +Y  KCD +S G+ L  +    +P+P ++ ++  S V+ + L  E P     S     
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD 309
Query: 350 -LANVMKRCWDANPD 363
            L+N++ R  D   D
Sbjct: 310 LLSNLLNRNVDERFD 324

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 126/293 (43%), Gaps = 59/293 (20%)
Query: 105 GAFARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--- 159
               +G FG V   R   D +  A+K +   EE   +      L A+   +  V +    
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK---NRRR 216
           L+  N  K + A    S L IQ                +EYC  G L   +     N++R
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQ----------------MEYCENGTLYDLIHSENLNQQR 115
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-------- 268
              +++  Q+       LSY+ S+ I+HRD+K  N+ +D++R VKI DFG+A        
Sbjct: 116 DEYWRLFRQIL----EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 269 --RLEASN----PHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPY 321
             +L++ N      ++T   GT  Y+A EVL+G+  YN K D+YS GI  +E     M Y
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-----MIY 226
Query: 322 PDLSFSEVTSAV-VRQNLRPEIPRCCPSSLANVMK-------RCWDANPDKRP 366
           P   FS     V + + LR       P    N MK          D +P+KRP
Sbjct: 227 P---FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 130/313 (41%), Gaps = 65/313 (20%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            +G +G V RG++ G+ VAVK+     E+S   E EI +              L H N+ 
Sbjct: 17  GKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL-----------LRHDNIL 65
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            FI + M +   + Q              ++  Y   G+L  +L   +R+ L   + ++L
Sbjct: 66  GFIASDMTSRNSSTQ------------LWLITHYHEHGSLYDFL---QRQTLEPHLALRL 110
Query: 227 ALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPH 276
           A+  A GL++L  +         I HRD K+ N+L+       IAD G+A +  + S+  
Sbjct: 111 AVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYL 170
Query: 277 DMTG--ETGTLGYMAPEVLNGSAYN------RKCDVYSFGICLWEIY------------- 315
           D+      GT  YMAPEVL+           +  D+++FG+ LWEI              
Sbjct: 171 DIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYR 230
Query: 316 --CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP-----SSLANVMKRCWDANPDKRPEM 368
               D+   D SF ++   V      P IP         S LA +M+ CW  NP  R   
Sbjct: 231 PPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTA 290
Query: 369 DEVVAMLEAIDTS 381
             +   L+ I  S
Sbjct: 291 LRIKKTLQKISNS 303

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 101 LIIKGAFA----------RGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRA 148
           L  +G FA          +G+FG V +       Q+ AVK+++     ++  + I     
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---- 69
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              +EV +  KLDHPN+ K                   I   S+   +V E   GG L  
Sbjct: 70  ---REVELLKKLDHPNIMKLF----------------EILEDSSSFYIVGELYTGGELFD 110
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT---VKIADF 265
            +IK  R++ +     ++   +  G++Y+    IVHRD+K EN+LL+       +KI DF
Sbjct: 111 EIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 266 GVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           G++     N   M    GT  Y+APEVL G+ Y+ KCDV+S G+ L+ +     P+
Sbjct: 169 GLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GLS+  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 53/284 (18%)
Query: 102 IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           II+     G+FG V    +    Q VA+K +       R   + + +     +E++    
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKL 65
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---- 215
           L HP++ K                   I  P++   +V+EY  GG L  Y+++ +R    
Sbjct: 66  LRHPHIIKLYDV---------------ITTPTDIV-MVIEYA-GGELFDYIVEKKRMTED 108
Query: 216 --RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
             R+   +++          + Y    KIVHRD+K EN+LLD    VKIADFG++ +  +
Sbjct: 109 EGRRFFQQIIC--------AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MT 159
Query: 274 NPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPY-----PDLSFS 327
           + + +    G+  Y APEV+NG  Y   + DV+S GI L+ +    +P+     P+L F 
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FK 218
Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +V S V        +P        ++++R   A+P +R  + E+
Sbjct: 219 KVNSCVYV------MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 26/270 (9%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           I     +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L H
Sbjct: 16  IGRPLGKGKFGNV----YLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+ +  G     + + +                ++EY   G +   L K  R     + 
Sbjct: 72  PNILRLYGYFHDATRVYL----------------ILEYAPLGTVYRELQKLSR--FDEQR 113
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
                 +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+  D     
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTL--C 171
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF--TF 229
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           P        +++ R    N  +R  + EV+
Sbjct: 230 PDFVTEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 126/268 (47%), Gaps = 35/268 (13%)
Query: 106 AFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
              +G+FG V   +    GQ+ AVK++   +   +++ E      +  +EV +  +LDHP
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE------SLLREVQLLKQLDHP 86
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K               D G+         +V E   GG L   +I   R++ +    
Sbjct: 87  NIXKL---------YEFFEDKGYF-------YLVGEVYTGGELFDEIIS--RKRFSEVDA 128
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVA-RLEASNPHDMT 279
            ++   +  G++Y    KIVHRD+K EN+LL+   K   ++I DFG++   EAS      
Sbjct: 129 ARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--XK 186
Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +    
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 340 PEIP--RCCPSSLANVMKRCWDANPDKR 365
            E+P  +    S  +++++     P  R
Sbjct: 246 FELPQWKKVSESAKDLIRKXLTYVPSXR 273

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 70
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 71  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 113
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 173
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 174 RAPEILLG------CKYYSTAVDIWSLGCI 197

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 35/242 (14%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 89
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 90  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY- 321
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P  
Sbjct: 148 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 322 ---------PDLSFSEVTSAVVRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEV 371
                    P ++  E+   +V +   P++P    S    + + +C   NP +R ++ ++
Sbjct: 205 PPDAKEDSRPPMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 263
Query: 372 VA 373
           + 
Sbjct: 264 MV 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK+++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 68  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 110
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 170
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 171 RAPEILLG------CKYYSTAVDIWSLGCI 194

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 73
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 74  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 116
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 177 RAPEILLG------CKYYSTAVDIWSLGCI 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 119/236 (50%), Gaps = 29/236 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 65  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 108
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 109 SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 166
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY- 321
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P  
Sbjct: 167 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223
Query: 322 ---PDLSFSEVTSAVVRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVVA 373
                ++  E+   +V +   P++P    S    + + +C   NP +R ++ +++ 
Sbjct: 224 SGSGSMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 21  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 73
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 74  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 116
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G  Y      YS  + +W + C 
Sbjct: 177 RAPEILLGXKY------YSTAVDIWSLGCI 200

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 101 LIIKGAFA----------RGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRA 148
           L  +G FA          +G+FG V +       Q+ AVK+++     ++  + I     
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---- 69
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              +EV +  KLDHPN+ K       +S   I                V E   GG L  
Sbjct: 70  ---REVELLKKLDHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFD 110
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADF 265
            +IK  R++ +     ++   +  G++Y+    IVHRD+K EN+LL   +K   +KI DF
Sbjct: 111 EIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 266 GVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           G++     N   M    GT  Y+APEVL G+ Y+ KCDV+S G+ L+ +     P+
Sbjct: 169 GLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G  Y      YS  + +W + C 
Sbjct: 170 RAPEILLGXKY------YSTAVDIWSLGCI 193

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 101 LIIKGAFA----------RGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRA 148
           L  +G FA          +G+FG V +       Q+ AVK+++     ++  + I     
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---- 69
Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              +EV +  KLDHPN+ K       +S   I                V E   GG L  
Sbjct: 70  ---REVELLKKLDHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFD 110
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADF 265
            +IK  R++ +     ++   +  G++Y+    IVHRD+K EN+LL   +K   +KI DF
Sbjct: 111 EIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 266 GVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           G++     N   M    GT  Y+APEVL G+ Y+ KCDV+S G+ L+ +     P+
Sbjct: 169 GLSTCFQQNTK-MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 31/265 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVT 166
           G    VH  R +   +DVAVK+L       R++ A   S    F +E      L+HP + 
Sbjct: 23  GGMSEVHLARDLRLHRDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSN-FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
                           D G    P+     +V+EY  G  L+   I +    +  K  I+
Sbjct: 76  AVY-------------DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIE 120
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +  D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T     +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 286 G---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           G   Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240
Query: 343 PR--CCPSSLANVMKRCWDANPDKR 365
            R     + L  V+ +    NP+ R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 69  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 111
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K EN+L++    +K+ADFG+AR           E  TL Y
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 172 RAPEILLG------CKYYSTAVDIWSLGCI 195

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 123 QDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           +DVAVK+L       R++ A   S    F +E      L+HP +                
Sbjct: 55  RDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIVAVY------------ 95
Query: 182 TDNGHIGMPSN-FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK 240
            D G    P+     +V+EY  G  L+   I +    +  K  I++  D  + L++    
Sbjct: 96  -DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQALNFSHQN 152
Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG---YMAPEVLNGSA 297
            I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T     +G   Y++PE   G +
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMK 355
            + + DVYS G  L+E+   + P+   S   V    VR++  P   R     + L  V+ 
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 272
Query: 356 RCWDANPDKR 365
           +    NP+ R
Sbjct: 273 KALAKNPENR 282

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LLD 
Sbjct: 131 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 257 TRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 189 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247
Query: 316 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+        PD +  +    V+ +  +  IPR      A+V+K   + +P +R
Sbjct: 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LLD 
Sbjct: 88  VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 257 TRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 146 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 316 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+        PD +  +    V+ +  +  IPR      A+V+K   + +P +R
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 68  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 110
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K EN+L++    +K+ADFG+AR           E  TL Y
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 171 RAPEILLG------CKYYSTAVDIWSLGCI 194

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 26/266 (9%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
             +G FG V    Y  ++   K +   +   +++ E A +     +EV +   L HPN+ 
Sbjct: 20  LGKGKFGNV----YLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G     + + +                ++EY   G +   L K  R     +     
Sbjct: 76  RLYGYFHDATRVYL----------------ILEYAPLGTVYRELQKLSR--FDEQRTATY 117
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +    S+    T   GTL 
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRTTLCGTLD 175
Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       P   
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF--TFPDFV 233
Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
                +++ R    N  +R  + EV+
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LLD 
Sbjct: 84  VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 141
Query: 257 TRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 142 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 200
Query: 316 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+        PD +  +    V+ +  +  IPR      A+V+K   + +P +R
Sbjct: 201 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K EN+L++    +K+ADFG+AR           E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           QE+A+  KLDHPNV K +       E+    +  H+ M       V E  + G +     
Sbjct: 85  QEIAILKKLDHPNVVKLV-------EVLDDPNEDHLYM-------VFELVNQGPVMEVPT 130
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
                +   +   Q   DL +G+ YL  +KI+HRD+K  N+L+ +   +KIADFGV+   
Sbjct: 131 LKPLSEDQARFYFQ---DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 272 ASNPHDMTGETGTLGYMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
             +   ++   GT  +MAPE L+ +      +  DV++ G+ L+       P+ D     
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 329 VTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           + S +  Q L  P+ P      L +++ R  D NP+ R  + E+
Sbjct: 248 LHSKIKSQALEFPDQPDIA-EDLKDLITRMLDKNPESRIVVPEI 290

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 107 FARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G  GTV+    +  GQ+VA++ ++  ++  +              E+ V  +  +PN
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMRENKNPN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  ++ + +   EL                 VV+EY  GG+L   + +    +     V 
Sbjct: 79  IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 342
             +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+ 
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 237
Query: 343 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P    +   + + RC D + +KR    E++
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LLD 
Sbjct: 99  VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 156
Query: 257 TRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              +K+ D+G+ + E   P D T    GT  Y+APE+L G  Y    D ++ G+ ++E+ 
Sbjct: 157 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 215
Query: 316 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+        PD +  +    V+ +  +  IPR      A+V+K   + +P +R
Sbjct: 216 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 107 FARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G  GTV+    +  GQ+VA++ ++  ++  +              E+ V  +  +PN
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMRENKNPN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  ++ + +   EL                 VV+EY  GG+L   + +    +     V 
Sbjct: 79  IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGT 179
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 342
             +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+ 
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 237
Query: 343 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P    +   + + RC D + +KR    E++
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK+++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 96/180 (53%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 56  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 99
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L + +R  +  +++ ++++ + RGL+YL+ K +I+HRDVK  N+L++    +K+ 
Sbjct: 100 SLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC 157
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +   G   T  YMAPE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 158 DFGVSGQLIDSMANSFVG---TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIP 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K     G FG V R I+   G+ VA+K         R E    + R  +  E+ +  KL
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIK-------QCRQELSPKN-RERWCLEIQIMKKL 69
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK--- 217
           +HPNV        G  +L           P++   + +EYC GG L+ YL  N+      
Sbjct: 70  NHPNVVSAREVPDGLQKL----------APNDLPLLAMEYCEGGDLRKYL--NQFENCCG 117
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD--KTRTV-KIADFGVARLEASN 274
           L    +  L  D++  L YL   +I+HRD+K EN++L     R + KI D G A+ E   
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQ 176
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
               T   GTL Y+APE+L    Y    D +SFG   +E      P+
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K     G FG V R I+   G+ VA+K         R E    + R  +  E+ +  KL
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIK-------QCRQELSPKN-RERWCLEIQIMKKL 70
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK--- 217
           +HPNV        G  +L           P++   + +EYC GG L+ YL  N+      
Sbjct: 71  NHPNVVSAREVPDGLQKL----------APNDLPLLAMEYCEGGDLRKYL--NQFENCCG 118
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD--KTRTV-KIADFGVARLEASN 274
           L    +  L  D++  L YL   +I+HRD+K EN++L     R + KI D G A+ E   
Sbjct: 119 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQ 177
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
               T   GTL Y+APE+L    Y    D +SFG   +E      P+
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 29/264 (10%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSE-AEIASLRAAFTQEVAVWHKLDHPNVT 166
           G    VH  R +   +DVAVK+L       R++ A   S    F +E      L+HP + 
Sbjct: 23  GGMSEVHLARDLRLHRDVAVKVL-------RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A   T E   +T  G +        +V+EY  G  L+   I +    +  K  I++
Sbjct: 76  ----AVYATGE--AETPAGPL------PYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEV 121
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T     +G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 287 ---YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
              Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P   
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241
Query: 344 R--CCPSSLANVMKRCWDANPDKR 365
           R     + L  V+ +    NP+ R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENR 265

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 28/270 (10%)
Query: 108 ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
            RG+F TV++G+     V V    W E   R   +  S R  F +E      L HPN+ +
Sbjct: 35  GRGSFKTVYKGLDTETTVEVA---WCELQDRKLTK--SERQRFKEEAEXLKGLQHPNIVR 89
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVV-EYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           F              D+    +    C V+V E    G LK+YL + +  K+  KV+   
Sbjct: 90  FY-------------DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI--KVLRSW 134
Query: 227 ALDLARGLSYLQSKK--IVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETG 283
              + +GL +L ++   I+HRD+K +N+ +   T +VKI D G+A L+ ++        G
Sbjct: 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV--IG 192
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-EI 342
           T  + APE      Y+   DVY+FG C  E    + PY +   +      V   ++P   
Sbjct: 193 TPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            +     +  +++ C   N D+R  + +++
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 69  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 111
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 172 RAPEILLG------CKYYSTAVDIWSLGCI 195

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 69  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 111
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 172 RAPEILLG------CKYYSTAVDIWSLGCI 195

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q W+     L   G   RG +G+V++ ++   GQ +AVK +       RS  +    +  
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-------RSTVDEKEQKQL 67
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
                 V    D P + +F GA     +  I              C+ +          Y
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWI--------------CMELMSTSFDKFYKY 113
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA 268
           +       +  +++ ++ L   + L++L+   KI+HRD+K  N+LLD++  +K+ DFG++
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPYPDL 324
             +  +    T + G   YMAPE ++ SA    Y+ + DV+S GI L+E+     PYP  
Sbjct: 174 G-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 325 S--FSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
           +  F ++T  V      L     R    S  N +  C   +  KRP+  E++
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 4/169 (2%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++ +  R K    V    A ++A GL +LQSK I++RD+K +N++LD 
Sbjct: 99  VMEYVNGGDLMYHIQQVGRFKEPHAVF--YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
              +KIADFG+ +    +        GT  Y+APE++    Y +  D ++FG+ L+E+  
Sbjct: 157 EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              P+      E+  +++  N+    P+        + K     +P KR
Sbjct: 217 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 125/293 (42%), Gaps = 59/293 (20%)
Query: 105 GAFARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--- 159
               +G FG V   R   D +  A+K +   EE   +      L A+   +  V +    
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK---NRRR 216
           L+  N  K + A    S L IQ                +EYC    L   +     N++R
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQ----------------MEYCENRTLYDLIHSENLNQQR 115
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-------- 268
              +++  Q+       LSY+ S+ I+HRD+K  N+ +D++R VKI DFG+A        
Sbjct: 116 DEYWRLFRQIL----EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 269 --RLEASN----PHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPY 321
             +L++ N      ++T   GT  Y+A EVL+G+  YN K D+YS GI  +E     M Y
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-----MIY 226
Query: 322 PDLSFSEVTSAV-VRQNLRPEIPRCCPSSLANVMK-------RCWDANPDKRP 366
           P   FS     V + + LR       P    N MK          D +P+KRP
Sbjct: 227 P---FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+  +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALXKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+  +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALXKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 129/297 (43%), Gaps = 46/297 (15%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             RG FG V   +   D  + A+K +           E+A  R    +EV    KL+HP 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRL------PNRELA--REKVMREVKALAKLEHPG 64
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL-----IKNRRRKLA 219
           + ++  A +  +     T+      P  +  + ++ C    LK ++     I+ R R + 
Sbjct: 65  IVRYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
             + +Q+A      + +L SK ++HRD+K  N+       VK+ DFG+      +  + T
Sbjct: 121 LHIFLQIA----EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 280 ------------GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP-DLSF 326
                       G+ GT  YM+PE ++G++Y+ K D++S G+ L+E+      YP     
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQM 231
Query: 327 SEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV--AMLEAID 379
             V +    +NL+  P   +  P     V +     +P +RPE   ++  A+ E +D
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMV-QDMLSPSPMERPEAINIIENAVFEDLD 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 18  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 70
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 71  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 113
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 173
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 174 RAPEILLG------CKYYSTAVDIWSLGCI 197

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 13  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 66  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 108
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 169 RAPEILLG------CKYYSTAVDIWSLGCI 192

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 4/170 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
            V+EY +GG L  ++ +  R K    V    A ++A GL +LQSK I++RD+K +N++LD
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVF--YAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
               +KIADFG+ +    +        GT  Y+APE++    Y +  D ++FG+ L+E+ 
Sbjct: 477 SEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
               P+      E+  +++  N+    P+        + K     +P KR
Sbjct: 537 AGQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 14  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 67  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 109
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 170 RAPEILLG------CKYYSTAVDIWSLGCI 193

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 68  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 110
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 171 RAPEILLG------CKYYSTAVDIWSLGCI 194

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+ H   LK ++  +    +   ++    
Sbjct: 68  LLDV--------IHTENK--------LYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYL 110
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 171 RAPEILLG------CKYYSTAVDIWSLGCI 194

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 107 FARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G  GTV+    +  GQ+VA++ ++  ++  +              E+ V  +  +PN
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMRENKNPN 79
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  ++ + +   EL                 VV+EY  GG+L   + +    +     V 
Sbjct: 80  IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 123
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT
Sbjct: 124 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 180
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 342
             +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+ 
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 238
Query: 343 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P    +   + + RC + + +KR    E++
Sbjct: 239 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 108 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 151
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 152 SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 209
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 210 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 266

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 33/257 (12%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G + A+K++       +S     S   A   EVAV  +LDHPN+ K              
Sbjct: 29  GAERAIKII------KKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE----------- 71
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                     N+  V+  Y  G      +++ +  ++   V+++  L    G +YL    
Sbjct: 72  ----FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLHKHN 124
Query: 242 IVHRDVKTENMLLD-KTR--TVKIADFGV-ARLEASNPHDMTGETGTLGYMAPEVLNGSA 297
           IVHRD+K EN+LL+ K+R   +KI DFG+ A  E      M    GT  Y+APEVL    
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIAPEVLR-KK 181
Query: 298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS--LANVMK 355
           Y+ KCDV+S G+ L+ + C   P+   +  E+   V +     + P     S     ++K
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 241
Query: 356 RCWDANPDKRPEMDEVV 372
                 P KR   +E +
Sbjct: 242 LMLTYEPSKRISAEEAL 258

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 116
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 117 SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 175 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 93/175 (53%), Gaps = 10/175 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFK---VVIQLALDLARGLSYLQSKKIVHRDVKTE 250
             +++++  GG L + L K    ++ F    V   LA +LA GL +L S  I++RD+K E
Sbjct: 105 LYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA-ELALGLDHLHSLGIIYRDLKPE 159
Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC 310
           N+LLD+   +K+ DFG+++    +        GT+ YMAPEV+N   ++   D +S+G+ 
Sbjct: 160 NILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVL 219
Query: 311 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           ++E+    +P+      E  + +++  L   +P+   +   ++++  +  NP  R
Sbjct: 220 MFEMLTGSLPFQGKDRKETMTLILKAKL--GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 107 FARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G  GTV+    +  GQ+VA++ ++  ++  +              E+ V  +  +PN
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMRENKNPN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  ++ + +   EL                 VV+EY  GG+L   + +    +     V 
Sbjct: 79  IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 179
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 342
             +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+ 
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 237
Query: 343 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P    +   + + RC + + +KR    E++
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 89
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 90  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 148 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 89
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 90  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 148 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 89
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 90  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 148 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 23/180 (12%)
Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
           ++R    +E+ V H+ + P +  F GA     E++I                 +E+  GG
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGG 89
Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIA 263
           +L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ 
Sbjct: 90  SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147
Query: 264 DFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
           DFGV+ +L  S  +      GT  YM+PE L G+ Y+ + D++S G+ L E+     P P
Sbjct: 148 DFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 97  DPAKLIIKGAFARGTFGTVH-----RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           DP++  +     +G+FG V       G    Q  A+K+L       R       +R    
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-----VRTKME 76
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +++ V  +++HP + K   A         QT+            +++++  GG L + L 
Sbjct: 77  RDILV--EVNHPFIVKLHYA--------FQTEGK--------LYLILDFLRGGDLFTRLS 118
Query: 212 KNRRRKLAFK---VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           K    ++ F    V   LA +LA  L +L S  I++RD+K EN+LLD+   +K+ DFG++
Sbjct: 119 K----EVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
           +    +        GT+ YMAPEV+N   + +  D +SFG+ ++E+    +P+      E
Sbjct: 174 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
             + +++  L   +P+       ++++  +  NP  R
Sbjct: 234 TMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 97  DPAKLIIKGAFARGTFGTVH-----RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           DP++  +     +G+FG V       G    Q  A+K+L       R       +R    
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-----VRTKME 76
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +++ V  +++HP + K   A         QT+            +++++  GG L + L 
Sbjct: 77  RDILV--EVNHPFIVKLHYA--------FQTEGK--------LYLILDFLRGGDLFTRLS 118
Query: 212 KNRRRKLAFK---VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           K    ++ F    V   LA +LA  L +L S  I++RD+K EN+LLD+   +K+ DFG++
Sbjct: 119 K----EVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
           +    +        GT+ YMAPEV+N   + +  D +SFG+ ++E+    +P+      E
Sbjct: 174 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
             + +++  L   +P+       ++++  +  NP  R
Sbjct: 234 TMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 113/257 (43%), Gaps = 33/257 (12%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G + A+K++       +S     S   A   EVAV  +LDHPN+ K              
Sbjct: 46  GAERAIKII------KKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL---------YEFF 90
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
            D        N+  V+  Y  G      +++ +  ++   V+++  L    G +YL    
Sbjct: 91  EDK------RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLHKHN 141
Query: 242 IVHRDVKTENMLLD-KTR--TVKIADFGV-ARLEASNPHDMTGETGTLGYMAPEVLNGSA 297
           IVHRD+K EN+LL+ K+R   +KI DFG+ A  E      M    GT  Y+APEVL    
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERLGTAYYIAPEVLR-KK 198
Query: 298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS--LANVMK 355
           Y+ KCDV+S G+ L+ + C   P+   +  E+   V +     + P     S     ++K
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 258
Query: 356 RCWDANPDKRPEMDEVV 372
                 P KR   +E +
Sbjct: 259 LMLTYEPSKRISAEEAL 275

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 97  DPAKLIIKGAFARGTFGTVH-----RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           DP++  +     +G+FG V       G    Q  A+K+L       R       +R    
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-----VRTKME 77
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +++ V  +++HP + K   A         QT+            +++++  GG L + L 
Sbjct: 78  RDILV--EVNHPFIVKLHYA--------FQTEGK--------LYLILDFLRGGDLFTRLS 119
Query: 212 KNRRRKLAFK---VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           K    ++ F    V   LA +LA  L +L S  I++RD+K EN+LLD+   +K+ DFG++
Sbjct: 120 K----EVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 174
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
           +    +        GT+ YMAPEV+N   + +  D +SFG+ ++E+    +P+      E
Sbjct: 175 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 234
Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
             + +++  L   +P+       ++++  +  NP  R
Sbjct: 235 TMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 269

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 36/230 (15%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
             +   E+AV HK+ HPN+             +I    GH+ +       +++   GG L
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALD---------DIYESGGHLYL-------IMQLVSGGEL 103
Query: 207 ------KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML---LDKT 257
                 K +  +    +L F+V+          + YL    IVHRD+K EN+L   LD+ 
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVL--------DAVKYLHDLGIVHRDLKPENLLYYSLDED 155
Query: 258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
             + I+DFG++++E      ++   GT GY+APEVL    Y++  D +S G+  + + C 
Sbjct: 156 SKIMISDFGLSKMEDPGSV-LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKR 365
             P+ D + +++   +++     + P       S  + ++   + +P+KR
Sbjct: 215 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL- 206
            +   E+AV HK+ HPN+             +I    GH+        ++++   GG L 
Sbjct: 61  GSMENEIAVLHKIKHPNIVALD---------DIYESGGHL-------YLIMQLVSGGELF 104
Query: 207 -----KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML---LDKTR 258
                K +  +    +L F+V+          + YL    IVHRD+K EN+L   LD+  
Sbjct: 105 DRIVEKGFYTERDASRLIFQVL--------DAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156
Query: 259 TVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            + I+DFG++++E  +P   ++   GT GY+APEVL    Y++  D +S G+  + + C 
Sbjct: 157 KIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKR 365
             P+ D + +++   +++     + P       S  + ++   + +P+KR
Sbjct: 215 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 99  AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
            + + KG FA+          Y+  D+  K +  G+   +S       +   + E+A+  
Sbjct: 31  GRFLGKGGFAK---------CYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHK 81
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            LD+P+V  F G          + D+        F  VV+E C   +L    +  RR+ +
Sbjct: 82  SLDNPHVVGFHGF--------FEDDD--------FVYVVLEICRRRSLLE--LHKRRKAV 123
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
                        +G+ YL + +++HRD+K  N+ L+    VKI DFG+A     +    
Sbjct: 124 TEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 183
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
               GT  Y+APEVL    ++ + D++S G  L+ +     P+      E T   +++N 
Sbjct: 184 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE-TYIRIKKN- 241
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGC 395
              +PR      + +++R   A+P  RP + E++      D     G  P+  P  C
Sbjct: 242 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT-----DEFFTSGYAPMRLPTSC 293

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 107 FARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G  GTV+    +  GQ+VA++ ++  ++  +              E+ V  +  +PN
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---------LIINEILVMRENKNPN 79
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +  ++ + +   EL                 VV+EY  GG+L   + +    +     V 
Sbjct: 80  IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 123
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +  L   + L +L S +++HR++K++N+LL    +VK+ DFG            +   GT
Sbjct: 124 RECL---QALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 342
             +MAPEV+   AY  K D++S GI   E+   + PY  L+ + + +  ++  N  PE+ 
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 238
Query: 343 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            P    +   + + RC + + +KR    E++
Sbjct: 239 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 143 IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
           I         E+++   LDHPN+ K                   +     +  +V E+  
Sbjct: 86  IEKFHEEIYNEISLLKSLDHPNIIKLFD----------------VFEDKKYFYLVTEFYE 129
Query: 203 GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--- 259
           GG L   +I   R K        +   +  G+ YL    IVHRD+K EN+LL+   +   
Sbjct: 130 GGELFEQII--NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 260 VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM 319
           +KI DFG++    S  + +    GT  Y+APEVL    YN KCDV+S G+ ++ + C   
Sbjct: 188 IKIVDFGLSSF-FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245
Query: 320 PY 321
           P+
Sbjct: 246 PF 247

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL- 206
            +   E+AV HK+ HPN+             +I    GH+ +       +++   GG L 
Sbjct: 61  GSMENEIAVLHKIKHPNIVALD---------DIYESGGHLYL-------IMQLVSGGELF 104
Query: 207 -----KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML---LDKTR 258
                K +  +    +L F+V+          + YL    IVHRD+K EN+L   LD+  
Sbjct: 105 DRIVEKGFYTERDASRLIFQVL--------DAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156
Query: 259 TVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            + I+DFG++++E  +P   ++   GT GY+APEVL    Y++  D +S G+  + + C 
Sbjct: 157 KIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKR 365
             P+ D + +++   +++     + P       S  + ++   + +P+KR
Sbjct: 215 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 99  AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
            + + KG FA+          Y+  D+  K +  G+   +S       +   + E+A+  
Sbjct: 47  GRFLGKGGFAK---------CYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHK 97
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            LD+P+V  F G          + D+        F  VV+E C   +L    +  RR+ +
Sbjct: 98  SLDNPHVVGFHGF--------FEDDD--------FVYVVLEICRRRSLLE--LHKRRKAV 139
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
                        +G+ YL + +++HRD+K  N+ L+    VKI DFG+A     +    
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
               GT  Y+APEVL    ++ + D++S G  L+ +     P+      E T   +++N 
Sbjct: 200 KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE-TYIRIKKN- 257
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGC 395
              +PR      + +++R   A+P  RP + E++      D     G  P+  P  C
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT-----DEFFTSGYAPMRLPTSC 309

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 99  AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
            + + KG FA+          Y+  D+  K +  G+   +S       +   + E+A+  
Sbjct: 47  GRFLGKGGFAK---------CYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHK 97
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            LD+P+V  F G          + D+        F  VV+E C   +L    +  RR+ +
Sbjct: 98  SLDNPHVVGFHGF--------FEDDD--------FVYVVLEICRRRSLLE--LHKRRKAV 139
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
                        +G+ YL + +++HRD+K  N+ L+    VKI DFG+A     +    
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
               GT  Y+APEVL    ++ + D++S G  L+ +     P+      E T   +++N 
Sbjct: 200 KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE-TYIRIKKN- 257
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGC 395
              +PR      + +++R   A+P  RP + E++      D     G  P+  P  C
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT-----DEFFTSGYAPMRLPTSC 309

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 99  AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
            + + KG FA+          Y+  D+  K +  G+   +S       +   + E+A+  
Sbjct: 47  GRFLGKGGFAK---------CYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHK 97
Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
            LD+P+V  F G          + D+        F  VV+E C   +L    +  RR+ +
Sbjct: 98  SLDNPHVVGFHGF--------FEDDD--------FVYVVLEICRRRSLLE--LHKRRKAV 139
Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
                        +G+ YL + +++HRD+K  N+ L+    VKI DFG+A     +    
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
               GT  Y+APEVL    ++ + D++S G  L+ +     P+      E T   +++N 
Sbjct: 200 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE-TYIRIKKN- 257
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGC 395
              +PR      + +++R   A+P  RP + E++      D     G  P+  P  C
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLT-----DEFFTSGYAPMRLPTSC 309

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+     LK ++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K EN+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL- 206
            +   E+AV HK+ HPN+             +I    GH+ +       +++   GG L 
Sbjct: 61  GSMENEIAVLHKIKHPNIVALD---------DIYESGGHLYL-------IMQLVSGGELF 104
Query: 207 -----KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML---LDKTR 258
                K +  +    +L F+V+          + YL    IVHRD+K EN+L   LD+  
Sbjct: 105 DRIVEKGFYTERDASRLIFQVL--------DAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156
Query: 259 TVKIADFGVARLEASNPHD-MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            + I+DFG++++E  +P   ++   GT GY+APEVL    Y++  D +S G+  + + C 
Sbjct: 157 KIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214
Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKR 365
             P+ D + +++   +++     + P       S  + ++   + +P+KR
Sbjct: 215 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 264

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              GT+ TV++G+     V V L +   +S       A       +E+++  +L H N+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENIV 66
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL----IKNRRRKLAFKV 222
           +            I T+N           +V E+     LK Y+    + N  R L   +
Sbjct: 67  RLYDV--------IHTENK--------LTLVFEFMDND-LKKYMDSRTVGNTPRGLELNL 109
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           V      L +GL++    KI+HRD+K +N+L++K   +K+ DFG+AR      +  + E 
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 283 GTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYP 322
            TL Y AP+VL GS  Y+   D++S G  L E+      +P
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 124/282 (43%), Gaps = 46/282 (16%)
Query: 97  DPAKLIIK-GAFARGTFGTVH--RGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQ 152
           DP KL         G+FG V+  R + + + VA+K + + G++S+    +I        +
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------IK 103
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV    KL HPN  ++ G  +                  +   +V+EYC G A  S L++
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLR----------------EHTAWLVMEYCLGSA--SDLLE 145
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             ++ L    +  +     +GL+YL S  ++HRDVK  N+LL +   VK+ DFG A + A
Sbjct: 146 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205
Query: 273 SNPHDMTGETGTLGYMAPEV---LNGSAYNRKCDVYSFGICLWEIYCCDMP--YPDLSFS 327
                     GT  +MAPEV   ++   Y+ K DV+S GI      C ++    P L   
Sbjct: 206 P----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT-----CIELAERKPPLFNM 256
Query: 328 EVTSAV--VRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRP 366
              SA+  + QN  P +     S    N +  C    P  RP
Sbjct: 257 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 15  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+     LK ++  +    +   ++    
Sbjct: 68  LLDV--------IHTENK--------LYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYL 110
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K EN+L++    +K+ADFG+AR           E  TL Y
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 171 RAPEILLG------CKYYSTAVDIWSLGCI 194

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 124/282 (43%), Gaps = 46/282 (16%)
Query: 97  DPAKLIIK-GAFARGTFGTVH--RGIYDGQDVAVKLLDW-GEESHRSEAEIASLRAAFTQ 152
           DP KL         G+FG V+  R + + + VA+K + + G++S+    +I        +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------IK 64
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV    KL HPN  ++ G  +                  +   +V+EYC G A  S L++
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLR----------------EHTAWLVMEYCLGSA--SDLLE 106
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             ++ L    +  +     +GL+YL S  ++HRDVK  N+LL +   VK+ DFG A + A
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 273 SNPHDMTGETGTLGYMAPEV---LNGSAYNRKCDVYSFGICLWEIYCCDMP--YPDLSFS 327
                     GT  +MAPEV   ++   Y+ K DV+S GI      C ++    P L   
Sbjct: 167 P----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT-----CIELAERKPPLFNM 217
Query: 328 EVTSAV--VRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRP 366
              SA+  + QN  P +     S    N +  C    P  RP
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 36/238 (15%)
Query: 97  DPAKLI-IKGAFARGTFGTVHRG--IYDGQDVAVKLLD-WGEESHRSEAEIASLRAAFTQ 152
           DPA +  +      GT+G V++G  +  GQ  A+K++D  G+E    + EI  L+     
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-- 78
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
                    H N+  + GA +  +           GM      +V+E+C  G++   +  
Sbjct: 79  --------HHRNIATYYGAFIKKNP---------PGMDDQLW-LVMEFCGAGSVTDLIKN 120
Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLE 271
            +   L  + +  +  ++ RGLS+L   K++HRD+K +N+LL +   VK+ DFGV A+L+
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 272 ASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIY-----CCDM 319
            +     T   GT  +MAPEV+       + Y+ K D++S GI   E+       CDM
Sbjct: 181 RTVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+     LK ++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     +G FG V+  R       VA+K+L       +S+ E   +     +E+ +   L
Sbjct: 27  IGRPLGKGKFGNVYLAREKKSHFIVALKVL------FKSQIEKEGVEHQLRREIEIQAHL 80
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +           N   D   I +       ++EY   G L     K  ++   F
Sbjct: 81  HHPNILRL---------YNYFYDRRRIYL-------ILEYAPRGEL----YKELQKSCTF 120
Query: 221 --KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             +    +  +LA  L Y   KK++HRD+K EN+LL     +KIADFG + + A +    
Sbjct: 121 DEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRK 179
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
           T   GTL Y+ PE++ G  +N K D++  G+  +E+   + P+   S +E    +V+ +L
Sbjct: 180 TM-CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL 238
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           +   P   P+   +++ +    NP +R  + +V A
Sbjct: 239 K--FPASVPTGAQDLISKLLRHNPSERLPLAQVSA 271

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 16  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+     LK ++  +    +   ++    
Sbjct: 69  LLDV--------IHTENK--------LYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYL 111
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 172 RAPEILLG------CKYYSTAVDIWSLGCI 195

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 104
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 105 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 223 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 275
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 276 IPARLPITC 284

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 102
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 103 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 160
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 221 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 273
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 274 IPARLPITC 282

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           GT+G V+  R    G+ VA+K +       R + E   + +   +E+++  +L+HPN+ K
Sbjct: 17  GTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +          I T+N           +V E+     LK ++  +    +   ++    
Sbjct: 70  LLDV--------IHTENK--------LYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYL 112
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
             L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR           E  TL Y
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
            APE+L G      C  YS  + +W + C 
Sbjct: 173 RAPEILLG------CKYYSTAVDIWSLGCI 196

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 104
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 105 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 162
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 163 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 223 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 275
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 276 IPARLPITC 284

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 65  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 108
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 109 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 166
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 167 LATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 226
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 227 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 279
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 280 IPARLPITC 288

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPN 164
           G +GTV+  R  + G  VA+K +               L  +  +EVA+  +L+   HPN
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +     TS  + +              +V E+     L++YL K     L  + + 
Sbjct: 76  VVRLMDVC-ATSRTDREIK----------VTLVFEHVDQD-LRTYLDKAPPPGLPAETIK 123
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            L     RGL +L +  IVHRD+K EN+L+    TVK+ADFG+AR+ +     +T    T
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVT 182
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           L Y APEVL  S Y    D++S G    E++
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 83  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 126
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 127 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 184
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 185 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 244
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 245 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 297
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 298 IPARLPITC 306

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 25/249 (10%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R   + E+++   L H +V  F G            DN       +F  VV+E C   +L
Sbjct: 85  REKMSMEISIHRSLAHQHVVGFHG---------FFEDN-------DFVFVVLELCRRRSL 128
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
               +  RR+ L           +  G  YL   +++HRD+K  N+ L++   VKI DFG
Sbjct: 129 LE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186
Query: 267 VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +A     +        GT  Y+APEVL+   ++ + DV+S G  ++ +     P+     
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246
Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
            E T   +++N    IP+      A+++++    +P  RP ++E++      D     G 
Sbjct: 247 KE-TYLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN-----DEFFTSGY 299
Query: 387 IPVDQPQGC 395
           IP   P  C
Sbjct: 300 IPARLPITC 308

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 23/193 (11%)
Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
            S  +   +EVAV   LDHPN+ K                        N+  V+  Y  G
Sbjct: 77  TSSNSKLLEEVAVLKLLDHPNIMKLYD---------------FFEDKRNYYLVMECYKGG 121
Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTV 260
                 + + +  ++   V+I+  L    G++YL    IVHRD+K EN+LL   +K   +
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP 320
           KI DFG++ +   N   M    GT  Y+APEVL    Y+ KCDV+S G+ L+ +     P
Sbjct: 179 KIVDFGLSAV-FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
Query: 321 YPDLSFSEVTSAV 333
           +   +  E+   V
Sbjct: 237 FGGQTDQEILRKV 249

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 45/286 (15%)
Query: 105 GAFARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--- 159
               +G FG V   R   D +  A+K +   EE   +      L A+   +  V +    
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK---NRRR 216
           L+  N  K   A    S L IQ                 EYC    L   +     N++R
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQX----------------EYCENRTLYDLIHSENLNQQR 115
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-------- 268
              +++  Q+       LSY+ S+ I+HR++K  N+ +D++R VKI DFG+A        
Sbjct: 116 DEYWRLFRQIL----EALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 269 --RLEASN----PHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWE-IYCCDMP 320
             +L++ N      ++T   GT  Y+A EVL+G+  YN K D YS GI  +E IY     
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTG 231
Query: 321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              ++  +   +V  +   P+           +++   D +P+KRP
Sbjct: 232 XERVNILKKLRSVSIE-FPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPN 164
           G +GTV+  R  + G  VA+K       S R       L  +  +EVA+  +L+   HPN
Sbjct: 15  GAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +     TS  + +              +V E+     L++YL K     L  + + 
Sbjct: 68  VVRLMDVC-ATSRTDREIK----------VTLVFEHVDQD-LRTYLDKAPPPGLPAETIK 115
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            L     RGL +L +  IVHRD+K EN+L+    TVK+ADFG+AR+ +     +     T
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALAPVVVT 174
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           L Y APEVL  S Y    D++S G    E++
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPN 164
           G +GTV+  R  + G  VA+K       S R       L  +  +EVA+  +L+   HPN
Sbjct: 15  GAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +     TS  + +              +V E+     L++YL K     L  + + 
Sbjct: 68  VVRLMDVC-ATSRTDREIK----------VTLVFEHVDQD-LRTYLDKAPPPGLPAETIK 115
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            L     RGL +L +  IVHRD+K EN+L+    TVK+ADFG+AR+  S    +     T
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI-YSYQMALDPVVVT 174
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           L Y APEVL  S Y    D++S G    E++
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 28/202 (13%)
Query: 120 YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN 179
           + G+ VAVK +D  ++  R              EV +     H NV     + +   EL 
Sbjct: 68  HTGKQVAVKKMDLRKQQRRE---------LLFNEVVIMRDYHHDNVVDMYSSYLVGDEL- 117
Query: 180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS 239
                           VV+E+  GGAL   +   R  +   + +  + L + R LSYL +
Sbjct: 118 ---------------WVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHN 159
Query: 240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN 299
           + ++HRD+K++++LL     +K++DFG     +          GT  +MAPEV++   Y 
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 300 RKCDVYSFGICLWEIYCCDMPY 321
            + D++S GI + E+   + PY
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPY 241

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPN 164
           G +GTV+  R  + G  VA+K       S R       L  +  +EVA+  +L+   HPN
Sbjct: 15  GAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +     TS  + +              +V E+     L++YL K     L  + + 
Sbjct: 68  VVRLMDVC-ATSRTDREIK----------VTLVFEHVDQD-LRTYLDKAPPPGLPAETIK 115
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
            L     RGL +L +  IVHRD+K EN+L+    TVK+ADFG+AR+ +     +     T
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALFPVVVT 174
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           L Y APEVL  S Y    D++S G    E++
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +VV+   GG L+ +L +N   K   + V     +L   L YLQ+++I+HRD+K +N+LLD
Sbjct: 92  MVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD 149
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLW 312
           +   V I DF +A +       +T   GT  YMAPE+ +   G+ Y+   D +S G+  +
Sbjct: 150 EHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 313 EIYCCDMPYPDLSFSEVTSAV-VRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     PY   S +     V   +      P      + +++K+  + NPD+R
Sbjct: 209 ELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 110 GTFGTVHRGI-YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF 168
           GT+G V++     G+ VA+K +       R +AE   + +   +E+++  +L HPN+   
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL 228
           I                   + S  C  +V       LK  L +N+      ++ I L  
Sbjct: 85  IDV-----------------IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-Y 126
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYM 288
            L RG+++    +I+HRD+K +N+L++    +K+ADFG+AR         T E  TL Y 
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 289 APEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLS 325
           AP+VL GS  Y+   D++S G    E+      +P ++
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+ G V   R  + G+ VAVK++D  ++  R              EV +     H NV +
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE---------LLFNEVVIMRDYQHFNVVE 106
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
              + +   EL                 V++E+  GGAL   + + R  +     V +  
Sbjct: 107 MYKSYLVGEEL----------------WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAV 150
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           L   + L+YL ++ ++HRD+K++++LL     VK++DFG     + +        GT  +
Sbjct: 151 L---QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYW 207
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 347
           MAPEV++ S Y  + D++S GI + E+   + PY    FS+ +     + LR   P    
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY----FSD-SPVQAMKRLRDSPPPKLK 262
Query: 348 SS------LANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQ 391
           +S      L + ++R    +P +R    E++     + T     ++P+ Q
Sbjct: 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQ 312

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 110 GTFGTVHRGI-YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF 168
           GT+G V++     G+ VA+K +       R +AE   + +   +E+++  +L HPN+   
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL 228
           I                   + S  C  +V       LK  L +N+      ++ I L  
Sbjct: 85  IDV-----------------IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-Y 126
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYM 288
            L RG+++    +I+HRD+K +N+L++    +K+ADFG+AR         T E  TL Y 
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 289 APEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLS 325
           AP+VL GS  Y+   D++S G    E+      +P ++
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 2/129 (1%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C+V+   +GG ++ ++         F+    I     +  GL +L  + I++RD+K EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           LLD    V+I+D G+A    +      G  GT G+MAPE+L G  Y+   D ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 313 EIYCCDMPY 321
           E+     P+
Sbjct: 381 EMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 2/129 (1%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C+V+   +GG ++ ++         F+    I     +  GL +L  + I++RD+K EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           LLD    V+I+D G+A    +      G  GT G+MAPE+L G  Y+   D ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 313 EIYCCDMPY 321
           E+     P+
Sbjct: 381 EMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 2/129 (1%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C+V+   +GG ++ ++         F+    I     +  GL +L  + I++RD+K EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           LLD    V+I+D G+A    +      G  GT G+MAPE+L G  Y+   D ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 313 EIYCCDMPY 321
           E+     P+
Sbjct: 381 EMIAARGPF 389

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 12/188 (6%)
Query: 186 HIGMPSNFCCV--------VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL 237
           H  +   FCC         V+E+ +GG L  ++ K+RR   A       A ++   L +L
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--YAAEIISALMFL 140
Query: 238 QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA 297
             K I++RD+K +N+LLD     K+ADFG+ +    N        GT  Y+APE+L    
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRC 357
           Y    D ++ G+ L+E+ C   P+   +  ++  A++   +    P         ++K  
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSF 258
Query: 358 WDANPDKR 365
              NP  R
Sbjct: 259 MTKNPTMR 266

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 2/129 (1%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C+V+   +GG ++ ++         F+    I     +  GL +L  + I++RD+K EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           LLD    V+I+D G+A    +      G  GT G+MAPE+L G  Y+   D ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 313 EIYCCDMPY 321
           E+     P+
Sbjct: 381 EMIAARGPF 389

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+EY +GG L  ++   +  K      +  A +++ GL +L  + I++RD+K +N++LD 
Sbjct: 98  VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDS 155
Query: 257 TRTVKIADFGVARLEASNPHDMTGET-----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
              +KIADFG+ +      H M G T     GT  Y+APE++    Y +  D +++G+ L
Sbjct: 156 EGHIKIADFGMCK-----EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 210
Query: 312 WEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+      E+  +++  N+    P+       ++ K     +P KR
Sbjct: 211 YEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPAKR 262

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 33/229 (14%)
Query: 104 KGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL- 160
           K    RG    V R ++   G + AVK+++   E    E ++  +R A  +E  +  ++ 
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE-QLEEVREATRRETHILRQVA 157
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP++   I +   +S                F  +V +    G L  YL +  +  L+ 
Sbjct: 158 GHPHIITLIDSYESSS----------------FMFLVFDLMRKGELFDYLTE--KVALSE 199
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMT 279
           K    +   L   +S+L +  IVHRD+K EN+LLD    ++++DFG +  LE   P +  
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKL 256
Query: 280 GET-GTLGYMAPEVLNGS------AYNRKCDVYSFGICLWEIYCCDMPY 321
            E  GT GY+APE+L  S       Y ++ D+++ G+ L+ +     P+
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 107 FARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
              GT+G V++   + G+  A+K +       R E E   + +   +E+++  +L H N+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K          L +  ++    +       +++ C GG L+S   K+            
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKK-----LLDVCEGG-LESVTAKS------------ 104
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
             L L  G++Y   ++++HRD+K +N+L+++   +KIADFG+AR         T E  TL
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
            Y AP+VL GS  Y+   D++S G    E+      +P +S ++    + R
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 107 FARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
              GT+G V++   + G+  A+K +       R E E   + +   +E+++  +L H N+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K          L +  ++    +       +++ C GG L+S   K+            
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKK-----LLDVCEGG-LESVTAKS------------ 104
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
             L L  G++Y   ++++HRD+K +N+L+++   +KIADFG+AR         T E  TL
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
            Y AP+VL GS  Y+   D++S G    E+      +P +S ++    + R
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 107 FARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
              GT+G V++   + G+  A+K +       R E E   + +   +E+++  +L H N+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K          L +  ++    +       +++ C GG L+S   K+            
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKK-----LLDVCEGG-LESVTAKS------------ 104
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
             L L  G++Y   ++++HRD+K +N+L+++   +KIADFG+AR         T E  TL
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL 164
Query: 286 GYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
            Y AP+VL GS  Y+   D++S G    E+      +P +S ++    + R
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFR 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 152 QEVAVWHKLD---HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           +EVAV   L+   HPNV +       +     +TD            +V E+     L +
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVS-----RTDR------ETKLTLVFEHVDQD-LTT 107
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           YL K     +  + +  +   L RGL +L S ++VHRD+K +N+L+  +  +K+ADFG+A
Sbjct: 108 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           R+  S    +T    TL Y APEVL  S+Y    D++S G    E++
Sbjct: 168 RI-YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 152 QEVAVWHKLD---HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           +EVAV   L+   HPNV +       +     +TD            +V E+     L +
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVS-----RTDR------ETKLTLVFEHVDQD-LTT 107
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           YL K     +  + +  +   L RGL +L S ++VHRD+K +N+L+  +  +K+ADFG+A
Sbjct: 108 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           R+  S    +T    TL Y APEVL  S+Y    D++S G    E++
Sbjct: 168 RI-YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
              G F TV+  R     Q VA+K +  G   HRSEA+    R A  +E+ +  +L HPN
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTAL-REIKLLQELSHPN 73
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +   + A    S +++  D         F    +E          +IK+    L    + 
Sbjct: 74  IIGLLDAFGHKSNISLVFD---------FMETDLEV---------IIKDNSLVLTPSHIK 115
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
              L   +GL YL    I+HRD+K  N+LLD+   +K+ADFG+A+   S       +  T
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVT 175
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
             Y APE+L G+       +Y  G+ +W + C
Sbjct: 176 RWYRAPELLFGAR------MYGVGVDMWAVGC 201

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 99  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 146
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 147 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 190
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 251 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 307 LLVRDPAQRATAAELL 322

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 152 QEVAVWHKLD---HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
           +EVAV   L+   HPNV +       +     +TD            +V E+     L +
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVS-----RTDR------ETKLTLVFEHVDQD-LTT 107
Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           YL K     +  + +  +   L RGL +L S ++VHRD+K +N+L+  +  +K+ADFG+A
Sbjct: 108 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           R+  S    +T    TL Y APEVL  S+Y    D++S G    E++
Sbjct: 168 RI-YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 108 ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G F  V R I    GQ  AVK++D  + +         L+    +E ++ H L HP++
Sbjct: 33  GKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK----REASICHMLKHPHI 88
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VV 223
            +          L   + +G + M       V E+  G  L   ++K       +   V 
Sbjct: 89  VEL---------LETYSSDGMLYM-------VFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
                 +   L Y     I+HRDVK EN+LL   + +  VK+ DFGVA     +     G
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             GT  +MAPEV+    Y +  DV+  G+ L+ +    +P+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 45  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 92
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 93  -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 136
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 252
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 253 LLVRDPAQRATAAELL 268

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 56  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 103
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 104 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 147
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 208 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 263
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 264 LLVRDPAQRATAAELL 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 49  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 96
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 97  -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 140
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 201 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 256
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 257 LLVRDPAQRATAAELL 272

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 54  GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 101
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 102 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 145
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 206 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 261
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 262 LLVRDPAQRATAAELL 277

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G+ VAVK +D  ++  R              EV +     H NV +   + +   EL   
Sbjct: 176 GKLVAVKKMDLRKQQRRE---------LLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 223
Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                         VV+E+  GGAL   +   R  +   + +  + L + + LS L ++ 
Sbjct: 224 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQG 267
Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           ++HRD+K++++LL     VK++DFG     +          GT  +MAPE+++   Y  +
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVVRQNLRPEIPRC--CPSSLANVMKR 356
            D++S GI + E+   + PY    F+E       ++R NL P +        SL   + R
Sbjct: 328 VDIWSLGIMVIEMVDGEPPY----FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383
Query: 357 CWDANPDKRPEMDEVV 372
               +P +R    E++
Sbjct: 384 LLVRDPAQRATAAELL 399

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 1/127 (0%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++    +        +  A ++  GL  L  ++IV+RD+K EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A +       + G  GT+GYMAPEV+    Y    D ++ G  L+E+
Sbjct: 320 DDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 315 YCCDMPY 321
                P+
Sbjct: 379 IAGQSPF 385

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 1/127 (0%)
Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++    +        +  A ++  GL  L  ++IV+RD+K EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A +       + G  GT+GYMAPEV+    Y    D ++ G  L+E+
Sbjct: 320 DDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 315 YCCDMPY 321
                P+
Sbjct: 379 IAGQSPF 385

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 54/279 (19%)
Query: 110 GTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G FG V R + D Q    VAVK ++ GE+          +     +E+     L HPN+ 
Sbjct: 30  GNFG-VARLMRDKQANELVAVKYIERGEK----------IDENVKREIINHRSLRHPNIV 78
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFK 221
           +F    +  + L                 +V+EY  GG L   +    R      +  F+
Sbjct: 79  RFKEVILTPTHL----------------AIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNPHDM- 278
            +I        G+SY  + ++ HRD+K EN LLD +    +KIADFG ++  AS  H   
Sbjct: 123 QLIS-------GVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK--ASVLHSQP 173
Query: 279 TGETGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
               GT  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D     +F +    +
Sbjct: 174 KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 334 VR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +  Q   P+     P    +++ R + A+P KR  + E+
Sbjct: 234 LNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEI 271

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K    +G F  V R ++   G + A K+++  + S R   ++        +E  +  KL
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-------EREARICRKL 85
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA- 219
            HPN+ +   +        IQ ++ H         +V +   GG L   ++       A 
Sbjct: 86  QHPNIVRLHDS--------IQEESFHY--------LVFDLVTGGELFEDIVAREFYSEAD 129
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPH 276
               IQ  L+    ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A +E ++  
Sbjct: 130 ASHCIQQILE---SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSE 185
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
              G  GT GY++PEVL    Y++  D+++ G+ L+ +     P+ D
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 54/279 (19%)
Query: 110 GTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G FG V R + D Q    VAVK ++ GE+          + A   +E+     L HPN+ 
Sbjct: 30  GNFG-VARLMRDKQSNELVAVKYIERGEK----------IAANVKREIINHRSLRHPNIV 78
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFK 221
           +F    +  + L                 +V+EY  GG L   +    R      +  F+
Sbjct: 79  RFKEVILTPTHL----------------AIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNPHDMT 279
            +I        G+SY  + ++ HRD+K EN LLD +    +KI DFG ++  +S  H   
Sbjct: 123 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 173
Query: 280 GET-GTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
             T GT  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D     +F +    +
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 334 VR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +  Q   P+     P    +++ R + A+P KR  + E+
Sbjct: 234 LNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEI 271

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K    +G F  V R ++   G + A K+++  + S R   ++        +E  +  KL
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-------EREARICRKL 62
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA- 219
            HPN+ +   +        IQ ++ H         +V +   GG L   ++       A 
Sbjct: 63  QHPNIVRLHDS--------IQEESFHY--------LVFDLVTGGELFEDIVAREFYSEAD 106
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPH 276
               IQ  L+    ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A +E ++  
Sbjct: 107 ASHCIQQILE---SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSE 162
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
              G  GT GY++PEVL    Y++  D+++ G+ L+ +     P+ D
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K    +G F  V R ++   G + A K+++  + S R   ++        +E  +  KL
Sbjct: 9   VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-------EREARICRKL 61
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA- 219
            HPN+ +           +IQ ++ H         +V +   GG L   ++       A 
Sbjct: 62  QHPNIVRL--------HDSIQEESFHY--------LVFDLVTGGELFEDIVAREFYSEAD 105
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPH 276
               IQ  L+    ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A +E ++  
Sbjct: 106 ASHCIQQILE---SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSE 161
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
              G  GT GY++PEVL    Y++  D+++ G+ L+ +     P+ D
Sbjct: 162 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 103 IKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K    +G F  V R ++   G + A K+++  + S R   ++        +E  +  KL
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-------EREARICRKL 62
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA- 219
            HPN+ +           +IQ ++ H         +V +   GG L   ++       A 
Sbjct: 63  QHPNIVRL--------HDSIQEESFHY--------LVFDLVTGGELFEDIVAREFYSEAD 106
Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPH 276
               IQ  L+    ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A +E ++  
Sbjct: 107 ASHCIQQILE---SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSE 162
Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
              G  GT GY++PEVL    Y++  D+++ G+ L+ +     P+ D
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 92/178 (51%), Gaps = 13/178 (7%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           ++++Y +GG L ++L   R R    +V I +  ++   L +L    I++RD+K EN+LLD
Sbjct: 136 LILDYINGGELFTHL-SQRERFTEHEVQIYVG-EIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 256 KTRTVKIADFGVARL----EASNPHDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGI 309
               V + DFG+++     E    +D     GT+ YMAP+++ G  S +++  D +S G+
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDF---CGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKR 365
            ++E+     P+         + + R+ L+  P  P+   +   ++++R    +P KR
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEIXINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL- 254
           +V+E  +GG L   +   +++  +      +   L   +S++    +VHRD+K EN+L  
Sbjct: 83  LVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140
Query: 255 --DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
             +    +KI DFG ARL+  +   +     TL Y APE+LN + Y+  CD++S G+ L+
Sbjct: 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200
Query: 313 EIYCCDMPY 321
            +    +P+
Sbjct: 201 TMLSGQVPF 209

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 4/163 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
            V++Y +GG L  +L   R R          A ++A  L YL S  IV+RD+K EN+LLD
Sbjct: 116 FVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
               + + DFG+ +    +    +   GT  Y+APEVL+   Y+R  D +  G  L+E+ 
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
Query: 316 CCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKR 356
               P+   + +E+   ++ +   L+P I       L  ++++
Sbjct: 234 YGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEIXINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 137/314 (43%), Gaps = 47/314 (14%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRG--IYDGQDVAVK-LLDWGEESHRSEAEIASLRA 148
           Q  E+   +L ++   A G F  V+    +  G++ A+K LL   EE +R          
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---------- 70
Query: 149 AFTQEVAVWHKLD-HPNVTKFI-GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           A  QEV    KL  HPN+ +F   A++G  E    +D G          ++ E C G  +
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEE----SDTGQAEF-----LLLTELCKGQLV 121
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIAD 264
           +       R  L+   V+++     R + ++  +K  I+HRD+K EN+LL    T+K+ D
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 265 FGVARLEASNP-------------HDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFG 308
           FG A   +  P              ++T  T  + Y  PE+++         K D+++ G
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPM-YRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 309 ICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
             L+ +     P+ D +   + +   + ++ P   +   +   ++++     NP++R  +
Sbjct: 241 CILYLLCFRQHPFEDGAKLRIVNG--KYSIPPHDTQY--TVFHSLIRAMLQVNPEERLSI 296
Query: 369 DEVVAMLEAIDTSK 382
            EVV  L+ I  ++
Sbjct: 297 AEVVHQLQEIAAAR 310

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
           T E+A+  +++H N+ K          L+I  + G       F  +V+E  HG  L  + 
Sbjct: 77  TLEIAILSRVEHANIIKV---------LDIFENQG-------FFQLVMEK-HGSGLDLFA 119
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
             +R  +L   +   +   L   + YL+ K I+HRD+K EN+++ +  T+K+ DFG A  
Sbjct: 120 FIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 271 EASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 329
                   T   GT+ Y APEVL G+ Y   + +++S G+ L+ +   + P+ +L     
Sbjct: 180 LERGKLFYTF-CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL----- 233
Query: 330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
               V   + P  P      L +++       P++R  ++++V 
Sbjct: 234 -EETVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEIXINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 95  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 154
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 155 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 213
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 214 IMYILLCGYPPF 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 17/140 (12%)
Query: 190 PSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK---VVIQLALDLARGLSYLQSKKIVHRD 246
           P  +  + ++ C    LK ++  NRR  L  +   V + + + +A  + +L SK ++HRD
Sbjct: 132 PKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMT------------GETGTLGYMAPEVLN 294
           +K  N+       VK+ DFG+      +  + T            G+ GT  YM+PE ++
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 295 GSAYNRKCDVYSFGICLWEI 314
           G+ Y+ K D++S G+ L+E+
Sbjct: 250 GNNYSHKVDIFSLGLILFEL 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 103 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 162
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 163 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 221
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 222 IMYILLCGYPPF 233

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 93  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 152
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 153 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 211
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 212 IMYILLCGYPPF 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 94  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 153
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 154 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 212
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 213 IMYILLCGYPPF 224

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 63
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 64  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 105
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 106 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 193 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 252 IMYILLCGYPPF 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 139 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 198
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 199 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 257
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 258 IMYILLCGYPPF 269

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
           ++   E+AV  K+ H N+                     I    N   +V++   GG L 
Sbjct: 65  SSIENEIAVLRKIKHENIVAL----------------EDIYESPNHLYLVMQLVSGGELF 108
Query: 208 SYLI-KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIA 263
             ++ K    +     +I+  LD    + YL    IVHRD+K EN+L    D+   + I+
Sbjct: 109 DRIVEKGFYTEKDASTLIRQVLD---AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMIS 165
Query: 264 DFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           DFG++++E      M+   GT GY+APEVL    Y++  D +S G+  + + C   P+ D
Sbjct: 166 DFGLSKMEGKGDV-MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 224
Query: 324 LSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKR 365
            + S++   +++     + P       S  + ++   + +P+KR
Sbjct: 225 ENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKR 268

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +GTFG V +  +   GQ VA+K +    E+ +    I +LR     E+ +   L H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALR-----EIKILQLLKHEN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V   I     T         G I +  +FC    E+   G L + L+K    ++  K V+
Sbjct: 79  VVNLI-EICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSEI--KRVM 131
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPHDMTG 280
           Q+ L+   GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+    
Sbjct: 132 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 281 ETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
              TL Y  PE+L G   Y    D++  G  + E++
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 105 GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
               +GTFG V +  +   GQ VA+K +    E+ +    I +LR     E+ +   L H
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALR-----EIKILQLLKH 75
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
            NV   I     T         G I +  +FC    E+   G L + L+K    ++  K 
Sbjct: 76  ENVVNLI-EICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSEI--KR 128
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPHDM 278
           V+Q+ L+   GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+  
Sbjct: 129 VMQMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 279 TGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
                TL Y  PE+L G   Y    D++  G  + E++
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 149 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 208 IMYILLCGYPPF 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 37/225 (16%)
Query: 96  IDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           ID  + I K     GT+G V++ I     + VA+K +       R E E   +     +E
Sbjct: 33  IDRYRRITK--LGEGTYGEVYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAIRE 83
Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           V++  +L H N+ +          L++                + EY     LK Y+ KN
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHL----------------IFEYAEND-LKKYMDKN 126
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-----KTRTVKIADFGVA 268
               ++ +V+      L  G+++  S++ +HRD+K +N+LL      +T  +KI DFG+A
Sbjct: 127 P--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 269 RLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLW 312
           R         T E  TL Y  PE+L GS  Y+   D++S   C+W
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIW 228

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 146
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 147 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 205
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 206 IMYILLCGYPPF 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +GTFG V +  +   GQ VA+K +    E+ +    I +LR     E+ +   L H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALR-----EIKILQLLKHEN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V   I     T         G I +  +FC    E+   G L + L+K    ++  K V+
Sbjct: 79  VVNLI-EICRTKASPYNRCKGSIYLVFDFC----EHDLAGLLSNVLVKFTLSEI--KRVM 131
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPHDMTG 280
           Q+ L+   GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+    
Sbjct: 132 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 281 ETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
              TL Y  PE+L G   Y    D++  G  + E++
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 88  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 147
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 148 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 206
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 207 IMYILLCGYPPF 218

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 149 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 208 IMYILLCGYPPF 219

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 13  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKMLNHE 64
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 65  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 106
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVLEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ADFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 146
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD++S G+
Sbjct: 147 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 205
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 206 IMYILLCGYPPF 217

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 104 KGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           K    RG    V R I+    ++ AVK++D       S  E+  LR A  +EV +  K+ 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 162 -HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +       T E N             F  +V +    G L  YL    +  L+ 
Sbjct: 82  GHPNIIQL----KDTYETN------------TFFFLVFDLMKKGELFDYL--TEKVTLSE 123
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           K   ++   L   +  L    IVHRD+K EN+LLD    +K+ DFG +  +      +  
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRS 182
Query: 281 ETGTLGYMAPEVL------NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             GT  Y+APE++      N   Y ++ D++S G+ ++ +     P+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
               G +G V   +     + VAVK++D        E           +E+ +   L+H 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINAMLNHE 65
Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           NV KF G      E NIQ              + +EYC GG L   +  +    +     
Sbjct: 66  NVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIEPDI--GMPEPDA 107
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGE 281
            +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  +  +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 282 TGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
            GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ADFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 40/225 (17%)
Query: 108 ARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            RG FG V   R     +  A+KLL   E   RS++      A F +E  +    + P V
Sbjct: 84  GRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSPWV 137
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRRKLAFK 221
            +   A         Q D         +  +V+EY  GG L     +Y +  +  K  + 
Sbjct: 138 VQLFCA--------FQDDK--------YLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-YT 180
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTG 280
             + LALD       + S  ++HRDVK +NMLLDK   +K+ADFG   +++ +       
Sbjct: 181 AEVVLALDA------IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT 234
Query: 281 ETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
             GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 235 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 104 KGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           K    RG    V R I+    ++ AVK++D       S  E+  LR A  +EV +  K+ 
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 162 -HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +       T E N             F  +V +    G L  YL    +  L+ 
Sbjct: 69  GHPNIIQL----KDTYETN------------TFFFLVFDLMKKGELFDYL--TEKVTLSE 110
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           K   ++   L   +  L    IVHRD+K EN+LLD    +K+ DFG +     +P +   
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLR 168
Query: 281 ET-GTLGYMAPEVL------NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           E  GT  Y+APE++      N   Y ++ D++S G+ ++ +     P+
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E+ +   L+H NV KF G      E NIQ              + +EYC GG L   + 
Sbjct: 53  KEICINKMLNHENVVKFYGHR---REGNIQY-------------LFLEYCSGGELFDRIE 96
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
            +    +      +    L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A + 
Sbjct: 97  PDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 154
Query: 272 ASNPHD--MTGETGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPY 321
             N  +  +    GTL Y+APE+L    ++ +  DV+S GI L  +   ++P+
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 54/279 (19%)
Query: 110 GTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G FG V R + D Q    VAVK ++ GE+          +     +E+     L HPN+ 
Sbjct: 29  GNFG-VARLMRDKQSNELVAVKYIERGEK----------IDENVKREIINHRSLRHPNIV 77
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFK 221
           +F    +  + L                 +V+EY  GG L   +    R      +  F+
Sbjct: 78  RFKEVILTPTHL----------------AIVMEYASGGELFERICNAGRFSEDEARFFFQ 121
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNPHDMT 279
            +I        G+SY  + ++ HRD+K EN LLD +    +KI DFG ++  +S  H   
Sbjct: 122 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 172
Query: 280 GET-GTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
             T GT  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D     +F +    +
Sbjct: 173 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 232
Query: 334 VR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +  Q   P+     P    +++ R + A+P KR  + E+
Sbjct: 233 LNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEI 270

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 104 KGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD 161
           K    RG    V R I+    ++ AVK++D       S  E+  LR A  +EV +  K+ 
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 162 -HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +       T E N             F  +V +    G L  YL    +  L+ 
Sbjct: 82  GHPNIIQL----KDTYETN------------TFFFLVFDLMKKGELFDYL--TEKVTLSE 123
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           K   ++   L   +  L    IVHRD+K EN+LLD    +K+ DFG +     +P +   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLR 181
Query: 281 ET-GTLGYMAPEVL------NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           E  GT  Y+APE++      N   Y ++ D++S G+ ++ +     P+
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ADFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C +++  C  GG L S + +   +    +   ++  D+   + +L S  I HRDVK EN+
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159
Query: 253 LL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    +K   +K+ DFG A+    N   +     T  Y+APEVL    Y++ CD++S G+
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 218 IMYILLCGFPPF 229

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ADFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIKVADFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 5/132 (3%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C ++V  C  GG L S +     +    +   ++   +   + YL S  I HRDVK EN+
Sbjct: 133 CLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENL 192
Query: 253 LLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    R    +K+ DFG A+ E ++ + +T    T  Y+APEVL    Y++ CD +S G+
Sbjct: 193 LYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGV 251
Query: 310 CLWEIYCCDMPY 321
             + + C   P+
Sbjct: 252 IXYILLCGYPPF 263

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 194 CCVVVEYC-HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           C +++  C  GG L S + +   +    +   ++  D+   + +L S  I HRDVK EN+
Sbjct: 81  CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 140
Query: 253 LL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           L    +K   +K+ DFG A+    N   +     T  Y+APEVL    Y++ CD++S G+
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 198
Query: 310 CLWEIYCCDMPY 321
            ++ + C   P+
Sbjct: 199 IMYILLCGFPPF 210

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 52/299 (17%)
Query: 101 LIIKGAFARGTFGTVHRGIYD-----GQ----DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           LI   +  +GTF  + +G+       GQ    +V +K+LD   ++HR+ +E      +F 
Sbjct: 10  LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSE------SFF 60
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +  ++  KL H ++    G  +   E NI               +V E+   G+L +YL 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDE-NI---------------LVQEFVKFGSLDTYLK 104
Query: 212 KNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--------VKI 262
           KN+    + +K  +++A  LA  + +L+   ++H +V  +N+LL +           +K+
Sbjct: 105 KNKNCINILWK--LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 263 ADFGVARLEASNPHDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           +D G++      P D+  E   + ++ PE + N    N   D +SFG  LWEI  C    
Sbjct: 163 SDPGISI--TVLPKDILQER--IPWVPPECIENPKNLNLATDKWSFGTTLWEI--CSGGD 216
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
             LS  +    +     R ++P    + LAN++  C D  PD RP    ++  L ++ T
Sbjct: 217 KPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 52/278 (18%)
Query: 110 GTFGT--VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G FG   + R     + VAVK ++ G          A++     +E+     L HPN+ +
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERG----------AAIDENVQREIINHRSLRHPNIVR 80
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK-NRRRKLAFKVVIQL 226
           F    +  + L I                ++EY  GG L   +    R  +   +   Q 
Sbjct: 81  FKEVILTPTHLAI----------------IMEYASGGELYERICNAGRFSEDEARFFFQ- 123
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNPHDMTGET-G 283
              L  G+SY  S +I HRD+K EN LLD +    +KI DFG ++  +S  H     T G
Sbjct: 124 --QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVG 179
Query: 284 TLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV--VRQ 336
           T  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D      + +    +  V+ 
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 337 NLRPEI---PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           ++  +I   P CC     +++ R + A+P  R  + E+
Sbjct: 240 SIPDDIRISPECC-----HLISRIFVADPATRISIPEI 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 108 ARGTFGTVH-------RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
            RG FG V        R +Y     A+KLL   E   RS++      A F +E  +    
Sbjct: 78  GRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDS------AFFWEERDIMAFA 126
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRR 216
           + P V +   A         Q D         +  +V+EY  GG L     +Y +  +  
Sbjct: 127 NSPWVVQLFYA--------FQDDR--------YLYMVMEYMPGGDLVNLMSNYDVPEKWA 170
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNP 275
           +  +   + LALD       + S   +HRDVK +NMLLDK+  +K+ADFG   ++     
Sbjct: 171 RF-YTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 276 HDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
                  GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 52/299 (17%)
Query: 101 LIIKGAFARGTFGTVHRGIYD-----GQ----DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           LI   +  +GTF  + +G+       GQ    +V +K+LD   ++HR+ +E      +F 
Sbjct: 10  LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSE------SFF 60
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +  ++  KL H ++    G      E NI               +V E+   G+L +YL 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCFCGDE-NI---------------LVQEFVKFGSLDTYLK 104
Query: 212 KNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--------VKI 262
           KN+    + +K  +++A  LA  + +L+   ++H +V  +N+LL +           +K+
Sbjct: 105 KNKNCINILWK--LEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 263 ADFGVARLEASNPHDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           +D G++      P D+  E   + ++ PE + N    N   D +SFG  LWEI  C    
Sbjct: 163 SDPGISI--TVLPKDILQER--IPWVPPECIENPKNLNLATDKWSFGTTLWEI--CSGGD 216
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
             LS  +    +     R ++P    + LAN++  C D  PD RP    ++  L ++ T
Sbjct: 217 KPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 108 ARGTFGTVH-------RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
            RG FG V        R +Y     A+KLL   E   RS++      A F +E  +    
Sbjct: 83  GRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDS------AFFWEERDIMAFA 131
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRR 216
           + P V +   A         Q D         +  +V+EY  GG L     +Y +  +  
Sbjct: 132 NSPWVVQLFYA--------FQDDR--------YLYMVMEYMPGGDLVNLMSNYDVPEKWA 175
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNP 275
           +  +   + LALD       + S   +HRDVK +NMLLDK+  +K+ADFG   ++     
Sbjct: 176 RF-YTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 276 HDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
                  GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 30/265 (11%)
Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     +G FG V+  R   +   +A+K+L       +S+ E   +     +E+ +   L
Sbjct: 19  IGRPLGKGKFGNVYLAREKQNKFIMALKVL------FKSQLEKEGVEHQLRREIEIQSHL 72
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +           N   D   I        +++E+   G L   L K+ R     
Sbjct: 73  RHPNILRMY---------NYFHDRKRI-------YLMLEFAPRGELYKELQKHGR--FDE 114
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +       +LA  L Y   +K++HRD+K EN+L+     +KIADFG +    S       
Sbjct: 115 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM- 173
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GTL Y+ PE++ G  ++ K D++  G+  +E      P+   S +E    +V  +L+ 
Sbjct: 174 -CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK- 231
Query: 341 EIPRCCPSSLANVMKRCWDANPDKR 365
             P        +++ +    +P +R
Sbjct: 232 -FPPFLSDGSKDLISKLLRYHPPQR 255

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 108 ARGTFGTVH-------RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
            RG FG V        R +Y     A+KLL   E   RS++      A F +E  +    
Sbjct: 83  GRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDS------AFFWEERDIMAFA 131
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL----KSYLIKNRRR 216
           + P V +   A         Q D         +  +V+EY  GG L     +Y +  +  
Sbjct: 132 NSPWVVQLFYA--------FQDDR--------YLYMVMEYMPGGDLVNLMSNYDVPEKWA 175
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNP 275
           +  +   + LALD       + S   +HRDVK +NMLLDK+  +K+ADFG   ++     
Sbjct: 176 RF-YTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 276 HDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPY 321
                  GT  Y++PEVL        Y R+CD +S G+ L+E+   D P+
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARV-ADPDHDHTGFLTEYVATR 191
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 30/265 (11%)
Query: 103 IKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     +G FG V+  R   +   +A+K+L       +S+ E   +     +E+ +   L
Sbjct: 18  IVRPLGKGKFGNVYLAREKQNKFIMALKVL------FKSQLEKEGVEHQLRREIEIQSHL 71
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+ +           N   D   I        +++E+   G L   L K+ R     
Sbjct: 72  RHPNILRMY---------NYFHDRKRI-------YLMLEFAPRGELYKELQKHGR--FDE 113
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           +       +LA  L Y   +K++HRD+K EN+L+     +KIADFG +    S       
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM- 172
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GTL Y+ PE++ G  ++ K D++  G+  +E      P+   S +E    +V  +L+ 
Sbjct: 173 -CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK- 230
Query: 341 EIPRCCPSSLANVMKRCWDANPDKR 365
             P        +++ +    +P +R
Sbjct: 231 -FPPFLSDGSKDLISKLLRYHPPQR 254

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 16/141 (11%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                M  E  T  Y APEV+ G  Y    D++S G  + E+ C  + +P   + +  + 
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNK 236
Query: 333 VVRQNLRPEIPRCCPSSLANV 353
           V+ Q   P     CP+ +  +
Sbjct: 237 VIEQLGTP-----CPAFMKKL 252

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + A       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +GTFG V +  +   GQ VA+K +    E+ +    I +LR     E+ +   L H N
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALR-----EIKILQLLKHEN 78
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V   I     T           I +  +FC    E+   G L + L+K    ++  K V+
Sbjct: 79  VVNLI-EICRTKASPYNRCKASIYLVFDFC----EHDLAGLLSNVLVKFTLSEI--KRVM 131
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR----LEASNPHDMTG 280
           Q+ L+   GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+    
Sbjct: 132 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 281 ETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
              TL Y  PE+L G   Y    D++  G  + E++
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATR 191
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATR 191
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARV-ADPDHDHTGFLTEYVATR 193
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 118 MVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ DFG+A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIKVTDFGLAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATR 211
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
             +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           +D+   +++ DFG A+        +    GT  Y+APE++    YN+  D ++ G+ ++E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 314 IYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 115/266 (43%), Gaps = 47/266 (17%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+FG V   + +  G   A+K+LD        + ++  L+        + H L+   + +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILD--------KQKVVKLKQ-------IEHTLNEKRILQ 97
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +     T       DN ++ M       V+EY  GG + S+L   R  + +       A
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-------VMEYAPGGEMFSHL--RRIGRFSEPHARFYA 148
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET----G 283
             +     YL S  +++RD+K EN+++D+   +K+ DFG A+        + G T    G
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCG 201
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLR 339
           T  Y+APE++    YN+  D ++ G+ ++E+     P+    P   + ++ S  VR    
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---- 257
Query: 340 PEIPRCCPSSLANVMKRCWDANPDKR 365
              P    S L ++++     +  KR
Sbjct: 258 --FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/266 (23%), Positives = 115/266 (43%), Gaps = 47/266 (17%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+FG V   + +  G   A+K+LD        + ++  L+        + H L+   + +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILD--------KQKVVKLKQ-------IEHTLNEKRILQ 97
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
            +     T       DN ++ M       V+EY  GG + S+L   R  + +       A
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-------VMEYAPGGEMFSHL--RRIGRFSEPHARFYA 148
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET----G 283
             +     YL S  +++RD+K EN+++D+   +K+ DFG A+        + G T    G
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCG 201
Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLR 339
           T  Y+APE++    YN+  D ++ G+ ++E+     P+    P   + ++ S  VR    
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---- 257
Query: 340 PEIPRCCPSSLANVMKRCWDANPDKR 365
              P    S L ++++     +  KR
Sbjct: 258 --FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
             +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L
Sbjct: 116 LYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           +D+   +++ DFG A+        +    GT  Y+APE++    YN+  D ++ G+ ++E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 314 IYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 74/134 (55%), Gaps = 21/134 (15%)
Query: 196 VVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           +V E   GG++ S++ K R   +L   VV+Q   D+A  L +L +K I HRD+K EN+L 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKGIAHRDLKPENILC 144
Query: 255 D---KTRTVKIADFGVA---RLEA-----SNPHDMTGETGTLGYMAPEVL-----NGSAY 298
           +   +   VKI DFG+    +L       S P  +T   G+  YMAPEV+       S Y
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT-PCGSAEYMAPEVVEAFSEEASIY 203
Query: 299 NRKCDVYSFGICLW 312
           +++CD++S G+ L+
Sbjct: 204 DKRCDLWSLGVILY 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 44/309 (14%)
Query: 96  IDPAKLIIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           ID    +       G F  V    G++DG   A+K +   E+  R EA          Q 
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA----------QR 75
Query: 154 VAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL-- 210
            A  H+L +HPN+ + +   +         + G      +   +++ +   G L + +  
Sbjct: 76  EADMHRLFNHPNILRLVAYCL--------RERG----AKHEAWLLLPFFKRGTLWNEIER 123
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV--- 267
           +K++   L    ++ L L + RGL  + +K   HRD+K  N+LL       + D G    
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 268 ------ARLEASNPHDMTGETGTLGYMAPEVLNGSAY---NRKCDVYSFGICLWEIYCCD 318
                    +A    D   +  T+ Y APE+ +  ++   + + DV+S G  L+ +   +
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 319 MPYPDLSFSE---VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML 375
            PY D+ F +   V  AV  Q   P+ PR   S+L  ++      +P +RP +  +++ L
Sbjct: 244 GPY-DMVFQKGDSVALAVQNQLSIPQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 376 EAIDTSKGG 384
           EA+     G
Sbjct: 302 EALQPPAPG 310

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG---QDVAVKLLDWGEESHRSEAEIASLRAAF 150
           WE+ P +L        G +G+V    YD    Q VAVK L       R    +   R  +
Sbjct: 24  WEV-PQRLQGLRPVGSGAYGSVCSA-YDARLRQKVAVKKLS------RPFQSLIHARRTY 75
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +E+ +   L H NV   +      + +             +F  V +     GA  + +
Sbjct: 76  -RELRLLKHLKHENVIGLLDVFTPATSIE------------DFSEVYLVTTLMGADLNNI 122
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
           +K++   L+ + V  L   L RGL Y+ S  I+HRD+K  N+ +++   ++I DFG+AR 
Sbjct: 123 VKSQ--ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR- 179
Query: 271 EASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
                 +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 118 MVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 119 MVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +K+ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 118/272 (43%), Gaps = 59/272 (21%)
Query: 110 GTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+FG V   + +  G   A+K+LD        + ++  L+        + H L+   + +
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILD--------KQKVVKLKQ-------IEHTLNEKRILQ 97
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------RKLAFK 221
            +     T       DN ++ M       V+EY  GG + S+L +  R      R  A +
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-------VMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
           +V+           YL S  +++RD+K EN+++D+   +K+ DFG A+        + G 
Sbjct: 151 IVLTF--------EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-------RVKGR 195
Query: 282 T----GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAV 333
           T    GT  Y+APE++    YN+  D ++ G+ ++E+     P+    P   + ++ S  
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 255
Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           VR       P    S L ++++     +  KR
Sbjct: 256 VR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+++D+   +K+ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLMIDQQGYIKVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 32/179 (17%)
Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E+ V  +L HPN+ K        +E+++                V+E   GG L   +++
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISL----------------VLELVTGGELFDRIVE 141
Query: 213 N-----RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT---VKIAD 264
                 R    A K +++        ++YL    IVHRD+K EN+L         +KIAD
Sbjct: 142 KGYYSERDAADAVKQILE-------AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIAD 194
Query: 265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           FG++++   +   M    GT GY APE+L G AY  + D++S GI  + + C   P+ D
Sbjct: 195 FGLSKI-VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 120/280 (42%), Gaps = 56/280 (20%)
Query: 110 GTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G FG V R + D Q    VAVK ++ GE+          +     +E+     L HPN+ 
Sbjct: 30  GNFG-VARLMRDKQSNELVAVKYIERGEK----------IDENVKREIINHRSLRHPNIV 78
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFK 221
           +F    +  + L                 +V+EY  GG L   +    R      +  F+
Sbjct: 79  RFKEVILTPTHL----------------AIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEA--SNPHD 277
            +I        G+SY  + ++ HRD+K EN LLD +    +KI  FG ++     S P D
Sbjct: 123 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD 175
Query: 278 MTGETGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSA 332
                GT  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D     +F +    
Sbjct: 176 T---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 333 VVR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           ++  Q   P+     P    +++ R + A+P KR  + E+
Sbjct: 233 ILNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEI 271

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 139 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 196
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 197 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATR 196
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 139 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 190
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 191 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 297
Query: 362 PDKR 365
             KR
Sbjct: 298 LTKR 301

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 40/245 (16%)
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA---- 205
             +E+    +  HPN+  +  + +   EL                 +V++   GG+    
Sbjct: 55  LLKEIQAMSQCHHPNIVSYYTSFVVKDEL----------------WLVMKLLSGGSVLDI 98
Query: 206 LKSYLIKNRRRK--LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           +K  + K   +   L    +  +  ++  GL YL     +HRDVK  N+LL +  +V+IA
Sbjct: 99  IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 158
Query: 264 DFGVARLEASNPHDMTGE------TGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYC 316
           DFGV+   A+   D+T         GT  +MAPEV+     Y+ K D++SFGI   E+  
Sbjct: 159 DFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217
Query: 317 CDMPYPDLSFSEVTSAVVRQNLRP---------EIPRCCPSSLANVMKRCWDANPDKRPE 367
              PY      +V   +  QN  P         E+ +    S   ++  C   +P+KRP 
Sbjct: 218 GAAPYHKYPPMKVL-MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276
Query: 368 MDEVV 372
             E++
Sbjct: 277 AAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 40/245 (16%)
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA---- 205
             +E+    +  HPN+  +  + +   EL                 +V++   GG+    
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDEL----------------WLVMKLLSGGSVLDI 103
Query: 206 LKSYLIKNRRRK--LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           +K  + K   +   L    +  +  ++  GL YL     +HRDVK  N+LL +  +V+IA
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163
Query: 264 DFGVARLEASNPHDMTGE------TGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYC 316
           DFGV+   A+   D+T         GT  +MAPEV+     Y+ K D++SFGI   E+  
Sbjct: 164 DFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
Query: 317 CDMPYPDLSFSEVTSAVVRQNLRP---------EIPRCCPSSLANVMKRCWDANPDKRPE 367
              PY      +V   +  QN  P         E+ +    S   ++  C   +P+KRP 
Sbjct: 223 GAAPYHKYPPMKVL-MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
Query: 368 MDEVV 372
             E++
Sbjct: 282 AAELL 286

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADEPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                M  E  T  Y APEV+ G  Y    D++S G  + E+ C  + +P   + +  + 
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 113 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 164
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 165 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 217
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 218 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 271
Query: 362 PDKR 365
             KR
Sbjct: 272 LTKR 275

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 139 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 196
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 197 QQGYIQVTDFGFAK-------RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 119 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 177 QQGYIQVTDFGFAK-------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 193
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/90 (41%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+L++ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARI-ADPEHDHTGFLTEXVATR 211
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 191
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 119 MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 170
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 277
Query: 362 PDKR 365
             KR
Sbjct: 278 LTKR 281

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 107 FARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
              GT+ TV++G     D  V L +   E H   A   ++R     EV++   L H N+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLE-HEEGAPCTAIR-----EVSLLKDLKHANIV 63
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                   T    I T+            +V EY     LK YL  +    +    V   
Sbjct: 64  --------TLHDIIHTEKS--------LTLVFEYLDKD-LKQYL-DDCGNIINMHNVKLF 105
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              L RGL+Y   +K++HRD+K +N+L+++   +K+ADFG+AR ++        E  TL 
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
           Y  P++L GS  Y+ + D++  G   +E+      +P  +  E    + R
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 4/163 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +++EY  GG L  ++   R              +++  L +L  K I++RD+K EN++L+
Sbjct: 98  LILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
               VK+ DFG+ +    +        GT+ YMAPE+L  S +NR  D +S G  ++++ 
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 316 CCDMPYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKR 356
               P+   +  +    ++  + NL P + +     L  ++KR
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           +V +  G  L + +   + +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++
Sbjct: 104 LVTHLMGADLNNIV---KXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160
Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIY 315
              +KI DFG+AR       +MTG   T  Y APE+ LN   YN+  D++S G  + E+ 
Sbjct: 161 DXELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 316 CCDMPYP 322
                +P
Sbjct: 218 TGRTLFP 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 189
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 219

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 4/163 (2%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +++EY  GG L  ++   R              +++  L +L  K I++RD+K EN++L+
Sbjct: 98  LILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155
Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
               VK+ DFG+ +    +        GT+ YMAPE+L  S +NR  D +S G  ++++ 
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 316 CCDMPYPDLSFSEVTSAVV--RQNLRPEIPRCCPSSLANVMKR 356
               P+   +  +    ++  + NL P + +     L  ++KR
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 104 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 161
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 162 QQGYIQVTDFGFAK-------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 214
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 215 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 189
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 219

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 196
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 226

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 197
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 227

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 188
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 218

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 195
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 118 MVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG+A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGLAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 193
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 199
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 229

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 191
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 169
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 276
Query: 362 PDKR 365
             KR
Sbjct: 277 LTKR 280

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 123 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 181
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+ C  + +P   + +  + 
Sbjct: 182 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 241
Query: 333 VVRQ 336
           V+ Q
Sbjct: 242 VIEQ 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 112 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 170
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+ C  + +P   + +  + 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 230
Query: 333 VVRQ 336
           V+ Q
Sbjct: 231 VIEQ 234

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG----ETGTL 285
           + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+ A   HD TG       T 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATR 211
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APE+ LN   Y +  D++S G  L E+
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 111 MVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 168
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 169 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 221
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 222 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 54/279 (19%)
Query: 110 GTFGTVHRGIYDGQD---VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G FG V R + D Q    VAVK ++ GE+          +     +E+     L HPN+ 
Sbjct: 30  GNFG-VARLMRDKQSNELVAVKYIERGEK----------IDENVKREIINHRSLRHPNIV 78
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFK 221
           +F    +  + L                 +V+EY  GG L   +    R      +  F+
Sbjct: 79  RFKEVILTPTHL----------------AIVMEYASGGELFERICNAGRFSEDEARFFFQ 122
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNPHDMT 279
            +I        G+SY  + ++ HRD+K EN LLD +    +KI  FG ++  +S  H   
Sbjct: 123 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK--SSVLHSQP 173
Query: 280 GET-GTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPD----LSFSEVTSAV 333
             T GT  Y+APEVL    Y+ K  DV+S G+ L+ +     P+ D     +F +    +
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 334 VR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +  Q   P+     P    +++ R + A+P KR  + E+
Sbjct: 234 LNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEI 271

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 105 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 162
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 163 EQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 215
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 216 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 196 VVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT 249
           +V+EY  GG + S+L +  R      R  A ++V+           YL S  +++RD+K 
Sbjct: 111 MVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF--------EYLHSLDLIYRDLKP 162
Query: 250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVY 305
           EN+L+D+   +++ DFG A+        + G T    GT  Y+APE++    YN+  D +
Sbjct: 163 ENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 306 SFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           + G+ ++E+     P+    P   + ++ S  VR       P    S L ++++     +
Sbjct: 216 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVD 269
Query: 362 PDKR 365
             KR
Sbjct: 270 LTKR 273

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 30/179 (16%)
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L ++VV +    +  G+ +  S  I+HRD+K EN+L+ ++  VK+ DFG AR  A+    
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180
Query: 278 MTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYP-DLSFSEVTSAVV- 334
              E  T  Y APE+L G   Y +  DV++ G  + E++  +  +P D    ++   ++ 
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 335 -------RQNL-----------RPEIPRCCP---------SSLANVMKRCWDANPDKRP 366
                   Q L            PEI    P           + ++ K+C   +PDKRP
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 118 MVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTD 182
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 110/274 (40%), Gaps = 32/274 (11%)
Query: 101 LIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
           ++      RG F  V + I    GQ+ A K L          AEI         E+AV  
Sbjct: 31  ILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-------HEIAVLE 83
Query: 159 KLDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK 217
                P V         TSE+                 +++EY  GG + S  +      
Sbjct: 84  LAKSCPRVINLHEVYENTSEI----------------ILILEYAAGGEIFSLCLPELAEM 127
Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR---TVKIADFGVARLEASN 274
           ++   VI+L   +  G+ YL    IVH D+K +N+LL        +KI DFG++R +  +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGH 186
Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
             ++    GT  Y+APE+LN        D+++ GI  + +     P+      E    + 
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
Query: 335 RQNL-RPEIPRCCPSSLA-NVMKRCWDANPDKRP 366
           + N+   E      S LA + ++     NP+KRP
Sbjct: 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR  A    +MTG   T 
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATR 193
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR  A   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/108 (37%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR  A   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTD 178
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 179 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 181
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 182 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 181
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 182 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTD 187
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 188 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+++D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG---QDVAVKLLDWGEESHRSEAEIASLRAAF 150
           WE+ P +L        G +G+V    YD    Q VAVK L       R    +   R  +
Sbjct: 24  WEV-PQRLQGLRPVGSGAYGSVCSA-YDARLRQKVAVKKLS------RPFQSLIHARRTY 75
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +E+ +   L H NV   +      + +             +F  V +     GA  + +
Sbjct: 76  -RELRLLKHLKHENVIGLLDVFTPATSIE------------DFSEVYLVTTLMGADLNNI 122
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
           +K +   L+ + V  L   L RGL Y+ S  I+HRD+K  N+ +++   ++I DFG+AR 
Sbjct: 123 VKCQ--ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR- 179
Query: 271 EASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
                 +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 180 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +++     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YQMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 188 GMPSNF--CCVVVEYCHGGALKSY------LIKNRRRKLAFKVVIQLALDLARGLSYLQS 239
           G+ +N+    ++ EY    ++  +      L KN    +  +V+  +   +    SY+ +
Sbjct: 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169
Query: 240 KK-IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL-NGSA 297
           +K I HRDVK  N+L+DK   VK++DFG +  E      + G  GT  +M PE   N S+
Sbjct: 170 EKNICHRDVKPSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEFMPPEFFSNESS 227
Query: 298 YN-RKCDVYSFGICLWEIYCCDMPYP-DLSFSEVTSAVVRQNLRPEIPR 344
           YN  K D++S GICL+ ++   +P+   +S  E+ + +  +N+   + R
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 4/110 (3%)
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
           + +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR    
Sbjct: 118 KXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---H 174
Query: 274 NPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
              +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 97  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 154
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 155 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 213
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 214 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 271 ARFTTEEAL 279

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRC 357
           +E+     P+    P   + ++ S  VR       P    S L ++++  
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNL 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 148
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 208 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 265 ARFTTEEAL 273

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 148
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 208 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 265 ARFTTEEAL 273

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 148
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 149 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 208 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 265 ARFTTEEAL 273

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 273
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 333 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 390 ARFTTEEAL 398

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 90  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 147
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 148 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 206
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 207 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 264 ARFTTEEAL 272

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 28/232 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTV--HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           WE+ P +         G +G+V     +  G  +AVK L       R    I   +  + 
Sbjct: 47  WEV-PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS------RPFQSIIHAKRTY- 98
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E+ +   + H NV   +      + L    D             +V +  G  L + + 
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFND-----------VYLVTHLMGADLNNIV- 146
Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
             + +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR  
Sbjct: 147 --KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 202
Query: 272 ASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
                +MTG   T  Y APE+ LN   YN   D++S G  + E+      +P
Sbjct: 203 -HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFP 253

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 21/134 (15%)
Query: 196 VVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           +V E   GG++ S++ K R   +L   VV+Q   D+A  L +L +K I HRD+K EN+L 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKGIAHRDLKPENILC 144
Query: 255 D---KTRTVKIADFGVA---RLEA-----SNPHDMTGETGTLGYMAPEVL-----NGSAY 298
           +   +   VKI DF +    +L       S P  +T   G+  YMAPEV+       S Y
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT-PCGSAEYMAPEVVEAFSEEASIY 203
Query: 299 NRKCDVYSFGICLW 312
           +++CD++S G+ L+
Sbjct: 204 DKRCDLWSLGVILY 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 199
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 200 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 247

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 195
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 196 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 179 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 226

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 18/189 (9%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+E   GG L   ++ N+R K A   +    + LA  + YL    I+HRD+K EN+LL 
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENGIIHRDLKPENVLLS 287
Query: 256 KTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGI 309
                  +KI DFG +++       M    GT  Y+APEVL     + YNR  D +S G+
Sbjct: 288 SQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 346
Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPD 363
            L   + C   YP  S      ++  Q      N  PE+         +++K+    +P 
Sbjct: 347 IL---FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 364 KRPEMDEVV 372
            R   +E +
Sbjct: 404 ARFTTEEAL 412

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 182
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 186
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 187 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 234

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 197 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 244

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           WE+ P   +       G +G+V   I    G+ VA+K L     S   ++EI + RA   
Sbjct: 20  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRA--Y 71
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF--CCVVVEYCHGGALKSY 209
           +E+ +   + H NV   +      S L             NF    +V+ +      K  
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLR------------NFYDFYLVMPFMQTDLQKIM 119
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
            +K    K+ +     L   + +GL Y+ S  +VHRD+K  N+ +++   +KI DFG+AR
Sbjct: 120 GLKFSEEKIQY-----LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 270 LEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
              +   +MTG   T  Y APEV L+   YN+  D++S G  + E+
Sbjct: 175 HADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 189 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 189 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 236

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 183
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 188
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 189 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 236

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 181
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 182 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 197 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 179 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 119 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 175
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 176 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 178
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 179 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 195
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 196 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 243

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 187
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 188 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G+ + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT  Y+AP ++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G+ + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 181
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 182 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +MTG   T 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATR 182
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 173
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 174 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 4/110 (3%)
Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
           + +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+ R    
Sbjct: 118 KSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR---H 174
Query: 274 NPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
              +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +MTG   T 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATR 182
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 103 IKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           +K     G++    R I+   ++  AVK++D  +     E EI  LR             
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL-LRYG----------- 73
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HPN+            L    D+G       +  VV E   GG L   ++  R++  + 
Sbjct: 74  QHPNIIT----------LKDVYDDG------KYVYVVTELMKGGELLDKIL--RQKFFSE 115
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENML-LDKT---RTVKIADFGVAR-LEASNP 275
           +    +   + + + YL ++ +VHRD+K  N+L +D++    +++I DFG A+ L A N 
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 276 HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY---PDLSFSEVTSA 332
             MT    T  ++APEVL    Y+  CD++S G+ L+ +     P+   PD +  E+ + 
Sbjct: 176 LLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 333 V 333
           +
Sbjct: 235 I 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 173
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 174 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 221

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 108 ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G F  V R I    GQ  AVK++D  + +         L+    +E ++ H L HP++
Sbjct: 35  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK----REASICHMLKHPHI 90
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VV 223
            +          L   + +G + M       V E+  G  L   ++K       +   V 
Sbjct: 91  VEL---------LETYSSDGMLYM-------VFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
                 +   L Y     I+HRDVK   +LL   + +  VK+  FGVA     +     G
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             GT  +MAPEV+    Y +  DV+  G+ L+ +    +P+
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +MTG   T 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATR 182
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK-IVHRDVKTENMLLDKTRTVKI 262
           G     L K  +  +  +++ ++ + + + L YL+ K  ++HRDVK  N+LLD+   +K+
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYC 316
            DFG++ RL      D +   G   YMAPE ++        Y+ + DV+S GI L E+  
Sbjct: 167 CDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS--LANVMKRCWDANPDKRPEMDEVV 372
              PY +          V Q   P +P     S    + +K C   +  KRP+ ++++
Sbjct: 225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 35/291 (12%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q +E+    L       RG +G V   R +  GQ +AVK +     S   +  +  L  +
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
                     +D P    F GA     ++ I             C  +++       K  
Sbjct: 104 M-------RTVDCPFTVTFYGALFREGDVWI-------------CMELMDTSLDKFYKQV 143
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA 268
           +  ++ + +   ++ ++A+ + + L +L SK  ++HRDVK  N+L++    VK+ DFG++
Sbjct: 144 I--DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201
Query: 269 RLEASNPHDMTGETGTLGYMAPE----VLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD- 323
                +    T + G   YMAPE     LN   Y+ K D++S GI + E+     PY   
Sbjct: 202 GYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 260
Query: 324 -LSFSEVTSAVVRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEVV 372
              F ++   V  +   P++P    S+   +   +C   N  +RP   E++
Sbjct: 261 GTPFQQLKQVV--EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 118 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 174
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 175 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 27/221 (12%)
Query: 108 ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            +G F  V R I    GQ  AVK++D  + +         L+    +E ++ H L HP++
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK----REASICHMLKHPHI 88
Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VV 223
            +          L   + +G + M       V E+  G  L   ++K       +   V 
Sbjct: 89  VEL---------LETYSSDGMLYM-------VFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
                 +   L Y     I+HRDVK   +LL   + +  VK+  FGVA     +     G
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             GT  +MAPEV+    Y +  DV+  G+ L+ +    +P+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 36/305 (11%)
Query: 107 FARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G F  V R +     Q+ A K+++  + S R   ++        +E  +   L HPN
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-------EREARICRLLKHPN 91
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +   +          ++ G       F  +V +   GG L   ++   R   +     
Sbjct: 92  IVRLHDSI---------SEEG-------FHYLVFDLVTGGELFEDIVA--REYYSEADAS 133
Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPHDMTGE 281
                +   ++++    IVHRD+K EN+LL    K   VK+ADFG+A           G 
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF 193
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD---LSFSEVTSAVVRQNL 338
            GT GY++PEVL    Y +  D+++ G+ L+ +     P+ D       +   A      
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFP 253
Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCF 398
            PE     P +  N++ +    NP KR   D+ +        S    M+   + +   C 
Sbjct: 254 SPEWDTVTPEA-KNLINQMLTINPAKRITADQALKHPWVCQRSTVASMM--HRQETVECL 310
Query: 399 RKYRG 403
           RK+  
Sbjct: 311 RKFNA 315

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG---QDVAVKLLDWGEESHRSEAEIASLRAAF 150
           WE+ P +L        G +G+V    YD    Q VAVK L       R    +   R  +
Sbjct: 16  WEV-PQRLQGLRPVGSGAYGSVCSA-YDARLRQKVAVKKLS------RPFQSLIHARRTY 67
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +E+ +   L H NV   +      + +             +F  V +     GA  + +
Sbjct: 68  -RELRLLKHLKHENVIGLLDVFTPATSIE------------DFSEVYLVTTLMGADLNNI 114
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
           +K +   L+ + V  L   L RGL Y+ S  I+HRD+K  N+ +++   ++I DFG+AR 
Sbjct: 115 VKCQ--ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR- 171
Query: 271 EASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
                 +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 172 --QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 222

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 29/243 (11%)
Query: 105 GAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           G    G++G V   R    GQ VA+K     E+          ++    +E+ +  +L H
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-------PVIKKIALREIRMLKQLKH 61
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PN+   +        L++                V EYC    L    +   +R +   +
Sbjct: 62  PNLVNLLEVFRRKRRLHL----------------VFEYCDHTVLHE--LDRYQRGVPEHL 103
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           V  +     + +++      +HRDVK EN+L+ K   +K+ DFG ARL          E 
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 283 GTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 341
            T  Y +PE+L G + Y    DV++ G    E+      +P  S  +    ++R+ L   
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDL 222
Query: 342 IPR 344
           IPR
Sbjct: 223 IPR 225

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 111 VIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TA 169
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 333 VVRQ 336
           V+ Q
Sbjct: 230 VIEQ 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT E  T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV +  ++ HPN+      T+     N +TD            +++E   GG L
Sbjct: 59  REEIEREVNILREIRHPNII-----TLHDIFEN-KTD----------VVLILELVSGGEL 102
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L      Q    +  G+ YL SK+I H D+K EN MLLDK      +K+
Sbjct: 103 FDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 160
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A ++EA N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 161 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 322 PDLSFSEVTSAV--VRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              +  E  + +  V  +   E          + ++R    +P +R
Sbjct: 219 LGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 264

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTL 285
           A ++  GL ++ ++ +V+RD+K  N+LLD+   V+I+D G+A       PH      GT 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 286 GYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GYMAPEVL  G AY+   D +S G  L+++     P+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTL 285
           A ++  GL ++ ++ +V+RD+K  N+LLD+   V+I+D G+A       PH      GT 
Sbjct: 297 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 353
Query: 286 GYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GYMAPEVL  G AY+   D +S G  L+++     P+
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV +  ++ HPN+      T+     N +TD            +++E   GG L
Sbjct: 73  REEIEREVNILREIRHPNII-----TLHDIFEN-KTD----------VVLILELVSGGEL 116
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L      Q    +  G+ YL SK+I H D+K EN MLLDK      +K+
Sbjct: 117 FDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 174
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A ++EA N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 175 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 322 PDLSFSEVTSAV--VRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              +  E  + +  V  +   E          + ++R    +P +R
Sbjct: 233 LGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 278

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTL 285
           A ++  GL ++ ++ +V+RD+K  N+LLD+   V+I+D G+A       PH      GT 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 286 GYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GYMAPEVL  G AY+   D +S G  L+++     P+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 5/97 (5%)
Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGETGTL 285
           A ++  GL ++ ++ +V+RD+K  N+LLD+   V+I+D G+A       PH      GT 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 286 GYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GYMAPEVL  G AY+   D +S G  L+++     P+
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           +V+EY  GG + S+L   R  + +       A  +     YL S  +++RD+K EN+L+D
Sbjct: 118 MVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 256 KTRTVKIADFGVARLEASNPHDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           +   +++ DFG A+        + G T    GT   +APE++    YN+  D ++ G+ +
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 312 WEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +E+     P+    P   + ++ S  VR       P    S L ++++     +  KR
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKVR------FPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV +  ++ HPN+      T+     N +TD            +++E   GG L
Sbjct: 52  REEIEREVNILREIRHPNII-----TLHDIFEN-KTD----------VVLILELVSGGEL 95
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L      Q    +  G+ YL SK+I H D+K EN MLLDK      +K+
Sbjct: 96  FDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A ++EA N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 154 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI D+G+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F QE+ +   LDHPN+ +               DN  I        +V+E C GG L   
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETF---------EDNTDI-------YLVMELCTGGELFER 113
Query: 210 LIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIAD 264
           ++  R  R   A +++     D+   ++Y     + HRD+K EN L         +K+ D
Sbjct: 114 VVHKRVFRESDAARIM----KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 169
Query: 265 FGV-ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           FG+ AR +      M  + GT  Y++P+VL G  Y  +CD +S G+ ++ + C   P+
Sbjct: 170 FGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 18/145 (12%)
Query: 233 GLSYLQSKKIVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
            + +  S+ +VHRD+K EN+L+D  R   K+ DFG   L    P+  T   GT  Y  PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPPE 208
Query: 292 VLNGSAYNR-KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI---PRCCP 347
            ++   Y+     V+S GI L+++ C D+P+      E    ++   L       P CC 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELHFPAHVSPDCC- 261
Query: 348 SSLANVMKRCWDANPDKRPEMDEVV 372
                +++RC    P  RP ++E++
Sbjct: 262 ----ALIRRCLAPKPSSRPSLEEIL 282

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F QE+ +   LDHPN+ +               DN  I +       V+E C GG L   
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETF---------EDNTDIYL-------VMELCTGGELFER 96
Query: 210 LIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIAD 264
           ++  R  R   A +++     D+   ++Y     + HRD+K EN L         +K+ D
Sbjct: 97  VVHKRVFRESDAARIM----KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 152
Query: 265 FGV-ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           FG+ AR +      M  + GT  Y++P+VL G  Y  +CD +S G+ ++ + C   P+
Sbjct: 153 FGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 196
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +M G   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 197 DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 244

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           WE+ P   +       G +G+V   I    G+ VA+K L     S   ++EI + RA   
Sbjct: 38  WEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRA--Y 89
Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF--CCVVVEYCHGGALKSY 209
           +E+ +   + H NV   +      S L             NF    +V+ +      K  
Sbjct: 90  RELLLLKHMQHENVIGLLDVFTPASSLR------------NFYDFYLVMPFMQTDLQKIM 137
Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
            ++    K+ +     L   + +GL Y+ S  +VHRD+K  N+ +++   +KI DFG+AR
Sbjct: 138 GMEFSEEKIQY-----LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192
Query: 270 LEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
              +   +MTG   T  Y APEV L+   YN+  D++S G  + E+
Sbjct: 193 HADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 235

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 107 FARGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G F  V R   I  GQ+ A K+++  + S R   ++        +E  +   L HPN
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL-------EREARICRLLKHPN 64
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA-FKVV 223
           + +   +          ++ G       F  +V +   GG L   ++       A     
Sbjct: 65  IVRLHDSI---------SEEG-------FHYLVFDLVTGGELFEDIVAREYYSEADASHC 108
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
           IQ  L+    +++     IVHRD+K EN+LL    K   VK+ADFG+A     +     G
Sbjct: 109 IQQILE---SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
             GT GY++PEVL    Y +  D+++ G+ L+ +     P+ D
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 44/232 (18%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           ++K     G++    R ++   ++  AVK++D  +     E EI  LR            
Sbjct: 30  VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL-LRYG---------- 78
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RR 216
             HPN+             ++  D  H+        +V E   GG L   +++ +    R
Sbjct: 79  -QHPNIITL---------KDVYDDGKHV-------YLVTELMRGGELLDKILRQKFFSER 121
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML-LDKT---RTVKIADFGVAR-LE 271
           + +F     +   + + + YL S+ +VHRD+K  N+L +D++     ++I DFG A+ L 
Sbjct: 122 EASF-----VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           A N   MT    T  ++APEVL    Y+  CD++S GI L+ +     P+ +
Sbjct: 177 AENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 31/249 (12%)
Query: 103 IKGAFARGTFGTVHRGIYDGQD--VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I     RG FG V        D   A+K+L+  E   R+E       A F +E  V    
Sbjct: 78  ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDVLVNG 131
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
           D   +T        T     Q DN           +V++Y  GG L + L K   R    
Sbjct: 132 DSKWIT--------TLHYAFQDDNN--------LYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG-VARLEASNPHDMT 279
                LA ++   +  +     VHRD+K +N+L+D    +++ADFG   +L        +
Sbjct: 176 MARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 280 GETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
              GT  Y++PE+L         Y  +CD +S G+C++E+   + P+   S  E    ++
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294
Query: 335 RQNLRPEIP 343
               R + P
Sbjct: 295 NHKERFQFP 303

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 44/232 (18%)
Query: 102 IIKGAFARGTFGTVHRGIYDGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           ++K     G++    R ++   ++  AVK++D  +     E EI  LR            
Sbjct: 30  VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL-LRYG---------- 78
Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR---RR 216
             HPN+             ++  D  H+        +V E   GG L   +++ +    R
Sbjct: 79  -QHPNIITL---------KDVYDDGKHV-------YLVTELMRGGELLDKILRQKFFSER 121
Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML-LDKT---RTVKIADFGVAR-LE 271
           + +F     +   + + + YL S+ +VHRD+K  N+L +D++     ++I DFG A+ L 
Sbjct: 122 EASF-----VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           A N   MT    T  ++APEVL    Y+  CD++S GI L+ +     P+ +
Sbjct: 177 AENGLLMT-PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 37/277 (13%)
Query: 107 FARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             RG +G V   R +  GQ +AVK +     S   +  +  L  +          +D P 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM-------RTVDCPF 67
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
              F GA     ++ I             C  +++       K  +  ++ + +   ++ 
Sbjct: 68  TVTFYGALFREGDVWI-------------CMELMDTSLDKFYKQVI--DKGQTIPEDILG 112
Query: 225 QLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGET 282
           ++A+ + + L +L SK  ++HRDVK  N+L++    VK+ DFG++  L      D+  + 
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DA 170
Query: 283 GTLGYMAPE----VLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD--LSFSEVTSAVVRQ 336
           G   YMAPE     LN   Y+ K D++S GI + E+     PY      F ++   V  +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--E 228
Query: 337 NLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEVV 372
              P++P    S+   +   +C   N  +RP   E++
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 199
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +M G   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 200 DEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 247

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 107 FARGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G F  V R   I  GQ+ A K+++  + S R   ++        +E  +   L HPN
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL-------EREARICRLLKHPN 64
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA-FKVV 223
           + +   +          ++ G       F  +V +   GG L   ++       A     
Sbjct: 65  IVRLHDSI---------SEEG-------FHYLVFDLVTGGELFEDIVAREYYSEADASHC 108
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
           IQ  L+    +++     IVHRD+K EN+LL    K   VK+ADFG+A     +     G
Sbjct: 109 IQQILE---SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
             GT GY++PEVL    Y +  D+++ G+ L+ +     P+ D
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +M G   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +M G   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDM 278
           +VIQ  L     + YL    IVHRD+K EN+L    ++   + I DFG++++E +    M
Sbjct: 110 LVIQQVLS---AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--M 164
Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           +   GT GY+APEVL    Y++  D +S G+  + + C   P+
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 112 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 170
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 230
Query: 333 VVRQ 336
           V+ Q
Sbjct: 231 VIEQ 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 177
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 237
Query: 333 VVRQ 336
           V+ Q
Sbjct: 238 VIEQ 241

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 169
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 333 VVRQ 336
           V+ Q
Sbjct: 230 VIEQ 233

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +M G   T 
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATR 182
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 117 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 175
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 176 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 235
Query: 333 VVRQ 336
           V+ Q
Sbjct: 236 VIEQ 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 112 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 170
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 230
Query: 333 VVRQ 336
           V+ Q
Sbjct: 231 VIEQ 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 177
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 237
Query: 333 VVRQ 336
           V+ Q
Sbjct: 238 VIEQ 241

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 156 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 214
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274
Query: 333 VVRQ 336
           V+ Q
Sbjct: 275 VIEQ 278

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           GT+GTV +         V L     +  R + +   + ++  +E+ +  +L H N+ +  
Sbjct: 13  GTYGTVFKAKNRETHEIVAL-----KRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
                  +L +                V E+C    LK Y   +    L  ++V      
Sbjct: 68  DVLHSDKKLTL----------------VFEFCDQD-LKKYF-DSCNGDLDPEIVKSFLFQ 109
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMA 289
           L +GL +  S+ ++HRD+K +N+L+++   +K+ADFG+AR         + E  TL Y  
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 290 PEVLNGSA-YNRKCDVYSFGICLWEI 314
           P+VL G+  Y+   D++S G    E+
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 62/124 (50%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 156 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 214
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P   + +  + 
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274
Query: 333 VVRQ 336
           V+ Q
Sbjct: 275 VIEQ 278

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI  FG+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 25/230 (10%)
Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
           A   +E+ +  +L H NV + +       +  +               +V+EYC  G ++
Sbjct: 51  ANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY--------------MVMEYCVCG-MQ 95
Query: 208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
             L     ++            L  GL YL S+ IVH+D+K  N+LL    T+KI+  GV
Sbjct: 96  EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV 155
Query: 268 ARLEASNPH--DMTGET--GTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPY 321
           A  EA +P   D T  T  G+  +  PE+ NG  +    K D++S G+ L+ I     P+
Sbjct: 156 A--EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
              +  ++   + + +    IP  C   L++++K   +  P KR  + ++
Sbjct: 214 EGDNIYKLFENIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI DF +AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 9/168 (5%)
Query: 242 IVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY 298
           +VHRD+K EN+LL    K   VK+ADFG+A     +     G  GT GY++PEVL   AY
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 299 NRKCDVYSFGICLWEIYCCDMPYPD---LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
            +  D+++ G+ L+ +     P+ D       +   A       PE     P +  N++ 
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEA-KNLIN 242
Query: 356 RCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVDQPQGCSCFRKYRG 403
           +    NP KR    E +        S    M+   + +   C +K+  
Sbjct: 243 QMLTINPAKRITAHEALKHPWVCQRSTVASMM--HRQETVECLKKFNA 288

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 7/147 (4%)
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYM 288
           D    L++L S+ +VH DVK  N+ L      K+ DFG+  +E         + G   YM
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL-VELGTAGAGEVQEGDPRYM 223
Query: 289 APEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 347
           APE+L GS Y    DV+S G+ + E+ C  ++P+    + ++        L PE      
Sbjct: 224 APELLQGS-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY----LPPEFTAGLS 278
Query: 348 SSLANVMKRCWDANPDKRPEMDEVVAM 374
           S L +V+    + +P  R   + ++A+
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEALLAL 305

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 177
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237
Query: 333 VVRQ 336
           V+ Q
Sbjct: 238 VIEQ 241

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 7/158 (4%)
Query: 192 NFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           N   +V++Y  GG L + L+     KL   +      ++   +  +     VHRD+K +N
Sbjct: 163 NHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDN 221
Query: 252 MLLDKTRTVKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVY 305
           +LLD    +++ADFG   ++        +   GT  Y++PE+L         Y  +CD +
Sbjct: 222 VLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281
Query: 306 SFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           S G+C++E+   + P+   S  E    ++    R + P
Sbjct: 282 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 319

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI D G+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 176
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                MT    T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 333 VVRQ 336
           V+ Q
Sbjct: 237 VIEQ 240

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 7/158 (4%)
Query: 192 NFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           N   +V++Y  GG L + L+     KL   +      ++   +  +     VHRD+K +N
Sbjct: 147 NHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDN 205
Query: 252 MLLDKTRTVKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVY 305
           +LLD    +++ADFG   ++        +   GT  Y++PE+L         Y  +CD +
Sbjct: 206 VLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 265
Query: 306 SFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           S G+C++E+   + P+   S  E    ++    R + P
Sbjct: 266 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 303

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI D G+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 72/134 (53%), Gaps = 21/134 (15%)
Query: 196 VVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
           +V E   GG++ +++ K +    + A +VV     D+A  L +L +K I HRD+K EN+L
Sbjct: 88  LVFEKLQGGSILAHIQKQKHFNEREASRVV----RDVAAALDFLHTKGIAHRDLKPENIL 143
Query: 254 L---DKTRTVKIADF----GVARLEASNP---HDMTGETGTLGYMAPEVL-----NGSAY 298
               +K   VKI DF    G+    +  P    ++T   G+  YMAPEV+       + Y
Sbjct: 144 CESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFY 203
Query: 299 NRKCDVYSFGICLW 312
           +++CD++S G+ L+
Sbjct: 204 DKRCDLWSLGVVLY 217

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VI + LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  +
Sbjct: 116 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS 175
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           +N   MT    T  Y APEV+ G  Y    D++S G  + E+
Sbjct: 176 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 193 FCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
           +  VV E   GG L   ++  R++  + +    +   + + + YL ++ +VHRD+K  N+
Sbjct: 90  YVYVVTELXKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNI 147
Query: 253 L-LDKT---RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG 308
           L +D++    +++I DFG A+   +    +     T  ++APEVL    Y+  CD++S G
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 309 ICLWEIYCCDMPY---PDLSFSEVTSAV 333
           + L+       P+   PD +  E+ + +
Sbjct: 208 VLLYTXLTGYTPFANGPDDTPEEILARI 235

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 4/108 (3%)
Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
           +KL    V  L   + RGL Y+ S  I+HRD+K  N+ +++   +KI D G+AR      
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTD 176
Query: 276 HDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            +MTG   T  Y APE+ LN   YN+  D++S G  + E+      +P
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 224

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
           I +  + L  + V      L RGL Y+ S +++HRD+K  N+L+++   +KI DFG+AR 
Sbjct: 149 IIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 208
Query: 271 EASNPHD----MTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
             ++P +    MT    T  Y APE+ L+   Y +  D++S G    E+      +P
Sbjct: 209 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 265

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           GT+GTV +         V L     +  R + +   + ++  +E+ +  +L H N+ +  
Sbjct: 13  GTYGTVFKAKNRETHEIVAL-----KRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALD 229
                  +L +                V E+C    LK Y   +    L  ++V      
Sbjct: 68  DVLHSDKKLTL----------------VFEFCDQD-LKKYF-DSCNGDLDPEIVKSFLFQ 109
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMA 289
           L +GL +  S+ ++HRD+K +N+L+++   +K+A+FG+AR         + E  TL Y  
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 290 PEVLNGSA-YNRKCDVYSFGICLWEI 314
           P+VL G+  Y+   D++S G    E+
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
           I +  + L  + V      L RGL Y+ S +++HRD+K  N+L+++   +KI DFG+AR 
Sbjct: 148 IIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207
Query: 271 EASNPHD----MTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
             ++P +    MT    T  Y APE+ L+   Y +  D++S G    E+      +P
Sbjct: 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGCLLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET- 282
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +         + 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 283 -GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   + ++  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 32/223 (14%)
Query: 107 FARGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G F  V R   +  GQ+ A K+++  + S R   ++        +E  +   L HPN
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL-------EREARICRLLKHPN 82
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA-FKVV 223
           + +   +          ++ GH         ++ +   GG L   ++       A     
Sbjct: 83  IVRLHDSI---------SEEGH-------HYLIFDLVTGGELFEDIVAREYYSEADASHC 126
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPHDMTG 280
           IQ  L+    + +     +VHRD+K EN+LL    K   VK+ADFG+A           G
Sbjct: 127 IQQILE---AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 183
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
             GT GY++PEVL    Y +  D+++ G+ L+ +     P+ D
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 226

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 19/165 (11%)
Query: 192 NFCCVVVEYCHGGALKSYLIKNRRRKLA-----FKVVIQLALDLARGLSYLQSKKIVHRD 246
           N+  +V+EY  GG L + L K   R  A     +   I +A+D    L Y      VHRD
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY------VHRD 187
Query: 247 VKTENMLLDKTRTVKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR----- 300
           +K +N+LLD+   +++ADFG   +L A          GT  Y++PE+L            
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247
Query: 301 --KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
             +CD ++ G+  +E++    P+   S +E    +V       +P
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VIQ+ LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR  A
Sbjct: 120 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TA 178
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
                M     T  Y APEV+ G  Y    D++S G  + E+    + +P     +  + 
Sbjct: 179 GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 238
Query: 333 VVRQ 336
           V+ Q
Sbjct: 239 VIEQ 242

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPN+          +++                 +++E   GG L
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDV----------------VLILELVSGGEL 102
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L+ +        +  G++YL +KKI H D+K EN MLLDK      +K+
Sbjct: 103 FDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A  E  +  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 161 IDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 223 VIQLALDLAR----------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           VI + LD  R          G+ +L S  I+HRD+K  N+++    T+KI DFG+AR   
Sbjct: 118 VIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 177
Query: 273 SNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           +N   MT    T  Y APEV+ G  Y    D++S G  + E+
Sbjct: 178 TN-FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 21  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 73
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 74  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 113
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 114 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-M 252
             +++E   GG L  +L   ++  L+ +        +  G++YL +KKI H D+K EN M
Sbjct: 90  VVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 253 LLDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           LLDK      +K+ DFG+A  E  +  +     GT  ++APE++N      + D++S G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 310 CLWEIYCCDMPY 321
             + +     P+
Sbjct: 207 ITYILLSGASPF 218

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 44  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 96
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 97  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 135
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET- 282
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +         + 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 283 -GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 41  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 93
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 94  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 132
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA--SNPHDMTGE 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +  S        
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 20  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 72
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 73  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 112
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 113 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +A   +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 19  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 71
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 72  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 111
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 57  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 100
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 101 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 57  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 100
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 101 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 18  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 70
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 71  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 110
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 111 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-M 252
             +++E   GG L  +L +  +  L+ +        +  G++YL +KKI H D+K EN M
Sbjct: 90  VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 253 LLDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           LLDK      +K+ DFG+A  E  +  +     GT  ++APE++N      + D++S G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 310 CLWEIYCCDMPY 321
             + +     P+
Sbjct: 207 ITYILLSGASPF 218

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 44  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 96
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 97  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 135
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 41  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 93
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 94  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 132
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 41  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 93
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 94  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 132
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-M 252
             +++E   GG L  +L +  +  L+ +        +  G++YL +KKI H D+K EN M
Sbjct: 90  VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 253 LLDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           LLDK      +K+ DFG+A  E  +  +     GT  ++APE++N      + D++S G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 310 CLWEIYCCDMPY 321
             + +     P+
Sbjct: 207 ITYILLSGASPF 218

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 46  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 98
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 99  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 137
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 138 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-M 252
             +++E   GG L  +L +  +  L+ +        +  G++YL +KKI H D+K EN M
Sbjct: 90  VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 253 LLDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           LLDK      +K+ DFG+A  E  +  +     GT  ++APE++N      + D++S G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 310 CLWEIYCCDMPY 321
             + +     P+
Sbjct: 207 ITYILLSGASPF 218

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-M 252
             +++E   GG L  +L +  +  L+ +        +  G++YL +KKI H D+K EN M
Sbjct: 90  VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 253 LLDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           LLDK      +K+ DFG+A  E  +  +     GT  ++APE++N      + D++S G+
Sbjct: 148 LLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 310 CLWEIYCCDMPY 321
             + +     P+
Sbjct: 207 ITYILLSGASPF 218

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 40  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 92
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 93  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 132
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-- 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +         +  
Sbjct: 133 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 192
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 43  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 95
Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
           K             Q D   + G+          Y   G L  Y+    R+  +F     
Sbjct: 96  KLY--------FTFQDDEKLYFGL---------SYAKNGELLKYI----RKIGSFDETCT 134
Query: 226 --LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE-- 281
                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +           
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 25  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 77
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 78  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 117
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 118 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 48  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 100
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 101 KLYFCFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 140
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 141 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 200
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 201 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 104 KGAFARGTFGT-VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
           K     G  GT V+RG++D +DVAVK +   E    ++ E+  LR +           +H
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRI-LPECFSFADREVQLLRES----------DEH 77
Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PNV ++       +E + Q           F  + +E C    L+ Y+ +     L  + 
Sbjct: 78  PNVIRYF-----CTEKDRQ-----------FQYIAIELC-AATLQEYVEQKDFAHLGLEP 120
Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT-----VKIADFGVARLEASNPHD 277
            I L      GL++L S  IVHRD+K  N+L+            I+DFG+ +  A   H 
Sbjct: 121 -ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 278 M---TGETGTLGYMAPEVLNGSAYNR---KCDVYSFGICLWEI 314
               +G  GT G++APE+L+           D++S G   + +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 110 GTFGTV--HRGIYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           G+F TV   R +   ++ A+K+L   E+ H   E ++  +    T+E  V  +LDHP   
Sbjct: 40  GSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYV----TRERDVMSRLDHPFFV 92
Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ- 225
           K         +L       + G+          Y   G L  Y+    R+  +F      
Sbjct: 93  KLYFTFQDDEKL-------YFGL---------SYAKNGELLKYI----RKIGSFDETCTR 132
Query: 226 -LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE--T 282
               ++   L YL  K I+HRD+K EN+LL++   ++I DFG A++ +            
Sbjct: 133 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +A   +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 225 QLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGET 282
           ++A+ + + L +L SK  ++HRDVK  N+L++    VK  DFG++  L      D+  + 
Sbjct: 140 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDI--DA 197
Query: 283 GTLGYMAPE----VLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD--LSFSEVTSAVVRQ 336
           G   Y APE     LN   Y+ K D++S GI   E+     PY      F ++   V  +
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV--E 255
Query: 337 NLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEV 371
              P++P    S+   +   +C   N  +RP   E+
Sbjct: 256 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            +++E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILILELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTR---TVKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +A   +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQGKAFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 26/176 (14%)
Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSY 209
           T+E  V  +LDHP   K             Q D   + G+          Y   G L  Y
Sbjct: 78  TRERDVMSRLDHPFFVKLY--------FTFQDDEKLYFGL---------SYAKNGELLKY 120
Query: 210 LIKNRRRKLAFKVVIQ--LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           +    R+  +F          ++   L YL  K I+HRD+K EN+LL++   ++I DFG 
Sbjct: 121 I----RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 268 ARLEASNPHDMTGE--TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           A++ +            GT  Y++PE+L   +  +  D+++ G  ++++     P+
Sbjct: 177 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 27/226 (11%)
Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R    +EV++  ++ HPNV      T+     N +TD            ++ E   GG L
Sbjct: 58  REDIEREVSILKEIQHPNVI-----TLHEVYEN-KTD----------VILIGELVAGGEL 101
Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN-MLLDKTRT---VKI 262
             +L +  +  L  +   +    +  G+ YL S +I H D+K EN MLLD+      +KI
Sbjct: 102 FDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 263 ADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
            DFG+A +++  N  +     GT  ++APE++N      + D++S G+  + +     P+
Sbjct: 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCC-PSSLA-NVMKRCWDANPDKR 365
              +  E  + V   N   E       S+LA + ++R    +P KR
Sbjct: 218 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           L   + +GL Y+ +  I+HRD+K  N+ +++   +KI DFG+AR   S   +M G   T 
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMXGXVVTR 189
Query: 286 GYMAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            Y APEV LN   Y +  D++S G  + E+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 110 GTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G FG VH+      G  +A K++       + E +          E++V ++LDH N+ +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---------NEISVMNQLDHANLIQ 150
Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
              A    +++                 +V+EY  GG L   +I           ++ + 
Sbjct: 151 LYDAFESKNDI----------------VLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHD-MTGETGT 284
             +  G+ ++    I+H D+K EN+L      + +KI DFG+AR     P + +    GT
Sbjct: 195 -QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPREKLKVNFGT 251
Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             ++APEV+N    +   D++S G+  + +     P+
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 107 FARGTFGTVHR--GIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             +G F  V R   +  GQ+ A  +++  + S R   ++        +E  +   L HPN
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-------EREARICRLLKHPN 71
Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA-FKVV 223
           + +   +          ++ GH         ++ +   GG L   ++       A     
Sbjct: 72  IVRLHDSI---------SEEGH-------HYLIFDLVTGGELFEDIVAREYYSEADASHC 115
Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPHDMTG 280
           IQ  L+    + +     +VHR++K EN+LL    K   VK+ADFG+A           G
Sbjct: 116 IQQILE---AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
             GT GY++PEVL    Y +  D+++ G+ L+ +     P+ D
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 34/192 (17%)
Query: 199 EYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           EYC+GG+L   + +N R    FK   +  L L + RGL Y+ S  +VH D+K  N+ + +
Sbjct: 87  EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 146
Query: 257 TRT-------------------VKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNGS 296
           T                      KI D G V R+  S+P     E G   ++A EVL  +
Sbjct: 147 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--SSPQ---VEEGDSRFLANEVLQEN 201
Query: 297 -AYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVM 354
             +  K D+++  + +      + +P     + E     +RQ   P IP+        ++
Sbjct: 202 YTHLPKADIFALALTVVXAAGAEPLPRNGDQWHE-----IRQGRLPRIPQVLSQEFTELL 256
Query: 355 KRCWDANPDKRP 366
           K     +P++RP
Sbjct: 257 KVMIHPDPERRP 268

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 32/191 (16%)
Query: 199 EYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           EYC+GG+L   + +N R    FK   +  L L + RGL Y+ S  +VH D+K  N+ + +
Sbjct: 91  EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 150
Query: 257 TRT-------------------VKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNGS 296
           T                      KI D G V R+  S+P     E G   ++A EVL  +
Sbjct: 151 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--SSPQ---VEEGDSRFLANEVLQEN 205
Query: 297 -AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
             +  K D+++  + +     C      L  +      +RQ   P IP+        ++K
Sbjct: 206 YTHLPKADIFALALTV----VCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK 261
Query: 356 RCWDANPDKRP 366
                +P++RP
Sbjct: 262 VMIHPDPERRP 272

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 32/191 (16%)
Query: 199 EYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           EYC+GG+L   + +N R    FK   +  L L + RGL Y+ S  +VH D+K  N+ + +
Sbjct: 89  EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 148
Query: 257 TRT-------------------VKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNGS 296
           T                      KI D G V R+  S+P     E G   ++A EVL  +
Sbjct: 149 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--SSPQ---VEEGDSRFLANEVLQEN 203
Query: 297 -AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
             +  K D+++  + +     C      L  +      +RQ   P IP+        ++K
Sbjct: 204 YTHLPKADIFALALTV----VCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK 259
Query: 356 RCWDANPDKRP 366
                +P++RP
Sbjct: 260 VMIHPDPERRP 270

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 32/191 (16%)
Query: 199 EYCHGGALKSYLIKNRRRKLAFKV--VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           EYC+GG+L   + +N R    FK   +  L L + RGL Y+ S  +VH D+K  N+ + +
Sbjct: 89  EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 148
Query: 257 TRT-------------------VKIADFG-VARLEASNPHDMTGETGTLGYMAPEVLNGS 296
           T                      KI D G V R+  S+P     E G   ++A EVL  +
Sbjct: 149 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI--SSPQ---VEEGDSRFLANEVLQEN 203
Query: 297 -AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
             +  K D+++  + +     C      L  +      +RQ   P IP+        ++K
Sbjct: 204 YTHLPKADIFALALTV----VCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK 259
Query: 356 RCWDANPDKRP 366
                +P++RP
Sbjct: 260 VMIHPDPERRP 270

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 39  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 87
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 88  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 195
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAEL 224

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 103/256 (40%), Gaps = 52/256 (20%)
Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGI---YDGQDVAVKLL---DWGEESHRSEAEIAS 145
           Q  ++  A+  I      G FG V   I     G+ VAVK++   D   E+ RSE ++  
Sbjct: 7   QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQV-- 64
Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
                         L+H N T           L     +GHI       C+V E   G +
Sbjct: 65  --------------LEHLNTTDPNSTFRCVQMLEWFEHHGHI-------CIVFELL-GLS 102
Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT-------- 257
              ++ +N         + ++A  + + +++L S K+ H D+K EN+L  ++        
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 258 ------RT-----VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYS 306
                 RT     +K+ DFG A  +  +   +     T  Y APEV+    +++ CDV+S
Sbjct: 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVS---TRHYRAPEVILALGWSQPCDVWS 219
Query: 307 FGICLWEIYCCDMPYP 322
            G  L E Y     +P
Sbjct: 220 IGCILIEYYLGFTVFP 235

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 32  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 80
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 81  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 188
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAEL 217

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 50  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 98
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 99  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 206
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAEL 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 35  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 83
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 84  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 191
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAEL 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 43  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 92  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 199
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 44  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 92
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 93  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 200
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAEL 229

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 43  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 92  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 199
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD----------MTGE 281
           R +  L    ++HRD+K  N+L++    +K+ DFG+AR+   +  D          MT  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 282 TGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
             T  Y APEV+  SA Y+R  DV+S G  L E++
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 65  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 114 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 221
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 188
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 238
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 239 LALRPSDRPTFEEI 252

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 31  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 80  YFFYSSGE---KKDVVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICSRY 187
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 55/125 (44%), Gaps = 4/125 (3%)
Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGSAYNRKC 302
           HRDVK EN+L+       + DFG+A           G T GTL Y APE  + S    + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 303 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL-RPEIPR-CCPSSLANVMKRCWDA 360
           D+Y+    L+E      PY     S V  A + Q + RP   R   P +   V+ R    
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLS-VXGAHINQAIPRPSTVRPGIPVAFDAVIARGXAK 275
Query: 361 NPDKR 365
           NP+ R
Sbjct: 276 NPEDR 280

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 193
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 243
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 244 LALRPSDRPTFEEI 257

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 192
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 193 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 242
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 243 LALRPSDRPTFEEI 256

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 215
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 216 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 265
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 266 LALRPSDRPTFEEI 279

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 191
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 192 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 241
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 242 LALRPSDRPTFEEI 255

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD----------MTGE 281
           R +  L    ++HRD+K  N+L++    +K+ DFG+AR+   +  D          MT  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 282 TGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
             T  Y APEV+  SA Y+R  DV+S G  L E++
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 65  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 114 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 221
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 188
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 238
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 239 LALRPSDRPTFEEI 252

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 193
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 243
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 244 LALRPSDRPTFEEI 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 193
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 194 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 243
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 244 LALRPSDRPTFEEI 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 59  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 107
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 108 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 215
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAEL 244

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 192
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 193 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 242
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 243 LALRPSDRPTFEEI 256

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 235
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 285
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 286 LALRPSDRPTFEEI 299

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 67  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 115
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 116 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 223
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAEL 252

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 36  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 84
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 85  YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 192
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAEL 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 11/95 (11%)
Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-------- 283
           R +  L    ++HRD+K  N+L++    +K+ DFG+AR+   +  D +  TG        
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 284 --TLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIY 315
             T  Y APEV+  SA Y+R  DV+S G  L E++
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 235
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 285
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 286 LALRPSDRPTFEEI 299

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 69  GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 117
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 118 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 225
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAEL 254

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 235
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 285
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 286 LALRPSDRPTFEEI 299

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 220
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 221 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 270
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 271 LALRPSDRPTFEEI 284

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 240
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 241 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 290
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 291 LALRPSDRPTFEEI 304

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 33/224 (14%)
Query: 103 IKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G FG VHR      G + A K +      H S+ E         +E+     L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVR------KEIQTMSVL 211
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP +     A    +E+                 ++ E+  GG L    + +   K++ 
Sbjct: 212 RHPTLVNLHDAFEDDNEM----------------VMIYEFMSGGELFE-KVADEHNKMSE 254
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGV-ARLEASNPHD 277
              ++    + +GL ++     VH D+K EN++    R+  +K+ DFG+ A L+      
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 278 MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           +T  TGT  + APEV  G       D++S G+  + +     P+
Sbjct: 315 VT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 169
           G+FG V++          KL D GE    +  ++   +    +E+ +  KLDH N+ +  
Sbjct: 110 GSFGVVYQA---------KLCDSGELV--AIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 158
Query: 170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL- 228
                + E   + D  ++ +       V++Y      +     +R ++    + ++L + 
Sbjct: 159 YFFYSSGE---KKDEVYLNL-------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 229 DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTGETGTLG 286
            L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+ L    P+       +  
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 266
Query: 287 YMAPEVLNGSA-YNRKCDVYSFGICLWEI 314
           Y APE++ G+  Y    DV+S G  L E+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAEL 295

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 208
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 258
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 259 LALRPSDRPTFEEI 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 207
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 208 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 257
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 258 LALRPSDRPTFEEI 271

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 227
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 228 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSSEC----QHLIRWC 277
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 278 LALRPSDRPTFEEI 291

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 207
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 208 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 257
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 258 LALRPSDRPTFEEI 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 208
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 258
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 259 LALRPSDRPTFEEI 272

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 22/115 (19%)
Query: 230 LARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL----------------EAS 273
           L + + YL S  ++HRD+K  N+LL+    VK+ADFG++R                 E +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 274 NPHD-----MTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYP 322
              D     +T    T  Y APE+L GS  Y +  D++S G  L EI C    +P
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 33/224 (14%)
Query: 103 IKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           I      G FG VHR      G + A K +      H S+ E         +E+     L
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVR------KEIQTMSVL 105
Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            HP +     A    +E+                 ++ E+  GG L    + +   K++ 
Sbjct: 106 RHPTLVNLHDAFEDDNEM----------------VMIYEFMSGGELFE-KVADEHNKMSE 148
Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGV-ARLEASNPHD 277
              ++    + +GL ++     VH D+K EN++    R+  +K+ DFG+ A L+      
Sbjct: 149 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 208
Query: 278 MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY 321
           +T  TGT  + APEV  G       D++S G+  + +     P+
Sbjct: 209 VT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 24/222 (10%)
Query: 185 GHIGMPSNFCC-------VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL 237
           G +G+P+   C       V+V    G +L+  L     RK + K V+ LA  +   + Y+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 238 QSKKIVHRDVKTENMLL---DKTRTVKIADFGV------ARLEASNPH-DMTGETGTLGY 287
            SK  +HRDVK +N L+    K   V I DFG+      AR     P+ +    TGT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---EVTSAVVRQNLRPEIPR 344
            +     G   +R+ D+ S G  L       +P+  L  +   +    +  + +   I  
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 345 CC---PSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
            C   PS  A  +  C     D +P+   +  +   +   +G
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 24/222 (10%)
Query: 185 GHIGMPSNFCC-------VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL 237
           G +G+P+   C       V+V    G +L+  L     RK + K V+ LA  +   + Y+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 238 QSKKIVHRDVKTENMLL---DKTRTVKIADFGV------ARLEASNPH-DMTGETGTLGY 287
            SK  +HRDVK +N L+    K   V I DFG+      AR     P+ +    TGT  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---EVTSAVVRQNLRPEIPR 344
            +     G   +R+ D+ S G  L       +P+  L  +   +    +  + +   I  
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 345 CC---PSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
            C   PS  A  +  C     D +P+   +  +   +   +G
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 208
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRC 357
           R   V+S GI L+++ C D+P+      E    ++R     R  +   C     ++++ C
Sbjct: 209 RSAAVWSLGILLYDMVCGDIPF------EHDEEIIRGQVFFRQRVSXEC----QHLIRWC 258
Query: 358 WDANPDKRPEMDEV 371
               P  RP  +E+
Sbjct: 259 LALRPXDRPTFEEI 272

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 12/132 (9%)
Query: 242 IVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN- 299
           ++HRD+K EN+L+D  R  +K+ DFG   L     +  T   GT  Y  PE +    Y+ 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHG 188
Query: 300 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD 359
           R   V+S GI L+++ C D+P+             RQ +         S   ++++ C  
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS--------SECQHLIRWCLA 240
Query: 360 ANPDKRPEMDEV 371
             P  RP  +E+
Sbjct: 241 LRPSDRPTFEEI 252
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	404
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-132
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-123
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-118
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-118
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-118
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-117
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-115
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-110
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-108
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-101
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-101
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-101
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-99
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-77
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-70
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-70
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-70
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-69
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-68
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-67
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-67
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-67
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-67
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-67
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-67
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-67
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-67
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-66
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-66
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-65
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-65
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-65
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-64
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-64
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-64
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-64
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-64
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-64
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-64
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-63
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-63
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-63
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-63
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-63
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-63
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-62
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-62
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-62
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-62
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-62
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-61
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-61
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-61
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-61
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-61
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-61
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-61
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-61
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-60
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-60
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-60
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-60
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-59
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-58
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-56
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-53
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-53
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-51
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-50
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-49
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-47
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-47
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-46
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-46
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-45
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-43
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-43
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-43
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-42
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-41
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-39
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-39
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-38
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-38
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-38
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-37
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-37
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-35
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-34
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-33
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-33
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-33
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-33
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-32
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-32
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-32
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-32
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-31
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-31
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-31
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-30
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-30
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-30
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-29
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-24
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  381 bits (980), Expect = e-132
 Identities = 107/320 (33%), Positives = 162/320 (50%), Gaps = 26/320 (8%)

Query: 65  HPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD 124
           H HH H        +  +     ++   + +I    L IK     G+FGTVHR  + G D
Sbjct: 3   HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62

Query: 125 VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN 184
           VAVK+L   +       E       F +EVA+  +L HPN+  F+GA      L      
Sbjct: 63  VAVKILMEQDFHAERVNE-------FLREVAIMKRLRHPNIVLFMGAVTQPPNL------ 109

Query: 185 GHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQLALDLARGLSYLQSKK-- 241
                      +V EY   G+L   L K+  R +L  +  + +A D+A+G++YL ++   
Sbjct: 110 ----------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK 301
           IVHR++K+ N+L+DK  TVK+ DFG++RL+AS         GT  +MAPEVL     N K
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 302 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
            DVYSFG+ LWE+     P+ +L+ ++V +AV  +  R EIPR     +A +++ CW   
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279

Query: 362 PDKRPEMDEVVAMLEAIDTS 381
           P KRP    ++ +L  +  S
Sbjct: 280 PWKRPSFATIMDLLRPLIKS 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  356 bits (915), Expect = e-123
 Identities = 70/291 (24%), Positives = 126/291 (43%), Gaps = 31/291 (10%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
              ID  +L           G + +G + G D+ VK+L   + S R   +       F +
Sbjct: 4   HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD-------FNE 56

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E        HPNV   +GA                  P+    ++  +   G+L + L +
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSP--------------PAPHPTLITHWMPYGSLYNVLHE 102

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDKTRTVKIADFGVARL 270
                +     ++ ALD+ARG+++L + +  I    + + ++++D+  T +I+   V   
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162

Query: 271 EASNPHDMTGETGTLGYMAPEVLNGSAYN---RKCDVYSFGICLWEIYCCDMPYPDLSFS 327
                    G      ++APE L     +   R  D++SF + LWE+   ++P+ DLS  
Sbjct: 163 F-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           E+   V  + LRP IP      ++ +MK C + +P KRP+ D +V +LE +
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  345 bits (886), Expect = e-118
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 37/296 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
            EID A+L ++     G FG V+R  + G +VAVK      +      +I+       QE
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQE 56

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             ++  L HPN+    G  +                  N C +V+E+  GG L   L   
Sbjct: 57  AKLFAMLKHPNIIALRGVCLK---------------EPNLC-LVMEFARGGPLNRVL--- 97

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKK---IVHRDVKTENMLLDKT--------RTVKI 262
             +++   +++  A+ +ARG++YL  +    I+HRD+K+ N+L+ +         + +KI
Sbjct: 98  SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157

Query: 263 ADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            DFG+AR             G   +MAPEV+  S +++  DV+S+G+ LWE+   ++P+ 
Sbjct: 158 TDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +    V   V    L   IP  CP   A +M+ CW+ +P  RP    ++  L  I
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  345 bits (887), Expect = e-118
 Identities = 84/302 (27%), Positives = 142/302 (47%), Gaps = 37/302 (12%)

Query: 90  RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLR 147
           + +   +   ++  +    +G FG VH+G    D   VA+K L  G+     E E+    
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE--GETEMIEKF 67

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
             F +EV +   L+HPN+ K  G                     N   +V+E+   G L 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMH------------------NPPRMVMEFVPCGDLY 109

Query: 208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDK-----TRTV 260
             L  ++   + + V ++L LD+A G+ Y+Q++   IVHRD+++ N+ L           
Sbjct: 110 HRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168

Query: 261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCD 318
           K+ADFG+++      H ++G  G   +MAPE +     +Y  K D YSF + L+ I   +
Sbjct: 169 KVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

Query: 319 MPYPDLSFSEVT--SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            P+ + S+ ++   + +  + LRP IP  CP  L NV++ CW  +P KRP    +V  L 
Sbjct: 226 GPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

Query: 377 AI 378
            +
Sbjct: 286 EL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  344 bits (884), Expect = e-118
 Identities = 90/306 (29%), Positives = 143/306 (46%), Gaps = 38/306 (12%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
              ID  ++ ++    RG FG V +  +  +DVA+K ++   E           R AF  
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-----------RKAFIV 50

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E+    +++HPN+ K  GA +                     C+V+EY  GG+L + L  
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNP------------------VCLVMEYAEGGSLYNVLHG 92

Query: 213 NRRR-KLAFKVVIQLALDLARGLSYLQS---KKIVHRDVKTENMLLDKTRTV-KIADFGV 267
                       +   L  ++G++YL S   K ++HRD+K  N+LL    TV KI DFG 
Sbjct: 93  AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152

Query: 268 ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
           A    ++   MT   G+  +MAPEV  GS Y+ KCDV+S+GI LWE+     P+ ++   
Sbjct: 153 ACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209

Query: 328 EVT-SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
                  V    RP + +  P  + ++M RCW  +P +RP M+E+V ++  +     G  
Sbjct: 210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269

Query: 387 IPVDQP 392
            P+  P
Sbjct: 270 EPLQYP 275

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  342 bits (880), Expect = e-117
 Identities = 71/316 (22%), Positives = 142/316 (44%), Gaps = 42/316 (13%)

Query: 78  RSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESH 137
           RS     +  S+  QEW+I   +L I     +G FG V+ G + G +VA++L+D   ++ 
Sbjct: 12  RSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDN- 69

Query: 138 RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVV 197
                      AF +EV  + +  H NV  F+GA M    L                 ++
Sbjct: 70  ------EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL----------------AII 107

Query: 198 VEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
              C G  L S + ++ +  L      Q+A ++ +G+ YL +K I+H+D+K++N+  D  
Sbjct: 108 TSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN- 165

Query: 258 RTVKIADFGVARLEA-----SNPHDMTGETGTLGYMAPEVLNGSA---------YNRKCD 303
             V I DFG+  +            +  + G L ++APE++   +         +++  D
Sbjct: 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225

Query: 304 VYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC-CPSSLANVMKRCWDANP 362
           V++ G   +E++  + P+       +    +   ++P + +      +++++  CW    
Sbjct: 226 VFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQ 284

Query: 363 DKRPEMDEVVAMLEAI 378
           ++RP   +++ MLE +
Sbjct: 285 EERPTFTKLMDMLEKL 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  336 bits (864), Expect = e-115
 Identities = 87/310 (28%), Positives = 148/310 (47%), Gaps = 35/310 (11%)

Query: 78  RSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESH 137
           +        +     +WEI   ++ +      G+FGTV++G + G DVAVK+L+    + 
Sbjct: 3   KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP 61

Query: 138 RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVV 197
           +           F  EV V  K  H N+  F+G +                       +V
Sbjct: 62  QQLQA-------FKNEVGVLRKTRHVNILLFMGYST----------------APQLA-IV 97

Query: 198 VEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
            ++C G +L  +L      K   K +I +A   ARG+ YL +K I+HRD+K+ N+ L + 
Sbjct: 98  TQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED 156

Query: 258 RTVKIADFGVARLEA--SNPHDMTGETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLW 312
            TVKI DFG+A  ++  S  H     +G++ +MAPEV+       Y+ + DVY+FGI L+
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216

Query: 313 EIYCCDMPYPDLS-FSEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEM 368
           E+    +PY +++   ++   V R +L P++ +    CP  +  +M  C     D+RP  
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 276

Query: 369 DEVVAMLEAI 378
             ++A +E +
Sbjct: 277 PRILAEIEEL 286

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  319 bits (820), Expect = e-108
 Identities = 90/331 (27%), Positives = 138/331 (41%), Gaps = 45/331 (13%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRA 148
                  P+ LI      +G FG   +  +   G+ + +K L   +E  +          
Sbjct: 2   MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-------- 53

Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
            F +EV V   L+HPNV KFIG             +  +         + EY  GG L+ 
Sbjct: 54  -FLKEVKVMRCLEHPNVLKFIGVL---------YKDKRL-------NFITEYIKGGTLRG 96

Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
            + K+   +  +   +  A D+A G++YL S  I+HRD+ + N L+ + + V +ADFG+A
Sbjct: 97  II-KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155

Query: 269 RLEASNPHD--------------MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           RL                          G   +MAPE++NG +Y+ K DV+SFGI L EI
Sbjct: 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

Query: 315 YCCDMPYPDLSFSEVTSAV-VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                  PD     +   + VR  L    P  CP S   +  RC D +P+KRP   ++  
Sbjct: 216 IGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

Query: 374 MLEAIDTSKGGGMIPVDQPQ--GCSCFRKYR 402
            LE +     G +    Q +      +  YR
Sbjct: 276 WLETLRMHLAGHLPLGPQLEQLDRGFWETYR 306

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  304 bits (780), Expect = e-101
 Identities = 94/345 (27%), Positives = 142/345 (41%), Gaps = 65/345 (18%)

Query: 81  SSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRS 139
           ++S + + +           ++++ +  +G FG V RG + G++VAVK+    EE S   
Sbjct: 24  TTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR 83

Query: 140 EAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVE 199
           EAEI                L H N+  FI A    +    Q              +V +
Sbjct: 84  EAEIYQTV-----------MLRHENILGFIAADNKDNGTWTQ------------LWLVSD 120

Query: 200 YCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--------KIVHRDVKTEN 251
           Y   G+L  YL    R  +  + +I+LAL  A GL++L  +         I HRD+K++N
Sbjct: 121 YHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177

Query: 252 MLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGSA------YNRK 301
           +L+ K  T  IAD G+A    S             GT  YMAPEVL+ S         ++
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237

Query: 302 CDVYSFGICLWEIYCC---------------DMPYPDLSFSEVTSAVVRQNLRPEIP--- 343
            D+Y+ G+  WEI                  D+   D S  E+   V  Q LRP IP   
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297

Query: 344 RCCP--SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM 386
           + C     +A +M+ CW AN   R     +   L  +   +G  M
Sbjct: 298 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 342

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  303 bits (778), Expect = e-101
 Identities = 87/341 (25%), Positives = 135/341 (39%), Gaps = 65/341 (19%)

Query: 81  SSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRS 139
            SS + + +          ++ +     +G +G V  G + G+ VAVK+    EE S   
Sbjct: 19  QSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFR 78

Query: 140 EAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVE 199
           E EI                + H N+  FI A +  +    Q              ++ +
Sbjct: 79  ETEIYQTV-----------LMRHENILGFIAADIKGTGSWTQ------------LYLITD 115

Query: 200 YCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--------KIVHRDVKTEN 251
           Y   G+L  YL   +   L  K +++LA     GL +L ++         I HRD+K++N
Sbjct: 116 YHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172

Query: 252 MLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGSA------YNRK 301
           +L+ K  T  IAD G+A    S+ ++         GT  YM PEVL+ S           
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232

Query: 302 CDVYSFGICLWEIYCC----------DMPYPDL-----SFSEVTSAVVRQNLRPEIPRC- 345
            D+YSFG+ LWE+              +PY DL     S+ ++   V  + LRP  P   
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292

Query: 346 ----CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
               C   +  +M  CW  NP  R     V   L  +  S+
Sbjct: 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  297 bits (762), Expect = 2e-99
 Identities = 82/318 (25%), Positives = 133/318 (41%), Gaps = 65/318 (20%)

Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHK 159
           + +     +G +G V RG + G++VAVK+    +E S   E E+ +              
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV-----------M 58

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           L H N+  FI + M +   + Q              ++  Y   G+L  YL   +   L 
Sbjct: 59  LRHENILGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTLD 103

Query: 220 FKVVIQLALDLARGLSYLQSK--------KIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
               +++ L +A GL++L  +         I HRD+K++N+L+ K     IAD G+A + 
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

Query: 272 ASNPHD----MTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYCC---- 317
           + + +          GT  YMAPEVL+ +         ++ D+++FG+ LWE+       
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

Query: 318 -----------DMPYPDLSFSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDAN 361
                      D+   D SF ++   V     RP IP         +SLA +MK CW  N
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283

Query: 362 PDKRPEMDEVVAMLEAID 379
           P  R     +   L  ID
Sbjct: 284 PSARLTALRIKKTLTKID 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  284 bits (729), Expect = 3e-94
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 65/337 (19%)

Query: 81  SSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRS 139
              ++   +  +        L +    ARG FG V +     + VAVK+    ++ S ++
Sbjct: 6   HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN 65

Query: 140 EAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVE 199
           E E+ SL             + H N+ +FIGA    + +++               ++  
Sbjct: 66  EYEVYSLP-----------GMKHENILQFIGAEKRGTSVDVD------------LWLITA 102

Query: 200 YCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK----------KIVHRDVKT 249
           +   G+L  +L   +   +++  +  +A  +ARGL+YL              I HRD+K+
Sbjct: 103 FHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159

Query: 250 ENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSA-----YNRKC 302
           +N+LL    T  IADFG+A       +  D  G+ GT  YMAPEVL G+         + 
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219

Query: 303 DVYSFGICLWEIYCCDMPY----------------PDLSFSEVTSAVVRQNLRPEIPRCC 346
           D+Y+ G+ LWE+                          S  ++   VV +  RP +    
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279

Query: 347 PS-----SLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
                   L   ++ CWD + + R     V   +  +
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  281 bits (721), Expect = 7e-93
 Identities = 78/340 (22%), Positives = 129/340 (37%), Gaps = 76/340 (22%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
            E  +D   L +     RG +G V++G  D + VAVK+  +                 F 
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR------------QNFI 53

Query: 152 QEVAVWH--KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
            E  ++    ++H N+ +FI             D            +V+EY   G+L  Y
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVG-----------DERVTADGRMEYLLVMEYYPNGSLXKY 102

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQS---------KKIVHRDVKTENMLLDKTRTV 260
           L         +    +LA  + RGL+YL +           I HRD+ + N+L+    T 
Sbjct: 103 L---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159

Query: 261 KIADFGVARLEASNP--------HDMTGETGTLGYMAPEVLNGS-------AYNRKCDVY 305
            I+DFG++     N         +    E GT+ YMAPEVL G+       +  ++ D+Y
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219

Query: 306 SFGICLWEIY--CCD-----------MPYPDL-----SFSEVTSAVVRQNLRPEIPRCC- 346
           + G+  WEI+  C D           M +        +F ++   V R+  RP+ P    
Sbjct: 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279

Query: 347 -----PSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
                  SL   ++ CWD + + R         +  +   
Sbjct: 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  242 bits (619), Expect = 5e-77
 Identities = 91/317 (28%), Positives = 145/317 (45%), Gaps = 33/317 (10%)

Query: 67  HHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ--D 124
           H     +P+  +S      +  V + +W ++   L++     RG FG V  G        
Sbjct: 84  HLLSTQQPLTKKSGVVLHRA--VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141

Query: 125 VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN 184
           VAVK           E     L+A F QE  +  +  HPN+ + IG         + T  
Sbjct: 142 VAVKSC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIG---------VCTQK 184

Query: 185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH 244
             I        +V+E   GG   ++L +    +L  K ++Q+  D A G+ YL+SK  +H
Sbjct: 185 QPI-------YIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236

Query: 245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY--MAPEVLNGSAYNRKC 302
           RD+   N L+ +   +KI+DFG++R EA   +  +G    +     APE LN   Y+ + 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296

Query: 303 DVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 361
           DV+SFGI LWE +     PYP+LS  +     V +  R   P  CP ++  +M++CW   
Sbjct: 297 DVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLPCPELCPDAVFRLMEQCWAYE 355

Query: 362 PDKRPEMDEVVAMLEAI 378
           P +RP    +   L++I
Sbjct: 356 PGQRPSFSTIYQELQSI 372

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  227 bits (580), Expect = 3e-70
 Identities = 88/345 (25%), Positives = 147/345 (42%), Gaps = 43/345 (12%)

Query: 41  NRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAK 100
           + + + +NL +   H+     G        L +P       ++       R  W ++  +
Sbjct: 141 DEEVYFENLMQLVEHYTTDADG----LCTRLIKPKVMEGTVAAQDE--FYRSGWALNMKE 194

Query: 101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL 160
           L +     +G FG V  G Y G  VAVK +              +   AF  E +V  +L
Sbjct: 195 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQAFLAEASVMTQL 243

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
            H N+ + +G         I  + G +        +V EY   G+L  YL    R  L  
Sbjct: 244 RHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSRGRSVLGG 288

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
             +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ +         + 
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASST 342

Query: 281 ETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQ 336
           +      + + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V    V +
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEK 401

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
             + + P  CP ++ +VMK CW  +   RP   ++   LE I T 
Sbjct: 402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  227 bits (581), Expect = 6e-70
 Identities = 86/345 (24%), Positives = 150/345 (43%), Gaps = 36/345 (10%)

Query: 41  NRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAK 100
           + +   + LAE  HHH     G        L  P   +    +    S    +WE++   
Sbjct: 167 SSESRFNTLAELVHHHSTVADGLITT----LHYPA-PKRNKPTIYGVSPNYDKWEMERTD 221

Query: 101 LIIKGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWH 158
           + +K     G +G V+ G++      VAVK L                   F +E AV  
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMK 271

Query: 159 KLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKL 218
           ++ HPN+ + +G         + T             ++ E+   G L  YL +  R+++
Sbjct: 272 EIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLLDYLRECNRQEV 315

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
           +  V++ +A  ++  + YL+ K  +HR++   N L+ +   VK+ADFG++RL   + +  
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375

Query: 279 TGETG-TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQ 336
                  + + APE L  + ++ K DV++FG+ LWEI      PYP +  S+V    + +
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEK 434

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           + R E P  CP  +  +M+ CW  NP  RP   E+    E +   
Sbjct: 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  226 bits (577), Expect = 9e-70
 Identities = 88/323 (27%), Positives = 140/323 (43%), Gaps = 38/323 (11%)

Query: 67  HHQHLPRPIYTRSR---SSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ 123
           H++     +  +      SS       +  WEI    L ++     G FG V    Y+  
Sbjct: 153 HYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH 212

Query: 124 -DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
             VAVK +  G  S            AF  E  V   L H  + K       T E     
Sbjct: 213 TKVAVKTMKPGSMS----------VEAFLAEANVMKTLQHDKLVKLHAVV--TKE----- 255

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
                  P     ++ E+   G+L  +L  +   K     +I  +  +A G+++++ +  
Sbjct: 256 -------P---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG---YMAPEVLNGSAYN 299
           +HRD++  N+L+  +   KIADFG+AR+   N  + T   G      + APE +N  ++ 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFT 363

Query: 300 RKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCW 358
            K DV+SFGI L EI     +PYP +S  EV  A + +  R   P  CP  L N+M RCW
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNIMMRCW 422

Query: 359 DANPDKRPEMDEVVAMLEAIDTS 381
              P++RP  + + ++L+   T+
Sbjct: 423 KNRPEERPTFEYIQSVLDDFYTA 445

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  220 bits (563), Expect = 2e-69
 Identities = 81/328 (24%), Positives = 134/328 (40%), Gaps = 35/328 (10%)

Query: 63  GHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG 122
           G   HH H    +  R             ++  ID   LI+      G FG+V  G    
Sbjct: 2   GSSHHHHHHSSGLVPRGSEELQNKL----EDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57

Query: 123 QD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE 177
           +D     VAVK +       + +         F  E A      HPNV + +G       
Sbjct: 58  EDGTSLKVAVKTM-------KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC----- 105

Query: 178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFKVVIQLALDLARG 233
                +    G+P     V++ +   G L +YL+ +R     + +  + +++  +D+A G
Sbjct: 106 ----IEMSSQGIPKPM--VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 234 LSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPE 291
           + YL ++  +HRD+   N +L    TV +ADFG+++   S  +   G    +   ++A E
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219

Query: 292 VLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSL 350
            L    Y  K DV++FG+ +WEI      PYP +   E+    +    R + P  C   L
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-LLHGHRLKQPEDCLDEL 278

Query: 351 ANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +M  CW  +P  RP    +   LE +
Sbjct: 279 YEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  221 bits (564), Expect = 7e-68
 Identities = 91/321 (28%), Positives = 141/321 (43%), Gaps = 31/321 (9%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ 123
           +  H   L   + T   +S   +  + +  WEI    L ++    +G FG V  G ++G 
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208

Query: 124 -DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
             VA+K L  G  S            AF QE  V  KL H  + +       + E     
Sbjct: 209 TRVAIKTLKPGTMSP----------EAFLQEAQVMKKLRHEKLVQLYAVV--SEE----- 251

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
                  P     +V EY   G+L  +L     + L    ++ +A  +A G++Y++    
Sbjct: 252 -------P---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-TLGYMAPEVLNGSAYNRK 301
           VHRD++  N+L+ +    K+ADFG+ARL   N +         + + APE      +  K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 302 CDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+SFGI L E+     +PYP +   EV    V +  R   P  CP SL ++M +CW  
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRK 420

Query: 361 NPDKRPEMDEVVAMLEAIDTS 381
            P++RP  + + A LE   TS
Sbjct: 421 EPEERPTFEYLQAFLEDYFTS 441

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  214 bits (548), Expect = 1e-67
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 35/305 (11%)

Query: 79  SRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESH 137
              ++ ++A +    WEIDP  L        G FG V  G + GQ DVA+K++  G    
Sbjct: 4   GSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---- 59

Query: 138 RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVV 197
                 +     F +E  V   L H  + +  G         + T    I        ++
Sbjct: 60  ------SMSEDEFIEEAKVMMNLSHEKLVQLYG---------VCTKQRPI-------FII 97

Query: 198 VEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
            EY   G L +YL +  R +   + ++++  D+   + YL+SK+ +HRD+   N L++  
Sbjct: 98  TEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156

Query: 258 RTVKIADFGVARLEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             VK++DFG++R    +  + T   G+     +  PEVL  S ++ K D+++FG+ +WEI
Sbjct: 157 GVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

Query: 315 YCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           Y    MPY   + SE     + Q LR   P      +  +M  CW    D+RP    +++
Sbjct: 215 YSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273

Query: 374 MLEAI 378
            +  +
Sbjct: 274 NILDV 278

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  214 bits (547), Expect = 2e-67
 Identities = 84/302 (27%), Positives = 130/302 (43%), Gaps = 47/302 (15%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAA 149
             EWE+    L +      G FG V  G Y+G   VAVK L  G          +    A
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----------SMSPDA 54

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCC------VVVEYCHG 203
           F  E  +  +L H  + +                                  ++ EY   
Sbjct: 55  FLAEANLMKQLQHQRLVRLYA-----------------------VVTQEPIYIITEYMEN 91

Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           G+L  +L      KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIA
Sbjct: 92  GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151

Query: 264 DFGVARLEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DM 319
           DFG+ARL   N  + T   G      + APE +N   +  K DV+SFGI L EI     +
Sbjct: 152 DFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID 379
           PYP ++  EV    + +  R   P  CP  L  +M+ CW   P+ RP  D + ++LE   
Sbjct: 210 PYPGMTNPEVIQN-LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

Query: 380 TS 381
           T+
Sbjct: 269 TA 270

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  214 bits (547), Expect = 2e-67
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 37/295 (12%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           R  W ++  +L +     +G FG V  G Y G  VAVK +              +   AF
Sbjct: 13  RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQAF 61

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
             E +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL
Sbjct: 62  LAEASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYL 106

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
               R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ + 
Sbjct: 107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166

Query: 271 EASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 326
            +      + +      + + APE L    ++ K DV+SFGI LWEIY    +PYP +  
Sbjct: 167 AS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            +V    V +  + + P  CP ++  VMK CW  +   RP   ++   LE I T 
Sbjct: 221 KDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  215 bits (550), Expect = 2e-67
 Identities = 79/348 (22%), Positives = 139/348 (39%), Gaps = 52/348 (14%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTT--SASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD 121
           +H HH H      T +        SA   R   + +   L       +G FG+V    YD
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYD 63

Query: 122 GQD------VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
                    VAVK L    E H  +         F +E+ +   L H N+ K+ G     
Sbjct: 64  PLQDNTGEVVAVKKLQHSTEEHLRD---------FEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLS 235
              N+               +++EY   G+L+ YL +  + ++    ++Q    + +G+ 
Sbjct: 115 GRRNL--------------KLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGME 159

Query: 236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEV 292
           YL +K+ +HRD+ T N+L++    VKI DFG+ ++   +      +      + + APE 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 293 LNGSAYNRKCDVYSFGICLWEI--YCCD--------------MPYPDLSFSEVTSAVVRQ 336
           L  S ++   DV+SFG+ L+E+  Y                      +    +    ++ 
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKN 278

Query: 337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
           N R   P  CP  +  +M  CW+ N ++RP   ++   ++ I     G
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  212 bits (542), Expect = 6e-67
 Identities = 84/294 (28%), Positives = 137/294 (46%), Gaps = 35/294 (11%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFT 151
           +W IDP++L        G FG VH G +  +  VA+K +  G          A     F 
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG----------AMSEEDFI 51

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           +E  V  KL HP + +  G         +  +   I       C+V E+   G L  YL 
Sbjct: 52  EEAEVMMKLSHPKLVQLYG---------VCLEQAPI-------CLVTEFMEHGCLSDYL- 94

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
           + +R   A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R  
Sbjct: 95  RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154

Query: 272 ASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 327
             +    T  TGT     + +PEV + S Y+ K DV+SFG+ +WE++    +PY + S S
Sbjct: 155 LDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV    +    R   PR   + +  +M  CW   P+ RP    ++  L  I  S
Sbjct: 213 EVVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  214 bits (547), Expect = 7e-67
 Identities = 75/299 (25%), Positives = 136/299 (45%), Gaps = 30/299 (10%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASL 146
           ++  I   +  +     +G FG+V       +D     VAVK+L   +    + ++    
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASSD---- 68

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
              F +E A   + DHP+V K +G +           +   G       V++ +   G L
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVS---------LRSRAKGRLPIPM-VILPFMKHGDL 118

Query: 207 KSYLIKNR----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI 262
            ++L+ +R       L  + +++  +D+A G+ YL S+  +HRD+   N +L +  TV +
Sbjct: 119 HAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178

Query: 263 ADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDM 319
           ADFG++R   S  +   G    L   ++A E L  + Y    DV++FG+ +WEI      
Sbjct: 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           PY  +  +E+ +  +    R + P  C   + ++M +CW A+P +RP    +   LE I
Sbjct: 239 PYAGIENAEIYNY-LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  214 bits (547), Expect = 7e-67
 Identities = 79/339 (23%), Positives = 142/339 (41%), Gaps = 35/339 (10%)

Query: 52  EHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGT 111
            HHHH    +   +   +      Y    +      + R    EI+ +++ I+     G 
Sbjct: 2   HHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGD 61

Query: 112 FGTVHRGIYDGQ-----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G V  G           VA+K L                R  F  E ++  + DHPN+ 
Sbjct: 62  SGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G         + T             +V EY   G+L ++L +    +     ++ +
Sbjct: 114 RLEG---------VVTRGRLA-------MIVTEYMENGSLDTFL-RTHDGQFTIMQLVGM 156

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT-- 284
              +  G+ YL     VHRD+   N+L+D     K++DFG++R+   +P      TG   
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 285 -LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 342
            + + APE +    ++   DV+SFG+ +WE+    + PY +++  +V S+ V +  R   
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPA 275

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           P  CP +L  +M  CW  +  +RP   ++V++L+A+  S
Sbjct: 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  213 bits (544), Expect = 8e-67
 Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 35/292 (11%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQ--DVAVKLLDWGEESHRSEAEIASLRAAF 150
           +WE++   + +K     G +G V+ G++      VAVK L                   F
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEF 56

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +E AV  ++ HPN+ + +G         + T             ++ E+   G L  YL
Sbjct: 57  LKEAAVMKEIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLLDYL 100

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
            +  R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++RL
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160

Query: 271 EASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 326
              +    T   G      + APE L  + ++ K DV++FG+ LWEI      PYP +  
Sbjct: 161 MTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           S+V    + ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 219 SQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  212 bits (541), Expect = 1e-66
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 35/290 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQ-DVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
            E+   ++ +      G FG V  G + GQ DVAVK++  G          +     F Q
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG----------SMSEDEFFQ 52

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E     KL HP + KF G         + +    I        +V EY   G L +YL +
Sbjct: 53  EAQTMMKLSHPKLVKFYG---------VCSKEYPI-------YIVTEYISNGCLLNYL-R 95

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
           +  + L    ++++  D+  G+++L+S + +HRD+   N L+D+   VK++DFG+ R   
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155

Query: 273 SNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 328
            +        GT     + APEV +   Y+ K DV++FGI +WE++    MPY   + SE
Sbjct: 156 DD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           V    V Q  R   P     ++  +M  CW   P+KRP   ++++ +E +
Sbjct: 214 VVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  219 bits (559), Expect = 2e-66
 Identities = 90/322 (27%), Positives = 140/322 (43%), Gaps = 35/322 (10%)

Query: 67  HHQHLPRPIYTRSRSSSTTSAS----VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG 122
           ++      +  R  +   TS      + +  WEI    L ++    +G FG V  G ++G
Sbjct: 231 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290

Query: 123 Q-DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
              VA+K L  G  S            AF QE  V  KL H  + +       + E    
Sbjct: 291 TTRVAIKTLKPGTMSP----------EAFLQEAQVMKKLRHEKLVQLYAVV--SEE---- 334

Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
                   P     +V EY   G+L  +L     + L    ++ +A  +A G++Y++   
Sbjct: 335 --------P---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG-TLGYMAPEVLNGSAYNR 300
            VHRD++  N+L+ +    K+ADFG+ARL   N +         + + APE      +  
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 301 KCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD 359
           K DV+SFGI L E+     +PYP +   EV    V +  R   P  CP SL ++M +CW 
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWR 502

Query: 360 ANPDKRPEMDEVVAMLEAIDTS 381
             P++RP  + + A LE   TS
Sbjct: 503 KEPEERPTFEYLQAFLEDYFTS 524

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  211 bits (539), Expect = 1e-65
 Identities = 92/332 (27%), Positives = 134/332 (40%), Gaps = 50/332 (15%)

Query: 65  HPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-- 122
           H HH H   P Y  +  +S+ S        E+    + +      G FG V+ G   G  
Sbjct: 3   HHHHHH--NPNYCFAGKTSSIS-----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 55

Query: 123 -----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE 177
                  VAVK L         E         F  E  +  K +H N+ + IG ++    
Sbjct: 56  NDPSPLQVAVKTL--------PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103

Query: 178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----RRKLAFKVVIQLALDLAR 232
                      +P     +++E   GG LKS+L + R        LA   ++ +A D+A 
Sbjct: 104 ---------QSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 233 GLSYLQSKKIVHRDVKTENMLLDKT---RTVKIADFGVARLEASNPHDMTGETGTLG--Y 287
           G  YL+    +HRD+   N LL      R  KI DFG+AR      +   G    L   +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 288 MAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           M PE      +  K D +SFG+ LWEI+    MPYP  S  EV   V     R + P+ C
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNC 270

Query: 347 PSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           P  +  +M +CW   P+ RP    ++  +E  
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  210 bits (538), Expect = 1e-65
 Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 43/304 (14%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+  G         VA+K +        +EA    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--------NEAASMR 70

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G           +             V++E    G 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVV---------SQGQPT-------LVIMELMTRGD 114

Query: 206 LKSYLIKNR--------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
           LKSYL   R            +   +IQ+A ++A G++YL + K VHRD+   N ++ + 
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174

Query: 258 RTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            TVKI DFG+ R      +   G  G L   +M+PE L    +    DV+SFG+ LWEI 
Sbjct: 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

Query: 316 -CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
              + PY  LS  +V   V+      + P  CP  L  +M+ CW  NP  RP   E+++ 
Sbjct: 235 TLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

Query: 375 LEAI 378
           ++  
Sbjct: 294 IKEE 297

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  210 bits (537), Expect = 2e-65
 Identities = 78/327 (23%), Positives = 145/327 (44%), Gaps = 38/327 (11%)

Query: 64  HHPHHQHLP--RPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD 121
           HH H   +P    +Y +    S  + +V +   EI P+ +  +     G FG V++G+  
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLK 66

Query: 122 G------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
                    VA+K L                R  F  E  +  +  H N+ +  G     
Sbjct: 67  TSSGKKEVPVAIKTL--------KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG----- 113

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLS 235
               + +    +        ++ EY   GAL  +L + +  + +   ++ +   +A G+ 
Sbjct: 114 ----VISKYKPM-------MIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEV 292
           YL +   VHRD+   N+L++     K++DFG++R+   +P      +G    + + APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

Query: 293 LNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLA 351
           ++   +    DV+SFGI +WE+    + PY +LS  EV  A +    R   P  CPS++ 
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTPMDCPSAIY 280

Query: 352 NVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +M +CW     +RP+  ++V++L+ +
Sbjct: 281 QLMMQCWQQERARRPKFADIVSILDKL 307

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  208 bits (532), Expect = 1e-64
 Identities = 83/343 (24%), Positives = 128/343 (37%), Gaps = 49/343 (14%)

Query: 59  GVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRG 118
           G  G          +    +                 I    +++K     G FG V   
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA 60

Query: 119 IYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA 171
                        VAVK L    ES R +         F +E  +   L H ++ +F G 
Sbjct: 61  ECHNLLPEQDKMLVAVKALKEASESARQD---------FQREAELLTMLQHQHIVRFFGV 111

Query: 172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------------RRKL 218
                     T+   +        +V EY   G L  +L  +                 L
Sbjct: 112 C---------TEGRPL-------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
               ++ +A  +A G+ YL     VHRD+ T N L+ +   VKI DFG++R   S  +  
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 279 TGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVR 335
            G    L   +M PE +    +  + DV+SFG+ LWEI+     P+  LS +E     + 
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-IT 274

Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           Q    E PR CP  +  +M+ CW   P +R  + +V A L+A+
Sbjct: 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  207 bits (529), Expect = 1e-64
 Identities = 71/317 (22%), Positives = 130/317 (41%), Gaps = 50/317 (15%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASL 146
             + +   L       +G FG+V    YD         VAVK L    E H  +      
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD------ 57

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
              F +E+ +   L H N+ K+ G        N+               +++EY   G+L
Sbjct: 58  ---FEREIEILKSLQHDNIVKYKGVCYSAGRRNL--------------KLIMEYLPYGSL 100

Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
           + YL +  + ++    ++Q    + +G+ YL +K+ +HRD+ T N+L++    VKI DFG
Sbjct: 101 RDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159

Query: 267 VARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEI--YCCD--- 318
           + ++   +      +      + + APE L  S ++   DV+SFG+ L+E+  Y      
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219

Query: 319 -----------MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
                           +    +    ++ N R   P  CP  +  +M  CW+ N ++RP 
Sbjct: 220 PPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278

Query: 368 MDEVVAMLEAIDTSKGG 384
             ++   ++ I  +  G
Sbjct: 279 FRDLALRVDQIRDNMAG 295

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  207 bits (529), Expect = 2e-64
 Identities = 82/313 (26%), Positives = 126/313 (40%), Gaps = 50/313 (15%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
              I    +++K     G FG V                VAVK L     + R +     
Sbjct: 9   VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD----- 63

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
               F +E  +   L H ++ KF G            D   +        +V EY   G 
Sbjct: 64  ----FQREAELLTNLQHEHIVKFYGVC---------GDGDPL-------IMVFEYMKHGD 103

Query: 206 LKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L  +L  +               + +L    ++ +A  +A G+ YL S+  VHRD+ T N
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN 163

Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGI 309
            L+     VKI DFG++R   S  +   G    L   +M PE +    +  + DV+SFG+
Sbjct: 164 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223

Query: 310 CLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     P+  LS +EV    + Q    E PR CP  + +VM  CW   P +R  +
Sbjct: 224 ILWEIFTYGKQPWFQLSNTEVIEC-ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNI 282

Query: 369 DEVVAMLEAIDTS 381
            E+  +L A+  +
Sbjct: 283 KEIYKILHALGKA 295

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  209 bits (533), Expect = 2e-64
 Identities = 95/362 (26%), Positives = 141/362 (38%), Gaps = 61/362 (16%)

Query: 53  HHHHLHGVQGGHHPHHQH-----LPRPIYTRSRSSSTT-------------SASVRRQEW 94
           HHHH + +    + + Q      L  P Y  S+  ++T               S      
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLR 147
           E+    + +      G FG V+ G   G         VAVK L         E       
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDE 118

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
             F  E  +  K +H N+ + IG ++               +P     +++E   GG LK
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSL-------------QSLP---RFILLELMAGGDLK 162

Query: 208 SYLIKNR-----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT---RT 259
           S+L + R        LA   ++ +A D+A G  YL+    +HRD+   N LL      R 
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222

Query: 260 VKIADFGVARLEASNPHDMTGETGTLG--YMAPEVLNGSAYNRKCDVYSFGICLWEIY-C 316
            KI DFG+AR      +   G    L   +M PE      +  K D +SFG+ LWEI+  
Sbjct: 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282

Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             MPYP  S  EV   V     R + P+ CP  +  +M +CW   P+ RP    ++  +E
Sbjct: 283 GYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

Query: 377 AI 378
             
Sbjct: 342 YC 343

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  205 bits (525), Expect = 4e-64
 Identities = 75/300 (25%), Positives = 123/300 (41%), Gaps = 38/300 (12%)

Query: 88  SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAE 142
           S+   ++ I    +++      G FG V+ G+Y         VAVK           +  
Sbjct: 1   SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--------KKDC 52

Query: 143 IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
               +  F  E  +   LDHP++ K IG                         +++E   
Sbjct: 53  TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-----------------TWIIMELYP 95

Query: 203 GGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI 262
            G L  YL +  +  L    ++  +L + + ++YL+S   VHRD+   N+L+     VK+
Sbjct: 96  YGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKL 154

Query: 263 ADFGVARLEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCD 318
            DFG++R       D    + T     +M+PE +N   +    DV+ F +C+WEI     
Sbjct: 155 GDFGLSRYIEDE--DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212

Query: 319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            P+  L   +V    + +  R   P  CP  L  +M RCWD +P  RP   E+V  L  +
Sbjct: 213 QPFFWLENKDVIGV-LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  206 bits (526), Expect = 4e-64
 Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 33/308 (10%)

Query: 83  STTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESH 137
           S     ++     I    L +      G+FG V RG +D        VAVK L     S 
Sbjct: 2   SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 138 RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVV 197
               +       F +EV   H LDH N+ +  G  +                      +V
Sbjct: 62  PEAMD------DFIREVNAMHSLDHRNLIRLYGVVLTPP-----------------MKMV 98

Query: 198 VEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
            E    G+L   L +  +       + + A+ +A G+ YL+SK+ +HRD+   N+LL   
Sbjct: 99  TELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157

Query: 258 RTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
             VKI DFG+ R    N      +        + APE L    ++   D + FG+ LWE+
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

Query: 315 Y-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           +     P+  L+ S++   + ++  R   P  CP  + NVM +CW   P+ RP    +  
Sbjct: 218 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

Query: 374 MLEAIDTS 381
            L     +
Sbjct: 278 FLLEAQPT 285

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  205 bits (525), Expect = 7e-64
 Identities = 89/307 (28%), Positives = 134/307 (43%), Gaps = 35/307 (11%)

Query: 82  SSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEES 136
           +     +V+          +       RG FG V+ G     D      AVK L+     
Sbjct: 8   NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-- 65

Query: 137 HRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCV 196
                E     + F  E  +     HPNV   +G         I   +    +      V
Sbjct: 66  --DIGE----VSQFLTEGIIMKDFSHPNVLSLLG---------ICLRSEGSPL------V 104

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           V+ Y   G L++++ +N       K +I   L +A+G+ YL SKK VHRD+   N +LD+
Sbjct: 105 VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163

Query: 257 TRTVKIADFGVAR-LEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLW 312
             TVK+ADFG+AR +     + +  +TG      +MA E L    +  K DV+SFG+ LW
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223

Query: 313 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           E+      PYPD++  ++T   + Q  R   P  CP  L  VM +CW    + RP   E+
Sbjct: 224 ELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282

Query: 372 VAMLEAI 378
           V+ + AI
Sbjct: 283 VSRISAI 289

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  206 bits (525), Expect = 1e-63
 Identities = 78/347 (22%), Positives = 132/347 (38%), Gaps = 61/347 (17%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG- 122
           HH HH H           +                  L        G FG V    YD  
Sbjct: 3   HHHHHHH-------HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPT 55

Query: 123 -----QDVAVKLL--DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
                + VAVK L  D G +           R+ + QE+ +   L H ++ K+ G     
Sbjct: 56  NDGTGEMVAVKALKADAGPQH----------RSGWKQEIDILRTLYHEHIIKYKGCCEDA 105

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLS 235
              ++               +V+EY   G+L+ YL    R  +    ++  A  +  G++
Sbjct: 106 GAASL--------------QLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMA 148

Query: 236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEV 292
           YL ++  +HRD+   N+LLD  R VKI DFG+A+                  + + APE 
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 293 LNGSAYNRKCDVYSFGICLWEI--YC-------------CDMPYPDLSFSEVTSAVVRQN 337
           L    +    DV+SFG+ L+E+  +C               +    ++   +T   + + 
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERG 267

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
            R   P  CP+ + ++MK CW+     RP  + ++ +L+ +     G
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  207 bits (528), Expect = 2e-63
 Identities = 91/328 (27%), Positives = 138/328 (42%), Gaps = 35/328 (10%)

Query: 61  QGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY 120
            G  + + Q         S  +     +V+          +       RG FG V+ G  
Sbjct: 51  AGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTL 110

Query: 121 DGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
              D      AVK L+          E     + F  E  +     HPNV   +G     
Sbjct: 111 LDNDGKKIHCAVKSLNRIT----DIGE----VSQFLTEGIIMKDFSHPNVLSLLG----- 157

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLS 235
               I   +    +      VV+ Y   G L++++ +N       K +I   L +A+G+ 
Sbjct: 158 ----ICLRSEGSPL------VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMK 206

Query: 236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEASNPHDMTGETGTL---GYMAPE 291
           +L SKK VHRD+   N +LD+  TVK+ADFG+AR +       +  +TG      +MA E
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 292 VLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSL 350
            L    +  K DV+SFG+ LWE+      PYPD++  ++T   + Q  R   P  CP  L
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPL 325

Query: 351 ANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             VM +CW    + RP   E+V+ + AI
Sbjct: 326 YEVMLKCWHPKAEMRPSFSELVSRISAI 353

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  204 bits (521), Expect = 2e-63
 Identities = 83/299 (27%), Positives = 137/299 (45%), Gaps = 36/299 (12%)

Query: 89  VRRQEWEIDPAKLIIKGAF-ARGTFGTVHRGIYDGQ----DVAVKLLDWGEESHRSEAEI 143
           +R +E  +D   L ++      G FGTV +G Y  +     VAVK+L       ++EA  
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEAND 58

Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
            +L+     E  V  +LD+P + + IG     S                   +V+E    
Sbjct: 59  PALKDELLAEANVMQQLDNPYIVRMIGICEAES-----------------WMLVMEMAEL 101

Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           G L  YL +NR   +  K +I+L   ++ G+ YL+    VHRD+   N+LL      KI+
Sbjct: 102 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159

Query: 264 DFGVARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DM 319
           DFG+++   ++ +    +T     + + APE +N   ++ K DV+SFG+ +WE +     
Sbjct: 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           PY  +  SEVT+  + +  R   P  CP  + ++M  CW  + + RP    V   L   
Sbjct: 220 PYRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  204 bits (520), Expect = 3e-63
 Identities = 88/307 (28%), Positives = 132/307 (42%), Gaps = 35/307 (11%)

Query: 82  SSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEES 136
            S   A V+      +           +G FG V+ G Y  Q       A+K L      
Sbjct: 4   DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------ 57

Query: 137 HRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCV 196
             S         AF +E  +   L+HPNV   IG         I      +        V
Sbjct: 58  --SRITEMQQVEAFLREGLLMRGLNHPNVLALIG---------IMLPPEGLPH------V 100

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           ++ Y   G L  ++ ++ +R    K +I   L +ARG+ YL  +K VHRD+   N +LD+
Sbjct: 101 LLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159

Query: 257 TRTVKIADFGVAR-LEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLW 312
           + TVK+ADFG+AR +     + +           + A E L    +  K DV+SFG+ LW
Sbjct: 160 SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219

Query: 313 EIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           E+      PY  +   ++T   + Q  R   P  CP SL  VM++CW+A+P  RP    +
Sbjct: 220 ELLTRGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278

Query: 372 VAMLEAI 378
           V  +E I
Sbjct: 279 VGEVEQI 285

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  203 bits (518), Expect = 4e-63
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 38/302 (12%)

Query: 86  SASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSE 140
           +     +++EI   ++ +      G FG VH+GIY   +     VA+K            
Sbjct: 2   AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-- 59

Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                 R  F QE     + DHP++ K IG                   P     +++E 
Sbjct: 60  ------REKFLQEALTMRQFDHPHIVKLIGVITEN--------------PV---WIIMEL 96

Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
           C  G L+S+L + R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     V
Sbjct: 97  CTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155

Query: 261 KIADFGVARLEASNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
           K+ DFG++R    +       +       +MAPE +N   +    DV+ FG+C+WEI   
Sbjct: 156 KLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 213

Query: 318 -DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              P+  +  ++V    +    R  +P  CP +L ++M +CW  +P +RP   E+ A L 
Sbjct: 214 GVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272

Query: 377 AI 378
            I
Sbjct: 273 TI 274

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  204 bits (522), Expect = 6e-63
 Identities = 83/344 (24%), Positives = 133/344 (38%), Gaps = 61/344 (17%)

Query: 67  HHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG---- 122
             +  P P+Y           + +    E     +        G FG V +    G    
Sbjct: 19  LDRLHPNPMY----QRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPY 74

Query: 123 ---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN 179
                VAVK+L   EE+          +A F +E A+  + D+PN+ K +G         
Sbjct: 75  EPFTMVAVKMLK--EEASADM------QADFQREAALMAEFDNPNIVKLLGVC------- 119

Query: 180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------RRK 217
                  +       C++ EY   G L  +L                             
Sbjct: 120 --AVGKPM-------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           L+    + +A  +A G++YL  +K VHRD+ T N L+ +   VKIADFG++R   S  + 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 278 MTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVV 334
                  +   +M PE +  + Y  + DV+++G+ LWEI+     PY  ++  EV   V 
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             N     P  CP  L N+M+ CW   P  RP    +  +L+ +
Sbjct: 291 DGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  203 bits (518), Expect = 1e-62
 Identities = 84/318 (26%), Positives = 135/318 (42%), Gaps = 57/318 (17%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE     L++      G FG V +              VAVK+L   E +  SE     
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSE----- 69

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
                  E  V  +++HP+V K  GA          + +G +        ++VEY   G+
Sbjct: 70  -LRDLLSEFNVLKQVNHPHVIKLYGAC---------SQDGPL-------LLIVEYAKYGS 112

Query: 206 LKSYLIKNR----------------------RRKLAFKVVIQLALDLARGLSYLQSKKIV 243
           L+ +L ++R                       R L    +I  A  +++G+ YL   K+V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172

Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRK 301
           HRD+   N+L+ + R +KI+DFG++R        +    G +   +MA E L    Y  +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232

Query: 302 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+SFG+ LWEI      PYP +    + +  ++   R E P  C   +  +M +CW  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-LKTGHRMERPDNCSEEMYRLMLQCWKQ 291

Query: 361 NPDKRPEMDEVVAMLEAI 378
            PDKRP   ++   LE +
Sbjct: 292 EPDKRPVFADISKDLEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  201 bits (514), Expect = 5e-62
 Identities = 86/313 (27%), Positives = 137/313 (43%), Gaps = 51/313 (16%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           +WE    +L        G FG V      G         VAVK+L     +H +E     
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE----- 69

Query: 146 LRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            R A   E+ V   L +H N+   +GA          T  G          V+ EYC  G
Sbjct: 70  -REALMSELKVLSYLGNHMNIVNLLGAC---------TIGGPT-------LVITEYCCYG 112

Query: 205 ALKSYLIKNR----------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK 248
            L ++L + R                   L  + ++  +  +A+G+++L SK  +HRD+ 
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172

Query: 249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYS 306
             N+LL   R  KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232

Query: 307 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +GI LWE++     PYP +        ++++  R   P   P+ + ++MK CWDA+P KR
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 366 PEMDEVVAMLEAI 378
           P   ++V ++E  
Sbjct: 293 PTFKQIVQLIEKQ 305

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  200 bits (512), Expect = 7e-62
 Identities = 74/323 (22%), Positives = 130/323 (40%), Gaps = 52/323 (16%)

Query: 82  SSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD------GQDVAVKLL--DWG 133
            S    +        +   L        G FG V    YD      G+ VAVK L  + G
Sbjct: 4   VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63

Query: 134 EESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF 193
                         A   +E+ +   L H N+ K+ G         I             
Sbjct: 64  GNH----------IADLKKEIEILRNLYHENIVKYKGICTEDGGNGI------------- 100

Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
             +++E+   G+LK YL    + K+  K  ++ A+ + +G+ YL S++ VHRD+   N+L
Sbjct: 101 -KLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158

Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGIC 310
           ++    VKI DFG+ +   ++    T +      + + APE L  S +    DV+SFG+ 
Sbjct: 159 VESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218

Query: 311 LWEI--YC-------------CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
           L E+  YC                 +  ++ + + +  +++  R   P  CP  +  +M+
Sbjct: 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMR 277

Query: 356 RCWDANPDKRPEMDEVVAMLEAI 378
           +CW+  P  R     ++   EA+
Sbjct: 278 KCWEFQPSNRTSFQNLIEGFEAL 300

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  210 bits (535), Expect = 7e-62
 Identities = 85/350 (24%), Positives = 144/350 (41%), Gaps = 41/350 (11%)

Query: 38  KNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEID 97
             K  +    ++ +  ++   GV+       +      Y        T      +++EI 
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSET---DDYAEIIDEEDTYTMPSTRDYEIQ 388

Query: 98  PAKLIIKGAFARGTFGTVHRGIYDGQD-----VAVKLLDWGEESHRSEAEIASLRAAFTQ 152
             ++ +      G FG VH+GIY   +     VA+K                 +R  F Q
Sbjct: 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--------VREKFLQ 440

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           E     + DHP++ K IG                         +++E C  G L+S+L  
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-----------------VWIIMELCTLGELRSFLQV 483

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
            +   L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG++R   
Sbjct: 484 RKFS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542

Query: 273 SNPHDMTGETGTL---GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 328
            +       +       +MAPE +N   +    DV+ FG+C+WEI      P+  +  ++
Sbjct: 543 DS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           V    +    R  +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 601 VIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  202 bits (517), Expect = 7e-62
 Identities = 76/324 (23%), Positives = 138/324 (42%), Gaps = 35/324 (10%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--- 120
            + H +      +    +    + +V     E+D   + I      G FG V  G     
Sbjct: 10  GNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLP 69

Query: 121 --DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL 178
                 VA+K L  G             R  F  E ++  + DHPN+ +  G        
Sbjct: 70  SKKEISVAIKTLKVGYTEK--------QRRDFLGEASIMGQFDHPNIIRLEG-------- 113

Query: 179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ 238
            + T +  +        +V EY   G+L S+L +    +     ++ +   +A G+ YL 
Sbjct: 114 -VVTKSKPV-------MIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEVLNG 295
               VHRD+   N+L++     K++DFG+ R+   +P       G    + + +PE +  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 296 SAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVM 354
             +    DV+S+GI LWE+    + PY ++S  +V  A V +  R   P  CP++L  +M
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLPPPMDCPAALYQLM 283

Query: 355 KRCWDANPDKRPEMDEVVAMLEAI 378
             CW  + + RP+ +++V++L+ +
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKL 307

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  200 bits (511), Expect = 2e-61
 Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 49/310 (15%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE     L        G FG V      G         VAVK+L     +H  E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK--STAHADE----- 92

Query: 146 LRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            + A   E+ +   L  H N+   +GA          T  G +        V+ EYC  G
Sbjct: 93  -KEALMSELKIMSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135

Query: 205 ALKSYLIKNRR------------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
            L ++L +  R               + + ++  +  +A+G+++L SK  +HRDV   N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195

Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGIC 310
           LL      KI DFG+AR   ++ + +      L   +MAPE +    Y  + DV+S+GI 
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255

Query: 311 LWEIYCC-DMPYP-DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
           LWEI+     PYP  L  S+     V+   +   P   P ++ ++M+ CW   P  RP  
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKL-VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 314

Query: 369 DEVVAMLEAI 378
            ++ + L+  
Sbjct: 315 QQICSFLQEQ 324

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  200 bits (510), Expect = 2e-61
 Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 40/301 (13%)

Query: 89  VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLL--DWGEESHRSE 140
           ++         +L        G FGTVH+G++  +       V +K++    G +S    
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS---- 58

Query: 141 AEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY 200
                   A T  +     LDH ++ + +G   G+S                   +V +Y
Sbjct: 59  ------FQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-----------------LQLVTQY 95

Query: 201 CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV 260
              G+L  ++ +  R  L  ++++   + +A+G+ YL+   +VHR++   N+LL     V
Sbjct: 96  LPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV 154

Query: 261 KIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CC 317
           ++ADFGVA L   +   +          +MA E ++   Y  + DV+S+G+ +WE+    
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214

Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
             PY  L  +EV    + +  R   P+ C   +  VM +CW  + + RP   E+      
Sbjct: 215 AEPYAGLRLAEVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273

Query: 378 I 378
           +
Sbjct: 274 M 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  201 bits (514), Expect = 3e-61
 Identities = 94/359 (26%), Positives = 148/359 (41%), Gaps = 58/359 (16%)

Query: 47  DNLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGA 106
           + +   HHHH H              + +                  WE+   +L++   
Sbjct: 23  NGMGYYHHHHHHDYDI--PTTENLYFQGMLAGVSEYELPEDP----RWELPRDRLVLGKP 76

Query: 107 FARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW 157
              G FG V      G D         VAVK+L    ++   +       +    E+ + 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKD------LSDLISEMEMM 128

Query: 158 HKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-- 214
             +  H N+   +GA          T +G +        V+VEY   G L+ YL   R  
Sbjct: 129 KMIGKHKNIINLLGAC---------TQDGPL-------YVIVEYASKGNLREYLQARRPP 172

Query: 215 ------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKI 262
                         +L+ K ++  A  +ARG+ YL SKK +HRD+   N+L+ +   +KI
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232

Query: 263 ADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DM 319
           ADFG+AR      +      G L   +MAPE L    Y  + DV+SFG+ LWEI+     
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292

Query: 320 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           PYP +   E+    +++  R + P  C + L  +M+ CW A P +RP   ++V  L+ I
Sbjct: 293 PYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  200 bits (510), Expect = 3e-61
 Identities = 93/344 (27%), Positives = 146/344 (42%), Gaps = 56/344 (16%)

Query: 62  GGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD 121
           G  H HH H   P+        +        +WE    KL +      G FG V      
Sbjct: 2   GSSHHHHHHSQDPMLA----GVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAV 57

Query: 122 G---------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA 171
           G           VAVK+L   +++   +       +    E+ +   +  H N+   +GA
Sbjct: 58  GIDKDKPKEAVTVAVKML--KDDATEKD------LSDLVSEMEMMKMIGKHKNIINLLGA 109

Query: 172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRK 217
                     T +G +        V+VEY   G L+ YL   R                +
Sbjct: 110 C---------TQDGPL-------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD 277
           + FK ++     LARG+ YL S+K +HRD+   N+L+ +   +KIADFG+AR   +  + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213

Query: 278 MTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVV 334
                G L   +MAPE L    Y  + DV+SFG+ +WEI+     PYP +   E+    +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-L 272

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           ++  R + P  C + L  +M+ CW A P +RP   ++V  L+ I
Sbjct: 273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  199 bits (509), Expect = 3e-61
 Identities = 67/292 (22%), Positives = 134/292 (45%), Gaps = 36/292 (12%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLRAA 149
           +   +         G FGTV++G++  +       VA+K L         EA        
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
              E  V   +D+P+V + +G  + ++   +Q              ++ +    G L  Y
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTST---VQ--------------LITQLMPFGCLLDY 106

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           + +  +  +  + ++   + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

Query: 270 LEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 326
           L  +   +   E G +   +MA E +    Y  + DV+S+G+ +WE+      PY  +  
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           SE++S  + +  R   P  C   +  +M++CW  + D RP+  E++     +
Sbjct: 226 SEISSI-LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  198 bits (506), Expect = 4e-61
 Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 49/308 (15%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASL 146
            EI  + +          FG V++G   G       Q VA+K L       + +AE   L
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-------KDKAE-GPL 55

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
           R  F  E  +  +L HPNV   +G           T +  +        ++  YC  G L
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVV---------TKDQPL-------SMIFSYCSHGDL 99

Query: 207 KSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM 252
             +L+                 +  L     + L   +A G+ YL S  +VH+D+ T N+
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 159

Query: 253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGIC 310
           L+     VKI+D G+ R   +  +        L   +MAPE +    ++   D++S+G+ 
Sbjct: 160 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219

Query: 311 LWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 369
           LWE++     PY   S  +V    +R       P  CP+ +  +M  CW+  P +RP   
Sbjct: 220 LWEVFSYGLQPYCGYSNQDVVEM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK 278

Query: 370 EVVAMLEA 377
           ++ + L A
Sbjct: 279 DIHSRLRA 286

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  198 bits (505), Expect = 4e-61
 Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 22/265 (8%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG V +     DG+   +K + +  E    E +  +             KLDH N+ 
Sbjct: 21  SGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALA-------------KLDHVNIV 67

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            + G   G       +        +    + +E+C  G L+ ++ K R  KL   + ++L
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              + +G+ Y+ SKK+++RD+K  N+ L  T+ VKI DFG+      N    T   GTL 
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTRSKGTLR 186

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           YM+PE ++   Y ++ D+Y+ G+ L E+        +      TS          I    
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGIISDIF 240

Query: 347 PSSLANVMKRCWDANPDKRPEMDEV 371
                 ++++     P+ RP   E+
Sbjct: 241 DKKEKTLLQKLLSKKPEDRPNTSEI 265

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  199 bits (507), Expect = 5e-61
 Identities = 89/311 (28%), Positives = 131/311 (42%), Gaps = 48/311 (15%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L   E +  SE     
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSE----- 73

Query: 146 LRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
              A   E+ +   +  H NV   +GA          T  G    P     V+VE+C  G
Sbjct: 74  -HRALMSELKILIHIGHHLNVVNLLGAC---------TKPGG---P---LMVIVEFCKFG 117

Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L +YL   R              +  L  + +I  +  +A+G+ +L S+K +HRD+   
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFG 308
           N+LL +   VKI DFG+AR    +P  +      L   +MAPE +    Y  + DV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237

Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
           + LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP 
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 297

Query: 368 MDEVVAMLEAI 378
             E+V  L  +
Sbjct: 298 FSELVEHLGNL 308

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  199 bits (507), Expect = 7e-61
 Identities = 73/312 (23%), Positives = 131/312 (41%), Gaps = 49/312 (15%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIA 144
           +     +   L       +G FG+V    YD         VAVK L       + +    
Sbjct: 15  QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---- 70

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
                F +E+ +   L    + K+ G + G    ++               +V+EY   G
Sbjct: 71  -----FQREIQILKALHSDFIVKYRGVSYGPGRQSL--------------RLVMEYLPSG 111

Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIAD 264
            L+ +L ++R R L    ++  +  + +G+ YL S++ VHRD+   N+L++    VKIAD
Sbjct: 112 CLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170

Query: 265 FGVARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMP 320
           FG+A+L   +             + + APE L+ + ++R+ DV+SFG+ L+E++  CD  
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

Query: 321 Y--------------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
                             + S +    + +  R   P  CP+ +  +MK CW  +P  RP
Sbjct: 231 CSPSAEFLRMMGCERDVPALSRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289

Query: 367 EMDEVVAMLEAI 378
               +   L+ +
Sbjct: 290 SFSALGPQLDML 301

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  197 bits (502), Expect = 1e-60
 Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 36/299 (12%)

Query: 92  QEWEIDPAKL-IIKGAFARGTFGTVHRGIYDGQ----DVAVKLLDWGEESHRSEAEIASL 146
           ++  +    L I       G FG+V +G+Y  +    DVA+K+L       +   E A  
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-------KQGTEKAD- 53

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
                +E  + H+LD+P + + IG     +                   +V+E   GG L
Sbjct: 54  TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGGPL 96

Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
             +L   +R ++    V +L   ++ G+ YL+ K  VHRD+   N+LL      KI+DFG
Sbjct: 97  HKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155

Query: 267 VARLEASNPHDMTGETGT---LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
           +++   ++    T  +     L + APE +N   ++ + DV+S+G+ +WE       PY 
Sbjct: 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
            +   EV +  + Q  R E P  CP  L  +M  CW    + RP+   V   + A   S
Sbjct: 216 KMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  199 bits (508), Expect = 1e-60
 Identities = 88/313 (28%), Positives = 139/313 (44%), Gaps = 52/313 (16%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEI 143
           +WE    KL +      G FG V      G D         VAVK+L   +++   +   
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKD--- 129

Query: 144 ASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
               +    E+ +   +  H N+   +GA          T +G +        V+VEY  
Sbjct: 130 ---LSDLVSEMEMMKMIGKHKNIINLLGAC---------TQDGPL-------YVIVEYAS 170

Query: 203 GGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK 248
            G L+ YL   R                ++ FK ++     LARG+ YL S+K +HRD+ 
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230

Query: 249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYS 306
             N+L+ +   +KIADFG+AR   +  +      G L   +MAPE L    Y  + DV+S
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290

Query: 307 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           FG+ +WEI+     PYP +   E+    +++  R + P  C + L  +M+ CW A P +R
Sbjct: 291 FGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

Query: 366 PEMDEVVAMLEAI 378
           P   ++V  L+ I
Sbjct: 350 PTFKQLVEDLDRI 362

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  198 bits (505), Expect = 2e-60
 Identities = 85/318 (26%), Positives = 130/318 (40%), Gaps = 56/318 (17%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIAS 145
           +WE     L        G FG V      G         VAVK+L   E++  SE     
Sbjct: 39  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSE----- 91

Query: 146 LRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
            R A   E+ +  +L  H N+   +GA          T +G I        ++ EYC  G
Sbjct: 92  -REALMSELKMMTQLGSHENIVNLLGAC---------TLSGPI-------YLIFEYCCYG 134

Query: 205 ALKSYLIKNR---------------------RRKLAFKVVIQLALDLARGLSYLQSKKIV 243
            L +YL   R                        L F+ ++  A  +A+G+ +L+ K  V
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194

Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL--GYMAPEVLNGSAYNRK 301
           HRD+   N+L+   + VKI DFG+AR   S+ + +      L   +MAPE L    Y  K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254

Query: 302 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 360
            DV+S+GI LWEI+     PYP +        +++   + + P      +  +M+ CW  
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314

Query: 361 NPDKRPEMDEVVAMLEAI 378
           +  KRP    + + L   
Sbjct: 315 DSRKRPSFPNLTSFLGCQ 332

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  195 bits (499), Expect = 3e-60
 Identities = 62/314 (19%), Positives = 112/314 (35%), Gaps = 66/314 (21%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD---------VAVKLLDWGEESHRSEAEIA 144
            +I    LI   +  +GTF  + +G+              V +K+LD    ++       
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES---- 58

Query: 145 SLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
                F +  ++  KL H ++    G         +               +V E+   G
Sbjct: 59  -----FFEAASMMSKLSHKHLVLNYG---------VCVCGDEN-------ILVQEFVKFG 97

Query: 205 ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK-------- 256
           +L +YL K  +  +     +++A  LA  + +L+   ++H +V  +N+LL +        
Sbjct: 98  SLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156

Query: 257 TRTVKIADFGVARLEASNPHDMTGETGTLGY-------MAPEVL-NGSAYNRKCDVYSFG 308
              +K++D G++                          + PE + N    N   D +SFG
Sbjct: 157 PPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFG 205

Query: 309 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 367
             LWEI    D P   L              +   P+     LAN++  C D  PD RP 
Sbjct: 206 TTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLPAPKAAE--LANLINNCMDYEPDHRPS 262

Query: 368 MDEVVAMLEAIDTS 381
              ++  L ++ T 
Sbjct: 263 FRAIIRDLNSLFTP 276

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  195 bits (499), Expect = 1e-59
 Identities = 81/314 (25%), Positives = 133/314 (42%), Gaps = 56/314 (17%)

Query: 90  RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDG----QDVAVKLLDWGEESHRSEAEIAS 145
                 +D   +  +     G FG V +          D A+K +   +E   S+ +   
Sbjct: 16  PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYA-SKDD--- 68

Query: 146 LRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG 204
               F  E+ V  KL  HPN+   +GA             G++        + +EY   G
Sbjct: 69  -HRDFAGELEVLCKLGHHPNIINLLGAC---------EHRGYL-------YLAIEYAPHG 111

Query: 205 ALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
            L  +L K+R                 L+ + ++  A D+ARG+ YL  K+ +HRD+   
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG-----YMAPEVLNGSAYNRKCDVY 305
           N+L+ +    KIADFG++R              T+G     +MA E LN S Y    DV+
Sbjct: 172 NILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 225

Query: 306 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+G+ LWEI      PY  ++ +E+    + Q  R E P  C   + ++M++CW   P +
Sbjct: 226 SYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 284

Query: 365 RPEMDEVVAMLEAI 378
           RP   +++  L  +
Sbjct: 285 RPSFAQILVSLNRM 298

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  191 bits (487), Expect = 6e-58
 Identities = 66/292 (22%), Positives = 131/292 (44%), Gaps = 36/292 (12%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLRAA 149
           +   +         G FGTV++G++  +       VA+K L         EA        
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
              E  V   +D+P+V + +G  + ++                   ++ +    G L  Y
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-----------------LITQLMPFGCLLDY 106

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           + +  +  +  + ++   + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

Query: 270 LEASNPHDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 326
           L  +   +   E G +   +MA E +    Y  + DV+S+G+ +WE+      PY  +  
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           SE++S  + +  R   P  C   +  +M +CW  + D RP+  E++     +
Sbjct: 226 SEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  195 bits (497), Expect = 1e-56
 Identities = 86/388 (22%), Positives = 148/388 (38%), Gaps = 44/388 (11%)

Query: 11  YVRADQIDLKSLDEQLQRHLSRAWTMEKNKNRKEHEDNLAEEHHHHLHGVQGGHHPHHQH 70
                   +  L E      +   +         H   L             G+ P    
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298

Query: 71  LPRPIYTRSRSSSTTSAS--------VRRQEWEIDPAKLII-KGAFARGTFGTVHRGIYD 121
           +  P   R     T+           ++ ++  +    L+I       G FG+V +G+Y 
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358

Query: 122 GQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE 177
            +    DVA+K+L  G E                +E  + H+LD+P + + IG     + 
Sbjct: 359 MRKKQIDVAIKVLKQGTEKA--------DTEEMMREAQIMHQLDNPYIVRLIGVCQAEA- 409

Query: 178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYL 237
                             +V+E   GG L  +L   +R ++    V +L   ++ G+ YL
Sbjct: 410 ----------------LMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL 452

Query: 238 QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT---LGYMAPEVLN 294
           + K  VHR++   N+LL      KI+DFG+++   ++    T  +     L + APE +N
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

Query: 295 GSAYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANV 353
              ++ + DV+S+G+ +WE       PY  +   EV +  + Q  R E P  CP  L  +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPPELYAL 571

Query: 354 MKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           M  CW    + RP+   V   + A   S
Sbjct: 572 MSDCWIYKWEDRPDFLTVEQRMRACYYS 599

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  180 bits (459), Expect = 2e-53
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 26/265 (9%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG         DG+   +K ++    S  S  E    R    +EVAV   + HPN+ 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESR----REVAVLANMKHPNIV 86

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++  +           +NG +        +V++YC GG L   +   +        ++  
Sbjct: 87  QYRESFE---------ENGSL-------YIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            + +   L ++  +KI+HRD+K++N+ L K  TV++ DFG+AR+  S         GT  
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y++PE+     YN K D+++ G  L+E+      +   S   +   ++  +  P +    
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VSLHY 249

Query: 347 PSSLANVMKRCWDANPDKRPEMDEV 371
              L +++ + +  NP  RP ++ +
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSI 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  179 bits (455), Expect = 2e-53
 Identities = 86/340 (25%), Positives = 126/340 (37%), Gaps = 54/340 (15%)

Query: 52  EHHHHLHGVQGG-----HHPHHQHLPRPIYTRSRSSSTTS---------ASVRRQEWEID 97
            HHHH  GV  G         HQ  PR +  R  +S T            S  +Q ++  
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL 62

Query: 98  PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
               +  G    G++G V +     DG+  AVK         R   + A        EV 
Sbjct: 63  --SRL--G---HGSYGEVFKVRSKEDGRLYAVKRSM---SPFRGPKDRARKL----AEVG 108

Query: 156 VWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
              K+  HP   +   A      L +QT                E C G +L     +  
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQT----------------ELC-GPSL-QQHCEAW 150

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASN 274
              L    V     D    L++L S+ +VH DVK  N+ L      K+ DFG+   E   
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGT 209

Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
                 + G   YMAPE+L GS Y    DV+S G+ + E+  C+M  P     E    + 
Sbjct: 210 AGAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEV-ACNMELP--HGGEGWQQLR 265

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
           +  L PE      S L +V+    + +P  R   + ++A+
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  174 bits (443), Expect = 8e-52
 Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 34/280 (12%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGE-ESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           RG FG V   +   D  + A+K +     E  R +           +EV    KL+HP +
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM---------REVKALAKLEHPGI 65

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVV 223
            ++  A +  +       +        +  + ++ C    LK   +  R         V 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSP----KVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVC 120

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL------------E 271
           + + L +A  + +L SK ++HRD+K  N+       VK+ DFG+                
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 272 ASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
                  TG+ GT  YM+PE ++G++Y+ K D++S G+ L+E+     P+        T 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             VR    P +          +++     +P +RPE   +
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  171 bits (435), Expect = 9e-51
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 31/272 (11%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G++G     R   DG+ +  K LD+      +EAE   L      EV +  +L HPN+ 
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLV----SEVNLLRELKHPNIV 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVVI 224
           ++        +  I   N  +        +V+EYC GG L S + K  + +     + V+
Sbjct: 69  RYY-------DRIIDRTNTTL-------YIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114

Query: 225 QLALDLARGLSYLQSKK-----IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
           ++   L   L     +      ++HRD+K  N+ LD  + VK+ DFG+AR+   +     
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
              GT  YM+PE +N  +YN K D++S G  L+E+     P+   S  E+   +     R
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             IP      L  ++ R  +     RP ++E+
Sbjct: 235 R-IPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  171 bits (436), Expect = 1e-50
 Identities = 66/282 (23%), Positives = 118/282 (41%), Gaps = 35/282 (12%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G FG V   R   D +  A+K +        +E +++++      EV +   L+H  V 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTIL----SEVMLLASLNHQYVV 65

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++  A +   E              +   + +EYC  G L    I +           +L
Sbjct: 66  RYYAAWL---ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL-IHSENLNQQRDEYWRL 121

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL--------------EA 272
              +   LSY+ S+ I+HRD+K  N+ +D++R VKI DFG+A+                 
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
            +  ++T   GT  Y+A EVL+G+  YN K D+YS GI  +E+         +    +  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239

Query: 332 AVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +   ++   P+           +++   D +P+KRP    +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  171 bits (435), Expect = 2e-50
 Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 35/309 (11%)

Query: 69  QHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRG--IYDGQDVA 126
           Q  P P +   ++            + I   K I  G   RG F  V+R   + DG  VA
Sbjct: 9   QGPPVPQFQPQKALRPDMGYNTLANFRI--EKKI--G---RGQFSEVYRAACLLDGVPVA 61

Query: 127 VKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGH 186
           +K +             A       +E+ +  +L+HPNV K+  + +  +ELNI      
Sbjct: 62  LKKVQI--FDLMDAKARADCI----KEIDLLKQLNHPNVIKYYASFIEDNELNI------ 109

Query: 187 IGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VVIQLALDLARGLSYLQSKKIVH 244
                     V+E    G L   +   +++K       V +  + L   L ++ S++++H
Sbjct: 110 ----------VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH 159

Query: 245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDV 304
           RD+K  N+ +  T  VK+ D G+ R  +S         GT  YM+PE ++ + YN K D+
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219

Query: 305 YSFGICLWEIYCCDMPY--PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 362
           +S G  L+E+     P+    ++   +   + + +  P         L  ++  C + +P
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 279

Query: 363 DKRPEMDEV 371
           +KRP++  V
Sbjct: 280 EKRPDVTYV 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  167 bits (425), Expect = 3e-49
 Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 30/264 (11%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG+F TV++G+      +VA   L    +   +++E    +    +E  +   L HPN+ 
Sbjct: 36  RGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFK----EEAEMLKGLQHPNIV 88

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +F       S  +       I        +V E    G LK+YL + +   +  KV+   
Sbjct: 89  RFYD-----SWESTVKGKKCI-------VLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 134

Query: 227 ALDLARGLSYL--QSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETG 283
              + +GL +L  ++  I+HRD+K +N+ +   T +VKI D G+A L            G
Sbjct: 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVIG 192

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVVRQNLRPEI 342
           T  +MAPE+     Y+   DVY+FG+C+ E+   + PY +    +++   V         
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251

Query: 343 PRCCPSSLANVMKRCWDANPDKRP 366
            +     +  +++ C   N D+R 
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERY 275

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  163 bits (415), Expect = 1e-47
 Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 40/269 (14%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +GT+G V+ G    +   +A+K     E   R       L     +E+A+   L H N+ 
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIK-----EIPERDSRYSQPLH----EEIALHKHLKHKNIV 82

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VVI 224
           +++G+      + I                 +E   GG+L + L++++   L      + 
Sbjct: 83  QYLGSFSENGFIKI----------------FMEQVPGGSLSA-LLRSKWGPLKDNEQTIG 125

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVA-RLEASNPHDMTGET 282
                +  GL YL   +IVHRD+K +N+L++  +  +KI+DFG + RL   NP   T  T
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-T 184

Query: 283 GTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA---VVRQN 337
           GTL YMAPE+++     Y +  D++S G  + E+     P+ +L   E  +A   V    
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFKVGMFK 242

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           + PEIP    +     + +C++ +PDKR 
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRA 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  164 bits (416), Expect = 1e-47
 Identities = 64/330 (19%), Positives = 125/330 (37%), Gaps = 46/330 (13%)

Query: 66  PHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVH--RGIYDGQ 123
            HH H          SS   +   +     ID    +       G F  V    G++DG 
Sbjct: 4   SHHHH--------HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGH 55

Query: 124 DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD 183
             A+K +   E+  R EA+         +E  +    +HPN+ + +   +          
Sbjct: 56  FYALKRILCHEQQDREEAQ---------READMHRLFNHPNILRLVAYCLRERG------ 100

Query: 184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVVIQLALDLARGLSYLQSKK 241
                   +   +++ +   G L + + + + +        ++ L L + RGL  + +K 
Sbjct: 101 ------AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGVARL---------EASNPHDMTGETGTLGYMAPEV 292
             HRD+K  N+LL       + D G             +A    D   +  T+ Y APE+
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 293 LNGSAY---NRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPS 348
            +  ++   + + DV+S G  L+ +   + PY  +    +  +  V+  L         S
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS 274

Query: 349 SLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +L  ++      +P +RP +  +++ LEA+
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  162 bits (413), Expect = 2e-47
 Identities = 64/288 (22%), Positives = 105/288 (36%), Gaps = 56/288 (19%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV 165
            G FG+V + +   DG   A+K           E           +EV     L  H +V
Sbjct: 21  SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA-------LREVYAHAVLGQHSHV 73

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK--VV 223
            ++  A      + IQ                 EYC+GG+L   + +N R    FK   +
Sbjct: 74  VRYFSAWAEDDHMLIQN----------------EYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT-------------------RTVKIAD 264
             L L + RGL Y+ S  +VH D+K  N+ + +T                      KI D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPD 323
            G      S+P       G   ++A EVL  +  +  K D+++  + +        P P 
Sbjct: 178 LGHVT-RISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCA-AGAEPLPR 232

Query: 324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +  +     +RQ   P IP+        ++K     +P++RP    +
Sbjct: 233 -NGDQW--HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  161 bits (408), Expect = 5e-46
 Identities = 82/346 (23%), Positives = 127/346 (36%), Gaps = 68/346 (19%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQD-------VAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V      G D       VAVK+L   E +  SE     
Sbjct: 16  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSE----- 68

Query: 146 LRAAFTQEVAVWHKLD-HPNVTKFIGA--------------------------------- 171
              A   E+ +   +  H NV   +GA                                 
Sbjct: 69  -HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

Query: 172 --TMGTSELNIQTDNGHIGM--------------PSNFCCVVVEYCHGGALKSYLIKNRR 215
             T G      +   G I +               ++   V  +       +       +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
             L  + +I  +  +A+G+ +L S+K +HRD+   N+LL +   VKI DFG+AR    +P
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 276 HDMTGETGTL--GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 332
             +      L   +MAPE +    Y  + DV+SFG+ LWEI+     PYP +   E    
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +++  R   P      +   M  CW   P +RP   E+V  L  +
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  159 bits (405), Expect = 8e-46
 Identities = 62/309 (20%), Positives = 98/309 (31%), Gaps = 42/309 (13%)

Query: 68  HQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAF-ARGTFGTVHRGI--YDGQD 124
                 P    +     T           +    +       RG+FG VHR      G  
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85

Query: 125 VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDN 184
            AVK +               L     +E+     L  P +    GA      +NI    
Sbjct: 86  CAVKKVR--------------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI---- 127

Query: 185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH 244
                        +E   GG+L   +   +   L     +        GL YL +++I+H
Sbjct: 128 ------------FMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 245 RDVKTENMLLDKT-RTVKIADFGVARLEASNPHDMTGET-----GTLGYMAPEVLNGSAY 298
            DVK +N+LL        + DFG A     +    +  T     GT  +MAPEV+ G   
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233

Query: 299 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN-LRPEIPRCCPSSLANVMKRC 357
           + K D++S    +  +     P+       +   +  +     EIP  C    A  ++  
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293

Query: 358 WDANPDKRP 366
               P  R 
Sbjct: 294 LRKEPVHRA 302

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  159 bits (403), Expect = 1e-45
 Identities = 65/322 (20%), Positives = 122/322 (37%), Gaps = 51/322 (15%)

Query: 67  HHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-GQDV 125
           HH H    +   + +    S SV+ + + I   K I  G    G    V + + +  Q  
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSIL--KQI--G---SGGSSKVFQVLNEKKQIY 55

Query: 126 AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSELNIQTD 183
           A+K ++           + S R     E+A  +KL   +  + +             +  
Sbjct: 56  AIKYVN---LEEADNQTLDSYR----NEIAYLNKLQQHSDKIIRLYD---------YEIT 99

Query: 184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIV 243
           + +I        +V+E C    L S+L K  ++ +          ++   +  +    IV
Sbjct: 100 DQYI-------YMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIV 149

Query: 244 HRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSA---- 297
           H D+K  N L+     +K+ DFG+A     +   +  ++  GT+ YM PE +   +    
Sbjct: 150 HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208

Query: 298 -------YNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPSS 349
                   + K DV+S G  L+ +     P+  +        A++  N   E P      
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268

Query: 350 LANVMKRCWDANPDKRPEMDEV 371
           L +V+K C   +P +R  + E+
Sbjct: 269 LQDVLKCCLKRDPKQRISIPEL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  154 bits (390), Expect = 1e-43
 Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 44/280 (15%)

Query: 109 RGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--V 165
            G    V + + +  Q  A+K ++           + S R     E+A  +KL   +  +
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYR----NEIAYLNKLQQHSDKI 71

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +             +  + +I        +V+E C    L S+L K  ++ +       
Sbjct: 72  IRLYD---------YEITDQYI-------YMVME-CGNIDLNSWLKK--KKSIDPWERKS 112

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--G 283
              ++   +  +    IVH D+K  N L+     +K+ DFG+A     +   +  ++  G
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 284 TLGYMAPEVLNGSA-----------YNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTS 331
           T+ YM PE +   +            + K DV+S G  L+ +     P+  +        
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231

Query: 332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           A++  N   E P      L +V+K C   +P +R  + E+
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  152 bits (386), Expect = 4e-43
 Identities = 78/295 (26%), Positives = 119/295 (40%), Gaps = 59/295 (20%)

Query: 109 RGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
            G FG V++G + DG  VA+K      ES +   E       F  E+       HP++  
Sbjct: 49  HGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE-------FETEIETLSFCRHPHLVS 99

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCV-------VVEYCHGGALKSYL--IKNRRRKL 218
            IG                        C        + +Y   G LK +L         +
Sbjct: 100 LIG-----------------------FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPH 276
           +++  +++ +  ARGL YL ++ I+HRDVK+ N+LLD+    KI DFG+++   E    H
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC----DMPYPDLSFSEVT-- 330
             T   GTLGY+ PE         K DVYSFG+ L+E+ C         P    +     
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

Query: 331 ---------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
                      +V  NL  +I         +   +C   + + RP M +V+  LE
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  153 bits (389), Expect = 6e-43
 Identities = 70/352 (19%), Positives = 126/352 (35%), Gaps = 68/352 (19%)

Query: 54  HHHLHGVQG------------GHHPHHQHLPRPIYTRSR-----SSSTTSASVRRQEWEI 96
           HHH H   G                  QH+  P           SS+    SV+ + + I
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 97  DPAKLIIKGAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA 155
              K I  G    G    V + + +  Q  A+K ++           + S R     E+A
Sbjct: 61  L--KQI--G---SGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYR----NEIA 106

Query: 156 VWHKLDHPN--VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
             +KL   +  + +             +  + +I        +V+E C    L S+L K 
Sbjct: 107 YLNKLQQHSDKIIRLYD---------YEITDQYI-------YMVME-CGNIDLNSWLKK- 148

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            ++ +          ++   +  +    IVH D+K  N L+     +K+ DFG+A     
Sbjct: 149 -KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 206

Query: 274 NPHDMTGET--GTLGYMAPEVLNGSA-----------YNRKCDVYSFGICLWEIYCCDMP 320
           +   +  ++  G + YM PE +   +            + K DV+S G  L+ +     P
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

Query: 321 YPDLSFS-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +  +        A++  N   E P      L +V+K C   +P +R  + E+
Sbjct: 267 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  150 bits (381), Expect = 2e-42
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 68/304 (22%)

Query: 109 RGTFGTVHRGIYDGQDVAVKLLDWGE--ESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG V++G  +   VAVK L       +   + +       F QE+ V  K  H N+ 
Sbjct: 41  EGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ-------FDQEIKVMAKCQHENLV 93

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCV-------VVEYCHGGALKSYL-IKNRRRKL 218
           + +G                                 V  Y   G+L   L   +    L
Sbjct: 94  ELLG-----------------------FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 219 AFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPH 276
           ++ +  ++A   A G+++L     +HRD+K+ N+LLD+  T KI+DFG+AR   + +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC----CDMPYPDLS------- 325
             +   GT  YMAPE L G     K D+YSFG+ L EI       D              
Sbjct: 191 MTSRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249

Query: 326 -FSEVTSAVVRQNLR----PEIPRCCPSSLANVMK---RCWDANPDKRPEMDEVVAMLEA 377
              E       + +      ++     +S+  +     +C     +KRP++ +V  +L+ 
Sbjct: 250 IEDE------EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 378 IDTS 381
           +  S
Sbjct: 304 MTAS 307

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  148 bits (376), Expect = 1e-41
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 41/290 (14%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q W+     L   G   RG +G+V++ ++   GQ +AVK +     S   E E   L   
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLL-- 68

Query: 150 FTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              ++ V  +  D P + +F GA     +  I                 +E       K 
Sbjct: 69  --MDLDVVMRSSDCPYIVQFYGALFREGDCWI----------------CMELMSTSFDKF 110

Query: 209 YLIKNRRRKLAF--KVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADF 265
           Y             +++ ++ L   + L++L+   KI+HRD+K  N+LLD++  +K+ DF
Sbjct: 111 YKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170

Query: 266 GV-ARLEASNPHDMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMP 320
           G+  +L  S     T + G   YMAPE ++ SA    Y+ + DV+S GI L+E+     P
Sbjct: 171 GISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

Query: 321 YPDL-SFSEVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRP 366
           YP   S  +  + VV+ +   L     R    S  N +  C   +  KRP
Sbjct: 229 YPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  148 bits (374), Expect = 2e-41
 Identities = 63/322 (19%), Positives = 112/322 (34%), Gaps = 73/322 (22%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V   +   D  + A+K +         E           +EV    KL+HP + 
Sbjct: 16  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--------VMREVKALAKLEHPGIV 67

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFC-------------------------------- 194
           ++  A + T     Q +   I +                                     
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 195 ---------CVVVEYCHGGALKSYLIKNRRRKLAF--KVVIQLALDLARGLSYLQSKKIV 243
                     + ++ C    LK   +  R         V + + + +A  + +L SK ++
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 244 HRDVKTENMLLDKTRTVKIADFGVARL------------EASNPHDMTGETGTLGYMAPE 291
           HRD+K  N+       VK+ DFG+                       TG+ GT  YM+PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 292 VLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNLRPEIPRCCPSS 349
            ++G+ Y+ K D++S G+ L+E     + Y   +  E    +  VR    P +       
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFE-----LLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQ 301

Query: 350 LANVMKRCWDANPDKRPEMDEV 371
              +++     +P +RPE  ++
Sbjct: 302 EHMMVQDMLSPSPTERPEATDI 323

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  144 bits (365), Expect = 5e-40
 Identities = 84/303 (27%), Positives = 125/303 (41%), Gaps = 70/303 (23%)

Query: 109 RGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           RG FG V++G + DG  VAVK L   E +   E +       F  EV +     H N+ +
Sbjct: 40  RGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQ-------FQTEVEMISMAVHRNLLR 91

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCV-------VVEYCHGGALKSYL--IKNRRRKL 218
             G                        C+       V  Y   G++ S L      +  L
Sbjct: 92  LRG-----------------------FCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128

Query: 219 AFKVVIQLALDLARGLSYL--QSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP 275
            +    ++AL  ARGL+YL      KI+HRDVK  N+LLD+     + DFG+A+L     
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL---MD 185

Query: 276 HDMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 331
           +  T  T    GT+G++APE L+    + K DV+ +G+ L E+      + DL+      
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDD 244

Query: 332 A------------------VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                              +V  +L+          L  V   C  ++P +RP+M EVV 
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

Query: 374 MLE 376
           MLE
Sbjct: 305 MLE 307

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  146 bits (370), Expect = 2e-39
 Identities = 76/320 (23%), Positives = 130/320 (40%), Gaps = 45/320 (14%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YD 121
           HH HH      +Y +    +T    +  ++  +             G +G V        
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
             + A+K++    ++  S +  + L     +EVAV   LDHPN+ K             +
Sbjct: 62  HVERAIKIIR---KTSVSTSSNSKLL----EEVAVLKLLDHPNIMKLYDF--------FE 106

Query: 182 TDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQ 238
                ++         V+E   GG L   +I   +     A  ++ Q+      G++YL 
Sbjct: 107 DKRNYYL---------VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL----SGVTYLH 153

Query: 239 SKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG 295
              IVHRD+K EN+LL   +K   +KI DFG++ +  +    M    GT  Y+APEVL  
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK 212

Query: 296 SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPSSLA- 351
             Y+ KCDV+S G+ L+ +     P+   +  E+   V +       PE      S  A 
Sbjct: 213 K-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV--SEGAK 269

Query: 352 NVMKRCWDANPDKRPEMDEV 371
           +++K+    +  +R    + 
Sbjct: 270 DLIKQMLQFDSQRRISAQQA 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  144 bits (366), Expect = 2e-39
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 45/278 (16%)

Query: 109 RGTFGT-VHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVT 166
            G  GT V+RG++D +DVAVK +             A       +EV +  + D HPNV 
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRIL------PECFSFAD------REVQLLRESDEHPNVI 81

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++            +           F  + +E C    L+ Y ++ +         I L
Sbjct: 82  RYFCT--------EKDRQ--------FQYIAIELC-AATLQEY-VEQKDFAHLGLEPITL 123

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFGVARL---EASNPHDM 278
                 GL++L S  IVHRD+K  N+L+            I+DFG+ +       +    
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183

Query: 279 TGETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVV 334
           +G  GT G++APE+L+           D++S G   + +      P+      +    + 
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243

Query: 335 RQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
             +L    P      +A  ++++    +P KRP    V
Sbjct: 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  142 bits (360), Expect = 4e-39
 Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 36/305 (11%)

Query: 78  RSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEE 135
           + R       + +++  E+             G  G V +  +   G  +A KL+     
Sbjct: 12  QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---- 67

Query: 136 SHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCC 195
                A    +     +E+ V H+ + P +  F GA     E++I               
Sbjct: 68  LEIKPAIRNQII----RELQVLHECNSPYIVGFYGAFYSDGEISI--------------- 108

Query: 196 VVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLL 254
             +E+  GG+L   L K  R  +  +++ ++++ + +GL+YL+ K KI+HRDVK  N+L+
Sbjct: 109 -CMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165

Query: 255 DKTRTVKIADFGVA-RLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE 313
           +    +K+ DFGV+ +L  S  +   G   T  YM+PE L G+ Y+ + D++S G+ L E
Sbjct: 166 NSRGEIKLCDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222

Query: 314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
           +     P P     E+         + E              R  +           +  
Sbjct: 223 MAVGRYPIPPPDAKELELM---FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279

Query: 374 MLEAI 378
           +L+ I
Sbjct: 280 LLDYI 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  144 bits (366), Expect = 7e-39
 Identities = 73/324 (22%), Positives = 123/324 (37%), Gaps = 42/324 (12%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YD 121
           HH HH    R        +      VR++E +I             G +G V        
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNG 60

Query: 122 GQDVAVKLLD----WGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE 177
             + A+K++                I         E+++   LDHPN+ K          
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV------ 114

Query: 178 LNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGL 234
              +     ++         V E+  GG L   +I   +     A  ++ Q+      G+
Sbjct: 115 --FEDKKYFYL---------VTEFYEGGELFEQIINRHKFDECDAANIMKQIL----SGI 159

Query: 235 SYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
            YL    IVHRD+K EN+LL   +    +KI DFG++   + + + +    GT  Y+APE
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPE 218

Query: 292 VLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPS 348
           VL    YN KCDV+S G+ ++ + C   P+   +  ++   V +        +      S
Sbjct: 219 VLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI--S 275

Query: 349 SLA-NVMKRCWDANPDKRPEMDEV 371
             A  ++K     + +KR   +E 
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEA 299

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  139 bits (353), Expect = 8e-39
 Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 38/269 (14%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G FG V+  R       +A+K+L       +++ E A +     +EV +   L HPN+ 
Sbjct: 19  KGKFGNVYLAREKQSKFILALKVLF------KAQLEKAGVEHQLRREVEIQSHLRHPNIL 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           +  G                + +       ++EY   G +   L K  +   +     + 
Sbjct: 73  RLYGY--------FHDAT-RVYL-------ILEYAPLGTVYRELQKLSKFDEQRTATYIT 116

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-- 282
           +LA      LSY  SK+++HRD+K EN+LL     +KIADFG +    S+          
Sbjct: 117 ELAN----ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLC 168

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E    + R       
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--F 226

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           P        +++ R    NP +RP + EV
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREV 255

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (353), Expect = 2e-38
 Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 40/287 (13%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q ++ +   L   G    GT G V +  +   G  +AVK +        ++ E   +   
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEENKRIL-- 71

Query: 150 FTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
              ++ V  K  D P + +  G  +  +++ I                 +E     A K 
Sbjct: 72  --MDLDVVLKSHDCPYIVQCFGTFITNTDVFI----------------AMELMGTCAEKL 113

Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGV 267
                    +  +++ ++ + + + L YL+ K  ++HRDVK  N+LLD+   +K+ DFG+
Sbjct: 114 KKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171

Query: 268 -ARLEASNPHDMTGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPY 321
             RL            G   YMAPE +         Y+ + DV+S GI L E+     PY
Sbjct: 172 SGRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

Query: 322 PDL-SFSEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRP 366
            +  +  EV + V+++                + +K C   +  KRP
Sbjct: 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (353), Expect = 3e-38
 Identities = 71/323 (21%), Positives = 122/323 (37%), Gaps = 43/323 (13%)

Query: 77  TRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGE 134
           +   +S    +    Q  E+   +L ++   A G F  V+  + +  G++ A+K L   E
Sbjct: 6   SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65

Query: 135 ESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF 193
           E                QEV    KL  HPN+ +F  A     E                
Sbjct: 66  EEKNRAII---------QEVCFMKKLSGHPNIVQFCSAASIGKE--------ESDTGQAE 108

Query: 194 CCVVVEYCHGGALKSYLIKNRRR-KLAFKVVIQLALDLARGLSYL--QSKKIVHRDVKTE 250
             ++ E C G  L  +L K   R  L+   V+++     R + ++  Q   I+HRD+K E
Sbjct: 109 FLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167

Query: 251 NMLLDKTRTVKIADFGVARLEASNP------------HDMTGETGTLGYMAPEVLN---G 295
           N+LL    T+K+ DFG A   +  P             +      T  Y  PE+++    
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227

Query: 296 SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 355
                K D+++ G  L+ +     P+ D         +V             +   ++++
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKYSIPPHDTQYTVFHSLIR 283

Query: 356 RCWDANPDKRPEMDEVVAMLEAI 378
                NP++R  + EVV  L+ I
Sbjct: 284 AMLQVNPEERLSIAEVVHQLQEI 306

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  141 bits (357), Expect = 3e-38
 Identities = 48/364 (13%), Positives = 108/364 (29%), Gaps = 44/364 (12%)

Query: 45  HEDNLAEEHHHHLHGVQGG---------HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWE 95
           H       +     G   G           P         Y +S + S  S S+      
Sbjct: 7   HSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 66

Query: 96  I-------DPAKLIIKGAF-ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAE--- 142
                   +  + +++G    +              G+   V +  + E    +  +   
Sbjct: 67  FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 126

Query: 143 -----IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL-NIQTDNGHIGMPSNFCCV 196
                +  LR    Q+ A  H          +       ++  ++ D   + + S F   
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVH--LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 197 VVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
                +       L+ +    + L     +QL L + R L+ L    +VH  ++  +++L
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL 244

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVLNGS-----AYNRKCDVYSFG 308
           D+   V +  F     + ++     G         A  +L              D ++ G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 309 ICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
           + ++ I+C D+P  D +    +  + R           P  +  +++       + R   
Sbjct: 305 LAIYWIWCADLPNTDDAALGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLP 358

Query: 369 DEVV 372
            + +
Sbjct: 359 LQAM 362

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  138 bits (350), Expect = 3e-38
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 43/286 (15%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           E+    L       RG +G V +  +   GQ +AVK +           E   L      
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----SQEQKRLL----M 54

Query: 153 EVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY-L 210
           ++ +  +  D P    F GA     ++ I                 +E       K Y  
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWI----------------CMELMDTSLDKFYKQ 98

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGV-A 268
           + ++ + +   ++ ++A+ + + L +L SK  ++HRDVK  N+L++    VK+ DFG+  
Sbjct: 99  VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158

Query: 269 RLEASNPHDMTGET--GTLGYMAPEV----LNGSAYNRKCDVYSFGICLWEIYCCDMPYP 322
            L       +  +   G   YMAPE     LN   Y+ K D++S GI + E+     PY 
Sbjct: 159 YLVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

Query: 323 DL-SFSEVTSAVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRP 366
              +  +    VV +   P++P     +   +   +C   N  +RP
Sbjct: 215 SWGTPFQQLKQVVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERP 259

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (351), Expect = 3e-38
 Identities = 54/312 (17%), Positives = 102/312 (32%), Gaps = 65/312 (20%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G    V RG     G   A+K+ +                    +E  V  KL+H N+ 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFN--------NISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQ 225
           K             +         +    +++E+C  G+L + L +      L     + 
Sbjct: 71  KLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGE 281
           +  D+  G+++L+   IVHR++K  N++     D     K+ DFG AR    +       
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSL 175

Query: 282 TGTLGYMAPEVLNGSA--------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            GT  Y+ P++   +         Y    D++S G+  +      +P+           V
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

Query: 334 VRQNLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRP 366
           + + +                              + R     L  V+    +A+ +K  
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295

Query: 367 EMDEVVAMLEAI 378
             D+  A    I
Sbjct: 296 GFDQFFAETSDI 307

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  138 bits (350), Expect = 1e-37
 Identities = 58/338 (17%), Positives = 116/338 (34%), Gaps = 63/338 (18%)

Query: 73  RPIYTRSRSSSTTSASVRRQEWEIDPAKLIIK--GAFARGTFGTVHRGIYDGQDVAVKLL 130
           + I +   +    +  V+ ++  I+  + II+      +G F  +     D +  A+K  
Sbjct: 7   KDILSNYSNLIYLNKYVKEKDKYINDYR-IIRTLN---QGKFNKIILCEKDNKFYALKKY 62

Query: 131 D--------WGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
           +           +S+  +  I S    F  E+ +   + +       G         I  
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI--------ITN 114

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------RKLAFKVVIQLALDLARGLSY 236
            +  + +       + EY    ++  +              +  +V+  +   +    SY
Sbjct: 115 YD-EVYI-------IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166

Query: 237 LQSKK-IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG 295
           + ++K I HRDVK  N+L+DK   VK++DFG +         + G  GT  +M PE  + 
Sbjct: 167 IHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSN 224

Query: 296 SA--YNRKCDVYSFGICLWE--------------------IYCCDMPYPDLSFSEVTSAV 333
            +     K D++S GICL+                     I   ++ YP           
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP--LDRNHFLYP 282

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +             +   + +K     NP +R   ++ 
Sbjct: 283 LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (352), Expect = 1e-37
 Identities = 54/316 (17%), Positives = 102/316 (32%), Gaps = 65/316 (20%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G    V RG     G   A+K+ +                    +E  V  KL+H N+ 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFN--------NISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQ 225
           K             +         +    +++E+C  G+L + L +      L     + 
Sbjct: 71  KLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGE 281
           +  D+  G+++L+   IVHR++K  N++     D     K+ DFG AR    +       
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSL 175

Query: 282 TGTLGYMAPEVLNGSA--------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
            GT  Y+ P++   +         Y    D++S G+  +      +P+           V
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

Query: 334 VRQNLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRP 366
           + + +                              + R     L  V+    +A+ +K  
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295

Query: 367 EMDEVVAMLEAIDTSK 382
             D+  A    I    
Sbjct: 296 GFDQFFAETSDILHRM 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  143 bits (361), Expect = 1e-37
 Identities = 65/243 (26%), Positives = 96/243 (39%), Gaps = 25/243 (10%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG V R I    G+ VA+K           +      R  +  E+ +  KL+HPNV 
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQCR--------QELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR-KLAFKVVIQ 225
                        +      +  P++   + +EYC GG L+ YL +      L    +  
Sbjct: 76  SA---------REVPDGLQKLA-PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLD---KTRTVKIADFGVARLEASNPHDMTGET 282
           L  D++  L YL   +I+HRD+K EN++L    +    KI D G A+         T   
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV 184

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           GTL Y+APE+L    Y    D +SFG   +E      P+            VR+     I
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244

Query: 343 PRC 345
              
Sbjct: 245 VVY 247

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  135 bits (341), Expect = 6e-37
 Identities = 73/315 (23%), Positives = 126/315 (40%), Gaps = 50/315 (15%)

Query: 81  SSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVH--RGIYDGQDVAVKLLD------- 131
           SS ++   V+  ++ +     I      +G++G V       D    A+K+L        
Sbjct: 2   SSGSSGDCVQLNQYTLK--DEI-----GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQ 54

Query: 132 ----------WGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
                         +     +         QE+A+  KLDHPNV K +       E+   
Sbjct: 55  AGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-------EVLDD 107

Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSK 240
            +  H+ M       V E  + G +             A      L      G+ YL  +
Sbjct: 108 PNEDHLYM-------VFELVNQGPVMEVPTLKPLSEDQARFYFQDLIK----GIEYLHYQ 156

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS--AY 298
           KI+HRD+K  N+L+ +   +KIADFGV+     +   ++   GT  +MAPE L+ +   +
Sbjct: 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF 216

Query: 299 N-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR-PEIPRCCPSSLANVMKR 356
           + +  DV++ G+ L+       P+ D     + S +  Q L  P+ P      L +++ R
Sbjct: 217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAE-DLKDLITR 275

Query: 357 CWDANPDKRPEMDEV 371
             D NP+ R  + E+
Sbjct: 276 MLDKNPESRIVVPEI 290

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  137 bits (346), Expect = 6e-37
 Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 46/272 (16%)

Query: 65  HPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DG 122
           H HH H+    +    S                   +I KG        TV+   Y   G
Sbjct: 3   HHHHHHMENLYFQGMSSFLPEGGCYELLT-------VIGKGF---EDLMTVNLARYKPTG 52

Query: 123 QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQT 182
           + V V+ ++    S+     +         E+ V    +HPN+  +    +  +EL +  
Sbjct: 53  EYVTVRRINLEACSNEMVTFLQ-------GELHVSKLFNHPNIVPYRATFIADNELWV-- 103

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLAL-DLARGLSYLQSKK 241
                         V  +   G+ K  LI         ++ I   L  + + L Y+    
Sbjct: 104 --------------VTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMG 148

Query: 242 IVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTGET------GTLGYMAPEVL- 293
            VHR VK  ++L+     V ++       + +                  L +++PEVL 
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 294 -NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
            N   Y+ K D+YS GI   E+    +P+ D+
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  139 bits (351), Expect = 7e-37
 Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 39/273 (14%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V        GQ+ AVK++       + + +  + + +  +EV +  +LDHPN+ 
Sbjct: 36  KGSFGEVILCKDKITGQECAVKVIS------KRQVKQKTDKESLLREVQLLKQLDHPNIM 89

Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRR--KLAFKVV 223
           K             +     ++         V E   GG L   +I  +R     A +++
Sbjct: 90  KLYEF--------FEDKGYFYL---------VGEVYTGGELFDEIISRKRFSEVDAARII 132

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
            Q+      G++Y+   KIVHRD+K EN+LL    K   ++I DFG++    ++   M  
Sbjct: 133 RQVL----SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKD 187

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR- 339
           + GT  Y+APEVL+G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V +     
Sbjct: 188 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246

Query: 340 PEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
                   S  A +++++     P  R    + 
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (339), Expect = 1e-36
 Identities = 67/294 (22%), Positives = 124/294 (42%), Gaps = 40/294 (13%)

Query: 84  TTSASVRRQEWEIDPAKLIIKGAFARGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEA 141
           T  A + ++++ ID     I     +G FG V+  R   +   +A+K+L       +S+ 
Sbjct: 1   TALAEMPKRKFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF------KSQL 52

Query: 142 EIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC 201
           E   +     +E+ +   L HPN+ +                   I +       ++E+ 
Sbjct: 53  EKEGVEHQLRREIEIQSHLRHPNILRMYNY--------FHDRK-RIYL-------MLEFA 96

Query: 202 HGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT 259
             G L   L K+ R   + +   + +LA      L Y   +K++HRD+K EN+L+     
Sbjct: 97  PRGELYKELQKHGRFDEQRSATFMEELAD----ALHYCHERKVIHRDIKPENLLMGYKGE 152

Query: 260 VKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC 317
           +KIADFG +    S        T  GTL Y+ PE++ G  ++ K D++  G+  +E    
Sbjct: 153 LKIADFGWSVHAPSLRRR----TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

Query: 318 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             P+   S +E    +V  +L+   P        +++ +    +P +R  +  V
Sbjct: 209 MPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  136 bits (343), Expect = 1e-36
 Identities = 42/290 (14%), Positives = 85/290 (29%), Gaps = 34/290 (11%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G    V         +D A+K+   G E+ RSE E         +      +L   +  
Sbjct: 72  VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE------RLHEATFAAARLLGESPE 125

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFC----------CVVVEYCHG--GALKSYL--IK 212
           +           +                          +++         L S L  + 
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEA 272
             R       +  L   L R  + LQSK +VH     +N+ +     + + D        
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 273 SNPHDMTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 330
           +        +  + Y   E LN S   +    + +  G+ ++ ++C  +P+  ++     
Sbjct: 246 TRGPAS---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 331 SAVVRQNLRPEIP----RCC---PSSLANVMKRCWDANPDKRPEMDEVVA 373
           S        P         C   P  +  ++ R  + +  +R    E + 
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  133 bits (338), Expect = 2e-36
 Identities = 84/304 (27%), Positives = 135/304 (44%), Gaps = 60/304 (19%)

Query: 81  SSSTTSASVRR-QEWEIDPAKL-IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEES 136
           + S   + +   Q  + DP +L        +G+FG V +GI     + VA+K++D  EE+
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEA 60

Query: 137 HRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCV 196
                +I        QE+ V  + D P VTK+ G+ +  ++L I                
Sbjct: 61  EDEIEDI-------QQEITVLSQCDSPYVTKYYGSYLKDTKLWI---------------- 97

Query: 197 VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK 256
           ++EY  GG+    L      +     +++  L   +GL YL S+K +HRD+K  N+LL +
Sbjct: 98  IMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSE 154

Query: 257 TRTVKIADFGV-ARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
              VK+ADFGV  +L  +     T   GT  +MAPEV+  SAY+ K D++S GI   E+ 
Sbjct: 155 HGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213

Query: 316 CCDMPYPDLSFSEVTSAVVRQNLRP-----EIPRCCPSSLA--------NVMKRCWDANP 362
             + P+ +L               P      IP+  P +L           ++ C +  P
Sbjct: 214 RGEPPHSELH--------------PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259

Query: 363 DKRP 366
             RP
Sbjct: 260 SFRP 263

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  134 bits (338), Expect = 5e-36
 Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 40/286 (13%)

Query: 48  NLAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLI-IKGA 106
           +    HHHH + +    + + Q    P+    R+ S     V    ++ DP KL      
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 107 FARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
              G+FG V+      + + VA+K + +  +    + +         +EV    KL HPN
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD------IIKEVRFLQKLRHPN 115

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
             ++ G  +      +                V+EYC G A    L++  ++ L    + 
Sbjct: 116 TIQYRGCYLREHTAWL----------------VMEYCLGSASD--LLEVHKKPLQEVEIA 157

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTGET- 282
            +     +GL+YL S  ++HRDVK  N+LL +   VK+ DFG  + +  +N       + 
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------SF 210

Query: 283 -GTLGYMAPEV---LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
            GT  +MAPEV   ++   Y+ K DV+S GI   E+     P  ++
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  132 bits (334), Expect = 7e-36
 Identities = 57/266 (21%), Positives = 107/266 (40%), Gaps = 28/266 (10%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F            +  A K++       +S       R   + E+++   L H +V 
Sbjct: 25  KGGFAKCFEISDADTKEVFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQHVV 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            F G          + ++  +        VV+E C   +L       RR+ L        
Sbjct: 79  GFHGF--------FEDND-FV-------FVVLELCRRRSLLELHK--RRKALTEPEARYY 120

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +  G  YL   +++HRD+K  N+ L++   VKI DFG+A     +        GT  
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APEVL+   ++ + DV+S G  ++ +     P+      E    + +      IP+  
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHI 238

Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
               A+++++    +P  RP ++E++
Sbjct: 239 NPVAASLIQKMLQTDPTARPTINELL 264

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  135 bits (342), Expect = 1e-35
 Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 44/275 (16%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V +       Q+ AVK+++   ++     + +++     +EV +  KLDHPN+ 
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTIL----REVELLKKLDHPNIM 84

Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVV 223
           K            ++  +  +I         V E   GG L   +IK +R     A +++
Sbjct: 85  KLFEI--------LEDSSSFYI---------VGELYTGGELFDEIIKRKRFSEHDAARII 127

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
            Q+      G++Y+    IVHRD+K EN+LL   +K   +KI DFG++     N   M  
Sbjct: 128 KQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKD 182

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL-- 338
             GT  Y+APEVL G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V       
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241

Query: 339 -RPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
             P+      S  A +++++    +P  R    + 
Sbjct: 242 DLPQWRTI--SDDAKDLIRKMLTFHPSLRITATQC 274

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  131 bits (332), Expect = 1e-35
 Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 50/282 (17%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G    V         + VA+K ++      + +  +  L     +E+    +  HPN+ 
Sbjct: 25  SGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELL----KEIQAMSQCHHPNIV 76

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI-- 224
            +  + +   EL                 +V++   GG++   +IK+   K   K  +  
Sbjct: 77  SYYTSFVVKDEL----------------WLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLD 119

Query: 225 --QLAL---DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDM 278
              +A    ++  GL YL     +HRDVK  N+LL +  +V+IADFGV A L        
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 279 TGE----TGTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                   GT  +MAPEV+     Y+ K D++SFGI   E+     PY      +V   +
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-ML 238

Query: 334 VRQNLRPEIPRCCPS---------SLANVMKRCWDANPDKRP 366
             QN  P +               S   ++  C   +P+KRP
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  132 bits (334), Expect = 2e-35
 Identities = 57/266 (21%), Positives = 107/266 (40%), Gaps = 28/266 (10%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F            +  A K++       +S       R   + E+++   L H +V 
Sbjct: 51  KGGFAKCFEISDADTKEVFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQHVV 104

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            F G          + ++  +        VV+E C   +L       RR+ L        
Sbjct: 105 GFHGF--------FEDND-FV-------FVVLELCRRRSLLELHK--RRKALTEPEARYY 146

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +  G  YL   +++HRD+K  N+ L++   VKI DFG+A     +        GT  
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APEVL+   ++ + DV+S G  ++ +     P+      E    + +      IP+  
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHI 264

Query: 347 PSSLANVMKRCWDANPDKRPEMDEVV 372
               A+++++    +P  RP ++E++
Sbjct: 265 NPVAASLIQKMLQTDPTARPTINELL 290

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (330), Expect = 2e-35
 Identities = 62/268 (23%), Positives = 111/268 (41%), Gaps = 33/268 (12%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+F  V+    I+ G +VA+K++D      +     A +      EV +  +L HP++ 
Sbjct: 21  KGSFAGVYRAESIHTGLEVAIKMID------KKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRR---KLAFKVV 223
           +             +  N ++ +       V+E CH G +  YL    +      A   +
Sbjct: 75  ELYNY--------FEDSN-YVYL-------VLEMCHNGEMNRYLKNRVKPFSENEARHFM 118

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
            Q+      G+ YL S  I+HRD+   N+LL +   +KIADFG+A              G
Sbjct: 119 HQII----TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T  Y++PE+   SA+  + DV+S G   + +     P+   +     + VV  +    +P
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MP 232

Query: 344 RCCPSSLANVMKRCWDANPDKRPEMDEV 371
                   +++ +    NP  R  +  V
Sbjct: 233 SFLSIEAKDLIHQLLRRNPADRLSLSSV 260

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  133 bits (337), Expect = 3e-35
 Identities = 66/298 (22%), Positives = 119/298 (39%), Gaps = 64/298 (21%)

Query: 109 RGTFGTV-HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVT 166
            G+ GTV  +G + G+ VAVK +           +IA        E+ +  + D HPNV 
Sbjct: 25  YGSSGTVVFQGSFQGRPVAVKRML------IDFCDIAL------MEIKLLTESDDHPNVI 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-----RRRKLAFK 221
           ++  +          TD         F  + +E C    L+  +          +     
Sbjct: 73  RYYCS--------ETTDR--------FLYIALELC-NLNLQDLVESKNVSDENLKLQKEY 115

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR-------------TVKIADFGVA 268
             I L   +A G+++L S KI+HRD+K +N+L+  +               + I+DFG+ 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 269 RL----EASNPHDMTGETGTLGYMAPEVLNGSA-------YNRKCDVYSFGICLWEIYCC 317
           +     ++S   ++   +GT G+ APE+L  S          R  D++S G   + I   
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 318 -DMPYPDLSFSE--VTSAVVRQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
              P+ D    E  +   +   +    +      + A +++ +  D +P KRP   +V
Sbjct: 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  132 bits (334), Expect = 3e-35
 Identities = 45/376 (11%), Positives = 102/376 (27%), Gaps = 76/376 (20%)

Query: 53  HHHHLHGVQG----------------GHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEI 96
           HHHH    +                    P         Y +S + S  S S+       
Sbjct: 3   HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPF 62

Query: 97  DPAKLIIKGAFA--------RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAE---- 142
                + +            +              G+   V +  + E    +  +    
Sbjct: 63  RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122

Query: 143 ---------------IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHI 187
                           A +   F     +        + +          L+        
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR-----FF 177

Query: 188 GMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV 247
             P     +      G  L S+   +  + L     +QL L + R L+ L    +VH  +
Sbjct: 178 LYPRMQSNL---QTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232

Query: 248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL-----------NGS 296
           +  +++LD+   V +  F     + +        + + G+  PE+              +
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRT 288

Query: 297 AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKR 356
                 D ++ G+ ++ I+C D+P    +    +  + R        +  P  +  +++ 
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEG 342

Query: 357 CWDANPDKRPEMDEVV 372
                 + R    + +
Sbjct: 343 FLRYPKEDRLLPLQAM 358

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (329), Expect = 4e-35
 Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 45/272 (16%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G  GTV+  +    GQ+VA++ ++  ++  +              E+ V  +  +PN+ 
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---------IINEILVMRENKNPNIV 80

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            ++ + +   EL +                V+EY  GG+L   + +    +     V + 
Sbjct: 81  NYLDSYLVGDELWV----------------VMEYLAGGSLTDVVTETCMDEGQIAAVCRE 124

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTGETGTL 285
            L   + L +L S +++HRD+K++N+LL    +VK+ DFG  A++        T   GT 
Sbjct: 125 CL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTP 180

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVTSAVVRQNLRP 340
            +MAPEV+   AY  K D++S GI   E+   + PY + +     +      ++  N  P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP 234

Query: 341 EI--PRCCPSSLANVMKRCWDANPDKRPEMDE 370
           E+  P    +   + + RC + + +KR    E
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (329), Expect = 5e-35
 Identities = 78/333 (23%), Positives = 136/333 (40%), Gaps = 58/333 (17%)

Query: 53  HHHHLH--GVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKL-IIKGAFAR 109
           HHHH H  GV  G    +            +     A++R    + DP  L         
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVV------THEQFKAALRMVVDQGDPRLLLDSYVKIGE 55

Query: 110 GTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           G+ G V        G+ VAVK++D  ++  R              EV +     H NV +
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---------LFNEVVIMRDYQHFNVVE 106

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
              + +   EL +                ++E+  GGAL   + + R  +     V +  
Sbjct: 107 MYKSYLVGEELWV----------------LMEFLQGGALTDIVSQVRLNEEQIATVCEAV 150

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTGETGTLG 286
           L   + L+YL ++ ++HRD+K++++LL     VK++DFG  A++    P   +   GT  
Sbjct: 151 L---QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPY 206

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVTSAVVRQNLRPE 341
           +MAPEV++ S Y  + D++S GI + E+   + PY   S             +R +  P+
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK------RLRDSPPPK 260

Query: 342 IPRCCPSSLANVMK----RCWDANPDKRPEMDE 370
           +       ++ V++    R    +P +R    E
Sbjct: 261 LKN--SHKVSPVLRDFLERMLVRDPQERATAQE 291

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (325), Expect = 2e-34
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 32/220 (14%)

Query: 108 ARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
             G++G+V++ I+   GQ VA+K +    +      EI        +E+++  + D P+V
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEI-------IKEISIMQQCDSPHV 86

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K+ G+    ++L I                V+EYC  G++   +I+ R + L    +  
Sbjct: 87  VKYYGSYFKNTDLWI----------------VMEYCGAGSVSD-IIRLRNKTLTEDEIAT 129

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV-ARLEASNPHDMTGETGT 284
           +     +GL YL   + +HRD+K  N+LL+     K+ADFGV  +L  +     T   GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGT 188

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
             +MAPEV+    YN   D++S GI   E+     PY D+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  128 bits (324), Expect = 2e-34
 Identities = 62/242 (25%), Positives = 112/242 (46%), Gaps = 40/242 (16%)

Query: 95  EIDPAKL-IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           ++DP ++  I G    G FG V++      G   A K+++   E    +         + 
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---------YI 64

Query: 152 QEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
            E+ +    DHP + K +GA     +L                 +++E+C GGA+ + ++
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKL----------------WIMIEFCPGGAVDA-IM 107

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLE 271
               R L    +  +   +   L++L SK+I+HRD+K  N+L+     +++ADFGV+   
Sbjct: 108 LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS--- 164

Query: 272 ASNPHDMTGET---GTLGYMAPEV-----LNGSAYNRKCDVYSFGICLWEIYCCDMPYPD 323
           A N   +       GT  +MAPEV     +  + Y+ K D++S GI L E+   + P+ +
Sbjct: 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224

Query: 324 LS 325
           L+
Sbjct: 225 LN 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  129 bits (327), Expect = 2e-34
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 27/210 (12%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F  V R I    GQ  AVK++D  + +         L+    +E ++ H L HP++ 
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK----REASICHMLKHPHIV 89

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVVI 224
           + +            +D            +V E+  G  L   ++K       +   V  
Sbjct: 90  ELLET--------YSSDG--------MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
                +   L Y     I+HRDVK   +LL   + +  VK+  FGVA     +     G 
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
            GT  +MAPEV+    Y +  DV+  G+ L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  130 bits (328), Expect = 5e-34
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 37/217 (17%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V         + VA++++   + +  S  E A        E+ +  KL+HP + 
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE-ADPALNVETEIEILKKLNHPCII 203

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           K               ++ +I         V+E   GG L   ++ N+R           
Sbjct: 204 KIKNF--------FDAEDYYI---------VLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
           Q+ L     + YL    I+HRD+K EN+LL   ++   +KI DFG +++       M   
Sbjct: 247 QMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTL 301

Query: 282 TGTLGYMAPEVLNGSA---YNRKCDVYSFG----ICL 311
            GT  Y+APEVL       YNR  D +S G    ICL
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (319), Expect = 8e-34
 Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 42/284 (14%)

Query: 108 ARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
             G   TV+    D      VA+K +           E       F +EV    +L H N
Sbjct: 20  GGGGMSTVYLA-EDTILNIKVAIKAI------FIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           +            +++  D         +  +V+EY  G  L  Y+       L+    I
Sbjct: 73  I------------VSMI-DVDEED-DCYY--LVMEYIEGPTLSEYI--ESHGPLSVDTAI 114

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-G 283
                +  G+ +    +IVHRD+K +N+L+D  +T+KI DFG+A+  +      T    G
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T+ Y +PE   G A +   D+YS GI L+E+   + P+      E   ++  ++++  +P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN----GETAVSIAIKHIQDSVP 230

Query: 344 RC-------CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT 380
                     P SL+NV+ R  + +   R +   +  M + + +
Sbjct: 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYK--TIQEMKDDLSS 272

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 9e-34
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 38/275 (13%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV 165
            GT+G V++G +   GQ  A+K++D   +    E EI        QE+ +  K   H N+
Sbjct: 34  NGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIK-------QEINMLKKYSHHRNI 83

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
             + GA +  +   +               +V+E+C  G++   LIKN +     +  I 
Sbjct: 84  ATYYGAFIKKNPPGMDDQ----------LWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIA 132

Query: 226 LAL-DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
               ++ RGLS+L   K++HRD+K +N+LL +   VK+ DFGV+              GT
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192

Query: 285 LGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
             +MAPEV+       + Y+ K D++S GI   E+     P  D+        + R    
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-- 250

Query: 340 PEIPRCCPSSLANVMK----RCWDANPDKRPEMDE 370
              PR      +   +     C   N  +RP  ++
Sbjct: 251 --APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 1e-33
 Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 47/293 (16%)

Query: 108 ARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSE-AEIASLRAAFTQE---VAVWHKL 160
             G    VH    D    +DVAVK+L       R++ A   S    F +E    A    L
Sbjct: 21  GFGGMSEVHLA-RDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAA---AL 69

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF 220
           +HP +          +  +        G P  +  +V+EY  G  L+  +  +    +  
Sbjct: 70  NHPAIV---------AVYDTGEAETPAG-PLPY--IVMEYVDGVTLRDIV--HTEGPMTP 115

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           K  I++  D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T 
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 281 ET---GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 337
                GT  Y++PE   G + + + DVYS G  L+E+   + P+      +   +V  Q+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQH 231

Query: 338 LRPEIPR------CCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
           +R +            + L  V+ +    NP+ R +      M   +     G
Sbjct: 232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMRADLVRVHNG 282

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (321), Expect = 2e-33
 Identities = 45/310 (14%), Positives = 99/310 (31%), Gaps = 55/310 (17%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEI 143
           + E+++    + +      G F  V+           + Q   +K+      ++  E  I
Sbjct: 57  KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYI 113

Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
                  TQ +            KF  A            NG          +V E    
Sbjct: 114 ------GTQLMERLKPSMQHMFMKFYSA--------HLFQNG--------SVLVGELYSY 151

Query: 204 GALKSYLIKNRR---RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL------ 254
           G L + +   +    + +   +VI  A+ +   +  +   +I+H D+K +N +L      
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211

Query: 255 -----DKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSF 307
                D +  + + D G +      P     T +  T G+   E+L+   +N + D +  
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271

Query: 308 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              ++ +     M   +         + R+    ++       + N+       +    P
Sbjct: 272 AATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIP------DCHHLP 325

Query: 367 EMDEVVAMLE 376
            +D +   L+
Sbjct: 326 SLDLLRQKLK 335

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  126 bits (318), Expect = 2e-33
 Identities = 65/334 (19%), Positives = 122/334 (36%), Gaps = 54/334 (16%)

Query: 49  LAEEHHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFA 108
           +   HHHH H         H   P      ++ +          ++++    L+      
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMA-PCNDLHATKLAPGKEKEPLESQYQVG--PLL-----G 52

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH--PN 164
            G FG+V+ G  + D   VA+K ++  ++      E+ +       EV +  K+      
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHVE--KDRISDWGELPNGTRVP-MEVVLLKKVSSGFSG 109

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG-GALKSYLIKNRR--RKLAFK 221
           V +          L+         +       ++E       L  ++ +      +LA  
Sbjct: 110 VIRL---------LDWFERPDSFVL-------ILERPEPVQDLFDFITERGALQEELARS 153

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTG 280
              Q+       + +  +  ++HRD+K EN+L+D     +K+ DFG   L      D   
Sbjct: 154 FFWQVL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVY 205

Query: 281 ET--GTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 337
               GT  Y  PE +    Y+ R   V+S GI L+++ C D+P+      E+    V   
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRGQVF-- 261

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                 +   S   ++++ C    P  RP  +E+
Sbjct: 262 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (317), Expect = 2e-33
 Identities = 73/337 (21%), Positives = 116/337 (34%), Gaps = 55/337 (16%)

Query: 61  QGGHHPHHQ--HLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRG 118
              HH HH    +PR  +    + S                   ++    RG  G V+  
Sbjct: 3   SSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYR---------LRRLVGRGGMGDVYEA 53

Query: 119 IYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
             D    + VA+KL+        + +     R    +E     +L  P+V          
Sbjct: 54  -EDTVRERIVALKLM------SETLSSDPVFRTRMQREARTAGRLQEPHV---------- 96

Query: 176 SELNIQTDNGHI-GMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGL 234
             + I  D G I G    +  V +   +G  L + L   R+  LA    + +   +   L
Sbjct: 97  --VPIH-DFGEIDGQL--Y--VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSAL 147

Query: 235 SYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-GTLGYMAPEVL 293
               +    HRDVK EN+L+       + DFG+A           G T GTL YMAPE  
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207

Query: 294 NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR------CCP 347
           + S    + D+Y+    L+E      P     +     +V+  ++   IPR        P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP-----YQGDQLSVMGAHINQAIPRPSTVRPGIP 262

Query: 348 SSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG 384
            +   V+ R    NP+ R        +  A   +   
Sbjct: 263 VAFDAVIARGMAKNPEDRYV--TCGDLSAAAHAALAT 297

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  130 bits (328), Expect = 4e-33
 Identities = 60/281 (21%), Positives = 107/281 (38%), Gaps = 43/281 (15%)

Query: 103 IKGAFARGTFGTVHRG---IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           +KG  A G  G ++       +G+ V +K L           + A  +A    E     +
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-------VHSGD-AEAQAMAMAERQFLAE 135

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
           + HP++ +           N        G P  +  +V+EY  G +LK        +KL 
Sbjct: 136 VVHPSIVQIF---------NFVEHTDRHGDPVGY--IVMEYVGGQSLKRSK----GQKLP 180

Query: 220 FKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
               I   L++   LSYL S  +V+ D+K EN++L + + +K+ D G          +  
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-----RINSF 234

Query: 280 GET-GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 338
           G   GT G+ APE++         D+Y+ G  L  +                  +   + 
Sbjct: 235 GYLYGTPGFQAPEIVRTGPTVA-TDIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDP 289

Query: 339 RPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVAMLEAI 378
             +       S   +++R  D +P +R    +E+ A L  +
Sbjct: 290 VLKTYD----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  124 bits (313), Expect = 5e-33
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F  V R +    G + A K+++       S  +   L     +E  +  KL HPN+ 
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLE----REARICRKLQHPNIV 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           +   +        IQ ++ H         +V +   GG L   ++         A   + 
Sbjct: 69  RLHDS--------IQEESFHY--------LVFDLVTGGELFEDIVAREFYSEADASHCIQ 112

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
           Q+       ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A  E ++     G 
Sbjct: 113 QIL----ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGF 167

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFG----ICL 311
            GT GY++PEVL    Y++  D+++ G    I L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (313), Expect = 5e-33
 Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 36/272 (13%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VH       G +  +K ++      RS+  +  +      E+ V   LDHPN+ 
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIE----AEIEVLKSLDHPNII 83

Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVV 223
           K             +  +  +I         V+E C GG L   ++  + R  A     V
Sbjct: 84  KIFEV--------FEDYHNMYI---------VMETCEGGELLERIVSAQARGKALSEGYV 126

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
            +L   +   L+Y  S+ +VH+D+K EN+L         +KI DFG+A L  S+    T 
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTN 185

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 340
             GT  YMAPEV        KCD++S G+ ++ +    +P+   S  EV      +    
Sbjct: 186 AAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244

Query: 341 EIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
            +     +  A +++K+    +P++RP   +V
Sbjct: 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  125 bits (316), Expect = 6e-33
 Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 74/315 (23%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G++G V   I        A+K+++  +    +  ++  ++     EV +  KL HPN+ 
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK----TEVRLMKKLHHPNIA 91

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +             + +         + C+V+E CHGG L   L            +  +
Sbjct: 92  RLYEV--------YEDEQ--------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 227 ALDLAR--------------------------------------GLSYLQSKKIVHRDVK 248
              +                                         L YL ++ I HRD+K
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195

Query: 249 TENMLL--DKTRTVKIADFGVARL----EASNPHDMTGETGTLGYMAPEVLNGSA--YNR 300
            EN L   +K+  +K+ DFG+++          + MT + GT  ++APEVLN +   Y  
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 301 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR---PEIPRCCPSSLA-NVMKR 356
           KCD +S G+ L  +    +P+P ++ ++  S V+ + L    P       S LA +++  
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL--SPLARDLLSN 313

Query: 357 CWDANPDKRPEMDEV 371
             + N D+R +    
Sbjct: 314 LLNRNVDERFDAMRA 328

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  124 bits (314), Expect = 9e-33
 Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 31/266 (11%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F  V     I  G++VA+K++D  + +  S  ++        +EV +   L+HPN+ 
Sbjct: 25  KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL-------FREVRIMKILNHPNIV 77

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K         E+ I+T+   +        +++EY  GG +  YL+ + R  +  K     
Sbjct: 78  KLF-------EV-IETEK-TL-------YLIMEYASGGEVFDYLVAHGR--MKEKEARSK 119

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +   + Y   K+IVHRD+K EN+LLD    +KIADFG +    +    +    G   
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPP 178

Query: 287 YMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
           Y APE+  G  Y+  + DV+S G+ L+ +    +P+   +  E+   V+R   R  IP  
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFY 236

Query: 346 CPSSLANVMKRCWDANPDKRPEMDEV 371
             +   N++KR    NP KR  ++++
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQI 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  123 bits (312), Expect = 9e-33
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 36/218 (16%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNV 165
           RG    V R I+    ++ AVK++D       S  E+  LR A  +EV +  K+  HPN+
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVV 223
            +             +T+         F  +V +    G L  YL +      K   K++
Sbjct: 87  IQLKDT--------YETNT--------FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
             L       +  L    IVHRD+K EN+LLD    +K+ DFG +         +    G
Sbjct: 131 RALL----EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCG 185

Query: 284 TLGYMAPEVLNGSA------YNRKCDVYSFG----ICL 311
           T  Y+APE++  S       Y ++ D++S G      L
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  123 bits (310), Expect = 3e-32
 Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 37/217 (17%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V         + VA+K++   + +  S  E A        E+ +  KL+HP + 
Sbjct: 20  SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE-ADPALNVETEIEILKKLNHPCII 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           K               ++ +I         V+E   GG L   ++ N+R           
Sbjct: 79  KIKNF--------FDAEDYYI---------VLELMEGGELFDKVVGNKRLKEATCKLYFY 121

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
           Q+ L     + YL    I+HRD+K EN+LL   ++   +KI DFG +++       M   
Sbjct: 122 QMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL 176

Query: 282 TGTLGYMAPEVLNGSA---YNRKCDVYSFG----ICL 311
            GT  Y+APEVL       YNR  D +S G    ICL
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  123 bits (311), Expect = 4e-32
 Identities = 66/271 (24%), Positives = 106/271 (39%), Gaps = 45/271 (16%)

Query: 54  HHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFA----- 108
           HHH H   G          + + + + S++  +AS+    W     +  +   F      
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 109 -RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            RG    V+R       +  A+K+L                +     E+ V  +L HPN+
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLK-----------KTVDKKIVRTEIGVLLRLSHPNI 110

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVV 223
            K             +T             +V+E   GG L   +++      + A   V
Sbjct: 111 IKLKEI--------FETPTEIS--------LVLELVTGGELFDRIVEKGYYSERDAADAV 154

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
            Q+       ++YL    IVHRD+K EN+L         +KIADFG++++   +   M  
Sbjct: 155 KQIL----EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKT 209

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
             GT GY APE+L G AY  + D++S GI  
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  123 bits (311), Expect = 4e-32
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F  V R ++   G + A K+++       S  +   L     +E  +  KL HPN+ 
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLE----REARICRKLQHPNIV 91

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +   +        IQ ++ H         +V +   GG L   ++   R   +       
Sbjct: 92  RLHDS--------IQEESFHY--------LVFDLVTGGELFEDIVA--REFYSEADASHC 133

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETG 283
              +   ++Y  S  IVHR++K EN+LL    K   VK+ADFG+A  E ++     G  G
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAG 192

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           T GY++PEVL    Y++  D+++ G+ L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  125 bits (315), Expect = 5e-32
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 30/208 (14%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G F  V R +    GQ+ A  +++       S  +   L     +E  +   L HPN+ 
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLE----REARICRLLKHPNIV 73

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +   +        I  +  H         ++ +   GG L   ++   R   +       
Sbjct: 74  RLHDS--------ISEEGHHY--------LIFDLVTGGELFEDIVA--REYYSEADASHC 115

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETG 283
              +   + +     +VHR++K EN+LL    K   VK+ADFG+A           G  G
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICL 311
           T GY++PEVL    Y +  D+++ G+ L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  122 bits (307), Expect = 6e-32
 Identities = 71/323 (21%), Positives = 115/323 (35%), Gaps = 63/323 (19%)

Query: 66  PHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRG--IYDGQ 123
              Q  P P  T +             E+ +    L+      +G FGTV  G  + D  
Sbjct: 5   KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLG--PLL-----GKGGFGTVFAGHRLTDRL 57

Query: 124 DVAVKLLD------WGEESH--RSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
            VA+K++       W   S       E+A L         V     HP V +        
Sbjct: 58  QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK-------VGAGGGHPGVIRL------- 103

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEY-CHGGALKSYLIKNRR--RKLAFKVVIQLALDLAR 232
             L+         +       V+E       L  Y+ +        +     Q+      
Sbjct: 104 --LDWFETQEGFML-------VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----A 150

Query: 233 GLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGET--GTLGYMA 289
            + +  S+ +VHRD+K EN+L+D +    K+ DFG   L     HD       GT  Y  
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDGTRVYSP 206

Query: 290 PEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS 348
           PE ++   Y+     V+S GI L+++ C D+P+      E+  A +        P     
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEILEAELH------FPAHVSP 258

Query: 349 SLANVMKRCWDANPDKRPEMDEV 371
               +++RC    P  RP ++E+
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEI 281

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  121 bits (305), Expect = 1e-31
 Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 48/279 (17%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLD------WGEESHRSEAEIASLRAAFTQEVAVWHKL 160
            G++G V            AVK+L               + EI  LR           +L
Sbjct: 15  EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-----------RL 63

Query: 161 DHPNVTKFIGATMGTSE-LNIQTDNGHIGMPSNFCCVVVEYCHGGA--LKSYLIKNR-RR 216
            H NV + +       + L  +     + M       V+EYC  G   +   + + R   
Sbjct: 64  RHKNVIQLV-------DVLYNEEKQ-KMYM-------VMEYCVCGMQEMLDSVPEKRFPV 108

Query: 217 KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
             A     QL      GL YL S+ IVH+D+K  N+LL    T+KI+  GVA        
Sbjct: 109 CQAHGYFCQLID----GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 277 DMTGET--GTLGYMAPEVLNGS-AYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
           D T  T  G+  +  PE+ NG   ++  K D++S G+ L+ I     P+   +  ++   
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           + + +    IP  C   L++++K   +  P KR  + ++
Sbjct: 225 IGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  120 bits (304), Expect = 1e-31
 Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 50/278 (17%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V +       Q+ AVK+++   ++     + +++     +EV +  KLDHPN+ 
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTIL----REVELLKKLDHPNIM 84

Query: 167 KFIGATMGTSELNIQTDNG-HIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVV 223
           K            ++  +  +I         V E   GG L   +IK +R     A +++
Sbjct: 85  KLFEI--------LEDSSSFYI---------VGELYTGGELFDEIIKRKRFSEHDAARII 127

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTG 280
            Q+      G++Y+    IVHRD+K EN+LL   +K   +KI DFG++         M  
Sbjct: 128 KQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKD 182

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR- 339
             GT  Y+APEVL G+ Y+ KCDV+S G+ L+ +     P+   +  ++   V       
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241

Query: 340 -----PEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
                  I     S  A +++++    +P  R    + 
Sbjct: 242 DLPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  121 bits (305), Expect = 2e-31
 Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 34/270 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG V   +     ++V VK +   +       E   L    T E+A+  +++H N+ 
Sbjct: 34  SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL-GKVTLEIAILSRVEHANII 92

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           K +           +           F  V+ ++  G  L +++ ++ R    LA  +  
Sbjct: 93  KVLDI--------FEN-------QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           QL       + YL+ K I+HRD+K EN+++ +  T+K+ DFG A          T   GT
Sbjct: 138 QLV----SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGT 192

Query: 285 LGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           + Y APEVL G+ Y   + +++S G+ L+ +   + P+ +    E   A +        P
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEAAIH------PP 244

Query: 344 RCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                 L +++       P++R  ++++V 
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (303), Expect = 2e-31
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 38/210 (18%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V        G+  A+K +             +SL      E+AV  K+ H N+ 
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLE----NEIAVLKKIKHENIV 69

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
                   T+   +                V++   GG L   +++      K A  V+ 
Sbjct: 70  TLEDIYESTTHYYL----------------VMQLVSGGELFDRILERGVYTEKDASLVIQ 113

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
           Q+       + YL    IVHRD+K EN+L    ++   + I DFG++++E      M+  
Sbjct: 114 QVL----SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA 167

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
            GT GY+APEVL    Y++  D +S G+  
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  119 bits (301), Expect = 2e-31
 Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 40/272 (14%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG++G V   +        A K +           ++   +    QE+ +   LDHPN+ 
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFK----QEIEIMKSLDHPNII 69

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVI 224
           +             + +            +V+E C GG L   ++  R      A +++ 
Sbjct: 70  RLYET--------FEDNTDIY--------LVMELCTGGELFERVVHKRVFRESDAARIMK 113

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
            +       ++Y     + HRD+K EN L         +K+ DFG+A         M  +
Sbjct: 114 DVL----SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTK 168

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR-P 340
            GT  Y++P+VL G  Y  +CD +S G+ ++ + C   P+   + SEV   +       P
Sbjct: 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP 227

Query: 341 EIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
           E      S  A ++++R    +P +R    + 
Sbjct: 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  119 bits (300), Expect = 4e-31
 Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 48/277 (17%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G +G V         + VAVK++D                    +E+ +   L+H NV 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHENVV 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           KF G          +  N           + +EYC GG L   +  +            +
Sbjct: 69  KFYGH--------RREGN-IQ-------YLFLEYCSGGELFDRIEPDIG----------M 102

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
               A+        G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  + 
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 279 TGET--GTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
                 GTL Y+APE+L    ++    DV+S GI L  +   ++P+   S S    +  +
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 336 QNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
           +      P     S    ++ +    NP  R  + ++
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  119 bits (301), Expect = 7e-31
 Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 41/251 (16%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YD 121
           HH HH      +  +       +      ++++    L   G    G  G V        
Sbjct: 3   HHHHHHSSGLEVLFQGPEPKKYAV---TDDYQLSKQVL---G---LGVNGKVLECFHRRT 53

Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           GQ  A+KLL    +S ++  E+             W     P++   +          + 
Sbjct: 54  GQKCALKLLY---DSPKARQEVDHH----------WQASGGPHIVCILD---------VY 91

Query: 182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK 241
            +  H         +++E   GG L S + +   +    +   ++  D+   + +L S  
Sbjct: 92  ENMHH---GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148

Query: 242 IVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY 298
           I HRDVK EN+L    +K   +K+ DFG A+    N   +     T  Y+APEVL    Y
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEKY 206

Query: 299 NRKCDVYSFGI 309
           ++ CD++S G+
Sbjct: 207 DKSCDMWSLGV 217

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  120 bits (302), Expect = 8e-31
 Identities = 44/207 (21%), Positives = 84/207 (40%), Gaps = 28/207 (13%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V +      G + A K +    +     +     R    +EV++  ++ HPN+ 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                         +     +        +++E   GG L  +L +  +  L+ +     
Sbjct: 79  TLHDV--------YENRTDVV--------LILELVSGGELFDFLAQ--KESLSEEEATSF 120

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGET 282
              +  G++YL +KKI H D+K EN++L         +K+ DFG+A        +     
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIF 179

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           GT  ++APE++N      + D++S G+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGV 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  118 bits (297), Expect = 9e-31
 Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V +      G++ A K +    +   S +     R    +EV +  ++ HPN+ 
Sbjct: 15  SGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                         +     +        +++E   GG L  +L +  +  L      Q 
Sbjct: 72  TLHDI--------FENKTDVV--------LILELVSGGELFDFLAE--KESLTEDEATQF 113

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGET 282
              +  G+ YL SK+I H D+K EN++L         +K+ DFG+A    +  ++     
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF 172

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           GT  ++APE++N      + D++S G+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGV 199

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  118 bits (298), Expect = 1e-30
 Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V +      G + A K +    +     +     R    +EV++  ++ H NV 
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                         +     +        +++E   GG L  +L +  +  L+ +     
Sbjct: 79  TLHDV--------YENRTDVV--------LILELVSGGELFDFLAQ--KESLSEEEATSF 120

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGET 282
              +  G++YL +KKI H D+K EN++L         +K+ DFG+A  E  +  +     
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIF 179

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           GT  ++APE++N      + D++S G+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGV 206

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  117 bits (295), Expect = 2e-30
 Identities = 72/272 (26%), Positives = 117/272 (43%), Gaps = 42/272 (15%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            GTFG V  G     G  VAVK+L+      R +     +     +E+       HP++ 
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR------RKLAF 220
           K         ++ I T      M       V+EY  GG L  Y+ K+ R      R+L F
Sbjct: 75  KLY-------QV-ISTPT-DFFM-------VMEYVSGGELFDYICKHGRVEEMEARRL-F 117

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
           + ++         + Y     +VHRD+K EN+LLD     KIADFG++ + +      T 
Sbjct: 118 QQILS-------AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT- 169

Query: 281 ETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
             G+  Y APEV++G  Y   + D++S G+ L+ + C  +P+ D     +   +      
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             IP     S+A ++      +P KR  + ++
Sbjct: 230 --IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (297), Expect = 3e-30
 Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G++    R I      + AVK++D  +     E EI            +     HPN+ 
Sbjct: 32  VGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------------LLRYGQHPNII 79

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                        +  D  ++        VV E   GG L   +++  ++  + +    +
Sbjct: 80  TLKD---------VYDDGKYV-------YVVTELMKGGELLDKILR--QKFFSEREASAV 121

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGET 282
              + + + YL ++ +VHRD+K  N+L         +++I DFG A+   +    +    
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
            T  ++APEVL    Y+  CD++S G+
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGV 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  117 bits (295), Expect = 3e-30
 Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 48/277 (17%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G +G V         + VAVK++D                    +E+ +   L+H NV 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHENVV 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           KF G          +  N           + +EYC GG L   +  +            +
Sbjct: 69  KFYGH--------RREGN-IQ-------YLFLEYCSGGELFDRIEPDIG----------M 102

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
               A+        G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +   N  + 
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 279 TGET--GTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
                 GTL Y+APE+L    ++    DV+S GI L  +   ++P+   S S    +  +
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 336 QNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
           +      P     S    ++ +    NP  R  + ++
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  117 bits (295), Expect = 4e-30
 Identities = 59/249 (23%), Positives = 96/249 (38%), Gaps = 36/249 (14%)

Query: 67  HHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQD 124
           HH H    +   + +    S       + +   +L       RG F  V + I    GQ+
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKEL------GRGKFAVVRQCISKSTGQE 56

Query: 125 VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVTKFIGATMGTSELNIQTD 183
            A K L    +  R +   A +      E+AV       P V               +  
Sbjct: 57  YAAKFLK---KRRRGQDCRAEIL----HEIAVLELAKSCPRVINLHEV--------YENT 101

Query: 184 NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIV 243
           +  I        +++EY  GG + S  +      ++   VI+L   +  G+ YL    IV
Sbjct: 102 SEII--------LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 244 HRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           H D+K +N+LL        +KI DFG++R       ++    GT  Y+APE+LN      
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITT 212

Query: 301 KCDVYSFGI 309
             D+++ GI
Sbjct: 213 ATDMWNIGI 221

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  116 bits (294), Expect = 6e-30
 Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 28/207 (13%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V +      G   A K +    +     +     R    +EV++  ++ HPNV 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                         +     I        +++E   GG L  +L +  +  L  +   + 
Sbjct: 78  TLHEV--------YENKTDVI--------LILELVAGGELFDFLAE--KESLTEEEATEF 119

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL----DKTRTVKIADFGVARLEASNPHDMTGET 282
              +  G+ YL S +I H D+K EN++L         +KI DFG+A       ++     
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF 178

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           GT  ++APE++N      + D++S G+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGV 205

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  116 bits (292), Expect = 1e-29
 Identities = 49/207 (23%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNV 165
            G+F    + +     Q  AVK++               + A   +E+      + HPN+
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIIS------------KRMEANTQKEITALKLCEGHPNI 68

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K                            +V+E  +GG L   + K  ++  +      
Sbjct: 69  VKLHEV--------FHDQL--------HTFLVMELLNGGELFERIKK--KKHFSETEASY 110

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGET 282
           +   L   +S++    +VHRD+K EN+L    +    +KI DFG ARL+  +   +    
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGI 309
            TL Y APE+LN + Y+  CD++S G+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGV 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  116 bits (293), Expect = 1e-29
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 37/218 (16%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV 165
           RG    V R ++   G + AVK+++   E   S  ++  +R A  +E  +  ++  HP++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAER-LSPEQLEEVREATRRETHILRQVAGHPHI 162

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVV 223
              I +         ++ +        F  +V +    G L  YL +      K    ++
Sbjct: 163 ITLIDS--------YESSS--------FMFLVFDLMRKGELFDYLTEKVALSEKETRSIM 206

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
             L       +S+L +  IVHRD+K EN+LLD    ++++DFG +         +    G
Sbjct: 207 RSLL----EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCG 261

Query: 284 TLGYMAPEVLNGSA------YNRKCDVYSFG----ICL 311
           T GY+APE+L  S       Y ++ D+++ G      L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (291), Expect = 4e-29
 Identities = 52/256 (20%), Positives = 92/256 (35%), Gaps = 46/256 (17%)

Query: 72  PRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFA-----------RGTFGTVHRGI- 119
           P P      +        +  ++ +     I K A              G  G V +   
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 120 -YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA--TMGTS 176
               +  A+K+L    +  ++  E+             W     P++ + +     +   
Sbjct: 84  KRTQEKFALKMLQ---DCPKARREVELH----------WRASQCPHIVRIVDVYENLYAG 130

Query: 177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY 236
              +      I         V+E   GG L S +     +    +   ++   +   + Y
Sbjct: 131 RKCL-----LI---------VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 237 LQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL 293
           L S  I HRDVK EN+L         +K+ DFG A+   S+ + +T    T  Y+APEVL
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL 235

Query: 294 NGSAYNRKCDVYSFGI 309
               Y++ CD++S G+
Sbjct: 236 GPEKYDKSCDMWSLGV 251

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (290), Expect = 5e-29
 Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 31/205 (15%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VHR +    G+    K ++          +  +++     E+++ ++L HP + 
Sbjct: 61  SGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVK----NEISIMNQLHHPKLI 111

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A         +     +        +++E+  GG L   +      K++   VI  
Sbjct: 112 NLHDA--------FEDKYEMV--------LILEFLSGGELFDRIAA-EDYKMSEAEVINY 154

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHDMTGETGT 284
                 GL ++    IVH D+K EN++    K  +VKI DFG+A  + +    +   T T
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTAT 213

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGI 309
             + APE+++        D+++ G+
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGV 238

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  115 bits (289), Expect = 5e-29
 Identities = 75/287 (26%), Positives = 113/287 (39%), Gaps = 68/287 (23%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGE-ESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            G FG     R     + VAVK ++ G       + EI + R            L HPN+
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHR-----------SLRHPNI 78

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +F        E+ I T   H+        +++EY  GG L   +    R          
Sbjct: 79  VRFK-------EV-ILTPT-HL-------AIIMEYASGGELYERICNAGR---------- 112

Query: 226 LALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRT--VKIADFGVARLEASNP 275
            + D AR        G+SY  S +I HRD+K EN LLD +    +KI DFG ++   S  
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVL 170

Query: 276 HDMTGET-GTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
           H     T GT  Y+APEVL    Y+ +  DV+S G+ L+ +     P     F +     
Sbjct: 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-----FEDPEEPR 225

Query: 334 VRQNLRPEIPRC---CPSSL------ANVMKRCWDANPDKRPEMDEV 371
             +     I       P  +       +++ R + A+P  R  + E+
Sbjct: 226 DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (287), Expect = 1e-28
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VH+      G  +A K++       R   +   ++     E++V ++LDH N+ 
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKII-----KTRGMKDKEEVK----NEISVMNQLDHANLI 149

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +   A         ++ N  +        +V+EY  GG L   +I      L     I  
Sbjct: 150 QLYDA--------FESKNDIV--------LVMEYVDGGELFDRIID-ESYNLTELDTILF 192

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHDMTGETGT 284
              +  G+ ++    I+H D+K EN+L      + +KI DFG+AR        +    GT
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGT 251

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGI 309
             ++APEV+N    +   D++S G+
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGV 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (284), Expect = 2e-28
 Identities = 73/274 (26%), Positives = 116/274 (42%), Gaps = 47/274 (17%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG V         Q VA+K +       R   + + +     +E++    L HP++ 
Sbjct: 19  EGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K         ++ I T    I M       V+EY  GG L  Y+++ +R          +
Sbjct: 73  KLY-------DV-ITTPT-DIVM-------VIEYA-GGELFDYIVEKKR----------M 105

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             D  R         + Y    KIVHRD+K EN+LLD    VKIADFG++ +        
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165

Query: 279 TGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 337
           T   G+  Y APEV+NG  Y   + DV+S GI L+ +    +P+ D     +   V    
Sbjct: 166 T-SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224

Query: 338 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
               +P        ++++R   A+P +R  + E+
Sbjct: 225 YV--MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  112 bits (283), Expect = 2e-28
 Identities = 37/205 (18%), Positives = 76/205 (37%), Gaps = 32/205 (15%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG VHR +     +    K +           +   ++    +E+++ +   H N+ 
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVK----KEISILNIARHRNIL 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               +         ++    +        ++ E+  G  +   +      +L  + ++  
Sbjct: 65  HLHES--------FESMEELV--------MIFEFISGLDIFERINT-SAFELNEREIVSY 107

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHDMTGETGT 284
              +   L +L S  I H D++ EN++    ++ T+KI +FG AR       +       
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTA 166

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGI 309
             Y APEV      +   D++S G 
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGT 191

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  114 bits (286), Expect = 5e-28
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 50/276 (18%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            GTFG V  G     G  VAVK+L+      R +     +     +E+       HP++ 
Sbjct: 26  VGTFGKVKVGKHELTGHKVAVKILN------RQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K         ++ I T +  I        +V+EY  GG L  Y+ KN R          L
Sbjct: 80  KLY-------QV-ISTPS-DI-------FMVMEYVSGGELFDYICKNGR----------L 113

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
               +R        G+ Y     +VHRD+K EN+LLD     KIADFG++ +        
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGE 170

Query: 279 TGET--GTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 335
              T  G+  Y APEV++G  Y   + D++S G+ L+ + C  +P+ D     +   +  
Sbjct: 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD 230

Query: 336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                  P+    S+ +++K     +P KR  + ++
Sbjct: 231 GIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  114 bits (288), Expect = 5e-28
 Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 33/206 (16%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VHR      G + A K +         E++  ++R    +E+     L HP + 
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV-----MTPHESDKETVR----KEIQTMSVLRHPTLV 217

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A         + DN  +        ++ E+  GG L   +      K++    ++ 
Sbjct: 218 NLHDA--------FEDDNEMV--------MIYEFMSGGELFEKVAD-EHNKMSEDEAVEY 260

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHD-MTGETG 283
              + +GL ++     VH D+K EN++    ++  +K+ DFG+      +P   +   TG
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTG 318

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGI 309
           T  + APEV  G       D++S G+
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGV 344

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  105 bits (265), Expect = 5e-26
 Identities = 54/271 (19%), Positives = 101/271 (37%), Gaps = 50/271 (18%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLR-AAFTQ-EVAVWHKLDHPN 164
            G+F TV   R +   ++ A+K+L+        +  I       +   E  V  +LDHP 
Sbjct: 40  EGSFSTVVLARELATSREYAIKILE--------KRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
             K             Q D              + Y   G L  Y+ K            
Sbjct: 92  FVKLYFT--------FQDDE--------KLYFGLSYAKNGELLKYIRKIGS--------- 126

Query: 225 QLALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
                  R         L YL  K I+HRD+K EN+LL++   ++I DFG A++ +    
Sbjct: 127 -FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185

Query: 277 DMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
                +  GT  Y++PE+L   +  +  D+++ G  ++++     P+   +   +   ++
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +       P        +++++    +  KR
Sbjct: 246 KLEYD--FPEKFFPKARDLVEKLLVLDATKR 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 5e-26
 Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 73/297 (24%)

Query: 110 GTFGTVHRG--IYDGQDVAVK--LLDWGEESHRSEA--EIASLRAAFTQEVAVWHKLDHP 163
           G++G V +      GQ VA+K  L    +   +  A  EI  L+           +L HP
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK-----------QLKHP 62

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+   +        L++                V EYC    +    +   +R +   +V
Sbjct: 63  NLVNLLEVFRRKRRLHL----------------VFEYCDHT-VLHE-LDRYQRGVPEHLV 104

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
             +     + +++      +HRDVK EN+L+ K   +K+ DFG ARL          E  
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164

Query: 284 TLGYMAPEVLNGSA-YNRKCDVYSFG------------------------IC-------- 310
           T  Y +PE+L G   Y    DV++ G                        I         
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224

Query: 311 -LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              +++  +  +  +   +       + L  + P     +L  ++K C   +P +R 
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPED---MEPLELKFPNISYPAL-GLLKGCLHMDPTERL 277

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (265), Expect = 6e-26
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 51/222 (22%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV 165
            G    V   I     Q+ AVK+++      +    I   R+   +EV + ++   H NV
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIE------KQPGHI---RSRVFREVEMLYQCQGHRNV 73

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---RKLAFKV 222
            + I           + ++           +V E   GG++ S++ K R     + +   
Sbjct: 74  LELIEF--------FEEED--------RFYLVFEKMRGGSILSHIHKRRHFNELEAS--- 114

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVAR-------LEA 272
              +  D+A  L +L +K I HRD+K EN+L    ++   VKI DF +            
Sbjct: 115 --VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172

Query: 273 SNPHDMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGI 309
            +  ++    G+  YMAPEV+       S Y+++CD++S G+
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (262), Expect = 1e-25
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 110 GTFGTVHRG--IYDGQDVAVK--LLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DH 162
           G +GTV++    + G  VA+K   +            I+++R     EVA+  +L   +H
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVR-----EVALLRRLEAFEH 73

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PNV +          +++   +           +V E+     L++YL K     L  + 
Sbjct: 74  PNVVRL---------MDVCATSRTDREIKVT--LVFEHVDQD-LRTYLDKAPPPGLPAET 121

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           +  L     RGL +L +  IVHRD+K EN+L+    TVK+ADFG+AR   S    +T   
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPVV 180

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFG 308
            TL Y APEVL  S Y    D++S G
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVG 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 42/213 (19%)

Query: 110 GTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAE-----IASLRAAFTQEVAVWHKLDHP 163
           GT+G V++     G+ VA+K +       R +AE       ++R     E+++  +L HP
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIR-----EISLLKELHHP 79

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+   I        L +                V E+     LK   +   +  L    +
Sbjct: 80  NIVSLIDVIHSERCLTL----------------VFEFMEKD-LKKV-LDENKTGLQDSQI 121

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                 L RG+++    +I+HRD+K +N+L++    +K+ADFG+AR         T E  
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           TL Y AP+VL GS        YS  + +W I C
Sbjct: 182 TLWYRAPDVLMGSKK------YSTSVDIWSIGC 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (259), Expect = 2e-25
 Identities = 60/294 (20%), Positives = 114/294 (38%), Gaps = 68/294 (23%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAE-----IASLRAAFTQEVAVWHKLDH 162
           GT+GTV +       + VA+K +       R + +      ++LR     E+ +  +L H
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALR-----EICLLKELKH 60

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
            N+ +         +L +                V E+C    LK Y   +    L  ++
Sbjct: 61  KNIVRLHDVLHSDKKLTL----------------VFEFCDQD-LKKYF-DSCNGDLDPEI 102

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           V      L +GL +  S+ ++HRD+K +N+L+++   +K+A+FG+AR         + E 
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 283 GTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPY-------------------- 321
            TL Y  P+VL G+  Y+   D++S G    E+     P                     
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

Query: 322 -----PDLS----FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
                P ++    +          +L   +P+   +   ++++     NP +R 
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR-DLLQNLLKCNPVQRI 275

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (261), Expect = 3e-25
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 28/206 (13%)

Query: 110 GTFGTVHRGI---YDGQDVAVK--LLDWGEESHRSEA--EIASLRAAFTQEVAVWHKLDH 162
           G +G V +       G+ VA+K   +  GEE        E+A LR             +H
Sbjct: 22  GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--------ETFEH 73

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PNV +           ++ T +           +V E+     L +YL K     +  + 
Sbjct: 74  PNVVRL---------FDVCTVSRTDRETKLT--LVFEHVDQD-LTTYLDKVPEPGVPTET 121

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           +  +   L RGL +L S ++VHRD+K +N+L+  +  +K+ADFG+AR   S    +T   
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVV 180

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFG 308
            TL Y APEVL  S+Y    D++S G
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVG 206

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  102 bits (258), Expect = 3e-25
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 42/213 (19%)

Query: 110 GTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAE-----IASLRAAFTQEVAVWHKLDHP 163
           GT+G V++   + G+  A+K +       R E E       ++R     E+++  +L H 
Sbjct: 13  GTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIR-----EISILKELKHS 60

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ K          L +                V E+     LK   +      L     
Sbjct: 61  NIVKLYDVIHTKKRLVL----------------VFEHLDQD-LKKL-LDVCEGGLESVTA 102

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
               L L  G++Y   ++++HRD+K +N+L+++   +KIADFG+AR         T E  
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           TL Y AP+VL GS        YS  I +W + C
Sbjct: 163 TLWYRAPDVLMGSKK------YSTTIDIWSVGC 189

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  103 bits (259), Expect = 5e-25
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C V+EY +GG L  +L  +R R    +       ++   L YL S+ +V+RD+K EN++L
Sbjct: 81  CFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           DK   +KI DFG+ + E  +       T  GT  Y+APEVL  + Y R  D +  G+ ++
Sbjct: 139 DKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+ C  +P+ +     +   ++ + +R   PR       +++      +P +R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  104 bits (261), Expect = 5e-25
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 17/181 (9%)

Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFK--VVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
             +VV+   GG L+ +L +N      FK   V     +L   L YLQ+++I+HRD+K +N
Sbjct: 90  MFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 252 MLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLN---GSAYNRKCDVYS 306
           +LLD+   V I DF +A      P +    T  GT  YMAPE+ +   G+ Y+   D +S
Sbjct: 146 ILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202

Query: 307 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDK 364
            G+  +E+     PY   S S  +  +V          P      + +++K+  + NPD+
Sbjct: 203 LGVTAYELLRGRRPYHIRS-STSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQ 261

Query: 365 R 365
           R
Sbjct: 262 R 262

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (257), Expect = 8e-25
 Identities = 64/297 (21%), Positives = 111/297 (37%), Gaps = 73/297 (24%)

Query: 110 GTFGTVHRG--IYDGQDVAVK--LLDWGEESHRSEA--EIASLRAAFTQEVAVWHKLDHP 163
           G++G V +      G+ VA+K  L    ++  +  A  EI  L+           +L H 
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK-----------QLRHE 84

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+   +          +                V E+     +   L +     L ++VV
Sbjct: 85  NLVNLLEVCKKKKRWYL----------------VFEFVDHT-ILDDL-ELFPNGLDYQVV 126

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
            +    +  G+ +  S  I+HRD+K EN+L+ ++  VK+ DFG AR  A+       E  
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186

Query: 284 TLGYMAPEVLNGSA-YNRKCDVYSFG------------------------IC-------- 310
           T  Y APE+L G   Y +  DV++ G                        I         
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246

Query: 311 -LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 366
              E++  +  +  +   E+     R+ L    P+     + ++ K+C   +PDKRP
Sbjct: 247 RHQELFNKNPVFAGVRLPEIKE---REPLERRYPKLSEVVI-DLAKKCLHIDPDKRP 299

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 1e-24
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 42/215 (19%)

Query: 110 GTFGTVHRG--IYDGQDVAVK--LLDWGEESHRSEAE----IASLRAAFTQEVAVWHKLD 161
           G F TV++       Q VA+K   L      HRSEA+      +LR     E+ +  +L 
Sbjct: 21  GQFATVYKARDKNTNQIVAIKKIKLG-----HRSEAKDGINRTALR-----EIKLLQELS 70

Query: 162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFK 221
           HPN+   + A    S +++                V ++     L+   IK+    L   
Sbjct: 71  HPNIIGLLDAFGHKSNISL----------------VFDFMETD-LEVI-IKDNSLVLTPS 112

Query: 222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGE 281
            +    L   +GL YL    I+HRD+K  N+LLD+   +K+ADFG+A+   S     T +
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
             T  Y APE+L G+        Y  G+ +W + C
Sbjct: 173 VVTRWYRAPELLFGARM------YGVGVDMWAVGC 201

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  101 bits (255), Expect = 2e-24
 Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 8/173 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++      K         A ++  GL +L SK IV+RD+K +N+LL
Sbjct: 94  FFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           DK   +KIADFG+ + E       T  T  GT  Y+APE+L G  YN   D +SFG+ L+
Sbjct: 152 DKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+      E+  ++   N     PR       +++ + +   P+KR
Sbjct: 210 EMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (252), Expect = 3e-24
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 43/216 (19%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAE----IASLRAAFTQEVAVWHKLDHP 163
           GT+ TV++G     G  VA+K +       + ++E      ++R     E+++  +L H 
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIR-----EISLMKELKHE 63

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH---GGALKSYLIKNRRRKLAF 220
           N+ +        ++L +                V E+        + S  + N  R L  
Sbjct: 64  NIVRLYDVIHTENKLTL----------------VFEFMDNDLKKYMDSRTVGNTPRGLEL 107

Query: 221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
            +V      L +GL++    KI+HRD+K +N+L++K   +K+ DFG+AR      +  + 
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           E  TL Y AP+VL GS        YS  I +W   C
Sbjct: 168 EVVTLWYRAPDVLMGSRT------YSTSIDIWSCGC 197

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  100 bits (252), Expect = 3e-24
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 42/213 (19%)

Query: 110 GTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAE----IASLRAAFTQEVAVWHKLDHP 163
           GT+ TV++G        VA+K +       R E E      ++R     EV++   L H 
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIR-----EVSLLKDLKHA 60

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+            L +                V EY     LK YL  +    +    V
Sbjct: 61  NIVTLHDIIHTEKSLTL----------------VFEYLDKD-LKQYL-DDCGNIINMHNV 102

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG 283
                 L RGL+Y   +K++HRD+K +N+L+++   +K+ADFG+AR ++        E  
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
           TL Y  P++L GS        YS  I +W + C
Sbjct: 163 TLWYRPPDILLGSTD------YSTQIDMWGVGC 189

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (257), Expect = 5e-24
 Identities = 46/183 (25%), Positives = 82/183 (44%), Gaps = 20/183 (10%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
           C+V+   +GG ++ ++         F+         A         GL +L  + I++RD
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQ------EPRAIFYTAQIVSGLEHLHQRNIIYRD 314

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYS 306
           +K EN+LLD    V+I+D G+A    +      G  GT G+MAPE+L G  Y+   D ++
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374

Query: 307 FGICLWEIYCCDMPYPD----LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 362
            G+ L+E+     P+      +   E+   V+ Q +    P     +  +  +     +P
Sbjct: 375 LGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDP 432

Query: 363 DKR 365
           +KR
Sbjct: 433 EKR 435

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  100 bits (252), Expect = 5e-24
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 34/211 (16%)

Query: 110 GTFGTVHRG--IYDGQDVAVK--LLDWGEESHRSEA--EIASLRAAFTQEVAVWHKLDHP 163
           GTFG V +      GQ VA+K  L++  +E     A  EI  L+            L H 
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-----------LLKHE 76

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC-HGGALKSYLIKNRRRKLAFKV 222
           NV   I     T         G I +       V ++C H   L   L  N   K     
Sbjct: 77  NVVNLIEI-CRTKASPYNRCKGSIYL-------VFDFCEHD--LAGLL-SNVLVKFTLSE 125

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL----EASNPHDM 278
           + ++   L  GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+  
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 279 TGETGTLGYMAPEVLNGS-AYNRKCDVYSFG 308
           T    TL Y  PE+L G   Y    D++  G
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 8/173 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+E+ +GG L  ++   + R+         A ++   L +L  K I++RD+K +N+LL
Sbjct: 100 FFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           D     K+ADFG+ + E       T  T  GT  Y+APE+L    Y    D ++ G+ L+
Sbjct: 158 DHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+ C   P+   +  ++  A++   +    P         ++K     NP  R
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (252), Expect = 2e-23
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 29/260 (11%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +GTFG V   +    G+  A+K+L       + E  +A        E  V     HP +T
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLT----ENRVLQNSRHPFLT 211

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               +         QT    +       C V+EY +GG L  +L  +R R  +       
Sbjct: 212 ALKYS--------FQTH-DRL-------CFVMEYANGGELFFHL--SRERVFSEDRARFY 253

Query: 227 ALDLARGLSYLQSKK-IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
             ++   L YL S+K +V+RD+K EN++LDK   +KI DFG+ +    +   M    GT 
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 345
            Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +    ++   ++ + +R   PR 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRT 371

Query: 346 CPSSLANVMKRCWDANPDKR 365
                 +++      +P +R
Sbjct: 372 LGPEAKSLLSGLLKKDPKQR 391

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (252), Expect = 2e-23
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 7/175 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
           C+V+   +GG LK ++    +        +  A ++  GL  L  ++IV+RD+K EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI 314
           D    ++I+D G+A         + G  GT+GYMAPEV+    Y    D ++ G  L+E+
Sbjct: 320 DDHGHIRISDLGLAV-HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

Query: 315 YCCDMPYPD----LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
                P+      +   EV   V                  ++  +    +P +R
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++   +  +      +  A ++A GL +LQSK I++RD+K +N++L
Sbjct: 97  YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           D    +KIADFG+ + E       T  T  GT  Y+APE++    Y +  D ++FG+ L+
Sbjct: 155 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+      E+  +++  N+    P+        + K     +P KR
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 13/180 (7%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LL
Sbjct: 86  FFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           D    +K+ D+G+ + E   P D T  T  GT  Y+APE+L G  Y    D ++ G+ ++
Sbjct: 144 DSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNL-------RPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+  +  S+         L       +  IPR      A+V+K   + +P +R
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 57/266 (21%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQE-WEIDPAKLIIKGAFARGTFGTVHRG--IY 120
           HH H   L          S + + S    + +     ++   G    GT+G V++     
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYR----RITKLGE---GTYGEVYKAIDTV 57

Query: 121 DGQDVAVKLLDWGEESHRSEAE-----IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT 175
             + VA+K +       R E E       ++R     EV++  +L H N+ +        
Sbjct: 58  TNETVAIKRI-------RLEHEEEGVPGTAIR-----EVSLLKELQHRNIIELKSVIHHN 105

Query: 176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLS 235
             L++                + EY     LK Y+  ++   ++ +V+      L  G++
Sbjct: 106 HRLHL----------------IFEYAEND-LKKYM--DKNPDVSMRVIKSFLYQLINGVN 146

Query: 236 YLQSKKIVHRDVKTENMLLDKTRT-----VKIADFGVARLEASNPHDMTGETGTLGYMAP 290
           +  S++ +HRD+K +N+LL  +       +KI DFG+AR         T E  TL Y  P
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206

Query: 291 EVLNGSAYNRKCDVYSFGICLWEIYC 316
           E+L GS +      YS  + +W I C
Sbjct: 207 EILLGSRH------YSTSVDIWSIAC 226

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 13/180 (7%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++   R+RKL  +     + +++  L+YL  + I++RD+K +N+LL
Sbjct: 129 FFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           D    +K+ D+G+ + E   P D T  T  GT  Y+APE+L G  Y    D ++ G+ ++
Sbjct: 187 DSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNL-------RPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+  +  S+         L       +  IPR      A+V+K   + +P +R
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 24/181 (13%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
             V++Y +GG L  +L + R     F          AR         L YL S  IV+RD
Sbjct: 115 YFVLDYINGGELFYHLQRERC----FL------EPRARFYAAEIASALGYLHSLNIVYRD 164

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDV 304
           +K EN+LLD    + + DFG+ + E    +  T  T  GT  Y+APEVL+   Y+R  D 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 305 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           +  G  L+E+     P+   + +E+   ++ + L+  +     +S  ++++     +  K
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTK 280

Query: 365 R 365
           R
Sbjct: 281 R 281

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 98.6 bits (245), Expect = 2e-22
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             V+EY +GG L  ++   +  +      +  A ++A GL +LQSK I++RD+K +N++L
Sbjct: 418 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475

Query: 255 DKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLW 312
           D    +KIADFG+ + E       T  T  GT  Y+APE++    Y +  D ++FG+ L+
Sbjct: 476 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533

Query: 313 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           E+     P+      E+  +++  N+    P+        + K     +P KR
Sbjct: 534 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 584

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 24/181 (13%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
            +++EY  GG L   L +       F        D A          L +L  K I++RD
Sbjct: 97  YLILEYLSGGELFMQLEREGI----FM------EDTACFYLAEISMALGHLHQKGIIYRD 146

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDV 304
           +K EN++L+    VK+ DFG+ + E+ +   +T  T  GT+ YMAPE+L  S +NR  D 
Sbjct: 147 LKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDW 204

Query: 305 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           +S G  ++++     P+   +  +    +++  L   +P        +++K+    N   
Sbjct: 205 WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAAS 262

Query: 365 R 365
           R
Sbjct: 263 R 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 24/181 (13%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
            +++++  GG L + L K       F        +  +         L +L S  I++RD
Sbjct: 102 YLILDFLRGGDLFTRLSKEVM----FT------EEDVKFYLAELALALDHLHSLGIIYRD 151

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDV 304
           +K EN+LLD+   +K+ DFG+++      H+    +  GT+ YMAPEV+N   + +  D 
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADW 209

Query: 305 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           +SFG+ ++E+    +P+      E  + +++  L   +P+       ++++  +  NP  
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPAN 267

Query: 365 R 365
           R
Sbjct: 268 R 268

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 62/252 (24%), Positives = 101/252 (40%), Gaps = 47/252 (18%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V   +     +  A+K+L+  E   R+E       A F +E  V    D   +T
Sbjct: 84  RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE------TACFREERDVLVNGDSKWIT 137

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A         Q DN           +V++Y  GG L + L K   R         L
Sbjct: 138 TLHYA--------FQDDN--------NLYLVMDYYVGGDLLTLLSKFEDR---------L 172

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             ++AR         +  +     VHRD+K +N+L+D    +++ADFG       +    
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 279 TGET-GTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
           +    GT  Y++PE+L         Y  +CD +S G+C++E+   + P+   S  E    
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292

Query: 333 VVRQNLRPEIPR 344
           ++    R + P 
Sbjct: 293 IMNHKERFQFPT 304

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 44/218 (20%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V   R     +  A+KLL   E   RS++        F +E  +    + P V 
Sbjct: 79  RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA------FFWEERDIMAFANSPWVV 132

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV--- 223
           +   A         Q D         +  +V+EY  GG L + +       +  K     
Sbjct: 133 QLFYA--------FQDDR--------YLYMVMEYMPGGDLVNLM---SNYDVPEKWARFY 173

Query: 224 ---IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTG 280
              + LALD       + S   +HRDVK +NMLLDK+  +K+ADFG              
Sbjct: 174 TAEVVLALD------AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227

Query: 281 ET-GTLGYMAPEVLNG----SAYNRKCDVYSFGICLWE 313
              GT  Y++PEVL        Y R+CD +S G+ L+E
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 56/273 (20%), Positives = 110/273 (40%), Gaps = 59/273 (21%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLR--AAFTQEVAVWHKLDHPN 164
            G+FG V   +    G   A+K+L         + ++  L+       E  +   ++ P 
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKIL--------DKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + K   +         + ++           +V+EY  GG + S+L +  R         
Sbjct: 103 LVKLEFSF--------KDNS--------NLYMVMEYVAGGEMFSHLRRIGR--------- 137

Query: 225 QLALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
             +   AR           YL S  +++RD+K EN+L+D+   +++ DFG A+       
Sbjct: 138 -FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------- 189

Query: 277 DMTGET----GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 332
            + G T    GT   +APE++    YN+  D ++ G+ ++E+     P+      ++   
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           +V   +R   P    S L ++++     +  KR
Sbjct: 250 IVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 49/223 (21%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG F  V   +    GQ  A+K+++  +   R E         F +E  V    D   +T
Sbjct: 71  RGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS------CFREERDVLVNGDRRWIT 124

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +   A         Q +N        +  +V+EY  GG L + L K   R         +
Sbjct: 125 QLHFA--------FQDEN--------YLYLVMEYYVGGDLLTLLSKFGER---------I 159

Query: 227 ALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM 278
             ++AR         +  +     VHRD+K +N+LLD+   +++ADFG      ++    
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219

Query: 279 TGET-GTLGYMAPEVLNG-------SAYNRKCDVYSFGICLWE 313
           +    GT  Y++PE+L          +Y  +CD ++ G+  +E
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.6 bits (231), Expect = 3e-21
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 55/271 (20%)

Query: 109 RGTFGTVH--RGIYDGQDVAVKLLDWGEESHRSEAEIASLR-AAFTQ-EVAVWHKLDHPN 164
            G+FG VH  R  ++G+  A+K+L         +  +  L+    T  E  +   + HP 
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVL--------KKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +  G          Q              ++++Y  GG L S L K++R    F    
Sbjct: 68  IIRMWGTF--------QDAQ--------QIFMIMDYIEGGELFSLLRKSQR----FP--- 104

Query: 225 QLALDLAR--------GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH 276
                +A+         L YL SK I++RD+K EN+LLDK   +KI DFG A+       
Sbjct: 105 ---NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----P 157

Query: 277 DMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
           D+T  T  GT  Y+APEV++   YN+  D +SFGI ++E+     P+ D +  +    ++
Sbjct: 158 DVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216

Query: 335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
              LR   P      + +++ R    +  +R
Sbjct: 217 NAELR--FPPFFNEDVKDLLSRLITRDLSQR 245

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.4 bits (232), Expect = 1e-20
 Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 12/176 (6%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL 254
             +++  +GG L  +L  ++    +   +   A ++  GL ++ ++ +V+RD+K  N+LL
Sbjct: 268 SFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325

Query: 255 DKTRTVKIADFGVARLEASNPHDMT-GETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLW 312
           D+   V+I+D G+A               GT GYMAPEVL  G AY+   D +S G  L+
Sbjct: 326 DEHGHVRISDLGLACD---FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382

Query: 313 EIYCCDMPY---PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           ++     P+         E+    +   +   +P      L ++++     + ++R
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRR 436

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 41/210 (19%), Positives = 69/210 (32%), Gaps = 56/210 (26%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V +       +  A+K+L       R E E+             W     P++ 
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL------------HWRASQCPHIV 74

Query: 167 KFIGA--TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + +     +      +      I         V+E   GG L S +     +    +   
Sbjct: 75  RIVDVYENLYAGRKCL-----LI---------VMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGE 281
           ++   +   + YL S  I HRDVK EN+L         +K+ DFG               
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------- 165

Query: 282 TGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
                  A E      Y++ CD++S G+ +
Sbjct: 166 ------FAKETTGEK-YDKSCDMWSLGVIM 188

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 41/187 (21%), Positives = 88/187 (47%), Gaps = 29/187 (15%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR--------GLSYLQSKKIVHRD 246
            ++++Y +GG L ++L +  R    F           +         L +L    I++RD
Sbjct: 135 HLILDYINGGELFTHLSQRER----FT------EHEVQIYVGEIVLALEHLHKLGIIYRD 184

Query: 247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET--GTLGYMAPEVLNGSA--YNRKC 302
           +K EN+LLD    V + DFG+++   ++  +       GT+ YMAP+++ G    +++  
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAV 243

Query: 303 DVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCW 358
           D +S G+ ++E+     P+       S +E++  +++       P+   +   ++++R  
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLL 301

Query: 359 DANPDKR 365
             +P KR
Sbjct: 302 MKDPKKR 308

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 47/248 (18%), Positives = 92/248 (37%), Gaps = 45/248 (18%)

Query: 74  PIYTRSRSSSTTSASVRRQEWEID--------PAKLIIKGAFARGTFGTVHRGIY--DGQ 123
           P+ +R+R  +  +    R+ W+ +             +     RG +  V   I   + +
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62

Query: 124 DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTD 183
            V VK+L    +  + + EI  L           +    PN+             +I  D
Sbjct: 63  KVVVKILK-PVKKKKIKREIKILE----------NLRGGPNIITL---------ADIVKD 102

Query: 184 NGHIGMPSNFCCV-VVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
                 P +     V E+ +    K        + L    +     ++ + L Y  S  I
Sbjct: 103 ------PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGI 151

Query: 243 VHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL-NGSAYNR 300
           +HRDVK  N+++D + R +++ D+G+A        +      +  +  PE+L +   Y+ 
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDY 210

Query: 301 KCDVYSFG 308
             D++S G
Sbjct: 211 SLDMWSLG 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 61/235 (25%), Positives = 92/235 (39%), Gaps = 54/235 (22%)

Query: 102 IIKGAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW 157
                  RGT+G V++       D +D A+K ++    S  +  EIA LR          
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR---------- 73

Query: 158 HKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC-HGGALKSYLIKNRRR 216
            +L HPNV       +  ++  +               ++ +Y  H   L    IK  R 
Sbjct: 74  -ELKHPNVISLQKVFLSHADRKV--------------WLLFDYAEHD--LWHI-IKFHRA 115

Query: 217 KLAFKVVIQLALD--------LARGLSYLQSKKIVHRDVKTENMLLDKTR----TVKIAD 264
             A K  +QL           +  G+ YL +  ++HRD+K  N+L+         VKIAD
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175

Query: 265 FGVARLEASNPHDMTGETG---TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC 316
            G ARL  S    +        T  Y APE+L G+ +      Y+  I +W I C
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH------YTKAIDIWAIGC 224

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 38/209 (18%)

Query: 109 RGTFGTVHRGI-YDGQDVAVK--LLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
            G+FG V +    +  +VA+K  L D     +R   E+  +R            + HPNV
Sbjct: 50  NGSFGVVFQAKLVESDEVAIKKVLQD-KRFKNR---ELQIMR-----------IVKHPNV 94

Query: 166 TKFIGATMGTSELNIQTD-NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF-KVV 223
                      +   +   N           +V+EY     +        + K     ++
Sbjct: 95  VDLKAFFYSNGDKKDEVFLN-----------LVLEYV-PETVYRASRHYAKLKQTMPMLL 142

Query: 224 IQLAL-DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVAR-LEASNPHDMTG 280
           I+L +  L R L+Y+ S  I HRD+K +N+LLD  +  +K+ DFG A+ L A  P     
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVS 200

Query: 281 ETGTLGYMAPEVLNGSA-YNRKCDVYSFG 308
              +  Y APE++ G+  Y    D++S G
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTG 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 32/282 (11%), Positives = 67/282 (23%), Gaps = 71/282 (25%)

Query: 108 ARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
                    +   D    + VA+  +               +            ++D P 
Sbjct: 40  GGVPPLQFWQA-LDTALDRQVALTFV------DPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +             D  H         VV E+  GG+L+           +    I
Sbjct: 93  VARVL-------------DVVHTR---AGGLVVAEWIRGGSLQEVA----DTSPSPVGAI 132

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGT 284
           +    LA          +         + +     V +A                     
Sbjct: 133 RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ-------- 336
              M          N + D+   G  L+ +     P P+       +   R         
Sbjct: 175 --TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225

Query: 337 -NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA 377
            ++  +IP      ++ V  R    +   R     ++ +++ 
Sbjct: 226 ADIDRDIPF----QISAVAARSVQGDGGIRSA-STLLNLMQQ 262

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 35/208 (16%)

Query: 109 RGTFGTVHRGIY--DGQDVAVK--LLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            G+FG V++      G+ VA+K  L D     +R   E+  +R           KLDH N
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNR---ELQIMR-----------KLDHCN 108

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF-KVV 223
           + +       + E   + D  ++        +V++Y     +        R K     + 
Sbjct: 109 IVRLRYFFYSSGE---KKDEVYL-------NLVLDYV-PETVYRVARHYSRAKQTLPVIY 157

Query: 224 IQLAL-DLARGLSYLQSKKIVHRDVKTENMLLDK-TRTVKIADFGVARLEASNPHDMTGE 281
           ++L +  L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+            
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSY 216

Query: 282 TGTLGYMAPEVLNGSA-YNRKCDVYSFG 308
             +  Y APE++ G+  Y    DV+S G
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAG 244

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 26/220 (11%)

Query: 109 RGTFGTVHRG--IYDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPNV 165
            G F TV     + +   VA+K++   +     +E EI  L+     +      +   ++
Sbjct: 29  WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            K +                H G       +V E   G  L + + K   R +    V Q
Sbjct: 89  LKLLDHFN------------HKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQ 135

Query: 226 LALDLARGLSYLQSK-KIVHRDVKTENMLLD------KTRTVKIADFGVARLEASNPHDM 278
           ++  L  GL Y+  +  I+H D+K EN+L++          +KIAD G A          
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHY 192

Query: 279 TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD 318
           T    T  Y +PEVL G+ +    D++S    ++E+   D
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 60/262 (22%), Positives = 101/262 (38%), Gaps = 33/262 (12%)

Query: 60  VQGGHHPHHQHLPRPIYTRSRSSSTT---SASVRRQEWEIDPAKLIIKGAFARGTFGTVH 116
            QG             Y  S+S       S  V    + +   +         G  G V 
Sbjct: 21  CQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTV-LKRYQNLKPIGSGAQGIVC 79

Query: 117 RGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG 174
                   ++VA+K L     S   + +  + RA   +E+ +   ++H N+   +     
Sbjct: 80  AAYDAVLDRNVAIKKL-----SRPFQNQTHAKRAY--RELVLMKCVNHKNIISLLNVFTP 132

Query: 175 TSELNIQTDNGHIG--MPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR 232
              L    D   +   M +N C V         ++  L   R   L ++++         
Sbjct: 133 QKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQML--------C 175

Query: 233 GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV 292
           G+ +L S  I+HRD+K  N+++    T+KI DFG+AR   ++   MT    T  Y APEV
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEV 234

Query: 293 LNGSAYNRKCDVYSFGICLWEI 314
           + G  Y    D++S G  + E+
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEM 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 43/180 (23%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
            G+ +L S  I+HRD+K  N+++    T+KI DFG+AR   ++   MT    T  Y APE
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAPE 196

Query: 292 VLNGSAYNRKCDVYSFGICLWEI------------------------------------- 314
           V+ G  Y    D++S G  + E+                                     
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 315 ---YCCDMP-YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 370
              Y  + P Y   SF ++   V+              +  +++ +    +  KR  +DE
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR-DLLSKMLVIDASKRISVDE 315

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 50/328 (15%), Positives = 109/328 (33%), Gaps = 53/328 (16%)

Query: 79  SRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVK----LLDWG 133
                     +  +   +     + +   + G++G V  G+  +G  VA+K     +  G
Sbjct: 3   QAKGEAAMRDLIAELHAMQSPYTVQR-FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61

Query: 134 EESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNF 193
              +         R    +E+ + +   HPN+             +I             
Sbjct: 62  RTVNILSDSFLCKRV--LREIRLLNHFHHPNILGL---------RDIFVHFE----EPAM 106

Query: 194 CCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML 253
             + +         + +I ++R  ++ + +      +  GL  L    +VHRD+   N+L
Sbjct: 107 HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166

Query: 254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLW 312
           L     + I DF +AR + ++ +  T       Y APE+ +    + +  D++S G  + 
Sbjct: 167 LADNNDITICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225

Query: 313 EIYCCD------------------MPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANV 353
           E++                     +  P +      +S   R  LR  +      +   V
Sbjct: 226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285

Query: 354 -----------MKRCWDANPDKRPEMDE 370
                      + +  + NP +R   ++
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQ 313

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 45/229 (19%), Positives = 81/229 (35%), Gaps = 45/229 (19%)

Query: 109 RGTFGTVHRGIY--DGQDVAVK--LLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            G+FG V        G+  A+K  L D          E+  ++            LDH N
Sbjct: 17  TGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMK-----------VLDHVN 61

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS--------YLIK---- 212
           + K +     T +   +                    H  ++           +I     
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 213 ---NRRRKLAFKVVIQLALD--------LARGLSYLQSKKIVHRDVKTENMLLD-KTRTV 260
              ++  K   +    + ++        L R + ++ S  I HRD+K +N+L++ K  T+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181

Query: 261 KIADFGVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFG 308
           K+ DFG A+    +         +  Y APE+ L  + Y    D++S G
Sbjct: 182 KLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 31/209 (14%)

Query: 109 RGTFGTVHRGIY--DGQDVAVK-LLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV 165
           +GTFGTV  G     G  VA+K ++      +R    +  L             L HPN+
Sbjct: 33  QGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLA-----------VLHHPNI 81

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV-I 224
            +           +     G       +  VV+EY     L        RR++A   + I
Sbjct: 82  VQL---------QSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILI 131

Query: 225 QLAL-DLARGLSYL--QSKKIVHRDVKTENMLLDK-TRTVKIADFGVARLEASNPHDMTG 280
           ++ L  L R +  L   S  + HRD+K  N+L+++   T+K+ DFG A+  + +      
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVA 190

Query: 281 ETGTLGYMAPEVLNGSA-YNRKCDVYSFG 308
              +  Y APE++ G+  Y    D++S G
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVG 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 61/267 (22%), Positives = 99/267 (37%), Gaps = 57/267 (21%)

Query: 65  HPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DG 122
           H HH H+          ++     VR Q +++   +         G +G V       + 
Sbjct: 1   HHHHHHMAAA-------AAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNK 52

Query: 123 QDVAVKLLDWGEESHRSEA-----EIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE 177
             VA+K +   E  H++       EI  L            +  H N+            
Sbjct: 53  VRVAIKKISPFE--HQTYCQRTLREIKILL-----------RFRHENIIGI--------- 90

Query: 178 LNIQTDNGHIGMPSNFCCV--VVEYCH---GGALKSYLIKNRRRKLAFKVVIQLALDLAR 232
            +I               V  V +         LK+  + N         + Q+     R
Sbjct: 91  NDIIRAPT----IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY---FLYQIL----R 139

Query: 233 GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL---EASNPHDMTGETGTLGYMA 289
           GL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR+   +  +   +T    T  Y A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 290 PEV-LNGSAYNRKCDVYSFGICLWEIY 315
           PE+ LN   Y +  D++S G  L E+ 
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEML 226

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 65/265 (24%), Positives = 108/265 (40%), Gaps = 58/265 (21%)

Query: 64  HHPHHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--D 121
           HH HH    RP + R          + +  WE+ P +         G +G+V        
Sbjct: 3   HHHHHHSQERPTFYRQ--------ELNKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKT 53

Query: 122 GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ 181
           G  VAVK L     S   ++ I + R    +E+ +   + H NV            L++ 
Sbjct: 54  GLRVAVKKL-----SRPFQSIIHAKRTY--RELRLLKHMKHENVIGL---------LDVF 97

Query: 182 TDNGHIG-----------MPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDL 230
           T    +            M ++   +         +K   + +   +    ++ Q+    
Sbjct: 98  TPARSLEEFNDVYLVTHLMGADLNNI---------VKCQKLTDDHVQF---LIYQIL--- 142

Query: 231 ARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAP 290
            RGL Y+ S  I+HRD+K  N+ +++   +KI DFG+AR       +MTG   T  Y AP
Sbjct: 143 -RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAP 198

Query: 291 EV-LNGSAYNRKCDVYSFGICLWEI 314
           E+ LN   YN+  D++S G  + E+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAEL 223

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 33/85 (38%), Positives = 50/85 (58%), Gaps = 4/85 (4%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
           +GL Y+ +  I+HRD+K  N+ +++   +KI DFG+AR   S   +MTG   T  Y APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPE 195

Query: 292 V-LNGSAYNRKCDVYSFGICLWEIY 315
           V LN   Y +  D++S G  + E+ 
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMI 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 33/85 (38%), Positives = 51/85 (60%), Gaps = 4/85 (4%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPE 291
           +GL Y+ S  +VHRD+K  N+ +++   +KI DFG+AR   +   +MTG   T  Y APE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPE 193

Query: 292 V-LNGSAYNRKCDVYSFGICLWEIY 315
           V L+   YN+  D++S G  + E+ 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEML 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 5/88 (5%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTR-TVKIADFGVARL---EASNPHDMTGETGTLGY 287
           RGL Y+ S  ++HRD+K  N+ ++     +KI DFG+AR+     S+   ++    T  Y
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190

Query: 288 MAPEV-LNGSAYNRKCDVYSFGICLWEI 314
            +P + L+ + Y +  D+++ G    E+
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEM 218

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 43/181 (23%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYM--- 288
           R +  L    ++HRD+K  N+L++    +K+ DFG+AR+   +  D +  TG    M   
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 289 -------APEV-LNGSAYNRKCDVYSFGICLWEIY--------------------CCDMP 320
                  APEV L  + Y+R  DV+S G  L E++                        P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242

Query: 321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANV-----------MKRCWDANPDKRPEMD 369
           + D     + S   R+ ++  +P    + L  +           ++R    +P KR    
Sbjct: 243 HSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 370 E 370
           E
Sbjct: 302 E 302

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 54/287 (18%), Positives = 100/287 (34%), Gaps = 58/287 (20%)

Query: 53  HHHHLHGVQGGHHPHHQHLPRPIYTRSRSSSTTSA--------SVRRQEWEIDPAKLIIK 104
           HHHH       HH     L          +++  A            ++W++       +
Sbjct: 2   HHHH-------HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLK--SFQTR 52

Query: 105 GAF-----ARGTFGTVHRGIYDGQDVAVKLLDWGEESHRS--EAEIASL-RAAFTQEVAV 156
                   A  T           Q  ++KL     ++       E     RAA   +V  
Sbjct: 53  DNQGILYEAAPTSTLTCDSGPQKQKFSLKL-----DAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 157 W---HKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
           W   +      +   +G   G  +               +  +V+    G +L+S L  +
Sbjct: 108 WKKLYSTPLLAIPTCMGF--GVHQ-------------DKYRFLVLPSL-GRSLQSALDVS 151

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVA-RL 270
            +  L+ + V+Q+A  L   L +L   + VH +V  EN+ +  +    V +A +G A R 
Sbjct: 152 PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

Query: 271 EASNPH------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICL 311
             S  H        +   G L +++ ++  G   +R+ D+ S G C+
Sbjct: 212 CPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 109 RGTFGTVHRGIYD---GQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHKLDHPN 164
           +G+FG V +  YD    Q VA+K++   +  HR +  EI  L     + +    K +  N
Sbjct: 107 KGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEEIRIL-----EHLRKQDKDNTMN 160

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V   +                HI       C+  E      L   + KN+ +  +  +V 
Sbjct: 161 VIHMLENFT---------FRNHI-------CMTFE-LLSMNLYELIKKNKFQGFSLPLVR 203

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHDMTGET 282
           + A  + + L  L   +I+H D+K EN+LL       +K+ DFG +  E      +    
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYI 260

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            +  Y APEV+ G+ Y    D++S G  L E+ 
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 32/220 (14%)

Query: 103 IKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHR-SEAEIASLRAAFTQEVAVWHK 159
           I     +G+FG V +     + + VA+K++   +     ++ E+  L     + +     
Sbjct: 58  IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL-----ELMNKHDT 112

Query: 160 LDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLA 219
                +       M            H+       C+V E      L   L     R ++
Sbjct: 113 EMKYYIVHLKRHFM---------FRNHL-------CLVFE-MLSYNLYDLLRNTNFRGVS 155

Query: 220 FKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLL--DKTRTVKIADFGVARLEASNP 275
             +  + A  +   L +L + +  I+H D+K EN+LL   K   +KI DFG +       
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212

Query: 276 HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
             +     +  Y +PEVL G  Y+   D++S G  L E++
Sbjct: 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.6 bits (164), Expect = 1e-12
 Identities = 44/287 (15%), Positives = 79/287 (27%), Gaps = 59/287 (20%)

Query: 110 GTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL--------- 160
           G FG V + I D   VA+K++   E                  E+ +  +L         
Sbjct: 31  GVFGEVFQTIADHTPVAIKIIAI-EGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89

Query: 161 DHPNVTKFIGATMGTSELNIQTDNGHIGM--------------PSNFCCVVVEYCHGGA- 205
                                                        +   +V+E+  GG  
Sbjct: 90  RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149

Query: 206 LKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADF 265
           L+    K      A  ++ QL   LA   + L   +  HRD+   N+LL KT   K+   
Sbjct: 150 LEQMRTKLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYT 206

Query: 266 G-------------VARLEASNPHDMTGET--GTLGYMAPEVLNGSAYNRKCDVYSFGI- 309
                         V+ ++ +                M  ++  G   + + D+Y     
Sbjct: 207 LNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD-GDYQFDIYRLMKK 265

Query: 310 --------------CLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
                          LW  Y  D     ++F    +    + ++ +I
Sbjct: 266 ENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 48/267 (17%), Positives = 96/267 (35%), Gaps = 40/267 (14%)

Query: 67  HHQHLPRPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAF------ARGTFGTVHRG-- 118
           HH H           +    +    +   +D    +    +        G FG ++    
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEGKVLD---DMEGNQWVLGKKIGSGGFGLIYLAFP 58

Query: 119 IYDGQDVAVKLLDWGEESHRS-EAEIASL-RAAFTQEVAVW---HKLDHPNVTKFIGATM 173
               +  A  ++    + +    +E+    R A    +  W    +LD+  +  F G+  
Sbjct: 59  TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS-- 116

Query: 174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARG 233
           G +E   +          ++  +V+E   G  L+      +        V+QL + +   
Sbjct: 117 GLTEFKGR----------SYRFMVMERL-GIDLQKIS--GQNGTFKKSTVLQLGIRMLDV 163

Query: 234 LSYLQSKKIVHRDVKTENMLLD--KTRTVKIADFGVA---RLEASNPH----DMTGETGT 284
           L Y+   + VH D+K  N+LL       V +AD+G++       ++         G  GT
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICL 311
           + + + +   G A +R+ DV   G C+
Sbjct: 224 IEFTSLDAHKGVALSRRSDVEILGYCM 250

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 22/99 (22%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD-------------- 277
           + + YL S  ++HRD+K  N+LL+    VK+ADFG++R   +                  
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 278 -------MTGETGTLGYMAPEV-LNGSAYNRKCDVYSFG 308
                  +T    T  Y APE+ L  + Y +  D++S G
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 28/105 (26%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD-------------- 277
            G+ Y+ S  I+HRD+K  N L+++  +VK+ DFG+AR      +               
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 278 -------------MTGETGTLGYMAPEV-LNGSAYNRKCDVYSFG 308
                        +TG   T  Y APE+ L    Y    DV+S G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 23/100 (23%)

Query: 232 RGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD-------------- 277
            G +++    I+HRD+K  N LL++  +VK+ DFG+AR   S                  
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199

Query: 278 --------MTGETGTLGYMAPEV-LNGSAYNRKCDVYSFG 308
                   +T    T  Y APE+ L    Y +  D++S G
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 40/235 (17%), Positives = 78/235 (33%), Gaps = 54/235 (22%)

Query: 109 RGTFGTVHRG-IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV-WHKLDHP--- 163
           +G FG ++   +   + V                              V     D+    
Sbjct: 45  QGGFGCIYLADMNSSESVGSDA-----------------------PCVVKVEPSDNGPLF 81

Query: 164 ---NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH-----------GGALKSY 209
                 +         +        ++G+P  +   + +              G  L+  
Sbjct: 82  TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKI 141

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD--KTRTVKIADFGV 267
              N + + + K V+QL+L +   L Y+   + VH D+K  N+LL+      V + D+G+
Sbjct: 142 YEANAK-RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 268 A---RLEASNPHDMTGE----TGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           A     E  +            GT+ + + +  NG A +R+ D+   G C+  I 
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM--IQ 253

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 43/183 (23%)

Query: 101 LIIKGAF------ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           L++   F        G FG +  G  +Y  + VA+KL     E  +S A           
Sbjct: 5   LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQ------LHL 53

Query: 153 EVAVWHKLDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           E   + +L     + +                  + G    +  +V+E   G +L   L 
Sbjct: 54  EYRFYKQLGSGDGIPQVY----------------YFGPCGKYNAMVLELL-GPSL-EDLF 95

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFG 266
               R  + K V+ +A+ L   + Y+ SK +++RDVK EN L+        + + I DF 
Sbjct: 96  DLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155

Query: 267 VAR 269
           +A+
Sbjct: 156 LAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 54/309 (17%)

Query: 100 KLIIKGAF------ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT 151
           +L +   +        G+FG ++ G  I  G++VA+KL     E  +++     L     
Sbjct: 4   ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHP--QLH---- 52

Query: 152 QEVAVWHKLDH-PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            E  ++  +     +                      G   ++  +V+E   G +L   L
Sbjct: 53  IESKIYKMMQGGVGIPTIR----------------WCGAEGDYNVMVMELL-GPSL-EDL 94

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGV 267
                RK + K V+ LA  +   + Y+ SK  +HRDVK +N L+    K   V I DFG+
Sbjct: 95  FNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154

Query: 268 A---RLEASNPH----DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP 320
           A   R   ++ H    +    TGT  Y +     G   +R+ D+ S G  L       +P
Sbjct: 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

Query: 321 YPDLSFSEVTSAVVR-----QNLRPE-IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
           +  L  +       R      +   E + +  PS  A  +  C     D +P+   +  +
Sbjct: 215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274

Query: 375 LEAIDTSKG 383
              +   +G
Sbjct: 275 FRNLFHRQG 283

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 42/171 (24%), Positives = 63/171 (36%), Gaps = 54/171 (31%)

Query: 195 CVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTENML 253
           C+V E   G  L  ++IK+  + L    V ++   + +GL YL +K +I+H D+K EN+L
Sbjct: 121 CMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 254 L-------------------------------------------------DKTRTVKIAD 264
           L                                                  +   VKIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 265 FGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            G A          T +  T  Y + EVL GS YN   D++S     +E+ 
Sbjct: 240 LGNACWV---HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 49/248 (19%), Positives = 88/248 (35%), Gaps = 68/248 (27%)

Query: 103 IKGAFARGTFGTVHRGIYD---GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK 159
           +      GTFG V          +  AVK++    + +   A+I         E  +  K
Sbjct: 39  VIRKMGDGTFGRVLLC-QHIDNKKYYAVKVVR-NIKKYTRSAKI---------EADILKK 87

Query: 160 L--DHPNVTKFIGATMGTSELNIQTDN-----GHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           +  D  N    +           +         H+       C++ E   G +L   + +
Sbjct: 88  IQNDDINNNNIV-----------KYHGKFMYYDHM-------CLIFE-PLGPSLYEIITR 128

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL------------------ 254
           N       + +    +++ + L+YL+   + H D+K EN+LL                  
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 255 -------DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSF 307
                   K+  +K+ DFG A  ++           T  Y APEV+    ++   D++SF
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKS---DYHGSIINTRQYRAPEVILNLGWDVSSDMWSF 245

Query: 308 GICLWEIY 315
           G  L E+Y
Sbjct: 246 GCVLAELY 253

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 38/150 (25%), Positives = 59/150 (39%), Gaps = 30/150 (20%)

Query: 185 GHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH 244
           GH+       C+  E   G     +L +N  +      V  +A  L   L +L   ++ H
Sbjct: 95  GHM-------CIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146

Query: 245 RDVKTENMLL-------------------DKTRTVKIADFGVARLEASNPHDMTGETGTL 285
            D+K EN+L                     K  ++++ADFG A  +       T    T 
Sbjct: 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH---EHHTTIVATR 203

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            Y  PEV+    + + CDV+S G  L+E Y
Sbjct: 204 HYRPPEVILELGWAQPCDVWSIGCILFEYY 233

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 46/221 (20%)

Query: 110 GTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVT 166
           G+FG +  G  + + Q VA+K      E  RS+A    LR     E   +  L     + 
Sbjct: 21  GSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAP--QLR----DEYRTYKLLAGCTGIP 69

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                              + G       +V++   G +L   L+    RK + K V   
Sbjct: 70  NVY----------------YFGQEGLHNVLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMA 111

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL-----DKTRTVKIADFGVA---RLEASNPH-- 276
           A  +   +  +  K +V+RD+K +N L+          + + DFG+    R   +  H  
Sbjct: 112 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171

Query: 277 --DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
             +    +GT  YM+     G   +R+ D+ + G     +Y
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF--MY 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 53/239 (22%), Positives = 88/239 (36%), Gaps = 66/239 (27%)

Query: 109 RGTFGTVHRGI---YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DH 162
            G FG V   I     G+ VAVK++    + +   A           E+ V   L   D 
Sbjct: 24  EGAFGKVVECIDHKAGGRHVAVKIVK-NVDRYCEAARS---------EIQVLEHLNTTDP 73

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
            +  + +        L     +GHI       C+V E   G +   ++ +N         
Sbjct: 74  NSTFRCVQM------LEWFEHHGHI-------CIVFELL-GLSTYDFIKENGFLPFRLDH 119

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-------------------KTRTVKIA 263
           + ++A  + + +++L S K+ H D+K EN+L                         +K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 264 DFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           DFG A  +  +        H          Y APEV+    +++ CDV+S G  L E Y
Sbjct: 180 DFGSATYDDEHHSTLVSTRH----------YRAPEVILALGWSQPCDVWSIGCILIEYY 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 52/234 (22%), Positives = 95/234 (40%), Gaps = 50/234 (21%)

Query: 101 LIIKGAF------ARGTFGTVHRG--IYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
             +   F        G+FG ++ G  I   ++VA+KL     E+ +++     L      
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHP--QLL----Y 51

Query: 153 EVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI 211
           E  ++  L     +                      G+  ++  +V++   G +L   L 
Sbjct: 52  ESKIYRILQGGTGIPNVR----------------WFGVEGDYNVLVMDLL-GPSL-EDLF 93

Query: 212 KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVA 268
               RKL+ K V+ LA  +   + ++ SK  +HRD+K +N L+    +   V I DFG+A
Sbjct: 94  NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

Query: 269 RL---EASNPH----DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           +     +++ H    +    TGT  Y +     G   +R+ D+ S G  L  +Y
Sbjct: 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL--MY 205

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 56/449 (12%), Positives = 116/449 (25%), Gaps = 156/449 (34%)

Query: 53  HHHHLH-GVQGGHHPHH---------------------QHLPRPIYTRSR-----SSSTT 85
           HHHH H   + G H +                      Q +P+ I ++        S   
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA 60

Query: 86  SASVRRQEWEIDPAKLIIKGAFARGTF-GTVHRGIYDGQDVAVKLLDWGEESHRSEAEIA 144
            +   R  W      L+ K       F   V R  Y           +     ++E    
Sbjct: 61  VSGTLRLFW-----TLLSKQEEMVQKFVEEVLRINY----------KFLMSPIKTEQRQP 105

Query: 145 SL-RAAFTQEVAVWHKLDHP----NVT---KFIGATMGTSELNIQTDNGHIGMPSNFCCV 196
           S+    + ++    +  +      NV+    ++       EL           P+    V
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR----------PAKN--V 153

Query: 197 VVEYCHG--GALKSYLIKN------RRRKLAFKV---------------VIQLAL----- 228
           ++    G  G+ K+++  +       + K+ FK+                +   L     
Sbjct: 154 LI---DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210

Query: 229 ------------------DLARGLSYLQSKK------IVHRDVKTENML---------LD 255
                              +   L  L   K      +V  +V+              L 
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL 270

Query: 256 KTRTVKIADF--GVARLEASNPHDMTGETG--TLGYMAPEVLNGSAY---NRKCDVYSFG 308
            TR  ++ DF         S  H     T       +  + L+                 
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLTTNPRR 329

Query: 309 ICLWEIYCCDMP-----YPDLSFSEVTSAVVR--QNLRPEIPRCCPSSLA---------- 351
           + +      D       +  ++  ++T+ +      L P   R     L+          
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389

Query: 352 NVMKRCWDANPDKRPE--MDEVV--AMLE 376
            ++   W           ++++   +++E
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	404
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.26
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.01
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.73
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.1
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.09
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.82
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.78
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.42
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.97
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.68
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.48
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.89

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-61  Score=450.61  Aligned_cols=265  Identities=31%  Similarity=0.596  Sum_probs=222.1

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ..|+|+.+++.+.+.||+|+||+||+|++.+ .||||+++.....   .    ...+.|.+|+.++++++|||||+++|+
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~---~----~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPT---P----EQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCC---H----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCC---H----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4699999999999999999999999999865 5999999754322   1    224678999999999999999999998


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+. .+                |||||||++|+|.++|... ..++++..+..|+.||+.||.|||+++||||||||+|
T Consensus       101 ~~~~-~~----------------~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~N  162 (307)
T 3omv_A          101 MTKD-NL----------------AIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN  162 (307)
T ss_dssp             ECSS-SC----------------EEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSS
T ss_pred             EECC-eE----------------EEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHH
Confidence            7543 33                8999999999999999654 4579999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          252 MLLDKTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      |||+.++.+||+|||+|+.....  .......+||+.|||||++.+   .+|+.++|||||||++|||+||..||.+.+.
T Consensus       163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN  242 (307)
T ss_dssp             EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999864432  223455689999999999854   4589999999999999999999999998776


Q ss_pred             HHHHHHHHhccC-CC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNL-RP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .......+.... .+   ..+..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus       243 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          243 RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            665555554443 22   456789999999999999999999999999999999887654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-60  Score=452.62  Aligned_cols=263  Identities=30%  Similarity=0.514  Sum_probs=223.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      .+.+..++|.+.++||+|+||+||+|.+       +++.||||+++...         ...++.|.+|+.+|++++||||
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnI  105 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTMLQHQHI  105 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---------HHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---------HHHHHHHHHHHHHHHhCCCCCC
Confidence            3567778999999999999999999986       36889999996321         1234678999999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------------cCCCcHHHHHHHHHHHHH
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------------RRKLAFKVVIQLALDLAR  232 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~  232 (404)
                      |+++|++.+...+                |||||||++|+|.+++.+..             ..++++.+++.|+.||+.
T Consensus       106 V~l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~  169 (329)
T 4aoj_A          106 VRFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA  169 (329)
T ss_dssp             CCEEEEECSSSSE----------------EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHH
T ss_pred             CcEEEEEEECCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHH
Confidence            9999999887766                89999999999999996542             246999999999999999


Q ss_pred             HHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHH
Q 015594          233 GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC  310 (404)
Q Consensus       233 ~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  310 (404)
                      ||.|||+++|+||||||+||||+.++.+||+|||+|+......  .......||+.|||||++.+..|+.++|||||||+
T Consensus       170 gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvv  249 (329)
T 4aoj_A          170 GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV  249 (329)
T ss_dssp             HHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHH
Confidence            9999999999999999999999999999999999998544332  22334679999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          311 LWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       311 l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +|||+| |+.||.+.+..+....+.. ..++..|..+|+++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       250 l~Ellt~G~~Pf~~~~~~~~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          250 LWEIFTYGKQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTTSCCTTCSSCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            999998 8999999998888777654 456778899999999999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-61  Score=459.01  Aligned_cols=252  Identities=24%  Similarity=0.453  Sum_probs=219.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++......       ..+..+.+|+.++++|+|||||++++++.+.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-------KEREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-------HHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            47899999999999999999998  68999999997654321       1246688999999999999999999999887


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |||||||+||+|.++|.......+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        96 ~~~----------------yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~  159 (350)
T 4b9d_A           96 GSL----------------YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT  159 (350)
T ss_dssp             TEE----------------EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC
T ss_pred             CEE----------------EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC
Confidence            766                9999999999999999777667789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+|.+||+|||+|+.........+..+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..++...+..
T Consensus       160 ~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  239 (350)
T 4b9d_A          160 KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS  239 (350)
T ss_dssp             TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            99999999999998654333333456799999999999999999999999999999999999999999999998888877


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+ +..+..+|+++.+||.+||+.||++|||++++++
T Consensus       240 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 GSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            665 3567789999999999999999999999999985

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5e-61  Score=450.43  Aligned_cols=263  Identities=29%  Similarity=0.502  Sum_probs=227.9

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .|..++|.+.+.||+|+||+||+|.+       +++.||||+++...         ....+.|.+|+.+|++++|||||+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV~   79 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVK   79 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---------hHHHHHHHHHHHHHHhCCCCCCcc
Confidence            57778999999999999999999986       36789999996321         122466899999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-----------cCCCcHHHHHHHHHHHHHHHHH
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-----------RRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ++|++.+...+                |||||||++|+|.++|.+..           ...+++..+..++.||+.||.|
T Consensus        80 l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  143 (299)
T 4asz_A           80 FYGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY  143 (299)
T ss_dssp             EEEEECSSSSE----------------EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeeCCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            99999887766                89999999999999997642           3579999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHH
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI  314 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  314 (404)
                      ||+++|+||||||+||||+.++.+||+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||
T Consensus       144 LH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~El  223 (299)
T 4asz_A          144 LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI  223 (299)
T ss_dssp             HHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             HHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999999999999999854433222  2234689999999999999999999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          315 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       315 ~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      +| |+.||.+.+..++...+... .++..|..+|+++.+||.+||+.||++|||+.+|++.|+++..+..
T Consensus       224 lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          224 FTYGKQPWYQLSNNEVIECITQG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             HTTTCCTTTTSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            98 89999999998888776654 4567788999999999999999999999999999999999876643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-61  Score=451.78  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=221.9

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      .+++|++.+.||+|+||+||+|++  +|+.||||++++..      .........+.+|+.++++++|||||+++++|++
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  103 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD  103 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH------CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            357899999999999999999998  78999999996421      1112224568899999999999999999999998


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+|||||+||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+||||
T Consensus       104 ~~~~----------------yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl  165 (311)
T 4aw0_A          104 DEKL----------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL  165 (311)
T ss_dssp             SSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCEE----------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence            8776                9999999999999999664  579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||+|+.....  .......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..++...
T Consensus       166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  245 (311)
T 4aw0_A          166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK  245 (311)
T ss_dssp             CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999865433  2334567899999999999999999999999999999999999999999999888888


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      +....+  .+|..+++++++||.+||+.||++|||++|++
T Consensus       246 i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          246 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            877654  56788999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-60  Score=450.02  Aligned_cols=260  Identities=28%  Similarity=0.513  Sum_probs=225.9

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .++..+++++.+.||+|+||+||+|.+       +++.||||+++.....        ..++.|.+|+.++++++|||||
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------~~~~~f~~E~~il~~l~HpNIV   92 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------PLREEFRHEAMLRARLQHPNVV   92 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------HHHHHHHHHHHHHHhCCCCCCC
Confidence            457778999999999999999999986       4578999999643321        1245688999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHH
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLAR  232 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~  232 (404)
                      +++|++.+...+                |||||||++|+|.++|....              ...+++..+..++.||+.
T Consensus        93 ~l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~  156 (308)
T 4gt4_A           93 CLLGVVTKDQPL----------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA  156 (308)
T ss_dssp             CEEEEECSSSSC----------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHH
T ss_pred             CcceEEEECCEE----------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHH
Confidence            999999887766                89999999999999996532              246899999999999999


Q ss_pred             HHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHH
Q 015594          233 GLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGIC  310 (404)
Q Consensus       233 ~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i  310 (404)
                      ||.|||+++||||||||+||||++++++||+|||+|+......  .......||+.|||||++.+..|+.++|||||||+
T Consensus       157 gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvv  236 (308)
T 4gt4_A          157 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV  236 (308)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHH
Confidence            9999999999999999999999999999999999998543322  23345679999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          311 LWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       311 l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +|||+| |..||.+.+..++...+.. ..+++.|..||+++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       237 l~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          237 LWEVFSYGLQPYCGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHTTTCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999998 8999999998888776654 445667889999999999999999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-60  Score=448.31  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=226.8

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ....+.|.+.++||+|+||+||+|++  +|+.||||+++....              ..+|+.++++++|||||++++++
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~~  119 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGAV  119 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEEE
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEEE
Confidence            34457899999999999999999998  689999999975321              23699999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |||||||+||+|.+++.+.  +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus       120 ~~~~~~----------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  181 (336)
T 4g3f_A          120 REGPWV----------------NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV  181 (336)
T ss_dssp             EETTEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGE
T ss_pred             EECCEE----------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence            887766                8999999999999999654  5799999999999999999999999999999999999


Q ss_pred             EEcCCC-cEEEeeccccccccCCCC-----cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          253 LLDKTR-TVKIADFGVARLEASNPH-----DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       253 li~~~~-~vkL~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      ||+.+| .+||+|||+|+.......     .....+||+.|||||++.+.+|+.++|||||||++|||++|..||.+.+.
T Consensus       182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~  261 (336)
T 4g3f_A          182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR  261 (336)
T ss_dssp             EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred             EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence            999887 699999999986543221     12235799999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHHhccCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 015594          327 SEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIP  388 (404)
Q Consensus       327 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~p  388 (404)
                      .++...+...... ..++..+++++.+||.+||+.||.+|||+.||++.|..+....+.-.+|
T Consensus       262 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             SCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             HHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence            7777777665543 2567889999999999999999999999999999999999888755555

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4e-60  Score=450.36  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=220.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|++.+.||+|+||+||+|++  +|+.||||+++......         .+.+.+|+.+|++++|||||+++++|.+..
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5699999999999999999998  68999999997654332         234679999999999999999999999887


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |||||||+||+|.+++.+   ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus       145 ~~----------------~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~  205 (346)
T 4fih_A          145 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH  205 (346)
T ss_dssp             EE----------------EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             EE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence            76                999999999999999864   46999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+...
T Consensus       206 ~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~  285 (346)
T 4fih_A          206 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN  285 (346)
T ss_dssp             TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             CCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence            99999999999987666556667789999999999999999999999999999999999999999999888887776554


Q ss_pred             cC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .. ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       286 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            32 22344578999999999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-59  Score=450.11  Aligned_cols=268  Identities=31%  Similarity=0.576  Sum_probs=231.5

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC-
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-  162 (404)
                      ...|+|+.++|++.+.||+|+||+||+|.+.       ++.||||.++....    .    ...+.|.+|+.+|.+++| 
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~----~----~~~~~~~~E~~il~~l~hh  127 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIHIGHH  127 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHCCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----h----HHHHHHHHHHHHHHHcCCC
Confidence            3469999999999999999999999999873       36799999964322    1    124568899999999965 


Q ss_pred             CceeEEEEEEecCC-ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHH
Q 015594          163 PNVTKFIGATMGTS-ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLA  227 (404)
Q Consensus       163 pniv~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~  227 (404)
                      ||||+++|+|.... .+                |||||||++|+|.++|.+..              ...+++..+..++
T Consensus       128 pnIV~l~g~~~~~~~~~----------------~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  191 (353)
T 4ase_A          128 LNVVNLLGACTKPGGPL----------------MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  191 (353)
T ss_dssp             TTBCCEEEEECCTTSCC----------------EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred             CcEEEEEEEEEecCCEE----------------EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence            89999999986543 34                89999999999999997643              2458999999999


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhH
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVY  305 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  305 (404)
                      .||+.||.|||+++||||||||+||||+.++.+||+|||+|+.......  ......||+.|||||++.+..|+.++|||
T Consensus       192 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw  271 (353)
T 4ase_A          192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  271 (353)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEe
Confidence            9999999999999999999999999999999999999999986543332  22345689999999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          306 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       306 slG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ||||++|||+| |..||.+.+..+.....+....++..|..+++++.+||.+||+.||++|||+.+|++.|+++..+.
T Consensus       272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            99999999998 899999987666666667777788899999999999999999999999999999999999987654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.5e-60  Score=444.14  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=216.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ..+++++|++.+.||+|+||+||+|++     +++.||||+++........       ...+.+|+.++++++|||||++
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l   91 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMERDILVEVNHPFIVKL   91 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-------CC------CCCCCCCCTTEECE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-------HHHHHHHHHHHHHCCCCCCCeE
Confidence            346678999999999999999999986     4688999999764322211       1236789999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+...+                |+|||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++||+|||||
T Consensus        92 ~~~~~~~~~~----------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  153 (304)
T 3ubd_A           92 HYAFQTEGKL----------------YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLK  153 (304)
T ss_dssp             EEEEEETTEE----------------EEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             EEEEEECCEE----------------EEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            9999987766                9999999999999999764  579999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      |+|||++.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+
T Consensus       154 p~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~  233 (304)
T 3ubd_A          154 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE  233 (304)
T ss_dssp             GGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             HHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence            99999999999999999999865555555667889999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      +...+....  ..+|..+|+++.+||.+||+.||++|||     ++||++
T Consensus       234 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          234 TMTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            888887764  3567889999999999999999999998     466664

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.4e-59  Score=430.33  Aligned_cols=247  Identities=28%  Similarity=0.507  Sum_probs=204.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||+++......      ......+.+|+.++++++|||||++++++.+..
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            6899999999999999999997  68999999997543221      223456889999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+ +|+|.+++.+.  +.+++..+..++.||+.||+|||++||+||||||+||||+.
T Consensus        87 ~~----------------~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~  147 (275)
T 3hyh_A           87 EI----------------IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE  147 (275)
T ss_dssp             EE----------------EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred             EE----------------EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC
Confidence            66                9999999 78999999664  67999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++++||+|||+|+.... .......+||+.|||||++.+..| +.++|||||||++|+|++|..||.+.+..++...+..
T Consensus       148 ~~~vkl~DFGla~~~~~-~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~  226 (275)
T 3hyh_A          148 HLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN  226 (275)
T ss_dssp             TCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCEEEeecCCCeecCC-CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            99999999999975433 334456789999999999998876 5899999999999999999999999988888777766


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..  ..+|..+|+++.+||.+||+.||++|||++|+++
T Consensus       227 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          227 GV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            54  3467889999999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.1e-59  Score=452.33  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=221.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...|++.+.||+|+||+||+|++  +|+.||||+++......         +..+.+|+.+|++++|||||+++++|.+.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  220 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVG  220 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---------GGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence            35699999999999999999998  68999999998654332         23467999999999999999999999988


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |||||||+||+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus       221 ~~~----------------~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~  281 (423)
T 4fie_A          221 DEL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT  281 (423)
T ss_dssp             TEE----------------EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred             CEE----------------EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            766                999999999999999854   4699999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+|.|||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+..
T Consensus       282 ~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  361 (423)
T 4fie_A          282 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  361 (423)
T ss_dssp             TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            99999999999998766655666778999999999999999999999999999999999999999999988888777665


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ....+..+++++.+||.+||+.||++|||+.||++
T Consensus       362 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            432 23445678999999999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-58  Score=427.87  Aligned_cols=249  Identities=27%  Similarity=0.481  Sum_probs=208.2

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |++.++||+|+||+||+|.+  +++.||||++......       ...+..|.+|+.++++|+|||||+++++|.+...-
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~  100 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence            47788999999999999998  5889999999754322       12246789999999999999999999998753211


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCCCEEEcC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLDK  256 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~Nili~~  256 (404)
                                  ...+|||||||+||+|.+++.+.  ..+++..+..++.||+.||.|||++|  |+||||||+||||+.
T Consensus       101 ------------~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~  166 (290)
T 3fpq_A          101 ------------KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG  166 (290)
T ss_dssp             ------------EEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS
T ss_pred             ------------CcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC
Confidence                        12238999999999999999664  67999999999999999999999998  999999999999974


Q ss_pred             -CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q 015594          257 -TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE-VTSAVV  334 (404)
Q Consensus       257 -~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~-~~~~~~  334 (404)
                       ++.+||+|||+|+...  .......+||+.|||||++.+. |+.++|||||||++|||+||..||.+.+... +...+.
T Consensus       167 ~~g~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~  243 (290)
T 3fpq_A          167 PTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  243 (290)
T ss_dssp             TTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             CCCCEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence             7899999999997533  2344567899999999999864 9999999999999999999999998765444 444444


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....++.++..+++++.+||.+||+.||++|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            433444566778999999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-56  Score=423.03  Aligned_cols=261  Identities=33%  Similarity=0.491  Sum_probs=207.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      .+|.+.+.||+|+||+||+|+++|+.||||+++...     ..     ...+..|+..+.+++|||||++++++.+....
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-----~~-----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-----HH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh-----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            468999999999999999999999999999996321     11     12234677777889999999999999765421


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC--------CceecccCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--------KIVHRDVKTE  250 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------givH~Dikp~  250 (404)
                                  ...+|||||||++|+|.+++.+   .++++..+..++.|++.||.|||++        +|+||||||+
T Consensus        73 ------------~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~  137 (303)
T 3hmm_A           73 ------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK  137 (303)
T ss_dssp             ------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred             ------------ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence                        1123899999999999999965   3699999999999999999999987        9999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCc----ccCCCCCccccCccccCCC------CCCcchhhHHHHHHHHHHHhCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGS------AYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||||+.++++||+|||+|+........    ....+||+.|||||++.+.      .|+.++|||||||++|||+||..|
T Consensus       138 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~  217 (303)
T 3hmm_A          138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  217 (303)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred             cEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence            999999999999999999865443222    2245799999999999765      367899999999999999999665


Q ss_pred             C----------CCC-----CHHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          321 Y----------PDL-----SFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       321 f----------~~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |          .+.     ...+....+....+++.+|..     ++..+.+||.+||+.||++|||+.+|++.|+++..
T Consensus       218 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            4          222     234444555566677776643     34678999999999999999999999999999987


Q ss_pred             hcCC
Q 015594          381 SKGG  384 (404)
Q Consensus       381 ~~~~  384 (404)
                      +.|.
T Consensus       298 ~~~i  301 (303)
T 3hmm_A          298 QEGI  301 (303)
T ss_dssp             C---
T ss_pred             HcCC
Confidence            7653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-56  Score=415.11  Aligned_cols=259  Identities=23%  Similarity=0.421  Sum_probs=192.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|++  +|+.||||+++....        ...++.+.+|+.+|++|+|||||+++++|.+..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--------ELAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            4699999999999999999998  689999999975432        122456889999999999999999999998665


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .....    ....+..++|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+||||+
T Consensus        77 ~~~~~----~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~  152 (299)
T 4g31_A           77 TTEKL----QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT  152 (299)
T ss_dssp             --------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             ccccc----cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence            43211    112234456999999999999999965422 2345677899999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC------------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          256 KTRTVKIADFGVARLEASNPH------------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      .++.+||+|||+|+.......            ..++.+||+.|||||++.+..|+.++|||||||++|||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            999999999999986443221            2344679999999999999999999999999999999995   7754


Q ss_pred             CCHH-HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          324 LSFS-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       324 ~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .... .....+....+ +..+...++.+.+||.+||+.||.+|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccHHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3211 12222222221 2222334567889999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=422.98  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=212.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++.....       ......+.+|+.+|+.|+|||||++++++....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-------VTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-------hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            6899999999999999999998  6999999999654322       122356789999999999999999999987543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..          ...+.+||||||| +|+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       127 ~~----------~~~~~~~ivmE~~-~g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~  193 (398)
T 4b99_A          127 PY----------GEFKSVYVVLDLM-ESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE  193 (398)
T ss_dssp             CT----------TTCCCEEEEEECC-SEEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred             cc----------ccCCEEEEEEeCC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC
Confidence            22          1234459999999 5789999854  468999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCC----CCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          257 TRTVKIADFGVARLEASN----PHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ++.+||+|||+|+.....    .......+||+.|||||++.+. .|+.++||||+||++|||++|..||.+.+..+.+.
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~  273 (398)
T 4b99_A          194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ  273 (398)
T ss_dssp             TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            999999999999864332    2344567899999999998875 56999999999999999999999999998888777


Q ss_pred             HHHhccCCCC-----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPE-----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+......+.                             ....+++++.+||.+||..||.+|||++|+++
T Consensus       274 ~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          274 LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            6654322111                             11346889999999999999999999999886

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.8e-52  Score=391.19  Aligned_cols=272  Identities=38%  Similarity=0.627  Sum_probs=225.4

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ......+++...+|.+.+.||+|+||+||+|.++|+.||||++......       ......+.+|+.++++++||||++
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~   98 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH-------AERVNEFLREVAIMKRLRHPNIVL   98 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS-------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC-------HHHHHHHHHHHHHHHhCCCCCEee
Confidence            4556678888999999999999999999999999999999999654322       112356789999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCC--cee
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKK--IVH  244 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH  244 (404)
                      +++++.+...+                ++||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||++|  |+|
T Consensus        99 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH  162 (309)
T 3p86_A           99 FMGAVTQPPNL----------------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH  162 (309)
T ss_dssp             EEEEECSTTCC----------------EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred             EEEEEEECCce----------------EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC
Confidence            99999877665                89999999999999996542 134999999999999999999999999  999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      |||||+||||+.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  242 (309)
T 3p86_A          163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL  242 (309)
T ss_dssp             TTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             CCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999986544444445567999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      +..+....+.........+..+++++.+||.+||+.||.+|||+.+|++.|+.+..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            9888877777677777888999999999999999999999999999999999998664

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-52  Score=424.27  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=210.2

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+..++|.+.++||+|+||+||+|++  +|+.||||++++........   .........++.+++.++|||||+++++|
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~---~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---HHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh---HHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            34567999999999999999999998  78999999997432111100   11112223456778888999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ++...+                |+|||||+||+|.++|.+.  +.+++..++.++.||+.||.|||++|||||||||+||
T Consensus       262 ~~~~~l----------------ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI  323 (689)
T 3v5w_A          262 HTPDKL----------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  323 (689)
T ss_dssp             ECSSEE----------------EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             EECCEE----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence            988877                9999999999999999764  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLS---FSE  328 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~---~~~  328 (404)
                      ||+.+|.|||+|||+|+....  ......+||+.|||||++. +..|+.++|||||||++|||++|..||.+.+   ..+
T Consensus       324 Lld~~G~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~  401 (689)
T 3v5w_A          324 LLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE  401 (689)
T ss_dssp             EECTTSCEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred             EEeCCCCEEecccceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            999999999999999986433  2344578999999999996 4579999999999999999999999997643   233


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      +...+...  ...+|..+++++++||.+||+.||.+|++     +++|++
T Consensus       402 i~~~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          402 IDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHhhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            33333333  44578889999999999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-52  Score=421.86  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=219.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||++.....     .    ....+.+|+.+|+.|+|||||+++++|.+.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----S----DKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----H----HHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----h----hHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            36899999999999999999998  789999999965321     1    135578999999999999999999999988


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |||||||+||+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       227 ~~~----------------~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~  289 (573)
T 3uto_A          227 NEM----------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT  289 (573)
T ss_dssp             SEE----------------EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred             CEE----------------EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhcccc
Confidence            776                9999999999999998543 45799999999999999999999999999999999999997


Q ss_pred             CC--CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          256 KT--RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~~--~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      .+  +.+||+|||+|+.... .......+||+.|||||++.+.+|+.++|||||||++|+|++|..||.+.+..+....+
T Consensus       290 ~~~~~~vKl~DFG~a~~~~~-~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i  368 (573)
T 3uto_A          290 TKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV  368 (573)
T ss_dssp             SSSCCCEEECCCSSCEECCT-TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             CCCCCCEEEeeccceeEccC-CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            54  8999999999986543 34445678999999999999999999999999999999999999999999999888888


Q ss_pred             HhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+..  ..+..+++++.+||.+||+.||.+|||+.|+++
T Consensus       369 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7765443  344678999999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-52  Score=398.15  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGAT  172 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  172 (404)
                      ++|++.+.||+|+||+||+|++     +++.||||.+.....           ..++.+|+.+++.+ +|||||+++++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            6799999999999999999986     368899999854321           13467899999998 699999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+|||||+||+|.+++     +.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        90 ~~~~~~----------------~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi  148 (361)
T 4f9c_A           90 RKNDHV----------------VIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF  148 (361)
T ss_dssp             EETTEE----------------EEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EECCEE----------------EEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence            887766                9999999999999988     3589999999999999999999999999999999999


Q ss_pred             EEcCC-CcEEEeeccccccccCCC----------------------------CcccCCCCCccccCccccCCC-CCCcch
Q 015594          253 LLDKT-RTVKIADFGVARLEASNP----------------------------HDMTGETGTLGYMAPEVLNGS-AYNRKC  302 (404)
Q Consensus       253 li~~~-~~vkL~Dfg~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~  302 (404)
                      ||+.+ +.+||+|||+|+......                            ...+..+||+.|||||++.+. .|+.++
T Consensus       149 Ll~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~  228 (361)
T 4f9c_A          149 LYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAI  228 (361)
T ss_dssp             EEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHH
T ss_pred             EEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCcc
Confidence            99876 899999999997533221                            122345799999999999876 489999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc---------------------------------------------
Q 015594          303 DVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQ---------------------------------------------  336 (404)
Q Consensus       303 DvwslG~il~el~~g~~Pf~~~-~~~~~~~~~~~~---------------------------------------------  336 (404)
                      ||||+||++|||++|..||... +..+.+..+...                                             
T Consensus       229 DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~  308 (361)
T 4f9c_A          229 DMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKL  308 (361)
T ss_dssp             HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------
T ss_pred             chhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccc
Confidence            9999999999999999999543 332222222110                                             


Q ss_pred             -------cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 -------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                             ....+....+++++.+||.+||+.||.+|||++|+++
T Consensus       309 ~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          309 TSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   0001123457899999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=385.79  Aligned_cols=266  Identities=27%  Similarity=0.536  Sum_probs=225.5

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ...++...+|.+.+.||+|+||+||+|.+     .+..||||+++....        ......+.+|+.++++++||||+
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv  113 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--------ERQRRDFLSEASIMGQFDHPNII  113 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--------HHHHHHHHHHHHHHHhCCCCCCC
Confidence            34567789999999999999999999997     234699999964321        12245688999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.+....                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus       114 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D  176 (325)
T 3kul_A          114 RLEGVVTRGRLA----------------MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD  176 (325)
T ss_dssp             CEEEEECGGGCC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             cEEEEEEeCCcc----------------EEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence            999999776655                8999999999999998543 45799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYP  322 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~  322 (404)
                      |||+||||+.++.+||+|||+++.......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999999999986543322   2233456788999999998889999999999999999999 999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ..+..+....+.. ......+..+++++.+||.+||+.||.+|||+.+|++.|+.+.....
T Consensus       257 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          257 NMTNRDVISSVEE-GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             cCCHHHHHHHHHc-CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            9988887766554 45566778899999999999999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.6e-50  Score=396.58  Aligned_cols=269  Identities=32%  Similarity=0.542  Sum_probs=227.5

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEEC-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ....|++..++|.+.+.||+|+||.||+|.+. +..||||+++.....          ...|.+|+.++++++||||+++
T Consensus       175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hp~iv~~  244 (452)
T 1fmk_A          175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQL  244 (452)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----------HHHHHHHHHHHHhCCCCCEeeE
Confidence            35679999999999999999999999999985 467999999754321          2457899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+ ...                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus       245 ~~~~~~-~~~----------------~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk  307 (452)
T 1fmk_A          245 YAVVSE-EPI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  307 (452)
T ss_dssp             EEEECS-SSC----------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEcC-Cce----------------EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            999865 333                899999999999999976555679999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      |+||||+.++.+||+|||+++...... ....+..+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+.
T Consensus       308 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~  387 (452)
T 1fmk_A          308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN  387 (452)
T ss_dssp             GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             hhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998544322 22234457889999999998889999999999999999999 9999999988


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                      .+....+. ...+...+..+|+.+.+||.+||+.||++|||+++|++.|+.+.++.....
T Consensus       388 ~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          388 REVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             HHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence            88776654 455667788899999999999999999999999999999999987765443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-49  Score=396.10  Aligned_cols=266  Identities=31%  Similarity=0.578  Sum_probs=230.9

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ....|++..++|.+.+.||+|+||+||+|.+ ++..||||+++.....          .+.|.+|+.++++++||||+++
T Consensus       179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~l  248 (454)
T 1qcf_A          179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----------VEAFLAEANVMKTLQHDKLVKL  248 (454)
T ss_dssp             CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHTTCCCTTBCCE
T ss_pred             cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----------HHHHHHHHHHHhhCCCCCEeeE
Confidence            3567999999999999999999999999998 4788999999754321          3458899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.. ..+                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus       249 ~~~~~~-~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk  311 (454)
T 1qcf_A          249 HAVVTK-EPI----------------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR  311 (454)
T ss_dssp             EEEECS-SSC----------------EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred             EEEEeC-Ccc----------------EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence            999863 233                899999999999999976545578999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      |+||||+.++.+||+|||+++...... ....+..+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+.
T Consensus       312 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~  391 (454)
T 1qcf_A          312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  391 (454)
T ss_dssp             GGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             HHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998643321 11234456789999999998889999999999999999999 9999999998


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .+....+.. ..+...+..+|+++.+||.+||+.||++|||+++|++.|+.+.+...
T Consensus       392 ~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          392 PEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            887766554 45666788899999999999999999999999999999999887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-49  Score=385.26  Aligned_cols=266  Identities=32%  Similarity=0.596  Sum_probs=228.0

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE---------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-C
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY---------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-D  161 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  161 (404)
                      ..|++..++|.+.+.||+|+||.||+|.+         ++..||||+++...    ..    .....+.+|+.+++++ +
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~~  145 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TE----KDLSDLVSEMEMMKMIGK  145 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BH----HHHHHHHHHHHHHHHSCC
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CH----HHHHHHHHHHHHHHHhcC
Confidence            35677889999999999999999999986         23579999996432    11    2245688999999999 8


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHH
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLA  227 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~  227 (404)
                      ||||+++++++.....+                |+||||+++|+|.+++....              ...+++..++.++
T Consensus       146 hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  209 (370)
T 2psq_A          146 HKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT  209 (370)
T ss_dssp             CTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred             CCCEeeEEEEEccCCCE----------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence            99999999999877665                89999999999999997653              2358999999999


Q ss_pred             HHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhH
Q 015594          228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVY  305 (404)
Q Consensus       228 ~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  305 (404)
                      .||+.||.|||++||+||||||+||||+.++.+||+|||+++......  .......+|+.|+|||++.+..++.++|||
T Consensus       210 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw  289 (370)
T 2psq_A          210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW  289 (370)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHH
Confidence            999999999999999999999999999999999999999998544332  222345578899999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          306 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       306 slG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      |||+++|||++ |..||.+.+..+....+ ....++..+..+++++.+||.+||+.||.+||++.+|++.|+++.+..
T Consensus       290 slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          290 SFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            99999999999 99999998887776554 444566778889999999999999999999999999999999988654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-49  Score=386.31  Aligned_cols=267  Identities=32%  Similarity=0.595  Sum_probs=229.1

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .....|.+..++|.+.+.||+|+||.||+|.+  +++.||||+++....        ......|.+|+.++++++||||+
T Consensus       104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv  175 (377)
T 3cbl_A          104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIV  175 (377)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--------HHHHTTTTHHHHHHTTCCCTTBC
T ss_pred             ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--------HHHHHHHHHHHHHHHhCCCCCEE
Confidence            34567899999999999999999999999998  589999999864311        12245678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.....+                |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus       176 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrD  238 (377)
T 3cbl_A          176 RLIGVCTQKQPI----------------YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRD  238 (377)
T ss_dssp             CEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             EEEEEEecCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcc
Confidence            999999877665                8999999999999999654 35699999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCccc--CCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMT--GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      |||+||||+.++.+||+|||+++..........  ...+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999975433221111  1235778999999998889999999999999999998 9999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+..+....+ ....+...+..+|+++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       319 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          319 LSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             SCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            9887765554 44556677888999999999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-49  Score=366.25  Aligned_cols=262  Identities=26%  Similarity=0.445  Sum_probs=229.8

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+.+..++|.+.+.||+|+||+||+|.++++.||||++.......       .....+.+|+.++++++||||+++++++
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST-------RKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCH-------HHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCH-------HHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            456778899999999999999999999999999999997643221       1235688999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCC
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTE  250 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~  250 (404)
                      .+...-              ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++|  ++||||||+
T Consensus        77 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~  142 (271)
T 3kmu_A           77 QSPPAP--------------HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR  142 (271)
T ss_dssp             CTTTSS--------------SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGG
T ss_pred             ccCCCC--------------CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccc
Confidence            776322              2289999999999999997765557999999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNR---KCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ||+++.++.++|+|||++...     ......||+.|+|||.+.+..++.   ++||||||+++|+|++|..||...+..
T Consensus       143 Nil~~~~~~~~l~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  217 (271)
T 3kmu_A          143 SVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM  217 (271)
T ss_dssp             GEEECTTSCEEEEGGGSCCTT-----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred             eEEEcCCcceeEEeccceeee-----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence            999999999999999987542     223456899999999998765554   799999999999999999999999988


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      +....+......+..+..+++++.++|.+||+.||++|||++++++.|+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            88888888888888899999999999999999999999999999999998853

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.1e-49  Score=377.97  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=220.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|.+.+.||+|+||.||++.+  +|+.||||+++...      .........+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~   75 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH------hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence            3457899999999999999999998  68999999996321      111112345778999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        76 ~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  137 (337)
T 1o6l_A           76 THDRL----------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  137 (337)
T ss_dssp             CSSEE----------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             eCCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence            87766                8999999999999998654  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      |+.++.+||+|||+++............+||+.|+|||++.+..++.++||||||+++|||++|..||...+..+....+
T Consensus       138 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i  217 (337)
T 1o6l_A          138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999999986444445556678999999999999999999999999999999999999999998888877777


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .....  .+|..+++++.+||.+||+.||.+||     ++++|++
T Consensus       218 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            66543  46778999999999999999999999     8999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-49  Score=375.58  Aligned_cols=248  Identities=27%  Similarity=0.488  Sum_probs=219.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|.+  +|+.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            46899999999999999999997  7899999999754322       12245678999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        87 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~  148 (328)
T 3fe3_A           87 KTL----------------YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD  148 (328)
T ss_dssp             SEE----------------EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CEE----------------EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc
Confidence            665                8999999999999999665  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++..... .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+..+....+.
T Consensus       149 ~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  227 (328)
T 3fe3_A          149 ADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL  227 (328)
T ss_dssp             TTSCEEECSTTCCGGGSS-SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEeeccCceecCC-CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999975443 3345567899999999999888765 89999999999999999999999999888888777


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....  .+|..+++++.+||.+||+.||.+|||++++++
T Consensus       228 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          228 RGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             hCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            7654  466778999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.3e-49  Score=371.41  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=217.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +|+.||||++.......         ...+.+|+.++++++||||+++++++...
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---------HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            36799999999999999999986  78999999997544322         24477899999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        90 ~~~----------------~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~  150 (297)
T 3fxz_A           90 DEL----------------WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG  150 (297)
T ss_dssp             TEE----------------EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CEE----------------EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence            665                8999999999999998653   699999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  230 (297)
T 3fxz_A          151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT  230 (297)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999998666555555667899999999999999999999999999999999999999998887766555544


Q ss_pred             ccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            332 34456778999999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.9e-49  Score=392.94  Aligned_cols=261  Identities=31%  Similarity=0.602  Sum_probs=228.3

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...|++..++|.+.+.||+|+||.||+|.+.|+.||||+++...           ..+.|.+|+.++++++||||+++++
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  253 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLG  253 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----------TSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----------HHHHHHHHHHHHHhccCCCEEEEEE
Confidence            56799999999999999999999999999999999999996432           1345789999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.....               .+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus       254 ~~~~~~~---------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  318 (450)
T 1k9a_A          254 VIVEEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  318 (450)
T ss_dssp             EEECTTS---------------CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEcCCC---------------ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            9865542               1289999999999999997765556899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      ||||+.++.+||+|||+++.....   .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+.
T Consensus       319 Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  395 (450)
T 1k9a_A          319 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  395 (450)
T ss_dssp             GEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred             hEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999999743322   222357889999999999999999999999999999998 9999999888777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ...+. ...+...+..+|+++.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       396 ~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          396 VPRVE-KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            66544 4566778889999999999999999999999999999999998765

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=382.16  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=213.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  172 (404)
                      +..++|.+.+.||+|+||+||++.+  +|+.||||+++..      ..........+.+|..++..+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~------~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD------VILQDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH------HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            5568999999999999999999998  6899999999632      111122345577899999988 799999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        94 ~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  155 (353)
T 3txo_A           94 QTPDRL----------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV  155 (353)
T ss_dssp             ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             EeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHE
Confidence            887766                8999999999999999664  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ||+.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus       156 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  235 (353)
T 3txo_A          156 LLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  235 (353)
T ss_dssp             EECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998644444555667899999999999998999999999999999999999999999999888888


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM------DEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~ll~  373 (404)
                      +.....  .+|..+++++.+||.+||+.||.+||++      ++|++
T Consensus       236 i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          236 ILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            877644  4567789999999999999999999998      67764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-49  Score=364.49  Aligned_cols=262  Identities=31%  Similarity=0.644  Sum_probs=227.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ..|.++.++|.+.+.||+|+||+||++.+ +++.||||++......          ...+.+|+.++++++||||+++++
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~   72 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYG   72 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence            45889999999999999999999999998 7888999999754322          134789999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+....                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        73 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~  135 (269)
T 4hcu_A           73 VCLEQAPI----------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR  135 (269)
T ss_dssp             EECSSSSE----------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             EEecCCce----------------EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchh
Confidence            99876655                8999999999999998554 457999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      ||+++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus       136 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~  215 (269)
T 4hcu_A          136 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  215 (269)
T ss_dssp             GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             eEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999999999997543221 22334557889999999998889999999999999999999 999999988887


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ....+.. ......+..+++++.++|.+||+.||.+||++.++++.|+++..+
T Consensus       216 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          216 VVEDIST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhc-CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            7666544 455666778899999999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=379.65  Aligned_cols=274  Identities=31%  Similarity=0.556  Sum_probs=233.6

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK  159 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  159 (404)
                      .....|++..++|.+.+.||+|+||+||+|.+.         +..||||+++....        ......+.+|+.++++
T Consensus        59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~  130 (382)
T 3tt0_A           59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--------EKDLSDLISEMEMMKM  130 (382)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHH
T ss_pred             ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--------HHHHHHHHHHHHHHHH
Confidence            344568899999999999999999999999862         25799999964321        1224567899999999


Q ss_pred             c-CCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHH
Q 015594          160 L-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVI  224 (404)
Q Consensus       160 l-~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~  224 (404)
                      + +||||+++++++......                |+||||+++|+|.+++....              ...+++..++
T Consensus       131 l~~hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  194 (382)
T 3tt0_A          131 IGKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  194 (382)
T ss_dssp             HCCCTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred             hcCCchhhhheeeeccCCce----------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence            9 999999999999877665                89999999999999997653              2459999999


Q ss_pred             HHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcch
Q 015594          225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKC  302 (404)
Q Consensus       225 ~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  302 (404)
                      .++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......  .......+|+.|+|||++.+..++.++
T Consensus       195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  274 (382)
T 3tt0_A          195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  274 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence            999999999999999999999999999999999999999999998544322  223345678899999999999999999


Q ss_pred             hhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          303 DVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       303 DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ||||||+++|+|++ |..||...+..+....+ ........+..+++++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            99999999999999 99999998887766554 44556677888999999999999999999999999999999999887


Q ss_pred             cCCCCC
Q 015594          382 KGGGMI  387 (404)
Q Consensus       382 ~~~~~~  387 (404)
                      ......
T Consensus       354 ~~~~~~  359 (382)
T 3tt0_A          354 TSNQEM  359 (382)
T ss_dssp             SCSCC-
T ss_pred             HhcCCC
Confidence            754433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-49  Score=399.55  Aligned_cols=269  Identities=32%  Similarity=0.542  Sum_probs=231.9

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEEC-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ....|++..++|.+.+.||+|+||.||+|.+. +..||||+++.....          ...|.+|+.+|++++||||+++
T Consensus       258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~  327 (535)
T 2h8h_A          258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQL  327 (535)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----------HHHHHHHHHHHHhCCCCCEeeE
Confidence            35679999999999999999999999999985 468999999754321          2457899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+ ..+                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus       328 ~~~~~~-~~~----------------~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk  390 (535)
T 2h8h_A          328 YAVVSE-EPI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  390 (535)
T ss_dssp             EEEECS-SSC----------------EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEee-ccc----------------eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            999865 333                899999999999999976545679999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      |+||||+.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus       391 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~  470 (535)
T 2h8h_A          391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN  470 (535)
T ss_dssp             GGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred             HhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997543221 11233456789999999998889999999999999999999 9999999988


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                      .+....+. ...+...+..+++++.+||.+||+.||++|||+++|++.|+.+.++.....
T Consensus       471 ~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  529 (535)
T 2h8h_A          471 REVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  529 (535)
T ss_dssp             HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence            88776654 455666788899999999999999999999999999999999987665443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.6e-49  Score=365.75  Aligned_cols=266  Identities=28%  Similarity=0.568  Sum_probs=225.4

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ......|++..++|.+.+.||+|+||+||++.+ ++..||||++......          ...+.+|+.++.+++||||+
T Consensus        13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~   82 (283)
T 3gen_A           13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLV   82 (283)
T ss_dssp             ---CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBC
T ss_pred             CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEe
Confidence            344568899999999999999999999999998 4568999999754322          13477999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.+....                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus        83 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d  145 (283)
T 3gen_A           83 QLYGVCTKQRPI----------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD  145 (283)
T ss_dssp             CEEEEECSSSSE----------------EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred             eEEEEEecCCCe----------------EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence            999999776655                8999999999999999653 45799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      |||+||+++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       146 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             CSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999997543221 22334557889999999998889999999999999999998 99999998


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +..+....+. .......+..+++.+.+||.+||+.||.+|||+.++++.|+++...
T Consensus       226 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          226 TNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ChhHHHHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            8877766554 4455666788899999999999999999999999999999998754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.2e-49  Score=379.95  Aligned_cols=269  Identities=31%  Similarity=0.564  Sum_probs=229.6

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-C
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-D  161 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  161 (404)
                      ....|++..++|.+.+.||+|+||.||+|.+       +++.||||+++....        ......+.+|+.++.++ +
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~   84 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGH   84 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--------HHHHHHHHHHHHHHHhhcC
Confidence            3457889999999999999999999999984       458899999964321        11235688999999999 8


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------------------
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------------------  215 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------------------  215 (404)
                      ||||+++++++.+....               .++||||+++|+|.+++.....                          
T Consensus        85 hpniv~~~~~~~~~~~~---------------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (359)
T 3vhe_A           85 HLNVVNLLGACTKPGGP---------------LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL  149 (359)
T ss_dssp             CTTBCCEEEEECSTTSC---------------CEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------
T ss_pred             CcceeeeeeeeecCCCc---------------eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhh
Confidence            99999999998765441               2899999999999999966432                          


Q ss_pred             --------------------------------------CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          216 --------------------------------------RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       216 --------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                                                            ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~  229 (359)
T 3vhe_A          150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  229 (359)
T ss_dssp             ----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             hccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence                                                  128999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~  334 (404)
                      +.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+......
T Consensus       230 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  309 (359)
T 3vhe_A          230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  309 (359)
T ss_dssp             GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH
Confidence            9999999999975433222  2334568899999999998899999999999999999998 999999887766666667


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ........+..+++++.++|.+||+.||.+|||+.+|++.|+.+..+
T Consensus       310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            77777778888999999999999999999999999999999998865

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.5e-49  Score=362.63  Aligned_cols=258  Identities=32%  Similarity=0.656  Sum_probs=215.9

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +++.++|.+.+.||+|+||+||+|.+.|+.||||++......     ........+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            467789999999999999999999999999999998643221     112224567899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC---ceecccCCCC
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK---IVHRDVKTEN  251 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---ivH~Dikp~N  251 (404)
                      ....                ++||||+++++|.+++.   ...+++..++.++.||+.||.|||++|   |+||||||+|
T Consensus        78 ~~~~----------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N  138 (271)
T 3dtc_A           78 EPNL----------------CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN  138 (271)
T ss_dssp             C--C----------------EEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred             CCce----------------EEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence            7665                89999999999999883   357999999999999999999999999   8999999999


Q ss_pred             EEEcC--------CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          252 MLLDK--------TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       252 ili~~--------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      |+++.        ++.+||+|||++......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus       139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          139 ILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             EEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             EEEecccccccccCcceEEccCCcccccccc--cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99985        778999999999754332  22345789999999999998899999999999999999999999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .+.................+..+++.+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             SCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            9888888787777777888899999999999999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-48  Score=381.47  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      ..+..++|.+.++||+|+||.||++++  +++.||||+++.......      .....+.+|..++.++ +||||+++++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~------~~~~~~~~E~~il~~~~~hp~Iv~l~~  120 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD------EDIDWVQTEKHVFEQASNHPFLVGLHS  120 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH------HHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence            345678999999999999999999998  688999999975432211      1123466889998887 8999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||+++|+|..++.+.  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       121 ~~~~~~~~----------------~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~  182 (396)
T 4dc2_A          121 CFQTESRL----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD  182 (396)
T ss_dssp             EEECSSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred             EEEECCEE----------------EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH
Confidence            99887766                8999999999999998664  57999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS-----  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~-----  325 (404)
                      ||||+.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||....     
T Consensus       183 NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~  262 (396)
T 4dc2_A          183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP  262 (396)
T ss_dssp             GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----
T ss_pred             HEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc
Confidence            999999999999999999864445555667889999999999999999999999999999999999999996432     


Q ss_pred             ----HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          326 ----FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       326 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                          .......+...  ...+|..+++++.+||.+||+.||.+||++
T Consensus       263 ~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          263 DQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             chhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                22233333333  345778899999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-48  Score=367.52  Aligned_cols=269  Identities=30%  Similarity=0.567  Sum_probs=232.5

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|++...+|.+.+.||+|+||.||+|.+       +++.||||++.....        ......+.+|+.+++++ +|
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h   86 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGNH   86 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--------HHHHHHHHHHHHHHhhcccC
Confidence            456888899999999999999999999985       468999999964321        11245688999999999 99


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc----------------CCCcHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----------------RKLAFKVVIQL  226 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i  226 (404)
                      |||+++++++......                ++||||+++|+|.+++.....                ..+++..++.+
T Consensus        87 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (313)
T 1t46_A           87 MNIVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF  150 (313)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred             CCeeeEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence            9999999999877655                899999999999999976532                24899999999


Q ss_pred             HHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhh
Q 015594          227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDV  304 (404)
Q Consensus       227 ~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  304 (404)
                      +.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ......+|+.|+|||.+.+..++.++||
T Consensus       151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  230 (313)
T 1t46_A          151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  230 (313)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence            99999999999999999999999999999999999999999975443322  1223456889999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          305 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       305 wslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||||+++|+|++ |..||.....................+..+++++.+||.+||+.||.+|||+.+|++.|+++....+
T Consensus       231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            999999999998 9999998877666666677777777788899999999999999999999999999999999988765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-48  Score=371.38  Aligned_cols=268  Identities=32%  Similarity=0.572  Sum_probs=227.9

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE---------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY---------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-  160 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  160 (404)
                      ...|++..++|.+.+.||+|+||.||+|.+         +++.||||++.....        ......+.+|+.+++++ 
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--------HHHHHHHHHHHHHHHHHC
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--------HHHHHHHHHHHHHHHHhh
Confidence            356788889999999999999999999986         356899999864321        12245678999999999 


Q ss_pred             CCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------CCCcHHHHHHH
Q 015594          161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------RKLAFKVVIQL  226 (404)
Q Consensus       161 ~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i  226 (404)
                      +||||+++++++.....+                |+||||+++++|.+++.....              ..+++..++.+
T Consensus        99 ~hp~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  162 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC  162 (334)
T ss_dssp             CCTTBCCEEEEECSSSCC----------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHH
T ss_pred             cCCCEeeEEEEEccCCce----------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHH
Confidence            999999999999876655                899999999999999976431              34899999999


Q ss_pred             HHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhh
Q 015594          227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDV  304 (404)
Q Consensus       227 ~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  304 (404)
                      +.||+.||.|||++||+||||||+||+|+.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||
T Consensus       163 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  242 (334)
T 2pvf_A          163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV  242 (334)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHH
Confidence            99999999999999999999999999999999999999999975443321  2233457889999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          305 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       305 wslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||||+++|+|++ |..||...+..+....+.. ......+..+++++.+||.+||+.||.+||++.+|++.|+++.+...
T Consensus       243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            999999999999 9999999888777655544 44556778899999999999999999999999999999999987655

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=382.85  Aligned_cols=251  Identities=21%  Similarity=0.336  Sum_probs=219.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||++.+  +|+.||+|++......       ......+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   82 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-------ARDHQKLEREARICRLLKHPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-------HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence            36799999999999999999987  7899999999754321       11245678999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        83 ~~~----------------~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~  144 (444)
T 3soa_A           83 GHH----------------YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA  144 (444)
T ss_dssp             SEE----------------EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred             CEE----------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence            666                8999999999999998664  5799999999999999999999999999999999999997


Q ss_pred             ---CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 ---KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                         .++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus       145 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~  224 (444)
T 3soa_A          145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ  224 (444)
T ss_dssp             BSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence               46789999999998666555556677899999999999999999999999999999999999999999998888888


Q ss_pred             HHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....+....  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       225 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            7776654433  3578999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-49  Score=376.48  Aligned_cols=270  Identities=29%  Similarity=0.521  Sum_probs=227.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|++..++|.+.+.||+|+||+||+|.+       +++.||||++.....        ......+.+|+.++.++ +|
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h  108 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSH  108 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCC
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--------HHHHHHHHHHHHHHHhhcCC
Confidence            346889999999999999999999999986       356899999964321        12245688999999999 99


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc---------------------CCCcHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---------------------RKLAFK  221 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~  221 (404)
                      |||+++++++......                |+||||+++|+|.+++.....                     ..+++.
T Consensus       109 p~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  172 (344)
T 1rjb_A          109 ENIVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE  172 (344)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred             CCeeeEEEEEeeCCcc----------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHH
Confidence            9999999999876655                899999999999999966432                     247999


Q ss_pred             HHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCC
Q 015594          222 VVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYN  299 (404)
Q Consensus       222 ~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  299 (404)
                      .++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........  ......+|+.|+|||++.+..++
T Consensus       173 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  252 (344)
T 1rjb_A          173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  252 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence            9999999999999999999999999999999999999999999999975443322  12234578899999999888899


Q ss_pred             cchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          300 RKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       300 ~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      .++||||||+++|+|++ |..||...+.................+..+++++.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       253 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            99999999999999998 99999988777766777777777788888999999999999999999999999999999998


Q ss_pred             HhhcCC
Q 015594          379 DTSKGG  384 (404)
Q Consensus       379 ~~~~~~  384 (404)
                      ......
T Consensus       333 ~~~~~~  338 (344)
T 1rjb_A          333 LADAEE  338 (344)
T ss_dssp             C-----
T ss_pred             HHHHHH
Confidence            876543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.3e-49  Score=375.64  Aligned_cols=270  Identities=27%  Similarity=0.440  Sum_probs=218.8

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ..+...+.+...+|++.+.||+|+||+||+|.+.++.||||++....          .....+.+|+.++++++||||++
T Consensus        13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~   82 (322)
T 3soc_A           13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD----------KQSWQNEYEVYSLPGMKHENILQ   82 (322)
T ss_dssp             -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG----------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc----------hHHHHHHHHHHHHhcCCCCCchh
Confidence            44556788899999999999999999999999999999999996421          11233456999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-------
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-------  240 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------  240 (404)
                      +++++......            ...+|+||||+++|+|.+++...   .+++..++.++.||+.||.|||+.       
T Consensus        83 ~~~~~~~~~~~------------~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~  147 (322)
T 3soc_A           83 FIGAEKRGTSV------------DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDG  147 (322)
T ss_dssp             EEEEEEEECSS------------SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred             hcceeccCCCC------------CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence            99999865432            12238999999999999999653   599999999999999999999999       


Q ss_pred             ---CceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCC-----CCCcchhhHHHHHH
Q 015594          241 ---KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGS-----AYNRKCDVYSFGIC  310 (404)
Q Consensus       241 ---givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~i  310 (404)
                         ||+||||||+||||+.++.+||+|||+++.......  ......||+.|+|||++.+.     .++.++||||||++
T Consensus       148 ~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i  227 (322)
T 3soc_A          148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV  227 (322)
T ss_dssp             EECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence               999999999999999999999999999975443322  23446799999999999873     45678899999999


Q ss_pred             HHHHHhCCCCCCCC----------------CHHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          311 LWEIYCCDMPYPDL----------------SFSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       311 l~el~~g~~Pf~~~----------------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      +|+|++|..||...                ...+....+......+..+.     .+++++.+||.+||+.||++|||+.
T Consensus       228 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (322)
T 3soc_A          228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG  307 (322)
T ss_dssp             HHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence            99999999999653                22233333333344443332     2345699999999999999999999


Q ss_pred             HHHHHHHHhHhhc
Q 015594          370 EVVAMLEAIDTSK  382 (404)
Q Consensus       370 ~ll~~L~~~~~~~  382 (404)
                      +|++.|+.+....
T Consensus       308 ell~~L~~l~~~~  320 (322)
T 3soc_A          308 CVGERITQMQRLT  320 (322)
T ss_dssp             HHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3e-48  Score=369.84  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=209.8

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ...+..++|.+.+.||+|+||.||++.+     +|+.||||+++......     .......+.+|+.+++.++||||++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~   85 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEVKHPFIVD   85 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCC
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHHhCCCCCccc
Confidence            4456778999999999999999999986     68899999997542211     1122345678999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.....+                |+||||+++++|.+++.+.  ..+++..++.++.||+.||.|||++||+||||
T Consensus        86 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dl  147 (327)
T 3a62_A           86 LIYAFQTGGKL----------------YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDL  147 (327)
T ss_dssp             EEEEEECSSCE----------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             eeEEEEcCCEE----------------EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccC
Confidence            99999877665                8999999999999999654  57899999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      ||+||||+.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus       148 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  227 (327)
T 3a62_A          148 KPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK  227 (327)
T ss_dssp             CTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999999999975444444445567999999999999999999999999999999999999999998888


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      +....+....  ..++..+++++.+||.+||+.||.+||     ++.++++
T Consensus       228 ~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          228 KTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            8777776654  346678899999999999999999999     7778765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-48  Score=378.76  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=210.4

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHH-HhhcCCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAV-WHKLDHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~  172 (404)
                      +..++|.+.+.||+|+||.||++++  +++.||||+++........      ....+.+|..+ ++.++||||+++++++
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~------~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK------EEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH------HHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            4568999999999999999999998  5789999999765332111      12335566666 5778999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       109 ~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  170 (373)
T 2r5t_A          109 QTADKL----------------YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  170 (373)
T ss_dssp             ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             EeCCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            887766                8999999999999999664  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ||+.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus       171 ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  250 (373)
T 2r5t_A          171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN  250 (373)
T ss_dssp             EECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH
T ss_pred             EECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            99999999999999998655445555667899999999999999999999999999999999999999999988888888


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      +.....  .++..+++++.+||.+||+.||.+||++.+
T Consensus       251 i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          251 ILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            776543  466788999999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-48  Score=373.90  Aligned_cols=267  Identities=29%  Similarity=0.499  Sum_probs=226.4

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEECC-------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDG-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      ..+++..++|.+.+.||+|+||.||+|.+.+       +.||||+++....        ......+.+|+.++++++|||
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~  111 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN  111 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCC
Confidence            4567888999999999999999999999843       8899999964321        123456889999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------------cCCCcHHH
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------RRKLAFKV  222 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~  222 (404)
                      |+++++++.+....                |+||||+++++|.+++....                      ...+++..
T Consensus       112 iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  175 (343)
T 1luf_A          112 IVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE  175 (343)
T ss_dssp             BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred             EEEEEEEEccCCce----------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHH
Confidence            99999999876655                89999999999999997642                      15799999


Q ss_pred             HHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCc
Q 015594          223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNR  300 (404)
Q Consensus       223 ~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  300 (404)
                      ++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......  .......+|+.|+|||++.+..++.
T Consensus       176 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  255 (343)
T 1luf_A          176 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT  255 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc
Confidence            99999999999999999999999999999999999999999999997543221  2233456789999999999888999


Q ss_pred             chhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          301 KCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       301 ~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ++||||||+++|+|++ |..||...+..+....+... .....+..+++++.+||.+||+.||.+||++.+|++.|+++.
T Consensus       256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            9999999999999999 99999999887776665544 345567889999999999999999999999999999999988


Q ss_pred             hhcC
Q 015594          380 TSKG  383 (404)
Q Consensus       380 ~~~~  383 (404)
                      ....
T Consensus       335 ~~~~  338 (343)
T 1luf_A          335 ERAE  338 (343)
T ss_dssp             C---
T ss_pred             hhhh
Confidence            6654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-48  Score=392.24  Aligned_cols=264  Identities=29%  Similarity=0.594  Sum_probs=231.7

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEEC--CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD--GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ....|++...+|.+.+.||+|+||.||+|.+.  +..||||+++.....          ...|.+|+.++++++||||++
T Consensus       211 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~  280 (495)
T 1opk_A          211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQ  280 (495)
T ss_dssp             SSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----------hHHHHHHHHHHHhcCCCCEee
Confidence            35679999999999999999999999999984  789999999654321          345789999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.....+                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||
T Consensus       281 l~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl  344 (495)
T 1opk_A          281 LLGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL  344 (495)
T ss_dssp             EEEEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             EEEEEecCCcE----------------EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999877665                89999999999999998766677999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      ||+||||+.++.+||+|||+++...... ....+..+++.|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus       345 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             SGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999998644322 22234456789999999998889999999999999999999 999999988


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ..+.... +....+...+..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       425 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          425 LSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             GGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            8776654 44566777888999999999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.9e-48  Score=358.96  Aligned_cols=261  Identities=30%  Similarity=0.570  Sum_probs=224.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      .+++..++|.+.+.||+|+||+||++.+ ++..||||++......          ...+.+|+.++.+++||||++++++
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~   71 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGV   71 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4677889999999999999999999998 4568999999754322          2347899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+....                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        72 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  134 (268)
T 3sxs_A           72 CSKEYPI----------------YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN  134 (268)
T ss_dssp             ECSSSSE----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGG
T ss_pred             EccCCce----------------EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcce
Confidence            9776655                8999999999999999664 3569999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      |+++.++.+||+|||++....... ....+..+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus       135 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  214 (268)
T 3sxs_A          135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV  214 (268)
T ss_dssp             EEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence            999999999999999997544332 22334556788999999998889999999999999999999 9999999888777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ...+.. ......+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       215 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          215 VLKVSQ-GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHHT-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHc-CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            655543 445556777899999999999999999999999999999988643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.8e-48  Score=365.47  Aligned_cols=266  Identities=26%  Similarity=0.495  Sum_probs=216.0

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .++...+|++.+.||+|+||+||++.+      +++.||||++....         ......+.+|+.++++++||||++
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~   75 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------EEHLRDFEREIEILKSLQHDNIVK   75 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEee
Confidence            346678999999999999999999984      67899999986322         122456889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.......              +++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus        76 ~~~~~~~~~~~~--------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di  140 (295)
T 3ugc_A           76 YKGVCYSAGRRN--------------LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL  140 (295)
T ss_dssp             EEEEECHHHHTS--------------CEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEEecCCCCc--------------eEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence            999986543321              28999999999999999665 346999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      ||+|||++.++.+||+|||++........   ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            99999999999999999999986443321   222345778899999999999999999999999999999999988643


Q ss_pred             CHHH---------------HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          325 SFSE---------------VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       325 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ....               ..........+...+..+++++.+||.+||+.||++|||+.+|++.|+.+....+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          221 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            2110               1122334455666788899999999999999999999999999999999987664

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=370.39  Aligned_cols=263  Identities=32%  Similarity=0.525  Sum_probs=217.4

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+..++|.+.+.||+|+||+||++.+  +++.||+|++....         ......+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   76 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---------EETQRTFLKEVKVMRCLEHPNVLKFIGVL   76 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence            35678999999999999999999998  58999999884321         12346688999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+....                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus        77 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  139 (310)
T 3s95_A           77 YKDKRL----------------NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC  139 (310)
T ss_dssp             EETTEE----------------EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred             ecCCee----------------EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeE
Confidence            877665                8999999999999999664 46799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcc--------------cCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDM--------------TGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  318 (404)
                      ||+.++.+||+|||+++.........              ....||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       140 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  219 (310)
T 3s95_A          140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV  219 (310)
T ss_dssp             EECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             EECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence            99999999999999997543322211              1457999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHH-HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          319 MPYPDLSFSEVT-SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       319 ~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .||......... ............+..+|+.+.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          220 NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             CSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            998764321110 00000111123466788899999999999999999999999999999987765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-48  Score=374.72  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=216.9

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      .+..++|.+.+.||+|+||.||+|.+  +|+.||||+++...      .........+..|..++..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV------VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH------hhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            35568999999999999999999998  68999999996421      11111234567888888877 99999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+...+                |+||||++||+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus        87 ~~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N  148 (345)
T 1xjd_A           87 FQTKENL----------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN  148 (345)
T ss_dssp             EECSSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred             EEeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhh
Confidence            9887766                8999999999999999654  579999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |||+.++.+||+|||+++............+||+.|+|||++.+..++.++||||||+++|||++|..||...+..+...
T Consensus       149 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  228 (345)
T 1xjd_A          149 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  228 (345)
T ss_dssp             EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999999854444444566789999999999999999999999999999999999999999998888877


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVV  372 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll  372 (404)
                      .+....  +.++..+++++.+||.+||+.||.+||++. +|+
T Consensus       229 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          229 SIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            776653  456778999999999999999999999987 664

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.7e-48  Score=362.38  Aligned_cols=264  Identities=24%  Similarity=0.384  Sum_probs=220.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|++.+.||+|+||+||++.+  +++.||||++.......      ......+.+|+.++.+++||||+++++++.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   81 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK------EETLKRFEREVHNSSQLSHQNIVSMIDVDE   81 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc------HHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence            3357899999999999999999997  68999999986543322      223466889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+
T Consensus        82 ~~~~~----------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil  143 (294)
T 4eqm_A           82 EDDCY----------------YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL  143 (294)
T ss_dssp             CSSEE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             eCCeE----------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            77665                8999999999999999654  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++.+||+|||++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  223 (294)
T 4eqm_A          144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK  223 (294)
T ss_dssp             ECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred             ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999997544332 222345689999999999999999999999999999999999999999887776655


Q ss_pred             HHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHhhcC
Q 015594          333 VVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       333 ~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~~~~~  383 (404)
                      ........   ..+..+|+.+.++|.+||+.||.+|| +++++.+.|+.+.....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            55443332   24567899999999999999999998 99999999998876554

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-48  Score=360.29  Aligned_cols=266  Identities=32%  Similarity=0.589  Sum_probs=227.8

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC-CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..+|++..++|.+.+.||+|+||.||+|.+. ++.||||++......          ...+.+|+.++++++||||++++
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~   74 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRLY   74 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----------HHHHHHHHHHHHhCCCcCcceEE
Confidence            3578999999999999999999999999984 568999999654321          24578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+.. .                ++||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||
T Consensus        75 ~~~~~~~-~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp  137 (279)
T 1qpc_A           75 AVVTQEP-I----------------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA  137 (279)
T ss_dssp             EEECSSS-C----------------EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEcCCC-c----------------EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            9876432 2                8999999999999998654444799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      +||+++.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  217 (279)
T 1qpc_A          138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (279)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             hhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence            999999999999999999986543322 2234457889999999998889999999999999999999 99999998887


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      +....+. .......+..+++++.+||.+||+.||++|||+.+|++.|+.+.+...+
T Consensus       218 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          218 EVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHh-cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            7665554 3455667788999999999999999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.9e-48  Score=364.77  Aligned_cols=268  Identities=30%  Similarity=0.559  Sum_probs=229.0

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH  162 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  162 (404)
                      ....|++...+|.+.+.||+|+||.||++.+       +++.||||++.....        ......+.+|+.++++++|
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h   85 (314)
T 2ivs_A           14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--------PSELRDLLSEFNVLKQVNH   85 (314)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCC
T ss_pred             CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCC
Confidence            3457788899999999999999999999986       347899999964321        1224567899999999999


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc----------------------CCCcH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----------------------RKLAF  220 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~~l~~  220 (404)
                      |||+++++++.+....                ++||||+++++|.+++.....                      ..+++
T Consensus        86 p~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (314)
T 2ivs_A           86 PHVIKLYGACSQDGPL----------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM  149 (314)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECH
T ss_pred             CceeeEEEEEecCCce----------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCH
Confidence            9999999999876655                899999999999999976432                      34899


Q ss_pred             HHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCC
Q 015594          221 KVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAY  298 (404)
Q Consensus       221 ~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~  298 (404)
                      ..++.++.||+.||.|||++||+||||||+||+|+.++.+||+|||+++.......  ......+|+.|+|||++.+..+
T Consensus       150 ~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  229 (314)
T 2ivs_A          150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY  229 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence            99999999999999999999999999999999999999999999999975443322  2233457889999999998889


Q ss_pred             CcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          299 NRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       299 ~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                      +.++||||||+++|+|++ |..||...+.......+ ........+..+++++.+||.+||+.||.+||++.+|++.|++
T Consensus       230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999999999999999999 99999998877766554 4445566778899999999999999999999999999999999


Q ss_pred             hHhhc
Q 015594          378 IDTSK  382 (404)
Q Consensus       378 ~~~~~  382 (404)
                      +...+
T Consensus       309 ~~~~~  313 (314)
T 2ivs_A          309 MMVKR  313 (314)
T ss_dssp             HHHTC
T ss_pred             HHhhc
Confidence            87653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.1e-48  Score=371.79  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=217.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  172 (404)
                      +...+|.+.+.||+|+||.||++.+  +|+.||||+++....      ........+.+|..++..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            4568999999999999999999998  468999999964211      1112234567899999988 899999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        91 ~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  152 (353)
T 2i0e_A           91 QTMDRL----------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV  152 (353)
T ss_dssp             ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             EcCCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence            887765                8999999999999999654  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ||+.++.+||+|||+++............+||+.|+|||++.+..++.++||||||+++|||++|..||...+..+....
T Consensus       153 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  232 (353)
T 2i0e_A          153 MLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  232 (353)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            99999999999999998644444455667899999999999999999999999999999999999999999998888888


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      +.....  .+|..+++++.+||.+||+.||.+||+     +++|++
T Consensus       233 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          233 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            776543  467789999999999999999999995     566664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.7e-48  Score=364.85  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=209.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ...++|++.+.||+|+||+||+|.+ +|+.||||++.....       .......+.+|+.++++++||||+++++++.+
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-------DEGIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            3458999999999999999999998 789999999964322       12234567899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                ++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        91 ~~~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~  152 (311)
T 3niz_A           91 ERCL----------------TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI  152 (311)
T ss_dssp             SSCE----------------EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCEE----------------EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence            6655                89999995 6888888654 4569999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.++.+||+|||+++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+
T Consensus       153 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  232 (311)
T 3niz_A          153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI  232 (311)
T ss_dssp             CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred             CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999999876555555566789999999999876 56899999999999999999999999887766665554


Q ss_pred             HhccCCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......+                            .....+++++.+||.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            4311110                            012346789999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.7e-48  Score=373.10  Aligned_cols=254  Identities=20%  Similarity=0.337  Sum_probs=217.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|.+.+.||+|+||+||++.+  +|+.||||+++.........   ......+.+|+.++++++||||+++++++.+.
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            36799999999999999999998  68999999998654322110   00134578999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        88 ~~~----------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~  149 (361)
T 2yab_A           88 TDV----------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL  149 (361)
T ss_dssp             SEE----------------EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CEE----------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence            665                899999999999999954  35799999999999999999999999999999999999998


Q ss_pred             CCC----cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          256 KTR----TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       256 ~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      .++    .+||+|||++..... .......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...
T Consensus       150 ~~~~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~  228 (361)
T 2yab_A          150 DKNIPIPHIKLIDFGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (361)
T ss_dssp             CTTSSSCCEEECCCSSCEECCT-TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             CCCCCccCEEEEecCCceEcCC-CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            776    799999999976443 334455789999999999999999999999999999999999999999998888877


Q ss_pred             HHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+....+..  ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       229 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            776654432  223578899999999999999999999999984

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.6e-48  Score=356.00  Aligned_cols=261  Identities=31%  Similarity=0.648  Sum_probs=226.3

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      .|.++.++|.+.+.||+|+||.||++.+ +++.||||++......          ...+.+|+.++++++||||++++++
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~   71 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV   71 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            5788999999999999999999999998 6789999999754322          1347899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+....                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+|
T Consensus        72 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N  134 (267)
T 3t9t_A           72 CLEQAPI----------------CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  134 (267)
T ss_dssp             ECSSSSC----------------EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred             EccCCCe----------------EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence            9876655                8999999999999999654 4578999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV  329 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~  329 (404)
                      |+++.++.+||+|||++....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus       135 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  214 (267)
T 3t9t_A          135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV  214 (267)
T ss_dssp             EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence            999999999999999997543221 12234567889999999998889999999999999999999 8999999888777


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ...+.. ......+..+++.+.++|.+||+.||.+||++.++++.|+++..+
T Consensus       215 ~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          215 VEDIST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhc-CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            665544 445566778899999999999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-48  Score=365.58  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=217.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|.+.+.||+|+||.||++.+  +|+.||||+++...      .........+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   76 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   76 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence            3457899999999999999999998  68999999996321      111112345778999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        77 ~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  138 (318)
T 1fot_A           77 DAQQI----------------FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL  138 (318)
T ss_dssp             CSSEE----------------EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             eCCEE----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence            77665                8999999999999999654  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      |+.++.+||+|||+++....   .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus       139 l~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  215 (318)
T 1fot_A          139 LDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI  215 (318)
T ss_dssp             ECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999975432   233567999999999999999999999999999999999999999998888887777


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .....  .+|..+++++.++|.+||+.||.+||     ++++|++
T Consensus       216 ~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          216 LNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            76643  46778899999999999999999999     8888884

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-48  Score=361.60  Aligned_cols=265  Identities=31%  Similarity=0.592  Sum_probs=219.4

Q ss_pred             ccccccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           87 ASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ....+..|.+...+|.+.+.||+|+||+||++.++|+.||||+++...           ..+.+.+|+.++++++||||+
T Consensus         9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv   77 (278)
T 1byg_A            9 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLV   77 (278)
T ss_dssp             ------CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBC
T ss_pred             hhhhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEe
Confidence            445667788999999999999999999999999999999999986322           134578999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.....               .+|+||||+++++|.+++.......+++..++.++.||+.||.|||++|++|+|
T Consensus        78 ~~~~~~~~~~~---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  142 (278)
T 1byg_A           78 QLLGVIVEEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD  142 (278)
T ss_dssp             CEEEEECCC-----------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEEcCCC---------------ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence            99998755432               128999999999999999765444589999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      |||+||+++.++.+||+|||++......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus       143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  219 (278)
T 1byg_A          143 LAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  219 (278)
T ss_dssp             CSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             CCcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999999753322   223457889999999998889999999999999999998 999999888


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ..+....+ ........+..+++.+.++|.+||+.||.+||++.++++.|+.+.+.
T Consensus       220 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          220 LKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             GGGHHHHH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHH-hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            77766554 34456677888999999999999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=363.41  Aligned_cols=261  Identities=26%  Similarity=0.381  Sum_probs=212.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccH-----------------HHHHHHHHHHHHHHHH
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSE-----------------AEIASLRAAFTQEVAV  156 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~  156 (404)
                      +...+|.+.+.||+|+||.||+|.+  +|+.||||++..........                 .........+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3457899999999999999999987  68999999997553211100                 0011123568899999


Q ss_pred             HhhcCCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHH
Q 015594          157 WHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       157 l~~l~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      +++++||||+++++++.+...-              .+|+||||+++++|.+++   ....+++..++.++.||+.||.|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~--------------~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~  152 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNED--------------HLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEY  152 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSS--------------EEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCeEEEEEEcCCCC--------------EEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHH
Confidence            9999999999999998764322              238999999999998864   23579999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC---CCcchhhHHHHHHHHH
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLWE  313 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~e  313 (404)
                      ||++||+||||||+||||+.++.+||+|||+++.............||+.|+|||++.+..   ++.++||||||+++|+
T Consensus       153 lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~  232 (298)
T 2zv2_A          153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC  232 (298)
T ss_dssp             HHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred             HHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence            9999999999999999999999999999999986554444455678999999999998765   3788999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       314 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |++|..||...........+............+++++.+||.+||+.||++||++.+|++
T Consensus       233 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            999999999988877777766665555555678999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-48  Score=361.73  Aligned_cols=265  Identities=29%  Similarity=0.587  Sum_probs=231.3

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ...|++...+|.+.+.||+|+||+||+|.+  +++.||||++.....          ....+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~   74 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQL   74 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----------HHHHHHHHHHHHHhCCCCCEeeE
Confidence            357889999999999999999999999998  488999999864321          13457899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+....                |+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+|||
T Consensus        75 ~~~~~~~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik  138 (288)
T 3kfa_A           75 LGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA  138 (288)
T ss_dssp             EEEECSSSSE----------------EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCS
T ss_pred             EEEEccCCCE----------------EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            9999876655                899999999999999987766789999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      |+||+++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus       139 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~  218 (288)
T 3kfa_A          139 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  218 (288)
T ss_dssp             GGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             cceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997644332 22334456889999999998889999999999999999999 9999998887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ......+ ........+..+++.+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus       219 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          219 SQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             GGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHH-hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            7765544 445566778889999999999999999999999999999999887654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-47  Score=367.07  Aligned_cols=247  Identities=22%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGAT  172 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~  172 (404)
                      +..++|.+.+.||+|+||.||++.+  +++.||||++.......      ......+.+|..++.++ +||||+++++++
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc------hHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            4457899999999999999999998  58999999997543221      12234577899999988 899999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+||||+++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        80 ~~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  141 (345)
T 3a8x_A           80 QTESRL----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV  141 (345)
T ss_dssp             ECSSEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             EeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            887665                8999999999999999654  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--------
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL--------  324 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~--------  324 (404)
                      ||+.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||...        
T Consensus       142 ll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  221 (345)
T 3a8x_A          142 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  221 (345)
T ss_dssp             EECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred             EECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence            999999999999999986444444556678999999999999999999999999999999999999999652        


Q ss_pred             -CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          325 -SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       325 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                       ........+...  ...+|..++.++.+||.+||+.||.+||++
T Consensus       222 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          222 NTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             222333344433  345678899999999999999999999995

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-48  Score=374.32  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=214.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  +|+.||+|++.....         .....+.+|+.+++.++||||+++++++.+..
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---------LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---------hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            6899999999999999999998  689999999964321         11345789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc-
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~-  255 (404)
                      .+                |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       122 ~~----------------~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~  184 (387)
T 1kob_A          122 EM----------------VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET  184 (387)
T ss_dssp             EE----------------EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred             EE----------------EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence            65                8999999999999988543 35799999999999999999999999999999999999997 


Q ss_pred             -CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 -KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 -~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                       ..+.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus       185 ~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~  263 (387)
T 1kob_A          185 KKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK  263 (387)
T ss_dssp             TTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             4578999999999864332 23344579999999999999999999999999999999999999999988877777776


Q ss_pred             hccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....  ......+++++.+||.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          264 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            65433  2344578999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=364.46  Aligned_cols=267  Identities=27%  Similarity=0.547  Sum_probs=220.3

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      .-.+++...+|.+.+.||+|+||+||+|.+.      +..||||++.....        ......+.+|+.++++++|||
T Consensus        36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~  107 (333)
T 1mqb_A           36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------EKQRVDFLGEAGIMGQFSHHN  107 (333)
T ss_dssp             --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred             hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCC
Confidence            3456788999999999999999999999863      23599999864321        122456889999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |+++++++......                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus       108 iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  170 (333)
T 1mqb_A          108 IIRLEGVISKYKPM----------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVH  170 (333)
T ss_dssp             BCCEEEEECSSSSE----------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             CCcEEEEEecCCCc----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            99999999776655                8999999999999998653 457999999999999999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      |||||+||+|+.++.+||+|||+++.......   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       171 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  250 (333)
T 1mqb_A          171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP  250 (333)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999976443321   1223446789999999998899999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |...+..+....+.. ......+..+++.+.+||.+||+.||.+||++.+|++.|+++.....
T Consensus       251 f~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          251 YWELSNHEVMKAIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TTTCCHHHHHHHHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             cccCCHHHHHHHHHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            999888777665544 44555677899999999999999999999999999999999876544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-47  Score=357.63  Aligned_cols=263  Identities=31%  Similarity=0.610  Sum_probs=213.5

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ..|++..++|.+.+.||+|+||.||+|.+.     +..||||++.....        ......+.+|+.++++++||||+
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv   79 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIV   79 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCccc
Confidence            457788899999999999999999999872     45799999854221        22356688999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.+. ..                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus        80 ~~~~~~~~~-~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  141 (281)
T 1mp8_A           80 KLIGVITEN-PV----------------WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRD  141 (281)
T ss_dssp             CEEEEECSS-SC----------------EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEccC-cc----------------EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            999997432 22                8999999999999999654 45799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      |||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          142 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            999999999999999999999975443221 2233456789999999998889999999999999999996 99999988


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +..+....+... .....+..+++++.++|.+||+.||++|||+.+|++.|+++...
T Consensus       222 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          222 KNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            877776665543 34557788999999999999999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-47  Score=358.68  Aligned_cols=259  Identities=32%  Similarity=0.644  Sum_probs=219.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++.||||++.........  ........+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET--EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCH--HHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccch--hHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            5568999999999999999999998  6899999999765433211  11112256889999999999999999999986


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCCC
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTEN  251 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~N  251 (404)
                      +..                  ++||||+++++|.+++... ...+++..++.++.||+.||.|||++|  |+||||||+|
T Consensus        94 ~~~------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N  154 (287)
T 4f0f_A           94 NPP------------------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN  154 (287)
T ss_dssp             TTT------------------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred             CCC------------------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence            543                  6899999999999988654 457999999999999999999999999  9999999999


Q ss_pred             EEEcCCCc-----EEEeeccccccccCCCCcccCCCCCccccCcccc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          252 MLLDKTRT-----VKIADFGVARLEASNPHDMTGETGTLGYMAPEVL--NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       252 ili~~~~~-----vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      ||++.++.     +||+|||+++...   .......||+.|+|||++  ....++.++||||||+++|+|++|..||...
T Consensus       155 il~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          155 IFLQSLDENAPVCAKVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             EEESCCCTTCSCCEEECCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             EEEeccCCCCceeEEeCCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99987776     9999999997432   234456789999999999  4456789999999999999999999999876


Q ss_pred             CHHHH--HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          325 SFSEV--TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       325 ~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +....  ...+......+..+..+++++.+||.+||+.||.+|||+.+|++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            54443  4555666777788899999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-47  Score=370.21  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=216.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +|+.||||++.......       .....+.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------RDFQKLEREARICRKLQHPNIVRLHDSIQEE  100 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            36799999999999999999998  68999999997544321       1235578999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus       101 ~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~  162 (362)
T 2bdw_A          101 SFH----------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  162 (362)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred             CEE----------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence            665                8999999999999998543  5799999999999999999999999999999999999997


Q ss_pred             CC---CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KT---RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .+   +.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus       163 ~~~~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~  241 (362)
T 2bdw_A          163 SKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  241 (362)
T ss_dssp             CSSTTCCEEECCCTTCBCCTT-CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCCEEEeecCcceEecC-CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            54   4599999999975442 3334557899999999999999999999999999999999999999999988888777


Q ss_pred             HHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....+....+  ..+++++.+||.+||+.||.+||++.++++
T Consensus       242 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          242 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            77665543322  467999999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-48  Score=372.81  Aligned_cols=265  Identities=30%  Similarity=0.502  Sum_probs=223.8

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      .+++...+|.+.+.||+|+||+||+|.+       +++.||||+++....    .    .....+.+|+.++++++||||
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~hpnI  136 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS----E----QDELDFLMEALIISKFNHQNI  136 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC----H----HHHHHHHHHHHHHHHCCCTTB
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC----h----hhHHHHHHHHHHHHhCCCCCC
Confidence            3567778999999999999999999984       456899999853211    1    123457889999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-----CCCcHHHHHHHHHHHHHHHHHHhhC
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFKVVIQLALDLARGLSYLQSK  240 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~  240 (404)
                      +++++++.+....                |+||||+++|+|.+++.....     ..+++..++.++.||+.||.|||++
T Consensus       137 v~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  200 (367)
T 3l9p_A          137 VRCIGVSLQSLPR----------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN  200 (367)
T ss_dssp             CCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CeEEEEEecCCCC----------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            9999999877665                899999999999999976532     4589999999999999999999999


Q ss_pred             CceecccCCCCEEEcCCC---cEEEeeccccccccCC--CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          241 KIVHRDVKTENMLLDKTR---TVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       241 givH~Dikp~Nili~~~~---~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      ||+||||||+||||+.++   .+||+|||+++.....  ........+|+.|+|||++.+..++.++|||||||++|||+
T Consensus       201 ~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell  280 (367)
T 3l9p_A          201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF  280 (367)
T ss_dssp             TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999998554   5999999999743222  12233356789999999998888999999999999999999


Q ss_pred             h-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          316 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       316 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      + |..||...+..+....+.. ......+..+++.+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus       281 t~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          281 SLGYMPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             TTSCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             hCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            8 9999999988877666554 3455667889999999999999999999999999999999887654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.7e-48  Score=375.09  Aligned_cols=264  Identities=28%  Similarity=0.566  Sum_probs=214.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ..++...+|.+.+.||+|+||.||+|.+     ++..||||+++....        ...+..|.+|+.++.+++||||++
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~  110 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--------EKQRRDFLGEASIMGQFDHPNIIR  110 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--------HHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3467778999999999999999999986     367899999964321        122466889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.+....                ++||||+++++|.+++.+. ...+++..++.++.||+.||.|||++||+||||
T Consensus       111 ~~~~~~~~~~~----------------~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  173 (373)
T 2qol_A          111 LEGVVTKSKPV----------------MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL  173 (373)
T ss_dssp             EEEEECSSSSC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEEeeCCce----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence            99999876655                8999999999999999653 457999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      ||+||||+.++.+||+|||+++........   .....+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       174 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          174 AARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             CGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             CcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999865433221   122345778999999998899999999999999999998 9999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .+..+....+. .......+..++.++.+||.+||+.||.+||++.+|++.|+.+....
T Consensus       254 ~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          254 MSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             CCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            98877766554 34455567789999999999999999999999999999999997654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-47  Score=368.71  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=217.4

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||.||++.+  +|+.||||+++...      .........+.+|+.+++.++||||+++++++.+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  112 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD  112 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH------hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            357899999999999999999998  68999999996321      1111224567899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+||||+++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       113 ~~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll  174 (350)
T 1rdq_E          113 NSNL----------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI  174 (350)
T ss_dssp             SSEE----------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCEE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE
Confidence            7665                8999999999999999664  569999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      +.++.+||+|||+++.....   ....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.
T Consensus       175 ~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  251 (350)
T 1rdq_E          175 DQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             CTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence            99999999999999854332   334679999999999999999999999999999999999999999998888887777


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      ...  ..+|..+++++.+||.+||+.||.+||+     +++|++
T Consensus       252 ~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 SGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            664  3467789999999999999999999998     888874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-47  Score=365.93  Aligned_cols=267  Identities=28%  Similarity=0.541  Sum_probs=229.2

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC--C-----ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD--G-----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|++..++|.+.+.||+|+||+||+|.+.  +     +.||||++.....        ......+.+|+.+++++ +|
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h  109 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--------ADEKEALMSELKIMSHLGQH  109 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--------hHHHHHHHHHHHHHHhhcCC
Confidence            3468899999999999999999999999973  2     4799999964321        12245688999999999 89


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc------------cCCCcHHHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR------------RRKLAFKVVIQLALDL  230 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi  230 (404)
                      |||+++++++......                |+||||+++|+|.+++....            ...+++..++.++.||
T Consensus       110 ~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi  173 (333)
T 2i1m_A          110 ENIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV  173 (333)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred             CCeeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence            9999999999877665                89999999999999996542            3468999999999999


Q ss_pred             HHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHH
Q 015594          231 ARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFG  308 (404)
Q Consensus       231 ~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  308 (404)
                      +.||.|||++||+||||||+||||+.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||
T Consensus       174 ~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  253 (333)
T 2i1m_A          174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG  253 (333)
T ss_dssp             HHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence            9999999999999999999999999999999999999975433322  12334568899999999988899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          309 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       309 ~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +++|+|++ |..||.....................+..+++.+.+||.+||+.||.+|||+.+|++.|+++...
T Consensus       254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            99999998 99999988776666677777777777888999999999999999999999999999999988764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-47  Score=358.21  Aligned_cols=263  Identities=33%  Similarity=0.657  Sum_probs=207.8

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+++...+|.+.+.||+|+||+||+|.+.+ .||||+++.....       ......+.+|+.++++++||||+++++
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT-------PQQLQAFKNEVGVLRKTRHVNILLFMG   87 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCC-------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCC-------HHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence            34578889999999999999999999998765 5999999754332       122456889999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      +... ...                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        88 ~~~~-~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~  149 (289)
T 3og7_A           88 YSTA-PQL----------------AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN  149 (289)
T ss_dssp             EECS-SSC----------------EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eccC-Ccc----------------EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            6543 223                8999999999999998543 467999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccC--CCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEAS--NPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      ||+|+.++.+||+|||++.....  .........||+.|+|||++.   +..++.++||||||+++|+|++|..||....
T Consensus       150 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  229 (289)
T 3og7_A          150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  229 (289)
T ss_dssp             GEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             eEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence            99999999999999999975332  122334457899999999986   6678999999999999999999999998866


Q ss_pred             HHHHHHHHHh-ccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          326 FSEVTSAVVR-QNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       326 ~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ..+....... ....+   .....+|+++.+||.+||+.||.+|||+.+|++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            5554444443 33333   234578999999999999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-48  Score=383.99  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=212.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .+.+..++|.+.+.||+|+||.||++.+  +|+.||||++.....      ........+.+|+.+++.++||||+++++
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~  215 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKY  215 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------C-------------CCCCCSCTTSCCEEE
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh------hhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence            3456668999999999999999999997  689999999963211      11122345678999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKT  249 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp  249 (404)
                      ++.....+                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+ .||+||||||
T Consensus       216 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp  277 (446)
T 4ejn_A          216 SFQTHDRL----------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL  277 (446)
T ss_dssp             EEEETTEE----------------EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCG
T ss_pred             EEeeCCEE----------------EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCH
Confidence            99887765                8999999999999998654  579999999999999999999998 9999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      +||||+.++.+||+|||+++............+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+.
T Consensus       278 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  357 (446)
T 4ejn_A          278 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  357 (446)
T ss_dssp             GGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence            99999999999999999998655555556667899999999999999999999999999999999999999999988888


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ...+.....  .++..+++++.+||.+||+.||.+||     +++++++
T Consensus       358 ~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          358 FELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            777776544  46778999999999999999999999     9999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-47  Score=355.72  Aligned_cols=271  Identities=29%  Similarity=0.527  Sum_probs=230.1

Q ss_pred             ccccCCCCeEEee-eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           93 EWEIDPAKLIIKG-AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        93 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .+.+..++|.+.+ .||+|+||.||+|.+    +++.||||+++....        ......+.+|+.++++++||||++
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~   74 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVR   74 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--------hhHHHHHHHHHHHHHhCCCCCEeE
Confidence            4667788898887 999999999999986    578899999975321        122456889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++... ..                ++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||
T Consensus        75 ~~~~~~~~-~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  136 (287)
T 1u59_A           75 LIGVCQAE-AL----------------MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL  136 (287)
T ss_dssp             EEEEEESS-SE----------------EEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             EEEEecCC-Cc----------------EEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCC
Confidence            99998432 22                8999999999999998543 457999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      ||+||+++.++.+||+|||++.........   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       137 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             chheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999865433221   223456899999999998889999999999999999998 9999998


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCCCCCC
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGMIPVD  390 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~~p~~  390 (404)
                      .+..+....+. ....+..+..+++++.++|.+||+.||.+||++.+|++.|+.+..+.+.+..+..
T Consensus       217 ~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~  282 (287)
T 1u59_A          217 MKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH  282 (287)
T ss_dssp             CCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             CCHHHHHHHHh-cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence            88777665544 3445667888999999999999999999999999999999999999887665543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-47  Score=363.71  Aligned_cols=267  Identities=27%  Similarity=0.497  Sum_probs=218.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|++.+.||+|+||.||++.+      +++.||||++....         ......+.+|+.++++++||||++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~   90 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---------PDQQRDFQREIQILKALHSDFIVKYR   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence            5668999999999999999999984      57899999986432         12245688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.....-              ..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||
T Consensus        91 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp  155 (327)
T 3lxl_A           91 GVSYGPGRQ--------------SLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA  155 (327)
T ss_dssp             EEEECSSSC--------------EEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEecCCCc--------------eEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence            998754332              238999999999999999664 34699999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      +||||+.++.+||+|||++........   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~  235 (327)
T 3lxl_A          156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA  235 (327)
T ss_dssp             GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred             hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence            999999999999999999986543322   22334578889999999998899999999999999999999999864332


Q ss_pred             H--------------HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          327 S--------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       327 ~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                      .              ...............+..+++++.+||.+||+.||.+|||+.+|++.|+.+.....+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             HHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             hhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            1              22333445556667788899999999999999999999999999999999987766443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=369.04  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=196.4

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ...++|.+.+.||+|+||+||+|.+  +++.||||+++...           ....+.+|+.++.+++||||+++++++.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----------DKKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----------hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            3346799999999999999999998  57899999996422           1244678999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus       119 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  180 (349)
T 2w4o_A          119 TPTEI----------------SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL  180 (349)
T ss_dssp             CSSEE----------------EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             cCCeE----------------EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEE
Confidence            77655                8999999999999998543  56999999999999999999999999999999999999


Q ss_pred             EcC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-H
Q 015594          254 LDK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE-V  329 (404)
Q Consensus       254 i~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~-~  329 (404)
                      |+.   ++.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||......+ .
T Consensus       181 l~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  259 (349)
T 2w4o_A          181 YATPAPDAPLKIADFGLSKIVEH-QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM  259 (349)
T ss_dssp             ESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH
T ss_pred             EecCCCCCCEEEccCccccccCc-ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH
Confidence            975   88999999999975432 223345678999999999999999999999999999999999999998766544 4


Q ss_pred             HHHHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+.......  .....++.++.+||.+||+.||++|||+.++++
T Consensus       260 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            44444443322  233578999999999999999999999999886

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=365.09  Aligned_cols=248  Identities=18%  Similarity=0.282  Sum_probs=216.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||++.+  +++.||+|++.....          ....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----------DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----------HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----------cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            46899999999999999999998  689999999864321          134577999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        74 ~~~----------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~  136 (321)
T 1tki_A           74 EEL----------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ  136 (321)
T ss_dssp             TEE----------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred             CEE----------------EEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence            665                8999999999999998543 35799999999999999999999999999999999999998


Q ss_pred             C--CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          256 K--TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~--~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      .  ++.+||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus       137 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  215 (321)
T 1tki_A          137 TRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI  215 (321)
T ss_dssp             SSSCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cCCCCCEEEEECCCCeECCC-CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence            6  78999999999976433 23344567899999999999998999999999999999999999999999888888877


Q ss_pred             HhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........  ....+++++.+||.+||..||.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            77655432  22568999999999999999999999999987

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.9e-47  Score=360.01  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=213.2

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|...+.||+|+||.||+|.+  +|+.||||++.......         ...+.+|+.++++++||||+++++++.....
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEE  116 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence            477888999999999999997  68999999997554321         3447799999999999999999999987766


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                ++||||+++++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+||||+.+
T Consensus       117 ~----------------~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          117 L----------------WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             E----------------EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred             E----------------EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence            5                899999999999998843   469999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  257 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP  257 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999999865554444556789999999999999999999999999999999999999999888777766655443


Q ss_pred             CCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 LRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 ~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... ..+..+++.+.++|.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            221 223457899999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.8e-47  Score=354.40  Aligned_cols=250  Identities=23%  Similarity=0.399  Sum_probs=208.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||++........       ....+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCC-------cchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            5899999999999999999998  689999999976543321       2345678999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                ++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~  136 (292)
T 3o0g_A           75 KL----------------TLVFEFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR  136 (292)
T ss_dssp             EE----------------EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             EE----------------EEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence            65                89999995 5777766543 467999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVV  334 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~P-f~~~~~~~~~~~~~  334 (404)
                      ++.+||+|||++..............||+.|+|||++.+.. ++.++||||||+++|+|++|..| |...+..+....+.
T Consensus       137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~  216 (292)
T 3o0g_A          137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_dssp             TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred             CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            99999999999987655555566678999999999998765 89999999999999999988777 56666666555554


Q ss_pred             hccCC---------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .....                           ......+++++.+||.+||+.||++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            32111                           0122357899999999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-47  Score=367.55  Aligned_cols=255  Identities=23%  Similarity=0.372  Sum_probs=211.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||+++........    ......+.+|+.+++.++||||+++++++.+.
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICHMLKHPHIVELLETYSSD   98 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS----SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc----cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            36799999999999999999997  6899999998632110000    00134578999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ..+                |+||||+++++|.+++.+..  ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        99 ~~~----------------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl  162 (351)
T 3c0i_A           99 GML----------------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL  162 (351)
T ss_dssp             TEE----------------EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CEE----------------EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence            665                89999999999998885542  345899999999999999999999999999999999999


Q ss_pred             EcCCCc---EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          254 LDKTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       254 i~~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ++.++.   +||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.... .+..
T Consensus       163 ~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~  241 (351)
T 3c0i_A          163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLF  241 (351)
T ss_dssp             ECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHH
T ss_pred             EecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHH
Confidence            976554   999999999866554444556789999999999999999999999999999999999999998753 4444


Q ss_pred             HHHHhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+........  ....+++++.+||.+||+.||++|||+.++++
T Consensus       242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            55555443322  12568899999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-47  Score=362.99  Aligned_cols=263  Identities=25%  Similarity=0.466  Sum_probs=218.0

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +....|++.+.||+|+||+||++.+      +++.||||+++....        ......+.+|+.++++++||||++++
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------PQHRSGWKQEIDILRTLYHEHIIKYK   99 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCcchhhEE
Confidence            3334459999999999999998865      678999999964321        12345688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+....              .+++||||+++++|.+++.+.   .+++..++.++.||+.||.|||+.||+|+||||
T Consensus       100 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp  162 (318)
T 3lxp_A          100 GCCEDAGAA--------------SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA  162 (318)
T ss_dssp             EEEEETTTT--------------EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEecCCCc--------------eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch
Confidence            999875332              238999999999999998543   599999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      +||+++.++.+||+|||++........   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       163 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~  242 (318)
T 3lxp_A          163 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT  242 (318)
T ss_dssp             GGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred             heEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence            999999999999999999986544322   22335578889999999998899999999999999999999999865322


Q ss_pred             H--------------HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          327 S--------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       327 ~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .              ...............+..+++++.+||.+||+.||.+|||+.+|++.|+.+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          243 KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            1              11223344555667788899999999999999999999999999999999987765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=369.40  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=213.0

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .+.+..++|.+.+.||+|+||.||++.+  +++.||||++....      .........+.+|+.+++.++||||+++++
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~   82 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK------CVERNEVRNVFKELQIMQGLEHPFLVNLWY   82 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh------cccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3456778999999999999999999998  67899999996321      111122456789999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||+.||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        83 ~~~~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~  144 (384)
T 4fr4_A           83 SFQDEEDM----------------FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD  144 (384)
T ss_dssp             EEECSSEE----------------EEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             EEEeCCEE----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence            99887766                8999999999999998653  57999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCC--
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLS--  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~--  325 (404)
                      ||||+.++.+||+|||++.... ........+||+.|+|||++.+   ..++.++|||||||++|+|++|..||...+  
T Consensus       145 NIll~~~g~vkL~DFG~a~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~  223 (384)
T 4fr4_A          145 NILLDEHGHVHITDFNIAAMLP-RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST  223 (384)
T ss_dssp             GEEECTTSCEEECCCTTCEECC-TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred             HeEECCCCCEEEeccceeeecc-CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence            9999999999999999997643 3344556789999999999974   458999999999999999999999997543  


Q ss_pred             -HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 015594          326 -FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVA  373 (404)
Q Consensus       326 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~  373 (404)
                       ..+....+..  .....+..+++++.+||.+||+.||.+||+ +++|++
T Consensus       224 ~~~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          224 SSKEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cHHHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             3333333332  234567789999999999999999999998 777664

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-47  Score=356.64  Aligned_cols=267  Identities=30%  Similarity=0.518  Sum_probs=222.1

Q ss_pred             cccccccCCCCeEEee-eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           90 RRQEWEIDPAKLIIKG-AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      ...++.++..+|.+.+ .||+|+||+||+|.+    .++.||||+++....       .......+.+|+.+++.++|||
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~   79 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPY   79 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTT
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCC
Confidence            3456677888999998 999999999999965    468899999964321       1223566889999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |+++++++. ....                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|
T Consensus        80 i~~~~~~~~-~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H  140 (291)
T 1xbb_A           80 IVRMIGICE-AESW----------------MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVH  140 (291)
T ss_dssp             BCCEEEEEE-SSSE----------------EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEEEEEEEC-CCCc----------------EEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEc
Confidence            999999983 2333                8999999999999999664  56999999999999999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMP  320 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~P  320 (404)
                      +||||+||+++.++.+||+|||++.........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       141 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p  220 (291)
T 1xbb_A          141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP  220 (291)
T ss_dssp             SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999764433221   222346789999999998889999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          321 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       321 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |...+..+....+. ....+..+..+++++.++|.+||+.||.+||++.+|++.|+++..+..
T Consensus       221 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          221 YRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             STTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            99988877665544 444566778899999999999999999999999999999999987754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-46  Score=356.07  Aligned_cols=265  Identities=26%  Similarity=0.452  Sum_probs=210.9

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ...+|.+.+.||+|+||.||+|.+  +|+.||||++.......      ......+.+|+.++++++||||+++++++..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  103 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD------AKARADCIKEIDLLKQLNHPNVIKYYASFIE  103 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            456899999999999999999997  68999999997533221      1234567899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ....                ++||||+++++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||
T Consensus       104 ~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI  167 (310)
T 2wqm_A          104 DNEL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV  167 (310)
T ss_dssp             TTEE----------------EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCcE----------------EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence            6655                8999999999999998652  345689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--CHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL--SFSEVT  330 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~--~~~~~~  330 (404)
                      +|+.++.+||+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|..||...  ......
T Consensus       168 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  247 (310)
T 2wqm_A          168 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC  247 (310)
T ss_dssp             EECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH
T ss_pred             EEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH
Confidence            999999999999999976554444444567899999999999999999999999999999999999999754  333444


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ..+....+.+..+..+++++.+||.+||+.||.+|||+.+|++.|+++.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          248 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             HHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            44444444444457789999999999999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.4e-48  Score=371.75  Aligned_cols=273  Identities=19%  Similarity=0.262  Sum_probs=213.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHH----HHHHHHHHHHHhhcCCCc
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASL----RAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~----~~~~~~E~~~l~~l~hpn  164 (404)
                      +...+|.+.+.||+|+||+||+|.+.       ++.||||++.......  ..+...+    ...+.+|+..++.++|||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL--FTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHH--HHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhH--HHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            45679999999999999999999872       4789999987543211  1111111    123556778888999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |+++++++.....-            ..+.|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus       110 iv~~~~~~~~~~~~------------~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH  175 (364)
T 3op5_A          110 VPKYWGSGLHDKNG------------KSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVH  175 (364)
T ss_dssp             SCCEEEEEEEEETT------------EEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             CCeEEeeeeeccCC------------cceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence            99999998765321            12248999999 99999998653 467999999999999999999999999999


Q ss_pred             cccCCCCEEEc--CCCcEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          245 RDVKTENMLLD--KTRTVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       245 ~Dikp~Nili~--~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      |||||+||||+  .++.+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus       176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  255 (364)
T 3op5_A          176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL  255 (364)
T ss_dssp             CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence            99999999998  889999999999975433211       113345999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          316 CCDMPYPDLSFSEVTSAVVRQNLRP---------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       316 ~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      +|..||.+.................         .....+|+++.+||..||+.||.+||++.+|++.|+.+....+.
T Consensus       256 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          256 TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            9999998643222211111111110         01256799999999999999999999999999999999988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=362.76  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=215.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +|+.||||+++.........   ......+.+|+.++++++||||+++++++.+..
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            5799999999999999999998  58999999997654321110   001345789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        88 ~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~  149 (326)
T 2y0a_A           88 DV----------------ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD  149 (326)
T ss_dssp             EE----------------EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred             EE----------------EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence            65                899999999999999854  367999999999999999999999999999999999999988


Q ss_pred             CC----cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          257 TR----TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       257 ~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++    .+||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       150 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  228 (326)
T 2y0a_A          150 RNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN  228 (326)
T ss_dssp             SSSSSCCEEECCCTTCEECCT-TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             CCCCCCCEEEEECCCCeECCC-CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence            77    899999999976432 2334456799999999999999999999999999999999999999999888777766


Q ss_pred             HHhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +........  .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            665443322  23567899999999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-48  Score=370.55  Aligned_cols=248  Identities=27%  Similarity=0.479  Sum_probs=209.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|.+  +|+.||||++...      ..........+.+|+.+++.++||||+++++++...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ------LLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehH------HccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            36899999999999999999998  7899999998632      111112234678999999999999999999999887


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+ +|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        82 ~~~----------------~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~  142 (336)
T 3h4j_B           82 TDI----------------VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD  142 (336)
T ss_dssp             SEE----------------EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC
T ss_pred             CEE----------------EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc
Confidence            765                8999999 89999998664  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++.... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+.
T Consensus       143 ~~~~~kl~DFG~s~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~  221 (336)
T 3h4j_B          143 DNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN  221 (336)
T ss_dssp             TTCCEEECCSSCTBTTT-TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC
T ss_pred             CCCCEEEEEeccceecc-CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            99999999999997543 3334455789999999999998876 789999999999999999999998765443322211


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                        .....+|..+++++.+||.+||+.||.+|||+++|++
T Consensus       222 --~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 --SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              1123467778999999999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.4e-47  Score=355.09  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=205.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++........       ....+.+|+.++++++||||+++++++.+...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-------cchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            5799999999999999999998 589999999975433211       12446789999999999999999999987765


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        75 ~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  136 (288)
T 1ob3_A           75 L----------------VLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE  136 (288)
T ss_dssp             E----------------EEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             E----------------EEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence            5                89999995 5999988553 4679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.+||+|||++..............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+...
T Consensus       137 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  216 (288)
T 1ob3_A          137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI  216 (288)
T ss_dssp             SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            999999999998655444445566789999999999764 5899999999999999999999999998877766555432


Q ss_pred             cCC----------------C-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLR----------------P-----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~----------------~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                +           .....+++++.+||.+||+.||++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100                0           112457899999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-47  Score=361.55  Aligned_cols=270  Identities=31%  Similarity=0.564  Sum_probs=227.9

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|++..++|.+.+.||+|+||+||+|.+       +++.||||++.....        ......+.+|+.++.++ +|
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h   90 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHH   90 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--------cHHHHHHHHHHHHHHhcccC
Confidence            346778889999999999999999999984       458999999964321        11235678999999999 79


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------------CCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------------RKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~  228 (404)
                      |||+++++++......               +++||||+++++|.+++.....              ..+++..++.++.
T Consensus        91 p~iv~~~~~~~~~~~~---------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T 2xir_A           91 LNVVNLLGACTKPGGP---------------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF  155 (316)
T ss_dssp             TTBCCEEEEECCTTSC---------------CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHH
T ss_pred             CCeeeEEEEEecCCCc---------------eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHH
Confidence            9999999998765431               2899999999999999966532              1289999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||++||+||||||+||+|+.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||
T Consensus       156 qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s  235 (316)
T 2xir_A          156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS  235 (316)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHH
Confidence            999999999999999999999999999999999999999975443322  223345788999999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          307 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       307 lG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ||+++|+|++ |..||......+..............+..+++++.++|.+||+.||.+|||+.+|++.|+.+.....
T Consensus       236 lG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            9999999998 9999988776655555555666667788899999999999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.8e-48  Score=378.14  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=217.2

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .+.+..++|.+.+.||+|+||+||++.+  +++.||||+++...      .........+.+|+.++..++||||+++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh------hhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4456678999999999999999999998  68899999996321      000111233678999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||++||+|.+++.+   ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       137 ~~~~~~~~----------------~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~  197 (410)
T 3v8s_A          137 AFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD  197 (410)
T ss_dssp             EEECSSEE----------------EEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             EEEECCEE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHH
Confidence            99887766                899999999999999854   36999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccCCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLNGSA----YNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      ||||+.++.+||+|||+++....... .....+||+.|+|||++.+..    ++.++|||||||++|||++|..||...+
T Consensus       198 NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          198 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             HeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            99999999999999999976443322 234578999999999998765    7899999999999999999999999999


Q ss_pred             HHHHHHHHHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 015594          326 FSEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDK--RPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~  373 (404)
                      ..+....+........+  ...+++++.+||.+||+.+|.+  ||++++|++
T Consensus       278 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          278 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            88888887765422233  3578999999999999988888  999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5e-47  Score=360.01  Aligned_cols=267  Identities=30%  Similarity=0.520  Sum_probs=226.2

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD  161 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  161 (404)
                      ....+|++..++|.+.+.||+|+||.||+|.+.       ++.||||++.....        ......+.+|+.++++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~   86 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFN   86 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--------HHHHHHHHHHHHHGGGCC
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--------HHHHHHHHHHHHHHHhcC
Confidence            345678899999999999999999999999763       67899999864321        112345789999999999


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--------CCCcHHHHHHHHHHHHHH
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--------RKLAFKVVIQLALDLARG  233 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~  233 (404)
                      ||||+++++++.+....                ++||||+++++|.+++.....        ..+++..++.++.||+.|
T Consensus        87 h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  150 (322)
T 1p4o_A           87 CHHVVRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG  150 (322)
T ss_dssp             CTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHH
T ss_pred             CCCEeeeEEEEccCCcc----------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHH
Confidence            99999999999776655                899999999999999965321        457899999999999999


Q ss_pred             HHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHH
Q 015594          234 LSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICL  311 (404)
Q Consensus       234 L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il  311 (404)
                      |.|||++||+||||||+||+|+.++.+||+|||++........  ......+|+.|+|||++.+..++.++||||||+++
T Consensus       151 l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  230 (322)
T 1p4o_A          151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL  230 (322)
T ss_dssp             HHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence            9999999999999999999999999999999999975433221  12234568899999999988899999999999999


Q ss_pred             HHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          312 WEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       312 ~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |+|++ |..||...+..+....+.... ....+..+++.+.+||.+||+.||.+|||+.++++.|+++..
T Consensus       231 ~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          231 WEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHhcCCCccccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            99999 899999988877766655543 345677899999999999999999999999999999987643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.9e-47  Score=365.33  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ....++|.+.+.||+|+||+||++.+  +++.||||++......          ...+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~   85 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----------DENVQREIINHRSLRHPNIVRFKEVI   85 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----------CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----------cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34568999999999999999999998  6899999999754322          13367899999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+...+                |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni  147 (361)
T 3uc3_A           86 LTPTHL----------------AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT  147 (361)
T ss_dssp             ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred             eeCCEE----------------EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            877665                8999999999999998654  5799999999999999999999999999999999999


Q ss_pred             EEcCCCc--EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCH---
Q 015594          253 LLDKTRT--VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRK-CDVYSFGICLWEIYCCDMPYPDLSF---  326 (404)
Q Consensus       253 li~~~~~--vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~Pf~~~~~---  326 (404)
                      ||+.++.  +||+|||+++... .........||+.|+|||++.+..++.+ +||||||+++|+|++|..||.....   
T Consensus       148 ll~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  226 (361)
T 3uc3_A          148 LLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD  226 (361)
T ss_dssp             EECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred             EEcCCCCceEEEeecCcccccc-ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence            9987665  9999999997422 2223345679999999999988877655 8999999999999999999987543   


Q ss_pred             -HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          327 -SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       327 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       ......+............+++++.+||.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence             33334444444444444568999999999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.1e-47  Score=369.79  Aligned_cols=255  Identities=20%  Similarity=0.335  Sum_probs=209.9

Q ss_pred             cCCCCeEEeeeeeee--cceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           96 IDPAKLIIKGAFARG--TFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G--~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      ....+|++.+.||+|  +||+||++.+  +|+.||||++......       ......+.+|+.+++.++||||++++++
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-------NEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            456789999999999  9999999998  5899999999754322       1234667899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+...+                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|
T Consensus        95 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  158 (389)
T 3gni_B           95 FIADNEL----------------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH  158 (389)
T ss_dssp             EEETTEE----------------EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             EEECCEE----------------EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            9877665                899999999999999987666789999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCC-------CcccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          252 MLLDKTRTVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      |||+.++.+||+|||.+.......       .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||.
T Consensus       159 Ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             EEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999886432211       11223478999999999987  579999999999999999999999998


Q ss_pred             CCCHHHHHHHHHhccC--------------------------------------------CCCCCCCCcHHHHHHHHHhh
Q 015594          323 DLSFSEVTSAVVRQNL--------------------------------------------RPEIPRCCPSSLANVMKRCW  358 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~li~~cl  358 (404)
                      +.+..+..........                                            ....+..+++++.+||.+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  318 (389)
T 3gni_B          239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL  318 (389)
T ss_dssp             TCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh
Confidence            7665554433222111                                            01234567899999999999


Q ss_pred             hhCCCCCCCHHHHHH
Q 015594          359 DANPDKRPEMDEVVA  373 (404)
Q Consensus       359 ~~dP~~Rpt~~~ll~  373 (404)
                      +.||.+|||+.++++
T Consensus       319 ~~dP~~Rpta~ell~  333 (389)
T 3gni_B          319 QRNPDARPSASTLLN  333 (389)
T ss_dssp             CSCTTTSCCHHHHTT
T ss_pred             hcCcccCCCHHHHhc
Confidence            999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.8e-47  Score=365.30  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=213.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ..|.+.+.||+|+||+||+|.+  +|+.||||++.......      ......+.+|+.++++++||||+++++++.+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            5599999999999999999996  78999999997543221      223456889999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus       128 ~~----------------~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  189 (348)
T 1u5q_A          128 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE  189 (348)
T ss_dssp             EE----------------EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred             eE----------------EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence            55                89999995 7888888543 467999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.+||+|||++.....    .....||+.|+|||++.   +..++.++||||||+++|||++|..||...+.......+
T Consensus       190 ~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          190 PGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             TTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             CCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999975432    23467899999999984   567899999999999999999999999988877777666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .........+..+++.+.+||.+||+.||++|||+++|++
T Consensus       266 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            6666555556788999999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-47  Score=361.58  Aligned_cols=275  Identities=27%  Similarity=0.496  Sum_probs=213.1

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC--Cc---eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD--GQ---DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~---~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ...+.+...+|.+.+.||+|+||+||+|.+.  +.   .||||+++.....       ......+.+|+.++++++||||
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i   87 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-------SSDIEEFLREAACMKEFDHPHV   87 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-------HHHHHHHHHHHHHHHHCCCCce
Confidence            3456678889999999999999999999873  32   7999998643211       1224568899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc----CCCcHHHHHHHHHHHHHHHHHHhhCC
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR----RKLAFKVVIQLALDLARGLSYLQSKK  241 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g  241 (404)
                      +++++++.......          ....+++||||+++|+|.+++.....    ..+++..++.++.||+.||.|||++|
T Consensus        88 v~~~~~~~~~~~~~----------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~  157 (323)
T 3qup_A           88 AKLVGVSLRSRAKG----------RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN  157 (323)
T ss_dssp             CCCCEEEECC-----------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ehhhceeecccccc----------CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence            99999987655431          11223899999999999999965421    25899999999999999999999999


Q ss_pred             ceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CC
Q 015594          242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CD  318 (404)
Q Consensus       242 ivH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~  318 (404)
                      |+||||||+||||+.++.+||+|||+++......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus       158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  237 (323)
T 3qup_A          158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ  237 (323)
T ss_dssp             CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCC
Confidence            9999999999999999999999999997543322  22233456889999999999999999999999999999999 99


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          319 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .||...+..+....+.... ....+..+++++.+||.+||+.||.+|||+.++++.|+++.....
T Consensus       238 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          238 TPYAGIENAEIYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             CTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             CCccccChHHHHHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            9999988888776655443 455677889999999999999999999999999999999987553

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.6e-47  Score=357.44  Aligned_cols=275  Identities=27%  Similarity=0.479  Sum_probs=219.5

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP  163 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  163 (404)
                      .....+.++..+|.+.+.||+|+||.||+|.+     +++.||||+++.....       ......+.+|+.++++++||
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~   96 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------QREIEEFLSEAACMKDFSHP   96 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-------HHHHHHHHHHHHHHHTCCCT
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-------hhHHHHHHHHHHHHhcCCCC
Confidence            34456678889999999999999999999986     2458999998654322       11235678999999999999


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN----RRRKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      ||+++++++.......           ...+++||||+++++|.+++...    ....+++..++.++.||+.||.|||+
T Consensus        97 ~iv~~~~~~~~~~~~~-----------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (313)
T 3brb_A           97 NVIRLLGVCIEMSSQG-----------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN  165 (313)
T ss_dssp             TBCCCCEEEEC------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CeeeeeEEEeeccccC-----------CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999987655431           12348999999999999998543    23579999999999999999999999


Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-  316 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-  316 (404)
                      +||+||||||+||+|+.++.+||+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       166 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  245 (313)
T 3brb_A          166 RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR  245 (313)
T ss_dssp             TTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence            999999999999999999999999999997543322  12233457889999999999999999999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       317 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      |..||...+..+....+.. ......+..+++++.++|.+||+.||.+||++.+|++.|+++..+.
T Consensus       246 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          246 GMTPYPGVQNHEMYDYLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             SCCSSTTCCGGGHHHHHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCccCCHHHHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            8999999888777666554 3456677889999999999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=356.05  Aligned_cols=259  Identities=33%  Similarity=0.635  Sum_probs=212.8

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ++..+|.+.+.||+|+||+||++.+.++.||||++....           ....+.+|+.++++++||||+++++++.+.
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   73 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-----------ERKAFIVELRQLSRVNHPNIVKLYGACLNP   73 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            567899999999999999999999999999999985211           235678999999999999999999987632


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhh---CCceecccCCCC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQS---KKIVHRDVKTEN  251 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~givH~Dikp~N  251 (404)
                        .                |+||||+++++|.+++..... ..++...++.++.||+.||.|||+   +||+||||||+|
T Consensus        74 --~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N  135 (307)
T 2eva_A           74 --V----------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN  135 (307)
T ss_dssp             --T----------------EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred             --c----------------EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence              2                899999999999999965432 347899999999999999999999   899999999999


Q ss_pred             EEEcCCCc-EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-
Q 015594          252 MLLDKTRT-VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV-  329 (404)
Q Consensus       252 ili~~~~~-vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~-  329 (404)
                      |+|+.++. +||+|||++.....   ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ 
T Consensus       136 Ill~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  212 (307)
T 2eva_A          136 LLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR  212 (307)
T ss_dssp             EEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH
T ss_pred             EEEeCCCCEEEEccccccccccc---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH
Confidence            99988886 79999999975332   22345689999999999999999999999999999999999999986543221 


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                      ..........+..+..+++.+.+||.+||+.||.+|||+.+|++.|+.+.....+.-
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          213 IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             HHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             HHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence            122233445566778899999999999999999999999999999999987765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-46  Score=350.69  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=214.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ...++|.+.+.||+|+||+||+|.+  +++.||||++...      ..........+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA------QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc------ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            3457899999999999999999998  5778999998531      1222223566889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus        80 ~~~~~----------------~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil  141 (279)
T 3fdn_A           80 DATRV----------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL  141 (279)
T ss_dssp             CSSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred             cCCEE----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence            77665                8999999999999999664  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      |+.++.+||+|||++.....  .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus       142 i~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          142 LGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  219 (279)
T ss_dssp             ECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcCCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            99999999999999864322  2334567899999999999999999999999999999999999999998888777666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ...  ....+..+++++.+||.+||+.||.+|||+.+|++.
T Consensus       220 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          220 SRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             HHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             HhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            554  344677789999999999999999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-47  Score=358.35  Aligned_cols=256  Identities=30%  Similarity=0.561  Sum_probs=204.6

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh--cCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||+||+|.++|+.||||++....            ...+.+|..++..  ++||||+++++++..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~   73 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------------EKSWFRETELYNTVMLRHENILGFIASDMT   73 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence            35789999999999999999999999999999985321            1234456666655  799999999998765


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh--------hCCceecc
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ--------SKKIVHRD  246 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~givH~D  246 (404)
                      ....            ....|+||||+++|+|.+++..   ..+++..++.++.||+.||.|||        +.||+|||
T Consensus        74 ~~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D  138 (301)
T 3q4u_A           74 SRHS------------STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD  138 (301)
T ss_dssp             EETT------------EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSC
T ss_pred             ccCC------------CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCC
Confidence            3221            1234899999999999999943   47999999999999999999999        99999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCc----ccCCCCCccccCccccCCC------CCCcchhhHHHHHHHHHHHh
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGS------AYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~  316 (404)
                      |||+||||+.++.+||+|||+++........    .....||+.|+|||++.+.      .++.++||||||+++|||++
T Consensus       139 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t  218 (301)
T 3q4u_A          139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR  218 (301)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999754433322    2334799999999999877      45579999999999999999


Q ss_pred             C----------CCCCCCCC-----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          317 C----------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       317 g----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |          ..||....     ..............+..+.     .+++++.+||.+||+.||.+|||+.+|++.|+
T Consensus       219 g~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             hhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            9          88886532     2222222333333444432     25678999999999999999999999999999


Q ss_pred             HhH
Q 015594          377 AID  379 (404)
Q Consensus       377 ~~~  379 (404)
                      +++
T Consensus       299 ~i~  301 (301)
T 3q4u_A          299 KID  301 (301)
T ss_dssp             HHC
T ss_pred             ccC
Confidence            873

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.8e-48  Score=379.67  Aligned_cols=258  Identities=22%  Similarity=0.372  Sum_probs=217.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+..++|.+.++||+|+||+||++.+  +++.||||+++...      .........+.+|+.++..++||||+++++
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE------MLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH------HHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH------hhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            4456678999999999999999999998  57899999996321      111111233778999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||++||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       142 ~~~~~~~~----------------~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~  204 (437)
T 4aw2_A          142 AFQDDNNL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD  204 (437)
T ss_dssp             EEECSSEE----------------EEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             EEeeCCEE----------------EEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHH
Confidence            99887766                8999999999999999653 457999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      ||||+.++.+||+|||+++....... .....+||+.|+|||++.     +..|+.++|||||||++|||++|..||...
T Consensus       205 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             HeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999975443332 234468999999999996     567899999999999999999999999999


Q ss_pred             CHHHHHHHHHhccCCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 015594          325 SFSEVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVA  373 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~--Rpt~~~ll~  373 (404)
                      +..+....+........+|   ..+++++.+||.+||..+|++  ||+++++++
T Consensus       285 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          285 SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            9888887776543333333   458999999999999888888  999999885

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-47  Score=362.14  Aligned_cols=258  Identities=20%  Similarity=0.286  Sum_probs=215.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      ...+|.+.+.||+|+||+||+|.+  +|+.||||++......           ..+.+|+.+++++ +||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~h~~i~~~~~~~~   75 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----------PQLHLEYRFYKQLGSGDGIPQVYYFGP   75 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----------CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----------HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence            347899999999999999999996  7899999998754322           2367899999999 9999999999988


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                ++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus        76 ~~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  137 (330)
T 2izr_A           76 CGKYN----------------AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL  137 (330)
T ss_dssp             ETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCcc----------------EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence            76655                8999999 99999999654 468999999999999999999999999999999999999


Q ss_pred             EcCCCc-----EEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          254 LDKTRT-----VKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       254 i~~~~~-----vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      |+.++.     +||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       138 l~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             ECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence            998887     99999999986443322       124567999999999999999999999999999999999999999


Q ss_pred             CCCCHH---HHHHHHHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          322 PDLSFS---EVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       322 ~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      ...+..   +....+.......   .....+| ++.+||.+||+.||.+||++++|++.|+++....|.
T Consensus       218 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          218 QGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             TTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            875433   3333332222111   1123456 999999999999999999999999999999887763

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=375.34  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=215.6

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      .++.+..++|.+.+.||+|+||.||++.+  +|+.||||+++...      .........+.+|..++..++||||++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~------~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD------MLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            34556778999999999999999999998  68999999996311      11111234477899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+...+                |+||||++||+|.+++.+. +..+++..++.++.||+.||.|||++||+||||||
T Consensus       128 ~~~~~~~~~----------------~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp  190 (412)
T 2vd5_A          128 FAFQDENYL----------------YLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP  190 (412)
T ss_dssp             EEEECSSEE----------------EEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             EEEeeCCEE----------------EEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH
Confidence            999887766                8999999999999999654 34799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC-cccCCCCCccccCccccC-------CCCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH-DMTGETGTLGYMAPEVLN-------GSAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      +||||+.++.+||+|||+++....... .....+||+.|+|||++.       +..|+.++|||||||++|||++|..||
T Consensus       191 ~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  270 (412)
T 2vd5_A          191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF  270 (412)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence            999999999999999999976543322 233468999999999997       456899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhccC---CCCCCCCCcHHHHHHHHHhhhhCCCCC---CCHHHHHH
Q 015594          322 PDLSFSEVTSAVVRQNL---RPEIPRCCPSSLANVMKRCWDANPDKR---PEMDEVVA  373 (404)
Q Consensus       322 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~~ll~  373 (404)
                      ...+..+....+.....   .+..+..+++++++||.+||. +|.+|   |++++|++
T Consensus       271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            99988888777765332   223346789999999999999 99998   58998874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=368.72  Aligned_cols=272  Identities=20%  Similarity=0.320  Sum_probs=206.3

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHH--HHHHHHHHHHHHHhhcCCCceeE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIA--SLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ++...+|.+.+.||+|+||+||+|.+     ++..||||++.........+....  .....+.+|+.+++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            35568999999999999999999998     468899999975533211111111  11234778999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.....            ....+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||
T Consensus       113 ~~~~~~~~~~------------~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  177 (345)
T 2v62_A          113 FYGSGLTEFK------------GRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDI  177 (345)
T ss_dssp             EEEEEEEESS------------SCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             eecccccccC------------CCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCc
Confidence            9999876311            112349999999 99999998554  37999999999999999999999999999999


Q ss_pred             CCCCEEEcCCC--cEEEeeccccccccCCC-------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC
Q 015594          248 KTENMLLDKTR--TVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       248 kp~Nili~~~~--~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  318 (404)
                      ||+||||+.++  .+||+|||+++......       .......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       178 kp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~  257 (345)
T 2v62_A          178 KAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK  257 (345)
T ss_dssp             SGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999998777  99999999997543221       1124457999999999999999999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhccCCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          319 MPYPDLSFSEVTSAVVRQNLRPEIP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       319 ~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .||....................++         ..+++++.++|.+||+.||++||++++|++.|+.+...
T Consensus       258 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          258 LPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             CTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             CCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            9996532221111111111111222         27889999999999999999999999999999986543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-46  Score=350.71  Aligned_cols=262  Identities=28%  Similarity=0.544  Sum_probs=219.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .|.+..++|.+.+.||+|+||+||+|.+.     +..||||++.....        ......+.+|+.++++++||||++
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~   77 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--------LDNKEKFMSEAVIMKNLDHPHIVK   77 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--------HHHHHHHHHHHHHHHHHCCTTBCC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--------chHHHHHHHHHHHHHhCCCCCcce
Confidence            45677889999999999999999999862     24599999864321        122456889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.+.. .                |+||||+++++|.+++.+. ...+++..++.++.||+.||.|||++||+|+||
T Consensus        78 ~~~~~~~~~-~----------------~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl  139 (281)
T 3cc6_A           78 LIGIIEEEP-T----------------WIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDI  139 (281)
T ss_dssp             EEEEECSSS-C----------------EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             EEEEEcCCC-C----------------EEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence            999976432 2                7999999999999999654 356999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      ||+||+++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       140 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~  219 (281)
T 3cc6_A          140 AVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE  219 (281)
T ss_dssp             SGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence            9999999999999999999997544322 12234557889999999998889999999999999999998 999998887


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ..+....+.. ......+..+++.+.++|.+||+.||++||++.+|++.|+.+...
T Consensus       220 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          220 NKDVIGVLEK-GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             GGGHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            7776655444 344556778999999999999999999999999999999998654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.1e-47  Score=355.56  Aligned_cols=263  Identities=26%  Similarity=0.454  Sum_probs=215.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ..+....|++.+.||+|+||.||++.+      +++.||||++......        .....+.+|+.++++++||||++
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~   87 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--------NHIADLKKEIEILRNLYHENIVK   87 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--------hhHHHHHHHHHHHHhCCCCCeee
Confidence            345567899999999999999999984      6899999999643211        12355789999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.....-              .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||
T Consensus        88 ~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di  152 (302)
T 4e5w_A           88 YKGICTEDGGN--------------GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDL  152 (302)
T ss_dssp             EEEEEEC---C--------------CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             eeeEEecCCCc--------------eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCC
Confidence            99999866322              238999999999999999654 357999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      ||+||+++.++.+||+|||++........   ......+|..|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus       153 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  232 (302)
T 4e5w_A          153 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP  232 (302)
T ss_dssp             SGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             chheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence            99999999999999999999986544332   233456888899999999988999999999999999999998876321


Q ss_pred             --------------CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          325 --------------SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       325 --------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                                    ..................+..+++++.+||.+||+.||.+|||+.++++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          233 MALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                          1222223334455566778889999999999999999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-47  Score=378.00  Aligned_cols=251  Identities=27%  Similarity=0.496  Sum_probs=217.9

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||.||+|.+  +|+.||||++....      .........+.+|+.+++.++||||+++++++.
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH------HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4457899999999999999999998  68999999996321      111123456889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ....+                |+||||+++|+|.+++.+  ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl  148 (476)
T 2y94_A           87 TPSDI----------------FMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL  148 (476)
T ss_dssp             CSSEE----------------EEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred             ECCEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence            77665                899999999999999854  367999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++.++.+||+|||++..... .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......
T Consensus       149 l~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~  227 (476)
T 2y94_A          149 LDAHMNAKIADFGLSNMMSD-GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK  227 (476)
T ss_dssp             ECTTCCEEECCCSSCEECCT-TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH
T ss_pred             EecCCCeEEEeccchhhccc-cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999986433 333455789999999999998765 7899999999999999999999999888777777


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....+  ..+..+++++.+||.+||+.||.+|||+.+|++
T Consensus       228 i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          228 ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            665543  456778999999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.5e-47  Score=361.07  Aligned_cols=258  Identities=25%  Similarity=0.543  Sum_probs=213.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCce----EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++.    ||+|.+....        .......+.+|+.++++++||||++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~   83 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--------SPKANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--------CHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            4457899999999999999999997  4544    5777764221        112245688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+.. .                ++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus        84 ~~~~~~~-~----------------~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp  145 (327)
T 3poz_A           84 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA  145 (327)
T ss_dssp             EEEESSS-E----------------EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             EEEecCC-e----------------EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence            9997653 2                7899999999999999664 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +||||+.++.+||+|||+++.......  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus       146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  225 (327)
T 3poz_A          146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence            999999999999999999986543322  2234456889999999999999999999999999999999 9999998887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      .+....+ ........+..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          226 SEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             GGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            7765544 4444556777899999999999999999999999999999998864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.2e-47  Score=359.66  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=197.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||+++.......        ...+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   75 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--------PSTAIREISLMKELKHENIVRLYDVIHTE   75 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--------CHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence            46899999999999999999987  689999999976542211        23467899999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      ..+                |+||||++ ++|.+++....    ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus        76 ~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N  138 (317)
T 2pmi_A           76 NKL----------------TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN  138 (317)
T ss_dssp             TEE----------------EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CeE----------------EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence            655                89999996 69999986542    2458999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||++.++.+||+|||+++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+..
T Consensus       139 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  218 (317)
T 2pmi_A          139 LLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL  218 (317)
T ss_dssp             EEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999999999999999998665554555667899999999999764 6899999999999999999999999998877766


Q ss_pred             HHHHhccC--------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNL--------------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~--------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.....                                .+..+..+++++.+||.+||+.||++|||+.++++
T Consensus       219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            65543210                                01112357889999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=357.52  Aligned_cols=263  Identities=24%  Similarity=0.378  Sum_probs=213.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTK  167 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  167 (404)
                      .........+|.+.+.||+|+||.||+|.+  +|+.||||++......          ...+.+|+.+++++ +||||++
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTBCC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCeee
Confidence            334445678999999999999999999998  7899999999754322          23467899999999 8999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++......          .....+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||
T Consensus        86 ~~~~~~~~~~~----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl  155 (326)
T 2x7f_A           86 YYGAFIKKNPP----------GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI  155 (326)
T ss_dssp             EEEEEEECC------------CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             eeeEEeeccCc----------cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence            99999764321          01233489999999999999998766678999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      ||+||+++.++.+||+|||++..............||+.|+|||++.     +..++.++||||||+++|+|++|..||.
T Consensus       156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  235 (326)
T 2x7f_A          156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  235 (326)
T ss_dssp             SGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999976544333344567899999999997     5668999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.......+.........+..+++.+.+||.+||..||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             TSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            888777666666555555556778999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-47  Score=357.76  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=208.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +++.||||++......      .......+.+|+.++.+++||||+++++++...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS------DPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            47899999999999999999997  6899999998643221      123356688999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus       107 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~  168 (309)
T 2h34_A          107 GQL----------------YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS  168 (309)
T ss_dssp             TEE----------------EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CeE----------------EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc
Confidence            655                8999999999999999654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+....... .
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~  247 (309)
T 2h34_A          169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-I  247 (309)
T ss_dssp             TTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-H
T ss_pred             CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-h
Confidence            99999999999997544322 223345789999999999999999999999999999999999999988766544333 3


Q ss_pred             hccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhHhhcC
Q 015594          335 RQNLR--PEIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       335 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~~~~~  383 (404)
                      .....  ...+..+|+++.+||.+||+.||++|| +++++++.|+.+.....
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          248 NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            33222  234567899999999999999999999 99999999998876665

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-46  Score=352.50  Aligned_cols=261  Identities=17%  Similarity=0.279  Sum_probs=217.9

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      .+...+|.+.+.||+|+||+||+|.+  +|+.||||++......           ..+.+|+.++..+ +|+|+++++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~~~~l~~~~~i~~~~~~   74 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----------PQLRDEYRTYKLLAGCTGIPNVYYF   74 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----------CCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----------HHHHHHHHHHHHHhcCCCCCeEEee
Confidence            34567899999999999999999996  7899999998644321           2356889999999 89999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +......                ++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        75 ~~~~~~~----------------~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N  136 (298)
T 1csn_A           75 GQEGLHN----------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN  136 (298)
T ss_dssp             EEETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred             cCCCcee----------------EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            8766655                8999999 99999999654 4569999999999999999999999999999999999


Q ss_pred             EEEcCCCc-----EEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCC
Q 015594          252 MLLDKTRT-----VKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDM  319 (404)
Q Consensus       252 ili~~~~~-----vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  319 (404)
                      |||+.++.     +||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       137 Il~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  216 (298)
T 1csn_A          137 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL  216 (298)
T ss_dssp             EEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence            99987765     99999999986543322       2345679999999999999999999999999999999999999


Q ss_pred             CCCCCC---HHHHHHHHHhccCC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          320 PYPDLS---FSEVTSAVVRQNLR---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       320 Pf~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      ||...+   ..+....+......   ......+|+++.+||.+||+.||++||++++|++.|+++....+.
T Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            998753   33333333322211   123457899999999999999999999999999999999988764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-46  Score=379.36  Aligned_cols=256  Identities=24%  Similarity=0.418  Sum_probs=213.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcc----cHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHR----SEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++........    ...........+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            47899999999999999999998  578999999975432211    011112335668899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+...+                |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       115 ~~~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N  176 (504)
T 3q5i_A          115 FEDKKYF----------------YLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN  176 (504)
T ss_dssp             EECSSEE----------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEcCCEE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence            9877665                8999999999999998664  579999999999999999999999999999999999


Q ss_pred             EEEcCCC---cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          252 MLLDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       252 ili~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      |||+.++   .+||+|||++..... ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  254 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSK-DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD  254 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCT-TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEecCCCCccEEEEECCCCEEcCC-CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9998765   699999999975433 334456789999999999986 48999999999999999999999999999888


Q ss_pred             HHHHHHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+....+....  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            88888776654332  2578999999999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=372.46  Aligned_cols=274  Identities=18%  Similarity=0.229  Sum_probs=214.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEEC----------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYD----------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~----------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ...+|.+.+.||+|+||+||+|.+.          ++.||||++...              ..+.+|+.++++++||||+
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv  105 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQV  105 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchh
Confidence            3579999999999999999999873          789999998643              2367899999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++.+.......+....+........+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|||
T Consensus       106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D  184 (352)
T 2jii_A          106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN  184 (352)
T ss_dssp             HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred             hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence            85444333222222211111111234559999999 99999999876557899999999999999999999999999999


Q ss_pred             cCCCCEEEcCCC--cEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 015594          247 VKTENMLLDKTR--TVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       247 ikp~Nili~~~~--~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      |||+|||++.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999988  899999999975432211       22345799999999999999999999999999999999999


Q ss_pred             CCCCCCCC--HHHHHHHHHh-ccCCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          318 DMPYPDLS--FSEVTSAVVR-QNLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       318 ~~Pf~~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ..||....  .......... ......+.      ..+++++.+||.+||+.||.+||++++|++.|+.+....+..
T Consensus       265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            99998764  2222222111 11111111      246899999999999999999999999999999999888743

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.2e-46  Score=346.55  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=216.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            47899999999999999999988  5899999999754322       11235578999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus        78 ~~~----------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~  139 (284)
T 3kk8_A           78 SFH----------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA  139 (284)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred             CEE----------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence            655                8999999999999988654  5799999999999999999999999999999999999997


Q ss_pred             CCCc---EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.   +||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       140 ~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  218 (284)
T 3kk8_A          140 SKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ  218 (284)
T ss_dssp             SSSTTCCEEECCCTTCEECCS-SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCcEEEeeceeeEEccc-CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH
Confidence            6655   99999999975433 3334557799999999999999999999999999999999999999999988888777


Q ss_pred             HHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.........  ...+++++.+||.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            7766544333  3578999999999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-46  Score=350.96  Aligned_cols=249  Identities=28%  Similarity=0.475  Sum_probs=206.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||++.+  +++.||+|++........        ...+.+|+.++++++||||+++++++.+..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--------HHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            6899999999999999999997  588999999975432211        345779999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ..                |+||||+++++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        94 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~  157 (285)
T 3is5_A           94 NM----------------YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF  157 (285)
T ss_dssp             EE----------------EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             eE----------------EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE
Confidence            65                8999999999999998553  24679999999999999999999999999999999999999


Q ss_pred             ---cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          255 ---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       255 ---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                         +.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+...
T Consensus       158 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~  235 (285)
T 3is5_A          158 QDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ  235 (285)
T ss_dssp             SSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ecCCCCCCEEEEeeecceecCC-cccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence               4567899999999975433 233445678999999999875 58999999999999999999999999988877766


Q ss_pred             HHHhccCCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPE-IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......... ....+++++.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             hhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            6554443322 22447899999999999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=385.45  Aligned_cols=268  Identities=29%  Similarity=0.535  Sum_probs=223.9

Q ss_pred             ccccccCCCCeEEee-eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           91 RQEWEIDPAKLIIKG-AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ...+.+...++.+.+ .||+|+||.||+|.+    ++..||||+++......        ....+.+|+.++++++||||
T Consensus       327 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~~E~~il~~l~hpni  398 (613)
T 2ozo_A          327 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--------DTEEMMREAQIMHQLDNPYI  398 (613)
T ss_dssp             CCCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--------THHHHHHHHHHHTTCCCTTB
T ss_pred             ccceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--------HHHHHHHHHHHHHhCCCCCE
Confidence            345667778888777 899999999999987    35679999997543211        13457899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      +++++++... .+                |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus       399 v~l~~~~~~~-~~----------------~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr  460 (613)
T 2ozo_A          399 VRLIGVCQAE-AL----------------MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHR  460 (613)
T ss_dssp             CCEEEEEESS-SE----------------EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeEEEEeccC-Ce----------------EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence            9999998753 23                8999999999999998543 4679999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPY  321 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf  321 (404)
                      ||||+||||+.++.+||+|||+++........   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       461 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             CCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999864432221   122345689999999998889999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ...+..+....+. ...+...+..+++++.+||.+||+.||++||++.+|++.|+.+..+.+..
T Consensus       541 ~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          541 KKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             TTCCSHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            9988887766554 44566778899999999999999999999999999999999998877644

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-47  Score=362.89  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=200.1

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||+||+|.+  +++.||||++......       ......+.+|+.++++++||||+++++++.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-------EGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-------cccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            357899999999999999999987  6899999999654321       1224456789999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+||||++ ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       105 ~~~~----------------~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll  165 (329)
T 3gbz_A          105 NHRL----------------HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL  165 (329)
T ss_dssp             TTEE----------------EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEE----------------EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEE
Confidence            7665                89999995 6999999665  469999999999999999999999999999999999999


Q ss_pred             -----cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 -----DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 -----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                           +..+.+||+|||+++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+
T Consensus       166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  245 (329)
T 3gbz_A          166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID  245 (329)
T ss_dssp             EC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence                 455569999999998765555555667789999999999875 48999999999999999999999999988777


Q ss_pred             HHHHHHhccCCCC----------------C------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPE----------------I------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~----------------~------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+......+.                .            +..+++++.+||.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          246 QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            6666554211110                0            0116789999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.8e-47  Score=361.60  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|.+  +++.||||++......        .....+.+|+.+++.++||||+++++++.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--------chHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            47899999999999999999988  6899999999643221        1234577999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        78 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~  139 (323)
T 3tki_A           78 NIQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  139 (323)
T ss_dssp             SEE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CeE----------------EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence            665                899999999999998843  35799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-H
Q 015594          256 KTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-S  331 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~-~  331 (404)
                      .++.+||+|||++.......  .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..... .
T Consensus       140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  219 (323)
T 3tki_A          140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  219 (323)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred             CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence            99999999999997543222  22345679999999999987765 78999999999999999999999876554322 2


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..............+++++.+||.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            333333333334668999999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.5e-47  Score=354.63  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=211.2

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEEC--C-------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYD--G-------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--g-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ++..++|.+.+.||+|+||+||+|.+.  +       ..||+|++.....         .....+.+|+.++++++||||
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i   74 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---------NYSESFFEAASMMSKLSHKHL   74 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---------GGHHHHHHHHHHHHTSCCTTB
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---------HHHHHHHHHHHHHHhCCCCCE
Confidence            466789999999999999999999873  3       5799999864321         123567899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      +++++++.+....                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus        75 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  137 (289)
T 4fvq_A           75 VLNYGVCVCGDEN----------------ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHG  137 (289)
T ss_dssp             CCEEEEECCTTCC----------------EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             eEEEEEEEeCCCC----------------EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence            9999999876655                8999999999999999664 3459999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCc--------EEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHh
Q 015594          246 DVKTENMLLDKTRT--------VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       246 Dikp~Nili~~~~~--------vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~  316 (404)
                      ||||+||||+.++.        +||+|||++.....    .....+|+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus       138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  213 (289)
T 4fvq_A          138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS  213 (289)
T ss_dssp             CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred             CcCcceEEEecCCcccccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence            99999999988887        99999999864322    123457889999999987 679999999999999999999


Q ss_pred             C-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          317 C-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       317 g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      | ..||.............   .....+..+++++.+||.+||+.||.+|||+.++++.|+.+.++.+.+
T Consensus       214 g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          214 GGDKPLSALDSQRKLQFYE---DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             TTCCTTTTSCHHHHHHHHH---TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             CCCCCccccchHHHHHHhh---ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            5 56666665544433322   234456667889999999999999999999999999999999877643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-46  Score=357.79  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=219.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ...+|.+.+.||+|+||.||++.+  +++.||+|++.......      ...+..+.+|+.+++.++||||+++++++.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  112 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFED  112 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            357899999999999999999998  57899999997543221      1234567899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       113 ~~~~----------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~  174 (335)
T 2owb_A          113 NDFV----------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL  174 (335)
T ss_dssp             SSEE----------------EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             CCeE----------------EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE
Confidence            6655                8999999999999988654  579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      +.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  254 (335)
T 2owb_A          175 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK  254 (335)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh
Confidence            99999999999999865544444555779999999999999989999999999999999999999999888777766655


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...  ..++..+++.+.+||.+||+.||++||++.+|++
T Consensus       255 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          255 KNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            543  3466788999999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=355.01  Aligned_cols=249  Identities=25%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGA  171 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~  171 (404)
                      ++...+|++.+.||+|+||+||+|.+  +|+.||||++.......   .    ....+..|+..+.++ +||||++++++
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP---K----DRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH---H----HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh---H----HHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            33447899999999999999999998  68999999986433221   1    122344555555555 99999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+...+                |+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus       126 ~~~~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  187 (311)
T 3p1a_A          126 WEEGGIL----------------YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN  187 (311)
T ss_dssp             EEETTEE----------------EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             EEeCCEE----------------EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence            9877665                8999999 88999988665 4579999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |||+.++.+||+|||++..... ........||+.|+|||++.+ .++.++||||||+++|||++|..|+...   +...
T Consensus       188 Ill~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~  262 (311)
T 3p1a_A          188 IFLGPRGRCKLGDFGLLVELGT-AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQ  262 (311)
T ss_dssp             EEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHH
T ss_pred             EEECCCCCEEEccceeeeeccc-CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHH
Confidence            9999999999999999975433 233345679999999999987 5999999999999999999997665432   2233


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+......+..+..+++++.+||.+||+.||++|||+.+|++
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            333334444456678999999999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.5e-47  Score=353.34  Aligned_cols=264  Identities=29%  Similarity=0.521  Sum_probs=215.8

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE---CC--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY---DG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~---~g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ..+...+|.+.+.||+|+||+||+|.+   ++  ..||||+++.....      .......+.+|+.++++++||||+++
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~   86 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRL   86 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC------CHHHHHHHHHHHHHHHhCCCCCcccE
Confidence            345678999999999999999999986   23  36899998643221      12235668899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.... .                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+|||
T Consensus        87 ~~~~~~~~-~----------------~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik  148 (291)
T 1u46_A           87 YGVVLTPP-M----------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA  148 (291)
T ss_dssp             EEEECSSS-C----------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEccCC-c----------------eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence            99987653 2                7999999999999999664 3569999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      |+||+++.++.+||+|||++.........   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       149 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  228 (291)
T 1u46_A          149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL  228 (291)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             hheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence            99999999999999999999765433221   223457889999999998889999999999999999999 99999999


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +..+....+.........+..+++++.++|.+||+.||.+|||+.+|++.|+++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          229 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            988888887777767777788999999999999999999999999999999988654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-47  Score=363.70  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=210.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +++.||||++.......    ........+.+|+.++++++||||+++++++.+.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ----INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc----cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            47899999999999999999988  67899999986421100    0122346688999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--------------------------------------ccCC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--------------------------------------RRRK  217 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------------------------------~~~~  217 (404)
                      ...                |+||||+++|+|.+++...                                      ....
T Consensus       101 ~~~----------------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (345)
T 3hko_A          101 QYI----------------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV  164 (345)
T ss_dssp             SEE----------------EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHH
T ss_pred             CeE----------------EEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence            655                8999999999999988421                                      0223


Q ss_pred             CcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCC--cEEEeeccccccccCCC----CcccCCCCCccccCcc
Q 015594          218 LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR--TVKIADFGVARLEASNP----HDMTGETGTLGYMAPE  291 (404)
Q Consensus       218 l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~--~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE  291 (404)
                      +++..++.++.||+.||.|||++||+||||||+||||+.++  .+||+|||++.......    .......||+.|+|||
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  244 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE  244 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence            46788999999999999999999999999999999997666  89999999997543221    1234567999999999


Q ss_pred             ccCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC
Q 015594          292 VLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPE  367 (404)
Q Consensus       292 ~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt  367 (404)
                      ++.+  ..++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++.+||.+||+.||.+||+
T Consensus       245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9975  678999999999999999999999999999888888877766554433  347899999999999999999999


Q ss_pred             HHHHHH
Q 015594          368 MDEVVA  373 (404)
Q Consensus       368 ~~~ll~  373 (404)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-46  Score=368.23  Aligned_cols=249  Identities=20%  Similarity=0.327  Sum_probs=195.1

Q ss_pred             CCeEEe-eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHH-hhcCCCceeEEEEEEec
Q 015594           99 AKLIIK-GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW-HKLDHPNVTKFIGATMG  174 (404)
Q Consensus        99 ~~~~~~-~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~  174 (404)
                      ++|.+. +.||+|+||+||++.+  +|+.||||+++..              ..+.+|+.++ +.++||||+++++++..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            567766 7899999999999998  6899999999521              2245777776 45589999999999864


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...            ....+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       127 ~~~------------~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill  194 (400)
T 1nxk_A          127 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY  194 (400)
T ss_dssp             EET------------TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             ccc------------CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE
Confidence            110            11234899999999999999976555679999999999999999999999999999999999999


Q ss_pred             cC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---
Q 015594          255 DK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE---  328 (404)
Q Consensus       255 ~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~---  328 (404)
                      +.   ++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   
T Consensus       195 ~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  273 (400)
T 1nxk_A          195 TSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP  273 (400)
T ss_dssp             SSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC
T ss_pred             ecCCCCccEEEEecccccccCC-CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH
Confidence            87   78999999999975432 233456788999999999999999999999999999999999999997654322   


Q ss_pred             -HHHHHHhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          329 -VTSAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       329 -~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                       ....+....+...  ....+++++.+||.+||+.||.+|||+.+|++.
T Consensus       274 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          274 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             3334444433322  235689999999999999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-46  Score=354.90  Aligned_cols=265  Identities=26%  Similarity=0.395  Sum_probs=213.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +++.||||++.......      ......+.+|+.++.+++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS------HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC------HHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            57899999999999999999997  78999999997543221      22345688999999999999999999998765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...            ....|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        85 ~~~------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~  150 (311)
T 3ork_A           85 TPA------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS  150 (311)
T ss_dssp             ETT------------EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred             CCC------------CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence            432            12238999999999999999654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.+||+|||++........   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  230 (311)
T 3ork_A          151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ  230 (311)
T ss_dssp             TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999999975443322   22335689999999999999999999999999999999999999999888777666


Q ss_pred             HHhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHHHHHHhHhhc
Q 015594          333 VVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPE-MDEVVAMLEAIDTSK  382 (404)
Q Consensus       333 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~ll~~L~~~~~~~  382 (404)
                      .......+.  ....+++++.+||.+||+.||.+||+ ++++...|..+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  283 (311)
T 3ork_A          231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE  283 (311)
T ss_dssp             HHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred             HhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence            665544332  23568999999999999999999985 555666777665443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.7e-47  Score=362.65  Aligned_cols=245  Identities=20%  Similarity=0.390  Sum_probs=208.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  174 (404)
                      .++|.+.+.||+|+||.||++.+  +|+.||||+++.....             ..+|+.++.++ +||||+++++++.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------~~~E~~~l~~~~~hp~iv~~~~~~~~   87 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------------PTEEIEILLRYGQHPNIITLKDVYDD   87 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence            36799999999999999999998  6899999999754322             23577777777 79999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~----------------~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~  149 (342)
T 2qr7_A           88 GKYV----------------YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY  149 (342)
T ss_dssp             SSEE----------------EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             CCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence            7665                8999999999999998654  579999999999999999999999999999999999998


Q ss_pred             cCC----CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHH
Q 015594          255 DKT----RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPD---LSFS  327 (404)
Q Consensus       255 ~~~----~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~---~~~~  327 (404)
                      ...    +.+||+|||++.............+||+.|+|||++.+..++.++||||||+++|+|++|..||..   .+..
T Consensus       150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  229 (342)
T 2qr7_A          150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE  229 (342)
T ss_dssp             SSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH
T ss_pred             ecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH
Confidence            432    359999999998655554555567899999999999988899999999999999999999999975   3555


Q ss_pred             HHHHHHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....+....+..  ..+..+++++.+||.+||..||++||++.++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            6666666555443  234678999999999999999999999999885

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.5e-46  Score=364.06  Aligned_cols=253  Identities=21%  Similarity=0.334  Sum_probs=209.1

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC--CCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~  170 (404)
                      ..+...+|.+.+.||+|+||+||++.+ +++.||||++......       ......+.+|+.+++++.  ||||+++++
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~  123 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLYD  123 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-------HHHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence            345556799999999999999999987 5889999999765432       122456889999999996  599999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.....+                |+|||+ .+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~~~~~~----------------~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~  184 (390)
T 2zmd_A          124 YEITDQYI----------------YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA  184 (390)
T ss_dssp             EEECSSEE----------------EEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG
T ss_pred             EEecCCEE----------------EEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence            98877655                899995 589999999764  47899999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCC-----------CCCCcchhhHHHHHHHHHHHhC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNG-----------SAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g  317 (404)
                      ||||+ ++.+||+|||+++.......  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|
T Consensus       185 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G  263 (390)
T 2zmd_A          185 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG  263 (390)
T ss_dssp             GEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred             HEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence            99996 57899999999986443221  2345679999999999865           3689999999999999999999


Q ss_pred             CCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          318 DMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       318 ~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..||.... .......+.........+...+.++.+||.+||+.||.+||++.+|++
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          264 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             SCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            99998754 334455566666666778888999999999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=346.08  Aligned_cols=261  Identities=33%  Similarity=0.526  Sum_probs=217.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      .|.+.+.||+|+||+||+|.+  ++   ..||+|++.....        ......+.+|+.++++++||||+++++++.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--------MQQVEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            456679999999999999986  33   3799999864221        1224567899999999999999999999876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....               .++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        94 ~~~~---------------~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili  157 (298)
T 3pls_A           94 PEGL---------------PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML  157 (298)
T ss_dssp             SSSC---------------CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCC---------------cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence            5543               2799999999999999855 34678999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCC----CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHH
Q 015594          255 DKTRTVKIADFGVARLEASN----PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEV  329 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~Pf~~~~~~~~  329 (404)
                      +.++.+||+|||+++.....    ........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+.
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~  237 (298)
T 3pls_A          158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL  237 (298)
T ss_dssp             CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH
T ss_pred             cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH
Confidence            99999999999999753322    2223345678999999999999999999999999999999995 555666666665


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ... .........+..+++.+.++|.+||+.||.+|||+.++++.|+++..+..+.
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          238 THF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             HHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             HHH-hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            544 4444456677889999999999999999999999999999999998877543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-47  Score=362.56  Aligned_cols=265  Identities=28%  Similarity=0.444  Sum_probs=214.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +.+....+|.+.+.||+|+||+||+|.+ +|+.||||++......         ....+.+|+.+++.++||||++++++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---------GIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---------HHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3344568899999999999999999997 5899999988654221         13457899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +......                ++||||+++|+|.+++....  ...+++..++.++.||+.||.|||++||+||||||
T Consensus       104 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  167 (321)
T 2qkw_B          104 CDERNEM----------------ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS  167 (321)
T ss_dssp             CCCTTCC----------------EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS
T ss_pred             EcCCCeE----------------EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH
Confidence            8776655                89999999999999885442  23589999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      +||+++.++.+||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus       168 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~  247 (321)
T 2qkw_B          168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR  247 (321)
T ss_dssp             TTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred             HHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence            99999999999999999997543221  2223455899999999998888999999999999999999999999754332


Q ss_pred             HHH------HHHHh-c--------cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          328 EVT------SAVVR-Q--------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       328 ~~~------~~~~~-~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      +..      ..... .        ......+..++..+.++|.+||+.||++|||+.++++.|+.+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            211      01111 1        1111223345678999999999999999999999999999887543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=351.31  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=188.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++....      .........+.+|+.++++++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh------hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            36899999999999999999997  78999999995321      11112245688999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus        84 ~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~  146 (278)
T 3cok_A           84 NYV----------------YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT  146 (278)
T ss_dssp             SEE----------------EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC
T ss_pred             CeE----------------EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence            655                8999999999999998643 46799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       147 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (278)
T 3cok_A          147 RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL  226 (278)
T ss_dssp             TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS
T ss_pred             CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh
Confidence            99999999999998654443344456789999999999999999999999999999999999999987765544433222


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .  ....+..++.++.+||.+||+.||++||+++++++
T Consensus       227 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 A--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             S--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            2  23456778999999999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.6e-46  Score=377.31  Aligned_cols=255  Identities=23%  Similarity=0.352  Sum_probs=215.8

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+..++|.+.+.||+|+||.||++.+  +|+.||||++....      .........+.+|+.++++++||||+++++++
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR------LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH------hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            35568999999999999999999998  68999999996321      11112235678999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      .+...+                |+||||++||+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       255 ~~~~~l----------------~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~  318 (543)
T 3c4z_A          255 ETKTDL----------------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE  318 (543)
T ss_dssp             ECSSEE----------------EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             eeCCEE----------------EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence            887766                89999999999999986643  457999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----H
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS----F  326 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~----~  326 (404)
                      ||||+.+|.+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|..||...+    .
T Consensus       319 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~  398 (543)
T 3c4z_A          319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN  398 (543)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred             HEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence            999999999999999999865544444455689999999999999999999999999999999999999998753    3


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVA  373 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~  373 (404)
                      .++...+...  ...+|..+++++.+||.+||+.||.+||++     ++|++
T Consensus       399 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          399 KELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            4454454443  335677899999999999999999999975     56653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.4e-46  Score=384.90  Aligned_cols=264  Identities=30%  Similarity=0.533  Sum_probs=219.7

Q ss_pred             ccccccCCCCeEEee-eeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           91 RQEWEIDPAKLIIKG-AFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ..+|.++...+.+.. .||+|+||+||+|.+    .++.||||+++......       .....+.+|+.++.+++||||
T Consensus       360 ~~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnI  432 (635)
T 4fl3_A          360 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-------ALKDELLAEANVMQQLDNPYI  432 (635)
T ss_dssp             CSSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-------GGHHHHHHHHHHHHHCCCTTB
T ss_pred             cccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCE
Confidence            345666666776654 899999999999976    45789999997543221       123558899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      |++++++.+.. .                ++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||
T Consensus       433 v~l~~~~~~~~-~----------------~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr  493 (635)
T 4fl3_A          433 VRMIGICEAES-W----------------MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHR  493 (635)
T ss_dssp             CCEEEEEESSS-E----------------EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeEEEEEecCC-E----------------EEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence            99999986432 3                7999999999999999654  579999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPY  321 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf  321 (404)
                      ||||+||||+.++.+||+|||+++.......   ......+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus       494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  573 (635)
T 4fl3_A          494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  573 (635)
T ss_dssp             CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999986543321   2233456789999999999899999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+.+..+....+. ...+...+..+|+++.+||.+||+.||++||++.+|++.|+++...
T Consensus       574 ~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          574 RGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             TTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9998887765554 4456677889999999999999999999999999999999988653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-46  Score=356.40  Aligned_cols=266  Identities=30%  Similarity=0.514  Sum_probs=219.8

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      ...++...+|.+.+.||+|+||.||+|.+       +++.||||++....    ..    .....+.+|+.++++++|||
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~   94 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SE----QDELDFLMEALIISKFNHQN   94 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CH----HHHHHHHHHHHHHHHCCCTT
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----ch----hhHHHHHHHHHHHhhCCCCC
Confidence            34467788999999999999999999983       46789999985321    11    12345789999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-----CCCcHHHHHHHHHHHHHHHHHHhh
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-----RKLAFKVVIQLALDLARGLSYLQS  239 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~  239 (404)
                      |+++++++......                |+||||+++++|.+++.....     ..+++..++.++.||+.||.|||+
T Consensus        95 iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  158 (327)
T 2yfx_A           95 IVRCIGVSLQSLPR----------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE  158 (327)
T ss_dssp             BCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEcCCCCc----------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            99999999876655                899999999999999976532     458999999999999999999999


Q ss_pred             CCceecccCCCCEEEcC---CCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHH
Q 015594          240 KKIVHRDVKTENMLLDK---TRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEI  314 (404)
Q Consensus       240 ~givH~Dikp~Nili~~---~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  314 (404)
                      +||+||||||+||||+.   +..+||+|||++.......  .......+|+.|+|||++.+..++.++||||||+++|+|
T Consensus       159 ~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  238 (327)
T 2yfx_A          159 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI  238 (327)
T ss_dssp             TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999984   4569999999997543322  122335678999999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          315 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       315 ~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ++ |..||...+..+....+.. ......+..+++.+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus       239 lt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          239 FSLGYMPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcCCCCCCCCcCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            98 9999998887776655544 3455667889999999999999999999999999999999887644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.5e-46  Score=360.92  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=211.1

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-----C
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-----H  162 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h  162 (404)
                      ..++..+...+|.+.+.||+|+||+||+|.+  +++.||||++...      .    .....+..|+.+++.+.     |
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------K----KYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------H----HHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------h----hhhhhhHHHHHHHHHhcccCCCC
Confidence            3445556678999999999999999999998  7899999998521      1    12344667999999996     9


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCc
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI  242 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi  242 (404)
                      |||+++++++.....+                |+||||+ +++|.+++.......+++..++.++.||+.||.|||++||
T Consensus        96 ~~iv~~~~~~~~~~~~----------------~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  158 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHM----------------CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSL  158 (360)
T ss_dssp             GGBCCEEEEEEETTEE----------------EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CCeecccceeeECCee----------------EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            9999999999877655                8999999 9999999987766679999999999999999999999999


Q ss_pred             eecccCCCCEEEcC-------------------------CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC
Q 015594          243 VHRDVKTENMLLDK-------------------------TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA  297 (404)
Q Consensus       243 vH~Dikp~Nili~~-------------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  297 (404)
                      +||||||+||||+.                         ++.+||+|||+++....   ......||+.|+|||++.+..
T Consensus       159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~  235 (360)
T 3llt_A          159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLG  235 (360)
T ss_dssp             ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCC
T ss_pred             eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCC
Confidence            99999999999975                         78999999999975332   234567899999999999999


Q ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------------------CCC----------
Q 015594          298 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP------------------------EIP----------  343 (404)
Q Consensus       298 ~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------~~~----------  343 (404)
                      ++.++|||||||++|+|++|..||...+..+....+.......                        ..+          
T Consensus       236 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  315 (360)
T 3llt_A          236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK  315 (360)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred             CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence            9999999999999999999999999887766655443321110                        001          


Q ss_pred             ----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          344 ----------RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       344 ----------~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                                ...++.+.+||.+||+.||.+|||+.++++
T Consensus       316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                      112377889999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=361.83  Aligned_cols=275  Identities=25%  Similarity=0.482  Sum_probs=221.7

Q ss_pred             CCccccccccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           85 TSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      +......++|++..++|.+.+.||+|+||+||+|.+.+ .||||+++........       ...+.+|+.++++++|||
T Consensus        19 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~   90 (319)
T 2y4i_B           19 SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ-------LKAFKREVMAYRQTRHEN   90 (319)
T ss_dssp             ---CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC-------CCCCCTTGGGGTTCCCTT
T ss_pred             cccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH-------HHHHHHHHHHHhcCCCCC
Confidence            33456678999999999999999999999999999866 5999999765322211       233568999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |+++++++.+....                ++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus        91 iv~~~~~~~~~~~~----------------~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H  153 (319)
T 2y4i_B           91 VVLFMGACMSPPHL----------------AIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILH  153 (319)
T ss_dssp             BCCCCEEEECSSCE----------------EEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EeEEEEEEecCCce----------------EEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999999877655                8999999999999998543 357999999999999999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccC-----CCCcccCCCCCccccCccccCC---------CCCCcchhhHHHHHH
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEAS-----NPHDMTGETGTLGYMAPEVLNG---------SAYNRKCDVYSFGIC  310 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~i  310 (404)
                      |||||+||+++ ++.+||+|||++.....     .........||+.|+|||++.+         ..++.++||||||++
T Consensus       154 ~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             CCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             cCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence            99999999998 67999999999864321     1222334568999999999975         457899999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          311 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       311 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      +|+|++|..||...+.......+.........+..++.++.+||.+||+.||.+|||+.+|++.|+.+......-
T Consensus       233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             HHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            999999999999988887776666554444445578899999999999999999999999999999998776543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=359.79  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=208.9

Q ss_pred             EEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccc
Q 015594          102 IIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELN  179 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  179 (404)
                      ...+.||+|+||.||+|.+  +|+.||||+++....         .....+.+|+.++++++||||+++++++.+...+ 
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-  161 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI-  161 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE-
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE-
Confidence            3467899999999999997  689999999974321         1235678999999999999999999999877665 


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE--cCC
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL--DKT  257 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili--~~~  257 (404)
                                     |+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+  +.+
T Consensus       162 ---------------~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  225 (373)
T 2x4f_A          162 ---------------VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA  225 (373)
T ss_dssp             ---------------EEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred             ---------------EEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence                           8999999999999988654 3569999999999999999999999999999999999999  567


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN  337 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~  337 (404)
                      +.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+....
T Consensus       226 ~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  304 (373)
T 2x4f_A          226 KQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR  304 (373)
T ss_dssp             TEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             CcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            89999999999864432 33445679999999999999999999999999999999999999999998888877777655


Q ss_pred             CCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 015594          338 LRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAI  378 (404)
Q Consensus       338 ~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~  378 (404)
                      ....  ....+++++.+||.+||+.||.+|||+.++++  .|...
T Consensus       305 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            4332  23568999999999999999999999999997  55443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-46  Score=349.67  Aligned_cols=256  Identities=26%  Similarity=0.471  Sum_probs=215.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||.||++.+  +|+.||+|++......       ......+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            46899999999999999999998  6899999999765432       12245688999999999999999999988643


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhCC-----ceecccC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSKK-----IVHRDVK  248 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g-----ivH~Dik  248 (404)
                      ..-              .+|+||||+++++|.+++....  ...+++..++.++.||+.||.|||+.|     |+|+|||
T Consensus        78 ~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~  143 (279)
T 2w5a_A           78 TNT--------------TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK  143 (279)
T ss_dssp             GGT--------------EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred             CCc--------------eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence            322              2389999999999999996542  345999999999999999999999999     9999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      |+||+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus       144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  223 (279)
T 2w5a_A          144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE  223 (279)
T ss_dssp             GGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             hhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH
Confidence            99999999999999999999765443333334568999999999999999999999999999999999999999988777


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAML  375 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L  375 (404)
                      ....+.... .+.++..+++++.++|.+||+.||.+||++.+|++.+
T Consensus       224 ~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          224 LAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHhhcc-cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            766655543 4466778999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-46  Score=358.27  Aligned_cols=258  Identities=26%  Similarity=0.529  Sum_probs=214.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCce----EEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQD----VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++.    ||+|++........        ...+.+|+.++.+++||||++++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~   81 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------FQAVTDHMLAIGSLDHAHIVRLL   81 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--------HHHHHHHHHHHhcCCCCCcCeEE
Confidence            4567899999999999999999997  4554    77787753321111        12356899999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+. ..                ++||||+.+|+|.+++... +..+++..++.++.||+.||.|||++||+||||||
T Consensus        82 ~~~~~~-~~----------------~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp  143 (325)
T 3kex_A           82 GLCPGS-SL----------------QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA  143 (325)
T ss_dssp             EEECBS-SE----------------EEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred             EEEcCC-cc----------------EEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence            988533 22                7999999999999998654 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +||||+.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  223 (325)
T 3kex_A          144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL  223 (325)
T ss_dssp             TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred             heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence            999999999999999999986543322  2344567889999999998889999999999999999999 9999998887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      .+....+. .......+..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          224 AEVPDLLE-KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             THHHHHHH-TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHHHHH-cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            77655544 444556677789999999999999999999999999999998864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.3e-46  Score=347.61  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=218.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +++.||+|++.......      ......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC------HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            46899999999999999999998  57899999987543221      12345678999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus        88 ~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  149 (294)
T 2rku_A           88 DFV----------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN  149 (294)
T ss_dssp             SEE----------------EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CEE----------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc
Confidence            655                8999999999999988654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+..
T Consensus       150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  229 (294)
T 2rku_A          150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK  229 (294)
T ss_dssp             TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence            99999999999998655444445556799999999999999999999999999999999999999999887776665554


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..  ...+..+++.+.++|.+||+.||++|||++++++.
T Consensus       230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          230 NE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            43  34677889999999999999999999999999873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=352.22  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=203.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.++++++||||+++++++.+..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-------PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            6899999999999999999998  5899999998654321       223456789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus        76 ~~----------------~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~  137 (311)
T 4agu_A           76 RL----------------HLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK  137 (311)
T ss_dssp             EE----------------EEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             eE----------------EEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC
Confidence            65                8999999999998887543  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+||+|||++..............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  217 (311)
T 4agu_A          138 HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK  217 (311)
T ss_dssp             TSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999865545455556789999999999976 5689999999999999999999999998887665544432


Q ss_pred             cc-------------------CCCCC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QN-------------------LRPEI----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~-------------------~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..                   .....          ...+++++.+||.+||+.||.+|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             HhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            10                   00000          1357889999999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.6e-46  Score=346.63  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=216.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +..++|.+.+.||+|+||.||+|.+  +++.||||++...      ..........+.+|+.++++++||||+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS------QLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccc------ccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            4457899999999999999999998  5789999998532      1111222456889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+
T Consensus        85 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  146 (284)
T 2vgo_A           85 DRKRI----------------YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL  146 (284)
T ss_dssp             CSSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred             cCCEE----------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            76655                8999999999999999664  47999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++.+||+|||++.....  .......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus       147 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  224 (284)
T 2vgo_A          147 MGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI  224 (284)
T ss_dssp             ECTTCCEEECCCTTCEECSS--SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcCCCCEEEecccccccCcc--cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence            99999999999999865332  2234567899999999999999999999999999999999999999988877776666


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...  ...++..+++++.++|.+||+.||.+||++.++++
T Consensus       225 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          225 VNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            543  33567788999999999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-46  Score=375.35  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=214.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||++.+  +++.||||++........       ....+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-------DTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-------HHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            36899999999999999999998  689999999964321111       134578999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        94 ~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~  155 (486)
T 3mwu_A           94 SSF----------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE  155 (486)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred             CEE----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence            665                8999999999999988664  5799999999999999999999999999999999999994


Q ss_pred             ---CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 ---KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                         .++.+||+|||+++.... ........||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..+....
T Consensus       156 ~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  233 (486)
T 3mwu_A          156 SKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR  233 (486)
T ss_dssp             SSSTTCCEEECSCSCTTTBCC-C----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCCCCEEEEECCcCeECCC-CCccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               456799999999975433 3344556799999999999875 99999999999999999999999999998888888


Q ss_pred             HHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....+....+  ..+++++.+||.+||+.||.+|||+.++++
T Consensus       234 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            87766554433  568999999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=354.68  Aligned_cols=263  Identities=21%  Similarity=0.328  Sum_probs=211.0

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||+||+|.+  +|+.||||++.......        ....+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--------hHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence            3457899999999999999999998  48999999996432211        1244678999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .....              ..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        78 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  143 (319)
T 4euu_A           78 ETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI  143 (319)
T ss_dssp             CTTTC--------------CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCCCc--------------eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            66532              23899999999999999966432 2399999999999999999999999999999999999


Q ss_pred             EE----cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC--------CCCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          253 LL----DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN--------GSAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       253 li----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||    +.++.+||+|||+++..... .......||+.|+|||++.        +..++.++||||||+++|+|++|..|
T Consensus       144 ll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p  222 (319)
T 4euu_A          144 MRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP  222 (319)
T ss_dssp             EEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             EEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99    78888999999999764433 3344567999999999985        56789999999999999999999999


Q ss_pred             CCCCCH----HHHHHHHHhccCC-----------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          321 YPDLSF----SEVTSAVVRQNLR-----------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       321 f~~~~~----~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |.....    .+....+......                       ...+..++..+.++|.+||+.||++|||++++++
T Consensus       223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~  302 (319)
T 4euu_A          223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (319)
T ss_dssp             EECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence            975432    3333344332211                       0122234678899999999999999999999999


Q ss_pred             HHHHhHhh
Q 015594          374 MLEAIDTS  381 (404)
Q Consensus       374 ~L~~~~~~  381 (404)
                      ...+-...
T Consensus       303 h~~d~~~~  310 (319)
T 4euu_A          303 ETSDILHR  310 (319)
T ss_dssp             HHHHHTC-
T ss_pred             ccHHHhhc
Confidence            88865543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.7e-46  Score=388.18  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=219.1

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      ..+..++|.+.+.||+|+||.||++.+  +++.||||+++...      .........+..|..++..+ +||||+++++
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV------VIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH------HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc------cccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            345678999999999999999999998  67899999996321      11111234567899999988 7999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+...+                |+||||+++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       410 ~~~~~~~~----------------~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~  471 (674)
T 3pfq_A          410 CFQTMDRL----------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD  471 (674)
T ss_dssp             ECBCSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCST
T ss_pred             EEEeCCEE----------------EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChh
Confidence            99877766                8999999999999999664  57999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||||+.++.+||+|||+++............+||+.|+|||++.+..|+.++||||||+++|||++|..||.+.+..++.
T Consensus       472 NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~  551 (674)
T 3pfq_A          472 NVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF  551 (674)
T ss_dssp             TEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             hEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH
Confidence            99999999999999999986554555566678999999999999999999999999999999999999999999988888


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~ll~  373 (404)
                      ..+....  ..+|..+++++.+||.+||+.||.+||++     ++|++
T Consensus       552 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          552 QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            8877654  35678899999999999999999999997     66653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=353.32  Aligned_cols=261  Identities=27%  Similarity=0.335  Sum_probs=207.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~  170 (404)
                      +..++|++.+.||+|+||+||+|.+  +|+.||||++..........    .....+.+|+.+++.+   +||||+++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG----GLPISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS----CCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc----ccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            3457899999999999999999996  78999999997543211100    0012244566666655   5999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.....-           ....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus        82 ~~~~~~~~-----------~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~  149 (308)
T 3g33_A           82 VCATSRTD-----------REIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE  149 (308)
T ss_dssp             EEEECCSS-----------SEEEEEEEEECC-CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred             eeeccCCC-----------CceeEEEEehhh-hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            98765421           011248999999 579999997766566999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |||++.++.+||+|||+++... .........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       150 Nil~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          150 NILVTSGGTVKLADFGLARIYS-YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             TEEECTTSCEEECSCSCTTTST-TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             HEEEcCCCCEEEeeCccccccC-CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999997543 233345567899999999999999999999999999999999999999998887777


Q ss_pred             HHHHhccCCCC-------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPE-------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+......+.                         ....+++++.+||.+||+.||++|||+.++++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            66654211110                         11357889999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.8e-46  Score=343.60  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=215.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  ++..||+|++.......         ...+.+|+.++++++||||+++++++.+..
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---------VDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            5799999999999999999998  56789999987543221         345789999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE--
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL--  254 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili--  254 (404)
                      ..                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||++  
T Consensus        80 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~  141 (277)
T 3f3z_A           80 DI----------------YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT  141 (277)
T ss_dssp             EE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred             eE----------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence            65                8999999999999998654  569999999999999999999999999999999999999  


Q ss_pred             -cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 -DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 -~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                       +.++.+||+|||++..... ........||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+
T Consensus       142 ~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  219 (277)
T 3f3z_A          142 DSPDSPLKLIDFGLAARFKP-GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI  219 (277)
T ss_dssp             SSTTCCEEECCCTTCEECCT-TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCcEEEEecccceeccC-ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence             7889999999999975433 3344556799999999999876 899999999999999999999999998888877777


Q ss_pred             HhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 015594          334 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAID  379 (404)
Q Consensus       334 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~  379 (404)
                      .........  ...+++++.+||.+||+.||.+|||+.++++  .+++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            665443321  1367899999999999999999999999985  454443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-45  Score=345.37  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=222.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||+++..........+....+..+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            57899999999999999999998  68999999998765444445555666788999999999995 9999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus        96 ~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~  157 (298)
T 1phk_A           96 NTFF----------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL  157 (298)
T ss_dssp             SSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCeE----------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE
Confidence            6655                8999999999999999654  579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN------GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +.++.+||+|||++..... ........+|+.|+|||++.      ...++.++||||||+++|+|++|..||...+..+
T Consensus       158 ~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          158 DDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             CTTCCEEECCCTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCCCcEEEecccchhhcCC-CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            9999999999999975433 23344567899999999984      4568899999999999999999999999988887


Q ss_pred             HHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+.........+  ..+++.+.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            777776665544333  468899999999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.6e-46  Score=377.45  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=215.4

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||.||++.+  +|+.||||++....      .........+.+|+.++..++||||+++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh------hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            5678899999999999999999998  68999999996321      111112345779999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                |+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       255 ~~~~l----------------~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL  318 (576)
T 2acx_A          255 TKDAL----------------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL  318 (576)
T ss_dssp             CSSEE----------------EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             eCCEE----------------EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence            87766                89999999999999997665556999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS----FSEV  329 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~----~~~~  329 (404)
                      |+.++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+    ..++
T Consensus       319 ld~~g~vKL~DFGla~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i  397 (576)
T 2acx_A          319 LDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV  397 (576)
T ss_dssp             ECTTSCEEECCCTTCEECCT-TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH
T ss_pred             EeCCCCeEEEecccceeccc-CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH
Confidence            99999999999999976433 233445689999999999999999999999999999999999999998753    2333


Q ss_pred             HHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          330 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ...+..  ....++..+++++.+||.+||+.||.+||     ++++|++
T Consensus       398 ~~~i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          398 ERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHhhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            333332  34456788999999999999999999999     7888874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=356.23  Aligned_cols=266  Identities=28%  Similarity=0.487  Sum_probs=205.6

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHH--HHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFT--QEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~~~~~  171 (404)
                      +.+..++|.+.+.||+|+||+||+|+++++.||||++....            ...+.  .|+..+..++||||+++++.
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~   75 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIVG   75 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhheec
Confidence            34677899999999999999999999999999999996422            11223  34444556899999999986


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC---------Cc
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK---------KI  242 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------gi  242 (404)
                      +.....           .....+|+||||+++|+|.+++...   ..++..++.++.||+.||.|||+.         ||
T Consensus        76 ~~~~~~-----------~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i  141 (336)
T 3g2f_A           76 DERVTA-----------DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI  141 (336)
T ss_dssp             EEEECT-----------TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE
T ss_pred             cccccc-----------CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccce
Confidence            543211           1122348999999999999999654   468999999999999999999999         99


Q ss_pred             eecccCCCCEEEcCCCcEEEeeccccccccCC--------CCcccCCCCCccccCccccCC-------CCCCcchhhHHH
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVARLEASN--------PHDMTGETGTLGYMAPEVLNG-------SAYNRKCDVYSF  307 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvwsl  307 (404)
                      +||||||+||||+.++.+||+|||+++.....        ........||+.|+|||++.+       ..++.++|||||
T Consensus       142 vH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  221 (336)
T 3g2f_A          142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL  221 (336)
T ss_dssp             ECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred             eecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence            99999999999999999999999999754332        122234569999999999987       356778999999


Q ss_pred             HHHHHHHHhCCCCCCCC-C-----------------HHHHHHHHHhccCCCCCCCC------CcHHHHHHHHHhhhhCCC
Q 015594          308 GICLWEIYCCDMPYPDL-S-----------------FSEVTSAVVRQNLRPEIPRC------CPSSLANVMKRCWDANPD  363 (404)
Q Consensus       308 G~il~el~~g~~Pf~~~-~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~  363 (404)
                      |+++|||++|..||... +                 ..+....+.....++.++..      +++++.+||.+||+.||+
T Consensus       222 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  301 (336)
T 3g2f_A          222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE  301 (336)
T ss_dssp             HHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChh
Confidence            99999999997665321 1                 12222222333444555544      345899999999999999


Q ss_pred             CCCCHHHHHHHHHHhHhhcCCC
Q 015594          364 KRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       364 ~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      +|||+.++++.|+++...-...
T Consensus       302 ~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          302 ARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             GSCCHHHHHHHHHHHHHCCCC-
T ss_pred             hCcchHHHHHHHHHHHHHHHhc
Confidence            9999999999999999776544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.8e-46  Score=352.94  Aligned_cols=254  Identities=20%  Similarity=0.325  Sum_probs=215.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +|+.||||++..........   ......+.+|+.++++++||||+++++++.+.
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            36799999999999999999998  68999999997654322110   00134578999999999999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus        88 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~  149 (321)
T 2a2a_A           88 TDV----------------VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL  149 (321)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred             CEE----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence            655                8999999999999999653  5799999999999999999999999999999999999998


Q ss_pred             CCC----cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          256 KTR----TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       256 ~~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      .++    .+||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus       150 ~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  228 (321)
T 2a2a_A          150 DKNIPIPHIKLIDFGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (321)
T ss_dssp             CTTSSSCCEEECCCTTCEECCT-TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             cCCCCcCCEEEccCccceecCc-cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            887    799999999975443 233445679999999999999999999999999999999999999999988877776


Q ss_pred             HHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+.......  ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       229 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            665543322  223568899999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-46  Score=357.39  Aligned_cols=265  Identities=30%  Similarity=0.527  Sum_probs=221.1

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceE--EEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDV--AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~v--AvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      ++.++|.+.+.||+|+||.||+|.+  ++..+  |||.+.....        ......+.+|+.+++++ +||||+++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--------hHHHHHHHHHHHHHHhccCCCchhhhce
Confidence            5568999999999999999999987  56644  9998863211        11235578999999999 9999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHH
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ++.+....                |+||||+++++|.+++....              ...+++..++.++.||+.||.|
T Consensus        94 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  157 (327)
T 1fvr_A           94 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  157 (327)
T ss_dssp             EEEETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             eeeeCCce----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            99877655                89999999999999996542              2479999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      ||++||+||||||+||||+.++.+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|+|++
T Consensus       158 LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  236 (327)
T 1fvr_A          158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  236 (327)
T ss_dssp             HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             HHhCCccCCCCccceEEEcCCCeEEEcccCcCccccc-cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence            9999999999999999999999999999999974221 122233456889999999998889999999999999999998


Q ss_pred             -CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 015594          317 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGGM  386 (404)
Q Consensus       317 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~~  386 (404)
                       |..||...+..+....+. .......+..+++++.+||.+||+.||.+|||+.++++.|+.+...+....
T Consensus       237 ~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          237 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             TSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             CCCCCCCCCcHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence             999999988777665543 445566778899999999999999999999999999999999998776443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-46  Score=363.86  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      ..+|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.+++.+. ||||+++++++..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~   80 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-------STDAQRTFREIMILTELSGHENIVNLLNVLRA   80 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence            46899999999999999999987  6899999998533211       122455779999999997 9999999999975


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....              .+|+||||++ ++|.+++..   ..+++..+..++.||+.||.|||+.||+||||||+||||
T Consensus        81 ~~~~--------------~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll  142 (388)
T 3oz6_A           81 DNDR--------------DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL  142 (388)
T ss_dssp             TTSS--------------CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCC--------------EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence            4422              2389999995 789998855   479999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCC---------------------CCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASN---------------------PHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLW  312 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~  312 (404)
                      +.++.+||+|||+++.....                     ....+..+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  222 (388)
T 3oz6_A          143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG  222 (388)
T ss_dssp             CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence            99999999999999754321                     122344679999999999987 57999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHhccCCC---------------------------------------------CCCCCCc
Q 015594          313 EIYCCDMPYPDLSFSEVTSAVVRQNLRP---------------------------------------------EIPRCCP  347 (404)
Q Consensus       313 el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~  347 (404)
                      ||++|..||.+.+..+....+....-.+                                             ..+..++
T Consensus       223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (388)
T 3oz6_A          223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN  302 (388)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence            9999999999988777665554211110                                             0123678


Q ss_pred             HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          348 SSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       348 ~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      +++.+||.+||+.||.+|||++++++.
T Consensus       303 ~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          303 EEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-46  Score=356.02  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=208.5

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC--CceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH--PNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~  170 (404)
                      ..+...+|.+.+.||+|+||+||++.+ +++.||||++......       ......+.+|+.++.+++|  |||+++++
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-------hHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            345678899999999999999999987 6789999999755432       1224567899999999976  99999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.....+                |+|||+. +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+
T Consensus        77 ~~~~~~~~----------------~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~  137 (343)
T 3dbq_A           77 YEITDQYI----------------YMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA  137 (343)
T ss_dssp             EEECSSEE----------------EEEECCC-SEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred             eEeeCCEE----------------EEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            99877655                8999955 89999999664  57999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCC-----------CCCCcchhhHHHHHHHHHHHhC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNG-----------SAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g  317 (404)
                      ||||+ ++.+||+|||+++.......  ......||+.|+|||++.+           ..++.++||||||+++|+|++|
T Consensus       138 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  216 (343)
T 3dbq_A          138 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG  216 (343)
T ss_dssp             GEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred             eEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence            99997 57899999999976443322  2335679999999999864           5689999999999999999999


Q ss_pred             CCCCCCCCH-HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          318 DMPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       318 ~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      ..||..... ......+.........+..++.++.+||.+||+.||.+|||+.++++.
T Consensus       217 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          217 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            999987533 344455555566667788889999999999999999999999999853

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=363.50  Aligned_cols=262  Identities=33%  Similarity=0.565  Sum_probs=209.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE---CC--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY---DG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~---~g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ..|.+.+.||+|+||+||+|.+   ++  ..||||.++.....        .....+.+|+.++++++||||+++++++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--------GEVSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--------HHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--------HHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            3477889999999999999986   22  46899988642211        12456889999999999999999999875


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....               .|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       161 ~~~~~---------------~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  224 (373)
T 3c1x_A          161 RSEGS---------------PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM  224 (373)
T ss_dssp             CCSSC---------------CEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             cCCCC---------------eEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence            43321               28999999999999999543 457899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCC----CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      |+.++.+||+|||+++......    .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+
T Consensus       225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~  304 (373)
T 3c1x_A          225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  304 (373)
T ss_dssp             ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred             ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence            9999999999999997543322    12234567889999999999899999999999999999999 788998877666


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ....+.. ......+..+++.+.++|.+||+.||++||++.+|++.|+.+..+..+.
T Consensus       305 ~~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          305 ITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            6555443 4455667889999999999999999999999999999999999877643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-46  Score=358.37  Aligned_cols=244  Identities=23%  Similarity=0.415  Sum_probs=183.8

Q ss_pred             CeEEe---eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEe
Q 015594          100 KLIIK---GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATM  173 (404)
Q Consensus       100 ~~~~~---~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  173 (404)
                      +|.+.   +.||+|+||+||++.+  +|+.||||++...            ....+.+|+.++..+. ||||+++++++.
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~   76 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------------MEANTQKEITALKLCEGHPNIVKLHEVFH   76 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            45554   7899999999999998  5899999999632            1234668999999997 999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        77 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  138 (325)
T 3kn6_A           77 DQLHT----------------FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL  138 (325)
T ss_dssp             CSSEE----------------EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCEE----------------EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence            77665                8999999999999999664  57999999999999999999999999999999999999


Q ss_pred             EcCCC---cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----
Q 015594          254 LDKTR---TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF----  326 (404)
Q Consensus       254 i~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~----  326 (404)
                      ++.++   .+||+|||+++.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+.    
T Consensus       139 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  218 (325)
T 3kn6_A          139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC  218 (325)
T ss_dssp             EEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C
T ss_pred             EecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            97665   89999999998655555555667789999999999999999999999999999999999999976432    


Q ss_pred             ---HHHHHHHHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          327 ---SEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       327 ---~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                         .+....+.........  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               3344444333322211  1357899999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=355.67  Aligned_cols=267  Identities=25%  Similarity=0.488  Sum_probs=217.5

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      .+..+...+|.+.+.||+|+||.||++.+      +|+.||||++.....         .....+.+|+.++++++||||
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i  104 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---------EHLRDFEREIEILKSLQHDNI  104 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---------HHHHHHHHHHHHHHTCCCTTB
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCe
Confidence            34456778999999999999999999984      588999999864321         124568899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      +++++++.....-              .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus       105 v~~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  169 (326)
T 2w1i_A          105 VKYKGVCYSAGRR--------------NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHR  169 (326)
T ss_dssp             CCEEEEECC------------------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             eeEEEEEEecCCC--------------ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            9999998765422              228999999999999999664 3569999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      ||||+||+|+.++.+||+|||++.........   .....++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             CCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999865433221   223456788999999998889999999999999999999999886


Q ss_pred             CCCHH---------------HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          323 DLSFS---------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       323 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      .....               ......+........+..+++++.+||.+||+.||.+|||+.+|++.|+.+..+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             SHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            42110               0112233444455677889999999999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.8e-46  Score=347.26  Aligned_cols=261  Identities=32%  Similarity=0.544  Sum_probs=215.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ..+|.+.+.||+|+||+||+|.+.     +..||||.+.....        ......+.+|+.++++++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--------HHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            356889999999999999999862     23589998864221        12245678999999999999999999986


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......               .++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus        96 ~~~~~~---------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Ni  159 (298)
T 3f66_A           96 LRSEGS---------------PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNC  159 (298)
T ss_dssp             CCSSSC---------------CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EcCCCc---------------eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            543322               28999999999999999543 46789999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCC----CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      +++.++.+||+|||++.......    .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||...+..
T Consensus       160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~  239 (298)
T 3f66_A          160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF  239 (298)
T ss_dssp             EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred             EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence            99999999999999997543221    22344567889999999999899999999999999999999 67788877766


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      +....+.. ......+..+++.+.++|.+||+.||.+|||+.++++.|+++....-
T Consensus       240 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          240 DITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             THHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             HHHHHHhc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            66555443 44555677889999999999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-46  Score=354.08  Aligned_cols=259  Identities=25%  Similarity=0.547  Sum_probs=212.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceE----EEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDV----AVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~v----AvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++.|    |+|.+.......        ....+.+|+.++++++||||++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~   83 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--------ANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--------CHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--------HHHHHHHHHHHHHhCCCCCeeEEE
Confidence            4568899999999999999999997  55554    666664322111        134578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.... .                ++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus        84 ~~~~~~~-~----------------~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  145 (327)
T 3lzb_A           84 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA  145 (327)
T ss_dssp             EEEESSS-E----------------EEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             EEEecCC-c----------------eEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence            9987654 2                7899999999999999664 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~  326 (404)
                      +||||+.++.+||+|||+++......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus       146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  225 (327)
T 3lzb_A          146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA  225 (327)
T ss_dssp             GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            99999999999999999997643322  22334557889999999999999999999999999999999 9999999887


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+....+ ........+..++.++.+||.+||+.||.+||++.+|++.|+++...
T Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          226 SEISSIL-EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             GGHHHHH-HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            7766554 44445566788999999999999999999999999999999998743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-46  Score=373.64  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=212.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  +++.||||++........       ....+.+|+.+++.++||||+++++++.+..
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  109 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-------SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR  109 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-------TTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            5799999999999999999998  688999999975432211       1345779999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus       110 ~~----------------~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~  171 (494)
T 3lij_A          110 NY----------------YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES  171 (494)
T ss_dssp             EE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             EE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence            65                8999999999999988654  57999999999999999999999999999999999999965


Q ss_pred             ---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          257 ---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       257 ---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                         ++.+||+|||++..... ........||+.|+|||++.+ .|+.++|||||||++|+|++|..||...+..+....+
T Consensus       172 ~~~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  249 (494)
T 3lij_A          172 KEKDALIKIVDFGLSAVFEN-QKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV  249 (494)
T ss_dssp             SSTTCCEEECCCTTCEECBT-TBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCCCcEEEEECCCCeECCC-CccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence               45599999999976443 334456789999999999875 4999999999999999999999999999998888888


Q ss_pred             HhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHh
Q 015594          334 VRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAI  378 (404)
Q Consensus       334 ~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~  378 (404)
                      ....+....+  ..+++++.+||.+||+.||.+|||+.++++  .|...
T Consensus       250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            7766554333  578999999999999999999999999985  35444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-45  Score=355.44  Aligned_cols=255  Identities=24%  Similarity=0.427  Sum_probs=218.7

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  175 (404)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||++....... ...........+.+|+.+++++ +||||+++++++...
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL-SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC-CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            5799999999999999999998  58999999997654322 2344455677889999999999 899999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||||+||||+
T Consensus       173 ~~~----------------~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          173 SFM----------------FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD  234 (365)
T ss_dssp             SEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CEE----------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            655                8999999999999999654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG------SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      .++.+||+|||++..... ........||+.|+|||++.+      ..++.++||||||+++|+|++|..||...+....
T Consensus       235 ~~~~ikl~DfG~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  313 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM  313 (365)
T ss_dssp             TTCCEEECCCTTCEECCT-TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCCEEEEecCcccccCC-CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999999975443 233455789999999999853      3588999999999999999999999998887777


Q ss_pred             HHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+.........+  ..+++++.+||.+||+.||.+|||+.++++
T Consensus       314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            77766655443322  467899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-46  Score=353.28  Aligned_cols=259  Identities=31%  Similarity=0.558  Sum_probs=207.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh--cCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||+|.++|+.||||++....            ...+.+|..++..  ++||||+++++++...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            4689999999999999999999999999999985321            1223345555554  4999999999998766


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC--------Cceeccc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK--------KIVHRDV  247 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------givH~Di  247 (404)
                      ...            ....|+||||+++|+|.+++...   .+++..++.++.|++.||.|||++        ||+||||
T Consensus       104 ~~~------------~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di  168 (337)
T 3mdy_A          104 TGS------------WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL  168 (337)
T ss_dssp             CGG------------GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred             CCC------------CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence            321            12248999999999999999543   699999999999999999999999        9999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCCCc----ccCCCCCccccCccccCCCCCCcc------hhhHHHHHHHHHHHhC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNPHD----MTGETGTLGYMAPEVLNGSAYNRK------CDVYSFGICLWEIYCC  317 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~el~~g  317 (404)
                      ||+||||+.++.+||+|||++.........    .....||+.|+|||++.+..+...      +||||||+++|||++|
T Consensus       169 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999999999999999999754433222    124579999999999988776665      9999999999999999


Q ss_pred             ----------CCCCCCCC-----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 015594          318 ----------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVAMLEA  377 (404)
Q Consensus       318 ----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~  377 (404)
                                ..||....     .......+......+..+.     .+++++.+||.+||+.||.+|||+.+|++.|+.
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence                      77776532     2233333333444454443     567889999999999999999999999999999


Q ss_pred             hHhhcC
Q 015594          378 IDTSKG  383 (404)
Q Consensus       378 ~~~~~~  383 (404)
                      +..+..
T Consensus       329 l~~~~~  334 (337)
T 3mdy_A          329 MSESQD  334 (337)
T ss_dssp             HHHTTT
T ss_pred             HHhhcc
Confidence            988764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.2e-46  Score=368.97  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..|.+ .++|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.+++.++||||++++
T Consensus        47 ~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~  118 (458)
T 3rp9_A           47 SDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-------LIDCKRILREIAILNRLNHDHVVKVL  118 (458)
T ss_dssp             SSCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-------HHHHHHHHHHHHHHHhCCCCCCCceE
Confidence            34444 47899999999999999999987  6899999998643221       12245688999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.....-           ....+|+||||+ +++|.+++..  ...+++..++.++.||+.||.|||++||+||||||
T Consensus       119 ~~~~~~~~~-----------~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp  184 (458)
T 3rp9_A          119 DIVIPKDVE-----------KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP  184 (458)
T ss_dssp             EECCCSCTT-----------TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred             EEEecCCcc-----------cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh
Confidence            998654321           123459999998 7899998854  35799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCC---------------------------CcccCCCCCccccCcccc-CCCCCCcc
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNP---------------------------HDMTGETGTLGYMAPEVL-NGSAYNRK  301 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~  301 (404)
                      +||||+.++.+||+|||+++......                           ...++.+||+.|+|||++ .+..|+.+
T Consensus       185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  264 (458)
T 3rp9_A          185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA  264 (458)
T ss_dssp             GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred             hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence            99999999999999999998643221                           134556789999999976 56679999


Q ss_pred             hhhHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHh---------------
Q 015594          302 CDVYSFGICLWEIYC-----------CDMPYPDLSF--------------------SEVTSAVVR---------------  335 (404)
Q Consensus       302 ~DvwslG~il~el~~-----------g~~Pf~~~~~--------------------~~~~~~~~~---------------  335 (404)
                      +|||||||++|||++           |..+|++.+.                    .+....+..               
T Consensus       265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  344 (458)
T 3rp9_A          265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK  344 (458)
T ss_dssp             HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred             hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence            999999999999998           6677765431                    111111110               


Q ss_pred             -------ccCC-------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 -------QNLR-------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 -------~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                             ..+.       ......+++++.+||.+||..||.+|||++++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                   0000       0112346899999999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-45  Score=346.62  Aligned_cols=249  Identities=30%  Similarity=0.481  Sum_probs=217.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|.+.+.||+|+||.||+|.+  +++.||||+++......        ....+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--------EIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--------THHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--------HHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            35699999999999999999987  68999999997654321        134578999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                |+||||+++++|.+++..   ..+++..++.++.||+.||.|||+.||+|+||||+||+++
T Consensus        93 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~  153 (303)
T 3a7i_A           93 TKL----------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS  153 (303)
T ss_dssp             TEE----------------EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             CeE----------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence            655                899999999999999843   5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  233 (303)
T 3a7i_A          154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK  233 (303)
T ss_dssp             TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence            99999999999997655444444556799999999999999999999999999999999999999998887766555443


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                       ...+..+..++..+.+||.+||+.||.+|||+.+|++.
T Consensus       234 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 -NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             44556777899999999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-45  Score=342.44  Aligned_cols=252  Identities=25%  Similarity=0.473  Sum_probs=207.6

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      .+..++|.+.+.||+|+||.||+|.+  +|+.||||++....      .........+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            34567899999999999999999998  58999999986321      11122345688999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||
T Consensus        81 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  142 (276)
T 2h6d_A           81 STPTDF----------------FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV  142 (276)
T ss_dssp             ECSSEE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred             ecCCeE----------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence            877655                8999999999999999664  5689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +++.++.+||+|||++...... .......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||...+......
T Consensus       143 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  221 (276)
T 2h6d_A          143 LLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK  221 (276)
T ss_dssp             EECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            9999999999999999754332 22344578999999999988765 689999999999999999999999888777766


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+....  ...+..++.++.++|.+||+.||.+|||+.+|++
T Consensus       222 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          222 KIRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            655443  3456778999999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4e-46  Score=355.12  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=214.2

Q ss_pred             ccccCCCCeEEe-eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015594           93 EWEIDPAKLIIK-GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKF  168 (404)
Q Consensus        93 ~~~~~~~~~~~~-~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  168 (404)
                      ..+.-..+|.+. +.||+|+||+||+|.+  +|+.||||++.........       ...+.+|+.++..+ +||||+++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-------RAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-------HHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHhccCCCCEEEE
Confidence            334445678887 8999999999999998  5899999999765433222       34577899999999 56999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+...+                |+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+|||||
T Consensus        95 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dik  158 (327)
T 3lm5_A           95 HEVYENTSEI----------------ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK  158 (327)
T ss_dssp             EEEEECSSEE----------------EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             EEEEEeCCeE----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence            9999877665                899999999999999866556789999999999999999999999999999999


Q ss_pred             CCCEEEcC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          249 TENMLLDK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       249 p~Nili~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |+||||+.   ++.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       159 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          159 PQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             GGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hHHEEEecCCCCCcEEEeeCccccccCC-ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999987   78999999999975433 223345679999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHHhccC--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          326 FSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+....+.....  .......+++.+.+||.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            8877766655443  33445678999999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=357.77  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=201.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  +++.||||++......        .....+.+|+.++++++||||+++++++.+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK   73 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence            5799999999999999999998  6899999999643211        11123457999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        74 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~  135 (324)
T 3mtl_A           74 SL----------------TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE  135 (324)
T ss_dssp             CE----------------EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred             EE----------------EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence            65                89999995 6999988664 457999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+||+|||+++.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+..
T Consensus       136 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  215 (324)
T 3mtl_A          136 RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR  215 (324)
T ss_dssp             TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999865555555566788999999999876 5689999999999999999999999999888777666544


Q ss_pred             ccCCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRPE----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+.                            ....+++++.+||.+||+.||.+|||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            211110                            11346889999999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-46  Score=356.25  Aligned_cols=262  Identities=32%  Similarity=0.548  Sum_probs=214.2

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh--cCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK--LDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~  174 (404)
                      ...+|.+.+.||+|+||+||+|.++|+.||||++....            ...+.+|+.++..  ++||||+++++++..
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------------HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            34789999999999999999999999999999985321            2345678888887  799999999999876


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh--------hCCceecc
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ--------SKKIVHRD  246 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~givH~D  246 (404)
                      ....            ...+|+||||+++|+|.+++.+   ..+++..++.++.||+.||.|||        +.||+|||
T Consensus       108 ~~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D  172 (342)
T 1b6c_B          108 DNGT------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD  172 (342)
T ss_dssp             CCSS------------CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred             cCCc------------cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCC
Confidence            6521            1134899999999999999965   36999999999999999999999        89999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCC----cccCCCCCccccCccccCCCC------CCcchhhHHHHHHHHHHHh
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~  316 (404)
                      |||+||||+.++.+||+|||++........    ......||+.|+|||++.+..      ++.++||||||+++|+|++
T Consensus       173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t  252 (342)
T 1b6c_B          173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR  252 (342)
T ss_dssp             CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence            999999999999999999999976544332    234457999999999998763      3378999999999999999


Q ss_pred             C----------CCCCCCCC-----HHHHHHHHHhccCCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          317 C----------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       317 g----------~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      |          ..||....     .......+.....++.++.     .+++.+.+||.+||+.||++|||+.+|++.|+
T Consensus       253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            9          78987652     3344444444555555553     34578999999999999999999999999999


Q ss_pred             HhHhhcCCC
Q 015594          377 AIDTSKGGG  385 (404)
Q Consensus       377 ~~~~~~~~~  385 (404)
                      .+..+.+..
T Consensus       333 ~i~~~~~~~  341 (342)
T 1b6c_B          333 QLSQQEGIK  341 (342)
T ss_dssp             HHHHTTC--
T ss_pred             HHHHHhcCC
Confidence            999877643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-46  Score=356.87  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +....++|.+.+.||+|+||.||++.+  +|+.||||++......       ......+.+|+.++++++||||++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMREIKLLKQLRHENLVNLLEV   92 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-------hHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            334568999999999999999999998  4899999998654322       1234557899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+....                |+||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        93 ~~~~~~~----------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~N  154 (331)
T 4aaa_A           93 CKKKKRW----------------YLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPEN  154 (331)
T ss_dssp             EEETTEE----------------EEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             eecCCEE----------------EEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChhe
Confidence            9877665                899999998888887643  3579999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |+|+.++.+||+|||++..............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+..
T Consensus       155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  234 (331)
T 4aaa_A          155 ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL  234 (331)
T ss_dssp             EEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            999999999999999998655545555567799999999999875 6899999999999999999999999988776655


Q ss_pred             HHHHhccC--------------------CCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNL--------------------RPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~--------------------~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.....                    .+.         ....+++++.+||.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            44432100                    000         01357899999999999999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=352.40  Aligned_cols=276  Identities=25%  Similarity=0.371  Sum_probs=206.6

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCc
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPN  164 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  164 (404)
                      ....+.+++...+|.+.+.||+|+||.||++.+  +|+.||||++....         ......+.+|+.++.++. |||
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~   87 (337)
T 3ll6_A           17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---------EEKNRAIIQEVCFMKKLSGHPN   87 (337)
T ss_dssp             SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHHHTTSTT
T ss_pred             HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---------hHHHHHHHHHHHHHHHhccCCC
Confidence            445567788889999999999999999999998  78999999985332         122455789999999995 999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHhhCC--
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN-RRRKLAFKVVIQLALDLARGLSYLQSKK--  241 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~g--  241 (404)
                      |+++++++......        .......+++||||+ +|+|.+++... ....+++..++.++.||+.||.|||+.|  
T Consensus        88 iv~~~~~~~~~~~~--------~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  158 (337)
T 3ll6_A           88 IVQFCSAASIGKEE--------SDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPP  158 (337)
T ss_dssp             BCCEEEEEEECTTT--------STTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred             hhhccccccccccc--------cccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            99999998543221        112234458999999 58999988652 3457999999999999999999999999  


Q ss_pred             ceecccCCCCEEEcCCCcEEEeeccccccccCCCCc------------ccCCCCCccccCcccc---CCCCCCcchhhHH
Q 015594          242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD------------MTGETGTLGYMAPEVL---NGSAYNRKCDVYS  306 (404)
Q Consensus       242 ivH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws  306 (404)
                      |+||||||+||||+.++.+||+|||++.........            .....||+.|+|||++   .+..++.++||||
T Consensus       159 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~s  238 (337)
T 3ll6_A          159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA  238 (337)
T ss_dssp             CBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHH
T ss_pred             EEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHH
Confidence            999999999999999999999999999764432211            1134589999999998   5667899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          307 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       307 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ||+++|+|++|..||.......    +.........+..++..+.+||.+||+.||.+|||+.++++.|+.+.......
T Consensus       239 lG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          239 LGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             HHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            9999999999999997655433    23334444556677888999999999999999999999999999999877644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2e-45  Score=346.44  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=212.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +|+.||||+++.....         ....+.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---------RDSSLENEIAVLKKIKHENIVTLEDIYEST   78 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---------chHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence            36799999999999999999998  6899999999743221         124577999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE-
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-  254 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili-  254 (404)
                      ...                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||++ 
T Consensus        79 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~  140 (304)
T 2jam_A           79 THY----------------YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL  140 (304)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred             CEE----------------EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence            655                8999999999999998654  579999999999999999999999999999999999999 


Q ss_pred             --cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          255 --DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 --~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                        +.++.+||+|||++.....  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       141 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  218 (304)
T 2jam_A          141 TPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK  218 (304)
T ss_dssp             SSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             cCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence              7889999999999974322  223345689999999999999999999999999999999999999999888877777


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.......  ..+..+++++.+||.+||+.||.+||++.++++
T Consensus       219 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          219 IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            76655433  344678999999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=355.84  Aligned_cols=265  Identities=23%  Similarity=0.356  Sum_probs=210.8

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .....|++ ..+|.+.+.||+|+||.||+|.+  +|+.||||++......       ......+.+|+.+++.++||||+
T Consensus        16 ~~~~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv   87 (367)
T 1cm8_A           16 VTKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMRHENVI   87 (367)
T ss_dssp             CSSSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCBTTBC
T ss_pred             ecCceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCcCCC
Confidence            33445555 47899999999999999999997  6899999998643221       22345678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.......          ....+|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||++||+|||
T Consensus        88 ~l~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~D  153 (367)
T 1cm8_A           88 GLLDVFTPDETLD----------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD  153 (367)
T ss_dssp             CCSEEECSCSSTT----------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             CceeeEecCCccc----------cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999997654321          112348999999 8999999865   4699999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |||+||||+.++.+||+|||+++....   ..+...+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       154 lkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          154 LKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999986432   3456788999999999877 679999999999999999999999999887


Q ss_pred             HHHHHHHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--H
Q 015594          326 FSEVTSAVVRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--M  374 (404)
Q Consensus       326 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~  374 (404)
                      ..+....+......                             ......+++++.+||.+||+.||.+|||++++++  .
T Consensus       231 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence            76665554331110                             0123467899999999999999999999999987  3


Q ss_pred             HHHh
Q 015594          375 LEAI  378 (404)
Q Consensus       375 L~~~  378 (404)
                      ++.+
T Consensus       311 f~~~  314 (367)
T 1cm8_A          311 FESL  314 (367)
T ss_dssp             GTTT
T ss_pred             HHhh
Confidence            4443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-46  Score=372.92  Aligned_cols=251  Identities=26%  Similarity=0.463  Sum_probs=218.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||+||++.+  +|+.||||++..........      ...+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH------HHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            347899999999999999999998  68999999997654322111      3457899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                |+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        98 ~~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  159 (484)
T 3nyv_A           98 KGYF----------------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL  159 (484)
T ss_dssp             SSEE----------------EEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCEE----------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence            7655                8999999999999998654  579999999999999999999999999999999999999


Q ss_pred             ---cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          255 ---DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       255 ---~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                         +.++.+||+|||+++.... ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...+..+...
T Consensus       160 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  237 (484)
T 3nyv_A          160 ESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK  237 (484)
T ss_dssp             SSSSTTCCEEECCTTHHHHBCC-CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ecCCCCCcEEEEeeeeeEEccc-ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence               5678999999999976443 233445679999999999987 59999999999999999999999999999988888


Q ss_pred             HHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+....+....+  ..+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            887776654443  568999999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-47  Score=363.26  Aligned_cols=266  Identities=31%  Similarity=0.427  Sum_probs=212.8

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ....++.+..++|.+.+.||+|+||+||+|.+ +|+.||||++.......        ....+.+|+.+++.++||||++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--------HHHHHHHHHHHHHhccCCCccc
Confidence            34456677889999999999999999999987 68999999986432211        1124789999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHhhC---Cc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--RRKLAFKVVIQLALDLARGLSYLQSK---KI  242 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi  242 (404)
                      +++++......                ++||||+++|+|.+++....  ...+++..+..++.||+.||.|||++   ||
T Consensus        92 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  155 (326)
T 3uim_A           92 LRGFCMTPTER----------------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI  155 (326)
T ss_dssp             CCEEECCSSCC----------------EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCE
T ss_pred             eEEEEecCCce----------------EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence            99999877665                89999999999999996643  23599999999999999999999999   99


Q ss_pred             eecccCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          243 VHRDVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       243 vH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      +||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       156 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  235 (326)
T 3uim_A          156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF  235 (326)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred             EeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence            999999999999999999999999998654332 2233456999999999998888999999999999999999999999


Q ss_pred             CCCC----HHHHHHHHHhcc-------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          322 PDLS----FSEVTSAVVRQN-------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       322 ~~~~----~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ....    ............             .....+...+..+.++|.+||+.||.+|||+.+|++.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            5211    000111111111             11112222357899999999999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-45  Score=345.07  Aligned_cols=261  Identities=22%  Similarity=0.371  Sum_probs=203.5

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      +++..++|++.+.||+|+||+||++.+  +|+.||||++.....       .......+.++...++.++||||++++++
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   74 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-------SQEQKRLLMDLDISMRTVDCPFTVTFYGA   74 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-------HHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-------cHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence            467778999999999999999999998  789999999964321       11223344566666888999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVK  248 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dik  248 (404)
                      +.+....                |+||||++ |+|.+++...  ....+++..++.++.||+.||.|||++ ||+|||||
T Consensus        75 ~~~~~~~----------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk  137 (290)
T 3fme_A           75 LFREGDV----------------WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK  137 (290)
T ss_dssp             EECSSSE----------------EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred             eeccCCE----------------EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            9877665                89999995 6888877542  346799999999999999999999998 99999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCcccc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      |+||+++.++.+||+|||++...... .......||+.|+|||++    .+..++.++||||||+++|+|++|..||...
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          138 PSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             HHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            99999999999999999999754332 223345789999999996    5667899999999999999999999999864


Q ss_pred             -CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 015594          325 -SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAID  379 (404)
Q Consensus       325 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~  379 (404)
                       ..................+..+++++.+||.+||+.||.+|||+.++++  .++...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             SCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence             3444444555555444555678999999999999999999999999987  555444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-46  Score=355.39  Aligned_cols=255  Identities=25%  Similarity=0.330  Sum_probs=206.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||+|.+  +|+.||||++........    .......+.+|+.++++++||||+++++++.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh----hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            46899999999999999999997  589999999965332111    112234577999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        85 ~~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  146 (346)
T 1ua2_A           85 SNI----------------SLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD  146 (346)
T ss_dssp             TCC----------------EEEEECCS-EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             Cce----------------EEEEEcCC-CCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc
Confidence            655                89999996 5898888543 45789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||+++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+.
T Consensus       147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~  226 (346)
T 1ua2_A          147 ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  226 (346)
T ss_dssp             TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999999999998765555556667899999999999764 58999999999999999999999999988777766655


Q ss_pred             hccCCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          335 RQNLRPE--------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       335 ~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                      .....+.                          ....+++++.+||.+||+.||.+|||+.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            4211110                          014567899999999999999999999998863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.3e-46  Score=344.53  Aligned_cols=267  Identities=24%  Similarity=0.409  Sum_probs=213.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||++.+  +|+.||||++....             ..+.+|+.++++++||||+++++++....
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            5799999999999999999998  58999999997542             12568999999999999999999886522


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .................+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence            11000000011122344599999999999999997766678999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...  ......+.  
T Consensus       158 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~--  232 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR--  232 (284)
T ss_dssp             TTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH--
T ss_pred             CCCEEECcchhheecccc-ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh--
Confidence            999999999999764432 2344567899999999999999999999999999999999999887421  12222222  


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                        ...++..++..+.++|.+||+.||.+|||+.++++.|..+..+...+
T Consensus       233 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          233 --DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             --TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             --cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence              23356678999999999999999999999999999999988665543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-45  Score=362.75  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=197.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.++++++||||+++++++...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-------LIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-------hHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            47899999999999999999998  6899999999643221       12245688999999999999999999998765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...           ....+|+||||+ +++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        98 ~~~-----------~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~  163 (432)
T 3n9x_A           98 DLL-----------KFDELYIVLEIA-DSDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN  163 (432)
T ss_dssp             CTT-----------TCCCEEEEEECC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCC-----------cCCeEEEEEecC-CcCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence            321           112349999999 5799999854  35799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC----------------------CcccCCCCCccccCcccc-CCCCCCcchhhHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP----------------------HDMTGETGTLGYMAPEVL-NGSAYNRKCDVYSFGICLW  312 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~  312 (404)
                      .++.+||+|||+++......                      ...+..+||+.|+|||++ .+..++.++|||||||++|
T Consensus       164 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~  243 (432)
T 3n9x_A          164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA  243 (432)
T ss_dssp             TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence            99999999999998644322                      123567899999999986 5667999999999999999


Q ss_pred             HHHhCCC-----------CCCCCCH-----------------HHHHHHHHh----------------------ccCCCCC
Q 015594          313 EIYCCDM-----------PYPDLSF-----------------SEVTSAVVR----------------------QNLRPEI  342 (404)
Q Consensus       313 el~~g~~-----------Pf~~~~~-----------------~~~~~~~~~----------------------~~~~~~~  342 (404)
                      ||++|..           +|++.+.                 .+....+..                      .......
T Consensus       244 ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  323 (432)
T 3n9x_A          244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK  323 (432)
T ss_dssp             HHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred             HHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCC
Confidence            9998543           3433220                 111111100                      0011111


Q ss_pred             -------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          343 -------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       343 -------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                             ...+++++.+||.+||+.||.+|||++++++
T Consensus       324 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             CCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   1457899999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=353.37  Aligned_cols=272  Identities=21%  Similarity=0.318  Sum_probs=214.9

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ...+.+...+|.+.+.||+|+||.||++.+  +|+.||||++....         ......+.+|+.+++.++||||+++
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~   91 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---------QQDREEAQREADMHRLFNHPNILRL   91 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---------HHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            345667889999999999999999999997  78999999986422         1224567899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++......            ...+|+||||+++++|.+++...  ....+++..++.++.||+.||.|||++||+|||
T Consensus        92 ~~~~~~~~~~------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~d  159 (317)
T 2buj_A           92 VAYCLRERGA------------KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD  159 (317)
T ss_dssp             CEEEEEEETT------------EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EEEEEeccCC------------CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            9998742211            12348999999999999999653  346799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCC---------cccCCCCCccccCccccCCCC---CCcchhhHHHHHHHHHH
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPH---------DMTGETGTLGYMAPEVLNGSA---YNRKCDVYSFGICLWEI  314 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el  314 (404)
                      |||+||+|+.++.+||+|||++........         ......||+.|+|||++.+..   ++.++||||||+++|+|
T Consensus       160 lkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  239 (317)
T 2buj_A          160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM  239 (317)
T ss_dssp             CCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999864322111         012235799999999998664   68999999999999999


Q ss_pred             HhCCCCCCCCCHH-HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          315 YCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       315 ~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ++|..||...... ...............+..+++++.+||.+||+.||.+||++.+|++.|+.+.....
T Consensus       240 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          240 MFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             HhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            9999999532110 01112233334444556789999999999999999999999999999999875544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.6e-46  Score=350.41  Aligned_cols=259  Identities=28%  Similarity=0.459  Sum_probs=208.4

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      |...+.||+|+||+||+|.++++.||||++........     ......+.+|+.++++++||||+++++++.+....  
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-----EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL--  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT-----TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch-----HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce--
Confidence            44558899999999999999999999999865432111     12245688999999999999999999999877655  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCc
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRT  259 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~  259 (404)
                                    ++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.
T Consensus       106 --------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~  171 (307)
T 2nru_A          106 --------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT  171 (307)
T ss_dssp             --------------EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred             --------------EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence                          89999999999999986432 356999999999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH
Q 015594          260 VKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT----SAV  333 (404)
Q Consensus       260 vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~----~~~  333 (404)
                      +||+|||++........  ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.........    ..+
T Consensus       172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  250 (307)
T 2nru_A          172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI  250 (307)
T ss_dssp             EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH
T ss_pred             EEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh
Confidence            99999999975443222  12345689999999999875 899999999999999999999999865432211    111


Q ss_pred             Hhc---------cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          334 VRQ---------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       334 ~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ...         ......+..++..+.++|.+||+.||.+|||+.+|++.|+.+.++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            110         111122334567899999999999999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-45  Score=343.78  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=212.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++......           ..+.+|+.+++.++|++++..+..+...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            47899999999999999999996  7899999998754322           2367899999999998877666665432


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE-
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-  254 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili-  254 (404)
                      ..               ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| 
T Consensus        77 ~~---------------~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~  139 (296)
T 3uzp_A           77 GD---------------YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG  139 (296)
T ss_dssp             TT---------------EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             CC---------------ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence            22               238999999 99999999643 4579999999999999999999999999999999999999 


Q ss_pred             --cCCCcEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          255 --DKTRTVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       255 --~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                        +.++.+||+|||++........       ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus       140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence              4888999999999986444322       1245679999999999999999999999999999999999999998643


Q ss_pred             H---HHHHHHHHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          326 F---SEVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       326 ~---~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      .   .+....+.......   ..+..+|+++.+||.+||+.||.+|||+.+|++.|+++....+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             chhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            2   22222322222211   23367899999999999999999999999999999999988874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=345.53  Aligned_cols=259  Identities=25%  Similarity=0.436  Sum_probs=210.4

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      ....+....++|.....||+|+||.||+|.+  +++.||||++......         ....+.+|+.+++.++||||++
T Consensus        13 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~   83 (295)
T 2clq_A           13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---------YSQPLHEEIALHKHLKHKNIVQ   83 (295)
T ss_dssp             -CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBCC
T ss_pred             ccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---------HHHHHHHHHHHHHhCCCCCEee
Confidence            3344555556666667999999999999998  6789999998754321         2345789999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      +++++......                ++||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|+|
T Consensus        84 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  147 (295)
T 2clq_A           84 YLGSFSENGFI----------------KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD  147 (295)
T ss_dssp             EEEEEEETTEE----------------EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EeeEEEeCCcE----------------EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccC
Confidence            99999876655                89999999999999996642 23567899999999999999999999999999


Q ss_pred             cCCCCEEEcC-CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          247 VKTENMLLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       247 ikp~Nili~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      |||+||+++. ++.+||+|||++..............||+.|+|||++.+..  ++.++||||||+++|+|++|..||..
T Consensus       148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             CSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             CChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            9999999987 89999999999976544333344567899999999997653  88999999999999999999999976


Q ss_pred             CCHHH-HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          324 LSFSE-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..... ...........+.++..+++++.+||.+||+.||++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          228 LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             GSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             CCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            54332 222333345566778889999999999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-45  Score=341.48  Aligned_cols=253  Identities=27%  Similarity=0.468  Sum_probs=209.0

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ....|.+.+.||+|+||+||+|.+  ++..||+|++......       ......+.+|+.++++++||||+++++++..
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            345689999999999999999998  6788999998754322       1224668899999999999999999999865


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCCCE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENM  252 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~Ni  252 (404)
                      ...            ....+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|  |+|+||||+||
T Consensus        97 ~~~------------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Ni  162 (290)
T 1t4h_A           97 TVK------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI  162 (290)
T ss_dssp             ESS------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred             ccC------------CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHE
Confidence            322            122348999999999999999654  57999999999999999999999999  99999999999


Q ss_pred             EEc-CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          253 LLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       253 li~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |++ .++.+||+|||++.....  .......||+.|+|||++.+. ++.++||||||+++|+|++|..||..........
T Consensus       163 l~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  239 (290)
T 1t4h_A          163 FITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY  239 (290)
T ss_dssp             EESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred             EEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH
Confidence            997 789999999999975332  233446789999999998865 9999999999999999999999998855444433


Q ss_pred             HHHh-ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .... .......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            3333 33334556677899999999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-45  Score=354.44  Aligned_cols=252  Identities=25%  Similarity=0.451  Sum_probs=210.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      .++..++|.+.+.||+|+||+||++.+  +++.||+|++.....        ......+.+|+.++++++||||++++++
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~   99 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGA   99 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--------HHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence            345668999999999999999999998  589999999975421        2234668899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTE  250 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~  250 (404)
                      +.+....                |+||||+++++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+
T Consensus       100 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~  161 (360)
T 3eqc_A          100 FYSDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS  161 (360)
T ss_dssp             EEETTEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred             EEECCEE----------------EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHH
Confidence            9877665                8999999999999999664  4799999999999999999999996 9999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||||+.++.+||+|||++......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+..
T Consensus       162 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  239 (360)
T 3eqc_A          162 NILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE  239 (360)
T ss_dssp             GEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred             HEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999999643221  223457899999999999999999999999999999999999999876654432


Q ss_pred             ------------------------------------------HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 015594          331 ------------------------------------------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM  368 (404)
Q Consensus       331 ------------------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  368 (404)
                                                                ..+............++.++.+||.+||+.||++|||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  319 (360)
T 3eqc_A          240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL  319 (360)
T ss_dssp             HHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             HHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH
Confidence                                                      12222222223334578999999999999999999999


Q ss_pred             HHHHH
Q 015594          369 DEVVA  373 (404)
Q Consensus       369 ~~ll~  373 (404)
                      +++++
T Consensus       320 ~ell~  324 (360)
T 3eqc_A          320 KQLMV  324 (360)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-45  Score=343.40  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=209.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++......           ..+.+|+.+++.++|++++..+..+...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----------CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----------hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            36899999999999999999996  7899999987543321           2367899999999988877777665433


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE-
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL-  254 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili-  254 (404)
                      ..               ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| 
T Consensus        77 ~~---------------~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~  139 (296)
T 4hgt_A           77 GD---------------YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG  139 (296)
T ss_dssp             TT---------------EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CC---------------ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence            22               238999999 99999998643 4579999999999999999999999999999999999999 


Q ss_pred             --cCCCcEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          255 --DKTRTVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       255 --~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                        +.++.+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus       140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence              7889999999999986443322       2234578999999999999999999999999999999999999998654


Q ss_pred             HH---HHHHHHHhccCCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCCC
Q 015594          326 FS---EVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGGG  385 (404)
Q Consensus       326 ~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~~  385 (404)
                      ..   .....+.......   .....+|+++.+||.+||+.||++|||+.+|++.|+++....+..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            32   2222222222211   123567899999999999999999999999999999999988743

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=361.28  Aligned_cols=255  Identities=21%  Similarity=0.365  Sum_probs=207.5

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKF  168 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  168 (404)
                      .+...+|.+.+.||+|+||+||++.+     +|+.||||+++........     .....+.+|+.++..+ +||||+++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~  124 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTL  124 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh-----hHHHHHHHHHHHHHHccCCCceeEE
Confidence            44557999999999999999999987     6899999998643211000     0012355789999999 79999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.....+                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+|||||
T Consensus       125 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  186 (355)
T 1vzo_A          125 HYAFQTETKL----------------HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK  186 (355)
T ss_dssp             EEEEEETTEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEeeCceE----------------EEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            9999877665                8999999999999999654  579999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |+||||+.++.+||+|||+++..... ........||+.|+|||++.+.  .++.++||||||+++|+|++|..||....
T Consensus       187 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             HHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            99999999999999999999754322 2223345799999999999863  47899999999999999999999997543


Q ss_pred             ----HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 015594          326 ----FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVAM  374 (404)
Q Consensus       326 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~~  374 (404)
                          .......+..  ..+..+..++..+.+||.+||+.||.+||     +++++++.
T Consensus       267 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          267 EKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             SCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ccchHHHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                2333333332  24456778899999999999999999999     99999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-45  Score=351.78  Aligned_cols=264  Identities=23%  Similarity=0.407  Sum_probs=201.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||++......        .....+.+|+.++++++||||+++++++.+..
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--------LAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--------THHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            5799999999999999999998  6899999999754321        12456789999999999999999999987654


Q ss_pred             ccccccC-----------------------------------------CCCCCCCCCceEEEEeccCCCCHHHHHHhcc-
Q 015594          177 ELNIQTD-----------------------------------------NGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-  214 (404)
Q Consensus       177 ~~~i~~~-----------------------------------------~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-  214 (404)
                      ...+...                                         .........+.++||||+++++|.+++.+.. 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence            3110000                                         0001123345799999999999999996643 


Q ss_pred             cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC------------CcccCCC
Q 015594          215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP------------HDMTGET  282 (404)
Q Consensus       215 ~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~------------~~~~~~~  282 (404)
                      ....++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......            .......
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            2345667789999999999999999999999999999999999999999999998654432            2234467


Q ss_pred             CCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCC
Q 015594          283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP  362 (404)
Q Consensus       283 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  362 (404)
                      ||+.|+|||++.+..++.++||||||+++|+|++|..|+..  ........ .....+......++++.+||.+||+.||
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p  314 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDV-RNLKFPLLFTQKYPQEHMMVQDMLSPSP  314 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHH-HTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHh-hccCCCcccccCChhHHHHHHHHccCCC
Confidence            99999999999999999999999999999999998766421  11111121 1222222223456788999999999999


Q ss_pred             CCCCCHHHHHH
Q 015594          363 DKRPEMDEVVA  373 (404)
Q Consensus       363 ~~Rpt~~~ll~  373 (404)
                      .+|||+.++++
T Consensus       315 ~~Rps~~~~l~  325 (332)
T 3qd2_B          315 TERPEATDIIE  325 (332)
T ss_dssp             GGSCCHHHHHH
T ss_pred             CcCCCHHHHhh
Confidence            99999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=344.65  Aligned_cols=250  Identities=25%  Similarity=0.435  Sum_probs=208.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ...++|.+.+.||+|+||.||+|.+  +|+.||||++.....           ...+.+|+.++..++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            4457899999999999999999998  489999999975331           234678999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      .....                |+||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+
T Consensus        95 ~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil  157 (314)
T 3com_A           95 KNTDL----------------WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNIL  157 (314)
T ss_dssp             ETTEE----------------EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             eCCEE----------------EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEE
Confidence            76655                8999999999999998543 467999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      ++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+
T Consensus       158 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  237 (314)
T 3com_A          158 LNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI  237 (314)
T ss_dssp             ECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999999976554444445567899999999999999999999999999999999999999988766655444


Q ss_pred             HhccC-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..... ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            33321 12335567899999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4e-45  Score=354.25  Aligned_cols=265  Identities=22%  Similarity=0.371  Sum_probs=212.7

Q ss_pred             CCCCccccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc
Q 015594           83 STTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL  160 (404)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  160 (404)
                      +..........|++. .+|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.+++.+
T Consensus        27 g~~~~~~~~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l   98 (371)
T 4exu_A           27 GFYKQDVNKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHM   98 (371)
T ss_dssp             TEEEEEETTEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHC
T ss_pred             cceeeeeccceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHHhc
Confidence            333445556677774 7999999999999999999987  6899999999653321       22346678999999999


Q ss_pred             CCCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC
Q 015594          161 DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK  240 (404)
Q Consensus       161 ~hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  240 (404)
                      +||||+++++++........          ....|+||||+. ++|.+++    ...+++..++.++.||+.||.|||++
T Consensus        99 ~h~niv~~~~~~~~~~~~~~----------~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~  163 (371)
T 4exu_A           99 QHENVIGLLDVFTPASSLRN----------FYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSA  163 (371)
T ss_dssp             CCTTBCCCSEEECSCSSSTT----------CCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCCCchhhhhheeccCCccc----------ceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            99999999999987654311          112389999994 7888876    24599999999999999999999999


Q ss_pred             CceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCC
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDM  319 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~  319 (404)
                      ||+||||||+||||+.++.+||+|||+++....   ......||+.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus       164 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  240 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT  240 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCcCHHHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999975332   3445678999999999987 679999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 015594          320 PYPDLSFSEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDE  370 (404)
Q Consensus       320 Pf~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~  370 (404)
                      ||...+..+....+....-.+                             ..+..+++++.+||.+||+.||++|||+.+
T Consensus       241 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  320 (371)
T 4exu_A          241 LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ  320 (371)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence            999888776665554311100                             112456899999999999999999999999


Q ss_pred             HHH
Q 015594          371 VVA  373 (404)
Q Consensus       371 ll~  373 (404)
                      +++
T Consensus       321 ll~  323 (371)
T 4exu_A          321 ALT  323 (371)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-45  Score=341.48  Aligned_cols=261  Identities=21%  Similarity=0.367  Sum_probs=215.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||++.+  +|+.||||+++.........   ......+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            5799999999999999999998  58999999997654321110   001345789999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+++.
T Consensus        82 ~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~  143 (283)
T 3bhy_A           82 DV----------------VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD  143 (283)
T ss_dssp             EE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             eE----------------EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec
Confidence            55                8999999999999999654  57999999999999999999999999999999999999987


Q ss_pred             CC----cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          257 TR----TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       257 ~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++    .+||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....
T Consensus       144 ~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  222 (283)
T 3bhy_A          144 KNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN  222 (283)
T ss_dssp             SSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             CCCCCCceEEEecccceeccC-CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence            76    899999999975433 2233456789999999999999999999999999999999999999999887777666


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHhh
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAIDTS  381 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~~  381 (404)
                      +.......  ..+..+++.+.+||.+||+.||.+||++.++++  .++.+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          223 ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             hHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            55443322  223567899999999999999999999999997  56666543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-45  Score=346.19  Aligned_cols=250  Identities=26%  Similarity=0.469  Sum_probs=208.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++......         ....+.+|+.++..++||||+++++++...
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---------ELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---------HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            47899999999999999999998  4899999998643221         135578999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++
T Consensus        89 ~~~----------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~  151 (302)
T 2j7t_A           89 GKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT  151 (302)
T ss_dssp             -CE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred             CeE----------------EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence            655                8999999999999988653 35799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCcccc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      .++.+||+|||++..............||+.|+|||++     .+..++.++||||||+++|+|++|..||...+.....
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  231 (302)
T 2j7t_A          152 LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  231 (302)
T ss_dssp             TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            99999999999986432222223345789999999998     4667899999999999999999999999998877766


Q ss_pred             HHHHhccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+....... ..+..++.++.++|.+||+.||.+|||+.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            6655544322 345678999999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-45  Score=364.38  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=201.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +|+.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-------hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            47899999999999999999987  6899999999643211       22345678999999999999999999999765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...          ......|+||||++ ++|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus       134 ~~~----------~~~~~~~lv~E~~~-~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~  198 (464)
T 3ttj_A          134 KTL----------EEFQDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  198 (464)
T ss_dssp             CST----------TTCCEEEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             Ccc----------ccCCeEEEEEeCCC-CCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence            432          11234599999995 55776662    3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.... ....+..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       199 ~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          199 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             TTSCEEECCCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999975433 3345567899999999999999999999999999999999999999999887766655543


Q ss_pred             ccCCC--------------------CC---------CCC-----------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLRP--------------------EI---------PRC-----------CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~~--------------------~~---------~~~-----------~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..-.+                    ..         +..           .++++.+||.+||+.||++|||++++++
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            21110                    00         000           1567999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=342.29  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=211.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +++.||||++.....     .........+.+|+.++++++||||+++++++...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-----RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-----HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-----cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            36899999999999999999998  678999999963211     11112346688999999999999999999998543


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..-              ..|+||||++++ |.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus        79 ~~~--------------~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~  143 (305)
T 2wtk_C           79 EKQ--------------KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT  143 (305)
T ss_dssp             -----------------CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             CCC--------------eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence            322              238999999665 88888776667899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNGSA--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      .++.+||+|||++......  ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||...+..+...
T Consensus       144 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  223 (305)
T 2wtk_C          144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE  223 (305)
T ss_dssp             TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence            9999999999999754322  22234566899999999998754  3789999999999999999999999988877776


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+....  ...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       224 ~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          224 NIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            665543  3467788999999999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.6e-45  Score=346.27  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=199.7

Q ss_pred             CCCeEEe-eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEe
Q 015594           98 PAKLIIK-GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATM  173 (404)
Q Consensus        98 ~~~~~~~-~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~  173 (404)
                      .+.|.+. +.||+|+||+||+|.+  +++.||||++......         ....+.+|+.++.++ +||||+++++++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---------CHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3678885 7899999999999987  6899999999754322         134577899999985 7999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                |+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        82 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil  143 (316)
T 2ac3_A           82 EEDRF----------------YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL  143 (316)
T ss_dssp             ETTEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             eCCEE----------------EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence            77655                8999999999999999664  57999999999999999999999999999999999999


Q ss_pred             EcCCCc---EEEeeccccccccCCC-------CcccCCCCCccccCccccCC-----CCCCcchhhHHHHHHHHHHHhCC
Q 015594          254 LDKTRT---VKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNG-----SAYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       254 i~~~~~---vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~  318 (404)
                      ++.++.   +||+|||++.......       .......||+.|+|||++.+     ..++.++||||||+++|+|++|.
T Consensus       144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~  223 (316)
T 2ac3_A          144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY  223 (316)
T ss_dssp             ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred             EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence            987765   9999999987543211       12233569999999999975     45889999999999999999999


Q ss_pred             CCCCCCCH---------------HHHHHHHHhccCCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          319 MPYPDLSF---------------SEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       319 ~Pf~~~~~---------------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .||...+.               ......+.........  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            99987542               2233344433332111  1467899999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.5e-46  Score=348.02  Aligned_cols=258  Identities=24%  Similarity=0.424  Sum_probs=195.8

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      .+|.+...+|.+.+.||+|+||+||++.+  +++.||||++.....        ......+.+|+.++++++||||++++
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~   79 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--------QTSMDELLKEIQAMSQCHHPNIVSYY   79 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEE
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--------chhHHHHHHHHHHHhhcCCCCEeeEE
Confidence            45788899999999999999999999987  789999999864321        12245578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN------RRRKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                      +++......                ++||||+++++|.+++...      ....+++..++.++.||+.||.|||++||+
T Consensus        80 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  143 (303)
T 2vwi_A           80 TSFVVKDEL----------------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI  143 (303)
T ss_dssp             EEEESSSCE----------------EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             EEEeecCCc----------------EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            999877665                8999999999999998642      245699999999999999999999999999


Q ss_pred             ecccCCCCEEEcCCCcEEEeeccccccccCCC-----CcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhC
Q 015594          244 HRDVKTENMLLDKTRTVKIADFGVARLEASNP-----HDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       244 H~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g  317 (404)
                      |+||||+||+++.++.+||+|||++.......     .......||+.|+|||++.+ ..++.++||||||+++|+|++|
T Consensus       144 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999999999999997543321     11234568999999999875 4689999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhccCC--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          318 DMPYPDLSFSEVTSAVVRQNLR--------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       318 ~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..||...+..............        ......+++++.+||.+||+.||.+||++.++++
T Consensus       224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          224 AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            9999988776665544433221        1233567899999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.9e-45  Score=351.23  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=206.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||.||++.+  +++.||||++.....        ......+.+|+.++.+++||||+++++++...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--------cHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            36899999999999999999987  688999999863221        12245678999999999999999999998755


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...           .....|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        98 ~~~-----------~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~  162 (364)
T 3qyz_A           98 TIE-----------QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN  162 (364)
T ss_dssp             STT-----------TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             Ccc-----------ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC
Confidence            321           1123489999995 699998854   3699999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC---cccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      .++.+||+|||++........   ......||+.|+|||++. +..++.++||||||+++|+|++|..||...+..+...
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  242 (364)
T 3qyz_A          163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN  242 (364)
T ss_dssp             TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred             CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence            999999999999975443221   234457999999999864 4558999999999999999999999999887776665


Q ss_pred             HHHhccCCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+......+                             .....+++++.+||.+||+.||.+|||+.++++
T Consensus       243 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            554211100                             012457889999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-45  Score=355.04  Aligned_cols=271  Identities=21%  Similarity=0.321  Sum_probs=209.6

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      +....+|.+.+.||+|+||+||+|.+  +|+.||||++......             ..+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------------~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------------KNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------------HHHHHHHHHHcCCCCccchhhee
Confidence            45567899999999999999999987  7899999998643221             23699999999999999999999


Q ss_pred             ecCCccccc------------cCC----------CCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHH
Q 015594          173 MGTSELNIQ------------TDN----------GHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLAL  228 (404)
Q Consensus       173 ~~~~~~~i~------------~~~----------~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~  228 (404)
                      .........            ...          ........++++||||++ ++|.+.+..  .....+++..++.++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            654331000            000          000123445789999996 688887754  2346799999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEc-CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws  306 (404)
                      ||+.||.|||++||+||||||+|||++ .++.+||+|||+++.... ........+|+.|+|||++.+. .++.++||||
T Consensus       149 qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP-SEPSVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT-TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC-CCCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            999999999999999999999999997 688999999999975433 3344556789999999998875 4899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------------------------CCCCCCCcHHHHHHHHHhhh
Q 015594          307 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR---------------------------PEIPRCCPSSLANVMKRCWD  359 (404)
Q Consensus       307 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~  359 (404)
                      |||++|+|++|..||.+.+..+....+....-.                           ..++..+++++.+||.+||+
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            999999999999999998877766665431100                           11355688999999999999


Q ss_pred             hCCCCCCCHHHHHH--HHHHhHh
Q 015594          360 ANPDKRPEMDEVVA--MLEAIDT  380 (404)
Q Consensus       360 ~dP~~Rpt~~~ll~--~L~~~~~  380 (404)
                      .||.+|||+.++++  .++.+..
T Consensus       308 ~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          308 YEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             CChhhCCCHHHHhcCHHHHHHHh
Confidence            99999999999983  4555544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.6e-45  Score=338.24  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=204.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  175 (404)
                      .+|.+.+.||+|+||+||+|.+  +++.||||++........       ....+.+|+..+..+ +||||+++++++.+.
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-------DEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-------HHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-------HHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            6799999999999999999998  689999999975433221       134567899999999 999999999999877


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR--RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ...                ++||||+++++|.+++.....  ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        84 ~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl  147 (289)
T 1x8b_A           84 DHM----------------LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF  147 (289)
T ss_dssp             TEE----------------EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CeE----------------EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence            655                899999999999999966432  56899999999999999999999999999999999999


Q ss_pred             EcC-------------------CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHH
Q 015594          254 LDK-------------------TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWE  313 (404)
Q Consensus       254 i~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~e  313 (404)
                      ++.                   ...+||+|||.+......    ....||+.|+|||++.+. .++.++||||||+++|+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~  223 (289)
T 1x8b_A          148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC  223 (289)
T ss_dssp             EC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred             EcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence            984                   447999999999754432    234589999999999876 56789999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          314 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       314 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |++|..|+.....   ... ......+..+..+++++.+||.+||+.||++|||+.++++
T Consensus       224 l~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          224 AAGAEPLPRNGDQ---WHE-IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HTTCCCCCSSSHH---HHH-HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhcCCCCCcchhH---HHH-HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            9999877654422   222 3344456678889999999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-44  Score=356.83  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=207.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc------CCCceeE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL------DHPNVTK  167 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~  167 (404)
                      ....+|.+.+.||+|+||+||+|.+  +++.||||++....          .....+.+|+.+++.+      +|+||++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----------RFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----------chHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            3456899999999999999999988  57999999996321          1234466788887777      6789999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.....+                |+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||
T Consensus       164 ~~~~~~~~~~~----------------~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl  226 (429)
T 3kvw_A          164 MLENFTFRNHI----------------CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDL  226 (429)
T ss_dssp             EEEEEEETTEE----------------EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCC
T ss_pred             EEeecccCCeE----------------EEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            99999877665                8999999 579999998776667999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCc--EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          248 KTENMLLDKTRT--VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       248 kp~Nili~~~~~--vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      ||+||||+.++.  +||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus       227 Kp~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          227 KPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             SGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CHHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999998887  99999999975332   2345678999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHHhccCCC---------------------------------------------------------CCCCCCcH
Q 015594          326 FSEVTSAVVRQNLRP---------------------------------------------------------EIPRCCPS  348 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~~~  348 (404)
                      ..+....+....-.+                                                         .++...++
T Consensus       304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  383 (429)
T 3kvw_A          304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP  383 (429)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred             HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence            777665544210000                                                         01224578


Q ss_pred             HHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          349 SLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       349 ~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ++.+||.+||+.||++|||+.++++
T Consensus       384 ~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          384 LFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhhCCCHHHHhC
Confidence            8999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-44  Score=348.34  Aligned_cols=259  Identities=23%  Similarity=0.341  Sum_probs=207.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||++.........       ...+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-------hHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            47899999999999999999998  6899999998655433221       23466899999999999999999999765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...        +....+.+|+||||++ ++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        89 ~~~--------~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~  158 (351)
T 3mi9_A           89 ASP--------YNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT  158 (351)
T ss_dssp             ----------------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred             ccc--------cccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence            432        1122344599999995 5888877543 45799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccC----CCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEAS----NPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      .++.+||+|||+++....    .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  238 (351)
T 3mi9_A          159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL  238 (351)
T ss_dssp             TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999999999999975432    2233445678999999999876 45899999999999999999999999998877766


Q ss_pred             HHHHhc--cCCCCCCCC----------------------------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQ--NLRPEIPRC----------------------------CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~--~~~~~~~~~----------------------------~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+...  ...+.....                            .++++.+||.+||+.||.+|||++++++
T Consensus       239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            555432  111111111                            2677999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.3e-45  Score=337.67  Aligned_cols=249  Identities=26%  Similarity=0.387  Sum_probs=207.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||+|.+  +++.||||+++.....        .....+.+|+.+++.++||||+++++++.+..
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--------THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            5799999999999999999998  5899999999754321        12355789999999999999999999998766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                |+||||+++++|.+++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.
T Consensus        79 ~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~  140 (276)
T 2yex_A           79 IQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE  140 (276)
T ss_dssp             EE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             EE----------------EEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence            55                899999999999998843  357999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Q 015594          257 TRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEV-TSA  332 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~-~~~  332 (404)
                      ++.+||+|||++.......  .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.... ...
T Consensus       141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  220 (276)
T 2yex_A          141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD  220 (276)
T ss_dssp             TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH
T ss_pred             CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence            9999999999997543222  22345678999999999988765 7899999999999999999999987654322 223


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .............+++.+.+||.+||+.||.+|||+.+|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            33322222333567899999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=351.67  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|.+.+.||+|+||+||+|.+  +++.||||+++........... ......+.+|+.++++++||||+++++++.+..
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE-DPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE-ETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            6899999999999999999987  7899999999765322110000 001223567999999999999999999998776


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCC-CHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGG-ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..                ++||||+.+| +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus       103 ~~----------------~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~  164 (335)
T 3dls_A          103 FF----------------QLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA  164 (335)
T ss_dssp             EE----------------EEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             EE----------------EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc
Confidence            65                8999999766 999998654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      .++.+||+|||++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......       
T Consensus       165 ~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------  236 (335)
T 3dls_A          165 EDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------  236 (335)
T ss_dssp             TTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred             CCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence            9999999999999764432 33445679999999999988876 88999999999999999999999763221       


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM  374 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~  374 (404)
                       .......+..+++++.+||.+||+.||++|||+.+|++.
T Consensus       237 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             112234566789999999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=363.43  Aligned_cols=264  Identities=21%  Similarity=0.326  Sum_probs=212.2

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||+||+|.+  +|+.||||++.......        ....+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--------PVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--------hHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            3457899999999999999999998  48999999996432211        1244678999999999999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR-RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      +....              ..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        78 ~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  143 (396)
T 4eut_A           78 ETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI  143 (396)
T ss_dssp             CTTTC--------------CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             cCCCC--------------eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence            65532              23899999999999999865422 2399999999999999999999999999999999999


Q ss_pred             EE----cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC--------CCCCcchhhHHHHHHHHHHHhCCCC
Q 015594          253 LL----DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--------SAYNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       253 li----~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||    +.++.+||+|||+++.... ........||+.|+|||++.+        ..++.++||||||+++|+|++|..|
T Consensus       144 ll~~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P  222 (396)
T 4eut_A          144 MRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP  222 (396)
T ss_dssp             EEEECTTSCEEEEECCGGGCEECCC-GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEeecCCCceeEEEecCCCceEccC-CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99    7778899999999975433 333445679999999999865        4578899999999999999999999


Q ss_pred             CCCCC----HHHHHHHHHhccCCC-----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          321 YPDLS----FSEVTSAVVRQNLRP-----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       321 f~~~~----~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |....    ..+....+.......                       .++..++..+.++|.+||+.||++||++.++++
T Consensus       223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             EECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            96432    234444444332110                       111234678899999999999999999999999


Q ss_pred             HHHHhHhhc
Q 015594          374 MLEAIDTSK  382 (404)
Q Consensus       374 ~L~~~~~~~  382 (404)
                      .++++...+
T Consensus       303 ~l~~il~~~  311 (396)
T 4eut_A          303 ETSDILHRM  311 (396)
T ss_dssp             HHHHHHTCE
T ss_pred             HHHHHhhce
Confidence            999987654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-44  Score=373.63  Aligned_cols=263  Identities=31%  Similarity=0.609  Sum_probs=221.3

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      ..+++..++|.+.+.||+|+||+||+|.+.     +..||||+++....        ...+..+.+|+.++++++||||+
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv  454 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIV  454 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--------HHHHHHHHHHHHHHHhCCCCCCC
Confidence            467788899999999999999999999872     45799998853221        22346688999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.+. ..                |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|||
T Consensus       455 ~l~~~~~~~-~~----------------~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD  516 (656)
T 2j0j_A          455 KLIGVITEN-PV----------------WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRD  516 (656)
T ss_dssp             CEEEEECSS-SC----------------EEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEecC-ce----------------EEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            999998542 23                8999999999999999654 35689999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      |||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus       517 ikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  596 (656)
T 2j0j_A          517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  596 (656)
T ss_dssp             CSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999997543322 12233456789999999998899999999999999999997 99999998


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +..+....+... .....+..+++.+.+||.+||+.||.+|||+.+|++.|+++...
T Consensus       597 ~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          597 KNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            888777666544 44567788999999999999999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=349.41  Aligned_cols=259  Identities=14%  Similarity=0.177  Sum_probs=213.4

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEE-------ECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGI-------YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-  161 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-  161 (404)
                      ...++++...+|.+.+.||+|+||+||+|.       .+++.||||+++...            ...+.+|+.++..++ 
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~  123 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKP  123 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCG
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhh
Confidence            345677888999999999999999999993       268999999996421            223567777887886 


Q ss_pred             --CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHH
Q 015594          162 --HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN---RRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       162 --hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                        |+||+++++++......                |+||||+++|+|.+++...   ....+++..++.++.||+.||.|
T Consensus       124 ~~~~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~  187 (365)
T 3e7e_A          124 SMQHMFMKFYSAHLFQNGS----------------VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ  187 (365)
T ss_dssp             GGGGGBCCEEEEEECSSCE----------------EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhheeeecCCCc----------------EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence              99999999999877766                8999999999999999653   24679999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcC-----------CCcEEEeecccccccc--CCCCcccCCCCCccccCccccCCCCCCcchh
Q 015594          237 LQSKKIVHRDVKTENMLLDK-----------TRTVKIADFGVARLEA--SNPHDMTGETGTLGYMAPEVLNGSAYNRKCD  303 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~-----------~~~vkL~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  303 (404)
                      ||++||+||||||+||||+.           ++.+||+|||+++...  .........+||+.|+|||++.+..++.++|
T Consensus       188 lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  267 (365)
T 3e7e_A          188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID  267 (365)
T ss_dssp             HHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHH
T ss_pred             HhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcccc
Confidence            99999999999999999988           8999999999997433  2333455678999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHhHhh
Q 015594          304 VYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI-PRCCPSSLANVMKRCWDANPDKR-PEMDEVVAMLEAIDTS  381 (404)
Q Consensus       304 vwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~R-pt~~~ll~~L~~~~~~  381 (404)
                      ||||||++|||++|..||........       .....+ ....++.+.+++..||+.+|.+| |++.++.+.|+++...
T Consensus       268 iwslG~il~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          268 YFGVAATVYCMLFGTYMKVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             HHHHHHHHHHHHHSSCCCEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCccccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            99999999999999999864322110       011111 11346789999999999999999 7899999999988776


Q ss_pred             cC
Q 015594          382 KG  383 (404)
Q Consensus       382 ~~  383 (404)
                      ..
T Consensus       341 ~~  342 (365)
T 3e7e_A          341 HY  342 (365)
T ss_dssp             HT
T ss_pred             hh
Confidence            43

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-44  Score=336.38  Aligned_cols=253  Identities=27%  Similarity=0.483  Sum_probs=215.2

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||++.+  +++.||||++.........       ...+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDS   93 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH-------HHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence            46899999999999999999998  6899999999754332221       34577999999999999999999999876


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||||+||+|+
T Consensus        94 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~  155 (287)
T 2wei_A           94 SSF----------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE  155 (287)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CeE----------------EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence            655                8999999999999988654  4799999999999999999999999999999999999996


Q ss_pred             CC---CcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KT---RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .+   +.+||+|||++...... .......+|+.|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....
T Consensus       156 ~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (287)
T 2wei_A          156 SKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR  233 (287)
T ss_dssp             CSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            54   47999999999754332 233345689999999999876 89999999999999999999999999988887777


Q ss_pred             HHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHH
Q 015594          333 VVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEA  377 (404)
Q Consensus       333 ~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~  377 (404)
                      +.........+  ..+++++.++|.+||+.||++|||+.++++  .+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            76665544333  568999999999999999999999999987  4444

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-46  Score=363.25  Aligned_cols=268  Identities=13%  Similarity=0.167  Sum_probs=199.4

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHH---HHHhhcCCCceeEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV---AVWHKLDHPNVTKF  168 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~~  168 (404)
                      +.....+|.+.+.||+|+||+||+|.+  +|+.||||++.........      ..+.+.+|+   .++++++||||+++
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~~l~hpniv~~  141 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN------AIKQMKEEVLRLRLLRGIKNQKQAKV  141 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT------HHHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH------HHHHHHHHHHHHHhccccCCHHHHHH
Confidence            344467899999999999999999996  6899999999754332221      235578999   55566689999999


Q ss_pred             E-------EEEecCCccccccCCCCCCCCC---CceEEEEeccCCCCHHHHHHhcc-----cCCCcHHHHHHHHHHHHHH
Q 015594          169 I-------GATMGTSELNIQTDNGHIGMPS---NFCCVVVEYCHGGALKSYLIKNR-----RRKLAFKVVIQLALDLARG  233 (404)
Q Consensus       169 ~-------~~~~~~~~~~i~~~~~~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~  233 (404)
                      +       +++.+.....+....  .....   ...|+||||+ +|+|.+++....     ...+++..++.++.||+.|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~a  218 (377)
T 3byv_A          142 HLRFIFPFDLVKDPQKKKMIRVR--LDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL  218 (377)
T ss_dssp             HHCBCCCSEEEECTTSCSEEEC--------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHH
T ss_pred             HhhhhhhhhhhhccCCccccccc--cCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHH
Confidence            8       444433220000000  00000   0248999999 789999997642     1234458888999999999


Q ss_pred             HHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-----------CCCcch
Q 015594          234 LSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-----------AYNRKC  302 (404)
Q Consensus       234 L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~  302 (404)
                      |.|||++||+||||||+||||+.++.+||+|||+++...   .......| +.|+|||++.+.           .++.++
T Consensus       219 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  294 (377)
T 3byv_A          219 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF  294 (377)
T ss_dssp             HHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred             HHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence            999999999999999999999999999999999997522   23445667 999999999887           899999


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhHh
Q 015594          303 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAIDT  380 (404)
Q Consensus       303 DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~~  380 (404)
                      ||||||+++|||++|..||...+.......+      ...+..+++++.+||.+||+.||++|||+.++++  .++.+..
T Consensus       295 DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          295 DAWALGLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            9999999999999999999765543322111      1223578999999999999999999999999986  5555544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.8e-45  Score=360.05  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++.......... ........+.+|+.++++++||||+++++++...
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc-ccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            47899999999999999999998  67899999997643221111 1112234578999999999999999999997543


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      . .                |+||||+++|+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       213 ~-~----------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~  273 (419)
T 3i6u_A          213 D-Y----------------YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS  273 (419)
T ss_dssp             E-E----------------EEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             c-e----------------EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence            2 3                899999999999998854  36799999999999999999999999999999999999996


Q ss_pred             CC---CcEEEeeccccccccCCCCcccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 015594          256 KT---RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV  329 (404)
Q Consensus       256 ~~---~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~  329 (404)
                      .+   ..+||+|||+++.... ........||+.|+|||++.+   ..++.++||||||+++|+|++|..||........
T Consensus       274 ~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  352 (419)
T 3i6u_A          274 SQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  352 (419)
T ss_dssp             SSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred             cCCCcceEEEeecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence            54   4599999999986433 333445679999999999864   5688999999999999999999999987544332


Q ss_pred             H-HHHHhccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 T-SAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~-~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . ..+......  +.....+++.+.+||.+||+.||.+|||+.++++
T Consensus       353 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            3 233332222  1223568899999999999999999999999885

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.4e-45  Score=353.39  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .....|++. ++|.+.+.||+|+||.||+|.+  +|+.||||++......       ......+.+|+.+++.++||||+
T Consensus        20 ~~~~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv   91 (367)
T 2fst_X           20 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVI   91 (367)
T ss_dssp             ETTEEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ecCcccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCCCCC
Confidence            344556664 8899999999999999999987  6899999998643221       12245678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      ++++++.......          ....+|+|+||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+|||
T Consensus        92 ~~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~D  157 (367)
T 2fst_X           92 GLLDVFTPARSLE----------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD  157 (367)
T ss_dssp             CCSEEECSCSSGG----------GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cEEEEEecCCccc----------cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence            9999987653321          112348999999 8999998854   4799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |||+||||+.++.+||+|||+++....   ..+...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       158 lkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          158 LKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             CCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999975432   2445678999999999987 679999999999999999999999999988


Q ss_pred             HHHHHHHHHhccCC---------------------CC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          326 FSEVTSAVVRQNLR---------------------PE--------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       326 ~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+....+....-.                     +.        ....+++++.+||.+||+.||.+|||+.++++
T Consensus       235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            76665554431100                     00        11346789999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-44  Score=340.93  Aligned_cols=244  Identities=18%  Similarity=0.290  Sum_probs=198.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      .++|++.+.||+|+||+||+|.+  +++.||||+++...            ...+.+|+.+++++. ||||+++++++.+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            47899999999999999999987  78999999986321            245779999999997 9999999999986


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....              ..++||||+++++|.+++.     .+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       103 ~~~~--------------~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  163 (330)
T 3nsz_A          103 PVSR--------------TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  163 (330)
T ss_dssp             TTTC--------------CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCCC--------------ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence            4332              2389999999999998872     48999999999999999999999999999999999999


Q ss_pred             cCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q 015594          255 DKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTS  331 (404)
Q Consensus       255 ~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~-~~~~~~~  331 (404)
                      +.++ .+||+|||+++.... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||... +..+...
T Consensus       164 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          164 DHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             ETTTTEEEECCCTTCEECCT-TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             cCCCCEEEEEeCCCceEcCC-CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            8776 899999999975433 233455678999999999987 67899999999999999999999999543 2222211


Q ss_pred             HHH-------------hcc----------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVV-------------RQN----------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~-------------~~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+.             ...                      .....+..+++++.+||.+||+.||.+|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111             000                      011122337899999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.7e-44  Score=347.45  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=198.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +++.||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-------hHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            47899999999999999999987  6899999999754321       12245678999999999999999999999765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...          .....+|+||||++ ++|.+++.    ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus        97 ~~~----------~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~  161 (371)
T 2xrw_A           97 KSL----------EEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  161 (371)
T ss_dssp             CST----------TTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             ccc----------ccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            432          11234599999995 67888874    3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus       162 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  240 (371)
T 2xrw_A          162 SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE  240 (371)
T ss_dssp             TTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred             CCCCEEEEEeeccccccc-ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999999975432 2234456789999999999999999999999999999999999999998887766655543


Q ss_pred             ccCC--------------------CCC--------------CC------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR--------------------PEI--------------PR------CCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~--------------------~~~--------------~~------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                    +..              +.      ..++++.+||.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            2111                    000              00      11578999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-45  Score=348.96  Aligned_cols=261  Identities=22%  Similarity=0.378  Sum_probs=212.8

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHH--------HHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEA--------EIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .+...+|.+.+.||+|+||.||+|.++|+.||||++...........        ........+.+|+.++++++||||+
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            34567999999999999999999999999999999964321110000        0000115678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHH------HHhcccCCCcHHHHHHHHHHHHHHHHHHhh-
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY------LIKNRRRKLAFKVVIQLALDLARGLSYLQS-  239 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-  239 (404)
                      ++++++.+....                |+||||+++++|.++      +.......+++..++.++.||+.||.|||+ 
T Consensus       107 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  170 (348)
T 2pml_X          107 TCEGIITNYDEV----------------YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE  170 (348)
T ss_dssp             CCSEEEESSSEE----------------EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEeeCCeE----------------EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence            999999877655                899999999999998      644335789999999999999999999999 


Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCc-chhhHHHHHHHHHHHhC
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNR-KCDVYSFGICLWEIYCC  317 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~~g  317 (404)
                      .||+|+||||+||+++.++.+||+|||++......  ......||+.|+|||++.+. .++. ++||||||+++|+|++|
T Consensus       171 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             SCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             CCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence            99999999999999999999999999999764332  34556789999999999887 5666 99999999999999999


Q ss_pred             CCCCCCCCH-HHHHHHHHhccCCCCC-----------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          318 DMPYPDLSF-SEVTSAVVRQNLRPEI-----------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       318 ~~Pf~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..||...+. .+....+.........                 ...+++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            999988766 5554444433222111                 1568999999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.1e-44  Score=340.34  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEE
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGA  171 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~  171 (404)
                      ..+|.+.+.||+|+||.||+|.+   +|+.||||++.........       ...+.+|+.+++.+   +||||++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-------CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            36899999999999999999987   4789999999754322111       11244666666665   89999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.....           .....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+|+||||+|
T Consensus        83 ~~~~~~-----------~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N  150 (326)
T 1blx_A           83 CTVSRT-----------DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  150 (326)
T ss_dssp             EEEEEC-----------SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             eeeccc-----------CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence            862210           01123489999995 799999987666679999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |+++.++.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  229 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eEEcCCCCEEEecCcccccccC-CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999975432 223445678999999999999999999999999999999999999999888777666


Q ss_pred             HHHhccCC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLR-------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+......                         ......+++.+.+||.+||+.||.+|||+.++++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            65532100                         1123567899999999999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.5e-44  Score=337.42  Aligned_cols=259  Identities=22%  Similarity=0.331  Sum_probs=209.6

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC--CCc
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPN  164 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn  164 (404)
                      ....+...+...+|.+.+.||+|+||.||++.+ +++.||||++......       ......+.+|+.++.+++  |||
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~   89 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDK   89 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-------HHHHHHHHHHHHHHHHHGGGCTT
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-------ccchHHHHHHHHHHHhccccCCc
Confidence            344455677788999999999999999999987 6889999999754432       122456789999999997  599


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      |+++++++......                |+|||+ .+++|.+++...  ..+++..++.++.||+.||.|||++||+|
T Consensus        90 iv~~~~~~~~~~~~----------------~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  150 (313)
T 3cek_A           90 IIRLYDYEITDQYI----------------YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVH  150 (313)
T ss_dssp             BCCEEEEEECSSEE----------------EEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eEEEEEEeecCCEE----------------EEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            99999999876655                899995 489999999764  57899999999999999999999999999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCC-----------CCCCcchhhHHHHHHH
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNG-----------SAYNRKCDVYSFGICL  311 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il  311 (404)
                      |||||+|||+++ +.+||+|||++........  ......||+.|+|||.+.+           ..++.++||||||+++
T Consensus       151 ~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il  229 (313)
T 3cek_A          151 SDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  229 (313)
T ss_dssp             CCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred             cCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence            999999999965 8999999999975433222  2234568999999999976           4688999999999999


Q ss_pred             HHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          312 WEIYCCDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       312 ~el~~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |+|++|..||.... .......+.........+..+++++.+||.+||+.||.+||++.++++
T Consensus       230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          230 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            99999999998754 333444555555666777888999999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-44  Score=353.57  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=204.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ..+|.+.+.||+|+||+||+|.+  +|+.||||++......             +.+|+.+++.++||||+++++++...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~E~~il~~l~hpniv~l~~~~~~~  119 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSS  119 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------------HHHHHHHHHHcCCCCccceeeEEecc
Confidence            35799999999999999999998  6899999998643211             23699999999999999999998643


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ...          ....++++||||++ ++|.+++..  .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       120 ~~~----------~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIL  188 (420)
T 1j1b_A          120 GEK----------KDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL  188 (420)
T ss_dssp             ETT----------TTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred             CCC----------CcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEE
Confidence            221          11223489999995 577776643  23467999999999999999999999999999999999999


Q ss_pred             EcCC-CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          254 LDKT-RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       254 i~~~-~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |+.+ +.+||+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+...
T Consensus       189 l~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~  267 (420)
T 1j1b_A          189 LDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV  267 (420)
T ss_dssp             EETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9855 67899999999854332 233456789999999999765 79999999999999999999999999988766655


Q ss_pred             HHHhcc--------------CC-CC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 015594          332 AVVRQN--------------LR-PE------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAID  379 (404)
Q Consensus       332 ~~~~~~--------------~~-~~------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~  379 (404)
                      .++...              +. ..            ++..+++++.+||.+||+.||.+||++.++++  .++.+.
T Consensus       268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            544310              00 01            23456899999999999999999999999985  444443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-44  Score=344.29  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=200.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||+|.+  +++.||||++.......... ........+.+|+.++++++||||+++++++....
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccc-ccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            6799999999999999999998  67999999996543211111 11122345789999999999999999999986543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                       .                |+||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus        89 -~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~  149 (322)
T 2ycf_A           89 -Y----------------YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS  149 (322)
T ss_dssp             -E----------------EEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred             -e----------------EEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence             2                899999999999998854  357999999999999999999999999999999999999986


Q ss_pred             CCc---EEEeeccccccccCCCCcccCCCCCccccCcccc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HH
Q 015594          257 TRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EV  329 (404)
Q Consensus       257 ~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-~~  329 (404)
                      ++.   +||+|||++...... .......||+.|+|||++   .+..++.++||||||+++|+|++|..||...... ..
T Consensus       150 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          150 QEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             CCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence            654   999999999754322 222345689999999997   3567899999999999999999999999765443 22


Q ss_pred             HHHHHhccCC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          330 TSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       330 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+......  +..+..+++++.+||.+||+.||.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            2333333222  1223567899999999999999999999999983

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7e-44  Score=355.94  Aligned_cols=258  Identities=21%  Similarity=0.339  Sum_probs=209.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc-eeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN-VTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~  174 (404)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++......           ..+.+|+.+++.+.|++ |..+..++..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----------CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            47899999999999999999997  5899999998754432           12568999999998754 4444444443


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...                .++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus        75 ~~~----------------~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl  136 (483)
T 3sv0_A           75 GDY----------------NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM  136 (483)
T ss_dssp             TTE----------------EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCE----------------EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence            333                38999999 99999998653 4579999999999999999999999999999999999999


Q ss_pred             ---cCCCcEEEeeccccccccCCCC-------cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          255 ---DKTRTVKIADFGVARLEASNPH-------DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       255 ---~~~~~vkL~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                         +.++.+||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~  216 (483)
T 3sv0_A          137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL  216 (483)
T ss_dssp             CCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence               6889999999999986543322       122567999999999999999999999999999999999999999875


Q ss_pred             CH---HHHHHHHHhccCC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcCC
Q 015594          325 SF---SEVTSAVVRQNLR---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKGG  384 (404)
Q Consensus       325 ~~---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~~  384 (404)
                      ..   .+....+......   ...+..+++++.+||.+||+.||++||++.+|+++|+.+....+.
T Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          217 KAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             CCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            43   2222222222211   123357789999999999999999999999999999999887763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.7e-44  Score=339.62  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=207.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc-----
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN-----  164 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----  164 (404)
                      ..++..++|.+.+.||+|+||+||++.+   +++.||||+++..      .    .....+.+|+.+++.++|++     
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~   77 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------D----RYCEAARSEIQVLEHLNTTDPNSTF   77 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------C----chhHHHHHHHHHHHHhhhcCCCCce
Confidence            3445568999999999999999999987   5789999998532      1    12355778999998887654     


Q ss_pred             -eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          165 -VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       165 -iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                       |+++++++......                |+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+
T Consensus        78 ~i~~~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  140 (339)
T 1z57_A           78 RCVQMLEWFEHHGHI----------------CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLT  140 (339)
T ss_dssp             CBCCEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             eeEeeecccccCCcE----------------EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCc
Confidence             99999999877655                8999999 99999999776556799999999999999999999999999


Q ss_pred             ecccCCCCEEEcC-------------------CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhh
Q 015594          244 HRDVKTENMLLDK-------------------TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDV  304 (404)
Q Consensus       244 H~Dikp~Nili~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  304 (404)
                      ||||||+|||++.                   ++.+||+|||++.....   ......||+.|+|||++.+..++.++||
T Consensus       141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di  217 (339)
T 1z57_A          141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDV  217 (339)
T ss_dssp             CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHH
T ss_pred             CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhh
Confidence            9999999999987                   66899999999975332   2344678999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------------------------------------CCC
Q 015594          305 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR------------------------------------------PEI  342 (404)
Q Consensus       305 wslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~------------------------------------------~~~  342 (404)
                      ||||+++|+|++|..||...+..+....+......                                          ...
T Consensus       218 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (339)
T 1z57_A          218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS  297 (339)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhccc
Confidence            99999999999999999988776654433221100                                          011


Q ss_pred             CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          343 PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       343 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..+++++.+||.+||+.||.+|||+.++++
T Consensus       298 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          298 QDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            2234678999999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-44  Score=342.87  Aligned_cols=258  Identities=26%  Similarity=0.474  Sum_probs=187.1

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHH-HHhhcCCCce
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVA-VWHKLDHPNV  165 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpni  165 (404)
                      .....|.+..++|.+.+.||+|+||.||+|.+  +|+.||||++.....    ..    ....+..|+. +++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~----~~~~~~~e~~~~~~~~~h~ni   83 (327)
T 3aln_A           12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EK----EQKQLLMDLDVVMRSSDCPYI   83 (327)
T ss_dssp             CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HH----HHHHHHHHHHHHHSSCCCTTB
T ss_pred             ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----ch----HHHHHHHHHHHHHHcCCCCcE
Confidence            45578889999999999999999999999998  589999999975421    11    1223445554 7788899999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHhhC-C
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK---NRRRKLAFKVVIQLALDLARGLSYLQSK-K  241 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g  241 (404)
                      +++++++......                ++||||++ ++|.+++..   .....+++..+..++.|++.||.|||+. |
T Consensus        84 v~~~~~~~~~~~~----------------~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  146 (327)
T 3aln_A           84 VQFYGALFREGDC----------------WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK  146 (327)
T ss_dssp             CCEEEEEECSSEE----------------EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             eeeeeEEEeCCce----------------EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence            9999999877655                89999995 588887753   2346799999999999999999999999 9


Q ss_pred             ceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCcccc----CCCCCCcchhhHHHHHHHHHHHhC
Q 015594          242 IVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL----NGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       242 ivH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      |+||||||+||+|+.++.+||+|||+++..... .......||+.|+|||++    .+..++.++||||||+++|+|++|
T Consensus       147 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (327)
T 3aln_A          147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG  225 (327)
T ss_dssp             CCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred             EeECCCCHHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999999999754332 223345789999999999    456789999999999999999999


Q ss_pred             CCCCCCCCHH-HHHHHHHhccCCCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          318 DMPYPDLSFS-EVTSAVVRQNLRPE----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       318 ~~Pf~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..||...... +....+. ....+.    ....+++++.+||.+||+.||.+||++.+|++
T Consensus       226 ~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          226 RFPYPKWNSVFDQLTQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCSSCC-------CCCC-CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcchHHHHHHHHh-cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            9999875432 1111111 111111    22468999999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=338.39  Aligned_cols=259  Identities=23%  Similarity=0.447  Sum_probs=195.5

Q ss_pred             cccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           88 SVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ....+.+.+..++|.+.+.||+|+||.||+|.+  +|+.||||++......       ......+.++..+++.++||||
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~~~~~~~~h~~i   86 (318)
T 2dyl_A           14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-------EENKRILMDLDVVLKSHDCPYI   86 (318)
T ss_dssp             EESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-------HHHHHHHHHHHHHHHTTTCTTB
T ss_pred             EecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCce
Confidence            345677888889999999999999999999998  6899999999754321       1123334556667888899999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-Ccee
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVH  244 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH  244 (404)
                      +++++++.+....                |+||||+ ++.+..+.. .....+++..++.++.||+.||.|||++ ||+|
T Consensus        87 ~~~~~~~~~~~~~----------------~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H  148 (318)
T 2dyl_A           87 VQCFGTFITNTDV----------------FIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHGVIH  148 (318)
T ss_dssp             CCEEEEEECSSEE----------------EEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             eeEEEEEecCCcE----------------EEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEe
Confidence            9999999877655                8999999 666655543 3356799999999999999999999996 9999


Q ss_pred             cccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCC
Q 015594          245 RDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDM  319 (404)
Q Consensus       245 ~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~  319 (404)
                      +||||+||+++.++.+||+|||++...... .......+|+.|+|||++.     +..++.++||||||+++|+|++|..
T Consensus       149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (318)
T 2dyl_A          149 RDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF  227 (318)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence            999999999999999999999999754332 2233457899999999994     4568999999999999999999999


Q ss_pred             CCCCC-CHHHHHHHHHhccCCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          320 PYPDL-SFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       320 Pf~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ||... ...+....+.... .+..+  ..+++++.+||.+||+.||.+||++.+|++
T Consensus       228 pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          228 PYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             TTTTCCSHHHHHHHHHHSC-CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccHHHHHHHhccC-CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            99874 3444444444432 23233  458999999999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.3e-44  Score=349.11  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC--------CCc
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--------HPN  164 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpn  164 (404)
                      ++...+|.+.+.||+|+||+||+|.+  +++.||||++...          ......+.+|+.+++.+.        |||
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~  102 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----------EHYTETALDEIRLLKSVRNSDPNDPNREM  102 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----------CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence            34468899999999999999999987  6899999999632          122455788999999985        888


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-Cce
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIV  243 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-giv  243 (404)
                      |+++++++.....            ....+|+||||+ +++|.+++.+.....+++..++.++.||+.||.|||++ ||+
T Consensus       103 iv~~~~~~~~~~~------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~giv  169 (397)
T 1wak_A          103 VVQLLDDFKISGV------------NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII  169 (397)
T ss_dssp             BCCEEEEEEEEET------------TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred             eeeeecceeecCC------------CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            9999999873211            112238999999 88888888776557799999999999999999999998 999


Q ss_pred             ecccCCCCEEEcCCC-------------------------------------------------cEEEeeccccccccCC
Q 015594          244 HRDVKTENMLLDKTR-------------------------------------------------TVKIADFGVARLEASN  274 (404)
Q Consensus       244 H~Dikp~Nili~~~~-------------------------------------------------~vkL~Dfg~a~~~~~~  274 (404)
                      ||||||+||||+.++                                                 .+||+|||+++.... 
T Consensus       170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-  248 (397)
T 1wak_A          170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-  248 (397)
T ss_dssp             CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-
T ss_pred             cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-
Confidence            999999999998775                                                 799999999976433 


Q ss_pred             CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--cc---------
Q 015594          275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS------EVTSAVVR--QN---------  337 (404)
Q Consensus       275 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~------~~~~~~~~--~~---------  337 (404)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..      +....+..  ..         
T Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  326 (397)
T 1wak_A          249 --HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG  326 (397)
T ss_dssp             --CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred             --cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcc
Confidence              244567899999999999999999999999999999999999999765421      11111111  00         


Q ss_pred             -CC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          338 -LR----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       338 -~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       ..                            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence             00                            0112234567899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-44  Score=346.82  Aligned_cols=267  Identities=19%  Similarity=0.286  Sum_probs=206.6

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCccc--HHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRS--EAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +.....++|.+.+.||+|+||.||+|.+ +|+.||||++.........  ..........+.+|+.++++++||||++++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR   95 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence            3445578999999999999999999987 6899999998654322111  111223356788999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++......           ....+|+||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||
T Consensus        96 ~~~~~~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  162 (362)
T 3pg1_A           96 DIFVHFEEP-----------AMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP  162 (362)
T ss_dssp             EEEEECCTT-----------TCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             eeEEeccCC-----------CcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCCh
Confidence            998654321           1234589999995 7888888643 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +||||+.++.+||+|||++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             GGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HHEEEcCCCCEEEEecCccccccc-ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999974332 233445678999999999877 679999999999999999999999999888777


Q ss_pred             HHHHHHhccCCC------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRP------------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+......+                              ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            665554311110                              112356788999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-45  Score=354.42  Aligned_cols=266  Identities=15%  Similarity=0.146  Sum_probs=186.8

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc--CCCceeEEEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL--DHPNVTKFIGAT  172 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~  172 (404)
                      ...+|.+.+.||+|+||+||+|.+  +|+.||||++.......      ......+.+|+.++..|  +||||++++..+
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~  133 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS------RSELERLHEATFAAARLLGESPEEARDRRRL  133 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH------HHHHHHHHHHHHHHHHHHC----------CB
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc------ccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence            345699999999999999999997  68999999998654321      12234567785544444  699988866433


Q ss_pred             -------ecCCccccccC-CCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHH------HHHHHHHHHHHHHHh
Q 015594          173 -------MGTSELNIQTD-NGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV------IQLALDLARGLSYLQ  238 (404)
Q Consensus       173 -------~~~~~~~i~~~-~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~qi~~~L~~LH  238 (404)
                             .......+... .+.-......+|+||||++ |+|.+++... ...+++..+      ..++.||+.||.|||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence                   32221110000 0000001134699999997 8999999764 234455555      678899999999999


Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHh
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~  316 (404)
                      ++||+||||||+||||+.++.+||+|||+++....   ......+|+.|+|||++.+  ..++.++||||||+++|+|++
T Consensus       212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999999999985432   1224556799999999988  679999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHH-----H--HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          317 CDMPYPDLSFSEVTSA-----V--VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       317 g~~Pf~~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |..||...........     .  .........+..+++.+.+||.+||+.||++|||+.++++
T Consensus       289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999987643211000     0  0111122233578999999999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-43  Score=339.98  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=206.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||++.....        ......+.+|+.++++++||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------PLFALRTLREIKILKHFKHENIITIFNIQRPD   81 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS--------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc--------chHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence            47899999999999999999998  589999999953221        12245577999999999999999999987654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..           ......|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        82 ~~-----------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~  146 (353)
T 2b9h_A           82 SF-----------ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN  146 (353)
T ss_dssp             CS-----------TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cc-----------CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence            21           11234599999995 799998865   4699999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC----------cccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 015594          256 KTRTVKIADFGVARLEASNPH----------DMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDL  324 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~  324 (404)
                      .++.+||+|||++........          ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus       147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999975443211          1223578999999998754 67899999999999999999999999988


Q ss_pred             CHHHHHHHHHhccCCC------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH-
Q 015594          325 SFSEVTSAVVRQNLRP------------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA-  373 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~-  373 (404)
                      +..+....+....-.+                              .....+++++.+||.+||+.||.+|||+.++++ 
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            7665544333210000                              012367899999999999999999999999986 


Q ss_pred             -HHHHh
Q 015594          374 -MLEAI  378 (404)
Q Consensus       374 -~L~~~  378 (404)
                       .|+.+
T Consensus       307 p~~~~~  312 (353)
T 2b9h_A          307 PYLQTY  312 (353)
T ss_dssp             GGGTTT
T ss_pred             cccccc
Confidence             44443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.5e-44  Score=343.79  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=198.8

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      ...++|.+.+.||+|+||+||+|.+  +|+.||||++.......          ..+.+|+..+..++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----------NRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----------CHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----------HHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            4457999999999999999999998  58999999986543221          22456777888899999999999986


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHh--hCCceecccCC
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQ--SKKIVHRDVKT  249 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH--~~givH~Dikp  249 (404)
                      .....         .....++++||||++ ++|...+..  .....+++..+..++.||+.||.|||  +.||+||||||
T Consensus        90 ~~~~~---------~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp  159 (360)
T 3e3p_A           90 TLGER---------DRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKP  159 (360)
T ss_dssp             EECSS---------CTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCG
T ss_pred             ccccc---------cccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCH
Confidence            54331         111223589999995 466555533  23567899999999999999999999  99999999999


Q ss_pred             CCEEEcC-CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          250 ENMLLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       250 ~Nili~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      +||||+. ++.+||+|||+++.... ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..
T Consensus       160 ~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  238 (360)
T 3e3p_A          160 HNVLVNEADGTLKLCDFGSAKKLSP-SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA  238 (360)
T ss_dssp             GGEEEETTTTEEEECCCTTCBCCCT-TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHEEEeCCCCcEEEeeCCCceecCC-CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence            9999986 89999999999975443 33344567899999999997654 899999999999999999999999998877


Q ss_pred             HHHHHHHhccC------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HH
Q 015594          328 EVTSAVVRQNL------------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--ML  375 (404)
Q Consensus       328 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L  375 (404)
                      +....+.....                              ....+..+++++.+||.+||+.||.+|||+.++++  .+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            76666543211                              11223346789999999999999999999999986  35


Q ss_pred             HHhHh
Q 015594          376 EAIDT  380 (404)
Q Consensus       376 ~~~~~  380 (404)
                      +.+..
T Consensus       319 ~~~~~  323 (360)
T 3e3p_A          319 DELHD  323 (360)
T ss_dssp             GGGGC
T ss_pred             cccCC
Confidence            55543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-43  Score=345.19  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      ...+|.+.+.||+|+||+||+|.+ .+..||+|.+......             ..+|+.+++.++||||+++++++...
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------------~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------------KNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence            346799999999999999999998 4566899887543221             13689999999999999999998654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK--NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      ...          ....++++||||+++ ++...+..  .....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       105 ~~~----------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil  173 (394)
T 4e7w_A          105 GDK----------KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL  173 (394)
T ss_dssp             SSS----------SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCC----------CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence            431          122345899999965 44444422  23467999999999999999999999999999999999999


Q ss_pred             Ec-CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          254 LD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       254 i~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |+ .++.+||+|||+++.... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...
T Consensus       174 l~~~~~~~kL~DFG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~  252 (394)
T 4e7w_A          174 LDPPSGVLKLIDFGSAKILIA-GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV  252 (394)
T ss_dssp             EETTTTEEEECCCTTCEECCT-TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EcCCCCcEEEeeCCCcccccC-CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            98 799999999999976433 2334456789999999999765 58999999999999999999999999988776665


Q ss_pred             HHHhccC---------------CC------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNL---------------RP------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~---------------~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+....-               ..            .++..+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            5543110               00            123457899999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=339.33  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..|++ ..+|.+.+.||+|+||.||+|.+  +|+.||||++......       ......+.+|+.+++.++||||++++
T Consensus        18 ~~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~   89 (353)
T 3coi_A           18 TAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLL   89 (353)
T ss_dssp             EEEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             ccccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCcccHh
Confidence            34444 37899999999999999999997  6899999999653321       22345678999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++........          ...+|+||||+. ++|.+++.    ..+++..++.++.||+.||.|||++||+||||||
T Consensus        90 ~~~~~~~~~~~----------~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp  154 (353)
T 3coi_A           90 DVFTPASSLRN----------FYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP  154 (353)
T ss_dssp             EEECSCSSGGG----------CCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred             heEeccccccc----------ceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence            99987654311          112389999995 78887662    3599999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +||+++.++.+||+|||+++....   ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+
T Consensus       155 ~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  231 (353)
T 3coi_A          155 GNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  231 (353)
T ss_dssp             GGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred             HHEeECCCCcEEEeecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999975332   2345678999999999987 678999999999999999999999999887766


Q ss_pred             HHHHHHhcc--------------------------CC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQN--------------------------LR---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~--------------------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+....                          ..   ......+++++.+||.+||+.||++|||+.++++
T Consensus       232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            555443210                          00   1223467899999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.2e-44  Score=341.30  Aligned_cols=249  Identities=20%  Similarity=0.336  Sum_probs=176.3

Q ss_pred             CCCeEEee-eeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           98 PAKLIIKG-AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~-~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      .++|.+.+ .||+|+||+||+|.+  +|+.||||++...      ...       ..+....++.++||||+++++++..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKA-------RQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHH-------HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHH-------HHHHHHHHHhcCCCChHHHHHHHhh
Confidence            46888854 699999999999998  5899999998532      110       1122334567799999999999875


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...-            ....++||||+++|+|.+++.+.....+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        94 ~~~~------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll  161 (336)
T 3fhr_A           94 MHHG------------KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY  161 (336)
T ss_dssp             EETT------------EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCC------------CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            3221            1224899999999999999977655689999999999999999999999999999999999999


Q ss_pred             cC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          255 DK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       255 ~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +.   ++.+||+|||++.....  .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus       162 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  239 (336)
T 3fhr_A          162 TSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP  239 (336)
T ss_dssp             SCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             EecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh
Confidence            75   45599999999975432  23344678999999999998889999999999999999999999997765444321


Q ss_pred             HH----Hhc--cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AV----VRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~----~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..    ...  .........+++++.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11    111  1222333578999999999999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-43  Score=343.93  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CC-----cee
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HP-----NVT  166 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv  166 (404)
                      +...++|.+.+.||+|+||+||+|.+  +++.||||+++..      .    .....+.+|+.++..+. |+     +|+
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------K----AFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------H----HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            34468999999999999999999987  5889999999632      1    12344667888888874 44     499


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHh--hCCcee
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQ--SKKIVH  244 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~givH  244 (404)
                      ++++++.....+                |+||||+ +++|.+++.......+++..+..++.||+.||.|||  ..||+|
T Consensus       120 ~~~~~~~~~~~~----------------~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH  182 (382)
T 2vx3_A          120 HLKRHFMFRNHL----------------CLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH  182 (382)
T ss_dssp             CEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEEC
T ss_pred             EeeeeeccCCce----------------EEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEc
Confidence            999999877665                8999999 569999998766567999999999999999999999  579999


Q ss_pred             cccCCCCEEEc--CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          245 RDVKTENMLLD--KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       245 ~Dikp~Nili~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      |||||+||||+  .++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       183 rDlkp~NIll~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          183 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             CCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCcccEEEecCCCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999994  578899999999976432   2345678999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhccCCCC----------------CC------------------C---C--------------------
Q 015594          323 DLSFSEVTSAVVRQNLRPE----------------IP------------------R---C--------------------  345 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~----------------~~------------------~---~--------------------  345 (404)
                      ..+..+....+......+.                .+                  .   .                    
T Consensus       260 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  339 (382)
T 2vx3_A          260 GANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES  339 (382)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCT
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccc
Confidence            9887776665543211000                00                  0   0                    


Q ss_pred             -----CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          346 -----CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       346 -----~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                           .++++.+||.+||+.||++|||+.++++
T Consensus       340 ~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             TCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence                 0147899999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.7e-43  Score=330.59  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=198.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||.||+|.+  +|+.||||++...      .    .....+.+|+.++++++||||+++++++.+..
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------E----EKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------H----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            5799999999999999999997  6899999998531      1    12456789999999999999999999987654


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .....   ..........|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.
T Consensus        76 ~~~~~---~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           76 NFVKP---MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE  151 (303)
T ss_dssp             CCCC---------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             chhhh---hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence            32100   01122345569999999999999999654 456888999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCC--------------CCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          257 TRTVKIADFGVARLEASN--------------PHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      ++.+||+|||++......              ........||+.|+|||++.+. .++.++||||||+++|+|++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            999999999999754321              1223345689999999999865 68999999999999999998   55


Q ss_pred             CCC-CHHHHHHHHHhc--cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          322 PDL-SFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       322 ~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ... +..+....+...  .+.+..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             SSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            432 222233333222  2334455677889999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=333.99  Aligned_cols=261  Identities=20%  Similarity=0.273  Sum_probs=202.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++....         ......+.+|+.++++++||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            47899999999999999999998  48999999986432         12245678999999999999999999998654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .....  ...........+|+||||++ |+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus        81 ~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           81 GSQLT--DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN  154 (320)
T ss_dssp             SCBCC--C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred             ccccc--cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence            32210  01112234456799999996 799998843   5799999999999999999999999999999999999997


Q ss_pred             -CCCcEEEeeccccccccCC---CCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 -KTRTVKIADFGVARLEASN---PHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 -~~~~vkL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                       .++.+||+|||+++.....   ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  234 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM  234 (320)
T ss_dssp             TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             5679999999999754322   122334567999999998865 67899999999999999999999999988876665


Q ss_pred             HHHHhccCC-----------------------C-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLR-----------------------P-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~-----------------------~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+......                       +     .....+++++.+||.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            554432110                       0     112467899999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=337.88  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=197.4

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc----CCCcee
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL----DHPNVT  166 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpniv  166 (404)
                      ..+....+|.+.+.||+|+||.||+|.+  +++.||||+++.........   ......+.+|+.++.++    +||||+
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~h~~i~  101 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP---LSDSVTCPLEVALLWKVGAGGGHPGVI  101 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc---chhhHHHHHHHHHHHhhcccCCCCCee
Confidence            4455568899999999999999999987  68899999997543321111   11233456789999998    899999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEec-cCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEY-CHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      ++++++......                ++|||+ +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||
T Consensus       102 ~~~~~~~~~~~~----------------~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  163 (312)
T 2iwi_A          102 RLLDWFETQEGF----------------MLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHR  163 (312)
T ss_dssp             CEEEEC-----C----------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECC
T ss_pred             eEEEEEecCCeE----------------EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            999998776655                899999 7899999999664  579999999999999999999999999999


Q ss_pred             ccCCCCEEEc-CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCC
Q 015594          246 DVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPD  323 (404)
Q Consensus       246 Dikp~Nili~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~  323 (404)
                      ||||+||+++ .++.+||+|||++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus       164 dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          164 DIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             CCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             CCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            9999999998 8899999999999764432  3445678999999999876655 4589999999999999999999975


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..      .+...  ...++..+++++.+||.+||+.||++|||+.++++
T Consensus       242 ~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          242 DQ------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HH------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hH------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            32      12222  34466788999999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-44  Score=342.40  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC--CCce
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPNV  165 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpni  165 (404)
                      ...+.+...++|.+.+.||+|+||.||+|.+  +++.||||++...........   .....+.+|+.+++++.  ||||
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCc
Confidence            3455566778999999999999999999987  789999999976532211000   00123567899999996  5999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCC-CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCcee
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG-GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVH  244 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH  244 (404)
                      +++++++......                ++|||++.+ ++|.+++...  ..+++..++.++.||+.||.|||++||+|
T Consensus       111 ~~~~~~~~~~~~~----------------~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH  172 (320)
T 3a99_A          111 IRLLDWFERPDSF----------------VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLH  172 (320)
T ss_dssp             CCEEEEEECSSEE----------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             eEEEEEEecCCcE----------------EEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            9999999877665                899999976 8999998654  57999999999999999999999999999


Q ss_pred             cccCCCCEEEc-CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 015594          245 RDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       245 ~Dikp~Nili~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      |||||+||||+ .++.+||+|||+++....  .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus       173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          173 RDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCCHHHEEEeCCCCCEEEeeCcccccccc--ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            99999999998 789999999999976443  23345678999999999976665 788999999999999999999997


Q ss_pred             CCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...      .+...  ....+..+++++.+||.+||+.||++|||+++|++
T Consensus       251 ~~~------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          251 HDE------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             SHH------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Chh------hhhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            532      12222  23456778999999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-42  Score=333.65  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CC-ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc------ee
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DG-QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN------VT  166 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv  166 (404)
                      ...++|.+.+.||+|+||+||+|.+  ++ +.||||+++..      .    .....+.+|+.+++.+.|++      ++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------G----KYREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------c----cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            3457999999999999999999997  34 78999999531      1    12455778999999997766      89


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      .+++++......                |+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|||
T Consensus        86 ~~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~D  148 (355)
T 2eu9_A           86 LMSDWFNFHGHM----------------CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD  148 (355)
T ss_dssp             CEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             EeeeeeeeCCeE----------------EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            999988876655                8999999 88888888776556899999999999999999999999999999


Q ss_pred             cCCCCEEE-------------------cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHH
Q 015594          247 VKTENMLL-------------------DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSF  307 (404)
Q Consensus       247 ikp~Nili-------------------~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  307 (404)
                      |||+||||                   +.++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||
T Consensus       149 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  225 (355)
T 2eu9_A          149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSI  225 (355)
T ss_dssp             CCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHH
Confidence            99999999                   5678999999999975332   2345678999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------------------------------------------CCCCC
Q 015594          308 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP------------------------------------------EIPRC  345 (404)
Q Consensus       308 G~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~  345 (404)
                      |+++|+|++|..||...+..+....+.......                                          .....
T Consensus       226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (355)
T 2eu9_A          226 GCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL  305 (355)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccch
Confidence            999999999999999887665444332211000                                          00112


Q ss_pred             CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          346 CPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       346 ~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+.++.+||.+||+.||.+|||+.++++
T Consensus       306 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          306 EHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            2468899999999999999999999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=346.29  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=182.1

Q ss_pred             CCeEE-eeeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           99 AKLII-KGAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        99 ~~~~~-~~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +.|.+ .++||+|+||+||+|.+    +++.||||++.....           ...+.+|+.++++++||||+++++++.
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFL   88 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------CHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------CHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            45666 45799999999999996    378999999964322           123678999999999999999999996


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-------cCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      .....              .+|+||||+ +++|.+++....       ...+++..++.++.||+.||.|||++||+|||
T Consensus        89 ~~~~~--------------~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~D  153 (405)
T 3rgf_A           89 SHADR--------------KVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD  153 (405)
T ss_dssp             ETTTT--------------EEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCCC--------------eEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCC
Confidence            53322              238999999 568888885432       12499999999999999999999999999999


Q ss_pred             cCCCCEEE----cCCCcEEEeeccccccccCCC---CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCC
Q 015594          247 VKTENMLL----DKTRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCD  318 (404)
Q Consensus       247 ikp~Nili----~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~  318 (404)
                      |||+||||    +.++.+||+|||+++......   .......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus       154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  233 (405)
T 3rgf_A          154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  233 (405)
T ss_dssp             CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence            99999999    677899999999998644322   233456789999999999874 5899999999999999999999


Q ss_pred             CCCCCCCHH---------HHHHHHHhc-cCCC-----------------------------------CCCCCCcHHHHHH
Q 015594          319 MPYPDLSFS---------EVTSAVVRQ-NLRP-----------------------------------EIPRCCPSSLANV  353 (404)
Q Consensus       319 ~Pf~~~~~~---------~~~~~~~~~-~~~~-----------------------------------~~~~~~~~~l~~l  353 (404)
                      .||......         +....+... ....                                   ......++.+.+|
T Consensus       234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L  313 (405)
T 3rgf_A          234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL  313 (405)
T ss_dssp             CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred             CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence            999765431         222222211 0000                                   0011226788999


Q ss_pred             HHHhhhhCCCCCCCHHHHHH
Q 015594          354 MKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       354 i~~cl~~dP~~Rpt~~~ll~  373 (404)
                      |.+||+.||.+|||++++++
T Consensus       314 l~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          314 LQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCcccCCCHHHHhc
Confidence            99999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-43  Score=340.77  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-----------C
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-----------H  162 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h  162 (404)
                      +...+|.+.+.||+|+||+||+|.+  +++.||||++...      .    .....+.+|+.+++++.           |
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   85 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------K----VYTEAAEDEIKLLQRVNDADNTKEDSMGA   85 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------c----cchhhhhHHHHHHHHhhcccccchhcccc
Confidence            4567899999999999999999997  7899999998632      1    12345678899888886           8


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-C
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-K  241 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-g  241 (404)
                      |||+++++++.....-            ...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ |
T Consensus        86 ~~i~~~~~~~~~~~~~------------~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~  152 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPN------------GVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG  152 (373)
T ss_dssp             TTBCCCCEEEEEEETT------------EEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             chHHHHHHHhhccCCC------------CceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999999998754311            11248999999 99999999876667799999999999999999999998 9


Q ss_pred             ceecccCCCCEEEc------CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHH
Q 015594          242 IVHRDVKTENMLLD------KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY  315 (404)
Q Consensus       242 ivH~Dikp~Nili~------~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  315 (404)
                      |+||||||+||||+      ..+.+||+|||++.....   ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus       153 ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  229 (373)
T 1q8y_A          153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI  229 (373)
T ss_dssp             EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred             EEecCCChHHeEEeccCCCcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH
Confidence            99999999999994      444899999999975433   234467899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCH------HHHHHHHHhc--c--------------------------------------CCCCCCCCCcHH
Q 015594          316 CCDMPYPDLSF------SEVTSAVVRQ--N--------------------------------------LRPEIPRCCPSS  349 (404)
Q Consensus       316 ~g~~Pf~~~~~------~~~~~~~~~~--~--------------------------------------~~~~~~~~~~~~  349 (404)
                      +|..||...+.      .+....+...  .                                      ....++..++++
T Consensus       230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (373)
T 1q8y_A          230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE  309 (373)
T ss_dssp             HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred             hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence            99999986542      1111121110  0                                      011233445678


Q ss_pred             HHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          350 LANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       350 l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.+||.+||+.||.+|||+.+|++
T Consensus       310 ~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          310 ISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHHHHhccCccccCCHHHHhh
Confidence            999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=348.42  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=191.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEE-EEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTV-HRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V-~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~  168 (404)
                      ...+.+...+|.+.+.||+|+||+| |++..+|+.||||++......            .+.+|+.+++.+ +||||+++
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l   83 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRY   83 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCE
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeE
Confidence            3445677778999999999999984 567779999999998643211            135799999999 79999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.+....                |+||||+ +|+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus        84 ~~~~~~~~~~----------------~lv~E~~-~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK  145 (432)
T 3p23_A           84 FCTEKDRQFQ----------------YIAIELC-AATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK  145 (432)
T ss_dssp             EEEEEETTEE----------------EEEEECC-SEEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             EEEEecCCEE----------------EEEEECC-CCCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC
Confidence            9999877655                8999999 57999998654 3345556678999999999999999999999999


Q ss_pred             CCCEEEcC-----CCcEEEeeccccccccCCC---CcccCCCCCccccCccccC---CCCCCcchhhHHHHHHHHHHHh-
Q 015594          249 TENMLLDK-----TRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLN---GSAYNRKCDVYSFGICLWEIYC-  316 (404)
Q Consensus       249 p~Nili~~-----~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~-  316 (404)
                      |+||||+.     ...+||+|||+++......   .......||+.|+|||++.   +..++.++|||||||++|+|++ 
T Consensus       146 p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~  225 (432)
T 3p23_A          146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE  225 (432)
T ss_dssp             TTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred             HHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence            99999943     3368899999997644322   2334567999999999997   4567889999999999999999 


Q ss_pred             CCCCCCCCCHHHHHHHHHhccCCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          317 CDMPYPDLSFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       317 g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      |..||................... ..+...+..+.+||.+||+.||.+|||+.+|+
T Consensus       226 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             SCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            999997655443322111111111 11233456789999999999999999999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-42  Score=324.98  Aligned_cols=234  Identities=13%  Similarity=0.115  Sum_probs=189.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +...+|.+.+.||+|+||.||+|.+  +|+.||||++.......      ......+.+|+.++.+++||||+++++++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP------DDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            4457899999999999999999998  48999999997543321      223466889999999999999999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....                |+||||++|++|.+++..   + .....+..++.||+.||.|||++||+||||||+|||
T Consensus       102 ~~~~~----------------~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIl  161 (286)
T 3uqc_A          102 TRAGG----------------LVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR  161 (286)
T ss_dssp             ETTEE----------------EEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred             ECCcE----------------EEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEE
Confidence            77655                899999999999999843   2 355678899999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS--  331 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~--  331 (404)
                      |+.++.+||++++                    |++       +++.++||||||+++|+|++|..||...+..+...  
T Consensus       162 l~~~g~~kl~~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~  214 (286)
T 3uqc_A          162 VSIDGDVVLAYPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA  214 (286)
T ss_dssp             EETTSCEEECSCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC
T ss_pred             EcCCCCEEEEecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH
Confidence            9999999998543                    333       37899999999999999999999998765432110  


Q ss_pred             -HHHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          332 -AVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       332 -~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                       .........  .....+++++.+||.+||+.||.+| |+.++++.|+.+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence             000111111  2235689999999999999999999 99999999999886654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-42  Score=340.35  Aligned_cols=244  Identities=26%  Similarity=0.405  Sum_probs=185.5

Q ss_pred             CCeEEeeeeeeecceEEE-EEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVH-RGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~-~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  176 (404)
                      ..|.+.+.||+|+||+|| .+..+|+.||||++....            ...+.+|+.+++++ +||||+++++++.+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            456677899999999996 445589999999985321            13457899999886 8999999999988766


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCC-----CcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRK-----LAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      .+                |+||||+ +|+|.+++.......     .++..++.++.||+.||.|||++||+||||||+|
T Consensus        83 ~~----------------~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~N  145 (434)
T 2rio_A           83 FL----------------YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQN  145 (434)
T ss_dssp             EE----------------EEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             eE----------------EEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHh
Confidence            55                8999999 579999996542211     1233457899999999999999999999999999


Q ss_pred             EEEcCC-------------CcEEEeeccccccccCCCC----cccCCCCCccccCccccCC-------CCCCcchhhHHH
Q 015594          252 MLLDKT-------------RTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNG-------SAYNRKCDVYSF  307 (404)
Q Consensus       252 ili~~~-------------~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvwsl  307 (404)
                      |||+.+             +.+||+|||++........    ......||+.|+|||++.+       ..++.++|||||
T Consensus       146 ILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl  225 (434)
T 2rio_A          146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM  225 (434)
T ss_dssp             EEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred             EEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence            999654             4899999999986543322    1234579999999999976       568999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          308 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEI-----PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       308 G~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ||++|||++ |..||......+  ..+.........     +..+++++.+||.+||+.||.+|||+.+|++
T Consensus       226 G~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          226 GCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999999999 999997765443  233333332221     1234688999999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.5e-41  Score=315.46  Aligned_cols=227  Identities=20%  Similarity=0.358  Sum_probs=179.9

Q ss_pred             CCeEEe-eeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHH-hhcCCCceeEEEEEEec
Q 015594           99 AKLIIK-GAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW-HKLDHPNVTKFIGATMG  174 (404)
Q Consensus        99 ~~~~~~-~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~  174 (404)
                      .+|.+. +.||+|+||.||++.+  +++.||||+++..              ..+.+|+.++ +.++||||+++++++..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            567776 7899999999999998  6899999998521              2345788777 66699999999999875


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...            .....|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        83 ~~~------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~  150 (299)
T 3m2w_A           83 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY  150 (299)
T ss_dssp             EET------------TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             hcC------------CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            110            11223899999999999999987666689999999999999999999999999999999999999


Q ss_pred             cC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          255 DK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       255 ~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      +.   ++.+||+|||++....                      +..++.++||||||+++|+|++|..||...+......
T Consensus       151 ~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  208 (299)
T 3m2w_A          151 TSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP  208 (299)
T ss_dssp             SSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C
T ss_pred             ecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH
Confidence            87   7889999999986422                      2347889999999999999999999997765433221


Q ss_pred             HHHhccCC--CCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLR--PEIP----RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~--~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........  ...+    ..+++++.+||.+||+.||.+|||+.++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111111  1112    467899999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-41  Score=331.98  Aligned_cols=261  Identities=14%  Similarity=0.171  Sum_probs=189.1

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC-Cce------
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNV------  165 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pni------  165 (404)
                      ......|.+.+.||+|+||+||+|.+  +|+.||||++........      ...+.+.+|+.++..+.| +|+      
T Consensus        74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~~~~~~~  147 (413)
T 3dzo_A           74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAKVH  147 (413)
T ss_dssp             SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH------HHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence            34456688999999999999999998  599999999874432211      123457899999999977 211      


Q ss_pred             ---eEEEEEEecCCcccccc-CCCCCCCCCCceEEEEeccCCCCHHHHHHh-----cccCCCcHHHHHHHHHHHHHHHHH
Q 015594          166 ---TKFIGATMGTSELNIQT-DNGHIGMPSNFCCVVVEYCHGGALKSYLIK-----NRRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       166 ---v~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                         +..+..........+.. ..+........++++|+++ +++|.+++..     .....+++..++.++.||+.||.|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  226 (413)
T 3dzo_A          148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  226 (413)
T ss_dssp             TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence               11111111111100000 0000000112347777777 8999998842     234568889999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCcccc----------CCCCCCcchhhHH
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVL----------NGSAYNRKCDVYS  306 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws  306 (404)
                      ||++||+||||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++          .+..++.++||||
T Consensus       227 LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          227 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             HHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            99999999999999999999999999999999754332   445667 999999999          6667899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 015594          307 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV  372 (404)
Q Consensus       307 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll  372 (404)
                      |||++|+|++|..||...+..+....+.      .....+|+++.+||.+||+.||++||++.+++
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999999998765443322211      12246789999999999999999999976664

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-41  Score=345.69  Aligned_cols=265  Identities=27%  Similarity=0.360  Sum_probs=202.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|.+.+.||+|+||+||+|.+  +|+.||||++.....        ......+.+|+.++++++||||+++++++....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~--------~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--------PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC--------HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC--------HHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            6899999999999999999987  689999999864321        122456889999999999999999999875522


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR-RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..          ......|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus        86 ~~----------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~  155 (676)
T 3qa8_A           86 KL----------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ  155 (676)
T ss_dssp             CC----------CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEE
T ss_pred             cc----------cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEee
Confidence            21          12334489999999999999996642 23689999999999999999999999999999999999998


Q ss_pred             CCCc---EEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Q 015594          256 KTRT---VKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS-  331 (404)
Q Consensus       256 ~~~~---vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~-  331 (404)
                      .++.   +||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... 
T Consensus       156 ~~g~~~~vKL~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~  234 (676)
T 3qa8_A          156 PGPQRLIHKIIDLGYAKELDQ-GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG  234 (676)
T ss_dssp             CCSSSCEEEECSCCCCCBTTS-CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred             cCCCceeEEEccccccccccc-ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence            7664   99999999976433 233455689999999999999999999999999999999999999997643221100 


Q ss_pred             --------HH-Hh----cc--C------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHhHhhc
Q 015594          332 --------AV-VR----QN--L------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDE-----VVAMLEAIDTSK  382 (404)
Q Consensus       332 --------~~-~~----~~--~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~-----ll~~L~~~~~~~  382 (404)
                              .. ..    ..  +      .......+++.+.+||.+||..||++|||+.+     ..+.++.+....
T Consensus       235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                    00 00    00  0      01122336789999999999999999999988     456666655443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-40  Score=344.65  Aligned_cols=248  Identities=24%  Similarity=0.299  Sum_probs=196.8

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      .++...+|.+.+.||+|+||+||++.+   +|+.||||++.....        ......+.+|+.++.+++||||+++++
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~  146 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--------AEAQAMAMAERQFLAEVVHPSIVQIFN  146 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--------HHHHHHHHHHHHHHHhcCCCCcCeEee
Confidence            345568999999999999999999997   579999999864221        122456789999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++......           .....|+||||++|++|.+++..    .+++..++.++.||+.||.|||++||+||||||+
T Consensus       147 ~~~~~~~~-----------~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~  211 (681)
T 2pzi_A          147 FVEHTDRH-----------GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE  211 (681)
T ss_dssp             EEEEECTT-----------SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             eEeecCCC-----------CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChH
Confidence            99865541           01123899999999999987632    6999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ||||+.+ .+||+|||+++.....    ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.......  
T Consensus       212 NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--  283 (681)
T 2pzi_A          212 NIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--  283 (681)
T ss_dssp             GEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--
T ss_pred             HeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--
Confidence            9999875 8999999999754332    446789999999999876 4899999999999999999988876432110  


Q ss_pred             HHHHhccCCCC-CCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhH
Q 015594          331 SAVVRQNLRPE-IPRCCPSSLANVMKRCWDANPDKRP-EMDEVVAMLEAID  379 (404)
Q Consensus       331 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~  379 (404)
                             .... ....+++.+.+||.+||+.||.+|| +++++...|..+.
T Consensus       284 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 -------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   0000 0011357899999999999999998 5777777777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.2e-41  Score=321.45  Aligned_cols=262  Identities=16%  Similarity=0.203  Sum_probs=190.0

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---------CCcee
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---------HPNVT  166 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------hpniv  166 (404)
                      +..++|.+.+.||+|+||+||+|+++|+.||||++.......... ........+.+|+.+++.++         ||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG-SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTT-BCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCcccccc-ccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            445789999999999999999999999999999998654221000 00011244677888888875         88888


Q ss_pred             EEEEEEecCC--ccccccCCCCC------------CCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHH
Q 015594          167 KFIGATMGTS--ELNIQTDNGHI------------GMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLAR  232 (404)
Q Consensus       167 ~~~~~~~~~~--~~~i~~~~~~~------------~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~  232 (404)
                      ++.+++....  +..+..-.+.+            ......+|+||||+++|++.+.+.+   ..+++..++.++.||+.
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence            8888764221  11110000000            0124556999999999987766633   56899999999999999


Q ss_pred             HHHHHh-hCCceecccCCCCEEEcCCC--------------------cEEEeeccccccccCCCCcccCCCCCccccCcc
Q 015594          233 GLSYLQ-SKKIVHRDVKTENMLLDKTR--------------------TVKIADFGVARLEASNPHDMTGETGTLGYMAPE  291 (404)
Q Consensus       233 ~L~~LH-~~givH~Dikp~Nili~~~~--------------------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  291 (404)
                      ||.||| ++||+||||||+||||+.++                    .+||+|||+|+.....     ...||+.|+|||
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence            999999 99999999999999998887                    8999999999865432     347899999999


Q ss_pred             ccCCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcc-CCCCC----CCCCcHHHHHHHHHhhhhCCCC
Q 015594          292 VLNGSAYNRKCDVYSFGIC-LWEIYCCDMPYPDLSF-SEVTSAVVRQN-LRPEI----PRCCPSSLANVMKRCWDANPDK  364 (404)
Q Consensus       292 ~~~~~~~~~~~DvwslG~i-l~el~~g~~Pf~~~~~-~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~cl~~dP~~  364 (404)
                      ++.+.. +.++|||||+++ .+++++|..||..... ......+.... .....    +..+++++.+||.+||+.|   
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            999886 999999998777 7778889999854221 11222222221 11111    2346889999999999976   


Q ss_pred             CCCHHHHH
Q 015594          365 RPEMDEVV  372 (404)
Q Consensus       365 Rpt~~~ll  372 (404)
                        |+++++
T Consensus       324 --sa~e~l  329 (336)
T 2vuw_A          324 --SATDLL  329 (336)
T ss_dssp             --SHHHHH
T ss_pred             --CHHHHH
Confidence              888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.2e-34  Score=290.15  Aligned_cols=190  Identities=14%  Similarity=0.119  Sum_probs=135.5

Q ss_pred             eeeeecceEEEEEE--ECCceEEEEEeecCCC-CcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEEEEecCCccccc
Q 015594          106 AFARGTFGTVHRGI--YDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       106 ~lg~G~~g~V~~~~--~~g~~vAvK~~~~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~i~  181 (404)
                      ..+.|++|.+..++  +.|+.||||++..... ......+.+..++.|.+|+.+|+++ .|+||+++++++++...+   
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~---  317 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG---  317 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE---
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE---
Confidence            35567777666443  4799999999976532 2233444455677899999999999 799999999999988877   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   ||||||++|++|.++|.+.  .+++..   +|+.||+.||.|||++|||||||||+||||+.+|+||
T Consensus       318 -------------yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK  379 (569)
T 4azs_A          318 -------------WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR  379 (569)
T ss_dssp             -------------EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred             -------------EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence                         9999999999999999654  567765   5789999999999999999999999999999999999


Q ss_pred             EeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 015594          262 IADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      |+|||+|+..........+.+||+.|||||++.+. +...+|+||+|++++++.++
T Consensus       380 L~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          380 LIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             ECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             EeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            99999998766655566667899999999999876 67889999999998876554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.7e-30  Score=261.33  Aligned_cols=192  Identities=15%  Similarity=0.182  Sum_probs=147.2

Q ss_pred             EEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCccccc
Q 015594          102 IIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       102 ~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i~  181 (404)
                      ...+.||+|+||+||++...++.+|+|........ ..........+++.+|+.++++++||||+++..++......   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~---  414 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYR-DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK---  414 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTS-CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT---
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEeccccc-chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc---
Confidence            34678999999999999889999999987543222 22223334467789999999999999999444444444443   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEE
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK  261 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vk  261 (404)
                                   |+||||+++++|.+++..          +..++.||+.||.|||++||+||||||+|||++.  .+|
T Consensus       415 -------------~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~k  469 (540)
T 3en9_A          415 -------------RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLY  469 (540)
T ss_dssp             -------------EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEE
T ss_pred             -------------EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEE
Confidence                         899999999999998843          5689999999999999999999999999999998  999


Q ss_pred             EeeccccccccCCCCc-------ccCCCCCccccCccccCC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          262 IADFGVARLEASNPHD-------MTGETGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       262 L~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      |+|||+++........       .....||+.|||||++.+  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999999865432111       134578999999999987  568888999999999888887777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.9e-26  Score=212.34  Aligned_cols=153  Identities=16%  Similarity=0.061  Sum_probs=115.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCccc---------HHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRS---------EAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ..|.+.+.||+|+||.||+|.+ +|+.||||+++.+......         .......+..+.+|+.++++++|   +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            3455669999999999999998 6899999999653221110         01111245678899999999984   444


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      .+++.. ...                |+||||++|++|.+ +.      .  .....++.||+.||.|||+.||+|||||
T Consensus       167 ~~~~~~-~~~----------------~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlk  220 (282)
T 1zar_A          167 PKVYAW-EGN----------------AVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLS  220 (282)
T ss_dssp             CCEEEE-ETT----------------EEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CeEEec-cce----------------EEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence            443322 222                89999999999988 41      1  2345799999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN  294 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  294 (404)
                      |+||||+ ++.+||+|||+++.             +..++|||.+.
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             HHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            9999999 99999999999973             44578898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.8e-21  Score=178.58  Aligned_cols=144  Identities=17%  Similarity=0.138  Sum_probs=106.9

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCce--EEEEEeecCCCCcccH---------------HHHHHHHHHHHHHHHHHhhc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQD--VAVKLLDWGEESHRSE---------------AEIASLRAAFTQEVAVWHKL  160 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~--vAvK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l  160 (404)
                      -|.+.+.||+|+||.||+|.+  +|+.  ||||+++.........               .........+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998  8999  9999975432111100               00112234678999999999


Q ss_pred             CCCce--eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCC-C----CHHHHHHhcccCCCcHHHHHHHHHHHHHH
Q 015594          161 DHPNV--TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG-G----ALKSYLIKNRRRKLAFKVVIQLALDLARG  233 (404)
Q Consensus       161 ~hpni--v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~  233 (404)
                      .|+++  ..+++.    ..                .++||||+.+ |    +|.++...     .++..+..++.||+.+
T Consensus       128 ~~~~i~~p~~~~~----~~----------------~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~  182 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MK----------------NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVEN  182 (258)
T ss_dssp             HHTTCCCCCEEEE----ET----------------TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc----CC----------------CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHH
Confidence            88754  334432    11                1899999942 3    67765422     3355678999999999


Q ss_pred             HHHHh-hCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          234 LSYLQ-SKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       234 L~~LH-~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      |.||| +.||+||||||+|||++.  .++|+|||+|..
T Consensus       183 l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          183 VKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             HHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             HHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            99999 999999999999999988  899999999974

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=9.4e-19  Score=167.56  Aligned_cols=143  Identities=16%  Similarity=0.139  Sum_probs=102.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCc-------------ccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESH-------------RSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~-------------~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      -|.+.+.||.|+||.||+|.. +|+.||||+++.+....             .........+....+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            388999999999999999997 78999999986432111             1111122223334567777877755443


Q ss_pred             --eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCce
Q 015594          166 --TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIV  243 (404)
Q Consensus       166 --v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~giv  243 (404)
                        ...++..    .                .+|||||++|++|..+.        .......++.||+.+|.+||+.|||
T Consensus       176 ~vp~p~~~~----~----------------~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIV  227 (397)
T 4gyi_A          176 PVPEPIAQS----R----------------HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLI  227 (397)
T ss_dssp             SCCCEEEEE----T----------------TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             CCCeeeecc----C----------------ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCc
Confidence              2222221    0                17999999998886542        1123457889999999999999999


Q ss_pred             ecccCCCCEEEcCCC----------cEEEeecccccc
Q 015594          244 HRDVKTENMLLDKTR----------TVKIADFGVARL  270 (404)
Q Consensus       244 H~Dikp~Nili~~~~----------~vkL~Dfg~a~~  270 (404)
                      ||||||.||||++++          .+.|+||+.+..
T Consensus       228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999999998766          389999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1.4e-12  Score=119.18  Aligned_cols=140  Identities=11%  Similarity=0.042  Sum_probs=107.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSE  177 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  177 (404)
                      ..|.+...++.|+++.||+....++.+++|+........         ...+.+|+.+++.+. +..+.+++++..+...
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            358888888989999999998888999999986421111         123668899998884 6677888888765443


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh------------------
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS------------------  239 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------  239 (404)
                      .                |+||||++|.+|.+.+.       +......++.+++.+|..||+                  
T Consensus        85 ~----------------~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~  141 (263)
T 3tm0_A           85 S----------------NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE  141 (263)
T ss_dssp             E----------------EEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred             e----------------EEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence            3                89999999999977531       112234678899999999998                  


Q ss_pred             -----------------------------------------CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 -----------------------------------------KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 -----------------------------------------~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                                                               ..++|+|++|.||++++++.+.|+||+.+..
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                                     4589999999999998765567999998853

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=6.4e-11  Score=107.53  Aligned_cols=133  Identities=15%  Similarity=0.072  Sum_probs=93.3

Q ss_pred             CeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCC
Q 015594          100 KLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTS  176 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~  176 (404)
                      .+.+....+.|..+.||+... +|+.++||+.....            ...+.+|+.+++.+.+.+  +.+++++..+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            455544445667799999876 46789999975321            123567888888885444  455777765543


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC---------------
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK---------------  241 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---------------  241 (404)
                      ..                ++||||++|.+|.  . .    ..+   ...++.+++..|..||+..               
T Consensus        89 ~~----------------~~v~e~i~G~~l~--~-~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~  142 (264)
T 1nd4_A           89 RD----------------WLLLGEVPGQDLL--S-S----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIE  142 (264)
T ss_dssp             CE----------------EEEEECCSSEETT--T-S----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHH
T ss_pred             CC----------------EEEEEecCCcccC--c-C----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            33                8999999998884  2 1    111   1255667777777777643               


Q ss_pred             -------------------------------------------ceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          242 -------------------------------------------IVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       242 -------------------------------------------ivH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                                                                 ++|+|++|.||++++++.+.|+||+.+..
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          143 RARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                                       99999999999998776667999999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=9.3e-11  Score=112.17  Aligned_cols=143  Identities=16%  Similarity=0.203  Sum_probs=104.9

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEee--cCCCCcccHHHHHHHHHHHHHHHHHHhhcC--CCceeEEEEEEecCCcc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLD--WGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPNVTKFIGATMGTSEL  178 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~  178 (404)
                      -.+.|+.|.++.||+....+..+++|+..  .+...        .....+.+|+.+++.|.  +..+.+++.++.+....
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            34678889999999998888889999874  22110        11234678999999986  45578888877654321


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-------------------
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-------------------  239 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------  239 (404)
                                   +..|+||||++|..+.+..    -..++......++.+++..|..||+                   
T Consensus       114 -------------g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3dxp_A          114 -------------GRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQ  176 (359)
T ss_dssp             -------------SSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHH
T ss_pred             -------------CCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchH
Confidence                         1238999999988875421    2347788888999999999999997                   


Q ss_pred             ---------------------------------------CCceecccCCCCEEEcCCCc--EEEeecccccc
Q 015594          240 ---------------------------------------KKIVHRDVKTENMLLDKTRT--VKIADFGVARL  270 (404)
Q Consensus       240 ---------------------------------------~givH~Dikp~Nili~~~~~--vkL~Dfg~a~~  270 (404)
                                                             ..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          177 RQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                                   36999999999999987653  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=3.2e-10  Score=105.89  Aligned_cols=185  Identities=19%  Similarity=0.213  Sum_probs=118.8

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCc--eeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPN--VTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~~~~i~  181 (404)
                      +.++.|.+..||+.   +..+++|+...       .    .....+.+|+.+++.+. +..  +.+.+.........   
T Consensus        26 ~~~~~G~~n~v~~v---~~~~vlR~~~~-------~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~---   88 (304)
T 3sg8_A           26 EISGEGNDCIAYEI---NRDFIFKFPKH-------S----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY---   88 (304)
T ss_dssp             CEEEECSSEEEEES---TTSEEEEEESS-------H----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC---
T ss_pred             EecCCCCcceEEEE---CCEEEEEecCC-------c----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC---
Confidence            35788999999986   36799998631       1    12355788999998883 322  33444433222111   


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh----------------------
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS----------------------  239 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------  239 (404)
                                ...|+|||+++|.+|.+...    ..++..+...++.+++..|..||+                      
T Consensus        89 ----------~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~  154 (304)
T 3sg8_A           89 ----------QMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN  154 (304)
T ss_dssp             ----------SCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred             ----------CcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence                      12278999999988876442    246777788888888888888886                      


Q ss_pred             ------------------------------------CCceecccCCCCEEEcC--CCcEEEeeccccccccCCCCcccCC
Q 015594          240 ------------------------------------KKIVHRDVKTENMLLDK--TRTVKIADFGVARLEASNPHDMTGE  281 (404)
Q Consensus       240 ------------------------------------~givH~Dikp~Nili~~--~~~vkL~Dfg~a~~~~~~~~~~~~~  281 (404)
                                                          ..++|+|++|.||++++  .+.+.|+||+.+... ....+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~  233 (304)
T 3sg8_A          155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISL  233 (304)
T ss_dssp             HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTT
T ss_pred             HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHH
Confidence                                                13799999999999987  556789999998652 221111111


Q ss_pred             CCCccccCccccC------CCC--------CCcchhhHHHHHHHHHHHhCCCCC
Q 015594          282 TGTLGYMAPEVLN------GSA--------YNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       282 ~gt~~y~aPE~~~------~~~--------~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                      .....-..|+...      +..        .....+.|+++.++|.+.+|..+|
T Consensus       234 ~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          234 MEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0000002222211      000        112368999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=6e-07  Score=83.69  Aligned_cols=133  Identities=18%  Similarity=0.182  Sum_probs=88.8

Q ss_pred             eeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC---ceeEEEEEEecCCccccc
Q 015594          105 GAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP---NVTKFIGATMGTSELNIQ  181 (404)
Q Consensus       105 ~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~~~~~i~  181 (404)
                      ..++.|....||+.   |..++||+..       ..    .....+.+|+.+++.+.+.   .+.+.+.+....      
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~-------~~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~------   84 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPK-------SQ----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS------   84 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEES-------SH----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT------
T ss_pred             eecCCCcceeEEEE---CCEEEEEecC-------Cc----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC------
Confidence            45688888999987   7889999852       11    1235678999999999652   245555554311      


Q ss_pred             cCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC---------------------
Q 015594          182 TDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK---------------------  240 (404)
Q Consensus       182 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------  240 (404)
                               .+..++||||++|.+|.+....    .++......++.++...|..||+.                     
T Consensus        85 ---------~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~  151 (306)
T 3tdw_A           85 ---------DGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILL  151 (306)
T ss_dssp             ---------TSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHH
T ss_pred             ---------CCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHH
Confidence                     1223799999999888763211    234444445555555555555532                     


Q ss_pred             ---------------------------------------CceecccCCCCEEEcC---CCcE-EEeecccccc
Q 015594          241 ---------------------------------------KIVHRDVKTENMLLDK---TRTV-KIADFGVARL  270 (404)
Q Consensus       241 ---------------------------------------givH~Dikp~Nili~~---~~~v-kL~Dfg~a~~  270 (404)
                                                             .++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       152 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          152 LSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                                   4599999999999987   4554 8999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.50  E-value=9e-07  Score=80.60  Aligned_cols=130  Identities=16%  Similarity=0.107  Sum_probs=88.1

Q ss_pred             eeeecce-EEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCcccccc
Q 015594          107 FARGTFG-TVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSELNIQT  182 (404)
Q Consensus       107 lg~G~~g-~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~i~~  182 (404)
                      +..|..| .||+...  .+..++||+-..+            ....+.+|..+|+.+. +--+.++++++.+....    
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~----   95 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA----   95 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE----
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE----
Confidence            3445554 6898665  4678999987421            1234668888888874 22255677776655443    


Q ss_pred             CCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC----------------------
Q 015594          183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK----------------------  240 (404)
Q Consensus       183 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------  240 (404)
                                  |+|||+++|.++.+.....      ......++.++...|..||+.                      
T Consensus        96 ------------~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~  157 (272)
T 4gkh_A           96 ------------WLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRM  157 (272)
T ss_dssp             ------------EEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHH
T ss_pred             ------------EEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHH
Confidence                        8999999998887765332      112234555666666666641                      


Q ss_pred             ------------------------------------CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 ------------------------------------KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 ------------------------------------givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                                                          .++|+|+.+.||++++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          158 NNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                                179999999999999877777999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.26  E-value=2.2e-06  Score=81.48  Aligned_cols=32  Identities=19%  Similarity=0.354  Sum_probs=26.9

Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35799999999999999655578999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.16  E-value=2.5e-05  Score=67.85  Aligned_cols=139  Identities=12%  Similarity=0.098  Sum_probs=95.0

Q ss_pred             CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCC
Q 015594          204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET  282 (404)
Q Consensus       204 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~  282 (404)
                      .+|.++|.. .+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|+|..+|.|-+.+ ..+.            .
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~   98 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------A   98 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------c
Confidence            478998854 46899999999999999999888722 1112333457899999999987663 1110            1


Q ss_pred             CCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhh--
Q 015594          283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA--  360 (404)
Q Consensus       283 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--  360 (404)
                      ....+.+||... ...+.+.=|||||+++|.-+-                   -++....+..+++.|.+||..|...  
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~  158 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVE  158 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhccc
Confidence            133466888764 345788999999999999763                   2334455677899999999999866  


Q ss_pred             -----------------------CCCCCCCHHHHHHHHH
Q 015594          361 -----------------------NPDKRPEMDEVVAMLE  376 (404)
Q Consensus       361 -----------------------dP~~Rpt~~~ll~~L~  376 (404)
                                             .+..|+++++|++.=.
T Consensus       159 d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          159 ADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             --------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence                                   2457889999886544

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.03  E-value=3.2e-05  Score=72.58  Aligned_cols=31  Identities=23%  Similarity=0.417  Sum_probs=27.8

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998778899999998853

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.01  E-value=2.6e-05  Score=75.17  Aligned_cols=31  Identities=19%  Similarity=0.356  Sum_probs=26.4

Q ss_pred             hCCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          239 SKKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ...++|+|+.+.||+++.++ ++|+||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence            45799999999999998764 89999988764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00014  Score=67.72  Aligned_cols=76  Identities=18%  Similarity=0.133  Sum_probs=55.4

Q ss_pred             EeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC---CCceeEEEEEEecCCccc
Q 015594          103 IKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD---HPNVTKFIGATMGTSELN  179 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~  179 (404)
                      -...|+.|.+..+|+...+++.++||+....            ....+..|+..|+.|.   ...+.+.+++......  
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~--  105 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH--  105 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE--
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc--
Confidence            4467888999999998888889999987521            1344678888888873   3557777776654332  


Q ss_pred             cccCCCCCCCCCCceEEEEeccCCCCH
Q 015594          180 IQTDNGHIGMPSNFCCVVVEYCHGGAL  206 (404)
Q Consensus       180 i~~~~~~~~~~~~~~~lv~E~~~~g~L  206 (404)
                                    .++||||++|..+
T Consensus       106 --------------~~lvme~l~G~~~  118 (312)
T 3jr1_A          106 --------------SFLLLEALNKSKN  118 (312)
T ss_dssp             --------------EEEEEECCCCCCC
T ss_pred             --------------eEEEEEeccCCCC
Confidence                          2899999988764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.73  E-value=0.00014  Score=70.67  Aligned_cols=78  Identities=13%  Similarity=0.209  Sum_probs=48.4

Q ss_pred             hhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCC--CccccCccccCCCC---CCcchhhHHHHHHHH
Q 015594          238 QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETG--TLGYMAPEVLNGSA---YNRKCDVYSFGICLW  312 (404)
Q Consensus       238 H~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~il~  312 (404)
                      +...++|+|++|.|||++.++ ++|+||+.+.... ...+......  ...|++|+......   -....++..+...+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            456899999999999998876 9999999986422 1111111111  13456665543211   122355567788888


Q ss_pred             HHHhC
Q 015594          313 EIYCC  317 (404)
Q Consensus       313 el~~g  317 (404)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.61  E-value=0.00012  Score=67.58  Aligned_cols=29  Identities=28%  Similarity=0.361  Sum_probs=24.9

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5566789999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.45  E-value=0.00081  Score=61.55  Aligned_cols=79  Identities=15%  Similarity=0.080  Sum_probs=53.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC--C-ceeEEEEEEec
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH--P-NVTKFIGATMG  174 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-niv~~~~~~~~  174 (404)
                      .++.-...+|.|..+.||+... +|+.|.||+........         ...|..|+..|+.|.-  + -+.+.+++.  
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---------DGLFRAEALGLDWLGRSFGSPVPQVAGWD--   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---------hhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence            4566678899999999999987 78999999865332211         1236678888887732  1 234444431  


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCH
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL  206 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L  206 (404)
                      ..                  ++||||++++..
T Consensus        84 ~~------------------~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 DR------------------TLAMEWVDERPP   97 (288)
T ss_dssp             TT------------------EEEEECCCCCCC
T ss_pred             Cc------------------eEEEEeecccCC
Confidence            11                  689999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.42  E-value=0.0001  Score=70.57  Aligned_cols=147  Identities=16%  Similarity=0.245  Sum_probs=82.4

Q ss_pred             ccc-cCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-
Q 015594           93 EWE-IDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-  161 (404)
Q Consensus        93 ~~~-~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-  161 (404)
                      .|. ++.+.+.+ +.|..|-...+|+....         ++.+++|+....  . ..       ...+.+|..+++.|. 
T Consensus        44 ~W~~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~-~~-------~~~~~rE~~vl~~L~~  112 (379)
T 3feg_A           44 AWRRVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L-QG-------VDSLVLESVMFAILAE  112 (379)
T ss_dssp             GGGGCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CC-------HHHHHHHHHHHHHHHH
T ss_pred             cCCCCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c-ch-------HHHHHHHHHHHHHHHh
Confidence            454 23345544 45666888899998763         478999985211  0 01       122347888887773 


Q ss_pred             CCceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHH--------------HHHhcc------cCCC--c
Q 015594          162 HPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS--------------YLIKNR------RRKL--A  219 (404)
Q Consensus       162 hpniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~--------------~l~~~~------~~~l--~  219 (404)
                      +.-..++++.+.+                    .+||||++|.+|..              .|.+-.      .+..  -
T Consensus       113 ~gv~P~ll~~~~~--------------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l  172 (379)
T 3feg_A          113 RSLGPQLYGVFPE--------------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL  172 (379)
T ss_dssp             TTSSCCEEEEETT--------------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred             cCCCCeEEEEcCC--------------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence            2223566665532                    26899998755421              111110      1111  2


Q ss_pred             HHHHHHHHHHHHH-------------------HHHHHh----h----CCceecccCCCCEEEcCC----CcEEEeecccc
Q 015594          220 FKVVIQLALDLAR-------------------GLSYLQ----S----KKIVHRDVKTENMLLDKT----RTVKIADFGVA  268 (404)
Q Consensus       220 ~~~~~~i~~qi~~-------------------~L~~LH----~----~givH~Dikp~Nili~~~----~~vkL~Dfg~a  268 (404)
                      +.++.++..++..                   .+..|.    .    ..++|+|+.+.||+++.+    +.+.|+||..+
T Consensus       173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            4556555544422                   223332    2    259999999999999876    78999999988


Q ss_pred             cc
Q 015594          269 RL  270 (404)
Q Consensus       269 ~~  270 (404)
                      ..
T Consensus       253 ~~  254 (379)
T 3feg_A          253 SY  254 (379)
T ss_dssp             EE
T ss_pred             Cc
Confidence            63

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.0014  Score=61.33  Aligned_cols=32  Identities=34%  Similarity=0.481  Sum_probs=27.6

Q ss_pred             hCCceecccCCCCEEEcCC----CcEEEeecccccc
Q 015594          239 SKKIVHRDVKTENMLLDKT----RTVKIADFGVARL  270 (404)
Q Consensus       239 ~~givH~Dikp~Nili~~~----~~vkL~Dfg~a~~  270 (404)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6799999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.10  E-value=0.0014  Score=62.21  Aligned_cols=29  Identities=17%  Similarity=0.433  Sum_probs=24.7

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+.+.|||+++++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            699999999999998655 89999998863

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.09  E-value=0.0014  Score=60.85  Aligned_cols=149  Identities=17%  Similarity=0.172  Sum_probs=76.6

Q ss_pred             eEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc--eeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN--VTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~  178 (404)
                      ..-.+.|+.|....+|+...++..+++|+......           ...+..|+.++..|...+  +.+++... +...+
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-----------~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~   91 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE-----------KNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELL   91 (322)
T ss_dssp             EEEEEEECC---EEEEEEEESSCCEEEEEECC--------------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSC
T ss_pred             ceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC-----------HHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEE
Confidence            34456678888899999887666899999853210           112345666666653222  22232211 00000


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHH-----------HHHHh---c-cc--CC----Cc---HHHHHH---------
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALK-----------SYLIK---N-RR--RK----LA---FKVVIQ---------  225 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~-----------~~l~~---~-~~--~~----l~---~~~~~~---------  225 (404)
                               ....+..++|++|++|..+.           ..+.+   . ..  .+    ..   +.....         
T Consensus        92 ---------~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           92 ---------GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             ---------EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ---------EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence                     00112348899999876531           11110   0 00  00    11   111000         


Q ss_pred             ---HHHHHHHHHHHHhh-------CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          226 ---LALDLARGLSYLQS-------KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       226 ---i~~qi~~~L~~LH~-------~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                         +...+...+..+..       .+++|+|+.+.||++++++.+.|+||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               00113344555542       3799999999999998876568999998863

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.03  E-value=0.0064  Score=59.54  Aligned_cols=73  Identities=14%  Similarity=0.029  Sum_probs=45.5

Q ss_pred             eeeeeeecceEEEEEEECC--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce-eEEEEEEecCCcccc
Q 015594          104 KGAFARGTFGTVHRGIYDG--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV-TKFIGATMGTSELNI  180 (404)
Q Consensus       104 ~~~lg~G~~g~V~~~~~~g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~i  180 (404)
                      ...|+.|-...+|+....+  ..+++|+........-.          ..+|..+++.|...++ .++++.+.  .    
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id----------R~~E~~vl~~L~~~gl~P~ll~~~~--~----  176 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN----------REREKKISCILYNKNIAKKIYVFFT--N----  176 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC----------HHHHHHHHHHHTTSSSBCCEEEEET--T----
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC----------HHHHHHHHHHHHhcCCCCCEEEEeC--C----
Confidence            3567778889999998865  88999987432211100          1368888888864444 56666652  1    


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCH
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGAL  206 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L  206 (404)
                                    .+||||++|.+|
T Consensus       177 --------------G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 --------------GRIEEFMDGYAL  188 (458)
T ss_dssp             --------------EEEEECCCSEEC
T ss_pred             --------------eEEEEeeCCccC
Confidence                          358999987443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.82  E-value=0.009  Score=55.40  Aligned_cols=29  Identities=24%  Similarity=0.229  Sum_probs=25.4

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4689999999999998 4 899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.78  E-value=0.0064  Score=59.02  Aligned_cols=59  Identities=12%  Similarity=0.096  Sum_probs=36.6

Q ss_pred             EeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc-eeEEEEEE
Q 015594          103 IKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN-VTKFIGAT  172 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~  172 (404)
                      -...|+.|....||+....         ++.+++|+....    ...       ..+.+|..+++.|...+ ..++++.+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~-------~~li~E~~~l~~L~~~g~~P~l~~~~  145 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-------SHLVAESVIFTLLSERHLGPKLYGIF  145 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-------HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcH-------HHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence            3456777888999998863         478999987321    110       11235777777774323 35666654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.63  E-value=0.0021  Score=61.83  Aligned_cols=29  Identities=24%  Similarity=0.500  Sum_probs=25.2

Q ss_pred             ceecccCCCCEEE------cCCCcEEEeecccccc
Q 015594          242 IVHRDVKTENMLL------DKTRTVKIADFGVARL  270 (404)
Q Consensus       242 ivH~Dikp~Nili------~~~~~vkL~Dfg~a~~  270 (404)
                      ++|+|+.+.|||+      ++++.++++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567799999998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.43  E-value=0.017  Score=54.16  Aligned_cols=31  Identities=23%  Similarity=0.433  Sum_probs=27.6

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999878899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.97  E-value=0.036  Score=53.56  Aligned_cols=29  Identities=17%  Similarity=0.525  Sum_probs=26.0

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            5899999999999 7788999999998863

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.68  E-value=1.4  Score=38.01  Aligned_cols=82  Identities=4%  Similarity=0.020  Sum_probs=59.5

Q ss_pred             CCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC
Q 015594          216 RKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG  295 (404)
Q Consensus       216 ~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  295 (404)
                      ..++....++++.+|+....+++  .-+|--|.|+|++++.++.+++.--|+-....                 |.    
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~-----------------P~----  132 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQNVVD-----------------PL----  132 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSCEEESCCEETTTBS-----------------CC----
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCCEEEEEccCccCCC-----------------CC----
Confidence            45788889999999988775444  34777899999999999999999888754321                 11    


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          296 SAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       296 ~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                       .++...=+-.+=+++..+++++..|
T Consensus       133 -~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          133 -PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             -CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence             1233334446677888888888776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.48  E-value=0.068  Score=52.29  Aligned_cols=61  Identities=10%  Similarity=0.008  Sum_probs=17.3

Q ss_pred             EeeeeeeecceEEEEEEECC--ceEEE------EEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594          103 IKGAFARGTFGTVHRGIYDG--QDVAV------KLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~~g--~~vAv------K~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      +.+.||   ||.||+|.+.+  .+|||      |..+-+..       ..+....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-------~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-------SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccc-------cccccccccccccccccccccccCCCcceEE
Confidence            445566   99999999854  57888      65532111       1122345778999999999999999987764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.89  E-value=4.5  Score=34.83  Aligned_cols=81  Identities=12%  Similarity=0.137  Sum_probs=56.5

Q ss_pred             CCcHHHHHHHHHHHHHHHH-HHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC
Q 015594          217 KLAFKVVIQLALDLARGLS-YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG  295 (404)
Q Consensus       217 ~l~~~~~~~i~~qi~~~L~-~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  295 (404)
                      .++....++++.+|+.... ++  ..-+|--|.|+|++++.++.++|...|+-...                 +|..   
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l-----------------pP~e---  138 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVKESL-----------------PPDE---  138 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEETTTB-----------------SSCS---
T ss_pred             hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCcccC-----------------CCCC---
Confidence            5788889999999887666 44  34477789999999999999999988875432                 1211   


Q ss_pred             CCCCcchhhHHHHHHHHHHHhCCCCC
Q 015594          296 SAYNRKCDVYSFGICLWEIYCCDMPY  321 (404)
Q Consensus       296 ~~~~~~~DvwslG~il~el~~g~~Pf  321 (404)
                        .+...=+-.+=+++..++.++..|
T Consensus       139 --~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          139 --WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             --CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             --CCHHHHHHHHHHHHHHHHcCCCCH
Confidence              222223335667777788776554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	404
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-74
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-46
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 2e-74
 Identities = 85/298 (28%), Positives = 144/298 (48%), Gaps = 35/298 (11%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQ 152
           +WEI   ++ +      G+FGTV++G + G DVAVK+L          A       AF  
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML-------NVTAPTPQQLQAFKN 53

Query: 153 EVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIK 212
           EV V  K  H N+  F+G +                       +V ++C G +L  +L  
Sbjct: 54  EVGVLRKTRHVNILLFMGYSTA-----------------PQLAIVTQWCEGSSLYHHL-H 95

Query: 213 NRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL-- 270
               K     +I +A   A+G+ YL +K I+HRD+K+ N+ L +  TVKI DFG+A +  
Sbjct: 96  IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155

Query: 271 EASNPHDMTGETGTLGYMAPEVL---NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
             S  H     +G++ +MAPEV+   + + Y+ + DVY+FGI L+E+    +PY +++  
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

Query: 328 EVTSAVVRQNLR----PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           +    +V +        ++   CP ++  +M  C     D+RP   +++A +E +  S
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 2e-72
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 31/290 (10%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQE 153
           W ++  +L +     +G FG V  G Y G  VAVK +     +             F  E
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----------FLAE 50

Query: 154 VAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN 213
            +V  +L H N+ + +G         I  + G +        +V EY   G+L  YL   
Sbjct: 51  ASVMTQLRHSNLVQLLGV--------IVEEKGGL-------YIVTEYMAKGSLVDYLRSR 95

Query: 214 RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEAS 273
            R  L    +++ +LD+   + YL+    VHRD+   N+L+ +    K++DFG+ +  +S
Sbjct: 96  GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 332
                      + + APE L    ++ K DV+SFGI LWEIY    +PYP +   +V   
Sbjct: 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK 382
            V +  + + P  CP ++  VMK CW  +   RP   ++   LE I T +
Sbjct: 213 -VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 1e-68
 Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 31/294 (10%)

Query: 91  RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
             EWE+    L +      G FG V  G Y     VAVK L  G  S  +          
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---------- 54

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F  E  +  +L H  + +            + T             ++ EY   G+L  +
Sbjct: 55  FLAEANLMKQLQHQRLVRLYA---------VVTQEPI--------YIITEYMENGSLVDF 97

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L      KL    ++ +A  +A G+++++ +  +HRD++  N+L+  T + KIADFG+AR
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157

Query: 270 -LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFS 327
            +E +      G    + + APE +N   +  K DV+SFGI L EI     +PYP ++  
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           EV   + R   R   P  CP  L  +M+ CW   P+ RP  D + ++LE   T+
Sbjct: 218 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-66
 Identities = 89/312 (28%), Positives = 133/312 (42%), Gaps = 35/312 (11%)

Query: 85  TSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEI 143
            +  + +  WEI    L ++    +G FG V  G +     VA+K L  G  S       
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 57

Query: 144 ASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
                AF QE  V  KL H  + +                            +V EY   
Sbjct: 58  -----AFLQEAQVMKKLRHEKLVQLYAVVS-----------------EEPIYIVTEYMSK 95

Query: 204 GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIA 263
           G+L  +L     + L    ++ +A  +A G++Y++    VHRD++  N+L+ +    K+A
Sbjct: 96  GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155

Query: 264 DFGVARL-EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPY 321
           DFG+ARL E +      G    + + APE      +  K DV+SFGI L E+     +PY
Sbjct: 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215

Query: 322 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS 381
           P +   EV   V R   R   P  CP SL ++M +CW   P++RP  + + A LE   TS
Sbjct: 216 PGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

Query: 382 KGGGMIPVDQPQ 393
                 P  QP 
Sbjct: 275 ----TEPQYQPG 282

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 5e-63
 Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 29/290 (10%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
            +WE++   + +K     G +G V+ G++      VAVK L                   
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---------- 59

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
           F +E AV  ++ HPN+ + +G                +        ++ E+   G L  Y
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLG----------------VCTREPPFYIITEFMTYGNLLDY 103

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L +  R++++  V++ +A  ++  + YL+ K  +HRD+   N L+ +   VK+ADFG++R
Sbjct: 104 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163

Query: 270 LEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 328
           L   +      G    + + APE L  + ++ K DV++FG+ LWEI    M         
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223

Query: 329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
               ++ ++ R E P  CP  +  +M+ CW  NP  RP   E+    E +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-62
 Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 29/285 (10%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP++L        G FG VH G + +   VA+K +  G  S             F +E 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 51

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V  KL HP + +  G  +  + +                C+V E+   G L  YL   R
Sbjct: 52  EVMMKLSHPKLVQLYGVCLEQAPI----------------CLVFEFMEHGCLSDYLRTQR 95

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEAS 273
               A + ++ + LD+  G++YL+   ++HRD+   N L+ + + +K++DFG+ R +   
Sbjct: 96  GLFAA-ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 333
                TG    + + +PEV + S Y+ K DV+SFG+ +WE++       +   +      
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214

Query: 334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +    R   PR   + +  +M  CW   P+ RP    ++  L  I
Sbjct: 215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 83/318 (26%), Positives = 126/318 (39%), Gaps = 56/318 (17%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGI-------YDGQDVAVKLLDWGEESHRSEAEIA 144
            +WE     L        G FG V                VAVK+L         E   +
Sbjct: 30  LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--------EKADS 81

Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
           S R A   E+ +  +L  H N+   +GA          T +G I        ++ EYC  
Sbjct: 82  SEREALMSELKMMTQLGSHENIVNLLGAC---------TLSGPI-------YLIFEYCCY 125

Query: 204 GALKSYLIKNRRR---------------------KLAFKVVIQLALDLARGLSYLQSKKI 242
           G L +YL   R +                      L F+ ++  A  +A+G+ +L+ K  
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185

Query: 243 VHRDVKTENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNR 300
           VHRD+   N+L+   + VKI DFG+AR     SN          + +MAPE L    Y  
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245

Query: 301 KCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD 359
           K DV+S+GI LWEI+     PYP +        +++   + + P      +  +M+ CW 
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 305

Query: 360 ANPDKRPEMDEVVAMLEA 377
            +  KRP    + + L  
Sbjct: 306 FDSRKRPSFPNLTSFLGC 323

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 3e-62
 Identities = 65/273 (23%), Positives = 116/273 (42%), Gaps = 31/273 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G++G   +     DG+ +  K LD+G  +          +     EV +  +L HPN+ 
Sbjct: 14  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-------KQMLVSEVNLLRELKHPNIV 66

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAF--KVVI 224
           ++    +  +                   +V+EYC GG L S + K  + +     + V+
Sbjct: 67  RYYDRIIDRTN--------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 112

Query: 225 QLALDLARGLSYLQSK-----KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMT 279
           ++   L   L     +      ++HRD+K  N+ LD  + VK+ DFG+AR+   +     
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
              GT  YM+PE +N  +YN K D++S G  L+E+     P+   S  E+   +      
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-F 231

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             IP      L  ++ R  +     RP ++E++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-62
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 31/286 (10%)

Query: 96  IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEV 154
           IDP  L        G FG V  G +    DVA+K++  G  S             F +E 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----------FIEEA 50

Query: 155 AVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR 214
            V   L H  + +  G           T    I        ++ EY   G L +YL    
Sbjct: 51  KVMMNLSHEKLVQLYGVC---------TKQRPI-------FIITEYMANGCLLNYLR-EM 93

Query: 215 RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR-LEAS 273
           R +   + ++++  D+   + YL+SK+ +HRD+   N L++    VK++DFG++R +   
Sbjct: 94  RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

Query: 274 NPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 332
                 G    + +  PEVL  S ++ K D+++FG+ +WEIY    MPY   + SE    
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213

Query: 333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +  Q LR   P      +  +M  CW    D+RP    +++ +  +
Sbjct: 214 IA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 7e-62
 Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 35/276 (12%)

Query: 109 RGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN 164
            G FGTV +G Y      + VAVK+L       ++EA   +L+     E  V  +LD+P 
Sbjct: 17  SGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDPALKDELLAEANVMQQLDNPY 69

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           + + IG     S                   +V+E    G L  YL +NR   +  K +I
Sbjct: 70  IVRMIGICEAES-----------------WMLVMEMAELGPLNKYLQQNRH--VKDKNII 110

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET-- 282
           +L   ++ G+ YL+    VHRD+   N+LL      KI+DFG+++   ++ +    +T  
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170

Query: 283 -GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRP 340
              + + APE +N   ++ K DV+SFG+ +WE +     PY  +  SEVT A++ +  R 
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERM 229

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
             P  CP  + ++M  CW  + + RP    V   L 
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-61
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 36/296 (12%)

Query: 92  QEWEIDPAKLIIKGA-FARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASL 146
           ++  +    L+I       G FG+V +G+Y       DVA+K+L  G E   +E      
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE----- 55

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
                +E  + H+LD+P + + IG     +                   +V+E   GG L
Sbjct: 56  ---MMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGGPL 95

Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
             +L+  +R ++    V +L   ++ G+ YL+ K  VHRD+   N+LL      KI+DFG
Sbjct: 96  HKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154

Query: 267 VARLEASNPHDMTGET---GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
           +++   ++    T  +     L + APE +N   ++ + DV+S+G+ +WE       PY 
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214

Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
            +   EV + +  Q  R E P  CP  L  +M  CW    + RP+   V   + A 
Sbjct: 215 KMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 6e-61
 Identities = 82/292 (28%), Positives = 134/292 (45%), Gaps = 32/292 (10%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLR 147
           ++EI   ++ +      G FG VH+GIY         VA+K                S+R
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--------NCTSDSVR 52

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
             F QE     + DHP++ K IG                  +  N   +++E C  G L+
Sbjct: 53  EKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGELR 95

Query: 208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
           S+ ++ R+  L    +I  A  L+  L+YL+SK+ VHRD+   N+L+     VK+ DFG+
Sbjct: 96  SF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154

Query: 268 AR-LEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSF 326
           +R +E S  +  +     + +MAPE +N   +    DV+ FG+C+WEI    +       
Sbjct: 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214

Query: 327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           +      +    R  +P  CP +L ++M +CW  +P +RP   E+ A L  I
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 32/282 (11%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAF 150
           +W ++     I     +G FG V+          +A+K+L       +++ E A +    
Sbjct: 2   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQL 53

Query: 151 TQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL 210
            +EV +   L HPN+ +  G                    +    +++EY   G +   L
Sbjct: 54  RREVEIQSHLRHPNILRLYGY----------------FHDATRVYLILEYAPLGTVYREL 97

Query: 211 IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL 270
              +  K   +       +LA  LSY  SK+++HRD+K EN+LL     +KIADFG +  
Sbjct: 98  --QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155

Query: 271 EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 330
             S+        GTL Y+ PE++ G  ++ K D++S G+  +E      P+   ++ E  
Sbjct: 156 APSSRRTTL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213

Query: 331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
             + R  +    P        +++ R    NP +RP + EV+
Sbjct: 214 KRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 3e-59
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 34/271 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG V++          A K++D   E    +         +  E+ +    DHPN+ 
Sbjct: 22  DGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---------YMVEIDILASCDHPNIV 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K + A                    N   +++E+C GGA+ + +++   R L    +  +
Sbjct: 73  KLLDA----------------FYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVV 115

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
                  L+YL   KI+HRD+K  N+L      +K+ADFGV+              GT  
Sbjct: 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY 175

Query: 287 YMAPEVL-----NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN-LRP 340
           +MAPEV+         Y+ K DV+S GI L E+   + P+ +L+   V   + +      
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
             P    S+  + +K+C + N D R    ++
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 9e-59
 Identities = 93/302 (30%), Positives = 137/302 (45%), Gaps = 43/302 (14%)

Query: 92  QEWEIDPAKLIIK-----GAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEA 141
           Q   I P+ LI+      G   RG FG V+ G            AVK L+   +      
Sbjct: 18  QHVVIGPSSLIVHFNEVIG---RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--- 71

Query: 142 EIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYC 201
                 + F  E  +     HPNV   +G  + +                    VV+ Y 
Sbjct: 72  -----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE---------------GSPLVVLPYM 111

Query: 202 HGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVK 261
             G L+++ I+N       K +I   L +A+G+ +L SKK VHRD+   N +LD+  TVK
Sbjct: 112 KHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 170

Query: 262 IADFGVARL----EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC- 316
           +ADFG+AR     E  + H+ TG    + +MA E L    +  K DV+SFG+ LWE+   
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230

Query: 317 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
              PYPD++  ++T  ++ Q  R   P  CP  L  VM +CW    + RP   E+V+ + 
Sbjct: 231 GAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

Query: 377 AI 378
           AI
Sbjct: 290 AI 291

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-58
 Identities = 75/279 (26%), Positives = 117/279 (41%), Gaps = 33/279 (11%)

Query: 109 RGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP 163
            G+FG V RG +D        VAVK L     S     +       F +EV   H LDH 
Sbjct: 18  DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD------DFIREVNAMHSLDHR 71

Query: 164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVV 223
           N+ +  G  +                 +    +V E    G+L   L K++        +
Sbjct: 72  NLIRLYGVVL-----------------TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTL 113

Query: 224 IQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET- 282
            + A+ +A G+ YL+SK+ +HRD+   N+LL     VKI DFG+ R    N      +  
Sbjct: 114 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 283 --GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLR 339
                 + APE L    ++   D + FG+ LWE++     P+  L+ S++   + ++  R
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              P  CP  + NVM +CW   P+ RP    +   L   
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (485), Expect = 2e-58
 Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 33/269 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG V+      + + VA+K +        S  +         +EV    KL HPN  
Sbjct: 25  HGSFGAVYFARDVRNSEVVAIKKM------SYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           ++ G                  +  +   +V+EYC G A     +   ++ L    +  +
Sbjct: 79  QYRGC----------------YLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAV 120

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
                +GL+YL S  ++HRDVK  N+LL +   VK+ DFG A +            GT  
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPY 176

Query: 287 YMAPEVLNGS---AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           +MAPEV+       Y+ K DV+S GI   E+     P  +++       + +        
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236

Query: 344 RCCPSSLANVMKRCWDANPDKRPEMDEVV 372
                   N +  C    P  RP  + ++
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 5e-58
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 37/296 (12%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRA 148
            EID + + I+     G FG V  G           VA+K L                R 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK--------SGYTEKQRR 72

Query: 149 AFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKS 208
            F  E ++  + DHPNV                     +   S    ++ E+   G+L S
Sbjct: 73  DFLSEASIMGQFDHPNVIHLE----------------GVVTKSTPVMIITEFMENGSLDS 116

Query: 209 YLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA 268
           +L +N  +      ++ +   +A G+ YL     VHRD+   N+L++     K++DFG++
Sbjct: 117 FLRQNDGQF-TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175

Query: 269 RLEASNPHDMT-----GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYP 322
           R    +  D T     G    + + APE +    +    DV+S+GI +WE+    + PY 
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235

Query: 323 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           D++  +V +A+  Q+ R   P  CPS+L  +M  CW  + + RP+  ++V  L+ +
Sbjct: 236 DMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  189 bits (481), Expect = 5e-58
 Identities = 79/321 (24%), Positives = 127/321 (39%), Gaps = 57/321 (17%)

Query: 90  RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAE 142
           +    E     +        G FG V +              VAVK+L         E  
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--------EEA 55

Query: 143 IASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
            A ++A F +E A+  + D+PN+ K +G       +                C++ EY  
Sbjct: 56  SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM----------------CLLFEYMA 99

Query: 203 GGALKSYLIKNRRR----------------------KLAFKVVIQLALDLARGLSYLQSK 240
            G L  +L                             L+    + +A  +A G++YL  +
Sbjct: 100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159

Query: 241 KIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAY 298
           K VHRD+ T N L+ +   VKIADFG++R    A        +   + +M PE +  + Y
Sbjct: 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219

Query: 299 NRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRC 357
             + DV+++G+ LWEI+   + PY  ++  EV   V   N     P  CP  L N+M+ C
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLC 278

Query: 358 WDANPDKRPEMDEVVAMLEAI 378
           W   P  RP    +  +L+ +
Sbjct: 279 WSKLPADRPSFCSIHRILQRM 299

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-58
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 30/270 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG+F TV++G+      +VA   L       +      S R  F +E  +   L HPN+ 
Sbjct: 19  RGSFKTVYKGLDTETTVEVAWCEL-------QDRKLTKSERQRFKEEAEMLKGLQHPNIV 71

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +F  +   T +                  +V E    G LK+YL   R + +  KV+   
Sbjct: 72  RFYDSWESTVKGK------------KCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSW 117

Query: 227 ALDLARGLSYLQSKK--IVHRDVKTENMLL-DKTRTVKIADFGVARLEASNPHDMTGETG 283
              + +GL +L ++   I+HRD+K +N+ +   T +VKI D G+A L            G
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVIG 175

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-EI 342
           T  +MAPE+     Y+   DVY+FG+C+ E+   + PY +   +      V   ++P   
Sbjct: 176 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 372
            +     +  +++ C   N D+R  + +++
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 43/302 (14%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIAS 145
           EWE+   K+ +     +G+FG V+ G+            VA+K ++        EA    
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 65

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
            R  F  E +V  + +  +V + +G                         V++E    G 
Sbjct: 66  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT----------------LVIMELMTRGD 109

Query: 206 LKSYLIKNRRR--------KLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT 257
           LKSYL   R            +   +IQ+A ++A G++YL + K VHRD+   N ++ + 
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169

Query: 258 RTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            TVKI DFG+ R   E             + +M+PE L    +    DV+SFG+ LWEI 
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229

Query: 316 CC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
              + PY  LS  +V   V+      + P  CP  L  +M+ CW  NP  RP   E+++ 
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 375 LE 376
           ++
Sbjct: 289 IK 290

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 58/266 (21%), Positives = 114/266 (42%), Gaps = 31/266 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G  GTV+  +    GQ+VA++ ++  ++  +              E+ V  +  +PN+ 
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---------IINEILVMRENKNPNIV 80

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            ++ +                 +  +   VV+EY  GG+L   + +    +     +  +
Sbjct: 81  NYLDS----------------YLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAV 121

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             +  + L +L S +++HRD+K++N+LL    +VK+ DFG            +   GT  
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN-LRPEIPRC 345
           +MAPEV+   AY  K D++S GI   E+   + PY + +       +        + P  
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241

Query: 346 CPSSLANVMKRCWDANPDKRPEMDEV 371
             +   + + RC D + +KR    E+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-57
 Identities = 62/294 (21%), Positives = 122/294 (41%), Gaps = 34/294 (11%)

Query: 94  WEIDPAKLIIKGAFARGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLR 147
            EI P+ +  +     G FG V++G+           VA+K L  G    +        R
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--------R 53

Query: 148 AAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALK 207
             F  E  +  +  H N+ +  G       +                 ++ EY   G   
Sbjct: 54  VDFLGEAGIMGQFSHHNIIRLEGVISKYKPM----------------MIITEYMENG-AL 96

Query: 208 SYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGV 267
              ++ +  + +   ++ +   +A G+ YL +   VHRD+   N+L++     K++DFG+
Sbjct: 97  DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156

Query: 268 ARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL 324
           +R+   +P   +  +G    + + APE ++   +    DV+SFGI +WE+          
Sbjct: 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216

Query: 325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
             +      +    R   P  CPS++  +M +CW     +RP+  ++V++L+ +
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-56
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 46/304 (15%)

Query: 95  EIDPAKLIIKGAFARGTFGTVHRGIYDG----QDVAVKLLDWGEESHRSEAEIASLRAAF 150
            +D   +  +     G FG V +          D A+K +         E         F
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--------EYASKDDHRDF 57

Query: 151 TQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
             E+ V  KL  HPN+   +GA                     +  + +EY   G L  +
Sbjct: 58  AGELEVLCKLGHHPNIINLLGA----------------CEHRGYLYLAIEYAPHGNLLDF 101

Query: 210 LIKN--------------RRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD 255
           L K+                  L+ + ++  A D+ARG+ YL  K+ +HRD+   N+L+ 
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161

Query: 256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
           +    KIADFG++R +        G    + +MA E LN S Y    DV+S+G+ LWEI 
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220

Query: 316 CCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
                PY  ++ +E+    + Q  R E P  C   + ++M++CW   P +RP   +++  
Sbjct: 221 SLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

Query: 375 LEAI 378
           L  +
Sbjct: 280 LNRM 283

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 93/314 (29%), Positives = 129/314 (41%), Gaps = 65/314 (20%)

Query: 109 RGTFGTVHRGIYDGQDVAVKLLDWGEE-SHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
           +G FG V RG + G++VAVK+    EE S   EAEI                L H N+  
Sbjct: 13  KGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTV-----------MLRHENILG 61

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
           FI A           DNG          +V +Y   G+L  YL    R  +  + +I+LA
Sbjct: 62  FIAA--------DNKDNGTW----TQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 106

Query: 228 LDLARGLSYL--------QSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDM- 278
           L  A GL++L            I HRD+K++N+L+ K  T  IAD G+A    S    + 
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166

Query: 279 ---TGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYC------------- 316
                  GT  YMAPEVL+ S         ++ D+Y+ G+  WEI               
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226

Query: 317 --CDMPYPDLSFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMD 369
              D+   D S  E+   V  Q LRP IP           +A +M+ CW AN   R    
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286

Query: 370 EVVAMLEAIDTSKG 383
            +   L  +   +G
Sbjct: 287 RIKKTLSQLSQQEG 300

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-56
 Identities = 83/314 (26%), Positives = 131/314 (41%), Gaps = 51/314 (16%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIA 144
            +WE    +L        G FG V                VAVK+L     +H +E    
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 69

Query: 145 SLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHG 203
             R A   E+ V   L +H N+   +GA                        V+ EYC  
Sbjct: 70  --REALMSELKVLSYLGNHMNIVNLLGA----------------CTIGGPTLVITEYCCY 111

Query: 204 GALKSYLIKNR----------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV 247
           G L ++L + R                   L  + ++  +  +A+G+++L SK  +HRD+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171

Query: 248 KTENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVY 305
              N+LL   R  KI DFG+AR     SN          + +MAPE +    Y  + DV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231

Query: 306 SFGICLWEIYCCDMP-YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 364
           S+GI LWE++      YP +        ++++  R   P   P+ + ++MK CWDA+P K
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291

Query: 365 RPEMDEVVAMLEAI 378
           RP   ++V ++E  
Sbjct: 292 RPTFKQIVQLIEKQ 305

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-56
 Identities = 82/310 (26%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIAS 145
           +WE    +L +     RG FG V              + VAVK+L         E    S
Sbjct: 7   KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--------EGATHS 58

Query: 146 LRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGA 205
              A   E+ +   + H                N+    G    P     V+VE+C  G 
Sbjct: 59  EHRALMSELKILIHIGHHL--------------NVVNLLGACTKPGGPLMVIVEFCKFGN 104

Query: 206 LKSYLIKNR--------------RRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN 251
           L +YL   R              +  L  + +I  +  +A+G+ +L S+K +HRD+   N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164

Query: 252 MLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGI 309
           +LL +   VKI DFG+AR    +P           L +MAPE +    Y  + DV+SFG+
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224

Query: 310 CLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 368
            LWEI+     PYP +   E     +++  R   P      +   M  CW   P +RP  
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

Query: 369 DEVVAMLEAI 378
            E+V  L  +
Sbjct: 285 SELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 87/313 (27%), Positives = 138/313 (44%), Gaps = 52/313 (16%)

Query: 93  EWEIDPAKLIIKGAFARGTFGTVHRGIY---------DGQDVAVKLLDWGEESHRSEAEI 143
            WE+   +L++      G FG V                  VAVK+L     S  +E ++
Sbjct: 7   RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDATEKDL 62

Query: 144 ASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCH 202
           +        E+ +   +  H N+   +G           T +G +        V+VEY  
Sbjct: 63  SD----LISEMEMMKMIGKHKNIINLLG---------ACTQDGPL-------YVIVEYAS 102

Query: 203 GGALKSYL--------------IKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK 248
            G L+ YL                N   +L+ K ++  A  +ARG+ YL SKK +HRD+ 
Sbjct: 103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162

Query: 249 TENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYS 306
             N+L+ +   +KIADFG+AR           T     + +MAPE L    Y  + DV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222

Query: 307 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 365
           FG+ LWEI+     PYP +   E+   ++++  R + P  C + L  +M+ CW A P +R
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

Query: 366 PEMDEVVAMLEAI 378
           P   ++V  L+ I
Sbjct: 282 PTFKQLVEDLDRI 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-55
 Identities = 66/279 (23%), Positives = 126/279 (45%), Gaps = 36/279 (12%)

Query: 109 RGTFGTVHRGIYDGQD------VAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH 162
            G FGTV++G++  +       VA+K L         EA           E  V   +D+
Sbjct: 19  SGAFGTVYKGLWIPEGEKVKIPVAIKELR--------EATSPKANKEILDEAYVMASVDN 70

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           P+V + +G           T    +         + +    G L  Y+ +++      + 
Sbjct: 71  PHVCRLLGI--------CLTSTVQL---------ITQLMPFGCLLDYVREHKDNI-GSQY 112

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPHDMTG 280
           ++   + +A+G++YL+ +++VHRD+   N+L+   + VKI DFG+A+L       +   G
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172

Query: 281 ETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLR 339
               + +MA E +    Y  + DV+S+G+ +WE+      PY  +  SE+ S+++ +  R
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER 231

Query: 340 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
              P  C   +  +M +CW  + D RP+  E++     +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 9e-54
 Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 32/269 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G +G V   +     + VAVK++D                    +E+ +   L+H NV 
Sbjct: 15  EGAYGEVQLAVNRVTEEAVAVKIVD--------MKRAVDCPENIKKEICINKMLNHENVV 66

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           KF G                     N   + +EYC GG L   +  +    +      + 
Sbjct: 67  KFYG----------------HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRF 108

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL--EASNPHDMTGETGT 284
              L  G+ YL    I HRD+K EN+LLD+   +KI+DFG+A +    +    +    GT
Sbjct: 109 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

Query: 285 LGYMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN-LRPEI 342
           L Y+APE+L    ++    DV+S GI L  +   ++P+   S S    +  ++       
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +   S+   ++ +    NP  R  + ++
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDI 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 28/278 (10%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G    VH        +DVAVK+L          A   S    F +E      L+HP + 
Sbjct: 17  FGGMSEVHLARDLRLHRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                    +                   +V+EY  G  L+  +  +    +  K  I++
Sbjct: 71  AVYDTGEAETPAG------------PLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEV 116

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET---G 283
             D  + L++     I+HRDVK  N+++  T  VK+ DFG+AR  A + + +T      G
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP--E 341
           T  Y++PE   G + + + DVYS G  L+E+   + P+   S   V    VR++  P   
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236

Query: 342 IPRCCPSSLANVMKRCWDANPDKRPE-MDEVVAMLEAI 378
                 + L  V+ +    NP+ R +   E+ A L  +
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-53
 Identities = 66/260 (25%), Positives = 106/260 (40%), Gaps = 27/260 (10%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +G+FG V    +    Q  A+K L         + E         ++  +    +HP +T
Sbjct: 12  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLSLAWEHPFLT 66

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                                         V+EY +GG L  ++      K         
Sbjct: 67  HMFCT----------------FQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFY 108

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A ++  GL +L SK IV+RD+K +N+LLDK   +KIADFG+ +             GT  
Sbjct: 109 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD 168

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APE+L G  YN   D +SFG+ L+E+     P+      E+  ++   N  P  PR  
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWL 226

Query: 347 PSSLANVMKRCWDANPDKRP 366
                +++ + +   P+KR 
Sbjct: 227 EKEAKDLLVKLFVREPEKRL 246

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 51/269 (18%), Positives = 94/269 (34%), Gaps = 33/269 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VHR      G + A K +    ES +             +E+     L HP + 
Sbjct: 36  TGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---------VRKEIQTMSVLRHPTLV 86

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A                    N   ++ E+  GG L   +      K++    ++ 
Sbjct: 87  NLHDA----------------FEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEY 129

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL--DKTRTVKIADFGVARLEASNPHDMTGETGT 284
              + +GL ++     VH D+K EN++    ++  +K+ DFG+              TGT
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGT 188

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP--EI 342
             + APEV  G       D++S G+  + +     P+   +  E    V   +       
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                    + +++   A+P+ R  + + 
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 53/269 (19%), Positives = 99/269 (36%), Gaps = 33/269 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G FG VHR +    G+    K ++      +              E+++ ++L HP + 
Sbjct: 39  SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---------VKNEISIMNQLHHPKLI 89

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A           D   +        +++E+  GG L    I     K++   VI  
Sbjct: 90  NLHDAF---------EDKYEM-------VLILEFLSGGELFDR-IAAEDYKMSEAEVINY 132

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTR--TVKIADFGVARLEASNPHDMTGETGT 284
                 GL ++    IVH D+K EN++ +  +  +VKI DFG+A     +   +   T T
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTAT 191

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP--EI 342
             + APE+++        D+++ G+  + +     P+      E    V R +     + 
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                    + +K      P KR  + + 
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  172 bits (437), Expect = 9e-52
 Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 30/274 (10%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNV 165
           RG    V R I+    ++ AVK++D       S  E+  LR A  +EV +  K+  HPN+
Sbjct: 13  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72

Query: 166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQ 225
            +                       + F  +V +    G L  YL    +  L+ K   +
Sbjct: 73  IQLKD----------------TYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRK 114

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           +   L   +  L    IVHRD+K EN+LLD    +K+ DFG +  +      +    GT 
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTP 173

Query: 286 GYMAPEVLNGS------AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            Y+APE++  S       Y ++ D++S G+ ++ +     P+       +   ++  N +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 340 PEIPRC--CPSSLANVMKRCWDANPDKRPEMDEV 371
              P       ++ +++ R     P KR   +E 
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-51
 Identities = 63/308 (20%), Positives = 122/308 (39%), Gaps = 73/308 (23%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V +  +   G  +A KL+    +         ++R    +E+ V H+ + P + 
Sbjct: 16  AGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIV 67

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
            F GA            +G I        + +E+  GG+L   L   +  ++  +++ ++
Sbjct: 68  GFYGAF---------YSDGEI-------SICMEHMDGGSLDQVL--KKAGRIPEQILGKV 109

Query: 227 ALDLARGLSYLQSK-KIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTL 285
           ++ + +GL+YL+ K KI+HRDVK  N+L++    +K+ DFGV+              GT 
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANSFVGTR 167

Query: 286 GYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPY------------------------ 321
            YM+PE L G+ Y+ + D++S G+ L E+     P                         
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 322 ------------------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPD 363
                             P ++  E+   +V +               + + +C   NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 364 KRPEMDEV 371
           +R ++ ++
Sbjct: 288 ERADLKQL 295

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 30/289 (10%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q  +  P           G+F TV         ++ A+K+L+      +      +    
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE------KRHIIKENKVPY 54

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
            T+E  V  +LDHP   K                              + Y   G L  Y
Sbjct: 55  VTRERDVMSRLDHPFFVKLYF----------------TFQDDEKLYFGLSYAKNGELLKY 98

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           + K                ++   L YL  K I+HRD+K EN+LL++   ++I DFG A+
Sbjct: 99  IRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156

Query: 270 L--EASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 327
           +    S         GT  Y++PE+L   +  +  D+++ G  ++++     P+   +  
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216

Query: 328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE 376
            +   ++   L  + P        +++++    +  KR   +E+     
Sbjct: 217 LIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (434), Expect = 7e-51
 Identities = 59/270 (21%), Positives = 115/270 (42%), Gaps = 34/270 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V         + VA+K +         +  +     +   E+AV HK+ HPN+ 
Sbjct: 19  TGAFSEVILAEDKRTQKLVAIKCIA--------KKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                        I    GH+        ++++   GG L   +++        +   +L
Sbjct: 71  ALDD---------IYESGGHL-------YLIMQLVSGGELFDRIVEKGF--YTERDASRL 112

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLL---DKTRTVKIADFGVARLEASNPHDMTGETG 283
              +   + YL    IVHRD+K EN+L    D+   + I+DFG++++E      ++   G
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACG 171

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 343
           T GY+APEVL    Y++  D +S G+  + + C   P+ D + +++   +++     + P
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231

Query: 344 RC--CPSSLANVMKRCWDANPDKRPEMDEV 371
                  S  + ++   + +P+KR   ++ 
Sbjct: 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-49
 Identities = 55/274 (20%), Positives = 103/274 (37%), Gaps = 37/274 (13%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V +       +  A+K+L    ++ R E E+             W     P++ 
Sbjct: 22  LGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELH------------WRASQCPHIV 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           + +         N+      +        +V+E   GG L S +     +    +   ++
Sbjct: 69  RIVDVYE-----NLYAGRKCL-------LIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTR---TVKIADFGVARLEASNPHDMTGETG 283
              +   + YL S  I HRDVK EN+L    R    +K+ DFG A+   S+    T    
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY- 175

Query: 284 TLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI- 342
           T  Y+APEVL    Y++ CD++S G+ ++ + C   P+       ++  +  +    +  
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 343 -----PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                       +  +++      P +R  + E 
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 44/269 (16%), Positives = 88/269 (32%), Gaps = 34/269 (12%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG VHR +     +    K +                +    +E+++ +   H N+ 
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVKVKGTD----------QVLVKKEISILNIARHRNIL 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               +                        ++ E+  G  +    I     +L  + ++  
Sbjct: 65  HLHES----------------FESMEELVMIFEFISGLDIFER-INTSAFELNEREIVSY 107

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTR--TVKIADFGVARLEASNPHDMTGETGT 284
              +   L +L S  I H D++ EN++    R  T+KI +FG AR +     +       
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFRLLFTA 166

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP--EI 342
             Y APEV      +   D++S G  ++ +     P+   +  ++   ++        E 
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +       + + R        R    E 
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-48
 Identities = 53/271 (19%), Positives = 101/271 (37%), Gaps = 30/271 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F  V +      G   A K +    +     +     R    +EV++  ++ HPNV 
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                               +        +++E   GG L  +     +  L  +   + 
Sbjct: 77  TLHE----------------VYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEF 118

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDK----TRTVKIADFGVARLEASNPHDMTGET 282
              +  G+ YL S +I H D+K EN++L         +KI DFG+A  +    ++     
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF 177

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN--LRP 340
           GT  ++APE++N      + D++S G+  + +     P+   +  E  + V   N     
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           E      +   + ++R    +P KR  + + 
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG VH     ++G+  A+K+L       +              E  +   + HP + 
Sbjct: 14  TGSFGRVHLIRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +  G                    +    ++++Y  GG L S L K++R      V    
Sbjct: 68  RMWGT----------------FQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFY 109

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A ++   L YL SK I++RD+K EN+LLDK   +KI DFG A+     P       GT  
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPD 166

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APEV++   YN+  D +SFGI ++E+     P+ D +  +    ++        P   
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFF 224

Query: 347 PSSLANVMKRCWDANPDKRP 366
              + +++ R    +  +R 
Sbjct: 225 NEDVKDLLSRLITRDLSQRL 244

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-45
 Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 36/269 (13%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPN 164
            G FG+V+ GI   D   VA+K ++   +   S+            EV +  K+      
Sbjct: 14  SGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVI 224
           V + +                      +   +++E           I   R  L  ++  
Sbjct: 71  VIRLLD----------------WFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELAR 113

Query: 225 QLALDLARGLSYLQSKKIVHRDVKTENMLLDKTR-TVKIADFGVARLEASNPHDMTGETG 283
                +   + +  +  ++HRD+K EN+L+D  R  +K+ DFG   L        T   G
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFDG 171

Query: 284 TLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 342
           T  Y  PE +    Y  R   V+S GI L+++ C D+P+           ++R  +    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQV--FF 223

Query: 343 PRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +   S   ++++ C    P  RP  +E+
Sbjct: 224 RQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 28/267 (10%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +GTFG V        G+  A+K+L       + E       A    E  V     HP +T
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRHPFLT 68

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
                              +     +  C V+EY +GG L  +L  +R R    +     
Sbjct: 69  ALK----------------YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFY 110

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
             ++   L YL S+ +V+RD+K EN++LDK   +KI DFG+ +   S+   M    GT  
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
           Y+APEVL  + Y R  D +  G+ ++E+ C  +P+ +     +   ++ +      PR  
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTL 228

Query: 347 PSSLANVMKRCWDANPDKRPEMDEVVA 373
                +++      +P +R       A
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDA 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 58/269 (21%), Positives = 109/269 (40%), Gaps = 27/269 (10%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           RG FG V+       G+  A+K LD   +      +  +L       +++    D P + 
Sbjct: 14  RGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
               A     +L+                 +++  +GG L  +L ++         +   
Sbjct: 71  CMSYAFHTPDKLSF----------------ILDLMNGGDLHYHLSQHGVFSE--ADMRFY 112

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A ++  GL ++ ++ +V+RD+K  N+LLD+   V+I+D G+A     +        GT G
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHASVGTHG 170

Query: 287 YMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR-QNLRPEIPR 344
           YMAPEVL  G AY+   D +S G  L+++     P+      +          +  E+P 
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230

Query: 345 CCPSSLANVMKRCWDANPDKRPEMDEVVA 373
                L ++++     + ++R       A
Sbjct: 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGA 259

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 1e-44
 Identities = 58/293 (19%), Positives = 101/293 (34%), Gaps = 46/293 (15%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG ++ G     G++VA+KL             + +       E  ++  +      
Sbjct: 17  SGSFGDIYLGTDIAAGEEVAIKLEC-----------VKTKHPQLHIESKIYKMMQGGVGI 65

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             I                  G   ++  +V+E          L     RK + K V+ L
Sbjct: 66  PTIR---------------WCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLL 108

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENML---LDKTRTVKIADFGVARLEASNP-------H 276
           A  +   + Y+ SK  +HRDVK +N L     K   V I DFG+A+              
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 277 DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 336
           +    TGT  Y +     G   +R+ D+ S G  L       +P+  L  +       R 
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228

Query: 337 NLR------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG 383
           + +        + +  PS  A  +  C     D +P+   +  +   +   +G
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 49/290 (16%), Positives = 92/290 (31%), Gaps = 48/290 (16%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG +  G    + Q VA+K         RS+A           E   +  L      
Sbjct: 15  EGSFGVIFEGTNLLNNQQVAIKFE-----PRRSDAP------QLRDEYRTYKLLAGCTGI 63

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             +                + G       +V++    G     L+    RK + K V   
Sbjct: 64  PNVY---------------YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMA 106

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDK-----TRTVKIADFGVARL-------EASN 274
           A  +   +  +  K +V+RD+K +N L+ +        + + DFG+ +        +   
Sbjct: 107 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166

Query: 275 PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 334
             +    +GT  YM+     G   +R+ D+ + G          +P+  L  +       
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226

Query: 335 R------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI 378
           R           E+    P      M    +   D  P+ D +  +   +
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-42
 Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 51/295 (17%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F TV++       Q VA+K +  G  S   +     +     +E+ +  +L HPN+ 
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD----GINRTALREIKLLQELSHPNII 63

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             +                +I        +V ++         +IK+    L    +   
Sbjct: 64  GLLD---------AFGHKSNI-------SLVFDFMETDLE--VIIKDNSLVLTPSHIKAY 105

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
            L   +GL YL    I+HRD+K  N+LLD+   +K+ADFG+A+   S     T +  T  
Sbjct: 106 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 165

Query: 287 YMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP----- 340
           Y APE+L G   Y    D+++ G  L E+       P  S  +  + +      P     
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225

Query: 341 ---------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM 374
                                 I       L ++++  +  NP  R    + + M
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-40
 Identities = 65/294 (22%), Positives = 111/294 (37%), Gaps = 51/294 (17%)

Query: 109 RGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DH 162
            G +G V +       G+ VA+K +       R +     +  +  +EVAV   L   +H
Sbjct: 17  EGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           PNV +       +                    +V E+       +YL K     +  + 
Sbjct: 70  PNVVRLFDVCTVSRTDRE-----------TKLTLVFEHVDQDLT-TYLDKVPEPGVPTET 117

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGET 282
           +  +   L RGL +L S ++VHRD+K +N+L+  +  +K+ADFG+AR+  S    +T   
Sbjct: 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVV 176

Query: 283 GTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-- 340
            TL Y APEVL  S+Y    D++S G    E++     +   S  +    ++     P  
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 341 -----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                                  +          +++ +C   NP KR      
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-40
 Identities = 60/293 (20%), Positives = 116/293 (39%), Gaps = 54/293 (18%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            GT+G V++      G+ VA+K +       R + E   + +   +E+++  +L+HPN+ 
Sbjct: 12  EGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K +          +      +        +V E+ H   LK ++  +    +   ++   
Sbjct: 65  KLLD---------VIHTENKL-------YLVFEFLHQD-LKKFMDASALTGIPLPLIKSY 107

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              L +GL++  S +++HRD+K +N+L++    +K+ADFG+AR         T E  TL 
Sbjct: 108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167

Query: 287 YMAPEVLNGSAYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP----- 340
           Y APE+L G  Y     D++S G    E+      +P  S  +    + R    P     
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 341 ----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                                 ++         +++ +    +P+KR      
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-39
 Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 54/300 (18%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
           +GTFG V +  +   GQ VA+K +         E E         +E+ +   L H NV 
Sbjct: 20  QGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKILQLLKHENVV 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             I           +T             +V ++C           N   K     + ++
Sbjct: 73  NLIEI--------CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRV 122

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARL----EASNPHDMTGET 282
              L  GL Y+   KI+HRD+K  N+L+ +   +K+ADFG+AR     + S P+  T   
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 283 GTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR------ 335
            TL Y  PE+L G   Y    D++  G  + E++         +     + + +      
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 336 -----------------------QNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 371
                                  + ++  +        A +++ +    +P +R + D+ 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (352), Expect = 3e-39
 Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 54/292 (18%)

Query: 109 RGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK 167
            GT+G V++     G+  A+K +       R E E   + +   +E+++  +L H N+ K
Sbjct: 12  EGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLA 227
                              +        +V E+         L+      L         
Sbjct: 65  LYD----------------VIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFL 106

Query: 228 LDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGY 287
           L L  G++Y   ++++HRD+K +N+L+++   +KIADFG+AR         T E  TL Y
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 288 MAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP------ 340
            AP+VL GS  Y+   D++S G    E+      +P +S ++    + R    P      
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 341 ---------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                                   +    S  +++ +    +P++R    + 
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 52/260 (20%), Positives = 103/260 (39%), Gaps = 31/260 (11%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG V    +   G   A+K+LD  +     + E          E  +   ++ P + 
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE------HTLNEKRILQAVNFPFLV 104

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K                       ++   +V+EY  GG + S+L   R  + +       
Sbjct: 105 KLEF----------------SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY 146

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
           A  +     YL S  +++RD+K EN+L+D+   +++ DFG A+        + G      
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---E 203

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCC 346
            +APE++    YN+  D ++ G+ ++E+     P+      ++   +V    +   P   
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHF 261

Query: 347 PSSLANVMKRCWDANPDKRP 366
            S L ++++     +  KR 
Sbjct: 262 SSDLKDLLRNLLQVDLTKRF 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 59/315 (18%), Positives = 113/315 (35%), Gaps = 59/315 (18%)

Query: 92  QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAA 149
           Q +++ P +         G +G V       +   VA+K +        S  E  +    
Sbjct: 2   QVFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--------SPFEHQTYCQR 52

Query: 150 FTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSY 209
             +E+ +  +  H N+          +   ++               +V +  G  L   
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMK------------DVYLVTHLMGADLYKL 100

Query: 210 LIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVAR 269
           L   + + L+   +      + RGL Y+ S  ++HRD+K  N+LL+ T  +KI DFG+AR
Sbjct: 101 L---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157

Query: 270 LEASNPHDMTGET---GTLGYMAPEVL-NGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS 325
           +   +       T    T  Y APE++ N   Y +  D++S G  L E+      +P   
Sbjct: 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217

Query: 326 FSEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKR 356
           + +  + ++     P                              +     S   +++ +
Sbjct: 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

Query: 357 CWDANPDKRPEMDEV 371
               NP KR E+++ 
Sbjct: 278 MLTFNPHKRIEVEQA 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-36
 Identities = 54/294 (18%), Positives = 94/294 (31%), Gaps = 54/294 (18%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G+FG V++      G+ VA+K +   +     E +I               KLDH N+ 
Sbjct: 30  NGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR-------------KLDHCNIV 76

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYL-IKNRRRKLAFKVVIQ 225
           +       + E               +  +V++Y      +        ++ L    V  
Sbjct: 77  RLRYFFYSSGE----------KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 226 LALDLARGLSYLQSKKIVHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGT 284
               L R L+Y+ S  I HRD+K +N+LLD  T  +K+ DFG A+       +++     
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186

Query: 285 LGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--------- 335
                  +   + Y    DV+S G  L E+      +P  S  +    +++         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 336 ------------------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                                        P     +  R  +  P  R    E 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-36
 Identities = 55/276 (19%), Positives = 109/276 (39%), Gaps = 34/276 (12%)

Query: 109 RGTFGTVHRGI-----YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH- 162
            G +G V           G+  A+K+L       +++            E  V   +   
Sbjct: 34  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT-----TEHTRTERQVLEHIRQS 88

Query: 163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKV 222
           P +                    +         ++++Y +GG L ++L  ++R +     
Sbjct: 89  PFLVTLH----------------YAFQTETKLHLILDYINGGELFTHL--SQRERFTEHE 130

Query: 223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVA-RLEASNPHDMTGE 281
           V     ++   L +L    I++RD+K EN+LLD    V + DFG++    A         
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190

Query: 282 TGTLGYMAPEVLNG--SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
            GT+ YMAP+++ G  S +++  D +S G+ ++E+     P+         + + R+ L+
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

Query: 340 --PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA 373
             P  P+   +   ++++R    +P KR       A
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 56/294 (19%), Positives = 112/294 (38%), Gaps = 56/294 (19%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            GT+GTV +       + VA+K +       R + +   + ++  +E+ +  +L H N+ 
Sbjct: 12  EGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           +                   +        +V E+C     K +   N       ++V   
Sbjct: 65  RLHD----------------VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP--EIVKSF 106

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              L +GL +  S+ ++HRD+K +N+L+++   +K+A+FG+AR         + E  TL 
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 287 YMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVVRQNLRP---- 340
           Y  P+VL G+  Y+   D++S G    E+     P +P     +    + R    P    
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 341 -----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
                                   +     ++  ++++     NP +R   +E 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 63/315 (20%), Positives = 112/315 (35%), Gaps = 57/315 (18%)

Query: 89  VRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASL 146
           V +  WE+  A          G +G V   +    G  VA+K L    +S          
Sbjct: 9   VTKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-------F 60

Query: 147 RAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL 206
                +E+ +   + H NV   +        L+  TD            +V+ +   G  
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD----------FYLVMPFM--GTD 108

Query: 207 KSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFG 266
              L+K+ +  L    +  L   + +GL Y+ +  I+HRD+K  N+ +++   +KI DFG
Sbjct: 109 LGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166

Query: 267 VARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS 325
           +AR       +MTG   T  Y APEV LN   Y +  D++S G  + E+      +    
Sbjct: 167 LAR---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223

Query: 326 FSEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKR 356
             +    +++    P                              I         N++++
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283

Query: 357 CWDANPDKRPEMDEV 371
               + ++R    E 
Sbjct: 284 MLVLDAEQRVTAGEA 298

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 6e-31
 Identities = 69/331 (20%), Positives = 116/331 (35%), Gaps = 65/331 (19%)

Query: 73  RPIYTRSRSSSTTSASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGI--YDGQDVAVKLL 130
           RP + R          + +  WE+ P +         G +G+V        G  VAVK L
Sbjct: 1   RPTFYRQE--------LNKTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 51

Query: 131 DWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNIQTDNGHIGMP 190
               +S               +E+ +   + H NV   +        L    D       
Sbjct: 52  SRPFQSIIHAKR-------TYRELRLLKHMKHENVIGLLDVFTPARSLEEFND------- 97

Query: 191 SNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE 250
                 +V +  G  L +     + +KL    V  L   + RGL Y+ S  I+HRD+K  
Sbjct: 98  ----VYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150

Query: 251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEV-LNGSAYNRKCDVYSFGI 309
           N+ +++   +KI DFG+AR       +MTG   T  Y APE+ LN   YN+  D++S G 
Sbjct: 151 NLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

Query: 310 CLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP----------------------------- 340
            + E+      +P     +    ++R    P                             
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267

Query: 341 EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
            +         +++++    + DKR    + 
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 51/347 (14%), Positives = 105/347 (30%), Gaps = 81/347 (23%)

Query: 74  PIYTRSRSSSTTSASVRRQEWEIDPAKL--------IIKGAFARGTFGTVHRGI--YDGQ 123
           P+ +R+R  +  +    R+ W+ +   +         +     RG +  V   I   + +
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61

Query: 124 DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIGATMGTSELNIQT 182
            V VK+L                +    +E+ +   L   PN+                 
Sbjct: 62  KVVVKILK------------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP-- 107

Query: 183 DNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKI 242
                        +V E+ +    K        + L    +     ++ + L Y  S  I
Sbjct: 108 ------------ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGI 150

Query: 243 VHRDVKTENMLLD-KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNR 300
           +HRDVK  N+++D + R +++ D+G+A        +      +  +  PE+L     Y+ 
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 301 KCDVYSFGICLWEIYCCDMPYP--------------------------------DLSFSE 328
             D++S G  L  +     P+                                 D  F++
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 329 VTSAVVRQNLR----PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 371
           +     R+        E          + + +    +   R    E 
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 9e-27
 Identities = 56/305 (18%), Positives = 106/305 (34%), Gaps = 65/305 (21%)

Query: 109 RGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G  G V         ++VA+K L    ++               +E+ +   ++H N+ 
Sbjct: 27  SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-------AYRELVLMKCVNHKNII 79

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
             +        L    D            +V+E       +   ++    ++++     L
Sbjct: 80  SLLNVFTPQKTLEEFQD----------VYLVMELMDANLCQVIQMELDHERMSY-----L 124

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +  G+ +L S  I+HRD+K  N+++    T+KI DFG+AR        MT    T  
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRY 183

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP------ 340
           Y APEV+ G  Y    D++S G  + E+    + +P   + +  + V+ Q   P      
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 341 ----------------------------------EIPRCCPSSLANVMKRCWDANPDKRP 366
                                             E  +   S   +++ +    +P KR 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 367 EMDEV 371
            +D+ 
Sbjct: 304 SVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 57/258 (22%), Positives = 99/258 (38%), Gaps = 24/258 (9%)

Query: 109 RGTFGTVHRGI--YDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT 166
            G F TV       +   VA+K++   +              A   E+ +  +++  + T
Sbjct: 23  WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----------AAEDEIKLLQRVNDADNT 72

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K     MG + +    D+ +   P+    V+V    G  L + + K   R +    V Q+
Sbjct: 73  KEDS--MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 227 ALDLARGLSYLQSK-KIVHRDVKTENMLLD------KTRTVKIADFGVARLEASNPHDMT 279
           +  L  GL Y+  +  I+H D+K EN+L++          +KIAD G A     +  +  
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 280 GETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 339
               T  Y +PEVL G+ +    D++S    ++E+   D  +        T         
Sbjct: 191 Q---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 340 PEIPRCCPSSLANVMKRC 357
            E+    PS L    K  
Sbjct: 248 IELLGELPSYLLRNGKYT 265

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.1 bits (176), Expect = 2e-15
 Identities = 28/209 (13%), Positives = 53/209 (25%), Gaps = 34/209 (16%)

Query: 109 RGTFGTVHRGI-YDGQDVAVKLLDWGEESHRSEAEIASLRAA-FTQEVAVWHKLDHPNVT 166
            G    V         +  VK    G  S +   E        F+       + +   + 
Sbjct: 10  EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69

Query: 167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQL 226
           K  G                         V++E      L    ++N            +
Sbjct: 70  KLQGL------------AVPKVYAWEGNAVLMELIDAKELYRVRVENPDE---------V 108

Query: 227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLG 286
              +   ++    + IVH D+   N+L+ +   + I DF  +  E               
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV-EVGEEGWRE------- 159

Query: 287 YMAPEVLNGSAYNRKCDVYSFGICLWEIY 315
            +  +V N   Y  +   Y     +    
Sbjct: 160 ILERDVRNIITYFSR--TYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	404
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.84
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.64
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.59

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-59  Score=436.65  Aligned_cols=263  Identities=29%  Similarity=0.605  Sum_probs=230.2

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      ..|+|+.++|++.+.||+|+||+||+|++  +|+.||||+++.....          .+.|.+|+.+|++++|||||+++
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~il~~l~HpnIv~~~   79 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQLL   79 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----------HHHHHHHHHHHHhCCCCCEecCC
Confidence            46999999999999999999999999998  5889999998654321          24578999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+...+                |+||||+++|+|.+++.+.....+++..+..++.||+.||.|||++||+||||||
T Consensus        80 ~~~~~~~~~----------------~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp  143 (287)
T d1opja_          80 GVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA  143 (287)
T ss_dssp             EEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             ccEeeCCee----------------EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCcccc
Confidence            999887766                8999999999999999877677899999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCHH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMP-YPDLSFS  327 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~P-f~~~~~~  327 (404)
                      +||||+.++.+||+|||+|+...... ....+..||+.|||||++.+..|+.++|||||||++|||++|..| |...+..
T Consensus       144 ~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~  223 (287)
T d1opja_         144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  223 (287)
T ss_dssp             GGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             CeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence            99999999999999999998654432 233445689999999999999999999999999999999997655 4555555


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +. ...+....++..+..+|+++.+||.+||+.||++|||+++|++.|+.+...
T Consensus       224 ~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         224 QV-YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HH-HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            54 445666778888999999999999999999999999999999999987543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-59  Score=431.34  Aligned_cols=265  Identities=32%  Similarity=0.620  Sum_probs=220.9

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      .+|+|+.++|.+.+.||+|+||+||+|++.+ .||||+++.......       ..+.|.+|+.++++++|||||+++++
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-------QLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTT-------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHH-------HHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            3699999999999999999999999998765 599999975543321       13568899999999999999999998


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.+. .+                ++|||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus        73 ~~~~-~~----------------~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N  134 (276)
T d1uwha_          73 STAP-QL----------------AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN  134 (276)
T ss_dssp             ECSS-SC----------------EEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             Eecc-EE----------------EEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence            7543 23                8999999999999999654 4579999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          252 MLLDKTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      |||+.++.+||+|||+|+.....  ........||+.|||||++.+   ..|+.++|||||||++|||+||..||.+.+.
T Consensus       135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999764432  223445679999999999864   3589999999999999999999999998876


Q ss_pred             HHHHHHHHhccC-CC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          327 SEVTSAVVRQNL-RP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       327 ~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      ............ .+   ..+..+|+++.+||.+||+.||++|||+++|++.|+.+..+.
T Consensus       215 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            655555544443 32   356789999999999999999999999999999999987653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-59  Score=429.68  Aligned_cols=264  Identities=31%  Similarity=0.586  Sum_probs=229.1

Q ss_pred             cccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           90 RRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        90 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ...+|+|+.++|++.+.||+|+||+||+|.+ +++.||||+++.....          .+.|.+|+.++++++|||||++
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~   73 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRL   73 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----------HHHHHHHHHHHHhCCCCCEeEE
Confidence            4578999999999999999999999999998 4678999999754322          2458899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      +|++.+. .+                |+||||+++|+|.+++......++++..+..++.||+.||.|||++||+|||||
T Consensus        74 ~g~~~~~-~~----------------~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK  136 (272)
T d1qpca_          74 YAVVTQE-PI----------------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR  136 (272)
T ss_dssp             EEEECSS-SC----------------EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             EeeeccC-Ce----------------EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence            9987543 23                899999999999998866555679999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC-DMPYPDLSF  326 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~Pf~~~~~  326 (404)
                      |+||||++++.+||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||+|| .+||...+.
T Consensus       137 p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~  216 (272)
T d1qpca_         137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN  216 (272)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998654432 233456789999999999988999999999999999999995 556667776


Q ss_pred             HHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          327 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+....+ ....++..|..+|+++.+||.+||+.||++|||+++|++.|+++.++
T Consensus       217 ~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         217 PEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHH-HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            6665554 45567778889999999999999999999999999999999998875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-58  Score=423.15  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=218.8

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....      .........+.+|+.++++++|||||++++++.+..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH------ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            6899999999999999999998  68999999986321      112223566889999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+|||||++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus        80 ~~----------------~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~  141 (263)
T d2j4za1          80 RV----------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS  141 (263)
T ss_dssp             EE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred             EE----------------EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC
Confidence            66                8999999999999999654  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||+|.....  .......||+.|||||++.+.+|+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus       142 ~~~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  219 (263)
T d2j4za1         142 AGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV  219 (263)
T ss_dssp             TSCEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             CCCEeecccceeeecCC--CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            99999999999975432  2334567999999999999999999999999999999999999999999988887776654


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .  ..+|..+|+++.+||.+||+.||++|||++|+++
T Consensus       220 ~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            4  4567889999999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-58  Score=422.58  Aligned_cols=258  Identities=31%  Similarity=0.639  Sum_probs=216.7

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      |++++|.+.+.||+|+||+||+|.+ +++.||||+++.....          .+.|.+|+.++++++|||||+++|++..
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----------HHHHHHHHHHHHhcCCCCcccccceecc
Confidence            5788999999999999999999998 6788999999754322          2347899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                ++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||||
T Consensus        72 ~~~~----------------~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill  134 (263)
T d1sm2a_          72 QAPI----------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV  134 (263)
T ss_dssp             SSSC----------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred             CCce----------------EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence            7766                8999999999999998654 4678999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||+++...... .......||+.|||||++.+..|+.++|||||||++|||+| |..||...+..+....
T Consensus       135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~  214 (263)
T d1sm2a_         135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED  214 (263)
T ss_dssp             CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred             cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence            999999999999998654332 22334678999999999999999999999999999999999 5777777777776665


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      +. ...++..|..+++++.+||.+||+.||++|||+++|++.|+++..+
T Consensus       215 i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         215 IS-TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH-hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            54 4566777889999999999999999999999999999999998765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=425.40  Aligned_cols=254  Identities=27%  Similarity=0.500  Sum_probs=208.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++.....   +.    ..+.+.+|+.++++++|||||++++++.+.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   75 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDR   75 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HH----HHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HH----HHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence            36899999999999999999998  6899999999765432   11    245688999999999999999999999764


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHhhCC-----ceecccC
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--RRRKLAFKVVIQLALDLARGLSYLQSKK-----IVHRDVK  248 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~g-----ivH~Dik  248 (404)
                      ..-.              +|+|||||++|+|.+++.+.  .+..+++..++.++.||+.||.|||++|     |+|||||
T Consensus        76 ~~~~--------------~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK  141 (269)
T d2java1          76 TNTT--------------LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK  141 (269)
T ss_dssp             ---C--------------EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred             CCCE--------------EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence            4322              28999999999999998653  2467999999999999999999999976     9999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      |+||||+.++.+||+|||+|+.............||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+
T Consensus       142 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~  221 (269)
T d2java1         142 PANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE  221 (269)
T ss_dssp             GGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence            99999999999999999999876555555566789999999999999999999999999999999999999999999888


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +...+..... +.++..+|+++.+||.+||+.||.+|||++||++
T Consensus       222 ~~~~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         222 LAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            8777766554 4567889999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-58  Score=426.85  Aligned_cols=247  Identities=25%  Similarity=0.431  Sum_probs=219.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|++.+.||+|+||+||+|.+  +|+.||||+++......         .+.+.+|+.++++++|||||++++++.+..
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---------HHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            5799999999999999999997  69999999997654322         245789999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+|||||+||+|.+++.+   +.+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus        91 ~~----------------~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~  151 (293)
T d1yhwa1          91 EL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM  151 (293)
T ss_dssp             EE----------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             EE----------------EEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence            66                899999999999998754   46999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++++||+|||+|+............+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus       152 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~  231 (293)
T d1yhwa1         152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN  231 (293)
T ss_dssp             TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred             CCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence            99999999999987665555566778999999999999999999999999999999999999999998877766666554


Q ss_pred             c-CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 N-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      . .....+..+++++++||.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3 334566788999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=422.55  Aligned_cols=269  Identities=32%  Similarity=0.547  Sum_probs=226.0

Q ss_pred             ccccccccccCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCce
Q 015594           87 ASVRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNV  165 (404)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  165 (404)
                      ......+|+|+.++|++.+.||+|+||+||+|++ +++.||||+++.....          .+.|.+|+.++++++||||
T Consensus         5 ~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nI   74 (285)
T d1fmka3           5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKL   74 (285)
T ss_dssp             SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTB
T ss_pred             CCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCE
Confidence            4456788999999999999999999999999998 4568999999754332          2458899999999999999


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceec
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHR  245 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~  245 (404)
                      |++++++.+. .+                ++||||+++|+|..++.......+++..++.++.||+.||+|||++||+||
T Consensus        75 v~~~g~~~~~-~~----------------~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~  137 (285)
T d1fmka3          75 VQLYAVVSEE-PI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR  137 (285)
T ss_dssp             CCEEEEECSS-SC----------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eEEEEEEecC-Ce----------------EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecc
Confidence            9999998643 33                899999999999999876655679999999999999999999999999999


Q ss_pred             ccCCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCC
Q 015594          246 DVKTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD  323 (404)
Q Consensus       246 Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~Pf~~  323 (404)
                      ||||+||||+.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|. +||..
T Consensus       138 DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998644332 3334467899999999999999999999999999999999965 55566


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      ....+....+ ....++..+..+|+++.+||.+||+.||++||++++|+++|+.+.++.-
T Consensus       218 ~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         218 MVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCHHHHHHHH-HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            6666665554 4456677889999999999999999999999999999999999887754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-58  Score=433.61  Aligned_cols=261  Identities=30%  Similarity=0.547  Sum_probs=226.1

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC--C-----ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCC
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD--G-----QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHP  163 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  163 (404)
                      ..|+++.++|++.+.||+|+||+||+|++.  +     ..||||++.....        ......+.+|+.++.++ +||
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~Hp  101 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSHE  101 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCT
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--------HHHHHHHHHHHHHHHHhcCCC
Confidence            458999999999999999999999999872  2     3699999854321        12245678999999998 899


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhccc---------------------CCCcHHH
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRR---------------------RKLAFKV  222 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~  222 (404)
                      |||++++++.+...+                |+|||||++|+|.+++.....                     ..+++..
T Consensus       102 nIv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  165 (325)
T d1rjba_         102 NIVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED  165 (325)
T ss_dssp             TBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHH
T ss_pred             cEeEEEEEEeeCCeE----------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHH
Confidence            999999999887776                899999999999999965421                     3589999


Q ss_pred             HHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCc
Q 015594          223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNR  300 (404)
Q Consensus       223 ~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  300 (404)
                      ++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......  ...+..||+.|||||++.+..|+.
T Consensus       166 ~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  245 (325)
T d1rjba_         166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI  245 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc
Confidence            999999999999999999999999999999999999999999999986444332  223456899999999999999999


Q ss_pred             chhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 015594          301 KCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLE  376 (404)
Q Consensus       301 ~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~  376 (404)
                      ++|||||||++|||++ |..||.+.+..+....++....++..|..+|+++.+||.+||+.||++|||+++|++.|.
T Consensus       246 ~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            9999999999999997 899999988777777888888888999999999999999999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-57  Score=422.84  Aligned_cols=261  Identities=29%  Similarity=0.563  Sum_probs=215.2

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CC---ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DG---QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      +++.++|.+.+.||+|+||+||+|.+  +|   ..||||.+.....        ...++.|.+|+.+|++++|||||+++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~   93 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--------EKQRRDFLSEASIMGQFDHPNVIHLE   93 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--------HHHHHHHHHHHHHHHhCCCCCCccEE
Confidence            57778999999999999999999997  33   2588888753321        12245689999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      |++.....+                |+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||
T Consensus        94 g~~~~~~~~----------------~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp  156 (299)
T d1jpaa_          94 GVVTKSTPV----------------MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA  156 (299)
T ss_dssp             EEECSSSSC----------------EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             EEEeeCCEE----------------EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc
Confidence            999877766                8999999999999988654 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCC-----cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPH-----DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPD  323 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~  323 (404)
                      +||||+.++.+||+|||+++.......     ...+..||+.|||||.+.+..++.++|||||||++|||+| |..||.+
T Consensus       157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence            999999999999999999986443322     1223457999999999999999999999999999999998 8999999


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+..+....+. ...++..+..+|+++.+||.+||+.||++|||+.+|++.|+++...
T Consensus       237 ~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         237 MTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            99888776654 4556677889999999999999999999999999999999988653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-57  Score=413.07  Aligned_cols=255  Identities=28%  Similarity=0.569  Sum_probs=225.3

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      +++++|++.+.||+|+||+||+|++ +++.||||+++.+...          ...|.+|+.++++++||||++++|++.+
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~   70 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTK   70 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence            4678999999999999999999998 5679999999865432          2347899999999999999999999987


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        71 ~~~~----------------~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill  133 (258)
T d1k2pa_          71 QRPI----------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV  133 (258)
T ss_dssp             SSSE----------------EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE
T ss_pred             CCce----------------EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE
Confidence            7666                8999999999999987554 4678999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||+++..... ........||+.|+|||.+.+..++.++||||||+++|||+| |..||...+..++...
T Consensus       134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~  213 (258)
T d1k2pa_         134 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH  213 (258)
T ss_dssp             CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH
T ss_pred             cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999754433 233445678999999999999999999999999999999998 8999999998888776


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      +.. ..++..|..+++++.+||.+||+.||++|||+++|++.|.+|
T Consensus       214 i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         214 IAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            654 557778899999999999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=423.91  Aligned_cols=249  Identities=27%  Similarity=0.446  Sum_probs=217.0

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      +.|++.+.||+|+||+||+|.+  +|+.||||+++......         .+.+.+|+.++++++|||||++++++.+..
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---------LEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---------GGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            4689999999999999999998  68999999997543221         245779999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+|||||++|+|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus        83 ~~----------------~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~  145 (288)
T d2jfla1          83 NL----------------WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL  145 (288)
T ss_dssp             EE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             eE----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence            66                8999999999999988654 457999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-----GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      ++.+||+|||+|+.............||+.|||||++.     +..|+.++|||||||++|||++|..||.+.+..+...
T Consensus       146 ~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~  225 (288)
T d2jfla1         146 DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL  225 (288)
T ss_dssp             TSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred             CCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence            99999999999975443333445678999999999983     5568999999999999999999999999998888887


Q ss_pred             HHHhccCC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+...... ...+..+|+++.+||.+||+.||.+|||++||++
T Consensus       226 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            77765432 3446778999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=423.63  Aligned_cols=251  Identities=21%  Similarity=0.342  Sum_probs=217.2

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      .+++|++.+.||+|+||+||+|.+  +|+.||||+++...      .........+.+|+.++++++||||+++++++.+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   79 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD   79 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH------ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence            457899999999999999999998  68999999996321      1112234568899999999999999999999988


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+|||||+||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        80 ~~~~----------------~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll  141 (288)
T d1uu3a_          80 DEKL----------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL  141 (288)
T ss_dssp             SSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CCEE----------------EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc
Confidence            7766                8999999999999988654  679999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCC--CCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASN--PHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      +.++.+||+|||+|+.....  .......+||+.|||||++.+..|+.++|||||||++|+|++|..||...+..++...
T Consensus       142 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  221 (288)
T d1uu3a_         142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK  221 (288)
T ss_dssp             CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence            99999999999999865432  2233456799999999999999999999999999999999999999999988888877


Q ss_pred             HHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +....  ..+|..+++++.+||.+||+.||.+|||++|+++
T Consensus       222 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         222 IIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            77654  4567889999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-57  Score=417.94  Aligned_cols=262  Identities=30%  Similarity=0.557  Sum_probs=224.4

Q ss_pred             cccCCCCeEEeee-eeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           94 WEIDPAKLIIKGA-FARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        94 ~~~~~~~~~~~~~-lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      +.+..++|.+.+. ||+|+||+||+|.+    ++..||||+++....    .    ...+.|.+|+.+|++++|||||++
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~----~----~~~~~~~~E~~il~~l~HpnIv~l   74 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----K----ADTEEMMREAQIMHQLDNPYIVRL   74 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC----H----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC----H----HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4566788999885 99999999999986    345799999964321    1    224568899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      +|++.+. .+                |+||||+++|+|.+++... +..+++..+..++.||+.||.|||++||+|||||
T Consensus        75 ~g~~~~~-~~----------------~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK  136 (285)
T d1u59a_          75 IGVCQAE-AL----------------MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA  136 (285)
T ss_dssp             EEEEESS-SE----------------EEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             eeeeccC-eE----------------EEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc
Confidence            9998653 23                8999999999999987543 4679999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCC---cccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPH---DMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDL  324 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~  324 (404)
                      |+||||+.++.+||+|||+++.......   ......||+.|||||++.+..++.++|||||||++|||+| |..||.+.
T Consensus       137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~  216 (285)
T d1u59a_         137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  216 (285)
T ss_dssp             GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999986544322   2234568999999999998899999999999999999998 89999999


Q ss_pred             CHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhc
Q 015594          325 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSK  382 (404)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~  382 (404)
                      +..++...+ ....+++.|..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus       217 ~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         217 KGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             CTHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            887776554 455677888999999999999999999999999999999999877654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=418.25  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++.....        ...+.+.+|+.++++++|||||++++++.+.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            36899999999999999999998  6899999999754221        1234578999999999999999999999887


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+|||||++|+|.+++.+  ...+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        76 ~~~----------------~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~  137 (271)
T d1nvra_          76 NIQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD  137 (271)
T ss_dssp             TEE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cee----------------EEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence            766                899999999999999843  46799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-H
Q 015594          256 KTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-S  331 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~-~  331 (404)
                      .++.+||+|||+|+......  ......+||+.|||||++.+..+ +.++|||||||++|||++|..||...+..... .
T Consensus       138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~  217 (271)
T d1nvra_         138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS  217 (271)
T ss_dssp             TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred             CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999999998654332  23455789999999999988776 67899999999999999999999776544333 3


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..............+++++.+||.+||+.||++|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333333333444678999999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=413.93  Aligned_cols=262  Identities=28%  Similarity=0.563  Sum_probs=217.3

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECC------ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDG------QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      .||+++.|.+.++||+|+||+||+|.+.+      ..||||+++....    .    .....|.+|+.++++++|||||+
T Consensus         2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~----~----~~~~~~~~E~~il~~l~H~nIv~   73 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----E----KQRVDFLGEAGIMGQFSHHNIIR   73 (283)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC----h----HHHHHHHHHHHHHHhcCCCCEee
Confidence            36888999999999999999999998732      4699999864321    1    12355889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      ++|++.+...+                ++||||+.+++|.+++... ...+++..+..++.||+.||.|||+++|+||||
T Consensus        74 ~~g~~~~~~~~----------------~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDl  136 (283)
T d1mqba_          74 LEGVISKYKPM----------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL  136 (283)
T ss_dssp             EEEEECSSSSE----------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             eeEEEecCCce----------------EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCcc
Confidence            99999877766                8999999999999987654 467999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCC---CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCC-CCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCD-MPYPD  323 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~Pf~~  323 (404)
                      ||+||||+.++.+||+|||+++......   ....+..||+.|||||++.+..++.++|||||||++|||+++. +||..
T Consensus       137 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~  216 (283)
T d1mqba_         137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE  216 (283)
T ss_dssp             CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence            9999999999999999999998644332   2233456899999999999999999999999999999999964 55666


Q ss_pred             CCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          324 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+..+.... +....++..+..+|+++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       217 ~~~~~~~~~-i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         217 LSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCHHHHHHH-HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCHHHHHHH-HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            666665544 455677788899999999999999999999999999999999988753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-57  Score=412.35  Aligned_cols=257  Identities=32%  Similarity=0.623  Sum_probs=222.2

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      |+|+.++|++.+.||+|+||+||+|.++|+.||||+++....           .+.|.+|+.++++++||||++++|++.
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-----------~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIV   70 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            899999999999999999999999999999999999964321           245789999999999999999999986


Q ss_pred             cC-CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          174 GT-SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~-~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      +. ..+                |+||||+++|+|.+++.+.....+++..++.++.||+.||.|||+.+|+||||||+||
T Consensus        71 ~~~~~~----------------~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Ni  134 (262)
T d1byga_          71 EEKGGL----------------YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV  134 (262)
T ss_dssp             CC--CC----------------EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCcE----------------EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhh
Confidence            54 333                8999999999999999776556799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS  331 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~~~~  331 (404)
                      |++.++.+||+|||+++.....   .....+|+.|+|||++.+..++.++||||||+++|||+| |..||...+..+...
T Consensus       135 l~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~  211 (262)
T d1byga_         135 LVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  211 (262)
T ss_dssp             EECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             eecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            9999999999999999753322   233467899999999998899999999999999999998 789999888887766


Q ss_pred             HHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          332 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      .+ ....+++++..+++++.+||.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       212 ~i-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         212 RV-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HH-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH-HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            64 44567788999999999999999999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=413.91  Aligned_cols=255  Identities=30%  Similarity=0.534  Sum_probs=214.6

Q ss_pred             CCCeEEe-eeeeeecceEEEEEEE----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           98 PAKLIIK-GAFARGTFGTVHRGIY----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        98 ~~~~~~~-~~lg~G~~g~V~~~~~----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ...+.+. ++||+|+||+||+|.+    .++.||||+++....       .....+.|.+|+.+|++++|||||++++++
T Consensus         5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~   77 (277)
T d1xbba_           5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-------DPALKDELLAEANVMQQLDNPYIVRMIGIC   77 (277)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-------CHHHHHHHHHHHHHHHhCCCCCCceEEEEe
Confidence            3444554 4699999999999986    246899999964321       123356789999999999999999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      .+. ..                |+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        78 ~~~-~~----------------~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Ni  138 (277)
T d1xbba_          78 EAE-SW----------------MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  138 (277)
T ss_dssp             ESS-SE----------------EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ccC-CE----------------EEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhh
Confidence            643 23                7999999999999998654  5799999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE  328 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~~  328 (404)
                      ||+.++.+||+|||+++........   .....||+.|||||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~  218 (277)
T d1xbba_         139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE  218 (277)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             cccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH
Confidence            9999999999999999865433222   233568999999999999999999999999999999998 899999998887


Q ss_pred             HHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          329 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      +...+. ...++..|..+|+++.+||.+||+.||++|||+++|++.|+.+.
T Consensus       219 ~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         219 VTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHH-cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            765554 45677888999999999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-56  Score=420.85  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=223.8

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEe
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATM  173 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  173 (404)
                      |..++|.+.+.||+|+||+||+|++  +|+.||||+++...      .........+.+|+.+|++++||||+++++++.
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   75 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh------ccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence            4567899999999999999999997  78999999996421      111122456789999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +...+                |+|||||+||+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        76 ~~~~~----------------~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL  137 (337)
T d1o6la_          76 THDRL----------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  137 (337)
T ss_dssp             CSSEE----------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             ccccc----------------ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence            88776                8999999999999998664  57999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          254 LDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       254 i~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      |+.+|.+||+|||+|+............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..++...+
T Consensus       138 l~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i  217 (337)
T d1o6la_         138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  217 (337)
T ss_dssp             ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence            99999999999999986655555666788999999999999999999999999999999999999999999998888777


Q ss_pred             HhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          334 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      ....  ..+|..+|+++.+||.+||+.||.+|++     +++|++
T Consensus       218 ~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         218 LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            7654  4578889999999999999999999994     888876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-56  Score=417.65  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=216.0

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      .|++.+.||+|+||+||+|++  +|+.||||+++......      ....+.+.+|+.++++++|||||++++++.+...
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            599999999999999999997  68999999997543321      2234668899999999999999999999988776


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      +                |+|||||.+|+|..++..  +.++++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus        90 ~----------------~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~  151 (309)
T d1u5ra_          90 A----------------WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP  151 (309)
T ss_dssp             E----------------EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred             E----------------EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC
Confidence            6                899999999998776644  3679999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG---SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      +.+||+|||+|+....    .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+....+.
T Consensus       152 ~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~  227 (309)
T d1u5ra_         152 GLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (309)
T ss_dssp             TEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999999999975332    334679999999999864   358999999999999999999999999998888887777


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ........+..+|+++.+||.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            777666667789999999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=410.77  Aligned_cols=262  Identities=31%  Similarity=0.612  Sum_probs=216.2

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC-----CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeE
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD-----GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTK  167 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  167 (404)
                      +|+|+.++|++.+.||+|+||+||+|++.     +..||||.++....        ...+..|.+|+.++++++|||||+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~   72 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIVK   72 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEee
Confidence            58999999999999999999999999873     34688888753221        223567889999999999999999


Q ss_pred             EEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceeccc
Q 015594          168 FIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDV  247 (404)
Q Consensus       168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Di  247 (404)
                      +++++.+ ..+                |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus        73 l~~~~~~-~~~----------------~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDl  134 (273)
T d1mp8a_          73 LIGVITE-NPV----------------WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDI  134 (273)
T ss_dssp             EEEEECS-SSC----------------EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEEec-CeE----------------EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeecccc
Confidence            9999854 233                8999999999999987654 467999999999999999999999999999999


Q ss_pred             CCCCEEEcCCCcEEEeeccccccccCCC-CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          248 KTENMLLDKTRTVKIADFGVARLEASNP-HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       248 kp~Nili~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      ||+||+++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus       135 Kp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~  214 (273)
T d1mp8a_         135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  214 (273)
T ss_dssp             SGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             chhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999998644332 23344568999999999999999999999999999999998 899999999


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ..++...+.. ..++.++..+|+++.+||.+||+.||++|||+.+|++.|+++...
T Consensus       215 ~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         215 NNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             GGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            8888777654 445677889999999999999999999999999999999988653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-56  Score=418.17  Aligned_cols=249  Identities=22%  Similarity=0.384  Sum_probs=203.3

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .+.|++.+.||+|+||+||+|.+  +|+.||||++......        .....+.+|+.++++++|||||++++++.+.
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   79 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--------GKEGSMENEIAVLHKIKHPNIVALDDIYESG   79 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            36799999999999999999998  6899999999754321        1234578999999999999999999999887


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+|||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++||+||||||+|||+.
T Consensus        80 ~~~----------------~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~  141 (307)
T d1a06a_          80 GHL----------------YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY  141 (307)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CEE----------------EEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence            766                8999999999999999653  6799999999999999999999999999999999999994


Q ss_pred             ---CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 ---KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ---~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                         +++.+||+|||+|+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....
T Consensus       142 ~~~~~~~vkl~DFG~a~~~~~-~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  220 (307)
T d1a06a_         142 SLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ  220 (307)
T ss_dssp             SSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccCCCceEEEeccceeEEccC-CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               578999999999975433 3334457899999999999999999999999999999999999999999998888888


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.......  ..+..+|+++.+||.+||+.||++|||++|+++
T Consensus       221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            77766544  344678999999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=406.29  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=207.3

Q ss_pred             eEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594          101 LIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      |++.+.||+|+||+||+|.+  +++.||||++......       ...++.+.+|+.+|++++|||||++++++.+...-
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   83 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG   83 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence            46778999999999999998  5789999998754322       12245688999999999999999999998753211


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCC--ceecccCCCCEEEc-
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKK--IVHRDVKTENMLLD-  255 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--ivH~Dikp~Nili~-  255 (404)
                                  ...+|+||||+++|+|.+++.+.  ..+++..++.++.||+.||+|||++|  |+||||||+||||+ 
T Consensus        84 ------------~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~  149 (270)
T d1t4ha_          84 ------------KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG  149 (270)
T ss_dssp             ------------CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred             ------------CCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence                        12348999999999999999664  57999999999999999999999998  99999999999996 


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE-VTSAVV  334 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~-~~~~~~  334 (404)
                      .++.+||+|||+|+...  .......+||+.|||||++.+. |+.++|||||||++|||++|..||.+..... ....+.
T Consensus       150 ~~~~~Kl~DFGla~~~~--~~~~~~~~GT~~Y~aPE~~~~~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~  226 (270)
T d1t4ha_         150 PTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  226 (270)
T ss_dssp             TTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             CCCCEEEeecCcceecc--CCccCCcccCccccCHHHhCCC-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence            57899999999997533  2334457899999999999875 9999999999999999999999998765444 444444


Q ss_pred             hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+..++..+++++.+||.+||+.||++|||++||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            433444566778999999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=413.19  Aligned_cols=268  Identities=31%  Similarity=0.570  Sum_probs=219.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|+|+.++|++.+.||+|+||.||+|.+       +++.||||+++....        ......+.+|+.++.++ +|
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~e~~~l~~~~~h   76 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------HSEHRALMSELKILIHIGHH   76 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--------HHHHHHHHHHHHHHHHHCCC
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--------cHHHHHHHHHHHHHHhhcCC
Confidence            457899999999999999999999999986       246899999863221        11234567777777776 78


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~  228 (404)
                      +||+.+++++......               +++|||||++|+|.+++....              ...+++..++.++.
T Consensus        77 ~~iv~~~~~~~~~~~~---------------~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (299)
T d1ywna1          77 LNVVNLLGACTKPGGP---------------LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF  141 (299)
T ss_dssp             TTBCCEEEEECSTTSC---------------CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHH
T ss_pred             CeEEEeeeeeccCCCe---------------EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHH
Confidence            9999999988655432               289999999999999996542              23589999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......  ......||+.|||||++.+..++.++||||
T Consensus       142 qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS  221 (299)
T d1ywna1         142 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS  221 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceee
Confidence            999999999999999999999999999999999999999985443322  234467999999999999999999999999


Q ss_pred             HHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          307 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       307 lG~il~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      |||++|||++| ..||...+..+.....+....++..+..+++++.+||.+||+.||++|||+++|++.|+++..+
T Consensus       222 ~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            99999999986 5689887766666677777778888999999999999999999999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-56  Score=418.42  Aligned_cols=258  Identities=26%  Similarity=0.478  Sum_probs=212.2

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT  172 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  172 (404)
                      ++..++|++.+.||+|+||+||+|++  +|+.||||+++.....        .....+.+|+.++++++|||||+++++|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~   73 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAF   73 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45678999999999999999999998  6899999999754321        1235678999999999999999999999


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhC-CceecccCCCC
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSK-KIVHRDVKTEN  251 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-givH~Dikp~N  251 (404)
                      .+...+                |+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus        74 ~~~~~~----------------~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N  135 (322)
T d1s9ja_          74 YSDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  135 (322)
T ss_dssp             ECSSEE----------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             EECCEE----------------EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence            988776                8999999999999999664  5799999999999999999999975 99999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS  331 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~  331 (404)
                      |||+.++.+||+|||+|+....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+...
T Consensus       136 ILl~~~~~vkl~DFGla~~~~~--~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~  213 (322)
T d1s9ja_         136 ILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  213 (322)
T ss_dssp             EEECTTCCEEECCCCCCHHHHH--HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred             eeECCCCCEEEeeCCCccccCC--CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999985432  22345689999999999999999999999999999999999999997654322110


Q ss_pred             H-----------------------------------------HHhccCCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHH
Q 015594          332 A-----------------------------------------VVRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMD  369 (404)
Q Consensus       332 ~-----------------------------------------~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~  369 (404)
                      .                                         .......+..+ ..++.++.+||.+||+.||.+|||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~  293 (322)
T d1s9ja_         214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  293 (322)
T ss_dssp             HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            0                                         00111112222 34678999999999999999999999


Q ss_pred             HHHH--HHHHhHh
Q 015594          370 EVVA--MLEAIDT  380 (404)
Q Consensus       370 ~ll~--~L~~~~~  380 (404)
                      |+++  .|++...
T Consensus       294 e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         294 QLMVHAFIKRSDA  306 (322)
T ss_dssp             HHHTSHHHHHHHH
T ss_pred             HHhhCHhhCcCCc
Confidence            9987  5665443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.9e-55  Score=402.23  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=227.7

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++...............+..+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999998  78999999998876665556666777888999999999997 9999999999998


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+|||||++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus        82 ~~~~----------------~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill  143 (277)
T d1phka_          82 NTFF----------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL  143 (277)
T ss_dssp             SSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             Ccce----------------EEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Confidence            8776                9999999999999999654  579999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN------GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE  328 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~  328 (404)
                      +.++.+||+|||+++.... ....+...||+.|+|||.+.      ...++.++||||+||++|+|++|..||.+.+..+
T Consensus       144 ~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         144 DDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             CTTCCEEECCCTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cCCCCeEEccchheeEccC-CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            9999999999999986544 33445678999999999984      3457889999999999999999999999999888


Q ss_pred             HHHHHHhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          329 VTSAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       329 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+........  ....+|+++++||.+||+.||++|||+++|++
T Consensus       223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            8888777765433  33478999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=409.29  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=219.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||+++.........   ....+.+.+|+.++++++|||||++++++.+..
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh---hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5799999999999999999998  68999999997653322111   112456789999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+|||||++|+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        87 ~~----------------~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~  148 (293)
T d1jksa_          87 DV----------------ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD  148 (293)
T ss_dssp             EE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred             EE----------------EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence            66                8999999999999999664  57999999999999999999999999999999999999987


Q ss_pred             CC----cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          257 TR----TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       257 ~~----~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      ++    .+||+|||+|..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus       149 ~~~~~~~vkl~DfG~a~~~~~-~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~  227 (293)
T d1jksa_         149 RNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN  227 (293)
T ss_dssp             SSSSSCCEEECCCTTCEECTT-SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCcccceEecchhhhhhcCC-CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            66    599999999976433 3344567899999999999999999999999999999999999999999998888877


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +.......  ..+..+|+++.+||.+||+.||++|||++++++
T Consensus       228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            77665443  234678999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=407.67  Aligned_cols=260  Identities=30%  Similarity=0.531  Sum_probs=217.3

Q ss_pred             ccCCCCeEEeeeeeeecceEEEEEEEC---C--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015594           95 EIDPAKLIIKGAFARGTFGTVHRGIYD---G--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFI  169 (404)
Q Consensus        95 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  169 (404)
                      -|+..+|++.+.||+|+||+||+|++.   +  ..||||+++.....      .....+.|.+|+.++++++||||++++
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~------~~~~~~~~~~Ei~~l~~l~H~nIv~~~   77 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLY   77 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC------CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            356788999999999999999999862   2  36899998643321      122345689999999999999999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      |++.+. .+                ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus        78 g~~~~~-~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp  139 (273)
T d1u46a_          78 GVVLTP-PM----------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA  139 (273)
T ss_dssp             EEECSS-SC----------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             EEEeec-ch----------------heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecH
Confidence            999653 33                7999999999999988654 45799999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCCCCc---ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASNPHD---MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLS  325 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~  325 (404)
                      +||||+.++.+||+|||+++........   .....|+..|+|||++.+..++.++||||||+++|||+| |..||.+.+
T Consensus       140 ~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             HHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence            9999999999999999999865443322   223457889999999999999999999999999999998 899999999


Q ss_pred             HHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHh
Q 015594          326 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAI  378 (404)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~  378 (404)
                      ..+....+.....+++.+..+|+++.+||.+||+.||++|||+.+|++.|+++
T Consensus       220 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            99999998888888888999999999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-55  Score=416.31  Aligned_cols=248  Identities=21%  Similarity=0.347  Sum_probs=217.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||++.....     .    ..+.+.+|+.++++++|||||++++++.+..
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-----~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----S----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-----H----HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-----h----hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5899999999999999999998  689999999964321     1    1356789999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc-
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~-  255 (404)
                      .+                |+|||||+||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+||||+ 
T Consensus        97 ~~----------------~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~  159 (350)
T d1koaa2          97 EM----------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT  159 (350)
T ss_dssp             EE----------------EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred             EE----------------EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence            66                8999999999999998543 45799999999999999999999999999999999999995 


Q ss_pred             -CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 -KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 -~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                       .++.+||+|||+|+.... ........||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.
T Consensus       160 ~~~~~vkL~DFG~a~~~~~-~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  238 (350)
T d1koaa2         160 KRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK  238 (350)
T ss_dssp             TTSCCEEECCCTTCEECCT-TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCeEEEeecchheeccc-ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             467899999999986443 334445789999999999999999999999999999999999999999999888888887


Q ss_pred             hccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .......  ....+++++.+||.+||+.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7665432  33568999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-55  Score=408.48  Aligned_cols=263  Identities=29%  Similarity=0.501  Sum_probs=226.2

Q ss_pred             cccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCc
Q 015594           92 QEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPN  164 (404)
Q Consensus        92 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  164 (404)
                      ..|++..++|++.+.||+|+||+||+|++.       ++.||||+++....        ......|.+|+.++++++|||
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~il~~l~h~n   77 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN   77 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--------hHHHHHHHHHHHHHHhcCCCC
Confidence            457888899999999999999999999873       47899999864321        123567889999999999999


Q ss_pred             eeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------------cCCCcHHH
Q 015594          165 VTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------------RRKLAFKV  222 (404)
Q Consensus       165 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~  222 (404)
                      |+++++++.....+                ++||||+++|+|.+++....                      ...+++..
T Consensus        78 iv~~~~~~~~~~~~----------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  141 (301)
T d1lufa_          78 IVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE  141 (301)
T ss_dssp             BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred             cccceeeeccCCce----------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHH
Confidence            99999999887766                89999999999999996532                      23588999


Q ss_pred             HHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCc
Q 015594          223 VIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNR  300 (404)
Q Consensus       223 ~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  300 (404)
                      +..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+......  .......||+.|+|||.+.+..|+.
T Consensus       142 ~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~  221 (301)
T d1lufa_         142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT  221 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence            99999999999999999999999999999999999999999999997543322  2233467899999999999999999


Q ss_pred             chhhHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhH
Q 015594          301 KCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAID  379 (404)
Q Consensus       301 ~~DvwslG~il~el~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~  379 (404)
                      ++|||||||++|||++|. .||.+.+..+....+... ..+.+|..+|+++.+||.+||+.||++|||+.+|++.|+++.
T Consensus       222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            999999999999999985 689999988887776554 466788899999999999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.2e-55  Score=416.00  Aligned_cols=248  Identities=22%  Similarity=0.336  Sum_probs=218.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||+++....     .    ....+.+|+.+|++++|||||+++++|.+..
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----L----DKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----H----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----h----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5799999999999999999998  689999999974321     1    1345789999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc-
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD-  255 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~-  255 (404)
                      .+                |+|||||+||+|.+++... ..++++..++.++.||+.||.|||++||+||||||+||||+ 
T Consensus       100 ~~----------------~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~  162 (352)
T d1koba_         100 EM----------------VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET  162 (352)
T ss_dssp             EE----------------EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred             EE----------------EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence            66                8999999999999877443 45799999999999999999999999999999999999997 


Q ss_pred             -CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          256 -KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       256 -~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                       .++.+||+|||+|+.... ........||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+..+....+.
T Consensus       163 ~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  241 (352)
T d1koba_         163 KKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK  241 (352)
T ss_dssp             TTCCCEEECCCTTCEECCT-TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             cCCCeEEEeecccceecCC-CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             678999999999986543 333445679999999999999999999999999999999999999999999988888887


Q ss_pred             hccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ......  ..+..+|+++.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            765543  345678999999999999999999999999976

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-54  Score=408.90  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=218.1

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++...      .......+.+.+|+.++++++|||||++++++.+.
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   76 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence            36899999999999999999997  58999999996321      11112245688999999999999999999999987


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+|||||+||+|..++...  ..+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        77 ~~~----------------~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~  138 (316)
T d1fota_          77 QQI----------------FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD  138 (316)
T ss_dssp             SEE----------------EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred             Cee----------------eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc
Confidence            766                9999999999999988654  5789999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .+|.+||+|||+|+....   .....+||+.|||||++.+.+|+.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       139 ~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~  215 (316)
T d1fota_         139 KNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN  215 (316)
T ss_dssp             TTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             CCCCEEEecCccceEecc---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence            999999999999986443   23457899999999999999999999999999999999999999999999888888776


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ...  .+|..+++++.++|.+||+.||.+|+     |+++|++
T Consensus       216 ~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         216 AEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            643  56778999999999999999999996     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-54  Score=399.76  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=217.9

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|.+  +|+.||||+++......      ......+.+|+.+++.++||||+++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC------HHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            36799999999999999999997  69999999997543321      22346688999999999999999999999765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...            ...+|+||||++|++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        80 ~~~------------~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~  145 (277)
T d1o6ya_          80 TPA------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS  145 (277)
T ss_dssp             CSS------------SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             cCC------------CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC
Confidence            432            12248999999999999988654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC---CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP---HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      .++.++|+|||.+.......   ......+||+.|||||++.+..++.++|||||||++|+|+||..||.+.+..+....
T Consensus       146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  225 (277)
T d1o6ya_         146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ  225 (277)
T ss_dssp             TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH
Confidence            99999999999987543322   234456799999999999999999999999999999999999999999998888777


Q ss_pred             HHhccCCC--CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHhH
Q 015594          333 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVAMLEAID  379 (404)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~ll~~L~~~~  379 (404)
                      .......+  .....+|+++.+||.+||+.||.+|| |++++++.|.++.
T Consensus       226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            77665443  33567899999999999999999998 8999999998875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=406.58  Aligned_cols=267  Identities=30%  Similarity=0.573  Sum_probs=232.8

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE-------CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY-------DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      ...|+++.++|++.+.||+|+||.||+|++       +++.||||+++....        ......|.+|+.++.++ +|
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------LTEREALMSELKVLSYLGNH   86 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCC
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--------HHHHHHHHHHHHHHHhccCC
Confidence            447999999999999999999999999986       346899999964321        11245688999999999 79


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc----------------cCCCcHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR----------------RRKLAFKVVIQL  226 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i  226 (404)
                      ||||++++++.+...+                ++|||||++|+|.+++.+..                ...+++..+..+
T Consensus        87 pnIv~~~g~~~~~~~~----------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  150 (311)
T d1t46a_          87 MNIVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF  150 (311)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred             CCEEEEEEEEeeCCEE----------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHH
Confidence            9999999999887766                89999999999999996643                236899999999


Q ss_pred             HHHHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCC--cccCCCCCccccCccccCCCCCCcchhh
Q 015594          227 ALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPH--DMTGETGTLGYMAPEVLNGSAYNRKCDV  304 (404)
Q Consensus       227 ~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  304 (404)
                      +.||+.||.|||++|++||||||+||+++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++||
T Consensus       151 ~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI  230 (311)
T d1t46a_         151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  230 (311)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence            99999999999999999999999999999999999999999986544332  2334678999999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          305 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       305 wslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ||||+++|||+| |.+||...+..+....++..+.++..+..+|+++.+||.+||+.||.+|||+++|+++|+++.+.
T Consensus       231 wS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            999999999998 66777777777777788888889999999999999999999999999999999999999987654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=402.07  Aligned_cols=264  Identities=33%  Similarity=0.584  Sum_probs=223.1

Q ss_pred             ccccCCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CC
Q 015594           93 EWEIDPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DH  162 (404)
Q Consensus        93 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  162 (404)
                      .|+|+.++|.+.+.||+|+||.||+|++.         +..||||+++....    .    .....+.+|+..+.++ +|
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~----~~~~~~~~e~~~l~~~~~H   78 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----E----KDLSDLISEMEMMKMIGKH   78 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC----H----HHHHHHHHHHHHHHHHCCC
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC----h----HHHHHHHHHHHHHHHhcCC
Confidence            49999999999999999999999999862         24799999864321    1    1234577888888888 89


Q ss_pred             CceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------------cCCCcHHHHHHHHH
Q 015594          163 PNVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------------RRKLAFKVVIQLAL  228 (404)
Q Consensus       163 pniv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~  228 (404)
                      ||||++++++.+...+                ++||||+++|+|.+++....              ...+++..++.++.
T Consensus        79 pnIv~~~~~~~~~~~~----------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  142 (299)
T d1fgka_          79 KNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  142 (299)
T ss_dssp             TTBCCEEEEECSSSSC----------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred             CeEEecccccccCCeE----------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence            9999999999877665                89999999999999996542              24689999999999


Q ss_pred             HHHHHHHHHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCC--CcccCCCCCccccCccccCCCCCCcchhhHH
Q 015594          229 DLARGLSYLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNP--HDMTGETGTLGYMAPEVLNGSAYNRKCDVYS  306 (404)
Q Consensus       229 qi~~~L~~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  306 (404)
                      ||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......+|+.|+|||.+.+..|+.++||||
T Consensus       143 qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS  222 (299)
T d1fgka_         143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS  222 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHH
Confidence            99999999999999999999999999999999999999998554332  2334467899999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhh
Q 015594          307 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTS  381 (404)
Q Consensus       307 lG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~  381 (404)
                      ||+++|||++ |..||.+.+..++...+ ....++..|..+++++.+||.+||+.||.+|||+.+|++.|+++.+.
T Consensus       223 ~Gvvl~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         223 FGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHhccCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            9999999998 79999998887776554 45677888999999999999999999999999999999999998653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=407.81  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=217.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHH-hhcCCCceeEEEEEEecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVW-HKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~  175 (404)
                      ++|++.+.||+|+||+||+|++  +|+.||||+++...      .........+..|..++ +.++|||||++++++.+.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~------~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV------VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh------ccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            5899999999999999999998  78999999996321      11111123455666655 478999999999999988


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        76 ~~~----------------yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~  137 (320)
T d1xjda_          76 ENL----------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD  137 (320)
T ss_dssp             SEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             Cce----------------eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec
Confidence            776                9999999999999999654  5799999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          256 KTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      .++.+||+|||+++.........+...||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..++...+..
T Consensus       138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  217 (320)
T d1xjda_         138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM  217 (320)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            99999999999998666555666677899999999999999999999999999999999999999999998888877765


Q ss_pred             ccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 015594          336 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVVA  373 (404)
Q Consensus       336 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~ll~  373 (404)
                      .  .+.+|..+|+++.+||.+||+.||.+||++. +|++
T Consensus       218 ~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            5  3467888999999999999999999999985 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-54  Score=409.55  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=217.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||+++...      .........+.+|+.+|+.++|||||++++++.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            6899999999999999999998  69999999996321      111122456789999999999999999999998877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                ++||||+.+|+|.+++.+.  +.+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus       115 ~~----------------~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~  176 (350)
T d1rdqe_         115 NL----------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ  176 (350)
T ss_dssp             EE----------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             cc----------------ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC
Confidence            66                8999999999999999665  57999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+||+|||+|+....   ......||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+.......+...
T Consensus       177 ~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~  253 (350)
T d1rdqe_         177 QGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG  253 (350)
T ss_dssp             TSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CCCEEeeeceeeeeccc---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Confidence            99999999999986543   234567999999999999999999999999999999999999999999988888877766


Q ss_pred             cCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          337 NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       337 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      ..  .++..+++++.+||.+||+.||.+|+     |+++|++
T Consensus       254 ~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         254 KV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            43  46778999999999999999999994     8999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-54  Score=402.01  Aligned_cols=265  Identities=30%  Similarity=0.512  Sum_probs=228.7

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEEC-------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCC
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIYD-------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHP  163 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  163 (404)
                      ...|+|++++|.+.+.||+|+||+||+|.+.       ++.||||+++....    .    .....|.+|+.++++++||
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~----~----~~~~~~~~E~~il~~l~h~   83 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----M----RERIEFLNEASVMKEFNCH   83 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC----H----HHHHHHHHHHHHGGGCCCT
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC----h----HHHHHHHHHHHHHHHcCCC
Confidence            3579999999999999999999999999873       46899999864321    1    1235688999999999999


Q ss_pred             ceeEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHH
Q 015594          164 NVTKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNR--------RRKLAFKVVIQLALDLARGLS  235 (404)
Q Consensus       164 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~  235 (404)
                      |||++++++......                ++||||+++|+|.+++....        ...+++..+..++.|++.||.
T Consensus        84 nIv~~~~~~~~~~~~----------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~  147 (308)
T d1p4oa_          84 HVVRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA  147 (308)
T ss_dssp             TBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             CEeeeeeEEecCCce----------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            999999999877766                89999999999999986532        135789999999999999999


Q ss_pred             HHhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHH
Q 015594          236 YLQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWE  313 (404)
Q Consensus       236 ~LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~e  313 (404)
                      |||+++|+||||||+||||+.++++||+|||+++........  .....||+.|+|||.+.+..++.++||||||+++||
T Consensus       148 ~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~E  227 (308)
T d1p4oa_         148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  227 (308)
T ss_dssp             HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             HHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHH
Confidence            999999999999999999999999999999999854433222  233468999999999999999999999999999999


Q ss_pred             HHhC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          314 IYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       314 l~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |++| .+||.+.+..+....+... .++..+..+|+.+.+||.+||+.||++|||+++|++.|++..+
T Consensus       228 l~t~~~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         228 IATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            9998 5899999998888776654 4567788999999999999999999999999999999987643

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-54  Score=404.01  Aligned_cols=257  Identities=25%  Similarity=0.546  Sum_probs=215.4

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCc----eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQ----DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      ...+|++.+.||+|+||+||+|.+  +|+    .||||.++....        ....+.|.+|+.++++++|||||+++|
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~g   78 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLLG   78 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            346799999999999999999987  444    588888753221        112456889999999999999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      ++.+.. .                ++++||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        79 ~~~~~~-~----------------~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~  140 (317)
T d1xkka_          79 ICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR  140 (317)
T ss_dssp             EEESSS-E----------------EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             EEecCC-e----------------eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh
Confidence            997653 2                6889999999999988654 568999999999999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCc--ccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHD--MTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS  327 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~Pf~~~~~~  327 (404)
                      ||||+.++.+||+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..
T Consensus       141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             cceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            999999999999999999865443322  233468999999999999999999999999999999998 89999998887


Q ss_pred             HHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          328 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      ++...+ ..+.++..|..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       221 ~~~~~i-~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         221 EISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             GHHHHH-HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHH-HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            776554 4556677888999999999999999999999999999999988753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.7e-53  Score=407.12  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEec
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMG  174 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  174 (404)
                      ..++|.+.+.||+|+||.||+|++  +|+.||||+++......   ...........+|+.+++.++|||||++++++.+
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~---~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~   78 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM---KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT   78 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch---hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence            357899999999999999999998  68999999996321100   0001111223345778888899999999999988


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ...+                |+|||||+||+|.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus        79 ~~~~----------------~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl  140 (364)
T d1omwa3          79 PDKL----------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL  140 (364)
T ss_dssp             SSEE----------------EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCEE----------------EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence            7766                8999999999999999664  578999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccCCCCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          255 DKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       255 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      +.++.+||+|||+|+.....  ......||+.|||||++. +..|+.++|||||||++|||++|..||...+..+.....
T Consensus       141 ~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         141 DEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             CSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             cCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999999999854432  344568999999999996 456899999999999999999999999876654433222


Q ss_pred             H-hccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 015594          334 V-RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVA  373 (404)
Q Consensus       334 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~ll~  373 (404)
                      . .......++..+|+++.+||.+||+.||.+|||     +++|++
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            2 223345667789999999999999999999999     688875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=402.79  Aligned_cols=248  Identities=18%  Similarity=0.291  Sum_probs=216.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||+++....      +    ...+.+|+.+|++++|||||+++++|.+.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------D----QVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------H----HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------c----HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            47899999999999999999998  689999999975321      1    23477999999999999999999999987


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..+                |+|||||+||+|.+++.+. ...+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus        74 ~~~----------------~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~  136 (321)
T d1tkia_          74 EEL----------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ  136 (321)
T ss_dssp             TEE----------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred             CEE----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence            766                9999999999999998543 34799999999999999999999999999999999999997


Q ss_pred             C--CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 015594          256 K--TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV  333 (404)
Q Consensus       256 ~--~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~  333 (404)
                      .  ...+||+|||+++.... ........+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+....+
T Consensus       137 ~~~~~~ikl~DFG~~~~~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i  215 (321)
T d1tkia_         137 TRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI  215 (321)
T ss_dssp             SSSCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CCCceEEEEcccchhhcccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            4  45899999999986433 23344567899999999999999999999999999999999999999999999888888


Q ss_pred             HhccCCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          334 VRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       334 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....+...  .+..+++++.+||.+||+.||.+|||++|+++
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            77655432  23568999999999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=392.93  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=211.5

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|.+  +|+.||||+++.....       ......+.+|+.++++++|||||++++++.+..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-------hHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence            6899999999999999999998  5899999999643221       122456889999999999999999999999877


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .+                |+||||+ ++.+.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        75 ~~----------------~iv~e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~  137 (298)
T d1gz8a_          75 KL----------------YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT  137 (298)
T ss_dssp             EE----------------EEEEECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             ce----------------eEEEeec-CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence            66                9999999 566666666666678999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR  335 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  335 (404)
                      ++.+||+|||+|+.............||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus       138 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~  217 (298)
T d1gz8a_         138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR  217 (298)
T ss_dssp             TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence            99999999999987666666667778999999999987765 58899999999999999999999998887776665543


Q ss_pred             ccCC----------------CCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          336 QNLR----------------PEI-----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       336 ~~~~----------------~~~-----------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                ...           ...+++++.+||.+||+.||++|||++||++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            2110                000           1245789999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=399.10  Aligned_cols=262  Identities=30%  Similarity=0.538  Sum_probs=221.6

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE--CCc--eEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc-CCCceeEEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY--DGQ--DVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL-DHPNVTKFIG  170 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~  170 (404)
                      |+.++|++.++||+|+||+||+|++  +|.  .||||.++....        ....+.|.+|+.+|+++ +|||||++++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~~HpnIv~~~~   78 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLG   78 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--------hHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence            6678999999999999999999997  454  467777653221        11245688999999999 7999999999


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhc--------------ccCCCcHHHHHHHHHHHHHHHHH
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKN--------------RRRKLAFKVVIQLALDLARGLSY  236 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~  236 (404)
                      ++.+...+                |+||||+++|+|.+++.+.              ....+++..+..++.||+.||.|
T Consensus        79 ~~~~~~~~----------------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~  142 (309)
T d1fvra_          79 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  142 (309)
T ss_dssp             EEEETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             EEecCCee----------------EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence            99987766                8999999999999999653              23679999999999999999999


Q ss_pred             HhhCCceecccCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHh
Q 015594          237 LQSKKIVHRDVKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYC  316 (404)
Q Consensus       237 LH~~givH~Dikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  316 (404)
                      ||++||+||||||+|||++.++.+||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++
T Consensus       143 lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~  221 (309)
T d1fvra_         143 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS  221 (309)
T ss_dssp             HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             hhcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHh
Confidence            99999999999999999999999999999999753322 22334568999999999999999999999999999999999


Q ss_pred             CC-CCCCCCCHHHHHHHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          317 CD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       317 g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      |. .||.+.+..++...+. ...++..+..+++++.+||.+||+.||++|||+++|++.|+++.....
T Consensus       222 ~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         222 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             TSCCTTTTCCHHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             cCCCCCCCCCHHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            65 6898888888776654 456778888999999999999999999999999999999999987654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=395.08  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=204.4

Q ss_pred             EeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcccc
Q 015594          103 IKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSELNI  180 (404)
Q Consensus       103 ~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~i  180 (404)
                      ..++||+|+||+||+|.+  +|+.||||+++.......    .......+.+|+.++++++|||||++++++.+...+  
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~--   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI--   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC--
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh----hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce--
Confidence            357899999999999997  689999999975432211    112345688999999999999999999999888766  


Q ss_pred             ccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCCCcE
Q 015594          181 QTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKTRTV  260 (404)
Q Consensus       181 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~~~v  260 (404)
                                    |+||||+.++++..++  ..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        76 --------------~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~  139 (299)
T d1ua2a_          76 --------------SLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL  139 (299)
T ss_dssp             --------------EEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             --------------eehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcc
Confidence                          8999999877666554  334679999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 015594          261 KIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR  339 (404)
Q Consensus       261 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~  339 (404)
                      ||+|||+|+............+||+.|+|||++.+. .|+.++|||||||++|||++|..||...+..+....+......
T Consensus       140 KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~  219 (299)
T d1ua2a_         140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  219 (299)
T ss_dssp             EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence            999999998766655556667899999999998654 6899999999999999999999999998888877666542111


Q ss_pred             C---------------------C-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          340 P---------------------E-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       340 ~---------------------~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +                     .     ....+++++.+||.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0                     0     01346789999999999999999999999976

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=399.74  Aligned_cols=249  Identities=21%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             CCCeEEee-eeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhh-cCCCceeEEEEEEe
Q 015594           98 PAKLIIKG-AFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHK-LDHPNVTKFIGATM  173 (404)
Q Consensus        98 ~~~~~~~~-~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~  173 (404)
                      .++|.+.+ .||+|+||+||+|++  +|+.||||+++..              ..+.+|+.++.+ ++|||||+++++|.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            36788765 699999999999997  6899999999631              235678988655 48999999999987


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENML  253 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nil  253 (404)
                      +....            ...+|+|||||+||+|.+++.+.....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        76 ~~~~~------------~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIl  143 (335)
T d2ozaa1          76 NLYAG------------RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL  143 (335)
T ss_dssp             EEETT------------EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             ecccC------------CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccc
Confidence            53111            123499999999999999997655567999999999999999999999999999999999999


Q ss_pred             EcC---CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          254 LDK---TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       254 i~~---~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      ++.   .+.+||+|||+|+.... ........||+.|||||++.+..|+.++|||||||++|+|+||..||.+.+..+..
T Consensus       144 l~~~~~~~~~Kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~  222 (335)
T d2ozaa1         144 YTSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  222 (335)
T ss_dssp             ESCSSTTCCEEECCCTTCEECCC-CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred             cccccccccccccccceeeeccC-CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence            975   56799999999986443 33445678999999999999999999999999999999999999999877655544


Q ss_pred             HHHHhccCCC--CCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRP--EIP----RCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~--~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+.......  .++    ..+|+++.+||.+||+.||++|||+.++++
T Consensus       223 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            4433322211  122    357899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-52  Score=389.01  Aligned_cols=258  Identities=32%  Similarity=0.513  Sum_probs=211.0

Q ss_pred             eEEeeeeeeecceEEEEEEEC---C--ceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594          101 LIIKGAFARGTFGTVHRGIYD---G--QDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~~---g--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      +.+.++||+|+||+||+|++.   +  ..||||.++...    .    ......|.+|+.+|++++||||++++|++...
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~  100 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----D----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  100 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----C----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----C----HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence            344688999999999999972   2  368999986322    1    12246689999999999999999999998654


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ..               .+++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||||+
T Consensus       101 ~~---------------~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~  164 (311)
T d1r0pa_         101 EG---------------SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD  164 (311)
T ss_dssp             TT---------------EEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CC---------------ceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC
Confidence            32               13899999999999998854 355788899999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC----CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~-~~~~~~  330 (404)
                      +++.+||+|||+++......    .......||+.|+|||.+.+..++.++||||||+++|||+||..||... +..+..
T Consensus       165 ~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~  244 (311)
T d1r0pa_         165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  244 (311)
T ss_dssp             TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred             CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            99999999999998543322    2223456899999999999999999999999999999999977776543 333443


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .. +..+.++..|..+++++.+||.+||+.||++||++.||++.|+.+..+.-
T Consensus       245 ~~-i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         245 VY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             HH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HH-HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence            44 44556777888999999999999999999999999999999999987643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-51  Score=381.64  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             CCeEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      ++|.+.++||+|+||+||+|.+ +|+.||||+++.......       ...++.+|+.++++++||||+++++++.+...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-------IPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-------CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH-------HHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            6899999999999999999998 689999999976533211       13457899999999999999999999998877


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcCC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDKT  257 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~~  257 (404)
                      .                |+++||+.++.+..+. . ..+.+++..+..++.||+.||+|||+.||+||||||+||||+.+
T Consensus        75 ~----------------~i~~e~~~~~~~~~~~-~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~  136 (286)
T d1ob3a_          75 L----------------VLVFEHLDQDLKKLLD-V-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE  136 (286)
T ss_dssp             E----------------EEEEECCSEEHHHHHH-T-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             e----------------eEEEEeehhhhHHHHH-h-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC
Confidence            6                8999999666555554 3 34789999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          258 RTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       258 ~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      +.+||+|||.+..............+++.|+|||.+.+. .++.++|||||||++|||++|..||.+.+..+....+...
T Consensus       137 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~  216 (286)
T d1ob3a_         137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI  216 (286)
T ss_dssp             SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999999999998765555555666799999999998654 5799999999999999999999999988877766554431


Q ss_pred             cCC---------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...                           ......+++++.+||.+||+.||++|||++|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110                           1123557889999999999999999999999974

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=386.91  Aligned_cols=262  Identities=32%  Similarity=0.468  Sum_probs=209.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCcc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSEL  178 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  178 (404)
                      .+|.+.+.||+|+||+||+|+++|+.||||+++...     ..     ...+..|+..+.+++|||||++++++.+....
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~-----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh-----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            468999999999999999999999999999985321     11     12233566666788999999999999765432


Q ss_pred             ccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh--------CCceecccCCC
Q 015594          179 NIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS--------KKIVHRDVKTE  250 (404)
Q Consensus       179 ~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~givH~Dikp~  250 (404)
                                  ...+|+||||+++|+|.+++.+.   ++++..++.++.|++.||.|||+        +||+||||||+
T Consensus        73 ------------~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~  137 (303)
T d1vjya_          73 ------------WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK  137 (303)
T ss_dssp             ------------SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred             ------------ceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence                        11248999999999999999653   69999999999999999999996        59999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCC----cccCCCCCccccCccccCCCC------CCcchhhHHHHHHHHHHHhCCCC
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPH----DMTGETGTLGYMAPEVLNGSA------YNRKCDVYSFGICLWEIYCCDMP  320 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~P  320 (404)
                      ||||+.++.+||+|||+++.......    ......||+.|||||++.+..      ++.++|||||||++|||+||..|
T Consensus       138 NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~  217 (303)
T d1vjya_         138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  217 (303)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred             ceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence            99999999999999999986544332    233467999999999987653      56789999999999999999877


Q ss_pred             CCC---------------CCHHHHHHHHHhccCCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHh
Q 015594          321 YPD---------------LSFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDT  380 (404)
Q Consensus       321 f~~---------------~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~  380 (404)
                      |..               .+............+++.++..     ++..+.+||.+||+.||.+|||+.+|++.|+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            632               1233444444555566655543     23568999999999999999999999999999998


Q ss_pred             hcCCC
Q 015594          381 SKGGG  385 (404)
Q Consensus       381 ~~~~~  385 (404)
                      +.|..
T Consensus       298 ~~~~~  302 (303)
T d1vjya_         298 QEGIK  302 (303)
T ss_dssp             HHCCC
T ss_pred             hcCCC
Confidence            87753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=384.04  Aligned_cols=245  Identities=22%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC--CCceeEEEEEEe
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD--HPNVTKFIGATM  173 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~  173 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++..........   ....++.+|+.++++++  |||||++++++.
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh---hHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            36899999999999999999998  689999999975432211100   00123568999999996  899999999998


Q ss_pred             cCCccccccCCCCCCCCCCceEEEEeccCC-CCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          174 GTSELNIQTDNGHIGMPSNFCCVVVEYCHG-GALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       174 ~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      +....                |+||||+.+ +++.+++.+.  ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus        80 ~~~~~----------------~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI  141 (273)
T d1xwsa_          80 RPDSF----------------VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI  141 (273)
T ss_dssp             CSSEE----------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             eCCeE----------------EEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccce
Confidence            87766                899999976 5777877554  5799999999999999999999999999999999999


Q ss_pred             EEcC-CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          253 LLDK-TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       253 li~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      |++. ++.+||+|||+|+....  ...+...||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+     
T Consensus       142 ll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----  214 (273)
T d1xwsa_         142 LIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----  214 (273)
T ss_dssp             EEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             EEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence            9985 47999999999975432  33456789999999999987654 678999999999999999999997532     


Q ss_pred             HHHHhccCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                       .+...  ...++..+|+++.+||.+||+.||++|||++|+++
T Consensus       215 -~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 -EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             23333  23466789999999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=380.86  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=205.2

Q ss_pred             CCeEEeeeeeeecceEEEEEEE---CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhc---CCCceeEEEEEE
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY---DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKL---DHPNVTKFIGAT  172 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~  172 (404)
                      ++|++.+.||+|+||+||+|++   +++.||||+++........       ...+.+|+.+++.|   +||||++++++|
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~   79 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDVC   79 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-------HHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence            6899999999999999999997   2578999999754322211       11244677766665   899999999998


Q ss_pred             ecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCE
Q 015594          173 MGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENM  252 (404)
Q Consensus       173 ~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Ni  252 (404)
                      ......           ....++++|||++++.+.. ........+++..++.++.||+.||+|||++||+||||||+||
T Consensus        80 ~~~~~~-----------~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NI  147 (305)
T d1blxa_          80 TVSRTD-----------RETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI  147 (305)
T ss_dssp             EEEECS-----------SEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             cccccc-----------cCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEE
Confidence            643211           1123489999997766544 3344567899999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 015594          253 LLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA  332 (404)
Q Consensus       253 li~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~  332 (404)
                      |++.++.+||+|||++.... .........||+.|+|||++.+.+|+.++|||||||++|||++|..||.+.+..+....
T Consensus       148 Li~~~~~~kl~dfg~~~~~~-~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  226 (305)
T d1blxa_         148 LVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  226 (305)
T ss_dssp             EECTTCCEEECSCCSCCCCC-GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EEcCCCCeeecchhhhhhhc-ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999999999999997533 23345567899999999999999999999999999999999999999999988777766


Q ss_pred             HHhccCC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          333 VVRQNLR-------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       333 ~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +......                         ...+..+++++.+||.+||+.||++|||++|+++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            5432100                         1234567899999999999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=377.63  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=209.8

Q ss_pred             ccccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 015594           89 VRRQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVT  166 (404)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  166 (404)
                      .....|++ .++|++.+.||+|+||+||+|.+  +|+.||||+++.....       ....+.+.+|+.+|++++|||||
T Consensus         9 ~~~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~hpniv   80 (346)
T d1cm8a_           9 VTKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMRHENVI   80 (346)
T ss_dssp             CSSSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCBTTBC
T ss_pred             ccCceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-------hHHHHHHHHHHHHHHhcCCCCee
Confidence            33445677 58999999999999999999998  5999999999643321       12345678999999999999999


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecc
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRD  246 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~D  246 (404)
                      +++++|........          ...+|+||||+ +.+|..++..   ..+++..++.++.||+.||.|||++||+|||
T Consensus        81 ~l~~~~~~~~~~~~----------~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrD  146 (346)
T d1cm8a_          81 GLLDVFTPDETLDD----------FTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD  146 (346)
T ss_dssp             CCSEEECSCSSTTT----------CCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             EEEEEeccCccccc----------cceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence            99999987664321          22348999999 7778777643   4799999999999999999999999999999


Q ss_pred             cCCCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          247 VKTENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       247 ikp~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                      |||+|||++.++.+||+|||+|+...   ...+...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       147 iKp~NIL~~~~~~~kl~Dfg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         147 LKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECC---SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCcchhhcccccccccccccceeccC---CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence            99999999999999999999997543   33456789999999999866 457899999999999999999999999887


Q ss_pred             HHHHHHHHHhccCC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--
Q 015594          326 FSEVTSAVVRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAM--  374 (404)
Q Consensus       326 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~--  374 (404)
                      ..............                             ......+++++.+||.+||..||.+|||++|+++.  
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~  303 (346)
T d1cm8a_         224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  303 (346)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence            66654443321110                             11234578999999999999999999999999873  


Q ss_pred             HHHh
Q 015594          375 LEAI  378 (404)
Q Consensus       375 L~~~  378 (404)
                      |+.+
T Consensus       304 f~~~  307 (346)
T d1cm8a_         304 FESL  307 (346)
T ss_dssp             GTTT
T ss_pred             hCcC
Confidence            5443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-49  Score=371.11  Aligned_cols=256  Identities=22%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEE-ecC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGAT-MGT  175 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~  175 (404)
                      ++|++.+.||+|+||+||+|++  +|+.||||++......           ..+.+|+.+++.++|+|++..+..+ .+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----------HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            5799999999999999999997  5899999998754322           1256899999999877755554444 443


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      ...                ++||||+ +++|.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus        76 ~~~----------------~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~  137 (299)
T d1ckia_          76 DYN----------------VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG  137 (299)
T ss_dssp             TEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             CEE----------------EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence            333                8999999 77777766443 46799999999999999999999999999999999999985


Q ss_pred             ---CCCcEEEeeccccccccCCC-------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 015594          256 ---KTRTVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLS  325 (404)
Q Consensus       256 ---~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~  325 (404)
                         .+..+||+|||+|+......       .......||+.|||||++.+..++.++|||||||++|||++|..||....
T Consensus       138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence               45679999999998654322       12334579999999999999999999999999999999999999998766


Q ss_pred             HHHHHHHHH---hc---cCCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          326 FSEVTSAVV---RQ---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       326 ~~~~~~~~~---~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      .......+.   ..   ...+.....+|+++.+||.+||+.||++||++++|.++|+.+....+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            544332221   11   11122346789999999999999999999999999999999877655

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=376.84  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             cccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEE
Q 015594           94 WEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGA  171 (404)
Q Consensus        94 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  171 (404)
                      |++. ++|++.+.||+|+||+||+|++  +|+.||||+++....        ......+.+|+.+|++++||||++++++
T Consensus         4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~Ei~il~~l~hp~iv~~~~~   74 (345)
T d1pmea_           4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGINDI   74 (345)
T ss_dssp             CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--------hHHHHHHHHHHHHHHHcCCCCCCcEEEE
Confidence            4453 5799999999999999999997  699999999964321        2224567899999999999999999999


Q ss_pred             EecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCC
Q 015594          172 TMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTEN  251 (404)
Q Consensus       172 ~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~N  251 (404)
                      +.......           ...+|+ ++|+.+|+|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus        75 ~~~~~~~~-----------~~~~~l-~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~N  139 (345)
T d1pmea_          75 IRAPTIEQ-----------MKDVYL-VTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN  139 (345)
T ss_dssp             ECCSSTTT-----------CCCEEE-EEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             Eeeccccc-----------cceEEE-EEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcce
Confidence            87654321           122244 455669999999854   369999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccCC---CCcccCCCCCccccCccccC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          252 MLLDKTRTVKIADFGVARLEASN---PHDMTGETGTLGYMAPEVLN-GSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       252 ili~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      |||+.++.+||+|||++......   .......+||+.|+|||++. +..++.++||||+||++|+|++|..||...+..
T Consensus       140 ILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~  219 (345)
T d1pmea_         140 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL  219 (345)
T ss_dssp             EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH
Confidence            99999999999999999753332   12234567999999999984 456799999999999999999999999887765


Q ss_pred             HHHHHHHhccC----------------------CC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          328 EVTSAVVRQNL----------------------RP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       328 ~~~~~~~~~~~----------------------~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +..........                      ..       .....+++++.+||.+||+.||.+|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            55444322110                      00       112356789999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.3e-49  Score=365.93  Aligned_cols=257  Identities=18%  Similarity=0.281  Sum_probs=211.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC-CceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~  174 (404)
                      ..+|++.+.||+|+||+||+|++  +|+.||||+++.....           ..+.+|+.++..+.| +|++.+++++..
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----------HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            46899999999999999999997  6899999998654322           124578888888865 899999998877


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      ....                |+||||+ +++|.+++... ...++...+..++.|++.||.|||++||+||||||+||||
T Consensus        73 ~~~~----------------~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili  134 (293)
T d1csna_          73 GLHN----------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI  134 (293)
T ss_dssp             TTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             CCcc----------------EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence            6655                8999999 89999988553 4679999999999999999999999999999999999999


Q ss_pred             cC-----CCcEEEeeccccccccCCC-------CcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 015594          255 DK-----TRTVKIADFGVARLEASNP-------HDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYP  322 (404)
Q Consensus       255 ~~-----~~~vkL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~  322 (404)
                      +.     .+.+||+|||+|+......       .......||+.|||||++.+..++.++||||||+++|||++|..||.
T Consensus       135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            64     5789999999998644321       12334579999999999999999999999999999999999999998


Q ss_pred             CCCHH---HHHHHHHhcc---CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHhHhhcC
Q 015594          323 DLSFS---EVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVAMLEAIDTSKG  383 (404)
Q Consensus       323 ~~~~~---~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~~L~~~~~~~~  383 (404)
                      +....   +....+....   ...+....+|+++.+||..||..+|++||+++.|.+.|+++....+
T Consensus       215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            65432   2222222211   1123346789999999999999999999999999999999887665

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=376.18  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=203.8

Q ss_pred             CeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCCc
Q 015594          100 KLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTSE  177 (404)
Q Consensus       100 ~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  177 (404)
                      +|...++||+|+||+||+|++  +|+.||||++......             +.+|+.+|++++||||++++++|.....
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------------~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------------HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            699999999999999999998  6899999999754322             2369999999999999999999865432


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHH-hcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLI-KNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      .          ....++|+|||||+++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus        88 ~----------~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~  157 (350)
T d1q5ka_          88 K----------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP  157 (350)
T ss_dssp             C----------CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred             c----------CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec
Confidence            1          12234589999996554333322 123467999999999999999999999999999999999999987


Q ss_pred             CC-cEEEeeccccccccCCCCcccCCCCCccccCccccCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 015594          257 TR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNG-SAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV  334 (404)
Q Consensus       257 ~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~  334 (404)
                      ++ .+||+|||+++.... ........||+.|+|||.+.+ ..|+.++|||||||++|||++|..||...+..+....+.
T Consensus       158 ~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~  236 (350)
T d1q5ka_         158 DTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  236 (350)
T ss_dssp             TTCCEEECCCTTCEECCT-TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred             CCCceeEecccchhhccC-CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence            75 899999999976433 334455789999999998865 468999999999999999999999999888777665554


Q ss_pred             hcc-------------------CC--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHhH
Q 015594          335 RQN-------------------LR--------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLEAID  379 (404)
Q Consensus       335 ~~~-------------------~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~~~~  379 (404)
                      ...                   +.        ......+++++.+||.+||+.||++|||+.|+++  .|+.+.
T Consensus       237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            210                   00        0112357889999999999999999999999985  455553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=370.19  Aligned_cols=259  Identities=22%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecC
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGT  175 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  175 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||++........       ...++.+|+.+|++++||||+++++++...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-------FPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-------HHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            47999999999999999999998  689999999865433221       134467999999999999999999999765


Q ss_pred             CccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEc
Q 015594          176 SELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLD  255 (404)
Q Consensus       176 ~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~  255 (404)
                      .....        ...+.+|+||||+.++.+..+.  .....+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus        82 ~~~~~--------~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~  151 (318)
T d3blha1          82 ASPYN--------RCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT  151 (318)
T ss_dssp             -----------------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             ccccc--------ccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec
Confidence            44321        2234569999999666555433  4456899999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccCCC----CcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 015594          256 KTRTVKIADFGVARLEASNP----HDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT  330 (404)
Q Consensus       256 ~~~~vkL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~  330 (404)
                      .++.+||+|||+++......    ......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+..
T Consensus       152 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~  231 (318)
T d3blha1         152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL  231 (318)
T ss_dssp             TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence            99999999999997544221    223345799999999998765 6899999999999999999999999988777666


Q ss_pred             HHHHhccCC--CCCCC----------------------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          331 SAVVRQNLR--PEIPR----------------------------CCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       331 ~~~~~~~~~--~~~~~----------------------------~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ..+......  +....                            ..++++.+||.+||+.||++|||++|+++
T Consensus       232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            554432111  11100                            12567889999999999999999999984

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=363.59  Aligned_cols=250  Identities=22%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      ++|++.+.||+|+||+||+|++  +|+.||||+++......       ....++.+|+.+++.++||||+++++++.+..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-------HHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence            5899999999999999999998  68999999997654322       12456789999999999999999999999887


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..                ++|+|++.+++|..++..  .+.+++..++.++.|++.||+|||++||+||||||+||||+.
T Consensus        75 ~~----------------~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~  136 (292)
T d1unla_          75 KL----------------TLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR  136 (292)
T ss_dssp             EE----------------EEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred             ce----------------eEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc
Confidence            76                899999988888877643  467899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCC-CCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSA-YNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVTSAVV  334 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~Pf-~~~~~~~~~~~~~  334 (404)
                      ++.+||+|||.++.............+++.|+|||++.+.. ++.++|||||||++|||++|..|| ...+..+....+.
T Consensus       137 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~  216 (292)
T d1unla_         137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_dssp             TCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred             CCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence            99999999999987666655666667889999999987765 689999999999999999999886 4445454444433


Q ss_pred             hccC---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          335 RQNL---------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       335 ~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ....                           .......+++++.+||.+||+.||.+|||++|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2111                           11233456889999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=374.08  Aligned_cols=255  Identities=21%  Similarity=0.356  Sum_probs=209.5

Q ss_pred             cCCCCeEEeeeeeeecceEEEEEEE-----CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCC-CceeEEE
Q 015594           96 IDPAKLIIKGAFARGTFGTVHRGIY-----DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDH-PNVTKFI  169 (404)
Q Consensus        96 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~  169 (404)
                      +..++|++.+.||+|+||+||+|.+     +|+.||||+++........     ...+.+.+|+.++++++| |||++++
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~~~E~~il~~l~h~pnIv~~~   95 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLH   95 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch-----HHHHHHHHHHHHHHhccCCCeEEEee
Confidence            3458899999999999999999986     4789999998653211110     012346789999999966 8999999


Q ss_pred             EEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCC
Q 015594          170 GATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKT  249 (404)
Q Consensus       170 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp  249 (404)
                      +++.+...+                ++||||+.+|+|.+++...  +.+++..+..++.||+.||.|||++||+||||||
T Consensus        96 ~~~~~~~~~----------------~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp  157 (322)
T d1vzoa_          96 YAFQTETKL----------------HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL  157 (322)
T ss_dssp             EEEEETTEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             eeeccCCce----------------eeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCc
Confidence            999888766                8999999999999998665  5688999999999999999999999999999999


Q ss_pred             CCEEEcCCCcEEEeeccccccccCC-CCcccCCCCCccccCccccCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Q 015594          250 ENMLLDKTRTVKIADFGVARLEASN-PHDMTGETGTLGYMAPEVLNGS--AYNRKCDVYSFGICLWEIYCCDMPYPDLSF  326 (404)
Q Consensus       250 ~Nili~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~Pf~~~~~  326 (404)
                      +||||+.++.+||+|||+++..... ........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||...+.
T Consensus       158 ~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~  237 (322)
T d1vzoa_         158 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE  237 (322)
T ss_dssp             GGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred             cceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999754332 3334456799999999999765  478899999999999999999999987655


Q ss_pred             HHHHHHHHhc--cCCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 015594          327 SEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVA  373 (404)
Q Consensus       327 ~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~ll~  373 (404)
                      .+....+...  ...+.++..+++++.+||.+||+.||++||     |++|+++
T Consensus       238 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         238 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            5444444332  234556778999999999999999999998     5888875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-48  Score=366.36  Aligned_cols=244  Identities=18%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             CCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEec
Q 015594           98 PAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMG  174 (404)
Q Consensus        98 ~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  174 (404)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++...            .+.+.+|+.+|+.+. ||||++++++|..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~  101 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD  101 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence            46899999999999999999998  68999999986322            234678999999995 9999999999975


Q ss_pred             CCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEE
Q 015594          175 TSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLL  254 (404)
Q Consensus       175 ~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili  254 (404)
                      .....              +++|||||.+++|..+.     +.+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       102 ~~~~~--------------~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi  162 (328)
T d3bqca1         102 PVSRT--------------PALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  162 (328)
T ss_dssp             TTTCS--------------EEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             cCCCc--------------eeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence            54322              38999999999997653     469999999999999999999999999999999999999


Q ss_pred             cCCC-cEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Q 015594          255 DKTR-TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTS  331 (404)
Q Consensus       255 ~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~-~~~~  331 (404)
                      +.++ .+||+|||+|+.... ........+|+.|+|||.+.+. .++.++|||||||++|+|++|..||...... +...
T Consensus       163 ~~~~~~vkl~DFG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~  241 (328)
T d3bqca1         163 DHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  241 (328)
T ss_dssp             ETTTTEEEECCGGGCEECCT-TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             cCCCCeeeecccccceeccC-CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence            8655 699999999975433 3345567899999999998765 4799999999999999999999999765422 1111


Q ss_pred             HHHh-------------cc----------------------CCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          332 AVVR-------------QN----------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       332 ~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      .+..             ..                      ........+++++.+||.+||..||.+|||++|+++
T Consensus       242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1110             00                      011122346889999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=371.45  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=209.1

Q ss_pred             ccccccCCCCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEE
Q 015594           91 RQEWEIDPAKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKF  168 (404)
Q Consensus        91 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  168 (404)
                      ...|++ +++|++.+.||+|+||+||+|++  +|+.||||+++......       .....+.+|+.++++++|||||++
T Consensus        11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~Ei~il~~l~h~~iv~~   82 (348)
T d2gfsa1          11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-------IHAKRTYRELRLLKHMKHENVIGL   82 (348)
T ss_dssp             SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-------HHHHHHHHHHHHHHhcCCCCeeeE
Confidence            345777 58899999999999999999997  69999999997543221       123457899999999999999999


Q ss_pred             EEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccC
Q 015594          169 IGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVK  248 (404)
Q Consensus       169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dik  248 (404)
                      ++++.......          ..+ .+++|+|+.+|+|.+++..   +++++..++.++.||+.||.|||++||+|||||
T Consensus        83 ~~~~~~~~~~~----------~~~-~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK  148 (348)
T d2gfsa1          83 LDVFTPARSLE----------EFN-DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  148 (348)
T ss_dssp             SEEECSCSSTT----------TCC-CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             EEEEeeccccc----------cCc-eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence            99987554321          111 2455667779999998843   479999999999999999999999999999999


Q ss_pred             CCCEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCccccCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Q 015594          249 TENMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGS-AYNRKCDVYSFGICLWEIYCCDMPYPDLSFS  327 (404)
Q Consensus       249 p~Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~Pf~~~~~~  327 (404)
                      |+|||++.++.+|++|||++....   .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus       149 p~NILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~  225 (348)
T d2gfsa1         149 PSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI  225 (348)
T ss_dssp             GGGEEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CccccccccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999996432   334557789999999987665 4689999999999999999999999988877


Q ss_pred             HHHHHHHhccCCC---------------------C--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHH
Q 015594          328 EVTSAVVRQNLRP---------------------E--------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVA--MLE  376 (404)
Q Consensus       328 ~~~~~~~~~~~~~---------------------~--------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~--~L~  376 (404)
                      .....+......+                     .        ....+++++.+||.+||..||.+|||++|+++  .|+
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence            6666554332111                     0        11357889999999999999999999999987  455


Q ss_pred             Hh
Q 015594          377 AI  378 (404)
Q Consensus       377 ~~  378 (404)
                      .+
T Consensus       306 ~~  307 (348)
T d2gfsa1         306 QY  307 (348)
T ss_dssp             TT
T ss_pred             CC
Confidence            44

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=369.05  Aligned_cols=252  Identities=22%  Similarity=0.302  Sum_probs=194.9

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcCCCceeEEEEEEecCC
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGTS  176 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  176 (404)
                      .+|++.++||+|+||+||+|.+  +|+.||||++......       .....++.+|+.++++++|||||+++++|....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            5799999999999999999998  5999999999754322       122456789999999999999999999997554


Q ss_pred             ccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCCCEEEcC
Q 015594          177 ELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTENMLLDK  256 (404)
Q Consensus       177 ~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~Nili~~  256 (404)
                      ..          ...+.+|+||||+.+ ++.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        90 ~~----------~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~  154 (355)
T d2b1pa1          90 TL----------EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  154 (355)
T ss_dssp             ST----------TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             cc----------ccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc
Confidence            32          223456999999955 5555442    46899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 015594          257 TRTVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ  336 (404)
Q Consensus       257 ~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~  336 (404)
                      ++.+|++|||+++.... ....+...+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus       155 ~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         155 DCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             TCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ccceeeechhhhhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999875433 34445567999999999999999999999999999999999999999988766655544321


Q ss_pred             cCCC---------------------C-------------C------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 015594          337 NLRP---------------------E-------------I------PRCCPSSLANVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       337 ~~~~---------------------~-------------~------~~~~~~~l~~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      ...+                     .             .      ....++++.+||.+||..||++|||++||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1100                     0             0      0113567899999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-41  Score=325.71  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=186.1

Q ss_pred             CCeEEeeeeeeecceEEEEEEE--CCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-----------CCce
Q 015594           99 AKLIIKGAFARGTFGTVHRGIY--DGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-----------HPNV  165 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpni  165 (404)
                      .+|++.++||+|+||+||+|++  +|+.||||+++...          .....+.+|+.+++.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            5699999999999999999997  68999999996321          11244567888877775           5789


Q ss_pred             eEEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCC-CHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh-CCce
Q 015594          166 TKFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGG-ALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS-KKIV  243 (404)
Q Consensus       166 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~giv  243 (404)
                      +++++++........              +++|+++..+ .............+++..+..++.||+.||.|||+ .||+
T Consensus        83 v~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~Iv  148 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGV--------------HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII  148 (362)
T ss_dssp             CCCCEEEEEEETTEE--------------EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred             EEEEEEeeeccccce--------------eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcc
Confidence            999988865433221              4555555444 34444445556789999999999999999999998 8999


Q ss_pred             ecccCCCCEEEcCCC------cEEEeeccccccccCCCCcccCCCCCccccCccccCCCCCCcchhhHHHHHHHHHHHhC
Q 015594          244 HRDVKTENMLLDKTR------TVKIADFGVARLEASNPHDMTGETGTLGYMAPEVLNGSAYNRKCDVYSFGICLWEIYCC  317 (404)
Q Consensus       244 H~Dikp~Nili~~~~------~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g  317 (404)
                      ||||||+||||+.++      .++|+|||.+.....   ......||+.|+|||++.+..++.++||||+||++++|++|
T Consensus       149 HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g  225 (362)
T d1q8ya_         149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG  225 (362)
T ss_dssp             CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHC
Confidence            999999999997654      399999999975433   23456799999999999999999999999999999999999


Q ss_pred             CCCCCCCCHH------HHHHHHHh--c------------------------c--------------CCCCCCCCCcHHHH
Q 015594          318 DMPYPDLSFS------EVTSAVVR--Q------------------------N--------------LRPEIPRCCPSSLA  351 (404)
Q Consensus       318 ~~Pf~~~~~~------~~~~~~~~--~------------------------~--------------~~~~~~~~~~~~l~  351 (404)
                      ..||......      +.......  .                        .              .....+...++++.
T Consensus       226 ~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
T d1q8ya_         226 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS  305 (362)
T ss_dssp             SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred             CCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHH
Confidence            9999754321      11111100  0                        0              00111223467899


Q ss_pred             HHHHHhhhhCCCCCCCHHHHHH
Q 015594          352 NVMKRCWDANPDKRPEMDEVVA  373 (404)
Q Consensus       352 ~li~~cl~~dP~~Rpt~~~ll~  373 (404)
                      +||.+||..||.+|||++|+++
T Consensus       306 dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         306 DFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.3e-26  Score=199.42  Aligned_cols=172  Identities=16%  Similarity=0.081  Sum_probs=122.7

Q ss_pred             eEEeeeeeeecceEEEEEEE-CCceEEEEEeecCCCCc---c------cHHHHHHHHHHHHHHHHHHhhcCCCceeEEEE
Q 015594          101 LIIKGAFARGTFGTVHRGIY-DGQDVAVKLLDWGEESH---R------SEAEIASLRAAFTQEVAVWHKLDHPNVTKFIG  170 (404)
Q Consensus       101 ~~~~~~lg~G~~g~V~~~~~-~g~~vAvK~~~~~~~~~---~------~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  170 (404)
                      +.+.+.||+|+||+||+|.+ +|+.||||+++.+....   .      .............+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999987 78999999986432110   0      00111222445668999999999999998886


Q ss_pred             EEecCCccccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhhCCceecccCCC
Q 015594          171 ATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQSKKIVHRDVKTE  250 (404)
Q Consensus       171 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~givH~Dikp~  250 (404)
                      +..    .                +++|||+++..+.+         ++...+..++.||+.+|.|||++||+||||||+
T Consensus        82 ~~~----~----------------~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~  132 (191)
T d1zara2          82 WEG----N----------------AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQY  132 (191)
T ss_dssp             EET----T----------------EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred             ecC----C----------------EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChh
Confidence            531    1                68999997765432         445556789999999999999999999999999


Q ss_pred             CEEEcCCCcEEEeeccccccccCCCCcccCCCCCccccCc------cccCCCCCCcchhhHHHHHHH
Q 015594          251 NMLLDKTRTVKIADFGVARLEASNPHDMTGETGTLGYMAP------EVLNGSAYNRKCDVYSFGICL  311 (404)
Q Consensus       251 Nili~~~~~vkL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~il  311 (404)
                      |||+++++ ++|+|||.|.....+..        ..|...      +. ....|+.++|+||+.--+
T Consensus       133 NILv~~~~-~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         133 NVLVSEEG-IWIIDFPQSVEVGEEGW--------REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             SEEEETTE-EEECCCTTCEETTSTTH--------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             heeeeCCC-EEEEECCCcccCCCCCc--------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99998654 89999999975432211        111111      11 124578899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=3e-07  Score=81.14  Aligned_cols=140  Identities=11%  Similarity=0.048  Sum_probs=87.6

Q ss_pred             CCeEEeeeeeeecceEEEEEEECCceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCceeEEEEEEecCCc
Q 015594           99 AKLIIKGAFARGTFGTVHRGIYDGQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVTKFIGATMGTSE  177 (404)
Q Consensus        99 ~~~~~~~~lg~G~~g~V~~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  177 (404)
                      +.|++.+..+-++.+.||+...+++.+.||.........         ...+.+|+.++..+. +--+.+++.+..+...
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~---------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc---------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            455666655545567899988788889999875432211         112456777776663 2224556655544433


Q ss_pred             cccccCCCCCCCCCCceEEEEeccCCCCHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHhh------------------
Q 015594          178 LNIQTDNGHIGMPSNFCCVVVEYCHGGALKSYLIKNRRRKLAFKVVIQLALDLARGLSYLQS------------------  239 (404)
Q Consensus       178 ~~i~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------  239 (404)
                      .                ++||++++|.++.+.....    .   ....++.++...|..||+                  
T Consensus        85 ~----------------~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~  141 (263)
T d1j7la_          85 S----------------NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE  141 (263)
T ss_dssp             E----------------EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHH
T ss_pred             e----------------EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhh
Confidence            3                8999999888876543111    1   112233344444444442                  


Q ss_pred             -----------------------------------------CCceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          240 -----------------------------------------KKIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       240 -----------------------------------------~givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                                                               ..++|+|+.|.||++++++.+-|+||+.+..
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                     1279999999999999876667999998863

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=1.3e-05  Score=69.85  Aligned_cols=29  Identities=21%  Similarity=0.350  Sum_probs=25.6

Q ss_pred             ceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          242 IVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       242 ivH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      ++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            89999999999999876678999998863

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.44  E-value=0.00014  Score=67.65  Aligned_cols=29  Identities=21%  Similarity=0.354  Sum_probs=25.7

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      .++|+|+.|.|||+++++ ++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            599999999999998765 89999998864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.84  E-value=0.0016  Score=58.50  Aligned_cols=28  Identities=25%  Similarity=0.264  Sum_probs=23.6

Q ss_pred             CceecccCCCCEEEcCCCcEEEeecccccc
Q 015594          241 KIVHRDVKTENMLLDKTRTVKIADFGVARL  270 (404)
Q Consensus       241 givH~Dikp~Nili~~~~~vkL~Dfg~a~~  270 (404)
                      +++|+|+.+.|||++++  ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            69999999999999753  45899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.64  E-value=0.0027  Score=56.50  Aligned_cols=30  Identities=20%  Similarity=0.305  Sum_probs=27.1

Q ss_pred             CCceecccCCCCEEEcCCCcEEEeeccccc
Q 015594          240 KKIVHRDVKTENMLLDKTRTVKIADFGVAR  269 (404)
Q Consensus       240 ~givH~Dikp~Nili~~~~~vkL~Dfg~a~  269 (404)
                      .|++|+|+.++||+++++...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.59  E-value=0.0037  Score=57.67  Aligned_cols=78  Identities=18%  Similarity=0.166  Sum_probs=48.2

Q ss_pred             CCCCeEEeeeeeeecceEEEEEEEC---------CceEEEEEeecCCCCcccHHHHHHHHHHHHHHHHHHhhcC-CCcee
Q 015594           97 DPAKLIIKGAFARGTFGTVHRGIYD---------GQDVAVKLLDWGEESHRSEAEIASLRAAFTQEVAVWHKLD-HPNVT  166 (404)
Q Consensus        97 ~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  166 (404)
                      +.+.+.+ +.|+.|-.-.+|+....         .+.|.+++.-. ..   ..       ....+|..+++.+. +.-..
T Consensus        41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~---~~-------idr~~E~~i~~~ls~~gl~P  108 (395)
T d1nw1a_          41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE---TE-------SHLVAESVIFTLLSERHLGP  108 (395)
T ss_dssp             CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC---CH-------HHHHHHHHHHHHHHHTTSSS
T ss_pred             CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc---hh-------hHHHHHHHHHHHHHhCCCCC
Confidence            4455555 46777888999998763         24577777642 11   11       11246788888774 33345


Q ss_pred             EEEEEEecCCccccccCCCCCCCCCCceEEEEeccCCCCH
Q 015594          167 KFIGATMGTSELNIQTDNGHIGMPSNFCCVVVEYCHGGAL  206 (404)
Q Consensus       167 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~E~~~~g~L  206 (404)
                      ++++++.+                    .+|+||++|.+|
T Consensus       109 kll~~~~~--------------------g~I~efi~g~~l  128 (395)
T d1nw1a_         109 KLYGIFSG--------------------GRLEEYIPSRPL  128 (395)
T ss_dssp             CEEEEETT--------------------EEEECCCCEEEC
T ss_pred             eEEEEcCC--------------------ceEEEEeccccC
Confidence            77776632                    579999987544